Citrus Sinensis ID: 007261

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-
Protein Sequence
MPKLHAQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTIIHYPPPPSSPIVPTRKYNQTSSRGIYLWVGIGIGISLLVICFVLSIVLFHHKRRRDEAARKDGKREKKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQTLLLERI
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccEEEEEEccccccHHHHHHHHcccHHHHHHHHcccccccccccccEEEEEEEccccccccccccEEEEccccccEEEEEcccccccHHHHHHHHHccccccccccccEEEEEEEccccccccccccccEEEEEEccccccHHHHHHHHcccHHHHHHHcccccccccEEEEEEEEEccccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHccccHHHHccccccccccccccccccccccccccccEEHHHHHHHHccccccccccccEEEEEEcccEEEEEEccHHHHHHHHHHHHccccccccEEEEEccccEEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEcccccccccccccccccccccccccccccccccEEEcccEEcccccccHHHHHcccccccccccHHHHHHHHHHHcccccccccccccHHHHHHHHHHHccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccHHHccc
Secondary Structure Prediction (SSPRO)
cccEcccccccccccccccccccccccccccEEcccccccccEEEEEEcccccccHHHHHHHHcccHHHHHHHccccccccccccccEEEEEEEcccccccccccEEEEEEcccccEEEEEccccccccHHHHHHHcccccccccccccEEEEEEEEccccccccccccEEEEEEEccccccHHHHHHHccccHHHHHHHccccccccEEEcccccccccccccccccccccccccccccccccccccccccccHHEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHcccccEEEEEEEcccHHHHHHHHHHHHHHHHHHHHHHHHcHHHEEEEEEccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEccccHcHEEEccccccHHccccHHEEcccccccEEEEEEEEEccccccHHHHHccccccHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHccccHHcHHHHccHcHccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHHcccccccccccccc
Coil and Loop (DISEMBL)
mpklhaqqnysgnsvmdcndddengpspaflytcngnnrpcqgflifksqppydtvssisnltssdptelarvnnisnsaaalpldkevivpvscycsglyyqantsfiipTIYHTYFSIanntyqglstcnilkhennysetsldqgltlrvplrcacptsnqivnGTKFLLTYLVSwgdsvpdisKRFNVSIESIVnangfteddpllfpfttilipltteplssqtiihyppppsspivptrkynqtssrgIYLWVGIGIGISLLVICFVLSIVLFHHKRRRDEaarkdgkrekkrnlpedfLVSVSNldrglkfykyeDLVVAtenfspknmidgsvfrgIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEngslsdwlhkkrypefvswnCRFRIALDVAhglhylhnctdpgyvhkdissgnilldkNLRAKLANFSFVRSAVReesgysstktavgtngymapeymeyglvtpemdTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLvdpnlqanKKEIAHHLIMLCLACIarepesrpsMAEVVSTLMKIQLDVQRSQTLLLERI
Flexible Loop (DISEMBL)
MPKLHAQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLTSSDPTELARVNNISNsaaalpldkeVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPDISKRFNVSIESIVNangfteddpLLFPFTTILIPLTTEPLSSQTIIHyppppsspivpTRKYNQTSSRGIYLWVGIGIGISLLVICFVLSIVLfhhkrrrdeaarkdgkrekkrnlpedflvsvsnldrglkFYKYEDLVVATenfspknmidgsvFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRsavreesgysstktavgtngymAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIqldvqrsqtllleri
Low Complexity Region (SEG)
MPKLHAQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDpllfpfttilipltteplSSQTIIHYppppsspIVPTRKYNQTSSRGIYLWVgigigiSLLVICFVLSIVLFHHKRRRDEAARKDGKREKKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQTLLLERI
Disordered region (IsUnstruct)
****************************AFLYTCNGNNRPCQGFLIFKSQ****************************SAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTIIHY*****************SSRGIYLWVGIGIGISLLVICFVLSIVLFHH**********************DFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAR*************TLMKIQL*************
Disordered Region (DISOPRED)
**KLHAQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQ*****************************WVGIGIGISLLVICFVLSIVLFH************************************KFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK*************ERI
Disordered Region (DISEMBL)
*********YSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTIIHYPPPPSSPIVPTRKYNQTSSRGIYLWVGIGIGISLLVICFVLSIVLFHHKR**************KRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSA***********TAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQTLLLERI
Disordered Region (DISPRO)
MPKLHAQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTI**********************RGIYLWVGIGIGISLLVICFVLSIVLFHHKRRRD***************************RGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL*************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPKLHAQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTIIHYPPPPSSPIVPTRKYNQTSSRGIYLWVGIGIGISLLVICFVLSIVLFHHKRRRDEAARKDGKREKKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQTLLLERI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	611	2.2.26 [Sep-21-2011]
O22808	664	Protein LYK5 OS=Arabidops	yes	no	0.968	0.891	0.381	1e-100
O64825	612	LysM domain receptor-like	no	no	0.932	0.931	0.381	1e-100
D7UPN3	605	Chitin elicitor receptor	no	no	0.795	0.803	0.312	1e-48
A8R7E6	617	Chitin elicitor receptor	no	no	0.831	0.823	0.296	6e-48
O64483	876	Senescence-induced recept	no	no	0.443	0.309	0.361	5e-42
C0LGI2	929	Probable LRR receptor-lik	no	no	0.554	0.364	0.337	1e-41
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.564	0.289	0.314	1e-41
Q9FN37	1036	Phytosulfokine receptor 2	no	no	0.579	0.341	0.329	2e-41
Q9CAL2	646	Cysteine-rich receptor-li	no	no	0.530	0.501	0.356	2e-41
F4IB81	651	LysM domain receptor-like	no	no	0.454	0.427	0.354	5e-41

>sp|O22808|LYK5_ARATH Protein LYK5 OS=Arabidopsis thaliana GN=LYK5 PE=1 SV=1

 Score =  367 bits (942), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 245/642 (38%), Positives = 356/642 (55%), Gaps = 50/642 (7%)

Query: 6   AQQNYSGNSVMDCN----DDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISN 61
           AQQ Y  N  + C     D+  NG      +TCNG    C+ +L F SQPPY+T  SI+ 
Sbjct: 26  AQQPYVNNHQLACEVRVYDNITNG------FTCNGP-PSCRSYLTFWSQPPYNTADSIAK 78

Query: 62  LTSSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSGL---YYQANTSFIIPTIY--HT 116
           L +    E+  +NN+  +   +P  + V++P +C CS     +YQ N ++ +       T
Sbjct: 79  LLNVSAAEIQSINNLPTATTRIPTRELVVIPANCSCSSSSGGFYQHNATYNLSGNRGDET 138

Query: 117 YFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYL 176
           YFS+AN+TYQ LSTC  +  +N Y E  L  GL L VPLRCACPT+ Q   G K+LLTYL
Sbjct: 139 YFSVANDTYQALSTCQAMMSQNRYGERQLTPGLNLLVPLRCACPTAKQTTAGFKYLLTYL 198

Query: 177 VSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTIIHYPPP 236
           V+ GDS+  I++ FN +  +I   N  T D+  +F FT +L+PLTTEP         PPP
Sbjct: 199 VAMGDSISGIAEMFNSTSAAITEGNELTSDN--IFFFTPVLVPLTTEPTKIVISPSPPPP 256

Query: 237 PSSPIVPTRKYNQTSSRGIYLWVGIGIGISLLVICFVLSIVLFHHKRRRDEAARKDGKRE 296
           P     P    +   S   + W+ IGIGI   ++  +  + L  +KRR  + +      E
Sbjct: 257 PVVATPPQTPVDPPGSSSSHKWIYIGIGIGAGLLLLLSILALCFYKRRSKKKSLPSSLPE 316

Query: 297 K--------KRNLPE----DFLVSVSNLDR--GLK-------FYKYEDLVVATENFSPKN 335
           +        K+++P      + + +SN     GLK        Y++ DL  AT NFS +N
Sbjct: 317 ENKLFDSSTKQSIPTTTTTQWSIDLSNSSEAFGLKSAIESLTLYRFNDLQSATSNFSDEN 376

Query: 336 MIDGSVFRGIINGSTVAIKCMRRSISK-EVNLLKKINHFNLINLFGACEHDGVFYLVYEF 394
            I GSV+R  ING   A+K ++  +S  E+NLLKK+NH N+I L G C  +G  YLV+E+
Sbjct: 377 RIKGSVYRATINGDDAAVKVIKGDVSSSEINLLKKLNHSNIIRLSGFCIREGTSYLVFEY 436

Query: 395 MENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK 454
            ENGS+SDWLH     + ++W  R  IA DVA  L YLHN   P ++HK++ S NILLD 
Sbjct: 437 SENGSISDWLHSSG-KKSLTWKQRVEIARDVAEALDYLHNYITPPHIHKNLESTNILLDS 495

Query: 455 NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLE 514
           N RAK+ANF   R     +     T+   GT GY+APEY+E G++T ++D +AFGV +LE
Sbjct: 496 NFRAKIANFGVARILDEGDLDLQLTRHVEGTQGYLAPEYVENGVITSKLDVFAFGVAVLE 555

Query: 515 LITGKEAA-----YKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK-EIAHHL 568
           L++G+EA       + + E  +L + + S++ G N   KL   +DP+L      E+A+ +
Sbjct: 556 LLSGREAVTIHKKKEGEEEVEMLCKVINSVLGGENVREKLKEFMDPSLGNEYPLELAYTM 615

Query: 569 IMLCLACIAREPESRPSMAEVVSTLMKI---QLDVQRSQTLL 607
             L  +C+A +  SRPS+ +V++TL  I    +D + S  LL
Sbjct: 616 AQLAKSCVATDLNSRPSVTQVLTTLSMIVSSSIDWEPSDDLL 657

May recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands.
Arabidopsis thaliana (taxid: 3702)

>sp|O64825|LYK4_ARATH LysM domain receptor-like kinase 4 OS=Arabidopsis thaliana GN=LYK4 PE=1 SV=1

 Score =  367 bits (942), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 233/610 (38%), Positives = 352/610 (57%), Gaps = 40/610 (6%)

Query: 6   AQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLTSS 65
           AQQ Y G S  DC+  D    +  F Y+CNG N+ CQ ++IF+S P + TV+SIS+L S 
Sbjct: 22  AQQPYVGISTTDCSVSDNT--TSVFGYSCNGLNKTCQAYVIFRSTPSFSTVTSISSLFSV 79

Query: 66  DPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANNTY 125
           DP+ ++ +N+ S S +  P  ++VI+P++C C+G   Q+N ++ I     +YF+IAN+T 
Sbjct: 80  DPSLVSSLNDASPSTS-FPSGQQVIIPLTCSCTGDDSQSNITYTIQP-NDSYFAIANDTL 137

Query: 126 QGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQI-VNGTKFLLTYLVSWGDSVP 184
           QGLSTC  L  +NN S  SL  G+ + VP+RCACPT+ QI  +G K+L++Y V + D++ 
Sbjct: 138 QGLSTCQALAKQNNVSSQSLFPGMRIVVPIRCACPTAKQINEDGVKYLMSYTVVFEDTIA 197

Query: 185 DISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTIIHYPPPPSSPIVPT 244
            IS RF V     + AN  + ++  +FPFTTILIPL   P ++ ++I  PPPP    V  
Sbjct: 198 IISDRFGVETSKTLKANEMSFENSEVFPFTTILIPLVNPPANTNSLIPPPPPPPPQSVSP 257

Query: 245 RKY---NQTSSRGIYLWVGIGIGISLLVICFVLSIVLFHHKRR-----RDEAARKD---G 293
                  + S +  +++   G+    LV+  + + +    K++     ++E    D   G
Sbjct: 258 PPLSPDGRKSKKKTWVYALAGVLGGALVLSVIGAAIFCLSKKKTKTQTQEETGNLDSFMG 317

Query: 294 KREKKRNLPEDFLVSVSNLD-RGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVA 352
           K+    +   D L  +S +    LK YK+ +L  AT +F+  + I GS + G ING    
Sbjct: 318 KKPPMSDQEFDPLDGLSGMVVESLKVYKFHELQSATSDFTSSSSIGGSGYIGKINGDGAM 377

Query: 353 IKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEF 412
           IK +  + S+EVNLL K+NH N+I L G C H+G +YLVYE   NGSLS+W+H  +    
Sbjct: 378 IKKIEGNASEEVNLLSKLNHLNIIRLSGFCFHEGDWYLVYEHASNGSLSEWIHTTK--SL 435

Query: 413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE 472
           +S   + +IALD+A GL+YLHN  DP YVH+D++S N+ LD   RAK+ +    RS   +
Sbjct: 436 LSLTQKLQIALDIATGLNYLHNFADPPYVHRDLNSNNVFLDLEFRAKIGSLGSARSTTED 495

Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILL 532
              +  TK   GT GY+APEY+E+GLV+ ++D YAFGVVLLE++TGKEA+  +  +EI  
Sbjct: 496 ---FVLTKHVEGTRGYLAPEYLEHGLVSTKLDVYAFGVVLLEIVTGKEASELK--KEIDE 550

Query: 533 AEAVFS-MVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVS 591
            +A+   ++ G      L+  V+                L + C+ ++  +RPSM E V 
Sbjct: 551 GKAIDEILIHGRLLPEGLTSFVE---------------RLVVDCLKKDHLNRPSMDENVM 595

Query: 592 TLMKIQLDVQ 601
           +L KI    Q
Sbjct: 596 SLSKILAATQ 605

Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to the pathogenic fungus Alternaria brassicicola and to the bacterial pathogen the bacterial pathogen Pseudomonas syringae pv tomato DC3000, probably by sensing microbe-associated molecular pattern (MAMP) and pathogen-associated molecular patterns (PAMP). May play a role in detecting peptidoglycans (e.g. PGNs) during bacterial growth.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|D7UPN3|CERK1_ORYSJ Chitin elicitor receptor kinase 1 OS=Oryza sativa subsp. japonica GN=CERK1 PE=1 SV=1

 Score =  194 bits (494), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 167/535 (31%), Positives = 254/535 (47%), Gaps = 49/535 (9%)

Query: 88  EVIVPVSCYCSGLYYQANTSFIIPTIYH----------TYFSIANNTYQGLSTCNILKHE 137
            V+VP  C C GL     ++F+   I +          TY ++A N Y  L+T   L+  
Sbjct: 80  RVLVPFPCSCLGLPAAPASTFLAGAIPYPLPLPRGGGDTYDAVAAN-YADLTTAAWLEAT 138

Query: 138 NNYSETSLDQG-LTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPDISKRFNVSIES 196
           N Y    +  G   + V + C+C    ++       LTY +  G++           +ES
Sbjct: 139 NAYPPGRIPGGDGRVNVTINCSC-GDERVSPRYGLFLTYPLWDGET-----------LES 186

Query: 197 IVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTIIHYP-PPPSSPIVPTRKYNQTSSRGI 255
           +    GF+   P          P     +S + I+  P   P+    P +     +S   
Sbjct: 187 VAAQYGFS--SPAEMELIRRYNP-GMGGVSGKGIVFIPVKDPNGSYHPLKSGGMGNSLSG 243

Query: 256 YLWVGIGIG-ISLLVICFVLSIVLFHHKRRRDEAARKDGKREKKRNLPEDFLVSVSNLDR 314
               GI I  I++ ++   L I+ +  ++ R   +R     E+  +L +        ++R
Sbjct: 244 GAIAGIVIACIAIFIVAIWLIIMFYRWQKFRKATSRP--SPEETSHLDDASQAEGIKVER 301

Query: 315 GLKFYKYEDLVVATENFSPKNMID----GSVFRGIINGSTVAIKCMRRSISKE----VNL 366
            ++F  YE++  AT+ FS ++ I     GSV+   + G   AIK M    ++E    + +
Sbjct: 302 SIEF-SYEEIFNATQGFSMEHKIGQGGFGSVYYAELRGEKTAIKKMGMQATQEFLAELKV 360

Query: 367 LKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVA 426
           L  ++H NL+ L G C  + +F LVYEF++NG+LS  L +  Y   +SW  R +IALD A
Sbjct: 361 LTHVHHLNLVRLIGYCVENCLF-LVYEFIDNGNLSQHLQRTGYAP-LSWATRVQIALDSA 418

Query: 427 HGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR-SAVREESGYSSTKTAVGT 485
            GL YLH    P YVH+DI S NILLDK+ RAK+A+F   + + V   S   ST+ A GT
Sbjct: 419 RGLEYLHEHVVPVYVHRDIKSANILLDKDFRAKIADFGLAKLTEVGSMSQSLSTRVA-GT 477

Query: 486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVE---G 542
            GYM PE   YG V+P++D YAFGVVL EL++ K+A  +           VF   E    
Sbjct: 478 FGYMPPE-ARYGEVSPKVDVYAFGVVLYELLSAKQAIVRSSESVSESKGLVFLFEEALSA 536

Query: 543 GNAEAKLSVLVDPNLQANKK-EIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            N    L  L+DP+LQ +   + A  +  L  +C   EP  RP+M  VV  LM +
Sbjct: 537 PNPTEALDELIDPSLQGDYPVDSALKIASLAKSCTHEEPGMRPTMRSVVVALMAL 591

Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands (By similarity). Lysin motif (LysM) receptor kinase required as a cell surface receptor for chitin elicitor (chitooligosaccharides) signaling leading to innate immunity in response to both biotic and abiotic stresses. Involved in the resistance to pathogenic fungi, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP).

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A8R7E6|CERK1_ARATH Chitin elicitor receptor kinase 1 OS=Arabidopsis thaliana GN=CERK1 PE=1 SV=1

 Score =  192 bits (488), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 170/574 (29%), Positives = 264/574 (45%), Gaps = 66/574 (11%)

Query: 49  SQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVSCYCS-GLYYQANTS 107
           S  PYD ++        DP  + R N+       + +   V+VP  C C  G +   N S
Sbjct: 54  SIAPYDQINF-------DP--ILRYNSNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFS 104

Query: 108 FIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVN 167
           + +     TY  +A + Y  L+T   L+  N +  T++    TL V + C+C     +  
Sbjct: 105 YSVRQ-EDTYERVAISNYANLTTMESLQARNPFPATNIPLSATLNVLVNCSC-GDESVSK 162

Query: 168 GTKFLLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSS 227
                +TY +   DS+  I++   VS + +   N     +                  S 
Sbjct: 163 DFGLFVTYPLRPEDSLSSIARSSGVSADILQRYNPGVNFN------------------SG 204

Query: 228 QTIIHYPPPPSSPIVPTRKYNQTSSRGIYLWVGIGIGI--SLLVICFVLSIVLFHHKRRR 285
             I++ P    +   P  K ++    G  +  GI IG+  +LL+I F++      +K + 
Sbjct: 205 NGIVYVPGRDPNGAFPPFKSSKQDGVGAGVIAGIVIGVIVALLLILFIVYYAYRKNKSKG 264

Query: 286 DEAARKDGKREKKRNLPEDFL-------------VSVSNLDRGLKFYKYEDLVVATENFS 332
           D  +       K  +     L             ++  ++D+ ++F   E+L  AT+NF+
Sbjct: 265 DSFSSSIPLSTKADHASSTSLQSGGLGGAGVSPGIAAISVDKSVEF-SLEELAKATDNFN 323

Query: 333 PKNMID----GSVFRGIINGSTVAIKCMRRSISK----EVNLLKKINHFNLINLFGACEH 384
               I     G+V+   + G   AIK M    SK    E+ +L +++H NL+ L G C  
Sbjct: 324 LSFKIGQGGFGAVYYAELRGEKAAIKKMDMEASKQFLAELKVLTRVHHVNLVRLIGYCV- 382

Query: 385 DGVFYLVYEFMENGSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHK 443
           +G  +LVYE++ENG+L   LH   R P  + W  R +IALD A GL Y+H  T P YVH+
Sbjct: 383 EGSLFLVYEYVENGNLGQHLHGSGREP--LPWTKRVQIALDSARGLEYIHEHTVPVYVHR 440

Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           DI S NIL+D+  RAK+A+F   +     E G S+T+ A+GT GYMAPE + YG V+ ++
Sbjct: 441 DIKSANILIDQKFRAKVADFGLTK---LTEVGGSATRGAMGTFGYMAPETV-YGEVSAKV 496

Query: 504 DTYAFGVVLLELITGKEAAYKQD---GEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN 560
           D YAFGVVL ELI+ K A  K     GE   L        +  + E  L  ++DP L  +
Sbjct: 497 DVYAFGVVLYELISAKGAVVKMTEAVGEFRGLVGVFEESFKETDKEEALRKIIDPRLGDS 556

Query: 561 KK-EIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +  + +  L  AC     + RPSM  +V  L
Sbjct: 557 YPFDSVYKMAELGKACTQENAQLRPSMRYIVVAL 590

Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity toward both biotic and abiotic stresses (e.g. tolerance to salinity, heavy-metal stresses, and Botrytis cinerea infection). Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to pathogenic fungi Alternaria brassicicola and Erysiphe cichoracearum, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP). Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Target of the bacterial type III effector E3-ligase protein hopAB2/avrPtoB of Pseudomonas syringae pv. tomato DC3000 that mediates ubiquitination and subsequent proteolysis, thus blocking all defense responses by suppressing PAMP-triggered immunity (PTI).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64483|SIRK_ARATH Senescence-induced receptor-like serine/threonine-protein kinase OS=Arabidopsis thaliana GN=SIRK PE=2 SV=1

 Score =  172 bits (437), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/293 (36%), Positives = 162/293 (55%), Gaps = 22/293 (7%)

Query: 317 KFYKYEDLVVATENFSPKNMID----GSVFRGIINGSTVAIKCMR-------RSISKEVN 365
           +++KY ++V  T NF  + +I     G V+ G+ING  VA+K +        +    EV+
Sbjct: 562 RYFKYSEVVNITNNF--ERVIGKGGFGKVYHGVINGEQVAVKVLSEESAQGYKEFRAEVD 619

Query: 366 LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDV 425
           LL +++H NL +L G C       L+YE+M N +L D+L  KR    +SW  R +I+LD 
Sbjct: 620 LLMRVHHTNLTSLVGYCNEINHMVLIYEYMANENLGDYLAGKR-SFILSWEERLKISLDA 678

Query: 426 AHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT 485
           A GL YLHN   P  VH+D+   NILL++ L+AK+A+F   RS   E SG  ST  A G+
Sbjct: 679 AQGLEYLHNGCKPPIVHRDVKPTNILLNEKLQAKMADFGLSRSFSVEGSGQISTVVA-GS 737

Query: 486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA 545
            GY+ PEY     +  + D Y+ GVVLLE+ITG+ A      E++ +++ V S++  G+ 
Sbjct: 738 IGYLDPEYYSTRQMNEKSDVYSLGVVLLEVITGQPAIASSKTEKVHISDHVRSILANGDI 797

Query: 546 EAKLSVLVDPNLQANKKEIAHHLIM--LCLACIAREPESRPSMAEVVSTLMKI 596
                 +VD  L+  + ++     M  + LAC       RP+M++VV  L +I
Sbjct: 798 RG----IVDQRLR-ERYDVGSAWKMSEIALACTEHTSAQRPTMSQVVMELKQI 845

Involved in innate immune response of plants.

Arabidopsis thaliana (taxid: 3702)

>sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1

 Score =  171 bits (434), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 124/367 (33%), Positives = 184/367 (50%), Gaps = 28/367 (7%)

Query: 246 KYN-----QTSSRGIYLWVGIGIGISLLVICFVLSIVLFHHK---RRRDEAARKDGKREK 297
           KYN     Q  ++  + W  +GI I+ + I  +L           R+   A + D    K
Sbjct: 513 KYNNNPELQNEAQRKHFWQILGISIAAVAILLLLVGGSLVLLCALRKTKRADKGDSTETK 572

Query: 298 KRNLPEDFLVSVSNL-DRGLKFY-KYEDLVVATENFSPK--NMIDGSVFRG-IINGSTVA 352
           K+ L     V   +L D G+ ++     L  AT+NFS K      GSV+ G + +G  VA
Sbjct: 573 KKGLVAYSAVRGGHLLDEGVAYFISLPVLEEATDNFSKKVGRGSFGSVYYGRMKDGKEVA 632

Query: 353 IKC-------MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH 405
           +K        + R    EV LL +I+H NL+ L G CE      LVYE+M NGSL D LH
Sbjct: 633 VKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLH 692

Query: 406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSF 465
                + + W  R +IA D A GL YLH   +P  +H+D+ S NILLD N+RAK+++F  
Sbjct: 693 GSSDYKPLDWLTRLQIAQDAAKGLEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGL 752

Query: 466 VRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQ 525
            R    EE     +  A GT GY+ PEY     +T + D Y+FGVVL EL++GK+    +
Sbjct: 753 SRQT--EEDLTHVSSVAKGTVGYLDPEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAE 810

Query: 526 D-GEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK-EIAHHLIMLCLACIAREPESR 583
           D G E+ +     S++  G+    +  ++DP + +N K E    +  +   C+ +   +R
Sbjct: 811 DFGPELNIVHWARSLIRKGD----VCGIIDPCIASNVKIESVWRVAEVANQCVEQRGHNR 866

Query: 584 PSMAEVV 590
           P M EV+
Sbjct: 867 PRMQEVI 873

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  171 bits (434), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 120/381 (31%), Positives = 193/381 (50%), Gaps = 36/381 (9%)

Query: 246  KYNQTSSRGIYLWVGIGIGISLLVICFVLSIVLFHHKRR---RDEAARKDGKREK---KR 299
            K   T  R  +   G+ +G +++V  FV S+  +   +R   RD+  R +  R K    +
Sbjct: 818  KIEGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQ 877

Query: 300  NL--------PEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMID----GSVFRGIIN 347
            NL         E   ++++  ++ L   +  D+V AT++FS KN+I     G+V++  + 
Sbjct: 878  NLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLP 937

Query: 348  G-STVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
            G  TVA+K +        R    E+  L K+ H NL++L G C       LVYE+M NGS
Sbjct: 938  GEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGS 997

Query: 400  LSDWLHKKR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
            L  WL  +    E + W+ R +IA+  A GL +LH+   P  +H+DI + NILLD +   
Sbjct: 998  LDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEP 1057

Query: 459  KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
            K+A+F   R     ES  S+     GT GY+ PEY +    T + D Y+FGV+LLEL+TG
Sbjct: 1058 KVADFGLARLISACESHVST--VIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTG 1115

Query: 519  KEAA---YKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLAC 575
            KE     +K+     L+  A+  + +G   +    +LV   L+ ++      L+ + + C
Sbjct: 1116 KEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQ----LRLLQIAMLC 1171

Query: 576  IAREPESRPSMAEVVSTLMKI 596
            +A  P  RP+M +V+  L +I
Sbjct: 1172 LAETPAKRPNMLDVLKALKEI 1192

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1

 Score =  171 bits (432), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 128/388 (32%), Positives = 189/388 (48%), Gaps = 34/388 (8%)

Query: 239  SPIVPTRKYNQTSSRG----IYLWVGIGIGISLLVICFVLSIVLFHHKRRRDEAARKDGK 294
            +P   +R+ N     G    + L + + IGI+LL     LS++L    R+  +    D  
Sbjct: 661  NPKGSSRRNNNGGKFGRSSIVVLTISLAIGITLL-----LSVILLRISRKDVDDRINDVD 715

Query: 295  REKKRNLPEDFLVSVSNL--DRGLKFYKYEDLVVATENFSPKNMIDGSVFRGII------ 346
             E    + +    S   L    G K    E+L+ +T NFS  N+I    F G++      
Sbjct: 716  EETISGVSKALGPSKIVLFHSCGCKDLSVEELLKSTNNFSQANIIGCGGF-GLVYKANFP 774

Query: 347  NGSTVAIK-----C--MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
            +GS  A+K     C  M R    EV  L +  H NL++L G C+H     L+Y FMENGS
Sbjct: 775  DGSKAAVKRLSGDCGQMEREFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGS 834

Query: 400  LSDWLHKKRYPEF-VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
            L  WLH++      + W+ R +IA   A GL YLH   +P  +H+D+ S NILLD+   A
Sbjct: 835  LDYWLHERVDGNMTLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEA 894

Query: 459  KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
             LA+F   R  +R    + +T   VGT GY+ PEY +  + T   D Y+FGVVLLEL+TG
Sbjct: 895  HLADFGLAR-LLRPYDTHVTTDL-VGTLGYIPPEYSQSLIATCRGDVYSFGVVLLELVTG 952

Query: 519  KEAAYKQDGEEIL-LAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLIMLCLACI 576
            +       G+    L   VF M     AE + + L+D  ++ N  E     ++ +   CI
Sbjct: 953  RRPVEVCKGKSCRDLVSRVFQM----KAEKREAELIDTTIRENVNERTVLEMLEIACKCI 1008

Query: 577  AREPESRPSMAEVVSTLMKIQLDVQRSQ 604
              EP  RP + EVV+ L  + ++  + Q
Sbjct: 1009 DHEPRRRPLIEEVVTWLEDLPMESVQQQ 1036

Phytosulfokine receptor with a serine/threonine-protein kinase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL2|CRK3_ARATH Cysteine-rich receptor-like protein kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=2 SV=1

 Score =  171 bits (432), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 128/359 (35%), Positives = 200/359 (55%), Gaps = 35/359 (9%)

Query: 259 VGIGIGISLLVICFVL--SIVLFHHKRRRDEAARKDGKREKKRNLPEDFLVSVSNLDRGL 316
           +G+ + ++  V+ FVL  S   F  K+R    A+K  +REKK+      L + SNL    
Sbjct: 259 LGVILAVTSSVVAFVLLVSAAGFLLKKRH---AKK--QREKKQLGSLFMLANKSNL---- 309

Query: 317 KFYKYEDLVVATENFSPKNMI----DGSVFRGII-NGSTVAIKCMRRSISK-------EV 364
             + YE+L  AT+ FS KN +     GSV++G++ NG TVA+K +  +  +       EV
Sbjct: 310 -CFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNTKQWVDHFFNEV 368

Query: 365 NLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALD 424
           NL+ +++H NL+ L G         LVYE++ N SL D+L  ++  + ++W  RF+I L 
Sbjct: 369 NLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLFVRKDVQPLNWAKRFKIILG 428

Query: 425 VAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG 484
            A G+ YLH  ++   +H+DI   NILL+ +   ++A+F   R    E+  + ST  A G
Sbjct: 429 TAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLAR-LFPEDKTHISTAIA-G 486

Query: 485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE-AAYKQDGEEILLAEAVFSMVEGG 543
           T GYMAPEY+  G +T + D Y+FGV+++E+ITGK   A+ QD   IL  ++V+S+    
Sbjct: 487 TLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQDAGSIL--QSVWSLYRTS 544

Query: 544 NAEAKLSVLVDPNLQANKKEI-AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ 601
           N E      VDP L  N  +I A  L+ + L C+    + RP+M+ VV  +MK  L++ 
Sbjct: 545 NVEEA----VDPILGDNFNKIEASRLLQIGLLCVQAAFDQRPAMS-VVVKMMKGSLEIH 598

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|F4IB81|LYK3_ARATH LysM domain receptor-like kinase 3 OS=Arabidopsis thaliana GN=LYK3 PE=2 SV=1

 Score =  169 bits (428), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 107/302 (35%), Positives = 162/302 (53%), Gaps = 24/302 (7%)

Query: 319 YKYEDLVVATENFSPKNMID----GSVFRGIINGSTVAIKCMRRSISKE----VNLLKKI 370
           + YE++  AT+ FS  N++     GSV+ G++    VA+K M  + +KE    + +L K+
Sbjct: 329 FTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVKRMTATKTKEFAAEMKVLCKV 388

Query: 371 NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH----KKRYPEFVSWNCRFRIALDVA 426
           +H NL+ L G        ++VYE++  G L   LH    K   P  +SW  R +IALD A
Sbjct: 389 HHSNLVELIGYAATVDELFVVYEYVRKGMLKSHLHDPQSKGNTP--LSWIMRNQIALDAA 446

Query: 427 HGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN 486
            GL Y+H  T   YVH+DI + NILLD+  RAK+++F   +   +   G  S    VGT 
Sbjct: 447 RGLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAKLVEKTGEGEISVTKVVGTY 506

Query: 487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDG------EEILLAEAVFSMV 540
           GY+APEY+  GL T + D YAFGVVL E+I+G+EA  + +       E   LA  + +++
Sbjct: 507 GYLAPEYLSDGLATSKSDIYAFGVVLFEIISGREAVIRTEAIGTKNPERRPLASIMLAVL 566

Query: 541 EGGNAEAKLSVL---VDPN-LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           +       +S L   VDPN +     +    +  L   C+  +P  RP+M +VV +L +I
Sbjct: 567 KNSPDSMNMSSLKEFVDPNMMDLYPHDCLFKIATLAKQCVDDDPILRPNMKQVVISLSQI 626

Query: 597 QL 598
            L
Sbjct: 627 LL 628

Putative Lysin motif (LysM) receptor kinase that may recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	611
255585148	617	serine-threonine protein kinase, plant-t	0.978	0.969	0.606	0.0
255538536	637	serine-threonine protein kinase, plant-t	0.965	0.926	0.527	1e-179
225458404	622	PREDICTED: probable LRR receptor-like se	0.970	0.953	0.538	1e-177
224136602	609	predicted protein [Populus trichocarpa]	0.965	0.968	0.515	1e-173
356552143	636	PREDICTED: leucine-rich repeat receptor	0.962	0.924	0.492	1e-160
356562319	633	PREDICTED: leucine-rich repeat receptor	0.957	0.924	0.495	1e-157
224096894	643	predicted protein [Populus trichocarpa]	0.955	0.908	0.450	1e-135
225430870	638	PREDICTED: wall-associated receptor kina	0.949	0.909	0.454	1e-133
297735221	1305	unnamed protein product [Vitis vinifera]	0.913	0.427	0.439	1e-133
224133922	630	predicted protein [Populus trichocarpa]	0.957	0.928	0.438	1e-131

>gi|255585148|ref|XP_002533279.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526904|gb|EEF29111.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  728 bits (1878), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/603 (60%), Positives = 459/603 (76%), Gaps = 5/603 (0%)

Query: 2   PKLHAQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISN 61
           PK++ QQ+YSGN VM+C+++D  GPSPAFLYTCNG    C+ FLI+KSQPPY TVSSIS 
Sbjct: 17  PKINTQQSYSGNLVMNCDNNDSTGPSPAFLYTCNGK-ESCKTFLIYKSQPPYHTVSSISK 75

Query: 62  LTSSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIA 121
           LTSSDP ELA +NNISN    LP +KEVIVP+ C CS  YYQANTS+IIP+IY TYFSIA
Sbjct: 76  LTSSDPLELALINNISN-FTVLPTNKEVIVPIICSCSSQYYQANTSYIIPSIYDTYFSIA 134

Query: 122 NNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGD 181
            +TY+GLSTCN L  +NNYSE SLD G+ LRVPLRCACPTSNQ  NGTK+LLTY VSWGD
Sbjct: 135 ESTYEGLSTCNSLMRQNNYSEFSLDVGMELRVPLRCACPTSNQSANGTKYLLTYSVSWGD 194

Query: 182 SVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTIIHYPPPPSSPI 241
            V  +S+RFN SI+S+  ANGFT+DD  LFPFTTIL+PL+TEP S QTI+HYPPPP SP 
Sbjct: 195 KVRAVSERFNASIDSVNYANGFTKDDTTLFPFTTILVPLSTEPSSFQTIVHYPPPPYSPP 254

Query: 242 VPTRKYNQTSSRGIYLWVGIGIGISLLVICFVLSIVLFHHKRRRDEAARKDGKREKKRNL 301
                  + S + I++WV   I +S L +  VL IVL    ++     +++ + + K  L
Sbjct: 255 FIPVHPIRRSRKKIHVWVIPVIIVSALPV--VLFIVLLLRNKKSHLGVQREKEGKNKEEL 312

Query: 302 PEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSIS 361
           P+DFL  V+++D GLK Y +E+L VATE+FS  N +  SV+RG+I+G  +AIK M + +S
Sbjct: 313 PDDFLDHVAHVDLGLKIYTFEELKVATEDFSTSNRLSDSVYRGVISGQVLAIKKMSKDVS 372

Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRI 421
            EV LL+KINHFNLI+L  ACEH GVFYL+YEFM+NGSL DWL+K+   E  SWN R +I
Sbjct: 373 NEVTLLRKINHFNLISLHAACEHHGVFYLMYEFMDNGSLRDWLYKRNCLEAQSWNRRIQI 432

Query: 422 ALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
           ALDVA+GLHYLHN TDP YVHKDISS N+LL ++LRAK+ANFS  RSA  EE   SS + 
Sbjct: 433 ALDVANGLHYLHNFTDPPYVHKDISSSNVLLSRHLRAKIANFSLARSAKAEEHVNSSLRL 492

Query: 482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVE 541
           A+G+ GY+APE++++GLVTPE+D YAFGVVLLEL+TGKEA Y Q+  ++ L+E + S++E
Sbjct: 493 ALGSKGYLAPEFIDFGLVTPEIDIYAFGVVLLELVTGKEAVYMQEERKVQLSETIISIME 552

Query: 542 GGNAEAKLSVLVDPNLQANKK-EIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV 600
             NAEA+L  +VDPNLQ+    E+   ++ L LAC+A+EPESRPSMAE+VS L+KIQLDV
Sbjct: 553 KENAEARLGCIVDPNLQSQHSMEVVLRMVKLSLACLAQEPESRPSMAEIVSALLKIQLDV 612

Query: 601 QRS 603
            RS
Sbjct: 613 HRS 615

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255538536|ref|XP_002510333.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223551034|gb|EEF52520.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  634 bits (1636), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 318/603 (52%), Positives = 432/603 (71%), Gaps = 13/603 (2%)

Query: 5   HAQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLTS 64
           +AQQNYS NS +DCN  DE GPSPAFLYTCNG NR CQ FLIF+S+PPYD+  +IS LTS
Sbjct: 19  YAQQNYSANSALDCNSSDETGPSPAFLYTCNGQNRTCQAFLIFRSRPPYDSAPTISALTS 78

Query: 65  SDPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANNT 124
           +   ELAR NN++   +  PL+KEVIVPVSC C G YYQANTSF + +  H+YF+IA+ T
Sbjct: 79  ASQEELARFNNVTG-LSEFPLNKEVIVPVSCSCLGQYYQANTSFQVAS-DHSYFTIASQT 136

Query: 125 YQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVP 184
           Y+GLSTC  LK  N Y E  L  G  L+VPLRCACPT++Q+ N TK+LLT+ +S  D + 
Sbjct: 137 YEGLSTCASLKKANIYGEFDLALGAELQVPLRCACPTASQVRNETKYLLTFPISESDHIA 196

Query: 185 DISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTIIHYPPPPSSPIVPT 244
            I++RFNVS ESI++ANG  E  P ++P TTILIPLTTEP +SQTIIH  P   SP + +
Sbjct: 197 AIAERFNVSKESIIDANGLRES-PTIYPDTTILIPLTTEPSNSQTIIHENPTEVSPPLAS 255

Query: 245 RKYNQTSSRGIYLWVGIGIGISLLVICFVLSIVLFHHKRRRDEAARKDGKREKKRNLPED 304
              N+ S R +Y  VGI    SLLV+  ++ I+    K RR +    + +RE+     ED
Sbjct: 256 PPDNRRSKRKLYEKVGITAACSLLVLSIIVVILFLLRKDRRHKFPEINRRREQ-----ED 310

Query: 305 FLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISKEV 364
             + ++++++ LK +  E++  AT+NFS K++I GS++ G  NG  +AIK M R +SKEV
Sbjct: 311 LRLEIASVEQVLKVFGLEEVKKATDNFSSKHIIKGSLYWGEFNGQILAIKKMNRDVSKEV 370

Query: 365 NLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALD 424
           N+LK+INHFNLI L G CE+ G FYL +E+M+NGSL +WL ++R+ +  SWN R +IALD
Sbjct: 371 NILKRINHFNLIKLHGVCENLGCFYLFFEYMKNGSLQEWLSRERFEDVGSWNQRIQIALD 430

Query: 425 VAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG 484
           +A+GL YLH+ T+P  VHKDI+SG+ILLD NLRAK+ANFS  R+A    +    TK   G
Sbjct: 431 IANGLFYLHSFTEPACVHKDITSGHILLDNNLRAKIANFSLARAA----ANAVLTKHIEG 486

Query: 485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN 544
           T GYMAPEY++ G VTP++D YAFG+VLLELITGK+A + +DG+E LL++A+FS++E  N
Sbjct: 487 TRGYMAPEYVQAGQVTPKIDVYAFGIVLLELITGKDAVFMRDGKETLLSKAIFSVMEKEN 546

Query: 545 AEAKLSVLVDPNLQANKK-EIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRS 603
           AEA+L+ ++DP+    ++ ++A  L  + LAC+ + P  RPSM EVVSTL+KIQ ++ +S
Sbjct: 547 AEAELAFVIDPSFTGGRQSKLALRLARVSLACLTQVPARRPSMGEVVSTLVKIQTELAKS 606

Query: 604 QTL 606
           ++L
Sbjct: 607 ESL 609

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225458404|ref|XP_002281880.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650-like [Vitis vinifera]

 Score =  629 bits (1623), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 328/609 (53%), Positives = 417/609 (68%), Gaps = 16/609 (2%)

Query: 4   LHAQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLT 63
           ++AQQ YSGNSV++C++ D++GPS AFLYTCNG    CQ FLIFKS+PPY++V +IS L 
Sbjct: 18  INAQQEYSGNSVLNCDNSDDSGPSSAFLYTCNGLYSSCQAFLIFKSEPPYNSVPTISMLM 77

Query: 64  SSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANN 123
           SS+P ELAR+N++  +    P  KEVIVPV+C C G YYQANT+F I     TYF I NN
Sbjct: 78  SSNPGELARINSV-KTLTVFPTGKEVIVPVNCSCLGQYYQANTTFHIQDNQQTYFIIGNN 136

Query: 124 TYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSV 183
           TYQGLSTC+ L   N YSE SL  GL L VPLRCAC T +Q  NGTK+LLTY VSW D+ 
Sbjct: 137 TYQGLSTCDSLMRANRYSEFSLSPGLELHVPLRCACHTEHQAENGTKYLLTYSVSWEDNF 196

Query: 184 PDISKRFNVSIESIVNANGF-TEDDPLLFPFTTILIPLTTEPLSSQTIIHY------PPP 236
           P I +RFNVS +SI +ANG  +E++P +FPFTTILIPL TEPLSSQT  H       PPP
Sbjct: 197 PTIGERFNVSAKSIADANGLISEENPTIFPFTTILIPLKTEPLSSQTKTHATQPVLDPPP 256

Query: 237 PSSPIVPTRKYNQTSSRGIYLWVGIGIGISLLVICFVLSIVLFHHKRRRDEAARKDGKRE 296
           P+S    +R     S R IYL  GI  G  LL    + SIV   +K+R  +     GK  
Sbjct: 257 PTSDSGSSR-----SKRRIYLGAGIAAGCFLLGPSVIFSIVFLFYKKRSKKVPPVHGK-- 309

Query: 297 KKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCM 356
            K  LPED LV ++++D   K ++++ L  AT NFS K+ I G VFR  +    VA+K M
Sbjct: 310 TKSVLPEDLLVEIASVDPVPKVFEFKKLKKATGNFSSKSRIKGCVFRAELGREIVAVKKM 369

Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +  IS+EVN+L K+NH NLI L G C++   FYLV+E+MENGSL +WLHK+      SW+
Sbjct: 370 KVDISEEVNILNKLNHCNLIKLHGVCKNGSCFYLVFEYMENGSLREWLHKESSNHSQSWS 429

Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
            R +IALDVA+GLHY+HN T P YVHK I S NILL KNLRAK+ANFS  R+AV+    +
Sbjct: 430 KRIQIALDVANGLHYIHNFTKPAYVHKHIKSSNILLTKNLRAKIANFSLARTAVKGAKTH 489

Query: 477 SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAV 536
           +     VGT GYMAPEY+E G +TP++D YAFGVV+LELITGK+A   Q+ EE+LL+EA+
Sbjct: 490 ALNMLVVGTRGYMAPEYIEAGSITPKVDVYAFGVVMLELITGKDAVIIQNEEEVLLSEAM 549

Query: 537 FSMVEGGNAEAKLSVLVDPNLQANKK-EIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
            S++E GNAE +L   +DP L  N   E A  +  L +AC+ ++   RPSM EVVSTL+K
Sbjct: 550 ISIMERGNAEIELGHFLDPCLLGNNGIESATRIAKLSIACLTKDQARRPSMGEVVSTLLK 609

Query: 596 IQLDVQRSQ 604
           IQ+D Q+S+
Sbjct: 610 IQVDQQKSE 618

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224136602|ref|XP_002326901.1| predicted protein [Populus trichocarpa] gi|222835216|gb|EEE73651.1| predicted protein [Populus trichocarpa]

 Score =  614 bits (1583), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 309/600 (51%), Positives = 423/600 (70%), Gaps = 10/600 (1%)

Query: 5   HAQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLTS 64
           +AQQNYS +S +DCN +D+ GPS AFLYT NG ++ CQ FLIFKSQP +++V SIS LTS
Sbjct: 19  NAQQNYSKDSALDCNANDDAGPSSAFLYTYNGQDQSCQAFLIFKSQPSFNSVPSISALTS 78

Query: 65  SDPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANNT 124
           ++  ELAR+NN++   +  P + EVIVPV+C+C G YYQANT+  + T   TY+ IAN T
Sbjct: 79  ANQEELARINNVTR-LSEFPTNNEVIVPVNCFCFGQYYQANTTIQVTTTRGTYYVIANET 137

Query: 125 YQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVP 184
           Y+GLSTC  LKH N + E  L  G  L+VPLRCACPT+NQ++ GTK+L+TY +S  D++P
Sbjct: 138 YEGLSTCAALKHLNIHGEYDLLPGEELQVPLRCACPTTNQMIRGTKYLVTYPLSSDDNIP 197

Query: 185 DISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTIIHYPPPPSSPIVPT 244
           DI+ RF VS + I++ANG  E++P L+P TTILIPL T+P SSQTIIH  P  S P   +
Sbjct: 198 DIADRFKVSTKDILDANGM-EENPTLYPDTTILIPLPTQPTSSQTIIHSNPNISPPSALS 256

Query: 245 RKYNQTSSRGIYLWVGIGIGISLLVICFVLSIVLFHHKRRRDEAARKDGKREKKRNLPED 304
            + N+ S +  Y   G+    SLLVI  + ++V    K+ R++ + +   RE+K+ +PED
Sbjct: 257 PR-NRGSKKKHYESAGLAAACSLLVISIITAVVFLSCKKTREKVSGRG--RERKQAVPED 313

Query: 305 FLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISKEV 364
             V +++ ++ LK +K+E++  ATEN S ++ I+GSV+RG   G  +A+K M R ++KEV
Sbjct: 314 IRVEIASYEQVLKVFKFEEVRKATENLSSESRINGSVYRGEFGGEILAVKKMSRDVTKEV 373

Query: 365 NLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALD 424
           N+LK+INHFNLI L G CE+ G FYLV E+MENGSL +WL  K++ E  +W  R +IALD
Sbjct: 374 NILKRINHFNLIKLEGVCENRGCFYLVLEYMENGSLREWLSCKKFEETGNWAQRIQIALD 433

Query: 425 VAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG 484
           VA+GL+YLH+ T+P YVHKDI S N+LL+ NLRAK+ANFS  R+A    +  + TK  VG
Sbjct: 434 VANGLYYLHSFTEPAYVHKDIKSSNVLLNGNLRAKIANFSLARAA----TSAAMTKHVVG 489

Query: 485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN 544
           + GYMAPEY+  G VTP++D YAFGV+LLELITGK+A + QDG E LL+  +FS++E  N
Sbjct: 490 SIGYMAPEYVREGQVTPKIDVYAFGVILLELITGKDAVFTQDGREALLSTEIFSIMENKN 549

Query: 545 AEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRS 603
            E +L   VDP L+ +     A  L  + +AC+ +EP  RPSM EVVS L+KIQ +VQ+S
Sbjct: 550 PEVELDFFVDPALKGSCGTNFALCLAKVSVACLMKEPARRPSMEEVVSVLLKIQANVQKS 609

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356552143|ref|XP_003544429.1| PREDICTED: leucine-rich repeat receptor protein kinase EXS-like [Glycine max]

 Score =  572 bits (1474), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 294/597 (49%), Positives = 403/597 (67%), Gaps = 9/597 (1%)

Query: 6   AQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLTSS 65
           AQQNYSGNS++ C +DD+ GPSP+FLYTCNG N+ C  FLIFKS+PP++++++ISNLTSS
Sbjct: 22  AQQNYSGNSILSCKNDDKMGPSPSFLYTCNGFNKTCMSFLIFKSKPPFNSITTISNLTSS 81

Query: 66  DPTELARVNNISNSAAALPLDKEVIVPVSCYC-SGLYYQANTSFIIPTIYHTYFSIANNT 124
           +P ELAR+N+++      P  KEVIVP++C C +  YYQA T +++     TYF++AN+T
Sbjct: 82  NPEELARINDVT-VLKVFPTGKEVIVPLNCSCLTREYYQAETKYVLGQ-SPTYFTVANDT 139

Query: 125 YQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVP 184
           ++GL+TC+ L   N+Y E  L  G+ L VPLRCACPT +QI NGTK+LLTY V+WGDS+ 
Sbjct: 140 FEGLTTCDTLMRANSYGELDLLPGMELHVPLRCACPTWHQITNGTKYLLTYSVNWGDSIK 199

Query: 185 DISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTIIHYPPPPSSPIVPT 244
           +I+ RFNV+  ++V+ANGF+     +FPFTT+LIPL +EP+SS  II   PP  SP+   
Sbjct: 200 NIAARFNVAAGNVVDANGFSTQTQTIFPFTTVLIPLPSEPVSSMAIIVNGPPAVSPLPVC 259

Query: 245 RKYNQTSSRGIYLWVGIGIGISLLVICFVLSIVLFHHKRRRDEAARKDGKREKKRNLPED 304
                 S R +Y+ +    G S+LV+C VL       KR      R +   + K+   ED
Sbjct: 260 SSEKCNSRRKLYIVIAT-TGGSMLVLCVVLFGGFLCRKRSARFIKRGEQSEKAKKLSSED 318

Query: 305 FLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIING--STVAIKCMRRSISK 362
               ++ ++   K YK+E++  ATENF  KN I GSVFRG+     + +A+K MR   S 
Sbjct: 319 IRGKIAIIEHHSKVYKFEEIEEATENFGSKNRIKGSVFRGVFGKEKNILAVKKMRGDASM 378

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           EVNLL++INHFNLI L G CE+DG  YLVYEFMENGSL +WL + R  E  S   R  IA
Sbjct: 379 EVNLLERINHFNLIKLQGYCENDGFPYLVYEFMENGSLREWLSRNRSKEHQSLAWRILIA 438

Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
           LDVA+GL YLHN T+P YVH++I+SGNILL+++LRAK+ANF+ V  +  + +   +    
Sbjct: 439 LDVANGLQYLHNFTEPCYVHRNINSGNILLNRDLRAKIANFALVEESESKITSGCAASHV 498

Query: 483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEG 542
           V + GY APEY+E G+VT +MD +AFGVVLLELITGK++    DG E++L   + +++  
Sbjct: 499 VKSRGYTAPEYLEAGMVTTKMDVFAFGVVLLELITGKDSVTLHDGREVMLHAIIVNLIGK 558

Query: 543 GNAEAKLSVLVDPNLQAN-KKEI--AHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            N E K+S+ +DP L      EI  A  L+ L LAC+ +EP  RP+M EVVS+L+KI
Sbjct: 559 ENLEEKVSLFIDPCLTVTGNSEIVCAPQLVKLGLACLIQEPAERPTMVEVVSSLLKI 615

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356562319|ref|XP_003549419.1| PREDICTED: leucine-rich repeat receptor protein kinase EXS-like [Glycine max]

 Score =  561 bits (1445), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 295/595 (49%), Positives = 406/595 (68%), Gaps = 10/595 (1%)

Query: 6   AQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLTSS 65
           AQQNY+GNS+  C +DD+ G SP+FLYTCNG N+ C  FLIFKS+PP++++++ISNLTSS
Sbjct: 22  AQQNYTGNSIFSCKNDDKMGASPSFLYTCNGLNKSCLAFLIFKSKPPFNSIATISNLTSS 81

Query: 66  DPTELARVNNISNSAAALPLDKEVIVPVSCYC-SGLYYQANTSFIIPTIYHTYFSIANNT 124
           +P ELAR+N++ N     P  KEV+VP++C C +  YYQA T++++     TY ++AN+T
Sbjct: 82  NPEELARINDV-NVLKVFPTGKEVLVPLNCSCLTRDYYQAETNYVLGQ-SPTYLTVANDT 139

Query: 125 YQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVP 184
            QGL+TC+ L   N Y E  L  G+ L VPLRCACPT +QI NGTK+LLTY V+WGD++ 
Sbjct: 140 LQGLTTCDSLMRANPYGELDLHPGMELHVPLRCACPTWHQITNGTKYLLTYSVNWGDNIT 199

Query: 185 DISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTIIHYPPPPSSPIVPT 244
           +I+ RFNV+  ++V+ANGF+     +FPFTT+LIPL +EP+SS T I   PP  SP+V +
Sbjct: 200 NIAARFNVAAGNVVDANGFSTQTQTIFPFTTVLIPLPSEPVSSMTRIVSDPPDVSPLVCS 259

Query: 245 RKYNQTSSRGIYLWVGIGIGISLLVICFVLSIVLFHHKRRRDEAARKDGKREKKRNLPED 304
            K    S R +Y  +    G S+LV+C VL  V    KR      R +   + K+   ED
Sbjct: 260 SK-KCNSKRKLYTVIAT-TGGSMLVLCVVLYGVFLFRKRSAMFIKRGEQGEKSKKLSSED 317

Query: 305 FLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIING--STVAIKCMRRSISK 362
               ++ ++   K YK+E++  ATENFS KN I GSV+RG+     + +A+K MR   SK
Sbjct: 318 IRGEIAIIEHHSKVYKFEEIEKATENFSSKNRIKGSVYRGVFGKEKNILAVKKMRGDASK 377

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           EVNLL+KINHFNLI L G CE+DG  YLVYE+MENGSL +WL +    E  S   R  IA
Sbjct: 378 EVNLLEKINHFNLIKLQGYCENDGCPYLVYEYMENGSLREWLSRNGSTEHQSLARRILIA 437

Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV-RSAVREESGYSSTKT 481
           LDVA+GL YLHN T+P YVH++I+SG+ILL+K+LRAK+A+F+    S  +  SG +S+  
Sbjct: 438 LDVANGLQYLHNFTEPCYVHRNINSGSILLNKDLRAKIADFALAEESESKITSGCASSHI 497

Query: 482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVE 541
           A  + GYMAPEY+E G VT +MD +AFGVVLLELITGK+A   QDG E++L   + +++ 
Sbjct: 498 A-KSRGYMAPEYLEAGKVTTKMDVFAFGVVLLELITGKDAVTLQDGREVMLRAFIVNLIG 556

Query: 542 GGNAEAKLSVLVDPNLQANKKEI-AHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
             + E K S+ +DP+L  N +++ A  L+ L LAC+ +E   RP+M EVVS+L+K
Sbjct: 557 KEDEEEKESLFIDPSLNGNIEKVWALQLVKLGLACLIQESAERPTMVEVVSSLLK 611

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224096894|ref|XP_002310777.1| predicted protein [Populus trichocarpa] gi|222853680|gb|EEE91227.1| predicted protein [Populus trichocarpa]

 Score =  489 bits (1259), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 276/612 (45%), Positives = 384/612 (62%), Gaps = 28/612 (4%)

Query: 4   LHAQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLT 63
           + AQQ Y G     C++ + +    A  Y+CNG N+ CQ +LIF+SQPPY TV+SIS L 
Sbjct: 21  IQAQQPYVGKGTTKCSNTENS----ALGYSCNGLNKSCQAYLIFRSQPPYSTVASISTLL 76

Query: 64  SSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANN 123
            SDP++L+++N++S + +  P ++ V+VPV+C CSG Y+QAN S+I+ +  +T F IANN
Sbjct: 77  GSDPSQLSQINSVSETTS-FPTNQLVLVPVNCSCSGDYFQANASYIVQS-GNTPFLIANN 134

Query: 124 TYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSV 183
           TYQGLSTC  +++E      ++  G TL VPLRCACPT NQ   G ++LL+YLV+WGD+V
Sbjct: 135 TYQGLSTCQAIRNEKGTRTVNIFAGETLTVPLRCACPTKNQSDLGIRYLLSYLVTWGDTV 194

Query: 184 PDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTIIHYPPPPSSPIVP 243
                RF   I   + AN  +E +P ++PFTT+LIPL   P SSQT++  PPP S    P
Sbjct: 195 SIAGVRFGADIGRALEANEISEKNPTIYPFTTLLIPLKNPPTSSQTVVPPPPPASPSPSP 254

Query: 244 TRKYNQTSSRG----IYLWVGIGIGISL-LVICFVLSIVLFHHKRRRD---------EAA 289
                 +        IY++VG   GI L LVI  ++  +LF   +++          EA 
Sbjct: 255 PSPSPNSDKSANKTWIYVFVGAVGGIVLTLVIGTIIFFMLFRKSKKQPGPIIVSQSFEAH 314

Query: 290 RKDGKREKKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGS 349
            K   R K    P+D L SV ++ + +K Y YEDL  AT+NFSP   I GSVFRG+ING 
Sbjct: 315 EKPLNR-KLDEEPQDLLESVYSIAQSIKVYNYEDLKAATDNFSPSFWIKGSVFRGLINGD 373

Query: 350 TVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH-KKR 408
             AIK M   +SKE++LL KINH NLI L G C +DG +YLVYE+  NG LSDW++    
Sbjct: 374 FAAIKKMNGDVSKEIDLLNKINHSNLIRLSGVCFNDGHWYLVYEYAANGPLSDWIYVSSN 433

Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
             +F+ W  R +IA DVA GL+YLH+ T+  +VHKDI S NILLDK+LRAK+ANFS  RS
Sbjct: 434 EGKFLKWTQRIQIATDVATGLNYLHSFTNYPHVHKDIKSSNILLDKDLRAKIANFSLARS 493

Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAA--YKQD 526
               E  ++ T+  VGT GYMAPEY+E G++  ++D YAFG++ LE++TGKE A  Y+++
Sbjct: 494 TDGPEGEFALTRHIVGTKGYMAPEYLENGIICTKLDVYAFGILTLEIMTGKEVAALYREE 553

Query: 527 GEEIL-LAEAVFSMVEGGNAEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRP 584
             E+  +   V S  E G  E  LS L+DP++Q N    +A  ++ L  +C+ + P  RP
Sbjct: 554 NRELSDVLNGVLS--EEGGLEESLSQLIDPSMQGNYPSGLAVLMVRLIDSCLNKNPAGRP 611

Query: 585 SMAEVVSTLMKI 596
           +M E+V +L  I
Sbjct: 612 AMDEIVQSLSGI 623

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225430870|ref|XP_002269408.1| PREDICTED: wall-associated receptor kinase-like 4-like [Vitis vinifera]

 Score =  483 bits (1243), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 275/605 (45%), Positives = 376/605 (62%), Gaps = 25/605 (4%)

Query: 6   AQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLTSS 65
           AQQ+Y G    DC   D N  +    Y CNG N  CQ FLIF+S+PPY+ VSSIS+L  S
Sbjct: 23  AQQSYVGKGTTDC---DNNNLTSVLGYACNGVNASCQAFLIFRSEPPYNDVSSISDLLGS 79

Query: 66  DPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANNTY 125
           DP++LA++N++ +  A     KEVIVPV+C CSG + QANTS+++     TY  IANNT+
Sbjct: 80  DPSQLAQINSV-DETATFETKKEVIVPVNCSCSGEFSQANTSYVVQH-GDTYLLIANNTF 137

Query: 126 QGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPD 185
           +GLSTC  L+ +     T++  G  L VPLRCACPT NQ   G K+L++YLV+ GD V  
Sbjct: 138 EGLSTCQALRSQRTSLTTNIYTGTKLTVPLRCACPTKNQSDVGVKYLMSYLVASGDYVSS 197

Query: 186 ISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTIIHYPPPPSSPIVPTR 245
           IS RF V     + AN  +E +P ++PFTT+LIPL   P SSQTI+  PPPP SP  PT 
Sbjct: 198 ISVRFGVDTGMTLEANELSEQNPNIYPFTTLLIPLQNLPSSSQTIVPPPPPPPSPPPPTA 257

Query: 246 KYNQTSS--RGIYLWVGIGIGISLLVICF--VLSIVLFHHKRRRD---------EAARKD 292
             + + S  +     V   +  S LV+ F  V+    F   R++          EA  K 
Sbjct: 258 VSSPSKSLKKTWVYVVVGVVAGSALVLLFGSVIFFKFFRKTRKKTDPIAISESFEACEKP 317

Query: 293 GKREKKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVA 352
            K E+      +FL S+S++ + LK YK+E+L  AT+NFSP   I GSV+RG I G   A
Sbjct: 318 LKEEQ-----HEFLESISSIAQSLKVYKFEELQSATDNFSPNCRIKGSVYRGTIKGDLAA 372

Query: 353 IKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY-PE 411
           IK M   +S E+ LL KINHFN+I L G C +DG +YLV+E+  NG L+DW++       
Sbjct: 373 IKKMDGEVSNEIALLNKINHFNVIRLSGICFNDGHWYLVHEYAVNGPLTDWIYNNNDDSR 432

Query: 412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR 471
           F+ W  R +IALDVA GL+YLH+ T P YVHKDI SGN+LLD + RAK+ANF   RSA  
Sbjct: 433 FLVWMQRIQIALDVATGLNYLHSYTSPPYVHKDIKSGNVLLDSDFRAKIANFGLARSAEG 492

Query: 472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
           +E  ++ T+  +GT GYMAPEY+E GLV+ ++D YAFGV++LE++TGKE A   +GE + 
Sbjct: 493 QEGQFALTRHIIGTRGYMAPEYLENGLVSTKLDVYAFGVLMLEMLTGKEVAALYEGENMH 552

Query: 532 LAEAVFSMVEGGNAEAKLSVLVDPNLQANKK-EIAHHLIMLCLACIAREPESRPSMAEVV 590
           L + + +++  G+ + KL   +DP+L  N   E+A  +I L  +C+ + P SRP M E+V
Sbjct: 553 LPDVLVAVLHEGDGKEKLRNFIDPSLSGNYPLELAIVMIRLIDSCLKKSPASRPDMVEIV 612

Query: 591 STLMK 595
             L +
Sbjct: 613 QALSR 617

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297735221|emb|CBI17583.3| unnamed protein product [Vitis vinifera]

 Score =  481 bits (1238), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 265/603 (43%), Positives = 363/603 (60%), Gaps = 45/603 (7%)

Query: 6   AQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLTSS 65
           AQQ+Y G    DC   D N  +    Y CNG N  CQ FLIF+S+PPY+ VSSIS+L  S
Sbjct: 43  AQQSYVGKGTTDC---DNNNLTSVLGYACNGVNASCQAFLIFRSEPPYNDVSSISDLLGS 99

Query: 66  DPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANNTY 125
           DP++LA++N++ +  A     KEVIVPV+C CSG + QANTS+++     TY  IANNT+
Sbjct: 100 DPSQLAQINSV-DETATFETKKEVIVPVNCSCSGEFSQANTSYVVQH-GDTYLLIANNTF 157

Query: 126 QGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPD 185
           +GLSTC  L+ +     T++  G  L VPLRCACPT NQ   G K+L++YLV+ GD V  
Sbjct: 158 EGLSTCQALRSQRTSLTTNIYTGTKLTVPLRCACPTKNQSDVGVKYLMSYLVASGDYVSS 217

Query: 186 ISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTIIHYPPPPSSPIVPTR 245
           IS RF V     + AN  +E +P ++PFTT+LIPL   P SSQTI  +       +    
Sbjct: 218 ISVRFGVDTGMTLEANELSEQNPNIYPFTTLLIPLQNLPSSSQTIKTWVYVVVGVVAG-- 275

Query: 246 KYNQTSSRGIYLWVGIGIGISLLVICF--VLSIVLFHHKRRRD---------EAARKDGK 294
                               S LV+ F  V+    F   R++          EA  K  K
Sbjct: 276 --------------------SALVLLFGSVIFFKFFRKTRKKTDPIAISESFEACEKPLK 315

Query: 295 REKKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIK 354
            E+      +FL S+S++ + LK YK+E+L  AT+NFSP   I GSV+RG I G   AIK
Sbjct: 316 EEQ-----HEFLESISSIAQSLKVYKFEELQSATDNFSPNCRIKGSVYRGTIKGDLAAIK 370

Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY-PEFV 413
            M   +S E+ LL KINHFN+I L G C +DG +YLV+E+  NG L+DW++       F+
Sbjct: 371 KMDGEVSNEIALLNKINHFNVIRLSGICFNDGHWYLVHEYAVNGPLTDWIYNNNDDSRFL 430

Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
            W  R +IALDVA GL+YLH+ T P YVHKDI SGN+LLD + RAK+ANF   RSA  +E
Sbjct: 431 VWMQRIQIALDVATGLNYLHSYTSPPYVHKDIKSGNVLLDSDFRAKIANFGLARSAEGQE 490

Query: 474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA 533
             ++ T+  +GT GYMAPEY+E GLV+ ++D YAFGV++LE++TGKE A   +GE + L 
Sbjct: 491 GQFALTRHIIGTRGYMAPEYLENGLVSTKLDVYAFGVLMLEMLTGKEVAALYEGENMHLP 550

Query: 534 EAVFSMVEGGNAEAKLSVLVDPNLQANKK-EIAHHLIMLCLACIAREPESRPSMAEVVST 592
           + + +++  G+ + KL   +DP+L  N   E+A  +I L  +C+ + P SRP M E+V  
Sbjct: 551 DVLVAVLHEGDGKEKLRNFIDPSLSGNYPLELAIVMIRLIDSCLKKSPASRPDMVEIVQA 610

Query: 593 LMK 595
           L +
Sbjct: 611 LSR 613

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224133922|ref|XP_002327712.1| predicted protein [Populus trichocarpa] gi|222836797|gb|EEE75190.1| predicted protein [Populus trichocarpa]

 Score =  474 bits (1220), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 267/609 (43%), Positives = 380/609 (62%), Gaps = 24/609 (3%)

Query: 4   LHAQQNYSGNSVMDCNDDDENGPSPAFLYTCNGNNRPCQGFLIFKSQPPYDTVSSISNLT 63
           + AQQ Y G +  +C+    N  + A  Y+CN  N+ CQ +LIF+SQPPY+TV+SIS L 
Sbjct: 10  IQAQQPYVGKATTNCS----NTENSALGYSCNALNKSCQAYLIFRSQPPYNTVASISTLL 65

Query: 64  SSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANN 123
            SDP++L+ VN++S + +  P ++ VIVPV+C CSG Y QAN S+I+     T F IANN
Sbjct: 66  GSDPSQLSEVNSVSETTS-FPSNQLVIVPVNCSCSGEYSQANASYIVQP-NDTLFLIANN 123

Query: 124 TYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSV 183
           TYQGLSTC  L+++       +  G TL VPLRCACPT NQ   G ++LL+YLV+ GD V
Sbjct: 124 TYQGLSTCQALQNQKTTRTDDILSGETLTVPLRCACPTKNQSDLGIRYLLSYLVTPGDDV 183

Query: 184 PDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTIIHYPPPPSSPIVP 243
           P IS++F  +    + ANG  E +P +FPFTT+LIPL + P SSQT++  PPP SS    
Sbjct: 184 PAISEQFGAATGRTLEANGLPEQNPTIFPFTTLLIPLQSTPTSSQTVVPPPPPASSSPPS 243

Query: 244 TRKYNQTSSRGIYLWVGIGIGISLLVICFVLSIVLFHHKRRRDEA-----------ARKD 292
                + SS+  +L+V +G+   + +   + +I+ F   R+  +            A + 
Sbjct: 244 PSPNPEKSSKKTWLYVVVGVVGGIALTIVIGTIIFFMLSRKSKKQPGPVIESQSFEAHEK 303

Query: 293 GKREKKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVA 352
              +K     ++F  S+S + + +K YK+EDL  AT+NFSP   I GSV+RG+ING   A
Sbjct: 304 PLNKKLDEESQEFFESISAIAQSIKVYKFEDLKAATDNFSPSCWIKGSVYRGLINGDFAA 363

Query: 353 IKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH-KKRYPE 411
           IK M   +SKE+ LL KINH NLI L G C +DG +YLVYE+  +G LSDW++ +    +
Sbjct: 364 IKKMNGDVSKEIELLNKINHSNLIRLSGVCFNDGHWYLVYEYAASGQLSDWIYDRSNEGK 423

Query: 412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR 471
           F++W  R +IA DVA GL+YLH+ T+  +VHKDI S NILLD +LRAK+ANFS  RS   
Sbjct: 424 FLNWTKRIQIASDVATGLNYLHSFTNYPHVHKDIKSSNILLDSDLRAKIANFSLARSTGD 483

Query: 472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
           ++  +  T+  VGT GYMAPEY+E G+V+ ++D YAFG++ LE+ITGKE A     E   
Sbjct: 484 QDDEFVLTRHIVGTKGYMAPEYLENGVVSSKLDVYAFGILTLEIITGKEVAALHSEESRN 543

Query: 532 LAEAV---FSMVEGGNAEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMA 587
           L++ +    S V+G   E  L  L+DP+L  N    +A  ++ L  +C+ + P  RP+M 
Sbjct: 544 LSDVLNGALSEVDG--QEESLKQLIDPSLHENYPSGLAVLVVRLIDSCLNKNPGDRPTMD 601

Query: 588 EVVSTLMKI 596
           E+V +L +I
Sbjct: 602 EIVQSLSRI 610

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	611
TAIR|locus:2050987	664	LYK5 "LysM-containing receptor	0.474	0.436	0.432	1.2e-100
TAIR|locus:2049029	612	LYK4 "LysM-containing receptor	0.379	0.379	0.451	4.9e-91
TAIR|locus:2089860	617	CERK1 "chitin elicitor recepto	0.453	0.448	0.394	6.8e-51
UNIPROTKB|D7UPN3	605	CERK1 "Chitin elicitor recepto	0.567	0.573	0.342	8.7e-51
TAIR|locus:2195814	651	LYK3 "LysM-containing receptor	0.466	0.437	0.358	2.1e-49
TAIR|locus:2012325	466	AT1G09440 [Arabidopsis thalian	0.471	0.618	0.338	3.3e-45
TAIR|locus:2026785	646	CRK3 "cysteine-rich RLK (RECEP	0.533	0.504	0.350	4.6e-45
TAIR|locus:2126540	876	AT4G29990 [Arabidopsis thalian	0.531	0.371	0.352	1.4e-43
TAIR|locus:2082359	654	LYK2 "LysM-containing receptor	0.440	0.411	0.312	3.1e-43
TAIR|locus:2045620	494	AT2G42960 [Arabidopsis thalian	0.456	0.564	0.357	8.5e-43

TAIR|locus:2050987 LYK5 "LysM-containing receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 618 (222.6 bits), Expect = 1.2e-100, Sum P(2) = 1.2e-100
 Identities = 131/303 (43%), Positives = 189/303 (62%)

Query:   316 LKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISK-EVNLLKKINHFN 374
             L  Y++ DL  AT NFS +N I GSV+R  ING   A+K ++  +S  E+NLLKK+NH N
Sbjct:   357 LTLYRFNDLQSATSNFSDENRIKGSVYRATINGDDAAVKVIKGDVSSSEINLLKKLNHSN 416

Query:   375 LINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHN 434
             +I L G C  +G  YLV+E+ ENGS+SDWLH     + ++W  R  IA DVA  L YLHN
Sbjct:   417 IIRLSGFCIREGTSYLVFEYSENGSISDWLHSSG-KKSLTWKQRVEIARDVAEALDYLHN 475

Query:   435 CTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM 494
                P ++HK++ S NILLD N RAK+ANF   R     +     T+   GT GY+APEY+
Sbjct:   476 YITPPHIHKNLESTNILLDSNFRAKIANFGVARILDEGDLDLQLTRHVEGTQGYLAPEYV 535

Query:   495 EYGLVTPEMDTYAFGVVLLELITGKEAAY---KQDGEEI--LLAEAVFSMVEGGNAEAKL 549
             E G++T ++D +AFGV +LEL++G+EA     K++GEE   +L + + S++ G N   KL
Sbjct:   536 ENGVITSKLDVFAFGVAVLELLSGREAVTIHKKKEGEEEVEMLCKVINSVLGGENVREKL 595

Query:   550 SVLVDPNLQANKK--EIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI---QLDVQRSQ 604
                +DP+L  N+   E+A+ +  L  +C+A +  SRPS+ +V++TL  I    +D + S 
Sbjct:   596 KEFMDPSL-GNEYPLELAYTMAQLAKSCVATDLNSRPSVTQVLTTLSMIVSSSIDWEPSD 654

Query:   605 TLL 607
              LL
Sbjct:   655 DLL 657

GO:0005576 "extracellular region" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

GO:0008061 "chitin binding" evidence=IDA

GO:0071323 "cellular response to chitin" evidence=IEP

TAIR|locus:2049029 LYK4 "LysM-containing receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 519 (187.8 bits), Expect = 4.9e-91, Sum P(2) = 4.9e-91
 Identities = 108/239 (45%), Positives = 153/239 (64%)

Query:   293 GKREKKRNLPEDFLVSVSNLD-RGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTV 351
             GK+    +   D L  +S +    LK YK+ +L  AT +F+  + I GS + G ING   
Sbjct:   317 GKKPPMSDQEFDPLDGLSGMVVESLKVYKFHELQSATSDFTSSSSIGGSGYIGKINGDGA 376

Query:   352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE 411
              IK +  + S+EVNLL K+NH N+I L G C H+G +YLVYE   NGSLS+W+H  +   
Sbjct:   377 MIKKIEGNASEEVNLLSKLNHLNIIRLSGFCFHEGDWYLVYEHASNGSLSEWIHTTK--S 434

Query:   412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR 471
              +S   + +IALD+A GL+YLHN  DP YVH+D++S N+ LD   RAK+ +    RS   
Sbjct:   435 LLSLTQKLQIALDIATGLNYLHNFADPPYVHRDLNSNNVFLDLEFRAKIGSLGSARSTTE 494

Query:   472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAA-YKQDGEE 529
             +   +  TK   GT GY+APEY+E+GLV+ ++D YAFGVVLLE++TGKEA+  K++ +E
Sbjct:   495 D---FVLTKHVEGTRGYLAPEYLEHGLVSTKLDVYAFGVVLLEIVTGKEASELKKEIDE 550

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0008061 "chitin binding" evidence=IDA

GO:0045087 "innate immune response" evidence=IMP

GO:0071219 "cellular response to molecule of bacterial origin" evidence=IEP

GO:0071323 "cellular response to chitin" evidence=IEP

TAIR|locus:2089860 CERK1 "chitin elicitor receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 437 (158.9 bits), Expect = 6.8e-51, Sum P(2) = 6.8e-51
 Identities = 119/302 (39%), Positives = 168/302 (55%)

Query:   307 VSVSNLDRGLKFYKYEDLVVATENFSPKNMID----GSVFRGIINGSTVAIKCMRRSISK 362
             ++  ++D+ ++F   E+L  AT+NF+    I     G+V+   + G   AIK M    SK
Sbjct:   299 IAAISVDKSVEF-SLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKAAIKKMDMEASK 357

Query:   363 ----EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYPEFVSWNC 417
                 E+ +L +++H NL+ L G C  +G  +LVYE++ENG+L   LH   R P  + W  
Sbjct:   358 QFLAELKVLTRVHHVNLVRLIGYCV-EGSLFLVYEYVENGNLGQHLHGSGREP--LPWTK 414

Query:   418 RFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS 477
             R +IALD A GL Y+H  T P YVH+DI S NIL+D+  RAK+A+F   +     E G S
Sbjct:   415 RVQIALDSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLTKLT---EVGGS 471

Query:   478 STKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQD---GEEILLAE 534
             +T+ A+GT GYMAPE + YG V+ ++D YAFGVVL ELI+ K A  K     GE   L  
Sbjct:   472 ATRGAMGTFGYMAPETV-YGEVSAKVDVYAFGVVLYELISAKGAVVKMTEAVGEFRGLV- 529

Query:   535 AVF--SMVEGGNAEAKLSVLVDPNL-QANKKEIAHHLIMLCLACIAREPESRPSMAEVVS 591
              VF  S  E    EA L  ++DP L  +   +  + +  L  AC     + RPSM  +V 
Sbjct:   530 GVFEESFKETDKEEA-LRKIIDPRLGDSYPFDSVYKMAELGKACTQENAQLRPSMRYIVV 588

Query:   592 TL 593
              L
Sbjct:   589 AL 590

GO:0005576 "extracellular region" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=IMP;IDA

GO:0032491 "detection of molecule of fungal origin" evidence=IEP;IMP

GO:0035556 "intracellular signal transduction" evidence=RCA;IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009817 "defense response to fungus, incompatible interaction" evidence=IMP

GO:0010200 "response to chitin" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0002752 "cell surface pattern recognition receptor signaling pathway" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IDA

GO:0008061 "chitin binding" evidence=IDA

GO:2001080 "chitosan binding" evidence=IDA

GO:0032499 "detection of peptidoglycan" evidence=IMP

GO:0045087 "innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0071219 "cellular response to molecule of bacterial origin" evidence=IEP

GO:0071323 "cellular response to chitin" evidence=IEP

UNIPROTKB|D7UPN3 CERK1 "Chitin elicitor receptor kinase 1" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 476 (172.6 bits), Expect = 8.7e-51, Sum P(2) = 8.7e-51
 Identities = 128/374 (34%), Positives = 199/374 (53%)

Query:   243 PTRKYNQTSSRGIYLWVXXXXXXSLLVIC---FVLSI---VLFHHKRRRDEAARKDGKRE 296
             P   Y+   S G+   +       +++ C   F+++I   ++F+  ++  +A  +    E
Sbjct:   225 PNGSYHPLKSGGMGNSLSGGAIAGIVIACIAIFIVAIWLIIMFYRWQKFRKATSRPSPEE 284

Query:   297 KKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMID----GSVFRGIINGSTVA 352
                +L +        ++R ++F  YE++  AT+ FS ++ I     GSV+   + G   A
Sbjct:   285 TS-HLDDASQAEGIKVERSIEF-SYEEIFNATQGFSMEHKIGQGGFGSVYYAELRGEKTA 342

Query:   353 IKCMRRSISKE----VNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             IK M    ++E    + +L  ++H NL+ L G C  + +F LVYEF++NG+LS  L +  
Sbjct:   343 IKKMGMQATQEFLAELKVLTHVHHLNLVRLIGYCVENCLF-LVYEFIDNGNLSQHLQRTG 401

Query:   409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR- 467
             Y   +SW  R +IALD A GL YLH    P YVH+DI S NILLDK+ RAK+A+F   + 
Sbjct:   402 YAP-LSWATRVQIALDSARGLEYLHEHVVPVYVHRDIKSANILLDKDFRAKIADFGLAKL 460

Query:   468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDG 527
             + V   S   ST+ A GT GYM PE   YG V+P++D YAFGVVL EL++ K+A  +   
Sbjct:   461 TEVGSMSQSLSTRVA-GTFGYMPPE-ARYGEVSPKVDVYAFGVVLYELLSAKQAIVRSS- 517

Query:   528 EEILLAEAVFSMVEGG----NAEAKLSVLVDPNLQANKK-EIAHHLIMLCLACIAREPES 582
             E +  ++ +  + E      N    L  L+DP+LQ +   + A  +  L  +C   EP  
Sbjct:   518 ESVSESKGLVFLFEEALSAPNPTEALDELIDPSLQGDYPVDSALKIASLAKSCTHEEPGM 577

Query:   583 RPSMAEVVSTLMKI 596
             RP+M  VV  LM +
Sbjct:   578 RPTMRSVVVALMAL 591

GO:0005515 "protein binding" evidence=IPI

GO:0008061 "chitin binding" evidence=IDA

GO:0010200 "response to chitin" evidence=IDA

GO:0043621 "protein self-association" evidence=IDA

TAIR|locus:2195814 LYK3 "LysM-containing receptor-like kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 434 (157.8 bits), Expect = 2.1e-49, Sum P(2) = 2.1e-49
 Identities = 112/312 (35%), Positives = 169/312 (54%)

Query:   319 YKYEDLVVATENFSPKNMID----GSVFRGIINGSTVAIKCMRRSISKE----VNLLKKI 370
             + YE++  AT+ FS  N++     GSV+ G++    VA+K M  + +KE    + +L K+
Sbjct:   329 FTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVKRMTATKTKEFAAEMKVLCKV 388

Query:   371 NHFNLINLFG-ACEHDGVFYLVYEFMENGSLSDWLH----KKRYPEFVSWNCRFRIALDV 425
             +H NL+ L G A   D +F +VYE++  G L   LH    K   P  +SW  R +IALD 
Sbjct:   389 HHSNLVELIGYAATVDELF-VVYEYVRKGMLKSHLHDPQSKGNTP--LSWIMRNQIALDA 445

Query:   426 AHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT 485
             A GL Y+H  T   YVH+DI + NILLD+  RAK+++F   +   +   G  S    VGT
Sbjct:   446 ARGLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAKLVEKTGEGEISVTKVVGT 505

Query:   486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDG------EEILLAEAVFSM 539
              GY+APEY+  GL T + D YAFGVVL E+I+G+EA  + +       E   LA  + ++
Sbjct:   506 YGYLAPEYLSDGLATSKSDIYAFGVVLFEIISGREAVIRTEAIGTKNPERRPLASIMLAV 565

Query:   540 VEGGNAEAKLSVL---VDPNLQ-ANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
             ++       +S L   VDPN+      +    +  L   C+  +P  RP+M +VV +L +
Sbjct:   566 LKNSPDSMNMSSLKEFVDPNMMDLYPHDCLFKIATLAKQCVDDDPILRPNMKQVVISLSQ 625

Query:   596 IQLD-VQRSQTL 606
             I L  ++   TL
Sbjct:   626 ILLSSIEWEATL 637

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016998 "cell wall macromolecule catabolic process" evidence=IEA

GO:0007020 "microtubule nucleation" evidence=RCA

TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)]

 Score = 435 (158.2 bits), Expect = 3.3e-45, Sum P(2) = 3.3e-45
 Identities = 105/310 (33%), Positives = 168/310 (54%)

Query:   310 SNLDRGLKFYKYEDLVVATENFSPKNMID----GSVFRG-IINGSTVAIKCMRRSISK-- 362
             S+L  G  ++   DL +AT  FS +N+I     G V+RG ++NGS VA+K +   + +  
Sbjct:   137 SHLGWG-HWFTLRDLEIATNRFSKENVIGEGGYGVVYRGELVNGSLVAVKKILNHLGQAE 195

Query:   363 -----EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH-KKRYPEFVSWN 416
                  EV+ +  + H NL+ L G C       LVYE+M NG+L +WLH   ++  +++W 
Sbjct:   196 KEFRVEVDAIGHVRHKNLVRLLGYCIEGTNRILVYEYMNNGNLEEWLHGAMKHHGYLTWE 255

Query:   417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
              R ++    +  L YLH   +P  VH+DI S NIL+D    AK+++F   +  + +   +
Sbjct:   256 ARMKVLTGTSKALAYLHEAIEPKVVHRDIKSSNILIDDRFNAKISDFGLAK-LLGDGKSH 314

Query:   477 SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAA-YKQDGEEILLAEA 535
              +T+  +GT GY+APEY   GL+  + D Y+FGV++LE ITG++   Y +   E+ L E 
Sbjct:   315 VTTRV-MGTFGYVAPEYANTGLLNEKSDVYSFGVLVLEAITGRDPVDYARPANEVNLVEW 373

Query:   536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML-CLACIAREPESRPSMAEVVSTLM 594
             +  MV G     +L  ++DPN+       A   ++L  L CI  + E RP M++VV  L 
Sbjct:   374 LKMMV-GSK---RLEEVIDPNIAVRPATRALKRVLLTALRCIDPDSEKRPKMSQVVRMLE 429

Query:   595 KIQLDVQRSQ 604
               +  V R +
Sbjct:   430 SEEYPVPREE 439

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2026785 CRK3 "cysteine-rich RLK (RECEPTOR-like protein kinase) 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 443 (161.0 bits), Expect = 4.6e-45, Sum P(2) = 4.6e-45
 Identities = 126/359 (35%), Positives = 200/359 (55%)

Query:   256 YLWVXXXXXXSLLVICFVLSIVLFHHKRRRDEAARKDGKREKKRNLPEDFLVSVSNLDRG 315
             +L V      S++    ++S   F  K+R    A+K  +REKK+      L + SNL   
Sbjct:   258 HLGVILAVTSSVVAFVLLVSAAGFLLKKRH---AKK--QREKKQLGSLFMLANKSNL--- 309

Query:   316 LKFYKYEDLVVATENFSPKNMI----DGSVFRGII-NGSTVAIKCM----RRSIS---KE 363
                + YE+L  AT+ FS KN +     GSV++G++ NG TVA+K +    ++ +     E
Sbjct:   310 --CFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNTKQWVDHFFNE 367

Query:   364 VNLLKKINHFNLINLFGACEHDGV-FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
             VNL+ +++H NL+ L G C   G    LVYE++ N SL D+L  ++  + ++W  RF+I 
Sbjct:   368 VNLISQVDHKNLVKLLG-CSITGPESLLVYEYIANQSLHDYLFVRKDVQPLNWAKRFKII 426

Query:   423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
             L  A G+ YLH  ++   +H+DI   NILL+ +   ++A+F   R    E+  + ST  A
Sbjct:   427 LGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLAR-LFPEDKTHISTAIA 485

Query:   483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA-AYKQDGEEILLAEAVFSMVE 541
              GT GYMAPEY+  G +T + D Y+FGV+++E+ITGK   A+ QD   IL  ++V+S+  
Sbjct:   486 -GTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQDAGSIL--QSVWSLYR 542

Query:   542 GGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV 600
               N E  +  ++  N   NK E A  L+ + L C+    + RP+M+ VV  +MK  L++
Sbjct:   543 TSNVEEAVDPILGDNF--NKIE-ASRLLQIGLLCVQAAFDQRPAMSVVVK-MMKGSLEI 597

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)]

 Score = 468 (169.8 bits), Expect = 1.4e-43, P = 1.4e-43
 Identities = 126/357 (35%), Positives = 188/357 (52%)

Query:   250 TSSRGI-YLWVXXXXXXSLLVICFVLSIVLFHHKRRRDEAARKDGKREKKRNLPEDFLVS 308
             T+ + I Y+         LL++   L+++ +H K+R         +R    N P    V+
Sbjct:   505 TTKKKIGYIVPVVASLAGLLIVLTALALI-WHFKKR--------SRRGTISNKPLG--VN 553

Query:   309 VSNLDRGLKFYKYEDLVVATENFSP---KNMIDGSVFRGIINGSTVAIKCMRRSISK--- 362
                LD   +++ Y ++V  T NF     K    G V+ G +NG  VA+K +    ++   
Sbjct:   554 TGPLDTAKRYFIYSEVVNITNNFERVLGKGGF-GKVYHGFLNGDQVAVKILSEESTQGYK 612

Query:   363 ----EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR 418
                 EV LL +++H NL +L G C  D    L+YE+M NG+L D+L  K     +SW  R
Sbjct:   613 EFRAEVELLMRVHHTNLTSLIGYCNEDNHMALIYEYMANGNLGDYLSGKS-SLILSWEER 671

Query:   419 FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS 478
              +I+LD A GL YLH    P  VH+D+   NILL++NL+AK+A+F   RS   E S   S
Sbjct:   672 LQISLDAAQGLEYLHYGCKPPIVHRDVKPANILLNENLQAKIADFGLSRSFPVEGSSQVS 731

Query:   479 TKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFS 538
             T  A GT GY+ PEY     +  + D Y+FGVVLLE+ITGK A +    E + L++ V S
Sbjct:   732 TVVA-GTIGYLDPEYYATRQMNEKSDVYSFGVVLLEVITGKPAIWHSRTESVHLSDQVGS 790

Query:   539 MVEGGNAEAKLSVLVDPNLQANKKEI--AHHLIMLCLACIAREPESRPSMAEVVSTL 593
             M+  G+ +     +VD  L  ++ E+  A  +  L LAC +   E RP+M++VV  L
Sbjct:   791 MLANGDIKG----IVDQRL-GDRFEVGSAWKITELALACASESSEQRPTMSQVVMEL 842

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2082359 LYK2 "LysM-containing receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 298 (110.0 bits), Expect = 3.1e-43, Sum P(2) = 3.1e-43
 Identities = 94/301 (31%), Positives = 151/301 (50%)

Query:   316 LKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISK--EVNLLKKINHF 373
             L+ Y +E+L  ATENFS  N I GSV+ G + G  +AIK +     K  +  LL   +H+
Sbjct:   330 LEIYAFEELEKATENFSSSNHIKGSVYFGSLKGKDLAIKQVNADEMKRFDFGLLNDQSHY 389

Query:   374 ---NLINLFGAC--EHDGVFYLVYEFMENGSLSDWLHKK-----RYPE----FVSWNCRF 419
                N+I + G C  E D   YLV+E+  NGSL DW+  K     ++ E    F++W  R 
Sbjct:   390 YNHNVIRVLGTCFREIDQDSYLVFEYARNGSLWDWIQNKLAIKNQFIESCYCFLAWKQRI 449

Query:   420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             +I  DVA  L Y+H      YVH +I S NI L+++LR K+ NF   +    E    ++ 
Sbjct:   450 KICHDVAIALKYMHRIN---YVHGNIKSRNIFLNEDLRGKVGNFGMSKCVTNE---LATE 503

Query:   480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDG-EEILLAEAVFS 538
             +  + ++   A +   YG++  E+ +     +LL L   +E      G +E  ++E  +S
Sbjct:   504 ENLIESSLSPASDIFAYGIIVMEVLSGQTPDMLLGL---QEVETTSLGTQETFVSE--WS 558

Query:   539 MVEG--GNAEAKLSVLVDPNL-QANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
              +    G+ E KL  ++D  L ++   + A  +  +   C A E ESRPS  E+   + +
Sbjct:   559 RLRRLLGDKE-KLREVMDSTLGESYSVDSAFEIASIARDCTAEEAESRPSAVEIAERVSR 617

Query:   596 I 596
             +
Sbjct:   618 L 618

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)]

 Score = 426 (155.0 bits), Expect = 8.5e-43, Sum P(2) = 8.5e-43
 Identities = 109/305 (35%), Positives = 163/305 (53%)

Query:   306 LVSVSNLDRGLKFYKYEDLVVATENFSPKNMID----GSVFRG-IINGSTVAIKCMRRSI 360
             L  +S+L  G  ++   DL +AT  F+P N++     G V+RG ++NG+ VA+K +  ++
Sbjct:   159 LPEISHLGWG-HWFTLRDLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNL 217

Query:   361 SK-------EVNLLKKINHFNLINLFGACEHDGVF-YLVYEFMENGSLSDWLH-KKRYPE 411
              +       EV  +  + H NL+ L G C  +GV   LVYE++ +G+L  WLH   R   
Sbjct:   218 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCI-EGVHRMLVYEYVNSGNLEQWLHGAMRQHG 276

Query:   412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR 471
              ++W  R +I    A  L YLH   +P  VH+DI + NIL+D    AKL++F   +    
Sbjct:   277 NLTWEARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLL-- 334

Query:   472 EESGYSSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAA-YKQDGEE 529
              +SG S   T V GT GY+APEY   GL+  + D Y+FGV+LLE ITG++   Y +   E
Sbjct:   335 -DSGESHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANE 393

Query:   530 ILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAE 588
             + L E +  MV    AE     +VDP L+    K      +++ L C+  E E RP M++
Sbjct:   394 VNLVEWLKMMVGTRRAEE----VVDPRLEPRPSKSALKRALLVSLRCVDPEAEKRPRMSQ 449

Query:   589 VVSTL 593
             V   L
Sbjct:   450 VARML 454

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O22808	LYK5_ARATH	No assigned EC number	0.3816	0.9689	0.8915	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00014691001 SubName- Full=Chromosome chr18 scaffold_1, whole genome shotgun sequence; (624 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	611
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-42
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-41
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-40
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-40
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-39
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-39
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-28
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-25
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-24
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-24
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-22
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-22
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-22
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	9e-22
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-21
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-20
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-18
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-18
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-17
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-16
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-16
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-16
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-13
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-13
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-13
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-12
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-12
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-11
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	8e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-09
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-08
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-07
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-07
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-06
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-06
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-05
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-05
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-05
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-05
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-05
cd00118	45	cd00118, LysM, Lysine Motif is a small domain invo	8e-05
pfam01476	43	pfam01476, LysM, LysM domain	8e-05
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-04
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-04
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-04
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-04
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.001
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.001
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.001
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.001
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.002
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.002
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.003
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.003
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  150 bits (380), Expect = 8e-42
 Identities = 77/267 (28%), Positives = 112/267 (41%), Gaps = 70/267 (26%)

Query: 339 GSVFRGIINGS--TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G+V+      +   VAIK +           + +E+ +LKK+NH N++ L+G  E +   
Sbjct: 7   GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHL 66

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           YLV E+ E GSL D L +      +S +   RI L +  GL YLH+    G +H+D+   
Sbjct: 67  YLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHSN---GIIHRDLKPE 121

Query: 449 NILLDK-NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE-YMEYGLVTPEMDTY 506
           NILLD  N + KLA+F     +    S  S  KT VGT  YMAPE  +  G  + + D +
Sbjct: 122 NILLDSDNGKVKLADFGL---SKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178

Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           + GV+L EL                                                   
Sbjct: 179 SLGVILYEL-----------------------------------------------PELK 191

Query: 567 HLIMLCLACIAREPESRPSMAEVVSTL 593
            LI   L    ++PE RPS  E++  L
Sbjct: 192 DLIRKML---QKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  148 bits (377), Expect = 7e-41
 Identities = 75/262 (28%), Positives = 115/262 (43%), Gaps = 37/262 (14%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS--------ISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G V+       G  VAIK +++         I +E+ +LKK+ H N++ L+   E +   
Sbjct: 13  GKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKL 72

Query: 389 YLVYEFMENGSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           YLV E+ E G L D L K+ R  E      RF     +   L YLH+    G VH+D+  
Sbjct: 73  YLVMEYCEGGDLFDLLKKRGRLSEDE---ARF-YLRQILSALEYLHSK---GIVHRDLKP 125

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            NILLD++   KLA+F       R+        T VGT  YMAPE +        +D ++
Sbjct: 126 ENILLDEDGHVKLADFGL----ARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWS 181

Query: 508 FGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
            GV+L EL+TGK   +  D + + L + +                  P     + +I+  
Sbjct: 182 LGVILYELLTGK-PPFPGDDQLLELFKKIGKP--------------KPPFPPPEWDISPE 226

Query: 568 LIMLCLACIAREPESRPSMAEV 589
              L    + ++PE R +  E 
Sbjct: 227 AKDLIRKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  147 bits (373), Expect = 2e-40
 Identities = 74/272 (27%), Positives = 127/272 (46%), Gaps = 43/272 (15%)

Query: 339 GSVFRGIINGS------TVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEH 384
           G V++G + G        VA+K ++   S        +E  +++K++H N++ L G C  
Sbjct: 13  GEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTE 72

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +    +V E+M  G L D+L K R P+ +S +     AL +A G+ YL +     ++H+D
Sbjct: 73  EEPLMIVMEYMPGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESK---NFIHRD 128

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG---YMAPEYMEYGLVTP 501
           +++ N L+ +NL  K+++F   R     +          G      +MAPE ++ G  T 
Sbjct: 129 LAARNCLVGENLVVKISDFGLSR-----DLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183

Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK 561
           + D ++FGV+L E+ T  E  Y      +  AE V   ++ G    K             
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEPY----PGMSNAE-VLEYLKKGYRLPKPPNCPP------- 231

Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            E+    +ML   C A +PE RP+ +E+V  L
Sbjct: 232 -ELYK--LMLQ--CWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  146 bits (370), Expect = 7e-40
 Identities = 72/272 (26%), Positives = 126/272 (46%), Gaps = 44/272 (16%)

Query: 339 GSVFRGIINGS------TVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEH 384
           G V++G + G        VA+K ++   S        +E  +++K++H N++ L G C  
Sbjct: 13  GEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTE 72

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +   Y+V E+ME G L  +L K R    +S +     AL +A G+ YL +     ++H+D
Sbjct: 73  EEPLYIVMEYMEGGDLLSYLRKNR--PKLSLSDLLSFALQIARGMEYLESK---NFIHRD 127

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG---YMAPEYMEYGLVTP 501
           +++ N L+ +NL  K+++F   R    ++          G      +MAPE ++ G  T 
Sbjct: 128 LAARNCLVGENLVVKISDFGLSRDLYDDD-----YYRKRGGKLPIRWMAPESLKEGKFTS 182

Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK 561
           + D ++FGV+L E+ T  E  Y      +   E V   ++ G    +             
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQPY----PGMSNEE-VLEYLKNGYRLPQPPNCPP------- 230

Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            E+    +ML   C A +PE RP+ +E+V  L
Sbjct: 231 -ELYD--LMLQ--CWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  144 bits (365), Expect = 3e-39
 Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 55/278 (19%)

Query: 339 GSVFRGIINGS------TVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEH 384
           G V++G + G        VA+K ++   S        +E +++KK++H N++ L G C  
Sbjct: 13  GEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQ 72

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
               Y+V E+M  G L D+L K      +      ++AL +A G+ YL +     +VH+D
Sbjct: 73  GEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLESK---NFVHRD 127

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY-----MAPEYMEYGLV 499
           +++ N L+ +NL  K+++F   R  + E+  Y          G      MAPE ++ G  
Sbjct: 128 LAARNCLVTENLVVKISDFGLSR-DIYEDDYYR-----KRGGGKLPIKWMAPESLKDGKF 181

Query: 500 TPEMDTYAFGVVLLELITGKEAAYKQ-DGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ 558
           T + D ++FGV+L E+ T  E  Y     EE+L       ++E G             L 
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL------ELLEDGY-----------RLP 224

Query: 559 ANK---KEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
             +    E+    +ML   C A +PE RP+ +E+V  L
Sbjct: 225 RPENCPDELYE--LMLQ--CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  144 bits (365), Expect = 4e-39
 Identities = 75/273 (27%), Positives = 124/273 (45%), Gaps = 42/273 (15%)

Query: 339 GSVFRGIINGS-----TVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHD 385
           G V++G + G       VA+K ++   S        KE  ++KK+ H N++ L G C  +
Sbjct: 9   GEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE 68

Query: 386 GVFYLVYEFMENGSLSDWLHKKR------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
              YLV E+ME G L D+L K R          +S       A+ +A G+ YL +     
Sbjct: 69  EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---K 125

Query: 440 YVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV 499
           +VH+D+++ N L+ ++L  K+++F   R    ++     T   +    +MAPE ++ G+ 
Sbjct: 126 FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPESLKDGIF 184

Query: 500 TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA 559
           T + D ++FGV+L E+ T     Y      +   E V   +  G        L  P    
Sbjct: 185 TSKSDVWSFGVLLWEIFTLGATPY----PGLSNEE-VLEYLRKGY------RLPKP---- 229

Query: 560 NKKEIAHH-LIMLCLACIAREPESRPSMAEVVS 591
              E     L  L L+C   +PE RP+ +E+V 
Sbjct: 230 ---EYCPDELYELMLSCWQLDPEDRPTFSELVE 259

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  135 bits (343), Expect = 4e-36
 Identities = 67/193 (34%), Positives = 103/193 (53%), Gaps = 21/193 (10%)

Query: 339 GSVFRGI--INGSTVAIKCMR-RSISK--------EVNLLKKINHFNLINLFGACEHDGV 387
           G+V++      G  VA+K ++ RS           E+ +L++++H N++ L  A E    
Sbjct: 13  GTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH 72

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
            YLV E+ E G L D+L +      +S +   +IAL +  GL YLH+    G +H+D+  
Sbjct: 73  LYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSN---GIIHRDLKP 126

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE-YMEYGLVTPEMDTY 506
            NILLD+N   K+A+F     A +     SS  T VGT  YMAPE  +      P++D +
Sbjct: 127 ENILLDENGVVKIADFGL---AKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVW 183

Query: 507 AFGVVLLELITGK 519
           + GV+L EL+TGK
Sbjct: 184 SLGVILYELLTGK 196

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  125 bits (316), Expect = 2e-32
 Identities = 67/266 (25%), Positives = 113/266 (42%), Gaps = 42/266 (15%)

Query: 339 GSVFRGI--INGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD-- 385
           GSV+  +    G  +A+K +           ++ +E+ +L  + H N++  +G+   +  
Sbjct: 14  GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73

Query: 386 GVFYLVYEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
               +  E++  GSLS  L K  + PE V    R +    +  GL YLH+    G VH+D
Sbjct: 74  NTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IR-KYTRQILEGLAYLHSN---GIVHRD 126

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSS--TKTAVGTNGYMAPEYMEYGLVTPE 502
           I   NIL+D +   KLA+F     A R     +   T +  GT  +MAPE +        
Sbjct: 127 IKGANILVDSDGVVKLADFG---CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA 183

Query: 503 MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK 562
            D ++ G  ++E+ TGK    +          A++ +   G           P +  +  
Sbjct: 184 ADIWSLGCTVIEMATGKPPWSELGN----PMAALYKIGSSGEP---------PEIPEHLS 230

Query: 563 EIAHHLIMLCLACIAREPESRPSMAE 588
           E A   +  CL    R+P+ RP+  E
Sbjct: 231 EEAKDFLRKCL---RRDPKKRPTADE 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 2e-28
 Identities = 62/193 (32%), Positives = 99/193 (51%), Gaps = 22/193 (11%)

Query: 339 GSVFRGI--INGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGV 387
           G V++G+    G  VAIK +          +SI +E++LLK + H N++   G+ E    
Sbjct: 14  GVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS 73

Query: 388 FYLVYEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            Y++ E+ ENGSL   + K   +PE +     + +   V  GL YLH     G +H+DI 
Sbjct: 74  LYIILEYAENGSLRQIIKKFGPFPESLV--AVY-VY-QVLQGLAYLHE---QGVIHRDIK 126

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL  K+   KLA+F  V + + + S      + VGT  +MAPE +E    +   D +
Sbjct: 127 AANILTTKDGVVKLADFG-VATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIW 183

Query: 507 AFGVVLLELITGK 519
           + G  ++EL+TG 
Sbjct: 184 SLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  110 bits (278), Expect = 2e-27
 Identities = 54/190 (28%), Positives = 86/190 (45%), Gaps = 18/190 (9%)

Query: 339 GSVFRGI--INGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G V++      G  VAIK +       +  I  E+ +LKK  H N++  +G+       +
Sbjct: 14  GEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELW 73

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           +V EF   GSL D L         S    + +  ++  GL YLH+    G +H+DI + N
Sbjct: 74  IVMEFCSGGSLKDLLKSTNQTLTESQ-IAY-VCKELLKGLEYLHS---NGIIHRDIKAAN 128

Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           ILL  +   KL +F     + +      +  T VGT  +MAPE +       + D ++ G
Sbjct: 129 ILLTSDGEVKLIDFGL---SAQLSDT-KARNTMVGTPYWMAPEVINGKPYDYKADIWSLG 184

Query: 510 VVLLELITGK 519
           +  +EL  GK
Sbjct: 185 ITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  110 bits (276), Expect = 2e-26
 Identities = 71/288 (24%), Positives = 122/288 (42%), Gaps = 28/288 (9%)

Query: 339 GSVFRGIINGSTVAIKCMR----------RSISKEVNLLKKINH-FNLINLFGACEHDGV 387
           G V+        VA+K +               +E+ +L  +NH  N++ L+   + +G 
Sbjct: 14  GEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS 72

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
            YLV E+++ GSL D L K      +S +    I   +   L YLH+    G +H+DI  
Sbjct: 73  LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKP 129

Query: 448 GNILLDKNL-RAKLANFSFVRSAVREES---GYSSTKTAVGTNGYMAPEYMEYGL---VT 500
            NILLD++    KL +F   +      S     +   T+VGT GYMAPE +        +
Sbjct: 130 ENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYAS 189

Query: 501 PEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN 560
              D ++ G+ L EL+TG      +  +          ++      +  S  + P+    
Sbjct: 190 SSSDIWSLGITLYELLTGLP--PFEGEKNSSATSQTLKIILELPTPSLAS-PLSPSNPEL 246

Query: 561 KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQTLLL 608
             + A  L+   L   A++P++R S +  +S  +   L ++ S    L
Sbjct: 247 ISKAASDLLKKLL---AKDPKNRLSSSSDLSHDLLAHLKLKESDLSDL 291

Length = 384

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  105 bits (264), Expect = 3e-25
 Identities = 61/194 (31%), Positives = 100/194 (51%), Gaps = 28/194 (14%)

Query: 339 GSVFRGI--INGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V++      G  VAIK MR        I  E+ ++K   H N+++ + +       ++
Sbjct: 33  GEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92

Query: 391 VYEFMENGSLSDWL--HKKRYPE-FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           V E+M+ GSL+D +  +  R  E  +++ CR     +V  GL YLH+      +H+DI S
Sbjct: 93  VMEYMDGGSLTDIITQNFVRMNEPQIAYVCR-----EVLQGLEYLHS---QNVIHRDIKS 144

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMD 504
            NILL K+   KLA+F F   A +     S   + VGT  +MAPE +   +YG   P++D
Sbjct: 145 DNILLSKDGSVKLADFGF---AAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG---PKVD 198

Query: 505 TYAFGVVLLELITG 518
            ++ G++ +E+  G
Sbjct: 199 IWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  104 bits (261), Expect = 5e-25
 Identities = 73/274 (26%), Positives = 110/274 (40%), Gaps = 58/274 (21%)

Query: 339 GSVF--RGIINGSTVAIKCM---------RRSISKEVNLLKKINHFNLINLFGACEHDGV 387
           G V+  R   +G    +K +         R     EV +LKK+NH N+I  + + E  G 
Sbjct: 14  GKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGK 73

Query: 388 FYLVYEFMENGSLSDWLHKKR-----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
             +V E+ + G LS  + K++     +PE    +   ++ L     L YLH       +H
Sbjct: 74  LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----ALKYLH---SRKILH 126

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---YGLV 499
           +DI   NI L  N   KL +F   +      S     KT VGT  Y++PE  +   Y   
Sbjct: 127 RDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLSPELCQNKPYNYK 183

Query: 500 TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA 559
           +   D ++ G VL EL T K                 F   EG N       L    L+ 
Sbjct: 184 S---DIWSLGCVLYELCTLKHP---------------F---EGENLLE----LALKILKG 218

Query: 560 NKKEIAHH----LIMLCLACIAREPESRPSMAEV 589
               I       L  L  + + ++PE RPS+A++
Sbjct: 219 QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (256), Expect = 2e-24
 Identities = 61/191 (31%), Positives = 104/191 (54%), Gaps = 23/191 (12%)

Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VA+K ++       +  +E  ++KK+ H  L+ L+  C  +   Y+V
Sbjct: 20  GEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79

Query: 392 YEFMENGSLSDWLH-----KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L      K R P+ V       +A  +A G+ YL +     Y+H+D++
Sbjct: 80  TEYMSKGSLLDFLKSGEGKKLRLPQLVD------MAAQIAEGMAYLES---RNYIHRDLA 130

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E+  Y++ + A     + APE   YG  T + D +
Sbjct: 131 ARNILVGENLVCKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188

Query: 507 AFGVVLLELIT 517
           +FG++L E++T
Sbjct: 189 SFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  101 bits (253), Expect = 5e-24
 Identities = 75/271 (27%), Positives = 121/271 (44%), Gaps = 46/271 (16%)

Query: 339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVF 388
             V+  I   N   VAIK +           + KEV  + + NH N++  + +       
Sbjct: 15  AVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL 74

Query: 389 YLVYEFMENGSLSDWLHKKRYPE-FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +LV  ++  GSL D + K  YP   +       +  +V  GL YLH     G +H+DI +
Sbjct: 75  WLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKA 130

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSST---KTAVGTNGYMAPEYME----YGLVT 500
           GNILL ++   K+A+F    SA   + G  +    KT VGT  +MAPE ME    Y    
Sbjct: 131 GNILLGEDGSVKIADFGV--SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY---D 185

Query: 501 PEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD-PNLQ- 558
            + D ++FG+  +EL TG     K    ++L+                L++  D P+L+ 
Sbjct: 186 FKADIWSFGITAIELATGAAPYSKYPPMKVLM----------------LTLQNDPPSLET 229

Query: 559 -ANKKEIAHHLIMLCLACIAREPESRPSMAE 588
            A+ K+ +     +   C+ ++P  RP+  E
Sbjct: 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 99.0 bits (246), Expect = 4e-23
 Identities = 73/254 (28%), Positives = 119/254 (46%), Gaps = 31/254 (12%)

Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 20  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 78

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E+M  GSL D+L K    +++       +A  +A G+ Y+       YVH+D+ + NIL
Sbjct: 79  TEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANIL 134

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           + +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D ++FG++
Sbjct: 135 VGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 192

Query: 512 LLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML 571
           L EL T     Y       ++   V   VE G                   E    L  L
Sbjct: 193 LTELTTKGRVPYPG-----MVNREVLDQVERGYR------------MPCPPECPESLHDL 235

Query: 572 CLACIAREPESRPS 585
              C  +EPE RP+
Sbjct: 236 MCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 68/264 (25%), Positives = 121/264 (45%), Gaps = 33/264 (12%)

Query: 339 GSVFRGIINGSTVAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVY 392
           G V  G   G  VA+KC++       +   E +++  + H NL+ L G        Y+V 
Sbjct: 20  GDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79

Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           E+M  GSL D+L + R    ++   +   ALDV  G+ YL    +  +VH+D+++ N+L+
Sbjct: 80  EYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLV 135

Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
            ++L AK+++F   + A     G  S K  V    + APE +     + + D ++FG++L
Sbjct: 136 SEDLVAKVSDFGLAKEA---SQGQDSGKLPV---KWTAPEALREKKFSTKSDVWSFGILL 189

Query: 513 LELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLC 572
            E+ +     Y +    I L + V  + +G   EA          +    E+  + +M  
Sbjct: 190 WEIYSFGRVPYPR----IPLKDVVPHVEKGYRMEAP---------EGCPPEV--YKVM-- 232

Query: 573 LACIAREPESRPSMAEVVSTLMKI 596
             C   +P  RP+  ++   L  I
Sbjct: 233 KDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 77/261 (29%), Positives = 119/261 (45%), Gaps = 40/261 (15%)

Query: 339 GSVFRGI-INGSTVAIKCMRRS-------ISKEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+  N   VAIK ++           KEV  LK++ H +LI+LF  C      Y+
Sbjct: 20  GEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79

Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCR--FRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           + E ME GSL  +L   R PE           +A  VA G+ YL    +   +H+D+++ 
Sbjct: 80  ITELMEKGSLLAFL---RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAAR 133

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           NIL+ ++L  K+A+F   R  + +E  Y S+   +    + APE   +G  + + D ++F
Sbjct: 134 NILVGEDLVCKVADFGLAR--LIKEDVYLSSDKKIPYK-WTAPEAASHGTFSTKSDVWSF 190

Query: 509 GVVLLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           G++L E+ T  +  Y    + E      A + M               P      +EI  
Sbjct: 191 GILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM---------------PCPAKCPQEI-- 233

Query: 567 HLIMLCLACIAREPESRPSMA 587
           + IM  L C A EPE RPS  
Sbjct: 234 YKIM--LECWAAEPEDRPSFK 252

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 56/193 (29%), Positives = 99/193 (51%), Gaps = 27/193 (13%)

Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G+ N +T VA+K ++      +    E  ++KK+ H  LI L+  C  +   Y+V
Sbjct: 20  GEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79

Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
            E M+ GSL ++L        + P+ +       +A  VA G+ YL   N     Y+H+D
Sbjct: 80  TELMKYGSLLEYLQGGAGRALKLPQLID------MAAQVASGMAYLEAQN-----YIHRD 128

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+ +N   K+A+F   R  V +E  Y + + A     + APE   Y   + + D
Sbjct: 129 LAARNVLVGENNICKVADFGLAR--VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186

Query: 505 TYAFGVVLLELIT 517
            ++FG++L E++T
Sbjct: 187 VWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 96.9 bits (242), Expect = 3e-22
 Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 36/211 (17%)

Query: 339 GSVFRG--IINGSTVAIK-CMRRSISKE-----VNLLKKI-----NHFNLINLFGACEHD 385
            +V            AIK   +R + KE     V + K++      H  +I L+   + +
Sbjct: 15  STVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE 74

Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
              Y V E+  NG L  ++ K  Y        RF  A ++   L YLH+    G +H+D+
Sbjct: 75  ENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRF-YAAEILLALEYLHSK---GIIHRDL 128

Query: 446 SSGNILLDKNLRAKLANF--------------SFVRSAVREESGYSSTKTA---VGTNGY 488
              NILLDK++  K+ +F              +   +   +     + +     VGT  Y
Sbjct: 129 KPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEY 188

Query: 489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           ++PE +         D +A G ++ +++TGK
Sbjct: 189 VSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 95.7 bits (239), Expect = 4e-22
 Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 28/196 (14%)

Query: 339 GSVFRGI--INGSTVAIK--------CMRRSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G V++      G   A+K          R+ + +E+  L+      ++  +GA   +G  
Sbjct: 15  GVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI 74

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
            +V E+M+ GSL+D L KK     +       IA  +  GL YLH  T    +H+DI   
Sbjct: 75  SIVLEYMDGGSLAD-LLKKV--GKIPEPVLAYIARQILKGLDYLH--TKRHIIHRDIKPS 129

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA- 507
           N+L++     K+A+F    S V E +      T VGT  YM+PE ++      E  +YA 
Sbjct: 130 NLLINSKGEVKIADFGI--SKVLENTLD-QCNTFVGTVTYMSPERIQ-----GESYSYAA 181

Query: 508 ----FGVVLLELITGK 519
                G+ LLE   GK
Sbjct: 182 DIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 95.3 bits (238), Expect = 6e-22
 Identities = 57/179 (31%), Positives = 88/179 (49%), Gaps = 21/179 (11%)

Query: 352 AIKCMR-RSISK---------EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           A+K ++ + I K         E N+L +INH  ++ L  A + +   YLV E+   G L 
Sbjct: 22  AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81

Query: 402 DWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKL 460
             L K  R+ E  +   RF  A ++   L YLH+    G +++D+   NILLD +   KL
Sbjct: 82  SHLSKEGRFSEERA---RFYAA-EIVLALEYLHSL---GIIYRDLKPENILLDADGHIKL 134

Query: 461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
            +F   +    E S    T T  GT  Y+APE +        +D ++ GV+L E++TGK
Sbjct: 135 TDFGLAKELSSEGS---RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 95.8 bits (238), Expect = 8e-22
 Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 41/224 (18%)

Query: 320 KYEDLVVATENFSPKNMIDGSVFRGII----NGSTVAIKCMR--------RSISKEVNLL 367
           K+ED++    NF       G V R +I         AIK ++        R  + E+ +L
Sbjct: 5   KFEDVI-GEGNF-------GQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVL 56

Query: 368 KKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY----PEF---------V 413
            K+ +H N+INL GACE+ G  Y+  E+   G+L D+L K R     P F         +
Sbjct: 57  CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116

Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
           +     + A DVA G+ YL   ++  ++H+D+++ N+L+ +NL +K+A+F   R     E
Sbjct: 117 TSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG----E 169

Query: 474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
             Y           +MA E + Y + T + D ++FGV+L E+++
Sbjct: 170 EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 94.7 bits (235), Expect = 9e-22
 Identities = 76/269 (28%), Positives = 124/269 (46%), Gaps = 45/269 (16%)

Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VA+K ++       S  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 20  GEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPI-YIV 78

Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L        + P  V       +A  VA G+ Y+       Y+H+D+ 
Sbjct: 79  TEYMSKGSLLDFLKDGEGRALKLPNLVD------MAAQVAAGMAYIERMN---YIHRDLR 129

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           S NIL+   L  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 130 SANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 507 AFGVVLLELITGKEAAYK-QDGEEIL-LAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
           +FG++L EL+T     Y   +  E+L   E  + M    +    L               
Sbjct: 188 SFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISL--------------- 232

Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
             H +M  L C  ++PE RP+   + S L
Sbjct: 233 --HELM--LQCWKKDPEERPTFEYLQSFL 257

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 95.4 bits (237), Expect = 1e-21
 Identities = 73/277 (26%), Positives = 133/277 (48%), Gaps = 50/277 (18%)

Query: 349 STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           +TVA+K ++        R +  E NLLK++NH ++I L+GAC  DG   L+ E+ + GSL
Sbjct: 31  TTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 90

Query: 401 SDWLHKKRY--PEFV-SWNCRFRIALD------------------VAHGLHYLHNCTDPG 439
             +L + R   P ++ S   R    LD                  ++ G+ YL    +  
Sbjct: 91  RSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMK 147

Query: 440 YVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV 499
            VH+D+++ N+L+ +  + K+++F   R    E+S    +K  +    +MA E +   + 
Sbjct: 148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVK-WMAIESLFDHIY 206

Query: 500 TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA 559
           T + D ++FGV+L E++T     Y       +  E +F++++ G    +      P    
Sbjct: 207 TTQSDVWSFGVLLWEIVTLGGNPYPG-----IAPERLFNLLKTGYRMER------PE--- 252

Query: 560 NKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           N  E  ++L+   L C  +EP+ RP+ A++   L K+
Sbjct: 253 NCSEEMYNLM---LTCWKQEPDKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 74/281 (26%), Positives = 125/281 (44%), Gaps = 58/281 (20%)

Query: 339 GSVFRGIINGS-----TVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHD 385
           G V RG +         VAIK ++   S         E +++ + +H N+I L G     
Sbjct: 18  GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77

Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
               ++ E+MENGSL  +L +       +      +   +A G+ YL   ++  YVH+D+
Sbjct: 78  RPVMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDL 132

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG------YMAPEYMEYGLV 499
           ++ NIL++ NL  K+++F   R     E+ Y+       T G      + APE + Y   
Sbjct: 133 AARNILVNSNLVCKVSDFGLSRRLEDSEATYT-------TKGGKIPIRWTAPEAIAYRKF 185

Query: 500 TPEMDTYAFGVVLLELITGKEAAY----KQDGEEILLAEAVFSMVEGGNAEAKLSVLVD- 554
           T   D ++FG+V+ E+++  E  Y     QD         V   VE G    +L   +D 
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERPYWDMSNQD---------VIKAVEDG---YRLPPPMDC 233

Query: 555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
           P+          + +M  L C  ++   RP+ +++VSTL K
Sbjct: 234 PSAL--------YQLM--LDCWQKDRNERPTFSQIVSTLDK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 94.4 bits (234), Expect = 1e-21
 Identities = 76/267 (28%), Positives = 128/267 (47%), Gaps = 41/267 (15%)

Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 20  GEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPI-YIV 78

Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            EFM  GSL D+L +      + P+ V       +A  +A G+ Y+       Y+H+D+ 
Sbjct: 79  TEFMGKGSLLDFLKEGDGKYLKLPQLVD------MAAQIADGMAYIERMN---YIHRDLR 129

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+  NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 130 AANILVGDNLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL+T     Y       ++   V   VE G           P  Q   + + H
Sbjct: 188 SFGILLTELVTKGRVPYPG-----MVNREVLEQVERGYRM--------PCPQGCPESL-H 233

Query: 567 HLIMLCLACIAREPESRPSMAEVVSTL 593
            L+ LC     ++P+ RP+   + S L
Sbjct: 234 ELMKLCW---KKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 74/264 (28%), Positives = 128/264 (48%), Gaps = 35/264 (13%)

Query: 339 GSVFRGIINGST-VAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VAIK +++      +   E NL+K++ H  L+ L+     + + Y++
Sbjct: 20  GEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPI-YII 78

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E+MENGSL D+L K      ++ N    +A  +A G+ ++       Y+H+D+ + NIL
Sbjct: 79  TEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANIL 134

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           + + L  K+A+F   R  + E++ Y++ + A     + APE + YG  T + D ++FG++
Sbjct: 135 VSETLCCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 192

Query: 512 LLELITGKEAAY--KQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI 569
           L E++T     Y    + E I   E  + M    N   +L                + L+
Sbjct: 193 LTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEEL----------------YELM 236

Query: 570 MLCLACIAREPESRPSMAEVVSTL 593
            LC      +PE RP+   + S L
Sbjct: 237 RLCW---KEKPEERPTFEYLRSVL 257

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 98.8 bits (246), Expect = 2e-21
 Identities = 92/373 (24%), Positives = 166/373 (44%), Gaps = 54/373 (14%)

Query: 238 SSPIVPTRKYNQTSSRGIYLWVGIGIGISLLVICFVLSIVLFHHKRRRDEAAR---KDGK 294
           +S + P ++  +T S   Y+   +G  + L ++ F     +F   R   E  R   +DG 
Sbjct: 613 TSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGF---VFIRGRNNLELKRVENEDGT 669

Query: 295 REKKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMI----DGSVFRG--IING 348
            E +      F  S     +  K     D++ + +    +N+I     G+ ++G  I NG
Sbjct: 670 WELQ------FFDS-----KVSKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNG 715

Query: 349 STVAIKCMRRSIS---KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH 405
               +K +    S    E+  + K+ H N++ L G C  +   YL++E++E  +LS+ L 
Sbjct: 716 MQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR 775

Query: 406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSF 465
                  +SW  R +IA+ +A  L +LH    P  V  ++S   I++D      L     
Sbjct: 776 N------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---- 825

Query: 466 VRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQ 525
               +       +      ++ Y+APE  E   +T + D Y FG++L+EL+TGK  A  +
Sbjct: 826 ----LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881

Query: 526 DG-EEILLAEAVFSMVEGGNAEAKLSVLVDP----NLQANKKEIAHHLIMLCLACIAREP 580
            G    ++  A +       ++  L + +DP    ++  N+ EI   ++ L L C A +P
Sbjct: 882 FGVHGSIVEWARYCY-----SDCHLDMWIDPSIRGDVSVNQNEIV-EVMNLALHCTATDP 935

Query: 581 ESRPSMAEVVSTL 593
            +RP   +V+ TL
Sbjct: 936 TARPCANDVLKTL 948

Length = 968

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 92.4 bits (230), Expect = 6e-21
 Identities = 57/197 (28%), Positives = 88/197 (44%), Gaps = 23/197 (11%)

Query: 339 GSVFRGI--INGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGV 387
           G V+  +    G  +A+K +R         + I+ E+ +L+ + H NL+  +G   H   
Sbjct: 14  GKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK 73

Query: 388 FYLVYEFMENGSLSDWLHKKRY-PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            Y+  E+   G+L + L   R   E    +      L +  GL YLH+    G VH+DI 
Sbjct: 74  VYIFMEYCSGGTLEELLEHGRILDE----HVIRVYTLQLLEGLAYLHSH---GIVHRDIK 126

Query: 447 SGNILLDKNLRAKLANF-SFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE--- 502
             NI LD N   KL +F   V+      +     ++  GT  YMAPE +  G        
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRA 186

Query: 503 MDTYAFGVVLLELITGK 519
            D ++ G V+LE+ TGK
Sbjct: 187 ADIWSLGCVVLEMATGK 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 92.1 bits (229), Expect = 8e-21
 Identities = 72/272 (26%), Positives = 121/272 (44%), Gaps = 38/272 (13%)

Query: 339 GSVFRGIINGST-----VAIKCMRR--------SISKEVNLLKKINHFNLINLFGACEHD 385
           G V RG  + S      VA+KC++            KE  ++  ++H NLI L+G     
Sbjct: 9   GVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTH 68

Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEF-VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
            +  +V E    GSL D L K     F +S  C +  A+ +A+G+ YL +     ++H+D
Sbjct: 69  PLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDY--AVQIANGMRYLES---KRFIHRD 122

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ NILL  + + K+ +F  +R+  + E  Y   +       + APE +     +   D
Sbjct: 123 LAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASD 182

Query: 505 TYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
            + FGV L E+ T G+E      G +IL              + +   L  P  +A  ++
Sbjct: 183 VWMFGVTLWEMFTYGEEPWAGLSGSQIL-----------KKIDKEGERLERP--EACPQD 229

Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
           I  + +M  L C A  P  RP+ A +   L +
Sbjct: 230 I--YNVM--LQCWAHNPADRPTFAALREFLPE 257

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 91.7 bits (228), Expect = 9e-21
 Identities = 78/270 (28%), Positives = 119/270 (44%), Gaps = 52/270 (19%)

Query: 339 GSVFRGI--INGSTVAIK-------------CMRRSISKEVNLLKKINHFNLINLFGACE 383
           GSV+ G+   +G   A+K              +++ + +E+ LL K+ H N++   G   
Sbjct: 14  GSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQ-LEQEIALLSKLQHPNIVQYLGTER 72

Query: 384 HDGVFYLVYEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
            +   Y+  E +  GSL+  L K   +PE V      +I L    GL YLH   D   VH
Sbjct: 73  EEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL----GLEYLH---DRNTVH 125

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----EYGL 498
           +DI   NIL+D N   KLA+F   +  V     +S  K+  G+  +MAPE +     YGL
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVE----FSFAKSFKGSPYWMAPEVIAQQGGYGL 181

Query: 499 VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ 558
                D ++ G  +LE+ TGK    + +G       AVF +             +  +L 
Sbjct: 182 ---AADIWSLGCTVLEMATGKPPWSQLEG-----VAAVFKIGRSKELPP-----IPDHLS 228

Query: 559 ANKKEIAHHLIMLCLACIAREPESRPSMAE 588
              K+     I+ CL    R+P  RP+ AE
Sbjct: 229 DEAKD----FILKCL---QRDPSLRPTAAE 251

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 90.9 bits (225), Expect = 2e-20
 Identities = 55/197 (27%), Positives = 105/197 (53%), Gaps = 23/197 (11%)

Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  N ST VA+K ++      ++  +E NL+K + H  L+ L+     +   Y++
Sbjct: 20  GEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79

Query: 392 YEFMENGSLSDWLH-----KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L      K   P+ + ++ +      +A G+ Y+       Y+H+D+ 
Sbjct: 80  TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIER---KNYIHRDLR 130

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + N+L+ ++L  K+A+F   R  V E++ Y++ + A     + APE + +G  T + D +
Sbjct: 131 AANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188

Query: 507 AFGVVLLELITGKEAAY 523
           +FG++L E++T  +  Y
Sbjct: 189 SFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 38/203 (18%)

Query: 339 GSVFRG--IINGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLFGAC--EHD 385
           G V++      G  VA+K +R    K         E+ LL+K+ H N++ L      +  
Sbjct: 13  GQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGK 72

Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
           G  Y+V+E+M++  L+  L      +F     +      +  GL YLH+    G +H+DI
Sbjct: 73  GSIYMVFEYMDH-DLTGLLDSPEV-KFTESQIKC-YMKQLLEGLQYLHSN---GILHRDI 126

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYM----EY 496
              NIL++ +   KLA+F   R        Y+   +A  TN      Y  PE +     Y
Sbjct: 127 KGSNILINNDGVLKLADFGLARP-------YTKRNSADYTNRVITLWYRPPELLLGATRY 179

Query: 497 GLVTPEMDTYAFGVVLLELITGK 519
           G   PE+D ++ G +L EL  GK
Sbjct: 180 G---PEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 71/278 (25%), Positives = 120/278 (43%), Gaps = 45/278 (16%)

Query: 339 GSVFRGIING-------STVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACE 383
           G V+ G+  G       + VAIK +        R     E +++K+ N  +++ L G   
Sbjct: 20  GMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR--------FRIALDVAHGLHYLHNC 435
                 +V E M  G L  +L  +R PE  +             ++A ++A G+ YL   
Sbjct: 80  TGQPTLVVMELMAKGDLKSYLRSRR-PEAENNPGLGPPTLQKFIQMAAEIADGMAYLA-- 136

Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME 495
               +VH+D+++ N ++ ++L  K+ +F   R  + E   Y      +    +MAPE ++
Sbjct: 137 -AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMAPESLK 194

Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
            G+ T + D ++FGVVL E+ T  E  Y+      L  E V   V  G        L  P
Sbjct: 195 DGVFTTKSDVWSFGVVLWEMATLAEQPYQG-----LSNEEVLKFVIDGG------HLDLP 243

Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
               N  +    L+ +C       P+ RP+  E+VS+L
Sbjct: 244 E---NCPDKLLELMRMCW---QYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 90.0 bits (223), Expect = 4e-20
 Identities = 69/265 (26%), Positives = 122/265 (46%), Gaps = 37/265 (13%)

Query: 339 GSVFRGI-INGSTVAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  +    VAIK +R          +E  ++ K++H  L+ L+G C       LV
Sbjct: 18  GLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
           +EFME+G LSD+L  +R     S      + LDV  G+ YL +      +H+D+++ N L
Sbjct: 78  FEFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCL 132

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           + +N   K+++F   R  + ++  Y+S+        + +PE   +   + + D ++FGV+
Sbjct: 133 VGENQVVKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVL 190

Query: 512 LLELITGKEAAY--KQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK-KEIAHHL 568
           + E+ +  +  Y  + + E          +VE  NA  +   L  P L +    E+  H 
Sbjct: 191 MWEVFSEGKTPYENRSNSE----------VVETINAGFR---LYKPRLASQSVYELMQH- 236

Query: 569 IMLCLACIAREPESRPSMAEVVSTL 593
                 C    PE RPS + ++  L
Sbjct: 237 ------CWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 90.0 bits (223), Expect = 4e-20
 Identities = 70/262 (26%), Positives = 130/262 (49%), Gaps = 33/262 (12%)

Query: 339 GSVFRGIINGSTVAIKCMRRSIS-----KEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           G+V +G   G  VA+K ++  ++     +E  ++ K++H NL+ L G   H+G+ Y+V E
Sbjct: 20  GAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGL-YIVME 78

Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
            M  G+L ++L + R    VS     + +LDVA G+ YL +      VH+D+++ NIL+ 
Sbjct: 79  LMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVS 134

Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLL 513
           ++  AK+++F   R       G  ++K  V    + APE +++   + + D +++GV+L 
Sbjct: 135 EDGVAKVSDFGLARV---GSMGVDNSKLPV---KWTAPEALKHKKFSSKSDVWSYGVLLW 188

Query: 514 ELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCL 573
           E+ +   A Y +     +  + V   VE G         ++P      +     + +L  
Sbjct: 189 EVFSYGRAPYPK-----MSLKEVKECVEKG-------YRMEP-----PEGCPADVYVLMT 231

Query: 574 ACIAREPESRPSMAEVVSTLMK 595
           +C   EP+ RPS  ++   L K
Sbjct: 232 SCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 90.1 bits (224), Expect = 5e-20
 Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 32/198 (16%)

Query: 339 GSVF--RGIINGSTVAIKCM---------RRSISKEVNLLKKINHFNLINLFGACEHDGV 387
           G V   R    G  VAIK           +++  +EV +L+++ H N++NL  A    G 
Sbjct: 15  GVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR 74

Query: 388 FYLVYEFMENGSLSDWLHKKRY---PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
            YLV+E++E  +L + L        P+ V           +   + Y H+      +H+D
Sbjct: 75  LYLVFEYVER-TLLELLEASPGGLPPDAVR-----SYIWQLLQAIAYCHS---HNIIHRD 125

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE----YMEYGLVT 500
           I   NIL+ ++   KL +F F R A+R       T   V T  Y APE       YG   
Sbjct: 126 IKPENILVSESGVLKLCDFGFAR-ALRARPASPLT-DYVATRWYRAPELLVGDTNYG--- 180

Query: 501 PEMDTYAFGVVLLELITG 518
             +D +A G ++ EL+ G
Sbjct: 181 KPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 89.4 bits (221), Expect = 8e-20
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 33/205 (16%)

Query: 339 GSVFRGIINGS----TVAIKCMR--------RSISKEVNLLKKINHF-NLINLFGACEHD 385
           G V +  I         AIK M+        R  + E+ +L K+ H  N+INL GACEH 
Sbjct: 9   GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 68

Query: 386 GVFYLVYEFMENGSLSDWLHKKRY----PEF---------VSWNCRFRIALDVAHGLHYL 432
           G  YL  E+  +G+L D+L K R     P F         +S       A DVA G+ YL
Sbjct: 69  GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 128

Query: 433 HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE 492
              +   ++H+D+++ NIL+ +N  AK+A+F   R     +  Y           +MA E
Sbjct: 129 ---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVKKTMGRLPVRWMAIE 181

Query: 493 YMEYGLVTPEMDTYAFGVVLLELIT 517
            + Y + T   D +++GV+L E+++
Sbjct: 182 SLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 25/225 (11%)

Query: 371 NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
           NH N++NL GAC   G   ++ E+   G L ++L +KR   F++       +  VA G+ 
Sbjct: 97  NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMA 155

Query: 431 YL--HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY 488
           +L   NC     +H+D+++ N+LL      K+ +F   R  +  +S Y     A     +
Sbjct: 156 FLASKNC-----IHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVVKGNARLPVKW 209

Query: 489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK 548
           MAPE +   + T E D +++G++L E+ +     Y      + +    + +++ G   A+
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP----GMPVDSKFYKLIKEGYRMAQ 265

Query: 549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                 P       EI  + IM    C   +P  RP+  ++V  +
Sbjct: 266 ------PEHAP--AEI--YDIM--KTCWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 88.4 bits (220), Expect = 3e-19
 Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 32/196 (16%)

Query: 339 GSVF--RGIINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDG 386
           G V   R   +G   A+K + ++          +  E  +L+ I H  L+NL+G+ + D 
Sbjct: 15  GRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS 74

Query: 387 VFYLVYEFMENGSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
             YLV E++  G L   L K  R+PE V    RF  A  V   L YLH+      V++D+
Sbjct: 75  NLYLVMEYVPGGELFSHLRKSGRFPEPV---ARFYAA-QVVLALEYLHSL---DIVYRDL 127

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---YGLVTPE 502
              N+LLD +   K+ +F F   A R +     T T  GT  Y+APE +    YG     
Sbjct: 128 KPENLLLDSDGYIKITDFGF---AKRVKGR---TYTLCGTPEYLAPEIILSKGYGK---A 178

Query: 503 MDTYAFGVVLLELITG 518
           +D +A G+++ E++ G
Sbjct: 179 VDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 49/192 (25%), Positives = 98/192 (51%), Gaps = 14/192 (7%)

Query: 339 GSVFRGIINGST-VAIKCMRR-SISK-----EVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V  G   G   VAIK +R  ++S+     E  ++ K++H NL+ L+G C      ++V
Sbjct: 18  GVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E+M NG L ++L +++      W     +  DV   + YL      G++H+D+++ N L
Sbjct: 78  TEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLE---SNGFIHRDLAARNCL 132

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           + ++   K+++F   R  + ++  Y+S++       +  PE  +Y   + + D ++FGV+
Sbjct: 133 VGEDNVVKVSDFGLARYVLDDQ--YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVL 190

Query: 512 LLELITGKEAAY 523
           + E+ +  +  Y
Sbjct: 191 MWEVFSEGKMPY 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 64/250 (25%), Positives = 118/250 (47%), Gaps = 32/250 (12%)

Query: 351 VAIKCMRR-SISK-----EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           VAIK +   ++S+     E  ++ K++H  L+ L+G C      Y+V EFMENG L ++L
Sbjct: 31  VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL 90

Query: 405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS 464
            +++    +S +    +  DV  G+ YL       ++H+D+++ N L+      K+++F 
Sbjct: 91  RQRQ--GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFG 145

Query: 465 FVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAY 523
             R  + +E  Y+S+  A     +  PE   +   + + D ++FGV++ E+ T GK    
Sbjct: 146 MTRYVLDDE--YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE 203

Query: 524 KQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESR 583
           K+   E      V  M+  G        L  P L       +  +  +  +C   +PE R
Sbjct: 204 KKSNYE------VVEMISRGFR------LYRPKLA------SMTVYEVMYSCWHEKPEGR 245

Query: 584 PSMAEVVSTL 593
           P+ AE++  +
Sbjct: 246 PTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 87.4 bits (216), Expect = 6e-19
 Identities = 57/177 (32%), Positives = 92/177 (51%), Gaps = 27/177 (15%)

Query: 358 RSISKEVNLLKKINHF-NLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY----PEF 412
           R  + E+ +L K+ H  N+INL GACEH G  YL  E+  +G+L D+L K R     P F
Sbjct: 52  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 111

Query: 413 ---------VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF 463
                    +S       A DVA G+ YL   +   ++H+D+++ NIL+ +N  AK+A+F
Sbjct: 112 AIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADF 168

Query: 464 SFVRSA---VREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
              R     V++  G    +       +MA E + Y + T   D +++GV+L E+++
Sbjct: 169 GLSRGQEVYVKKTMGRLPVR-------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 87.6 bits (217), Expect = 6e-19
 Identities = 83/295 (28%), Positives = 129/295 (43%), Gaps = 62/295 (21%)

Query: 339 GSVF--RGIINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDG 386
           G+V+  R +     VAIK M  S          I KEV  L+++ H N I   G    + 
Sbjct: 29  GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH 88

Query: 387 VFYLVYEFMENGSLSDWL--HKK--RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
             +LV E+   GS SD L  HKK  +  E  +      I      GL YLH+      +H
Sbjct: 89  TAWLVMEYCL-GSASDILEVHKKPLQEVEIAA------ICHGALQGLAYLHSH---ERIH 138

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEY---MEYGLV 499
           +DI +GNILL +    KLA+F    SA    S  S   + VGT  +MAPE    M+ G  
Sbjct: 139 RDIKAGNILLTEPGTVKLADFG---SA----SLVSPANSFVGTPYWMAPEVILAMDEGQY 191

Query: 500 TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD---PN 556
             ++D ++ G+  +EL   K                +F+M    NA + L  +     P 
Sbjct: 192 DGKVDVWSLGITCIELAERK--------------PPLFNM----NAMSALYHIAQNDSPT 233

Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQTLLLERI 611
           L +N  + + +      +C+ + P+ RPS +E +     +  +  R  T++++ I
Sbjct: 234 LSSN--DWSDYFRNFVDSCLQKIPQDRPS-SEELLKHRFVLRE--RPPTVIIDLI 283

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 86.6 bits (214), Expect = 7e-19
 Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 45/269 (16%)

Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+    N  T VA+K M+       +   E N++K + H  L+ L      + + Y++
Sbjct: 20  GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YII 78

Query: 392 YEFMENGSLSDWL-----HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            EFM  GSL D+L      K+  P+ + ++ +      +A G+ ++       Y+H+D+ 
Sbjct: 79  TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQ---RNYIHRDLR 129

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+  +L  K+A+F   R  V E++ Y++ + A     + APE + +G  T + D +
Sbjct: 130 AANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187

Query: 507 AFGVVLLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
           +FG++L+E++T     Y    + E I   E  + M               P  +   +E 
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---------------PRPENCPEE- 231

Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              L  + + C    PE RP+   + S L
Sbjct: 232 ---LYNIMMRCWKNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 25/198 (12%)

Query: 339 GSVF--RGIINGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDG 386
           G VF  +    G   AIK +++           +  E ++L +     ++ L+ + +   
Sbjct: 7   GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK 66

Query: 387 VFYLVYEFMENGSLSDWLHKKRY-PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
             YLV E++  G L+  L       E V+      I L     L YLH+    G +H+D+
Sbjct: 67  NLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVL----ALEYLHSN---GIIHRDL 119

Query: 446 SSGNILLDKNLRAKLANF-----SFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVT 500
              NIL+D N   KL +F       VR  +         K  VGT  Y+APE +     +
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHS 179

Query: 501 PEMDTYAFGVVLLELITG 518
             +D ++ G +L E + G
Sbjct: 180 KTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 54/193 (27%), Positives = 99/193 (51%), Gaps = 14/193 (7%)

Query: 339 GSVFRGIIN--GSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 20  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79

Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L ++   + V+      +A  ++  + YL       ++H+D+++ N 
Sbjct: 80  ITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 135

Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R  +  ++ Y++   A     + APE + Y   + + D +AFGV
Sbjct: 136 LVGENHLVKVADFGLSR-LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 193

Query: 511 VLLELITGKEAAY 523
           +L E+ T   + Y
Sbjct: 194 LLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 72/270 (26%), Positives = 119/270 (44%), Gaps = 44/270 (16%)

Query: 339 GSVF--RGIINGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G V+  R I  G  VAIK +          I +E+++LK+  H N++  FG+       +
Sbjct: 17  GDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW 76

Query: 390 LVYEFMENGSLSDWLHKKRYP---EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
           +V E+   GSL D     R P     +++ CR     +   GL YLH     G +H+DI 
Sbjct: 77  IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLHE---TGKIHRDIK 128

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---YGLVTPEM 503
             NILL ++   KLA+F    SA    +  +  K+ +GT  +MAPE       G    + 
Sbjct: 129 GANILLTEDGDVKLADFGV--SAQLTAT-IAKRKSFIGTPYWMAPEVAAVERKGGYDGKC 185

Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK- 562
           D +A G+  +EL   +   +     ++    A+F +          S    P L+  +K 
Sbjct: 186 DIWALGITAIELAELQPPMF-----DLHPMRALFLI--------SKSNFPPPKLKDKEKW 232

Query: 563 -EIAHHLIMLCLACIAREPESRPSMAEVVS 591
             + H  I  CL    ++P+ RP+  +++ 
Sbjct: 233 SPVFHDFIKKCL---TKDPKKRPTATKLLQ 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 31/196 (15%)

Query: 339 GSVFRGI--INGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           GSV++ I    G  VAIK +      + I KE+++LK+ +   ++  +G+   +   ++V
Sbjct: 17  GSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76

Query: 392 YEFMENGSLSDWLH--KKRYPEFVSWNCRFRIAL---DVAHGLHYLHNCTDPGYVHKDIS 446
            E+   GS+SD +    K   E         IA        GL YLH+      +H+DI 
Sbjct: 77  MEYCGAGSVSDIMKITNKTLTEE-------EIAAILYQTLKGLEYLHS---NKKIHRDIK 126

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---YGLVTPEM 503
           +GNILL++  +AKLA+F     + +     +   T +GT  +MAPE ++   Y       
Sbjct: 127 AGNILLNEEGQAKLADFGV---SGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKA--- 180

Query: 504 DTYAFGVVLLELITGK 519
           D ++ G+  +E+  GK
Sbjct: 181 DIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 43/226 (19%)

Query: 339 GSVFRGII-------NGSTVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACE 383
           G VF G         +   VA+K +        R+   +E  LL    H N++  +G C 
Sbjct: 19  GKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT 78

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR------------FRIALDVAHGLHY 431
                 +V+E+ME+G L+ +L +   P+                    +IA+ +A G+ Y
Sbjct: 79  EGDPPIMVFEYMEHGDLNKFL-RSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVY 137

Query: 432 LHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG---- 487
           L       +VH+D+++ N L+  +L  K+ +F   R        Y++    VG +     
Sbjct: 138 L---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYYRVGGHTMLPI 188

Query: 488 -YMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEIL 531
            +M PE + Y   T E D ++FGVVL E+ T GK+  Y    EE++
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 52/186 (27%), Positives = 83/186 (44%), Gaps = 26/186 (13%)

Query: 347 NGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME 396
              T A+KC+++           I  E  +L++ NH  ++ L+   +     Y++ E+  
Sbjct: 17  KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCL 76

Query: 397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
            G L   L  +    F  +  RF IA  V     YLHN    G +++D+   N+LLD N 
Sbjct: 77  GGELWTILRDRGL--FDEYTARFYIAC-VVLAFEYLHN---RGIIYRDLKPENLLLDSNG 130

Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---YGLVTPEMDTYAFGVVLL 513
             KL +F F +           T T  GT  Y+APE +    Y       D ++ G++L 
Sbjct: 131 YVKLVDFGFAKKL----KSGQKTWTFCGTPEYVAPEIILNKGYDFSV---DYWSLGILLY 183

Query: 514 ELITGK 519
           EL+TG+
Sbjct: 184 ELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 85.4 bits (211), Expect = 3e-18
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 47/276 (17%)

Query: 349 STVAIKCMRRSIS--------KEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGS 399
            TVA+K ++ + +         E+ L+K I  H N+INL G C  +G  Y++ E+   G+
Sbjct: 45  VTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGN 104

Query: 400 LSDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYLHN--CTDPGYVHKD 444
           L ++L  +R P             E +S+      A  VA G+ YL +  C     +H+D
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC-----IHRD 159

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+ ++   K+A+F   R  V +   Y  T        +MAPE +   + T + D
Sbjct: 160 LAARNVLVTEDNVMKIADFGLAR-GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSD 218

Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FG+++ E+ T   + Y       +  E +F ++  G+   K S              
Sbjct: 219 VWSFGILMWEIFTLGGSPYP-----GIPVEELFKLLREGHRMDKPS------------NC 261

Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV 600
            H L ML   C    P  RP+  ++V  L K+   V
Sbjct: 262 THELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 83.9 bits (208), Expect = 5e-18
 Identities = 71/277 (25%), Positives = 124/277 (44%), Gaps = 55/277 (19%)

Query: 339 GSVFRGII---NGS--TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHD 385
           GSV +G+    +G    VA+K ++        +   +E +++ +++H  ++ L G C+ +
Sbjct: 9   GSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE 68

Query: 386 GVFYLVYEFMENGSLSDWLHKKRY---PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
               LV E    G L  +L K+R     +          A  VA G+ YL +     +VH
Sbjct: 69  P-LMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESKH---FVH 118

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYMEYG 497
           +D+++ N+LL    +AK+++F   R A+   S Y    TA    G     + APE + YG
Sbjct: 119 RDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRATTA----GRWPLKWYAPECINYG 173

Query: 498 LVTPEMDTYAFGVVLLELITGKEAAYKQ-DGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
             + + D +++GV L E  +     Y +  G E++      +M+E G        L  P 
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI------AMLESGER------LPRPE 221

Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                 E    +  + L+C    PE RP+ +E+ ST 
Sbjct: 222 ------ECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 83.7 bits (207), Expect = 5e-18
 Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 48/272 (17%)

Query: 339 GSVFRGIINGST-VAIK-C-------MRRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G V++G++ G+T VA+K C       ++R   +E  +LK+ +H N++ L G C      Y
Sbjct: 9   GDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIY 68

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH--NCTDPGYVHKDISS 447
           +V E +  GSL  +L KK+    ++     +++LD A G+ YL   NC     +H+D+++
Sbjct: 69  IVMELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKNC-----IHRDLAA 121

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGY--SSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
            N L+ +N   K+++F   R    EE G    S         + APE + YG  T E D 
Sbjct: 122 RNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178

Query: 506 YAFGVVLLELITGKEAAYK----QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK 561
           +++G++L E  +  +  Y     Q   E          +E G        +  P L    
Sbjct: 179 WSYGILLWETFSLGDTPYPGMSNQQTRE---------RIESGYR------MPAPQL---- 219

Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                 +  L L C A +PE+RPS +E+ + L
Sbjct: 220 --CPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 23/212 (10%)

Query: 339 GSVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGA-CEHDGVFYLVY 392
           G V  G   G+ VA+KC++     ++   E +++ ++ H NL+ L G   E  G  Y+V 
Sbjct: 20  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79

Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           E+M  GSL D+L + R    +  +C  + +LDV   + YL       +VH+D+++ N+L+
Sbjct: 80  EYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLV 135

Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTK-TAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
            ++  AK+++F   + A       SST+ T      + APE +     + + D ++FG++
Sbjct: 136 SEDNVAKVSDFGLTKEA-------SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 188

Query: 512 LLELITGKEAAYKQDGEEILLAEAVFSMVEGG 543
           L E+ +     Y +    I L + V   VE G
Sbjct: 189 LWEIYSFGRVPYPR----IPLKDVV-PRVEKG 215

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 84.4 bits (209), Expect = 5e-18
 Identities = 53/218 (24%), Positives = 98/218 (44%), Gaps = 58/218 (26%)

Query: 339 GSVFRGIING-------STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACE 383
           G V++G + G       ++VAIK ++ +          +E  L+  + H N++ L G C 
Sbjct: 19  GKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT 78

Query: 384 HDGVFYLVYEFMENGSLSDWL-------------------HKKRYPEFVSWNCRFRIALD 424
            +    +++E++ +G L ++L                         +F+       IA+ 
Sbjct: 79  KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH------IAIQ 132

Query: 425 VAHGLHYL--HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
           +A G+ YL  H+     +VH+D+++ N L+ + L  K+++F   R        YS+    
Sbjct: 133 IAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRD------IYSADYYR 181

Query: 483 VGTNG-----YMAPEYMEYGLVTPEMDTYAFGVVLLEL 515
           V +       +M PE + YG  T E D ++FGVVL E+
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 84.0 bits (208), Expect = 7e-18
 Identities = 65/237 (27%), Positives = 98/237 (41%), Gaps = 30/237 (12%)

Query: 358 RSISKEVNLLKKINHFNLINLFGAC--EHDGVFYLVYEFMENGSLSDWLHKK------RY 409
           + I +E+ + K      ++  +GA   E      +  E+ E GSL D ++KK      R 
Sbjct: 44  KQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRI 102

Query: 410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSA 469
            E V      +IA  V  GL YLH       +H+DI   NILL +  + KL +F      
Sbjct: 103 GEKVLG----KIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDF-----G 150

Query: 470 VREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE 529
           V  E   S   T  GT+ YMAPE ++    +   D ++ G+ LLE+   +   +  +GE 
Sbjct: 151 VSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR-FPFPPEGEP 209

Query: 530 ILLAEAVFSMVEGGNAEAKLSVLVD-PNLQANKKEIAHHLIMLCLACIAREPESRPS 585
            L    + S +           L D P       E     I  CL    ++P  RP+
Sbjct: 210 PLGPIELLSYI----VNMPNPELKDEPGNGIKWSEEFKDFIKQCL---EKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 84.3 bits (208), Expect = 8e-18
 Identities = 68/270 (25%), Positives = 121/270 (44%), Gaps = 43/270 (15%)

Query: 349 STVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGS 399
           + VA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+
Sbjct: 51  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110

Query: 400 LSDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
           L ++L  +R P             E +S+      A  VA G+ YL        +H+D++
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLA 167

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + N+L+ ++   K+A+F   R  +     Y  T        +MAPE +   + T + D +
Sbjct: 168 ARNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226

Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FGV+L E+ T   + Y       +  E +F +++ G+   K S               +
Sbjct: 227 SFGVLLWEIFTLGGSPYPG-----VPVEELFKLLKEGHRMDKPS------------NCTN 269

Query: 567 HLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            L M+   C    P  RP+  ++V  L +I
Sbjct: 270 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.4 bits (206), Expect = 9e-18
 Identities = 72/263 (27%), Positives = 123/263 (46%), Gaps = 48/263 (18%)

Query: 351 VAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD 402
           VAIK +        RR    E +++ + +H N+I+L G         +V E+MENGSL  
Sbjct: 35  VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA 94

Query: 403 WLHKKRYPEFVSWNCRFRIALDV------AHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
           +L K         + +F +   V      A G+ YL   +D GYVH+D+++ NIL++ NL
Sbjct: 95  FLRKH--------DGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNL 143

Query: 457 RAKLANFSFVRSAVRE---ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLL 513
             K+++F   R  V E   E+ Y++    +    + APE + Y   T   D +++G+V+ 
Sbjct: 144 VCKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR-WTAPEAIAYRKFTSASDVWSYGIVMW 200

Query: 514 ELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCL 573
           E+++  E  Y     E+   + + ++ EG    A +               A H +M  L
Sbjct: 201 EVMSYGERPY----WEMSNQDVIKAIEEGYRLPAPMDC-----------PAALHQLM--L 243

Query: 574 ACIAREPESRPSMAEVVSTLMKI 596
            C  ++   RP   ++VS L K+
Sbjct: 244 DCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 65/251 (25%), Positives = 117/251 (46%), Gaps = 35/251 (13%)

Query: 348 GSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           G  VA+K M       R  +  EV +++   H N++ ++ +       ++V EF+E G+L
Sbjct: 44  GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103

Query: 401 SDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           +D + H +   E ++  C       V   L +LH     G +H+DI S +ILL  + R K
Sbjct: 104 TDIVTHTRMNEEQIATVCLA-----VLKALSFLHA---QGVIHRDIKSDSILLTSDGRVK 155

Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           L++F F  + V +E      K+ VGT  +MAPE +       E+D ++ G++++E++   
Sbjct: 156 LSDFGFC-AQVSKE--VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV--- 209

Query: 520 EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIARE 579
                 DGE     E          A  ++   + P L+ N  +++  L       + R+
Sbjct: 210 ------DGEPPYFNEPPL------QAMKRIRDNLPPKLK-NLHKVSPRLRSFLDRMLVRD 256

Query: 580 PESRPSMAEVV 590
           P  R + AE++
Sbjct: 257 PAQRATAAELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 29/196 (14%)

Query: 339 GSVF--RGIINGSTVAIKCMRRSISK--------EVNLLKKINHFNLINLFGACEHDGVF 388
           G V        G  +A+K +R  I++        E+++L K N   ++  +GA  ++G  
Sbjct: 15  GVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI 74

Query: 389 YLVYEFMENGSLSDWLH--KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            +  E+M+ GSL   L   + R PE +      +IA+ V  GL YLH       +H+D+ 
Sbjct: 75  SICMEYMDGGSLDKILKEVQGRIPERILG----KIAVAVLKGLTYLHE--KHKIIHRDVK 128

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGY---SSTKTAVGTNGYMAPEYMEYGLVTPEM 503
             NIL++   + KL +F          SG    S  KT VGT+ YMAPE ++    + + 
Sbjct: 129 PSNILVNSRGQIKLCDFGV--------SGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKS 180

Query: 504 DTYAFGVVLLELITGK 519
           D ++ G+ L+EL TG+
Sbjct: 181 DIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 83.0 bits (205), Expect = 2e-17
 Identities = 69/253 (27%), Positives = 117/253 (46%), Gaps = 23/253 (9%)

Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE 411
           A K  R    KE+ ++ ++   N+I L   C       ++ E+MENG L+ +L +    E
Sbjct: 58  ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117

Query: 412 --------FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF 463
                    +S++    +A  +A G+ YL +     +VH+D+++ N L+ KN   K+A+F
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADF 174

Query: 464 SFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAA 522
              R+    +  Y     AV    +M+ E +  G  T   D +AFGV L E++T  KE  
Sbjct: 175 GMSRNLYSGDY-YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233

Query: 523 YKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPES 582
           Y Q  +E    + + +  E    + +   L  P L  +       L  L L+C  R  + 
Sbjct: 234 YSQLSDE----QVIENTGEFFRDQGRQVYLPKPALCPDS------LYKLMLSCWRRNAKE 283

Query: 583 RPSMAEVVSTLMK 595
           RPS  E+ +TL++
Sbjct: 284 RPSFQEIHATLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 82.8 bits (204), Expect = 3e-17
 Identities = 69/271 (25%), Positives = 121/271 (44%), Gaps = 47/271 (17%)

Query: 350 TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K ++          +  E+ ++K I  H N+INL GAC  DG  Y++ E+   G+L
Sbjct: 46  TVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105

Query: 401 SDWLHKKRYP--EFVSWNCRF-----------RIALDVAHGLHYL--HNCTDPGYVHKDI 445
            ++L  +R P  ++    C+              A  VA G+ YL    C     +H+D+
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC-----IHRDL 160

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+L+ ++   K+A+F   R  V     Y  T        +MAPE +   + T + D 
Sbjct: 161 AARNVLVTEDNVMKIADFGLARD-VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219

Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV+L E+ T   + Y       +  E +F +++ G+   K +               
Sbjct: 220 WSFGVLLWEIFTLGGSPYPG-----IPVEELFKLLKEGHRMDKPA------------NCT 262

Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           H L M+   C    P  RP+  ++V  L ++
Sbjct: 263 HELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 49/167 (29%), Positives = 75/167 (44%), Gaps = 18/167 (10%)

Query: 363 EVNLLKKINHFNLINLFGACEHD---GVFYLVYEFMENGSLSDWLHK-----KRYPEFVS 414
           EVN+L+++ H N++  +     D      Y+V E+ E G L+  + K     K   E   
Sbjct: 49  EVNILRELKHPNIVRYYDR-IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107

Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYV--HKDISSGNILLDKNLRAKLANFSFVRSAVRE 472
           W    RI   +   L+  HN +DPG    H+D+   NI LD N   KL +F   +     
Sbjct: 108 W----RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL--- 160

Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
               S  KT VGT  YM+PE + +     + D ++ G ++ EL    
Sbjct: 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 63/254 (24%), Positives = 118/254 (46%), Gaps = 26/254 (10%)

Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +R+ I +E+ ++ +     +++ +GA  ++    +  EFM+ GSL D ++KK  P  +  
Sbjct: 46  VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGP--IPV 102

Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
               +IA+ V  GL YL+N      +H+DI   NIL++   + KL +F      V  E  
Sbjct: 103 EILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDF-----GVSGELI 155

Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK--EAAYKQDGEEILLA 533
            S   T VGT+ YM+PE ++ G  T + D ++ G+ ++EL  GK   A    D +     
Sbjct: 156 NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP 215

Query: 534 EAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAE----- 588
             +  +++         ++ +P  +    +    L     AC+ ++P  RP+  +     
Sbjct: 216 MGILDLLQ--------QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267

Query: 589 -VVSTLMKIQLDVQ 601
             +  L    +D+Q
Sbjct: 268 PFIQALRASNVDLQ 281

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 81.2 bits (200), Expect = 6e-17
 Identities = 55/187 (29%), Positives = 97/187 (51%), Gaps = 19/187 (10%)

Query: 347 NGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
            G  VA+K M       R  +  EV +++  +H N+++++ +       ++V EF+E G+
Sbjct: 46  TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105

Query: 400 LSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           L+D + H +   E ++  C     L V   L YLHN    G +H+DI S +ILL  + R 
Sbjct: 106 LTDIVTHTRMNEEQIATVC-----LSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRI 157

Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           KL++F F     +E       K+ VGT  +MAPE +       E+D ++ G++++E+I G
Sbjct: 158 KLSDFGFCAQVSKE---VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214

Query: 519 KEAAYKQ 525
           +   + +
Sbjct: 215 EPPYFNE 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 80.4 bits (198), Expect = 6e-17
 Identities = 55/188 (29%), Positives = 96/188 (51%), Gaps = 22/188 (11%)

Query: 339 GSVFRGIINGST-VAIKCMRRSISKEVNL--------LKKINHFNLINLFGACEHDGVFY 389
           G VF+G +   T VA+K  +  + +E+ +        LK+ +H N++ L G C      Y
Sbjct: 9   GEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIY 68

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH--NCTDPGYVHKDISS 447
           +V E +  G    +L KK+  + +      + ALD A G+ YL   NC     +H+D+++
Sbjct: 69  IVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNC-----IHRDLAA 121

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESG-YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
            N L+ +N   K+++F   R   +E+ G YSS+        + APE + YG  + E D +
Sbjct: 122 RNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178

Query: 507 AFGVVLLE 514
           ++G++L E
Sbjct: 179 SYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 80.9 bits (200), Expect = 8e-17
 Identities = 76/300 (25%), Positives = 123/300 (41%), Gaps = 76/300 (25%)

Query: 339 GSVFRGIING-------STVAIK-----CMRRSIS---KEVNLLKKI-NHFNLINLFGAC 382
           G V +    G       STVA+K        + +S    E+ ++K I  H N+INL G C
Sbjct: 26  GQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85

Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKRYPE-------------------FVSWNCRFRIAL 423
             +G  Y+V E+  +G+L D+L  +R P                     VS+      A 
Sbjct: 86  TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF------AY 139

Query: 424 DVAHGLHYL--HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
            VA G+ +L    C     +H+D+++ N+L+ ++   K+A+F   R  +     Y  T  
Sbjct: 140 QVARGMEFLASKKC-----IHRDLAARNVLVTEDHVMKIADFGLARD-IHHIDYYRKT-- 191

Query: 482 AVGTNG-----YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAV 536
              TNG     +MAPE +   + T + D ++FGV+L E+ T   + Y      I + E  
Sbjct: 192 ---TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG----IPVEELF 244

Query: 537 FSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
             + EG   E   +                 L  L   C    P  RP+  ++V  L ++
Sbjct: 245 KLLKEGYRMEKPQNC-------------TQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 52/196 (26%), Positives = 85/196 (43%), Gaps = 30/196 (15%)

Query: 339 GSVFRGIINGS--TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G V++ I   +   VAIK +           I +E+  L +     +   +G+       
Sbjct: 15  GEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL 74

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA---LDVAHGLHYLHNCTDPGYVHKDI 445
           +++ E+   GS  D L   +  E         IA    +V  GL YLH     G +H+DI
Sbjct: 75  WIIMEYCGGGSCLDLLKPGKLDETY-------IAFILREVLLGLEYLHE---EGKIHRDI 124

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTK--TAVGTNGYMAPEYMEYGLVTPEM 503
            + NILL +    KLA+F      V  +   + +K  T VGT  +MAPE ++      + 
Sbjct: 125 KAANILLSEEGDVKLADF-----GVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKA 179

Query: 504 DTYAFGVVLLELITGK 519
           D ++ G+  +EL  G+
Sbjct: 180 DIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 69/271 (25%), Positives = 124/271 (45%), Gaps = 35/271 (12%)

Query: 339 GSVFRGII-----NGSTVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHD 385
           G VFRGI+         VAIK +        R+    E +++ + +H N+I L G     
Sbjct: 19  GEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78

Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
               ++ E+MENG+L  +L +    EF S+     +   +A G+ YL   +D  YVH+D+
Sbjct: 79  KPAMIITEYMENGALDKYL-RDHDGEFSSYQL-VGMLRGIAAGMKYL---SDMNYVHRDL 133

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ NIL++ NL  K+++F   R    +  G  +T        + APE + Y   T   D 
Sbjct: 134 AARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDV 193

Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FG+V+ E+++  E  Y     ++   E + ++ +G    A +             +  
Sbjct: 194 WSFGIVMWEVMSFGERPY----WDMSNHEVMKAINDGFRLPAPM-------------DCP 236

Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
             +  L L C  ++   RP   ++V+ L K+
Sbjct: 237 SAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 20/169 (11%)

Query: 359 SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR 418
           ++ KE+ L+ ++NH ++I + GA   D  F L  E+M  GS+S  L K  Y  F      
Sbjct: 49  ALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK--YGAF-KEAVI 105

Query: 419 FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN-LRAKLANFSFVRSAVREESGYS 477
                 +  GL YLH   +   +H+D+   N+L+D    R ++A+F    +A R  +  +
Sbjct: 106 INYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFG---AAARLAAKGT 159

Query: 478 STK----TAVGTNGYMAPEYM---EYGLVTPEMDTYAFGVVLLELITGK 519
                    +GT  +MAPE +   +YG      D ++ G V++E+ T K
Sbjct: 160 GAGEFQGQLLGTIAFMAPEVLRGEQYG---RSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 51/183 (27%), Positives = 86/183 (46%), Gaps = 20/183 (10%)

Query: 347 NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME 396
                A+K M           R++  E  +L+++NH  L+NL+ + + +   YLV + + 
Sbjct: 24  TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLL 83

Query: 397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
            G L    H  +  +F     +F I  ++   L YLH+    G +H+DI   NILLD+  
Sbjct: 84  GGDLR--YHLSQKVKFSEEQVKFWIC-EIVLALEYLHS---KGIIHRDIKPDNILLDEQG 137

Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI 516
              + +F+    A +      +T T+ GT GYMAPE +     +  +D ++ GV   E +
Sbjct: 138 HVHITDFNI---ATKVTPDTLTTSTS-GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECL 193

Query: 517 TGK 519
            GK
Sbjct: 194 RGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 66/254 (25%), Positives = 108/254 (42%), Gaps = 31/254 (12%)

Query: 330 NFSPKNMID----GSVFRGI--INGSTVAIK---------CMRRSISKEVNLLKKINHFN 374
           +F   N I     G VF+ +   +    A+K           R     E  +L K++   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 375 LINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR---YPEFVSWNCRFRIALDVAHGLHY 431
           +I  + +    G   +V E+ ENG L   L  +R    PE   W    R  + +  GL +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116

Query: 432 LHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP 491
           LH+      +H+DI S N+ LD     K+ +    +  + + + ++   T VGT  Y++P
Sbjct: 117 LHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTNFA--NTIVGTPYYLSP 170

Query: 492 EYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQD-GEEIL-LAEAVFSMVEGGNAEAKL 549
           E  E      + D +A GVVL E  TGK      + G  IL +   VF  V    ++  L
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQ-L 229

Query: 550 SVLVDPNLQANKKE 563
           + L+D  L  + ++
Sbjct: 230 AQLIDQCLTKDYRQ 243

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 69/271 (25%), Positives = 121/271 (44%), Gaps = 47/271 (17%)

Query: 350 TVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+L
Sbjct: 49  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 108

Query: 401 SDWLHKKRYPEF-------------VSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDI 445
            ++L  +R P               +++         VA G+ YL    C     +H+D+
Sbjct: 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC-----IHRDL 163

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+L+ +N   K+A+F   R  V     Y  T        +MAPE +   + T + D 
Sbjct: 164 AARNVLVTENNVMKIADFGLARD-VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222

Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV++ E+ T   + Y       +  E +F +++ G+   K          AN     
Sbjct: 223 WSFGVLMWEIFTLGGSPYPG-----IPVEELFKLLKEGHRMDK---------PAN---CT 265

Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           + L M+   C    P  RP+  ++V  L +I
Sbjct: 266 NELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 55/191 (28%), Positives = 93/191 (48%), Gaps = 22/191 (11%)

Query: 351 VAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD 402
           VA+K +R  ++        KE+ ++ ++ + N+I L G C  D    ++ E+MENG L+ 
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 403 WLHKKR-YPEF--------VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
           +L ++     F        VS      +A+ +A G+ YL +     +VH+D+++ N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVG 163

Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLL 513
            +   K+A+F   R+    +  Y     AV    +MA E +  G  T   D +AFGV L 
Sbjct: 164 NHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222

Query: 514 ELIT-GKEAAY 523
           E+ T  KE  Y
Sbjct: 223 EMFTLCKEQPY 233

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 58/258 (22%), Positives = 117/258 (45%), Gaps = 28/258 (10%)

Query: 348 GSTVAIKCMRRS--------ISKEVNLLKKINHFNLINLFGACEHDG--VFYLVYEFMEN 397
           G  VA+K +  S          +E+ +L+ ++H N++   G CE  G     L+ E++ +
Sbjct: 33  GEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS 92

Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
           GSL D+L + R  + ++       +  +  G+ YL +     Y+H+D+++ NIL++    
Sbjct: 93  GSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDL 147

Query: 458 AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
            K+++F   +    ++  Y   +       + APE +     +   D ++FGV L EL T
Sbjct: 148 VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Query: 518 GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK-----KEIAHHLIMLC 572
             + +     E + +      + +G     +L  L+    +  +      E+ + L+ LC
Sbjct: 208 YGDPSQSPPAEFLRM----IGIAQGQMIVTRLLELLKEGERLPRPPSCPDEV-YDLMKLC 262

Query: 573 LACIAREPESRPSMAEVV 590
                 EP+ RPS A+++
Sbjct: 263 WEA---EPQDRPSFADLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 53/187 (28%), Positives = 95/187 (50%), Gaps = 19/187 (10%)

Query: 347 NGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +G  VA+K M       R  +  EV +++   H N++ ++ +       ++V EF+E G+
Sbjct: 44  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103

Query: 400 LSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           L+D + H +   E ++  C     L V   L  LH     G +H+DI S +ILL  + R 
Sbjct: 104 LTDIVTHTRMNEEQIAAVC-----LAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRV 155

Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           KL++F F     +E       K+ VGT  +MAPE +      PE+D ++ G++++E++ G
Sbjct: 156 KLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

Query: 519 KEAAYKQ 525
           +   + +
Sbjct: 213 EPPYFNE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 56/285 (19%)

Query: 339 GSVFRG----IINGST----VAIKCMRRSIS--------KEVNLLKKINHFNLINLFGAC 382
           G V+ G    I+   +    VA+K +R+  +        KE +L+   NH N++ L G C
Sbjct: 9   GEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC 68

Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDP 438
             +   Y++ E ME G L  +L   R     P  ++      I LDVA G  YL      
Sbjct: 69  LLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QM 125

Query: 439 GYVHKDISSGNILL-----DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----Y 488
            ++H+D+++ N L+     D +   K+ +F   R        Y S        G     +
Sbjct: 126 HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI------YKSDYYRKEGEGLLPVRW 179

Query: 489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK 548
           MAPE +  G  T + D ++FGV++ E++T  +  Y     + +L      +  GG  +  
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH----VTAGGRLQK- 234

Query: 549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                 P    +K      +  L   C A++P  RP+   +   L
Sbjct: 235 ------PENCPDK------IYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 74/291 (25%), Positives = 123/291 (42%), Gaps = 47/291 (16%)

Query: 325 VVATENFSPKNMIDGSVFRGIINGST--VAIKCMRRSIS--------KEVNLLKKINHFN 374
           V   E    ++  + +        +   VA+K +R   S        KEV +L +++  N
Sbjct: 21  VHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPN 80

Query: 375 LINLFGACEHDGVFYLVYEFMENGSLSDWLHK--------KRYPEFVSWNCRFRIALDVA 426
           +  L G C  D    ++ E+MENG L+ +L K            + +S++    +A  +A
Sbjct: 81  IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIA 140

Query: 427 HGLHYL--HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG 484
            G+ YL   N     +VH+D+++ N L+ KN   K+A+F   R+       YSS    V 
Sbjct: 141 SGMRYLESLN-----FVHRDLATRNCLVGKNYTIKIADFGMSRNL------YSSDYYRVQ 189

Query: 485 TNG-----YMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFS 538
                   +MA E +  G  T + D +AFGV L E++T  +E  Y+      L  + V  
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH-----LTDQQVIE 244

Query: 539 MVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                  +    + + P      K+I      L L C  R+ E RP+  E+
Sbjct: 245 NAGHFFRDDGRQIYL-PRPPNCPKDIYE----LMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 78.3 bits (194), Expect = 5e-16
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 35/200 (17%)

Query: 339 GSVFRGII--NGSTVAIKCMRRSIS--------KEVNLLKKIN-HFNLINLFGACEHDGV 387
           GSV+       G  VAIK M++           +EV  L+K+N H N++ L      +  
Sbjct: 13  GSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDE 72

Query: 388 FYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHK 443
            Y V+E+ME G+L   L K R    + E V  +  ++I      GL ++H     G+ H+
Sbjct: 73  LYFVFEYME-GNLYQ-LMKDRKGKPFSESVIRSIIYQILQ----GLAHIHKH---GFFHR 123

Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----EYGLV 499
           D+   N+L+      K+A+F   R  +R    Y+     V T  Y APE +     Y   
Sbjct: 124 DLKPENLLVSGPEVVKIADFGLARE-IRSRPPYT---DYVSTRWYRAPEILLRSTSY--- 176

Query: 500 TPEMDTYAFGVVLLELITGK 519
           +  +D +A G ++ EL T +
Sbjct: 177 SSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 67/253 (26%), Positives = 125/253 (49%), Gaps = 38/253 (15%)

Query: 351 VAIKCMRR-SISK-----EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           VAIK ++  S+S+     E  ++ K++H  L+ L+G C      Y+V E+M NG L ++L
Sbjct: 31  VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL 90

Query: 405 --HKKRY-PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
             H KR+ P  +   C+     DV  G+ YL +     ++H+D+++ N L+D     K++
Sbjct: 91  REHGKRFQPSQLLEMCK-----DVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVS 142

Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKE 520
           +F   R  + +E  Y+S+  +     +  PE + Y   + + D +AFGV++ E+ + GK 
Sbjct: 143 DFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200

Query: 521 AAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREP 580
              + +  E      V  + +G         L  P+L + K     + IM   +C   + 
Sbjct: 201 PYERFNNSET-----VEKVSQGLR-------LYRPHLASEKV----YAIM--YSCWHEKA 242

Query: 581 ESRPSMAEVVSTL 593
           E RP+  +++S++
Sbjct: 243 EERPTFQQLLSSI 255

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 72/271 (26%), Positives = 116/271 (42%), Gaps = 43/271 (15%)

Query: 339 GSVFRGIIN-GSTVAIKCMR-------------RSISKEVNLLKKINHFNLINLFGACEH 384
           G+V+ G+ N G  +A+K +                + +EV+LLK + H N++   G C  
Sbjct: 14  GTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD 73

Query: 385 DGVFYLVYEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLH-NCTDPGYVH 442
           D    +  EF+  GS+S  L++    PE V   C++     +  G+ YLH NC     VH
Sbjct: 74  DNTISIFMEFVPGGSISSILNRFGPLPEPVF--CKY--TKQILDGVAYLHNNCV----VH 125

Query: 443 KDISSGNILLDKNLRAKLANFSFVRS-AVREESGYSST--KTAVGTNGYMAPEYMEYGLV 499
           +DI   N++L  N   KL +F   R  A     G  S   K+  GT  +MAPE +     
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY 185

Query: 500 TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA 559
             + D ++ G  + E+ TGK      D        A+F +   G     +  L D +  A
Sbjct: 186 GRKSDIWSIGCTVFEMATGKPPLASMDR-----LAAMFYI---GAHRGLMPRLPD-SFSA 236

Query: 560 NKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
              +          +C+ R+   RPS  +++
Sbjct: 237 AAIDFVT-------SCLTRDQHERPSALQLL 260

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 52/184 (28%), Positives = 89/184 (48%), Gaps = 25/184 (13%)

Query: 348 GSTVAIK--------CMRRSIS-KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENG 398
           G  VAIK         M + I+ +E+ +LK++ H NL+NL          YLV+EF+++ 
Sbjct: 26  GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85

Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
            L D    ++YP  +  +   +    +  G+ + H+      +H+DI   NIL+ ++   
Sbjct: 86  VLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVV 139

Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLE 514
           KL +F F R+       Y+     V T  Y APE +    +YG     +D +A G ++ E
Sbjct: 140 KLCDFGFARTLAAPGEVYTDY---VATRWYRAPELLVGDTKYG---RAVDIWAVGCLVTE 193

Query: 515 LITG 518
           ++TG
Sbjct: 194 MLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 43/256 (16%)

Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH----------K 406
           R+   +E  LL  + H +++  +G C       +V+E+M++G L+ +L           +
Sbjct: 51  RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAE 110

Query: 407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV 466
              P  ++ +    IA  +A G+ YL       +VH+D+++ N L+ +NL  K+ +F   
Sbjct: 111 GNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167

Query: 467 RSAVREESGYSSTKTAVGTNG-----YMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKE 520
           R        YS+    VG +      +M PE + Y   T E D ++ GVVL E+ T GK+
Sbjct: 168 RDV------YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221

Query: 521 AAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREP 580
             Y+    E+     +  + +G        VL  P      +     +  L L C  REP
Sbjct: 222 PWYQLSNNEV-----IECITQG-------RVLQRP------RTCPKEVYDLMLGCWQREP 263

Query: 581 ESRPSMAEVVSTLMKI 596
             R ++ E+ S L  +
Sbjct: 264 HMRLNIKEIHSLLQNL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 67/254 (26%), Positives = 112/254 (44%), Gaps = 42/254 (16%)

Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK---KRYPEF 412
           M+    +E  L+ + +H N++ L G C       L++E+M  G L+++L     +     
Sbjct: 51  MQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSL 110

Query: 413 VSWNCRFR----------------IALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
                  R                IA  VA G+ YL   ++  +VH+D+++ N L+ +N+
Sbjct: 111 SHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENM 167

Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI 516
             K+A+F   R+    +   +S   A+    +M PE + Y   T E D +A+GVVL E+ 
Sbjct: 168 VVKIADFGLSRNIYSADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIF 226

Query: 517 T-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLAC 575
           + G +  Y    EE      V   V  GN      VL  P+   N     ++L+ LC   
Sbjct: 227 SYGMQPYYGMAHEE------VIYYVRDGN------VLSCPD---NCPLELYNLMRLCW-- 269

Query: 576 IAREPESRPSMAEV 589
            ++ P  RPS A +
Sbjct: 270 -SKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 76.0 bits (188), Expect = 3e-15
 Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 33/199 (16%)

Query: 339 GSVFRGI--INGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLFGACEHDGV 387
           G V++      G  VA+K +R    +         E++LLK++ H N++ L      +  
Sbjct: 13  GVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERK 72

Query: 388 FYLVYEFMENGSLSDWLHKKRY---PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
            YLV+E+ +   L  +L K+     P  +       I   +  GL Y H       +H+D
Sbjct: 73  LYLVFEYCDM-DLKKYLDKRPGPLSPNLIK-----SIMYQLLRGLAYCH---SHRILHRD 123

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----EYGLVT 500
           +   NIL++++   KLA+F   R+       Y+     V T  Y APE +     Y    
Sbjct: 124 LKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE---VVTLWYRAPEILLGSKHYS--- 177

Query: 501 PEMDTYAFGVVLLELITGK 519
             +D ++ G +  E+ITGK
Sbjct: 178 TAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 52/188 (27%), Positives = 95/188 (50%), Gaps = 20/188 (10%)

Query: 347 NGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +G  VA+K M       R  +  EV +++   H N++ ++ +       +++ EF++ G+
Sbjct: 45  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104

Query: 400 LSDWLHKKRY-PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           L+D + + R   E ++  C       V   L YLH+    G +H+DI S +ILL  + R 
Sbjct: 105 LTDIVSQTRLNEEQIATVCE-----SVLQALCYLHS---QGVIHRDIKSDSILLTLDGRV 156

Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           KL++F F     ++       K+ VGT  +MAPE +       E+D ++ G++++E++ G
Sbjct: 157 KLSDFGFCAQISKD---VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Query: 519 KEAAYKQD 526
            E  Y  D
Sbjct: 214 -EPPYFSD 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 71/282 (25%), Positives = 132/282 (46%), Gaps = 55/282 (19%)

Query: 339 GSVFRGIIN-----GSTVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHD 385
           G V RG +         VAIK +        RR    E +++ + +H N+I+L G     
Sbjct: 18  GEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77

Query: 386 GVFYLVYEFMENGSLSDWLHKK--RYP--EFVSWNCRFRIALDVAHGLHYLHNCTDPGYV 441
               ++ EFMENG+L  +L +   ++   + V       +   +A G+ YL   ++  YV
Sbjct: 78  RPVMIITEFMENGALDSFLRQNDGQFTVIQLVG------MLRGIAAGMKYL---SEMNYV 128

Query: 442 HKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGL 498
           H+D+++ NIL++ NL  K+++F   R  + +++   +  +++G      + APE + Y  
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSR-FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187

Query: 499 VTPEMDTYAFGVVLLELITGKEAAY----KQDGEEILLAEAVFSMVEGGNAEAKLSVLVD 554
            T   D +++G+V+ E+++  E  Y     QD         V + +E    + +L   +D
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---------VINAIE---QDYRLPPPMD 235

Query: 555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                     A H +M  L C  ++  +RP   ++VSTL K+
Sbjct: 236 C-------PTALHQLM--LDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 76.1 bits (187), Expect = 4e-15
 Identities = 70/259 (27%), Positives = 115/259 (44%), Gaps = 31/259 (11%)

Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE 411
           A K  R    KEV +L ++   N+I L G C  +    ++ E+MENG L+ +L      +
Sbjct: 58  ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDD 117

Query: 412 ----------------FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN 455
                            +S++    +AL +A G+ YL +     +VH+D+++ N L+ +N
Sbjct: 118 KEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGEN 174

Query: 456 LRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLE- 514
           L  K+A+F   R+    +  Y     AV    +MA E +  G  T   D +AFGV L E 
Sbjct: 175 LTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233

Query: 515 LITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLA 574
           L+  KE  Y +  +E ++  A     E    + +   L  P            L  L L 
Sbjct: 234 LMLCKEQPYGELTDEQVIENA----GEFFRDQGRQVYLFRP------PPCPQGLYELMLQ 283

Query: 575 CIAREPESRPSMAEVVSTL 593
           C +R+   RPS +++ + L
Sbjct: 284 CWSRDCRERPSFSDIHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 65/270 (24%), Positives = 113/270 (41%), Gaps = 52/270 (19%)

Query: 351 VAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW 403
           VA+K +       R+   +E  LL  + H +++  +G C       +V+E+M +G L+ +
Sbjct: 38  VAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRF 97

Query: 404 LH------------KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
           L             +   P  ++      IA  +A G+ YL +     +VH+D+++ N L
Sbjct: 98  LRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCL 154

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYMEYGLVTPEMDTY 506
           + + L  K+ +F   R        YS+    VG        +M PE + Y   T E D +
Sbjct: 155 VGQGLVVKIGDFGMSRDI------YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIW 208

Query: 507 AFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           +FGVVL E+ T GK+  Y+         EA+  + +G   E   +    P          
Sbjct: 209 SFGVVLWEIFTYGKQPWYQLSN-----TEAIECITQGRELERPRTC---PP--------- 251

Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMK 595
             +  +   C  REP+ R  + ++ S L  
Sbjct: 252 -EVYAIMQGCWQREPQQRMVIKDIHSRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 75.0 bits (185), Expect = 8e-15
 Identities = 55/197 (27%), Positives = 84/197 (42%), Gaps = 30/197 (15%)

Query: 339 GSVFRGII--NGSTVAIK--CMRR-------SISKEVNLLKKINHFNLINLFGACEHDGV 387
           G VF+      G TVA+K   +RR          +E+  L+   H  ++ L     H   
Sbjct: 14  GIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSG 73

Query: 388 FYLVYEFMENGSLSDWLHKKRYP-EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
           F LV E+M    LS+ L  +  P          R+ L    G+ Y+H     G +H+D+ 
Sbjct: 74  FVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK---GVAYMHA---NGIMHRDLK 126

Query: 447 SGNILLDKNLRAKLANFSFVRS-AVREESGYSSTKTAVGTNGYMAPEYM----EYGLVTP 501
             N+L+  +   K+A+F   R  +  E   YS     V T  Y APE +    +Y    P
Sbjct: 127 PANLLISADGVLKIADFGLARLFSEEEPRLYSH---QVATRWYRAPELLYGARKYD---P 180

Query: 502 EMDTYAFGVVLLELITG 518
            +D +A G +  EL+ G
Sbjct: 181 GVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 61/237 (25%), Positives = 97/237 (40%), Gaps = 31/237 (13%)

Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL---HKKRYPEFV 413
           RR    E+ +L  + H N+I  +     D    +  E+   G+L D +     + + E +
Sbjct: 43  RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEM 102

Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
                F+I   V+    Y+H     G +H+DI + NI L K    KL +F   +    E 
Sbjct: 103 VLWYLFQIVSAVS----YIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE- 154

Query: 474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA 533
             YS  +T VGT  YM+PE  +      + D +A G VL EL+T K              
Sbjct: 155 --YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT------------ 200

Query: 534 EAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
                  +  N    +  +V  N        +  LI L  + + ++PE RP+  EV+
Sbjct: 201 ------FDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 64/272 (23%), Positives = 110/272 (40%), Gaps = 38/272 (13%)

Query: 339 GSVFRGIINGST----VAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHDG 386
           G V  G  +       V +K +R S +        +EV   +++NH N++   G C    
Sbjct: 9   GKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI 68

Query: 387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF--RIALDVAHGLHYLHNCTDPGYVHKD 444
            + LV EF   G L ++L   R             R+A +VA GL +LH      ++H D
Sbjct: 69  PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSD 125

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY-------G 497
           ++  N  L  +L  K+ ++        E+   +    AV    ++APE +E         
Sbjct: 126 LALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR-WLAPELVEIRGQDLLPK 184

Query: 498 LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNL 557
             T + + ++ GV + EL T  +  Y    +E +L + V         + KL     P L
Sbjct: 185 DQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR------EQDIKLP---KPQL 235

Query: 558 QANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                +  + ++  C      +PE+RP+  EV
Sbjct: 236 DLKYSDRWYEVMQFCWL----DPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 45/223 (20%)

Query: 335 NMIDGSVFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLIN----------------- 377
              D  V + I  G+   ++ +R   SK+V  +K ++ F +I                  
Sbjct: 41  KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100

Query: 378 -------LFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
                  L  A + D   Y+V E+M  G L + +     PE   W  RF  A +V   L 
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--KW-ARFYTA-EVVLALD 156

Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR-EESGYSSTKTAVGTNGYM 489
            +H+    G++H+D+   N+LLDK+   KLA+F    + ++ + +G     TAVGT  Y+
Sbjct: 157 AIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMDANGMVRCDTAVGTPDYI 210

Query: 490 APEYM-------EYGLVTPEMDTYAFGVVLLELITGKEAAYKQ 525
           +PE +        YG    E D ++ GV L E++ G    Y  
Sbjct: 211 SPEVLKSQGGDGYYG---RECDWWSVGVFLYEMLVGDTPFYAD 250

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 74.1 bits (182), Expect = 3e-14
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 18/169 (10%)

Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +RR I +E+ +L+ +NH N++      +H+G   ++ EFM+ GSL          +F++ 
Sbjct: 115 VRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG--THIADEQFLA- 171

Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
                +A  +  G+ YLH       VH+DI   N+L++     K+A+F   R   +    
Sbjct: 172 ----DVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224

Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA-----FGVVLLELITGK 519
            +S+   VGT  YM+PE +   L     D YA      GV +LE   G+
Sbjct: 225 CNSS---VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 71/269 (26%), Positives = 119/269 (44%), Gaps = 53/269 (19%)

Query: 351 VAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW 403
           VA+K +       R+   +E  LL  + H +++  +G C       +V+E+M++G L+ +
Sbjct: 38  VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 97

Query: 404 L--HKKRYPEFVSWNCR-----------FRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           L  H       V    R             IA  +A G+ YL       +VH+D+++ N 
Sbjct: 98  LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNC 154

Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYMEYGLVTPEMDT 505
           L+  NL  K+ +F   R        YS+    VG +      +M PE + Y   T E D 
Sbjct: 155 LVGANLLVKIGDFGMSRDV------YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 208

Query: 506 YAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
           ++FGV+L E+ T GK+  ++    E+     +  + +G        VL  P +    KE+
Sbjct: 209 WSFGVILWEIFTYGKQPWFQLSNTEV-----IECITQG-------RVLERPRV--CPKEV 254

Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
             + IM  L C  REP+ R ++ E+   L
Sbjct: 255 --YDIM--LGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 27/238 (11%)

Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL------HKKRYPEFVSW 415
           +E+++ +K++H N++ L G C      Y++ E+ + G L  +L       +K  P  +S 
Sbjct: 57  RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116

Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
             +  +   +A G+ +L N     +VH+D+++ N L+      K++  S  +     E  
Sbjct: 117 KQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-- 171

Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEA 535
           Y   + A+    ++APE ++    + + D ++FGV++ E+ T  E  +       L  E 
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG-----LSDEE 226

Query: 536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
           V + ++ G  E  +       L             L   C A  P+ RPS +E+VS L
Sbjct: 227 VLNRLQAGKLELPVPEGCPSRLYK-----------LMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 69/277 (24%), Positives = 123/277 (44%), Gaps = 43/277 (15%)

Query: 339 GSVFRGIING-------STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACE 383
           G V+ GI  G       + VAIK +  + S         E +++K+ N  +++ L G   
Sbjct: 20  GMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPE-------FVSWNCRFRIALDVAHGLHYLHNCT 436
                 ++ E M  G L  +L   R            S     ++A ++A G+ YL+   
Sbjct: 80  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK 139

Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
              +VH+D+++ N ++ ++   K+ +F   R  + E   Y      +    +M+PE ++ 
Sbjct: 140 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMSPESLKD 195

Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
           G+ T   D ++FGVVL E+ T  E  Y+    E +L    F M EGG       +L  P+
Sbjct: 196 GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR---FVM-EGG-------LLDKPD 244

Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
              N  ++   L+ +C       P+ RPS  E++S++
Sbjct: 245 ---NCPDMLFELMRMCW---QYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 60/239 (25%), Positives = 107/239 (44%), Gaps = 33/239 (13%)

Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR---YPEFV 413
           R +   E  +LK ++H N+I  +     D    +V E+   G+L++++ K+      E  
Sbjct: 43  RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT 102

Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN-LRAKLANFSFVRSAVRE 472
             +   +I L     LH++H       +H+D+ + NILLDK+ +  K+ +F       + 
Sbjct: 103 ILHFFVQILL----ALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGI----SKI 151

Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILL 532
            S  S   T VGT  Y++PE  E      + D +A G VL EL + K A    +     L
Sbjct: 152 LSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF---EAAN--L 206

Query: 533 AEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVS 591
              V  ++ G    A +S    P+L+            L L+ +  +P  RP ++++++
Sbjct: 207 PALVLKIMSG--TFAPISDRYSPDLR-----------QLILSMLNLDPSKRPQLSQIMA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 5e-14
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 39/208 (18%)

Query: 339 GSVFRGII--NGSTVAIK------CMRRSISKEVNLLKKI-NHFNLINLFGA-------C 382
           G V++      G  VAIK           I +E N+L+K  NH N+   +GA        
Sbjct: 20  GKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79

Query: 383 EHDGVFYLVYEFMENGSLSDWLHK-----KRYPE-FVSWNCRFRIALDVAHGLHYLHNCT 436
             D + +LV E    GS++D +       KR  E ++++  R     +   GL YLH   
Sbjct: 80  NDDQL-WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR-----ETLRGLAYLH--- 130

Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEY--- 493
           +   +H+DI   NILL KN   KL +F  V + +    G     T +GT  +MAPE    
Sbjct: 131 ENKVIHRDIKGQNILLTKNAEVKLVDFG-VSAQLDSTLG--RRNTFIGTPYWMAPEVIAC 187

Query: 494 MEYGLVTPEM--DTYAFGVVLLELITGK 519
            E    + +   D ++ G+  +EL  GK
Sbjct: 188 DEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 31/197 (15%)

Query: 339 GSVF--RGIINGSTVAIK---------CMRRSISKEVNLLKKINHFNLINLFGACEHDGV 387
           G VF  R    G  VAIK          +++   +E+ +LK++ H NL+NL         
Sbjct: 15  GVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK 74

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH--NCTDPGYVHKDI 445
            +LV+E+ ++  L++    ++ P  V  +   +I       +++ H  NC     +H+D+
Sbjct: 75  LHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC-----IHRDV 126

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEY----MEYGLVTP 501
              NIL+ K  + KL +F F R        Y+     V T  Y APE      +YG   P
Sbjct: 127 KPENILITKQGQIKLCDFGFARILTGPGDDYTDY---VATRWYRAPELLVGDTQYG---P 180

Query: 502 EMDTYAFGVVLLELITG 518
            +D +A G V  EL+TG
Sbjct: 181 PVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 72.8 bits (178), Expect = 5e-14
 Identities = 80/290 (27%), Positives = 129/290 (44%), Gaps = 52/290 (17%)

Query: 339 GSVF--RGIINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDG 386
           G+V+  R +     VAIK M  S          I KEV  L++I H N I   G    + 
Sbjct: 39  GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH 98

Query: 387 VFYLVYEFMENGSLSDWL--HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             +LV E+   GS SD L  HKK   E         I      GL YLH+      +H+D
Sbjct: 99  TAWLVMEYCL-GSASDLLEVHKKPLQEVEI----AAITHGALQGLAYLHSHN---MIHRD 150

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEY---MEYGLVTP 501
           I +GNILL +  + KLA+F          S  S   + VGT  +MAPE    M+ G    
Sbjct: 151 IKAGNILLTEPGQVKLADFG-------SASIASPANSFVGTPYWMAPEVILAMDEGQYDG 203

Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK 561
           ++D ++ G+  +EL   K   +  +        A++ + +  +          P LQ+N 
Sbjct: 204 KVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNES----------PTLQSN- 247

Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQTLLLERI 611
            E + +      +C+ + P+ RP+  E++  +  ++   +R +T+L++ I
Sbjct: 248 -EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR---ERPETVLIDLI 293

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 66/278 (23%), Positives = 110/278 (39%), Gaps = 45/278 (16%)

Query: 339 GSVFRGIINGST-------VAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACE 383
           G V+ G+  G         VA+K +  S S         E  ++ K NH N++ L G   
Sbjct: 20  GEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF 79

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++       A DVA G  YL    +  
Sbjct: 80  ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENH 136

Query: 440 YVHKDISSGNILLD---KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
           ++H+DI++ N LL        AK+A+F   R   R    Y     A+    +M PE    
Sbjct: 137 FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY-YRKGGRAMLPIKWMPPEAFLD 195

Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYK-QDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
           G+ T + D ++FGV+L E+ +     Y  +  +E++       +  GG  +         
Sbjct: 196 GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF-----VTGGGRLDP-------- 242

Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                 K     +  +   C    PE RP+ A ++  +
Sbjct: 243 -----PKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 71.9 bits (176), Expect = 6e-14
 Identities = 63/255 (24%), Positives = 118/255 (46%), Gaps = 34/255 (13%)

Query: 351 VAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD 402
           VAI  +R        R    E   L + +H N++ L G         +V E+M NG+L  
Sbjct: 36  VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS 95

Query: 403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLAN 462
           +L  +++   +       +   +A G+ YL   ++ GYVHK +++  +L++ +L  K++ 
Sbjct: 96  FL--RKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISG 150

Query: 463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAA 522
           F  ++   + E+ Y +T +      + APE ++Y   +   D ++FG+V+ E+++  E  
Sbjct: 151 FRRLQED-KSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Query: 523 Y-KQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE 581
           Y    G++++ A      VE G        L  P    N   + H L+   L C  +E  
Sbjct: 209 YWDMSGQDVIKA------VEDGFR------LPAP---RNCPNLLHQLM---LDCWQKERG 250

Query: 582 SRPSMAEVVSTLMKI 596
            RP  +++ S L K+
Sbjct: 251 ERPRFSQIHSILSKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 31/194 (15%)

Query: 339 GSVFRGI--INGSTVAIKC--------MRRSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G+V++    +    +A+K         +++ I  E+ +L K +   +I  +GA   +   
Sbjct: 15  GTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRI 74

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
            +  EFM+ GSL  +   ++ PE V      RIA+ V  GL YL +      +H+D+   
Sbjct: 75  SICTEFMDGGSLDVY---RKIPEHVLG----RIAVAVVKGLTYLWSLK---ILHRDVKPS 124

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++   + KL +F      V      S  KT VGTN YMAPE +   +YG+ +   D 
Sbjct: 125 NMLVNTRGQVKLCDFGVSTQLVN-----SIAKTYVGTNAYMAPERISGEQYGIHS---DV 176

Query: 506 YAFGVVLLELITGK 519
           ++ G+  +EL  G+
Sbjct: 177 WSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 72.5 bits (178), Expect = 7e-14
 Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 25/226 (11%)

Query: 339 GSVF-----RGIINGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLFGACEH 384
           G VF      G   G   A+K ++++  K         E ++L ++NH  ++ L  A + 
Sbjct: 10  GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT 69

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G  YL+ +F+  G L   L K+    F   + +F +A ++A  L +LH+    G +++D
Sbjct: 70  EGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLA-ELALALDHLHSL---GIIYRD 123

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +   NILLD+    KL +F   + ++  E       +  GT  YMAPE +     T   D
Sbjct: 124 LKPENILLDEEGHIKLTDFGLSKESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSAD 180

Query: 505 TYAFGVVLLELITGKEAAYKQDGEEI--LLAEAVFSMVEGGNAEAK 548
            ++FGV++ E++TG      +D +E   ++ +A   M +  + EA+
Sbjct: 181 WWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 226

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 10/161 (6%)

Query: 371 NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            H  L  L    +     + V E++  G L    H +R   F     RF  A ++  GL 
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARF-YAAEIVLGLQ 110

Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           +LH   + G +++D+   N+LLD     K+A+F   +  +       +T T  GT  Y+A
Sbjct: 111 FLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---TTSTFCGTPDYIA 164

Query: 491 PEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
           PE + Y    P +D +A GV+L E++ G ++ ++ D E+ L
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAG-QSPFEGDDEDEL 204

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 53/195 (27%), Positives = 87/195 (44%), Gaps = 25/195 (12%)

Query: 339 GSVF--RGIINGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGV 387
           G V+  R  + G  VAIK ++             +E+ LLK++NH N+I L     H G 
Sbjct: 13  GVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGD 72

Query: 388 FYLVYEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            YLV+EFM+    +D     K     +  +        +  GL + H+    G +H+D+ 
Sbjct: 73  LYLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLK 125

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYG--LVTPEMD 504
             N+L++     KLA+F   RS       Y+     V T  Y APE +  G    +  +D
Sbjct: 126 PENLLINTEGVLKLADFGLARSFGSPVRPYTHY---VVTRWYRAPELL-LGDKGYSTPVD 181

Query: 505 TYAFGVVLLELITGK 519
            ++ G +  EL++ +
Sbjct: 182 IWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 61/235 (25%), Positives = 108/235 (45%), Gaps = 31/235 (13%)

Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK-KRYPEFVS 414
           +R  I +E+ +L + N   ++  +GA   DG   +  E M+ GSL   L + KR PE + 
Sbjct: 46  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEIL 105

Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
                ++++ V  GL YL        +H+D+   NIL++     KL +F      +    
Sbjct: 106 G----KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156

Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
             S   + VGT  YM+PE ++    + + D ++ G+ L+EL  G+      D +E+   E
Sbjct: 157 --SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL---E 211

Query: 535 AVFS--MVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMA 587
           A+F   +V+G   E      + P  +   + ++ H +           +SRP+MA
Sbjct: 212 AIFGRPVVDGEEGEPH---SISPRPRPPGRPVSGHGM-----------DSRPAMA 252

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 17/180 (9%)

Query: 348 GSTVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHDG--VFYLVYEFMEN 397
           G  VA+K ++R           KE+N+LK + H N++   G C   G     L+ E++  
Sbjct: 33  GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92

Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
           GSL D+L K +    ++       A  +  G+ YLH+     Y+H+D+++ N+LLD +  
Sbjct: 93  GSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRL 145

Query: 458 AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
            K+ +F   ++       Y   +       + A E ++    +   D ++FGV L EL+T
Sbjct: 146 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 72/255 (28%), Positives = 109/255 (42%), Gaps = 47/255 (18%)

Query: 351 VAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           VA+K M  S          I KEV  L+++ H N I   G    +   +LV E+   GS 
Sbjct: 49  VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSA 107

Query: 401 SDWL--HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SD L  HKK   E         I      GL YLH+      +H+DI +GNILL +  + 
Sbjct: 108 SDLLEVHKKPLQEVEI----AAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQV 160

Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEY---MEYGLVTPEMDTYAFGVVLLEL 515
           KLA+F          S  S   + VGT  +MAPE    M+ G    ++D ++ G+  +EL
Sbjct: 161 KLADFG-------SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Query: 516 ITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLAC 575
              K   +  +        A++ + +  +          P LQ+N  E           C
Sbjct: 214 AERKPPLFNMNA-----MSALYHIAQNDS----------PTLQSN--EWTDSFRGFVDYC 256

Query: 576 IAREPESRPSMAEVV 590
           + + P+ RP+ AE++
Sbjct: 257 LQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 18/167 (10%)

Query: 359 SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR 418
           ++  E+ LLK + H  ++  +G    D    +  E+M  GS+ D L  K Y   ++    
Sbjct: 50  ALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGA-LTETVT 106

Query: 419 FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS 478
            +    +  G+ YLH       VH+DI   NIL D     KL +F    ++ R ++  SS
Sbjct: 107 RKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFG---ASKRLQTICSS 160

Query: 479 T---KTAVGTNGYMAPEYME---YGLVTPEMDTYAFGVVLLELITGK 519
               K+  GT  +M+PE +    YG    + D ++ G  ++E++T K
Sbjct: 161 GTGMKSVTGTPYWMSPEVISGEGYG---RKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 32/224 (14%)

Query: 306 LVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGI--INGSTVAIKCMRRS---- 359
           +VSV +  +  K+ ++E +              G+V+  I    G  VAIK M       
Sbjct: 11  IVSVGDPKK--KYTRFEKIGQGAS---------GTVYTAIDVATGQEVAIKQMNLQQQPK 59

Query: 360 ---ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE-FVSW 415
              I  E+ ++++  H N++N   +       ++V E++  GSL+D + +    E  ++ 
Sbjct: 60  KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA 119

Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
            CR     +    L +LH+      +H+DI S NILL  +   KL +F F      E+S 
Sbjct: 120 VCR-----ECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171

Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
            S   T VGT  +MAPE +      P++D ++ G++ +E++ G+
Sbjct: 172 RS---TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 27/208 (12%)

Query: 339 GSVFRGIIN---GST--VAIKCMRRSIS---------KEVNLLKKINHFNLINLFGAC-- 382
           GSV  G ++   GS   VA+K M+  I           E   +K  +H N++ L G C  
Sbjct: 13  GSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFE 72

Query: 383 -EHDGVF---YLVYEFMENGSLSDWLHKKRY---PEFVSWNCRFRIALDVAHGLHYLHNC 435
                      ++  FM++G L  +L   R    PE +      +  +D+A G+ YL N 
Sbjct: 73  ASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN- 131

Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME 495
               ++H+D+++ N +L +++   +A+F   +  +     Y   + A     ++A E + 
Sbjct: 132 --RNFIHRDLAARNCMLREDMTVCVADFGLSKK-IYSGDYYRQGRIAKMPVKWIAIESLA 188

Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAY 523
             + T + D +AFGV + E+ T  +  Y
Sbjct: 189 DRVYTSKSDVWAFGVTMWEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 18/164 (10%)

Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEF-----VSWN 416
           KEV LL K+ H N++  F + + +G  ++V E+ + G L   ++++R   F     +SW 
Sbjct: 48  KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW- 106

Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN-LRAKLANFSFVRSAVREESG 475
                 + ++ GL ++H   D   +H+DI S NI L KN + AKL +F   R        
Sbjct: 107 -----FVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDS 155

Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
                T VGT  Y++PE  +      + D ++ G VL EL T K
Sbjct: 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 48/182 (26%), Positives = 88/182 (48%), Gaps = 24/182 (13%)

Query: 348 GSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
           G   AIKC+++           +++E ++L +++H  ++N+  + + +   Y + EF+  
Sbjct: 43  GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG 102

Query: 398 GSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
           G L   L K  R+P  V+   +F  A ++     YLH+      +++D+   N+LLD   
Sbjct: 103 GELFTHLRKAGRFPNDVA---KFYHA-ELVLAFEYLHSK---DIIYRDLKPENLLLDNKG 155

Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI 516
             K+ +F F +  V +      T T  GT  Y+APE ++       +D +  GV+L E I
Sbjct: 156 HVKVTDFGFAKK-VPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209

Query: 517 TG 518
            G
Sbjct: 210 AG 211

Length = 329

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 70.3 bits (172), Expect = 4e-13
 Identities = 57/190 (30%), Positives = 86/190 (45%), Gaps = 13/190 (6%)

Query: 371 NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
           NH  L  L+   +     + V EF+  G L   + K R   F     RF  A ++   L 
Sbjct: 54  NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAA-EITSALM 110

Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           +LH   D G +++D+   N+LLD     KLA+F   +  +       +T T  GT  Y+A
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---TTSTFCGTPDYIA 164

Query: 491 PEYMEYGLVTPEMDTYAFGVVLLELITGK---EAAYKQD-GEEILLAEAVFSMVEGGNAE 546
           PE ++  L  P +D +A GV+L E++ G    EA  + D  E IL  E V+      +A 
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAV 224

Query: 547 AKLSVLVDPN 556
             L   +  N
Sbjct: 225 DILKAFMTKN 234

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 18/229 (7%)

Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK-KRYPEFVS 414
           +R  I +E+ +L + N   ++  +GA   DG   +  E M+ GSL   L K  R PE   
Sbjct: 42  IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--- 98

Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
            N   +I++ V  GL YL        +H+D+   NIL++     KL +F      V  + 
Sbjct: 99  -NILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF-----GVSGQL 150

Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
             S   + VGT  YM+PE ++    T + D ++ G+ L+E+  G+      D +E+   E
Sbjct: 151 IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---E 207

Query: 535 AVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESR 583
           A+F          +    V  +   + + +A   I   L  I  EP  +
Sbjct: 208 AMFGRPVSEGEAKESHRPVSGHPPDSPRPMA---IFELLDYIVNEPPPK 253

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 69.5 bits (171), Expect = 6e-13
 Identities = 54/211 (25%), Positives = 82/211 (38%), Gaps = 54/211 (25%)

Query: 339 GSVFRGI--INGSTVAIKCMR------------RSISKEVNLLKKINHFNLINLFGACEH 384
             V++      G  VAIK ++             +  +E+ LL+++ H N+I L     H
Sbjct: 14  AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH 73

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAH----------GLHYLHN 434
                LV+EFME   L   +  K             I L  A           GL YLH+
Sbjct: 74  KSNINLVFEFME-TDLEKVIKDK------------SIVLTPADIKSYMLMTLRGLEYLHS 120

Query: 435 CTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTK--TAVGTNGYMAPE 492
                 +H+D+   N+L+  +   KLA+F   RS      G  + K    V T  Y APE
Sbjct: 121 N---WILHRDLKPNNLLIASDGVLKLADFGLARS-----FGSPNRKMTHQVVTRWYRAPE 172

Query: 493 YM----EYGLVTPEMDTYAFGVVLLELITGK 519
            +     YG     +D ++ G +  EL+   
Sbjct: 173 LLFGARHYG---VGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 69.7 bits (170), Expect = 6e-13
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 20/216 (9%)

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           E  +LK   H  L +L  + +       V E++  G L  + H  R   F     RF  A
Sbjct: 45  ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGA 102

Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
            ++   L YLH+      V++D+   N++LDK+   K+ +F   +  + + +   + KT 
Sbjct: 103 -EIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TMKTF 155

Query: 483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE----ILLAEAVFS 538
            GT  Y+APE +E       +D +  GVV+ E++ G+   Y QD E+    IL+ +  F 
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP 215

Query: 539 MVEGGNAEAKLSVLV--DPNLQA-----NKKEIAHH 567
                +A++ LS L+  DPN +      + KEI  H
Sbjct: 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 59/240 (24%), Positives = 101/240 (42%), Gaps = 36/240 (15%)

Query: 357 RRSISKEVNLLKKINHFNLINLFGACE-HDGVFYLVYEFMENGSLSDWLHKKR---YPE- 411
           R++  +E  LL ++ H N++    + E  DG+ Y+V  F E G L   L +++    PE 
Sbjct: 43  RKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPEN 102

Query: 412 -FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
             V W  +  +AL   H  H LH         +D+ + N+ L +    K+ +    R   
Sbjct: 103 QVVEWFVQIAMALQYLHEKHILH---------RDLKTQNVFLTRTNIIKVGDLGIARVL- 152

Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
             E+      T +GT  YM+PE         + D +A G  + E+ T K A   +D    
Sbjct: 153 --ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---- 206

Query: 531 LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
            +   V+ ++EG              L    K+ +  L  L    +++ PE RPS+  ++
Sbjct: 207 -MNSLVYRIIEG-------------KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 69.0 bits (169), Expect = 6e-13
 Identities = 67/266 (25%), Positives = 114/266 (42%), Gaps = 30/266 (11%)

Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     LV E++  G
Sbjct: 33  GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92

Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL D+L K R  E +        A  +  G+ YL       YVH+D+++ NIL++   R 
Sbjct: 93  SLRDYLQKHR--ERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESENRV 147

Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           K+ +F   +   +++  Y   +       + APE +     +   D ++FGVVL EL T 
Sbjct: 148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 207

Query: 519 KEAA-------YKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML 571
            + +        +  G +      V+ ++E      +L     P       EI  + IM 
Sbjct: 208 SDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRL-----PAPPGCPAEI--YAIM- 259

Query: 572 CLACIAREPESRPSMAEVVSTLMKIQ 597
              C   +P  RPS +E+   +  I+
Sbjct: 260 -KECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 69.7 bits (170), Expect = 9e-13
 Identities = 66/241 (27%), Positives = 105/241 (43%), Gaps = 40/241 (16%)

Query: 311 NLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISKEVNLLKKI 370
           N+D  L   +YE +V        K   D  V + I  G+   ++ +R   S++V  +K +
Sbjct: 20  NIDNFLN--RYEKIVRKIRKLQMKAE-DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL 76

Query: 371 NHFNLI------------------------NLFGACEHDGVFYLVYEFMENGSLSDWLHK 406
           + F +I                         LF A + D   Y+V E+M  G L + +  
Sbjct: 77  SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN 136

Query: 407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV 466
              PE   W  +F  A +V   L  +H+    G +H+D+   N+LLDK+   KLA+F   
Sbjct: 137 YDVPE--KW-AKFYTA-EVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189

Query: 467 RSAVREESGYSSTKTAVGTNGYMAPEYMEY----GLVTPEMDTYAFGVVLLELITGKEAA 522
                +E+G     TAVGT  Y++PE ++     G    E D ++ GV L E++ G    
Sbjct: 190 MKM--DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Query: 523 Y 523
           Y
Sbjct: 248 Y 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 65/226 (28%), Positives = 104/226 (46%), Gaps = 28/226 (12%)

Query: 363 EVNLLKKINHFNLINL-FGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRI 421
           E  +L+   H  L  L +    HD + + V E+   G L  + H  R   F     RF  
Sbjct: 45  ESRVLQNTRHPFLTALKYSFQTHDRLCF-VMEYANGGEL--FFHLSRERVFSEDRARFYG 101

Query: 422 ALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
           A ++   L YLH+C     V++D+   N++LDK+   K+ +F   +  +   S  ++ KT
Sbjct: 102 A-EIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI---SDGATMKT 154

Query: 482 AVGTNGYMAPEYME---YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGE---EILLAEA 535
             GT  Y+APE +E   YG     +D +  GVV+ E++ G+   Y QD E   E++L E 
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211

Query: 536 V-FSMVEGGNAEAKLSVLV--DPNL-----QANKKEIAHHLIMLCL 573
           + F       A++ L+ L+  DP         + KEI  H     +
Sbjct: 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 20/195 (10%)

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHK 443
           HD + + V E+   G L  + H  R   F     RF  A ++   L YLH  ++   V++
Sbjct: 67  HDRLCF-VMEYANGGEL--FFHLSRERVFSEDRARFYGA-EIVSALDYLH--SEKNVVYR 120

Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           D+   N++LDK+   K+ +F   +  +++ +   + KT  GT  Y+APE +E       +
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYLAPEVLEDNDYGRAV 177

Query: 504 DTYAFGVVLLELITGKEAAYKQDGEE----ILLAEAVFSMVEGGNAEAKLSVLV--DPNL 557
           D +  GVV+ E++ G+   Y QD E+    IL+ E  F       A++ LS L+  DP  
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237

Query: 558 Q-----ANKKEIAHH 567
           +      + KEI  H
Sbjct: 238 RLGGGPDDAKEIMQH 252

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 47/186 (25%), Positives = 93/186 (50%), Gaps = 17/186 (9%)

Query: 343 RGIINGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDG--VFYLVY 392
            G   G  VA+K ++          + KE+ +L+ + H N++   G C  DG     L+ 
Sbjct: 28  EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 87

Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           EF+ +GSL ++L + +    ++   + + A+ +  G+ YL +     YVH+D+++ N+L+
Sbjct: 88  EFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLV 142

Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY-MAPEYMEYGLVTPEMDTYAFGVV 511
           +   + K+ +F   + A+  +  Y + K  + +  +  APE +         D ++FGV 
Sbjct: 143 ESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVT 201

Query: 512 LLELIT 517
           L EL+T
Sbjct: 202 LYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 66/259 (25%), Positives = 113/259 (43%), Gaps = 42/259 (16%)

Query: 348 GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           G T+A+K +R          I  E+++L K     +++ +GA   +G  Y+  E+M+ GS
Sbjct: 26  GVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGS 85

Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           L          E +  +   RI   V  GL +L    +   +H+D+   N+L++ N + K
Sbjct: 86  LDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVK 143

Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYG------LVTPEMDTYAFGVVLL 513
           L +F    + V      S  KT +G   YMAPE ++ G        T + D ++ G+ +L
Sbjct: 144 LCDFGVSGNLVA-----SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198

Query: 514 ELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD---PNLQANKKEIAHHLIM 570
           E+  G    Y    E       +F+         +LS +VD   P L +   + A   + 
Sbjct: 199 EMALG---RYPYPPE---TYANIFA---------QLSAIVDGDPPTLPSGYSDDAQDFVA 243

Query: 571 LCLACIAREPESRPSMAEV 589
            CL    + P  RP+ A++
Sbjct: 244 KCL---NKIPNRRPTYAQL 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 52/166 (31%), Positives = 82/166 (49%), Gaps = 13/166 (7%)

Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRI 421
           +E +++   N   ++ LF A + D   Y+V E+M  G L + +     PE   W  RF  
Sbjct: 92  EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE--KW-ARFYT 148

Query: 422 ALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
           A +V   L  +H+    G++H+D+   N+LLDK+   KLA+F       +E  G     T
Sbjct: 149 A-EVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--GMVRCDT 202

Query: 482 AVGTNGYMAPEYMEY----GLVTPEMDTYAFGVVLLELITGKEAAY 523
           AVGT  Y++PE ++     G    E D ++ GV L E++ G    Y
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 71/277 (25%), Positives = 121/277 (43%), Gaps = 41/277 (14%)

Query: 336 MIDGSVFRGIING---STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEH 384
           M+     R II G   + VA+K +  S S         E +++K     +++ L G    
Sbjct: 21  MVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR--------FRIALDVAHGLHYLHNCT 436
                +V E M +G L  +L   R PE  +   R         ++A ++A G+ YL+   
Sbjct: 81  GQPTLVVMELMAHGDLKSYLRSLR-PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-- 137

Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
              +VH+D+++ N ++  +   K+ +F   R  + E   Y      +    +MAPE ++ 
Sbjct: 138 -KKFVHRDLAARNCMVAHDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMAPESLKD 195

Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
           G+ T   D ++FGVVL E+ +  E  Y+    E +L    F M +GG        L  P+
Sbjct: 196 GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK---FVM-DGG-------YLDQPD 244

Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
              N  E    L+ +C       P+ RP+  E+V+ L
Sbjct: 245 ---NCPERVTDLMRMCW---QFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 61/269 (22%), Positives = 108/269 (40%), Gaps = 55/269 (20%)

Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY-----PEFVS 414
           + +E+   +++ H N++    +   D   Y+V   M  GS  D L  K +     PE   
Sbjct: 46  LQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELA- 102

Query: 415 WNCRFRIAL---DVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF----SFVR 467
                 IA    DV + L Y+H+    G++H+ + + +ILL  + +  L+      S ++
Sbjct: 103 ------IAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK 153

Query: 468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGL--VTPEMDTYAFGVVLLELITGKEAAYKQ 525
              R+   +   K++V    +++PE ++  L     + D Y+ G+   EL  G    +K 
Sbjct: 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG-HVPFKD 212

Query: 526 DGEEILLAEAV------------FSMVEGGNAEAKLSVLVDPNLQANKKEIA-------- 565
                +L E V            + + E  +     S    PN + +             
Sbjct: 213 MPATQMLLEKVRGTVPCLLDKSTYPLYE-DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHF 271

Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLM 594
           H  + LCL    R+PESRPS     S L+
Sbjct: 272 HQFVELCL---QRDPESRPS----ASQLL 293

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 39/202 (19%)

Query: 339 GSVFRGI--INGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLF----GACE 383
           GSV   I    G  VAIK + R            +E+ LLK + H N+I L      A  
Sbjct: 29  GSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88

Query: 384 HDGV--FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYV 441
            D    FYLV  +M+       L K           ++ +   +  GL Y+H+    G +
Sbjct: 89  GDEFQDFYLVMPYMQTD-----LQKIMGHPLSEDKVQYLV-YQMLCGLKYIHSA---GII 139

Query: 442 HKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE----YMEYG 497
           H+D+  GN+ ++++   K+ +F   R A  E +GY      V T  Y APE    +M Y 
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY------VVTRWYRAPEVILNWMHY- 192

Query: 498 LVTPEMDTYAFGVVLLELITGK 519
                +D ++ G ++ E++TGK
Sbjct: 193 --NQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 59/266 (22%), Positives = 114/266 (42%), Gaps = 44/266 (16%)

Query: 351 VAIKCMRRSISKEVN--------LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD 402
           VAIK +R   S + N        ++  ++H +++ L G C    V  L+ + M  G L D
Sbjct: 39  VAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLD 97

Query: 403 WLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           ++   +        ++W       + +A G+ YL    +   VH+D+++ N+L+      
Sbjct: 98  YVRNHKDNIGSQYLLNW------CVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHV 148

Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT- 517
           K+ +F   +    +E  Y +    V    +MA E + + + T + D +++GV + EL+T 
Sbjct: 149 KITDFGLAKLLDVDEKEYHAEGGKVPIK-WMALESILHRIYTHKSDVWSYGVTVWELMTF 207

Query: 518 GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH-HLIMLCLACI 576
           G +        EI        ++E G              +  +  I    + M+ + C 
Sbjct: 208 GAKPYEGIPAVEIP------DLLEKG-------------ERLPQPPICTIDVYMVLVKCW 248

Query: 577 AREPESRPSMAEVVSTLMKIQLDVQR 602
             + ESRP+  E+++   K+  D QR
Sbjct: 249 MIDAESRPTFKELINEFSKMARDPQR 274

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 23/231 (9%)

Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRI 421
           +E+ L   + H N++   G+   +G F +  E +  GSLS  L  K  P   +       
Sbjct: 54  EEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFY 113

Query: 422 ALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
              +  GL YLH   D   VH+DI   N+L+  N  + +   S   ++ R       T+T
Sbjct: 114 TKQILEGLKYLH---DNQIVHRDIKGDNVLV--NTYSGVVKISDFGTSKRLAGINPCTET 168

Query: 482 AVGTNGYMAPEYMEYGL--VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSM 539
             GT  YMAPE ++ G        D ++ G  ++E+ TGK    +       L E   +M
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE-------LGEPQAAM 221

Query: 540 VEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
            + G  +      + P +  +    A + I   L C   +P+ R S  +++
Sbjct: 222 FKVGMFK------IHPEIPESLSAEAKNFI---LRCFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 37/194 (19%)

Query: 343 RGIINGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINL---FGACEHDGVFYL 390
           R  + G  VAIK + +  S         +E+ LLK + H N+I+L   F +   D   Y 
Sbjct: 30  RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED--IYF 87

Query: 391 VYEFMENGSLSDWLHKKRY-PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           V E +    L   L  +    +F+ +         +  GL Y+H+    G VH+D+   N
Sbjct: 88  VTELLGT-DLHRLLTSRPLEKQFIQY-----FLYQILRGLKYVHSA---GVVHRDLKPSN 138

Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----EYGLVTPEMDT 505
           IL+++N   K+ +F   R    + +GY ST+       Y APE M    +Y +   E+D 
Sbjct: 139 ILINENCDLKICDFGLARIQDPQMTGYVSTRY------YRAPEIMLTWQKYDV---EVDI 189

Query: 506 YAFGVVLLELITGK 519
           ++ G +  E++ GK
Sbjct: 190 WSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 51/170 (30%), Positives = 78/170 (45%), Gaps = 17/170 (10%)

Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR---YPE-- 411
           R    KEV +L  + H N++    + E +G  Y+V ++ E G L   ++ +R   +PE  
Sbjct: 43  REESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ 102

Query: 412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR 471
            + W  +  +AL   H         D   +H+DI S NI L K+   KL +F   R    
Sbjct: 103 ILDWFVQICLALKHVH---------DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-- 151

Query: 472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
             S     +T +GT  Y++PE  E      + D +A G VL E+ T K A
Sbjct: 152 -NSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 32/194 (16%)

Query: 339 GSVFRGII--NGSTVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHDGVF 388
           G VF G +  + + VA+K  R ++         +E  +LK+ +H N++ L G C      
Sbjct: 9   GEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 68

Query: 389 YLVYEFMENGSLSDWLHKK----RYPEFVSWNCRFRIALDVAHGLHYLHN--CTDPGYVH 442
           Y+V E ++ G    +L  +    +  E +      ++  + A G+ YL +  C     +H
Sbjct: 69  YIVMELVQGGDFLTFLRTEGPRLKVKELI------QMVENAAAGMEYLESKHC-----IH 117

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESG-YSSTKTAVGTN-GYMAPEYMEYGLVT 500
           +D+++ N L+ +    K+++F   R    EE G Y+ST         + APE + YG  +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174

Query: 501 PEMDTYAFGVVLLE 514
            E D ++FG++L E
Sbjct: 175 SESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 75/291 (25%), Positives = 123/291 (42%), Gaps = 54/291 (18%)

Query: 339 GSVF--RGIINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDG 386
           G+V+  R + N   VAIK M  S          I KEV  L+K+ H N I   G    + 
Sbjct: 29  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88

Query: 387 VFYLVYEFMENGSLSDWL--HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             +LV E+   GS SD L  HKK   E         +      GL YLH+      +H+D
Sbjct: 89  TAWLVMEYCL-GSASDLLEVHKKPLQEVEI----AAVTHGALQGLAYLHS---HNMIHRD 140

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEY---MEYGLVTP 501
           + +GNILL +    KL +F          S  +     VGT  +MAPE    M+ G    
Sbjct: 141 VKAGNILLSEPGLVKLGDFG-------SASIMAPANXFVGTPYWMAPEVILAMDEGQYDG 193

Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK 561
           ++D ++ G+  +EL   K   +  +        A++ + +  +          P LQ+  
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNES----------PALQSG- 237

Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ-LDVQRSQTLLLERI 611
              + +      +C+ + P+ RP+       L+K + +  +R  T++++ I
Sbjct: 238 -HWSEYFRNFVDSCLQKIPQDRPTS----EVLLKHRFVLRERPPTVIMDLI 283

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 20/160 (12%)

Query: 375 LINLFGACEHDGVFYLVYEFMENGSLSDWLHK--KRYPEFVS--WNCRFRIALDVAHGLH 430
           +  L  A + +   YLV ++   G L   L K   R PE ++  +     IA+D  H LH
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           Y         VH+DI   NIL+D N   +LA+F      +  E G   +  AVGT  Y++
Sbjct: 123 Y---------VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYIS 171

Query: 491 PEYMEY-----GLVTPEMDTYAFGVVLLELITGKEAAYKQ 525
           PE ++      G   PE D ++ GV + E++ G+   Y +
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 50/216 (23%), Positives = 98/216 (45%), Gaps = 37/216 (17%)

Query: 344 GIINGSTVAIKCMRR--------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFM 395
           G+ +   VAIK ++            +E +L+ +++H N++ L G    +    +++E++
Sbjct: 30  GMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89

Query: 396 ENGSLSDWLHKKRYPEFVSWNCR--------------FRIALDVAHGLHYLHNCTDPGYV 441
             G L ++L  +     V  +                  IA+ +A G+ YL   +   +V
Sbjct: 90  NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFV 146

Query: 442 HKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYMEY 496
           HKD+++ NIL+ + L  K+++    R        YS+    V         +M PE + Y
Sbjct: 147 HKDLAARNILIGEQLHVKISDLGLSREI------YSADYYRVQPKSLLPIRWMPPEAIMY 200

Query: 497 GLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEIL 531
           G  + + D ++FGVVL E+ + G +  Y    +E++
Sbjct: 201 GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 65.2 bits (159), Expect = 9e-12
 Identities = 53/232 (22%), Positives = 94/232 (40%), Gaps = 35/232 (15%)

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK-----KRYPEFVSWNC 417
           E+ +L  +NH N+I+   A        +V E+   G LS  + K     K  PE   W  
Sbjct: 49  EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW-- 106

Query: 418 RFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS 477
             RI + +  GL  LH   +   +H+D+ S NILL  N   K+ +    +   +     +
Sbjct: 107 --RIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK-----N 156

Query: 478 STKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVF 537
             KT +GT  YMAPE  +    + + D ++ G +L E+ T       +  +++       
Sbjct: 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK---- 212

Query: 538 SMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
             V+ G           P +     +    L     + +  +P+ RP+  ++
Sbjct: 213 --VQRGKY---------PPIPPIYSQ---DLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 62/234 (26%), Positives = 107/234 (45%), Gaps = 31/234 (13%)

Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYPEFVS 414
           +R  I +E+ +L + N   ++  +GA   DG   +  E M+ GSL   L K  R PE + 
Sbjct: 46  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL 105

Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
                ++++ V  GL YL        +H+D+   NIL++     KL +F      +    
Sbjct: 106 G----KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156

Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
             S   + VGT  YM+PE ++    + + D ++ G+ L+E+  G+      D +E+   E
Sbjct: 157 --SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL---E 211

Query: 535 AVFSM-VEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMA 587
            +F   VEG  AE++ S    P  +   + ++ +            P+SRP MA
Sbjct: 212 LMFGCPVEGDPAESETS----PRPRPPGRPLSSY-----------GPDSRPPMA 250

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 65.9 bits (160), Expect = 1e-11
 Identities = 52/191 (27%), Positives = 94/191 (49%), Gaps = 21/191 (10%)

Query: 339 GSVFRG--IINGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+VF    +  G  VAIK +       +  I  E+ ++K++ + N++N   +       +
Sbjct: 33  GTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF 92

Query: 390 LVYEFMENGSLSDWLHKKRYPEF-VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +V E++  GSL+D + +    E  ++  CR     +    L +LH       +H+DI S 
Sbjct: 93  VVMEYLAGGSLTDVVTETCMDEAQIAAVCR-----ECLQALEFLHANQ---VIHRDIKSD 144

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           N+LL  +   KL +F F      E+S  S   T VGT  +MAPE +      P++D ++ 
Sbjct: 145 NVLLGMDGSVKLTDFGFCAQITPEQSKRS---TMVGTPYWMAPEVVTRKAYGPKVDIWSL 201

Query: 509 GVVLLELITGK 519
           G++ +E++ G+
Sbjct: 202 GIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 53/191 (27%), Positives = 94/191 (49%), Gaps = 21/191 (10%)

Query: 339 GSVFRG--IINGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V+    I  G  VAIK M       +  I  E+ ++++  + N++N   +       +
Sbjct: 33  GTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 92

Query: 390 LVYEFMENGSLSDWLHKKRYPEF-VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +V E++  GSL+D + +    E  ++  CR     +    L +LH+      +H+DI S 
Sbjct: 93  VVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALDFLHSNQ---VIHRDIKSD 144

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           NILL  +   KL +F F      E+S  S   T VGT  +MAPE +      P++D ++ 
Sbjct: 145 NILLGMDGSVKLTDFGFCAQITPEQSKRS---TMVGTPYWMAPEVVTRKAYGPKVDIWSL 201

Query: 509 GVVLLELITGK 519
           G++ +E++ G+
Sbjct: 202 GIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 23/221 (10%)

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           E  +L+K++   +++L  A E      LV   M  G L   ++    P F      F  A
Sbjct: 43  EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102

Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
             +  GL +LH       V++D+   N+LLD +   ++++      AV E  G    K  
Sbjct: 103 -QIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGL---AV-ELKGGKKIKGR 154

Query: 483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEG 542
            GT GYMAPE ++  +    +D +A G  L E+I G+ + ++Q  E++            
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR-SPFRQRKEKV------------ 201

Query: 543 GNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESR 583
              E K   L       +K   +     LC A + ++PE R
Sbjct: 202 EKEELKRRTLEMAVEYPDK--FSPEAKDLCEALLQKDPEKR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 68/268 (25%), Positives = 116/268 (43%), Gaps = 35/268 (13%)

Query: 339 GSVFRGIINGSTVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V  G    + V +K +R S S        +E    + + H NL+   G C     + L
Sbjct: 14  GEVNSGY-TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLL 72

Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRF--RIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           V EF   G L  +L   R  E ++ +     R+A ++A GL +LH      ++H D++  
Sbjct: 73  VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALR 129

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME--YG--LV---TP 501
           N LL  +L  K+ ++    +  +E+   +  +  V    ++APE ++  +G  LV   T 
Sbjct: 130 NCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR-WIAPELVDEVHGNLLVVDQTK 188

Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK 561
           E + ++ GV + EL       Y+   +E +L   V         E +L  L  P L+   
Sbjct: 189 ESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV--------REQQLK-LPKPRLKLPL 239

Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEV 589
            +  + ++  C      +PE RPS  EV
Sbjct: 240 SDRWYEVMQFC----WLQPEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 51/155 (32%), Positives = 77/155 (49%), Gaps = 22/155 (14%)

Query: 381 ACEHDGVFYLVYEFMENGSLSDWLHK--KRYPEFVSWNCRFRIALDV--AHGLHYLHNCT 436
           A + +   YLV ++   G L   L K   R PE ++   RF IA  V   H +H LH   
Sbjct: 69  AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA---RFYIAEMVLAIHSIHQLH--- 122

Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR-EESGYSSTKTAVGTNGYMAPEYME 495
              YVH+DI   N+LLD N   +LA+F    S ++  + G   +  AVGT  Y++PE ++
Sbjct: 123 ---YVHRDIKPDNVLLDMNGHIRLADFG---SCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 496 -----YGLVTPEMDTYAFGVVLLELITGKEAAYKQ 525
                 G   PE D ++ GV + E++ G+   Y +
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 14/158 (8%)

Query: 363 EVNLLKKINHFNLINLFGACEHDGVF-YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRI 421
           E  +LK+++H  +I LF   EHD  F Y++ E++  G L  +L       F +    F  
Sbjct: 51  EKRVLKEVSHPFIIRLF-WTEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLF-Y 106

Query: 422 ALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
           A ++   L YLH+      V++D+   NILLDK    KL +F F +           T T
Sbjct: 107 ASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR------DRTWT 157

Query: 482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
             GT  Y+APE ++       +D +A G+++ E++ G 
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 54/219 (24%), Positives = 107/219 (48%), Gaps = 27/219 (12%)

Query: 339 GSVFRGIIN----GSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHD 385
           G+V +G+        TVA+K ++           + +E N+++++++  ++ + G CE +
Sbjct: 9   GTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE 68

Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
             + LV E  E G L+ +L K ++   V+      +   V+ G+ YL    +  +VH+D+
Sbjct: 69  S-WMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLE---ETNFVHRDL 121

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+LL     AK+++F   ++   +E+ Y +         + APE M Y   + + D 
Sbjct: 122 AARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDV 181

Query: 506 YAFGVVLLELITGKEAAYK-QDGEEILLAEAVFSMVEGG 543
           ++FGV++ E  +  +  YK   G E      V  M+E G
Sbjct: 182 WSFGVLMWEAFSYGQKPYKGMKGNE------VTQMIESG 214

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 58/248 (23%), Positives = 116/248 (46%), Gaps = 34/248 (13%)

Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVY-EFMENGSLSDWLHKKRYP 410
             K M +++  E+  LK ++H N++   G  E    +  ++ E++  GS+   L  + Y 
Sbjct: 47  RQKDMVKALRSEIETLKDLDHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCL--RTYG 103

Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
            F     RF     V  GL YLH+    G +H+D+ + N+L+D +   K+++F   +   
Sbjct: 104 RFEEQLVRF-FTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK--- 156

Query: 471 REESGYSS--TKTAVGTNGYMAPEYME-----YGLVTPEMDTYAFGVVLLELITGKEAAY 523
           + +  Y +    +  G+  +MAPE +      Y   + ++D ++ G V+LE+  G+    
Sbjct: 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGY---SAKVDIWSLGCVVLEMFAGRRPWS 213

Query: 524 KQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESR 583
            +        EA+ +M + GN   + +  + P++  N   +A   +    AC    P++R
Sbjct: 214 DE--------EAIAAMFKLGN--KRSAPPIPPDVSMNLSPVALDFLN---ACFTINPDNR 260

Query: 584 PSMAEVVS 591
           P+  E++ 
Sbjct: 261 PTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 25/224 (11%)

Query: 348 GSTVAIKCMRRS--ISK--------EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
           G   A+K +R+   I+K        E  +L+   H  L  L  A +       V E+   
Sbjct: 20  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79

Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
           G L  + H  R   F     RF  A ++   L YLH+      V++DI   N++LDK+  
Sbjct: 80  GEL--FFHLSRERVFTEERARFYGA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDGH 133

Query: 458 AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
            K+ +F   +  + + +   + KT  GT  Y+APE +E       +D +  GVV+ E++ 
Sbjct: 134 IKITDFGLCKEGISDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190

Query: 518 GKEAAYKQDGEE----ILLAEAVFSMVEGGNAEAKLSVLV--DP 555
           G+   Y QD E     IL+ E  F       A++ L+ L+  DP
Sbjct: 191 GRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 11/195 (5%)

Query: 334 KNMIDGSVFR-GIINGSTVAIKCMRRSISKEVN-LLKKINHFNLINLFGACEHDGVFYLV 391
           K   DGS +   ++   T+  K  +  I  E N LLK + H  L+ L  + +     Y V
Sbjct: 15  KRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFV 74

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            +++  G L  + H +R   F+    RF  A +VA  + YLH+      +++D+   NIL
Sbjct: 75  LDYVNGGEL--FFHLQRERCFLEPRARF-YAAEVASAIGYLHSLN---IIYRDLKPENIL 128

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           LD      L +F   +  V  E    +T T  GT  Y+APE +        +D +  G V
Sbjct: 129 LDSQGHVVLTDFGLCKEGVEPEE---TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAV 185

Query: 512 LLELITGKEAAYKQD 526
           L E++ G    Y +D
Sbjct: 186 LYEMLYGLPPFYSRD 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 65/261 (24%), Positives = 110/261 (42%), Gaps = 39/261 (14%)

Query: 339 GSVF--RGIINGSTVAIKCMRRS-------ISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G V+  R +  G   AIK ++         + +E+ ++K   H N++  FG+       +
Sbjct: 23  GDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82

Query: 390 LVYEFMENGSLSDWLH--KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +  EF   GSL D  H         +++  R     +   GL+YLH+    G +H+DI  
Sbjct: 83  ICMEFCGGGSLQDIYHVTGPLSESQIAYVSR-----ETLQGLYYLHS---KGKMHRDIKG 134

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMD 504
            NILL  N   KLA+F     + +  +  +  K+ +GT  +MAPE       G      D
Sbjct: 135 ANILLTDNGHVKLADFGV---SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCD 191

Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +A G+  +EL   +   +     ++    A+F M +      KL    D    +N    
Sbjct: 192 IWAVGITAIELAELQPPMF-----DLHPMRALFLMTKSNFQPPKLK---DKMKWSNS--- 240

Query: 565 AHHLIMLCLACIAREPESRPS 585
            HH + + L    + P+ RP+
Sbjct: 241 FHHFVKMAL---TKNPKKRPT 258

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 53/191 (27%), Positives = 85/191 (44%), Gaps = 36/191 (18%)

Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGV------FYLVY 392
           G+ VAIK + R            +E+ LLK + H N+I L      D        FYLV 
Sbjct: 40  GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99

Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
            FM         H+K   + + +     +   +  GL Y+H     G +H+D+  GN+ +
Sbjct: 100 PFMGTDLGKLMKHEKLSEDRIQF-----LVYQMLKGLKYIHAA---GIIHRDLKPGNLAV 151

Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE----YMEYGLVTPEMDTYAF 508
           +++   K+ +F   R    E +GY      V T  Y APE    +M Y   T  +D ++ 
Sbjct: 152 NEDCELKILDFGLARQTDSEMTGY------VVTRWYRAPEVILNWMHY---TQTVDIWSV 202

Query: 509 GVVLLELITGK 519
           G ++ E++TGK
Sbjct: 203 GCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 51/194 (26%), Positives = 87/194 (44%), Gaps = 26/194 (13%)

Query: 339 GSVFRGIIN--GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G VF+GI N     VAIK +           I +E+ +L + +   +   +G+       
Sbjct: 18  GEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL 77

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIAL---DVAHGLHYLHNCTDPGYVHKDI 445
           +++ E++  GS  D L    + EF       +IA    ++  GL YLH+      +H+DI
Sbjct: 78  WIIMEYLGGGSALDLLRAGPFDEF-------QIATMLKEILKGLDYLHS---EKKIHRDI 127

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
            + N+LL +    KLA+F         +       T VGT  +MAPE ++      + D 
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIQQSAYDSKADI 184

Query: 506 YAFGVVLLELITGK 519
           ++ G+  +EL  G+
Sbjct: 185 WSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 64.9 bits (159), Expect = 2e-11
 Identities = 56/213 (26%), Positives = 80/213 (37%), Gaps = 54/213 (25%)

Query: 339 GSVFRGI--INGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLF-------G 380
           G V   +    G  VAIK +              +E+ LL+ + H N+I L         
Sbjct: 14  GVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP 73

Query: 381 ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAH----------GLH 430
              +D   Y+V E ME    +D LHK       S        L   H          GL 
Sbjct: 74  EDFND--VYIVTELME----TD-LHKV----IKS-----PQPLTDDHIQYFLYQILRGLK 117

Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           YLH+      +H+D+   NIL++ N   K+ +F   R    +E         V T  Y A
Sbjct: 118 YLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174

Query: 491 PE----YMEYGLVTPEMDTYAFGVVLLELITGK 519
           PE       Y   T  +D ++ G +  EL+T K
Sbjct: 175 PELLLSSSRY---TKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 67/282 (23%), Positives = 126/282 (44%), Gaps = 46/282 (16%)

Query: 339 GSVFRGIINGS------TVAIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G+           VAIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 21  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80

Query: 385 DGVFYLVYEFMENGSLSDWL--HKKRY--PEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
             V  L+ + M  G L D++  HK        ++W       + +A G++YL    +   
Sbjct: 81  STV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---ERRL 130

Query: 441 VHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVT 500
           VH+D+++ N+L+      K+ +F   +    +E  Y +    V    +MA E + + + T
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK-WMALESILHRIYT 189

Query: 501 PEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN 560
            + D +++GV + EL+T     Y  DG   + A  + S++E G        L  P +   
Sbjct: 190 HQSDVWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPICT- 237

Query: 561 KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              I  ++IM+   C   + +SRP   E++    K+  D QR
Sbjct: 238 ---IDVYMIMV--KCWMIDADSRPKFRELIIEFSKMARDPQR 274

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 55/160 (34%), Positives = 77/160 (48%), Gaps = 28/160 (17%)

Query: 377 NLFGACEHDGVFYLVYEFMENGSLSDWLHK--KRYPEFVSWNCRFRIALDV--AHGLHYL 432
           NL  A + +   YLV ++   G L   L K   R PE ++   RF +A  V     +H L
Sbjct: 65  NLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA---RFYLAEMVLAIDSVHQL 121

Query: 433 HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR-EESGYSSTKTAVGTNGYMAP 491
                  YVH+DI   N+LLDKN   +LA+F    S +R    G   +  AVGT  Y++P
Sbjct: 122 G------YVHRDIKPDNVLLDKNGHIRLADFG---SCLRLLADGTVQSNVAVGTPDYISP 172

Query: 492 EY---ME-----YGLVTPEMDTYAFGVVLLELITGKEAAY 523
           E    ME     YG   PE D ++ GV + E++ G+   Y
Sbjct: 173 EILQAMEDGKGRYG---PECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 47/159 (29%), Positives = 73/159 (45%), Gaps = 13/159 (8%)

Query: 372 HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHY 431
           H  L+NLF   + +     V E+   G L   +H   + E       F  A  V  GL Y
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAVFYAA-CVVLGLQY 116

Query: 432 LHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS-TKTAVGTNGYMA 490
           LH   +   V++D+   N+LLD     K+A+F   +    E  G+   T T  GT  ++A
Sbjct: 117 LH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCGTPEFLA 169

Query: 491 PEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE 529
           PE +     T  +D +  GV++ E++ G E+ +  D EE
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVG-ESPFPGDDEE 207

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 51/161 (31%), Positives = 76/161 (47%), Gaps = 13/161 (8%)

Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR---YPEFVSWNCR 418
           KE  LL K+ H N++    + E DG  Y+V E+ + G L   +  +R   +PE       
Sbjct: 47  KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF 106

Query: 419 FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS 478
            ++ L V H +H      +   +H+DI S NI L +N + KL +F    SA    S  + 
Sbjct: 107 VQMCLGVQH-IH------EKRVLHRDIKSKNIFLTQNGKVKLGDFG---SARLLTSPGAY 156

Query: 479 TKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
             T VGT  Y+ PE  E      + D ++ G +L EL T K
Sbjct: 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 50/194 (25%), Positives = 83/194 (42%), Gaps = 28/194 (14%)

Query: 339 GSVF--RGIINGSTVAIKCMRRS--ISKE----VNLLKKINHF-----NLINLFGACEHD 385
           GSV+  +    G   AIK +++S  I+K     V   + I         +  L+ + +  
Sbjct: 10  GSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK 69

Query: 386 GVFYLVYEFMENGSLSDWLHKKRY-PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
              YLV E++  G  +  +      PE   W  ++    +V  G+  LH     G +H+D
Sbjct: 70  DYLYLVMEYLNGGDCASLIKTLGGLPE--DWAKQY--IAEVVLGVEDLH---QRGIIHRD 122

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           I   N+L+D+    KL +F   R      +G  + K  VGT  Y+APE +         D
Sbjct: 123 IKPENLLIDQTGHLKLTDFGLSR------NGLEN-KKFVGTPDYLAPETILGVGDDKMSD 175

Query: 505 TYAFGVVLLELITG 518
            ++ G V+ E + G
Sbjct: 176 WWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 62/262 (23%), Positives = 112/262 (42%), Gaps = 38/262 (14%)

Query: 339 GSVFRGIINGS--TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G VF+GI N +   VAIK +           I +E+ +L + +   +   +G+   D   
Sbjct: 18  GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 77

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +++ E++  GS  D L     P  +       I  ++  GL YLH+      +H+DI + 
Sbjct: 78  WIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAA 130

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           N+LL ++   KLA+F         +       T VGT  +MAPE ++      + D ++ 
Sbjct: 131 NVLLSEHGEVKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 187

Query: 509 GVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL 568
           G+  +EL  G+    +    ++L       ++   N          P L+ N  +     
Sbjct: 188 GITAIELAKGEPPHSELHPMKVLF------LIPKNNP---------PTLEGNYSKPLKEF 232

Query: 569 IMLCLACIAREPESRPSMAEVV 590
           +    AC+ +EP  RP+  E++
Sbjct: 233 VE---ACLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 65/261 (24%), Positives = 107/261 (40%), Gaps = 73/261 (27%)

Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLV-YEFMENGSLSDWLHKKRY-----PEFVSW 415
           +E  LL  ++H N++ +   C  DG    V Y +M  G+L  +L + R      P+ +S 
Sbjct: 57  QESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALST 116

Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
                +A+ +A G+ YLH     G +HKDI++ N ++D+ L+ K+ + +  R        
Sbjct: 117 QQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDL------ 167

Query: 476 YSSTKTAVGTNGY-----MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
           +      +G N       MA E +     +   D ++FGV+L EL+T  +  Y     EI
Sbjct: 168 FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY----VEI 223

Query: 531 LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL------------------IMLC 572
                                  DP       E+A +L                  +M C
Sbjct: 224 -----------------------DP------FEMAAYLKDGYRLAQPINCPDELFAVMAC 254

Query: 573 LACIAREPESRPSMAEVVSTL 593
             C A +PE RPS +++V  L
Sbjct: 255 --CWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 49/160 (30%), Positives = 68/160 (42%), Gaps = 40/160 (25%)

Query: 389 YLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           YLV E+M  G L + L  K  +PE      RF IA  V   L  +H     G++H+DI  
Sbjct: 77  YLVMEYMPGGDLMNLLIRKDVFPE--ET-ARFYIAELVL-ALDSVHKL---GFIHRDIKP 129

Query: 448 GNILLDKNLRAKLANF----SFVRSAVREESGYSST----------------------KT 481
            NIL+D +   KLA+F       ++  RE     S                        +
Sbjct: 130 DNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANS 189

Query: 482 AVGTNGYMAPEY---MEYGLVTPEMDTYAFGVVLLELITG 518
            VGT  Y+APE      YG    E D ++ GV+L E++ G
Sbjct: 190 TVGTPDYIAPEVLRGTPYG---LECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 71/276 (25%), Positives = 128/276 (46%), Gaps = 43/276 (15%)

Query: 339 GSVFRG-IINGSTVAIKCMRRSIS------------KEVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +I+     I C  +S++            KE  ++K  +H N+++L G C   
Sbjct: 9   GCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS 68

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ YL +     +VH+D
Sbjct: 69  EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGF--GLQVAKGMEYLAS---KKFVHRD 123

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGLVTP 501
           +++ N +LD++   K+A+F   R    +E  Y S     G      +MA E ++    T 
Sbjct: 124 LAARNCMLDESFTVKVADFGLARDIYDKE--YYSVHNHTGAKLPVKWMALESLQTQKFTT 181

Query: 502 EMDTYAFGVVLLELITGKEAAYKQ-DGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN 560
           + D ++FGV+L EL+T     Y   D  +I        +++G         L+ P    +
Sbjct: 182 KSDVWSFGVLLWELMTRGAPPYPDVDSFDI-----TVYLLQGRR-------LLQPEYCPD 229

Query: 561 KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                  L  + L+C   +PE RP+ +E+VS + +I
Sbjct: 230 P------LYEVMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 49/191 (25%), Positives = 89/191 (46%), Gaps = 22/191 (11%)

Query: 352 AIKCMRRS------------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           AIK +++             + + V  L   + F L +LF   +     + V E++  G 
Sbjct: 24  AIKALKKDVVLEDDDVECTMVERRVLALAWEHPF-LTHLFCTFQTKEHLFFVMEYLNGGD 82

Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           L    H +    F     RF  A ++  GL +LH     G +++D+   N+LLDK+   K
Sbjct: 83  L--MFHIQSSGRFDEARARF-YAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIK 136

Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +A+F   +  +   +G     T  GT  Y+APE ++       +D ++FGV+L E++ G+
Sbjct: 137 IADFGMCKENM---NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Query: 520 EAAYKQDGEEI 530
              + +D +E+
Sbjct: 194 SPFHGEDEDEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 63.2 bits (154), Expect = 6e-11
 Identities = 58/255 (22%), Positives = 108/255 (42%), Gaps = 35/255 (13%)

Query: 351 VAIK-C-------MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD 402
           VA+K C       +R    +E  ++++ +H +++ L G    + V ++V E    G L  
Sbjct: 37  VAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPV-WIVMELAPLGELRS 95

Query: 403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLAN 462
           +L   +Y   ++    +  +  ++  L YL +     +VH+DI++ N+L+      KL +
Sbjct: 96  YLQVNKYSLDLASLILY--SYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGD 150

Query: 463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLE-LITGKEA 521
           F   R  + +ES Y ++K  +    +MAPE + +   T   D + FGV + E L+ G + 
Sbjct: 151 FGLSR-YLEDESYYKASKGKLPIK-WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Query: 522 AYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE 581
                  +      V   +E G             +  N     + L+  C    A +P 
Sbjct: 209 FQGVKNND------VIGRIENGER---------LPMPPNCPPTLYSLMTKCW---AYDPS 250

Query: 582 SRPSMAEVVSTLMKI 596
            RP   E+ + L  I
Sbjct: 251 KRPRFTELKAQLSDI 265

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 63.2 bits (153), Expect = 6e-11
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 35/204 (17%)

Query: 339 GSVFRG--IINGSTVAIKCM------RRSISKEVNLLKKINHF-NLINLFGAC------E 383
           G V++G  +  G   AIK M         I +E+N+LKK +H  N+   +GA        
Sbjct: 20  GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
            D   +LV EF   GS++D +   +      E++++ CR     ++  GL +LH      
Sbjct: 80  MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-----EILRGLSHLHQHK--- 131

Query: 440 YVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EY 496
            +H+DI   N+LL +N   KL +F     + + +       T +GT  +MAPE +   E 
Sbjct: 132 VIHRDIKGQNVLLTENAEVKLVDFGV---SAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 188

Query: 497 GLVTPEM--DTYAFGVVLLELITG 518
              T +   D ++ G+  +E+  G
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 63.2 bits (153), Expect = 7e-11
 Identities = 51/191 (26%), Positives = 94/191 (49%), Gaps = 21/191 (10%)

Query: 339 GSVFRG--IINGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V+    +  G  VAI+ M       +  I  E+ ++++  + N++N   +       +
Sbjct: 34  GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93

Query: 390 LVYEFMENGSLSDWLHKKRYPEF-VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +V E++  GSL+D + +    E  ++  CR     +    L +LH+      +H+DI S 
Sbjct: 94  VVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQ---VIHRDIKSD 145

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           NILL  +   KL +F F      E+S  S+    VGT  +MAPE +      P++D ++ 
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVTRKAYGPKVDIWSL 202

Query: 509 GVVLLELITGK 519
           G++ +E+I G+
Sbjct: 203 GIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 63.5 bits (155), Expect = 8e-11
 Identities = 52/191 (27%), Positives = 86/191 (45%), Gaps = 36/191 (18%)

Query: 348 GSTVAIKCMRR---------SISKEVNLLKKINHFNLINL---FGACEHDGVF---YLVY 392
           G  VAIK + R            +E+ LLK ++H N+I L   F        F   YLV 
Sbjct: 40  GRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99

Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M    L++ +  ++       + +F +   +  GL Y+H+    G +H+D+   NI +
Sbjct: 100 HLM-GADLNNIVKCQK---LSDDHIQF-LVYQILRGLKYIHSA---GIIHRDLKPSNIAV 151

Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE----YMEYGLVTPEMDTYAF 508
           +++   K+ +F   R    E +GY      V T  Y APE    +M Y      +D ++ 
Sbjct: 152 NEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHY---NQTVDIWSV 202

Query: 509 GVVLLELITGK 519
           G ++ EL+TGK
Sbjct: 203 GCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 8e-11
 Identities = 50/202 (24%), Positives = 83/202 (41%), Gaps = 24/202 (11%)

Query: 339 GSVFRG--IINGSTVAIKCMR--------RSISKEVNLLKKINHF---NLINLFGACEHD 385
           G+V+RG  +  G  VA+K +           I +EV LL ++      N+   +G+    
Sbjct: 15  GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74

Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
              +++ E+ E GS+   +        ++      I  +V   L Y+H     G +H+DI
Sbjct: 75  PRLWIIMEYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHKV---GVIHRDI 127

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM-D 504
            + NIL+      KL +F             S   T VGT  +MAPE +  G       D
Sbjct: 128 KAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFVGTPYWMAPEVITEGKYYDTKAD 184

Query: 505 TYAFGVVLLELITGKEAAYKQD 526
            ++ G+ + E+ TG       D
Sbjct: 185 IWSLGITIYEMATGNPPYSDVD 206

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 35/206 (16%)

Query: 339 GSVFRGI--INGSTVAIK----------------CMRRSISKEVNLLKKINHFNLINLFG 380
           GSV+ G+   +G  +A+K                 M  ++++E+ LLK++ H N++   G
Sbjct: 14  GSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLG 73

Query: 381 ACEHDGVFYLVYEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
           +        +  E++  GS++  L+    + E +  N        +  GL+YLHN    G
Sbjct: 74  SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQILKGLNYLHN---RG 126

Query: 440 YVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV------GTNGYMAPEY 493
            +H+DI   NIL+D     K+++F   +   + E+   STKT        G+  +MAPE 
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISK---KLEANSLSTKTNGARPSLQGSVFWMAPEV 183

Query: 494 MEYGLVTPEMDTYAFGVVLLELITGK 519
           ++    T + D ++ G +++E++TGK
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 10/175 (5%)

Query: 357 RRSISKEVN-LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           ++ I  E N LLK + H  L+ L  + +     Y V +F+  G L  + H +R   F   
Sbjct: 39  QKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEP 96

Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
             RF  A ++A  L YLH+      V++D+   NILLD      L +F   +  +   + 
Sbjct: 97  RARFYAA-EIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGI---AQ 149

Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
             +T T  GT  Y+APE +        +D +  G VL E++ G    Y +D  E+
Sbjct: 150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 38/195 (19%)

Query: 347 NGSTVAIK----------CMRRSISKEVNLLKKINHFNLINLF------GACEHDGVFYL 390
            G  VAIK          C R    +E+ +L++  H N+I +            + V Y+
Sbjct: 29  TGVKVAIKKISPFEHQTFCQR--TLREIKILRRFKHENIIGILDIIRPPSFESFNDV-YI 85

Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWN--CRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           V E ME    +D L+K    + +S +    F     +  GL Y+H+      +H+D+   
Sbjct: 86  VQELME----TD-LYKLIKTQHLSNDHIQYF--LYQILRGLKYIHSA---NVLHRDLKPS 135

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----EYGLVTPEMD 504
           N+LL+ N   K+ +F   R A  E          V T  Y APE M     Y   T  +D
Sbjct: 136 NLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGY---TKAID 192

Query: 505 TYAFGVVLLELITGK 519
            ++ G +L E+++ +
Sbjct: 193 IWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 30/173 (17%)

Query: 339 GSVFRG--IINGSTVAIKCM------RRSISKEVNLLKKINHF-NLINLFGA------CE 383
           G V++G  +  G   AIK M         I  E+N+LKK +H  N+   +GA        
Sbjct: 30  GQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
           HD   +LV EF   GS++D +   +      +++++ CR     ++  GL +LH      
Sbjct: 90  HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR-----EILRGLAHLHA---HK 141

Query: 440 YVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE 492
            +H+DI   N+LL +N   KL +F  V + +    G  +  T +GT  +MAPE
Sbjct: 142 VIHRDIKGQNVLLTENAEVKLVDFG-VSAQLDRTVGRRN--TFIGTPYWMAPE 191

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 49/174 (28%), Positives = 84/174 (48%), Gaps = 14/174 (8%)

Query: 360 ISKEVNLLKKINHF--NLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNC 417
           + K V  L   N F  +L   F   EH    + V EF+  G L    H +    F  +  
Sbjct: 44  VEKRVLALAWENPFLTHLYCTFQTKEH---LFFVMEFLNGGDL--MFHIQDKGRFDLYRA 98

Query: 418 RFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS 477
            F  A ++  GL +LH+    G +++D+   N++LD++   K+A+F   +  V    G +
Sbjct: 99  TF-YAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENV---FGDN 151

Query: 478 STKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
              T  GT  Y+APE ++    T  +D ++FGV+L E++ G+   +  D +E+ 
Sbjct: 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 29/191 (15%)

Query: 348 GSTVAIKCMRRSI----------SKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
           G   A+K M++S+           +E ++L   N   +  L  A +     YLV E+   
Sbjct: 26  GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85

Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
           G L   L++     F     +F +A ++   +H +H     GYVH+DI   N+L+D+   
Sbjct: 86  GDLLSLLNRYEDQ-FDEDMAQFYLA-ELVLAIHSVHQM---GYVHRDIKPENVLIDRTGH 140

Query: 458 AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---------YGLVTPEMDTYAF 508
            KLA+F    +A    +   ++K  VGT  Y+APE +          YG    E D ++ 
Sbjct: 141 IKLADFG--SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYG---VECDWWSL 195

Query: 509 GVVLLELITGK 519
           GV+  E+I G+
Sbjct: 196 GVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 66/254 (25%), Positives = 108/254 (42%), Gaps = 50/254 (19%)

Query: 279 FHHKRRRDEAARKDGKREKKRNLPEDFLVSVSNLDRGLKFYKYEDLVVAT---ENFSPKN 335
               +++D  + K+ KR+ K    EDF     N  R L    +  +++AT   E+F P  
Sbjct: 7   LQLHKKKDSDSTKEPKRKNKMKY-EDF-----NFIRTLGTGSFGRVILATYKNEDFPP-- 58

Query: 336 MIDGSVFRGIINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHD 385
                          VAIK   +S          +  E  +L  INH   +NL+G+ + +
Sbjct: 59  ---------------VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103

Query: 386 GVFYLVYEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
              YLV EF+  G    +L + KR+P  V   C +  A  +     YL +      V++D
Sbjct: 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVG--CFY--AAQIVLIFEYLQSLN---IVYRD 156

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +   N+LLDK+   K+ +F F +         + T T  GT  Y+APE +         D
Sbjct: 157 LKPENLLLDKDGFIKMTDFGFAKVV------DTRTYTLCGTPEYIAPEILLNVGHGKAAD 210

Query: 505 TYAFGVVLLELITG 518
            +  G+ + E++ G
Sbjct: 211 WWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 9/145 (6%)

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           Y V E++  G L    H ++  +F   +  F  A ++A GL +LH+    G +++D+   
Sbjct: 77  YFVMEYVNGGDL--MYHIQQVGKFKEPHAVF-YAAEIAIGLFFLHS---KGIIYRDLKLD 130

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           N++LD     K+A+F   +  +       +T+T  GT  Y+APE + Y      +D +AF
Sbjct: 131 NVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187

Query: 509 GVVLLELITGKEAAYKQDGEEILLA 533
           GV+L E++ G+     +D +E+  +
Sbjct: 188 GVLLYEMLAGQPPFDGEDEDELFQS 212

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 54/191 (28%), Positives = 88/191 (46%), Gaps = 25/191 (13%)

Query: 339 GSVF--RGIINGSTVAIKCMRRS-------ISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G V+  R +  G   A+K ++         I +E+ ++K+  H N++  FG+       +
Sbjct: 23  GDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82

Query: 390 LVYEFMENGSLSDWLH-KKRYPEF-VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +  E+   GSL D  H      E  +++ CR     +   GL YLH+    G +H+DI  
Sbjct: 83  ICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHS---KGKMHRDIKG 134

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMD 504
            NILL  N   KLA+F     A +  +  +  K+ +GT  +MAPE     + G      D
Sbjct: 135 ANILLTDNGDVKLADFGV---AAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCD 191

Query: 505 TYAFGVVLLEL 515
            +A G+  +EL
Sbjct: 192 IWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 9/144 (6%)

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
            Y V E++  G L      ++   F   +  F  A ++A GL +LH+    G +++D+  
Sbjct: 76  LYFVMEYVNGGDL--MYQIQQVGRFKEPHAVF-YAAEIAIGLFFLHS---KGIIYRDLKL 129

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            N++LD     K+A+F   +  + +     +TKT  GT  Y+APE + Y      +D +A
Sbjct: 130 DNVMLDSEGHIKIADFGMCKENMWDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWA 186

Query: 508 FGVVLLELITGKEAAYKQDGEEIL 531
           FGV+L E++ G+     +D +E+ 
Sbjct: 187 FGVLLYEMLAGQAPFEGEDEDELF 210

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 50/207 (24%), Positives = 97/207 (46%), Gaps = 26/207 (12%)

Query: 339 GSVFRGIINGS----TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGAC--- 382
           GSV  G +N       VA+K M+ +I           E   +K+ +H N++ L G C   
Sbjct: 13  GSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQT 72

Query: 383 -EHDG--VFYLVYEFMENGSLSDWLHKKRY---PEFVSWNCRFRIALDVAHGLHYLHNCT 436
            E +G     ++  FM++G L  +L   R    P+++      +   D+A G+ YL   +
Sbjct: 73  VESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---S 129

Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
              ++H+D+++ N +L++N+   +A+F   +  +     Y   + A     ++A E +  
Sbjct: 130 SKSFIHRDLAARNCMLNENMNVCVADFGLSKK-IYNGDYYRQGRIAKMPVKWIAIESLAD 188

Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAY 523
            + T + D ++FGV + E+ T  +  Y
Sbjct: 189 RVYTTKSDVWSFGVTMWEIATRGQTPY 215

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 64/278 (23%), Positives = 123/278 (44%), Gaps = 38/278 (13%)

Query: 339 GSVFRGII--NGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++GI    G TV    AIK +  +   + N        ++  ++H +L+ L G C  
Sbjct: 21  GTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 80

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             +  LV + M +G L D++H+ +  + +         + +A G+ YL    +   VH+D
Sbjct: 81  PTI-QLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRD 134

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   R    +E  Y++    +    +MA E + Y   T + D
Sbjct: 135 LAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK-WMALECIHYRKFTHQSD 193

Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   +    +  ++E G        L  P +       
Sbjct: 194 VWSYGVTIWELMTFGGKPY--DG---IPTREIPDLLEKGER------LPQPPI------C 236

Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E+ +   ++  D QR
Sbjct: 237 TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQR 274

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 33/188 (17%)

Query: 347 NGSTVAIKCMR---RSI-----SKEVNLLKKIN-HFNLINLFGACEH-----DGVFYLVY 392
            G   AIKCM+   +S+      +E+  L++++ H N++ L    E       G   LV+
Sbjct: 23  TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRL---IEVLFDRKTGRLALVF 79

Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           E M+  +L + +  ++ P  +           +   L ++H     G  H+DI   NIL+
Sbjct: 80  ELMD-MNLYELIKGRKRP--LPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILI 133

Query: 453 DKNLRAKLANFSFVRSAVREE--SGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFG 509
             ++  KLA+F   R    +   + Y ST+       Y APE +   G   P+MD +A G
Sbjct: 134 KDDI-LKLADFGSCRGIYSKPPYTEYISTRW------YRAPECLLTDGYYGPKMDIWAVG 186

Query: 510 VVLLELIT 517
            V  E+++
Sbjct: 187 CVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 43/156 (27%), Positives = 81/156 (51%), Gaps = 9/156 (5%)

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           E N+L+ + H  +++L  A +  G  YL+ E++  G L  ++H +R   F+     F ++
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLS 107

Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
            +++  L +LH     G +++D+   NILLD     KL +F   + ++ E    + T T 
Sbjct: 108 -EISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHTF 160

Query: 483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
            GT  YMAPE +        +D ++ G ++ +++TG
Sbjct: 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.9 bits (153), Expect = 4e-10
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 26/203 (12%)

Query: 348 GSTVAIKCMR----------RSISKEVNLLKKINHFNLINLF--GACEHDGVFYLVYEFM 395
           G  VAIK +R              +E  L  ++ H N++ L   G     G+ + V+E++
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAP-PGLLFAVFEYV 61

Query: 396 ENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL--- 452
              +L + L        +      R+ L V   L   HN    G VH+D+   NI++   
Sbjct: 62  PGRTLREVLAAD---GALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQT 115

Query: 453 DKNLRAKLANF--SFVRSAVREESGYSSTKTA--VGTNGYMAPEYMEYGLVTPEMDTYAF 508
                AK+ +F    +   VR+    + T+T   +GT  Y APE +    VTP  D YA+
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 509 GVVLLELITGKEAAYKQDGEEIL 531
           G++ LE +TG+         EIL
Sbjct: 176 GLIFLECLTGQRVVQGASVAEIL 198

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 22/206 (10%)

Query: 339 GSVFRGIINGST--VAIKCMRRSI-----SKEVNLLKK------INHFNLINLFGACEHD 385
           G VF   + G+    AIK +++ +       E  +++K        H  L +L+   +  
Sbjct: 9   GKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK 68

Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
              + V E++  G L    H +   +F      F  A ++  GL +LH+    G V++D+
Sbjct: 69  ENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATF-YAAEIICGLQFLHS---KGIVYRDL 122

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
              NILLD +   K+A+F   +  +    G + T T  GT  Y+APE +        +D 
Sbjct: 123 KLDNILLDTDGHIKIADFGMCKENML---GDAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179

Query: 506 YAFGVVLLELITGKEAAYKQDGEEIL 531
           ++FGV+L E++ G+   +  D EE+ 
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 39/144 (27%), Positives = 73/144 (50%), Gaps = 9/144 (6%)

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
            Y V E++  G L    H ++  +F      F  A +++ GL +LH     G +++D+  
Sbjct: 76  LYFVMEYVNGGDL--MYHIQQVGKFKEPQAVF-YAAEISVGLFFLH---RRGIIYRDLKL 129

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            N++LD     K+A+F   +  + +     +T+T  GT  Y+APE + Y      +D +A
Sbjct: 130 DNVMLDSEGHIKIADFGMCKEHMVDGV---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186

Query: 508 FGVVLLELITGKEAAYKQDGEEIL 531
           +GV+L E++ G+     +D +E+ 
Sbjct: 187 YGVLLYEMLAGQPPFDGEDEDELF 210

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 60.1 bits (146), Expect = 8e-10
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 39/206 (18%)

Query: 339 GSVF--RGIINGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLFGAC----- 382
           G VF  R       VA+K +     K         E+ +L+ + H N++NL   C     
Sbjct: 26  GEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 85

Query: 383 ---EHDGVFYLVYEFMEN---GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
               + G FYLV+EF E+   G LS+   K    E        ++   + +GL+Y+H   
Sbjct: 86  PYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK------KVMKMLLNGLYYIHRNK 139

Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYM- 494
               +H+D+ + NIL+ K+   KLA+F   R+    ++   +  T  V T  Y  PE + 
Sbjct: 140 ---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLL 196

Query: 495 ---EYGLVTPEMDTYAFGVVLLELIT 517
              +YG   P +D +  G ++ E+ T
Sbjct: 197 GERDYG---PPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 60.0 bits (146), Expect = 8e-10
 Identities = 53/222 (23%), Positives = 84/222 (37%), Gaps = 60/222 (27%)

Query: 339 GSVFRG--IINGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLFG-ACEHD- 385
           G V++   I  G  VA+K +     K         E+ +LKK+ H N++ L   A E   
Sbjct: 22  GEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD 81

Query: 386 ------GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFR--------IALDVAHGLHY 431
                 G  Y+V  +M++  LS  L           N   +          L +  G++Y
Sbjct: 82  KSKRKRGSVYMVTPYMDH-DLSGLLE----------NPSVKLTESQIKCYMLQLLEGINY 130

Query: 432 LHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA--------- 482
           LH   +   +H+DI + NIL+D     K+A+F   R    +    +              
Sbjct: 131 LH---ENHILHRDIKAANILIDNQGILKIADFGLAR--PYDGPPPNPKGGGGGGTRKYTN 185

Query: 483 -VGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELITGK 519
            V T  Y  PE +     Y   T  +D +  G V  E+ T +
Sbjct: 186 LVVTRWYRPPELLLGERRY---TTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.1 bits (145), Expect = 9e-10
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 15/152 (9%)

Query: 371 NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
           NH  L+ L    + +   + V E++  G L    H +R  +    + RF  A +++  L+
Sbjct: 54  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALN 110

Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           YLH   + G +++D+   N+LLD     KL ++   +  +R      +T T  GT  Y+A
Sbjct: 111 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGTPNYIA 164

Query: 491 PEYM---EYGLVTPEMDTYAFGVVLLELITGK 519
           PE +   +YG     +D +A GV++ E++ G+
Sbjct: 165 PEILRGEDYGF---SVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 60.2 bits (146), Expect = 9e-10
 Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 16/164 (9%)

Query: 371 NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            H  L  L    +     + V E++  G L   + + R  +F     RF  A +V   L 
Sbjct: 54  KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR--KFDEPRSRF-YAAEVTLALM 110

Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           +LH     G +++D+   NILLD     KLA+F   +  +       +T T  GT  Y+A
Sbjct: 111 FLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---TTTTFCGTPDYIA 164

Query: 491 PEY---MEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
           PE    +EYG   P +D +A GV++ E++ G +  ++ D E+ L
Sbjct: 165 PEILQELEYG---PSVDWWALGVLMYEMMAG-QPPFEADNEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 15/148 (10%)

Query: 375 LINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHN 434
           L+ L    +     +LV E++  G L    H +R  +    + RF  A ++   L++LH 
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARF-YAAEICIALNFLH- 113

Query: 435 CTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM 494
             + G +++D+   N+LLD +   KL ++   +  +       +T T  GT  Y+APE +
Sbjct: 114 --ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---DTTSTFCGTPNYIAPEIL 168

Query: 495 ---EYGLVTPEMDTYAFGVVLLELITGK 519
              EYG     +D +A GV++ E++ G+
Sbjct: 169 RGEEYGF---SVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 10/174 (5%)

Query: 358 RSISKEVN-LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           + I  E N LLK + H  L+ L  + +     Y V +++  G L  + H +R   F+   
Sbjct: 40  KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPR 97

Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
            RF  A ++A  L YLH+      V++D+   NILLD      L +F   +  +      
Sbjct: 98  ARF-YAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-- 151

Query: 477 SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
            +T T  GT  Y+APE +        +D +  G VL E++ G    Y ++  E+
Sbjct: 152 -TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 52/240 (21%), Positives = 106/240 (44%), Gaps = 33/240 (13%)

Query: 358 RSISKEVNLLKK-INHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH-----KKRYPE 411
             I  EV ++K+ + H N++  +     +   Y+V + +E   L +  +     K+R+ E
Sbjct: 53  GDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE 112

Query: 412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR 471
              WN   ++ L     L YLH   +   VH+D++  NI+L ++ +  + +F   +    
Sbjct: 113 ERIWNIFVQMVL----ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP 166

Query: 472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
           E    S   + VGT  Y  PE ++      + D +AFG +L ++ T +   Y  +    +
Sbjct: 167 E----SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN----M 218

Query: 532 LAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVS 591
           L+ A   +VE          + +P     +   +  +  +  +C+  + E+RP + +V +
Sbjct: 219 LSLAT-KIVEA---------VYEP---LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 54/176 (30%), Positives = 81/176 (46%), Gaps = 33/176 (18%)

Query: 362 KEVNLLKKINHFNLINLFGACEHD----------GVFYLVYEFMENGSLSDWLHKKRYPE 411
           +E+ +L+++NH N++NL                 G FYLV+E+M++  L   L       
Sbjct: 55  REIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG---- 109

Query: 412 FVSWN----CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR 467
            V ++      F   L    GL+Y H      ++H+DI   NILL+   + KLA+F   R
Sbjct: 110 LVHFSEDHIKSFMKQL--LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLAR 164

Query: 468 SAVREESGYSSTKTAVGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELITGK 519
               EES   + K  V T  Y  PE +     YG   P +D ++ G +L EL T K
Sbjct: 165 LYNSEESRPYTNK--VITLWYRPPELLLGEERYG---PAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 58.7 bits (143), Expect = 3e-09
 Identities = 53/180 (29%), Positives = 82/180 (45%), Gaps = 46/180 (25%)

Query: 362 KEVNLLKKI-NHFN---LINLFGACEHDGVFYLVYEFMENGSLSDWLHK----------- 406
           +E+  L+++ +H N   L+N+  A E+D   YLV+E+ME    +D LH            
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKA-ENDKDIYLVFEYME----TD-LHAVIRANILEDVH 108

Query: 407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV 466
           KRY           I   +   L Y+H+      +H+D+   NILL+ + R KLA+F   
Sbjct: 109 KRY-----------IMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLA 154

Query: 467 RSAVREESGYSSTKTA---VGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELITGK 519
           RS + E             V T  Y APE +     Y   T  +D ++ G +L E++ GK
Sbjct: 155 RS-LSELEENPENPVLTDYVATRWYRAPEILLGSTRY---TKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 67/282 (23%), Positives = 122/282 (43%), Gaps = 46/282 (16%)

Query: 339 GSVFRGII--NGST----VAIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++GI   +G      VAIK +R + S + N        ++  +    +  L G C  
Sbjct: 21  GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80

Query: 385 DGVFYLVYEFMENGSLSDWL--HKKRY--PEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
             V  LV + M  G L D++  +K R    + ++W       + +A G+ YL    +   
Sbjct: 81  STV-QLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE---EVRL 130

Query: 441 VHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVT 500
           VH+D+++ N+L+      K+ +F   R    +E+ Y +    V    +MA E + +   T
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK-WMALESILHRRFT 189

Query: 501 PEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN 560
            + D +++GV + EL+T     Y     + + A  +  ++E G    +L        Q  
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPY-----DGIPAREIPDLLEKGE---RLP-------QPP 234

Query: 561 KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              I  ++IM+   C   + E RP   E+V    ++  D  R
Sbjct: 235 ICTIDVYMIMV--KCWMIDSECRPRFRELVDEFSRMARDPSR 274

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 41/196 (20%)

Query: 348 GSTVAIKCMRRSI-SKEVNLL--------KKINHFNLINLFGACEHDGVFYLVYEFMENG 398
           G+ +A+K +R ++ S+E   L        + ++    +  +GA   +G  ++  E M+  
Sbjct: 26  GTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDT- 84

Query: 399 SLSDWLHKKRY--PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
           SL D  +KK Y     +  +   +IA+ +   L YLH  +    +H+D+   N+L+++N 
Sbjct: 85  SL-DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNG 141

Query: 457 RAKLANFSFVRSAVREESGY---SSTKTA-VGTNGYMAPEYMEYGLVTPEM--------- 503
           + KL +F          SGY   S  KT   G   YMAPE      + PE+         
Sbjct: 142 QVKLCDFGI--------SGYLVDSVAKTIDAGCKPYMAPER-----INPELNQKGYDVKS 188

Query: 504 DTYAFGVVLLELITGK 519
           D ++ G+ ++EL TG+
Sbjct: 189 DVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 61/271 (22%), Positives = 113/271 (41%), Gaps = 45/271 (16%)

Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHD------GVFYLV 391
           +   VA+K ++  I          +E   +K+ +H N+I L G            +  ++
Sbjct: 26  SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85

Query: 392 YEFMENGSLSDWLHKKRY---PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
             FM++G L  +L   R    P  +      R  +D+A G+ YL +     ++H+D+++ 
Sbjct: 86  LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAAR 142

Query: 449 NILLDKNLRAKLANFSFVR---SAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           N +L++N+   +A+F   +   S      G  ++K  V    ++A E +   + T   D 
Sbjct: 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQG-CASKLPVK---WLALESLADNVYTTHSDV 198

Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           +AFGV + E++T  +  Y   G E              N+E   + L+  N      +  
Sbjct: 199 WAFGVTMWEIMTRGQTPYA--GVE--------------NSEI-YNYLIKGNRLKQPPDCL 241

Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
             +  L   C + EP+ RPS   +   L  I
Sbjct: 242 EDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 8/157 (5%)

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           E  +L+K+N   ++NL  A E      LV   M  G L   ++    P F      F  A
Sbjct: 50  EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF-YA 108

Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
            ++  GL  LH       V++D+   NILLD     ++++      AV+   G  S +  
Sbjct: 109 AEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGL---AVKIPEG-ESIRGR 161

Query: 483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           VGT GYMAPE +     T   D +  G ++ E+I G+
Sbjct: 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 39/158 (24%), Positives = 75/158 (47%), Gaps = 13/158 (8%)

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           E+++L +  H N++ L+ A  ++   +++ EF + G+L   + +           R+ + 
Sbjct: 52  EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRY-VC 109

Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
             +   L++LH+      +H+D+ +GNILL  +   KLA+F                 T 
Sbjct: 110 RQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD---TF 163

Query: 483 VGTNGYMAPEYM--EYGLVTP---EMDTYAFGVVLLEL 515
           +GT  +MAPE +  E     P   + D ++ G+ L+EL
Sbjct: 164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 15/152 (9%)

Query: 371 NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
           NH  L+ L    + +   + V EF+  G L    H +R  +    + RF  A +++  L+
Sbjct: 54  NHPFLVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSA-EISLALN 110

Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           +LH   + G +++D+   N+LLD     KL ++   +  +R      +T T  GT  Y+A
Sbjct: 111 FLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---DTTSTFCGTPNYIA 164

Query: 491 PEYM---EYGLVTPEMDTYAFGVVLLELITGK 519
           PE +   +YG     +D +A GV++ E++ G+
Sbjct: 165 PEILRGEDYGF---SVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 59/275 (21%), Positives = 115/275 (41%), Gaps = 54/275 (19%)

Query: 340 SVFRGIINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFG----ACEHD 385
           S+++GI N   V I+  ++              E+  L++I+  N++ ++G      +  
Sbjct: 35  SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
               L+ E+   G L + L K++    +S+  +  +A+D   GL+ L+  T     +K++
Sbjct: 95  PRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNL 149

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE-----YMEYGLVT 500
           +S + L+ +N + K+           E+   S     V    Y + +     + EY   T
Sbjct: 150 TSVSFLVTENYKLKII------CHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEY---T 200

Query: 501 PEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN 560
            + D Y+ GVVL E+ TGK        +EI      + ++   N   KL           
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFENLTTKEI------YDLIINKNNSLKL----------- 243

Query: 561 KKEIAHHLIMLCL--ACIAREPESRPSMAEVVSTL 593
              +   L + C+  AC + +   RP++ E++  L
Sbjct: 244 --PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 57.0 bits (137), Expect = 7e-09
 Identities = 48/192 (25%), Positives = 87/192 (45%), Gaps = 22/192 (11%)

Query: 339 GSVFRGIINGS--TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G V++GI N +   VAIK +           I +E+ +L + +   +   +G+       
Sbjct: 18  GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL 77

Query: 389 YLVYEFMENGSLSDWLHKKRYPE-FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +++ E++  GS  D L      E +++      I  ++  GL YLH+      +H+DI +
Sbjct: 78  WIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHS---ERKIHRDIKA 129

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            N+LL +    KLA+F         +       T VGT  +MAPE ++      + D ++
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDFKADIWS 186

Query: 508 FGVVLLELITGK 519
            G+  +EL  G+
Sbjct: 187 LGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 64/268 (23%), Positives = 115/268 (42%), Gaps = 42/268 (15%)

Query: 341 VFRG--IINGSTVAIKCM----------RRSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           V+R   +++G  VA+K +          R    KE++LLK++NH N+I  + +   D   
Sbjct: 18  VYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 77

Query: 389 YLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
            +V E  + G LS  + H K+    +     ++  + +   L ++H+      +H+DI  
Sbjct: 78  NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKP 134

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA----VGTNGYMAPEYMEYGLVTPEM 503
            N+ +      KL +    R        +SS  TA    VGT  YM+PE +       + 
Sbjct: 135 ANVFITATGVVKLGDLGLGRF-------FSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 187

Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++ G +L E+   +   Y   G+++ L    +S+ +      K+     P L ++   
Sbjct: 188 DIWSLGCLLYEMAALQSPFY---GDKMNL----YSLCK------KIEQCDYPPLPSD--H 232

Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVS 591
            +  L  L   CI  +PE RP +  V  
Sbjct: 233 YSEELRQLVNMCINPDPEKRPDITYVYD 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 57.1 bits (138), Expect = 9e-09
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 11/199 (5%)

Query: 334 KNMIDGSVFR-GIINGSTVAIKCMRRSISKEVN-LLKKINHFNLINLFGACEHDGVFYLV 391
           K+  DG  +   ++    +  K  ++ I  E N LLK + H  L+ L  + +     Y V
Sbjct: 15  KHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFV 74

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            +++  G L  + H +R   F     RF  A ++A  L YLH+      +++D+   NIL
Sbjct: 75  LDYVNGGEL--FFHLQRERSFPEPRARF-YAAEIASALGYLHSLN---IIYRDLKPENIL 128

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           LD      L +F   +  +       +T T  GT  Y+APE +        +D +  G V
Sbjct: 129 LDSQGHVVLTDFGLCKEGI---EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAV 185

Query: 512 LLELITGKEAAYKQDGEEI 530
           L E++ G    Y +D  E+
Sbjct: 186 LYEMLYGLPPFYSRDTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 56.5 bits (136), Expect = 9e-09
 Identities = 40/190 (21%), Positives = 92/190 (48%), Gaps = 11/190 (5%)

Query: 354 KCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFV 413
           K +R  + +E  ++ ++++  ++ + G CE + +  LV E    G L+ +L  K+  + +
Sbjct: 36  KSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALM-LVMEMASGGPLNKFLSGKK--DEI 92

Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
           + +    +   V+ G+ YL       +VH+D+++ N+LL     AK+++F   ++   ++
Sbjct: 93  TVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149

Query: 474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA 533
           S Y +         + APE + +   +   D +++G+ + E  +  +  YK+     +  
Sbjct: 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKK-----MKG 204

Query: 534 EAVFSMVEGG 543
             V S +E G
Sbjct: 205 PEVMSFIEQG 214

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 30/199 (15%)

Query: 339 GSVF--RGIINGSTVAIKCMRRSISKEVN---------LLKKINHFNLINLFGACEHDGV 387
           G V+  R    G  +A+K MRR+ +KE N         +LK  +   ++  +G    D  
Sbjct: 29  GQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88

Query: 388 FYLVYEFMENGSLSDWLHKKRY---PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
            ++  E M   +  D L K+     PE +      ++ + +   LHYL      G +H+D
Sbjct: 89  VFICMELM--STCLDKLLKRIQGPIPEDILG----KMTVAIVKALHYLK--EKHGVIHRD 140

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +   NILLD +   KL +F     + R     + T++A G   YMAPE ++     P+ D
Sbjct: 141 VKPSNILLDASGNVKLCDFGI---SGRLVDSKAKTRSA-GCAAYMAPERIDPPDPNPKYD 196

Query: 505 TYA----FGVVLLELITGK 519
             A     G+ L+EL TG+
Sbjct: 197 IRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 55/239 (23%), Positives = 102/239 (42%), Gaps = 41/239 (17%)

Query: 364 VNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIAL 423
            +L+ +++H +L+ L+G C  D    +V E+++ G L  +LH+++    VS + +  +A 
Sbjct: 52  ASLMSQLSHKHLVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNN--VSLHWKLDVAK 108

Query: 424 DVAHGLHYLHNCTDPGYVHKDISSGNILLDKN-------LRAKLANFSFVRSAVREESGY 476
            +A  LHYL    D   VH ++   NIL+ +           KL++     + +  E   
Sbjct: 109 QLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV 165

Query: 477 SSTKTAVGTNGYMAPEYMEYGLVTPE--MDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
                      ++APE +  G  +     D ++FG  LLE+ +        +GEE L   
Sbjct: 166 ERIP-------WIAPECIRNGQASLTIAADKWSFGTTLLEICS--------NGEEPLSTL 210

Query: 535 AVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
           +          + +L +        +  E+A +LI  C      +P  RPS   ++  L
Sbjct: 211 SSSEKERFYQDQHRLPMP-------DCAELA-NLINQCW---TYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 60/251 (23%), Positives = 106/251 (42%), Gaps = 40/251 (15%)

Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL-----HKKRYPE 411
           R+   KE++LLK++NH N+I    +   D    +V E  + G LS  +      K+  PE
Sbjct: 46  RQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPE 105

Query: 412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR 471
              W    +  + +   + ++H+      +H+DI   N+ +      KL +    R    
Sbjct: 106 RTVW----KYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF--- 155

Query: 472 EESGYSSTKTA----VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDG 527
               +SS  TA    VGT  YM+PE +       + D ++ G +L E+   +   Y   G
Sbjct: 156 ----FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY---G 208

Query: 528 EEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMA 587
           +++ L    FS+ +      K+     P L    +  +  L  L   CI  +P+ RP + 
Sbjct: 209 DKMNL----FSLCQ------KIEQCDYPPLP--TEHYSEKLRELVSMCIYPDPDQRPDIG 256

Query: 588 EV--VSTLMKI 596
            V  ++  M +
Sbjct: 257 YVHQIAKQMHV 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 55.5 bits (133), Expect = 2e-08
 Identities = 56/233 (24%), Positives = 93/233 (39%), Gaps = 30/233 (12%)

Query: 363 EVNLLKKINHFNLINLFGACEHDG--VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFR 420
           E+ LLK + H  ++  +G           +  E+M  GS+ D L  K Y        R +
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTR-K 110

Query: 421 IALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTK 480
               +  G+ YLH+      VH+DI   NIL D     KL +F   +         +  +
Sbjct: 111 YTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR 167

Query: 481 TAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE--AAYKQDGEEILLAEAVFS 538
           +  GT  +M+PE +       + D ++ G  ++E++T K   A Y+          A+F 
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MAAIFK 220

Query: 539 MVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVS 591
           +          +   +P L ++  E A       L CI  E   RPS  E++ 
Sbjct: 221 IA---------TQPTNPQLPSHISEHARDF----LGCIFVEARHRPSAEELLR 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 24/231 (10%)

Query: 354 KCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEF- 412
           K   +    E  +L+K+N   ++NL  A E      LV   M  G L    H     E  
Sbjct: 34  KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLK--YHIYNVGERG 91

Query: 413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE 472
           +        +  +  G+ +LH+      V++D+   N+LLD     +L++      AV  
Sbjct: 92  LEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGL---AVEL 145

Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILL 532
           + G + T+ A GTNGYMAPE ++    +  +D +A G  + E++ G+   +K   E++  
Sbjct: 146 KDGKTITQRA-GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR-TPFKDHKEKVAK 203

Query: 533 AEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESR 583
            E     +E    E K       N     K+I       C   +A++PE R
Sbjct: 204 EELKRRTLED---EVKFE---HQNFTEESKDI-------CRLFLAKKPEDR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 9/168 (5%)

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           E  +L+K+N   +++L  A E      LV   M  G L   ++    P F      F  A
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-YA 108

Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
            ++  GL  LH       V++D+   NILLD     ++++      AV    G  + +  
Sbjct: 109 AEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGL---AVEIPEG-ETIRGR 161

Query: 483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
           VGT GYMAPE ++    T   D +  G ++ E+I GK + ++Q  E++
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK-SPFRQRKEKV 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 11/162 (6%)

Query: 375 LINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHN 434
           L+ L  A + D   +L+ +++  G L   L+++ +  F     R  IA ++   L +LH 
Sbjct: 67  LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH--FTESEVRVYIA-EIVLALDHLHQ 123

Query: 435 CTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM 494
               G +++DI   NILLD      L +F   +  + EE       +  GT  YMAPE +
Sbjct: 124 L---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE--ERAYSFCGTIEYMAPEVI 178

Query: 495 EYGLV--TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
             G       +D ++ GV+  EL+TG  + +  DGE+   +E
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGA-SPFTVDGEQNSQSE 219

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 65/252 (25%), Positives = 110/252 (43%), Gaps = 28/252 (11%)

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           E  +L+K+N   +++L  A E      LV   M  G L   ++      F      F  A
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YA 108

Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
            ++  GL  LH       V++D+   NILLD +   ++++      AV    G  + K  
Sbjct: 109 AEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGL---AVHVPEG-QTIKGR 161

Query: 483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEG 542
           VGT GYMAPE ++    T   D +A G +L E+I G ++ ++Q  ++I   E V  +V+ 
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG-QSPFQQRKKKI-KREEVERLVKE 219

Query: 543 GNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESR-----PSMAEVVSTLMKIQ 597
              E   S    P+ ++           LC   + ++P+ R         EV    +  Q
Sbjct: 220 VQEE--YSEKFSPDARS-----------LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266

Query: 598 LDVQRSQTLLLE 609
           ++ +R +  +LE
Sbjct: 267 INFKRLEAGMLE 278

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 48/159 (30%), Positives = 74/159 (46%), Gaps = 27/159 (16%)

Query: 428 GLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG 487
           GL +LH       +++D+   N+LLD +   ++++      AV  + G S TK   GT G
Sbjct: 109 GLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGL---AVELKDGQSKTKGYAGTPG 162

Query: 488 YMAPEYM---EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN 544
           +MAPE +   EY      +D +A GV L E+I  +   ++  GE+          VE  N
Sbjct: 163 FMAPELLQGEEYDF---SVDYFALGVTLYEMIAAR-GPFRARGEK----------VE--N 206

Query: 545 AEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESR 583
            E K  +L D     +K   A      C A +A++PE R
Sbjct: 207 KELKQRILNDSVTYPDKFSPASKSF--CEALLAKDPEKR 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 63/280 (22%), Positives = 117/280 (41%), Gaps = 52/280 (18%)

Query: 340 SVFRGI--INGSTVAIKCM----------RRSISKEVNLLKKINHFNLINLFGACEHDGV 387
            V++ I  ++G  VA+K +          R+   KE++LLK+++H N+I    +   +  
Sbjct: 17  VVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE 76

Query: 388 FYLVYEFMENGSLSDWL-----HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
             +V E  + G LS  +      K+  PE   W       + +   L ++H+      +H
Sbjct: 77  LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK----YFVQLCSALEHMHS---KRIMH 129

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-----VGTNGYMAPEYMEYG 497
           +DI   N+ +      KL +    R        + S+KT      VGT  YM+PE +   
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGR--------FFSSKTTAAHSLVGTPYYMSPERIHEN 181

Query: 498 LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNL 557
               + D ++ G +L E+   +   Y   G+++ L  ++   +E  +          P L
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFY---GDKMNLY-SLCKKIEKCDY---------PPL 228

Query: 558 QANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
            A+    +  L  L   CI  +PE RP ++ V+    ++ 
Sbjct: 229 PADH--YSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 49/189 (25%), Positives = 87/189 (46%), Gaps = 19/189 (10%)

Query: 352 AIKCMRRS--ISK--------EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           A+K +R++  +S+        E  +L ++N   ++ L  + +     YLV  F+  G L 
Sbjct: 22  ALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL- 80

Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
            + H +R   F     RF  A ++   L  LH       +++D+   NILLD      L 
Sbjct: 81  -FHHLQREGRFDLSRARFYTA-ELLCALENLHKFN---VIYRDLKPENILLDYQGHIALC 135

Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
           +F   +  ++++     T T  GT  Y+APE +     T  +D +  GV+L E++TG   
Sbjct: 136 DFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Query: 522 AYKQDGEEI 530
            Y ++  E+
Sbjct: 193 FYDENVNEM 201

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 53.3 bits (129), Expect = 1e-07
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 15/162 (9%)

Query: 371 NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
           ++ N I L+ +        L+ +++++G L D L K+          +  I   +   L+
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKK-IIRQLVEALN 123

Query: 431 YLHNCTDPGYVHKDISSGNILLDKNL-RAKLANFSFVRSAVREESGYSSTKTAVGTNGYM 489
            LH       +H DI   N+L D+   R  L ++   +  +   S Y       GT  Y 
Sbjct: 124 DLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI-IGTPSCYD------GTLDYF 173

Query: 490 APEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
           +PE ++        D +A GV+  EL+TGK   +K+D +E L
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKH-PFKEDEDEEL 214

Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 43/160 (26%), Positives = 69/160 (43%), Gaps = 10/160 (6%)

Query: 363 EVNLLKKINHFNLINLFGACEHDG---VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           E+ LLK + H  ++  +G C  D       +  E M  GS+ D L  K Y      N   
Sbjct: 54  EIQLLKNLLHERIVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTE-NVTR 109

Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
           +    +  G+ YLH+      VH+DI   NIL D     KL +F   +         +  
Sbjct: 110 KYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166

Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           K+  GT  +M+PE +       + D ++ G  ++E++T K
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 35/115 (30%), Positives = 58/115 (50%), Gaps = 16/115 (13%)

Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST--- 479
           + V   +H++H+      +H+DI S NILL  N   KL +F F +        Y++T   
Sbjct: 150 IQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKM-------YAATVSD 199

Query: 480 ---KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
              +T  GT  Y+APE       + + D ++ GV+L EL+T K     ++ EE++
Sbjct: 200 DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM 254

Length = 496

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 16/132 (12%)

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            + + M  G L    H  ++  F     RF  A ++  GL ++HN      V++D+   N
Sbjct: 74  FILDLMNGGDLH--YHLSQHGVFSEAEMRF-YAAEIILGLEHMHN---RFVVYRDLKPAN 127

Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTK--TAVGTNGYMAPEYMEYGLV-TPEMDTY 506
           ILLD++   ++++             +S  K   +VGT+GYMAPE ++ G+      D +
Sbjct: 128 ILLDEHGHVRISDLGLA-------CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 180

Query: 507 AFGVVLLELITG 518
           + G +L +L+ G
Sbjct: 181 SLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 23/172 (13%)

Query: 361 SKEVN-------LLKKINHFNLINLFGACEHDGV---FYLVYEFMENGSLSDWLHKKRYP 410
           SKEVN       LLK + H  ++  +G C  D       +  E+M  GS+ D L  K Y 
Sbjct: 45  SKEVNALECEIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL--KAYG 101

Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
                N   R    +  G+ YLH+      VH+DI   NIL D     KL +F    ++ 
Sbjct: 102 ALTE-NVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG---ASK 154

Query: 471 REESGYSS---TKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           R ++   S    K+  GT  +M+PE +       + D ++    ++E++T K
Sbjct: 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 12/145 (8%)

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
            YLV ++M  G L  + H ++   F     +F IA ++   L +LH       V++D+  
Sbjct: 71  LYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIA-ELVLALEHLH---KYDIVYRDLKP 124

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM--EYGLVTPEMDT 505
            NILLD      L +F   ++ + +     +T T  GT  Y+APE +  E G  T  +D 
Sbjct: 125 ENILLDATGHIALCDFGLSKANLTDN---KTTNTFCGTTEYLAPEVLLDEKGY-TKHVDF 180

Query: 506 YAFGVVLLELITGKEAAYKQDGEEI 530
           ++ GV++ E+  G    Y +D +++
Sbjct: 181 WSLGVLVFEMCCGWSPFYAEDTQQM 205

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 27/172 (15%)

Query: 358 RSISKEVNLLKKINHFNLINLF------GACEHDGVFYLVYEFMENGSLSDWLHKKRYPE 411
           R   +E+ LLK + H N+I L        + E+    YLV   M     +D  +  +  +
Sbjct: 59  RRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMG----ADLNNIVKCQK 114

Query: 412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR 471
               + +F I   +  GL Y+H+    G +H+D+   N+ ++++   ++ +F   R A  
Sbjct: 115 LSDEHVQFLI-YQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170

Query: 472 EESGYSSTKTAVGTNGYMAPE----YMEYGLVTPEMDTYAFGVVLLELITGK 519
           E +GY      V T  Y APE    +M Y      +D ++ G ++ EL+ GK
Sbjct: 171 EMTGY------VATRWYRAPEIMLNWMHY---NQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 38/154 (24%), Positives = 76/154 (49%), Gaps = 19/154 (12%)

Query: 370 INHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR---YPE-FVSWNCRFRIALDV 425
           ++H  ++ L G C       LV +    GSL D + + R    P+  ++W       + +
Sbjct: 66  LDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQI 118

Query: 426 AHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG--YSSTKTAV 483
           A G++YL    +   VH+++++ NILL  +   ++A+F        ++    YS  KT +
Sbjct: 119 AKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175

Query: 484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
               +MA E + +G  T + D +++GV + E+++
Sbjct: 176 K---WMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 37/237 (15%)

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL-SDWLHKKR---YPEFVSWNCR 418
           E+ +L   NH  ++ L GA   DG  +++ EF   G++ +  L   R    P+ +   CR
Sbjct: 59  EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-IQVICR 117

Query: 419 FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS 478
                 +   L YLH+      +H+D+ +GN+LL  +   KLA+F      V+       
Sbjct: 118 -----QMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT---LQR 166

Query: 479 TKTAVGTNGYMAPEYM--EYGLVTP---EMDTYAFGVVLLELITGKEAAYKQDGEEILLA 533
             + +GT  +MAPE +  E    TP   + D ++ G+ L+E+   +   ++ +   +LL 
Sbjct: 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL- 225

Query: 534 EAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
                         K++    P L    K        L  A + + PE+RPS A+++
Sbjct: 226 --------------KIAKSEPPTLSQPSKWSMEFRDFLKTA-LDKHPETRPSAAQLL 267

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 4e-07
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 44/204 (21%)

Query: 339 GSVFRG--IINGSTVAIKCMRRSIS---------KEVNLLKKINHF---NLINLFGAC-- 382
           G+V++   +  G  VA+K +R  +S         +E+ LLK++  F   N++ L   C  
Sbjct: 13  GTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHG 72

Query: 383 ---EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAH----GLHYLH-N 434
              + +    LV+E ++   L+ +L K   P             D+      G+ +LH +
Sbjct: 73  PRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPE-----TIKDLMRQLLRGVDFLHSH 126

Query: 435 CTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM 494
                 VH+D+   NIL+  + + K+A+F   R    E     +  + V T  Y APE +
Sbjct: 127 RI----VHRDLKPQNILVTSDGQVKIADFGLARIYSFE----MALTSVVVTLWYRAPEVL 178

Query: 495 ---EYGLVTPEMDTYAFGVVLLEL 515
               Y   TP +D ++ G +  EL
Sbjct: 179 LQSSYA--TP-VDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 39/159 (24%), Positives = 78/159 (49%), Gaps = 13/159 (8%)

Query: 365 NLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALD 424
           +++ +++H +L+  +G C       +V E+++ GSL  +L K +    +SW  +  +A  
Sbjct: 51  SMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQ 108

Query: 425 VAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-- 482
           +A  LH+L    D G  H ++ + N+LL +    K  N  F++ +   + G S T     
Sbjct: 109 LAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS---DPGISITVLPKE 162

Query: 483 --VGTNGYMAPEYMEYGL-VTPEMDTYAFGVVLLELITG 518
             +    ++ PE +E    ++   D ++FG  L E+ +G
Sbjct: 163 ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 18/168 (10%)

Query: 365 NLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALD 424
           +L+ +++H +L  + G C       +V EF+E+G L   L K++    V+W  +  +A  
Sbjct: 68  SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQ 125

Query: 425 VAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS--FVRSAVREESGYS----S 478
           +A  L YL    D   VH ++ + NILL    R  LA  +  F++ +   + G S    S
Sbjct: 126 LASALSYLE---DKNLVHGNVCAKNILL---ARLGLAEGTSPFIKLS---DPGVSFTALS 176

Query: 479 TKTAVGTNGYMAPEYMEYGL-VTPEMDTYAFGVVLLELITGKEAAYKQ 525
            +  V    ++APE +  G  ++   D ++FG  LLE+    E   K+
Sbjct: 177 REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 41/179 (22%), Positives = 81/179 (45%), Gaps = 22/179 (12%)

Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRI 421
           +E++L+K++ H N++ L      +    LV+E+M+          K+Y +          
Sbjct: 47  REISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-------DLKKYMDTHGVRG---- 95

Query: 422 ALDVAHGLHYLHN-------CTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
           ALD      + +        C +   +H+D+   N+L++K    KLA+F   R+     +
Sbjct: 96  ALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155

Query: 475 GYSSTKTAVGTNGYMAPE-YMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILL 532
            +S+    V T  Y AP+  +     +  +D ++ G ++ E+ITG+      + E+ LL
Sbjct: 156 TFSNE---VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 51.6 bits (124), Expect = 6e-07
 Identities = 50/197 (25%), Positives = 79/197 (40%), Gaps = 34/197 (17%)

Query: 339 GSVF--RGIINGSTVAIKCM----------RRSISKEVNLLKKINHFNLINLFGACEHDG 386
           G VF  +    G  VA+K M           R +  E ++L       L+ L  A + D 
Sbjct: 15  GQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE 74

Query: 387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA--LDVAHGLHYLHNCTDPGYVHKD 444
             YL  E++  G     L+          + RF +A   +    LH L      GY+H+D
Sbjct: 75  YLYLAMEYVPGGDFRTLLNNLGV--LSEDHARFYMAEMFEAVDALHEL------GYIHRD 126

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---YGLVTP 501
           +   N L+D +   KL +F   +  V      +   + VG+  YMAPE +    Y     
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSKGIV------TYANSVVGSPDYMAPEVLRGKGYDF--- 177

Query: 502 EMDTYAFGVVLLELITG 518
            +D ++ G +L E + G
Sbjct: 178 TVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 51.3 bits (123), Expect = 7e-07
 Identities = 42/175 (24%), Positives = 71/175 (40%), Gaps = 29/175 (16%)

Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRI 421
           +E+ ++ +I H N++ L           LV + M    L   + +K         C   I
Sbjct: 69  RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKC---I 124

Query: 422 ALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
            L + +GL+ LH      ++H+D+S  NI ++     K+A+F   R       GY     
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARR-----YGYPPYSD 176

Query: 482 AVGTNGYMAP-EYMEYGLVT-----PEM-----------DTYAFGVVLLELITGK 519
            +  +  M   E M   +VT     PE+           D ++ G +  EL+TGK
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 15/148 (10%)

Query: 375 LINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHN 434
           L+ L  A + +   +L+ +++  G +   L+++    F     RF    ++   L +LH 
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSG-EIILALEHLHK 123

Query: 435 CTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM 494
               G V++DI   NILLD      L +F   +  + EE     T +  GT  YMAPE +
Sbjct: 124 L---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK--ERTYSFCGTIEYMAPEII 178

Query: 495 E----YGLVTPEMDTYAFGVVLLELITG 518
                +G     +D ++ G+++ EL+TG
Sbjct: 179 RGKGGHGKA---VDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 27/168 (16%)

Query: 362 KEVNLLKKINHFNLINLFG------ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +E+ LLK + H N+I L        + E     YLV   M     +D  +  +  +    
Sbjct: 65  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDD 120

Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
           + +F I   +  GL Y+H+      +H+D+   N+ ++++   K+ +F   R    E +G
Sbjct: 121 HVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 176

Query: 476 YSSTKTAVGTNGYMAPE----YMEYGLVTPEMDTYAFGVVLLELITGK 519
           Y      V T  Y APE    +M Y      +D ++ G ++ EL+TG+
Sbjct: 177 Y------VATRWYRAPEIMLNWMHYNQT---VDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 16/132 (12%)

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            + + M  G L    H  ++  F     RF  A ++  GL ++HN      V++D+   N
Sbjct: 74  FILDLMNGGDLH--YHLSQHGVFSEKEMRF-YATEIILGLEHMHN---RFVVYRDLKPAN 127

Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTK--TAVGTNGYMAPEYMEYGLV-TPEMDTY 506
           ILLD++   ++++             +S  K   +VGT+GYMAPE ++ G       D +
Sbjct: 128 ILLDEHGHVRISDLGLA-------CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWF 180

Query: 507 AFGVVLLELITG 518
           + G +L +L+ G
Sbjct: 181 SLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 35/204 (17%)

Query: 343 RGIINGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R             +E++LLK++NH N++ L      +   YLV+E
Sbjct: 20  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79

Query: 394 FMENGSLSDWLHKKRY-----PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           F+ +  L      K++        +           +  GL + H+      +H+D+   
Sbjct: 80  FL-HQDL------KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQ 129

Query: 449 NILLDKNLRAKLANFSFVRS---AVREESGYSSTKTAVGTNGYMAPE-YMEYGLVTPEMD 504
           N+L++     KLA+F   R+    VR     + T   V T  Y APE  +     +  +D
Sbjct: 130 NLLINTEGAIKLADFGLARAFGVPVR-----TYTHEVV-TLWYRAPEILLGCKYYSTAVD 183

Query: 505 TYAFGVVLLELITGKEAAYKQDGE 528
            ++ G +  E++T + A +  D E
Sbjct: 184 IWSLGCIFAEMVT-RRALFPGDSE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 41/175 (23%), Positives = 79/175 (45%), Gaps = 27/175 (15%)

Query: 425 VAHGLHYL--HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
           VA G+ +L   NC     VH+D+++ N+LL +    K+ +F   R  +  +S Y S  + 
Sbjct: 246 VARGMEFLASKNC-----VHRDLAARNVLLAQGKIVKICDFGLARD-IMHDSNYVSKGST 299

Query: 483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEG 542
                +MAPE +   L T   D +++G++L E+ +     Y      +++    ++ ++ 
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG----MIVDSTFYNKIKS 355

Query: 543 GNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPS---MAEVVSTLM 594
           G   AK                   +  + + C   EPE RPS   ++++V +L+
Sbjct: 356 GYRMAK------------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 49.5 bits (119), Expect = 2e-06
 Identities = 54/225 (24%), Positives = 94/225 (41%), Gaps = 59/225 (26%)

Query: 329 ENFSPKNMID----GSVFRG--IINGSTVAIK--CMRRSIS-------KEVNLLKKINHF 373
           + +   N I+    G V+R      G  VA+K   M +          +E+N+L K+ H 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64

Query: 374 NLINL----FGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA------L 423
           N++ +     G+       Y+V E++E+  L   +   + P        F  +      L
Sbjct: 65  NIVTVKEVVVGSNLDK--IYMVMEYVEH-DLKSLMETMKQP--------FLQSEVKCLML 113

Query: 424 DVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS----- 478
            +  G+ +LH   D   +H+D+ + N+LL+     K+ +F   R        Y S     
Sbjct: 114 QLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLARE-------YGSPLKPY 163

Query: 479 TKTAVGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELITGK 519
           T+  V T  Y APE +    EY   +  +D ++ G +  EL+T K
Sbjct: 164 TQLVV-TLWYRAPELLLGAKEY---STAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 11/157 (7%)

Query: 375 LINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHN 434
           L+ L  A + D   +L+ +++  G L  + H  +   F     +     ++   L +LH 
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSG-EIVLALEHLHK 123

Query: 435 CTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM 494
               G +++DI   NILLD N    L +F   +    +E       +  GT  YMAP+ +
Sbjct: 124 L---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV--ERAYSFCGTIEYMAPDIV 178

Query: 495 EYGLVTPE--MDTYAFGVVLLELITGKEAAYKQDGEE 529
             G    +  +D ++ GV++ EL+TG  + +  DGE+
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGA-SPFTVDGEK 214

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 27/88 (30%), Positives = 50/88 (56%), Gaps = 5/88 (5%)

Query: 365 NLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALD 424
           +++++++H +++ L+G C  D    +V EF+E G L  ++H+K       W  +F++A  
Sbjct: 56  SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQ 113

Query: 425 VAHGLHYLHNCTDPGYVHKDISSGNILL 452
           +A  L YL    D   VH ++ + NILL
Sbjct: 114 LASALSYLE---DKDLVHGNVCTKNILL 138

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 43/213 (20%), Positives = 87/213 (40%), Gaps = 44/213 (20%)

Query: 339 GSVFRGIINGST-------VAIKCM--------RRSISKEVNLLKKINHFNLINLFGACE 383
           G V++G + G+        VAIK +        R     E  +  ++ H N++ L G   
Sbjct: 19  GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT 78

Query: 384 HDGVFYLVYEFMENGSLSDWLHKK-------------------RYPEFVSWNCRFRIALD 424
            +    +++ +  +  L ++L  +                      +F        I   
Sbjct: 79  KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF------VHIVTQ 132

Query: 425 VAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG 484
           +A G+ +L   +    VHKD+++ N+L+   L  K+++    R  V     Y     ++ 
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFRE-VYAADYYKLMGNSLL 188

Query: 485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
              +M+PE + YG  + + D +++GVVL E+ +
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 42/191 (21%)

Query: 349 STVAIKCMRRSISKEVNLLKKINHF-NLINLFGACEHDGVFYLVYEFMENGSLSDWLHK- 406
           STV  K  +R +  +++++ + +    ++  +GA   +G  ++  E M+  SL D  +K 
Sbjct: 39  STVDEKEQKR-LLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SL-DKFYKY 95

Query: 407 ------KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKL 460
                    PE        +IA+     L+YL    +   +H+D+   NILLD+N   KL
Sbjct: 96  VYEVLKSVIPE----EILGKIAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKL 149

Query: 461 ANFSFVRSAVREESGY---SSTKTA-VGTNGYMAPEYMEYGLVTPEM--------DTYAF 508
            +F          SG    S  KT   G   YMAPE      + P          D ++ 
Sbjct: 150 CDFGI--------SGQLVDSIAKTRDAGCRPYMAPER-----IDPSARDGYDVRSDVWSL 196

Query: 509 GVVLLELITGK 519
           G+ L E+ TGK
Sbjct: 197 GITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 60/284 (21%), Positives = 116/284 (40%), Gaps = 38/284 (13%)

Query: 358 RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNC 417
           +++  EV L     H N++  +         +++  FM  GS +  L K  +PE +S   
Sbjct: 44  KALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLL-KTYFPEGMSEAL 102

Query: 418 RFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLAN----FSFVRSAVREE 473
              I      GL+YLH     GY+H++I + +IL+  +    L+     +S VR+  + +
Sbjct: 103 IGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159

Query: 474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEM--DTYAFGVVLLELITGKEAAYKQDGEEIL 531
             Y   + +     +++PE +   L    +  D Y+ G+   EL TG+         ++L
Sbjct: 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219

Query: 532 LAE-----------AVF-----------SMVEGGNAEAKLSVLVDPNLQANK------KE 563
           L +             F           S V+ G  E+ ++  +   + + +      K 
Sbjct: 220 LQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKT 279

Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQTLL 607
            +     L   C+ ++PE RPS + ++S     Q+  Q   ++L
Sbjct: 280 FSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQGSIL 323

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 48/182 (26%), Positives = 87/182 (47%), Gaps = 25/182 (13%)

Query: 420 RIALDVAHGLHYL--HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS 477
           R +  VA G+ +L   NC     +H+D+++ N+LL     AK+ +F   R  +  +S Y 
Sbjct: 216 RFSSQVAQGMDFLASKNC-----IHRDVAARNVLLTDGRVAKICDFGLARD-IMNDSNYV 269

Query: 478 STKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVF 537
               A     +MAPE +   + T + D +++G++L E+ +  ++ Y      IL+    +
Sbjct: 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG----ILVNSKFY 325

Query: 538 SMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
            MV+ G   ++      P+      EI  + IM    C   EP  RP+ ++ +S L++ Q
Sbjct: 326 KMVKRGYQMSR------PDFAP--PEI--YSIM--KMCWNLEPTERPTFSQ-ISQLIQRQ 372

Query: 598 LD 599
           L 
Sbjct: 373 LG 374

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 12/166 (7%)

Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS--DWLHKKRYPEFV 413
           ++ +  +E+ +L+ +   N++ L  A    G  YLV+E++E   L   + +     PE  
Sbjct: 43  VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE-- 100

Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
                 ++   +   +  +H C     VH+DI   N+L+  N   KL +F F R+    E
Sbjct: 101 ------KVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL--SE 152

Query: 474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
              ++    V T  Y +PE +        +D ++ G +L EL  G+
Sbjct: 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 48.9 bits (117), Expect = 4e-06
 Identities = 45/194 (23%), Positives = 85/194 (43%), Gaps = 32/194 (16%)

Query: 347 NGSTVAIKCM----------RRSISKEVNLLKKINHFNLINL---FGACEHDGV-FYLVY 392
           +G  VAIK +          +R++ +E+ +L+   H N+I +         D    Y+V 
Sbjct: 29  SGKKVAIKKIPHAFDVPTLAKRTL-RELKILRHFKHDNIIAIRDILRPPGADFKDVYVVM 87

Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIAL-DVAHGLHYLHNCTDPGYVHKDISSGNIL 451
           + ME    SD LH   + +        R  L  +  GL Y+H+      +H+D+   N+L
Sbjct: 88  DLME----SD-LHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLL 139

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYMEYGLVTPE----MDTY 506
           ++++   ++ +F   R      + +    T  V T  Y APE +   L  PE    +D +
Sbjct: 140 VNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL---LSLPEYTTAIDMW 196

Query: 507 AFGVVLLELITGKE 520
           + G +  E++  ++
Sbjct: 197 SVGCIFAEMLGRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 26/194 (13%)

Query: 340 SVFRG--IINGSTVAIKCMRR--------SISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           +VF+G   +  + VA+K +R         +  +EV+LLK + H N++ L      +    
Sbjct: 20  TVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLT 79

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           LV+E++++  L  +L        +S +        +  GL Y   C     +H+D+   N
Sbjct: 80  LVFEYLDS-DLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSY---CHKRKILHRDLKPQN 133

Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----EYGLVTPEMDT 505
           +L+++    KLA+F   R+       YS+    V T  Y  P+ +    EY   TP +D 
Sbjct: 134 LLINEKGELKLADFGLARAKSVPTKTYSN---EVVTLWYRPPDVLLGSTEYS--TP-IDM 187

Query: 506 YAFGVVLLELITGK 519
           +  G +L E+ TG+
Sbjct: 188 WGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.5 bits (116), Expect = 5e-06
 Identities = 50/223 (22%), Positives = 86/223 (38%), Gaps = 63/223 (28%)

Query: 347 NGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME 396
            G   A+K +R+S          +  E ++L + ++  ++ L+ + + +   YL+ E++ 
Sbjct: 25  TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84

Query: 397 NGSLSDWLHKKRYPEFVSWNCRFRI-----ALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            G +   L K     F     RF I     A+D  H L         GY+H+DI   N+L
Sbjct: 85  GGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKL---------GYIHRDIKPDNLL 133

Query: 452 LDKNLRAKLANF------------SFVRSAVREESGYSSTKTA----------------- 482
           LD     KL++F             F R              +                 
Sbjct: 134 LDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRR 193

Query: 483 ------VGTNGYMAPE-YMEYGLVTPEMDTYAFGVVLLELITG 518
                 VGT  Y+APE +++ G    E D ++ GV++ E++ G
Sbjct: 194 ALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 42/187 (22%), Positives = 76/187 (40%), Gaps = 25/187 (13%)

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY-------PEFVSW 415
           E  LL K++H  ++    +      F ++ E+ E   L   L + ++        +   W
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
             +  +      G+HY+H       +H+D+ + NI L  NL  K+ +F   R  +     
Sbjct: 112 FIQLLL------GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM---GS 158

Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEA 535
                T  GT  YM+PE +++     + D ++ G +L E+     A   Q+         
Sbjct: 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSV 213

Query: 536 VFSMVEG 542
           V  +VEG
Sbjct: 214 VLRIVEG 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 31/213 (14%)

Query: 327 ATENFSPKNMIDGS---VFRGI--INGSTVAIKCMRRSIS--------KEVNLLKKINHF 373
           AT   + + + +GS   V++GI  ING  VA+K +             +E +LLK + H 
Sbjct: 4   ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63

Query: 374 NLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFV-SWNCRFRIALDVAHGLHYL 432
           N++ L            V+E+M    L+ ++   ++P  +  +N R      +  GL Y+
Sbjct: 64  NIVLLHDIIHTKETLTFVFEYMHT-DLAQYM--IQHPGGLHPYNVRL-FMFQLLRGLAYI 119

Query: 433 HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE 492
           H       +H+D+   N+L+      KLA+F   R+       YSS    V T  Y  P+
Sbjct: 120 HG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS---EVVTLWYRPPD 173

Query: 493 YM----EYGLVTPEMDTYAFGVVLLELITGKEA 521
            +    +Y   +  +D +  G + +E++ G+ A
Sbjct: 174 VLLGATDY---SSALDIWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 48.2 bits (115), Expect = 7e-06
 Identities = 56/209 (26%), Positives = 84/209 (40%), Gaps = 53/209 (25%)

Query: 342 FRGIINGSTVAIKCMRRSISKEVNL------LKKINHF----NLINLFGACEHDGVF--- 388
                   TVAIK +    SK++        LK + HF    N+  L+   + D VF   
Sbjct: 21  NAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLY---DMDIVFPGN 77

Query: 389 ----YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAH----------GLHYLHN 434
               YL  E ME    +D LH+           R    L  AH          GL Y+H+
Sbjct: 78  FNELYLYEELME----AD-LHQI---------IRSGQPLTDAHFQSFIYQILCGLKYIHS 123

Query: 435 CTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS---AVREESGYSSTKTAVGTNGYMAP 491
                 +H+D+  GN+L++ +   K+ +F   R       E +G+      V T  Y AP
Sbjct: 124 AN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF--MTEYVATRWYRAP 178

Query: 492 EYM-EYGLVTPEMDTYAFGVVLLELITGK 519
           E M  +   T  +D ++ G +L EL+  K
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 49.0 bits (116), Expect = 7e-06
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 32/199 (16%)

Query: 363 EVNLLKKINHFNLINLFGAC--EHDGVFYLVYEFMENGSLSDWLHKKRYPEF--VSWNCR 418
           EVN+++++ H N++        + +   Y++ EF + G LS  + +K Y  F  +  +  
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI-QKCYKMFGKIEEHAI 120

Query: 419 FRIALDVAHGLHYLHNCTD-PG---YVHKDISSGNILLDKNLR----------------- 457
             I   + H L Y HN  D P     +H+D+   NI L   +R                 
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180

Query: 458 AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM--EYGLVTPEMDTYAFGVVLLEL 515
           AK+ +F   ++   E   +S     VGT  Y +PE +  E      + D +A G ++ EL
Sbjct: 181 AKIGDFGLSKNIGIESMAHS----CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236

Query: 516 ITGKEAAYKQDGEEILLAE 534
            +GK   +K +    L++E
Sbjct: 237 CSGKTPFHKANNFSQLISE 255

Length = 1021

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 28/201 (13%)

Query: 339 GSVFRGI--INGSTVAIKCMR------RSISKEVNLLKKI-NHFNLINLFGACEHDGV-- 387
           G VF+ +   NGS  A+K +         I  E N+LK + +H N++  +G      V  
Sbjct: 32  GKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91

Query: 388 ---FYLVYEFMENGSLSDWLHK--KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
               +LV E    GS++D +    KR          + I  +   GL +LH       +H
Sbjct: 92  GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-ILHEALMGLQHLHVNKT---IH 147

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM--EYGLVT 500
           +D+   NILL      KL +F     + +  S      T+VGT  +MAPE +  E  L +
Sbjct: 148 RDVKGNNILLTTEGGVKLVDFGV---SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDS 204

Query: 501 ---PEMDTYAFGVVLLELITG 518
                 D ++ G+  +EL  G
Sbjct: 205 TYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 47.8 bits (114), Expect = 9e-06
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 12/96 (12%)

Query: 428 GLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG 487
           GL YLH+    G +H+DI  GN+L++ N   K+ +F   R    +ES + + +  V T  
Sbjct: 115 GLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE--VVTQY 169

Query: 488 YMAPEYM----EYGLVTPEMDTYAFGVVLLELITGK 519
           Y APE +     Y   T  +D ++ G +  EL+  +
Sbjct: 170 YRAPEILMGSRHY---TSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 48/186 (25%), Positives = 85/186 (45%), Gaps = 28/186 (15%)

Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK +NH N+I+L        + E     YLV 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           E M+  +L   +H +   E +S+     +   +  G+ +LH+    G +H+D+   NI++
Sbjct: 106 ELMD-ANLCQVIHMELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVV 156

Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
             +   K+ +F   R+A    + +  T   V T  Y APE +        +D ++ G ++
Sbjct: 157 KSDCTLKILDFGLARTAC---TNFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIM 212

Query: 513 LELITG 518
            EL+ G
Sbjct: 213 GELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 8/95 (8%)

Query: 425 VAHGLHYL--HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
           VA+G+ +L   NC     VH+D+++ N+L+ +    K+ +F   R  +R+ S Y S  + 
Sbjct: 248 VANGMEFLASKNC-----VHRDLAARNVLICEGKLVKICDFGLARDIMRD-SNYISKGST 301

Query: 483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
                +MAPE +   L T   D ++FG++L E+ T
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 19/163 (11%)

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN------ 416
           E++ L   +HF ++  F   + D    L+ E+   G L+  + K+R  E + +       
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-KQRLKEHLPFQEYEVGL 173

Query: 417 --CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
              +  +ALD  H    +H         +D+ S NI L      KL +F F +      S
Sbjct: 174 LFYQIVLALDEVHSRKMMH---------RDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224

Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
                 +  GT  Y+APE  E    + + D ++ GV+L EL+T
Sbjct: 225 -LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 45/168 (26%), Positives = 76/168 (45%), Gaps = 9/168 (5%)

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           E  +L+K+N   +++L  A E      LV   M  G L   ++    P F      F  A
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF-YA 108

Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
            ++  GL  L        V++D+   NILLD     ++++      AV+   G  + +  
Sbjct: 109 AELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGL---AVQIPEG-ETVRGR 161

Query: 483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
           VGT GYMAPE +     T   D +  G ++ E+I G ++ +++  E +
Sbjct: 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQG-QSPFRKRKERV 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 46/140 (32%), Positives = 58/140 (41%), Gaps = 23/140 (16%)

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRY---PE--FVSWNCRFRIALDVAHGLHYLHNCTDPG 439
           D VF LV +  E G L  W H  ++   PE     W     +ALD  H           G
Sbjct: 58  DSVF-LVLQHAEGGKL--WSHISKFLNIPEECVKRWAAEMVVALDALH---------REG 105

Query: 440 YVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV 499
            V +D++  NILLD     +L  FS        E   S    AV  N Y APE       
Sbjct: 106 IVCRDLNPNNILLDDRGHIQLTYFSRWS-----EVEDSCDGEAV-ENMYCAPEVGGISEE 159

Query: 500 TPEMDTYAFGVVLLELITGK 519
           T   D ++ G +L EL+TGK
Sbjct: 160 TEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 57/201 (28%), Positives = 84/201 (41%), Gaps = 35/201 (17%)

Query: 339 GSVFRG--IINGSTVAIKCMRR-------SIS--KEVNLLKKINHFNLINLFGAC---EH 384
           G V+R     +G  VA+K +R         IS  +E+ LL  + H N++ L         
Sbjct: 21  GIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL 80

Query: 385 DGVFYLVYEFMEN--GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
           D +F LV E+ E    SL D +    + E     C   + L +  GL YLH   +   +H
Sbjct: 81  DSIF-LVMEYCEQDLASLLDNM-PTPFSE-SQVKC---LMLQLLRGLQYLH---ENFIIH 131

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----EYGL 498
           +D+   N+LL      K+A+F   R               V T  Y APE +     Y  
Sbjct: 132 RDLKVSNLLLTDKGCLKIADFGLAR---TYGLPAKPMTPKVVTLWYRAPELLLGCTTY-- 186

Query: 499 VTPEMDTYAFGVVLLELITGK 519
            T  +D +A G +L EL+  K
Sbjct: 187 -TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 2e-05
 Identities = 44/185 (23%), Positives = 76/185 (41%), Gaps = 36/185 (19%)

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK---KRYPEFVSWNCRF 419
           E  +L  ++H  L  L+ + + +    LV ++   G L   L +   K   E V+   RF
Sbjct: 51  EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVA---RF 107

Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF-----SFVRSAVREES 474
             A +V   L YLH     G V++D+   NILL ++    L++F     S V      ++
Sbjct: 108 YAA-EVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163

Query: 475 GYSSTKTA---------------------VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLL 513
               ++ +                     VGT  Y+APE +        +D +  G++L 
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223

Query: 514 ELITG 518
           E++ G
Sbjct: 224 EMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 35/138 (25%), Positives = 58/138 (42%), Gaps = 19/138 (13%)

Query: 389 YLVYEFMENG-----SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHK 443
           Y+V+E ME+        +D L  + +  F+    R          L Y+H        H+
Sbjct: 80  YVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR---------ALKYIHTA---NVFHR 127

Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME--YGLVTP 501
           D+   NIL + + + K+ +F   R A  +          V T  Y APE     +   TP
Sbjct: 128 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 187

Query: 502 EMDTYAFGVVLLELITGK 519
            +D ++ G +  E++TGK
Sbjct: 188 AIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 46.1 bits (110), Expect = 3e-05
 Identities = 47/185 (25%), Positives = 83/185 (44%), Gaps = 33/185 (17%)

Query: 362 KEVNLLKKINHFNLINLFGAC-EH-DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +E+ LL+++ H N+++L     EH D   YL++++ E+  L   +   R  + VS     
Sbjct: 51  REIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSM 109

Query: 420 --RIALDVAHGLHYLHNCTDPGYV-HKDISSGNILL----DKNLRAKLANFSFVR---SA 469
              +   + +G+HYLH+     +V H+D+   NIL+     +    K+ +    R   + 
Sbjct: 110 VKSLLWQILNGVHYLHS----NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165

Query: 470 VREESGYSSTKTAVGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELIT------GK 519
           ++           V T  Y APE +     Y   T  +D +A G +  EL+T      G+
Sbjct: 166 LK--PLADLDPVVV-TIWYRAPELLLGARHY---TKAIDIWAIGCIFAELLTLEPIFKGR 219

Query: 520 EAAYK 524
           EA  K
Sbjct: 220 EAKIK 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 49/198 (24%), Positives = 85/198 (42%), Gaps = 28/198 (14%)

Query: 339 GSVFRGI--INGSTVAIKCMRR--------SISKEVNLLKKINHFNLINLFGACEHDGVF 388
            +V++G   +NG  VA+K +R         +  +E +LLK + H N++ L          
Sbjct: 19  ATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYV-HKDISS 447
            LV+E++    L  ++ K  +P  +           +  GL Y+H      Y+ H+D+  
Sbjct: 79  TLVFEYVHT-DLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQ----RYILHRDLKP 131

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----EYGLVTPEM 503
            N+L+      KLA+F   R+       YS+    V T  Y  P+ +    EY      +
Sbjct: 132 QNLLISDTGELKLADFGLARAKSVPSHTYSNE---VVTLWYRPPDVLLGSTEYSTC---L 185

Query: 504 DTYAFGVVLLELITGKEA 521
           D +  G + +E+I G  A
Sbjct: 186 DMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 28/176 (15%)

Query: 422 ALDVAHGLHYL--HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
           +  VA G+ +L    C     +H+D+++ NILL +N   K+ +F   R  + ++  Y   
Sbjct: 180 SFQVARGMEFLASRKC-----IHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRK 233

Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYK--QDGEEILLAEAVF 537
            +A     +MAPE +   + T + D ++FGV+L E+ +   + Y   Q  EE        
Sbjct: 234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ----- 288

Query: 538 SMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            + +G    A       P       EI  + IM  LAC   +P+ RP+ + +V  L
Sbjct: 289 RLKDGTRMRA-------PENAT--PEI--YRIM--LACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 30/101 (29%), Positives = 52/101 (51%), Gaps = 8/101 (7%)

Query: 425 VAHGLHYL--HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
           VA G+ +L   NC     +H+D+++ NILL      K+ +F   R  +R +S Y     A
Sbjct: 223 VAKGMSFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARD-IRNDSNYVVKGNA 276

Query: 483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAY 523
                +MAPE +   + T E D +++G++L E+ +   + Y
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 35/201 (17%)

Query: 339 GSVFRGI--INGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGV 387
           G V++    +   T+A+K +R          +  +E++LLK++ H N++ L      +  
Sbjct: 16  GVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR 75

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIAL-DVAHGLHYLHNCTDPGYVHKDIS 446
            YLV+E+++   L    H    P+F       +  L  +  G+ Y H+      +H+D+ 
Sbjct: 76  LYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLK 129

Query: 447 SGNILLDKNLRA-KLANFSFVRS---AVREESGYSSTKTAVGTNGYMAPEYM----EYGL 498
             N+L+D+   A KLA+F   R+    VR     + T   V T  Y APE +     Y  
Sbjct: 130 PQNLLIDRRTNALKLADFGLARAFGIPVR-----TFTHEVV-TLWYRAPEILLGSRHYS- 182

Query: 499 VTPEMDTYAFGVVLLELITGK 519
            TP +D ++ G +  E++  K
Sbjct: 183 -TP-VDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 27/165 (16%)

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP---EFVSWNCRF 419
           E+++L   +H N++ L  A  ++   +++ EF   G++   + +   P     +   C+ 
Sbjct: 52  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCK- 110

Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSF----VRSAVREESG 475
                    L+YLH   +   +H+D+ +GNIL   +   KLA+F       R+  R +S 
Sbjct: 111 ----QTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS- 162

Query: 476 YSSTKTAVGTNGYMAPEYM--EYGLVTP---EMDTYAFGVVLLEL 515
                  +GT  +MAPE +  E     P   + D ++ G+ L+E+
Sbjct: 163 ------FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 54/216 (25%)

Query: 348 GSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
           G   A+K +R++          I  E ++L + +   ++ +F + +     YL+ EF+  
Sbjct: 26  GHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG 85

Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDV--AHGLHYLHNCTDPGYVHKDISSGNILLDKN 455
           G +   L KK          +F IA  V     +H L      G++H+DI   N+LLD  
Sbjct: 86  GDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL------GFIHRDIKPDNLLLDSK 137

Query: 456 LRAKLANFSF---VRSAVREE---------------SGYSSTKTA--------------V 483
              KL++F     ++ A R E                  +S + A              V
Sbjct: 138 GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTV 197

Query: 484 GTNGYMAPE-YMEYGLVTPEMDTYAFGVVLLELITG 518
           GT  Y+APE +M+ G      D ++ GV++ E++ G
Sbjct: 198 GTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 45.0 bits (107), Expect = 5e-05
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 48/207 (23%)

Query: 339 GSVF--RGIINGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDG 386
           G V+  R  + G  VA+K +R           +I +E++LLK++NH N++ L      + 
Sbjct: 13  GVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-REISLLKELNHPNIVRLLDVVHSEN 71

Query: 387 VFYLVYEFMENGSLSDWLHKKRY----PEFVSWNCRFRIA---LDVAHGLHYLHNCTDPG 439
             YLV+EF++       L  K+Y    P          I      +  G+ Y H+     
Sbjct: 72  KLYLVFEFLD-------LDLKKYMDSSPLTG--LDPPLIKSYLYQLLQGIAYCHSHR--- 119

Query: 440 YVHKDISSGNILLDKNLRAKLANFSFVRS---AVREESGYSSTKTAVGTNGYMAPEYM-- 494
            +H+D+   N+L+D+    KLA+F   R+    VR    Y+     V T  Y APE +  
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR---TYTH---EVVTLWYRAPEILLG 173

Query: 495 --EYGLVTPEMDTYAFGVVLLELITGK 519
             +Y   TP +D ++ G +  E++  +
Sbjct: 174 SRQYS--TP-VDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 29/207 (14%)

Query: 394 FMENGSLSDWLHKKR-----YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDIS 446
           F+E  SLSD   ++      Y + ++       +  VA G+ +L    C     +H+D++
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKC-----IHRDLA 206

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NILL +N   K+ +F   R  + ++  Y     A     +MAPE +   + T + D +
Sbjct: 207 ARNILLSENNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 265

Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FGV+L E+ +   + Y   G +I   E    + EG    A       P+    +     
Sbjct: 266 SFGVLLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE----- 310

Query: 567 HLIMLCLACIAREPESRPSMAEVVSTL 593
            +    L C   EP  RP+ +E+V  L
Sbjct: 311 -MYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.0 bits (106), Expect = 6e-05
 Identities = 29/86 (33%), Positives = 50/86 (58%), Gaps = 14/86 (16%)

Query: 336 MIDGSVFRGIINGS---TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGAC- 382
           +++ S F GI   S   TVA+K ++        +++  E+ +L  I NH N++NL GAC 
Sbjct: 23  VVEASAF-GIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81

Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKR 408
           + +G   ++ EF + G+LS++L  KR
Sbjct: 82  KPNGPLMVIVEFCKYGNLSNFLRAKR 107

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 40/186 (21%), Positives = 72/186 (38%), Gaps = 48/186 (25%)

Query: 375 LINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR-YPEFVSWNCRFRIALDVAHGLHYLH 433
           ++ L+ + +     Y V +++  G +   L +   + E ++   RF IA ++   +  +H
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA---RFYIA-ELTCAIESVH 118

Query: 434 NCTDPGYVHKDISSGNILLDKNLRAKLANF------------------------SFVRSA 469
                G++H+DI   NIL+D++   KL +F                        S   S 
Sbjct: 119 KM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 470 VREESGYSSTKTA----------------VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLL 513
              E      K                  VGT  Y+APE +     T   D ++ GV+L 
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235

Query: 514 ELITGK 519
           E++ G+
Sbjct: 236 EMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 16/206 (7%)

Query: 326 VATENFSPKNMIDGSVFRGIINGS--TVAIKC-MRRSISKEVNLLKKINHFNLINLFGAC 382
              E F+P    +G  F  I N +   V IK   R   + E ++L+ INH ++I L G  
Sbjct: 95  SILETFTPG--AEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTF 152

Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
            ++    L+    +   L  +L  KR            I   V   + YLH       +H
Sbjct: 153 TYNKFTCLILPRYKT-DLYCYLAAKRNIAICDI---LAIERSVLRAIQYLHENR---IIH 205

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVR-EESGYSSTKTAVGTNGYMAPEYMEYGLVTP 501
           +DI + NI ++      L +F      V    + Y      + TN   APE +      P
Sbjct: 206 RDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN---APELLARDPYGP 262

Query: 502 EMDTYAFGVVLLELITGKEAAYKQDG 527
            +D ++ G+VL E+ T  ++ +++DG
Sbjct: 263 AVDIWSAGIVLFEMATCHDSLFEKDG 288

Length = 391

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 44.7 bits (106), Expect = 7e-05
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 40/200 (20%)

Query: 340 SVFRGI--INGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGV- 387
           +V++G   + G  VA+K +R          +I +E +LLK + H N++ L     HD + 
Sbjct: 20  TVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKDLKHANIVTL-----HDIIH 73

Query: 388 ----FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIAL-DVAHGLHYLHNCTDPGYVH 442
                 LV+E+++   L  ++        +S +   R+ L  +  GL Y H       +H
Sbjct: 74  TKKTLTLVFEYLDT-DLKQYM--DDCGGGLSMH-NVRLFLFQLLRGLAYCH---QRRVLH 126

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----EYGL 498
           +D+   N+L+ +    KLA+F   R+       YS+    V T  Y  P+ +    EY  
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN---EVVTLWYRPPDVLLGSTEY-- 181

Query: 499 VTPEMDTYAFGVVLLELITG 518
            +  +D +  G +  E+ TG
Sbjct: 182 -STSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|212030 cd00118, LysM, Lysine Motif is a small domain involved in binding peptidoglycan

 Score = 39.8 bits (94), Expect = 8e-05
 Identities = 13/45 (28%), Positives = 25/45 (55%), Gaps = 1/45 (2%)

Query: 174 TYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILI 218
           TY V  GD++  I+K++ V++E +  AN    +   ++P   + I
Sbjct: 2   TYTVKPGDTLWSIAKKYGVTVEELAAANPLI-NPDCIYPGQKLKI 45

LysM, a small globular domain with approximately 40 amino acids, is a widespread protein module involved in binding peptidoglycan in bacteria and chitin in eukaryotes. The domain was originally identified in enzymes that degrade bacterial cell walls, but proteins involved in many other biological functions also contain this domain. It has been reported that the LysM domain functions as a signal for specific plant-bacteria recognition in bacterial pathogenesis. Many of these enzymes are modular and are composed of catalytic units linked to one or several repeats of LysM domains. LysM domains are found in bacteria and eukaryotes. Length = 45

>gnl|CDD|144899 pfam01476, LysM, LysM domain

 Score = 39.7 bits (94), Expect = 8e-05
 Identities = 14/45 (31%), Positives = 24/45 (53%), Gaps = 2/45 (4%)

Query: 175 YLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIP 219
           Y V  GD++  I+KR+ +++E +   NG     P L+    + IP
Sbjct: 1   YTVKKGDTLSSIAKRYGITVEELAELNGL--SSPNLYVGQKLKIP 43

The LysM (lysin motif) domain is about 40 residues long. It is found in a variety of enzymes involved in bacterial cell wall degradation. This domain may have a general peptidoglycan binding function. The structure of this domain is known. Length = 43

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 44.3 bits (105), Expect = 8e-05
 Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 39/198 (19%)

Query: 339 GSVFRGI--INGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGV 387
           G+VF+         VA+K +R          S  +E+ LLK++ H N++ L+     D  
Sbjct: 14  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKK 73

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHY-----LHNCTDPGYVH 442
             LV+E+ +          K+Y +    +C   I  ++     +     L  C     +H
Sbjct: 74  LTLVFEYCDQ-------DLKKYFD----SCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLH 122

Query: 443 KDISSGNILLDKNLRAKLANFSFVRS---AVREESGYSSTKTAVGTNGYMAPEYMEYG-- 497
           +D+   N+L++KN   KLA+F   R+    VR    YS+    V T  Y  P+ + +G  
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRC---YSA---EVVTLWYRPPDVL-FGAK 175

Query: 498 LVTPEMDTYAFGVVLLEL 515
           L +  +D ++ G +  EL
Sbjct: 176 LYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 44.6 bits (105), Expect = 9e-05
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 60/219 (27%)

Query: 348 GSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
           G   A+K +R++          I  E ++L + +   ++ +F + +     YL+ EF+  
Sbjct: 26  GHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85

Query: 398 GSLSDWLHKKRYPEFVSWNCRFRI-----ALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           G +   L KK          +F I     A+D  H L         G++H+DI   N+LL
Sbjct: 86  GDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL---------GFIHRDIKPDNLLL 134

Query: 453 DKNLRAKLANFSF---VRSAVREE----------SGYS-----STKTA------------ 482
           D     KL++F     ++ A R E          S +S     S + A            
Sbjct: 135 DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAY 194

Query: 483 --VGTNGYMAPE-YMEYGLVTPEMDTYAFGVVLLELITG 518
             VGT  Y+APE +M+ G      D ++ GV++ E++ G
Sbjct: 195 STVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 51/195 (26%), Positives = 84/195 (43%), Gaps = 34/195 (17%)

Query: 347 NGSTVAIKC------MRRSISKEVNLLKKI-NHFNLINLFG---ACEH--DGVFYLVYEF 394
           +GS  A+K       +   I  E N+L+ + NH N++  +G     +    G  +LV E 
Sbjct: 46  DGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105

Query: 395 MENGSLSDWLHK-----KRYPE-FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
              GS+++ +       +R  E  +S+     I      GL +LHN      +H+D+   
Sbjct: 106 CNGGSVTELVKGLLICGQRLDEAMISY-----ILYGALLGLQHLHNNR---IIHRDVKGN 157

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----EYGL-VTPEM 503
           NILL      KL +F     + +  S      T+VGT  +MAPE +    +Y        
Sbjct: 158 NILLTTEGGVKLVDFGV---SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARC 214

Query: 504 DTYAFGVVLLELITG 518
           D ++ G+  +EL  G
Sbjct: 215 DVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 30/201 (14%)

Query: 339 GSVF--RGIINGSTVAIKCMR---------RSISKEVNLLKKINHF---NLINLFGAC-- 382
           G+V+  R   +G  VA+K +R          S  +EV LLK++  F   N++ L   C  
Sbjct: 14  GTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCAT 73

Query: 383 ---EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH-NCTDP 438
              + +    LV+E ++   L  +L K   P   +   +  +      GL +LH NC   
Sbjct: 74  SRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIK-DLMRQFLRGLDFLHANCI-- 129

Query: 439 GYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL 498
             VH+D+   NIL+    + KLA+F   R      S   +    V T  Y APE +    
Sbjct: 130 --VHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYRAPEVLLQST 183

Query: 499 VTPEMDTYAFGVVLLELITGK 519
               +D ++ G +  E+   K
Sbjct: 184 YATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 24/166 (14%)

Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE----FVSWNC 417
           +EV+LLK + H N++ L      D    LV+E+++          K+Y +     +S + 
Sbjct: 53  REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-------DLKQYMDDCGNIMSMHN 105

Query: 418 RFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS 477
                  +  GL Y H       +H+D+   N+L+++    KLA+F   R+       YS
Sbjct: 106 VKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162

Query: 478 STKTAVGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELITGK 519
           +    V T  Y  P+ +    EY   + ++D +  G +  E+ +G+
Sbjct: 163 N---EVVTLWYRPPDVLLGSSEY---STQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 54/225 (24%), Positives = 87/225 (38%), Gaps = 38/225 (16%)

Query: 351 VAIKCMRRSISKEVNLLKK-----------INHFNLINLFGACEHDGVFYLVYEFMENGS 399
           VA+K +R  +S E  LLKK           + H  ++ ++  C      Y    ++E  +
Sbjct: 30  VALKKIREDLS-ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYT 88

Query: 400 LSDWLH--------KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
           L   L          K   E  S      I   +   + Y+H+    G +H+D+   NIL
Sbjct: 89  LKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNIL 145

Query: 452 LDKNLRAKLANFSFVRSAVREE------------SGYSS-TKTA--VGTNGYMAPEYMEY 496
           L       + ++        EE              YSS T     VGT  YMAPE +  
Sbjct: 146 LGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205

Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVE 541
              +   D YA GV+L +++T      ++ G +I   + + S +E
Sbjct: 206 VPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIE 250

Length = 932

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 42/168 (25%), Positives = 75/168 (44%), Gaps = 17/168 (10%)

Query: 356 MRRSISKEVNLLKKINHF---NLINLFGAC-----EHDGVFYLVYEFMENGSLSDWLHKK 407
           M  S  +EV +L+ +  F   N++ LF  C     + +    LV+E ++   L+ +L K 
Sbjct: 44  MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKV 102

Query: 408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR 467
             P   +   +  +   +  GL +LH+      VH+D+   NIL+  + + KLA+F   R
Sbjct: 103 PEPGVPTETIK-DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 158

Query: 468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLEL 515
                 S   +  + V T  Y APE +        +D ++ G +  E+
Sbjct: 159 IY----SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 40/170 (23%), Positives = 75/170 (44%), Gaps = 32/170 (18%)

Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRI 421
           +EV+LLK + H N++ L      +    LV+E+++   L  +L           +C   I
Sbjct: 53  REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD----------DCGNSI 101

Query: 422 AL--------DVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
            +         +  GL+Y H       +H+D+   N+L+++    KLA+F   R+     
Sbjct: 102 NMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158

Query: 474 SGYSSTKTAVGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELITGK 519
             YS+    V T  Y  P+ +    +Y   + ++D +  G +  E+ TG+
Sbjct: 159 KTYSN---EVVTLWYRPPDILLGSTDY---STQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 49/169 (28%), Positives = 83/169 (49%), Gaps = 26/169 (15%)

Query: 362 KEVNLLKKINHFNLINLFGACE--HDGVF---YLVYEFMENGSLSDWLHK-KRYPEFVSW 415
           +E+ LL+ ++H N+I +       H   F   Y+VYE M+    +D LH+  R  + +S 
Sbjct: 53  REIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD----TD-LHQIIRSSQTLSD 107

Query: 416 N-CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
           + C++ +   +  GL Y+H+      +H+D+   N+LL+ N   K+ +F   R     E 
Sbjct: 108 DHCQYFL-YQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEK 161

Query: 475 GYSSTKTAVGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELITGK 519
           G   T+  V T  Y APE +    EY   T  +D ++ G +  EL+  K
Sbjct: 162 GDFMTEYVV-TRWYRAPELLLNCSEY---TTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 50/229 (21%), Positives = 90/229 (39%), Gaps = 27/229 (11%)

Query: 370 INHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL--HKKRYPEFVSWNCRFRIALDVAH 427
           + H N++   G C     + LV+E+ E G L  +L   +           + R+A ++A 
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-RMACEIAA 110

Query: 428 GLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG 487
           G+ ++H      ++H D++  N  L  +L  K+ ++    S  +E+   +     V    
Sbjct: 111 GVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR- 166

Query: 488 YMAPEYM---EYGLVTPEMDTY----AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMV 540
           ++APE +     GL+T E        A GV L EL       Y    +  +L   +    
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI---- 222

Query: 541 EGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                + +   L  P L+    E  + ++  C       PE R +  EV
Sbjct: 223 -----KDQQVKLFKPQLELPYSERWYEVLQFCWL----SPEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 30/185 (16%)

Query: 351 VAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVYEFM 395
           VAIK + R            +E+ L+K +NH N+I L        + E     Y+V E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111

Query: 396 ENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN 455
           +  +L   +  +   E +S+     +   +  G+ +LH+    G +H+D+   NI++  +
Sbjct: 112 D-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD 162

Query: 456 LRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLE 514
              K+ +F   R+A     G S   T  V T  Y APE +        +D ++ G ++ E
Sbjct: 163 CTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

Query: 515 LITGK 519
           +I G 
Sbjct: 218 MIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 15/38 (39%), Positives = 24/38 (63%)

Query: 372 HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY 409
           H N++NL GAC   G  Y++ E+   G L D+LH+ ++
Sbjct: 100 HLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKH 137

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 30/84 (35%), Positives = 49/84 (58%), Gaps = 14/84 (16%)

Query: 350 TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGAC-EHDGVFYLVYEFMENGS 399
           TVA+K ++        R++  E+ +L  I +H N++NL GAC +  G   ++ EF + G+
Sbjct: 39  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 98

Query: 400 LSDWLHKKRYPEFVSW---NCRFR 420
           LS++L  KR  EFV +   + RFR
Sbjct: 99  LSNYLRSKR-GEFVPYKTKDARFR 121

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 46/174 (26%), Positives = 73/174 (41%), Gaps = 38/174 (21%)

Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEF--MENGSLSDWLHKKRYPEFVSWNCRF 419
           +E++LLK++ H N++ L      +   YL++EF  M+     D L K +Y          
Sbjct: 48  REISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY---------- 97

Query: 420 RIALDVAHGLHYLHNCTDPGY-------VHKDISSGNILLDKNLRAKLANFSFVRS---A 469
              +D      YL+              +H+D+   N+L+D     KLA+F   R+    
Sbjct: 98  ---MDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154

Query: 470 VREESGYSSTKTAVGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELITGK 519
           VR       T   V T  Y APE +     Y   TP +D ++ G +  E+ T K
Sbjct: 155 VR-----VYTHEVV-TLWYRAPEVLLGSPRYS--TP-VDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 17/53 (32%), Positives = 32/53 (60%), Gaps = 1/53 (1%)

Query: 357 RRSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
           ++++  E+ ++  +  H N++NL GAC   G  Y++ E+   G L ++LHK R
Sbjct: 84  KQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNR 136

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 41.6 bits (98), Expect = 0.001
 Identities = 48/192 (25%), Positives = 82/192 (42%), Gaps = 34/192 (17%)

Query: 346 INGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGVF------YL 390
           + G  VAIK + R            +E+ L+K +NH N+I L                YL
Sbjct: 39  VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98

Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           V E M+  +L   +      E +S+     +   +  G+ +LH+    G +H+D+   NI
Sbjct: 99  VMELMD-ANLCQVIQMDLDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNI 149

Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEY---MEYGLVTPEMDTYA 507
           ++  +   K+ +F   R+A    + +  T   V T  Y APE    M Y      +D ++
Sbjct: 150 VVKSDCTLKILDFGLARTA---GTSFMMTPYVV-TRYYRAPEVILGMGY---KENVDIWS 202

Query: 508 FGVVLLELITGK 519
            G ++ E+I G 
Sbjct: 203 VGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 47/185 (25%), Positives = 83/185 (44%), Gaps = 30/185 (16%)

Query: 351 VAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVYEFM 395
           VAIK + R            +E+ L+K +NH N+I+L        + E     YLV E M
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104

Query: 396 ENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN 455
           +  +L   +  +   E +S+     +   +  G+ +LH+    G +H+D+   NI++  +
Sbjct: 105 D-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD 155

Query: 456 LRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLE 514
              K+ +F   R+A     G S   T  V T  Y APE +        +D ++ G ++ E
Sbjct: 156 CTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210

Query: 515 LITGK 519
           ++  K
Sbjct: 211 MVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 39.3 bits (92), Expect = 0.001
 Identities = 25/96 (26%), Positives = 42/96 (43%), Gaps = 12/96 (12%)

Query: 362 KEVNLLKKINHFNLI--NLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +EV +L+ +    L    +  + E DG  YL+ E++E  +L +   +++           
Sbjct: 40  REVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKE---------- 89

Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN 455
            IA  +A  L  LH        H D+  GNIL+D  
Sbjct: 90  DIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 22/69 (31%), Positives = 41/69 (59%), Gaps = 10/69 (14%)

Query: 350 TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGAC-EHDGVFYLVYEFMENGS 399
           TVA+K ++        +++  E+ +L  I +H N++NL GAC +  G   ++ E+ + G+
Sbjct: 39  TVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGN 98

Query: 400 LSDWLHKKR 408
           LS++L  KR
Sbjct: 99  LSNYLRSKR 107

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 28/98 (28%), Positives = 51/98 (52%), Gaps = 8/98 (8%)

Query: 422 ALDVAHGLHYL--HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
           +  VA G+ +L    C     +H+D+++ NILL +N   K+ +F   R  + ++  Y   
Sbjct: 179 SFQVARGMEFLASRKC-----IHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRK 232

Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
             A     +MAPE +   + T + D ++FGV+L E+ +
Sbjct: 233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 33/131 (25%), Positives = 59/131 (45%), Gaps = 26/131 (19%)

Query: 348 GSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
           G   A+K + +S          +  E ++L + +   +++L+ + +     YL+ EF+  
Sbjct: 26  GKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG 85

Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIA-----LDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           G L   L K  Y  F     RF +A     ++  H L         G++H+DI   NIL+
Sbjct: 86  GDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKL---------GFIHRDIKPDNILI 134

Query: 453 DKNLRAKLANF 463
           D+    KL++F
Sbjct: 135 DRGGHIKLSDF 145

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 58/243 (23%), Positives = 94/243 (38%), Gaps = 45/243 (18%)

Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLI------------------------NLFG 380
           I NG+  A+  +R   +++   +KKIN  NLI                        ++F 
Sbjct: 9   ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFC 68

Query: 381 ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
           + E      +V E++E G  +  L K      V    R   A  V   L YLHN    G 
Sbjct: 69  SFETKRHLCMVMEYVEGGDCATLL-KNIGALPVDM-ARMYFAETVL-ALEYLHNY---GI 122

Query: 441 VHKDISSGNILLDKNLRAKLANFSFVR------------SAVREESGYSSTKTAVGTNGY 488
           VH+D+   N+L+      KL +F   +              + +++     K   GT  Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182

Query: 489 MAPEY-MEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA 547
           +APE  +  G   P +D +A G++L E + G    +    EE L  + +   +E    + 
Sbjct: 183 IAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISDDIEWPEGDE 240

Query: 548 KLS 550
            L 
Sbjct: 241 ALP 243

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 46/232 (19%), Positives = 92/232 (39%), Gaps = 62/232 (26%)

Query: 343 RGIINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVY 392
             +   +  A+K +R+           +  E ++L + ++  ++ L+ + +     Y V 
Sbjct: 21  CKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80

Query: 393 EFMENGSLSDWLHKKR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
           +++  G +   L +   +PE ++   RF IA ++   +  +H     G++H+DI   NIL
Sbjct: 81  DYIPGGDMMSLLIRMEVFPEVLA---RFYIA-ELTLAIESVHKM---GFIHRDIKPDNIL 133

Query: 452 LDKNLRAKLANFSFVR--------------SAVREESGYSS------------------- 478
           +D +   KL +F                  S +R++S   S                   
Sbjct: 134 IDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLE 193

Query: 479 -----------TKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
                        + VGT  Y+APE +     T   D ++ GV+L E++ G+
Sbjct: 194 QRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.5 bits (92), Expect = 0.004
 Identities = 40/162 (24%), Positives = 71/162 (43%), Gaps = 10/162 (6%)

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           E+++ K  NH N++        D   ++V  FM  GS  D L    + + +S      I 
Sbjct: 49  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMSELAIAYIL 107

Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKL----ANFSFVRSAVREESGYSS 478
             V   L Y+H+    GYVH+ + + +IL+  + +  L    +N S +    R    +  
Sbjct: 108 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDF 164

Query: 479 TKTAVGTNGYMAPEYMEYGL--VTPEMDTYAFGVVLLELITG 518
            K +V    +++PE ++  L     + D Y+ G+   EL  G
Sbjct: 165 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	611
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.98
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.98
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.98
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.98
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.98
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.98
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.98
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.98
PLN00009	294	cyclin-dependent kinase A; Provisional	99.98
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.98
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.98
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.98
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.98
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.98
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.98
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.91
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.91
PRK06347	592	autolysin; Reviewed	99.91
KOG1152	772	consensus Signal transduction serine/threonine kin	99.91
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.9
PRK06347	592	autolysin; Reviewed	99.9
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
PRK09188	365	serine/threonine protein kinase; Provisional	99.82
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.8
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.77
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.75
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.75
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.75
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.74
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.72
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.71
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.7
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.69
PRK12274	218	serine/threonine protein kinase; Provisional	99.69
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.68
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.66
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.62
PRK10345	210	hypothetical protein; Provisional	99.61
PRK14879	211	serine/threonine protein kinase; Provisional	99.61
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.58
smart00090	237	RIO RIO-like kinase.	99.55
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.55
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.53
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.49
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	99.47
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.46
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.46
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.44
PRK13914	481	invasion associated secreted endopeptidase; Provis	99.43
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.33
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.29
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.28
KOG1243	690	consensus Protein kinase [General function predict	99.23
PF01476	44	LysM: LysM domain; InterPro: IPR018392 This domain	99.15
COG1388	124	LytE FOG: LysM repeat [Cell envelope biogenesis, o	99.15
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.1
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.08
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.03
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.98
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.92
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.87
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.86
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.84
KOG3087	229	consensus Serine/threonine protein kinase [General	98.82
PRK14125	103	cell division suppressor protein YneA; Provisional	98.82
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.78
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.76
TIGR02899	44	spore_safA spore coat assembly protein SafA. in wh	98.74
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.73
PF01476	44	LysM: LysM domain; InterPro: IPR018392 This domain	98.7
cd00118	46	LysM Lysin domain, found in a variety of enzymes i	98.62
COG3858	423	Predicted glycosyl hydrolase [General function pre	98.55
COG4248	637	Uncharacterized protein with protein kinase and he	98.51
PRK10871	319	nlpD lipoprotein NlpD; Provisional	98.5
TIGR02907	338	spore_VI_D stage VI sporulation protein D. SpoVID,	98.48
PRK14125	103	cell division suppressor protein YneA; Provisional	98.46
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.43
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.41
smart00257	44	LysM Lysin motif.	98.3
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.28
PRK13914	481	invasion associated secreted endopeptidase; Provis	98.26
PRK09902	216	hypothetical protein; Provisional	98.25
TIGR02899	44	spore_safA spore coat assembly protein SafA. in wh	98.21
COG3858	423	Predicted glycosyl hydrolase [General function pre	98.12
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.1
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.09
PRK11198	147	LysM domain/BON superfamily protein; Provisional	98.08
cd00118	46	LysM Lysin domain, found in a variety of enzymes i	98.04
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.03
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.97
TIGR02907	338	spore_VI_D stage VI sporulation protein D. SpoVID,	97.93
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.89
PRK10871	319	nlpD lipoprotein NlpD; Provisional	97.87
PRK11198	147	LysM domain/BON superfamily protein; Provisional	97.8
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.66
PF01636	239	APH: Phosphotransferase enzyme family This family	97.49
smart00257	44	LysM Lysin motif.	97.47
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.41
COG1388	124	LytE FOG: LysM repeat [Cell envelope biogenesis, o	97.31
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.3
PLN02876	822	acyl-CoA dehydrogenase	97.27
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.2
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.15
PRK10593	297	hypothetical protein; Provisional	97.05
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	96.96
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.95
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.85
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.82
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	96.73
PF04225	85	OapA: Opacity-associated protein A LysM-like domai	96.56

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-52  Score=432.22  Aligned_cols=275  Identities=42%  Similarity=0.727  Sum_probs=239.3

Q ss_pred             CccccchhHHHHHhhcCCCCCccc----ceEEEEEE-cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeecccee
Q 007261          315 GLKFYKYEDLVVATENFSPKNMID----GSVFRGII-NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGAC  382 (611)
Q Consensus       315 ~~~~~~~~el~~at~~f~~~~~ig----g~Vy~g~~-~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~  382 (611)
                      ..+.|+++|+..||++|+..+.+|    |.||+|.+ +|..||||++.       ++|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            567899999999999999999997    88999999 55899999874       3699999999999999999999999


Q ss_pred             ccCC-eEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 007261          383 EHDG-VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA  461 (611)
Q Consensus       383 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~  461 (611)
                      .+.+ +.+||||||++|+|.++|+..... .++|..|++||.++|+||+|||+.+.++|+|||||++|||||+++.+||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9988 599999999999999999986543 79999999999999999999999888899999999999999999999999


Q ss_pred             eecCcccccc-ccCCccccccc-ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCC-ChhhHHHHHHHH
Q 007261          462 NFSFVRSAVR-EESGYSSTKTA-VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQD-GEEILLAEAVFS  538 (611)
Q Consensus       462 Dfgla~~~~~-~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~-~~~~~l~~~~~~  538 (611)
                      |||+|+.... ..    ..... .||.+|+|||+...+..+.|+|||||||+|+||+||+++..... ..+..+.+|...
T Consensus       220 DFGLa~~~~~~~~----~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  220 DFGLAKLGPEGDT----SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             CccCcccCCcccc----ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            9999976543 21    11112 89999999999999999999999999999999999998887543 333446777777


Q ss_pred             HHhcCCcccccccccCccCC-cC-hH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          539 MVEGGNAEAKLSVLVDPNLQ-AN-KK-EIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       539 ~~~~~~~~~~l~~~~d~~l~-~~-~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      .+..+    .+.+++|+.+. .. .. .....+..++.+|++.+|.+||+|.||++.|+.+..
T Consensus       296 ~~~~~----~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  296 LLEEG----KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHCc----chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            76643    78899999986 33 33 677889999999999999999999999999966554

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-47  Score=391.04  Aligned_cols=244  Identities=29%  Similarity=0.548  Sum_probs=206.9

Q ss_pred             HHHhhcCCCCCcccceEEEEEEcCc-EEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCC
Q 007261          325 VVATENFSPKNMIDGSVFRGIINGS-TVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN  397 (611)
Q Consensus       325 ~~at~~f~~~~~igg~Vy~g~~~g~-~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  397 (611)
                      +.+++.|       |.||.|.|+|. .||+|.++      .+|.+|+.+|++|+|+|||+++|+|..++.+|||||||+.
T Consensus       213 ~LG~G~F-------G~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  213 ELGSGQF-------GEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HhcCCcc-------ceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            3456666       99999999887 89999986      5799999999999999999999999998999999999999


Q ss_pred             CCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcc
Q 007261          398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS  477 (611)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  477 (611)
                      |+|.++|+.. ....+...+.+.++.|||+||+||+   ++++|||||.++||||+++..+||+|||||+....  ..+.
T Consensus       286 GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d--~~Y~  359 (468)
T KOG0197|consen  286 GSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD--DEYT  359 (468)
T ss_pred             CcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCC--Ccee
Confidence            9999999973 2345888999999999999999999   79999999999999999999999999999994433  3344


Q ss_pred             cccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCcc
Q 007261          478 STKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN  556 (611)
Q Consensus       478 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  556 (611)
                      ......-+..|.|||.+..++++.|||||||||+||||+| |+.|+......+      +...++.+            .
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e------v~~~le~G------------y  421 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE------VLELLERG------------Y  421 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH------HHHHHhcc------------C
Confidence            4455566789999999999999999999999999999999 666665554432      22222222            2


Q ss_pred             CCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       557 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      ..+.|..|+++++++|..||+.+|++|||++.+...|+++...
T Consensus       422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            2334677999999999999999999999999999999987654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-46  Score=386.84  Aligned_cols=239  Identities=36%  Similarity=0.590  Sum_probs=202.0

Q ss_pred             ceEEEEEEcCcE-EEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccCC-eEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGIINGST-VAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHDG-VFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~~g~~-vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|.|.|+. ||||++..         +|.+|+.+|.+++|||||+++|+|.+.. ..+||||||++|+|.++|+..
T Consensus        55 g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~  134 (362)
T KOG0192|consen   55 GTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK  134 (362)
T ss_pred             eeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc
Confidence            999999999998 99999973         7999999999999999999999999887 799999999999999999885


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCCeeeCCCC-cEEEeeecCccccccccCCcccccccccC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG-YVHKDISSGNILLDKNL-RAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~-ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                       ....+++..+++||.|||+||+|||+   .+ |||||||++|||++.++ ++||+|||+++......   .......||
T Consensus       135 -~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~---~~~~~~~GT  207 (362)
T KOG0192|consen  135 -RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK---TSMTSVAGT  207 (362)
T ss_pred             -ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc---ccccCCCCC
Confidence             23569999999999999999999994   55 99999999999999998 99999999998664321   233347899


Q ss_pred             CCccchhhhc--cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          486 NGYMAPEYME--YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       486 ~~y~aPE~~~--~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      +.|||||++.  ...|+.|+||||||++||||+||+.||........     ...+....            .....+..
T Consensus       208 ~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~-----~~~v~~~~------------~Rp~~p~~  270 (362)
T KOG0192|consen  208 YRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV-----ASAVVVGG------------LRPPIPKE  270 (362)
T ss_pred             ccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHhcC------------CCCCCCcc
Confidence            9999999999  56999999999999999999999999987654211     11111111            11122344


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                      +...+..|+.+||+.||+.||++.+++..|+.+.....
T Consensus       271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  271 CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            77889999999999999999999999999998877544

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.1e-45  Score=397.50  Aligned_cols=240  Identities=29%  Similarity=0.544  Sum_probs=207.1

Q ss_pred             ceEEEEEEcC-------cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIING-------STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~g-------~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |+||+|...|       ..||||.++        .+|++|+++|..++|||||+|+|+|.+++..++|+|||..|||.+|
T Consensus       500 GkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eF  579 (774)
T KOG1026|consen  500 GKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEF  579 (774)
T ss_pred             hhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHH
Confidence            9999998733       479999997        4799999999999999999999999999999999999999999999


Q ss_pred             hhccCC-----------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          404 LHKKRY-----------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       404 l~~~~~-----------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      |.....           +.+|+..+.+.||.|||.||+||-   +..+|||||..+|+||.++..+||+||||+|.....
T Consensus       580 Lra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYss  656 (774)
T KOG1026|consen  580 LRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSS  656 (774)
T ss_pred             HHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEecccccchhhhhh
Confidence            975421           234899999999999999999999   688999999999999999999999999999987654


Q ss_pred             cCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCccccccc
Q 007261          473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV  551 (611)
Q Consensus       473 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  551 (611)
                      +. +.......-..+||+||.+..++||.+||||||||+|||++| |+.|+++...++..                  ..
T Consensus       657 DY-Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI------------------e~  717 (774)
T KOG1026|consen  657 DY-YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI------------------EC  717 (774)
T ss_pred             hh-hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH------------------HH
Confidence            42 223334556789999999999999999999999999999999 88888877665421                  22


Q ss_pred             ccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          552 LVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       552 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      +.+..+.+.+..|+.+++.||..||+.+|.+||+++||-..|+......
T Consensus       718 i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  718 IRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             HHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence            3345555668899999999999999999999999999999998876543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=355.89  Aligned_cols=233  Identities=25%  Similarity=0.424  Sum_probs=198.1

Q ss_pred             ccceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCC-eEEEEEeecCCCCHHHHhh
Q 007261          337 IDGSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDG-VFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       337 igg~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~  405 (611)
                      -||.||++..  ++..+|+|++.        +++.+|++++++.+||+||.++|.|...+ ...|+||||++|||++++.
T Consensus        91 ~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k  170 (364)
T KOG0581|consen   91 NGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILK  170 (364)
T ss_pred             CCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHh
Confidence            3599999988  68999999983        56889999999999999999999999888 5999999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ..+   .+++...-+|+.+|++||.|||+  ..+||||||||+|||++.+|++||||||.++.....     .....+||
T Consensus       171 ~~g---~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-----~a~tfvGT  240 (364)
T KOG0581|consen  171 RVG---RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-----IANTFVGT  240 (364)
T ss_pred             hcC---CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-----hccccccc
Confidence            753   38899999999999999999995  589999999999999999999999999998876432     44668999


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH-HH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK-EI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~-~~  564 (611)
                      ..|||||.+.+..|+.++||||||++++|+.+|+.|+...........+...             .+.+......+. .+
T Consensus       241 ~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~-------------~Iv~~ppP~lP~~~f  307 (364)
T KOG0581|consen  241 SAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC-------------AIVDEPPPRLPEGEF  307 (364)
T ss_pred             ccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH-------------HHhcCCCCCCCcccC
Confidence            9999999999999999999999999999999999998765222122222222             223322223333 48


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ++++..++..||++||.+||+++|++++
T Consensus       308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  308 SPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            8999999999999999999999999985

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-45  Score=385.79  Aligned_cols=258  Identities=27%  Similarity=0.467  Sum_probs=215.5

Q ss_pred             cchhHHHHHhhcCCC---------CCccc----ceEEEEEE--cC---cEEEEEEec--------HHHHHHHHHHHhcCC
Q 007261          319 YKYEDLVVATENFSP---------KNMID----GSVFRGII--NG---STVAIKCMR--------RSISKEVNLLKKINH  372 (611)
Q Consensus       319 ~~~~el~~at~~f~~---------~~~ig----g~Vy~g~~--~g---~~vavK~~~--------~~~~~E~~~l~~l~H  372 (611)
                      ++|||-..|-..|..         +..||    |.|++|.+  .|   ..||||.++        ++|..|..||.+++|
T Consensus       610 ~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH  689 (996)
T KOG0196|consen  610 HTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH  689 (996)
T ss_pred             ccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC
Confidence            456666666555543         23344    89999998  34   479999996        589999999999999


Q ss_pred             CceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 007261          373 FNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL  452 (611)
Q Consensus       373 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl  452 (611)
                      |||++|.|+.......+||.|||+||+|+.||+.+.  ..+++.+...+..+||.||.||-   +.++|||||.++|||+
T Consensus       690 PNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILV  764 (996)
T KOG0196|consen  690 PNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILV  764 (996)
T ss_pred             CcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheee
Confidence            999999999999999999999999999999999875  34999999999999999999999   7899999999999999


Q ss_pred             CCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhH
Q 007261          453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEIL  531 (611)
Q Consensus       453 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~  531 (611)
                      +.+..+|++||||+|....+......+....-..+|.|||.+...+++.++||||||++|||.++ |.+|+-++...+.+
T Consensus       765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI  844 (996)
T KOG0196|consen  765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI  844 (996)
T ss_pred             ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH
Confidence            99999999999999977555434444555556789999999999999999999999999999998 77787666543321


Q ss_pred             HHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          532 LAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       532 l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                            ..+            .+.-..+.|.+|+..|.+||+.||++|-.+||.+.+|+..|+++-..
T Consensus       845 ------kaI------------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  845 ------KAI------------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             ------HHH------------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence                  111            12222334778999999999999999999999999999999997653

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-42  Score=351.30  Aligned_cols=233  Identities=26%  Similarity=0.451  Sum_probs=201.3

Q ss_pred             ceEEEEEEcCcEEEEEEecHHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHH
Q 007261          339 GSVFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR  418 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~  418 (611)
                      |.||.|++.++.||||++++--..+|+-|++|+|+||+.|.|+|.....+|||||||..|-|...|+..+   .+.....
T Consensus       138 GAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~---~itp~ll  214 (904)
T KOG4721|consen  138 GAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR---PITPSLL  214 (904)
T ss_pred             cceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccC---ccCHHHH
Confidence            8999999999999999999888889999999999999999999999999999999999999999999764   4778888


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhccCC
Q 007261          419 FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL  498 (611)
Q Consensus       419 ~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  498 (611)
                      ++|..+||.||.|||   ...|||||||+-||||..+..+||+|||-++.....    .......||..|||||+++...
T Consensus       215 v~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~----STkMSFaGTVaWMAPEvIrneP  287 (904)
T KOG4721|consen  215 VDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK----STKMSFAGTVAWMAPEVIRNEP  287 (904)
T ss_pred             HHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh----hhhhhhhhhHhhhCHHHhhcCC
Confidence            999999999999999   689999999999999999999999999988765322    3455678999999999999999


Q ss_pred             CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCC-cChHHHHHHHHHHHHHhhc
Q 007261          499 VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ-ANKKEIAHHLIMLCLACIA  577 (611)
Q Consensus       499 ~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~-~~~~~~~~~l~~l~~~Cl~  577 (611)
                      +++|.||||||||||||+||..|+.+-+...+.+     .+             -...+. ..+..|++.+.-|+++||+
T Consensus       288 csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw-----GV-------------GsNsL~LpvPstcP~GfklL~Kqcw~  349 (904)
T KOG4721|consen  288 CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW-----GV-------------GSNSLHLPVPSTCPDGFKLLLKQCWN  349 (904)
T ss_pred             cccccceehhHHHHHHHHhcCCCccccchheeEE-----ec-------------cCCcccccCcccCchHHHHHHHHHHh
Confidence            9999999999999999999999986544332211     11             001111 2266788889999999999


Q ss_pred             cCCCCCCCHHHHHHHHHhchhh
Q 007261          578 REPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       578 ~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      ..|..|||+.+++.+|+=...+
T Consensus       350 sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  350 SKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             cCCCCCccHHHHHHHHhhcCHH
Confidence            9999999999999999754443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-41  Score=333.86  Aligned_cols=181  Identities=30%  Similarity=0.530  Sum_probs=163.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|+.  ++..||||.+.+         .+..|+.+|+.++|||||++++++..++..|||||||.||+|.+|++..
T Consensus        24 avVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~  103 (429)
T KOG0595|consen   24 AVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRR  103 (429)
T ss_pred             EEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHc
Confidence            89999998  788999999853         3567999999999999999999999999999999999999999999987


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC------CcEEEeeecCccccccccCCcccccc
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN------LRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~------~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +   .+++.....++.|||.||++||   +++||||||||+||||+..      -.+||+|||+||.....    .....
T Consensus       104 ~---~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~----~~a~t  173 (429)
T KOG0595|consen  104 G---RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG----SMAET  173 (429)
T ss_pred             C---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch----hHHHH
Confidence            4   3899999999999999999999   7999999999999999765      46899999999987533    24456


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChh
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE  529 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~  529 (611)
                      .+|++.|||||++...+|+.|+|+||+|++||++++|+.||......+
T Consensus       174 lcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  174 LCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             hhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            789999999999999999999999999999999999999998766554

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=378.02  Aligned_cols=240  Identities=31%  Similarity=0.544  Sum_probs=200.2

Q ss_pred             ceEEEEEE---cCc----EEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII---NGS----TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~---~g~----~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|.+   +|.    .||||.++        .+|.+|..+|++++|||||+++|.|.+.+..+|++|||++|+|..|
T Consensus       706 G~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sf  785 (1025)
T KOG1095|consen  706 GEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSF  785 (1025)
T ss_pred             cceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHH
Confidence            99999998   444    49999986        3699999999999999999999999999999999999999999999


Q ss_pred             hhccCC----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccc
Q 007261          404 LHKKRY----PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       404 l~~~~~----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      |++.+.    +..++..+.+.++.|||+|+.||+   ++++|||||.++|+||++...+||+|||||+.....+. +...
T Consensus       786 lr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~y-yr~~  861 (1025)
T KOG1095|consen  786 LRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDY-YRKH  861 (1025)
T ss_pred             HHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhHhhhhchh-eecc
Confidence            998642    346899999999999999999999   79999999999999999999999999999997655443 2222


Q ss_pred             cccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCC
Q 007261          480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ  558 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~  558 (611)
                      ....-..+|||||.+..+.++.|+|||||||+|||++| |..|+......+..     ..++++             ...
T Consensus       862 ~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~-----~~~~~g-------------gRL  923 (1025)
T KOG1095|consen  862 GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL-----LDVLEG-------------GRL  923 (1025)
T ss_pred             CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH-----HHHHhC-------------Ccc
Confidence            22355679999999999999999999999999999999 44555444433221     112221             123


Q ss_pred             cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          559 ANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      +.+..|++.++++|..||+.+|++||++..|++.+.++....
T Consensus       924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            346788999999999999999999999999999888876543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-41  Score=320.70  Aligned_cols=240  Identities=24%  Similarity=0.393  Sum_probs=195.5

Q ss_pred             HHHhhcCCCCCcccceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccc-eeccCCe-EEEE
Q 007261          325 VVATENFSPKNMIDGSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFG-ACEHDGV-FYLV  391 (611)
Q Consensus       325 ~~at~~f~~~~~igg~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lV  391 (611)
                      .++.+.|       |+||++..  +|..||.|.+.         ++...|+.+|++|+|||||++++ .+.++.+ .+||
T Consensus        26 ~IG~GsF-------g~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   26 KIGRGSF-------GEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHcCCcc-------hheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3455666       99999986  89999999984         46788999999999999999999 4555555 8999


Q ss_pred             EeecCCCCHHHHhhcc-CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          392 YEFMENGSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG--YVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       392 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      ||||.+|+|..+++.- ...+.+++..+++++.|++.||.++|+.. ++  |+||||||.||+|+.+|.+||+||||++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999763 23456999999999999999999999522 44  99999999999999999999999999997


Q ss_pred             cccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc
Q 007261          469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK  548 (611)
Q Consensus       469 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  548 (611)
                      .....   ......+||+.||+||.+.+..|+.|+||||+||++|||..-..||++..-.  .+.+   ..         
T Consensus       178 l~s~~---tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~--~L~~---KI---------  240 (375)
T KOG0591|consen  178 LSSKT---TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL--SLCK---KI---------  240 (375)
T ss_pred             hcchh---HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH--HHHH---HH---------
Confidence            75432   3455679999999999999999999999999999999999999999876311  1111   11         


Q ss_pred             cccccCccCCcCh-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          549 LSVLVDPNLQANK-KEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       549 l~~~~d~~l~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                          -.......+ ...+..+.+|+..|+..||+.||+...+++.+
T Consensus       241 ----~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  241 ----EQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             ----HcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence                112223333 56788999999999999999999854444433

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-41  Score=335.93  Aligned_cols=231  Identities=26%  Similarity=0.402  Sum_probs=189.5

Q ss_pred             ceEEEEEE--cCcEEEEEEecH--------------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMRR--------------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~--------------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      |.|-.|..  +|+.||||++.+              +..+|+++|++|+|||||++.++|...+..||||||++||+|.+
T Consensus       186 g~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd  265 (475)
T KOG0615|consen  186 GLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFD  265 (475)
T ss_pred             eEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHH
Confidence            77888876  799999999852              34689999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEeeecCccccccccCCcccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN---LRAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      .+-.++.   +....-..++.|++.|+.|||   +.||+||||||+|||+..+   ..+||+|||+|+..+..    ..+
T Consensus       266 ~vv~nk~---l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~----sfm  335 (475)
T KOG0615|consen  266 KVVANKY---LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG----SFM  335 (475)
T ss_pred             HHHhccc---cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhhccccc----eeh
Confidence            9987653   666777889999999999999   7999999999999999766   78999999999987532    356


Q ss_pred             cccccCCCccchhhhccCC---CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCcc
Q 007261          480 KTAVGTNGYMAPEYMEYGL---VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN  556 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~~~---~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  556 (611)
                      +..+||+.|.|||++....   +..+.|+||+||+||-+++|..||........ +.+   +...+..       .+   
T Consensus       336 ~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-l~e---QI~~G~y-------~f---  401 (475)
T KOG0615|consen  336 KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-LKE---QILKGRY-------AF---  401 (475)
T ss_pred             hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-HHH---HHhcCcc-------cc---
Confidence            7889999999999997643   33488999999999999999999986654321 111   1111100       00   


Q ss_pred             CCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       557 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      -.......+++..+|+.+||..||++|||+.|++++=
T Consensus       402 ~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp  438 (475)
T KOG0615|consen  402 GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP  438 (475)
T ss_pred             cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence            1122467888999999999999999999999999853

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-40  Score=346.91  Aligned_cols=226  Identities=23%  Similarity=0.412  Sum_probs=194.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      ..+|+++.  .|+.||+|++.+          .+.+|+++.++|+|||||+++++|++.+..|||.|+|++++|..+++.
T Consensus        32 A~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr  111 (592)
T KOG0575|consen   32 ARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR  111 (592)
T ss_pred             eEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh
Confidence            68999987  799999999853          477899999999999999999999999999999999999999999985


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .   +.+++.+++.+..||+.||.|||   +.+|+|||||..|+|+++++++||+|||||.....++   ......+||+
T Consensus       112 r---k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~---Erk~TlCGTP  182 (592)
T KOG0575|consen  112 R---KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG---ERKKTLCGTP  182 (592)
T ss_pred             c---CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc---cccceecCCC
Confidence            4   45999999999999999999999   6899999999999999999999999999998776443   2445689999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||++.....+..+||||+||+||-|+.|++||....-.+..     ......              -...|...+.
T Consensus       183 NYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety-----~~Ik~~--------------~Y~~P~~ls~  243 (592)
T KOG0575|consen  183 NYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY-----NKIKLN--------------EYSMPSHLSA  243 (592)
T ss_pred             cccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH-----HHHHhc--------------CcccccccCH
Confidence            999999999999999999999999999999999999765433321     111110              0111345677


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +..+|+.++|+.||.+|||+++|+.+
T Consensus       244 ~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  244 EAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            78999999999999999999999975

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-40  Score=332.04  Aligned_cols=257  Identities=27%  Similarity=0.411  Sum_probs=196.1

Q ss_pred             HHHhhcCCCCCcccceEEEEEEcCcEEEEEEec----HHHHHHHHHHHh--cCCCceeeccceeccCC----eEEEEEee
Q 007261          325 VVATENFSPKNMIDGSVFRGIINGSTVAIKCMR----RSISKEVNLLKK--INHFNLINLFGACEHDG----VFYLVYEF  394 (611)
Q Consensus       325 ~~at~~f~~~~~igg~Vy~g~~~g~~vavK~~~----~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~E~  394 (611)
                      .++.++|       |.||+|.++++.||||++.    ..|.+|-+|++.  |+|+||++|++.-....    +++||+||
T Consensus       217 li~~Grf-------g~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f  289 (534)
T KOG3653|consen  217 LIGRGRF-------GCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF  289 (534)
T ss_pred             HhhcCcc-------ceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence            3567778       9999999999999999995    568888888776  48999999999876555    89999999


Q ss_pred             cCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcC------CCCCeEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          395 MENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNC------TDPGYVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~------~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      .++|||.+||+.+.    ++|....+|+..+++||+|||+.      .+++|+|||||++||||.+|+++.|+|||||..
T Consensus       290 h~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  290 HPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             ccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence            99999999999875    99999999999999999999973      367899999999999999999999999999987


Q ss_pred             cccccCCcccccccccCCCccchhhhccCCCC------CccchHHHHHHHHHHHhCCCCCcCCCCh--------hhH---
Q 007261          469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVT------PEMDTYAFGVVLLELITGKEAAYKQDGE--------EIL---  531 (611)
Q Consensus       469 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s------~ksDV~s~Gvvl~elltG~~p~~~~~~~--------~~~---  531 (611)
                      ........ .....+||.+|||||++.+...-      .+.||||+|.|||||++.-..++.....        +..   
T Consensus       366 ~~p~~~~~-d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  366 LEPGKPQG-DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             ecCCCCCc-chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            76544332 33347999999999999765322      3689999999999999866544321111        110   


Q ss_pred             -HHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          532 -LAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       532 -l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                       +.+. ...+-    .++.+..+...+..  ..-..-+.+.+..||+.||+.|.|+.=+.+++.++....
T Consensus       445 t~e~m-q~~VV----~kK~RP~~p~~W~~--h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  445 TLEEM-QELVV----RKKQRPKIPDAWRK--HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             CHHHH-HHHHH----hhccCCCChhhhhc--CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence             1111 11111    11111111111111  133456889999999999999999999999988876543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-40  Score=338.11  Aligned_cols=242  Identities=28%  Similarity=0.454  Sum_probs=197.4

Q ss_pred             ceEEEEEEcC-cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGIING-STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~~g-~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.|-....+| ..||||+++        ++|.+|+++|.+++|||||+++|+|..++.+++|+|||++|+|.+||..+..
T Consensus       552 GEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~ahea  631 (807)
T KOG1094|consen  552 GEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHEL  631 (807)
T ss_pred             ceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccC
Confidence            7888888766 899999996        5799999999999999999999999999999999999999999999998754


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                      +. +.-...++|+.||+.||+||.   +.++|||||.++|+|+|.++++||+|||++|.....+. +......+-+.+||
T Consensus       632 pt-~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y-y~vqgr~vlpiRwm  706 (807)
T KOG1094|consen  632 PT-AETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY-YRVQGRAVLPIRWM  706 (807)
T ss_pred             cc-cccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCc-eeeecceeeeeeeh
Confidence            33 455667889999999999999   68899999999999999999999999999997765543 23344456788999


Q ss_pred             chhhhccCCCCCccchHHHHHHHHHHHh--CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHH
Q 007261          490 APEYMEYGLVTPEMDTYAFGVVLLELIT--GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH  567 (611)
Q Consensus       490 aPE~~~~~~~s~ksDV~s~Gvvl~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  567 (611)
                      |+|.+..++++.++|||+||++|||+++  ...|+.....+.  ..+..-.++..+..         ......|.-|+.+
T Consensus       707 awEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~~~---------~~~l~~P~~cp~~  775 (807)
T KOG1094|consen  707 AWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQGR---------QVVLSRPPACPQG  775 (807)
T ss_pred             hHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCCCc---------ceeccCCCcCcHH
Confidence            9999999999999999999999999875  556665444332  12222222221111         0112235667888


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          568 LIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      ++++|.+||..|-++||+++++...|.+.
T Consensus       776 lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  776 LYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             HHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            99999999999999999999999988764

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=342.41  Aligned_cols=257  Identities=29%  Similarity=0.500  Sum_probs=207.6

Q ss_pred             hHHHHHhhcCCCCCccc----ceEEEEEEcCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeE
Q 007261          322 EDLVVATENFSPKNMID----GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVF  388 (611)
Q Consensus       322 ~el~~at~~f~~~~~ig----g~Vy~g~~~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  388 (611)
                      ++..+.-+.+....+||    |+||+|.|.|+ ||||++.         +.|++|+..+++-+|.||+-|.|+|..... 
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence            34444444455555565    99999999986 8999996         569999999999999999999999998877 


Q ss_pred             EEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       389 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      .||+.+|+|-+|..+||..+  ..+...+.++||.|||.||.|||   .++|||||||+.||++.+++++||+||||+..
T Consensus       463 AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceee
Confidence            99999999999999999865  34888999999999999999999   79999999999999999999999999999876


Q ss_pred             cccccCCcccccccccCCCccchhhhcc---CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc
Q 007261          469 AVREESGYSSTKTAVGTNGYMAPEYMEY---GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA  545 (611)
Q Consensus       469 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  545 (611)
                      .... .+........|...|||||+++.   .+|++.+||||||+++|||++|..|+.....+.+.+      ++..+  
T Consensus       538 k~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif------mVGrG--  608 (678)
T KOG0193|consen  538 KTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF------MVGRG--  608 (678)
T ss_pred             eeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE------Eeccc--
Confidence            5443 22223345568889999999864   469999999999999999999999998444332211      11111  


Q ss_pred             ccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          546 EAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       546 ~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                            ..-+.+.....+++.+|.+|+..||..++++||.+.+|+..|+.+..+.
T Consensus       609 ------~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  609 ------YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             ------ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence                  1112222334567889999999999999999999999999998887744

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4e-39  Score=329.16  Aligned_cols=232  Identities=22%  Similarity=0.340  Sum_probs=190.0

Q ss_pred             ceEEEEEEcCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceecc----CCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGIINGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEH----DGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.++|+.||||+++          +.+.+|+.+|++++||||++++|++.+    ....++||||+++|+|.+++
T Consensus        34 ~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l  113 (283)
T PHA02988         34 NSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL  113 (283)
T ss_pred             eEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHH
Confidence            8899999999999999985          345689999999999999999999866    34689999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ....   .++|...++++.+++.||.|||+  ..+++||||||+|||+++++.+||+|||+++.....      .....+
T Consensus       114 ~~~~---~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~------~~~~~~  182 (283)
T PHA02988        114 DKEK---DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP------PFKNVN  182 (283)
T ss_pred             hhCC---CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc------cccccC
Confidence            8653   48899999999999999999994  247889999999999999999999999998754321      123467


Q ss_pred             CCCccchhhhcc--CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          485 TNGYMAPEYMEY--GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       485 t~~y~aPE~~~~--~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      +..|+|||.+.+  ..++.++||||||+++|||++|+.||......+.     .........         .+.   .+.
T Consensus       183 ~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-----~~~i~~~~~---------~~~---~~~  245 (283)
T PHA02988        183 FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-----YDLIINKNN---------SLK---LPL  245 (283)
T ss_pred             cccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHhcCC---------CCC---CCC
Confidence            889999999976  6899999999999999999999999976543221     111111110         001   122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          563 EIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      .++..+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus       246 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        246 DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            356679999999999999999999999999998753

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-40  Score=339.48  Aligned_cols=248  Identities=28%  Similarity=0.492  Sum_probs=205.5

Q ss_pred             hcCCCCCccc----ceEEEEEEc--CcEEEEEEecH------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecC
Q 007261          329 ENFSPKNMID----GSVFRGIIN--GSTVAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME  396 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  396 (611)
                      .+..-++++|    |.||.|+|.  .-.||||.+++      +|.+|..+|+.++|||+|+|+|+|..+..+|||+|||.
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            3344455554    899999994  56899999984      69999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc
Q 007261          397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY  476 (611)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  476 (611)
                      +|+|.+||+... ...++-...+.+|.||+.||+||.   .+++|||||.++|+|+.++..+|++||||++....+.  +
T Consensus       347 yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT--Y  420 (1157)
T KOG4278|consen  347 YGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT--Y  420 (1157)
T ss_pred             CccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc--e
Confidence            999999999864 345777788999999999999999   7999999999999999999999999999999765432  2


Q ss_pred             ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCc
Q 007261          477 SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP  555 (611)
Q Consensus       477 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  555 (611)
                      ...........|.|||.+....++.|+|||+|||+||||.| |..|+.+-+     + ..+..+++.+.           
T Consensus       421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----l-SqVY~LLEkgy-----------  483 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----L-SQVYGLLEKGY-----------  483 (1157)
T ss_pred             ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----H-HHHHHHHhccc-----------
Confidence            23333455789999999999999999999999999999998 666654322     1 23444444332           


Q ss_pred             cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       556 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                       ....+..|++.+++||+.||+.+|.+||++.|+.+.++.+-.+.
T Consensus       484 -RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  484 -RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             -cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence             12336778999999999999999999999999999998876543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=336.27  Aligned_cols=228  Identities=28%  Similarity=0.480  Sum_probs=196.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||.+..  +++.||||++.       +-+.+|+.+|+..+|+|||++++.|..++++|.|||||++|+|.+.+.... 
T Consensus       287 G~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~-  365 (550)
T KOG0578|consen  287 GGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR-  365 (550)
T ss_pred             cceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc-
Confidence            89999987  78899999984       347899999999999999999999999999999999999999999998765 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                         +++.++..|+.+++.||+|||   ..+|+|||||.+|||++.+|.+||+|||++.......   ......+||+.||
T Consensus       366 ---~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~---~KR~TmVGTPYWM  436 (550)
T KOG0578|consen  366 ---MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ---SKRSTMVGTPYWM  436 (550)
T ss_pred             ---ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc---CccccccCCCCcc
Confidence               899999999999999999999   7999999999999999999999999999987665443   2455679999999


Q ss_pred             chhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          490 APEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       490 aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      |||+.....|.+|.||||||++++||+-|.+||.....-     ..++.....+.+          . ...+...+..+.
T Consensus       437 APEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl-----rAlyLIa~ng~P----------~-lk~~~klS~~~k  500 (550)
T KOG0578|consen  437 APEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----RALYLIATNGTP----------K-LKNPEKLSPELK  500 (550)
T ss_pred             chhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH-----HHHHHHhhcCCC----------C-cCCccccCHHHH
Confidence            999999999999999999999999999999999864432     112222221111          1 122566788899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 007261          570 MLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +++.+||+.|+++||++.|+|++
T Consensus       501 dFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  501 DFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             HHHHHHhhcchhcCCCHHHHhcC
Confidence            99999999999999999999985

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=328.76  Aligned_cols=242  Identities=25%  Similarity=0.419  Sum_probs=195.3

Q ss_pred             ceEEEEEE--cCcEEEEEEecHHH--------HHHHHHHHhcC-CCceeeccceeccCC-eEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRRSI--------SKEVNLLKKIN-HFNLINLFGACEHDG-VFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~~--------~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |+||+|+-  .|+.||||++++.|        .+|+..|++|+ |||||++..++.+.+ .+++|||||+ .+|.++++.
T Consensus        24 GsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~  102 (538)
T KOG0661|consen   24 GSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKD  102 (538)
T ss_pred             eeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhh
Confidence            99999987  78999999998654        57999999998 999999999998877 9999999996 699999988


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .  ++.++...+..|+.||+.||+|+|   ++|++|||+||+|||+..+..+||+||||||......    ..+..+.|.
T Consensus       103 R--~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp----PYTeYVSTR  173 (538)
T KOG0661|consen  103 R--NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP----PYTEYVSTR  173 (538)
T ss_pred             c--CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccCC----Ccchhhhcc
Confidence            7  467999999999999999999999   7999999999999999999999999999999875432    234567899


Q ss_pred             Cccchhhh-ccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc-----ccccccC---c--
Q 007261          487 GYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA-----KLSVLVD---P--  555 (611)
Q Consensus       487 ~y~aPE~~-~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~-----~l~~~~d---~--  555 (611)
                      +|.|||++ +.+.|+.+.|+||+||+++|+.+-++.|.+..+-+...  .+-.++.......     .+...+.   |  
T Consensus       174 WYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~--KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~  251 (538)
T KOG0661|consen  174 WYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY--KICEVLGTPDKDSWPEGYNLASAMNFRFPQV  251 (538)
T ss_pred             cccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH--HHHHHhCCCccccchhHHHHHHHhccCCCcC
Confidence            99999976 67889999999999999999999998887665433221  2223332222111     1111111   1  


Q ss_pred             ---cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          556 ---NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       556 ---~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                         .+......++.+..+++.+|+..||++|||+.|++++
T Consensus       252 ~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  252 KPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             CCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence               1112223477889999999999999999999999875

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=318.49  Aligned_cols=240  Identities=26%  Similarity=0.418  Sum_probs=193.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      +.||+|..  .++.||||++.        ..+.+|+..|+.++||||++++..|..+..+|+||.||.+||+.++++..-
T Consensus        40 a~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~  119 (516)
T KOG0582|consen   40 AVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYY  119 (516)
T ss_pred             eEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHc
Confidence            78999988  78999999995        457889999999999999999999999999999999999999999998753


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccc-cccccCCC
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST-KTAVGTNG  487 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~-~~~~gt~~  487 (611)
                       +..+++..+..|..++++||.|||   .+|.||||||+.||||+++|.+||+|||.+............. ...+||+.
T Consensus       120 -~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~  195 (516)
T KOG0582|consen  120 -PDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPC  195 (516)
T ss_pred             -cccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCccc
Confidence             344899999999999999999999   7999999999999999999999999999876554432221222 56789999


Q ss_pred             ccchhhhcc--CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCC-cChHHH
Q 007261          488 YMAPEYMEY--GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ-ANKKEI  564 (611)
Q Consensus       488 y~aPE~~~~--~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~-~~~~~~  564 (611)
                      |||||++..  ..|+.|+||||||++..||.+|..||.........+..     +....+ ...   . ..+. +.....
T Consensus       196 wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-----Lqn~pp-~~~---t-~~~~~d~~k~~  265 (516)
T KOG0582|consen  196 WMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-----LQNDPP-TLL---T-SGLDKDEDKKF  265 (516)
T ss_pred             ccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-----hcCCCC-Ccc---c-ccCChHHhhhh
Confidence            999999643  45999999999999999999999999876654332211     111111 000   0 0111 123455


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ...+.+++..||..||.+|||+++++++
T Consensus       266 ~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  266 SKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            6689999999999999999999999874

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-39  Score=322.01  Aligned_cols=237  Identities=28%  Similarity=0.445  Sum_probs=191.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecHH-------HHHHHHHHHhcCCCceeeccceeccCC--eEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMRRS-------ISKEVNLLKKINHFNLINLFGACEHDG--VFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~-------~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||.+..  +|+..|||.+...       +.+|+.+|++++|||||+++|......  .+++.|||+++|||.+++...
T Consensus        31 G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~  110 (313)
T KOG0198|consen   31 GSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRY  110 (313)
T ss_pred             eEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHc
Confidence            99999998  4899999998643       789999999999999999999854444  699999999999999999987


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeecCccccccccCCcccccccccCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-NLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      +.  .++...+..+..||++||+|||   +++|+||||||+|||++. ++.+||+|||+++................||+
T Consensus       111 g~--~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp  185 (313)
T KOG0198|consen  111 GG--KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTP  185 (313)
T ss_pred             CC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCc
Confidence            53  4899999999999999999999   799999999999999999 79999999999886653112223345678999


Q ss_pred             CccchhhhccCC-CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          487 GYMAPEYMEYGL-VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       487 ~y~aPE~~~~~~-~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      .|||||++..+. ...++|||||||++.||+||+.||....    ....+......            ....+..+..++
T Consensus       186 ~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~----~~~~~~~~ig~------------~~~~P~ip~~ls  249 (313)
T KOG0198|consen  186 NYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF----EEAEALLLIGR------------EDSLPEIPDSLS  249 (313)
T ss_pred             cccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc----chHHHHHHHhc------------cCCCCCCCcccC
Confidence            999999998643 4469999999999999999999987531    11111111111            111222355577


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      .+..+++.+|+..||+.|||+.+++++.-..
T Consensus       250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence            8899999999999999999999999986543

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-38  Score=315.80  Aligned_cols=250  Identities=27%  Similarity=0.412  Sum_probs=196.5

Q ss_pred             ceEEEEEEcCcEEEEEEec----HHHHHHHHHHHhc--CCCceeeccceeccC----CeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGIINGSTVAIKCMR----RSISKEVNLLKKI--NHFNLINLFGACEHD----GVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~----~~~~~E~~~l~~l--~H~niv~l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|.|.|+.||||++-    +.+.+|.+|++.+  +|+||+.|++.-..+    .++|||.+|.+.|||.|||....
T Consensus       225 GEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t  304 (513)
T KOG2052|consen  225 GEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT  304 (513)
T ss_pred             cceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhcc
Confidence            9999999999999999994    5789999999875  999999999875433    36899999999999999998754


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhc-----CCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC-ccccccc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHN-----CTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG-YSSTKTA  482 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~-----~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~  482 (611)
                          ++....++++..+|.||+|||.     ..++.|.|||||+.||||.+++.+.|+|+|||......... .......
T Consensus       305 ----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~r  380 (513)
T KOG2052|consen  305 ----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPR  380 (513)
T ss_pred             ----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCc
Confidence                8999999999999999999995     45789999999999999999999999999999765544222 2345677


Q ss_pred             ccCCCccchhhhccCCC------CCccchHHHHHHHHHHHh----CC------CCCcCCCChhhHHHHHHHHHHhcCCcc
Q 007261          483 VGTNGYMAPEYMEYGLV------TPEMDTYAFGVVLLELIT----GK------EAAYKQDGEEILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~------s~ksDV~s~Gvvl~ellt----G~------~p~~~~~~~~~~l~~~~~~~~~~~~~~  546 (611)
                      +||.+|||||++.....      -..+||||||+++||+..    |.      .||++.-..+....     .+..-.+.
T Consensus       381 VGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e-----eMrkVVCv  455 (513)
T KOG2052|consen  381 VGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE-----EMRKVVCV  455 (513)
T ss_pred             cceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH-----HHhcceee
Confidence            99999999999976431      236899999999999964    22      35554322221111     11111223


Q ss_pred             cccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       547 ~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      .+++..++.++..  .+....+.++|+.||..+|..|-|+-.+-+.|.++...
T Consensus       456 ~~~RP~ipnrW~s--~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  456 QKLRPNIPNRWKS--DPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             cccCCCCCccccc--CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            4444444444433  46677899999999999999999999999999998753

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.3e-37  Score=367.71  Aligned_cols=262  Identities=27%  Similarity=0.473  Sum_probs=206.3

Q ss_pred             cchhHHHHHhhcCCCCCccc----ceEEEEEE--cCcEEEEEEecH---HHHHHHHHHHhcCCCceeeccceeccCCeEE
Q 007261          319 YKYEDLVVATENFSPKNMID----GSVFRGII--NGSTVAIKCMRR---SISKEVNLLKKINHFNLINLFGACEHDGVFY  389 (611)
Q Consensus       319 ~~~~el~~at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  389 (611)
                      +.++++.   ..|.....+|    |.||+|..  +|..||||+++.   ....|++.+++++|||||+++|+|.+++..+
T Consensus       683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~  759 (968)
T PLN00113        683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAY  759 (968)
T ss_pred             hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence            3444443   3455555665    89999986  788999999863   2356799999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccc
Q 007261          390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSA  469 (611)
Q Consensus       390 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~  469 (611)
                      +||||+++|+|.++++.      ++|..+.+|+.|++.||+|||+.+.++++||||||+||+++.++..++. ||.....
T Consensus       760 lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        760 LIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             EEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            99999999999999963      8999999999999999999997667899999999999999999998876 6655432


Q ss_pred             ccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccc
Q 007261          470 VREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL  549 (611)
Q Consensus       470 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  549 (611)
                      ..       .....++..|+|||++.+..++.++|||||||++|||+||+.|+...........++.......    ...
T Consensus       833 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~  901 (968)
T PLN00113        833 CT-------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD----CHL  901 (968)
T ss_pred             cc-------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc----cch
Confidence            11       1223678999999999999999999999999999999999999865433322333333332221    223


Q ss_pred             ccccCccCCcC---hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          550 SVLVDPNLQAN---KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       550 ~~~~d~~l~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                      ..++|+.+...   ......++.+++.+||+.||++||+|.|+++.|+++.....
T Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  956 (968)
T PLN00113        902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS  956 (968)
T ss_pred             hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence            34455554322   34556678999999999999999999999999999876544

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-39  Score=337.13  Aligned_cols=238  Identities=27%  Similarity=0.486  Sum_probs=196.4

Q ss_pred             ceEEEEEE---cC--cE-EEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII---NG--ST-VAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~---~g--~~-vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||+|.+   ++  .. ||||..+          .+|.+|+++|++++|||||+++|++..+..++||||+|+||+|.+
T Consensus       171 GeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~  250 (474)
T KOG0194|consen  171 GEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDD  250 (474)
T ss_pred             cEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHH
Confidence            99999998   22  23 8999986          368899999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccc-c
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTK-T  481 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~-~  481 (611)
                      +|+....  .++..+++.++.+.|.||+|||   +.+++||||.++|+|++.++.+||+||||++....    +.... .
T Consensus       251 ~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~----~~~~~~~  321 (474)
T KOG0194|consen  251 YLKKNKK--SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ----YVMKKFL  321 (474)
T ss_pred             HHHhCCC--CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCcc----eeecccc
Confidence            9998753  5999999999999999999999   79999999999999999999999999999876531    11222 2


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN  560 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~  560 (611)
                      ..-+..|+|||.+..+.|+.++|||||||++||+++ |..|+.+....+.      ...+.           .+......
T Consensus       322 ~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v------~~kI~-----------~~~~r~~~  384 (474)
T KOG0194|consen  322 KKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV------KAKIV-----------KNGYRMPI  384 (474)
T ss_pred             ccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH------HHHHH-----------hcCccCCC
Confidence            346789999999999999999999999999999999 7888766544321      11111           01111112


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          561 KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       561 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                      +...+..+..++.+||..+|++||+|.++.+.|+.+......
T Consensus       385 ~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  385 PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            335667788999999999999999999999999998776553

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.3e-38  Score=330.67  Aligned_cols=239  Identities=27%  Similarity=0.478  Sum_probs=188.0

Q ss_pred             ceEEEEEE-------cCcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccC-CeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII-------NGSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHD-GVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~~~lV~E~~~~gsL~  401 (611)
                      |.||+|..       .+..||||+++        +.+.+|+.++.++ +||||++++++|... +..++||||+++|+|.
T Consensus        21 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~  100 (338)
T cd05102          21 GKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLS  100 (338)
T ss_pred             ceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHH
Confidence            89999974       24679999985        2477899999999 899999999988764 4689999999999999


Q ss_pred             HHhhccCC-----------------------------------------------------------CCccCHHHHHHHH
Q 007261          402 DWLHKKRY-----------------------------------------------------------PEFVSWNCRFRIA  422 (611)
Q Consensus       402 ~~l~~~~~-----------------------------------------------------------~~~l~~~~~~~ia  422 (611)
                      +++.....                                                           ...+++..++.++
T Consensus       101 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  180 (338)
T cd05102         101 NFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYS  180 (338)
T ss_pred             HHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHH
Confidence            99975321                                                           1347888999999


Q ss_pred             HHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCc
Q 007261          423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE  502 (611)
Q Consensus       423 ~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  502 (611)
                      .||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++....... ........++..|+|||.+.+..++.+
T Consensus       181 ~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~  256 (338)
T cd05102         181 FQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLPLKWMAPESIFDKVYTTQ  256 (338)
T ss_pred             HHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCCccccCcHHhhcCCCCcc
Confidence            99999999999   68999999999999999999999999999976532211 111223345678999999999999999


Q ss_pred             cchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCC
Q 007261          503 MDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE  581 (611)
Q Consensus       503 sDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~  581 (611)
                      +||||||++||||++ |..||......+..     ......+.            ....+..++..+.+++.+||+.||+
T Consensus       257 sDiwslG~il~el~~~g~~pf~~~~~~~~~-----~~~~~~~~------------~~~~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         257 SDVWSFGVLLWEIFSLGASPYPGVQINEEF-----CQRLKDGT------------RMRAPENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             cCHHHHHHHHHHHHhCCCCCCCCCCccHHH-----HHHHhcCC------------CCCCCCCCCHHHHHHHHHHccCChh
Confidence            999999999999997 88888654332211     11111110            0111223456789999999999999


Q ss_pred             CCCCHHHHHHHHHhchh
Q 007261          582 SRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       582 ~RPs~~evl~~L~~i~~  598 (611)
                      +||++.|+++.|+++..
T Consensus       320 ~RPs~~el~~~l~~~~~  336 (338)
T cd05102         320 ERPTFSALVEILGDLLQ  336 (338)
T ss_pred             hCcCHHHHHHHHHHHHh
Confidence            99999999999998654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=314.68  Aligned_cols=242  Identities=25%  Similarity=0.390  Sum_probs=194.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||..+-  .++.+|+|++++          ....|..+|.+++||.||+++-.|++.+.+|||+||+.||.|..+|.+
T Consensus        39 GkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~  118 (357)
T KOG0598|consen   39 GKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQR  118 (357)
T ss_pred             ceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHh
Confidence            89998876  788999999974          356799999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .+   .+++....-++.+|+.||.|||   +.+||||||||+|||||++|+++|+||||++......   ..+...+||+
T Consensus       119 eg---~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~---~~t~tfcGT~  189 (357)
T KOG0598|consen  119 EG---RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG---DATRTFCGTP  189 (357)
T ss_pred             cC---CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC---CccccccCCc
Confidence            64   2777877788999999999999   7999999999999999999999999999998654332   3455689999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|||||++.+..++..+|+||+|+++|||++|.+||...+....     ......             ..+...+...+.
T Consensus       190 eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~-----~~~I~~-------------~k~~~~p~~ls~  251 (357)
T KOG0598|consen  190 EYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-----YDKILK-------------GKLPLPPGYLSE  251 (357)
T ss_pred             cccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH-----HHHHhc-------------CcCCCCCccCCH
Confidence            99999999999999999999999999999999999987654321     111211             111222334567


Q ss_pred             HHHHHHHHhhccCCCCCC----CHHHHHHHHHhchhhhhhchhhhhhc
Q 007261          567 HLIMLCLACIAREPESRP----SMAEVVSTLMKIQLDVQRSQTLLLER  610 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP----s~~evl~~L~~i~~~~~~~~~~~~~~  610 (611)
                      +..+++.+.+..||++|.    .+.+|-++   --.....|+..+.++
T Consensus       252 ~ardll~~LL~rdp~~RLg~~~d~~~ik~H---pfF~~inW~~l~~k~  296 (357)
T KOG0598|consen  252 EARDLLKKLLKRDPRQRLGGPGDAEEIKRH---PFFKGINWEKLLAKK  296 (357)
T ss_pred             HHHHHHHHHhccCHHHhcCCCCChHHhhcC---cccccCCHHHHHhcC
Confidence            789999999999999996    33332221   112344566665554

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-38  Score=320.74  Aligned_cols=244  Identities=25%  Similarity=0.373  Sum_probs=195.0

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccC--CeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHD--GVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+++.  +|+.||+|+++-         -..+||.||++|+||||++|.+...+.  +.+|||+|||++ +|.-++.
T Consensus       131 g~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~  209 (560)
T KOG0600|consen  131 GQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLS  209 (560)
T ss_pred             hheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhc
Confidence            99999997  899999999972         357899999999999999999988766  789999999975 8888887


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ....  .++..++..++.|++.||+|+|   ..+|+|||||.+|||||.+|.+||+|||||+.......  ...+..+.|
T Consensus       210 ~p~v--kft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~--~~~T~rVvT  282 (560)
T KOG0600|consen  210 SPGV--KFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS--APYTSRVVT  282 (560)
T ss_pred             CCCc--ccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCCC--cccccceEE
Confidence            6532  3889999999999999999999   79999999999999999999999999999997654432  235667889


Q ss_pred             CCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc----cc--cccC----
Q 007261          486 NGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK----LS--VLVD----  554 (611)
Q Consensus       486 ~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~----l~--~~~d----  554 (611)
                      .+|.|||.+.+. .|+.+.|+||.||||.||+.|++.+.+..+.+.  ...++.+........+    +.  ..+.    
T Consensus       283 LWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ--l~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~  360 (560)
T KOG0600|consen  283 LWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ--LHKIFKLCGSPTEDYWPVSKLPHATIFKPQQP  360 (560)
T ss_pred             eeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH--HHHHHHHhCCCChhccccccCCcccccCCCCc
Confidence            999999998764 699999999999999999999998877665443  2334444433222111    11  1111    


Q ss_pred             --ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 --PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 --~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        ..+.+.....+....+|+..+|..||.+|.|+.++++.
T Consensus       361 y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  361 YKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             ccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence              11122234556778899999999999999999998863

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.2e-38  Score=302.28  Aligned_cols=243  Identities=24%  Similarity=0.341  Sum_probs=187.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+.+.  .|+.||||++.         +-..+|+++|++++|+|+|.++.+|..++.++||+|||+..-| +-|...
T Consensus        16 GvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL-~eLe~~   94 (396)
T KOG0593|consen   16 GVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVL-HELERY   94 (396)
T ss_pred             eEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHH-HHHHhc
Confidence            89999987  79999999984         3478999999999999999999999999999999999986444 444433


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .  ..++.....+++.|++.|+.|+|   +.+++||||||+||||+.++.+||||||+|+.......   ..+..+.|.+
T Consensus        95 p--~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd---~YTDYVATRW  166 (396)
T KOG0593|consen   95 P--NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD---NYTDYVATRW  166 (396)
T ss_pred             c--CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc---hhhhhhhhhh
Confidence            2  33888899999999999999999   78999999999999999999999999999998753322   2344678999


Q ss_pred             ccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc--------ccccccc-----c
Q 007261          488 YMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA--------EAKLSVL-----V  553 (611)
Q Consensus       488 y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--------~~~l~~~-----~  553 (611)
                      |.|||.+.+ ..|....||||+||++.||++|.+.|.+..+-+...  .+...+..-.+        ...+..+     -
T Consensus       167 YRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy--~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~  244 (396)
T KOG0593|consen  167 YRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY--LIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPE  244 (396)
T ss_pred             ccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH--HHHHHHcccCHHHHHHhccCCceeeeecCCCC
Confidence            999999877 689999999999999999999998887765543221  11111110000        0011111     1


Q ss_pred             CccCCcC-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          554 DPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       554 d~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ++...+. ....+.-+.++++.|++.||++|++-+|++.+
T Consensus       245 ~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  245 HPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             CccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            1111111 23445678999999999999999999999863

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=320.02  Aligned_cols=229  Identities=23%  Similarity=0.416  Sum_probs=191.1

Q ss_pred             ceEEEEEE--cCcEEEEEEecHH----------HHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRRS----------ISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      .+||+++.  .+..+|||++.++          +..|-+.|.+| .||.|++|+-.|.++..+|+|+||+++|+|.++|+
T Consensus        87 StV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~  166 (604)
T KOG0592|consen   87 STVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIK  166 (604)
T ss_pred             eeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHH
Confidence            68999987  7889999999643          45699999999 89999999999999999999999999999999999


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC--------cc
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG--------YS  477 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~--------~~  477 (611)
                      +.+   .++......+|.+|+.||+|||   +.|||||||||+|||||+|+++||+|||-|+........        ..
T Consensus       167 K~G---sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a  240 (604)
T KOG0592|consen  167 KYG---SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQA  240 (604)
T ss_pred             HhC---cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccc
Confidence            874   3888899999999999999999   799999999999999999999999999999876543211        01


Q ss_pred             c--ccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCc
Q 007261          478 S--TKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP  555 (611)
Q Consensus       478 ~--~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  555 (611)
                      .  ....+||..|.+||++.++..++.+|+|+|||+||+|+.|.+||....+.  ...+.+..+              | 
T Consensus       241 ~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--liFqkI~~l--------------~-  303 (604)
T KOG0592|consen  241 SSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--LIFQKIQAL--------------D-  303 (604)
T ss_pred             cCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH--HHHHHHHHh--------------c-
Confidence            1  24579999999999999999999999999999999999999999765432  111111111              1 


Q ss_pred             cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       556 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        ...+...++.+.+|+.+.|..||.+|++..+|.++
T Consensus       304 --y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  304 --YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             --ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence              11133444678899999999999999999888775

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.8e-37  Score=289.05  Aligned_cols=243  Identities=23%  Similarity=0.324  Sum_probs=195.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|..  +|+.||||+++         ....+|++.|+.++|+||+.++++|.+.+...||+|||+ .+|+..+++.
T Consensus        16 gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~   94 (318)
T KOG0659|consen   16 GVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDK   94 (318)
T ss_pred             EEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhccc
Confidence            89999998  79999999996         357899999999999999999999999999999999996 5999999886


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .  ..++..++..++.++++||+|||   .+.|+||||||.|+|++++|.+||+|||+|+.....+.   ...+.+.|.+
T Consensus        95 ~--i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~---~~~~~V~TRW  166 (318)
T KOG0659|consen   95 N--IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR---IQTHQVVTRW  166 (318)
T ss_pred             c--cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc---ccccceeeee
Confidence            4  45899999999999999999999   78999999999999999999999999999998865543   2334488999


Q ss_pred             ccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc--ccccccC---------c
Q 007261          488 YMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA--KLSVLVD---------P  555 (611)
Q Consensus       488 y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~--~l~~~~d---------~  555 (611)
                      |.|||.+.+ ..|+...||||.||++.||+-|.+-|.+..+-+  -...++..+.....+.  .+..+-|         +
T Consensus       167 YRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--QL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~  244 (318)
T KOG0659|consen  167 YRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--QLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKP  244 (318)
T ss_pred             ccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--HHHHHHHHcCCCCcccCccccccccHHHHhcCCCC
Confidence            999998866 469999999999999999998876655443322  2233444444333221  1111111         1


Q ss_pred             cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       556 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+......++....+|+..+|..||.+|+++.|++++
T Consensus       245 ~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  245 PLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1111234456677999999999999999999999875

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=321.93  Aligned_cols=235  Identities=23%  Similarity=0.444  Sum_probs=201.6

Q ss_pred             ceEEEEEEc----Cc--EEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGIIN----GS--TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~~----g~--~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|++.    |+  .||||..+        +.|..|..+|++++|||||+++|.|.+ ...|||||.++-|.|..||
T Consensus       403 GdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yL  481 (974)
T KOG4257|consen  403 GDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYL  481 (974)
T ss_pred             cceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHH
Confidence            899999982    32  59999987        358999999999999999999999975 4679999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      +.++.  .++......++.||+.||.|||   +.++|||||..+|||+.....+||+||||+|......  +.......-
T Consensus       482 q~nk~--sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~--yYkaS~~kL  554 (974)
T KOG4257|consen  482 QQNKD--SLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA--YYKASRGKL  554 (974)
T ss_pred             Hhccc--cchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccc--hhhcccccc
Confidence            98763  4888888999999999999999   6899999999999999999999999999999775443  233335566


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      +..|||||.+...+++.++|||.|||.+||+++ |..||.+-...+                  .+..+-.+...+.|+.
T Consensus       555 PIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD------------------VI~~iEnGeRlP~P~n  616 (974)
T KOG4257|consen  555 PIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD------------------VIGHIENGERLPCPPN  616 (974)
T ss_pred             ceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc------------------eEEEecCCCCCCCCCC
Confidence            789999999999999999999999999999987 888987654322                  2333444555666889


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      |+..++.||.+||..||.+||.+.|+...|+.+...
T Consensus       617 CPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  617 CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999987663

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=330.70  Aligned_cols=239  Identities=26%  Similarity=0.438  Sum_probs=203.0

Q ss_pred             ceEEEEEE--cCc----EEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGS----TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~----~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |+||+|.|  +|+    +||||++.        .++.+|+.+|.+|+|||+++++|+|.... +.||++||+.|+|.+++
T Consensus       710 GtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyv  788 (1177)
T KOG1025|consen  710 GTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYV  788 (1177)
T ss_pred             eeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHH
Confidence            99999999  554    79999985        46889999999999999999999998765 88999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      +.++.  .+.-+..+.|..|||+||.|||   +.+++||||.++||||.+-..+||.|||+++....++..+ ......-
T Consensus       789 r~hr~--~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey-~~~~gK~  862 (1177)
T KOG1025|consen  789 REHRD--NIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY-SAPGGKV  862 (1177)
T ss_pred             HHhhc--cccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc-ccccccc
Confidence            98764  3788899999999999999999   7999999999999999999999999999999876554433 3334455


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      .+.|||-|.+....++.++|||||||++|||+| |..|.++...++      +...++            ++....++..
T Consensus       863 pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------I~dlle------------~geRLsqPpi  924 (1177)
T KOG1025|consen  863 PIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------IPDLLE------------KGERLSQPPI  924 (1177)
T ss_pred             CcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------hhHHHh------------ccccCCCCCC
Confidence            788999999999999999999999999999999 778877665443      223332            2223445777


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                      ++.+++.+|.+||..|++.||+++++...+.++..+..+
T Consensus       925 CtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr  963 (1177)
T KOG1025|consen  925 CTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR  963 (1177)
T ss_pred             ccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence            888999999999999999999999999999887765443

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.9e-38  Score=314.61  Aligned_cols=232  Identities=31%  Similarity=0.556  Sum_probs=181.9

Q ss_pred             ceEEEEEEc------CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGIIN------GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~~------g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.+.      +..|+||.++        +++.+|++.+++++||||++++|+|...+..++|+||+++|+|.++|
T Consensus        13 g~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L   92 (259)
T PF07714_consen   13 GKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYL   92 (259)
T ss_dssp             EEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHH
T ss_pred             cEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccccccccccc
Confidence            899999997      6789999994        46889999999999999999999999888899999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      .... ...+++..++.|+.||+.||.|||   +.+++|+||+++|||+++++.+||+|||+++....... .........
T Consensus        93 ~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~-~~~~~~~~~  167 (259)
T PF07714_consen   93 KSKN-KEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK-YKNDSSQQL  167 (259)
T ss_dssp             HHTC-TTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-EEESTTSES
T ss_pred             cccc-cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence            9872 244899999999999999999999   57899999999999999999999999999876522211 122334456


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      ...|+|||.+....++.++||||||+++|||++ |+.|+......+     ......+             ......+..
T Consensus       168 ~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-----~~~~~~~-------------~~~~~~~~~  229 (259)
T PF07714_consen  168 PLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-----IIEKLKQ-------------GQRLPIPDN  229 (259)
T ss_dssp             GGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-----HHHHHHT-------------TEETTSBTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccc-----ccccccc-------------cccceeccc
Confidence            788999999999999999999999999999999 567765443222     1111111             111112334


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      ++..+.+++.+||+.||++||++.++++.|
T Consensus       230 ~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  230 CPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            566789999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.4e-37  Score=319.72  Aligned_cols=225  Identities=25%  Similarity=0.420  Sum_probs=193.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||||+.  +.+.||+|.+.         +.+.+|++++++++|||||.++++|+...++|+|.||+.| +|..+|...
T Consensus        16 g~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d   94 (808)
T KOG0597|consen   16 GRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQD   94 (808)
T ss_pred             ceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhc
Confidence            99999986  67899999985         2478899999999999999999999999999999999975 999999886


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      ..   +++.....|+.++..||.|||   +.+|+|||+||+|||++.++.+|+||||+|+......   .......||+.
T Consensus        95 ~~---lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t---~vltsikGtPl  165 (808)
T KOG0597|consen   95 GK---LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT---SVLTSIKGTPL  165 (808)
T ss_pred             cC---CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc---eeeeeccCccc
Confidence            43   899999999999999999999   7999999999999999999999999999999765432   35566789999


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHH
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH  567 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  567 (611)
                      |||||...++.|+..+|.||+||+|||+++|++||+...-     ...+...+.            |+..  .+...+..
T Consensus       166 YmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si-----~~Lv~~I~~------------d~v~--~p~~~S~~  226 (808)
T KOG0597|consen  166 YMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI-----TQLVKSILK------------DPVK--PPSTASSS  226 (808)
T ss_pred             ccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-----HHHHHHHhc------------CCCC--CcccccHH
Confidence            9999999999999999999999999999999999975421     112222211            1111  23467788


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +..++...+.+||..|.+..+++.+
T Consensus       227 f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  227 FVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             HHHHHHHHhhcChhhcccHHHHhcC
Confidence            9999999999999999999999875

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=325.26  Aligned_cols=235  Identities=26%  Similarity=0.420  Sum_probs=199.3

Q ss_pred             ceEEEEEE---cCc--EEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII---NGS--TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~---~g~--~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.|++|.|   +|+  .||||.++        .+|.+|+.+|.+|+|+|+++|||+..+ ....+|||+++.|||.+.|+
T Consensus       124 gvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLr  202 (1039)
T KOG0199|consen  124 GVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLR  202 (1039)
T ss_pred             eeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHh
Confidence            99999999   344  69999997        579999999999999999999999987 67889999999999999999


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      +.. ...+-......++.|||.||.||.   .+++|||||..+|+||-....+||+||||.|.....+..+.......-.
T Consensus       203 ka~-~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvP  278 (1039)
T KOG0199|consen  203 KAK-KAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVP  278 (1039)
T ss_pred             hcc-ccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCc
Confidence            832 344667778899999999999999   6899999999999999999999999999999988877767666667778


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      ..|.|||.+....++.++|||+|||+||||+| |..||.+..+..+.      ..            +-+..+..-+..|
T Consensus       279 fAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL------~~------------iD~~erLpRPk~c  340 (1039)
T KOG0199|consen  279 FAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL------KN------------IDAGERLPRPKYC  340 (1039)
T ss_pred             ccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH------Hh------------ccccccCCCCCCC
Confidence            89999999999999999999999999999999 56777665543211      11            1122233347789


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      ++.++++|+.||.++|++||++..|.+.+-..
T Consensus       341 sedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  341 SEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             hHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence            99999999999999999999999998655443

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.7e-36  Score=310.29  Aligned_cols=241  Identities=27%  Similarity=0.446  Sum_probs=185.3

Q ss_pred             ceEEEEEEc------------------CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEE
Q 007261          339 GSVFRGIIN------------------GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVY  392 (611)
Q Consensus       339 g~Vy~g~~~------------------g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  392 (611)
                      |.||++.++                  +..||+|.++        .++.+|+.++.+++||||+++++++.+.+..++||
T Consensus        19 g~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   98 (304)
T cd05096          19 GEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMIT   98 (304)
T ss_pred             eEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEE
Confidence            899999752                  2369999985        35888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccC----------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC
Q 007261          393 EFMENGSLSDWLHKKR----------------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL  456 (611)
Q Consensus       393 E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~  456 (611)
                      ||+++|+|.+++....                ....++|...++++.||+.||.|||   +.+++||||||+|||+++++
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH~dlkp~Nill~~~~  175 (304)
T cd05096          99 EYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENL  175 (304)
T ss_pred             ecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccccCcchhheEEcCCc
Confidence            9999999999986532                1124788999999999999999999   68999999999999999999


Q ss_pred             cEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhC--CCCCcCCCChhhHHHH
Q 007261          457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG--KEAAYKQDGEEILLAE  534 (611)
Q Consensus       457 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG--~~p~~~~~~~~~~l~~  534 (611)
                      .+||+|||+++....... ........++..|+|||.+..+.++.++||||||+++|||+++  ..|+......+.  ..
T Consensus       176 ~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~--~~  252 (304)
T cd05096         176 TIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQV--IE  252 (304)
T ss_pred             cEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHH--HH
Confidence            999999999875432221 1122334567889999999988999999999999999999874  455554332221  11


Q ss_pred             HHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          535 AVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       535 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      ...........     ...    ...+..++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus       253 ~~~~~~~~~~~-----~~~----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         253 NAGEFFRDQGR-----QVY----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             HHHHHhhhccc-----ccc----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            11111111000     000    0112234567899999999999999999999998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-36  Score=307.42  Aligned_cols=233  Identities=26%  Similarity=0.480  Sum_probs=188.1

Q ss_pred             ceEEEEEE-----cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII-----NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~-----~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|.+     .+..||+|.++        ..+.+|+.++++++||||++++|++..++..++||||+++|+|.+++.
T Consensus        19 g~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   98 (266)
T cd05064          19 GELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR   98 (266)
T ss_pred             CeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHH
Confidence            89999976     25689999976        257789999999999999999999999999999999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...  ..++|..++.++.|++.||+|||   +.+++||||||+|||++.++.+|++|||.+.......  ........++
T Consensus        99 ~~~--~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~  171 (266)
T cd05064          99 KHE--GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA--IYTTMSGKSP  171 (266)
T ss_pred             hCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc--hhcccCCCCc
Confidence            643  35899999999999999999999   6899999999999999999999999999876432111  1112233456


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      ..|+|||.+.+..++.++||||||+++||+++ |+.||......+.      ......+.            ....+..+
T Consensus       172 ~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~------~~~~~~~~------------~~~~~~~~  233 (266)
T cd05064         172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV------IKAVEDGF------------RLPAPRNC  233 (266)
T ss_pred             eeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH------HHHHHCCC------------CCCCCCCC
Confidence            78999999999999999999999999999875 8888865543221      11111110            01113345


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      +..+.+++.+||+.+|++||++.+|++.|.++
T Consensus       234 ~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         234 PNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            66789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.1e-36  Score=308.41  Aligned_cols=236  Identities=25%  Similarity=0.545  Sum_probs=192.0

Q ss_pred             ceEEEEEEcC-------cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIING-------STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~g-------~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|...+       ..||+|.++        .++.+|+.++++++||||+++++++...+..+++|||+++|+|.++
T Consensus        19 g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~   98 (283)
T cd05048          19 GKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEF   98 (283)
T ss_pred             CcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHH
Confidence            8999998732       469999985        3578899999999999999999999999999999999999999999


Q ss_pred             hhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccc
Q 007261          404 LHKKRY-------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV  470 (611)
Q Consensus       404 l~~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~  470 (611)
                      +.....             ...+++..++.++.|++.||+|||   ..+++|+||||+||++++++.+||+|||+++...
T Consensus        99 l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~  175 (283)
T cd05048          99 LVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY  175 (283)
T ss_pred             HHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCcEEECCCcceeecc
Confidence            976421             145888999999999999999999   6899999999999999999999999999987543


Q ss_pred             cccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCccccc
Q 007261          471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL  549 (611)
Q Consensus       471 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  549 (611)
                      .... ........++..|+|||.+.+..++.++||||||+++|||++ |..||......+.      ...+..+      
T Consensus       176 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~------~~~i~~~------  242 (283)
T cd05048         176 SADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV------IEMIRSR------  242 (283)
T ss_pred             cccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHcC------
Confidence            2221 122333456788999999998999999999999999999998 9989876544321      1111111      


Q ss_pred             ccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       550 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                            .....+..++.++.+|+.+||+.||++||++.||+++|+.+
T Consensus       243 ------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         243 ------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             ------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence                  11112345678899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=317.51  Aligned_cols=231  Identities=24%  Similarity=0.344  Sum_probs=190.4

Q ss_pred             ceEEEEEE--cCcEEEEEEecHH------------HHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMRRS------------ISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~------------~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.|+.|..  .|..||+|++.++            +.+|+.++++++ ||||++++.++......++||||+.+|+|.++
T Consensus        31 gkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~  110 (370)
T KOG0583|consen   31 GKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDY  110 (370)
T ss_pred             eeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHH
Confidence            89999977  7899999976542            347999999998 99999999999999999999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeecCccccccccCCccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN-LRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      +...+   .+.+.....++.|++.|++|+|   +.+|+||||||+|||+|.+ +.+||+|||++....   .........
T Consensus       111 i~~~g---~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~---~~~~~l~t~  181 (370)
T KOG0583|consen  111 IVNKG---RLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP---GEDGLLKTF  181 (370)
T ss_pred             HHHcC---CCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccccC---CCCCcccCC
Confidence            99842   3788999999999999999999   7899999999999999999 999999999998763   112355678


Q ss_pred             ccCCCccchhhhccCC-CC-CccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC
Q 007261          483 VGTNGYMAPEYMEYGL-VT-PEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN  560 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~-~s-~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~  560 (611)
                      +||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.......     ....... +             ....
T Consensus       182 cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-----l~~ki~~-~-------------~~~~  242 (370)
T KOG0583|consen  182 CGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-----LYRKIRK-G-------------EFKI  242 (370)
T ss_pred             CCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-----HHHHHhc-C-------------CccC
Confidence            9999999999999876 75 78999999999999999999998743221     1111111 1             0111


Q ss_pred             hHHH-HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          561 KKEI-AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       561 ~~~~-~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      +..+ +.++..|+.+|+..||.+|+++.+++ .-..++.
T Consensus       243 p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~  280 (370)
T KOG0583|consen  243 PSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK  280 (370)
T ss_pred             CCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence            2233 77889999999999999999999999 4444443

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2e-36  Score=309.40  Aligned_cols=231  Identities=23%  Similarity=0.303  Sum_probs=186.8

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||+|.++.          .+.+|+.++++++|+||+++++++.+++..++||||+++|+|.+++..
T Consensus        14 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~   93 (285)
T cd05631          14 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN   93 (285)
T ss_pred             EEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHh
Confidence            89999987  689999998752          356799999999999999999999999999999999999999988865


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .. ...+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||++.......    ......|+.
T Consensus        94 ~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~~~g~~  165 (285)
T cd05631          94 MG-NPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVRGRVGTV  165 (285)
T ss_pred             hC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----eecCCCCCC
Confidence            43 234889999999999999999999   6899999999999999999999999999987642211    223457899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++|||||||++|||++|+.||........  ...+.......             ....+...+.
T Consensus       166 ~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~-------------~~~~~~~~s~  230 (285)
T cd05631         166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVKED-------------QEEYSEKFSE  230 (285)
T ss_pred             CccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhhcc-------------cccCCccCCH
Confidence            99999999999999999999999999999999999976543211  01111111100             0011233456


Q ss_pred             HHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPS-----MAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs-----~~evl~~  592 (611)
                      .+.+|+.+||+.||.+||+     +++++++
T Consensus       231 ~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         231 DAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             HHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            7889999999999999997     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.5e-36  Score=320.93  Aligned_cols=237  Identities=24%  Similarity=0.432  Sum_probs=186.4

Q ss_pred             ceEEEEEE-------cCcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII-------NGSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||++.+       .+..||||+++        +.+.+|+.++..+ +||||++++++|.+.+..++||||+++|+|.+
T Consensus        49 G~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~  128 (375)
T cd05104          49 GKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLN  128 (375)
T ss_pred             ceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHH
Confidence            89999974       34589999985        2477899999999 89999999999999999999999999999999


Q ss_pred             HhhccCC------------------------------------------------------------------------C
Q 007261          403 WLHKKRY------------------------------------------------------------------------P  410 (611)
Q Consensus       403 ~l~~~~~------------------------------------------------------------------------~  410 (611)
                      +++....                                                                        .
T Consensus       129 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  208 (375)
T cd05104         129 FLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDE  208 (375)
T ss_pred             HHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccC
Confidence            9975321                                                                        1


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA  490 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~a  490 (611)
                      ..++|..+++++.||+.||+|||   +.+++||||||+|||+++++.+||+|||+++....... ........++..|+|
T Consensus       209 ~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~~y~a  284 (375)
T cd05104         209 LALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN-YVVKGNARLPVKWMA  284 (375)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc-ccccCCCCCCcceeC
Confidence            24788999999999999999999   68999999999999999999999999999876533221 111222345678999


Q ss_pred             hhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          491 PEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       491 PE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      ||.+.+..++.++||||||+++|||++ |..|+........     .......+..            ...+...+.++.
T Consensus       285 PE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-----~~~~~~~~~~------------~~~~~~~~~~l~  347 (375)
T cd05104         285 PESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-----FYKMIKEGYR------------MLSPECAPSEMY  347 (375)
T ss_pred             hhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-----HHHHHHhCcc------------CCCCCCCCHHHH
Confidence            999999999999999999999999998 7777654433221     1111111100            001112345789


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          570 MLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      +|+.+||+.||++||++.||++.|++.
T Consensus       348 ~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         348 DIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-37  Score=321.31  Aligned_cols=227  Identities=25%  Similarity=0.376  Sum_probs=193.8

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.|-.|+.  .|+.+|||++.+          .+.+|+.+|+-+.|||++++|+++++..++|||.||+++|.|.++|..
T Consensus        26 g~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~  105 (786)
T KOG0588|consen   26 GCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVR  105 (786)
T ss_pred             ceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHh
Confidence            77888876  899999999964          377899999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ++   .++..+..++++||+.|+.|+|   ..+|+||||||+|+|||.++.+||+|||+|..-..+    ......+|.+
T Consensus       106 kG---~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g----klLeTSCGSP  175 (786)
T KOG0588|consen  106 KG---PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG----KLLETSCGSP  175 (786)
T ss_pred             hC---CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCC----ccccccCCCc
Confidence            64   3888999999999999999999   689999999999999999999999999998754322    3556779999


Q ss_pred             CccchhhhccCCCC-CccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          487 GYMAPEYMEYGLVT-PEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       487 ~y~aPE~~~~~~~s-~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      .|.|||.+.+..|. .++||||.|||||.|+||+.||.+.+-..      +...+..+             ....|..++
T Consensus       176 HYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~------LLlKV~~G-------------~f~MPs~Is  236 (786)
T KOG0588|consen  176 HYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV------LLLKVQRG-------------VFEMPSNIS  236 (786)
T ss_pred             ccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH------HHHHHHcC-------------cccCCCcCC
Confidence            99999999998875 68999999999999999999998543221      11122222             112356677


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      .+..+|+.+|+..||+.|.|+.||+++-.
T Consensus       237 ~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  237 SEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             HHHHHHHHHHhccCccccccHHHHhhCch
Confidence            88999999999999999999999999754

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.2e-36  Score=316.92  Aligned_cols=226  Identities=23%  Similarity=0.357  Sum_probs=186.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||++++          .+.+|+.++++++||||+++++++..++..++||||+++|+|.+++..
T Consensus         9 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   88 (323)
T cd05571           9 GKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR   88 (323)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH
Confidence            89999987  688999999863          355799999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .+   .+++.....++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||+
T Consensus        89 ~~---~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~---~~~~~~~gt~  159 (323)
T cd05571          89 ER---VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTP  159 (323)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC---CcccceecCc
Confidence            53   4889999999999999999999   6899999999999999999999999999987532211   1233456899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++|||||||++|||++|+.||.........      .......          .   ..+...+.
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~------~~~~~~~----------~---~~p~~~~~  220 (323)
T cd05571         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------ELILMEE----------I---RFPRTLSP  220 (323)
T ss_pred             cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH------HHHHcCC----------C---CCCCCCCH
Confidence            999999999999999999999999999999999999765432211      1111000          0   11223456


Q ss_pred             HHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      ++.+++.+||+.||++||     ++.+++++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             HHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            788999999999999999     78888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.3e-36  Score=319.78  Aligned_cols=238  Identities=24%  Similarity=0.437  Sum_probs=187.4

Q ss_pred             ceEEEEEE-------cCcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII-------NGSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||++..       ++..||||+++        ..+.+|+.+++.+ +|+||++++++|...+..++||||+++|+|.+
T Consensus        52 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~  131 (374)
T cd05106          52 GKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLN  131 (374)
T ss_pred             ccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHH
Confidence            89999875       23479999985        2477899999999 89999999999999999999999999999999


Q ss_pred             HhhccCC-------------------------------------------------------------------CCccCH
Q 007261          403 WLHKKRY-------------------------------------------------------------------PEFVSW  415 (611)
Q Consensus       403 ~l~~~~~-------------------------------------------------------------------~~~l~~  415 (611)
                      +++....                                                                   ...+++
T Consensus       132 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  211 (374)
T cd05106         132 FLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDL  211 (374)
T ss_pred             HHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCH
Confidence            9864210                                                                   124788


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhc
Q 007261          416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME  495 (611)
Q Consensus       416 ~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  495 (611)
                      ..+++++.||+.||.|||   +.+++||||||+|||+++++.+||+|||+++....... ........++..|+|||++.
T Consensus       212 ~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~  287 (374)
T cd05106         212 DDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YVVKGNARLPVKWMAPESIF  287 (374)
T ss_pred             HHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-eeeccCCCCccceeCHHHhc
Confidence            899999999999999999   68999999999999999999999999999876533211 11122233567899999999


Q ss_pred             cCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHH
Q 007261          496 YGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLA  574 (611)
Q Consensus       496 ~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~  574 (611)
                      +..++.++||||||+++|||++ |+.||........     .......+.         .+.   .+...+.++.+++.+
T Consensus       288 ~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-----~~~~~~~~~---------~~~---~~~~~~~~l~~li~~  350 (374)
T cd05106         288 DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-----FYKMVKRGY---------QMS---RPDFAPPEIYSIMKM  350 (374)
T ss_pred             CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-----HHHHHHccc---------Ccc---CCCCCCHHHHHHHHH
Confidence            8999999999999999999997 9988865433221     111111110         000   011234678999999


Q ss_pred             hhccCCCCCCCHHHHHHHHHhch
Q 007261          575 CIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       575 Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                      ||+.||++||++.+|++.|+++.
T Consensus       351 cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         351 CWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HcCCChhhCcCHHHHHHHHHHHh
Confidence            99999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=313.17  Aligned_cols=226  Identities=22%  Similarity=0.323  Sum_probs=184.2

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +++.||+|.+++          .+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         7 g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~   86 (312)
T cd05585           7 GKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR   86 (312)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh
Confidence            89999988  578999999863          356799999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||+
T Consensus        87 ~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~  157 (312)
T cd05585          87 EG---RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD---DKTNTFCGTP  157 (312)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC---CccccccCCc
Confidence            43   3889999999999999999999   6899999999999999999999999999987542221   1233456899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++|||||||++|||++|+.||......+.     ........              ...+...+.
T Consensus       158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-----~~~~~~~~--------------~~~~~~~~~  218 (312)
T cd05585         158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-----YRKILQEP--------------LRFPDGFDR  218 (312)
T ss_pred             ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH-----HHHHHcCC--------------CCCCCcCCH
Confidence            99999999999999999999999999999999999976543221     11111100              011223456


Q ss_pred             HHHHHHHHhhccCCCCCCC---HHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPS---MAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs---~~evl~~  592 (611)
                      .+.+++.+||+.||++||+   +.|++.+
T Consensus       219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         219 DAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            7889999999999999986   5555543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=309.85  Aligned_cols=223  Identities=24%  Similarity=0.344  Sum_probs=185.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||+|+++          +.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   94 (291)
T cd05612          15 GRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN   94 (291)
T ss_pred             eEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH
Confidence            89999998  58899999985          2367899999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .+   .+++.....++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.....      .....|++
T Consensus        95 ~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~  162 (291)
T cd05612          95 SG---RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------TWTLCGTP  162 (291)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC------cccccCCh
Confidence            53   3888999999999999999999   689999999999999999999999999998754321      22356899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||......+.     ...... ..             ...+...+.
T Consensus       163 ~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-----~~~i~~-~~-------------~~~~~~~~~  223 (291)
T cd05612         163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-----YEKILA-GK-------------LEFPRHLDL  223 (291)
T ss_pred             hhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHh-CC-------------cCCCccCCH
Confidence            99999999998899999999999999999999999876543221     111111 00             001222355


Q ss_pred             HHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPS-----MAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs-----~~evl~~  592 (611)
                      .+.+++.+||+.||.+||+     +.|++++
T Consensus       224 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         224 YAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             HHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            6889999999999999995     8888876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-36  Score=313.94  Aligned_cols=231  Identities=23%  Similarity=0.340  Sum_probs=188.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|..  +|+.||||+++.          .+.+|+.++.+++||||+++++++.+++..|+||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~   94 (333)
T cd05600          15 GQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN   94 (333)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH
Confidence            89999998  588999999863          356799999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++.....++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++....      ......||+
T Consensus        95 ~~---~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~------~~~~~~gt~  162 (333)
T cd05600          95 LG---VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------YANSVVGSP  162 (333)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc------ccCCcccCc
Confidence            53   3888999999999999999999   68999999999999999999999999999875432      223457899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||......+..  ..+..+.      ..   +..+.........+.
T Consensus       163 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~i~~~~------~~---~~~~~~~~~~~~~s~  231 (333)
T cd05600         163 DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW--ENLKYWK------ET---LQRPVYDDPRFNLSD  231 (333)
T ss_pred             cccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH--HHHHhcc------cc---ccCCCCCccccccCH
Confidence            999999999999999999999999999999999998765433211  1111110      00   001111111124567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ++.+++.+||..+|.+||++.+++++
T Consensus       232 ~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         232 EAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            78999999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-35  Score=310.65  Aligned_cols=243  Identities=22%  Similarity=0.370  Sum_probs=188.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++..  +|..+|+|.++        ..+.+|+++|++++||||+++++++..++..++||||+++|+|.+++....
T Consensus        19 g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   98 (331)
T cd06649          19 GVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK   98 (331)
T ss_pred             EEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC
Confidence            89999998  57899999875        357889999999999999999999999999999999999999999997653


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         .+++..+..++.|++.||.|||+  ..+++||||||+|||++.++.+||+|||+++.....     ......++..|
T Consensus        99 ---~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~g~~~y  168 (331)
T cd06649          99 ---RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSY  168 (331)
T ss_pred             ---CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-----ccccCCCCcCc
Confidence               38889999999999999999994  346999999999999999999999999998754321     22345689999


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc--cc------------------
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE--AK------------------  548 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--~~------------------  548 (611)
                      +|||.+.+..++.++||||||+++|||++|+.||......+.  ...+..........  ..                  
T Consensus       169 ~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (331)
T cd06649         169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL--EAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMD  246 (331)
T ss_pred             CCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcccccccccCCccccCcccccccccccccccc
Confidence            999999999999999999999999999999999865443221  11110000000000  00                  


Q ss_pred             ----------cccccCccCCcC-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          549 ----------LSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       549 ----------l~~~~d~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                                +..+........ ....+.++.+|+.+||+.||++||++.|++++-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         247 SRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                      000000000000 113456799999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=8.6e-36  Score=300.81  Aligned_cols=234  Identities=28%  Similarity=0.492  Sum_probs=189.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      |.||+|.+  .++.||+|.++      .++.+|++++++++|+||+++++++..++..++||||+++++|.+++.... .
T Consensus        20 ~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~   98 (263)
T cd05052          20 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-R   98 (263)
T ss_pred             ceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCC-C
Confidence            89999988  57899999986      357889999999999999999999999999999999999999999997643 2


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA  490 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~a  490 (611)
                      ..+++..++.++.|++.||+|||   ..+++||||||+||++++++.+||+|||+++.......  ........+..|+|
T Consensus        99 ~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~~~y~a  173 (263)
T cd05052          99 QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTA  173 (263)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee--eccCCCCCccccCC
Confidence            45899999999999999999999   68999999999999999999999999999876532211  11112234568999


Q ss_pred             hhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          491 PEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       491 PE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      ||.+.+..++.++||||||+++|||++ |..|+......+.      ........         .   ...+...+..+.
T Consensus       174 PE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~~~~~---------~---~~~~~~~~~~~~  235 (263)
T cd05052         174 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKGY---------R---MERPEGCPPKVY  235 (263)
T ss_pred             HHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCCC---------C---CCCCCCCCHHHH
Confidence            999999999999999999999999998 7778754432211      11111110         0   011233456789


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          570 MLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      +++.+||+.||++||++.++++.|+.+
T Consensus       236 ~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         236 ELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=8.6e-36  Score=300.03  Aligned_cols=234  Identities=23%  Similarity=0.462  Sum_probs=186.6

Q ss_pred             ceEEEEEE----cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII----NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~----~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|.+    .+..||+|.++        +.+.+|+.++++++|+||+++++++.. ...++||||+++|+|.+++..
T Consensus         9 g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~   87 (257)
T cd05115           9 GCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSG   87 (257)
T ss_pred             ccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHh
Confidence            89999987    24569999885        347889999999999999999999864 568999999999999999975


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..  ..+++..+++++.|++.||+|||   ..+++||||||+|||++.++.+||+|||+++................++.
T Consensus        88 ~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~  162 (257)
T cd05115          88 KK--DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPL  162 (257)
T ss_pred             CC--CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCc
Confidence            43  34899999999999999999999   68999999999999999999999999999875433322122222233467


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      .|+|||.+....++.++||||||+++||+++ |..|+......+.      ...+..+.            ....+..++
T Consensus       163 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~------------~~~~~~~~~  224 (257)
T cd05115         163 KWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV------MSFIEQGK------------RLDCPAECP  224 (257)
T ss_pred             ccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH------HHHHHCCC------------CCCCCCCCC
Confidence            8999999998889999999999999999996 8888865543221      11111111            011123346


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      .++.+++.+||..||++||++.+|.+.|+.+
T Consensus       225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            7788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.9e-36  Score=304.42  Aligned_cols=245  Identities=24%  Similarity=0.452  Sum_probs=189.4

Q ss_pred             hcCCCCCccc----ceEEEEEEc-------CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEE
Q 007261          329 ENFSPKNMID----GSVFRGIIN-------GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFY  389 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~~-------g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  389 (611)
                      ++|.....+|    |.||+|.+.       +..||||+++        .++.+|+.+++.++|+||+++++++..+...+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            3444444443    889998764       3579999874        24778999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhccCC-------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 007261          390 LVYEFMENGSLSDWLHKKRY-------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLAN  462 (611)
Q Consensus       390 lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D  462 (611)
                      +||||+++|+|.+++.....       ...+++..++.++.|++.||.|||   +.+++|+||||+||++++++.+||+|
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEECC
Confidence            99999999999999976321       124688899999999999999999   68999999999999999999999999


Q ss_pred             ecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHh
Q 007261          463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVE  541 (611)
Q Consensus       463 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  541 (611)
                      ||+++....... ........++..|+|||.+.++.++.++||||||+++|||++ |..|+......+.     ......
T Consensus       163 fg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~-----~~~~~~  236 (277)
T cd05062         163 FGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV-----LRFVME  236 (277)
T ss_pred             CCCccccCCcce-eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-----HHHHHc
Confidence            999875433221 111122345778999999999899999999999999999999 5666654432211     111111


Q ss_pred             cCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 007261          542 GGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK  595 (611)
Q Consensus       542 ~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  595 (611)
                       .            .....+..++..+.+++.+||+.||++||++.|+++.|++
T Consensus       237 -~------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         237 -G------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             -C------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence             0            0111122345678999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-36  Score=299.92  Aligned_cols=234  Identities=26%  Similarity=0.475  Sum_probs=188.5

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||+|.+ ++..||+|.++      +++.+|+.++++++|+||+++++++...+..++||||+++++|.+++.... ..
T Consensus        20 ~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~   98 (261)
T cd05068          20 GEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA-GR   98 (261)
T ss_pred             ccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccC-CC
Confidence            79999988 56689999986      468899999999999999999999999999999999999999999997653 34


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||+++.......  ........+..|+||
T Consensus        99 ~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aP  173 (261)
T cd05068          99 ALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY--EAREGAKFPIKWTAP  173 (261)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc--cccCCCcCceeccCc
Confidence            5899999999999999999999   68999999999999999999999999999876542211  111112234579999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+.+..++.++||||||+++|||++ |+.|+........ +    . ......     .       ...+...+..+.+
T Consensus       174 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~----~-~~~~~~-----~-------~~~~~~~~~~~~~  235 (261)
T cd05068         174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV-L----Q-QVDQGY-----R-------MPCPPGCPKELYD  235 (261)
T ss_pred             cccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-H----H-HHHcCC-----C-------CCCCCcCCHHHHH
Confidence            99999999999999999999999999 8777754432211 1    1 111100     0       0112234567899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      ++.+||+.+|++||++.++++.|+.+
T Consensus       236 li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         236 IMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            99999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.9e-36  Score=314.80  Aligned_cols=223  Identities=22%  Similarity=0.357  Sum_probs=184.1

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||.+++          .+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++..
T Consensus        32 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  111 (329)
T PTZ00263         32 GRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK  111 (329)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH
Confidence            89999998  678999999863          367899999999999999999999999999999999999999999986


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++.....++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....      .....|++
T Consensus       112 ~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~  179 (329)
T PTZ00263        112 AG---RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR------TFTLCGTP  179 (329)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC------cceecCCh
Confidence            53   3788888899999999999999   689999999999999999999999999998755321      12356899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++|||||||++|||++|+.||......+.     ...... +..             ..+...+.
T Consensus       180 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~i~~-~~~-------------~~p~~~~~  240 (329)
T PTZ00263        180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-----YEKILA-GRL-------------KFPNWFDG  240 (329)
T ss_pred             hhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-----HHHHhc-CCc-------------CCCCCCCH
Confidence            99999999999999999999999999999999999975443211     111111 100             00112345


Q ss_pred             HHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPS-----MAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs-----~~evl~~  592 (611)
                      .+.+|+.+||+.||.+||+     +.+++.+
T Consensus       241 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        241 RARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            6789999999999999996     6777755

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.7e-36  Score=312.40  Aligned_cols=226  Identities=24%  Similarity=0.362  Sum_probs=185.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|..||+|+++.          .+.+|+.++++++||||+++++++...+..++||||+++|+|..++..
T Consensus         9 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~   88 (323)
T cd05595           9 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR   88 (323)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH
Confidence            89999987  688999999863          245799999999999999999999999999999999999999999876


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..+..++.||+.||+|||   +.+++||||||+|||++.++.+||+|||+++......   .......||+
T Consensus        89 ~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~gt~  159 (323)
T cd05595          89 ER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTP  159 (323)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC---CccccccCCc
Confidence            53   4889999999999999999999   6899999999999999999999999999987532221   1223456899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||......+..     ..... ..          .   ..+...+.
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-----~~~~~-~~----------~---~~p~~~~~  220 (323)
T cd05595         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-----ELILM-EE----------I---RFPRTLSP  220 (323)
T ss_pred             CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH-----HHHhc-CC----------C---CCCCCCCH
Confidence            999999999999999999999999999999999998765432211     11110 00          0   01223456


Q ss_pred             HHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      ++.+++.+||+.||++||     ++.+++++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             HHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            788999999999999998     88888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.2e-35  Score=298.52  Aligned_cols=230  Identities=27%  Similarity=0.499  Sum_probs=185.3

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||++.+ ++..+|+|.++      .++.+|+.++++++||||+++++++..++..++||||+++|+|.++++...  .
T Consensus        18 ~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~   95 (256)
T cd05114          18 GVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ--G   95 (256)
T ss_pred             ceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCc--c
Confidence            89999988 55689999875      368889999999999999999999999999999999999999999997643  2


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .++|..++.++.|++.||+|||   ..+++|+||||+||++++++.+||+|||+++.......  .......++..|+||
T Consensus        96 ~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~y~aP  170 (256)
T cd05114          96 KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY--TSSSGAKFPVKWSPP  170 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce--eccCCCCCchhhCCh
Confidence            4899999999999999999999   68999999999999999999999999999875432211  111223355689999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+.+..++.++||||||+++|||++ |+.|+......+.     +..... +.      ....      +...+..+.+
T Consensus       171 E~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~-----~~~i~~-~~------~~~~------~~~~~~~~~~  232 (256)
T cd05114         171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV-----VEMISR-GF------RLYR------PKLASMTVYE  232 (256)
T ss_pred             hhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-----HHHHHC-CC------CCCC------CCCCCHHHHH
Confidence            99998889999999999999999999 7888765443221     111111 10      0001      1123456899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHH
Q 007261          571 LCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      ++.+||+.+|++||++.++++.|
T Consensus       233 li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         233 VMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHHHHccCCcccCcCHHHHHHhh
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-35  Score=299.02  Aligned_cols=234  Identities=28%  Similarity=0.498  Sum_probs=189.1

Q ss_pred             ceEEEEEEc-----CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGIIN-----GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~~-----g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|.+.     ...||||.++        .++.+|+.++++++|+||+++++++...+..++||||+++++|.+++.
T Consensus        18 g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~   97 (266)
T cd05033          18 GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR   97 (266)
T ss_pred             ceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHH
Confidence            899999883     3479999975        357789999999999999999999999999999999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...  ..+++..++.++.|++.||+|||   +.+++|+||||+|||+++++.+||+|||+++........ .......++
T Consensus        98 ~~~--~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~  171 (266)
T cd05033          98 END--GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT-YTTKGGKIP  171 (266)
T ss_pred             hcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc-eeccCCCCC
Confidence            653  25899999999999999999999   689999999999999999999999999999876422211 112233456


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      ..|+|||.+.+..++.++||||||+++|||++ |..|+......+.      ........            ....+..+
T Consensus       172 ~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~------~~~~~~~~------------~~~~~~~~  233 (266)
T cd05033         172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV------IKAVEDGY------------RLPPPMDC  233 (266)
T ss_pred             ccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH------HHHHHcCC------------CCCCCCCC
Confidence            78999999999999999999999999999998 8888755433221      11111110            00112234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      +..+.+++.+||+.+|++||++.|++++|.++
T Consensus       234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         234 PSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            56789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.6e-36  Score=311.94  Aligned_cols=226  Identities=24%  Similarity=0.369  Sum_probs=186.1

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|..||+|++++          .+.+|+.++++++||||+++++++..++..++||||+++|+|.+++..
T Consensus         9 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~   88 (328)
T cd05593           9 GKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR   88 (328)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh
Confidence            89999987  688999999863          356799999999999999999999999999999999999999999876


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||+
T Consensus        89 ~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~---~~~~~~~gt~  159 (328)
T cd05593          89 ER---VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA---ATMKTFCGTP  159 (328)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc---cccccccCCc
Confidence            53   4889999999999999999999   6899999999999999999999999999987532211   1223456899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++|||||||++|||++|+.||......+..     ..... .          +.   ..+...+.
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-----~~~~~-~----------~~---~~p~~~~~  220 (328)
T cd05593         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-----ELILM-E----------DI---KFPRTLSA  220 (328)
T ss_pred             CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-----HHhcc-C----------Cc---cCCCCCCH
Confidence            999999999999999999999999999999999999765432211     01100 0          00   01223456


Q ss_pred             HHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      ++.+++.+||+.||++||     ++.|++++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            788999999999999997     88998865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=306.80  Aligned_cols=226  Identities=26%  Similarity=0.425  Sum_probs=191.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  .++.||+|++.        .++.+|+.+|.+++++||.+++|.+..+..++++||||.+|++.+.|+...
T Consensus        27 G~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~  106 (467)
T KOG0201|consen   27 GEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGN  106 (467)
T ss_pred             ceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCC
Confidence            99999998  68899999996        467889999999999999999999999999999999999999999998764


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         .+++....-|..++..||.|||   ..+.+|||||+.|||+..+|.+||+|||.+-......   ......+||+.|
T Consensus       107 ---~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~---~rr~tfvGTPfw  177 (467)
T KOG0201|consen  107 ---ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV---KRRKTFVGTPFW  177 (467)
T ss_pred             ---CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechh---hccccccccccc
Confidence               2466777778899999999999   6889999999999999999999999999987654332   233678999999


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC-hHHHHHH
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN-KKEIAHH  567 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~  567 (611)
                      ||||++....|+.|+||||||++.+||.+|.+|+......                   +...++....++. ...++..
T Consensus       178 MAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-------------------rvlflIpk~~PP~L~~~~S~~  238 (467)
T KOG0201|consen  178 MAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-------------------RVLFLIPKSAPPRLDGDFSPP  238 (467)
T ss_pred             cchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-------------------eEEEeccCCCCCccccccCHH
Confidence            9999999889999999999999999999999998655432                   1111222222221 2367778


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.+++..||+.||+.||++.+++++
T Consensus       239 ~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  239 FKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             HHHHHHHHhhcCcccCcCHHHHhhh
Confidence            9999999999999999999999975

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.7e-35  Score=296.53  Aligned_cols=238  Identities=21%  Similarity=0.359  Sum_probs=192.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|..  +|+.||||.++          .++.+|++++++++||||+++++++...+..++|+||+++|+|.+++..
T Consensus        16 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~   95 (267)
T cd08228          16 SEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKY   95 (267)
T ss_pred             eeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHH
Confidence            88999987  78999999763          2577899999999999999999999999999999999999999999865


Q ss_pred             cC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          407 KR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       407 ~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      .. ....+++...+.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.......   .......++
T Consensus        96 ~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~  169 (267)
T cd08228          96 FKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGT  169 (267)
T ss_pred             hhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh---HHHhcCCCC
Confidence            32 2245788999999999999999999   6899999999999999999999999999987653221   112234678


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      ..|+|||.+.+..++.++|+||||+++|||++|+.|+.........+..    .+...         ..+.  ......+
T Consensus       170 ~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~----~~~~~---------~~~~--~~~~~~~  234 (267)
T cd08228         170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ----KIEQC---------DYPP--LPTEHYS  234 (267)
T ss_pred             ccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHH----HHhcC---------CCCC--CChhhcC
Confidence            8999999998888999999999999999999999998654332111111    11100         0011  1123456


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                      ..+.+++.+||+.+|++||++.++++.|++++
T Consensus       235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         235 EKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             HHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            77999999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.4e-35  Score=316.82  Aligned_cols=238  Identities=25%  Similarity=0.479  Sum_probs=189.0

Q ss_pred             ceEEEEEEc-------CcEEEEEEec--------HHHHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGIIN-------GSTVAIKCMR--------RSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~~-------g~~vavK~~~--------~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||+|+..       +..||||+++        ..+.+|+.+|++++ ||||++++++|.+.+..+|||||+++|+|.+
T Consensus        51 G~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~  130 (400)
T cd05105          51 GKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVN  130 (400)
T ss_pred             ceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHH
Confidence            899999862       2369999985        35788999999995 9999999999999999999999999999999


Q ss_pred             HhhccCC-------------------------------------------------------------------------
Q 007261          403 WLHKKRY-------------------------------------------------------------------------  409 (611)
Q Consensus       403 ~l~~~~~-------------------------------------------------------------------------  409 (611)
                      +|+....                                                                         
T Consensus       131 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (400)
T cd05105         131 YLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDR  210 (400)
T ss_pred             HHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccc
Confidence            9875320                                                                         


Q ss_pred             --------------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccc
Q 007261          410 --------------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSA  469 (611)
Q Consensus       410 --------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~  469 (611)
                                          ...+++..++.++.|++.||+|||   ..+++||||||+|||+++++.+||+|||+++..
T Consensus       211 ~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~  287 (400)
T cd05105         211 PASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDI  287 (400)
T ss_pred             cccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCCEEEEEeCCcceec
Confidence                                124788889999999999999999   689999999999999999999999999998765


Q ss_pred             ccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccc
Q 007261          470 VREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAK  548 (611)
Q Consensus       470 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  548 (611)
                      ..... ........++..|+|||.+.+..++.++||||||+++|||++ |+.|+.........     ......+.    
T Consensus       288 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~-----~~~~~~~~----  357 (400)
T cd05105         288 MHDSN-YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF-----YNKIKSGY----  357 (400)
T ss_pred             ccccc-ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH-----HHHHhcCC----
Confidence            33221 112223456788999999999999999999999999999997 88887654322211     11111110    


Q ss_pred             cccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       549 l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                              ....+..++..+.+++.+||+.||++||++.+|.+.|+++.
T Consensus       358 --------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         358 --------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             --------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence                    00112345667899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.1e-35  Score=308.65  Aligned_cols=239  Identities=24%  Similarity=0.441  Sum_probs=188.9

Q ss_pred             ceEEEEEE--cCc----EEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGS----TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~----~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.+  +|+    .||+|.++        +++.+|+.+++.++||||++++|+|... ..++|+||+++|+|.+++
T Consensus        21 g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l   99 (316)
T cd05108          21 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV   99 (316)
T ss_pred             ceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHH
Confidence            89999987  444    38999974        3577899999999999999999999765 567999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ....  ..+++..++.++.||+.||+|||   +.+++||||||+|||+++++.+||+|||+++........ ........
T Consensus       100 ~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~  173 (316)
T cd05108         100 REHK--DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE-YHAEGGKV  173 (316)
T ss_pred             Hhcc--ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCCCcc-eeccCCcc
Confidence            8753  34889999999999999999999   689999999999999999999999999999865432211 11122334


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      +..|+|||.+.+..++.++||||||+++|||++ |+.|+......+.      .........            ...+..
T Consensus       174 ~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~------------~~~~~~  235 (316)
T cd05108         174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGER------------LPQPPI  235 (316)
T ss_pred             ceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHhCCCC------------CCCCCC
Confidence            678999999999999999999999999999998 8888765432221      111111100            011122


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                      ++..+.+++.+||+.+|++||++.+++..|.++..+..+
T Consensus       236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~  274 (316)
T cd05108         236 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR  274 (316)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCch
Confidence            345688999999999999999999999999988765443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.6e-35  Score=303.64  Aligned_cols=239  Identities=25%  Similarity=0.505  Sum_probs=192.5

Q ss_pred             ceEEEEEE-------cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII-------NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||++..       ++..+++|.++       +.+.+|+.++++++|+||+++++++...+..++||||+++++|.+++
T Consensus        19 g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i   98 (291)
T cd05094          19 GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL   98 (291)
T ss_pred             CeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHH
Confidence            88999975       23469999985       45888999999999999999999999999999999999999999999


Q ss_pred             hccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccccc
Q 007261          405 HKKRY-------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR  471 (611)
Q Consensus       405 ~~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~  471 (611)
                      .....             ...++|..++.++.||+.||+|||   ..+++||||||+|||++.++.+||+|||+++....
T Consensus        99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~  175 (291)
T cd05094          99 RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS  175 (291)
T ss_pred             HhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEECCCCcccccCC
Confidence            76431             234899999999999999999999   68999999999999999999999999999875533


Q ss_pred             ccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccc
Q 007261          472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLS  550 (611)
Q Consensus       472 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~  550 (611)
                      ... ........++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+..      .....+       
T Consensus       176 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~------~~~~~~-------  241 (291)
T cd05094         176 TDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI------ECITQG-------  241 (291)
T ss_pred             Cce-eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHhCC-------
Confidence            211 112233456788999999999999999999999999999999 88887654432211      111111       


Q ss_pred             cccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          551 VLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       551 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                           .....+..++..+.+++.+||+.||++||++.+|++.|.++...
T Consensus       242 -----~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         242 -----RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             -----CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence                 11111223456789999999999999999999999999998664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.4e-35  Score=298.27  Aligned_cols=233  Identities=25%  Similarity=0.474  Sum_probs=186.3

Q ss_pred             ceEEEEEE----cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII----NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~----~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|.+    ++..+|+|+++         +++.+|+.++++++|+||+++++++. .+..++||||+++|+|.+++.
T Consensus         9 g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~   87 (257)
T cd05116           9 GTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQ   87 (257)
T ss_pred             cceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHH
Confidence            89999976    46789999985         35788999999999999999999986 456789999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..++.++.|++.||+|||   +.+++||||||.||++++++.+||+|||+++................++
T Consensus        88 ~~~---~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  161 (257)
T cd05116          88 KNK---HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP  161 (257)
T ss_pred             hcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCC
Confidence            643   4889999999999999999999   6899999999999999999999999999987654332211112233446


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      ..|+|||.+....++.++||||||+++|||++ |+.||......+.      ......+..            ...+..+
T Consensus       162 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~i~~~~~------------~~~~~~~  223 (257)
T cd05116         162 VKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV------TQMIESGER------------MECPQRC  223 (257)
T ss_pred             ccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHCCCC------------CCCCCCC
Confidence            78999999988889999999999999999998 8888865433221      111111110            0112235


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      +.++.+++.+||+.||++||++.+|.+.|+..
T Consensus       224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         224 PPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            56789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.1e-35  Score=298.57  Aligned_cols=235  Identities=28%  Similarity=0.500  Sum_probs=187.7

Q ss_pred             ceEEEEEE--cCc---EEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGS---TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~---~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|..  ++.   .+|+|.++        .++.+|++++++++|+|++++.+++...+..++||||+++++|.+++.
T Consensus        19 g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   98 (268)
T cd05063          19 GEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLR   98 (268)
T ss_pred             ccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHH
Confidence            88999987  333   79999975        347789999999999999999999999999999999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...  ..+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++..................+
T Consensus        99 ~~~--~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  173 (268)
T cd05063          99 DHD--GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP  173 (268)
T ss_pred             hcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcC
Confidence            643  34899999999999999999999   6899999999999999999999999999987554322111111222335


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      ..|+|||.+....++.++||||||+++|||++ |+.|+......+.     ...... ..            .......+
T Consensus       174 ~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~-----~~~i~~-~~------------~~~~~~~~  235 (268)
T cd05063         174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-----MKAIND-GF------------RLPAPMDC  235 (268)
T ss_pred             ceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-----HHHHhc-CC------------CCCCCCCC
Confidence            67999999998889999999999999999998 8988865443221     111111 00            00112234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      +..+.+++.+||+.+|++||++.+|++.|.++
T Consensus       236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            56789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.3e-35  Score=301.04  Aligned_cols=248  Identities=23%  Similarity=0.414  Sum_probs=187.8

Q ss_pred             ceEEEEEE------cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccC--CeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII------NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHD--GVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~------~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~gsL~~  402 (611)
                      |.||.+.+      ++..||+|.++        ..+.+|++++++++||||+++++++...  ...++||||+++++|.+
T Consensus        18 g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~   97 (283)
T cd05080          18 GKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD   97 (283)
T ss_pred             cEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHH
Confidence            88987653      56789999985        2467899999999999999999988653  46899999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++....    +++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++...............
T Consensus        98 ~~~~~~----l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  170 (283)
T cd05080          98 YLPKHK----LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG  170 (283)
T ss_pred             HHHHcC----CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCC
Confidence            997653    899999999999999999999   6899999999999999999999999999987654322211122233


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCC-cCh
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ-ANK  561 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~-~~~  561 (611)
                      .++..|+|||.+.+..++.++||||||+++|||++|+.|+.............    .........+....+.... ..+
T Consensus       171 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  246 (283)
T cd05080         171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP----KQGQMTVVRLIELLERGMRLPCP  246 (283)
T ss_pred             CCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcc----cccccchhhhhhhhhcCCCCCCC
Confidence            45667999999998899999999999999999999999875433211000000    0000000011111111111 113


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                      ..++..+.+++.+||+.+|++||+++++++.|+++.
T Consensus       247 ~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         247 KNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            345678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.7e-35  Score=298.07  Aligned_cols=234  Identities=26%  Similarity=0.487  Sum_probs=188.5

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||+|.. ++..||+|.+.      +.+.+|+.++++++|+||+++++.+.+++..+++|||+++|+|.++++... ..
T Consensus        20 g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~   98 (261)
T cd05072          20 GEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDE-GG   98 (261)
T ss_pred             ceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhc-CC
Confidence            89999987 56789999875      367889999999999999999999999999999999999999999997642 23


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.++.|++.||+|||   ..+++||||||+||++++++.+||+|||+++.......  .......++..|+||
T Consensus        99 ~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aP  173 (261)
T cd05072          99 KVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY--TAREGAKFPIKWTAP  173 (261)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce--eccCCCccceecCCH
Confidence            5889999999999999999999   68999999999999999999999999999876532211  112223456789999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+....++.++||||||+++|||++ |+.|+......+..  .    ......        ..+    .....+..+.+
T Consensus       174 E~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~--~----~~~~~~--------~~~----~~~~~~~~~~~  235 (261)
T cd05072         174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM--S----ALQRGY--------RMP----RMENCPDELYD  235 (261)
T ss_pred             HHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH--H----HHHcCC--------CCC----CCCCCCHHHHH
Confidence            99998899999999999999999998 88887544332211  1    111110        001    11224567889


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      ++.+||+.+|++||+++++.+.|+++
T Consensus       236 li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         236 IMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HHHHHccCCcccCcCHHHHHHHHhcC
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.6e-35  Score=300.10  Aligned_cols=243  Identities=21%  Similarity=0.290  Sum_probs=185.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +++.||+|+++         +.+.+|+.++++++|+||+++++++..++..++||||++++.|..+....
T Consensus        15 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~   94 (287)
T cd07848          15 GVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP   94 (287)
T ss_pred             EEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcC
Confidence            89999998  57899999885         24678999999999999999999999999999999999987776554332


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                         ..+++..++.++.|++.||.|||   ..+++||||||+||+++.++.+||+|||+++.......  .......++..
T Consensus        95 ---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~  166 (287)
T cd07848          95 ---NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--ANYTEYVATRW  166 (287)
T ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc--ccccccccccc
Confidence               34888999999999999999999   68999999999999999999999999999876532211  12223568999


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc---------ccccccCccCC
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA---------KLSVLVDPNLQ  558 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~---------~l~~~~d~~l~  558 (611)
                      |+|||.+.+..++.++|||||||++|||++|+.||......+...  .+..... .....         .......+...
T Consensus       167 y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  243 (287)
T cd07848         167 YRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF--TIQKVLG-PLPAEQMKLFYSNPRFHGLRFPAVN  243 (287)
T ss_pred             cCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhhC-CCCHHHHHhhhccchhcccccCccc
Confidence            999999998899999999999999999999999987654322111  0111100 00000         00000001000


Q ss_pred             c-------ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 A-------NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 ~-------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .       .....+..+.+|+.+||+.||++|||++|++++
T Consensus       244 ~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         244 HPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             CcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0       012345679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2e-35  Score=300.62  Aligned_cols=235  Identities=28%  Similarity=0.539  Sum_probs=189.4

Q ss_pred             ceEEEEEE-c------CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII-N------GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~-~------g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|.. +      +..||||.++        +++.+|++++++++|+||+++++++......++||||+++++|.++
T Consensus        19 ~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   98 (280)
T cd05049          19 GKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKF   98 (280)
T ss_pred             ceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHH
Confidence            89999976 2      3689999985        3678899999999999999999999999999999999999999999


Q ss_pred             hhccCC-----------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          404 LHKKRY-----------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       404 l~~~~~-----------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      +...+.           ...+++..+..++.|++.||.|||   ..+++||||||+||+++.++.+||+|||+++.....
T Consensus        99 i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~  175 (280)
T cd05049          99 LRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT  175 (280)
T ss_pred             HHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeEEECCcccceecccC
Confidence            976431           235789999999999999999999   689999999999999999999999999998754322


Q ss_pred             cCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCccccccc
Q 007261          473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV  551 (611)
Q Consensus       473 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  551 (611)
                      .. ........++..|+|||.+.+..++.++||||||+++|||++ |..||......+..  ..   . ..+        
T Consensus       176 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~--~~---~-~~~--------  240 (280)
T cd05049         176 DY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI--EC---I-TQG--------  240 (280)
T ss_pred             cc-eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH--HH---H-HcC--------
Confidence            11 111223345788999999999999999999999999999998 99888765443211  11   1 111        


Q ss_pred             ccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 007261          552 LVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK  595 (611)
Q Consensus       552 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  595 (611)
                          .....+...+..+.+++.+||+.||++||++.|+++.|++
T Consensus       241 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         241 ----RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ----CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                1111122345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.8e-35  Score=301.35  Aligned_cols=241  Identities=27%  Similarity=0.512  Sum_probs=191.6

Q ss_pred             ceEEEEEE-------cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII-------NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||++..       ++..+|+|.++       +.+.+|++++++++|+||+++++++...+..++||||+++++|.+++
T Consensus        19 ~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i   98 (288)
T cd05093          19 GKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL   98 (288)
T ss_pred             eeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHH
Confidence            89999974       23568999985       35788999999999999999999999999999999999999999999


Q ss_pred             hccC----------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC
Q 007261          405 HKKR----------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES  474 (611)
Q Consensus       405 ~~~~----------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~  474 (611)
                      ....          ....+++..++.++.|++.||+|||   ..+++||||||+|||+++++.+||+|||+++.......
T Consensus        99 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  175 (288)
T cd05093          99 RAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY  175 (288)
T ss_pred             HHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEeccCCccccccCCce
Confidence            7542          1234899999999999999999999   68999999999999999999999999999875532211


Q ss_pred             CcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCccccccccc
Q 007261          475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV  553 (611)
Q Consensus       475 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  553 (611)
                       ........++..|+|||.+.+..++.++||||||++++||++ |..|+......+.     ...... +.         
T Consensus       176 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~-----~~~i~~-~~---------  239 (288)
T cd05093         176 -YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-----IECITQ-GR---------  239 (288)
T ss_pred             -eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHc-CC---------
Confidence             112223445778999999999999999999999999999998 7777755433221     111111 10         


Q ss_pred             CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       554 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                         ....+...+..+.+++.+||+.||.+||++.|+++.|+++.....
T Consensus       240 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~  284 (288)
T cd05093         240 ---VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP  284 (288)
T ss_pred             ---cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence               000111234568999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.5e-35  Score=299.24  Aligned_cols=240  Identities=23%  Similarity=0.416  Sum_probs=188.0

Q ss_pred             ceEEEEEE--cCc----EEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGS----TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~----~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.+  +|+    .+++|.+.        .++..|+..+++++||||+++++++.. ...++++||+++|+|.+++
T Consensus        21 ~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l   99 (279)
T cd05111          21 GTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHV   99 (279)
T ss_pred             cceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHH
Confidence            89999998  454    47888874        245667788899999999999999864 4578899999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ....  ..++|..++.|+.||+.||+|||   ..+++||||||+|||+++++.+||+|||+++........ .......+
T Consensus       100 ~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~  173 (279)
T cd05111         100 RQHR--DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK-YFYSEHKT  173 (279)
T ss_pred             Hhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc-cccCCCCC
Confidence            8643  34899999999999999999999   688999999999999999999999999998765332211 12223456


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      +..|+|||.+.++.++.++||||||+++|||++ |+.|+......+.      ......+..      ...      +..
T Consensus       174 ~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~~~~~~------~~~------~~~  235 (279)
T cd05111         174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV------PDLLEKGER------LAQ------PQI  235 (279)
T ss_pred             cccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCCCc------CCC------CCC
Confidence            778999999999999999999999999999998 8888865433221      111111110      001      112


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhhc
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRS  603 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~  603 (611)
                      +...+.+++.+||..||++||++.|+++.|..+..+...|
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~  275 (279)
T cd05111         236 CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRY  275 (279)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcce
Confidence            3456788999999999999999999999999887765443

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-35  Score=310.37  Aligned_cols=245  Identities=22%  Similarity=0.326  Sum_probs=182.5

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccC-----CeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHD-----GVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~  402 (611)
                      |.||+|+.  +|..||||+++.         .+.+|+.++++++||||+++++++...     ...|+||||++ ++|.+
T Consensus        14 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~   92 (338)
T cd07859          14 GVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQ   92 (338)
T ss_pred             eEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHH
Confidence            89999987  688999998852         367899999999999999999987533     35899999995 79999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++....   .+++..+..++.||+.||.|||   +.+++||||||+|||++.++.+||+|||+++...............
T Consensus        93 ~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~  166 (338)
T cd07859          93 VIKAND---DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY  166 (338)
T ss_pred             HHHhcc---cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCC
Confidence            987653   3899999999999999999999   6899999999999999999999999999987643322211122345


Q ss_pred             ccCCCccchhhhcc--CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc-----------cccc
Q 007261          483 VGTNGYMAPEYMEY--GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA-----------EAKL  549 (611)
Q Consensus       483 ~gt~~y~aPE~~~~--~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-----------~~~l  549 (611)
                      .++..|+|||++.+  ..++.++||||||+++|||++|+.||........  ...+.........           ...+
T Consensus       167 ~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~  244 (338)
T cd07859         167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ--LDLITDLLGTPSPETISRVRNEKARRYL  244 (338)
T ss_pred             CCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhhhhhHHHHH
Confidence            78999999999875  6789999999999999999999999865443211  1111111100000           0000


Q ss_pred             ccccCc---cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          550 SVLVDP---NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       550 ~~~~d~---~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+...   .........+..+.+++.+||+.||++||++.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         245 SSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000000   0000011234567899999999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-36  Score=294.97  Aligned_cols=258  Identities=25%  Similarity=0.373  Sum_probs=208.5

Q ss_pred             hHHHHHhhcCCCCCccc----ceEEEEEEc-------CcEEEEEEecH--------HHHHHHHHHHhcCCCceeecccee
Q 007261          322 EDLVVATENFSPKNMID----GSVFRGIIN-------GSTVAIKCMRR--------SISKEVNLLKKINHFNLINLFGAC  382 (611)
Q Consensus       322 ~el~~at~~f~~~~~ig----g~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~  382 (611)
                      .|+.....+|.....+.    |.||+|.|.       .+.|-+|.+++        .+..|.-++..+.|||+.++.|++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            45555555555544442    999999772       23577888763        366788888999999999999998


Q ss_pred             ccC-CeEEEEEeecCCCCHHHHhh-----ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC
Q 007261          383 EHD-GVFYLVYEFMENGSLSDWLH-----KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL  456 (611)
Q Consensus       383 ~~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~  456 (611)
                      .++ ..++.+|.++.-|+|..||.     +....+.++..+.+.++.|++.||+|||   +.++||.||.++|++||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence            654 67899999999999999998     3444567889999999999999999999   79999999999999999999


Q ss_pred             cEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHH
Q 007261          457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEA  535 (611)
Q Consensus       457 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~  535 (611)
                      ++||+|-.|+|.....+. .........+..||+||.+.+..|+..+|||||||+||||+| |+.|+-.-+..|.     
T Consensus       434 qVkltDsaLSRDLFP~DY-hcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-----  507 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDY-HCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-----  507 (563)
T ss_pred             eEEeccchhccccCcccc-cccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-----
Confidence            999999999998765542 334445566789999999999999999999999999999999 6666543332221     


Q ss_pred             HHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       536 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                                   -..+.|+....+|.+|+++++.+|..||..+|++||++.+++.-|.++.....
T Consensus       508 -------------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt  560 (563)
T KOG1024|consen  508 -------------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT  560 (563)
T ss_pred             -------------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence                         12234455556688899999999999999999999999999999998876554

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.6e-35  Score=295.83  Aligned_cols=238  Identities=23%  Similarity=0.380  Sum_probs=192.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|..++||.+.          .++.+|+.+++.++|+||+++++++..++..+++|||+++++|.+++..
T Consensus        16 g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~   95 (267)
T cd08229          16 SEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH   95 (267)
T ss_pred             eEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHH
Confidence            89999986  78999999764          3577899999999999999999999999999999999999999999875


Q ss_pred             cC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          407 KR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       407 ~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      .. ....+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.......   .......++
T Consensus        96 ~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~  169 (267)
T cd08229          96 FKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGT  169 (267)
T ss_pred             hhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC---cccccccCC
Confidence            32 2345899999999999999999999   6899999999999999999999999999987553221   112234678


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      ..|+|||.+.+..++.++||||||+++|||++|..|+............   ...          ....+..  .....+
T Consensus       170 ~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~----------~~~~~~~--~~~~~~  234 (267)
T cd08229         170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---KIE----------QCDYPPL--PSDHYS  234 (267)
T ss_pred             cCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh---hhh----------cCCCCCC--Cccccc
Confidence            8999999999888999999999999999999999998654322111111   110          0011111  123456


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                      ..+.+++.+||+.||++|||+.+|++.++++.
T Consensus       235 ~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         235 EELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             HHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            78999999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.3e-35  Score=313.04  Aligned_cols=226  Identities=25%  Similarity=0.422  Sum_probs=178.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++..  +|+.||||++.        ..+.+|++++++++|+||+++++++.+++..++||||+++|+|.+..    
T Consensus        88 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~----  163 (353)
T PLN00034         88 GTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH----  163 (353)
T ss_pred             eEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc----
Confidence            89999988  68899999984        35788999999999999999999999999999999999999986532    


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         ...+..+..++.||+.||+|||   +.+++||||||+|||+++++.+||+|||+++......   .......||..|
T Consensus       164 ---~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~---~~~~~~~gt~~y  234 (353)
T PLN00034        164 ---IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM---DPCNSSVGTIAY  234 (353)
T ss_pred             ---cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc---ccccccccCccc
Confidence               2456777889999999999999   6899999999999999999999999999987653221   122345789999


Q ss_pred             cchhhhcc-----CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          489 MAPEYMEY-----GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       489 ~aPE~~~~-----~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      +|||.+..     ...+.++|||||||++|||++|+.||......+.  .........             ......+..
T Consensus       235 ~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~-------------~~~~~~~~~  299 (353)
T PLN00034        235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW--ASLMCAICM-------------SQPPEAPAT  299 (353)
T ss_pred             cCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHHhc-------------cCCCCCCCc
Confidence            99998743     2345689999999999999999999874332211  111111100             000111234


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+.++.+|+.+||+.||++||++.|++++
T Consensus       300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        300 ASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            55678999999999999999999999986

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.7e-35  Score=306.94  Aligned_cols=242  Identities=24%  Similarity=0.390  Sum_probs=185.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++..  +|..+|+|.++        ..+.+|++++++++|+||++++++|.+++..++||||+++|+|.+++....
T Consensus        19 g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~   98 (333)
T cd06650          19 GVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG   98 (333)
T ss_pred             EEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC
Confidence            89999988  57889999874        347889999999999999999999999999999999999999999997653


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         .+++.....++.+++.||.|||+  ..+++|+||||+|||++.++.+||+|||++......     ......++..|
T Consensus        99 ---~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-----~~~~~~~~~~y  168 (333)
T cd06650          99 ---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSY  168 (333)
T ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-----ccccCCCCccc
Confidence               37888999999999999999994  357999999999999999999999999998754221     12234688999


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc--------------------
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK--------------------  548 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~--------------------  548 (611)
                      +|||.+.+..++.++|||||||++|||++|+.||......+..  ...............                    
T Consensus       169 ~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (333)
T cd06650         169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE--LMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSR  246 (333)
T ss_pred             cCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH--HHhcCcccCCccccccCcccCCccchhhhhccccc
Confidence            9999999989999999999999999999999998754432211  000000000000000                    


Q ss_pred             ----cccccC----ccCCcC-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          549 ----LSVLVD----PNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       549 ----l~~~~d----~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                          ...+.+    ...... ....+.++.+|+.+||+.||++||++.|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         247 PPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             ccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                000000    000000 01234678999999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.2e-35  Score=293.24  Aligned_cols=229  Identities=24%  Similarity=0.383  Sum_probs=188.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.|++|.+.         .++.+|++++++++||||+++++++.+++..++||||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   93 (256)
T cd08529          14 GVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ   93 (256)
T ss_pred             eEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHh
Confidence            89999988  68899999874         35778999999999999999999999999999999999999999999875


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      . ...+++..+..++.+++.||.|||   ..+++|+||||+||++++++.+||+|||+++......   .......++..
T Consensus        94 ~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~  166 (256)
T cd08529          94 R-GRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---NFANTIVGTPY  166 (256)
T ss_pred             c-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc---chhhccccCcc
Confidence            2 245899999999999999999999   6899999999999999999999999999987654322   12233467889


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHH
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH  567 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  567 (611)
                      |+|||++.+..++.++|+||||+++|||++|+.|+......+.     ......             ......+...+..
T Consensus       167 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~-------------~~~~~~~~~~~~~  228 (256)
T cd08529         167 YLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL-----ILKIIR-------------GVFPPVSQMYSQQ  228 (256)
T ss_pred             ccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHc-------------CCCCCCccccCHH
Confidence            9999999999999999999999999999999999865542211     111111             0011112245567


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.+++.+||+.+|++||++.+++++
T Consensus       229 ~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         229 LAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHHHHHHHccCCcccCcCHHHHhhC
Confidence            8999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.3e-35  Score=299.86  Aligned_cols=235  Identities=24%  Similarity=0.511  Sum_probs=187.8

Q ss_pred             ceEEEEEE------cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII------NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~------~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.+      .+..|++|.++        .++.+|+.++++++||||+++++++..+...++||||+++++|.+++
T Consensus        19 g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   98 (283)
T cd05090          19 GKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFL   98 (283)
T ss_pred             cceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHH
Confidence            89999985      45689999996        35788999999999999999999999999999999999999999999


Q ss_pred             hccCC--------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccc
Q 007261          405 HKKRY--------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV  470 (611)
Q Consensus       405 ~~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~  470 (611)
                      .....              ...+++...+.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++...
T Consensus        99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (283)
T cd05090          99 IMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHVKISDLGLSREIY  175 (283)
T ss_pred             HhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCcEEecccccccccc
Confidence            64321              234789999999999999999999   6899999999999999999999999999987653


Q ss_pred             cccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCccccc
Q 007261          471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL  549 (611)
Q Consensus       471 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  549 (611)
                      .... ........++..|+|||.+.+..++.++||||||+++|||++ |..||......+.      ........     
T Consensus       176 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~------~~~~~~~~-----  243 (283)
T cd05090         176 SADY-YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV------IEMVRKRQ-----  243 (283)
T ss_pred             CCcc-eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHcCC-----
Confidence            3221 112233345678999999988889999999999999999999 7777765432211      11111110     


Q ss_pred             ccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 007261          550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK  595 (611)
Q Consensus       550 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  595 (611)
                             ....+..++..+.+++.+||+.||++||++.+|.++|..
T Consensus       244 -------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         244 -------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                   011122345678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.4e-35  Score=322.83  Aligned_cols=232  Identities=21%  Similarity=0.301  Sum_probs=186.9

Q ss_pred             ceEEEEEE--c-CcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc-
Q 007261          339 GSVFRGII--N-GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-  407 (611)
Q Consensus       339 g~Vy~g~~--~-g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~-  407 (611)
                      |.||++..  + +..||+|.+.       ..+.+|+.+|+.++||||++++++|..++..+|||||+++|+|.++|+.. 
T Consensus        81 g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~  160 (478)
T PTZ00267         81 TAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRL  160 (478)
T ss_pred             cEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHH
Confidence            88999976  3 6789999763       24678999999999999999999999999999999999999999998753 


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .....+++.....++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++....... ........||+.
T Consensus       161 ~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~-~~~~~~~~gt~~  236 (478)
T PTZ00267        161 KEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS-LDVASSFCGTPY  236 (478)
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc-cccccccCCCcc
Confidence            22345888999999999999999999   68999999999999999999999999999986532211 112334568999


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHH
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH  567 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  567 (611)
                      |+|||.+.+..++.++||||||+++|||++|+.||......+.     .......             .....+..++.+
T Consensus       237 y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~-----~~~~~~~-------------~~~~~~~~~s~~  298 (478)
T PTZ00267        237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI-----MQQVLYG-------------KYDPFPCPVSSG  298 (478)
T ss_pred             ccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhC-------------CCCCCCccCCHH
Confidence            9999999999999999999999999999999999865443221     1111110             011112234567


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.+++.+||+.||++||++.+++.+
T Consensus       299 ~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        299 MKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             HHHHHHHHhccChhhCcCHHHHHhC
Confidence            8999999999999999999998753

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.8e-35  Score=299.27  Aligned_cols=233  Identities=21%  Similarity=0.268  Sum_probs=185.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.+|+|.+.+          .+..|+.++++++|+||+++.+++..+...++||||+++|+|.+++..
T Consensus         7 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~   86 (280)
T cd05608           7 GEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYN   86 (280)
T ss_pred             eeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHh
Confidence            89999987  688999999852          345799999999999999999999999999999999999999988854


Q ss_pred             cC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          407 KR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       407 ~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      .. ....+++..++.++.||+.||.|||   +.+|+||||||+||++++++.+||+|||++.......   .......|+
T Consensus        87 ~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~g~  160 (280)
T cd05608          87 VDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKTKGYAGT  160 (280)
T ss_pred             ccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---ccccccCCC
Confidence            32 2345899999999999999999999   6899999999999999999999999999987543222   122335689


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||........ ........             .... ...+...+
T Consensus       161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~-------------~~~~-~~~~~~~~  225 (280)
T cd05608         161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRI-------------LNDS-VTYPDKFS  225 (280)
T ss_pred             cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhh-------------cccC-CCCcccCC
Confidence            999999999999999999999999999999999999875432210 00000000             0000 01123456


Q ss_pred             HHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      ..+.+++.+||+.||++||     ++++++++
T Consensus       226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            7789999999999999999     66777764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.7e-36  Score=310.69  Aligned_cols=227  Identities=23%  Similarity=0.368  Sum_probs=185.2

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|..||+|.+++          .+.+|+.++..++||||+++++++...+..++||||+++|+|.+++..
T Consensus         9 g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~   88 (325)
T cd05594           9 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR   88 (325)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh
Confidence            89999987  788999999863          245688999999999999999999999999999999999999999876


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..+..++.||+.||+|||+  ..+|+||||||+|||+++++.+||+|||+++......   .......||+
T Consensus        89 ~~---~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~gt~  160 (325)
T cd05594          89 ER---VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKTFCGTP  160 (325)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC---cccccccCCc
Confidence            53   48999999999999999999993  3789999999999999999999999999987542221   1223456899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||.....++..      .......          ..   .+...+.
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~------~~i~~~~----------~~---~p~~~~~  221 (325)
T cd05594         161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------ELILMEE----------IR---FPRTLSP  221 (325)
T ss_pred             ccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH------HHHhcCC----------CC---CCCCCCH
Confidence            999999999999999999999999999999999999765432211      1110000          00   1122345


Q ss_pred             HHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      ++.+++.+||+.||++|+     ++.+++++
T Consensus       222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            688999999999999996     89999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2e-35  Score=297.37  Aligned_cols=233  Identities=29%  Similarity=0.508  Sum_probs=190.1

Q ss_pred             ceEEEEEE-cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      |.||+|.. ++..+++|.++       .++.+|+.+++.++|+||+++++++.+.+..++||||+++++|.+++.... .
T Consensus        20 ~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~   98 (261)
T cd05148          20 GEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE-G   98 (261)
T ss_pred             ccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCC-C
Confidence            89999998 67889999985       357789999999999999999999999999999999999999999998753 2


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA  490 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~a  490 (611)
                      ..+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++.......   .......++..|++
T Consensus        99 ~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~---~~~~~~~~~~~~~~  172 (261)
T cd05148          99 QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV---YLSSDKKIPYKWTA  172 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc---ccccCCCCceEecC
Confidence            45899999999999999999999   6899999999999999999999999999987653221   11223345678999


Q ss_pred             hhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          491 PEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       491 PE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      ||.+....++.++||||||+++++|++ |+.|+......+..  .   .... .            .....+..++..+.
T Consensus       173 PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~--~---~~~~-~------------~~~~~~~~~~~~~~  234 (261)
T cd05148         173 PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY--D---QITA-G------------YRMPCPAKCPQEIY  234 (261)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH--H---HHHh-C------------CcCCCCCCCCHHHH
Confidence            999998899999999999999999998 77777554422211  1   1111 0            00111234456789


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          570 MLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      +++.+||+.||.+|||+.++++.|+.+
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         235 KIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-35  Score=293.81  Aligned_cols=240  Identities=22%  Similarity=0.349  Sum_probs=190.2

Q ss_pred             cCCCCCccc----ceEEEEEE--cCcEEEEEEec------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEE
Q 007261          330 NFSPKNMID----GSVFRGII--NGSTVAIKCMR------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV  391 (611)
Q Consensus       330 ~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  391 (611)
                      +|.....+|    |.||++..  ++..+|+|.++            ..+.+|+.++++++||||+++++++.+++..++|
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            344444443    88999986  68899999874            2467799999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccccc
Q 007261          392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR  471 (611)
Q Consensus       392 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~  471 (611)
                      +||+++++|.+++....   .+++.....++.|++.||.|||   ..+++|+||+|+||++++++.++|+|||+++....
T Consensus        83 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          83 MEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            99999999999997653   3788889999999999999999   68999999999999999999999999999875432


Q ss_pred             ccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccc
Q 007261          472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV  551 (611)
Q Consensus       472 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  551 (611)
                      ............++..|+|||.+.+..++.++||||||+++|||++|+.||......+..     ......         
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~---------  222 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-----FKIATQ---------  222 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-----HHHhcc---------
Confidence            211111112345778999999999988999999999999999999999998654332211     111100         


Q ss_pred             ccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          552 LVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       552 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                         ......+......+.+++.+||..+|++||++.|++++
T Consensus       223 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 ---PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ---CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence               00111123455678899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.8e-35  Score=298.62  Aligned_cols=243  Identities=23%  Similarity=0.361  Sum_probs=185.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  ++..||+|.++        ..+.+|+.++++++||||+++++++..++..++||||++ |+|.+++....
T Consensus        19 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~   97 (288)
T cd07871          19 ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCG   97 (288)
T ss_pred             EEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhcC
Confidence            89999987  67899999885        246789999999999999999999999999999999997 59999987643


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                        ..+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++......   .......++..|
T Consensus        98 --~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~---~~~~~~~~~~~y  169 (288)
T cd07871          98 --NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT---KTYSNEVVTLWY  169 (288)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC---ccccCceecccc
Confidence              34788999999999999999999   6899999999999999999999999999987543221   122345678999


Q ss_pred             cchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc--------ccccccccCccCCc
Q 007261          489 MAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA--------EAKLSVLVDPNLQA  559 (611)
Q Consensus       489 ~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--------~~~l~~~~d~~l~~  559 (611)
                      +|||.+.+ ..++.++||||||+++|||++|+.||......+..  ..+.........        ...+.....+....
T Consensus       170 ~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (288)
T cd07871         170 RPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL--HLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRA  247 (288)
T ss_pred             cChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCChHHhhccccchhhhccccCccCC
Confidence            99998865 56899999999999999999999998765443221  111111111100        00011111111111


Q ss_pred             C-----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          560 N-----KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       560 ~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .     ......++.+|+.+||+.||.+|||++|++++
T Consensus       248 ~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         248 QPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             CchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            1     11234568899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.9e-35  Score=293.85  Aligned_cols=232  Identities=24%  Similarity=0.418  Sum_probs=184.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  +|+.+|+|.++        ..+.+|++++++++||||++++++|...+..++||||+++++|.+++....
T Consensus         9 g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   88 (252)
T cd05084           9 GEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG   88 (252)
T ss_pred             ccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCC
Confidence            89999987  78899999864        357889999999999999999999999999999999999999999997643


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                        ..+++..++.++.|++.||.|||   +.+++|+||||+|||++.++.+||+|||++........ .........+..|
T Consensus        89 --~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y  162 (252)
T cd05084          89 --PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-ASTGGMKQIPVKW  162 (252)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccc-cccCCCCCCceee
Confidence              34889999999999999999999   68999999999999999999999999999875432110 0011111234579


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHH
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH  567 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  567 (611)
                      +|||.+.++.++.++||||||+++|||++ |..|+.......      .........            ....+...+..
T Consensus       163 ~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~------~~~~~~~~~------------~~~~~~~~~~~  224 (252)
T cd05084         163 TAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ------TREAIEQGV------------RLPCPELCPDA  224 (252)
T ss_pred             cCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH------HHHHHHcCC------------CCCCcccCCHH
Confidence            99999999999999999999999999998 766665433221      111111100            00112234567


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      +.+++.+||+.+|++||++.++++.|.
T Consensus       225 ~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         225 VYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.4e-35  Score=298.96  Aligned_cols=247  Identities=26%  Similarity=0.430  Sum_probs=186.3

Q ss_pred             ceEEEEEE------cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceecc--CCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII------NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEH--DGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~------~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++.+      ++..||+|.++       +.+.+|++++++++||||+++++++..  ....++||||+++|+|.++
T Consensus        18 g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~   97 (284)
T cd05081          18 GSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDY   97 (284)
T ss_pred             ceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHH
Confidence            89999874      47789999985       357889999999999999999998743  4568999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      +...+  ..++|..++.++.|++.||+|||   ..+++||||||+||++++++.+||+|||+++................
T Consensus        98 l~~~~--~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  172 (284)
T cd05081          98 LQKHR--ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE  172 (284)
T ss_pred             HHhcC--cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCC
Confidence            97643  34899999999999999999999   68999999999999999999999999999886543322111222233


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc----ccccccccC-ccCC
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA----EAKLSVLVD-PNLQ  558 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~----~~~l~~~~d-~~l~  558 (611)
                      ++..|+|||.+.+..++.++||||||+++|||++|..++.......       .........    ...+...+. ....
T Consensus       173 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (284)
T cd05081         173 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-------MRMMGNDKQGQMIVYHLIELLKNNGRL  245 (284)
T ss_pred             CceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-------hhhcccccccccchHHHHHHHhcCCcC
Confidence            4456999999998899999999999999999999877654322110       000000000    000000000 0111


Q ss_pred             cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          559 ANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                      ..+..++..+.+++.+||+.+|++|||+.||++.|++++
T Consensus       246 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         246 PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            112345567999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=282.50  Aligned_cols=220  Identities=25%  Similarity=0.393  Sum_probs=186.8

Q ss_pred             HHhhcCCCCCcccceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEe
Q 007261          326 VATENFSPKNMIDGSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE  393 (611)
Q Consensus       326 ~at~~f~~~~~igg~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  393 (611)
                      .+++.|       |.|-..+.  +|..+|+|++.+          ...+|..+|+.+.||.++++++.|.+.+..|||||
T Consensus        52 lGtGSF-------GrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme  124 (355)
T KOG0616|consen   52 LGTGSF-------GRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME  124 (355)
T ss_pred             eccCcc-------ceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence            346666       89988876  789999999963          24579999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccccccc
Q 007261          394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE  473 (611)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~  473 (611)
                      |++||.|.++|++.+.   ++....+-+|.||+.||+|||   +..|++|||||+|||+|.+|.+||+|||+|+...   
T Consensus       125 yv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~---  195 (355)
T KOG0616|consen  125 YVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS---  195 (355)
T ss_pred             ccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence            9999999999998643   888888899999999999999   6899999999999999999999999999998763   


Q ss_pred             CCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccccc
Q 007261          474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV  553 (611)
Q Consensus       474 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  553 (611)
                         ..+...+||+.|+|||.+....+..++|.|||||++|||+.|..||+......+  .   ...+++.          
T Consensus       196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i--Y---~KI~~~~----------  257 (355)
T KOG0616|consen  196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI--Y---EKILEGK----------  257 (355)
T ss_pred             ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH--H---HHHHhCc----------
Confidence               236678999999999999999999999999999999999999999997765221  1   1111111          


Q ss_pred             CccCCcChHHHHHHHHHHHHHhhccCCCCC
Q 007261          554 DPNLQANKKEIAHHLIMLCLACIAREPESR  583 (611)
Q Consensus       554 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R  583 (611)
                          ...|...+..+.+|+...++.|-.+|
T Consensus       258 ----v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 ----VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ----ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence                11244556678889999999999988

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.8e-35  Score=295.05  Aligned_cols=231  Identities=25%  Similarity=0.472  Sum_probs=185.2

Q ss_pred             ceEEEEEEcC-cEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGIING-STVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~~g-~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||.|.+.+ ..+|||.++      .++.+|+.++++++||||+++++++...+..++||||+++|+|.+++.....  
T Consensus        18 ~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~--   95 (256)
T cd05113          18 GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK--   95 (256)
T ss_pred             ceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC--
Confidence            8999998854 469999886      3578899999999999999999999988899999999999999999976432  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.++.||+.||+|||   +.+++|+||||+||++++++.+||+|||+++......  ........++..|++|
T Consensus        96 ~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~--~~~~~~~~~~~~y~~p  170 (256)
T cd05113          96 RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPP  170 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc--eeecCCCccChhhCCH
Confidence            4899999999999999999999   6899999999999999999999999999987553221  1111223356789999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+.+..++.++||||||+++|||++ |..|+......+.  ..   .... +..            ...+...+..+.+
T Consensus       171 e~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~--~~---~~~~-~~~------------~~~~~~~~~~~~~  232 (256)
T cd05113         171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET--VE---KVSQ-GLR------------LYRPHLASEKVYA  232 (256)
T ss_pred             HHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HH---HHhc-CCC------------CCCCCCCCHHHHH
Confidence            99998889999999999999999999 8888764433211  11   1111 100            0011123567899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHH
Q 007261          571 LCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      ++.+||+.+|.+||++.++++.|+
T Consensus       233 li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         233 IMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHHHhhC
Confidence            999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.3e-35  Score=298.22  Aligned_cols=235  Identities=21%  Similarity=0.429  Sum_probs=187.2

Q ss_pred             ceEEEEEEc-------CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIIN-------GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~-------g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|...       +..||||+++        ..+.+|+.++.+++||||+++++++...+..++++||+++++|.++
T Consensus        19 g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~   98 (283)
T cd05091          19 GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEF   98 (283)
T ss_pred             CeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHH
Confidence            899999863       3689999986        3477899999999999999999999999999999999999999999


Q ss_pred             hhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccc
Q 007261          404 LHKKR-------------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV  470 (611)
Q Consensus       404 l~~~~-------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~  470 (611)
                      +....             ....+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++...
T Consensus        99 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (283)
T cd05091          99 LVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY  175 (283)
T ss_pred             HHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCceEecccccccccc
Confidence            86321             1234888999999999999999999   6899999999999999999999999999987653


Q ss_pred             cccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCccccc
Q 007261          471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL  549 (611)
Q Consensus       471 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  549 (611)
                      .... ........+++.|+|||.+.++.++.++||||||+++|||++ |..|+......+.     . .....       
T Consensus       176 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-----~-~~i~~-------  241 (283)
T cd05091         176 AADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV-----I-EMIRN-------  241 (283)
T ss_pred             cchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----H-HHHHc-------
Confidence            3221 112233455778999999988899999999999999999998 6667654332211     1 11111       


Q ss_pred             ccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 007261          550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK  595 (611)
Q Consensus       550 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  595 (611)
                           ......+..++..+.+++.+||+.+|++||++.+|+..|+.
T Consensus       242 -----~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         242 -----RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -----CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                 11111133466778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-35  Score=310.70  Aligned_cols=223  Identities=24%  Similarity=0.333  Sum_probs=183.2

Q ss_pred             ceEEEEEEc---CcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGIIN---GSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~~---g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|.+.   +..||+|++..          .+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++.
T Consensus        44 g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~  123 (340)
T PTZ00426         44 GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR  123 (340)
T ss_pred             eEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence            899999862   35899999852          35679999999999999999999999999999999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++....      ......||
T Consensus       124 ~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~------~~~~~~gt  191 (340)
T PTZ00426        124 RNK---RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT------RTYTLCGT  191 (340)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC------CcceecCC
Confidence            653   3889999999999999999999   68999999999999999999999999999875422      12345789


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+.+..++.++|||||||++|||++|+.||........  .   ..... +.             ...+...+
T Consensus       192 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--~---~~i~~-~~-------------~~~p~~~~  252 (340)
T PTZ00426        192 PEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI--Y---QKILE-GI-------------IYFPKFLD  252 (340)
T ss_pred             hhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH--H---HHHhc-CC-------------CCCCCCCC
Confidence            999999999998899999999999999999999999976543211  1   11111 00             00112234


Q ss_pred             HHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      ..+.+++.+||+.||++|+     ++++++++
T Consensus       253 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        253 NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            5678999999999999995     88888775

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.7e-34  Score=291.45  Aligned_cols=237  Identities=21%  Similarity=0.358  Sum_probs=192.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|..  +|+.||+|.++          ..+.+|++++++++|+|++++++++..++..++||||+++|+|.+++..
T Consensus        16 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   95 (267)
T cd08224          16 SVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKH   95 (267)
T ss_pred             eEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999998  68999999874          3577899999999999999999999999999999999999999999875


Q ss_pred             cC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          407 KR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       407 ~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      .. ....+++..++.++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++......   .......++
T Consensus        96 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~  169 (267)
T cd08224          96 FKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGT  169 (267)
T ss_pred             hcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC---cccceecCC
Confidence            32 2345899999999999999999999   6899999999999999999999999999987543221   112234578


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcCh-HHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK-KEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~-~~~  564 (611)
                      ..|+|||.+.+..++.++||||||+++|||++|+.|+......-   .+.......             ......+ ...
T Consensus       170 ~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~-------------~~~~~~~~~~~  233 (267)
T cd08224         170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCKKIEK-------------CDYPPLPADHY  233 (267)
T ss_pred             ccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH---HHHHhhhhc-------------CCCCCCChhhc
Confidence            89999999998889999999999999999999999986543221   111111110             0111111 245


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                      +..+.+++.+||+.+|++||++.+|++.|.+++
T Consensus       234 ~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         234 SEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            667899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.2e-35  Score=286.01  Aligned_cols=243  Identities=22%  Similarity=0.293  Sum_probs=191.5

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceecc--CCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEH--DGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|+.  +++.||+|+++-         ...+|+.+|.+.+|||||.+-.+...  -+..|||||||+. +|...+.
T Consensus        90 GiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d  168 (419)
T KOG0663|consen   90 GVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLME  168 (419)
T ss_pred             eeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHH
Confidence            99999998  788999999973         36799999999999999999887754  3579999999975 9999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ..+  +.+...+...+..|+++|++|||   ..-|+|||||++|+|+...|.+||+||||||..+..-   ...+..+-|
T Consensus       169 ~m~--q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~---k~~T~lVVT  240 (419)
T KOG0663|consen  169 TMK--QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL---KPYTPLVVT  240 (419)
T ss_pred             hcc--CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCCc---ccCcceEEE
Confidence            765  45888899999999999999999   6889999999999999999999999999999886542   345567889


Q ss_pred             CCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc--ccccc--c-Cc----
Q 007261          486 NGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA--KLSVL--V-DP----  555 (611)
Q Consensus       486 ~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~--~l~~~--~-d~----  555 (611)
                      .+|.|||.+.+. .|+...|+||+|||+.||+++++.|.+...  +.-...++.++.......  .+..+  . .-    
T Consensus       241 LWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE--~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~  318 (419)
T KOG0663|consen  241 LWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE--IDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSE  318 (419)
T ss_pred             eeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch--HHHHHHHHHHhCCCccccCCCccccchhhccccCC
Confidence            999999998765 599999999999999999999988766543  233344555554332110  00000  0 00    


Q ss_pred             ----cCCcC-h-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          556 ----NLQAN-K-KEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       556 ----~l~~~-~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                          .+... . ...++.-++|+...+..||.+|.|+.|.+++
T Consensus       319 ~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  319 HPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             CCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence                01111 0 1145677899999999999999999999875

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.3e-35  Score=310.35  Aligned_cols=244  Identities=24%  Similarity=0.310  Sum_probs=186.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec-HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccCH
Q 007261          339 GSVFRGII--NGSTVAIKCMR-RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW  415 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~  415 (611)
                      |.||++..  .++.||+|... ..+.+|+.++++++||||+++++++..+...++|+|++. ++|.+++....   .+++
T Consensus       106 g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~l~~  181 (391)
T PHA03212        106 GFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKR---NIAI  181 (391)
T ss_pred             eEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcC---CCCH
Confidence            89999987  68899999876 467899999999999999999999999999999999995 78998887643   3889


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhc
Q 007261          416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME  495 (611)
Q Consensus       416 ~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  495 (611)
                      ..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  ........||+.|+|||++.
T Consensus       182 ~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~  256 (391)
T PHA03212        182 CDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN--ANKYYGWAGTIATNAPELLA  256 (391)
T ss_pred             HHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc--ccccccccCccCCCChhhhc
Confidence            999999999999999999   6899999999999999999999999999986532211  11223457899999999999


Q ss_pred             cCCCCCccchHHHHHHHHHHHhCCCCCcCCCCh------hhHHHHHHHHHHhcCCcc------ccccc---------ccC
Q 007261          496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGE------EILLAEAVFSMVEGGNAE------AKLSV---------LVD  554 (611)
Q Consensus       496 ~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~------~~~l~~~~~~~~~~~~~~------~~l~~---------~~d  554 (611)
                      +..++.++||||||+++|||++|+.|++.....      ...+.. +.........+      ..+..         ...
T Consensus       257 ~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~-i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (391)
T PHA03212        257 RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL-IIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRK  335 (391)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH-HHHHhcCChhhcCcchhHHHHHHHHHHHhccCCC
Confidence            999999999999999999999999887653211      111111 11110000000      00000         000


Q ss_pred             ccCCc---ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 PNLQA---NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 ~~l~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +....   .....+.++.+|+.+||+.||++|||+.|++++
T Consensus       336 ~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        336 PGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             CCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            11111   122456688999999999999999999999864

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.1e-35  Score=295.29  Aligned_cols=235  Identities=28%  Similarity=0.500  Sum_probs=187.8

Q ss_pred             ceEEEEEE--cC---cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NG---STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g---~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|..  ++   ..+|+|.++        +.+.+|+.++++++||||+++++++..++..++||||+++++|.+++.
T Consensus        18 g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   97 (267)
T cd05066          18 GEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR   97 (267)
T ss_pred             CceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHH
Confidence            89999986  23   379999875        357889999999999999999999999999999999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...  ..+++.+++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++................++
T Consensus        98 ~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  172 (267)
T cd05066          98 KHD--GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP  172 (267)
T ss_pred             hcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccc
Confidence            653  34899999999999999999999   6899999999999999999999999999987654322111111223345


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      ..|++||.+.+..++.++|+||||++++|+++ |..|+......+.  ..    ....+..            ...+...
T Consensus       173 ~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~--~~----~~~~~~~------------~~~~~~~  234 (267)
T cd05066         173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV--IK----AIEEGYR------------LPAPMDC  234 (267)
T ss_pred             eeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH--HH----HHhCCCc------------CCCCCCC
Confidence            68999999998899999999999999999887 9988865443221  11    1111100            0111234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      +..+.+++.+||+.+|.+||++.++++.|.++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         235 PAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            56788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.8e-35  Score=296.87  Aligned_cols=234  Identities=21%  Similarity=0.300  Sum_probs=185.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.+|+|.+..          .+..|++++++++||||+++++++..+...++||||+++++|.+++..
T Consensus         7 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~   86 (277)
T cd05607           7 GEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYN   86 (277)
T ss_pred             eEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHh
Confidence            89999987  689999999852          234599999999999999999999999999999999999999998865


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .. ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++.......    ......++.
T Consensus        87 ~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~  158 (277)
T cd05607          87 VG-ERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGTN  158 (277)
T ss_pred             cc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----eeeccCCCC
Confidence            43 234889999999999999999999   6899999999999999999999999999987543221    223356889


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++|||||||++|||++|+.|+....... ...........             ..........+.
T Consensus       159 ~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~-------------~~~~~~~~~~~~  224 (277)
T cd05607         159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLE-------------DEVKFEHQNFTE  224 (277)
T ss_pred             CccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhc-------------cccccccccCCH
Confidence            9999999998889999999999999999999999986543211 11111111110             011111123456


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      ++.+++.+||+.||++||++.|+++.+.
T Consensus       225 ~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         225 ESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             HHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            7899999999999999999977765444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.4e-35  Score=307.05  Aligned_cols=226  Identities=25%  Similarity=0.398  Sum_probs=184.0

Q ss_pred             ceEEEEEE-----cCcEEEEEEecH-----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII-----NGSTVAIKCMRR-----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||++..     .|+.||||++++           .+.+|+.+|++++||||+++++++..++..|+||||+++|+|.+
T Consensus        10 g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   89 (323)
T cd05584          10 GKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFM   89 (323)
T ss_pred             eEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHH
Confidence            89999875     577899999863           24579999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++....   .+.+.....++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......   ......
T Consensus        90 ~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~  160 (323)
T cd05584          90 HLEREG---IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHTF  160 (323)
T ss_pred             HHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC---Cccccc
Confidence            997653   3778888889999999999999   6899999999999999999999999999987543221   122345


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      .|++.|+|||.+.+..++.++||||||+++|||++|+.||.......     ....... +.             ...+.
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-----~~~~~~~-~~-------------~~~~~  221 (323)
T cd05584         161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-----TIDKILK-GK-------------LNLPP  221 (323)
T ss_pred             CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-----HHHHHHc-CC-------------CCCCC
Confidence            68999999999998889999999999999999999999987544321     1111111 00             01122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      ..+..+.+++.+||+.||++||     ++.+++++
T Consensus       222 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         222 YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            3456688999999999999999     78888764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-35  Score=292.71  Aligned_cols=234  Identities=27%  Similarity=0.509  Sum_probs=186.8

Q ss_pred             ceEEEEEE--cC---cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NG---STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g---~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|++  .+   ..+|+|.++        +++.+|+.++++++|+||+++++++. ....++||||+++|+|.+++.
T Consensus         9 g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~   87 (257)
T cd05060           9 GSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLK   87 (257)
T ss_pred             eeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHH
Confidence            89999987  22   679999975        35678999999999999999999886 446799999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..++.++.|++.||+|||   ..+++|+||||+|||++.++.+||+|||+++................++
T Consensus        88 ~~~---~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~  161 (257)
T cd05060          88 KRR---EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWP  161 (257)
T ss_pred             hCC---CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcccc
Confidence            754   4899999999999999999999   6889999999999999999999999999988664333222222223345


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      ..|+|||.+.+..++.++||||||+++|||++ |+.|+......+  +..    .......            ...+..+
T Consensus       162 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--~~~----~~~~~~~------------~~~~~~~  223 (257)
T cd05060         162 LKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--VIA----MLESGER------------LPRPEEC  223 (257)
T ss_pred             ccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--HHH----HHHcCCc------------CCCCCCC
Confidence            68999999999999999999999999999998 888876543322  111    1111100            0112234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                      +..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.7e-35  Score=300.95  Aligned_cols=237  Identities=28%  Similarity=0.498  Sum_probs=188.5

Q ss_pred             ceEEEEEEc-------CcEEEEEEecH--------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGIIN-------GSTVAIKCMRR--------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||++...       ...+|+|.++.        ++.+|++++.++ +|+||+++++++..++..+++|||+++|+|.+
T Consensus        26 g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~  105 (293)
T cd05053          26 GQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRD  105 (293)
T ss_pred             ccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHH
Confidence            899999863       25799998852        477899999999 89999999999999999999999999999999


Q ss_pred             HhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccc
Q 007261          403 WLHKKR-------------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSA  469 (611)
Q Consensus       403 ~l~~~~-------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~  469 (611)
                      +++...             ....+++..++.++.|++.||+|||   ..+++||||||+|||+++++.+||+|||+++..
T Consensus       106 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~  182 (293)
T cd05053         106 FLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDI  182 (293)
T ss_pred             HHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCCCeEEeCcccccccc
Confidence            997531             2345899999999999999999999   689999999999999999999999999998765


Q ss_pred             ccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccc
Q 007261          470 VREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAK  548 (611)
Q Consensus       470 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  548 (611)
                      ..... ........++..|+|||.+.+..++.++||||||+++|||++ |..|+......+.      ........    
T Consensus       183 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~~~~~~~----  251 (293)
T cd05053         183 HHIDY-YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL------FKLLKEGY----  251 (293)
T ss_pred             ccccc-eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH------HHHHHcCC----
Confidence            43221 111222345678999999998999999999999999999998 8887765433221      11111110    


Q ss_pred             cccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       549 l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                              ....+..++..+.+|+.+||+.||++|||+.|+++.|+++.
T Consensus       252 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         252 --------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                    00112234567889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.4e-35  Score=297.40  Aligned_cols=234  Identities=27%  Similarity=0.466  Sum_probs=184.6

Q ss_pred             ceEEEEEEc-------CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIIN-------GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~-------g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|.+.       +..|++|.++        .++.+|+.++++++|+||+++++++.+.+..++||||+++++|.++
T Consensus        20 g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~   99 (277)
T cd05036          20 GEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSF   99 (277)
T ss_pred             CcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHH
Confidence            899999883       3579999875        3578899999999999999999999988899999999999999999


Q ss_pred             hhccCC----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEEeeecCccccccccCCc
Q 007261          404 LHKKRY----PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL---RAKLANFSFVRSAVREESGY  476 (611)
Q Consensus       404 l~~~~~----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgla~~~~~~~~~~  476 (611)
                      +...+.    ...++|..+++++.||+.||+|||   ..+++|+||||+|||++.++   .+||+|||+++....... .
T Consensus       100 i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~  175 (277)
T cd05036         100 LRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY-Y  175 (277)
T ss_pred             HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEeccCccccccCCccc-e
Confidence            976532    235899999999999999999999   68899999999999998754   699999999876532211 1


Q ss_pred             ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCc
Q 007261          477 SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP  555 (611)
Q Consensus       477 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  555 (611)
                      ........+..|+|||.+.+..++.++|||||||++|||++ |..||......+.      .........          
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~----------  239 (277)
T cd05036         176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV------MEFVTGGGR----------  239 (277)
T ss_pred             ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHcCCc----------
Confidence            11112233568999999999999999999999999999997 8888765443221      111111100          


Q ss_pred             cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       556 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                        ...+..++..+.+++.+||+.+|++||++.+|+++|.
T Consensus       240 --~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         240 --LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence              0112234567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-35  Score=299.15  Aligned_cols=231  Identities=23%  Similarity=0.312  Sum_probs=187.0

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +++.||+|.++.          .+.+|+.++++++|+||+++++.+..++..++||||+++|+|.+++..
T Consensus        14 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   93 (285)
T cd05605          14 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYN   93 (285)
T ss_pred             eEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHh
Confidence            89999987  688999999853          356799999999999999999999999999999999999999998875


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .. ...+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||+++......    ......|+.
T Consensus        94 ~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~  165 (285)
T cd05605          94 MG-NPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----TIRGRVGTV  165 (285)
T ss_pred             cC-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----ccccccCCC
Confidence            42 234899999999999999999999   6899999999999999999999999999987543211    122346899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||........  .+.+......             .....+...+.
T Consensus       166 ~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~~~~~~~~-------------~~~~~~~~~~~  230 (285)
T cd05605         166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REEVERRVKE-------------DQEEYSEKFSE  230 (285)
T ss_pred             CccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHHHHHHhhh-------------cccccCcccCH
Confidence            99999999988999999999999999999999999976443211  1111111110             00111234566


Q ss_pred             HHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      .+.+|+.+||+.||++||     ++++++++
T Consensus       231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         231 AARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             HHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            789999999999999999     88888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-35  Score=292.42  Aligned_cols=230  Identities=25%  Similarity=0.510  Sum_probs=184.8

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||++.+ .+..+|+|.++      .++.+|++++++++|+||+++++++...+..++||||+++++|.+++....  .
T Consensus        18 ~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~   95 (256)
T cd05059          18 GVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK--G   95 (256)
T ss_pred             ceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc--c
Confidence            89999988 45589999985      357889999999999999999999999999999999999999999997653  2


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.......  .......++..|+||
T Consensus        96 ~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~P  170 (256)
T cd05059          96 KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--TSSQGTKFPVKWAPP  170 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc--cccCCCCCCccccCH
Confidence            5899999999999999999999   68999999999999999999999999999876532211  111122344579999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+.+..++.++||||||+++|||++ |+.|+......+..  .   .. ...         ...   ..+...+..+.+
T Consensus       171 e~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~---~~-~~~---------~~~---~~~~~~~~~~~~  232 (256)
T cd05059         171 EVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV--E---SV-SAG---------YRL---YRPKLAPTEVYT  232 (256)
T ss_pred             HHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH--H---HH-HcC---------CcC---CCCCCCCHHHHH
Confidence            99999999999999999999999999 67777544332211  1   11 100         000   111234667999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHH
Q 007261          571 LCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      ++.+||+.+|++||++.|+++.|
T Consensus       233 li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         233 IMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHHHhcCChhhCcCHHHHHHHh
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=299.12  Aligned_cols=234  Identities=26%  Similarity=0.372  Sum_probs=184.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------------------HHHHHHHHHHHhcCCCceeeccceeccC--CeEEEEEe
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------------------RSISKEVNLLKKINHFNLINLFGACEHD--GVFYLVYE  393 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------------------~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E  393 (611)
                      |.|-++..  +|+.||||++.                     +...+|+.+|++++|||||+|+.+..+.  +.+|||+|
T Consensus       111 GkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVle  190 (576)
T KOG0585|consen  111 GKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLE  190 (576)
T ss_pred             ceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEE
Confidence            88888877  78999999984                     2567899999999999999999998764  67999999


Q ss_pred             ecCCCCHHHHhhccCCCCc-cCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          394 FMENGSLSDWLHKKRYPEF-VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~-l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      ||..|.+...=    .... ++..+.++++.++..||+|||   .++|+||||||+|+||+++|++||+|||.+......
T Consensus       191 y~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~  263 (576)
T KOG0585|consen  191 YCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQG  263 (576)
T ss_pred             eccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEEeeccceeeecccC
Confidence            99988764322    2233 899999999999999999999   699999999999999999999999999988755222


Q ss_pred             c--CCcccccccccCCCccchhhhccCC----CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc
Q 007261          473 E--SGYSSTKTAVGTNGYMAPEYMEYGL----VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       473 ~--~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  546 (611)
                      .  .........+||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||.+...-+  +.+            
T Consensus       264 ~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~--l~~------------  329 (576)
T KOG0585|consen  264 SDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE--LFD------------  329 (576)
T ss_pred             CccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH--HHH------------
Confidence            1  1112234478999999999987633    4568999999999999999999998654221  111            


Q ss_pred             cccccccCccC-CcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          547 AKLSVLVDPNL-QANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       547 ~~l~~~~d~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                          .++...+ -+...++.+.+.+|++++|+.||+.|.+..+|..+...-+
T Consensus       330 ----KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  330 ----KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             ----HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence                1111111 1223356788999999999999999999999988875443

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-34  Score=293.10  Aligned_cols=236  Identities=25%  Similarity=0.455  Sum_probs=185.8

Q ss_pred             ceEEEEEEc-----CcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCe------EEEEEeecCCC
Q 007261          339 GSVFRGIIN-----GSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGV------FYLVYEFMENG  398 (611)
Q Consensus       339 g~Vy~g~~~-----g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~lV~E~~~~g  398 (611)
                      |.||+|...     +..||||.++         ..+.+|+++++.++|+||+++++++.....      .++++||+++|
T Consensus        13 g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~   92 (273)
T cd05035          13 GSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHG   92 (273)
T ss_pred             ceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCC
Confidence            899999872     2679999885         247789999999999999999998866544      79999999999


Q ss_pred             CHHHHhhccC---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC
Q 007261          399 SLSDWLHKKR---YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG  475 (611)
Q Consensus       399 sL~~~l~~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~  475 (611)
                      +|..++....   ....+++...+.++.|++.||+|||   ..+++||||||+||++++++.+||+|||+++........
T Consensus        93 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  169 (273)
T cd05035          93 DLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYY  169 (273)
T ss_pred             CHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCccceeeccccccc
Confidence            9999986532   2346899999999999999999999   689999999999999999999999999998765433211


Q ss_pred             cccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccC
Q 007261          476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD  554 (611)
Q Consensus       476 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  554 (611)
                       ........+..|+|||.+....++.++||||||+++|||++ |..|+......+.     . .....+           
T Consensus       170 -~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~-----~-~~~~~~-----------  231 (273)
T cd05035         170 -RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI-----Y-DYLRHG-----------  231 (273)
T ss_pred             -cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH-----H-HHHHcC-----------
Confidence             11122334678999999998899999999999999999999 7777654332211     1 111111           


Q ss_pred             ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       555 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                       .....+..++..+.+++.+||+.||++||++.|+++.|+++
T Consensus       232 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 -NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             01111234556789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.1e-35  Score=297.79  Aligned_cols=238  Identities=29%  Similarity=0.525  Sum_probs=188.7

Q ss_pred             ceEEEEEEc-------CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIIN-------GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~-------g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|...       ...+++|.+.        .++.+|+.++++++||||+++++.|..++..++++||+++|+|.++
T Consensus        14 g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   93 (290)
T cd05045          14 GKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSF   93 (290)
T ss_pred             cceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHH
Confidence            899999863       2469999874        2577899999999999999999999999999999999999999999


Q ss_pred             hhccC---------------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 007261          404 LHKKR---------------------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLAN  462 (611)
Q Consensus       404 l~~~~---------------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D  462 (611)
                      +....                     ....+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|
T Consensus        94 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~nill~~~~~~kl~d  170 (290)
T cd05045          94 LRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISD  170 (290)
T ss_pred             HHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheEEEcCCCcEEecc
Confidence            87532                     1235889999999999999999999   68999999999999999999999999


Q ss_pred             ecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHh
Q 007261          463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVE  541 (611)
Q Consensus       463 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  541 (611)
                      ||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..|+......+      +.....
T Consensus       171 fg~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~  243 (290)
T cd05045         171 FGLSRDVYEEDS-YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER------LFNLLK  243 (290)
T ss_pred             ccccccccCccc-hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHh
Confidence            999875532221 111222345678999999988889999999999999999998 888875443222      111221


Q ss_pred             cCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          542 GGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       542 ~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      ...         ..   ..+...+.++.+++.+||+.+|++||++.|+++.|+++..
T Consensus       244 ~~~---------~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         244 TGY---------RM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CCC---------CC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            110         00   0122345678899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7e-35  Score=305.31  Aligned_cols=239  Identities=26%  Similarity=0.462  Sum_probs=187.1

Q ss_pred             ceEEEEEE-------cCcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceecc-CCeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII-------NGSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEH-DGVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~  401 (611)
                      |.||+|..       .++.||+|+++        +.+.+|+.++.++ +|+||++++++|.. +...+++|||+++++|.
T Consensus        21 g~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~  100 (337)
T cd05054          21 GKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLS  100 (337)
T ss_pred             ceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHH
Confidence            89999975       23689999975        2466799999999 89999999998864 45689999999999999


Q ss_pred             HHhhccCC----------------------------------------------------------CCccCHHHHHHHHH
Q 007261          402 DWLHKKRY----------------------------------------------------------PEFVSWNCRFRIAL  423 (611)
Q Consensus       402 ~~l~~~~~----------------------------------------------------------~~~l~~~~~~~ia~  423 (611)
                      +++.....                                                          ...++|..+..++.
T Consensus       101 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  180 (337)
T cd05054         101 NYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSF  180 (337)
T ss_pred             HHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHH
Confidence            99864321                                                          12589999999999


Q ss_pred             HHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCcc
Q 007261          424 DVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM  503 (611)
Q Consensus       424 ~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ks  503 (611)
                      ||+.||+|||   ..+|+||||||+|||+++++.+||+|||+++........ .......++..|+|||++.+..++.++
T Consensus       181 qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~  256 (337)
T cd05054         181 QVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPESIFDKVYTTQS  256 (337)
T ss_pred             HHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCccccCcHHhcCCCCCccc
Confidence            9999999999   689999999999999999999999999999865332211 112234556789999999999999999


Q ss_pred             chHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCC
Q 007261          504 DTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPES  582 (611)
Q Consensus       504 DV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~  582 (611)
                      |||||||+++||++ |..||......+. +    ........            ....+.....++.+++.+||+.+|++
T Consensus       257 Di~SlGv~l~el~t~g~~p~~~~~~~~~-~----~~~~~~~~------------~~~~~~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         257 DVWSFGVLLWEIFSLGASPYPGVQIDEE-F----CRRLKEGT------------RMRAPEYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             cHHHHHHHHHHHHHcCCCCCCCCCccHH-H----HHHHhccC------------CCCCCccCCHHHHHHHHHHccCChhh
Confidence            99999999999998 8888765332221 1    11111110            00112234567899999999999999


Q ss_pred             CCCHHHHHHHHHhchh
Q 007261          583 RPSMAEVVSTLMKIQL  598 (611)
Q Consensus       583 RPs~~evl~~L~~i~~  598 (611)
                      ||++.|++++|.++..
T Consensus       320 RPs~~ell~~l~~~~~  335 (337)
T cd05054         320 RPTFSELVEILGDLLQ  335 (337)
T ss_pred             CcCHHHHHHHHHHHHh
Confidence            9999999999998654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.4e-35  Score=311.56  Aligned_cols=238  Identities=25%  Similarity=0.492  Sum_probs=188.5

Q ss_pred             ceEEEEEEcC-------cEEEEEEec--------HHHHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGIING-------STVAIKCMR--------RSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~~g-------~~vavK~~~--------~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||+|.+.+       ..||||+++        ..+.+|+.+|.++. ||||++++|+|...+..++||||+++|+|.+
T Consensus        51 G~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~  130 (401)
T cd05107          51 GRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVD  130 (401)
T ss_pred             eeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHH
Confidence            8999998643       579999996        24778999999997 9999999999999999999999999999999


Q ss_pred             HhhccCC-------------------------------------------------------------------------
Q 007261          403 WLHKKRY-------------------------------------------------------------------------  409 (611)
Q Consensus       403 ~l~~~~~-------------------------------------------------------------------------  409 (611)
                      +++..+.                                                                         
T Consensus       131 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (401)
T cd05107         131 YLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYE  210 (401)
T ss_pred             HHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcC
Confidence            9975321                                                                         


Q ss_pred             ----------------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          410 ----------------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       410 ----------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                                            ...++|...+.++.|++.||+|||   ..+++||||||+|||+++++.+||+|||+++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~  287 (401)
T cd05107         211 SPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLAR  287 (401)
T ss_pred             CchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeCCCEEEEEecCcce
Confidence                                  124678889999999999999999   6899999999999999999999999999987


Q ss_pred             ccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcc
Q 007261          468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       468 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  546 (611)
                      ....... ........++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+.     ....+..+.. 
T Consensus       288 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-----~~~~~~~~~~-  360 (401)
T cd05107         288 DIMRDSN-YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-----FYNAIKRGYR-  360 (401)
T ss_pred             ecccccc-cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-----HHHHHHcCCC-
Confidence            6432211 111223356788999999998889999999999999999998 7777754433221     1111111100 


Q ss_pred             cccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       547 ~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                                 ...+..++.++.+++.+||+.+|.+||++.||++.|+++.
T Consensus       361 -----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         361 -----------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                       0012234567999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4e-35  Score=305.01  Aligned_cols=220  Identities=24%  Similarity=0.409  Sum_probs=179.8

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +++.||||++++          .+..|..++..+ +||||+++++++...+..++||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~   88 (320)
T cd05590           9 GKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQ   88 (320)
T ss_pred             eEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHH
Confidence            89999987  578999999863          245688888776 79999999999999999999999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......   .......||
T Consensus        89 ~~~---~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---~~~~~~~gt  159 (320)
T cd05590          89 KSR---RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---KTTSTFCGT  159 (320)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC---CcccccccC
Confidence            653   3888999999999999999999   6899999999999999999999999999987532221   123345789


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||......+.     ...... ..             ...+...+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----~~~i~~-~~-------------~~~~~~~~  220 (320)
T cd05590         160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-----FEAILN-DE-------------VVYPTWLS  220 (320)
T ss_pred             ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-----HHHHhc-CC-------------CCCCCCCC
Confidence            999999999999999999999999999999999999876543221     111111 10             00112245


Q ss_pred             HHHHHHHHHhhccCCCCCCCH
Q 007261          566 HHLIMLCLACIAREPESRPSM  586 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~  586 (611)
                      .++.+++.+||+.||++||++
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         221 QDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHHHHHHHHHcccCHHHCCCC
Confidence            678899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9.4e-35  Score=299.75  Aligned_cols=244  Identities=22%  Similarity=0.315  Sum_probs=183.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  +|+.||||+++        ..+.+|+.++++++||||+++++++.++...++||||++ ++|.+++....
T Consensus        19 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   97 (303)
T cd07869          19 ATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHP   97 (303)
T ss_pred             EEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCC
Confidence            89999988  68899999985        246789999999999999999999999999999999995 68888887643


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                        ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++......   .......+++.|
T Consensus        98 --~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y  169 (303)
T cd07869          98 --GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS---HTYSNEVVTLWY  169 (303)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC---ccCCCCcccCCC
Confidence              34788899999999999999999   6899999999999999999999999999987542221   122345678999


Q ss_pred             cchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc-----cccccCccC----C
Q 007261          489 MAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK-----LSVLVDPNL----Q  558 (611)
Q Consensus       489 ~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~-----l~~~~d~~l----~  558 (611)
                      +|||.+.+ ..++.++||||||+++|||++|+.||.........+... ............     .........    .
T Consensus       170 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (303)
T cd07869         170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERI-FLVLGTPNEDTWPGVHSLPHFKPERFTLYSP  248 (303)
T ss_pred             CChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH-HHHhCCCChhhccchhhccccccccccccCC
Confidence            99998865 458899999999999999999999997654322222111 111111100000     000000000    0


Q ss_pred             cCh------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 ANK------KEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 ~~~------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ...      ......+.+|+.+||+.||++|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         249 KNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             ccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            000      0123567899999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-34  Score=293.67  Aligned_cols=236  Identities=25%  Similarity=0.475  Sum_probs=182.8

Q ss_pred             ceEEEEEEc--Cc--EEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccC------CeEEEEEeecCCCC
Q 007261          339 GSVFRGIIN--GS--TVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD------GVFYLVYEFMENGS  399 (611)
Q Consensus       339 g~Vy~g~~~--g~--~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~E~~~~gs  399 (611)
                      |.||+|.+.  +.  .+|+|.++         +.+.+|+.++++++|+||+++++++...      ...+++|||+++|+
T Consensus        13 g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~   92 (272)
T cd05075          13 GSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGD   92 (272)
T ss_pred             ceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCc
Confidence            899999983  32  69999874         3577899999999999999999987432      24689999999999


Q ss_pred             HHHHhhccC---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc
Q 007261          400 LSDWLHKKR---YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY  476 (611)
Q Consensus       400 L~~~l~~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  476 (611)
                      |.+++...+   ....+++...+.++.|++.||+|||   ..+|+||||||+|||+++++.+||+|||+++....... .
T Consensus        93 l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  168 (272)
T cd05075          93 LHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY-Y  168 (272)
T ss_pred             HHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCcccccCcccc-e
Confidence            999885322   2345899999999999999999999   68999999999999999999999999999876533221 1


Q ss_pred             ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCc
Q 007261          477 SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP  555 (611)
Q Consensus       477 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  555 (611)
                      .......++..|++||.+.+..++.++||||||+++|||++ |+.||......+  .    ......+..          
T Consensus       169 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~----~~~~~~~~~----------  232 (272)
T cd05075         169 RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--I----YDYLRQGNR----------  232 (272)
T ss_pred             ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H----HHHHHcCCC----------
Confidence            11223345678999999999999999999999999999999 677765433221  1    111111110          


Q ss_pred             cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       556 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                        ...+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus       233 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 --LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              011123455689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-34  Score=290.44  Aligned_cols=230  Identities=25%  Similarity=0.506  Sum_probs=189.5

Q ss_pred             ceEEEEEEcCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCc
Q 007261          339 GSVFRGIINGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEF  412 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~  412 (611)
                      |.||++...|+.||+|.++      +.+.+|+.++++++|+||+++++++.+....++||||+++++|.+++..... ..
T Consensus        20 g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~   98 (256)
T cd05039          20 GDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR-AV   98 (256)
T ss_pred             ceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCC-CC
Confidence            8999999999999999986      3577899999999999999999999989999999999999999999976532 35


Q ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchh
Q 007261          413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE  492 (611)
Q Consensus       413 l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE  492 (611)
                      +++..+..++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||+++......      .....+..|+|||
T Consensus        99 ~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~ape  169 (256)
T cd05039          99 ITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ------DSGKLPVKWTAPE  169 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc------ccCCCcccccCch
Confidence            899999999999999999999   6899999999999999999999999999987653211      1234466899999


Q ss_pred             hhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHH
Q 007261          493 YMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML  571 (611)
Q Consensus       493 ~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l  571 (611)
                      .+..+.++.++||||||+++||+++ |..|+......+.      ........            ....+...+..+.++
T Consensus       170 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~------------~~~~~~~~~~~~~~l  231 (256)
T cd05039         170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPHVEKGY------------RMEAPEGCPPEVYKV  231 (256)
T ss_pred             hhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH------HHHHhcCC------------CCCCccCCCHHHHHH
Confidence            9998899999999999999999998 8888765432221      11111110            001122345778999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          572 CLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       572 ~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      +.+||..+|++||++.|+++.|..+
T Consensus       232 i~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         232 MKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HHHHhccChhhCcCHHHHHHHHhcC
Confidence            9999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.2e-35  Score=304.97  Aligned_cols=226  Identities=22%  Similarity=0.355  Sum_probs=183.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|..  +|+.||||++++          .+..|.+++..+ +||||+++++++.+++..|+||||+++|+|..++.
T Consensus         9 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~   88 (321)
T cd05591           9 GKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQ   88 (321)
T ss_pred             eEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHH
Confidence            89999988  567999999863          245688888876 89999999999999999999999999999999987


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ..+   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||
T Consensus        89 ~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~gt  159 (321)
T cd05591          89 RSR---KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---VTTTTFCGT  159 (321)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC---ccccccccC
Confidence            653   3889999999999999999999   6899999999999999999999999999987542221   122345689


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||......+.     ........        .      ..+...+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-----~~~i~~~~--------~------~~p~~~~  220 (321)
T cd05591         160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-----FESILHDD--------V------LYPVWLS  220 (321)
T ss_pred             ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-----HHHHHcCC--------C------CCCCCCC
Confidence            999999999999999999999999999999999999976543221     11111100        0      0112234


Q ss_pred             HHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRP-------SMAEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RP-------s~~evl~~  592 (611)
                      .++.+++.+||+.||++||       ++.+++++
T Consensus       221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            6788999999999999999       77787765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.3e-34  Score=291.00  Aligned_cols=230  Identities=26%  Similarity=0.487  Sum_probs=186.4

Q ss_pred             ceEEEEEEcCcEEEEEEec-----HHHHHHHHHHHhcCCCceeeccceec-cCCeEEEEEeecCCCCHHHHhhccCCCCc
Q 007261          339 GSVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGACE-HDGVFYLVYEFMENGSLSDWLHKKRYPEF  412 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~  412 (611)
                      |.||++...|..||+|.++     +.+.+|+.++++++|+|++++++++. .++..++||||+++++|.+++.... ...
T Consensus        20 ~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~   98 (256)
T cd05082          20 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSV   98 (256)
T ss_pred             CeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcC-CCC
Confidence            8999999999999999986     35788999999999999999999764 5567899999999999999998653 235


Q ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchh
Q 007261          413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE  492 (611)
Q Consensus       413 l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE  492 (611)
                      +++..++.++.|++.||+|||   ..+++||||||+||++++++.+||+|||+++......      .....+..|+|||
T Consensus        99 ~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE  169 (256)
T cd05082          99 LGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPE  169 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC------CCCccceeecCHH
Confidence            889999999999999999999   6899999999999999999999999999987543211      2233456899999


Q ss_pred             hhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHH
Q 007261          493 YMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML  571 (611)
Q Consensus       493 ~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l  571 (611)
                      .+.+..++.++||||||+++|||++ |+.|+......+     ... ....+..         +   ..+..++..+.++
T Consensus       170 ~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-----~~~-~~~~~~~---------~---~~~~~~~~~~~~l  231 (256)
T cd05082         170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVP-RVEKGYK---------M---DAPDGCPPVVYDV  231 (256)
T ss_pred             HHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHH-HHhcCCC---------C---CCCCCCCHHHHHH
Confidence            9999899999999999999999998 887775433211     111 1111100         0   1122345678999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          572 CLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       572 ~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      +.+||+.+|++||++.++++.|+++
T Consensus       232 i~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         232 MKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHHHHhcC
Confidence            9999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=309.82  Aligned_cols=232  Identities=25%  Similarity=0.397  Sum_probs=187.5

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||+++.          .+.+|+.++..++|+||+++++++.+++..++||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   94 (350)
T cd05573          15 GEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR   94 (350)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH
Confidence            89999998  489999999863          366799999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC------------
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES------------  474 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~------------  474 (611)
                      .   ..+++..+..++.||+.||+|||   ..+++||||||+|||++.++.+||+|||+++.......            
T Consensus        95 ~---~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~  168 (350)
T cd05573          95 K---DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL  168 (350)
T ss_pred             c---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccc
Confidence            5   34888999999999999999999   68999999999999999999999999999876543220            


Q ss_pred             --------------CcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHH
Q 007261          475 --------------GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMV  540 (611)
Q Consensus       475 --------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  540 (611)
                                    .........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.     .....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~-----~~~i~  243 (350)
T cd05573         169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET-----YNKII  243 (350)
T ss_pred             ccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH-----HHHHh
Confidence                          00122345689999999999999999999999999999999999999976553221     11111


Q ss_pred             hcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 007261          541 EGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPS-MAEVVST  592 (611)
Q Consensus       541 ~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~  592 (611)
                      ...   ..   ..-+    .....+..+.+++.+|+. ||.+||+ +.+++++
T Consensus       244 ~~~---~~---~~~p----~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         244 NWK---ES---LRFP----PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             ccC---Cc---ccCC----CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            100   00   0000    011145678899999997 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-34  Score=296.69  Aligned_cols=235  Identities=29%  Similarity=0.515  Sum_probs=186.5

Q ss_pred             ceEEEEEE-------cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII-------NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++..       ++..||+|.++        +++.+|+.++++++||||+++++++.+++..++||||+++|+|.++
T Consensus        19 g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   98 (288)
T cd05050          19 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF   98 (288)
T ss_pred             ccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHH
Confidence            89999986       35689999875        3577899999999999999999999999999999999999999999


Q ss_pred             hhccCC-------------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeec
Q 007261          404 LHKKRY-------------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS  464 (611)
Q Consensus       404 l~~~~~-------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg  464 (611)
                      +.....                   ...+++..++.++.|++.||+|||   ..+++||||||+||++++++.+||+|||
T Consensus        99 l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg  175 (288)
T cd05050          99 LRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFG  175 (288)
T ss_pred             HHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhheEecCCCceEECccc
Confidence            975321                   124788999999999999999999   6899999999999999999999999999


Q ss_pred             CccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcC
Q 007261          465 FVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGG  543 (611)
Q Consensus       465 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~  543 (611)
                      +++....... .........+..|+|||.+.+..++.++||||||+++|||++ |..|+......+.     . ..... 
T Consensus       176 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~-----~-~~~~~-  247 (288)
T cd05050         176 LSRNIYSADY-YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV-----I-YYVRD-  247 (288)
T ss_pred             cceecccCcc-ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----H-HHHhc-
Confidence            9875432211 111222334667999999998999999999999999999998 7777765433221     1 11111 


Q ss_pred             CcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 007261          544 NAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK  595 (611)
Q Consensus       544 ~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  595 (611)
                                 ......+..++.++.+++.+||+.||++||++.|+++.|++
T Consensus       248 -----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         248 -----------GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -----------CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                       11111122345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9.2e-35  Score=299.89  Aligned_cols=239  Identities=30%  Similarity=0.512  Sum_probs=188.8

Q ss_pred             ceEEEEEE--cCc--EEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGS--TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~--~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|.+  +|.  .+++|.++        ..+.+|++++.++ +|+||+++++++..++..++||||+++|+|.++++
T Consensus        21 g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  100 (303)
T cd05088          21 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR  100 (303)
T ss_pred             ceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHH
Confidence            89999987  454  46888765        2577899999999 89999999999999999999999999999999997


Q ss_pred             ccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          406 KKRY-------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       406 ~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      ....             ...+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++.....
T Consensus       101 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  177 (303)
T cd05088         101 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY  177 (303)
T ss_pred             hcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcEEeCccccCcccchh
Confidence            6431             235789999999999999999999   689999999999999999999999999998632211


Q ss_pred             cCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCccccccc
Q 007261          473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV  551 (611)
Q Consensus       473 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  551 (611)
                          ........+..|+|||.+.+..++.++||||||+++|||+| |..||......+.     . .......       
T Consensus       178 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----~-~~~~~~~-------  240 (303)
T cd05088         178 ----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-----Y-EKLPQGY-------  240 (303)
T ss_pred             ----hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-----H-HHHhcCC-------
Confidence                11122234667999999988889999999999999999998 8888865443221     1 1111000       


Q ss_pred             ccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          552 LVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       552 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                           ....+...+..+.+++.+||+.+|++||++.++++.|.++......
T Consensus       241 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~  286 (303)
T cd05088         241 -----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  286 (303)
T ss_pred             -----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence                 0011122445688999999999999999999999999988766554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.5e-34  Score=296.08  Aligned_cols=243  Identities=24%  Similarity=0.340  Sum_probs=182.2

Q ss_pred             ceEEEEEE---cCcEEEEEEec---------HHHHHHHHHHHhc---CCCceeeccceec-----cCCeEEEEEeecCCC
Q 007261          339 GSVFRGII---NGSTVAIKCMR---------RSISKEVNLLKKI---NHFNLINLFGACE-----HDGVFYLVYEFMENG  398 (611)
Q Consensus       339 g~Vy~g~~---~g~~vavK~~~---------~~~~~E~~~l~~l---~H~niv~l~g~~~-----~~~~~~lV~E~~~~g  398 (611)
                      |.||++..   +|..||||.++         ..+.+|+.+++.+   +||||++++++|.     .....++||||++ +
T Consensus        15 g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~   93 (290)
T cd07862          15 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-Q   93 (290)
T ss_pred             eEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-C
Confidence            89999986   46789999885         2456788887776   6999999999884     3456899999996 6


Q ss_pred             CHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccc
Q 007261          399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS  478 (611)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  478 (611)
                      +|.+++..... ..+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++.....    ..
T Consensus        94 ~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~  165 (290)
T cd07862          94 DLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ----MA  165 (290)
T ss_pred             CHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC----cc
Confidence            99999976432 34889999999999999999999   689999999999999999999999999998754322    12


Q ss_pred             ccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccc------ccc
Q 007261          479 TKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL------SVL  552 (611)
Q Consensus       479 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l------~~~  552 (611)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+..  ..+.............      ...
T Consensus       166 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~  243 (290)
T cd07862         166 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GKILDVIGLPGEEDWPRDVALPRQA  243 (290)
T ss_pred             cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH--HHHHHHhCCCChhhchhhhcccchh
Confidence            33456899999999999889999999999999999999999998765443211  1111111111000000      000


Q ss_pred             cCccCCcC----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          553 VDPNLQAN----KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       553 ~d~~l~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+.....    ....+..+.+++.+||+.||++|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         244 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             ccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            11111000    12345677899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.1e-35  Score=302.59  Aligned_cols=225  Identities=24%  Similarity=0.387  Sum_probs=180.1

Q ss_pred             ceEEEEEE--cCcEEEEEEecHH----------HHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRRS----------ISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +++.||||+++.+          +..|..++..+ +||||+++++++..++..++||||+++|+|.+++.
T Consensus         9 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~   88 (316)
T cd05592           9 GKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQ   88 (316)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence            89999988  5778999998642          34466666654 89999999999999999999999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++.....++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++......   .......||
T Consensus        89 ~~~---~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~~~~~~gt  159 (316)
T cd05592          89 SSG---RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKASTFCGT  159 (316)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---CccccccCC
Confidence            653   3888899999999999999999   6899999999999999999999999999987543221   123345689


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||......+..     ..... ..          +   ..+...+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~-----~~i~~-~~----------~---~~~~~~~  220 (316)
T cd05592         160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF-----DSILN-DR----------P---HFPRWIS  220 (316)
T ss_pred             ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHc-CC----------C---CCCCCCC
Confidence            9999999999999999999999999999999999998765432211     11111 00          0   1122345


Q ss_pred             HHHHHHHHHhhccCCCCCCCHH-HHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMA-EVVS  591 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~-evl~  591 (611)
                      .++.+++.+||+.||++||++. ++++
T Consensus       221 ~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         221 KEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            5678999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.9e-35  Score=304.28  Aligned_cols=225  Identities=26%  Similarity=0.380  Sum_probs=179.8

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHH---HhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLL---KKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++..  +|+.||||++++          .+.+|..++   ++++||||+++++++..++..|+||||+++|+|..+
T Consensus        13 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~   92 (324)
T cd05589          13 GKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMH   92 (324)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHH
Confidence            89999987  688999999963          234455544   566899999999999999999999999999999998


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      ++..    .+++..+..++.||+.||+|||   +.+++||||||+|||+++++.+||+|||+++......   .......
T Consensus        93 ~~~~----~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~  162 (324)
T cd05589          93 IHTD----VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG---DRTSTFC  162 (324)
T ss_pred             hhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC---Ccccccc
Confidence            8653    3899999999999999999999   6899999999999999999999999999986532211   1223456


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      |++.|+|||.+.+..++.++||||||+++|||++|+.||......+.     ........           .   ..+..
T Consensus       163 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-----~~~i~~~~-----------~---~~p~~  223 (324)
T cd05589         163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-----FDSIVNDE-----------V---RYPRF  223 (324)
T ss_pred             cCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCC-----------C---CCCCC
Confidence            89999999999999999999999999999999999999875543221     11111100           0   01223


Q ss_pred             HHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      .+..+.+++.+||+.||.+||     ++.+++++
T Consensus       224 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            456688999999999999999     46666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-35  Score=307.87  Aligned_cols=222  Identities=26%  Similarity=0.384  Sum_probs=181.4

Q ss_pred             ceEEEEEE-----cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII-----NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~-----~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||++..     +|+.+|+|++++         .+.+|++++++++||||+++++++.+.+..|+||||+++|+|.+++
T Consensus        10 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   89 (318)
T cd05582          10 GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL   89 (318)
T ss_pred             EEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHH
Confidence            89998864     578999999863         2457999999999999999999999999999999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ....   .+++..+..++.||+.||+|||   +.+++||||||+|||+++++.+||+|||+++......   .......|
T Consensus        90 ~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~g  160 (318)
T cd05582          90 SKEV---MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---KKAYSFCG  160 (318)
T ss_pred             HHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC---CceecccC
Confidence            7643   4899999999999999999999   6899999999999999999999999999987543221   12334578


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      +..|+|||.+.+..++.++||||||+++|||++|+.||......+.     ........              ...+...
T Consensus       161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-----~~~i~~~~--------------~~~p~~~  221 (318)
T cd05582         161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET-----MTMILKAK--------------LGMPQFL  221 (318)
T ss_pred             ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH-----HHHHHcCC--------------CCCCCCC
Confidence            9999999999988899999999999999999999999875443221     11111100              0112234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAE  588 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~e  588 (611)
                      +..+.+++.+||+.||++||++.+
T Consensus       222 ~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         222 SPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CHHHHHHHHHHhhcCHhHcCCCCC
Confidence            567889999999999999999555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-34  Score=291.35  Aligned_cols=238  Identities=26%  Similarity=0.437  Sum_probs=183.6

Q ss_pred             ceEEEEEE-----cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceec-cCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII-----NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACE-HDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~-----~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.+     ++..||+|.+.        ..+.+|+.+++.++||||+++++++. .++..++|+||+.+|+|.+++
T Consensus         9 g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   88 (262)
T cd05058           9 GCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI   88 (262)
T ss_pred             ceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHH
Confidence            89999986     23479999874        25678999999999999999999775 456689999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC-cccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG-YSSTKTAV  483 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~  483 (611)
                      ....  ..+++..++.++.|++.||+|||   ..+++||||||+|||+++++.+||+|||+++........ ........
T Consensus        89 ~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  163 (262)
T cd05058          89 RSET--HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAK  163 (262)
T ss_pred             HhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCc
Confidence            7643  23678888999999999999999   689999999999999999999999999998754322110 11112334


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      ++..|+|||.+....++.++||||||+++|||++|+.|++...... ....   .... +.            ....+..
T Consensus       164 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~~~~---~~~~-~~------------~~~~~~~  226 (262)
T cd05058         164 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-DITV---YLLQ-GR------------RLLQPEY  226 (262)
T ss_pred             CCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH---HHhc-CC------------CCCCCCc
Confidence            5678999999998899999999999999999999766554332211 1111   1111 10            0011122


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      .+..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus       227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         227 CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            34578899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.9e-34  Score=291.75  Aligned_cols=246  Identities=23%  Similarity=0.356  Sum_probs=189.3

Q ss_pred             HHHhhcCCCCCccc----ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEE
Q 007261          325 VVATENFSPKNMID----GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV  391 (611)
Q Consensus       325 ~~at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  391 (611)
                      +.++.++.....+|    |.||+|..  ++..|++|.+.       +.+.+|+.++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            34445555444453    89999987  56789999875       3578899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeecCccccc
Q 007261          392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-NLRAKLANFSFVRSAV  470 (611)
Q Consensus       392 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~  470 (611)
                      +||+++++|.+++.........++..+..++.|++.||.|||   ..+++||||||+||+++. ++.+||+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            999999999999986532212378888899999999999999   689999999999999986 6799999999987543


Q ss_pred             cccCCcccccccccCCCccchhhhccCC--CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc
Q 007261          471 REESGYSSTKTAVGTNGYMAPEYMEYGL--VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK  548 (611)
Q Consensus       471 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  548 (611)
                      ....   ......++..|+|||.+....  ++.++||||||+++|||++|+.|+............  ...         
T Consensus       161 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~--~~~---------  226 (268)
T cd06624         161 GINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK--VGM---------  226 (268)
T ss_pred             cCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh--hhh---------
Confidence            2211   222345788999999986644  788999999999999999999998654322111100  000         


Q ss_pred             cccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       549 l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                           .......+....+++.+++.+||+.+|++||++.|++++
T Consensus       227 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         227 -----FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             -----hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                 000111133455678999999999999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=9.4e-35  Score=295.93  Aligned_cols=238  Identities=26%  Similarity=0.443  Sum_probs=189.7

Q ss_pred             ceEEEEEEc------CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceecc-CCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIIN------GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEH-DGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~------g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|...      +..|++|.++        ..+.+|+.++++++|+||+++++++.. +...++++||+++|+|.++
T Consensus        20 g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~   99 (280)
T cd05043          20 GRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLF   99 (280)
T ss_pred             ceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHH
Confidence            899999973      5789999885        347789999999999999999998765 4678999999999999999


Q ss_pred             hhccCCC-----CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccc
Q 007261          404 LHKKRYP-----EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS  478 (611)
Q Consensus       404 l~~~~~~-----~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  478 (611)
                      +......     ..+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++........ ..
T Consensus       100 l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~-~~  175 (280)
T cd05043         100 LQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-CL  175 (280)
T ss_pred             HHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceE-Ee
Confidence            9764322     45899999999999999999999   689999999999999999999999999998755332211 11


Q ss_pred             ccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccC
Q 007261          479 TKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNL  557 (611)
Q Consensus       479 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l  557 (611)
                      .....++..|+|||.+.+..++.++||||||+++||+++ |+.|+......+  +.    .....+.         .   
T Consensus       176 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~----~~~~~~~---------~---  237 (280)
T cd05043         176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--MA----AYLKDGY---------R---  237 (280)
T ss_pred             CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--HH----HHHHcCC---------C---
Confidence            122345678999999998889999999999999999999 888886543221  11    1111110         0   


Q ss_pred             CcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          558 QANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      ......++.++.+++.+||+.||++||++.++++.|..+..
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         238 LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            00122345678999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-34  Score=298.50  Aligned_cols=240  Identities=28%  Similarity=0.491  Sum_probs=189.8

Q ss_pred             ceEEEEEE---------cCcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCH
Q 007261          339 GSVFRGII---------NGSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~---------~g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      |.||++..         ++..||+|.++        +++.+|+.+++.+ +||||+++++++...+..++||||+++|+|
T Consensus        29 g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  108 (304)
T cd05101          29 GQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  108 (304)
T ss_pred             ceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcH
Confidence            89999974         23479999985        2477899999999 899999999999999999999999999999


Q ss_pred             HHHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          401 SDWLHKKRY-------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       401 ~~~l~~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      .+++.....             ...++|..++.++.||+.||.|||   +.+++||||||+|||+++++.+||+|||+++
T Consensus       109 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili~~~~~~kl~D~g~~~  185 (304)
T cd05101         109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR  185 (304)
T ss_pred             HHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEEcCCCcEEECCCccce
Confidence            999976431             235789999999999999999999   6899999999999999999999999999987


Q ss_pred             ccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcc
Q 007261          468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       468 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  546 (611)
                      ....... ........++..|+|||.+.+..++.++||||||+++|||++ |..|+......+     . ........  
T Consensus       186 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~-~~~~~~~~--  256 (304)
T cd05101         186 DVNNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-----L-FKLLKEGH--  256 (304)
T ss_pred             ecccccc-cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-----H-HHHHHcCC--
Confidence            6532221 112223345678999999998899999999999999999998 666665433221     1 11111110  


Q ss_pred             cccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       547 ~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                                ....+..++..+.+++.+||+.+|++||++.|+++.|.++....
T Consensus       257 ----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         257 ----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             ----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence                      00112245567899999999999999999999999999877643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.5e-34  Score=297.39  Aligned_cols=237  Identities=29%  Similarity=0.515  Sum_probs=187.2

Q ss_pred             ceEEEEEE--cCc--EEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGS--TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~--~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|..  +|.  .+++|.++        +++.+|+.++.++ +||||+++++++...+..++|+||+++|+|.+++.
T Consensus        16 g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   95 (297)
T cd05089          16 GQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLR   95 (297)
T ss_pred             ceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHH
Confidence            89999987  333  47888876        2578899999999 79999999999999999999999999999999997


Q ss_pred             ccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          406 KKR-------------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       406 ~~~-------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      ...             ....+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||++......
T Consensus        96 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  172 (297)
T cd05089          96 KSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY  172 (297)
T ss_pred             hccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeEEECCcCCCccccce
Confidence            542             1235889999999999999999999   689999999999999999999999999998643211


Q ss_pred             cCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCccccccc
Q 007261          473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV  551 (611)
Q Consensus       473 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  551 (611)
                          ........+..|+|||.+....++.++||||||+++|||++ |..||......+.     ...... +        
T Consensus       173 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-----~~~~~~-~--------  234 (297)
T cd05089         173 ----VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-----YEKLPQ-G--------  234 (297)
T ss_pred             ----eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----HHHHhc-C--------
Confidence                11112233567999999998889999999999999999998 8888865443221     111110 0        


Q ss_pred             ccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          552 LVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       552 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                       .   ....+..++..+.+++.+||+.+|.+||++.++++.|..+....
T Consensus       235 -~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         235 -Y---RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             -C---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence             0   00112234567899999999999999999999999998876643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5e-35  Score=320.87  Aligned_cols=232  Identities=23%  Similarity=0.332  Sum_probs=185.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCC--------eEEEEEeecCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDG--------VFYLVYEFMENGS  399 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~--------~~~lV~E~~~~gs  399 (611)
                      |.||++..  +|+.||||+++         ..+.+|+.++..++|+|++++.+.+...+        ..++||||+++|+
T Consensus        46 G~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gs  125 (496)
T PTZ00283         46 GTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGD  125 (496)
T ss_pred             EEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCc
Confidence            89999987  78999999984         24678999999999999999988764332        3689999999999


Q ss_pred             HHHHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccc
Q 007261          400 LSDWLHKKR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS  478 (611)
Q Consensus       400 L~~~l~~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  478 (611)
                      |.++++... ....+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus       126 L~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~-~~~  201 (496)
T PTZ00283        126 LRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS-DDV  201 (496)
T ss_pred             HHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEecccCeecccccc-ccc
Confidence            999997532 2346889999999999999999999   68999999999999999999999999999876532211 112


Q ss_pred             ccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCC
Q 007261          479 TKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ  558 (611)
Q Consensus       479 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~  558 (611)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.     ......             ....
T Consensus       202 ~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~-----~~~~~~-------------~~~~  263 (496)
T PTZ00283        202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV-----MHKTLA-------------GRYD  263 (496)
T ss_pred             cccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-----HHHHhc-------------CCCC
Confidence            3445789999999999999999999999999999999999999865433221     111111             0111


Q ss_pred             cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+...+.++.+++.+||+.||.+||++.+++.+
T Consensus       264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1123455678999999999999999999999874

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=310.97  Aligned_cols=241  Identities=25%  Similarity=0.402  Sum_probs=194.0

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.|+.+..  +++.+|||++++          ....|..|+... +||.+++++.+|...+++|.||||+.||++..+.+
T Consensus       382 GkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~  461 (694)
T KOG0694|consen  382 GKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH  461 (694)
T ss_pred             ceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEe
Confidence            99999998  677999999984          356688888777 69999999999999999999999999999555554


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ..    .++.....-+|..|+.||+|||   +++||+||||.+|||||.+|.+||+||||++.....   ...+...+||
T Consensus       462 ~~----~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~---g~~TsTfCGT  531 (694)
T KOG0694|consen  462 TD----VFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ---GDRTSTFCGT  531 (694)
T ss_pred             cc----cccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCC---CCccccccCC
Confidence            33    3888888899999999999999   799999999999999999999999999999865422   2366788999


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|||||++.+..|+...|+|||||+||||+.|..||.+.+.++..  +   ..+.           .|+.   .|..++
T Consensus       532 pey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F--d---sI~~-----------d~~~---yP~~ls  592 (694)
T KOG0694|consen  532 PEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF--D---SIVN-----------DEVR---YPRFLS  592 (694)
T ss_pred             hhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH--H---HHhc-----------CCCC---CCCccc
Confidence            9999999999999999999999999999999999999877665421  1   1110           0111   145577


Q ss_pred             HHHHHHHHHhhccCCCCCCCH-----HHHHHHHHhchhhhhhchhhhhhcC
Q 007261          566 HHLIMLCLACIAREPESRPSM-----AEVVSTLMKIQLDVQRSQTLLLERI  611 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~-----~evl~~L~~i~~~~~~~~~~~~~~~  611 (611)
                      .+...++++++.++|++|--+     .+|.++   =-.....|+.++.++|
T Consensus       593 ~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h---pFFr~i~w~~L~~r~i  640 (694)
T KOG0694|consen  593 KEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH---PFFRSIDWDDLLNRRI  640 (694)
T ss_pred             HHHHHHHHHHhccCcccccCCCCCCchhhhhC---CccccCCHHHHhhccC
Confidence            788999999999999999866     333322   2223344666665554

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-35  Score=273.78  Aligned_cols=227  Identities=23%  Similarity=0.313  Sum_probs=190.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||.|+.  ++-.||+|++.          +.+.+|++|-+.|+||||++++++|.+....||++||.++|+|...|..
T Consensus        36 G~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~  115 (281)
T KOG0580|consen   36 GNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQE  115 (281)
T ss_pred             ccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHh
Confidence            89999998  67799999985          3578899999999999999999999999999999999999999999986


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .+. ..++......+..|+|.||.|+|   .++++||||||+|+|++.++..||+|||-+....     .......+||.
T Consensus       116 ~~~-~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-----~~kR~tlcgt~  186 (281)
T KOG0580|consen  116 GRM-KRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-----SNKRKTLCGTL  186 (281)
T ss_pred             ccc-ccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC-----CCCceeeeccc
Confidence            543 33666677788999999999999   7999999999999999999999999999875432     23445678999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|.+||...+...+...|+|++|++.+|++.|.+||.....++.  ...   ...        ..+.+      +...+.
T Consensus       187 dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et--Ykr---I~k--------~~~~~------p~~is~  247 (281)
T KOG0580|consen  187 DYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET--YKR---IRK--------VDLKF------PSTISG  247 (281)
T ss_pred             ccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH--HHH---HHH--------ccccC------CcccCh
Confidence            99999999999999999999999999999999999987653321  111   110        01111      234566


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      +..+++.+|+..+|.+|.+..|++.+-
T Consensus       248 ~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  248 GAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             hHHHHHHHHhccCccccccHHHHhhhH
Confidence            788999999999999999999998763

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7.3e-35  Score=302.80  Aligned_cols=226  Identities=23%  Similarity=0.397  Sum_probs=184.0

Q ss_pred             ceEEEEEE--cCcEEEEEEecHH----------HHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRRS----------ISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  ++..||||+++++          +.+|..++..+ +||||+++++++...+..++||||+++|+|..++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   88 (318)
T cd05570           9 GKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ   88 (318)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH
Confidence            89999988  5779999998742          45688888888 79999999999999999999999999999999987


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..+..++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++......   .......|+
T Consensus        89 ~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~g~  159 (318)
T cd05570          89 RSG---RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGT  159 (318)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC---CcccceecC
Confidence            653   3899999999999999999999   6899999999999999999999999999986532211   122334689


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      ..|+|||.+.+..++.++|||||||++|||++|+.||......+.     ...... ..          .   ..+...+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~-----~~~i~~-~~----------~---~~~~~~~  220 (318)
T cd05570         160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL-----FQSILE-DE----------V---RYPRWLS  220 (318)
T ss_pred             ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH-----HHHHHc-CC----------C---CCCCcCC
Confidence            999999999999999999999999999999999999875543221     111111 00          0   0112345


Q ss_pred             HHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPSM-----AEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~-----~evl~~  592 (611)
                      ..+.+++.+||+.||++||++     .+++++
T Consensus       221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            678999999999999999999     777754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.3e-35  Score=303.01  Aligned_cols=224  Identities=23%  Similarity=0.390  Sum_probs=180.5

Q ss_pred             ceEEEEEE--cCcEEEEEEecHH----------HHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRRS----------ISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +|+.||+|.+++.          +..|..++..+ +||||+++++++.+++..|+||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~   88 (316)
T cd05620           9 GKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQ   88 (316)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHH
Confidence            89999998  6789999998642          34577777655 89999999999999999999999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||
T Consensus        89 ~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt  159 (316)
T cd05620          89 DKG---RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---NRASTFCGT  159 (316)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC---CceeccCCC
Confidence            643   3788999999999999999999   6899999999999999999999999999987432111   123345689


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      ..|+|||.+.+..++.++||||||+++|||++|+.||......+.  .+    .....          .+..   +...+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~--~~----~~~~~----------~~~~---~~~~~  220 (316)
T cd05620         160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL--FE----SIRVD----------TPHY---PRWIT  220 (316)
T ss_pred             cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhC----------CCCC---CCCCC
Confidence            999999999999999999999999999999999999975543221  11    11100          0111   12244


Q ss_pred             HHHHHHHHHhhccCCCCCCCHH-HHH
Q 007261          566 HHLIMLCLACIAREPESRPSMA-EVV  590 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~-evl  590 (611)
                      .++.+++.+||+.||++||++. +++
T Consensus       221 ~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         221 KESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCChHHHH
Confidence            5688999999999999999984 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.5e-34  Score=306.44  Aligned_cols=247  Identities=19%  Similarity=0.255  Sum_probs=184.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec-HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccCH
Q 007261          339 GSVFRGII--NGSTVAIKCMR-RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW  415 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~  415 (611)
                      |.||++..  .+..||||... ..+.+|+++|++++|+|||++++++..++..++|||++. ++|.+++....  ..++|
T Consensus       183 G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~l~~  259 (461)
T PHA03211        183 GCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARL--RPLGL  259 (461)
T ss_pred             eEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcC--CCCCH
Confidence            78999998  57889999764 467899999999999999999999999999999999994 79999887643  35899


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhc
Q 007261          416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME  495 (611)
Q Consensus       416 ~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  495 (611)
                      ..++.|+.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++....... ........||..|+|||++.
T Consensus       260 ~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~~GT~~Y~APE~~~  335 (461)
T PHA03211        260 AQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS-TPFHYGIAGTVDTNAPEVLA  335 (461)
T ss_pred             HHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc-cccccccCCCcCCcCHHHHc
Confidence            999999999999999999   68999999999999999999999999999876432211 11122356899999999999


Q ss_pred             cCCCCCccchHHHHHHHHHHHhCCCCCcCCCCh--hhHHHHHHHHHHhcCCc-cccccc----------------ccCcc
Q 007261          496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGE--EILLAEAVFSMVEGGNA-EAKLSV----------------LVDPN  556 (611)
Q Consensus       496 ~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~--~~~l~~~~~~~~~~~~~-~~~l~~----------------~~d~~  556 (611)
                      +..++.++|||||||+||||++|..+++.....  .......+...+..... ...+..                ...+.
T Consensus       336 ~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  415 (461)
T PHA03211        336 GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPA  415 (461)
T ss_pred             CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCc
Confidence            999999999999999999999988776543211  00000111111111000 000000                00000


Q ss_pred             CC-cC---hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          557 LQ-AN---KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       557 l~-~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .. ..   .......+.+|+.+||+.||.+|||+.|++++
T Consensus       416 ~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        416 YTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00 00   01223468899999999999999999999975

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-34  Score=295.50  Aligned_cols=240  Identities=22%  Similarity=0.423  Sum_probs=187.7

Q ss_pred             ceEEEEEE------cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccC--CeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII------NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHD--GVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~------~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~gsL~~  402 (611)
                      |.||.+.+      ++..||+|.++        ..+.+|+.++++++|+|++++++++...  ...++||||+++++|.+
T Consensus        18 g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~   97 (284)
T cd05079          18 GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE   97 (284)
T ss_pred             eeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHH
Confidence            89999874      46789999985        3578899999999999999999998765  56899999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++....  ..++|..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++...............
T Consensus        98 ~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  172 (284)
T cd05079          98 YLPRNK--NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL  172 (284)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCC
Confidence            997643  34899999999999999999999   6899999999999999999999999999988654332211222334


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCCh----------hhHHHHHHHHHHhcCCcccccccc
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGE----------EILLAEAVFSMVEGGNAEAKLSVL  552 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~----------~~~l~~~~~~~~~~~~~~~~l~~~  552 (611)
                      .++..|+|||.+.+..++.++||||||+++|||++++.|.......          +......+. ...           
T Consensus       173 ~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-----------  240 (284)
T cd05079         173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-VLE-----------  240 (284)
T ss_pred             CCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-HHH-----------
Confidence            5677899999999889999999999999999999987664322110          000111110 000           


Q ss_pred             cCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          553 VDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       553 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                       +......+..++..+.+|+.+||+.||++||++.++++.|+++
T Consensus       241 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         241 -EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             -cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence             1111111233567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.1e-34  Score=309.14  Aligned_cols=233  Identities=20%  Similarity=0.336  Sum_probs=181.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  ++..||||++++          .+.+|+.++++++|+||+++++++.+.+..++||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~   94 (381)
T cd05626          15 GEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR   94 (381)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHh
Confidence            89999988  678999999852          356799999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC-----------
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG-----------  475 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-----------  475 (611)
                      ..   .+++.....++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++........           
T Consensus        95 ~~---~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~  168 (381)
T cd05626          95 ME---VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQ  168 (381)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccc
Confidence            53   3788888899999999999999   689999999999999999999999999997533110000           


Q ss_pred             ---------------------------------cccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCC
Q 007261          476 ---------------------------------YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAA  522 (611)
Q Consensus       476 ---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~  522 (611)
                                                       ........||+.|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf  248 (381)
T cd05626         169 DSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF  248 (381)
T ss_pred             cccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCC
Confidence                                             00112346999999999999888999999999999999999999999


Q ss_pred             cCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHH--hhccCCCCCCCHHHHHHH
Q 007261          523 YKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLA--CIAREPESRPSMAEVVST  592 (611)
Q Consensus       523 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~evl~~  592 (611)
                      ......+...     ......   ..+      .. ......+.++.+|+.+  |+..+|..||++.|++.+
T Consensus       249 ~~~~~~~~~~-----~i~~~~---~~~------~~-~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         249 LAPTPTETQL-----KVINWE---NTL------HI-PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             cCCCHHHHHH-----HHHccc---ccc------CC-CCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            7654332211     111000   000      00 0011234567778877  556677779999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.5e-34  Score=283.34  Aligned_cols=249  Identities=22%  Similarity=0.329  Sum_probs=194.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCc-eeeccceeccCC------eEEEEEeecCCCCH
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFN-LINLFGACEHDG------VFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------~~~lV~E~~~~gsL  400 (611)
                      |.||+|+.  +|+.||+|+++-         ...+|+.+|++++|+| ||++++++....      ..+|||||++ -+|
T Consensus        25 g~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL  103 (323)
T KOG0594|consen   25 GVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDL  103 (323)
T ss_pred             eEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccH
Confidence            89999987  889999999972         3578999999999999 999999998776      7899999995 699


Q ss_pred             HHHhhccCCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccc
Q 007261          401 SDWLHKKRYP-EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       401 ~~~l~~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      ..++...... ..++...+..++.||+.||+|||   +.+|+||||||.||||+++|.+||+|||+|+....+.   ...
T Consensus       104 ~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~---~~y  177 (323)
T KOG0594|consen  104 KKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM---RTY  177 (323)
T ss_pred             HHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHHHhcCCc---ccc
Confidence            9999876532 34666888999999999999999   7999999999999999999999999999999664332   234


Q ss_pred             cccccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc--cccccCcc
Q 007261          480 KTAVGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK--LSVLVDPN  556 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~--l~~~~d~~  556 (611)
                      .+.++|.+|.|||++.+. .|+...||||+||++.||++++..|.+..+  ......++..+.......+  ...+.+-.
T Consensus       178 t~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~e~~Wp~v~~~~~~k  255 (323)
T KOG0594|consen  178 TPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPNEKDWPGVSSLPDYK  255 (323)
T ss_pred             cccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCCccCCCCcccccccc
Confidence            567899999999998876 699999999999999999998877766544  2333445555544332111  11111111


Q ss_pred             -----CC---cChH---HHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhc
Q 007261          557 -----LQ---ANKK---EIAHHLIMLCLACIAREPESRPSMAEVVST--LMKI  596 (611)
Q Consensus       557 -----l~---~~~~---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i  596 (611)
                           +.   ....   .......+++.+|++.+|.+|.|++.++++  +..+
T Consensus       256 ~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  256 APFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             ccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence                 11   1111   112468899999999999999999999987  5544

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-34  Score=306.58  Aligned_cols=233  Identities=21%  Similarity=0.342  Sum_probs=179.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||++++          .+.+|+.++.+++|+||+++++.+.++...|+||||+++|+|.+++..
T Consensus        15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~   94 (363)
T cd05628          15 GEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK   94 (363)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh
Confidence            89999987  688999999863          356799999999999999999999999999999999999999999986


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC-----------
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG-----------  475 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-----------  475 (611)
                      ..   .+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........           
T Consensus        95 ~~---~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~  168 (363)
T cd05628          95 KD---TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP  168 (363)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccccccc
Confidence            53   4899999999999999999999   689999999999999999999999999998754221100           


Q ss_pred             ---------------------cccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHH
Q 007261          476 ---------------------YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE  534 (611)
Q Consensus       476 ---------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~  534 (611)
                                           ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..  .
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~--~  246 (363)
T cd05628         169 SDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY--K  246 (363)
T ss_pred             ccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHH--H
Confidence                                 00112347999999999999999999999999999999999999999765433211  1


Q ss_pred             HHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhc--cCCCCCCCHHHHHHH
Q 007261          535 AVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIA--REPESRPSMAEVVST  592 (611)
Q Consensus       535 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~--~dP~~RPs~~evl~~  592 (611)
                         ......   ..  ..+.+.     ...++++.+++.+++.  .++..||++.|++++
T Consensus       247 ---~i~~~~---~~--~~~p~~-----~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         247 ---KVMNWK---ET--LIFPPE-----VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             ---HHHcCc---Cc--ccCCCc-----CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence               111100   00  001111     1123455666666333  344567999999886

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.4e-34  Score=326.61  Aligned_cols=246  Identities=23%  Similarity=0.335  Sum_probs=192.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|..  +|+.||||+++          +++.+|+.++++++||||+++++++.+++..++||||+++|+|.+++..
T Consensus        16 G~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s   95 (932)
T PRK13184         16 GEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKS   95 (932)
T ss_pred             EEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHH
Confidence            89999987  58899999985          3578899999999999999999999999999999999999999999875


Q ss_pred             cC--------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC---
Q 007261          407 KR--------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG---  475 (611)
Q Consensus       407 ~~--------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~---  475 (611)
                      ..        ....+++..+++++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++........   
T Consensus        96 ~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~  172 (932)
T PRK13184         96 VWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD  172 (932)
T ss_pred             hhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecCcceecccccccccc
Confidence            21        1234677888999999999999999   689999999999999999999999999999765211100   


Q ss_pred             ------------cccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcC
Q 007261          476 ------------YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGG  543 (611)
Q Consensus       476 ------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  543 (611)
                                  ........||+.|+|||.+.+..++.++|||||||++|||++|+.||............         
T Consensus       173 l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~---------  243 (932)
T PRK13184        173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRD---------  243 (932)
T ss_pred             cccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhh---------
Confidence                        01112346899999999999999999999999999999999999998754332211100         


Q ss_pred             CcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhchhhhhhc
Q 007261          544 NAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRP-SMAEVVSTLMKIQLDVQRS  603 (611)
Q Consensus       544 ~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~~~  603 (611)
                             ...++.......+.+..+.+++.+||+.||++|| +++++.+.|+.......+|
T Consensus       244 -------~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w  297 (932)
T PRK13184        244 -------VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEW  297 (932)
T ss_pred             -------hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCccc
Confidence                   0011110011123456788999999999999995 6777888888776554444

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.8e-35  Score=301.86  Aligned_cols=225  Identities=24%  Similarity=0.400  Sum_probs=181.4

Q ss_pred             ceEEEEEE--cCcEEEEEEecHH----------HHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRRS----------ISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|..  +++.||||.++..          +..|..++..+ +||||+++++++.+++..++||||+++|+|.+++.
T Consensus         9 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~   88 (316)
T cd05619           9 GKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQ   88 (316)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence            89999998  5779999998743          34577777764 99999999999999999999999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++.....++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++......   .......||
T Consensus        89 ~~~---~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt  159 (316)
T cd05619          89 SCH---KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCTFCGT  159 (316)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC---CceeeecCC
Confidence            643   3888999999999999999999   6899999999999999999999999999987532211   122345689


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      ..|+|||.+.+..++.++|||||||++|||++|+.||......+.  ...    ....          .+..   +...+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~--~~~----i~~~----------~~~~---~~~~~  220 (316)
T cd05619         160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL--FQS----IRMD----------NPCY---PRWLT  220 (316)
T ss_pred             ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH--HHH----HHhC----------CCCC---CccCC
Confidence            999999999999999999999999999999999999876543221  111    1100          0111   12244


Q ss_pred             HHHHHHHHHhhccCCCCCCCHH-HHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMA-EVVS  591 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~-evl~  591 (611)
                      .++.+++.+||+.||++||++. ++.+
T Consensus       221 ~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         221 REAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            5688999999999999999997 5654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.4e-34  Score=290.71  Aligned_cols=232  Identities=26%  Similarity=0.416  Sum_probs=184.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|+.  +|+.||+|+++       ..+.+|+.++++++||||+++++++..++..++||||+++++|.++++... 
T Consensus        23 g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-  101 (267)
T cd06646          23 GDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-  101 (267)
T ss_pred             eEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-
Confidence            89999997  68899999985       246789999999999999999999999999999999999999999997543 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                        .+++..+..++.|++.||.|||   ..+++||||||+||++++++.+||+|||+++......   .......++..|+
T Consensus       102 --~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~  173 (267)
T cd06646         102 --PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI---AKRKSFIGTPYWM  173 (267)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc---cccCccccCcccc
Confidence              4889999999999999999999   6899999999999999999999999999987553211   1223346788999


Q ss_pred             chhhhc---cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          490 APEYME---YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       490 aPE~~~---~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      |||.+.   ...++.++||||||+++|||++|+.|+......+...     ...        ...+..+... .....+.
T Consensus       174 ~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-----~~~--------~~~~~~~~~~-~~~~~~~  239 (267)
T cd06646         174 APEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-----LMS--------KSNFQPPKLK-DKTKWSS  239 (267)
T ss_pred             CHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-----eee--------cCCCCCCCCc-cccccCH
Confidence            999874   4557889999999999999999999986443221100     000        0001111111 1223456


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      .+.+++.+||+.+|++||++++++++|
T Consensus       240 ~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         240 TFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            789999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3e-34  Score=288.17  Aligned_cols=234  Identities=28%  Similarity=0.475  Sum_probs=188.8

Q ss_pred             ceEEEEEEc---Cc--EEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGIIN---GS--TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~~---g~--~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|.+.   +.  .||||.++        +++.+|+.++++++|+||+++++.+.. ...++||||+++|+|.+++.
T Consensus         9 ~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~   87 (257)
T cd05040           9 GVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLR   87 (257)
T ss_pred             ccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHH
Confidence            899999872   22  69999986        256789999999999999999999988 88999999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      .... ..++|.....++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||+++................++
T Consensus        88 ~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  163 (257)
T cd05040          88 KDAL-GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP  163 (257)
T ss_pred             hccc-ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCC
Confidence            7542 45899999999999999999999   6899999999999999999999999999988764433222223345577


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      ..|+|||.+.+..++.++||||||+++|||++ |+.|+......+..  ..+   ....            .....+...
T Consensus       164 ~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~--~~~---~~~~------------~~~~~~~~~  226 (257)
T cd05040         164 FAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL--KKI---DKEG------------ERLERPEAC  226 (257)
T ss_pred             ceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHH---HhcC------------CcCCCCccC
Confidence            89999999999999999999999999999999 99888654332211  111   1000            000112234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      +..+.+++.+||+.+|++||++.++++.|.
T Consensus       227 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         227 PQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.8e-34  Score=297.67  Aligned_cols=245  Identities=23%  Similarity=0.449  Sum_probs=192.2

Q ss_pred             cCCCCCccc----ceEEEEEE-------cCcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEE
Q 007261          330 NFSPKNMID----GSVFRGII-------NGSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFY  389 (611)
Q Consensus       330 ~f~~~~~ig----g~Vy~g~~-------~g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  389 (611)
                      +|.....+|    |.||++..       .+..||||.++        ..+.+|+.+++++ +|+||+++++++...+..+
T Consensus        36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  115 (302)
T cd05055          36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL  115 (302)
T ss_pred             HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence            444444443    88999875       23479999885        2477899999999 8999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccc
Q 007261          390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSA  469 (611)
Q Consensus       390 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~  469 (611)
                      +||||+++|+|.++++.... ..+++.+++.++.|++.||+|||   +.+++|+||||+|||++.++.+||+|||+++..
T Consensus       116 lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         116 VITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            99999999999999976432 34899999999999999999999   689999999999999999999999999998765


Q ss_pred             ccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccc
Q 007261          470 VREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAK  548 (611)
Q Consensus       470 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  548 (611)
                      ..... ........++..|+|||.+.+..++.++||||||+++|||++ |..|+......+.     .......+.    
T Consensus       192 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-----~~~~~~~~~----  261 (302)
T cd05055         192 MNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-----FYKLIKEGY----  261 (302)
T ss_pred             cCCCc-eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-----HHHHHHcCC----
Confidence            33221 111222345778999999999999999999999999999998 8888765443221     111111110    


Q ss_pred             cccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       549 l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                              ....+...+.++.+++.+||+.+|++||++.|+++.|.++
T Consensus       262 --------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 --------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                    0011122346789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=294.48  Aligned_cols=234  Identities=26%  Similarity=0.478  Sum_probs=187.1

Q ss_pred             ceEEEEEEcC-------cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIING-------STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~g-------~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|...+       ..||+|.+.        ..+.+|+.+++.++|+||+++++++......++||||+++|+|.++
T Consensus        20 g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~   99 (277)
T cd05032          20 GMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSY   99 (277)
T ss_pred             ceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHH
Confidence            8999998732       579999975        2477899999999999999999999999999999999999999999


Q ss_pred             hhccCC-------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc
Q 007261          404 LHKKRY-------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY  476 (611)
Q Consensus       404 l~~~~~-------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  476 (611)
                      +.....       ...++|..++.++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++....... .
T Consensus       100 l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~-~  175 (277)
T cd05032         100 LRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY-Y  175 (277)
T ss_pred             HHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECCcccchhhccCcc-c
Confidence            975432       224789999999999999999999   68999999999999999999999999999876543221 1


Q ss_pred             ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCc
Q 007261          477 SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP  555 (611)
Q Consensus       477 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  555 (611)
                      .......++..|+|||.+.++.++.++||||||+++||+++ |..|+......+.  ..    ....+            
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~----~~~~~------------  237 (277)
T cd05032         176 RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV--LK----FVIDG------------  237 (277)
T ss_pred             ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH--HH----HHhcC------------
Confidence            12233456788999999998899999999999999999998 7777754433221  11    11110            


Q ss_pred             cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       556 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      .....+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            011112233667899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.4e-35  Score=310.08  Aligned_cols=230  Identities=24%  Similarity=0.342  Sum_probs=183.4

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|..||+|.+++          .+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++..
T Consensus        57 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~  136 (370)
T cd05596          57 GEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN  136 (370)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh
Confidence            89999987  688999999852          256799999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..    ++......++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  ........||+
T Consensus       137 ~~----l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~--~~~~~~~~gt~  207 (370)
T cd05596         137 YD----IPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG--MVRCDTAVGTP  207 (370)
T ss_pred             cC----CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC--cccCCCCCCCc
Confidence            43    677788889999999999999   6899999999999999999999999999987543221  11223457899


Q ss_pred             CccchhhhccC----CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          487 GYMAPEYMEYG----LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       487 ~y~aPE~~~~~----~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      .|+|||.+.+.    .++.++|||||||++|||++|+.||........     .........   .   +   .. ....
T Consensus       208 ~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~i~~~~~---~---~---~~-~~~~  272 (370)
T cd05596         208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----YSKIMDHKN---S---L---TF-PDDI  272 (370)
T ss_pred             CeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-----HHHHHcCCC---c---C---CC-CCcC
Confidence            99999998643    478999999999999999999999976543221     111111000   0   0   00 0111


Q ss_pred             HHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPES--RPSMAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  592 (611)
                      ..+.++.+++.+||+.+|.+  ||++.|++++
T Consensus       273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            34567889999999999988  9999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-34  Score=291.82  Aligned_cols=234  Identities=31%  Similarity=0.533  Sum_probs=184.9

Q ss_pred             ceEEEEEE--cCc--EEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGS--TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~--~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|..  +|.  .+++|.++        ..+.+|++++.++ +||||+++++++...+..++||||+++|+|.+++.
T Consensus         9 g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~   88 (270)
T cd05047           9 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR   88 (270)
T ss_pred             ceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHH
Confidence            89999987  333  57888875        2567899999999 89999999999999999999999999999999997


Q ss_pred             ccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          406 KKRY-------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       406 ~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      ..+.             ...+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++.....
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~  165 (270)
T cd05047          89 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY  165 (270)
T ss_pred             hccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCCccccchh
Confidence            6431             134789999999999999999999   689999999999999999999999999997532211


Q ss_pred             cCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCccccccc
Q 007261          473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV  551 (611)
Q Consensus       473 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  551 (611)
                          ........+..|+|||++....++.++||||||+++|||++ |..||......+.      ........       
T Consensus       166 ----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~-------  228 (270)
T cd05047         166 ----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKLPQGY-------  228 (270)
T ss_pred             ----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH------HHHHhCCC-------
Confidence                11112233567999999988899999999999999999997 8888865432211      11111100       


Q ss_pred             ccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          552 LVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       552 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                           ....+...+..+.+++.+||+.||.+||++.+++..|.++.
T Consensus       229 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 -----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -----CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                 00112234456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-34  Score=288.51  Aligned_cols=234  Identities=30%  Similarity=0.565  Sum_probs=191.4

Q ss_pred             ceEEEEEEc-----CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGIIN-----GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~~-----g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++...     +..|++|.++        +.+.+|++++++++|+|++++++++..+...++||||+++++|.+++.
T Consensus         9 g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   88 (262)
T cd00192           9 GEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLR   88 (262)
T ss_pred             eEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHh
Confidence            899999984     7799999986        356789999999999999999999999999999999999999999998


Q ss_pred             ccCC------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccc
Q 007261          406 KKRY------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       406 ~~~~------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      ....      ...+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||.+........ ....
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  164 (262)
T cd00192          89 KSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY-YRKK  164 (262)
T ss_pred             hccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccccccccccc-cccc
Confidence            7521      245899999999999999999999   68999999999999999999999999999886643321 1223


Q ss_pred             cccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCC
Q 007261          480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ  558 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~  558 (611)
                      ....++..|+|||.+....++.++||||||++++||++ |..|+......+.      ......            ....
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~------------~~~~  226 (262)
T cd00192         165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV------LEYLRK------------GYRL  226 (262)
T ss_pred             cCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH------HHHHHc------------CCCC
Confidence            44567889999999998899999999999999999999 5777765532211      111111            1111


Q ss_pred             cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          559 ANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      ..+...+.++.+++.+||+.+|.+|||+.|++++|+
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            123344678999999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.2e-35  Score=303.89  Aligned_cols=232  Identities=19%  Similarity=0.345  Sum_probs=183.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  ++..||||++++          .+.+|..++.++ +||||+++++++.+.+..++||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~   88 (329)
T cd05588           9 AKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ   88 (329)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHH
Confidence            89999988  688999999973          255788899888 79999999999999999999999999999999987


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ..+   .+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++......   .......||
T Consensus        89 ~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~gt  159 (329)
T cd05588          89 RQR---KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---DTTSTFCGT  159 (329)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC---CccccccCC
Confidence            643   4899999999999999999999   6899999999999999999999999999987432211   122345789


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCCh---hhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGE---EILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      ..|+|||.+.+..++.++||||||+++|||++|+.||......   .....+..........             ...+.
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~p~  226 (329)
T cd05588         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-------------IRIPR  226 (329)
T ss_pred             ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-------------CCCCC
Confidence            9999999999999999999999999999999999998632111   0011111111111110             00122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRPS------MAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~  592 (611)
                      ..+..+.+++.+||+.||.+||+      +.+++++
T Consensus       227 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            34556889999999999999997      6777654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-35  Score=308.76  Aligned_cols=232  Identities=22%  Similarity=0.335  Sum_probs=183.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||+++.          .+.+|+.++..++|+||+++++++.+++..++||||+++|+|.+++..
T Consensus        15 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~   94 (364)
T cd05599          15 GEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK   94 (364)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH
Confidence            89999988  688999999863          256799999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc----------
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY----------  476 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~----------  476 (611)
                      ..   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.........          
T Consensus        95 ~~---~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~  168 (364)
T cd05599          95 KD---TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP  168 (364)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccc
Confidence            53   3899999999999999999999   6899999999999999999999999999986542211000          


Q ss_pred             -------------------------ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhH
Q 007261          477 -------------------------SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL  531 (611)
Q Consensus       477 -------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~  531 (611)
                                               .......||+.|+|||++....++.++|||||||++|||++|+.||......+. 
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~-  247 (364)
T cd05599         169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQET-  247 (364)
T ss_pred             ccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHH-
Confidence                                     001124689999999999999999999999999999999999999976543221 


Q ss_pred             HHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 007261          532 LAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPS---MAEVVST  592 (611)
Q Consensus       532 l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~  592 (611)
                          ........   ..+   .-+    .....+..+.+++.+|+. +|.+|++   +.|++++
T Consensus       248 ----~~~i~~~~---~~~---~~~----~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         248 ----YRKIINWK---ETL---QFP----DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             ----HHHHHcCC---Ccc---CCC----CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence                11111100   000   000    011234567889999996 9999998   8888774

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2e-34  Score=293.74  Aligned_cols=235  Identities=26%  Similarity=0.497  Sum_probs=186.6

Q ss_pred             ceEEEEEE-------cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII-------NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||++..       ++..+|+|.++       .++.+|++++++++|+||+++++++...+..+++|||+++|+|.+++
T Consensus        19 g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i   98 (280)
T cd05092          19 GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFL   98 (280)
T ss_pred             CeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHH
Confidence            89999964       35689999875       36889999999999999999999999999999999999999999999


Q ss_pred             hccCC------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          405 HKKRY------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       405 ~~~~~------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      .....            ...+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++.....
T Consensus        99 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~  175 (280)
T cd05092          99 RSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST  175 (280)
T ss_pred             HhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEEECCCCceeEcCCC
Confidence            76431            134889999999999999999999   689999999999999999999999999998754322


Q ss_pred             cCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCccccccc
Q 007261          473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV  551 (611)
Q Consensus       473 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  551 (611)
                      .. ........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.     ........        
T Consensus       176 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-----~~~~~~~~--------  241 (280)
T cd05092         176 DY-YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-----IECITQGR--------  241 (280)
T ss_pred             ce-eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-----HHHHHcCc--------
Confidence            11 111222345678999999999999999999999999999998 7777754433221     11111100        


Q ss_pred             ccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 007261          552 LVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK  595 (611)
Q Consensus       552 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  595 (611)
                           ....+..++..+.+++.+||+.||++||++.||++.|++
T Consensus       242 -----~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         242 -----ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             -----cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                 001122345668899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.4e-34  Score=298.29  Aligned_cols=240  Identities=29%  Similarity=0.500  Sum_probs=188.9

Q ss_pred             ceEEEEEE---------cCcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCH
Q 007261          339 GSVFRGII---------NGSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~---------~g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      |.||++..         .+..+|+|.++        .++.+|+.+++++ +||||++++++|..++..++||||+++|+|
T Consensus        26 g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  105 (314)
T cd05099          26 GQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL  105 (314)
T ss_pred             ccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcH
Confidence            88999874         23479999876        2467899999999 699999999999999999999999999999


Q ss_pred             HHHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          401 SDWLHKKRY-------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       401 ~~~l~~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      .+++.....             ...++|..+++++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++
T Consensus       106 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~  182 (314)
T cd05099         106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLAR  182 (314)
T ss_pred             HHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEcCCCcEEEccccccc
Confidence            999976421             235899999999999999999999   6899999999999999999999999999997


Q ss_pred             ccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcc
Q 007261          468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       468 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  546 (611)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++ |..|+......+.      ........  
T Consensus       183 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~--  253 (314)
T cd05099         183 GVHDIDYY-KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL------FKLLREGH--  253 (314)
T ss_pred             cccccccc-cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCC--
Confidence            65322111 11122234567999999998899999999999999999999 7777754432221      11111110  


Q ss_pred             cccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       547 ~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                                ....+..++..+.+++.+||+.+|++||++.|+++.|.++....
T Consensus       254 ----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         254 ----------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence                      00112234557889999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.2e-34  Score=302.74  Aligned_cols=232  Identities=19%  Similarity=0.357  Sum_probs=182.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +++.||+|++++          .+.+|+.++.++ +||||+++++++..++..++||||+++|+|..++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~   88 (329)
T cd05618           9 AKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ   88 (329)
T ss_pred             eEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHH
Confidence            89999987  678999999864          255688888877 89999999999999999999999999999999887


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..+..++.|++.||+|||   ..+++||||||+|||++.++.+||+|||+++......   .......||
T Consensus        89 ~~~---~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---~~~~~~~gt  159 (329)
T cd05618          89 RQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGT  159 (329)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC---CccccccCC
Confidence            653   3889999999999999999999   6899999999999999999999999999987532221   122345789


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCCh---hhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGE---EILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      ..|+|||.+.+..++.++||||||+++|||++|+.||......   .......+........             ...+.
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------------~~~p~  226 (329)
T cd05618         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------------IRIPR  226 (329)
T ss_pred             ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-------------CCCCC
Confidence            9999999999999999999999999999999999998532111   1111111111111110             01122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRPS------MAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~  592 (611)
                      ..+..+.+++.+||+.||++||+      +.+++++
T Consensus       227 ~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         227 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            34566889999999999999998      4666554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.6e-34  Score=288.44  Aligned_cols=232  Identities=30%  Similarity=0.500  Sum_probs=185.1

Q ss_pred             ceEEEEEEc-CcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGIIN-GSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~~-g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||++.+. +..+|+|.++      ..+.+|+.++++++|+|++++++++. .+..++||||+++|+|.++++... ..
T Consensus        20 ~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~-~~   97 (260)
T cd05069          20 GEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGD-GK   97 (260)
T ss_pred             CeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCC-CC
Confidence            899999884 4579999875      35788999999999999999999885 456789999999999999997643 34


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .++|..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++.......  .......++..|+||
T Consensus        98 ~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~~P  172 (260)
T cd05069          98 YLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY--TARQGAKFPIKWTAP  172 (260)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc--cccCCCccchhhCCH
Confidence            5899999999999999999999   68899999999999999999999999999875532211  111223456789999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+.+..++.++||||||+++|||++ |+.|+......+..      .......            ....+...+..+.+
T Consensus       173 e~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~------~~~~~~~------------~~~~~~~~~~~~~~  234 (260)
T cd05069         173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL------EQVERGY------------RMPCPQGCPESLHE  234 (260)
T ss_pred             HHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHcCC------------CCCCCcccCHHHHH
Confidence            99998999999999999999999999 77777654332211      1111100            00112345567899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHh
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMK  595 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~  595 (611)
                      ++.+||+.||++||++.++++.|++
T Consensus       235 li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         235 LMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHHccCCcccCcCHHHHHHHHhc
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.6e-34  Score=287.44  Aligned_cols=231  Identities=26%  Similarity=0.478  Sum_probs=185.6

Q ss_pred             ceEEEEEE-cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|.. ++..+|+|.++        ..+.+|++++++++||||+++++++...+..++||||+++++|.+++.... 
T Consensus         9 g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-   87 (250)
T cd05085           9 GEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK-   87 (250)
T ss_pred             ceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcC-
Confidence            89999987 67889999875        247789999999999999999999999999999999999999999997643 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                       ..+++..++.++.|++.||.|||   ..+++|+||||+||++++++.+||+|||++.......  ........++..|+
T Consensus        88 -~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~y~  161 (250)
T cd05085          88 -DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI--YSSSGLKQIPIKWT  161 (250)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccc--cccCCCCCCccccc
Confidence             34789999999999999999999   6899999999999999999999999999986432211  11112223456799


Q ss_pred             chhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHH
Q 007261          490 APEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL  568 (611)
Q Consensus       490 aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l  568 (611)
                      |||++..+.++.++||||||+++||+++ |..||........     . .......     .       ...+..++..+
T Consensus       162 aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-----~-~~~~~~~-----~-------~~~~~~~~~~~  223 (250)
T cd05085         162 APEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-----R-EQVEKGY-----R-------MSCPQKCPDDV  223 (250)
T ss_pred             CHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-----H-HHHHcCC-----C-------CCCCCCCCHHH
Confidence            9999999999999999999999999998 8888764432211     1 1111110     0       01122345678


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          569 IMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       569 ~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      .+++.+||+.+|++||++.|+++.|.
T Consensus       224 ~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         224 YKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHcccCcccCCCHHHHHHHhc
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.8e-34  Score=288.79  Aligned_cols=233  Identities=30%  Similarity=0.482  Sum_probs=185.1

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||+|.+ ++..||+|.++      .++.+|+.++++++|+||+++++++.. +..++||||+++|+|.+++.... ..
T Consensus        20 ~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-~~   97 (262)
T cd05071          20 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEM-GK   97 (262)
T ss_pred             CcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhcc-cc
Confidence            89999988 34579999986      357889999999999999999998754 55799999999999999997642 23


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++.......  .......++..|+||
T Consensus        98 ~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~--~~~~~~~~~~~y~~P  172 (262)
T cd05071          98 YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY--TARQGAKFPIKWTAP  172 (262)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc--ccccCCcccceecCH
Confidence            5799999999999999999999   68999999999999999999999999999875533221  112233456789999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |...+..++.++||||||+++|||++ |..|+......+. .     .......            ........+..+.+
T Consensus       173 E~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~-----~~~~~~~------------~~~~~~~~~~~l~~  234 (262)
T cd05071         173 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-L-----DQVERGY------------RMPCPPECPESLHD  234 (262)
T ss_pred             hHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-H-----HHHhcCC------------CCCCccccCHHHHH
Confidence            99998899999999999999999999 6666654432221 1     1111000            00112345667899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      ++.+||+.||++||++.++++.|+..
T Consensus       235 li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         235 LMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             HHHHHccCCcccCCCHHHHHHHHHHh
Confidence            99999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.2e-34  Score=294.71  Aligned_cols=237  Identities=22%  Similarity=0.407  Sum_probs=185.4

Q ss_pred             ceEEEEEEc-------CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIIN-------GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~-------g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|...       +..||+|.++        .++.+|+.++++++|+||+++++++...+..++||||+++|+|.++
T Consensus        20 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~   99 (288)
T cd05061          20 GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY   99 (288)
T ss_pred             cEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHH
Confidence            899999752       3479999874        2467899999999999999999999999999999999999999999


Q ss_pred             hhccCC-------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc
Q 007261          404 LHKKRY-------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY  476 (611)
Q Consensus       404 l~~~~~-------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  476 (611)
                      +.....       ...+++..+..++.|++.||.|||   +++++||||||+|||+++++.+||+|||+++....... .
T Consensus       100 l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~-~  175 (288)
T cd05061         100 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY-Y  175 (288)
T ss_pred             HHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEECcCCcccccccccc-c
Confidence            975321       133567888999999999999999   68999999999999999999999999999875432221 1


Q ss_pred             ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCc
Q 007261          477 SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP  555 (611)
Q Consensus       477 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  555 (611)
                      .......++..|+|||.+.++.++.++||||||+++|||++ |..|+.....++.     ......             .
T Consensus       176 ~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~-----~~~~~~-------------~  237 (288)
T cd05061         176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV-----LKFVMD-------------G  237 (288)
T ss_pred             cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHc-------------C
Confidence            11222345678999999999999999999999999999999 5667654332221     111111             1


Q ss_pred             cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       556 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                      .....+..++..+.+++.+||+.||++||++.++++.|.+..
T Consensus       238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            111112234567999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.8e-34  Score=296.24  Aligned_cols=183  Identities=25%  Similarity=0.374  Sum_probs=151.3

Q ss_pred             ceEEEEEE----cCcEEEEEEec-----HHHHHHHHHHHhcCCCceeeccceecc--CCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII----NGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGACEH--DGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~----~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|..    ++..+|+|.++     ..+.+|+.++++++||||+++++++..  +...++||||+. ++|.+++...
T Consensus        15 g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   93 (317)
T cd07868          15 GHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFH   93 (317)
T ss_pred             eEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhc
Confidence            89999986    35689999986     357889999999999999999998854  467899999995 5898887643


Q ss_pred             C------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee----CCCCcEEEeeecCccccccccCCcc
Q 007261          408 R------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL----DKNLRAKLANFSFVRSAVREESGYS  477 (611)
Q Consensus       408 ~------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgla~~~~~~~~~~~  477 (611)
                      .      ....+++..+..++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++..........
T Consensus        94 ~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~  170 (317)
T cd07868          94 RASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA  170 (317)
T ss_pred             ccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCcccc
Confidence            2      1235888999999999999999999   6899999999999999    4668999999999976543322222


Q ss_pred             cccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCC
Q 007261          478 STKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQ  525 (611)
Q Consensus       478 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~  525 (611)
                      ......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus       171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            3345678999999999876 45899999999999999999999998644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.7e-35  Score=291.47  Aligned_cols=250  Identities=22%  Similarity=0.313  Sum_probs=190.2

Q ss_pred             HHhhcCCCCCcccceEEEEEE--cCcEEEEEEecH---HHHHHHHHHHhcCCCceeeccceeccCC-----eEEEEEeec
Q 007261          326 VATENFSPKNMIDGSVFRGII--NGSTVAIKCMRR---SISKEVNLLKKINHFNLINLFGACEHDG-----VFYLVYEFM  395 (611)
Q Consensus       326 ~at~~f~~~~~igg~Vy~g~~--~g~~vavK~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E~~  395 (611)
                      .+++.|       |.||+|+.  +++.||||+.-.   --.+|+.+|++++|||||++.-+|....     ...||||||
T Consensus        32 iG~GsF-------g~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   32 IGSGSF-------GVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             Eeeccc-------ceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            456666       99999998  678999999853   2457999999999999999998885332     346899999


Q ss_pred             CCCCHHHHhhcc-CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeecCcccccccc
Q 007261          396 ENGSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN-LRAKLANFSFVRSAVREE  473 (611)
Q Consensus       396 ~~gsL~~~l~~~-~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~~~~~~~  473 (611)
                      |. +|.+.++.. .....++...+.-+.+||++||.|||   ..+|+||||||.|+|+|.+ |.+||||||.|+.....+
T Consensus       105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            85 899988852 12234777777789999999999999   6999999999999999977 999999999999886654


Q ss_pred             CCcccccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc------
Q 007261          474 SGYSSTKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE------  546 (611)
Q Consensus       474 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~------  546 (611)
                      ..    .....|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.++.+..  ..+..++.....+      
T Consensus       181 pn----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL--~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  181 PN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL--VEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             Cc----eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH--HHHHHHhCCCCHHHHhhcC
Confidence            32    33456889999998866 46999999999999999999999988876554322  2333333322211      


Q ss_pred             -----cccccccCccCCc-ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          547 -----AKLSVLVDPNLQA-NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       547 -----~~l~~~~d~~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                           .+...+....+.. .....+.+..+|+.+++..+|.+|.++.|++.+
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                 1111222222212 234556789999999999999999999998864

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3e-34  Score=292.17  Aligned_cols=240  Identities=24%  Similarity=0.416  Sum_probs=188.3

Q ss_pred             ceEEEEEE--cCc----EEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGS----TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~----~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.+  +|+    .||+|.++        +++.+|+.+++.++|+||+++++++... ..++++||+++|+|.+++
T Consensus        21 g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l   99 (279)
T cd05109          21 GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYV   99 (279)
T ss_pred             ceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHH
Confidence            89999987  454    48999875        3577899999999999999999999754 467999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      +...  ..+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++........ .......+
T Consensus       100 ~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~-~~~~~~~~  173 (279)
T cd05109         100 RENK--DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE-YHADGGKV  173 (279)
T ss_pred             hhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccccce-eecCCCcc
Confidence            8643  34899999999999999999999   689999999999999999999999999998765322211 11122344


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      +..|+|||.+.+..++.++||||||+++|||++ |..|+.......  +    .........            ...+..
T Consensus       174 ~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~----~~~~~~~~~------------~~~~~~  235 (279)
T cd05109         174 PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--I----PDLLEKGER------------LPQPPI  235 (279)
T ss_pred             chhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H----HHHHHCCCc------------CCCCcc
Confidence            678999999998899999999999999999998 777775433221  1    111111110            011123


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhhc
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRS  603 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~  603 (611)
                      ++..+.+++.+||+.||++||++.++++.|.++..+..++
T Consensus       236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~  275 (279)
T cd05109         236 CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRF  275 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCe
Confidence            4567889999999999999999999999998887665443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.5e-35  Score=302.67  Aligned_cols=221  Identities=24%  Similarity=0.347  Sum_probs=176.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHH-HHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEV-NLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +|+.||+|++.+          .+..|. .+++.++||||+++++++.+.+..++||||+++|+|..++.
T Consensus         9 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   88 (321)
T cd05603           9 GKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQ   88 (321)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH
Confidence            89999998  688999999853          233344 35778899999999999999999999999999999999887


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .++......++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++......   .......||
T Consensus        89 ~~~---~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt  159 (321)
T cd05603          89 RER---CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---ETTSTFCGT  159 (321)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC---CccccccCC
Confidence            643   3778888899999999999999   6899999999999999999999999999987532221   123345689


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+.+..++.++|||||||++|||++|+.||...+....     ...... ..             ...+....
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~i~~-~~-------------~~~~~~~~  220 (321)
T cd05603         160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-----YDNILH-KP-------------LQLPGGKT  220 (321)
T ss_pred             cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-----HHHHhc-CC-------------CCCCCCCC
Confidence            999999999998999999999999999999999999976543211     111111 00             01112234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHH
Q 007261          566 HHLIMLCLACIAREPESRPSMA  587 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~  587 (611)
                      ..+.+++.+||+.||.+||+..
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         221 VAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHHHHHHHccCCHhhcCCCC
Confidence            5688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4e-34  Score=288.06  Aligned_cols=232  Identities=29%  Similarity=0.485  Sum_probs=185.2

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||++.. .+..+|+|.++      .++.+|+.++++++|+|++++++++. ....+++|||+++++|.+++.... ..
T Consensus        20 ~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-~~   97 (260)
T cd05070          20 GEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGE-GR   97 (260)
T ss_pred             ceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcC-CC
Confidence            89999987 56789999986      46889999999999999999999885 456789999999999999997643 23


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.++.+++.||+|||   +.+++||||||+||++++++.+||+|||++........  .......++..|+||
T Consensus        98 ~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aP  172 (260)
T cd05070          98 ALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY--TARQGAKFPIKWTAP  172 (260)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc--ccccCCCCCccccCh
Confidence            4899999999999999999999   68999999999999999999999999999875432211  111223356689999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+.+..++.++||||||+++|||++ |..||......+.     ...... ..            ....+...+..+.+
T Consensus       173 E~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~-----~~~~~~-~~------------~~~~~~~~~~~~~~  234 (260)
T cd05070         173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV-----LEQVER-GY------------RMPCPQDCPISLHE  234 (260)
T ss_pred             HHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH-----HHHHHc-CC------------CCCCCCcCCHHHHH
Confidence            99988899999999999999999999 7777755432221     111111 00            00112344567999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHh
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMK  595 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~  595 (611)
                      ++.+||+.+|++|||+.++.+.|++
T Consensus       235 li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         235 LMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHHHHhc
Confidence            9999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=308.66  Aligned_cols=232  Identities=21%  Similarity=0.315  Sum_probs=180.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||++.+          .+.+|++++++++||||+++++++.+.+..|+||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~   94 (377)
T cd05629          15 GEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK   94 (377)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh
Confidence            89999987  788999999852          356799999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC-----------
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG-----------  475 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-----------  475 (611)
                      ..   .+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........           
T Consensus        95 ~~---~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~  168 (377)
T cd05629          95 YD---TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS  168 (377)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccc
Confidence            53   4788888899999999999999   689999999999999999999999999998632110000           


Q ss_pred             -c--------------------------------ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCC
Q 007261          476 -Y--------------------------------SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAA  522 (611)
Q Consensus       476 -~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~  522 (611)
                       .                                .......||+.|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf  248 (377)
T cd05629         169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPF  248 (377)
T ss_pred             cccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCC
Confidence             0                                0001246899999999999999999999999999999999999998


Q ss_pred             cCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 007261          523 YKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESR---PSMAEVVST  592 (611)
Q Consensus       523 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~  592 (611)
                      ......+..  .   ......   ..+      .+ ......+.++.+++.+|+. +|.+|   +++.|++.+
T Consensus       249 ~~~~~~~~~--~---~i~~~~---~~~------~~-p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         249 CSENSHETY--R---KIINWR---ETL------YF-PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             CCCCHHHHH--H---HHHccC---Ccc------CC-CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            765432211  1   111100   000      00 0111234568889999997 66665   599998876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=9.4e-35  Score=303.77  Aligned_cols=231  Identities=23%  Similarity=0.325  Sum_probs=182.3

Q ss_pred             ceEEEEEE-----cCcEEEEEEecH-----------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII-----NGSTVAIKCMRR-----------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  401 (611)
                      |.||++..     +|..||+|++++           .+.+|+.++.++ +|+||+++++++..++..++||||+++|+|.
T Consensus        14 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~   93 (332)
T cd05614          14 GKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMF   93 (332)
T ss_pred             EEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHH
Confidence            89999875     578999999853           356799999999 5999999999999999999999999999999


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +++....   .+++..+..++.||+.||+|||   +.+++||||||+|||++.++.+||+|||+++.......  .....
T Consensus        94 ~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~--~~~~~  165 (332)
T cd05614          94 THLYQRD---NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK--ERTYS  165 (332)
T ss_pred             HHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC--Ccccc
Confidence            9997643   3889999999999999999999   68999999999999999999999999999875432221  12234


Q ss_pred             cccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC
Q 007261          482 AVGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN  560 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~  560 (611)
                      ..||..|+|||.+.+. .++.++||||||+++|||++|+.||........ ..........           .++.+   
T Consensus       166 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~-----------~~~~~---  230 (332)
T cd05614         166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILK-----------CDPPF---  230 (332)
T ss_pred             ccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhc-----------CCCCC---
Confidence            5789999999999765 478899999999999999999999864332211 0011111111           11111   


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          561 KKEIAHHLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       561 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      +...+..+.+++.+||+.||++||     ++.+++++
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         231 PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            223456688999999999999999     77788764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.3e-34  Score=293.61  Aligned_cols=245  Identities=21%  Similarity=0.321  Sum_probs=185.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|..  +|..||||.++         ..+.+|+.++++++||||+++++++.+++..++||||++ ++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~   92 (285)
T cd07861          14 GVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSL   92 (285)
T ss_pred             eEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcC
Confidence            89999987  68899999875         347789999999999999999999999999999999997 6899998765


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .....+++..+..++.|++.||.|||   ..+++|+||||+|||+++++.+||+|||++.......   .......++..
T Consensus        93 ~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~  166 (285)
T cd07861          93 PKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV---RVYTHEVVTLW  166 (285)
T ss_pred             CCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc---ccccCCccccc
Confidence            44456899999999999999999999   6899999999999999999999999999987543221   12233456889


Q ss_pred             ccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCC------------cccccccccC
Q 007261          488 YMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN------------AEAKLSVLVD  554 (611)
Q Consensus       488 y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~------------~~~~l~~~~d  554 (611)
                      |+|||.+.+ ..++.++||||||+++|||++|+.|+......... ... ........            ..........
T Consensus       167 y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (285)
T cd07861         167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL-FRI-FRILGTPTEDVWPGVTSLPDYKNTFPKWKK  244 (285)
T ss_pred             ccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHH-HHHhCCCChhhhhcchhhHHHHhhccccCc
Confidence            999998865 45789999999999999999999988754332111 110 00000000            0000000011


Q ss_pred             ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..........+.++.+++.+||+.||++|||+.+|+++
T Consensus       245 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         245 GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             chhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            11111112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.6e-35  Score=305.22  Aligned_cols=231  Identities=22%  Similarity=0.335  Sum_probs=184.8

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||+|+++.          .+.+|+.+++.++|+||+++++++.+++..++||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   94 (330)
T cd05601          15 GEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR   94 (330)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHH
Confidence            89999987  788999999863          356799999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..  ..+++.....++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++........  .......||+
T Consensus        95 ~~--~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~~gt~  167 (330)
T cd05601          95 YE--DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM--VNSKLPVGTP  167 (330)
T ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc--eeeecccCCc
Confidence            53  34889999999999999999999   68999999999999999999999999999876532221  1223356899


Q ss_pred             Cccchhhhc------cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC
Q 007261          487 GYMAPEYME------YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN  560 (611)
Q Consensus       487 ~y~aPE~~~------~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~  560 (611)
                      .|+|||.+.      ...++.++||||||+++|||++|+.||......+.     .........       ...  . ..
T Consensus       168 ~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----~~~i~~~~~-------~~~--~-~~  232 (330)
T cd05601         168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-----YNNIMNFQR-------FLK--F-PE  232 (330)
T ss_pred             cccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-----HHHHHcCCC-------ccC--C-CC
Confidence            999999986      45678999999999999999999999876543221     111111000       000  0 01


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          561 KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       561 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ....+..+.+|+.+|++ +|.+||++.+++.+
T Consensus       233 ~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         233 DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            11245668889999997 99999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.7e-34  Score=290.43  Aligned_cols=226  Identities=24%  Similarity=0.439  Sum_probs=185.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  +|..||+|.++        +.+.+|+.++++++|+||+++++++..+...++||||+++++|.+++... 
T Consensus        18 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-   96 (277)
T cd06642          18 GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG-   96 (277)
T ss_pred             eeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcC-
Confidence            89999987  57899999875        25788999999999999999999999999999999999999999998653 


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         .+++..+..++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||++.......   .......++..|
T Consensus        97 ---~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y  167 (277)
T cd06642          97 ---PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---IKRNTFVGTPFW  167 (277)
T ss_pred             ---CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc---hhhhcccCcccc
Confidence               3889999999999999999999   6899999999999999999999999999987543221   112234578899


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHH
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL  568 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l  568 (611)
                      +|||.+.+..++.++||||||+++|||++|+.|+.........     . .....         ..+   ......+..+
T Consensus       168 ~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----~-~~~~~---------~~~---~~~~~~~~~~  229 (277)
T cd06642         168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-----F-LIPKN---------SPP---TLEGQYSKPF  229 (277)
T ss_pred             cCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-----h-hhhcC---------CCC---CCCcccCHHH
Confidence            9999999989999999999999999999999998644322111     0 00000         011   1122345678


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHH
Q 007261          569 IMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       569 ~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+++.+||+.+|++||++.+++++
T Consensus       230 ~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         230 KEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHccCCcccCcCHHHHHHh
Confidence            999999999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=7.2e-34  Score=291.72  Aligned_cols=241  Identities=27%  Similarity=0.448  Sum_probs=186.0

Q ss_pred             ceEEEEEEcC------------------cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEE
Q 007261          339 GSVFRGIING------------------STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVY  392 (611)
Q Consensus       339 g~Vy~g~~~g------------------~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  392 (611)
                      |.||++...+                  ..||+|.+.        .++.+|++++++++|+||+++++++..++..++||
T Consensus        19 g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   98 (296)
T cd05051          19 GEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIM   98 (296)
T ss_pred             ccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEE
Confidence            8899987632                  458999985        35778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCC--------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeec
Q 007261          393 EFMENGSLSDWLHKKRY--------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS  464 (611)
Q Consensus       393 E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg  464 (611)
                      ||+++++|.+++.....        ...+++..++.++.|++.||+|||   +.+++|+||||+||++++++.++|+|||
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Nili~~~~~~~l~dfg  175 (296)
T cd05051          99 EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFG  175 (296)
T ss_pred             ecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhceeecCCCceEEcccc
Confidence            99999999999976531        225899999999999999999999   6899999999999999999999999999


Q ss_pred             CccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh--CCCCCcCCCChhhHHHHHHHHHHhc
Q 007261          465 FVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT--GKEAAYKQDGEEILLAEAVFSMVEG  542 (611)
Q Consensus       465 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~  542 (611)
                      +++....... ........++..|+|||.+.+..++.++||||||+++|||++  |..|+......+.  ..........
T Consensus       176 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~--~~~~~~~~~~  252 (296)
T cd05051         176 MSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV--IENAGHFFRD  252 (296)
T ss_pred             ceeecccCcc-eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH--HHHHHhcccc
Confidence            9875432211 122234456788999999998899999999999999999998  5556544332221  1111111110


Q ss_pred             CCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          543 GNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       543 ~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      ..    ..     .....+...+.++.+++.+||+.||++||++.||++.|.
T Consensus       253 ~~----~~-----~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         253 DG----RQ-----IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             cc----cc-----ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            00    00     001112234567999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.8e-34  Score=292.29  Aligned_cols=230  Identities=26%  Similarity=0.450  Sum_probs=181.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhc-CCCceeeccceeccC------CeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKI-NHFNLINLFGACEHD------GVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l-~H~niv~l~g~~~~~------~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|..  .++.||+|.+.      ..+.+|+.+++++ +|+||+++++++...      ...++||||+++++|.++
T Consensus        20 g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (272)
T cd06637          20 GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL   99 (272)
T ss_pred             eEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHH
Confidence            89999987  67899999985      3578899999999 799999999998642      468999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      +.... ...+++..+..++.|++.||+|||   ..+++|+||||+||++++++.+||+|||+++......   .......
T Consensus       100 l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~  172 (272)
T cd06637         100 IKNTK-GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV---GRRNTFI  172 (272)
T ss_pred             HHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc---ccCCccc
Confidence            98643 245889999999999999999999   6899999999999999999999999999987543221   1223456


Q ss_pred             cCCCccchhhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCC
Q 007261          484 GTNGYMAPEYME-----YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ  558 (611)
Q Consensus       484 gt~~y~aPE~~~-----~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~  558 (611)
                      |+..|+|||++.     +..++.++||||||+++|||++|+.|+.........     .....     ..     .+.. 
T Consensus       173 g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~~~~~-----~~-----~~~~-  236 (272)
T cd06637         173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----FLIPR-----NP-----APRL-  236 (272)
T ss_pred             ccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----HHHhc-----CC-----CCCC-
Confidence            888999999986     345888999999999999999999998644322111     00000     00     0000 


Q ss_pred             cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                       .....+..+.+|+.+||..||.+||++.|++++
T Consensus       237 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         237 -KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             -CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence             112344568899999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.3e-35  Score=302.67  Aligned_cols=221  Identities=25%  Similarity=0.381  Sum_probs=177.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecHH----------HHHHHH-HHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRRS----------ISKEVN-LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~----------~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +|+.||||++.+.          +..|.. +++.++||||+++++++...+..++||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~   88 (323)
T cd05575           9 GKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQ   88 (323)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHH
Confidence            89999998  6899999998632          233433 5677899999999999999999999999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++.....++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||
T Consensus        89 ~~~---~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt  159 (323)
T cd05575          89 RER---SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---KTTSTFCGT  159 (323)
T ss_pred             hcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC---CccccccCC
Confidence            643   4888899999999999999999   6899999999999999999999999999987532211   123345689


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||......+.     ........           ..+   +...+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-----~~~i~~~~-----------~~~---~~~~~  220 (323)
T cd05575         160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-----YDNILNKP-----------LRL---KPNIS  220 (323)
T ss_pred             hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH-----HHHHHcCC-----------CCC---CCCCC
Confidence            999999999999999999999999999999999999976543221     11111100           001   11235


Q ss_pred             HHHHHHHHHhhccCCCCCCCHH
Q 007261          566 HHLIMLCLACIAREPESRPSMA  587 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~  587 (611)
                      ..+.+++.+||+.||.+||++.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         221 VSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHHHHHhhcCHHhCCCCC
Confidence            6688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.5e-35  Score=278.07  Aligned_cols=222  Identities=27%  Similarity=0.480  Sum_probs=183.3

Q ss_pred             cCcEEEEEEec---------------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          347 NGSTVAIKCMR---------------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       347 ~g~~vavK~~~---------------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      .|...|+|++.               +.-.+|+.||+++ .||+|+.+.++++.+...++|+|.|+.|.|.|+|...   
T Consensus        41 t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~---  117 (411)
T KOG0599|consen   41 TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK---  117 (411)
T ss_pred             cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh---
Confidence            67788888874               2346799999999 7999999999999999999999999999999999875   


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA  490 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~a  490 (611)
                      ..++.+...+|+.|+.+|++|||   ...||||||||+|||+|+|..+||+|||++.....++    ..+..+||++|+|
T Consensus       118 VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge----kLrelCGTPgYLA  190 (411)
T KOG0599|consen  118 VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE----KLRELCGTPGYLA  190 (411)
T ss_pred             eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeeccCCch----hHHHhcCCCcccC
Confidence            35999999999999999999999   7999999999999999999999999999998876543    4566799999999


Q ss_pred             hhhhcc------CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          491 PEYMEY------GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       491 PE~~~~------~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      ||.+..      ..|+...|+|+.||+||-|+.|.+||.-...  ..+    ..+...+...     +    ..++..+.
T Consensus       191 PEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--mlM----LR~ImeGkyq-----F----~speWadi  255 (411)
T KOG0599|consen  191 PETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--MLM----LRMIMEGKYQ-----F----RSPEWADI  255 (411)
T ss_pred             hhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--HHH----HHHHHhcccc-----c----CCcchhhc
Confidence            998853      3578899999999999999999999863321  111    1111112111     1    11234567


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      +....+|+.+||+.||.+|.|++|++.+=
T Consensus       256 s~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  256 SATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             cccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence            78899999999999999999999999764

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.5e-34  Score=288.61  Aligned_cols=238  Identities=26%  Similarity=0.400  Sum_probs=180.8

Q ss_pred             ceEEEEEEc----CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGIIN----GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~~----g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|.+.    +..+|+|.++        ..+.+|+.++++++||||+++++++.+....++||||+++|+|.+++..
T Consensus         9 g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~   88 (269)
T cd05087           9 GKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRS   88 (269)
T ss_pred             ceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHH
Confidence            899999863    3479999885        2577899999999999999999999999999999999999999999976


Q ss_pred             cCC--CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          407 KRY--PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       407 ~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ...  ....++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++....... ........+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~  164 (269)
T cd05087          89 CRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-YVTPDQLWV  164 (269)
T ss_pred             hhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcce-eecCCCcCC
Confidence            432  224677888899999999999999   68999999999999999999999999999865432211 111223456


Q ss_pred             CCCccchhhhccC-------CCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCcc
Q 007261          485 TNGYMAPEYMEYG-------LVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN  556 (611)
Q Consensus       485 t~~y~aPE~~~~~-------~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  556 (611)
                      +..|+|||++...       .++.++||||||+++|||++ |+.||......+... .    ....     ......++.
T Consensus       165 ~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~-~----~~~~-----~~~~~~~~~  234 (269)
T cd05087         165 PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT-Y----TVRE-----QQLKLPKPR  234 (269)
T ss_pred             cccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH-H----Hhhc-----ccCCCCCCc
Confidence            7889999988642       35789999999999999996 888886544332111 0    0000     001111222


Q ss_pred             CCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       557 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      +.   ...+..+.+++.+|| .+|++|||++||+..|+
T Consensus       235 ~~---~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         235 LK---LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cC---CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11   123445788999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4e-34  Score=300.40  Aligned_cols=239  Identities=27%  Similarity=0.457  Sum_probs=184.4

Q ss_pred             ceEEEEEE-------cCcEEEEEEecH--------HHHHHHHHHHhc-CCCceeeccceeccC-CeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII-------NGSTVAIKCMRR--------SISKEVNLLKKI-NHFNLINLFGACEHD-GVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~~~lV~E~~~~gsL~  401 (611)
                      |.||+|.+       .++.||||+++.        .+.+|+.++.++ +|+||++++++|... ...++||||+++|+|.
T Consensus        21 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~  100 (343)
T cd05103          21 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS  100 (343)
T ss_pred             ceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHH
Confidence            89999974       467899999852        467899999999 789999999988654 5679999999999999


Q ss_pred             HHhhccCC----------------------------------------------------------------CCccCHHH
Q 007261          402 DWLHKKRY----------------------------------------------------------------PEFVSWNC  417 (611)
Q Consensus       402 ~~l~~~~~----------------------------------------------------------------~~~l~~~~  417 (611)
                      +++.....                                                                ...++|..
T Consensus       101 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (343)
T cd05103         101 NYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLED  180 (343)
T ss_pred             HHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHH
Confidence            99875321                                                                12368889


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhccC
Q 007261          418 RFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYG  497 (611)
Q Consensus       418 ~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  497 (611)
                      +..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++....... ........++..|+|||.+.+.
T Consensus       181 ~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~  256 (343)
T cd05103         181 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDR  256 (343)
T ss_pred             HHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-hhhcCCCCCCcceECcHHhcCC
Confidence            9999999999999999   68999999999999999999999999999876432211 1111223456789999999988


Q ss_pred             CCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhh
Q 007261          498 LVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACI  576 (611)
Q Consensus       498 ~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl  576 (611)
                      .++.++||||||+++|||++ |..|+......+.     .......+..            ...+...+.++.+++.+||
T Consensus       257 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~~~~~~------------~~~~~~~~~~~~~~~~~cl  319 (343)
T cd05103         257 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEGTR------------MRAPDYTTPEMYQTMLDCW  319 (343)
T ss_pred             CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-----HHHHHhccCC------------CCCCCCCCHHHHHHHHHHc
Confidence            99999999999999999997 7777754332211     1111111100            0001123456899999999


Q ss_pred             ccCCCCCCCHHHHHHHHHhchh
Q 007261          577 AREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       577 ~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      +.||++||++.||+++|+.+..
T Consensus       320 ~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         320 HGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             cCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-34  Score=288.28  Aligned_cols=233  Identities=30%  Similarity=0.542  Sum_probs=187.7

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||++.. ++..||||.+.      .++.+|+.++++++|+||+++++++..+...++||||+++++|.+++.... ..
T Consensus        20 ~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~   98 (261)
T cd05034          20 GEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGE-GK   98 (261)
T ss_pred             eEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccc-cC
Confidence            89999987 45789999986      468899999999999999999999998899999999999999999998753 23


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..+..++.+++.||.|||   +.+++|+||||+||++++++.+||+|||+++......  .........+..|+||
T Consensus        99 ~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~y~~P  173 (261)
T cd05034          99 KLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE--YTAREGAKFPIKWTAP  173 (261)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh--hhhhhccCCCccccCH
Confidence            5899999999999999999999   6899999999999999999999999999987653221  1111222345689999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+.+..++.++||||||++++||++ |+.|+........ + .   .... .     ..       ...+...+.++.+
T Consensus       174 E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-~-~---~~~~-~-----~~-------~~~~~~~~~~~~~  235 (261)
T cd05034         174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV-L-E---QVER-G-----YR-------MPRPPNCPEELYD  235 (261)
T ss_pred             HHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-H-H---HHHc-C-----CC-------CCCCCCCCHHHHH
Confidence            99998899999999999999999999 8888754432221 1 1   1111 0     00       0111223567899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHh
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMK  595 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~  595 (611)
                      ++.+||+.+|++||+++++++.|+.
T Consensus       236 ~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         236 LMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHHcccCcccCCCHHHHHHHHhc
Confidence            9999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.1e-34  Score=294.06  Aligned_cols=228  Identities=25%  Similarity=0.441  Sum_probs=186.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|..  ++..|++|.+.       ..+.+|+.+++.++|+|++++++.+..+...++||||+++++|.+++.... 
T Consensus        34 ~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-  112 (296)
T cd06654          34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-  112 (296)
T ss_pred             eEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhcC-
Confidence            89999986  68899999885       357789999999999999999999999999999999999999999997542 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                         +++.++..++.|++.||+|||   ..+++|+||||+|||++.++.+||+|||++........   ......+++.|+
T Consensus       113 ---~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~  183 (296)
T cd06654         113 ---MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWM  183 (296)
T ss_pred             ---CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc---ccCcccCCcccc
Confidence               789999999999999999999   68999999999999999999999999999875432211   122346888999


Q ss_pred             chhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          490 APEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       490 aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      |||.+.+..++.++||||||+++|||++|+.||......+..     ........          +. ...+......+.
T Consensus       184 aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~-----~~~~~~~~----------~~-~~~~~~~~~~l~  247 (296)
T cd06654         184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATNGT----------PE-LQNPEKLSAIFR  247 (296)
T ss_pred             CHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH-----HHHhcCCC----------CC-CCCccccCHHHH
Confidence            999999888999999999999999999999998755432211     11111000          00 011234556788


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 007261          570 MLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +++.+||..||++||++.+++++
T Consensus       248 ~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         248 DFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             HHHHHHCcCCcccCcCHHHHhhC
Confidence            99999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.6e-34  Score=288.47  Aligned_cols=238  Identities=26%  Similarity=0.424  Sum_probs=178.9

Q ss_pred             ceEEEEEE-c---CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII-N---GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~-~---g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|.. +   ...+++|.++        ..+.+|+.+++.++|+||+++++.+.+....++||||+++|+|.+++..
T Consensus         9 g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~   88 (269)
T cd05042           9 GKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRS   88 (269)
T ss_pred             ceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHh
Confidence            89999975 2   3478899774        2477899999999999999999999999999999999999999999987


Q ss_pred             cCC--CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          407 KRY--PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       407 ~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ...  ....++...+.++.||+.||+|||   +.+++||||||+|||+++++.+||+|||+++....... ........+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~  164 (269)
T cd05042          89 NRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY-YITKDCHAV  164 (269)
T ss_pred             ccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchh-eeccCCCCC
Confidence            542  233567888899999999999999   68999999999999999999999999999865432211 111223345


Q ss_pred             CCCccchhhhcc-------CCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCcc
Q 007261          485 TNGYMAPEYMEY-------GLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN  556 (611)
Q Consensus       485 t~~y~aPE~~~~-------~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  556 (611)
                      +..|+|||++..       ..++.++||||||+++|||++ |..|+......+. +    ........     ..+.++.
T Consensus       165 ~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~----~~~~~~~~-----~~~~~~~  234 (269)
T cd05042         165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-L----KQVVREQD-----IKLPKPQ  234 (269)
T ss_pred             cccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-H----HHHhhccC-----ccCCCCc
Confidence            678999998743       356889999999999999999 5566654332221 1    11111110     0111111


Q ss_pred             CCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       557 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      +   +...+..+.+++..|| .||++||+++||++.|.
T Consensus       235 ~---~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         235 L---DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             c---cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1   2334566778889998 59999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8.6e-34  Score=284.37  Aligned_cols=230  Identities=26%  Similarity=0.435  Sum_probs=188.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec-----HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||+|..  ++..+++|.++     .++.+|++++++++|+||+++++++..+...++++||+++++|.+++....  .
T Consensus        17 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~   94 (256)
T cd06612          17 GSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN--K   94 (256)
T ss_pred             eEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCc--c
Confidence            89999998  47899999986     358899999999999999999999999999999999999999999997643  3


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..+..++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||++.......   .......++..|+||
T Consensus        95 ~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~~P  168 (256)
T cd06612          95 TLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM---AKRNTVIGTPFWMAP  168 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc---cccccccCCccccCH
Confidence            4899999999999999999999   6899999999999999999999999999987653322   122334578899999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML  571 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l  571 (611)
                      |.+.+..++.++||||||+++|||++|+.|+..........     ...          .. .......+......+.++
T Consensus       169 E~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-----~~~----------~~-~~~~~~~~~~~~~~~~~~  232 (256)
T cd06612         169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-----MIP----------NK-PPPTLSDPEKWSPEFNDF  232 (256)
T ss_pred             HHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-----hhc----------cC-CCCCCCchhhcCHHHHHH
Confidence            99999899999999999999999999999986543321110     000          00 000111133455678999


Q ss_pred             HHHhhccCCCCCCCHHHHHHH
Q 007261          572 CLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       572 ~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.+||+.||++||++.|++++
T Consensus       233 i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         233 VKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             HHHHHhcChhhCcCHHHHhcC
Confidence            999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.3e-34  Score=296.24  Aligned_cols=240  Identities=28%  Similarity=0.490  Sum_probs=189.2

Q ss_pred             ceEEEEEEc---------CcEEEEEEecH--------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCH
Q 007261          339 GSVFRGIIN---------GSTVAIKCMRR--------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~~---------g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      |.||++...         +..+|+|.++.        ++.+|+.+++++ +|+||+++++++..++..++||||+++|+|
T Consensus        32 g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  111 (307)
T cd05098          32 GQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  111 (307)
T ss_pred             eeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcH
Confidence            889999752         24699999862        467799999999 899999999999999999999999999999


Q ss_pred             HHHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          401 SDWLHKKRY-------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       401 ~~~l~~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      .+++...+.             ...++|..+++++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++
T Consensus       112 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~  188 (307)
T cd05098         112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR  188 (307)
T ss_pred             HHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEcCCCcEEECCCcccc
Confidence            999976432             135899999999999999999999   6899999999999999999999999999987


Q ss_pred             ccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcc
Q 007261          468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       468 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  546 (611)
                      ....... ........++..|+|||.+.+..++.++||||||+++|||++ |..|+.....++      +........  
T Consensus       189 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~--  259 (307)
T cd05098         189 DIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGH--  259 (307)
T ss_pred             cccccch-hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHHcCC--
Confidence            5532211 111122234568999999998899999999999999999998 777765433221      111111110  


Q ss_pred             cccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       547 ~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                                ....+...+.++.+++.+||+.+|++||++.++++.|.++....
T Consensus       260 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         260 ----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             ----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence                      01112334567889999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2e-34  Score=300.32  Aligned_cols=226  Identities=24%  Similarity=0.402  Sum_probs=180.4

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCC-CceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINH-FNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|..  +++.||||++++          .+..|..++..++| ++|+++++++.+.+..|+||||+++|+|.+++.
T Consensus        14 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~   93 (324)
T cd05587          14 GKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ   93 (324)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence            89999988  467899999863          34568888988866 568889999999999999999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++......   .......||
T Consensus        94 ~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~gt  164 (324)
T cd05587          94 QVG---KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG---KTTRTFCGT  164 (324)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC---CceeeecCC
Confidence            653   3788999999999999999999   6899999999999999999999999999986432211   123345689


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||......+..     ..... ..          .   ..+...+
T Consensus       165 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~-----~~i~~-~~----------~---~~~~~~~  225 (324)
T cd05587         165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-----QSIME-HN----------V---SYPKSLS  225 (324)
T ss_pred             ccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-----HHHHc-CC----------C---CCCCCCC
Confidence            9999999999999999999999999999999999998765432211     11111 00          0   0122345


Q ss_pred             HHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPSM-----AEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~-----~evl~~  592 (611)
                      .++.+++.+||+.||.+|++.     .+++++
T Consensus       226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         226 KEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            678899999999999999976     555543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.6e-34  Score=296.12  Aligned_cols=243  Identities=20%  Similarity=0.370  Sum_probs=190.8

Q ss_pred             HhhcCCCCCccc----ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEE
Q 007261          327 ATENFSPKNMID----GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYL  390 (611)
Q Consensus       327 at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  390 (611)
                      ..++|..-..||    |+||.++-  .|+.+|+|++++          .++.|-++|...++|+||+|+-.|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            344555444554    99999976  899999999974          25668899999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccc
Q 007261          391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV  470 (611)
Q Consensus       391 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~  470 (611)
                      ||||++||++..+|...+   .|+.......+.+++.|++-||   +.|+|||||||+|+|||..|++||+||||+....
T Consensus       219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999998764   4888888889999999999999   7999999999999999999999999999985332


Q ss_pred             cc--------------------cCCcc------------------------cccccccCCCccchhhhccCCCCCccchH
Q 007261          471 RE--------------------ESGYS------------------------STKTAVGTNGYMAPEYMEYGLVTPEMDTY  506 (611)
Q Consensus       471 ~~--------------------~~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~  506 (611)
                      ..                    .....                        .....+|||.|||||++.+..|+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                    00000                        01234799999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCC-
Q 007261          507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPS-  585 (611)
Q Consensus       507 s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-  585 (611)
                      |+|||+||||.|.+||......+..  +.+..+...      +.       .+....++.+..+||.+|+. ||++|-- 
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~--rkI~nwr~~------l~-------fP~~~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETY--RKIVNWRET------LK-------FPEEVDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhhh------cc-------CCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence            9999999999999999987765422  222222111      00       01112334778899999999 9999975 


Q ss_pred             --HHHHHH
Q 007261          586 --MAEVVS  591 (611)
Q Consensus       586 --~~evl~  591 (611)
                        +.||.+
T Consensus       437 ~G~~EIK~  444 (550)
T KOG0605|consen  437 KGAEEIKK  444 (550)
T ss_pred             ccHHHHhc
Confidence              444443

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.2e-34  Score=289.40  Aligned_cols=235  Identities=28%  Similarity=0.489  Sum_probs=186.1

Q ss_pred             ceEEEEEE--cC---cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NG---STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g---~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|..  +|   ..||||.++        .+|..|+.++++++||||+++++++.+++..++||||+++|+|.+++.
T Consensus        18 g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   97 (269)
T cd05065          18 GEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLR   97 (269)
T ss_pred             CeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHh
Confidence            89999987  33   369999975        357889999999999999999999999999999999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc--c
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA--V  483 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~--~  483 (611)
                      ...  ..+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++................  .
T Consensus        98 ~~~--~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  172 (269)
T cd05065          98 QND--GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK  172 (269)
T ss_pred             hCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCC
Confidence            653  34899999999999999999999   6899999999999999999999999999987553322111111111  1


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      .+..|+|||.+.+..++.++||||||+++||+++ |..|+......+.  ...    .....           . ...+.
T Consensus       173 ~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~--~~~----i~~~~-----------~-~~~~~  234 (269)
T cd05065         173 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--INA----IEQDY-----------R-LPPPM  234 (269)
T ss_pred             cceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH--HHH----HHcCC-----------c-CCCcc
Confidence            2457999999999999999999999999999887 8888865433211  111    11100           0 01122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          563 EIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      +++..+.+++.+||+.+|++||++.+++..|+++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         235 DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            3456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.5e-34  Score=301.31  Aligned_cols=225  Identities=24%  Similarity=0.350  Sum_probs=178.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHH-HHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEV-NLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +++.||+|++++          .+..|. .+++.++|+||+++++++...+..++||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   88 (325)
T cd05602           9 GKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ   88 (325)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHH
Confidence            89999988  577899999863          122333 34677899999999999999999999999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .++......++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||
T Consensus        89 ~~~---~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~---~~~~~~~gt  159 (325)
T cd05602          89 RER---CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---GTTSTFCGT  159 (325)
T ss_pred             hcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC---CCcccccCC
Confidence            643   3677888889999999999999   6899999999999999999999999999987542221   123345789


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||......+.     ........             . ......+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~i~~~~-------------~-~~~~~~~  220 (325)
T cd05602         160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-----YDNILNKP-------------L-QLKPNIT  220 (325)
T ss_pred             ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH-----HHHHHhCC-------------c-CCCCCCC
Confidence            999999999999999999999999999999999999976543221     11111100             0 0112345


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      ..+.+++.+||+.||.+||++.+.+.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         221 NSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             HHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            56889999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.6e-34  Score=299.36  Aligned_cols=220  Identities=25%  Similarity=0.406  Sum_probs=178.2

Q ss_pred             ceEEEEEE--cCcEEEEEEecHH----------HHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRRS----------ISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  ++..||||.+++.          +..|..++..+ +|++|+++++++.+.+..++||||+++|+|.+++.
T Consensus        14 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~   93 (323)
T cd05616          14 GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ   93 (323)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHH
Confidence            89999988  5679999998632          44577777777 68999999999999999999999999999999987


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++......   .......||
T Consensus        94 ~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~---~~~~~~~gt  164 (323)
T cd05616          94 QVG---RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGT  164 (323)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC---CccccCCCC
Confidence            653   3889999999999999999999   6899999999999999999999999999987542211   122345689


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+.+..++.++|||||||++|||++|+.||......+.  .   ..... ..             ...+...+
T Consensus       165 ~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--~---~~i~~-~~-------------~~~p~~~s  225 (323)
T cd05616         165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--F---QSIME-HN-------------VAYPKSMS  225 (323)
T ss_pred             hhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--H---HHHHh-CC-------------CCCCCcCC
Confidence            999999999999999999999999999999999999976543221  1   11111 00             01122345


Q ss_pred             HHHHHHHHHhhccCCCCCCCH
Q 007261          566 HHLIMLCLACIAREPESRPSM  586 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~  586 (611)
                      .++.+++.+|++.||++|++.
T Consensus       226 ~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         226 KEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             HHHHHHHHHHcccCHHhcCCC
Confidence            678899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-35  Score=300.81  Aligned_cols=230  Identities=25%  Similarity=0.395  Sum_probs=195.8

Q ss_pred             ceEE--EEEEcCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCe-EEEEEeecCCCCHHHHhhc
Q 007261          339 GSVF--RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGV-FYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy--~g~~~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.++  +++.++..+++|.++         +...+|+.++++++|||||.+.+.|.+++. .+|||+||+||+|.+.+..
T Consensus        18 G~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~   97 (426)
T KOG0589|consen   18 GSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKE   97 (426)
T ss_pred             chhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHH
Confidence            6555  445578899999985         467889999999999999999999998888 9999999999999999988


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .+ ...++...+..|+.|++.|+.|||   +..|+|||||+.|||++.+..+||+|||+|+......   ......+||+
T Consensus        98 ~k-~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~---~~a~tvvGTp  170 (426)
T KOG0589|consen   98 QK-GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED---SLASTVVGTP  170 (426)
T ss_pred             Hh-hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch---hhhheecCCC
Confidence            65 456889999999999999999999   7999999999999999999999999999999876543   2455689999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .||+||.+.+..|..|+|||||||++|||++-+.+|...+....     +.....             ......+...+.
T Consensus       171 ~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-----i~ki~~-------------~~~~Plp~~ys~  232 (426)
T KOG0589|consen  171 YYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-----ILKINR-------------GLYSPLPSMYSS  232 (426)
T ss_pred             cccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-----HHHHhh-------------ccCCCCCccccH
Confidence            99999999999999999999999999999999999976654332     111111             112233556778


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      ++..++..|++.+|..||++.+++.+-
T Consensus       233 el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  233 ELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             HHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence            899999999999999999999999873

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.3e-34  Score=286.87  Aligned_cols=229  Identities=26%  Similarity=0.381  Sum_probs=186.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++..  ++..+|+|.++        +.+.+|+.++++++|+||+++++.+.+++..++||||+++|+|.+++....
T Consensus        14 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~   93 (255)
T cd08219          14 GRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQR   93 (255)
T ss_pred             eEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhcc
Confidence            78999987  68899999874        357789999999999999999999999999999999999999999987543


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                       ...+++...+.++.|++.||.|||   +.+++|+||||+||++++++.++|+|||+++......   .......++..|
T Consensus        94 -~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~  166 (255)
T cd08219          94 -GKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTYVGTPYY  166 (255)
T ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc---cccccccCCccc
Confidence             234788999999999999999999   6899999999999999999999999999987553221   112235688899


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHH
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL  568 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l  568 (611)
                      +|||.+.+..++.++|+||||+++|+|++|+.||........     ...... +            .....+...+..+
T Consensus       167 ~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-----~~~~~~-~------------~~~~~~~~~~~~~  228 (255)
T cd08219         167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-----ILKVCQ-G------------SYKPLPSHYSYEL  228 (255)
T ss_pred             cCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-----HHHHhc-C------------CCCCCCcccCHHH
Confidence            999999998999999999999999999999999875432211     111111 1            0111122345568


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHH
Q 007261          569 IMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       569 ~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+++.+||+.||++||++.+++..
T Consensus       229 ~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         229 RSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHhCCcccCCCHHHHhhc
Confidence            899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-34  Score=286.98  Aligned_cols=225  Identities=25%  Similarity=0.418  Sum_probs=189.1

Q ss_pred             ceEEEEEE--cCcEEEEEEecHH----------HHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.|-++..  .|+.||||.++++          +.+|++||+.|+||||+.++.+|+..+...|||||..+|.|.+|+..
T Consensus        67 GKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSe  146 (668)
T KOG0611|consen   67 GKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISE  146 (668)
T ss_pred             cceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHH
Confidence            77888765  7999999999743          67899999999999999999999999999999999999999999998


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .+   .|+..+..+++.||..|+.|+|   +++++|||||.+|||+|.|+.+||+||||+-.....    ......+|++
T Consensus       147 r~---~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~----kfLqTFCGSP  216 (668)
T KOG0611|consen  147 RG---SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK----KFLQTFCGSP  216 (668)
T ss_pred             hc---cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccc----cHHHHhcCCc
Confidence            75   3999999999999999999999   799999999999999999999999999998765432    2345678999


Q ss_pred             CccchhhhccCCC-CCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          487 GYMAPEYMEYGLV-TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       487 ~y~aPE~~~~~~~-s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      .|.+||.+.+..| .+..|-|||||+||-|+.|..||.+.+..     ..+.+.-.+.        ...|.       .+
T Consensus       217 LYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-----~lvrQIs~Ga--------YrEP~-------~P  276 (668)
T KOG0611|consen  217 LYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-----RLVRQISRGA--------YREPE-------TP  276 (668)
T ss_pred             ccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-----HHHHHhhccc--------ccCCC-------CC
Confidence            9999999998877 47999999999999999999999876543     2222222111        11111       12


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      ....-|+++||..||++|.|+.+|..+.
T Consensus       277 SdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  277 SDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             chHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            2356699999999999999999999875

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.1e-34  Score=305.37  Aligned_cols=230  Identities=25%  Similarity=0.353  Sum_probs=181.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +++.+|+|.+.+          .+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++..
T Consensus        57 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~  136 (370)
T cd05621          57 GEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN  136 (370)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh
Confidence            89999988  578999999852          366899999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..    +++.....++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++......  ........||+
T Consensus       137 ~~----~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~--~~~~~~~~gt~  207 (370)
T cd05621         137 YD----VPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG--MVRCDTAVGTP  207 (370)
T ss_pred             cC----CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccCC--ceecccCCCCc
Confidence            43    788888999999999999999   6899999999999999999999999999987653221  11223457999


Q ss_pred             CccchhhhccC----CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          487 GYMAPEYMEYG----LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       487 ~y~aPE~~~~~----~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      .|+|||.+...    .++.++||||||+++|||++|+.||......+.     .........   .+      .. ....
T Consensus       208 ~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-----~~~i~~~~~---~~------~~-p~~~  272 (370)
T cd05621         208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-----YSKIMDHKN---SL------NF-PEDV  272 (370)
T ss_pred             ccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCCc---cc------CC-CCcc
Confidence            99999998653    378999999999999999999999976543221     111111100   00      00 0112


Q ss_pred             HHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPES--RPSMAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  592 (611)
                      ..+..+.+++.+|+..++.+  |+++.|++++
T Consensus       273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            34566788899999755543  8999999887

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.2e-34  Score=286.68  Aligned_cols=232  Identities=29%  Similarity=0.514  Sum_probs=186.7

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||++.. +++.||+|.+.      .++.+|+.++++++|+||+++++++. ++..+++|||+++++|.+++.... ..
T Consensus        20 g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~-~~   97 (260)
T cd05067          20 GEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPE-GI   97 (260)
T ss_pred             ceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcC-CC
Confidence            89999988 77899999886      46889999999999999999999874 456899999999999999987643 24


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++.......  ........++..|+||
T Consensus        98 ~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~y~~p  172 (260)
T cd05067          98 KLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE--YTAREGAKFPIKWTAP  172 (260)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC--cccccCCcccccccCH
Confidence            5899999999999999999999   6899999999999999999999999999987553221  1112233456789999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+....++.++||||||++++||++ |+.||......+.  ..    ......         .   ...+...+.++.+
T Consensus       173 e~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~~---------~---~~~~~~~~~~~~~  234 (260)
T cd05067         173 EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV--IQ----NLERGY---------R---MPRPDNCPEELYE  234 (260)
T ss_pred             HHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH--HH----HHHcCC---------C---CCCCCCCCHHHHH
Confidence            99998899999999999999999999 8888865443221  11    111110         0   0112234567999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHh
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMK  595 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~  595 (611)
                      ++.+||+.+|++||+++++++.|+.
T Consensus       235 li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         235 LMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHHccCChhhCCCHHHHHHHhhc
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-34  Score=291.77  Aligned_cols=241  Identities=26%  Similarity=0.435  Sum_probs=183.4

Q ss_pred             ceEEEEEEcC----------------cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEee
Q 007261          339 GSVFRGIING----------------STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEF  394 (611)
Q Consensus       339 g~Vy~g~~~g----------------~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  394 (611)
                      |.||++...+                ..||+|.++        ..+.+|++++++++|+|++++++++..++..++||||
T Consensus        19 g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   98 (295)
T cd05097          19 GEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEY   98 (295)
T ss_pred             ceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEec
Confidence            8899886522                258999985        2477899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCC---------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecC
Q 007261          395 MENGSLSDWLHKKRY---------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSF  465 (611)
Q Consensus       395 ~~~gsL~~~l~~~~~---------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl  465 (611)
                      +++++|.+++.....         ...++|..++.++.|++.||+|||   ..+++|+||||+||++++++.+||+|||+
T Consensus        99 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nill~~~~~~kl~dfg~  175 (295)
T cd05097          99 MENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGM  175 (295)
T ss_pred             CCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEEEcCCCcEEeccccc
Confidence            999999999965321         124789999999999999999999   68999999999999999999999999999


Q ss_pred             ccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh--CCCCCcCCCChhhHHHHHHHHHHhcC
Q 007261          466 VRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT--GKEAAYKQDGEEILLAEAVFSMVEGG  543 (611)
Q Consensus       466 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~~  543 (611)
                      ++....... ........++..|+|||.+.++.++.++||||||++++||++  |..|+......+..  ..........
T Consensus       176 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~--~~~~~~~~~~  252 (295)
T cd05097         176 SRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI--ENTGEFFRNQ  252 (295)
T ss_pred             ccccccCcc-eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH--HHHHHhhhhc
Confidence            875432211 112223345678999999998899999999999999999998  44555443332211  1111111100


Q ss_pred             CcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          544 NAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       544 ~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      .   .  .    .....+...+..+.+|+.+||+.||++||++.+|++.|.
T Consensus       253 ~---~--~----~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         253 G---R--Q----IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             c---c--c----ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            0   0  0    000111223567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.3e-34  Score=288.66  Aligned_cols=242  Identities=22%  Similarity=0.460  Sum_probs=190.6

Q ss_pred             ceEEEEEEc------CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceecc--CCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGIIN------GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEH--DGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~~------g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||++.++      +..+|||.++        .++.+|++++++++|+||+++++++..  +...++||||+++++|.+
T Consensus        18 ~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~   97 (284)
T cd05038          18 GKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRD   97 (284)
T ss_pred             eeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHH
Confidence            899999873      6789999985        357889999999999999999999877  567899999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++....  ..+++..++.++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||++................
T Consensus        98 ~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  172 (284)
T cd05038          98 YLQRHR--DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG  172 (284)
T ss_pred             HHHhCc--cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCC
Confidence            998754  24899999999999999999999   6899999999999999999999999999988664322212222233


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhH---------HHHHHHHHHhcCCccccccccc
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL---------LAEAVFSMVEGGNAEAKLSVLV  553 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~---------l~~~~~~~~~~~~~~~~l~~~~  553 (611)
                      .++..|++||.+.+..++.++||||||++++||++|+.|+.........         ............          
T Consensus       173 ~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------  242 (284)
T cd05038         173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG----------  242 (284)
T ss_pred             CCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC----------
Confidence            4566799999999889999999999999999999999887654322100         000011111100          


Q ss_pred             CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       554 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                        .....+..++.++.+++.+||+.+|++||++.||+++|+++.
T Consensus       243 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         243 --ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             --CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence              001112344577999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.2e-34  Score=290.32  Aligned_cols=232  Identities=26%  Similarity=0.446  Sum_probs=186.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++..  +|..||+|.++        ..+.+|+.++++++|+||+++++.+...+..++||||+++++|..++....
T Consensus        15 g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~   94 (286)
T cd06622          15 GSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGV   94 (286)
T ss_pred             eEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhcc
Confidence            89999998  58899999875        257789999999999999999999999999999999999999999998753


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                      ....+++..+..++.+++.||.|||+  +.+++|+||||+||+++.++.+||+|||++......     ......++..|
T Consensus        95 ~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~y  167 (286)
T cd06622          95 ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-----LAKTNIGCQSY  167 (286)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-----ccccCCCccCc
Confidence            33458999999999999999999994  458999999999999999999999999998654221     22334578899


Q ss_pred             cchhhhccCC------CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          489 MAPEYMEYGL------VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       489 ~aPE~~~~~~------~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      +|||.+.+..      ++.++|+||||+++|||++|+.||........  ...+..             ..+......+.
T Consensus       168 ~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~-------------~~~~~~~~~~~  232 (286)
T cd06622         168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI--FAQLSA-------------IVDGDPPTLPS  232 (286)
T ss_pred             cCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH--HHHHHH-------------HhhcCCCCCCc
Confidence            9999986543      58899999999999999999999865432211  111111             11111112233


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+.++.+++.+||+.+|++||++.+++.+
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             ccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            467778999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-34  Score=311.69  Aligned_cols=246  Identities=19%  Similarity=0.308  Sum_probs=196.9

Q ss_pred             HHhhcCCCCCcccceEEEEEE-cC-cEEEEEEec-------HHHHHHHHHHHhcC-CCceeecccee-cc------CCeE
Q 007261          326 VATENFSPKNMIDGSVFRGII-NG-STVAIKCMR-------RSISKEVNLLKKIN-HFNLINLFGAC-EH------DGVF  388 (611)
Q Consensus       326 ~at~~f~~~~~igg~Vy~g~~-~g-~~vavK~~~-------~~~~~E~~~l~~l~-H~niv~l~g~~-~~------~~~~  388 (611)
                      .|.++|       +.||.+.. .+ ..+|+|++-       +.+.+|+++|++|+ |+|||.+++.. ..      .-+.
T Consensus        45 LAEGGF-------a~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   45 LAEGGF-------AQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EccCCc-------EEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            456677       89999998 34 899999983       46789999999995 99999999933 21      1368


Q ss_pred             EEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       389 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      +|.||||++|+|-+++....... |+..++++|+.|+++|+.+||.+ +++|||||||-+||||+.++..||||||.|..
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            99999999999999998754333 99999999999999999999964 68899999999999999999999999999865


Q ss_pred             cccccCC-c-----ccccccccCCCccchhhh---ccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHH
Q 007261          469 AVREESG-Y-----SSTKTAVGTNGYMAPEYM---EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSM  539 (611)
Q Consensus       469 ~~~~~~~-~-----~~~~~~~gt~~y~aPE~~---~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~  539 (611)
                      ....... .     ...-...-|+.|+|||.+   .+..+++|+|||+|||+||-|+....||.....            
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------------  263 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------------  263 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------------
Confidence            4332210 0     001123468999999987   466799999999999999999999999865422            


Q ss_pred             HhcCCcccccccccCccCCcC-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          540 VEGGNAEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       540 ~~~~~~~~~l~~~~d~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                                ..+++....-. ....+..|.+||..||+.||++||++-+|++.+.+|+.....
T Consensus       264 ----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~  317 (738)
T KOG1989|consen  264 ----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP  317 (738)
T ss_pred             ----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence                      12233332222 356788999999999999999999999999999998876544

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.5e-34  Score=288.91  Aligned_cols=235  Identities=27%  Similarity=0.527  Sum_probs=186.0

Q ss_pred             ceEEEEEEcC--------cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGIING--------STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~~g--------~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||+|....        ..+|||.+.        ..+.+|+.++++++||||+++++++...+..++||||+++++|.+
T Consensus         9 g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   88 (269)
T cd05044           9 GEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLS   88 (269)
T ss_pred             eeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHH
Confidence            8999998732        579999874        257789999999999999999999999999999999999999999


Q ss_pred             HhhccC----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-----cEEEeeecCcccccccc
Q 007261          403 WLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL-----RAKLANFSFVRSAVREE  473 (611)
Q Consensus       403 ~l~~~~----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-----~~kl~Dfgla~~~~~~~  473 (611)
                      ++....    ....++|..++.++.|++.||+|||   +.+++|+||||+||+++.++     .+||+|||+++......
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~  165 (269)
T cd05044          89 YLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD  165 (269)
T ss_pred             HHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccccccccccc
Confidence            997532    2234789999999999999999999   68899999999999999887     89999999987553221


Q ss_pred             CCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccc
Q 007261          474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVL  552 (611)
Q Consensus       474 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  552 (611)
                      . ........++..|+|||.+.++.++.++||||||+++|||++ |+.|+......+.  ..    ....+         
T Consensus       166 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~--~~----~~~~~---------  229 (269)
T cd05044         166 Y-YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV--LQ----HVTAG---------  229 (269)
T ss_pred             c-cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH--HH----HHhcC---------
Confidence            1 111223345678999999999999999999999999999998 8888754432211  11    11100         


Q ss_pred             cCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 007261          553 VDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK  595 (611)
Q Consensus       553 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  595 (611)
                         .....+...+..+.+++.+||+.+|.+||++.++++.|.+
T Consensus       230 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         230 ---GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ---CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence               0011123356778999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1e-33  Score=293.66  Aligned_cols=183  Identities=25%  Similarity=0.372  Sum_probs=150.6

Q ss_pred             ceEEEEEE----cCcEEEEEEec-----HHHHHHHHHHHhcCCCceeeccceec--cCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII----NGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGACE--HDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~----~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|..    ++..||+|.++     ..+.+|+.++++++||||+++++++.  .+...++||||++ ++|.+++...
T Consensus        15 g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   93 (317)
T cd07867          15 GHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFH   93 (317)
T ss_pred             eeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhh
Confidence            89999986    34689999986     35788999999999999999999884  4567899999996 5888877532


Q ss_pred             C------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee----CCCCcEEEeeecCccccccccCCcc
Q 007261          408 R------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL----DKNLRAKLANFSFVRSAVREESGYS  477 (611)
Q Consensus       408 ~------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgla~~~~~~~~~~~  477 (611)
                      .      ....+++..+..++.||+.||.|||   +.+++||||||+|||+    ++++.+||+|||+++..........
T Consensus        94 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~  170 (317)
T cd07867          94 RASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA  170 (317)
T ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCccccc
Confidence            1      1235889999999999999999999   6899999999999999    5678999999999986543322222


Q ss_pred             cccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCC
Q 007261          478 STKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQ  525 (611)
Q Consensus       478 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~  525 (611)
                      ......+|..|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus       171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            2334578999999999876 45899999999999999999999998654

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.6e-33  Score=286.52  Aligned_cols=227  Identities=25%  Similarity=0.423  Sum_probs=187.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  ++..||||.++        ..+.+|+.++++++|+||+++++++.++...++||||+++|+|.+++... 
T Consensus        18 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-   96 (277)
T cd06640          18 GEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG-   96 (277)
T ss_pred             eEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC-
Confidence            89999987  57899999875        24778999999999999999999999999999999999999999999754 


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         .+++.....++.|++.||+|||   ..+++|+||+|+||+++.++.++|+|||++.......   .......++..|
T Consensus        97 ---~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y  167 (277)
T cd06640          97 ---PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---IKRNTFVGTPFW  167 (277)
T ss_pred             ---CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc---cccccccCcccc
Confidence               2788899999999999999999   6899999999999999999999999999987653322   122334678899


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHH
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL  568 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l  568 (611)
                      +|||.+.+..++.++|+||||+++|||++|..|+.........     . ....            ..........+..+
T Consensus       168 ~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----~-~~~~------------~~~~~~~~~~~~~~  229 (277)
T cd06640         168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----F-LIPK------------NNPPTLTGEFSKPF  229 (277)
T ss_pred             cCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----h-hhhc------------CCCCCCchhhhHHH
Confidence            9999999888999999999999999999999998654332110     0 0000            00111234567788


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          569 IMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       569 ~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      .+++.+||+.+|++||++.+++++-
T Consensus       230 ~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06640         230 KEFIDACLNKDPSFRPTAKELLKHK  254 (277)
T ss_pred             HHHHHHHcccCcccCcCHHHHHhCh
Confidence            9999999999999999999998863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.3e-33  Score=290.30  Aligned_cols=232  Identities=27%  Similarity=0.460  Sum_probs=178.2

Q ss_pred             cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC--------CCc
Q 007261          349 STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY--------PEF  412 (611)
Q Consensus       349 ~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~  412 (611)
                      ..||+|.++        .++.+|+.++++++|+||+++++++..++..++||||+++|+|.+++.....        ...
T Consensus        47 ~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  126 (296)
T cd05095          47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT  126 (296)
T ss_pred             eEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccc
Confidence            469999986        2578899999999999999999999999999999999999999999976431        124


Q ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchh
Q 007261          413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE  492 (611)
Q Consensus       413 l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE  492 (611)
                      +++...+.++.|++.||+|||   +.+++|+||||+|||+++++.+||+|||+++....... ........++..|++||
T Consensus       127 ~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe  202 (296)
T cd05095         127 ISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWE  202 (296)
T ss_pred             cCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheEEEcCCCCEEeccCcccccccCCcc-eeccCcCcCccccCCHH
Confidence            788899999999999999999   68999999999999999999999999999875432211 11122234467899999


Q ss_pred             hhccCCCCCccchHHHHHHHHHHHh--CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          493 YMEYGLVTPEMDTYAFGVVLLELIT--GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       493 ~~~~~~~s~ksDV~s~Gvvl~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      ....+.++.++||||||+++|||++  |..|+......+..  ............     ..    ....+..++..+.+
T Consensus       203 ~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~-----~~----~~~~~~~~~~~~~~  271 (296)
T cd05095         203 SILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI--ENTGEFFRDQGR-----QV----YLPKPALCPDSLYK  271 (296)
T ss_pred             HHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH--HHHHHHHhhccc-----cc----cCCCCCCCCHHHHH
Confidence            9888899999999999999999998  55676544332211  111111110000     00    00112234567899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHh
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMK  595 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~  595 (611)
                      ++.+||+.||++||++.||++.|++
T Consensus       272 li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         272 LMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHcCCCcccCCCHHHHHHHHhC
Confidence            9999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.8e-34  Score=286.84  Aligned_cols=230  Identities=23%  Similarity=0.402  Sum_probs=185.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCH
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      |.||+|..  +++.+|+|.+.                +.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus        14 ~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   93 (267)
T cd06628          14 GSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSV   93 (267)
T ss_pred             eEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCH
Confidence            89999987  67899999774                2467899999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc---c
Q 007261          401 SDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY---S  477 (611)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~---~  477 (611)
                      .+++....   .+++..+..++.|++.||+|||   +.+++||||+|+||++++++.+||+|||+++.........   .
T Consensus        94 ~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  167 (267)
T cd06628          94 AALLNNYG---AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG  167 (267)
T ss_pred             HHHHHhcc---CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccc
Confidence            99997653   3788899999999999999999   6899999999999999999999999999987664221110   1


Q ss_pred             cccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccC
Q 007261          478 STKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNL  557 (611)
Q Consensus       478 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l  557 (611)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.||........     +.....          ...   
T Consensus       168 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~----------~~~---  229 (267)
T cd06628         168 ARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-----IFKIGE----------NAS---  229 (267)
T ss_pred             cccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-----HHHHhc----------cCC---
Confidence            11223578899999999988899999999999999999999999875432211     111111          001   


Q ss_pred             CcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          558 QANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ...+...+..+.+++.+||+.||.+||++.|++++
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            11123455778999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.7e-34  Score=307.11  Aligned_cols=232  Identities=21%  Similarity=0.331  Sum_probs=181.4

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||++++          .+.+|+++|++++|+||+++++.+.+++..++||||+++|+|.+++..
T Consensus        15 g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~   94 (376)
T cd05598          15 GEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR   94 (376)
T ss_pred             eEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHh
Confidence            89999987  688999999852          366799999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC------------
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES------------  474 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~------------  474 (611)
                      .+   .++......++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++........            
T Consensus        95 ~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~  168 (376)
T cd05598          95 LG---IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQ  168 (376)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccccc
Confidence            53   3788888889999999999999   68999999999999999999999999999753210000            


Q ss_pred             ----------------------------CcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCC
Q 007261          475 ----------------------------GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQD  526 (611)
Q Consensus       475 ----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~  526 (611)
                                                  .........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  248 (376)
T cd05598         169 DSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADT  248 (376)
T ss_pred             ccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCC
Confidence                                        0001123468999999999999999999999999999999999999997654


Q ss_pred             ChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHH
Q 007261          527 GEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRP---SMAEVVST  592 (611)
Q Consensus       527 ~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl~~  592 (611)
                      ..+...     .... .  ..   ....+.    ....+..+.+++.+|+ .+|.+|+   ++.|++++
T Consensus       249 ~~~~~~-----~i~~-~--~~---~~~~~~----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         249 PAETQL-----KVIN-W--ET---TLHIPS----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             HHHHHH-----HHhc-c--Cc---cccCCC----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            332111     1110 0  00   000000    1123455677888876 5999999   89999876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3e-34  Score=305.86  Aligned_cols=232  Identities=20%  Similarity=0.342  Sum_probs=179.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +++.||+|++++          .+.+|+.++++++|+||+++++.+.+++..++||||+++|+|.+++..
T Consensus        15 g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~   94 (382)
T cd05625          15 GEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR   94 (382)
T ss_pred             EEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHh
Confidence            89999987  678999999853          367799999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC------------
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES------------  474 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~------------  474 (611)
                      .+   .+++.....++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......            
T Consensus        95 ~~---~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~  168 (382)
T cd05625          95 MG---IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQ  168 (382)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccc
Confidence            53   3788888899999999999999   68999999999999999999999999999753211000            


Q ss_pred             --------------------------------CcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCC
Q 007261          475 --------------------------------GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAA  522 (611)
Q Consensus       475 --------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~  522 (611)
                                                      .........||+.|+|||++.+..++.++|||||||+||||++|+.||
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf  248 (382)
T cd05625         169 DSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF  248 (382)
T ss_pred             ccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCC
Confidence                                            000112346899999999999999999999999999999999999999


Q ss_pred             cCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 007261          523 YKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPS---MAEVVST  592 (611)
Q Consensus       523 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~  592 (611)
                      ......+...     ......   ..   .   .. ......+.++.+++.+++ .+|++|++   +.|++++
T Consensus       249 ~~~~~~~~~~-----~i~~~~---~~---~---~~-p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  305 (382)
T cd05625         249 LAQTPLETQM-----KVINWQ---TS---L---HI-PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH  305 (382)
T ss_pred             CCCCHHHHHH-----HHHccC---CC---c---CC-CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence            7654332111     111000   00   0   00 011223455677777765 59999987   8887764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.1e-33  Score=295.11  Aligned_cols=258  Identities=20%  Similarity=0.294  Sum_probs=186.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.||+|.++.         .+.+|+.+++.++||||++++++|..++..++||||+++|+|.+++...
T Consensus        14 ~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~   93 (327)
T cd08227          14 MTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH   93 (327)
T ss_pred             EEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhh
Confidence            68999987  789999999862         3567999999999999999999999999999999999999999999764


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc----ccccccc
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY----SSTKTAV  483 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~----~~~~~~~  483 (611)
                      .. ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.++++||+............    .......
T Consensus        94 ~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (327)
T cd08227          94 FM-DGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSV  169 (327)
T ss_pred             cc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccccccccccc
Confidence            32 34899999999999999999999   6899999999999999999999999998654332111100    0112235


Q ss_pred             cCCCccchhhhcc--CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhc----C-Cccccc-----cc
Q 007261          484 GTNGYMAPEYMEY--GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEG----G-NAEAKL-----SV  551 (611)
Q Consensus       484 gt~~y~aPE~~~~--~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~----~-~~~~~l-----~~  551 (611)
                      ++..|+|||++.+  ..++.++||||||+++|||++|+.||............ .......    . ...+.+     ..
T Consensus       170 ~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (327)
T cd08227         170 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDTTTIPAEELTMKPSRS  248 (327)
T ss_pred             ceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccccchhhhhcccCCccc
Confidence            6778999999876  45899999999999999999999998754332211110 0000000    0 000000     00


Q ss_pred             ccCcc------------------CCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhchhhhh
Q 007261          552 LVDPN------------------LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST--LMKIQLDVQ  601 (611)
Q Consensus       552 ~~d~~------------------l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~~~~  601 (611)
                      ..+..                  ...........+.+++.+||+.||++|||+.|++++  +.++.....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~~~  318 (327)
T cd08227         249 GANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRAS  318 (327)
T ss_pred             CCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchhhh
Confidence            00000                  000112345678999999999999999999999874  444443333

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.4e-34  Score=285.18  Aligned_cols=230  Identities=29%  Similarity=0.545  Sum_probs=185.7

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||++.+ ++..+|+|.++      .++.+|++++++++|||++++++++......++||||+++++|.+++....  .
T Consensus        18 g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~   95 (256)
T cd05112          18 GLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR--G   95 (256)
T ss_pred             ceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCc--c
Confidence            89999988 48899999886      368899999999999999999999999999999999999999999997653  2


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.++.+++.||+|||   +.+++|+||||+||+++.++.+||+|||+++......  ........++..|+||
T Consensus        96 ~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~aP  170 (256)
T cd05112          96 KFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWSSP  170 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc--ccccCCCccchhhcCH
Confidence            4789999999999999999999   6889999999999999999999999999987553221  1111223346789999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+.++.++.++||||||+++|||++ |+.|+......+.     .... ..+.      ....+      ...+..+.+
T Consensus       171 e~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~-~~~~------~~~~~------~~~~~~~~~  232 (256)
T cd05112         171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV-----VETI-NAGF------RLYKP------RLASQSVYE  232 (256)
T ss_pred             hHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH-----HHHH-hCCC------CCCCC------CCCCHHHHH
Confidence            99998899999999999999999998 8888765433221     1111 1000      01111      113467899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHH
Q 007261          571 LCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      |+.+||+.+|++||++.|+++.|
T Consensus       233 l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         233 LMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             HHHHHcccChhhCCCHHHHHHhh
Confidence            99999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.9e-34  Score=298.53  Aligned_cols=226  Identities=19%  Similarity=0.329  Sum_probs=179.8

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  ++..||+|++++          .+.+|..++.++ +|+||+++++++...+..++||||+++|+|..++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   88 (327)
T cd05617           9 AKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ   88 (327)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence            89999987  678999999973          256788888888 69999999999999999999999999999999887


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ..+   .+++..++.++.||+.||+|||   +.+++||||||+|||++.++.+||+|||+++......   .......||
T Consensus        89 ~~~---~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt  159 (327)
T cd05617          89 RQR---KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---DTTSTFCGT  159 (327)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC---CceecccCC
Confidence            643   3899999999999999999999   6899999999999999999999999999987432211   122345789


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChh-hHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE-ILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||....... ...............             ...+...
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------~~~p~~~  226 (327)
T cd05617         160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-------------IRIPRFL  226 (327)
T ss_pred             cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-------------CCCCCCC
Confidence            99999999999999999999999999999999999996432211 111111111111100             0012234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCH
Q 007261          565 AHHLIMLCLACIAREPESRPSM  586 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~  586 (611)
                      +..+.+++.+||+.||++|+++
T Consensus       227 ~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         227 SVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CHHHHHHHHHHhccCHHHcCCC
Confidence            4567899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.2e-33  Score=283.65  Aligned_cols=230  Identities=26%  Similarity=0.355  Sum_probs=187.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||.+..  +++.+++|.+.         +++.+|++++++++|+||+++++++.+.+..+++|||+++++|.+++...
T Consensus        14 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~   93 (256)
T cd08221          14 GEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ   93 (256)
T ss_pred             ceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhc
Confidence            66676665  78899999864         35788999999999999999999999999999999999999999999865


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      . ...+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++........   ......++..
T Consensus        94 ~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~---~~~~~~~~~~  166 (256)
T cd08221          94 K-GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS---MAETVVGTPY  166 (256)
T ss_pred             c-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---cccccCCCcc
Confidence            3 245899999999999999999999   68899999999999999999999999999876533221   2234568899


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHH
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH  567 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  567 (611)
                      |+|||.+.+..++.++||||||+++|||++|+.|+......+     .......             ..+.......+..
T Consensus       167 y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-----~~~~~~~-------------~~~~~~~~~~~~~  228 (256)
T cd08221         167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-----LVVKIVQ-------------GNYTPVVSVYSSE  228 (256)
T ss_pred             ccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHc-------------CCCCCCccccCHH
Confidence            999999988889999999999999999999999986543322     1111111             1111112344567


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      +.+++.+||+.+|++||++.++++++
T Consensus       229 ~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         229 LISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             HHHHHHHHcccCcccCCCHHHHhhCc
Confidence            88999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.7e-33  Score=291.15  Aligned_cols=244  Identities=24%  Similarity=0.396  Sum_probs=186.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++..  +|..+|+|.++        .++.+|++++++++||||++++++|..++..++||||+++++|.++++...
T Consensus        15 g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~   94 (308)
T cd06615          15 GVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG   94 (308)
T ss_pred             eEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC
Confidence            89999987  67889999874        247789999999999999999999999999999999999999999998653


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         .+++..+..++.|++.||.|||+  ..+++|+||||+|||++.++.+||+|||++......     ......++..|
T Consensus        95 ---~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~  164 (308)
T cd06615          95 ---RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSY  164 (308)
T ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc-----ccccCCCCcCc
Confidence               38889999999999999999994  358999999999999999999999999998654221     12335678999


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc--------------------
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK--------------------  548 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~--------------------  548 (611)
                      +|||.+.+..++.++||||||+++|||++|+.|+........  ................                    
T Consensus       165 ~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (308)
T cd06615         165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL--EAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFEL  242 (308)
T ss_pred             cChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH--HHhhcCccccccccCCcccccCCCCCccchhhHHHH
Confidence            999999888899999999999999999999999865432211  1111000000000000                    


Q ss_pred             cccccCccCCcC-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          549 LSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       549 l~~~~d~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      ............ ....+.++.+++.+||+.||++||++.|++++.-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         243 LDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             HHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence            000000000000 1124567899999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-33  Score=285.40  Aligned_cols=223  Identities=24%  Similarity=0.433  Sum_probs=175.3

Q ss_pred             ceEEEEEEcC--------------cEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCC
Q 007261          339 GSVFRGIING--------------STVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN  397 (611)
Q Consensus       339 g~Vy~g~~~g--------------~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  397 (611)
                      |.||+|++..              ..|++|.+.       ..+.+|+.+++.++||||+++++++..+...++||||+++
T Consensus         9 ~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   88 (262)
T cd05077           9 TQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEF   88 (262)
T ss_pred             ceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccC
Confidence            8999998622              258999875       2567789999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc-------EEEeeecCccccc
Q 007261          398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR-------AKLANFSFVRSAV  470 (611)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~-------~kl~Dfgla~~~~  470 (611)
                      |+|..++....  ..+++..+++++.||+.||+|||   +.+++||||||+|||++.++.       +|++|||++....
T Consensus        89 ~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~  163 (262)
T cd05077          89 GPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL  163 (262)
T ss_pred             CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCcccc
Confidence            99999987643  34899999999999999999999   689999999999999987664       8999999876442


Q ss_pred             cccCCcccccccccCCCccchhhhc-cCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccc
Q 007261          471 REESGYSSTKTAVGTNGYMAPEYME-YGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAK  548 (611)
Q Consensus       471 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  548 (611)
                      .       .....++..|+|||.+. +..++.++||||||+++|||++ |..|+......+.      ..... ..    
T Consensus       164 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~-~~----  225 (262)
T cd05077         164 S-------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------ERFYE-GQ----  225 (262)
T ss_pred             C-------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH------HHHHh-cC----
Confidence            1       12345778899999886 4668999999999999999984 6666544322111      00110 00    


Q ss_pred             cccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       549 l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      . ..        ......++.+|+.+||+.||++||++.+|++.+
T Consensus       226 ~-~~--------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         226 C-ML--------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             c-cC--------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            0 00        011235688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7e-34  Score=285.24  Aligned_cols=228  Identities=29%  Similarity=0.507  Sum_probs=184.6

Q ss_pred             ceEEEEEEcCcEEEEEEec-----HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCcc
Q 007261          339 GSVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFV  413 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l  413 (611)
                      |.||++..+++.||+|.++     ..+.+|+.++++++|||++++++++..++ .++||||+++++|.+++.... ...+
T Consensus        20 g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~   97 (254)
T cd05083          20 GAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRG-RALV   97 (254)
T ss_pred             CceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCCHHHHHHhcC-cCCC
Confidence            8999999999999999986     35788999999999999999999987654 699999999999999997653 2358


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhh
Q 007261          414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEY  493 (611)
Q Consensus       414 ~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~  493 (611)
                      ++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....      ......+..|+|||.
T Consensus        98 ~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~y~~pe~  168 (254)
T cd05083          98 SVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG------VDNSKLPVKWTAPEA  168 (254)
T ss_pred             CHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc------CCCCCCCceecCHHH
Confidence            89999999999999999999   689999999999999999999999999998754221      112233567999999


Q ss_pred             hccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHH
Q 007261          494 MEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLC  572 (611)
Q Consensus       494 ~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~  572 (611)
                      +.++.++.++|+||||+++|||++ |+.|+......+.      ......+.       ..     ..+...+..+.+++
T Consensus       169 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~-------~~-----~~~~~~~~~~~~li  230 (254)
T cd05083         169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV------KECVEKGY-------RM-----EPPEGCPADVYVLM  230 (254)
T ss_pred             hccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH------HHHHhCCC-------CC-----CCCCcCCHHHHHHH
Confidence            998899999999999999999998 8888765433221      11111110       00     01223456788999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHHh
Q 007261          573 LACIAREPESRPSMAEVVSTLMK  595 (611)
Q Consensus       573 ~~Cl~~dP~~RPs~~evl~~L~~  595 (611)
                      .+||+.+|++||++.++++.|++
T Consensus       231 ~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         231 TSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHHcCCChhhCcCHHHHHHHHcc
Confidence            99999999999999999998764

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.7e-34  Score=290.85  Aligned_cols=231  Identities=24%  Similarity=0.324  Sum_probs=185.3

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +++.+|||.+..          .+.+|+.++++++|+|++++++.+.+++..++||||+++++|.+++..
T Consensus        14 g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~   93 (285)
T cd05630          14 GEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH   93 (285)
T ss_pred             eEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHH
Confidence            89999988  678999998752          356799999999999999999999999999999999999999999865


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .. ...+++..++.++.|++.||.|||   +.+++||||||+||++++++.++|+|||++.......    ......|+.
T Consensus        94 ~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~g~~  165 (285)
T cd05630          94 MG-EAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTV  165 (285)
T ss_pred             hc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----cccCCCCCc
Confidence            43 234889999999999999999999   6899999999999999999999999999986543211    122346899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||........  ...........      .       ...+...+.
T Consensus       166 ~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~~~~~~~~~------~-------~~~~~~~~~  230 (285)
T cd05630         166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKEV------Q-------EEYSEKFSP  230 (285)
T ss_pred             cccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHHHHhhhhhh------h-------hhcCccCCH
Confidence            99999999999999999999999999999999999975432210  01111111100      0       001123445


Q ss_pred             HHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPS-----MAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs-----~~evl~~  592 (611)
                      ++.+|+.+||+.||++||+     +.|++++
T Consensus       231 ~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         231 DARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             HHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            6889999999999999999     8888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.9e-34  Score=292.42  Aligned_cols=228  Identities=25%  Similarity=0.441  Sum_probs=186.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|..  +|+.|++|.+.       +.+.+|+.+++.++|+|++++++++...+..++|+||+++++|.+++...  
T Consensus        33 g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--  110 (296)
T cd06655          33 GTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET--  110 (296)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc--
Confidence            89999986  78999999885       35778999999999999999999999999999999999999999999754  


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                        .+++.+++.++.+++.||+|||   +.+++|+||||+||+++.++.+||+|||++........   ......++..|+
T Consensus       111 --~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~  182 (296)
T cd06655         111 --CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWM  182 (296)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc---cCCCcCCCcccc
Confidence              3899999999999999999999   68999999999999999999999999999875433221   122346788999


Q ss_pred             chhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          490 APEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       490 aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      |||.+.+..++.++||||||+++|||++|+.||......+...     .......          + ....+...+..+.
T Consensus       183 aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~-----~~~~~~~----------~-~~~~~~~~~~~~~  246 (296)
T cd06655         183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGT----------P-ELQNPEKLSPIFR  246 (296)
T ss_pred             CcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhcCC----------c-ccCCcccCCHHHH
Confidence            9999998889999999999999999999999987654322111     1110000          0 0111233456788


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 007261          570 MLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +++.+||..||++||++.+++.+
T Consensus       247 ~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         247 DFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             HHHHHHhhcChhhCCCHHHHhhC
Confidence            99999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.7e-33  Score=284.50  Aligned_cols=230  Identities=23%  Similarity=0.376  Sum_probs=180.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec------------HHHHHHHHHHHhcCCCceeeccceecc--CCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR------------RSISKEVNLLKKINHFNLINLFGACEH--DGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------------~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||++..  .|..|++|.++            ..+.+|+.++++++|+||+++++++.+  +...++++||+++++|.+
T Consensus        16 g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~   95 (266)
T cd06651          16 GRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKD   95 (266)
T ss_pred             EEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHH
Confidence            89999987  68899999874            246779999999999999999998865  367899999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++....   .+++...+.++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||+++...............
T Consensus        96 ~l~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  169 (266)
T cd06651          96 QLKAYG---ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV  169 (266)
T ss_pred             HHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccC
Confidence            997653   3788999999999999999999   6899999999999999999999999999987543211111122234


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      .++..|+|||.+.+..++.++||||||+++|||++|+.||........     +.....         ....+   ..+.
T Consensus       170 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-----~~~~~~---------~~~~~---~~~~  232 (266)
T cd06651         170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-----IFKIAT---------QPTNP---QLPS  232 (266)
T ss_pred             CccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-----HHHHhc---------CCCCC---CCch
Confidence            578899999999998899999999999999999999999865432211     111100         00011   1123


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .....+.+++ +||..+|++||+++||+++
T Consensus       233 ~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         233 HISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             hcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            3445566676 6888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.3e-34  Score=297.34  Aligned_cols=240  Identities=28%  Similarity=0.498  Sum_probs=189.1

Q ss_pred             ceEEEEEEc---------CcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCH
Q 007261          339 GSVFRGIIN---------GSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~~---------g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      |.||++...         +..||+|.++        +++.+|+.+++++ +|+||++++++|..++..+++|||+++|+|
T Consensus        26 g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  105 (334)
T cd05100          26 GQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL  105 (334)
T ss_pred             CcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcH
Confidence            889999752         2368999875        3577899999999 899999999999999999999999999999


Q ss_pred             HHHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          401 SDWLHKKR-------------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       401 ~~~l~~~~-------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      .+++....             ....++|..++.++.|++.||+|||   ..+++||||||+|||+++++.+||+|||+++
T Consensus       106 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~~~~~~kL~Dfg~~~  182 (334)
T cd05100         106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLAR  182 (334)
T ss_pred             HHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCcccce
Confidence            99997632             1235889999999999999999999   6899999999999999999999999999987


Q ss_pred             ccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcc
Q 007261          468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       468 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  546 (611)
                      ....... ........++..|+|||.+.+..++.++||||||+++|||++ |..|+.....++.      ........  
T Consensus       183 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~~~~~~~--  253 (334)
T cd05100         183 DVHNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL------FKLLKEGH--  253 (334)
T ss_pred             ecccccc-cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH------HHHHHcCC--
Confidence            6532211 111222344567999999999999999999999999999998 7777654432221      11111110  


Q ss_pred             cccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       547 ~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                                ....+..++..+.+++.+||+.+|++||++.|+++.|.++....
T Consensus       254 ----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         254 ----------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence                      00112234567889999999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.9e-34  Score=300.52  Aligned_cols=226  Identities=24%  Similarity=0.364  Sum_probs=179.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecHH----------HHHHHH-HHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRRS----------ISKEVN-LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~----------~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +|+.+|+|++++.          +..|.. +++.++||||+++++++..++..++||||+++|+|..++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   88 (325)
T cd05604           9 GKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQ   88 (325)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHH
Confidence            89999987  6889999998632          334444 4677899999999999999999999999999999999987


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++.....++.||+.||+|||   +.+++||||||+|||+++++.+||+|||+++......   .......|+
T Consensus        89 ~~~---~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---~~~~~~~gt  159 (325)
T cd05604          89 RER---SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---DTTTTFCGT  159 (325)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC---CCcccccCC
Confidence            643   4889999999999999999999   6899999999999999999999999999987532211   122345689


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      ..|+|||.+.+..++.++||||||+++|||++|+.||......+.     ...... ..      ..+       ....+
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-----~~~~~~-~~------~~~-------~~~~~  220 (325)
T cd05604         160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-----YDNILH-KP------LVL-------RPGAS  220 (325)
T ss_pred             hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH-----HHHHHc-CC------ccC-------CCCCC
Confidence            999999999999999999999999999999999999976543221     111111 00      001       11234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+.+++.+|++.+|.+||++.+.++.
T Consensus       221 ~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         221 LTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             HHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence            567889999999999999988644333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.9e-34  Score=289.88  Aligned_cols=231  Identities=24%  Similarity=0.311  Sum_probs=185.3

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.+|+|.++.          .+.+|++++++++|+|++++.+++..++..++||||+++++|.+++..
T Consensus        14 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   93 (285)
T cd05632          14 GEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYN   93 (285)
T ss_pred             eEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHH
Confidence            89999988  688999999852          256799999999999999999999999999999999999999999876


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ... ..+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++.......    ......|+.
T Consensus        94 ~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~~~~g~~  165 (285)
T cd05632          94 MGN-PGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRGRVGTV  165 (285)
T ss_pred             hcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC----cccCCCCCc
Confidence            432 35899999999999999999999   6899999999999999999999999999986542211    123457899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++|+||||+++|||++|+.||........ . ..+........             ...+...+.
T Consensus       166 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~-~~~~~~~~~~~-------------~~~~~~~~~  230 (285)
T cd05632         166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-R-EEVDRRVLETE-------------EVYSAKFSE  230 (285)
T ss_pred             CccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHHhhhccc-------------cccCccCCH
Confidence            99999999989999999999999999999999999875433211 1 11111111000             001223455


Q ss_pred             HHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPS-----MAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs-----~~evl~~  592 (611)
                      .+.+|+.+||+.||++||+     +.+++.+
T Consensus       231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         231 EAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             HHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            6789999999999999999     6676664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.2e-34  Score=303.30  Aligned_cols=247  Identities=25%  Similarity=0.365  Sum_probs=189.0

Q ss_pred             HHHHHhhcCCCCCccc----ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCC
Q 007261          323 DLVVATENFSPKNMID----GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDG  386 (611)
Q Consensus       323 el~~at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~  386 (611)
                      ++....++|.....+|    |.||++..  +++.+|+|++.+          .+.+|+.+++.++||||+++++++.+++
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            3334445555555554    89999988  678999999852          3567999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCc
Q 007261          387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV  466 (611)
Q Consensus       387 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla  466 (611)
                      ..++||||+++|+|.+++....    ++...+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            9999999999999999997643    777888889999999999999   689999999999999999999999999998


Q ss_pred             cccccccCCcccccccccCCCccchhhhccC----CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhc
Q 007261          467 RSAVREESGYSSTKTAVGTNGYMAPEYMEYG----LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEG  542 (611)
Q Consensus       467 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  542 (611)
                      +......  ........||+.|+|||.+...    .++.++|||||||++|||++|+.||.......     ........
T Consensus       190 ~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----~~~~i~~~  262 (371)
T cd05622         190 MKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-----TYSKIMNH  262 (371)
T ss_pred             eEcCcCC--cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-----HHHHHHcC
Confidence            7653221  1122345799999999998653    37899999999999999999999997654321     11111111


Q ss_pred             CCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 007261          543 GNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPES--RPSMAEVVSTL  593 (611)
Q Consensus       543 ~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L  593 (611)
                      ..   .+      .. ......+..+.+++.+|+..++.+  |+++.|++++.
T Consensus       263 ~~---~~------~~-~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         263 KN---SL------TF-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CC---cc------cC-CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            00   00      00 112235567888999999844433  78999998865

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.5e-33  Score=299.52  Aligned_cols=243  Identities=24%  Similarity=0.351  Sum_probs=183.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCC-----eEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDG-----VFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E~~~~gsL~~  402 (611)
                      |.||++..  +|+.||||++.         +.+.+|+++++.++|+||+++++++...+     ..|+|+||+. ++|.+
T Consensus        14 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~   92 (372)
T cd07853          14 GVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHK   92 (372)
T ss_pred             EEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHH
Confidence            89999986  78999999874         34678999999999999999999998766     7899999996 68888


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++...   ..+++..+..++.||+.||+|||   +.+++||||||+|||++.++.+||+|||+++.......  ......
T Consensus        93 ~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~  164 (372)
T cd07853          93 IIVSP---QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES--KHMTQE  164 (372)
T ss_pred             HHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc--ccCCCC
Confidence            88654   34899999999999999999999   68999999999999999999999999999876432221  122334


Q ss_pred             ccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc----------c-cc
Q 007261          483 VGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA----------K-LS  550 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~----------~-l~  550 (611)
                      .++..|+|||.+.+. .++.++|||||||++|||++|+.||......+.  ...+.........+.          . ..
T Consensus       165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~~~~~~~~~~~~~  242 (372)
T cd07853         165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDLITDLLGTPSLEAMRSACEGARAHILR  242 (372)
T ss_pred             CcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHHHhhHHHHHHHHh
Confidence            678899999998764 479999999999999999999999876543221  111111111000000          0 00


Q ss_pred             cccCcc----CCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          551 VLVDPN----LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       551 ~~~d~~----l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ....+.    +.......++++.+|+.+||+.||++|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         243 GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             CCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            000000    000112235678899999999999999999999975

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.5e-33  Score=290.04  Aligned_cols=227  Identities=24%  Similarity=0.407  Sum_probs=186.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  +|+.||+|.+.       ..+.+|+.+++.++|+||+++++++..++..++||||+++++|.+++.... 
T Consensus        33 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-  111 (297)
T cd06656          33 GTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-  111 (297)
T ss_pred             eEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhCC-
Confidence            89999986  78999999985       346789999999999999999999999999999999999999999997543 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                         +++.++..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++........   ......++..|+
T Consensus       112 ---~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~  182 (297)
T cd06656         112 ---MDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWM  182 (297)
T ss_pred             ---CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc---CcCcccCCcccc
Confidence               788999999999999999999   68999999999999999999999999999875432211   122346788999


Q ss_pred             chhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCcc-CCcChHHHHHHH
Q 007261          490 APEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN-LQANKKEIAHHL  568 (611)
Q Consensus       490 aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~-l~~~~~~~~~~l  568 (611)
                      |||.+.+..++.++|+||||+++|++++|+.||..........     ..            ..... ....+...+..+
T Consensus       183 aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-----~~------------~~~~~~~~~~~~~~~~~~  245 (297)
T cd06656         183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LI------------ATNGTPELQNPERLSAVF  245 (297)
T ss_pred             CHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-----ee------------ccCCCCCCCCccccCHHH
Confidence            9999999889999999999999999999999986543221100     00            00000 011133455678


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHH
Q 007261          569 IMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       569 ~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+++.+||+.+|++||++.+++++
T Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         246 RDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcC
Confidence            899999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=283.83  Aligned_cols=243  Identities=23%  Similarity=0.342  Sum_probs=187.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceecc-----CCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEH-----DGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~lV~E~~~~gsL~~  402 (611)
                      |.|..+..  +|+.||||++.         ++..+|+.+|+.++|+||+.+++.+..     -...|+|+|+| +.+|..
T Consensus        36 GvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~  114 (359)
T KOG0660|consen   36 GVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQ  114 (359)
T ss_pred             eeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHH
Confidence            88999887  78999999986         345689999999999999999998854     35789999999 579999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      .++...   .++.....-+..|+++||.|+|   +.+++||||||+|+|++.+-.+||+||||||..... ......+..
T Consensus       115 iik~~~---~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-~~~~~mTeY  187 (359)
T KOG0660|consen  115 IIKSQQ---DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF-FEDGFMTEY  187 (359)
T ss_pred             HHHcCc---cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeecccc-Ccccchhcc
Confidence            998764   3888888889999999999999   689999999999999999999999999999987543 222334556


Q ss_pred             ccCCCccchhhhc-cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccccc--------
Q 007261          483 VGTNGYMAPEYME-YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV--------  553 (611)
Q Consensus       483 ~gt~~y~aPE~~~-~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~--------  553 (611)
                      +.|.+|.|||.+. ...|+...||||.||++.||++|+..|.+.+.-+..  ..+...+.... ++.+..+-        
T Consensus       188 VaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql--~lI~~~lGtP~-~e~l~~i~s~~ar~yi  264 (359)
T KOG0660|consen  188 VATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQL--QLILELLGTPS-EEDLQKIRSEKARPYI  264 (359)
T ss_pred             eeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHH--HHHHHhcCCCC-HHHHHHhccHHHHHHH
Confidence            7899999999874 567999999999999999999999988766543211  11222221111 11111111        


Q ss_pred             C--ccCCc-----ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          554 D--PNLQA-----NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       554 d--~~l~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .  |....     ..........+|+.+||..||.+|+|++|.+++
T Consensus       265 ~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  265 KSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0  00110     122445678899999999999999999999985

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.4e-34  Score=296.34  Aligned_cols=220  Identities=23%  Similarity=0.397  Sum_probs=177.8

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +|+.||+|++++          .+..|..++..+. |++|+++++++.+.+..++||||+++|+|.+++.
T Consensus        14 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~   93 (323)
T cd05615          14 GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ   93 (323)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHH
Confidence            89999987  688999999863          2456888888885 5778889999999999999999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..++.++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++......   .......||
T Consensus        94 ~~~---~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~---~~~~~~~gt  164 (323)
T cd05615          94 QVG---KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGT  164 (323)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC---ccccCccCC
Confidence            653   3899999999999999999999   6899999999999999999999999999987542221   123345689


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||........     ........              ...+...+
T Consensus       165 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-----~~~i~~~~--------------~~~p~~~~  225 (323)
T cd05615         165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-----FQSIMEHN--------------VSYPKSLS  225 (323)
T ss_pred             ccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCC--------------CCCCccCC
Confidence            999999999999999999999999999999999999876543221     11111100              00122345


Q ss_pred             HHHHHHHHHhhccCCCCCCCH
Q 007261          566 HHLIMLCLACIAREPESRPSM  586 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~  586 (611)
                      ..+.+++.+||+.+|.+|++.
T Consensus       226 ~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         226 KEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHHHHHHHHHcccCHhhCCCC
Confidence            568899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=298.17  Aligned_cols=231  Identities=29%  Similarity=0.452  Sum_probs=195.1

Q ss_pred             HHhhcCCCCCcccceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEe
Q 007261          326 VATENFSPKNMIDGSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE  393 (611)
Q Consensus       326 ~at~~f~~~~~igg~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  393 (611)
                      ++.+.|       |.||.+..  +.+.||||++.          .++.+|+.+|++++|||++.+-|+|..+...|||||
T Consensus        34 IGHGSF-------GAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   34 IGHGSF-------GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             hcCCcc-------ceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            455666       99999987  78899999994          578999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccccccc
Q 007261          394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE  473 (611)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~  473 (611)
                      || -||-.|+|.-++  +++....+..|+.+.+.||+|||   +.+.||||||+.|||+++.|.+||+|||.|....   
T Consensus       107 YC-lGSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---  177 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---  177 (948)
T ss_pred             HH-hccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcC---
Confidence            99 578888887654  34888999999999999999999   6889999999999999999999999999886542   


Q ss_pred             CCcccccccccCCCccchhhh---ccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccc
Q 007261          474 SGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLS  550 (611)
Q Consensus       474 ~~~~~~~~~~gt~~y~aPE~~---~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~  550 (611)
                          .....+||+.|||||++   ..+.|+-|+||||||++..||.-.++|.++++....     +.......       
T Consensus       178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-----LYHIAQNe-------  241 (948)
T KOG0577|consen  178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNE-------  241 (948)
T ss_pred             ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-----HHHHHhcC-------
Confidence                34567999999999987   568899999999999999999999999987765322     22222211       


Q ss_pred             cccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          551 VLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       551 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                         .|.+.  ..+.++.++.++..||+.-|.+|||..+++++-
T Consensus       242 ---sPtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  242 ---SPTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             ---CCCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence               12222  456778899999999999999999999998863

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-33  Score=287.57  Aligned_cols=213  Identities=25%  Similarity=0.406  Sum_probs=168.0

Q ss_pred             EEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHH
Q 007261          350 TVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA  422 (611)
Q Consensus       350 ~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia  422 (611)
                      .|++|.+.       ..+.+|+.++++++||||++++++|.++...++||||+++|+|..++....  ..+++..++.++
T Consensus        46 ~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~  123 (274)
T cd05076          46 RVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVA  123 (274)
T ss_pred             eEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHH
Confidence            58999985       356788999999999999999999999999999999999999999997643  348889999999


Q ss_pred             HHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-------cEEEeeecCccccccccCCcccccccccCCCccchhhhc
Q 007261          423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL-------RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME  495 (611)
Q Consensus       423 ~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-------~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  495 (611)
                      .||+.||+|||   +.+++||||||+|||+++.+       .+|++|||++......       ....++..|+|||.+.
T Consensus       124 ~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~  193 (274)
T cd05076         124 QQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVP  193 (274)
T ss_pred             HHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-------cccccCCcccCchhhc
Confidence            99999999999   68999999999999997643       4899999987543211       2235678899999886


Q ss_pred             c-CCCCCccchHHHHHHHHHHH-hCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHH
Q 007261          496 Y-GLVTPEMDTYAFGVVLLELI-TGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCL  573 (611)
Q Consensus       496 ~-~~~s~ksDV~s~Gvvl~ell-tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~  573 (611)
                      + ..++.++||||||+++|||+ +|+.|+......+.  ..    .....           ...   +......+.+++.
T Consensus       194 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~-----------~~~---~~~~~~~~~~li~  253 (274)
T cd05076         194 GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--ER----FYEKK-----------HRL---PEPSCKELATLIS  253 (274)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--HH----HHHhc-----------cCC---CCCCChHHHHHHH
Confidence            5 56899999999999999995 68887765433221  01    11100           000   0112245889999


Q ss_pred             HhhccCCCCCCCHHHHHHHHH
Q 007261          574 ACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       574 ~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      +||+.+|++||++.++++.|+
T Consensus       254 ~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         254 QCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHcccChhhCcCHHHHHHhhC
Confidence            999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-34  Score=318.25  Aligned_cols=239  Identities=28%  Similarity=0.509  Sum_probs=193.3

Q ss_pred             ceEEEEEEc---------CcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCH
Q 007261          339 GSVFRGIIN---------GSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~~---------g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      |.|++|...         ...||||.++        +++..|+++|+.+ +|+||+.++|+|..++..++|+||++.|+|
T Consensus       310 G~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L  389 (609)
T KOG0200|consen  310 GQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDL  389 (609)
T ss_pred             cceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcH
Confidence            899999863         3479999986        4688999999999 799999999999999999999999999999


Q ss_pred             HHHhhccC---------C--C--CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          401 SDWLHKKR---------Y--P--EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       401 ~~~l~~~~---------~--~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      .++|+..+         .  .  ..++..+.+.++.|||.||+||+   +.+++||||.++|||+.++..+||+|||+++
T Consensus       390 ~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar  466 (609)
T KOG0200|consen  390 LEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNKVIKIADFGLAR  466 (609)
T ss_pred             HHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCCEEEEcccccee
Confidence            99999876         0  1  23889999999999999999999   6889999999999999999999999999999


Q ss_pred             ccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc
Q 007261          468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA  547 (611)
Q Consensus       468 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  547 (611)
                      ................-...|||||.+....|+.|+|||||||+||||+|.+.+++..-...    ..+...++      
T Consensus       467 ~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~----~~l~~~l~------  536 (609)
T KOG0200|consen  467 DHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT----EELLEFLK------  536 (609)
T ss_pred             ccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH----HHHHHHHh------
Confidence            76544322111111114567999999999999999999999999999999554444321101    11122332      


Q ss_pred             ccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          548 KLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       548 ~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                            ++.....|..+..+++++|+.||+.+|++||++.++++.+..+
T Consensus       537 ------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  537 ------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             ------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                  2233344677889999999999999999999999999999884

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.1e-34  Score=307.87  Aligned_cols=252  Identities=21%  Similarity=0.322  Sum_probs=183.0

Q ss_pred             cCCCCCccc----ceEEEEEE--cCcEEEEEEecH---HHHHHHHHHHhcCCCceeeccceeccC--------CeEEEEE
Q 007261          330 NFSPKNMID----GSVFRGII--NGSTVAIKCMRR---SISKEVNLLKKINHFNLINLFGACEHD--------GVFYLVY  392 (611)
Q Consensus       330 ~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~lV~  392 (611)
                      +|.....+|    |.||+|..  +++.||||++..   ...+|+.+|++++|+||+++++++...        ...++||
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm  146 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM  146 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence            444444454    89999987  678999999853   356799999999999999998876321        2467999


Q ss_pred             eecCCCCHHHHhhcc-CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeecCccccc
Q 007261          393 EFMENGSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL-RAKLANFSFVRSAV  470 (611)
Q Consensus       393 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~  470 (611)
                      ||++ ++|.+++... .....+++.....++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+++...
T Consensus       147 E~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  222 (440)
T PTZ00036        147 EFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL  222 (440)
T ss_pred             ecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence            9997 5787777542 22345889999999999999999999   68999999999999999664 79999999998653


Q ss_pred             cccCCcccccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccc
Q 007261          471 REESGYSSTKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL  549 (611)
Q Consensus       471 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  549 (611)
                      ...    ......+|+.|+|||.+.+ ..++.++|||||||+||||++|..||......+.. .. +........ .+.+
T Consensus       223 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~-~~-i~~~~~~p~-~~~~  295 (440)
T PTZ00036        223 AGQ----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL-VR-IIQVLGTPT-EDQL  295 (440)
T ss_pred             CCC----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HH-HHHHhCCCC-HHHH
Confidence            221    1223467899999998865 46899999999999999999999998765443211 11 111111000 0000


Q ss_pred             -------ccccCccCC-----c-ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          550 -------SVLVDPNLQ-----A-NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       550 -------~~~~d~~l~-----~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                             ..+.-+...     . .+...+.++.+|+.+||+.||.+|||+.|++++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                   000000110     0 012245678999999999999999999999865

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.5e-33  Score=285.60  Aligned_cols=235  Identities=22%  Similarity=0.404  Sum_probs=186.6

Q ss_pred             ceEEEEEEcC-----cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGIING-----STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~~g-----~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|.+..     ..|+||...        +.+.+|+.++++++|+||+++++++.+ ...++||||+++|+|.+++.
T Consensus        20 g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~   98 (270)
T cd05056          20 GDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQ   98 (270)
T ss_pred             eeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHH
Confidence            8999998722     368999875        357789999999999999999999875 45789999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...  ..+++..++.++.+++.||+|||   ..+++|+||||+|||++.++.+||+|||+++.......  .......++
T Consensus        99 ~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~  171 (270)
T cd05056          99 VNK--YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY--YKASKGKLP  171 (270)
T ss_pred             hCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccccc--eecCCCCcc
Confidence            643  34899999999999999999999   68999999999999999999999999999875533211  111223345


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      ..|+|||.+....++.++||||||+++||+++ |..||......+..     .. ...+.            ....+..+
T Consensus       172 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-----~~-~~~~~------------~~~~~~~~  233 (270)
T cd05056         172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-----GR-IENGE------------RLPMPPNC  233 (270)
T ss_pred             ccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-----HH-HHcCC------------cCCCCCCC
Confidence            68999999988889999999999999999986 99888655433211     11 11110            00112234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      +..+.+++.+||..+|++||++.++++.|.++..+
T Consensus       234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         234 PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            56789999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-33  Score=286.39  Aligned_cols=238  Identities=24%  Similarity=0.449  Sum_probs=188.8

Q ss_pred             ceEEEEEE--cCc----EEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGS----TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~----~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.+  +|+    .+|+|.++        .++.+|+.++++++|+||++++++|.. ...++||||+++|+|.+++
T Consensus        21 g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l   99 (279)
T cd05057          21 GTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYV   99 (279)
T ss_pred             ccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHH
Confidence            89999987  343    58999875        357789999999999999999999987 7889999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      .....  .+++..++.++.|++.||+|||   +.+++|+||||+|||+++++.+||+|||+++......... ......+
T Consensus       100 ~~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~-~~~~~~~  173 (279)
T cd05057         100 RNHKD--NIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY-HAEGGKV  173 (279)
T ss_pred             HhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCcccce-ecCCCcc
Confidence            87542  3899999999999999999999   6899999999999999999999999999987654322111 1112234


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      +..|+|||.+....++.++|+||||+++||+++ |+.|+......+.      ...+....            ....+..
T Consensus       174 ~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~------------~~~~~~~  235 (279)
T cd05057         174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI------PDLLEKGE------------RLPQPPI  235 (279)
T ss_pred             cccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH------HHHHhCCC------------CCCCCCC
Confidence            568999999988899999999999999999999 8888865443221      11111110            0011122


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                      ++..+.+++.+||..||++||++.++++.|.++..+..
T Consensus       236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05057         236 CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ  273 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence            34568899999999999999999999999998865433

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.4e-33  Score=284.82  Aligned_cols=231  Identities=19%  Similarity=0.335  Sum_probs=184.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|..  ++..+++|.+.       ..+.+|+++++.++|+|++++++++..++..++||||+++++|..++.... 
T Consensus        19 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-   97 (282)
T cd06643          19 GKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-   97 (282)
T ss_pred             eEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcC-
Confidence            89999998  56788999874       357789999999999999999999999999999999999999999887533 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                       ..+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++.......   .......++..|+
T Consensus        98 -~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~  170 (282)
T cd06643          98 -RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---QRRDSFIGTPYWM  170 (282)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc---ccccccccccccc
Confidence             34899999999999999999999   6899999999999999999999999999986543221   1223356888999


Q ss_pred             chhhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          490 APEYME-----YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       490 aPE~~~-----~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      |||.+.     +..++.++|||||||++|||++|+.|+......+..     .......          .+. ...+...
T Consensus       171 aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-----~~~~~~~----------~~~-~~~~~~~  234 (282)
T cd06643         171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL-----LKIAKSE----------PPT-LAQPSRW  234 (282)
T ss_pred             CHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH-----HHHhhcC----------CCC-CCCcccc
Confidence            999983     455788999999999999999999988654322211     1111100          000 0112334


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      +.++.+++.+||+.||.+||++.+++++-
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         235 SSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence            56789999999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-33  Score=296.72  Aligned_cols=255  Identities=17%  Similarity=0.286  Sum_probs=186.9

Q ss_pred             hhcCCCCCccc----ceEEEEEE--cCcEEEEEEec-HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCH
Q 007261          328 TENFSPKNMID----GSVFRGII--NGSTVAIKCMR-RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       328 t~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      ..+|.....+|    |.||+|..  ++..||+|... .....|+.++++++|+||+++++++......++|+||+. ++|
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l  143 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDL  143 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcH
Confidence            34555555554    89999998  56789999865 356679999999999999999999999999999999994 789


Q ss_pred             HHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccc
Q 007261          401 SDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTK  480 (611)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  480 (611)
                      .+++....  ..+++..++.|+.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++.....    ....
T Consensus       144 ~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~~  214 (357)
T PHA03209        144 YTYLTKRS--RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA----PAFL  214 (357)
T ss_pred             HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC----cccc
Confidence            99887643  34899999999999999999999   689999999999999999999999999998743221    1223


Q ss_pred             ccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChh--hHH---HHHHHHHHhc-C-Cccc------
Q 007261          481 TAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE--ILL---AEAVFSMVEG-G-NAEA------  547 (611)
Q Consensus       481 ~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~--~~l---~~~~~~~~~~-~-~~~~------  547 (611)
                      ...||..|+|||.+.+..++.++|||||||++|||+++..+++......  ...   ...+...... + .+..      
T Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  294 (357)
T PHA03209        215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG  294 (357)
T ss_pred             cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence            3568999999999999999999999999999999999776664432111  000   0111111110 0 0000      


Q ss_pred             --ccccccC-------ccCC-c--ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          548 --KLSVLVD-------PNLQ-A--NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       548 --~l~~~~d-------~~l~-~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        ....+++       +... .  .....+..+.+|+.+||+.||++|||+.|++++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence              0000000       0000 0  011233456679999999999999999999875

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=285.91  Aligned_cols=227  Identities=26%  Similarity=0.439  Sum_probs=186.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  +|+.||+|.+.        ..+.+|+.+++.++|+||+++++++.++...++|+||+++++|.+++... 
T Consensus        15 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-   93 (274)
T cd06609          15 GEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-   93 (274)
T ss_pred             eEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-
Confidence            89999987  68899999975        24678999999999999999999999999999999999999999999865 


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         .+++..+..++.|++.||.|||   ..+++|+||+|+||++++++.++|+|||+++......   .......++..|
T Consensus        94 ---~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~y  164 (274)
T cd06609          94 ---KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM---SKRNTFVGTPFW  164 (274)
T ss_pred             ---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc---cccccccCCccc
Confidence               4899999999999999999999   6899999999999999999999999999987664321   122334678899


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHH
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL  568 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l  568 (611)
                      +|||.+.+..++.++||||||+++|||++|+.|+........     ...... .         ..+.+..  ...+..+
T Consensus       165 ~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-----~~~~~~-~---------~~~~~~~--~~~~~~~  227 (274)
T cd06609         165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-----LFLIPK-N---------NPPSLEG--NKFSKPF  227 (274)
T ss_pred             cChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-----HHHhhh-c---------CCCCCcc--cccCHHH
Confidence            999999988899999999999999999999999865432211     111110 0         0111111  1145678


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHH
Q 007261          569 IMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       569 ~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+++.+||..+|++||++++++++
T Consensus       228 ~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         228 KDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             HHHHHHHhhCChhhCcCHHHHhhC
Confidence            899999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.3e-33  Score=298.50  Aligned_cols=242  Identities=24%  Similarity=0.311  Sum_probs=180.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccC------CeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD------GVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~E~~~~gsL~  401 (611)
                      |.||++..  .|..||||++.         ..+.+|+.+++.++||||+++++++...      ...|+||||+++ +|.
T Consensus        35 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~  113 (359)
T cd07876          35 GIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLC  113 (359)
T ss_pred             EEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHH
Confidence            89999987  68899999984         2467899999999999999999988644      357999999964 677


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +.++..     +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....    .....
T Consensus       114 ~~~~~~-----~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~----~~~~~  181 (359)
T cd07876         114 QVIHME-----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN----FMMTP  181 (359)
T ss_pred             HHHhcc-----CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCccccccC----ccCCC
Confidence            766432     788888999999999999999   689999999999999999999999999998754322    12234


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHH-----------------HHHHHHHHhcCC
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILL-----------------AEAVFSMVEGGN  544 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l-----------------~~~~~~~~~~~~  544 (611)
                      ..+|..|+|||.+.+..++.++||||||+++|||++|+.||...+..+...                 ...+........
T Consensus       182 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (359)
T cd07876         182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRP  261 (359)
T ss_pred             CcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCC
Confidence            578999999999999999999999999999999999999997654322100                 000000110000


Q ss_pred             c--ccccccc----cCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          545 A--EAKLSVL----VDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       545 ~--~~~l~~~----~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      .  ...+...    ..+............+.+|+.+||+.||++|||+.|++++-
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         262 QYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             CCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            0  0000000    00000011122346689999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.2e-33  Score=281.74  Aligned_cols=229  Identities=26%  Similarity=0.428  Sum_probs=185.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceecc-CCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEH-DGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +++.||+|.+.         +.+.+|++++++++|+|++++++.+.. +...++||||+++++|.+++..
T Consensus        14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~   93 (257)
T cd08223          14 GEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKE   93 (257)
T ss_pred             eEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHH
Confidence            89999987  67899999984         246779999999999999999998764 4568999999999999999986


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .. ...+++.+++.++.+++.||+|||   +.+++|+||||+||+++.++.++|+|||++.......   .......+++
T Consensus        94 ~~-~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~  166 (257)
T cd08223          94 QK-GKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC---DMASTLIGTP  166 (257)
T ss_pred             hc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC---CccccccCCc
Confidence            43 245899999999999999999999   6899999999999999999999999999987553221   1223456788


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||++++||++|+.|+...+....     .......             .+...+...+.
T Consensus       167 ~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-----~~~~~~~-------------~~~~~~~~~~~  228 (257)
T cd08223         167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-----VYRIIEG-------------KLPPMPKDYSP  228 (257)
T ss_pred             CccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-----HHHHHhc-------------CCCCCccccCH
Confidence            99999999999999999999999999999999998864432211     1111110             01111234556


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+.+++.+||+.||++||++.+++++
T Consensus       229 ~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         229 ELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             HHHHHHHHHhccCcccCCCHHHHhcC
Confidence            78999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2e-33  Score=283.70  Aligned_cols=231  Identities=25%  Similarity=0.428  Sum_probs=185.4

Q ss_pred             ceEEEEEE-cCcEEEEEEec-------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII-NGSTVAIKCMR-------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~-------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.. +|+.+|||.++             ..+.+|++++++++|+||+++++++.+.+..++||||+++++|.+++
T Consensus        14 ~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   93 (265)
T cd06631          14 GTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL   93 (265)
T ss_pred             eEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHH
Confidence            89999987 78899999874             24778999999999999999999999999999999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC---Ccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES---GYSSTKT  481 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~---~~~~~~~  481 (611)
                      ....   .+++..+..++.|++.||+|||   ..+++|+||+|+||++++++.+||+|||++........   .......
T Consensus        94 ~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  167 (265)
T cd06631          94 NRFG---PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS  167 (265)
T ss_pred             HhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccc
Confidence            7653   3788999999999999999999   68899999999999999999999999999875422111   1112233


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcCh
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK  561 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  561 (611)
                      ..++..|+|||.+.+..++.++||||||++++||++|+.||.........     ......   ..     .   ....+
T Consensus       168 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----~~~~~~---~~-----~---~~~~~  231 (265)
T cd06631         168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-----FYIGAH---RG-----L---MPRLP  231 (265)
T ss_pred             cCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-----HHhhhc---cC-----C---CCCCC
Confidence            46888999999999888999999999999999999999998654322111     011000   00     0   01112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          562 KEIAHHLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      ...+.++.+++.+||+.+|++||++.|+++
T Consensus       232 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         232 DSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            234567899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.2e-34  Score=293.19  Aligned_cols=243  Identities=22%  Similarity=0.358  Sum_probs=184.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  +++.||+|.++        ..+.+|+.++++++|+||+++++++..++..++||||++ ++|.+++....
T Consensus        20 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   98 (309)
T cd07872          20 ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCG   98 (309)
T ss_pred             EEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcC
Confidence            89999987  67889999986        246789999999999999999999999999999999997 48888887653


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                        ..+++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++......   .......++..|
T Consensus        99 --~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y  170 (309)
T cd07872          99 --NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT---KTYSNEVVTLWY  170 (309)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc---cccccccccccc
Confidence              34788999999999999999999   6899999999999999999999999999987543221   122334678899


Q ss_pred             cchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc--------cccccccCccCC-
Q 007261          489 MAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE--------AKLSVLVDPNLQ-  558 (611)
Q Consensus       489 ~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--------~~l~~~~d~~l~-  558 (611)
                      +|||.+.+ ..++.++||||||+++|||++|+.||......+..  ..+..........        ......-.+... 
T Consensus       171 ~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (309)
T cd07872         171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL--HLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKP  248 (309)
T ss_pred             cCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCC
Confidence            99998865 56899999999999999999999998765443211  1111111110000        000000000000 


Q ss_pred             ----cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 ----ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 ----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                          ......+.++.+++.+||+.||.+|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         249 QPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             CchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence                0112345678899999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.3e-33  Score=283.57  Aligned_cols=231  Identities=26%  Similarity=0.430  Sum_probs=184.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  +++.||+|.++       ..+.+|+.+++.++||||+++++.+..++..++||||+++++|.+++...+ 
T Consensus        23 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-  101 (267)
T cd06645          23 GDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-  101 (267)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC-
Confidence            89999987  68899999985       246789999999999999999999999999999999999999999987653 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                        .+++.+.+.++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||++......   ........|+..|+
T Consensus       102 --~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~y~  173 (267)
T cd06645         102 --PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT---IAKRKSFIGTPYWM  173 (267)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc---ccccccccCccccc
Confidence              4889999999999999999999   689999999999999999999999999998654321   11223456889999


Q ss_pred             chhhhc---cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          490 APEYME---YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       490 aPE~~~---~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      |||.+.   ...++.++||||||+++|||++|+.|+..........     ......        ...+.. ......+.
T Consensus       174 aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~-----~~~~~~--------~~~~~~-~~~~~~~~  239 (267)
T cd06645         174 APEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-----LMTKSN--------FQPPKL-KDKMKWSN  239 (267)
T ss_pred             ChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH-----hhhccC--------CCCCcc-cccCCCCH
Confidence            999874   4568899999999999999999999986544322111     110000        000111 11112345


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+.+++.+||+.+|++||++.+++++
T Consensus       240 ~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         240 SFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhcC
Confidence            68899999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.4e-33  Score=288.03  Aligned_cols=250  Identities=24%  Similarity=0.380  Sum_probs=189.6

Q ss_pred             hHHHHHhhcCCCCCccc----ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhc-CCCceeeccceec-----
Q 007261          322 EDLVVATENFSPKNMID----GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKI-NHFNLINLFGACE-----  383 (611)
Q Consensus       322 ~el~~at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l-~H~niv~l~g~~~-----  383 (611)
                      +++..+.++|.....+|    |.||++..  +|+.+|+|.++      .++.+|+.+++++ +|+||+++++++.     
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            33444455555444444    89999987  67899999875      3577899999999 7999999999873     


Q ss_pred             cCCeEEEEEeecCCCCHHHHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 007261          384 HDGVFYLVYEFMENGSLSDWLHKKR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLAN  462 (611)
Q Consensus       384 ~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D  462 (611)
                      .++..++||||+++++|.+++.... ....+++..+..++.|++.||.|||   ..+++||||||+||++++++.+||+|
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~d  167 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVD  167 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEcc
Confidence            4467899999999999999886432 2245888999999999999999999   68999999999999999999999999


Q ss_pred             ecCccccccccCCcccccccccCCCccchhhhcc-----CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHH
Q 007261          463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY-----GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVF  537 (611)
Q Consensus       463 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~  537 (611)
                      ||+++......   .......++..|+|||.+..     ..++.++||||||+++|||++|+.|+.........     .
T Consensus       168 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~-----~  239 (286)
T cd06638         168 FGVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-----F  239 (286)
T ss_pred             CCceeecccCC---CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-----h
Confidence            99987653221   12233468899999998853     45788999999999999999999998654322110     0


Q ss_pred             HHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          538 SMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       538 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      ....          ...+.+ ..+...+..+.+++.+||+.||++||++.|+++++
T Consensus       240 ~~~~----------~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 KIPR----------NPPPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hccc----------cCCCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            0000          000000 01222345688999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6e-33  Score=281.06  Aligned_cols=238  Identities=21%  Similarity=0.358  Sum_probs=176.5

Q ss_pred             ceEEEEEE-cC---cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII-NG---STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~-~g---~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|.. ++   ..+++|.++        +.+.+|+.+++.++||||+++++.|......++||||+++|+|.++++.
T Consensus         9 g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   88 (268)
T cd05086           9 GKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQ   88 (268)
T ss_pred             ceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHh
Confidence            89999976 33   246677654        3578899999999999999999999999999999999999999999986


Q ss_pred             cCC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          407 KRY-PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       407 ~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ... ....++.....++.||+.||+|||   +.+++||||||+|||++.++.+||+|||++....... .........++
T Consensus        89 ~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~  164 (268)
T cd05086          89 EQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YIETEDDKCVP  164 (268)
T ss_pred             hhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcch-hhhcccCCcCc
Confidence            432 234667778899999999999999   6889999999999999999999999999976432111 01112234678


Q ss_pred             CCccchhhhcc-------CCCCCccchHHHHHHHHHHHhCC-CCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccC
Q 007261          486 NGYMAPEYMEY-------GLVTPEMDTYAFGVVLLELITGK-EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNL  557 (611)
Q Consensus       486 ~~y~aPE~~~~-------~~~s~ksDV~s~Gvvl~elltG~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l  557 (611)
                      ..|+|||++..       ..++.++||||||+++|||+++. .|+......+     .........     ...+.++.+
T Consensus       165 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~~~~~~~-----~~~~~~~~~  234 (268)
T cd05086         165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-----VLNHVIKDQ-----QVKLFKPQL  234 (268)
T ss_pred             ccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHhhc-----ccccCCCcc
Confidence            89999998743       24578999999999999999864 4554332211     111111111     111222222


Q ss_pred             CcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          558 QANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      ..   ...+.+.+++..|| .+|++||++++|++.|.
T Consensus       235 ~~---~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         235 EL---PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CC---CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            21   23456788999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.4e-33  Score=282.48  Aligned_cols=233  Identities=26%  Similarity=0.484  Sum_probs=185.9

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||++.. ++..+++|.++      ..+.+|+.++++++|+||+++.+++.+ ...+++|||+++++|.+++.... ..
T Consensus        20 ~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~-~~   97 (260)
T cd05073          20 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDE-GS   97 (260)
T ss_pred             eEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCC-cc
Confidence            89999987 56689999885      357789999999999999999999887 77899999999999999997643 24


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||++.......  ........++..|+||
T Consensus        98 ~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~y~~P  172 (260)
T cd05073          98 KQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAP  172 (260)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC--cccccCCcccccccCH
Confidence            5889999999999999999999   6899999999999999999999999999987543221  1112223456789999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+....++.++|+||||++++|+++ |+.|+........  ..    .......            .......+.++.+
T Consensus       173 E~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~--~~----~~~~~~~------------~~~~~~~~~~~~~  234 (260)
T cd05073         173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--IR----ALERGYR------------MPRPENCPEELYN  234 (260)
T ss_pred             hHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH--HH----HHhCCCC------------CCCcccCCHHHHH
Confidence            99998889999999999999999999 7877765432211  11    1111100            0011234567889


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      ++.+||+.+|++||++.++++.|+.+
T Consensus       235 ~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         235 IMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHHHHhcC
Confidence            99999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-33  Score=280.95  Aligned_cols=232  Identities=25%  Similarity=0.424  Sum_probs=187.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  +++.+++|.+.       +.+.+|++++++++||||+++++++.+++..+++|||+++++|.+++.... 
T Consensus        17 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~-   95 (262)
T cd06613          17 GDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-   95 (262)
T ss_pred             eEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc-
Confidence            89999987  57889999975       357889999999999999999999999999999999999999999987652 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                       ..+++..+..++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||++.......   .......++..|+
T Consensus        96 -~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~  168 (262)
T cd06613          96 -GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI---AKRKSFIGTPYWM  168 (262)
T ss_pred             -cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh---hccccccCCcccc
Confidence             24889999999999999999999   6899999999999999999999999999987543221   1223346788899


Q ss_pred             chhhhccC---CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          490 APEYMEYG---LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       490 aPE~~~~~---~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      |||.+...   .++.++||||||+++|||++|+.|+......+...     .....        . ..+.........+.
T Consensus       169 ~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-----~~~~~--------~-~~~~~~~~~~~~~~  234 (262)
T cd06613         169 APEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-----LISKS--------N-FPPPKLKDKEKWSP  234 (262)
T ss_pred             CchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhc--------c-CCCccccchhhhhH
Confidence            99999776   88999999999999999999999987544322111     11100        0 01111112344567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ++.+++.+||..+|.+||++.+++.+
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         235 VFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            79999999999999999999999853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.1e-33  Score=281.91  Aligned_cols=229  Identities=25%  Similarity=0.387  Sum_probs=187.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.+|++..  +|..||+|.+.         +++.+|+.++++++|+||+++++++...+..++||||+++++|.+++...
T Consensus        14 g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~   93 (256)
T cd08218          14 GKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ   93 (256)
T ss_pred             eEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhc
Confidence            78998887  78899999874         25788999999999999999999999999999999999999999999764


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .. ..+++..++.++.|++.||.|||   ..+++|+||+|+|||++.++.++|+|||++.......   .......++..
T Consensus        94 ~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~  166 (256)
T cd08218          94 RG-VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV---ELARTCIGTPY  166 (256)
T ss_pred             cC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch---hhhhhccCCcc
Confidence            32 34789999999999999999999   6899999999999999999999999999987553221   11223457889


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHH
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH  567 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  567 (611)
                      |+|||.+.+..++.++|+||||++++||++|+.|+......+.     +......             .....+...+..
T Consensus       167 ~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-----~~~~~~~-------------~~~~~~~~~~~~  228 (256)
T cd08218         167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL-----VLKIIRG-------------SYPPVSSHYSYD  228 (256)
T ss_pred             ccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH-----HHHHhcC-------------CCCCCcccCCHH
Confidence            9999999999999999999999999999999999865433221     1111111             111112344667


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.+++.+||+.+|++||++.+|+++
T Consensus       229 ~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         229 LRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhhC
Confidence            8999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.5e-33  Score=285.95  Aligned_cols=244  Identities=23%  Similarity=0.333  Sum_probs=184.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.+|+|.++         ..+.+|+.++++++|+||+++++++.+....++|+||++ ++|.+++...
T Consensus        14 ~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   92 (284)
T cd07839          14 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSC   92 (284)
T ss_pred             eEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhc
Confidence            89999998  68899999985         246789999999999999999999999999999999996 5888888754


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .  ..+++...+.++.||++||.|||   ..+++||||||+||+++.++.+||+|||+++......   .......++..
T Consensus        93 ~--~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~  164 (284)
T cd07839          93 N--GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---RCYSAEVVTLW  164 (284)
T ss_pred             C--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC---CCcCCCccccC
Confidence            3  34899999999999999999999   6899999999999999999999999999987543221   12233457889


Q ss_pred             ccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc--cccccccC----ccCC--
Q 007261          488 YMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE--AKLSVLVD----PNLQ--  558 (611)
Q Consensus       488 y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--~~l~~~~d----~~l~--  558 (611)
                      |+|||.+.+. .++.++||||||+++|||++|+.|++.....+..+. .+..........  ..+....+    +...  
T Consensus       165 y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
T cd07839         165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLGTPTEESWPGVSKLPDYKPYPMYPAT  243 (284)
T ss_pred             CcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHH-HHHHHhCCCChHHhHHhhhcccccccCCCCCc
Confidence            9999998764 478999999999999999999998765444332221 111111110000  00000000    0000  


Q ss_pred             ----cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 ----ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 ----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                          ......+.++.+++.+||+.||.+|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         244 TSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             chhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence                0012345778899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.4e-33  Score=282.13  Aligned_cols=230  Identities=23%  Similarity=0.336  Sum_probs=181.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec------------HHHHHHHHHHHhcCCCceeeccceeccC--CeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR------------RSISKEVNLLKKINHFNLINLFGACEHD--GVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------------~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~gsL~~  402 (611)
                      |.||+|..  +|..||||.++            +.+.+|+.++++++|+||+++++++.+.  ...++||||+++++|.+
T Consensus        16 g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~   95 (265)
T cd06652          16 GRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKD   95 (265)
T ss_pred             eEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHH
Confidence            89999987  67899999874            2467799999999999999999988663  56889999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++....   .+++...++++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++...............
T Consensus        96 ~l~~~~---~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  169 (265)
T cd06652          96 QLKSYG---ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV  169 (265)
T ss_pred             HHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccC
Confidence            997653   3788889999999999999999   6889999999999999999999999999987543221111122334


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      .++..|+|||.+.+..++.++||||||+++|||++|+.|+........     ......            .+.....+.
T Consensus       170 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~------------~~~~~~~~~  232 (265)
T cd06652         170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-----IFKIAT------------QPTNPVLPP  232 (265)
T ss_pred             CCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-----HHHHhc------------CCCCCCCch
Confidence            688899999999888899999999999999999999999865432211     111110            011111234


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .....+.+++.+||. +|++||+++|++++
T Consensus       233 ~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         233 HVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             hhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            556678889999994 99999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.7e-33  Score=286.88  Aligned_cols=228  Identities=25%  Similarity=0.411  Sum_probs=181.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++..  ++..||+|.+.        +++.+|++++++++||||+++++++..++..++||||+++++|..+.    
T Consensus        15 ~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~----   90 (279)
T cd06619          15 GTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR----   90 (279)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh----
Confidence            89999987  78899999974        35778999999999999999999999999999999999999997653    


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         .+++.....++.|++.||.|||   +.+++|+||||+|||++.++.+||+|||++......     ......++..|
T Consensus        91 ---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~y  159 (279)
T cd06619          91 ---KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-----IAKTYVGTNAY  159 (279)
T ss_pred             ---cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-----cccCCCCChhh
Confidence               2677888899999999999999   689999999999999999999999999998754322     22335688999


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhH--HHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL--LAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~--l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      +|||.+.+..++.++||||||+++|||++|+.||......+..  .......... .         ..+.+.  ....+.
T Consensus       160 ~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~---------~~~~~~--~~~~~~  227 (279)
T cd06619         160 MAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-E---------DPPVLP--VGQFSE  227 (279)
T ss_pred             cCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-c---------CCCCCC--CCcCCH
Confidence            9999999889999999999999999999999998653322110  0011111110 0         001111  112345


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      ++.+++.+||+.+|++||+++|++++-
T Consensus       228 ~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         228 KFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             HHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence            688999999999999999999998763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-33  Score=279.98  Aligned_cols=232  Identities=28%  Similarity=0.514  Sum_probs=185.5

Q ss_pred             ceEEEEEEc-CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGIIN-GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~~-g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..+ ++.|++|.++        ..+.+|++++++++|+||+++++++......++||||+++++|.+++.... 
T Consensus         9 g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~-   87 (251)
T cd05041           9 GDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK-   87 (251)
T ss_pred             ceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcC-
Confidence            899999984 8999999875        357789999999999999999999999999999999999999999997643 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                       ..+++..++.++.+++.||+|||   ..+++||||||+|||++.++.+||+|||++........ .........+..|+
T Consensus        88 -~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~y~  162 (251)
T cd05041          88 -NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-TVSDGLKQIPIKWT  162 (251)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc-eeccccCcceeccC
Confidence             24789999999999999999999   68999999999999999999999999999875432111 01111223456799


Q ss_pred             chhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHH
Q 007261          490 APEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL  568 (611)
Q Consensus       490 aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l  568 (611)
                      |||.+.++.++.++|+||||++++||++ |..|+........  ..    ......            ....+...+..+
T Consensus       163 ~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~--~~----~~~~~~------------~~~~~~~~~~~~  224 (251)
T cd05041         163 APEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT--RE----RIESGY------------RMPAPQLCPEEI  224 (251)
T ss_pred             ChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH--HH----HHhcCC------------CCCCCccCCHHH
Confidence            9999998899999999999999999999 6666654432211  11    111000            001123445679


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          569 IMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       569 ~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      .+++.+||+.+|++||++.|+++.|.
T Consensus       225 ~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         225 YRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHhccChhhCcCHHHHHHHhh
Confidence            99999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.1e-33  Score=289.70  Aligned_cols=238  Identities=25%  Similarity=0.466  Sum_probs=186.8

Q ss_pred             ceEEEEEE--cCc----EEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGS----TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~----~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.+  +|.    .||+|.+.        .++.+|+.++++++||||++++|+|... ..++++||+++|+|.+++
T Consensus        21 g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~   99 (303)
T cd05110          21 GTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYV   99 (303)
T ss_pred             ccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHH
Confidence            89999987  454    57888875        2577899999999999999999998754 467999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ....  ..+++..++.++.|++.||.|||   ..+++|+||||+|||+++++.+||+|||+++........ .......+
T Consensus       100 ~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~  173 (303)
T cd05110         100 HEHK--DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE-YNADGGKM  173 (303)
T ss_pred             Hhcc--cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCcccc-cccCCCcc
Confidence            7653  34889999999999999999999   689999999999999999999999999999765332211 11222345


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      +..|+|||.+.+..++.++||||||+++|||++ |+.|+......+      .......+..           . ..+..
T Consensus       174 ~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~-----------~-~~~~~  235 (303)
T cd05110         174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE------IPDLLEKGER-----------L-PQPPI  235 (303)
T ss_pred             ccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHCCCC-----------C-CCCCC
Confidence            678999999999999999999999999999998 888876543221      1111111100           0 00112


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                      ++..+.+++.+||..+|++||++.++++.|.++..+..
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         236 CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence            34568899999999999999999999999998866543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-33  Score=300.85  Aligned_cols=245  Identities=20%  Similarity=0.300  Sum_probs=185.7

Q ss_pred             ceEEEEEE----cCcEEEEEEec--HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCc
Q 007261          339 GSVFRGII----NGSTVAIKCMR--RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEF  412 (611)
Q Consensus       339 g~Vy~g~~----~g~~vavK~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~  412 (611)
                      |.||++..    .+..||+|.+.  +...+|+++|++++||||+++++++......++|||++. ++|.+++...   ..
T Consensus       106 g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~  181 (392)
T PHA03207        106 GEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRS---GP  181 (392)
T ss_pred             eEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhc---CC
Confidence            89999876    34679999986  356789999999999999999999999999999999995 7899988543   34


Q ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchh
Q 007261          413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE  492 (611)
Q Consensus       413 l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE  492 (611)
                      +++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++....... ........||..|+|||
T Consensus       182 l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE  257 (392)
T PHA03207        182 LPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD-TPQCYGWSGTLETNSPE  257 (392)
T ss_pred             CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc-cccccccccccCccCHh
Confidence            899999999999999999999   68999999999999999999999999999875543221 11223457899999999


Q ss_pred             hhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChh--hHHHHHHHHHHhcCCcc----------cccccc---cCccC
Q 007261          493 YMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE--ILLAEAVFSMVEGGNAE----------AKLSVL---VDPNL  557 (611)
Q Consensus       493 ~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~----------~~l~~~---~d~~l  557 (611)
                      .+.+..++.++|||||||++|||++|+.||.......  ..+.. +...+.....+          ..+...   ..+..
T Consensus       258 ~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (392)
T PHA03207        258 LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS-IIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPY  336 (392)
T ss_pred             HhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH-HHHHhccCccccCCccchhHHHHHHhhcccccCCc
Confidence            9999999999999999999999999999997654321  11111 11111100000          000000   00000


Q ss_pred             C--cC--hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          558 Q--AN--KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       558 ~--~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .  ..  ......++.+++.+||..||++||++.|++.+
T Consensus       337 ~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        337 TIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0  00  01234567889999999999999999999976

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.1e-33  Score=281.07  Aligned_cols=236  Identities=28%  Similarity=0.428  Sum_probs=190.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  ++..+++|++.        +.+.+|+.+++.++|+|++++++.+..++..++|+||+++++|.+++....
T Consensus        15 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~   94 (267)
T cd06610          15 AVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSY   94 (267)
T ss_pred             eEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhc
Confidence            89999987  67899999874        357889999999999999999999999999999999999999999998754


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc-ccccccccCCC
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY-SSTKTAVGTNG  487 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~gt~~  487 (611)
                      ....+++.....++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++.......... .......++..
T Consensus        95 ~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~  171 (267)
T cd06610          95 PRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC  171 (267)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChh
Confidence            3345899999999999999999999   6899999999999999999999999999987654332211 12233468889


Q ss_pred             ccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC--hHHH
Q 007261          488 YMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN--KKEI  564 (611)
Q Consensus       488 y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~--~~~~  564 (611)
                      |++||.+... .++.++|+||||+++|||++|+.|+......+.     .......          ..+.+...  ....
T Consensus       172 y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-----~~~~~~~----------~~~~~~~~~~~~~~  236 (267)
T cd06610         172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-----LMLTLQN----------DPPSLETGADYKKY  236 (267)
T ss_pred             hcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-----HHHHhcC----------CCCCcCCccccccc
Confidence            9999998777 789999999999999999999999875543221     1111111          01111111  1245


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +..+.+++.+||+.||++||++.+++++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         237 SKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            6778999999999999999999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-34  Score=299.05  Aligned_cols=226  Identities=23%  Similarity=0.328  Sum_probs=177.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecHH----------HHHHHHHHHhc---CCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMRRS----------ISKEVNLLKKI---NHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++..  +|+.||||++.+.          +..|..++.+.   +||||+++++++.+....++||||+++|+|.++
T Consensus         7 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~   86 (330)
T cd05586           7 GQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWH   86 (330)
T ss_pred             eEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHH
Confidence            89999987  6889999998531          23456666655   699999999999999999999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      +....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......
T Consensus        87 l~~~~---~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~  157 (330)
T cd05586          87 LQKEG---RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---KTTNTFC  157 (330)
T ss_pred             HHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC---CCccCcc
Confidence            87643   3889999999999999999999   6899999999999999999999999999987542221   1233456


Q ss_pred             cCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          484 GTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       484 gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      ||..|+|||.+.+. .++.++|||||||++|||++|+.||......+.     ...... +.          ..+.  ..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-----~~~i~~-~~----------~~~~--~~  219 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-----YRNIAF-GK----------VRFP--KN  219 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-----HHHHHc-CC----------CCCC--Cc
Confidence            89999999998764 489999999999999999999999976543221     111111 00          0010  11


Q ss_pred             HHHHHHHHHHHHhhccCCCCCC----CHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRP----SMAEVVS  591 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RP----s~~evl~  591 (611)
                      ..+..+.+++.+||+.||.+||    ++.++++
T Consensus       220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            2355678999999999999998    4566655

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.8e-33  Score=283.88  Aligned_cols=243  Identities=24%  Similarity=0.359  Sum_probs=184.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.||+|++.         +.+.+|+.++++++|+|++++++++..+...++||||++++.|..++...
T Consensus        15 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~   94 (286)
T cd07847          15 GVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP   94 (286)
T ss_pred             eEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCC
Confidence            89999988  58899999874         34678999999999999999999999999999999999999888877643


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .   .+++..++.++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||++........   ......++..
T Consensus        95 ~---~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~  165 (286)
T cd07847          95 R---GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD---DYTDYVATRW  165 (286)
T ss_pred             C---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc---cccCcccccc
Confidence            2   3899999999999999999999   68999999999999999999999999999876533221   1223457788


Q ss_pred             ccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcC--------CcccccccccCccCC
Q 007261          488 YMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGG--------NAEAKLSVLVDPNLQ  558 (611)
Q Consensus       488 y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--------~~~~~l~~~~d~~l~  558 (611)
                      |+|||.+.+ ..++.++||||||+++|||++|+.||......+....  +.......        ...........+...
T Consensus       166 ~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (286)
T cd07847         166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL--IRKTLGDLIPRHQQIFSTNQFFKGLSIPEPE  243 (286)
T ss_pred             cCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHHHhCCCChHHhhhcccccccccccCCCcc
Confidence            999999876 5578999999999999999999999876544322111  00000000        000000000111110


Q ss_pred             c------ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 A------NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 ~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .      .....+..+.+++.+||+.+|++||++.|++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         244 TREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            0      012335678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2e-33  Score=289.57  Aligned_cols=243  Identities=21%  Similarity=0.333  Sum_probs=184.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  ++..||+|.++        ..+.+|+.++++++|+||+++++++..++..++||||++ ++|.+++....
T Consensus        20 g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~   98 (301)
T cd07873          20 ATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG   98 (301)
T ss_pred             EEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcC
Confidence            89999987  57899999985        246789999999999999999999999999999999997 69999987643


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                        ..+++.....++.|++.||+|||   +.+++|+||||+|||+++++.+||+|||++.......   .......++..|
T Consensus        99 --~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y  170 (301)
T cd07873          99 --NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT---KTYSNEVVTLWY  170 (301)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC---Ccccccceeecc
Confidence              34788999999999999999999   6899999999999999999999999999987543221   122234568899


Q ss_pred             cchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc--------cccccccCccCCc
Q 007261          489 MAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE--------AKLSVLVDPNLQA  559 (611)
Q Consensus       489 ~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--------~~l~~~~d~~l~~  559 (611)
                      +|||.+.+ ..++.++||||||+++|||++|+.||......+.  ...+..........        ........+....
T Consensus       171 ~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (301)
T cd07873         171 RPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ--LHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRA  248 (301)
T ss_pred             cCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCChhhchhhhccccccccccCcccc
Confidence            99998865 4578899999999999999999999876544321  11111111110000        0000000011100


Q ss_pred             -----ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          560 -----NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       560 -----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                           .....+..+.+|+.+||+.||.+|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         249 DCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                 112345578899999999999999999999873

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8.1e-34  Score=300.12  Aligned_cols=232  Identities=22%  Similarity=0.345  Sum_probs=180.5

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||+++.          .+.+|+.++.+++|+||+++++.+.+++..++||||+++|+|.+++..
T Consensus        15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~   94 (360)
T cd05627          15 GEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK   94 (360)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh
Confidence            89999987  688999999852          356799999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC-----------
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG-----------  475 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-----------  475 (611)
                      ..   .+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........           
T Consensus        95 ~~---~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~  168 (360)
T cd05627          95 KD---TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP  168 (360)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCc
Confidence            53   3888999999999999999999   689999999999999999999999999998754221100           


Q ss_pred             ---------------------cccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHH
Q 007261          476 ---------------------YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE  534 (611)
Q Consensus       476 ---------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~  534 (611)
                                           ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+..   
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~---  245 (360)
T cd05627         169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY---  245 (360)
T ss_pred             ccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHH---
Confidence                                 00112346899999999999999999999999999999999999999765443211   


Q ss_pred             HHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 007261          535 AVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPS---MAEVVST  592 (611)
Q Consensus       535 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~  592 (611)
                        .......   ..  ..+.+.     ...+.++.+++.+|+ .||.+|++   +.|++++
T Consensus       246 --~~i~~~~---~~--~~~p~~-----~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         246 --RKVMNWK---ET--LVFPPE-----VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             --HHHHcCC---Cc--eecCCC-----CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence              1111000   00  001111     113456777888766 49999985   5666654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.9e-33  Score=288.57  Aligned_cols=228  Identities=26%  Similarity=0.451  Sum_probs=185.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  ++..||||.+.       +.+.+|+.+++.++|+||+++++.+..++..++||||+++++|.+++...  
T Consensus        36 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--  113 (292)
T cd06658          36 GIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT--  113 (292)
T ss_pred             eEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC--
Confidence            89999987  68899999975       35778999999999999999999999999999999999999999998654  


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                        .+++.....++.||+.||.|||   +.+++||||||+||++++++.+||+|||++.......   .......++..|+
T Consensus       114 --~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~~~y~  185 (292)
T cd06658         114 --RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV---PKRKSLVGTPYWM  185 (292)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc---ccCceeecCcccc
Confidence              2889999999999999999999   6899999999999999999999999999986543221   1223346788999


Q ss_pred             chhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          490 APEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       490 aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      |||.+.+..++.++||||||++++||++|+.|+.........     ... .         ....+... .....+..+.
T Consensus       186 aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-----~~~-~---------~~~~~~~~-~~~~~~~~~~  249 (292)
T cd06658         186 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM-----RRI-R---------DNLPPRVK-DSHKVSSVLR  249 (292)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHH-H---------hcCCCccc-cccccCHHHH
Confidence            999998888999999999999999999999998754332211     001 0         00111111 1123455688


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 007261          570 MLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +++.+||..||++||++.|++++
T Consensus       250 ~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         250 GFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHHHHHccCChhHCcCHHHHhhC
Confidence            89999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.5e-33  Score=288.37  Aligned_cols=228  Identities=25%  Similarity=0.433  Sum_probs=185.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  +++.||+|.+.       +.+.+|+.+++.++||||+++++++..++..++|+||+++++|.+++...  
T Consensus        35 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--  112 (297)
T cd06659          35 GIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT--  112 (297)
T ss_pred             eeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc--
Confidence            89999987  68899999984       35778999999999999999999999999999999999999999988653  


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                        .+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.......   .......++..|+
T Consensus       113 --~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~~~y~  184 (297)
T cd06659         113 --RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV---PKRKSLVGTPYWM  184 (297)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc---ccccceecCcccc
Confidence              3889999999999999999999   6899999999999999999999999999986543221   1223356889999


Q ss_pred             chhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          490 APEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       490 aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      |||.+.+..++.++||||||++++||++|+.|+......+..     ... ....         .+ ........+..+.
T Consensus       185 aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-----~~~-~~~~---------~~-~~~~~~~~~~~l~  248 (297)
T cd06659         185 APEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-----KRL-RDSP---------PP-KLKNAHKISPVLR  248 (297)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHH-hccC---------CC-CccccCCCCHHHH
Confidence            999999889999999999999999999999998754432211     111 1000         00 0011122345688


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 007261          570 MLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +++.+||+.+|++||++.+++++
T Consensus       249 ~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         249 DFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHHHHhcCCcccCcCHHHHhhC
Confidence            99999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.8e-33  Score=284.42  Aligned_cols=243  Identities=24%  Similarity=0.339  Sum_probs=181.8

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhc---CCCceeeccceecc-----CCeEEEEEeecCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKI---NHFNLINLFGACEH-----DGVFYLVYEFMENGS  399 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~~~~lV~E~~~~gs  399 (611)
                      |.||++..  +|+.||+|.++.         .+.+|+.+++++   +||||+++++++..     ....++||||++ ++
T Consensus        14 g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~   92 (288)
T cd07863          14 GTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QD   92 (288)
T ss_pred             eEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cC
Confidence            89999987  688999998852         456788888776   69999999998754     345899999997 58


Q ss_pred             HHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccc
Q 007261          400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       400 L~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      |.+++..... ..+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++......    ..
T Consensus        93 l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~----~~  164 (288)
T cd07863          93 LRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM----AL  164 (288)
T ss_pred             HHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccccccCcc----cC
Confidence            9999876432 34899999999999999999999   6899999999999999999999999999987553221    22


Q ss_pred             cccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc---c---cccc
Q 007261          480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK---L---SVLV  553 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~---l---~~~~  553 (611)
                      ....++..|+|||.+.+..++.++|||||||++|||++|+.||......+ .+. .+............   .   ....
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  242 (288)
T cd07863         165 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLG-KIFDLIGLPPEDDWPRDVTLPRGAF  242 (288)
T ss_pred             CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHH-HHHHHhCCCChhhCccccccccccc
Confidence            33567899999999998899999999999999999999998886544322 111 11111110000000   0   0001


Q ss_pred             CccCC----cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          554 DPNLQ----ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       554 d~~l~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+...    ......+..+.+++.+||+.||++|||+.|++.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         243 SPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             CCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11111    0112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-33  Score=285.24  Aligned_cols=230  Identities=21%  Similarity=0.385  Sum_probs=185.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  ++..+|+|.++       +.+.+|++++++++|+||+++++.+..+...++||||+++++|.+++.... 
T Consensus        19 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-   97 (280)
T cd06611          19 GKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE-   97 (280)
T ss_pred             ceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhc-
Confidence            89999988  57899999985       357789999999999999999999999999999999999999999997643 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                       ..+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.......   .......++..|+
T Consensus        98 -~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~  170 (280)
T cd06611          98 -RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL---QKRDTFIGTPYWM  170 (280)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc---cccceeecchhhc
Confidence             34899999999999999999999   6899999999999999999999999999876543221   1223346788999


Q ss_pred             chhhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          490 APEYME-----YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       490 aPE~~~-----~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      +||.+.     ...++.++||||||+++|||++|+.|+......+.     ........          .+. ...+...
T Consensus       171 ~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~----------~~~-~~~~~~~  234 (280)
T cd06611         171 APEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-----LLKILKSE----------PPT-LDQPSKW  234 (280)
T ss_pred             CHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-----HHHHhcCC----------CCC-cCCcccC
Confidence            999874     34577899999999999999999999865433221     11111100          000 1112334


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.++.+++.+||+.+|.+||++.+++++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         235 SSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            5678899999999999999999999886

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.4e-33  Score=281.80  Aligned_cols=232  Identities=20%  Similarity=0.400  Sum_probs=184.9

Q ss_pred             ceEEEEEEc---CcEEEEEEec-----------------HHHHHHHHHHHh-cCCCceeeccceeccCCeEEEEEeecCC
Q 007261          339 GSVFRGIIN---GSTVAIKCMR-----------------RSISKEVNLLKK-INHFNLINLFGACEHDGVFYLVYEFMEN  397 (611)
Q Consensus       339 g~Vy~g~~~---g~~vavK~~~-----------------~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~E~~~~  397 (611)
                      |.||+|...   ++.+|+|.+.                 .++.+|+.++.+ ++|+||+++++++.+++..++||||+++
T Consensus        14 ~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (269)
T cd08528          14 GCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEG   93 (269)
T ss_pred             ceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCC
Confidence            899999983   5789999874                 235678888875 6999999999999999999999999999


Q ss_pred             CCHHHHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc
Q 007261          398 GSLSDWLHKKR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY  476 (611)
Q Consensus       398 gsL~~~l~~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  476 (611)
                      ++|.+++.... ....+++..++.++.|++.||.|||+  ..+++|+||+|+||+++.++.+||+|||++.......   
T Consensus        94 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---  168 (269)
T cd08528          94 APLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---  168 (269)
T ss_pred             CcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecccceeeccccc---
Confidence            99999986421 23458899999999999999999994  3679999999999999999999999999987643321   


Q ss_pred             ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCcc
Q 007261          477 SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN  556 (611)
Q Consensus       477 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  556 (611)
                       ......++..|++||.+.+..++.++||||||+++|||++|+.|+........     ......             ..
T Consensus       169 -~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~-----~~~~~~-------------~~  229 (269)
T cd08528         169 -KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL-----ATKIVE-------------AV  229 (269)
T ss_pred             -ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH-----HHHHhh-------------cc
Confidence             22345678899999999998899999999999999999999999864432211     111111             00


Q ss_pred             CCcC-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          557 LQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       557 l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      .... ....+..+.+++.+||+.||++||++.|+..+++
T Consensus       230 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         230 YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            0010 1123467899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5e-33  Score=280.45  Aligned_cols=231  Identities=27%  Similarity=0.436  Sum_probs=187.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++..  +++.+++|.+.        .++.+|++++++++||||+++++.+..++..++++||+++++|.+++....
T Consensus        15 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   94 (265)
T cd06605          15 GVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ   94 (265)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc
Confidence            89999998  58899999875        347889999999999999999999999999999999999999999998753


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTD-PGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~-~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                        ..+++....+++.|++.||+|||   . .+++|+||||+||++++++.+||+|||++.......     .....++..
T Consensus        95 --~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~  164 (265)
T cd06605          95 --GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-----AKTFVGTSS  164 (265)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH-----hhcccCChh
Confidence              34888999999999999999999   5 899999999999999999999999999986553221     112567889


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH-HHHH
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK-EIAH  566 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~-~~~~  566 (611)
                      |+|||.+.+..++.++||||||+++|+|++|+.|+...........+.......             ......+. ..+.
T Consensus       165 y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~  231 (265)
T cd06605         165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-------------EPPPRLPSGKFSP  231 (265)
T ss_pred             ccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-------------CCCCCCChhhcCH
Confidence            999999999999999999999999999999999987543211111111111111             11111111 2567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+.+++.+||..||++||++.+++.+
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         232 DFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            78999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.9e-33  Score=288.09  Aligned_cols=252  Identities=23%  Similarity=0.390  Sum_probs=192.5

Q ss_pred             cchhHHHHHhhcCCCCCccc----ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhc-CCCceeeccceeccC
Q 007261          319 YKYEDLVVATENFSPKNMID----GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKI-NHFNLINLFGACEHD  385 (611)
Q Consensus       319 ~~~~el~~at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l-~H~niv~l~g~~~~~  385 (611)
                      +.++++..++++|.....+|    |.||++..  +|+.+|+|.+.      ..+.+|+.++.++ +|||++++++++...
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            33445555566666655554    89999987  68899999985      3567899999999 899999999998643


Q ss_pred             -----CeEEEEEeecCCCCHHHHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 007261          386 -----GVFYLVYEFMENGSLSDWLHKKR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK  459 (611)
Q Consensus       386 -----~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k  459 (611)
                           +..++||||+++++|.++++... ....+++..++.++.|++.||+|||   ..+++|+||||+||++++++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence                 46899999999999999987532 2245899999999999999999999   68999999999999999999999


Q ss_pred             EeeecCccccccccCCcccccccccCCCccchhhhccC-----CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHH
Q 007261          460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYG-----LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE  534 (611)
Q Consensus       460 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~  534 (611)
                      |+|||++........   ......++..|+|||.+...     .++.++||||||+++|||++|+.|+......+.    
T Consensus       169 l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~----  241 (291)
T cd06639         169 LVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT----  241 (291)
T ss_pred             Eeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH----
Confidence            999999876532211   12234678899999998643     368999999999999999999999875433211    


Q ss_pred             HHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          535 AVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       535 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                       +.......     .     +.+ ..+......+.+++.+||+.+|++||++.|++++
T Consensus       242 -~~~~~~~~-----~-----~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         242 -LFKIPRNP-----P-----PTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -HHHHhcCC-----C-----CCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence             11111100     0     000 1122344568999999999999999999999874

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.8e-33  Score=284.37  Aligned_cols=246  Identities=27%  Similarity=0.421  Sum_probs=187.5

Q ss_pred             HHHHHhhcCCCCCccc----ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhc-CCCceeeccceecc-----
Q 007261          323 DLVVATENFSPKNMID----GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKI-NHFNLINLFGACEH-----  384 (611)
Q Consensus       323 el~~at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l-~H~niv~l~g~~~~-----  384 (611)
                      ++..+.+.|.....+|    |.||+|..  +++.+|+|.+.      .++..|+.+++++ +|+||+++++++..     
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            3333444444444443    89999998  67899999874      3567899999998 79999999999853     


Q ss_pred             -CCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeee
Q 007261          385 -DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF  463 (611)
Q Consensus       385 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df  463 (611)
                       ....+++|||+++|+|.+++..... ..+++..+..++.|++.||.|||   ..+++|+||||+||++++++.++|+||
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~df  165 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDF  165 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeC
Confidence             4678999999999999999976432 34788888999999999999999   689999999999999999999999999


Q ss_pred             cCccccccccCCcccccccccCCCccchhhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHH
Q 007261          464 SFVRSAVREESGYSSTKTAVGTNGYMAPEYME-----YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFS  538 (611)
Q Consensus       464 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~  538 (611)
                      |++.......   .......++..|+|||.+.     ...++.++||||||+++|||++|+.||......+..     ..
T Consensus       166 g~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-----~~  237 (282)
T cd06636         166 GVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-----FL  237 (282)
T ss_pred             cchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----hh
Confidence            9987543211   1223356888999999875     346888999999999999999999998654321111     00


Q ss_pred             HHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          539 MVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       539 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ...          ...+..  .....+..+.+++.+||+.||.+||++.|++++
T Consensus       238 ~~~----------~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         238 IPR----------NPPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             Hhh----------CCCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            000          000111  122355679999999999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.5e-33  Score=286.29  Aligned_cols=233  Identities=24%  Similarity=0.392  Sum_probs=188.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++..  +|..||+|++.        +.+.+|+++++.++||||+++++++...+..++||||+++++|.+++...+
T Consensus        19 g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   98 (284)
T cd06620          19 GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG   98 (284)
T ss_pred             eEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc
Confidence            89999988  58899999864        357889999999999999999999999999999999999999999987643


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         .+++.....++.+++.||.|||+  ..+++|+||||+||++++++.++|+|||++......     ......++..|
T Consensus        99 ---~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-----~~~~~~~~~~~  168 (284)
T cd06620          99 ---PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-----IADTFVGTSTY  168 (284)
T ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-----ccCccccCccc
Confidence               48999999999999999999995  358999999999999999999999999997644221     12235688999


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChh------hHHHHHHHHHHhcCCcccccccccCccCCcC-h
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE------ILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN-K  561 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~------~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~  561 (611)
                      +|||.+.+..++.++||||||+++|||++|+.||......+      ...........             ....... .
T Consensus       169 ~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~  235 (284)
T cd06620         169 MSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-------------QEPPPRLPS  235 (284)
T ss_pred             CCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-------------hccCCCCCc
Confidence            99999988899999999999999999999999987544321      00111111111             1111111 1


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      ...+..+.+|+.+||+.||++||++.|++++..
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            235667899999999999999999999998743

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.5e-33  Score=280.48  Aligned_cols=222  Identities=24%  Similarity=0.428  Sum_probs=176.5

Q ss_pred             ceEEEEEEcCc------------EEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCH
Q 007261          339 GSVFRGIINGS------------TVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~~g~------------~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      |.||+|...+.            .|++|.++      ..+.+|+.++++++|+||+++++++.. ...++||||+++|+|
T Consensus         9 ~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L   87 (259)
T cd05037           9 TNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPL   87 (259)
T ss_pred             ceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcH
Confidence            89999998332            48888765      357789999999999999999999987 778999999999999


Q ss_pred             HHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-------cEEEeeecCcccccccc
Q 007261          401 SDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL-------RAKLANFSFVRSAVREE  473 (611)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-------~~kl~Dfgla~~~~~~~  473 (611)
                      .+++.....  .+++..++.++.||+.||+|||   +.+++||||||+|||++.++       .+||+|||++.....  
T Consensus        88 ~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~--  160 (259)
T cd05037          88 DVFLHREKN--NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS--  160 (259)
T ss_pred             HHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc--
Confidence            999987542  4889999999999999999999   68999999999999999888       799999999876432  


Q ss_pred             CCcccccccccCCCccchhhhccC--CCCCccchHHHHHHHHHHHhC-CCCCcCCCChhhHHHHHHHHHHhcCCcccccc
Q 007261          474 SGYSSTKTAVGTNGYMAPEYMEYG--LVTPEMDTYAFGVVLLELITG-KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLS  550 (611)
Q Consensus       474 ~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~s~Gvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~  550 (611)
                           .....++..|+|||++...  .++.++||||||+++|||++| ..|+......+..  .    ....        
T Consensus       161 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~--~----~~~~--------  221 (259)
T cd05037         161 -----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE--R----FYQD--------  221 (259)
T ss_pred             -----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH--H----HHhc--------
Confidence                 1234466789999999876  789999999999999999995 5555443221110  0    0000        


Q ss_pred             cccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          551 VLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       551 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                          ......+  ....+.+++.+||..+|.+||++.++++.|
T Consensus       222 ----~~~~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         222 ----QHRLPMP--DCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             ----CCCCCCC--CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                0000000  116788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.9e-33  Score=285.28  Aligned_cols=230  Identities=22%  Similarity=0.375  Sum_probs=183.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|..  ++..+++|.+.       +++.+|+.++++++|+||+++++.+..++..++||||+++++|..++.+.. 
T Consensus        26 g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-  104 (292)
T cd06644          26 GKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD-  104 (292)
T ss_pred             eEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhc-
Confidence            89999987  57899999985       357789999999999999999999999999999999999999999886543 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                       ..+++..+..++.|++.||.|||   ..+++||||||+||+++.++.+||+|||++.......   .......++..|+
T Consensus       105 -~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~  177 (292)
T cd06644         105 -RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL---QRRDSFIGTPYWM  177 (292)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc---cccceecCCcccc
Confidence             34899999999999999999999   6899999999999999999999999999876532211   1123345788999


Q ss_pred             chhhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          490 APEYME-----YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       490 aPE~~~-----~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      |||.+.     ...++.++||||||+++|||++|+.|+......+.     ........          .+. ...+...
T Consensus       178 aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~----------~~~-~~~~~~~  241 (292)
T cd06644         178 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAKSE----------PPT-LSQPSKW  241 (292)
T ss_pred             CceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-----HHHHhcCC----------Ccc-CCCCccc
Confidence            999884     34578899999999999999999999865432211     11111100          000 0112344


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.++.+++.+||+.||++||++.+++++
T Consensus       242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         242 SMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            5678899999999999999999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.3e-33  Score=293.31  Aligned_cols=240  Identities=23%  Similarity=0.290  Sum_probs=180.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccC------CeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD------GVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~E~~~~gsL~  401 (611)
                      |.||++..  .++.||||.+.         ..+.+|+.+++.++||||+++++++...      ...++||||++ ++|.
T Consensus        31 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  109 (355)
T cd07874          31 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLC  109 (355)
T ss_pred             EEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHH
Confidence            89999986  68899999985         2466799999999999999999988543      35799999996 4777


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +++...     +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....    .....
T Consensus       110 ~~~~~~-----l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~~  177 (355)
T cd07874         110 QVIQME-----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTP  177 (355)
T ss_pred             HHHhhc-----CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc----cccCC
Confidence            777532     788889999999999999999   689999999999999999999999999998754322    12234


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHH------------------HHHHhcC
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAV------------------FSMVEGG  543 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~------------------~~~~~~~  543 (611)
                      ..+|..|+|||.+.+..++.++||||||+++|||++|+.||......+. +...+                  ....+..
T Consensus       178 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (355)
T cd07874         178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQPTVRNYVENR  256 (355)
T ss_pred             ccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhhcHHHHHHHhcC
Confidence            5689999999999998999999999999999999999999875542211 11111                  0111000


Q ss_pred             Cccc--ccccccCccC----CcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          544 NAEA--KLSVLVDPNL----QANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       544 ~~~~--~l~~~~d~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ....  .+........    ..........+.+|+.+||+.||++|||+.|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            0000  0000000000    00112234678999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-33  Score=283.67  Aligned_cols=224  Identities=22%  Similarity=0.423  Sum_probs=176.3

Q ss_pred             ceEEEEEEc---------CcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGIIN---------GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~~---------g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||+|...         ...|++|.+.       +.+.+|+.+++.++|||++++++++..++..++||||+++|+|.+
T Consensus         9 ~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~   88 (258)
T cd05078           9 TKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDT   88 (258)
T ss_pred             hhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHH
Confidence            899999762         2348888875       356789999999999999999999999889999999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc--------EEEeeecCccccccccC
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR--------AKLANFSFVRSAVREES  474 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~--------~kl~Dfgla~~~~~~~~  474 (611)
                      +++....  .+++..++.++.||+.||+|||   +.+++||||||+|||++.++.        ++++|||++.....   
T Consensus        89 ~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~---  160 (258)
T cd05078          89 YLKKNKN--LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP---  160 (258)
T ss_pred             HHhcCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccccCC---
Confidence            9987542  4889999999999999999999   689999999999999987765        59999998764421   


Q ss_pred             CcccccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccccc
Q 007261          475 GYSSTKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV  553 (611)
Q Consensus       475 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  553 (611)
                          .....++..|+|||.+.+ ..++.++||||||+++|||++|..++.........     .......          
T Consensus       161 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-----~~~~~~~----------  221 (258)
T cd05078         161 ----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-----LQFYEDR----------  221 (258)
T ss_pred             ----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-----HHHHHcc----------
Confidence                123457788999999976 45799999999999999999996554332221110     0111100          


Q ss_pred             CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       554 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                       ..+   +.....++.+++.+||+.||++||+++++++.|
T Consensus       222 -~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         222 -HQL---PAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             -ccC---CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence             001   112235689999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3e-33  Score=292.43  Aligned_cols=233  Identities=21%  Similarity=0.320  Sum_probs=181.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  .++.+|+|.+.+          .+.+|+.++..++|+||+++++++.+.+..++||||+++|+|.+++..
T Consensus        15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~   94 (332)
T cd05623          15 GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK   94 (332)
T ss_pred             eEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHH
Confidence            89999988  567899999852          267789999999999999999999999999999999999999999986


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++........  .......||+
T Consensus        95 ~~--~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~--~~~~~~~gt~  167 (332)
T cd05623          95 FE--DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--VQSSVAVGTP  167 (332)
T ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc--ceecccccCc
Confidence            43  24888999999999999999999   68999999999999999999999999999875432211  1223357899


Q ss_pred             Cccchhhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcCh
Q 007261          487 GYMAPEYME-----YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK  561 (611)
Q Consensus       487 ~y~aPE~~~-----~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  561 (611)
                      .|+|||++.     ...++.++|||||||++|||++|+.||......+.     .........         ........
T Consensus       168 ~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~-----~~~i~~~~~---------~~~~p~~~  233 (332)
T cd05623         168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIMNHKE---------RFQFPAQV  233 (332)
T ss_pred             cccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH-----HHHHhCCCc---------cccCCCcc
Confidence            999999986     35688999999999999999999999976543221     111111100         00111112


Q ss_pred             HHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 007261          562 KEIAHHLIMLCLACIAREPES--RPSMAEVVST  592 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  592 (611)
                      ..++..+.+|+.+|+..++.+  |+++.|++++
T Consensus       234 ~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            334567888898888654444  6899999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.6e-33  Score=280.12  Aligned_cols=234  Identities=21%  Similarity=0.408  Sum_probs=184.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec-----------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-----------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS  399 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-----------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  399 (611)
                      |.||+|..  +|+.+|+|.++                 +.+.+|+.++++++|+|++++++++...+..++||||+++++
T Consensus        15 ~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   94 (272)
T cd06629          15 GRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGS   94 (272)
T ss_pred             eEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCc
Confidence            89999986  68899999874                 136779999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccc
Q 007261          400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       400 L~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      |.+++....   .+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||+++....... ....
T Consensus        95 L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~  167 (272)
T cd06629          95 IGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYD-NDQN  167 (272)
T ss_pred             HHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccccccccc-cccc
Confidence            999998752   4888999999999999999999   68999999999999999999999999999875432211 1122


Q ss_pred             cccccCCCccchhhhccCC--CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccC
Q 007261          480 KTAVGTNGYMAPEYMEYGL--VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNL  557 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~~~--~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l  557 (611)
                      ....++..|+|||.+....  ++.++|+||||+++||+++|..|+......+..     .....     ......++.. 
T Consensus       168 ~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~-----~~~~~~~~~~-  236 (272)
T cd06629         168 MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM-----FKLGN-----KRSAPPIPPD-  236 (272)
T ss_pred             ccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH-----HHhhc-----cccCCcCCcc-
Confidence            3346788999999987654  889999999999999999999998643322111     11100     0000111111 


Q ss_pred             CcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          558 QANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        ....++..+.+++.+||+.+|++||++.+++++
T Consensus       237 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         237 --VSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             --ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence              122356788999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-33  Score=291.72  Aligned_cols=233  Identities=23%  Similarity=0.358  Sum_probs=180.2

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +++.||+|++++          .+.+|..++..++|+||+++++++.+++..|+||||+++|+|.+++..
T Consensus        15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~   94 (331)
T cd05597          15 GEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK   94 (331)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHH
Confidence            89999987  688999999853          367799999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..  ..+++..+..++.||+.||+|||   +.+++||||||+|||++.++.+||+|||++........  .......||+
T Consensus        95 ~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~  167 (331)
T cd05597          95 FE--DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--VQSNVAVGTP  167 (331)
T ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC--ccccceeccc
Confidence            42  34888999999999999999999   68999999999999999999999999999865432211  1122346899


Q ss_pred             Cccchhhhcc-----CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcCh
Q 007261          487 GYMAPEYMEY-----GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK  561 (611)
Q Consensus       487 ~y~aPE~~~~-----~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  561 (611)
                      .|+|||.+..     ..++.++|||||||++|||++|+.||......+.     .........   ..      .+....
T Consensus       168 ~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-----~~~i~~~~~---~~------~~~~~~  233 (331)
T cd05597         168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIMNHKE---HF------QFPPDV  233 (331)
T ss_pred             cccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-----HHHHHcCCC---cc------cCCCcc
Confidence            9999999863     4578899999999999999999999875433221     111111100   00      011111


Q ss_pred             HHHHHHHHHHHHHhhcc--CCCCCCCHHHHHHH
Q 007261          562 KEIAHHLIMLCLACIAR--EPESRPSMAEVVST  592 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~  592 (611)
                      ...+..+.+++.+|+..  ++..||++.+++++
T Consensus       234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            22456678888887754  33448899999887

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.7e-33  Score=294.74  Aligned_cols=239  Identities=21%  Similarity=0.265  Sum_probs=179.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccC------CeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD------GVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~E~~~~gsL~  401 (611)
                      |.||++..  .++.||||++.         ..+.+|+.+++.++||||+++++++...      ...|+||||++ ++|.
T Consensus        38 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  116 (364)
T cd07875          38 GIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLC  116 (364)
T ss_pred             eEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHH
Confidence            89999987  68899999985         2467899999999999999999987543      35799999996 5787


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +++...     +++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++.....    .....
T Consensus       117 ~~~~~~-----~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----~~~~~  184 (364)
T cd07875         117 QVIQME-----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTP  184 (364)
T ss_pred             HHHHhc-----CCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC----CcccC
Confidence            777532     788889999999999999999   689999999999999999999999999999754322    12234


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCC-----------------
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN-----------------  544 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-----------------  544 (611)
                      ..+|..|+|||.+.+..++.++|||||||++|||++|+.||...+..+. + ..+........                 
T Consensus       185 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (364)
T cd07875         185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-W-NKVIEQLGTPCPEFMKKLQPTVRTYVEN  262 (364)
T ss_pred             CcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHHhcCCCCHHHHHhhhHHHHHHHhh
Confidence            5689999999999999999999999999999999999999876543221 1 11111000000                 


Q ss_pred             -cc---cccccccCc----cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          545 -AE---AKLSVLVDP----NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       545 -~~---~~l~~~~d~----~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                       +.   .........    ............+.+|+.+||+.||.+|||+.|++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence             00   000000000    0000111234568899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=264.32  Aligned_cols=241  Identities=24%  Similarity=0.327  Sum_probs=186.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccC-----CeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHD-----GVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l  404 (611)
                      ..||.++-  +++.+|+|++.       +...+|++..++++|||++++++++..+     .+.||+++|...|+|.+.+
T Consensus        35 sfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i  114 (302)
T KOG2345|consen   35 SFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEI  114 (302)
T ss_pred             eeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHH
Confidence            56777764  88899999984       4578899999999999999999987543     3589999999999999999


Q ss_pred             hccCC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc------c
Q 007261          405 HKKRY-PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY------S  477 (611)
Q Consensus       405 ~~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~------~  477 (611)
                      ..... +.++++.+.++|+.+|++||++||.. .++++||||||.|||+.+.+.++|.|||.++...-.-...      .
T Consensus       115 ~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQ  193 (302)
T KOG2345|consen  115 ERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQ  193 (302)
T ss_pred             HHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHH
Confidence            87543 34899999999999999999999953 3569999999999999999999999999887543221110      0


Q ss_pred             cccccccCCCccchhhhc---cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccc-cc
Q 007261          478 STKTAVGTNGYMAPEYME---YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV-LV  553 (611)
Q Consensus       478 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~-~~  553 (611)
                      .-.....|..|.|||.+.   +...++++|||||||+||+|+.|..||...-+.              +   +.+.. ..
T Consensus       194 e~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------------G---gSlaLAv~  256 (302)
T KOG2345|consen  194 EWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------------G---GSLALAVQ  256 (302)
T ss_pred             HHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--------------C---CeEEEeee
Confidence            111235688999999884   456889999999999999999999998532111              1   11111 11


Q ss_pred             CccCC-cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          554 DPNLQ-ANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       554 d~~l~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                      .+.+. +.....++.+.+++++|++.||.+||++.+++..++++.
T Consensus       257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            11111 112237788999999999999999999999999988753

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.9e-33  Score=277.36  Aligned_cols=231  Identities=30%  Similarity=0.579  Sum_probs=185.4

Q ss_pred             ceEEEEEEcC------cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGIING------STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~~g------~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||++....      ..||+|.++        +.+.+|+.++.+++|+||+++++++.+.+..+++|||+++++|.+++
T Consensus        13 g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~   92 (258)
T smart00219       13 GEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYL   92 (258)
T ss_pred             cceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHH
Confidence            8999999843      789999986        25778999999999999999999999999999999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ..... ..+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||+++........  ......+
T Consensus        93 ~~~~~-~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~  166 (258)
T smart00219       93 RKNRP-KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY--KKKGGKL  166 (258)
T ss_pred             Hhhhh-ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccccc--ccccCCC
Confidence            86532 22899999999999999999999   689999999999999999999999999998765433211  1112336


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      +..|+|||.+.+..++.++||||||++++||++ |..|+........  .    .......            ....+..
T Consensus       167 ~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~--~----~~~~~~~------------~~~~~~~  228 (258)
T smart00219      167 PIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV--L----EYLKKGY------------RLPKPEN  228 (258)
T ss_pred             cccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHhcCC------------CCCCCCc
Confidence            789999999988899999999999999999999 6666654322211  1    1111110            0111222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      .+.++.+++.+||..||++|||+.|+++.|
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      229 CPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            566789999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.9e-33  Score=278.92  Aligned_cols=228  Identities=24%  Similarity=0.403  Sum_probs=185.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +++.+|||.+.         +.+.+|+.++++++|+|++++++.+..++..++||||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   93 (256)
T cd08220          14 GIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR   93 (256)
T ss_pred             eEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHh
Confidence            88999887  67899999874         35788999999999999999999999999999999999999999999864


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeecCccccccccCCcccccccccCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN-LRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      . ...+++..++.++.+++.||.|||   +.+++|+||+|+||+++++ +.+||+|||++.......    ......++.
T Consensus        94 ~-~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~  165 (256)
T cd08220          94 C-NSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS----KAYTVVGTP  165 (256)
T ss_pred             c-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc----cccccccCC
Confidence            3 244899999999999999999999   6899999999999999865 568999999987653321    122346788


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|+|++|+.|+........     .......             .....+...+.
T Consensus       166 ~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-----~~~~~~~-------------~~~~~~~~~~~  227 (256)
T cd08220         166 CYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL-----VLKIMSG-------------TFAPISDRYSP  227 (256)
T ss_pred             cccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH-----HHHHHhc-------------CCCCCCCCcCH
Confidence            99999999988899999999999999999999999865433221     1111110             00111223456


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+.+++.+||+.+|++||++.|++.+
T Consensus       228 ~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         228 DLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhhC
Confidence            78999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.7e-33  Score=283.26  Aligned_cols=244  Identities=20%  Similarity=0.311  Sum_probs=183.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|..  +|..||||.++         ..+.+|++++++++||||+++++++.+++..++||||+. ++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~   92 (284)
T cd07860          14 GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDAS   92 (284)
T ss_pred             eEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhC
Confidence            89999987  68899999885         357789999999999999999999999999999999995 6899998764


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      . ...+++..++.++.|++.||+|||   ..+++|+||+|+||++++++.+||+|||++.......   .......++..
T Consensus        93 ~-~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~  165 (284)
T cd07860          93 P-LSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLW  165 (284)
T ss_pred             C-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc---ccccccccccc
Confidence            3 245899999999999999999999   6899999999999999999999999999987543221   12233456789


Q ss_pred             ccchhhhccCC-CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc------------ccccccccC
Q 007261          488 YMAPEYMEYGL-VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA------------EAKLSVLVD  554 (611)
Q Consensus       488 y~aPE~~~~~~-~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~------------~~~l~~~~d  554 (611)
                      |+|||.+.+.. ++.++||||||+++|||+||+.||......+ ...... ........            ...+.....
T Consensus       166 y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
T cd07860         166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIF-RTLGTPDEVVWPGVTSLPDYKPSFPKWAR  243 (284)
T ss_pred             ccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHH-HHhCCCChhhhhhhhHHHHHHhhcccccc
Confidence            99999886644 6889999999999999999999886543322 111111 11100000            000000000


Q ss_pred             ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+.......+.++.+++.+||+.||++||++.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         244 QDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             cCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            00000011234668899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-33  Score=278.50  Aligned_cols=233  Identities=24%  Similarity=0.336  Sum_probs=189.4

Q ss_pred             ceEEEEEEcC--cEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGIING--STVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~~g--~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |+||.+.+.|  ..+|+|++.+          +...|-+||+.++||.+..||+.|+.+...|||||||+||+|...+++
T Consensus        91 G~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~Lrqk  170 (459)
T KOG0610|consen   91 GTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQK  170 (459)
T ss_pred             eeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhh
Confidence            9999999955  7899999964          355699999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc--------------
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE--------------  472 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~--------------  472 (611)
                      .. .+.++...+.-+|.+|+-||+|||   -.|||.|||||+||||.++|++-|+||.|+......              
T Consensus       171 Qp-~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~  246 (459)
T KOG0610|consen  171 QP-GKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGS  246 (459)
T ss_pred             CC-CCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCC
Confidence            64 355888888889999999999999   699999999999999999999999999987432110              


Q ss_pred             --------------c---C-C---------------------cccccccccCCCccchhhhccCCCCCccchHHHHHHHH
Q 007261          473 --------------E---S-G---------------------YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLL  513 (611)
Q Consensus       473 --------------~---~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~  513 (611)
                                    .   . .                     .......+||-.|+|||++.+...+.+.|+|+|||+||
T Consensus       247 ~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflY  326 (459)
T KOG0610|consen  247 QPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLY  326 (459)
T ss_pred             CcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHH
Confidence                          0   0 0                     01122357899999999999999999999999999999


Q ss_pred             HHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCC----HHHH
Q 007261          514 ELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPS----MAEV  589 (611)
Q Consensus       514 elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~ev  589 (611)
                      ||+.|..||.+...++..     ..++..           +....+.+ ..+..+.+||++.|.+||.+|..    +.||
T Consensus       327 EmLyG~TPFKG~~~~~Tl-----~NIv~~-----------~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  327 EMLYGTTPFKGSNNKETL-----RNIVGQ-----------PLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             HHHhCCCCcCCCCchhhH-----HHHhcC-----------CCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHh
Confidence            999999999887765432     222221           11222222 56677899999999999999987    6666


Q ss_pred             HHH
Q 007261          590 VST  592 (611)
Q Consensus       590 l~~  592 (611)
                      -++
T Consensus       390 K~H  392 (459)
T KOG0610|consen  390 KRH  392 (459)
T ss_pred             hcC
Confidence            553

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6e-33  Score=281.75  Aligned_cols=235  Identities=25%  Similarity=0.479  Sum_probs=185.9

Q ss_pred             ceEEEEEE-------cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII-------NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++..       +...|++|.+.        .++.+|+.++++++|+||+++++++.+.+..++||||+++|+|.++
T Consensus        19 g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   98 (275)
T cd05046          19 GEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQF   98 (275)
T ss_pred             eEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHH
Confidence            89999986       23579999884        3578899999999999999999999999999999999999999999


Q ss_pred             hhccCCC------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcc
Q 007261          404 LHKKRYP------EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS  477 (611)
Q Consensus       404 l~~~~~~------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  477 (611)
                      +......      ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++|||+++......  ..
T Consensus        99 i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~--~~  173 (275)
T cd05046          99 LRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE--YY  173 (275)
T ss_pred             HHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcccccccccCccc--cc
Confidence            9865421      25899999999999999999999   6899999999999999999999999999986543221  12


Q ss_pred             cccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCcc
Q 007261          478 STKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN  556 (611)
Q Consensus       478 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  556 (611)
                      ......++..|+|||.+.+..++.++||||||++++||++ |..|+........     +. ....+.    +. .    
T Consensus       174 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~-----~~-~~~~~~----~~-~----  238 (275)
T cd05046         174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV-----LN-RLQAGK----LE-L----  238 (275)
T ss_pred             ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH-----HH-HHHcCC----cC-C----
Confidence            2233456778999999988889999999999999999999 6667654322211     11 111010    00 0    


Q ss_pred             CCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 007261          557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK  595 (611)
Q Consensus       557 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  595 (611)
                        ..+..++..+.+++.+||+.+|++||++.|++..|.+
T Consensus       239 --~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         239 --PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence              0112345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-32  Score=278.05  Aligned_cols=234  Identities=24%  Similarity=0.420  Sum_probs=186.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++..  +|+.||+|.++             +.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.++
T Consensus        14 ~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~   93 (268)
T cd06630          14 SSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHL   93 (268)
T ss_pred             eEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHH
Confidence            89999986  78899999884             2477899999999999999999999999999999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeecCccccccccCC-cccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL-RAKLANFSFVRSAVREESG-YSSTKT  481 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~~~-~~~~~~  481 (611)
                      +....   .+++.....++.|++.||.|||   +.+++|+||+|+||+++.++ .+||+|||++......... ......
T Consensus        94 l~~~~---~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  167 (268)
T cd06630          94 LSKYG---AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ  167 (268)
T ss_pred             HHHhC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccc
Confidence            97643   4889999999999999999999   68999999999999998776 6999999998765432111 111223


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcCh
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK  561 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  561 (611)
                      ..++..|+|||.+.+..++.++||||+|++++||++|..|+........  ..........            ......+
T Consensus       168 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~------------~~~~~~~  233 (268)
T cd06630         168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALIFKIASA------------TTAPSIP  233 (268)
T ss_pred             cccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHHHHHhcc------------CCCCCCc
Confidence            4678899999999888899999999999999999999999864432211  0111111000            0011123


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          562 KEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ...+..+.+++.+||+.+|++||++.+++++
T Consensus       234 ~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         234 EHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             hhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            4566778999999999999999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.9e-33  Score=286.13  Aligned_cols=235  Identities=19%  Similarity=0.284  Sum_probs=184.2

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  .++.|++|.+..          .+.+|+++++.++||||+++++.+..++..++||||+++++|.+++..
T Consensus        15 ~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~   94 (305)
T cd05609          15 GAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN   94 (305)
T ss_pred             eeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHH
Confidence            88999987  578999998852          356799999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC------------
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES------------  474 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~------------  474 (611)
                      .+   .+++.....++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.......            
T Consensus        95 ~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  168 (305)
T cd05609          95 IG---ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT  168 (305)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccch
Confidence            53   4889999999999999999999   68999999999999999999999999999864211100            


Q ss_pred             CcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccC
Q 007261          475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD  554 (611)
Q Consensus       475 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  554 (611)
                      .........++..|+|||.+.+..++.++|+||||+++|||++|..||......+.     ........        ...
T Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~-----~~~~~~~~--------~~~  235 (305)
T cd05609         169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-----FGQVISDD--------IEW  235 (305)
T ss_pred             hhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcc--------cCC
Confidence            00011123578899999999888899999999999999999999999875433221     11111100        000


Q ss_pred             ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 007261          555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK  595 (611)
Q Consensus       555 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  595 (611)
                      +   ......+..+.+++.+||+.||++||++.++.+.|+.
T Consensus       236 ~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         236 P---EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             C---CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            1   1112355678999999999999999997666655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9.9e-33  Score=280.77  Aligned_cols=226  Identities=26%  Similarity=0.436  Sum_probs=185.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  ++..||||.+.        ..+.+|+.++++++|+||+++++++..++..++||||+++++|.+++... 
T Consensus        18 ~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~-   96 (277)
T cd06641          18 GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-   96 (277)
T ss_pred             eEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC-
Confidence            89999987  67899999874        35778999999999999999999999999999999999999999999754 


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         .+++.....++.+++.|+.|||   ..+++|+||+|+||+++.++.++|+|||++.......   .......++..|
T Consensus        97 ---~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y  167 (277)
T cd06641          97 ---PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---IKRNTFVGTPFW  167 (277)
T ss_pred             ---CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch---hhhccccCCccc
Confidence               3889999999999999999999   6899999999999999999999999999987543221   112234578899


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHH
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL  568 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l  568 (611)
                      +|||.+.+..++.++|+||||+++|||++|..|+.......     ....... ..            ........+.++
T Consensus       168 ~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~-~~------------~~~~~~~~~~~~  229 (277)
T cd06641         168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-----VLFLIPK-NN------------PPTLEGNYSKPL  229 (277)
T ss_pred             cChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-----HHHHHhc-CC------------CCCCCcccCHHH
Confidence            99999998889999999999999999999999986433211     1111110 00            011122345678


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHH
Q 007261          569 IMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       569 ~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+++.+||+.+|.+||++.+++++
T Consensus       230 ~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         230 KEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHccCChhhCcCHHHHHhC
Confidence            899999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1e-32  Score=276.77  Aligned_cols=227  Identities=29%  Similarity=0.473  Sum_probs=184.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGSTVAIKCMR------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|..  +++.|++|.+.            +.+.+|+.++++++|+||+++++++..+...++|+||+++++|.+++
T Consensus        14 ~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   93 (258)
T cd06632          14 GSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLL   93 (258)
T ss_pred             ceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHH
Confidence            89999988  68899999863            24778999999999999999999999999999999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ....   .+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.+||+|||++.......    ......+
T Consensus        94 ~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~----~~~~~~~  163 (258)
T cd06632          94 KKYG---SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS----FAKSFKG  163 (258)
T ss_pred             HhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----cccccCC
Confidence            7653   3889999999999999999999   6899999999999999999999999999987643222    2234567


Q ss_pred             CCCccchhhhccCC-CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          485 TNGYMAPEYMEYGL-VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       485 t~~y~aPE~~~~~~-~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      +..|++||.+.... ++.++|+||||+++|+|++|+.||........     ........            .....+..
T Consensus       164 ~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~------------~~~~~~~~  226 (258)
T cd06632         164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA-----VFKIGRSK------------ELPPIPDH  226 (258)
T ss_pred             CcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH-----HHHHHhcc------------cCCCcCCC
Confidence            88999999987766 89999999999999999999999865442111     11111100            00111223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ....+.+++.+||+.+|++||++.+++.+
T Consensus       227 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         227 LSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            45678899999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.5e-33  Score=291.01  Aligned_cols=233  Identities=21%  Similarity=0.328  Sum_probs=181.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+++.  +++.||+|.+.+          .+.+|..++..++|+||+++++++.+++..|+||||+++|+|.+++..
T Consensus        15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~   94 (331)
T cd05624          15 GEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK   94 (331)
T ss_pred             eEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH
Confidence            89999987  678999999853          266789999999999999999999999999999999999999999986


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  .......|++
T Consensus        95 ~~--~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~gt~  167 (331)
T cd05624          95 FE--DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT--VQSSVAVGTP  167 (331)
T ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc--eeeccccCCc
Confidence            43  24888899999999999999999   68999999999999999999999999999876533221  1222356899


Q ss_pred             Cccchhhhcc-----CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcCh
Q 007261          487 GYMAPEYMEY-----GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK  561 (611)
Q Consensus       487 ~y~aPE~~~~-----~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  561 (611)
                      .|+|||.+.+     +.++.++||||||++||||++|+.||......+.     .........   .      ..+....
T Consensus       168 ~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-----~~~i~~~~~---~------~~~p~~~  233 (331)
T cd05624         168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIMNHEE---R------FQFPSHI  233 (331)
T ss_pred             ccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-----HHHHHcCCC---c------ccCCCcc
Confidence            9999999875     5688999999999999999999999975543221     111111000   0      0011112


Q ss_pred             HHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 007261          562 KEIAHHLIMLCLACIAREPES--RPSMAEVVST  592 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  592 (611)
                      ...++++.+++.+|+..++.+  |+++++++++
T Consensus       234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            234567888999998866544  4688888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-32  Score=279.68  Aligned_cols=236  Identities=24%  Similarity=0.430  Sum_probs=182.8

Q ss_pred             ceEEEEEE-----cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccCC------eEEEEEeecCCC
Q 007261          339 GSVFRGII-----NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHDG------VFYLVYEFMENG  398 (611)
Q Consensus       339 g~Vy~g~~-----~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV~E~~~~g  398 (611)
                      |.||+|.+     +|..||||.++.         ++.+|+.++++++||||+++++++....      ..++++||+++|
T Consensus        13 g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (273)
T cd05074          13 GSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHG   92 (273)
T ss_pred             CCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCC
Confidence            89999986     357899998852         4778999999999999999999885432      347899999999


Q ss_pred             CHHHHhhccC---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC
Q 007261          399 SLSDWLHKKR---YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG  475 (611)
Q Consensus       399 sL~~~l~~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~  475 (611)
                      +|.+++....   ....+++...+.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....... 
T Consensus        93 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~-  168 (273)
T cd05074          93 DLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY-  168 (273)
T ss_pred             cHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcccccccccCCcc-
Confidence            9999875432   2234788999999999999999999   68999999999999999999999999999876532221 


Q ss_pred             cccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccC
Q 007261          476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD  554 (611)
Q Consensus       476 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  554 (611)
                      ........++..|++||.+....++.++||||||+++|||++ |+.|+......+  ...    ......   .      
T Consensus       169 ~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--~~~----~~~~~~---~------  233 (273)
T cd05074         169 YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--IYN----YLIKGN---R------  233 (273)
T ss_pred             eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--HHH----HHHcCC---c------
Confidence            111223345678999999998889999999999999999999 777765433221  111    111110   0      


Q ss_pred             ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       555 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                         ...+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       234 ---~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 ---LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence               001123446789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.1e-32  Score=277.29  Aligned_cols=233  Identities=24%  Similarity=0.380  Sum_probs=187.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceecc--CCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEH--DGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +|..+|+|.+.         +.+.+|+.++++++|+||+++++++..  +...+++|||+++++|.+++.
T Consensus        14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~   93 (265)
T cd08217          14 GTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQ   93 (265)
T ss_pred             eEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHH
Confidence            89999987  67899999874         246779999999999999999997753  456899999999999999997


Q ss_pred             ccC-CCCccCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          406 KKR-YPEFVSWNCRFRIALDVAHGLHYLHNCT--DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       406 ~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ... ....+++..++.++.|++.||.|||..+  ..+++|+||+|+||++++++.+||+|||++........   .....
T Consensus        94 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~---~~~~~  170 (265)
T cd08217          94 KCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS---FAKTY  170 (265)
T ss_pred             HHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcc---ccccc
Confidence            642 2345899999999999999999999433  57899999999999999999999999999886543221   12334


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      .++..|+|||.+....++.++|+||||+++|+|++|+.|+......+  +.    .....            ......+.
T Consensus       171 ~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~----~~~~~------------~~~~~~~~  232 (265)
T cd08217         171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--LA----SKIKE------------GKFRRIPY  232 (265)
T ss_pred             ccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--HH----HHHhc------------CCCCCCcc
Confidence            68899999999998889999999999999999999999987654221  11    11111            11111133


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+..+.+++.+||+.+|++||++.+|+++
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            455678999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6e-33  Score=278.42  Aligned_cols=229  Identities=26%  Similarity=0.417  Sum_probs=185.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|..+|+|.+.         +.+.+|+.++++++|+||+++++.+..++..++|+||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   93 (257)
T cd08225          14 GKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ   93 (257)
T ss_pred             ceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhc
Confidence            89999998  67899999984         24678999999999999999999999999999999999999999999764


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeecCccccccccCCcccccccccCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL-RAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .. ..+++..++.++.|++.||.|||   ..+++|+||||+||++++++ .+||+|||.+.......   .......+++
T Consensus        94 ~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  166 (257)
T cd08225          94 RG-VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM---ELAYTCVGTP  166 (257)
T ss_pred             cC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---ccccccCCCc
Confidence            32 34799999999999999999999   68999999999999999885 56999999987653221   1222346888


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++|+||||+++|||++|+.|+......+     .+......             .+.......+.
T Consensus       167 ~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~-------------~~~~~~~~~~~  228 (257)
T cd08225         167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-----LVLKICQG-------------YFAPISPNFSR  228 (257)
T ss_pred             cccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHhcc-------------cCCCCCCCCCH
Confidence            9999999998889999999999999999999999986443221     11111110             01111123345


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+.+++.+||+.+|++||++.|++++
T Consensus       229 ~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         229 DLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHhhC
Confidence            78999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.4e-32  Score=284.07  Aligned_cols=225  Identities=28%  Similarity=0.430  Sum_probs=181.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|..  +|+.||+|.+.          +++.+|+++++.++||||+++.++|.+++..++||||++ |+|.+++..
T Consensus        29 g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~  107 (307)
T cd06607          29 GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEV  107 (307)
T ss_pred             eEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHH
Confidence            89999987  68899999874          357789999999999999999999999999999999996 688887765


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..  ..+++..+..++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||++.....       .....++.
T Consensus       108 ~~--~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-------~~~~~~~~  175 (307)
T cd06607         108 HK--KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANSFVGTP  175 (307)
T ss_pred             cc--cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCC-------CCCccCCc
Confidence            43  34899999999999999999999   68999999999999999999999999999865421       12345788


Q ss_pred             Cccchhhhc---cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          487 GYMAPEYME---YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       487 ~y~aPE~~~---~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      .|+|||.+.   .+.++.++||||||+++|||++|+.|+........     ........          .+.+  ....
T Consensus       176 ~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-----~~~~~~~~----------~~~~--~~~~  238 (307)
T cd06607         176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQND----------SPTL--SSND  238 (307)
T ss_pred             cccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-----HHHHhcCC----------CCCC--Cchh
Confidence            999999874   46688999999999999999999999865432211     11111000          0111  1233


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      .+..+.+++.+||+.+|++||++.+++.+.
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         239 WSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             hCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            566799999999999999999999998854

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-32  Score=286.26  Aligned_cols=233  Identities=22%  Similarity=0.345  Sum_probs=185.3

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +++.+|+|.+..          .+.+|+++++.++|+||+++++.+.++...++||||+.+++|.+++..
T Consensus        15 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   94 (316)
T cd05574          15 GRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQR   94 (316)
T ss_pred             EEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHh
Confidence            89999988  578999998852          367799999999999999999999999999999999999999999975


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc----------
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY----------  476 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~----------  476 (611)
                      .. ...+++..+..++.|++.||+|||   ..+++|+||||+||+++.++.++|+|||++..........          
T Consensus        95 ~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  170 (316)
T cd05574          95 QP-GKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR  170 (316)
T ss_pred             CC-CCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccccccccccccc
Confidence            42 245899999999999999999999   6899999999999999999999999999986543221100          


Q ss_pred             ----------------ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHH
Q 007261          477 ----------------SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMV  540 (611)
Q Consensus       477 ----------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  540 (611)
                                      .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......+..     ....
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~-----~~~~  245 (316)
T cd05574         171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF-----SNIL  245 (316)
T ss_pred             ccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHH-----HHHh
Confidence                            0112336788999999999888999999999999999999999998755433211     1111


Q ss_pred             hcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCC----HHHHHHH
Q 007261          541 EGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPS----MAEVVST  592 (611)
Q Consensus       541 ~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~~  592 (611)
                      ...           ... ......+..+.+++.+||+.||++||+    +.|++.+
T Consensus       246 ~~~-----------~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         246 KKE-----------VTF-PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             cCC-----------ccC-CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            100           000 111125678999999999999999999    6666653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.4e-33  Score=302.37  Aligned_cols=252  Identities=20%  Similarity=0.270  Sum_probs=182.4

Q ss_pred             HhhcCCCCCccc----ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcCCC------ceeeccceeccC-Ce
Q 007261          327 ATENFSPKNMID----GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKINHF------NLINLFGACEHD-GV  387 (611)
Q Consensus       327 at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~H~------niv~l~g~~~~~-~~  387 (611)
                      .+++|.....||    |.||++..  .++.||||+++      +++..|+.++..++|.      +++++++++..+ +.
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            345555555554    89999987  67899999985      2456788888887554      588888888654 57


Q ss_pred             EEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-----------
Q 007261          388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL-----------  456 (611)
Q Consensus       388 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-----------  456 (611)
                      .++|||++ +++|.+++...+   .+++..+..|+.||+.||+|||+  ..+|+||||||+|||++.++           
T Consensus       207 ~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             EEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccccccc
Confidence            89999998 789999987653   48999999999999999999994  25899999999999998765           


Q ss_pred             -----cEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhH
Q 007261          457 -----RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL  531 (611)
Q Consensus       457 -----~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~  531 (611)
                           .+||+|||++....      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..
T Consensus       281 ~~~~~~vkl~DfG~~~~~~------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  354 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDER------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL  354 (467)
T ss_pred             CCCCceEEECCCCccccCc------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                 49999999875322      1223467899999999999999999999999999999999999999765433211


Q ss_pred             HHHHHHHHHhcCC--------c---------ccccccccCccC-----C--cC-hHHHHHHHHHHHHHhhccCCCCCCCH
Q 007261          532 LAEAVFSMVEGGN--------A---------EAKLSVLVDPNL-----Q--AN-KKEIAHHLIMLCLACIAREPESRPSM  586 (611)
Q Consensus       532 l~~~~~~~~~~~~--------~---------~~~l~~~~d~~l-----~--~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~  586 (611)
                        ..+...+....        .         ...+....++..     .  .. .......+.+|+.+||+.||++|||+
T Consensus       355 --~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta  432 (467)
T PTZ00284        355 --HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA  432 (467)
T ss_pred             --HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence              11111100000        0         000000000000     0  00 00113457899999999999999999


Q ss_pred             HHHHHH
Q 007261          587 AEVVST  592 (611)
Q Consensus       587 ~evl~~  592 (611)
                      .|++++
T Consensus       433 ~e~L~H  438 (467)
T PTZ00284        433 RQMTTH  438 (467)
T ss_pred             HHHhcC
Confidence            999974

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.2e-33  Score=316.83  Aligned_cols=231  Identities=24%  Similarity=0.370  Sum_probs=180.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceecc--CCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEH--DGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  .+..||+|.+.         ..+..|+.+|++|+|||||+++++|.+  ...+||||||+++|+|.++|.
T Consensus        27 GtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~  106 (1021)
T PTZ00266         27 GEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ  106 (1021)
T ss_pred             eEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHH
Confidence            89999988  67789999875         347789999999999999999998854  457899999999999999997


Q ss_pred             ccC-CCCccCHHHHHHHHHHHHHHHHHHhcCC----CCCeEecCCCCCCeeeCC-----------------CCcEEEeee
Q 007261          406 KKR-YPEFVSWNCRFRIALDVAHGLHYLHNCT----DPGYVHKDISSGNILLDK-----------------NLRAKLANF  463 (611)
Q Consensus       406 ~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~----~~~ivH~Dlk~~NILl~~-----------------~~~~kl~Df  463 (611)
                      ... ....+++..++.|+.||+.||.|||+..    ..+|+||||||+||||+.                 .+.+||+||
T Consensus       107 k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDF  186 (1021)
T PTZ00266        107 KCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF  186 (1021)
T ss_pred             HHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccC
Confidence            632 2245899999999999999999999532    146999999999999964                 345899999


Q ss_pred             cCccccccccCCcccccccccCCCccchhhhcc--CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHh
Q 007261          464 SFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY--GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVE  541 (611)
Q Consensus       464 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  541 (611)
                      |+++......    ......||+.|+|||++.+  ..++.++|||||||+||||++|+.||.........    + ..+.
T Consensus       187 GlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ql----i-~~lk  257 (1021)
T PTZ00266        187 GLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL----I-SELK  257 (1021)
T ss_pred             Cccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHH----H-HHHh
Confidence            9987653221    2234578999999999854  45889999999999999999999999754432211    1 1111


Q ss_pred             cCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          542 GGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       542 ~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      ..           +.+.  ....+..+.+|+..||+.+|.+||++.|++.
T Consensus       258 ~~-----------p~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        258 RG-----------PDLP--IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cC-----------CCCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            10           0010  1123467889999999999999999999985

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-32  Score=276.96  Aligned_cols=233  Identities=30%  Similarity=0.506  Sum_probs=184.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +++.+|+|.+..         ...+|+.++++++|+||+++++++.++...++||||+++++|.+++...
T Consensus        13 g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~   92 (260)
T PF00069_consen   13 GTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKN   92 (260)
T ss_dssp             EEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHH
T ss_pred             EEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccccccccccc
Confidence            89999999  566899999852         2345999999999999999999999999999999999999999999833


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                         ..+++..++.++.|+++||.|||   +.+++|+||||+||++++++.++|+|||.+....   ..........++..
T Consensus        93 ---~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~---~~~~~~~~~~~~~~  163 (260)
T PF00069_consen   93 ---KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS---ENNENFNPFVGTPE  163 (260)
T ss_dssp             ---SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST---STTSEBSSSSSSGG
T ss_pred             ---ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc---cccccccccccccc
Confidence               23899999999999999999999   5899999999999999999999999999986531   11223445678899


Q ss_pred             ccchhhhc-cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          488 YMAPEYME-YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       488 y~aPE~~~-~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      |+|||.+. +..++.++||||+|+++|+|++|+.|+......+.  ............         ..... .......
T Consensus       164 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~--~~~~~~~~~~~~---------~~~~~-~~~~~~~  231 (260)
T PF00069_consen  164 YMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ--LEIIEKILKRPL---------PSSSQ-QSREKSE  231 (260)
T ss_dssp             GSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH--HHHHHHHHHTHH---------HHHTT-SHTTSHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhh--hhhhhhcccccc---------ccccc-ccchhHH
Confidence            99999998 88899999999999999999999999876522111  111111110000         00000 0011127


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+.+++.+||+.||++||++.+++++
T Consensus       232 ~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  232 ELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcC
Confidence            89999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.8e-32  Score=279.50  Aligned_cols=245  Identities=21%  Similarity=0.332  Sum_probs=185.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|+.  +|..||||.++        ..+.+|+.++++++|+||+++++++.+.+..++||||++ ++|.+++....
T Consensus        14 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   92 (284)
T cd07836          14 ATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHG   92 (284)
T ss_pred             eEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcC
Confidence            89999998  68899999875        246689999999999999999999999999999999998 58999887654


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                      ....+++..+..++.|++.||.|||   ..+++|+||||+||++++++.+||+|||+++......   .......++..|
T Consensus        93 ~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~y  166 (284)
T cd07836          93 VRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVVTLWY  166 (284)
T ss_pred             CCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc---cccccccccccc
Confidence            4445899999999999999999999   6889999999999999999999999999987543221   122234568899


Q ss_pred             cchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc--cccc---cccc-------Cc
Q 007261          489 MAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA--EAKL---SVLV-------DP  555 (611)
Q Consensus       489 ~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--~~~l---~~~~-------d~  555 (611)
                      ++||.+.+ ..++.++||||||+++|||++|+.|+......+..  ..+.........  ...+   ..+.       +.
T Consensus       167 ~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
T cd07836         167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL--LKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQ  244 (284)
T ss_pred             cChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHHHhCCCChhhHHHHhcCchhcccccCCChH
Confidence            99998865 45789999999999999999999998765443211  111111110000  0000   0000       00


Q ss_pred             cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       556 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .........+..+.+++.+||+.||.+||++.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         245 DLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             HHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000112345678899999999999999999999853

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.4e-33  Score=283.65  Aligned_cols=243  Identities=22%  Similarity=0.358  Sum_probs=184.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.||+|.+.         +.+.+|+++++.++||||+++++++..++..++||||+++++|.++....
T Consensus        15 ~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~   94 (286)
T cd07846          15 GMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP   94 (286)
T ss_pred             eEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhcc
Confidence            88999998  57899999874         34678999999999999999999999999999999999999998887654


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .   .++|..++.++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++.......   .......++..
T Consensus        95 ~---~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~  165 (286)
T cd07846          95 N---GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---EVYTDYVATRW  165 (286)
T ss_pred             C---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---cccCcccceee
Confidence            2   3899999999999999999999   6899999999999999999999999999987653322   12233457889


Q ss_pred             ccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc--------cccccccCccCC
Q 007261          488 YMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE--------AKLSVLVDPNLQ  558 (611)
Q Consensus       488 y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--------~~l~~~~d~~l~  558 (611)
                      |+|||.+.+ ..++.++||||||+++|||++|+.|+......+.  ...+......-...        ........+...
T Consensus       166 y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (286)
T cd07846         166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ--LYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVK  243 (286)
T ss_pred             ccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH--HHHHHHHhCCCchhhHHHhccchHhhcccccccc
Confidence            999998865 4578899999999999999999988764432211  11111111100000        000000001110


Q ss_pred             c------ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 A------NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 ~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .      .....+..+.+++.+||+.+|++||++.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         244 EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             CcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0      012346779999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.9e-33  Score=290.59  Aligned_cols=238  Identities=24%  Similarity=0.347  Sum_probs=178.2

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccC------CeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHD------GVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~E~~~~gsL~  401 (611)
                      |.||++..  ++..||||.++.         .+.+|+.++++++|+||+++++++...      ...++++|++ +++|.
T Consensus        29 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~  107 (343)
T cd07878          29 GSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLN  107 (343)
T ss_pred             eEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHH
Confidence            89999987  678999999852         356799999999999999999987543      3579999998 78999


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +++...    .+++..+..++.||+.||+|||   ..+|+||||||+|||+++++.+||+|||+++.....      ...
T Consensus       108 ~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~------~~~  174 (343)
T cd07878         108 NIVKCQ----KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE------MTG  174 (343)
T ss_pred             HHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccceecCCC------cCC
Confidence            888654    3899999999999999999999   689999999999999999999999999998754321      223


Q ss_pred             cccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc-------ccccccc
Q 007261          482 AVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE-------AKLSVLV  553 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~-------~~l~~~~  553 (611)
                      ..+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. + ..+..........       .......
T Consensus       175 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (343)
T cd07878         175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ-L-KRIMEVVGTPSPEVLKKISSEHARKYI  252 (343)
T ss_pred             ccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-H-HHHHHHhCCCCHHHHHhcchhhHHHHh
Confidence            468999999999876 5689999999999999999999999865433211 1 1111111000000       0000000


Q ss_pred             C--ccCCc-----ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          554 D--PNLQA-----NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       554 d--~~l~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .  +....     ........+.+|+.+||+.||++|||+.|++.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         253 QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0  00000     001123457899999999999999999999975

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=294.33  Aligned_cols=231  Identities=25%  Similarity=0.405  Sum_probs=188.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH-------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMRR-------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||.|+.  +...+|||.+..       -+..|+.+.++|+|.|||+++|.|.+++.+-|.||-++||||.+.|+..=.
T Consensus       589 G~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWG  668 (1226)
T KOG4279|consen  589 GTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWG  668 (1226)
T ss_pred             eEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccC
Confidence            89999987  445789999863       267899999999999999999999999999999999999999999987422


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                      +-.-.+...--...||++||.|||   ...|||||||-.||||+. .|.+||+|||-++.....+   ..+....||..|
T Consensus       669 PlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin---P~TETFTGTLQY  742 (1226)
T KOG4279|consen  669 PLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN---PCTETFTGTLQY  742 (1226)
T ss_pred             CCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC---ccccccccchhh
Confidence            211256666678899999999999   799999999999999965 5899999999887664332   356678899999


Q ss_pred             cchhhhccCC--CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          489 MAPEYMEYGL--VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       489 ~aPE~~~~~~--~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      ||||++..+.  |..++|||||||++.||.||++||........-       +++-+         +-..-++.|.+.+.
T Consensus       743 MAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-------MFkVG---------myKvHP~iPeelsa  806 (1226)
T KOG4279|consen  743 MAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-------MFKVG---------MYKVHPPIPEELSA  806 (1226)
T ss_pred             hChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-------hhhhc---------ceecCCCCcHHHHH
Confidence            9999998764  899999999999999999999999865443211       11100         11112233778899


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      +...++++|+..||.+||++.++++
T Consensus       807 eak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  807 EAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHcCCCcccCccHHHhcc
Confidence            9999999999999999999999986

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.7e-32  Score=276.24  Aligned_cols=232  Identities=28%  Similarity=0.500  Sum_probs=185.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|..  ++..|++|.++         +.+.+|+.++++++|+||+++++++...+..++|+||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   93 (264)
T cd06626          14 GKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG   93 (264)
T ss_pred             cEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc
Confidence            89999987  67899999985         25678999999999999999999999999999999999999999999865


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccc-ccccccCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS-TKTAVGTN  486 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~-~~~~~gt~  486 (611)
                      .   .+++..+..++.+++.||.|||   +.+++|+||+|+||++++++.+||+|||++............ .....++.
T Consensus        94 ~---~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~  167 (264)
T cd06626          94 R---ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP  167 (264)
T ss_pred             C---CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCc
Confidence            3   3788999999999999999999   689999999999999999999999999998765433221111 22346788


Q ss_pred             CccchhhhccCC---CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          487 GYMAPEYMEYGL---VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       487 ~y~aPE~~~~~~---~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      .|++||.+....   .+.++||||||+++||+++|+.||..........    ..... .         ..+.+. ....
T Consensus       168 ~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~----~~~~~-~---------~~~~~~-~~~~  232 (264)
T cd06626         168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM----FHVGA-G---------HKPPIP-DSLQ  232 (264)
T ss_pred             CccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH----HHHhc-C---------CCCCCC-cccc
Confidence            999999998766   8899999999999999999999986543221111    01100 0         001111 1122


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      .+..+.+++.+||+.+|++||++.|++.
T Consensus       233 ~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         233 LSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            3566789999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-33  Score=280.03  Aligned_cols=243  Identities=28%  Similarity=0.432  Sum_probs=187.7

Q ss_pred             hhcCCCCCccc----ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhc-CCCceeeccceeccC------CeE
Q 007261          328 TENFSPKNMID----GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKI-NHFNLINLFGACEHD------GVF  388 (611)
Q Consensus       328 t~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l-~H~niv~l~g~~~~~------~~~  388 (611)
                      +++|.....+|    |.||+|..  ++..+++|.++      .++.+|+.+++++ +|+||+++++++...      ...
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            34444444443    78999998  57889999985      4688899999999 799999999998654      358


Q ss_pred             EEEEeecCCCCHHHHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          389 YLVYEFMENGSLSDWLHKKR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       389 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      ++||||+++++|.+++.... ....+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++.
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence            99999999999999987532 2345899999999999999999999   6899999999999999999999999999987


Q ss_pred             ccccccCCcccccccccCCCccchhhhcc-----CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhc
Q 007261          468 SAVREESGYSSTKTAVGTNGYMAPEYMEY-----GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEG  542 (611)
Q Consensus       468 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  542 (611)
                      ......   .......++..|+|||.+..     ..++.++||||||++++||++|+.||........     .......
T Consensus       162 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~  233 (275)
T cd06608         162 QLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-----LFKIPRN  233 (275)
T ss_pred             ecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-----HHHhhcc
Confidence            543221   12234568889999998753     3477899999999999999999999865432211     1111110


Q ss_pred             CCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          543 GNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       543 ~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                                ..+.+ ..+...+..+.+++.+||..||++|||+.+++++
T Consensus       234 ----------~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         234 ----------PPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             ----------CCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                      00011 1123456789999999999999999999999863

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=267.49  Aligned_cols=229  Identities=22%  Similarity=0.372  Sum_probs=184.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      +.||+...  .|+.+|+|.+.         +++.+|+.|-+.|+|||||++.....+.+..|||+|+|.|++|..-+...
T Consensus        25 SvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R  104 (355)
T KOG0033|consen   25 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR  104 (355)
T ss_pred             HHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH
Confidence            45666544  67777777763         46789999999999999999999999999999999999999998766554


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeecCccccccccCCccccccccc
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK---NLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                         ...++...-+.+.||+++|.|+|   .++|||||+||.|+|+-.   .--+||+|||+|......    ..-...+|
T Consensus       105 ---~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g----~~~~G~~G  174 (355)
T KOG0033|consen  105 ---EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG----EAWHGFAG  174 (355)
T ss_pred             ---HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCCc----cccccccC
Confidence               34777888889999999999999   799999999999999943   346899999999877522    23445789


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      |++|||||+++..+|+..+|||+.||+||-|+.|..||.+.+....     ..+...+.       .-+++   ...+..
T Consensus       175 tP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl-----ye~I~~g~-------yd~~~---~~w~~i  239 (355)
T KOG0033|consen  175 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-----YEQIKAGA-------YDYPS---PEWDTV  239 (355)
T ss_pred             CCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH-----HHHHhccc-------cCCCC---cccCcC
Confidence            9999999999999999999999999999999999999987654321     11111111       11121   123456


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .++..+|+.+||..||.+|.|+.|.+.+
T Consensus       240 s~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  240 TPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             CHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            6778999999999999999999999875

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.7e-32  Score=280.51  Aligned_cols=228  Identities=25%  Similarity=0.442  Sum_probs=185.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  ++..+++|+++       +.+.+|+.++++++|+||+++++++...+..++|+||+++++|.+++...  
T Consensus        33 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--  110 (285)
T cd06648          33 GIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT--  110 (285)
T ss_pred             eEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhC--
Confidence            89999986  67899999874       34778999999999999999999999999999999999999999999873  


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                        .+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++.......   .......++..|+
T Consensus       111 --~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~  182 (285)
T cd06648         111 --RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV---PRRKSLVGTPYWM  182 (285)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC---cccccccCCcccc
Confidence              3889999999999999999999   6899999999999999999999999999876543221   1223346888999


Q ss_pred             chhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          490 APEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       490 aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      |||.+.+..++.++||||||+++|||++|+.|+......+.     ...... ..         .+. .......+..+.
T Consensus       183 aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~-----~~~~~~-~~---------~~~-~~~~~~~~~~l~  246 (285)
T cd06648         183 APEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-----MKRIRD-NL---------PPK-LKNLHKVSPRLR  246 (285)
T ss_pred             CHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH-----HHHHHh-cC---------CCC-CcccccCCHHHH
Confidence            99999888899999999999999999999999875432211     111111 00         001 111222456799


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 007261          570 MLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +++.+||+.+|++||++.+++++
T Consensus       247 ~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         247 SFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             HHHHHHcccChhhCcCHHHHccC
Confidence            99999999999999999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-34  Score=272.03  Aligned_cols=229  Identities=25%  Similarity=0.414  Sum_probs=193.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec-----HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |+||++..  .|+.||||.+.     +++.+|+.+|++.+.+++|++||.+.....+|+|||||..||..+.++..+  +
T Consensus        47 GSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~--K  124 (502)
T KOG0574|consen   47 GSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARR--K  124 (502)
T ss_pred             hHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhc--C
Confidence            89999976  79999999985     567889999999999999999999988889999999999999999998764  5


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      +++..++..+..+.+.||+|||   ...-+|||||+.|||++.+|.+||+|||.|......   ........||+.||||
T Consensus       125 ~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT---MAKRNTVIGTPFWMAP  198 (502)
T KOG0574|consen  125 PLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT---MAKRNTVIGTPFWMAP  198 (502)
T ss_pred             CccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhh---HHhhCccccCcccccH
Confidence            6999999999999999999999   567899999999999999999999999998655332   2345667899999999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCc-cCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP-NLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~-~l~~~~~~~~~~l~~  570 (611)
                      |++..-.|..++||||||++..||..|++|+.+-.....                 .+.....| ..-..+...+.++.+
T Consensus       199 EVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-----------------IFMIPT~PPPTF~KPE~WS~~F~D  261 (502)
T KOG0574|consen  199 EVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-----------------IFMIPTKPPPTFKKPEEWSSEFND  261 (502)
T ss_pred             HHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-----------------eEeccCCCCCCCCChHhhhhHHHH
Confidence            999999999999999999999999999999765332110                 00111111 111226677889999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHH
Q 007261          571 LCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +++.||-.+|++|-++.+++++
T Consensus       262 Fi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  262 FIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             HHHHHhcCCHHHHHHHHHHhhh
Confidence            9999999999999999999885

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=279.81  Aligned_cols=244  Identities=20%  Similarity=0.329  Sum_probs=184.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|..  +|..||+|++.         ..+.+|++++++++|+|++++++++.+++..+++|||++ ++|.+++...
T Consensus        13 ~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~   91 (283)
T cd07835          13 GVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSS   91 (283)
T ss_pred             eEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhC
Confidence            89999987  78999999875         357789999999999999999999999999999999995 7999998765


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .. ..+++..++.++.|++.||+|||   ..+++|+||+|+||+++.++.++|+|||+++......   .......++..
T Consensus        92 ~~-~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~  164 (283)
T cd07835          92 PL-TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV---RTYTHEVVTLW  164 (283)
T ss_pred             CC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc---cccCccccccC
Confidence            32 35899999999999999999999   6899999999999999999999999999986543221   11223356889


Q ss_pred             ccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc------------ccccccccC
Q 007261          488 YMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA------------EAKLSVLVD  554 (611)
Q Consensus       488 y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~------------~~~l~~~~d  554 (611)
                      |+|||.+.+. .++.++||||||+++|||++|+.||........ +... .........            .........
T Consensus       165 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (283)
T cd07835         165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRI-FRTLGTPDEDVWPGVTSLPDYKPTFPKWAR  242 (283)
T ss_pred             CCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-HHHhCCCChHHhhhhhhchhhhhhcccccc
Confidence            9999987654 578999999999999999999998865433221 1111 111000000            000000001


Q ss_pred             ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..........+..+.+++.+||+.||++||+++|++++
T Consensus       243 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         243 QDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             cchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            11111122344678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2e-32  Score=281.42  Aligned_cols=243  Identities=23%  Similarity=0.314  Sum_probs=184.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH------------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR------------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|..  +|+.||||.++.            .+.+|++++++++|+||+++++++.+.+..++||||+ +|+|.+++
T Consensus        14 ~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i   92 (298)
T cd07841          14 AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVI   92 (298)
T ss_pred             cEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHH
Confidence            89999987  688999999852            2457999999999999999999999999999999999 89999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ....  ..+++..++.++.||++||.|||   ..+++|+||+|+||+++.++.+||+|||+++.......   ......+
T Consensus        93 ~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~  164 (298)
T cd07841          93 KDKS--IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR---KMTHQVV  164 (298)
T ss_pred             hccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc---ccccccc
Confidence            7653  35899999999999999999999   68999999999999999999999999999876543221   1223356


Q ss_pred             CCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc-----cccccccC----
Q 007261          485 TNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE-----AKLSVLVD----  554 (611)
Q Consensus       485 t~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~-----~~l~~~~d----  554 (611)
                      +..|+|||.+.+ ..++.++||||||++++||++|..++......+ .+.. ...........     ..+.....    
T Consensus       165 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (298)
T cd07841         165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGK-IFEALGTPTEENWPGVTSLPDYVEFKPF  242 (298)
T ss_pred             ceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHH-HHHHcCCCchhhhhhccccccccccccc
Confidence            788999998854 467899999999999999999976665443322 1111 11111100000     00000000    


Q ss_pred             --ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 --PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 --~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        ..........+..+.+++.+||+.||++|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         243 PPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             CCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              00011123346788999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-32  Score=279.37  Aligned_cols=244  Identities=23%  Similarity=0.350  Sum_probs=184.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +++.||+|.++         +.+.+|++++++++|+||+++++++..++..++||||++++.|..++...
T Consensus        15 ~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~   94 (288)
T cd07833          15 GVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP   94 (288)
T ss_pred             eeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcC
Confidence            88999988  57899999875         35788999999999999999999999999999999999987776665443


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                         ..+++..+..++.||+.||.|||   ..+++|+||+|+||++++++.+||+|||++........  .......++..
T Consensus        95 ---~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~  166 (288)
T cd07833          95 ---GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA--SPLTDYVATRW  166 (288)
T ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--ccccCcccccC
Confidence               23889999999999999999999   68999999999999999999999999999876543321  12223467889


Q ss_pred             ccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc--------cccc--cccCcc
Q 007261          488 YMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE--------AKLS--VLVDPN  556 (611)
Q Consensus       488 y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--------~~l~--~~~d~~  556 (611)
                      |+|||.+.+. .++.++||||||+++|||++|+.|+......+.. . ............        ....  ...+..
T Consensus       167 ~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (288)
T cd07833         167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL-Y-LIQKCLGPLPPSHQELFSSNPRFAGVAFPEPS  244 (288)
T ss_pred             CcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-H-HHHHHhCCCCHHHhhhcccCccccccccCCCC
Confidence            9999999887 8899999999999999999999888654332211 1 111111000000        0000  000000


Q ss_pred             CCc-----ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          557 LQA-----NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       557 l~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ...     .+..++.++.+++++||+.+|++||++++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         245 QPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             CcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            000     012236789999999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.2e-32  Score=280.73  Aligned_cols=228  Identities=26%  Similarity=0.442  Sum_probs=185.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  ++..|++|.+.       ..+.+|+.++++++|||++++++.+...+..++|+||+++++|.+++.... 
T Consensus        33 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-  111 (293)
T cd06647          33 GTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-  111 (293)
T ss_pred             eEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcC-
Confidence            89999986  67899999985       347789999999999999999999999999999999999999999997643 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                         +++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++........   ......+++.|+
T Consensus       112 ---l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~  182 (293)
T cd06647         112 ---MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWM  182 (293)
T ss_pred             ---CCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc---ccccccCChhhc
Confidence               788999999999999999999   68999999999999999999999999998765432221   122346788999


Q ss_pred             chhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          490 APEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       490 aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      +||.+....++.++||||||+++||+++|+.||......+...     .....+          .+. ...+...+..+.
T Consensus       183 ~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-----~~~~~~----------~~~-~~~~~~~~~~l~  246 (293)
T cd06647         183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNG----------TPE-LQNPEKLSAIFR  246 (293)
T ss_pred             CchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-----ehhcCC----------CCC-CCCccccCHHHH
Confidence            9999988889999999999999999999999986543321100     000000          000 111233556788


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 007261          570 MLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +++.+||..+|++||++.+++.+
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         247 DFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HHHHHHccCChhhCcCHHHHhcC
Confidence            99999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.4e-32  Score=283.74  Aligned_cols=230  Identities=27%  Similarity=0.422  Sum_probs=184.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+++.  +|..||+|.+.          .++.+|+.++++++|+|++++++++.++...++||||++ |+|.+++..
T Consensus        39 ~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~  117 (317)
T cd06635          39 GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEV  117 (317)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHH
Confidence            89999987  68899999985          247789999999999999999999999999999999996 588888765


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..  ..++|..+..++.+++.||.|||   ..+++||||+|+||+++.++.+||+|||++.....       .....++.
T Consensus       118 ~~--~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-------~~~~~~~~  185 (317)
T cd06635         118 HK--KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-------ANSFVGTP  185 (317)
T ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC-------cccccCCc
Confidence            43  34899999999999999999999   68999999999999999999999999998764321       22346788


Q ss_pred             Cccchhhhc---cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          487 GYMAPEYME---YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       487 ~y~aPE~~~---~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      .|+|||.+.   .+.++.++||||||+++|||++|+.|+........     .........            .......
T Consensus       186 ~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~~~~------------~~~~~~~  248 (317)
T cd06635         186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNES------------PTLQSNE  248 (317)
T ss_pred             cccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHHhccC------------CCCCCcc
Confidence            999999873   46789999999999999999999999875432221     111111100            0011223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      .+..+.+++.+||+.+|.+||++.++++++..+..
T Consensus       249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence            45678999999999999999999999997654443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.4e-32  Score=277.10  Aligned_cols=228  Identities=24%  Similarity=0.370  Sum_probs=185.8

Q ss_pred             ceEEEEEEc--CcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGIIN--GSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~~--g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++...  +..+++|.+.          +.+.+|+.++++++|+||+++++.+.++...++|+||+++++|.+++..
T Consensus         7 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   86 (262)
T cd05572           7 GRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD   86 (262)
T ss_pred             eEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh
Confidence            899999985  8899999985          2477899999999999999999999999999999999999999999986


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||+++......    ......++.
T Consensus        87 ~~---~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~  156 (262)
T cd05572          87 RG---LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGTP  156 (262)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----ccccccCCc
Confidence            53   3888999999999999999999   6899999999999999999999999999987654321    223346788


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|++||.+....++.++|+||||+++|||++|..|+.....+......   .....            ......+...+.
T Consensus       157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~------------~~~~~~~~~~~~  221 (262)
T cd05572         157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN---DILKG------------NGKLEFPNYIDK  221 (262)
T ss_pred             CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH---HHhcc------------CCCCCCCcccCH
Confidence            999999998888999999999999999999999998765532211111   11100            000111223366


Q ss_pred             HHHHHHHHhhccCCCCCCC-----HHHHHH
Q 007261          567 HLIMLCLACIAREPESRPS-----MAEVVS  591 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs-----~~evl~  591 (611)
                      .+.+++.+||+.+|++||+     +.|+++
T Consensus       222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            7999999999999999999     677665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-32  Score=278.02  Aligned_cols=227  Identities=26%  Similarity=0.456  Sum_probs=183.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcC---CCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKIN---HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|..  +|..+|+|.++        .++.+|+.++++++   |||++++++++..+...++||||+++++|.+++.
T Consensus        15 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   94 (277)
T cd06917          15 GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK   94 (277)
T ss_pred             ceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHH
Confidence            89999997  68899999874        35778999999996   9999999999999999999999999999999987


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ..    .+++...+.++.|++.||.|||   ..+++|+||+|+||++++++.++|+|||++.......   .......++
T Consensus        95 ~~----~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~  164 (277)
T cd06917          95 AG----PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS---SKRSTFVGT  164 (277)
T ss_pred             cc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc---cccccccCC
Confidence            54    4899999999999999999999   6899999999999999999999999999987654322   122334688


Q ss_pred             CCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      ..|+|||.+.++ .++.++||||||+++|+|++|+.|+........     .. .         +.....+.+..  ...
T Consensus       165 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-----~~-~---------~~~~~~~~~~~--~~~  227 (277)
T cd06917         165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-----MM-L---------IPKSKPPRLED--NGY  227 (277)
T ss_pred             cceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-----hh-c---------cccCCCCCCCc--ccC
Confidence            899999988654 468999999999999999999999865432110     00 0         00001111111  124


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.++.+++.+||+.||++||++.|++++
T Consensus       228 ~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         228 SKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            5678999999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.5e-32  Score=281.79  Aligned_cols=250  Identities=22%  Similarity=0.346  Sum_probs=185.3

Q ss_pred             ceEEEEEEcCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      +.+|++..+|+.||||+++         +.+.+|++++++++|+||+++++++..++..+++|||+++|+|.+++.....
T Consensus        16 v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~   95 (314)
T cd08216          16 VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP   95 (314)
T ss_pred             EEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcc
Confidence            3455555689999999974         3578899999999999999999999999999999999999999999986532


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC----CcccccccccC
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES----GYSSTKTAVGT  485 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~----~~~~~~~~~gt  485 (611)
                       ..+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.+........    .........++
T Consensus        96 -~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (314)
T cd08216          96 -EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN  171 (314)
T ss_pred             -cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccc
Confidence             34788889999999999999999   68999999999999999999999999998865432211    01122334567


Q ss_pred             CCccchhhhcc--CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHH----hcCCc---ccccc----cc
Q 007261          486 NGYMAPEYMEY--GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMV----EGGNA---EAKLS----VL  552 (611)
Q Consensus       486 ~~y~aPE~~~~--~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~----~~~~~---~~~l~----~~  552 (611)
                      ..|+|||.+..  ..++.++||||||+++|||++|+.||.........+ +......    .....   .....    ..
T Consensus       172 ~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
T cd08216         172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL-EKVRGTVPCLLDKSTYPLYEDSMSQSRSSN  250 (314)
T ss_pred             ccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCccccccCchhhhcCCcCcccccc
Confidence            78999999876  358899999999999999999999987644322111 1110000    00000   00000    00


Q ss_pred             cCccC-----CcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          553 VDPNL-----QANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       553 ~d~~l-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      .++..     .........++.+++.+||+.||++||++.+++++-
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence            11110     011234556789999999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.2e-32  Score=282.03  Aligned_cols=223  Identities=24%  Similarity=0.360  Sum_probs=183.4

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +++.||+|.+++          .+.+|++++++++||||+++++++.+++..++||||+++++|.+++..
T Consensus        15 ~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~   94 (290)
T cd05580          15 GRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK   94 (290)
T ss_pred             eEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHH
Confidence            89999988  678999999852          366799999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..+..++.|++.||.|||   ..+++|+||+|+|||++.++.+||+|||+++.....      .....+++
T Consensus        95 ~~---~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------~~~~~~~~  162 (290)
T cd05580          95 SG---RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TYTLCGTP  162 (290)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------CCCCCCCc
Confidence            53   4889999999999999999999   689999999999999999999999999998765322      23346788


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+...+.++||||||++++||++|+.|+......+  ...   ... .+.          .   ..+...+.
T Consensus       163 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~---~~~-~~~----------~---~~~~~~~~  223 (290)
T cd05580         163 EYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ--IYE---KIL-EGK----------V---RFPSFFSP  223 (290)
T ss_pred             cccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--HHH---HHh-cCC----------c---cCCccCCH
Confidence            9999999988889999999999999999999999986544211  111   111 110          0   01122356


Q ss_pred             HHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      .+.+++.+||..||.+|+     ++.|++++
T Consensus       224 ~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         224 DAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             HHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            788999999999999999     77777654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.4e-32  Score=278.70  Aligned_cols=244  Identities=25%  Similarity=0.350  Sum_probs=185.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|..  +|+.|++|++.         ..+.+|+.++++++|+||+++++++..+...++||||+ +++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~   92 (286)
T cd07832          14 GIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE   92 (286)
T ss_pred             cEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhc
Confidence            89999987  68899999985         35788999999999999999999999999999999999 99999999765


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .  ..+++..++.++.||+.||+|||   +.+++|+||||+||+++.++.++|+|||++........  .......++..
T Consensus        93 ~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~  165 (286)
T cd07832          93 E--RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--RLYSHQVATRW  165 (286)
T ss_pred             C--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC--CccccccCccc
Confidence            4  45899999999999999999999   68999999999999999999999999999876543221  12234568889


Q ss_pred             ccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc--c------ccccccCccCC
Q 007261          488 YMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE--A------KLSVLVDPNLQ  558 (611)
Q Consensus       488 y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--~------~l~~~~d~~l~  558 (611)
                      |+|||.+.+. .++.++||||||++++||++|..++......+ .+ ..+..........  .      .......+...
T Consensus       166 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (286)
T cd07832         166 YRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QL-AIVFRTLGTPNEETWPGLTSLPDYNKITFPESK  243 (286)
T ss_pred             ccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HH-HHHHHHcCCCChHHHhhccCcchhhcccCCCCC
Confidence            9999988654 46899999999999999999976665433221 11 1111111111000  0      00000000000


Q ss_pred             -----cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 -----ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 -----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                           ....+....+.+++.+||+.||++||++++++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         244 PIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                 0012345789999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.3e-32  Score=278.17  Aligned_cols=230  Identities=28%  Similarity=0.481  Sum_probs=187.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      |.||++..  ++..+++|+++      ..+.+|++++++++|+|++++++.+......++|+||+++++|.+++....  
T Consensus        33 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--  110 (286)
T cd06614          33 GEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF--  110 (286)
T ss_pred             eEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc--
Confidence            89999998  48899999986      357789999999999999999999999999999999999999999998764  


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA  490 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~a  490 (611)
                      ..+++..+..++.+++.||.|||   ..+++|+||+|+||+++.++.++|+|||++.......   .......++..|++
T Consensus       111 ~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~~  184 (286)
T cd06614         111 VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK---SKRNSVVGTPYWMA  184 (286)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch---hhhccccCCcccCC
Confidence            35999999999999999999999   6999999999999999999999999999876543221   11223457889999


Q ss_pred             hhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          491 PEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       491 PE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      ||.+.+..++.++||||||+++|||++|+.|+..........     ......           ..........+..+.+
T Consensus       185 PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~-----~~~~~~-----------~~~~~~~~~~~~~l~~  248 (286)
T cd06614         185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-----LITTKG-----------IPPLKNPEKWSPEFKD  248 (286)
T ss_pred             HhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhcC-----------CCCCcchhhCCHHHHH
Confidence            999988889999999999999999999999986543322111     111100           0001112235567899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHH
Q 007261          571 LCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ++.+||+.+|.+||++.+++++
T Consensus       249 li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         249 FLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             HHHHHhccChhhCcCHHHHhhC
Confidence            9999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.8e-32  Score=277.24  Aligned_cols=239  Identities=23%  Similarity=0.338  Sum_probs=184.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceecc--CCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEH--DGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +++.+|+|.+.        ..+.+|++++++++||||++++++|..  .+..++||||+++++|.+++..
T Consensus        15 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   94 (287)
T cd06621          15 GSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK   94 (287)
T ss_pred             eEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHH
Confidence            89999998  67899999875        357889999999999999999998854  3468999999999999998764


Q ss_pred             cC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          407 KR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       407 ~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      .. ....+++.....++.|++.||.|||   ..+++|+||+|+||++++++.++|+|||++.......     .....++
T Consensus        95 ~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~  166 (287)
T cd06621          95 VKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-----AGTFTGT  166 (287)
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-----cccccCC
Confidence            22 2345888999999999999999999   6899999999999999999999999999986543221     1234567


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      ..|+|||.+.+..++.++||||||+++|||++|+.|+...........+.. ........    .. +.... ......+
T Consensus       167 ~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~----~~-~~~~~-~~~~~~~  239 (287)
T cd06621         167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVNMPN----PE-LKDEP-GNGIKWS  239 (287)
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHHhcCCc----hh-hccCC-CCCCchH
Confidence            889999999999999999999999999999999999875522100111111 11111000    00 00000 0011245


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+.+++.+||+.+|++|||+.|++++
T Consensus       240 ~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         240 EEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            678999999999999999999999984

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-32  Score=279.81  Aligned_cols=244  Identities=23%  Similarity=0.343  Sum_probs=181.5

Q ss_pred             ceEEEEEE--cCcEEEEEEecH--------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMRR--------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  +|+.||||.++.        .+.+|++++++++|+||+++++++.+++..++||||++ ++|.+++....
T Consensus        19 ~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~   97 (291)
T cd07844          19 ATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCG   97 (291)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCC
Confidence            89999987  688999999852        35679999999999999999999999999999999997 59999987653


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                        ..+++.....++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.......   ......++..|
T Consensus        98 --~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~  169 (291)
T cd07844          98 --GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK---TYSNEVVTLWY  169 (291)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc---ccccccccccc
Confidence              35889999999999999999999   68999999999999999999999999999865422111   11223467889


Q ss_pred             cchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc-------------cccccC
Q 007261          489 MAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK-------------LSVLVD  554 (611)
Q Consensus       489 ~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~-------------l~~~~d  554 (611)
                      +|||.+.+ ..++.++||||||+++|||++|+.||.........+ ......+........             ......
T Consensus       170 ~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (291)
T cd07844         170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL-HKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPP  248 (291)
T ss_pred             CCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH-HHHHHhcCCCChhhhhhhhhccccccccccccCC
Confidence            99998865 458899999999999999999999986544221111 111111111100000             000000


Q ss_pred             ccCCcChHHH--HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 PNLQANKKEI--AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 ~~l~~~~~~~--~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+.......  ...+.+++.+||+.+|++||++.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         249 RPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            0000000111  2567899999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-32  Score=285.04  Aligned_cols=228  Identities=28%  Similarity=0.405  Sum_probs=194.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+++.  +|+.+|+|.+.          ..+.+|+.+|+++. |||||.+.+++++....++|||++.||.|.+.+.
T Consensus        49 g~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~  128 (382)
T KOG0032|consen   49 GVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIV  128 (382)
T ss_pred             eEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHH
Confidence            99999988  68999999985          25788999999997 9999999999999999999999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC----CcEEEeeecCccccccccCCcccccc
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN----LRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      ..   . ++......++.|++.++.|||   ..+++||||||+|+|+...    +.+|++|||++.....    ......
T Consensus       129 ~~---~-~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~----~~~~~~  197 (382)
T KOG0032|consen  129 KK---H-YSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP----GERLHT  197 (382)
T ss_pred             Hc---c-CCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC----CceEee
Confidence            76   2 899999999999999999999   6999999999999999543    5799999999987654    234567


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcCh
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK  561 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  561 (611)
                      .+||+.|+|||++....|+...||||+|+++|.|++|..||......+...     .... +..     .+    ..+..
T Consensus       198 ~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~i~~-~~~-----~f----~~~~w  262 (382)
T KOG0032|consen  198 IVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----AILR-GDF-----DF----TSEPW  262 (382)
T ss_pred             ecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----HHHc-CCC-----CC----CCCCc
Confidence            899999999999999999999999999999999999999998876544322     1111 110     01    11224


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          562 KEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +..++.+.+++..|+..||.+|+++.+++++
T Consensus       263 ~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  263 DDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             cccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            5567889999999999999999999999996

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.7e-32  Score=278.52  Aligned_cols=244  Identities=19%  Similarity=0.272  Sum_probs=180.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  +|..||+|.++        ..+.+|+.++++++|+||+++.+++..++..++||||+. ++|.+++....
T Consensus        19 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   97 (291)
T cd07870          19 ATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHP   97 (291)
T ss_pred             EEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCC
Confidence            89999987  68899999985        246789999999999999999999999999999999995 78877776543


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                        ..+.+..+..++.|++.||.|||   ..+++|+||||+|||++.++.+||+|||+++......   .......++..|
T Consensus        98 --~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~~y  169 (291)
T cd07870          98 --GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS---QTYSSEVVTLWY  169 (291)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC---CCCCCccccccc
Confidence              34788888999999999999999   6899999999999999999999999999987543221   112234568899


Q ss_pred             cchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc---------ccccccccCccCC
Q 007261          489 MAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA---------EAKLSVLVDPNLQ  558 (611)
Q Consensus       489 ~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~---------~~~l~~~~d~~l~  558 (611)
                      +|||.+.+. .++.++||||||+++|||++|+.||.........+.+. .........         .............
T Consensus       170 ~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (291)
T cd07870         170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI-WTVLGVPTEDTWPGVSKLPNYKPEWFLPCKP  248 (291)
T ss_pred             cCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH-HHHcCCCChhhhhhhhhcccccchhccccCC
Confidence            999998754 57889999999999999999999987544322221111 111000000         0000000000000


Q ss_pred             cC------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 AN------KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 ~~------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..      .......+.+++.+|++.||.+|||+.|++.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         249 QQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             cchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            00      00124568899999999999999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-33  Score=291.20  Aligned_cols=244  Identities=25%  Similarity=0.441  Sum_probs=192.9

Q ss_pred             CCccccchhHHHHHhhcCCCCCcccceEEEEEE--cCcEEEEEEe---------c--HHHHHHHHHHHhcCCCceeeccc
Q 007261          314 RGLKFYKYEDLVVATENFSPKNMIDGSVFRGII--NGSTVAIKCM---------R--RSISKEVNLLKKINHFNLINLFG  380 (611)
Q Consensus       314 ~~~~~~~~~el~~at~~f~~~~~igg~Vy~g~~--~g~~vavK~~---------~--~~~~~E~~~l~~l~H~niv~l~g  380 (611)
                      .+.++.+|+++ .+.+-|       -+||||.+  .|-.||=-.+         +  +.|..|+.+|+.|+|+|||+++.
T Consensus        37 p~gRy~k~~ev-LGrGaf-------KtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~  108 (632)
T KOG0584|consen   37 PTGRYLKFDEV-LGRGAF-------KTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYD  108 (632)
T ss_pred             CCCceeehhhh-cccccc-------eeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeee
Confidence            34455555543 333333       68999987  4555552211         1  46889999999999999999999


Q ss_pred             eeccCC--eEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-Cc
Q 007261          381 ACEHDG--VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN-LR  457 (611)
Q Consensus       381 ~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~  457 (611)
                      ++.+..  ..-+|+|.|..|+|..|+++.+.   ++.+....|+.||++||.|||+. .++|+|||||-+||+|+.+ |.
T Consensus       109 SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~  184 (632)
T KOG0584|consen  109 SWVDTDNKTINFITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGE  184 (632)
T ss_pred             heecCCCceeeeeeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCc
Confidence            997654  48899999999999999998754   88899999999999999999985 6899999999999999876 89


Q ss_pred             EEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHH
Q 007261          458 AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVF  537 (611)
Q Consensus       458 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~  537 (611)
                      +||+|+|||......     ...+..|||.|||||... ..|++..||||||+.|+||+|+..|+..-...     ..+.
T Consensus       185 VKIGDLGLAtl~r~s-----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-----AQIY  253 (632)
T KOG0584|consen  185 VKIGDLGLATLLRKS-----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-----AQIY  253 (632)
T ss_pred             eeecchhHHHHhhcc-----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-----HHHH
Confidence            999999999876433     334579999999999988 77999999999999999999999998644332     2233


Q ss_pred             HHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          538 SMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       538 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+..+.....+...-|           .++.++|.+|+.. ..+|||+.|++..
T Consensus       254 KKV~SGiKP~sl~kV~d-----------Pevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  254 KKVTSGIKPAALSKVKD-----------PEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             HHHHcCCCHHHhhccCC-----------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            34444444444554444           3478899999999 9999999999874

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2e-32  Score=278.98  Aligned_cols=231  Identities=21%  Similarity=0.373  Sum_probs=177.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecH--------HHHHHHHH-HHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR--------SISKEVNL-LKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.||+|.++.        ++..|+.+ ++.++||||+++++++..++..++||||++ |+|.+++...
T Consensus        15 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~   93 (283)
T cd06617          15 GVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKV   93 (283)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHh
Confidence            89999998  689999998852        34456665 555699999999999999999999999996 7898888653


Q ss_pred             C-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          408 R-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       408 ~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      . ....+++..++.++.|++.||+|||+  ..+++||||||+|||++.++.+||+|||+++......    ......++.
T Consensus        94 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~  167 (283)
T cd06617          94 YDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV----AKTIDAGCK  167 (283)
T ss_pred             ccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc----ccccccCCc
Confidence            2 23458999999999999999999993  2389999999999999999999999999987543211    122346788


Q ss_pred             Cccchhhhcc----CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          487 GYMAPEYMEY----GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       487 ~y~aPE~~~~----~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      .|+|||.+.+    ..++.++|+||||+++|||++|+.|+.........    ........          .+...  ..
T Consensus       168 ~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~----------~~~~~--~~  231 (283)
T cd06617         168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ----LKQVVEEP----------SPQLP--AE  231 (283)
T ss_pred             cccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH----HHHHHhcC----------CCCCC--cc
Confidence            9999998865    44688999999999999999999998643221111    11111100          01110  12


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+.++.+++.+||..+|++||++.+++++
T Consensus       232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         232 KFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            345678999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.5e-32  Score=273.81  Aligned_cols=230  Identities=26%  Similarity=0.412  Sum_probs=188.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++..  +|+.|+||+++        ..+.+|+..+.+++|+|++++++++...+..++||||+++++|.+++... 
T Consensus        15 ~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-   93 (264)
T cd06623          15 GVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-   93 (264)
T ss_pred             eEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-
Confidence            78999988  58899999875        35788999999999999999999999999999999999999999999865 


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTD-PGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~-~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                        ..+++..++.++.|++.||+|||   . .+++|+||+|+||+++.++.++|+|||++........   ......++..
T Consensus        94 --~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~  165 (264)
T cd06623          94 --GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD---QCNTFVGTVT  165 (264)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC---cccceeeccc
Confidence              34899999999999999999999   6 8999999999999999999999999999876543221   1123457889


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH-HHH
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAH  566 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~-~~~  566 (611)
                      |+|||.+....++.++|+||||+++|||++|+.|+.......  ..+.......             ......+.. .+.
T Consensus       166 y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~-------------~~~~~~~~~~~~~  230 (264)
T cd06623         166 YMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--FFELMQAICD-------------GPPPSLPAEEFSP  230 (264)
T ss_pred             ccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--HHHHHHHHhc-------------CCCCCCCcccCCH
Confidence            999999999999999999999999999999999986553211  1111111111             111111222 567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+.+++.+||+.+|++||++.|++++
T Consensus       231 ~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         231 EFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHhC
Confidence            89999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.8e-32  Score=279.76  Aligned_cols=245  Identities=18%  Similarity=0.280  Sum_probs=181.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhc-CCCceeeccceeccCCe-----EEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKI-NHFNLINLFGACEHDGV-----FYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~-----~~lV~E~~~~gsL~  401 (611)
                      |.||+|..  +|+.||||.++         ..+.+|+.+++++ +|+||+++++++...+.     .|+||||+++ +|.
T Consensus        15 g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~   93 (295)
T cd07837          15 GKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLK   93 (295)
T ss_pred             eEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHH
Confidence            89999998  68899999875         3467899999999 56999999999876655     8999999985 899


Q ss_pred             HHhhccCC--CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeecCccccccccCCccc
Q 007261          402 DWLHKKRY--PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-NLRAKLANFSFVRSAVREESGYSS  478 (611)
Q Consensus       402 ~~l~~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~  478 (611)
                      +++.....  ...+++..++.++.||+.||.|||   ..+++||||||+||+++. ++.+||+|||+++......   ..
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~---~~  167 (295)
T cd07837          94 KFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV---KS  167 (295)
T ss_pred             HHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecccceecCCCc---cc
Confidence            98865432  245899999999999999999999   689999999999999998 8999999999987543221   11


Q ss_pred             ccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc--c---cccc
Q 007261          479 TKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA--K---LSVL  552 (611)
Q Consensus       479 ~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~--~---l~~~  552 (611)
                      .....+++.|+|||.+.+ ..++.++||||||+++|||++|..||......+..  ..+...........  .   +...
T Consensus       168 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  245 (295)
T cd07837         168 YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIFKLLGTPTEQVWPGVSKLRDW  245 (295)
T ss_pred             cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHHHhCCCChhhCcchhhccch
Confidence            223456788999998865 45799999999999999999999988754432211  11111111110000  0   0000


Q ss_pred             c-CccCC-----cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          553 V-DPNLQ-----ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       553 ~-d~~l~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      . -+...     ......+.++.+++.+||+.||.+||++.|++.+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         246 HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0 00000     0112356778999999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.5e-32  Score=276.69  Aligned_cols=230  Identities=23%  Similarity=0.289  Sum_probs=182.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.+|+|.+..          .+.+|++++++++||||+++++.+...+..|+||||+++++|.+++..
T Consensus         7 g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   86 (277)
T cd05577           7 GEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYN   86 (277)
T ss_pred             eeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHH
Confidence            89999986  688999998852          346799999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ... ..+++..++.++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||++......    .......++.
T Consensus        87 ~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~  158 (277)
T cd05577          87 VGE-PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG----KKIKGRAGTP  158 (277)
T ss_pred             cCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC----CccccccCCC
Confidence            532 35899999999999999999999   689999999999999999999999999998754321    1223345778


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|++||.+.+..++.++||||||+++++|++|+.||........  ...+....             .......+...+.
T Consensus       159 ~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~-------------~~~~~~~~~~~~~  223 (277)
T cd05577         159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KEELKRRT-------------LEMAVEYPDKFSP  223 (277)
T ss_pred             CcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HHHHHhcc-------------ccccccCCccCCH
Confidence            99999999888899999999999999999999999865433110  00000000             0000111223466


Q ss_pred             HHHHHHHHhhccCCCCCC-----CHHHHHH
Q 007261          567 HLIMLCLACIAREPESRP-----SMAEVVS  591 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP-----s~~evl~  591 (611)
                      .+.+++.+||+.||++||     ++.+++.
T Consensus       224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         224 EAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            789999999999999999     5665654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2e-32  Score=275.23  Aligned_cols=226  Identities=24%  Similarity=0.327  Sum_probs=184.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +++.||+|.+.          +.+.+|++++++++||||+++++++.++...++|+||+++++|.+++..
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   93 (258)
T cd05578          14 GKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ   93 (258)
T ss_pred             ceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHh
Confidence            89999988  48899999885          2467899999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .   ..+++.....++.|++.||.|||   ..+++|+||+|+||++++++.++|+|||++.......    ......++.
T Consensus        94 ~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~  163 (258)
T cd05578          94 K---VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT----LTTSTSGTP  163 (258)
T ss_pred             c---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc----cccccCCCh
Confidence            5   24889999999999999999999   6899999999999999999999999999987653321    123345788


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+....++.++|+||||+++|+|++|+.|+........   .........             .....+...+.
T Consensus       164 ~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~-------------~~~~~~~~~~~  227 (258)
T cd05578         164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR---DQIRAKQET-------------ADVLYPATWST  227 (258)
T ss_pred             hhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH---HHHHHHhcc-------------ccccCcccCcH
Confidence            99999999988899999999999999999999999876554211   111111110             00111233457


Q ss_pred             HHHHHHHHhhccCCCCCCCH--HHHH
Q 007261          567 HLIMLCLACIAREPESRPSM--AEVV  590 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~--~evl  590 (611)
                      .+.+++.+||+.||.+||++  +|++
T Consensus       228 ~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         228 EAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             HHHHHHHHHccCChhHcCCccHHHHh
Confidence            78999999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.7e-32  Score=277.11  Aligned_cols=227  Identities=21%  Similarity=0.299  Sum_probs=178.1

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHh---cCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKK---INHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~---l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++..  +|+.+|+|.+++          .+.+|..+++.   .+|+||+.+++++..++..++||||+++|+|.++
T Consensus         8 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   87 (279)
T cd05633           8 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH   87 (279)
T ss_pred             eEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHH
Confidence            89999987  688999998752          13344444433   3799999999999999999999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      +....   .+++.....++.|++.||.|||   ..+++|+||||+|||+++++.+||+|||++......     ......
T Consensus        88 i~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-----~~~~~~  156 (279)
T cd05633          88 LSQHG---VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASV  156 (279)
T ss_pred             HHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-----CccCcC
Confidence            97653   3899999999999999999999   688999999999999999999999999998654221     112346


Q ss_pred             cCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          484 GTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       484 gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      ++..|+|||.+.. ..++.++||||||++++||++|+.||.........   .+.....          ..+.   ..+.
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~----------~~~~---~~~~  220 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTL----------TVNV---ELPD  220 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HHHHHhh----------cCCc---CCcc
Confidence            8999999998864 56899999999999999999999998754332211   0111100          0011   1123


Q ss_pred             HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      ..+.++.+++.+||+.||++||     +++|++++
T Consensus       221 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         221 SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            4567789999999999999999     59999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.6e-32  Score=268.21  Aligned_cols=229  Identities=27%  Similarity=0.470  Sum_probs=187.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  +|..+++|+++       +.+.+|++++++++|+|++++++++..+...++++||+++++|.+++.... 
T Consensus        14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-   92 (253)
T cd05122          14 GEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-   92 (253)
T ss_pred             eEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC-
Confidence            89999998  58899999985       357789999999999999999999999999999999999999999997753 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                       ..+++..+..++.+++.||.|||   ..+++|+||+|+||++++++.++|+|||.+........    .....++..|+
T Consensus        93 -~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~  164 (253)
T cd05122          93 -QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA----RNTMVGTPYWM  164 (253)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----ccceecCCccc
Confidence             34899999999999999999999   68999999999999999999999999999876543321    23456788999


Q ss_pred             chhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          490 APEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       490 aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      +||.+....++.++||||||+++++|++|+.|+...........     ... .          +..........+..+.
T Consensus       165 ~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~-~----------~~~~~~~~~~~~~~~~  228 (253)
T cd05122         165 APEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-----IAT-N----------GPPGLRNPEKWSDEFK  228 (253)
T ss_pred             CHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-----HHh-c----------CCCCcCcccccCHHHH
Confidence            99999988899999999999999999999999865532221111     100 0          0000011112356789


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 007261          570 MLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +++.+||+.||++||++.|++++
T Consensus       229 ~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         229 DFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             HHHHHHccCChhhCCCHHHHhcC
Confidence            99999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.9e-32  Score=276.79  Aligned_cols=243  Identities=21%  Similarity=0.296  Sum_probs=183.1

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccC--CeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHD--GVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|..  +++.+++|.++.         .+.+|+.++++++||||+++++++...  +..++||||++ ++|.+++.
T Consensus        19 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~   97 (293)
T cd07843          19 GVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLME   97 (293)
T ss_pred             eEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHH
Confidence            89999998  578999999851         356899999999999999999998777  88999999997 59999987


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...  ..+++..++.++.|++.||+|||   ..+++|+||||+||++++++.+||+|||+++.......   ......++
T Consensus        98 ~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~  169 (293)
T cd07843          98 TMK--QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK---PYTQLVVT  169 (293)
T ss_pred             hcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc---cccccccc
Confidence            653  25899999999999999999999   68999999999999999999999999999876543221   12234568


Q ss_pred             CCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc------------c-ccccc
Q 007261          486 NGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA------------E-AKLSV  551 (611)
Q Consensus       486 ~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~------------~-~~l~~  551 (611)
                      ..|+|||.+.+. .++.++|+||||+++|||++|+.|+......+. . ..+.........            . .....
T Consensus       170 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (293)
T cd07843         170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-L-NKIFKLLGTPTEKIWPGFSELPGAKKKTFTK  247 (293)
T ss_pred             ccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-H-HHHHHHhCCCchHHHHHhhccchhccccccc
Confidence            889999988754 468999999999999999999999875543221 1 111111100000            0 00000


Q ss_pred             ccCccCCcC-hHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          552 LVDPNLQAN-KKE-IAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       552 ~~d~~l~~~-~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .....+... +.. .+..+.+++.+||+.||++|||+.|++.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         248 YPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             ccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            001111111 111 36678899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.1e-31  Score=280.24  Aligned_cols=246  Identities=23%  Similarity=0.354  Sum_probs=184.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  .|+.||+|.++         +.+.+|+.+++.++||||++++++|..++..++|+||+++++|.+++...
T Consensus        14 ~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~   93 (328)
T cd08226          14 TSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY   93 (328)
T ss_pred             eeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhh
Confidence            78999987  78999999975         34678999999999999999999999999999999999999999999875


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc----ccccccc
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY----SSTKTAV  483 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~----~~~~~~~  483 (611)
                      .. ..+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+|++||+.+..........    .......
T Consensus        94 ~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (328)
T cd08226          94 FP-EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST  169 (328)
T ss_pred             cc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccccccccc
Confidence            32 34889999999999999999999   6899999999999999999999999998654322111100    0111123


Q ss_pred             cCCCccchhhhccC--CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc----------------
Q 007261          484 GTNGYMAPEYMEYG--LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA----------------  545 (611)
Q Consensus       484 gt~~y~aPE~~~~~--~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~----------------  545 (611)
                      ++..|+|||++.+.  .++.++||||||+++|||++|+.||...........     .......                
T Consensus       170 ~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  244 (328)
T cd08226         170 SVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ-----KLKGPPYSPLDITTFPCEESRMK  244 (328)
T ss_pred             CccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHH-----HhcCCCCCCccccccchhhhhhc
Confidence            45679999999764  478999999999999999999999865543221110     0000000                


Q ss_pred             -----------ccccc-----cccCccCCc-ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          546 -----------EAKLS-----VLVDPNLQA-NKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       546 -----------~~~l~-----~~~d~~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                                 +....     ...+..+.. ....+...+.+|+.+||+.||++|||+.|++++-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         245 NSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             cchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence                       00000     001111111 1345677899999999999999999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.3e-32  Score=269.81  Aligned_cols=228  Identities=23%  Similarity=0.334  Sum_probs=188.0

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.+++|.+..         ++.+|+.++++++|+||+++++++.++...++||||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~   93 (256)
T cd08530          14 GSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKR   93 (256)
T ss_pred             eeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHH
Confidence            88999987  678999999752         4668999999999999999999999999999999999999999998763


Q ss_pred             C-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          408 R-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       408 ~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      . ....+++..++.++.|++.||.|||   +.+++|+||+|.||++++++.+||+|||++......     ......++.
T Consensus        94 ~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~  165 (256)
T cd08530          94 KKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-----MAKTQIGTP  165 (256)
T ss_pred             HhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-----CcccccCCc
Confidence            2 1245899999999999999999999   689999999999999999999999999998765432     222345788


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|++||.+.+..++.++|+||||+++|||++|+.|+......+..  .    ....            ......+...+.
T Consensus       166 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~--~----~~~~------------~~~~~~~~~~~~  227 (256)
T cd08530         166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR--Y----KVQR------------GKYPPIPPIYSQ  227 (256)
T ss_pred             cccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H----HHhc------------CCCCCCchhhCH
Confidence            999999999999999999999999999999999998655432211  1    1110            111122335667


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ++.+++.+||+.+|++||++.+++++
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         228 DLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            79999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-32  Score=272.11  Aligned_cols=230  Identities=21%  Similarity=0.320  Sum_probs=182.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec------------HHHHHHHHHHHhcCCCceeeccceeccC--CeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR------------RSISKEVNLLKKINHFNLINLFGACEHD--GVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------------~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~gsL~~  402 (611)
                      |.||+|..  +|..||+|.+.            ..+.+|+.++++++|+||+++++++.+.  ...++|+||+++++|.+
T Consensus        16 g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~   95 (264)
T cd06653          16 GEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKD   95 (264)
T ss_pred             eEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHH
Confidence            89999987  68899999863            2577899999999999999999998653  56889999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++....   .+++...++++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++...............
T Consensus        96 ~~~~~~---~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  169 (264)
T cd06653          96 QLKAYG---ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV  169 (264)
T ss_pred             HHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCcccccc
Confidence            997643   3788899999999999999999   6899999999999999999999999999987643211111112234


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      .++..|+|||.+.+..++.++|+||||++++||++|+.||......+.     +......            +.....+.
T Consensus       170 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~------------~~~~~~p~  232 (264)
T cd06653         170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-----IFKIATQ------------PTKPMLPD  232 (264)
T ss_pred             CCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-----HHHHHcC------------CCCCCCCc
Confidence            678899999999988899999999999999999999999865432211     1111100            01111234


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ...+.+.+++.+||. +|..||+..+++.+
T Consensus       233 ~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         233 GVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             ccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            566779999999999 57999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-32  Score=279.93  Aligned_cols=250  Identities=20%  Similarity=0.281  Sum_probs=183.3

Q ss_pred             ceEEEEEE----cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccC--CeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII----NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHD--GVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~----~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~gsL~~  402 (611)
                      |.||+|..    ++..||+|.+..          .+.+|+.++++++||||+++++++.+.  ...++||||++ ++|.+
T Consensus        14 g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~   92 (316)
T cd07842          14 GRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQ   92 (316)
T ss_pred             EEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHH
Confidence            89999998    468999999864          467899999999999999999999887  78999999997 47777


Q ss_pred             HhhccCC--CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC----CCcEEEeeecCccccccccCCc
Q 007261          403 WLHKKRY--PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK----NLRAKLANFSFVRSAVREESGY  476 (611)
Q Consensus       403 ~l~~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~Dfgla~~~~~~~~~~  476 (611)
                      ++.....  ...++......++.|++.||+|||   +.+++||||||+||+++.    ++.+||+|||+++.........
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  169 (316)
T cd07842          93 IIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL  169 (316)
T ss_pred             HHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccc
Confidence            7754322  235888999999999999999999   689999999999999999    9999999999987654332212


Q ss_pred             ccccccccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChh-------hHHHHHHHHHHhcCCccc-
Q 007261          477 SSTKTAVGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEE-------ILLAEAVFSMVEGGNAEA-  547 (611)
Q Consensus       477 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~-------~~l~~~~~~~~~~~~~~~-  547 (611)
                      .......++..|+|||.+.+. .++.++||||||++++||++|+.|+.......       ......+...+....... 
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  249 (316)
T cd07842         170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDW  249 (316)
T ss_pred             cccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHH
Confidence            223345678899999988664 57899999999999999999999987544321       000111111111000000 


Q ss_pred             -------cccc----ccCccCC-cCh-H------HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          548 -------KLSV----LVDPNLQ-ANK-K------EIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       548 -------~l~~----~~d~~l~-~~~-~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                             ....    ....... ... .      ..+..+.+++.+||+.||++|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         250 PDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                   0000    0000000 000 1      234568999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.98  E-value=6.2e-32  Score=277.33  Aligned_cols=228  Identities=27%  Similarity=0.480  Sum_probs=184.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  +|+.||||.+.       ..+.+|+.++++++|+|++++++.+...+..++||||+++++|.+++...  
T Consensus        34 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--  111 (292)
T cd06657          34 GIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--  111 (292)
T ss_pred             eEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC--
Confidence            89999988  68899999874       35778999999999999999999999999999999999999999988654  


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                        .+++.....++.|++.||+|||   ..+++|+||+|+||++++++.++|+|||++.......   .......++..|+
T Consensus       112 --~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~  183 (292)
T cd06657         112 --RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---PRRKSLVGTPYWM  183 (292)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc---ccccccccCcccc
Confidence              2789999999999999999999   6899999999999999999999999999876543221   1123346788999


Q ss_pred             chhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          490 APEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       490 aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      +||.+.+..++.++|+||||+++|||++|..|+......+..  .    .....         ..+.+. .....+..+.
T Consensus       184 ~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~--~----~~~~~---------~~~~~~-~~~~~~~~l~  247 (292)
T cd06657         184 APELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM--K----MIRDN---------LPPKLK-NLHKVSPSLK  247 (292)
T ss_pred             CHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H----HHHhh---------CCcccC-CcccCCHHHH
Confidence            999998888999999999999999999999998754332110  1    11100         011111 1122345678


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 007261          570 MLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +++.+||+.+|.+||++.+++++
T Consensus       248 ~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         248 GFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             HHHHHHHhCCcccCcCHHHHhcC
Confidence            89999999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.98  E-value=9.2e-32  Score=275.05  Aligned_cols=233  Identities=23%  Similarity=0.416  Sum_probs=180.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCHHHHhhc-
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK-  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~-  406 (611)
                      |.||++..  +|+.+|+|.+.        ..+.+|+.++.++. |+||+++++++..++..+++|||+. ++|.++... 
T Consensus        18 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~   96 (288)
T cd06616          18 GTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYV   96 (288)
T ss_pred             eEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHH
Confidence            89999988  67899999985        24678999999995 9999999999998999999999986 466554321 


Q ss_pred             -cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          407 -KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       407 -~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                       ......+++.....++.+++.||+|||+  ..+++||||||+||+++.++.+||+|||+++......    ......++
T Consensus        97 ~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~  170 (288)
T cd06616          97 YEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI----AKTRDAGC  170 (288)
T ss_pred             HHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC----ccccccCc
Confidence             1112458999999999999999999995  4589999999999999999999999999987543221    12234678


Q ss_pred             CCccchhhhccC---CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC-h
Q 007261          486 NGYMAPEYMEYG---LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN-K  561 (611)
Q Consensus       486 ~~y~aPE~~~~~---~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~  561 (611)
                      ..|+|||.+...   .++.++||||||+++|||++|+.||.....    ...........          ..+.+... .
T Consensus       171 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~----------~~~~~~~~~~  236 (288)
T cd06616         171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVKG----------DPPILSNSEE  236 (288)
T ss_pred             cCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcCC----------CCCcCCCcCC
Confidence            899999998776   689999999999999999999999864431    11111111110          01111111 2


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          562 KEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ...+..+.+|+.+||+.||++||++.+|+++
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         237 REFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            3356679999999999999999999999985

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.98  E-value=4e-32  Score=284.42  Aligned_cols=243  Identities=21%  Similarity=0.322  Sum_probs=181.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccC-----CeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHD-----GVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|..  +|+.||||.+.        ..+.+|+.++++++|+||+++++++...     ...++|+||++ ++|.++
T Consensus        19 g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   97 (336)
T cd07849          19 GMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKL   97 (336)
T ss_pred             eEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHH
Confidence            88999987  68899999874        2467799999999999999999987543     35899999996 588888


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      +...    .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++................
T Consensus        98 ~~~~----~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  170 (336)
T cd07849          98 IKTQ----HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV  170 (336)
T ss_pred             HhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcC
Confidence            8654    3899999999999999999999   68999999999999999999999999999876543222112223356


Q ss_pred             cCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCcc------
Q 007261          484 GTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN------  556 (611)
Q Consensus       484 gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~------  556 (611)
                      ++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+...  ....+...+..... +.+..+.+..      
T Consensus       171 ~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  247 (336)
T cd07849         171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLILGVLGTPSQ-EDLNCIISLRARNYIK  247 (336)
T ss_pred             cCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCH-HHHHHhhchhhhhHHh
Confidence            7899999998754 568999999999999999999999986543221  11111111111100 0011000000      


Q ss_pred             ------CCc---ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          557 ------LQA---NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       557 ------l~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                            ...   .....+.++.+++.+||+.||++||++.|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         248 SLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             hcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  000   011235678999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=8.9e-34  Score=315.84  Aligned_cols=241  Identities=27%  Similarity=0.407  Sum_probs=193.8

Q ss_pred             hcCCCCCccc----ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEe
Q 007261          329 ENFSPKNMID----GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE  393 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  393 (611)
                      -+...+..||    |.||-++.  +|+..|+|.++         +.+.+|+.+|..|+|||+|+++|+-.+++..+|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            3344455555    88999987  79999999886         357889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccccccc
Q 007261          394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE  473 (611)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~  473 (611)
                      ||++|+|.+.+...+.   .++.....+..|++.|+.|||   +.+||||||||.||+|+.+|.+|++|||.|.......
T Consensus      1315 yC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            9999999999987653   455555567889999999999   7999999999999999999999999999998765442


Q ss_pred             -CCcccccccccCCCccchhhhccCC---CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccc
Q 007261          474 -SGYSSTKTAVGTNGYMAPEYMEYGL---VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL  549 (611)
Q Consensus       474 -~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  549 (611)
                       .-........||+.|||||++.+..   -..+.||||+|||++||+||+.||...+.+-..+     ..+..+      
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM-----y~V~~g------ 1457 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM-----YHVAAG------ 1457 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH-----hHHhcc------
Confidence             1122345678999999999996543   4568999999999999999999998766542211     111111      


Q ss_pred             ccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       550 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                            ..+..|...+.+-.+++.+||+.||++|+++.|++++
T Consensus      1458 ------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 ------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                  1122255578888999999999999999999988875

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.98  E-value=5.8e-32  Score=276.62  Aligned_cols=247  Identities=21%  Similarity=0.267  Sum_probs=192.7

Q ss_pred             ceEEEEEE-----cCcEEEEEEecH-----------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII-----NGSTVAIKCMRR-----------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  401 (611)
                      |.||++..     +++.||||.+++           .+.+|+.++.++ +|+||+++++.+..+...++||||+++|+|.
T Consensus        14 ~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (288)
T cd05583          14 GKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELF   93 (288)
T ss_pred             ceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHH
Confidence            88999875     467899999852           356799999999 6999999999999999999999999999999


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +++....   .+++.....++.|+++||.|||   ..+++|+||+|+||+++.++.++|+|||+++.......  .....
T Consensus        94 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~  165 (288)
T cd05583          94 THLYQRE---HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE--ERAYS  165 (288)
T ss_pred             HHHhhcC---CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccccccc--ccccc
Confidence            9987642   4888999999999999999999   68999999999999999999999999999876533221  11223


Q ss_pred             cccCCCccchhhhccCC--CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc
Q 007261          482 AVGTNGYMAPEYMEYGL--VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA  559 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~--~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~  559 (611)
                      ..++..|+|||.+.+..  .+.++||||||+++|||++|..|+....... ........... .          .   ..
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~-~----------~---~~  230 (288)
T cd05583         166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILK-S----------K---PP  230 (288)
T ss_pred             ccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHc-c----------C---CC
Confidence            45788999999987665  7889999999999999999999985432211 11111111111 0          0   11


Q ss_pred             ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhhchhhhh
Q 007261          560 NKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQTLLL  608 (611)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~  608 (611)
                      .+...+..+.+++.+||+.||++|||+.++.+.|...-.....|+....
T Consensus       231 ~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~  279 (288)
T cd05583         231 FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAA  279 (288)
T ss_pred             CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhh
Confidence            1223445688999999999999999999998888877666666765543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=5.9e-32  Score=271.98  Aligned_cols=233  Identities=24%  Similarity=0.383  Sum_probs=185.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.+++|.+..          .+.+|++++++++|+||+++++.+..+...++||||+++++|.+++..
T Consensus         7 ~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   86 (265)
T cd05579           7 GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN   86 (265)
T ss_pred             eEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHH
Confidence            89999998  489999999852          467799999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC-----cccccc
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG-----YSSTKT  481 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-----~~~~~~  481 (611)
                      ..   .+++..+..++.|++.||+|||   ..+++|+||+|+||++++++.+||+|||++.........     ......
T Consensus        87 ~~---~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          87 VG---SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            53   4899999999999999999999   689999999999999999999999999998754322110     112233


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcCh
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK  561 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  561 (611)
                      ..++..|++||.+.....+.++||||||++++||++|+.|+......+.     ...... +..          ... ..
T Consensus       161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~~~~~~-~~~----------~~~-~~  223 (265)
T cd05579         161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-----FQNILN-GKI----------EWP-ED  223 (265)
T ss_pred             cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHhc-CCc----------CCC-cc
Confidence            4578899999999888899999999999999999999999865543221     111111 000          000 01


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      ...+..+.+++.+||+.+|++||++.++.+.|+
T Consensus       224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         224 VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            113567899999999999999999955555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=9e-32  Score=270.80  Aligned_cols=227  Identities=21%  Similarity=0.315  Sum_probs=178.2

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHH-HhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLL-KKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +|+.||||.+++          .+..|..++ ...+|+|++++++++..++..++|+||+++++|.+++.
T Consensus        10 ~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   89 (260)
T cd05611          10 GSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK   89 (260)
T ss_pred             eeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHH
Confidence            89999987  688999999853          123344443 34489999999999999999999999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..+..++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||+++....       .....++
T Consensus        90 ~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-------~~~~~~~  156 (260)
T cd05611          90 TLG---GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-------NKKFVGT  156 (260)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------cccCCCC
Confidence            653   3788899999999999999999   68999999999999999999999999999875422       2234578


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC-hHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN-KKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~  564 (611)
                      ..|++||.+.+..++.++||||||++++||++|..|+........     ...... ..          ...... ...+
T Consensus       157 ~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~-~~----------~~~~~~~~~~~  220 (260)
T cd05611         157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-----FDNILS-RR----------INWPEEVKEFC  220 (260)
T ss_pred             cCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHh-cc----------cCCCCcccccC
Confidence            899999999888899999999999999999999999865443221     111111 00          000111 1234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      +..+.+++.+||+.+|++||++.++.+.|.
T Consensus       221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         221 SPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             CHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            567899999999999999998765555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.98  E-value=6.9e-32  Score=279.11  Aligned_cols=232  Identities=26%  Similarity=0.393  Sum_probs=184.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|+.  ++..+|+|.+.          +++.+|++++++++|+|++++++++......++||||+. |+|.+++..
T Consensus        29 g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~  107 (308)
T cd06634          29 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV  107 (308)
T ss_pred             EEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH
Confidence            89999987  67899999874          246789999999999999999999999999999999996 688888765


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..  ..+++..+..++.|++.||.|||   ..+++||||+|+||+++.++.+||+|||++.....       .....++.
T Consensus       108 ~~--~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-------~~~~~~~~  175 (308)
T cd06634         108 HK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTP  175 (308)
T ss_pred             cC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC-------cccccCCc
Confidence            43  34789999999999999999999   68999999999999999999999999999865422       12345788


Q ss_pred             Cccchhhhc---cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          487 GYMAPEYME---YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       487 ~y~aPE~~~---~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      .|+|||.+.   .+.++.++||||||+++|||++|+.|+......+..     ........          +.  .....
T Consensus       176 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~~~----------~~--~~~~~  238 (308)
T cd06634         176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHIAQNES----------PA--LQSGH  238 (308)
T ss_pred             cccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH-----HHHhhcCC----------CC--cCccc
Confidence            999999874   456888999999999999999999998654332211     11111000          00  01223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      .+..+.+++.+||+.+|++||++.+++++..-+....
T Consensus       239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             ccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence            5567889999999999999999999998765444433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.98  E-value=2e-31  Score=269.90  Aligned_cols=226  Identities=20%  Similarity=0.246  Sum_probs=180.0

Q ss_pred             ceEEEEEE--cCcEEEEEEecHHHHH--HHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCcc
Q 007261          339 GSVFRGII--NGSTVAIKCMRRSISK--EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFV  413 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~~~~--E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l  413 (611)
                      |.||++..  +|..+|+|.+.....+  |+.....+ +|+||+++++.+...+..++||||+++++|.+++....   .+
T Consensus        30 g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l  106 (267)
T PHA03390         30 GKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KL  106 (267)
T ss_pred             eEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC---CC
Confidence            89999986  6789999998754322  34333333 79999999999999999999999999999999998753   48


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeecCccccccccCCcccccccccCCCccchh
Q 007261          414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL-RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE  492 (611)
Q Consensus       414 ~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE  492 (611)
                      ++..+..++.|++.||.|||   +.+++||||||+||+++.++ .++|+|||+++.....       ....++..|+|||
T Consensus       107 ~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~y~aPE  176 (267)
T PHA03390        107 SEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-------SCYDGTLDYFSPE  176 (267)
T ss_pred             CHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-------ccCCCCCcccChh
Confidence            99999999999999999999   68899999999999999998 9999999998754321       2245788999999


Q ss_pred             hhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHH
Q 007261          493 YMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLC  572 (611)
Q Consensus       493 ~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~  572 (611)
                      .+.+..++.++||||||++++||++|+.|+......+.....+.... .              .........+..+.+++
T Consensus       177 ~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--------------~~~~~~~~~~~~~~~li  241 (267)
T PHA03390        177 KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q--------------KKLPFIKNVSKNANDFV  241 (267)
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c--------------ccCCcccccCHHHHHHH
Confidence            99998999999999999999999999999875544332222211111 0              00011224567789999


Q ss_pred             HHhhccCCCCCCC-HHHHHHH
Q 007261          573 LACIAREPESRPS-MAEVVST  592 (611)
Q Consensus       573 ~~Cl~~dP~~RPs-~~evl~~  592 (611)
                      .+||+.+|.+||+ ++|++++
T Consensus       242 ~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        242 QSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             HHHhccChhhCCchHHHHhcC
Confidence            9999999999995 6888753

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.98  E-value=9.2e-32  Score=284.55  Aligned_cols=179  Identities=24%  Similarity=0.383  Sum_probs=153.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecH------HHHHHHHHHHhcC-C-----CceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR------SISKEVNLLKKIN-H-----FNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.|.++..  +++.||||+++.      +...|+.+|..|+ |     -|+|+++++|...++.|||+|.++ -+|.++|
T Consensus       200 GQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~NLYell  278 (586)
T KOG0667|consen  200 GQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-TNLYELL  278 (586)
T ss_pred             ceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh-hhHHHHH
Confidence            99999987  689999999983      3456999999996 4     489999999999999999999994 6999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC--CcEEEeeecCccccccccCCccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN--LRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      +.++. ..++......|+.||+.||.+||   +.+|||+||||+||||.+-  ..+||+|||.+......-      ...
T Consensus       279 K~n~f-~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v------ytY  348 (586)
T KOG0667|consen  279 KNNKF-RGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV------YTY  348 (586)
T ss_pred             HhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccccCCcc------eee
Confidence            98865 34889999999999999999999   7999999999999999654  479999999987653221      134


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCCh
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGE  528 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~  528 (611)
                      ..+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+.+..
T Consensus       349 iQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~  394 (586)
T KOG0667|consen  349 IQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY  394 (586)
T ss_pred             eeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence            5677899999999999999999999999999999997666554443

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.98  E-value=1e-31  Score=275.74  Aligned_cols=243  Identities=20%  Similarity=0.300  Sum_probs=180.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|..  +|+.||+|.++         +.+.+|++++++++|+||+++++++..+...++||||++ ++|.+++...
T Consensus        16 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   94 (294)
T PLN00009         16 GVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSS   94 (294)
T ss_pred             EEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhC
Confidence            89999987  67899999875         347789999999999999999999999999999999996 5888887654


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeecCccccccccCCcccccccccCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-NLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .. ..+++.....++.||+.||+|||   ..+++|+||+|+||+++. ++.+||+|||++.......   .......++.
T Consensus        95 ~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~  167 (294)
T PLN00009         95 PD-FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV---RTFTHEVVTL  167 (294)
T ss_pred             CC-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc---cccccCceee
Confidence            32 23678888899999999999999   689999999999999985 5679999999987543221   1123345688


Q ss_pred             CccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccc------ccc-------
Q 007261          487 GYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL------SVL-------  552 (611)
Q Consensus       487 ~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l------~~~-------  552 (611)
                      .|+|||.+.+. .++.++||||||+++|+|++|+.||......+... . ......... ....      ...       
T Consensus       168 ~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~-~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  244 (294)
T PLN00009        168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF-K-IFRILGTPN-EETWPGVTSLPDYKSAFPKW  244 (294)
T ss_pred             cccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-H-HHHHhCCCC-hhhccccccchhhhhhcccC
Confidence            99999988664 57899999999999999999999987654322111 1 111111100 0000      000       


Q ss_pred             cCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          553 VDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       553 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ............+.++.+++.+|++.+|++||++.+++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        245 PPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             CCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000000112345668899999999999999999999874

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=5.2e-32  Score=275.57  Aligned_cols=220  Identities=25%  Similarity=0.437  Sum_probs=186.4

Q ss_pred             EEcCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccCH
Q 007261          345 IINGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW  415 (611)
Q Consensus       345 ~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~  415 (611)
                      ++.|+.||||++.+         .+.+|+..|+-++|||||+||.+......+|||+|.=++|+|.+|+-++..  .+.+
T Consensus        40 VFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~--Gl~E  117 (864)
T KOG4717|consen   40 VFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEE--GLNE  117 (864)
T ss_pred             hcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhc--cccH
Confidence            45899999999963         477899999999999999999999999999999999999999999977643  3888


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee-CCCCcEEEeeecCccccccccCCcccccccccCCCccchhhh
Q 007261          416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL-DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM  494 (611)
Q Consensus       416 ~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl-~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~  494 (611)
                      ....+++.||..|+.|+|   +..+|||||||+||.+ .+-|-+||.|||++-....+    ......+|+..|-|||.+
T Consensus       118 ~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG----~kL~TsCGSLAYSAPEIL  190 (864)
T KOG4717|consen  118 DLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG----KKLTTSCGSLAYSAPEIL  190 (864)
T ss_pred             HHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCc----chhhcccchhhccCchhh
Confidence            889999999999999999   7889999999999876 55689999999998655433    244567899999999999


Q ss_pred             ccCCCC-CccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHH
Q 007261          495 EYGLVT-PEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCL  573 (611)
Q Consensus       495 ~~~~~s-~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~  573 (611)
                      .+..|. ++.|||||||+||.|++|+.||....+.+.                  +..++|-. ..-|...+.++.+|+.
T Consensus       191 LGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET------------------LTmImDCK-YtvPshvS~eCrdLI~  251 (864)
T KOG4717|consen  191 LGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET------------------LTMIMDCK-YTVPSHVSKECRDLIQ  251 (864)
T ss_pred             hcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh------------------hhhhhccc-ccCchhhhHHHHHHHH
Confidence            988776 689999999999999999999986654432                  22233322 2236778899999999


Q ss_pred             HhhccCCCCCCCHHHHHHH
Q 007261          574 ACIAREPESRPSMAEVVST  592 (611)
Q Consensus       574 ~Cl~~dP~~RPs~~evl~~  592 (611)
                      .||.+||.+|.+.+||+..
T Consensus       252 sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  252 SMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             HHHhcCchhhccHHHHhcc
Confidence            9999999999999999864

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.98  E-value=1.7e-31  Score=267.16  Aligned_cols=231  Identities=25%  Similarity=0.433  Sum_probs=188.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccC--CeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD--GVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|..  ++..|++|.++         +.+.+|+.++++++|+||+++++.+...  ...++|+||+++++|.+++.
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   93 (260)
T cd06606          14 GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK   93 (260)
T ss_pred             eEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHH
Confidence            89999998  48899999885         2477899999999999999999999888  89999999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..+..++.+++.||+|||   +.+++|+||+|+||+++.++.++|+|||.+......... .......++
T Consensus        94 ~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~  166 (260)
T cd06606          94 KFG---KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-EGTGSVRGT  166 (260)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc-ccccCCCCC
Confidence            754   5899999999999999999999   689999999999999999999999999998766443211 112345688


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      ..|++||.+.....+.++||||||+++++|++|+.|+.........    ......            .......+...+
T Consensus       167 ~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~------------~~~~~~~~~~~~  230 (260)
T cd06606         167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA----LYKIGS------------SGEPPEIPEHLS  230 (260)
T ss_pred             ccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH----HHhccc------------cCCCcCCCcccC
Confidence            8999999999888999999999999999999999998765421111    111100            001111233446


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+.+++.+|++.||++||++.|++.+
T Consensus       231 ~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         231 EEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             HHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.98  E-value=2e-31  Score=271.30  Aligned_cols=241  Identities=22%  Similarity=0.324  Sum_probs=180.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecH--------HHHHHHHHHHhcC-CCceeeccceeccC--CeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR--------SISKEVNLLKKIN-HFNLINLFGACEHD--GVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|..  ++..||+|.++.        ...+|+.++.++. |+|++++++++.+.  +..++||||++ |+|.+++.
T Consensus        13 ~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~   91 (282)
T cd07831          13 SEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIK   91 (282)
T ss_pred             ceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHH
Confidence            89999987  688999999863        2346888999984 99999999999877  88999999996 68888887


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...  ..++|..++.++.|++.||+|||   ..+++||||+|+||+++. +.+||+|||+++......    ......++
T Consensus        92 ~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~----~~~~~~~~  161 (282)
T cd07831          92 GRK--RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP----PYTEYIST  161 (282)
T ss_pred             hcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC----CcCCCCCC
Confidence            643  35899999999999999999999   689999999999999999 999999999987653221    11224578


Q ss_pred             CCccchhhhc-cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc-------ccccccccCcc-
Q 007261          486 NGYMAPEYME-YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA-------EAKLSVLVDPN-  556 (611)
Q Consensus       486 ~~y~aPE~~~-~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-------~~~l~~~~d~~-  556 (611)
                      ..|+|||.+. ++.++.++|||||||++|||++|..||...+..+.  .............       .........+. 
T Consensus       162 ~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
T cd07831         162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ--IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSK  239 (282)
T ss_pred             cccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH--HHHHHHHcCCCCHHHHHhhcccccccccCccc
Confidence            8999999764 45678999999999999999999998866543221  1111111110000       00000000000 


Q ss_pred             ----CCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          557 ----LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       557 ----l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                          +.......+..+.+++.+||+.+|++||++.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         240 KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence                001112456889999999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=1.7e-31  Score=274.84  Aligned_cols=243  Identities=26%  Similarity=0.370  Sum_probs=181.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCC----------eEEEEEeecCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDG----------VFYLVYEFMEN  397 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~----------~~~lV~E~~~~  397 (611)
                      |.||+|..  +|+.||+|.++         ..+.+|+.++++++||||+++++++.+..          ..++|+||+++
T Consensus        21 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~  100 (302)
T cd07864          21 GQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH  100 (302)
T ss_pred             EEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc
Confidence            89999998  68899999985         24678999999999999999999987654          78999999975


Q ss_pred             CCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcc
Q 007261          398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS  477 (611)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  477 (611)
                       +|.+.+....  ..+++..++.++.|++.||+|||   ..+++|+||||+||++++++.+||+|||++........  .
T Consensus       101 -~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~--~  172 (302)
T cd07864         101 -DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES--R  172 (302)
T ss_pred             -cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcc--c
Confidence             7777776542  34899999999999999999999   68999999999999999999999999999876533221  1


Q ss_pred             cccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccc----
Q 007261          478 STKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVL----  552 (611)
Q Consensus       478 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~----  552 (611)
                      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+......+  ....+........ ......+    
T Consensus       173 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~  249 (302)
T cd07864         173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLELISRLCGSPC-PAVWPDVIKLP  249 (302)
T ss_pred             ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCC-hhhcccccccc
Confidence            1122345778999998864 457899999999999999999998886543221  1112222211111 0000000    


Q ss_pred             ----cCc------cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          553 ----VDP------NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       553 ----~d~------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                          .++      .........+..+.+++.+||+.||.+||++.+++.+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         250 YFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             cccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                000      0011112245778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.98  E-value=1.5e-31  Score=276.62  Aligned_cols=243  Identities=24%  Similarity=0.311  Sum_probs=181.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccC--CeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHD--GVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|..  +|+.||+|.++.         .+.+|+.++++++|+||+++++++.+.  +..++||||++ ++|.+++.
T Consensus        21 ~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~   99 (309)
T cd07845          21 GIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLD   99 (309)
T ss_pred             EEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHH
Confidence            89999998  689999999852         356799999999999999999998654  56899999996 58999887


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...  ..+++..+..++.|++.||+|||   ..+++||||||+||++++++.+||+|||++.......   .......++
T Consensus       100 ~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~  171 (309)
T cd07845         100 NMP--TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA---KPMTPKVVT  171 (309)
T ss_pred             hcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc---CCCCccccc
Confidence            643  45899999999999999999999   6899999999999999999999999999987654321   112233457


Q ss_pred             CCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc--cccc------cc-cCc
Q 007261          486 NGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE--AKLS------VL-VDP  555 (611)
Q Consensus       486 ~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--~~l~------~~-~d~  555 (611)
                      ..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.  ...+..........  ..+.      .. ...
T Consensus       172 ~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (309)
T cd07845         172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ--LDLIIQLLGTPNESIWPGFSDLPLVGKFTLPK  249 (309)
T ss_pred             ccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCChhhchhhhcccccccccccC
Confidence            88999999865 4578999999999999999999999875543221  11111111100000  0000      00 000


Q ss_pred             c-CC---cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          556 N-LQ---ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       556 ~-l~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      . ..   ......+..+.+++.+||+.||++||++.|++.+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         250 QPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             CCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0 00   0011235678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.98  E-value=2.7e-31  Score=270.36  Aligned_cols=242  Identities=23%  Similarity=0.350  Sum_probs=186.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.+++|.++         ..+.+|+.++++++|+||+++++++..++..++|+||+++ +|.+++...
T Consensus        13 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~   91 (283)
T cd05118          13 GVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDR   91 (283)
T ss_pred             ceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhh
Confidence            88999987  68899999875         2467899999999999999999999999999999999974 898888764


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .  ..+++..+..++.|++.||.|||   ..+++|+||||+||++++++.+||+|||.+.......   .......++..
T Consensus        92 ~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~  163 (283)
T cd05118          92 Q--RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV---RPYTHYVVTRW  163 (283)
T ss_pred             c--ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---ccccCccCccc
Confidence            3  34899999999999999999999   6899999999999999999999999999987654332   11223457788


Q ss_pred             ccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccccc-------------
Q 007261          488 YMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV-------------  553 (611)
Q Consensus       488 y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~-------------  553 (611)
                      |+|||.+.+. .++.++|+||||+++|+|++|+.||......+..  ......+.... ......+.             
T Consensus       164 ~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05118         164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL--FKIFRTLGTPD-PEVWPKFTSLARNYKFSFPKK  240 (283)
T ss_pred             ccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHcCCCc-hHhcccchhhhhhhhhhhccc
Confidence            9999998776 7899999999999999999999888655432211  11111111100 00000000             


Q ss_pred             -CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          554 -DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       554 -d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                       +..........+.++.+++.+||+.||.+||++.+++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence             001111133467889999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=3.1e-31  Score=270.16  Aligned_cols=243  Identities=24%  Similarity=0.361  Sum_probs=182.8

Q ss_pred             ceEEEEEE--cCcEEEEEEecH--------HHHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR--------SISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|..  +++.|+||++..        ...+|+..+++++ |+|++++++++..++..++||||+ +|+|.+++...
T Consensus        13 g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~   91 (283)
T cd07830          13 GSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDR   91 (283)
T ss_pred             eEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhc
Confidence            89999998  578999999863        2356899999998 999999999999999999999999 88999998775


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      . ...+++..++.++.|++.+|.|||   ..+++|+||+|+||++++++.++|+|||++.......    ......++..
T Consensus        92 ~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~  163 (283)
T cd07830          92 K-GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP----PYTDYVSTRW  163 (283)
T ss_pred             c-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC----CcCCCCCccc
Confidence            3 235899999999999999999999   6899999999999999999999999999987543221    1123457889


Q ss_pred             ccchhhhc-cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc---------ccccccccCcc-
Q 007261          488 YMAPEYME-YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA---------EAKLSVLVDPN-  556 (611)
Q Consensus       488 y~aPE~~~-~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~---------~~~l~~~~d~~-  556 (611)
                      |+|||.+. ...++.++|+||||+++|||++|+.|+......+..  ......+.....         .......+... 
T Consensus       164 ~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T cd07830         164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL--YKICSVLGTPTKQDWPEGYKLASKLGFRFPQFA  241 (283)
T ss_pred             ccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHH--HHHHHhcCCCChhhhhhHhhhhccccccccccc
Confidence            99999874 456899999999999999999999888655432211  011111100000         00000000000 


Q ss_pred             ---CCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          557 ---LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       557 ---l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                         +..........+.+++.+||+.||++||++.|++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         242 PTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence               000011124678999999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=1.7e-31  Score=267.37  Aligned_cols=230  Identities=26%  Similarity=0.393  Sum_probs=188.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  ++..+++|++.         +.+.+|++++++++|+|++++++.+..++..++|+||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   93 (258)
T cd08215          14 GKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQ   93 (258)
T ss_pred             eEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHh
Confidence            89999998  48899999985         24778999999999999999999999999999999999999999999874


Q ss_pred             C-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          408 R-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       408 ~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      . ....+++..+..++.+++.||.|||   ..+++|+||+|+||++++++.++|+|||++.......   .......+++
T Consensus        94 ~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  167 (258)
T cd08215          94 KKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV---DLAKTVVGTP  167 (258)
T ss_pred             hccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc---ceecceeeee
Confidence            2 1245899999999999999999999   6799999999999999999999999999987653322   1223346788


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+....++.++|+||||+++++|++|+.|+......+     .......             ......+...+.
T Consensus       168 ~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~-------------~~~~~~~~~~~~  229 (258)
T cd08215         168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-----LALKILK-------------GQYPPIPSQYSS  229 (258)
T ss_pred             cccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-----HHHHHhc-------------CCCCCCCCCCCH
Confidence            9999999998889999999999999999999999986543221     1111111             001111224456


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+.+++.+||..+|++||++.|++++
T Consensus       230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         230 ELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            78999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=2.3e-31  Score=271.09  Aligned_cols=227  Identities=21%  Similarity=0.308  Sum_probs=177.8

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHH---HHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNL---LKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++..  +|+.||+|.+.+          .+..|..+   ++..+||||+++++++...+..++||||+++|+|.++
T Consensus         8 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~   87 (278)
T cd05606           8 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH   87 (278)
T ss_pred             eEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHH
Confidence            89999987  678999998752          13334333   3445799999999999999999999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      +...   ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||++......     ......
T Consensus        88 l~~~---~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~  156 (278)
T cd05606          88 LSQH---GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASV  156 (278)
T ss_pred             HHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-----CCcCcC
Confidence            8754   34899999999999999999999   689999999999999999999999999998754321     122346


Q ss_pred             cCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          484 GTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       484 gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      |+..|+|||.+.++ .++.++||||||+++|||++|+.||..........   ......          ..++.+   +.
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~----------~~~~~~---~~  220 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTL----------TMAVEL---PD  220 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH---HHHHhh----------ccCCCC---CC
Confidence            88999999998754 68999999999999999999999987653321110   000000          001111   22


Q ss_pred             HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      ..+..+.+++.+|+..+|.+||     ++.+++++
T Consensus       221 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         221 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            3456789999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.6e-31  Score=265.66  Aligned_cols=226  Identities=30%  Similarity=0.515  Sum_probs=185.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.+|++..  +++.+++|.+.         ..+.+|++++++++|+|++++++++.+++..++||||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~   93 (254)
T cd06627          14 GVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF   93 (254)
T ss_pred             eEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc
Confidence            89999987  67899999985         24778999999999999999999999999999999999999999999765


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                         ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++........   ......++..
T Consensus        94 ---~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~  164 (254)
T cd06627          94 ---GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK---DDASVVGTPY  164 (254)
T ss_pred             ---cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc---cccccccchh
Confidence               34899999999999999999999   68999999999999999999999999999876543321   1233467889


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHH
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH  567 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  567 (611)
                      |+|||.+.+..++.++||||||+++|+|++|+.|+..........     ......             ....+...+..
T Consensus       165 y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~-----~~~~~~-------------~~~~~~~~~~~  226 (254)
T cd06627         165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF-----RIVQDD-------------HPPLPEGISPE  226 (254)
T ss_pred             hcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHH-----HHhccC-------------CCCCCCCCCHH
Confidence            999999988888999999999999999999999986544221111     111100             01112234567


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      +.+++.+||..+|++||++.+++.
T Consensus       227 ~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         227 LKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HHHHHHHHHhCChhhCcCHHHHhc
Confidence            889999999999999999999885

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-32  Score=259.87  Aligned_cols=236  Identities=21%  Similarity=0.307  Sum_probs=189.9

Q ss_pred             cceEEEEEE--cCcEEEEEEec--HHHHHHHHHHHhc-CCCceeeccceecc----CCeEEEEEeecCCCCHHHHhhccC
Q 007261          338 DGSVFRGII--NGSTVAIKCMR--RSISKEVNLLKKI-NHFNLINLFGACEH----DGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       338 gg~Vy~g~~--~g~~vavK~~~--~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      .|.|-....  .|+.+|+|++.  ....+|+++.-.. .|||||++++++..    ...+.+|||.|+||.|.+.+.+.+
T Consensus        75 nGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g  154 (400)
T KOG0604|consen   75 NGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRG  154 (400)
T ss_pred             CCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcc
Confidence            388887765  78999999997  4678899887666 69999999998854    456789999999999999998875


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeecCccccccccCCcccccccccC
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK---NLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                       ...+++.+.-.|+.||+.|+.|||   ..+|.||||||+|+|...   |-.+||+|||+|+.....    ......+.|
T Consensus       155 -~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~----~~L~TPc~T  226 (400)
T KOG0604|consen  155 -DQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP----GDLMTPCFT  226 (400)
T ss_pred             -cccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCCC----ccccCCccc
Confidence             356899999999999999999999   689999999999999964   457999999999875432    244567889


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|.|||++...+|+...|+||+||++|-|++|.+||+...+..+..  -.......+.         -....++.+..+
T Consensus       227 PyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp--gMk~rI~~gq---------y~FP~pEWs~VS  295 (400)
T KOG0604|consen  227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKRRIRTGQ---------YEFPEPEWSCVS  295 (400)
T ss_pred             ccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh--hHHhHhhccC---------ccCCChhHhHHH
Confidence            99999999999999999999999999999999999999876532110  0000000000         011122356778


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +...++++.+|..+|.+|.++.+++.+
T Consensus       296 e~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  296 EAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             HHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            889999999999999999999999875

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=1.9e-31  Score=274.11  Aligned_cols=231  Identities=23%  Similarity=0.413  Sum_probs=178.4

Q ss_pred             ceEEEEEEc--CcEEEEEEecH--------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGIIN--GSTVAIKCMRR--------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|.++  |+.||||.++.        .+.+|+.++.+. .|+||++++++|.++...++||||++ ++|.+++...
T Consensus        29 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~  107 (296)
T cd06618          29 GQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRI  107 (296)
T ss_pred             eEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHh
Confidence            899999995  89999999862        345677777776 59999999999999999999999985 5787777653


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .  ..+++..+..++.|++.||+|||+  ..+++||||+|+||++++++.+||+|||++.......    ......++..
T Consensus       108 ~--~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~----~~~~~~~~~~  179 (296)
T cd06618         108 Q--GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK----AKTRSAGCAA  179 (296)
T ss_pred             c--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC----cccCCCCCcc
Confidence            3  358999999999999999999994  3589999999999999999999999999986543221    1123357789


Q ss_pred             ccchhhhccCC----CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          488 YMAPEYMEYGL----VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       488 y~aPE~~~~~~----~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      |+|||.+....    ++.++||||||+++|||++|+.|+.......    +..........          +.. .....
T Consensus       180 y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~----------~~~-~~~~~  244 (296)
T cd06618         180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF----EVLTKILQEEP----------PSL-PPNEG  244 (296)
T ss_pred             ccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH----HHHHHHhcCCC----------CCC-CCCCC
Confidence            99999987553    7889999999999999999999986432211    11111111110          000 00112


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      .+.++.+++.+||+.||++||++.+++++-
T Consensus       245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            456789999999999999999999998765

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=2.1e-31  Score=264.86  Aligned_cols=214  Identities=22%  Similarity=0.233  Sum_probs=173.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH--HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccC
Q 007261          339 GSVFRGII--NGSTVAIKCMRR--SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVS  414 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~--~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~  414 (611)
                      |.||++..  +|+.+|+|.++.  .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++....   .++
T Consensus         7 ~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~   83 (237)
T cd05576           7 DKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL---NIP   83 (237)
T ss_pred             ceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc---CCC
Confidence            88999987  788999999975  35666666666789999999999999999999999999999999997653   389


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhhh
Q 007261          415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM  494 (611)
Q Consensus       415 ~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~  494 (611)
                      +.....++.|++.||+|||   +.+++||||||+||+++.++.++++|||++......      .....++..|+|||.+
T Consensus        84 ~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~y~aPE~~  154 (237)
T cd05576          84 EECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDGEAVENMYCAPEVG  154 (237)
T ss_pred             HHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc------cccCCcCccccCCccc
Confidence            9999999999999999999   689999999999999999999999999987654321      1223456789999999


Q ss_pred             ccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHH
Q 007261          495 EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLA  574 (611)
Q Consensus       495 ~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~  574 (611)
                      ....++.++||||+|++++||++|+.++.......                ..    ...   ...+...+..+.+++.+
T Consensus       155 ~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------~~----~~~---~~~~~~~~~~~~~li~~  211 (237)
T cd05576         155 GISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------NT----HTT---LNIPEWVSEEARSLLQQ  211 (237)
T ss_pred             CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------cc----ccc---cCCcccCCHHHHHHHHH
Confidence            88889999999999999999999997754321100                00    000   01122345678999999


Q ss_pred             hhccCCCCCCCHH
Q 007261          575 CIAREPESRPSMA  587 (611)
Q Consensus       575 Cl~~dP~~RPs~~  587 (611)
                      ||+.||++||++.
T Consensus       212 ~l~~dp~~R~~~~  224 (237)
T cd05576         212 LLQFNPTERLGAG  224 (237)
T ss_pred             HccCCHHHhcCCC
Confidence            9999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=3.3e-31  Score=270.14  Aligned_cols=244  Identities=27%  Similarity=0.395  Sum_probs=184.0

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccC--CeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHD--GVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|..  +|+.+|+|.++.         ++.+|+.++++++|+|++++++++...  +..++|+||++ ++|.+++.
T Consensus        13 ~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   91 (287)
T cd07840          13 GQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLD   91 (287)
T ss_pred             eEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHh
Confidence            89999998  578999999963         467899999999999999999999887  88999999997 58999887


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...  ..+++..++.++.|++.||+|||   ..+++|+||+|+||++++++.+||+|||++........  .......++
T Consensus        92 ~~~--~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~  164 (287)
T cd07840          92 SPE--VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS--ADYTNRVIT  164 (287)
T ss_pred             ccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--ccccccccc
Confidence            653  34899999999999999999999   68999999999999999999999999999876543321  112234567


Q ss_pred             CCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc--ccccc-----c----
Q 007261          486 NGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA--KLSVL-----V----  553 (611)
Q Consensus       486 ~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~--~l~~~-----~----  553 (611)
                      ..|+|||.+.+ ..++.++||||||+++|||++|+.|+........  ...+...........  .....     .    
T Consensus       165 ~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (287)
T cd07840         165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ--LEKIFELCGSPTDENWPGVSKLPWFENLKPKK  242 (287)
T ss_pred             cccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCchhhccccccchhhhhccccc
Confidence            88999997764 4578999999999999999999999876543221  111111111110000  00000     0    


Q ss_pred             --CccCCcChHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          554 --DPNLQANKKE-IAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       554 --d~~l~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        ...+...... ++..+.+++.+||+.+|.+||++.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         243 PYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             cchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              0000011111 26778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=5.6e-31  Score=268.61  Aligned_cols=243  Identities=23%  Similarity=0.341  Sum_probs=183.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhc---CCCceeeccceeccCCe-----EEEEEeecCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKI---NHFNLINLFGACEHDGV-----FYLVYEFMENGS  399 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~-----~~lV~E~~~~gs  399 (611)
                      |.||+|..  +|+.+|+|+++         ..+.+|+.+++++   +|+|++++++++...+.     .+++|||++ ++
T Consensus        13 ~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~   91 (287)
T cd07838          13 GTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QD   91 (287)
T ss_pred             eEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cC
Confidence            89999998  48899999986         2356788887776   59999999999987766     999999997 58


Q ss_pred             HHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccc
Q 007261          400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       400 L~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      |.+++..... ..+++..++.++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||++.......    ..
T Consensus        92 l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~----~~  163 (287)
T cd07838          92 LATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM----AL  163 (287)
T ss_pred             HHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcceeccCCc----cc
Confidence            9999876432 34899999999999999999999   6899999999999999999999999999987653321    11


Q ss_pred             cccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc----------cc
Q 007261          480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA----------KL  549 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~----------~l  549 (611)
                      ....++..|+|||.+.+..++.++|+||||+++|||++|..|+......+ .+.. +...........          ..
T Consensus       164 ~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  241 (287)
T cd07838         164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDK-IFDVIGLPSEEEWPRNVSLPRSSF  241 (287)
T ss_pred             ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHH-HHHHcCCCChHhcCCCcccchhhc
Confidence            22346888999999999999999999999999999999988876544322 1111 111111000000          00


Q ss_pred             ccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       550 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..................+.+++.+||+.||++||++.|++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         242 PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            0000111111123456778899999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=3e-31  Score=277.90  Aligned_cols=244  Identities=24%  Similarity=0.351  Sum_probs=181.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhc-CCCceeeccceeccC--CeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKI-NHFNLINLFGACEHD--GVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|..  +|+.+|+|++.         ..+.+|+.+++++ +|+||++++++|...  ...++||||++ ++|..++
T Consensus        21 ~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~   99 (337)
T cd07852          21 GIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVI   99 (337)
T ss_pred             eeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHH
Confidence            89999987  57899999873         2366799999999 999999999988643  46899999997 5999998


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC--ccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG--YSSTKTA  482 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~--~~~~~~~  482 (611)
                      ...    .++|..+..++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||+++........  .......
T Consensus       100 ~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~  172 (337)
T cd07852         100 RAN----ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY  172 (337)
T ss_pred             hcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcc
Confidence            764    3889999999999999999999   689999999999999999999999999998765433211  1122334


Q ss_pred             ccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhc-----------CCcccccc
Q 007261          483 VGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEG-----------GNAEAKLS  550 (611)
Q Consensus       483 ~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~-----------~~~~~~l~  550 (611)
                      .++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. . .........           ......+.
T Consensus       173 ~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (337)
T cd07852         173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-L-EKIIEVIGPPSAEDIESIKSPFAATMLD  250 (337)
T ss_pred             cccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-H-HHHHHHhCCCCHHHHHHHHhhhHHHhhh
Confidence            67889999998754 5678999999999999999999999865433221 1 111000000           00000000


Q ss_pred             cccCcc---CCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          551 VLVDPN---LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       551 ~~~d~~---l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ......   ........+.++.+++.+||+.||++|||+.+++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         251 SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000000   011112246788999999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-32  Score=282.13  Aligned_cols=230  Identities=19%  Similarity=0.363  Sum_probs=187.6

Q ss_pred             ceEEEEEEc--CcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGIIN--GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~~--g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+++..  +-..|-|++.       .+|.-|++||...+||+||+|++.|..++.+|+..|||.||-.+..+-... 
T Consensus        46 GKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~-  124 (1187)
T KOG0579|consen   46 GKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELG-  124 (1187)
T ss_pred             hhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhc-
Confidence            999999873  4456777774       478889999999999999999999999999999999999999998887654 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                       ..|+..++.-++.|++.||.|||   +.+|||||||+.|||++-+|.++|+|||.+....   ..........||+.||
T Consensus       125 -r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~---~t~qkRDsFIGTPYWM  197 (1187)
T KOG0579|consen  125 -RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK---STRQKRDSFIGTPYWM  197 (1187)
T ss_pred             -cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch---hHHhhhccccCCcccc
Confidence             44899999999999999999999   6899999999999999999999999999864322   1123345678999999


Q ss_pred             chhhh-----ccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          490 APEYM-----EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       490 aPE~~-----~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      |||+.     ...+|+.++||||||++|.||.-+.+|-..-.....     +.....           -+|.....|...
T Consensus       198 APEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV-----llKiaK-----------SePPTLlqPS~W  261 (1187)
T KOG0579|consen  198 APEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAK-----------SEPPTLLQPSHW  261 (1187)
T ss_pred             cchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH-----HHHHhh-----------cCCCcccCcchh
Confidence            99976     467899999999999999999999887554332221     111111           122223346677


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +..+.+++.+||..||..||++.+++++
T Consensus       262 s~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  262 SRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             hhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            7889999999999999999999999975

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=5.2e-31  Score=277.91  Aligned_cols=239  Identities=23%  Similarity=0.292  Sum_probs=181.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccC------CeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD------GVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~E~~~~gsL~  401 (611)
                      |.||++..  +|+.||||.+.         ..+.+|+.++++++|+||+++++++...      ...++||||+. ++|.
T Consensus        30 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  108 (353)
T cd07850          30 GIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLC  108 (353)
T ss_pred             EEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHH
Confidence            89999987  78899999985         2466799999999999999999988543      35799999995 5888


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +.+...     +++..+..++.|++.||+|||   ..+++||||||+||+++.++.+||+|||+++......    ....
T Consensus       109 ~~~~~~-----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~----~~~~  176 (353)
T cd07850         109 QVIQMD-----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTP  176 (353)
T ss_pred             HHHhhc-----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC----CCCC
Confidence            888643     788889999999999999999   6899999999999999999999999999987653221    1233


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcC------------------
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGG------------------  543 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~------------------  543 (611)
                      ..++..|+|||.+.+..++.++||||||+++++|++|+.||...+..+.  ...+...+...                  
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (353)
T cd07850         177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ--WNKIIEQLGTPSDEFMSRLQPTVRNYVEN  254 (353)
T ss_pred             CcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHHhhhhhhHHhhc
Confidence            4678899999999999999999999999999999999999875543211  11111100000                  


Q ss_pred             -Cc--ccccccccCccCC----cC-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          544 -NA--EAKLSVLVDPNLQ----AN-KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       544 -~~--~~~l~~~~d~~l~----~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                       ..  ...+.........    .. ....+..+.+++.+||+.||++||++.|++.+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         255 RPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             00  0001111111110    01 22346678899999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=4.4e-31  Score=272.57  Aligned_cols=245  Identities=22%  Similarity=0.306  Sum_probs=178.5

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccCC--------eEEEEEeecCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHDG--------VFYLVYEFMENGS  399 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~--------~~~lV~E~~~~gs  399 (611)
                      |.||++..  +|+.||||.+..         .+.+|+.++++++||||++++++|...+        ..++||||+. ++
T Consensus        26 ~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~  104 (310)
T cd07865          26 GEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HD  104 (310)
T ss_pred             EEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cC
Confidence            89999987  688999998842         3567999999999999999999886543        4599999996 58


Q ss_pred             HHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc-cc
Q 007261          400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY-SS  478 (611)
Q Consensus       400 L~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~  478 (611)
                      |.+++....  ..+++...+.++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||++.......... ..
T Consensus       105 l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  179 (310)
T cd07865         105 LAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR  179 (310)
T ss_pred             HHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCC
Confidence            888887643  34899999999999999999999   6899999999999999999999999999987654322111 11


Q ss_pred             ccccccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccc------
Q 007261          479 TKTAVGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV------  551 (611)
Q Consensus       479 ~~~~~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~------  551 (611)
                      .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+.......  ....+...... ........      
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~  256 (310)
T cd07865         180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--QLTLISQLCGS-ITPEVWPGVDKLEL  256 (310)
T ss_pred             ccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCC-CChhhcccccchhh
Confidence            2234578889999988664 47889999999999999999998886544321  11111111110 00000000      


Q ss_pred             ---ccCcc-CCcC------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          552 ---LVDPN-LQAN------KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       552 ---~~d~~-l~~~------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                         ...+. ....      .......+.+++.+||+.||++||++.|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         257 FKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence               00000 0000      00123456789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=4e-31  Score=270.71  Aligned_cols=231  Identities=23%  Similarity=0.318  Sum_probs=180.2

Q ss_pred             ceEEEEEE-----cCcEEEEEEecH-----------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII-----NGSTVAIKCMRR-----------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  401 (611)
                      |.||.+..     +|..||+|+++.           .+.+|+.++.++ +|+||+++++++..+...++||||+++++|.
T Consensus        14 g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (290)
T cd05613          14 GKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELF   93 (290)
T ss_pred             ceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHH
Confidence            88999876     678999999852           356799999999 6999999999999999999999999999999


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +++....   .+++.....++.|++.||.|||   +.+++||||+|+|||+++++.+||+|||+++.......  .....
T Consensus        94 ~~l~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~  165 (290)
T cd05613          94 THLSQRE---RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV--ERAYS  165 (290)
T ss_pred             HHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc--ccccc
Confidence            9997653   3788888899999999999999   68999999999999999999999999999876432211  12233


Q ss_pred             cccCCCccchhhhccC--CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc
Q 007261          482 AVGTNGYMAPEYMEYG--LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA  559 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~--~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~  559 (611)
                      ..++..|+|||.+...  .++.++||||||+++|||++|+.|+....... ............           .   ..
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~-----------~---~~  230 (290)
T cd05613         166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISRRILKS-----------E---PP  230 (290)
T ss_pred             ccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHHHhhcc-----------C---CC
Confidence            5678899999998653  46789999999999999999999986432211 111111111110           0   01


Q ss_pred             ChHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          560 NKKEIAHHLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      .+......+.+++.+||+.||++||     ++.+++.+
T Consensus       231 ~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         231 YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            1223456788999999999999997     67777664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=282.85  Aligned_cols=259  Identities=25%  Similarity=0.363  Sum_probs=197.9

Q ss_pred             HHHHHhhcCCCCCcccceEEEEEE--cCcEEEEEEecH--------HHHHHHHHHHhcCCCceeeccceeccCC------
Q 007261          323 DLVVATENFSPKNMIDGSVFRGII--NGSTVAIKCMRR--------SISKEVNLLKKINHFNLINLFGACEHDG------  386 (611)
Q Consensus       323 el~~at~~f~~~~~igg~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~------  386 (611)
                      +-..+++.|       |.||+|+.  .|+.||||.+++        ...+|+++|++++|+|||++++.-++..      
T Consensus        18 ~e~LG~Ga~-------g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   18 DERLGKGAF-------GNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             hhhhcCCcc-------ceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            334566666       99999986  899999999863        4678999999999999999999876543      


Q ss_pred             eEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC--C--CCcEEEee
Q 007261          387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD--K--NLRAKLAN  462 (611)
Q Consensus       387 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~--~--~~~~kl~D  462 (611)
                      ...+|||||.+|||...|.+..+...|+..+.+.+..+++.||.|||   +++|+||||||.||++-  +  .-.-||+|
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtD  167 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTD  167 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeec
Confidence            57899999999999999998666566999999999999999999999   79999999999999982  3  33579999


Q ss_pred             ecCccccccccCCcccccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHh
Q 007261          463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVE  541 (611)
Q Consensus       463 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  541 (611)
                      ||.|+....+.    .....+||..|++||.... ..|+...|.|||||++||++||..||-...+... ..+..+....
T Consensus       168 fG~Arel~d~s----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~-~~~~~~~~~t  242 (732)
T KOG4250|consen  168 FGAARELDDNS----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN-NKEIMWHIIT  242 (732)
T ss_pred             ccccccCCCCC----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc-cchhhhhhhc
Confidence            99999875443    5567899999999999984 8899999999999999999999999976544321 1111111111


Q ss_pred             cCCcccc-------------cccccCccCCcChHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHhchh
Q 007261          542 GGNAEAK-------------LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRP--SMAEVVSTLMKIQL  598 (611)
Q Consensus       542 ~~~~~~~-------------l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP--s~~evl~~L~~i~~  598 (611)
                      + .+...             ....+. ............+-.++..++..+|.+|.  .+.+....+..|..
T Consensus       243 k-kp~~v~i~~~~~eNgpv~~s~~lP-~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  243 K-KPSGVAIGAQEEENGPVEWSSTLP-QPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             c-CCCceeEeeecccCCceeeeccCC-CcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            1 11100             000000 01111345556677788888899999999  77777777776543

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=3.8e-31  Score=276.83  Aligned_cols=245  Identities=18%  Similarity=0.306  Sum_probs=182.1

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceecc----CCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEH----DGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++..  +|..||+|++..         .+.+|+.++++++||||+++++++..    ....++||||+. ++|.++
T Consensus        19 g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   97 (334)
T cd07855          19 GVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHI   97 (334)
T ss_pred             eEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHH
Confidence            78999987  688999998752         46679999999999999999998753    356899999995 689999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC-ccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG-YSSTKTA  482 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~  482 (611)
                      +....   .+++.....++.||+.||.|||   ..+++||||||+||++++++.+||+|||++......... .......
T Consensus        98 ~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  171 (334)
T cd07855          98 IHSDQ---PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY  171 (334)
T ss_pred             hccCC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccc
Confidence            87543   3899999999999999999999   689999999999999999999999999998765332211 1111234


Q ss_pred             ccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc-------ccccccccC
Q 007261          483 VGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA-------EAKLSVLVD  554 (611)
Q Consensus       483 ~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-------~~~l~~~~d  554 (611)
                      .++..|+|||.+.. ..++.++||||||+++|||++|+.||.........  ..+.........       ...+....+
T Consensus       172 ~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~--~~~~~~~g~~~~~~~~~~~~~~~~~~~~  249 (334)
T cd07855         172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL--KLILSVLGSPSEEVLNRIGSDRVRKYIQ  249 (334)
T ss_pred             cccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH--HHHHHHhCCChhHhhhhhchhhHHHHHh
Confidence            67889999998865 56899999999999999999999998665432211  111111100000       000000000


Q ss_pred             ---cc----CCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 ---PN----LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 ---~~----l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                         ..    +.......+..+.+++.+||+.+|++||++.+++.+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         250 NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               00    000012346789999999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=4.1e-31  Score=266.02  Aligned_cols=229  Identities=22%  Similarity=0.327  Sum_probs=180.4

Q ss_pred             ceEEEEEEc--CcEEEEEEecH------------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGIIN--GSTVAIKCMRR------------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~~--g~~vavK~~~~------------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||++...  +..+++|.++.            ++..|+.++++++||||+++++++.+....++||||+++++|.+++
T Consensus        14 g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~   93 (260)
T cd08222          14 GTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKL   93 (260)
T ss_pred             ceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHH
Confidence            899999873  44555665531            3567899999999999999999999999999999999999999998


Q ss_pred             hccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc
Q 007261          405 HKKR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       405 ~~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      .... ....+++..++.++.|++.||.|||   +.+++|+||+|+||++++ +.+||+|||+++......   .......
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~---~~~~~~~  166 (260)
T cd08222          94 EELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC---DLATTFT  166 (260)
T ss_pred             HHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCCCc---ccccCCC
Confidence            7532 2346899999999999999999999   689999999999999975 569999999987653221   1222345


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..|+.......     .......             ......+..
T Consensus       167 ~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~~~~~~-------------~~~~~~~~~  228 (260)
T cd08222         167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS-----VVLRIVE-------------GPTPSLPET  228 (260)
T ss_pred             CCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHHc-------------CCCCCCcch
Confidence            7889999999988889999999999999999999999985432211     1111111             111112345


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+.++.+++.+||+.+|++||++.|++++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         229 YSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             hcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            56788999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.9e-31  Score=277.00  Aligned_cols=251  Identities=24%  Similarity=0.329  Sum_probs=189.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCC-----eEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDG-----VFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E~~~~gsL~~  402 (611)
                      |.||++..  +|+.||||++.         +.+.+|+.+++.++|+||+++++++....     ..++||||++ ++|.+
T Consensus        14 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~   92 (330)
T cd07834          14 GVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHK   92 (330)
T ss_pred             eEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHH
Confidence            89999997  57899999875         35778999999999999999999997765     7899999997 58999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++....   .+++..++.++.+++.||+|||   ..+++|+||||.|||++.++.++|+|||++................
T Consensus        93 ~l~~~~---~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~  166 (330)
T cd07834          93 VIKSPQ---PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY  166 (330)
T ss_pred             HHhCCC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccccccccc
Confidence            987653   5899999999999999999999   6899999999999999999999999999987654332111122344


Q ss_pred             ccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc-------cccccccC
Q 007261          483 VGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE-------AKLSVLVD  554 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~-------~~l~~~~d  554 (611)
                      .++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+.  ...+..........       ......+.
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  244 (330)
T cd07834         167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ--LNLIVEVLGTPSEEDLKFITSEKARNYLK  244 (330)
T ss_pred             ccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHhcCCCChhHhhhccccchhhHHh
Confidence            678899999999887 899999999999999999999999876654321  11111111100000       00000000


Q ss_pred             ---c----cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhchh
Q 007261          555 ---P----NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST--LMKIQL  598 (611)
Q Consensus       555 ---~----~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~  598 (611)
                         .    .+.......+..+.+++.+||+.+|++||++.+++.+  ++.+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         245 SLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             hcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence               0    0000112246778999999999999999999999985  555444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=2.7e-31  Score=269.77  Aligned_cols=229  Identities=22%  Similarity=0.357  Sum_probs=185.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +|..||+|++..          .+.+|..++++++ |+||+++++++..++..++||||+++++|.+++.
T Consensus        15 ~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   94 (280)
T cd05581          15 STVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR   94 (280)
T ss_pred             eEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHH
Confidence            89999988  789999999853          4677999999998 9999999999999999999999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC----------
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG----------  475 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~----------  475 (611)
                      ...   .+++..++.++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++.........          
T Consensus        95 ~~~---~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  168 (280)
T cd05581          95 KYG---SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI  168 (280)
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccc
Confidence            753   4999999999999999999999   689999999999999999999999999998765432210          


Q ss_pred             -------cccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc
Q 007261          476 -------YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK  548 (611)
Q Consensus       476 -------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  548 (611)
                             ........++..|++||.+....++.++||||||++++++++|+.|+....... .    .......      
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~----~~~~~~~------  237 (280)
T cd05581         169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-T----FQKILKL------  237 (280)
T ss_pred             cccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-H----HHHHHhc------
Confidence                   012233457889999999988889999999999999999999999987554211 1    1111100      


Q ss_pred             cccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCH----HHHHHH
Q 007261          549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSM----AEVVST  592 (611)
Q Consensus       549 l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~~  592 (611)
                              ....+...+..+.+++.+||+.+|++||++    .+++++
T Consensus       238 --------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         238 --------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             --------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence                    001122335678999999999999999999    777653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=4.2e-31  Score=276.52  Aligned_cols=246  Identities=22%  Similarity=0.274  Sum_probs=184.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------------------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeec
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------------------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFM  395 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------------------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  395 (611)
                      |.||++..  .|+.||||.++.                     .+.+|++++++++|+||+++++++..++..++||||+
T Consensus        23 g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  102 (335)
T PTZ00024         23 GKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM  102 (335)
T ss_pred             eeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEecc
Confidence            89999986  688999998752                     3668999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC-
Q 007261          396 ENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES-  474 (611)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-  474 (611)
                      + |+|.+++....   .+++.....++.|++.||+|||   ..+++|+||+|+||+++.++.+||+|||+++....... 
T Consensus       103 ~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~  175 (335)
T PTZ00024        103 A-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS  175 (335)
T ss_pred             c-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCccceeeccccccc
Confidence            6 69999987543   3888999999999999999999   68999999999999999999999999999875531110 


Q ss_pred             ----------CcccccccccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcC
Q 007261          475 ----------GYSSTKTAVGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGG  543 (611)
Q Consensus       475 ----------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  543 (611)
                                .........++..|+|||.+.+. .++.++||||||+++|||++|+.|+......+.  ...+.......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~i~~~~~~~  253 (335)
T PTZ00024        176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ--LGRIFELLGTP  253 (335)
T ss_pred             ccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCC
Confidence                      00111223467889999998764 468999999999999999999999876554321  12222222111


Q ss_pred             Cccccc-----------ccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          544 NAEAKL-----------SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       544 ~~~~~l-----------~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      ......           .....+.........+..+.+++.+||+.+|++||++.|++.+-
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        254 NEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             chhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            110000           00000111111123356788999999999999999999999753

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=7.4e-31  Score=272.07  Aligned_cols=224  Identities=29%  Similarity=0.459  Sum_probs=180.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|+.  +|..|++|.+.          .++.+|++++++++|+|++++++++.++...++||||+. |+|.+++..
T Consensus        35 g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~  113 (313)
T cd06633          35 GAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEV  113 (313)
T ss_pred             eEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHh
Confidence            89999987  68899999975          246789999999999999999999999999999999995 688888865


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..  ..+++..++.++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||++....       ......++.
T Consensus       114 ~~--~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-------~~~~~~~~~  181 (313)
T cd06633         114 HK--KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-------PANSFVGTP  181 (313)
T ss_pred             cC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC-------CCCCccccc
Confidence            43  34899999999999999999999   6899999999999999999999999999875432       122346788


Q ss_pred             Cccchhhhc---cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          487 GYMAPEYME---YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       487 ~y~aPE~~~---~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      .|+|||.+.   .+.++.++||||||+++|||++|..|+.........     ........          +...  ...
T Consensus       182 ~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-----~~~~~~~~----------~~~~--~~~  244 (313)
T cd06633         182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHIAQNDS----------PTLQ--SNE  244 (313)
T ss_pred             cccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHHhcCC----------CCCC--ccc
Confidence            999999974   466889999999999999999999998765432211     11111000          0000  122


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+..+.+++.+||+.+|.+||++.+++.+
T Consensus       245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         245 WTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            34568899999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-30  Score=265.82  Aligned_cols=243  Identities=25%  Similarity=0.354  Sum_probs=184.8

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|+.  +++.+|+|.++.         .+..|+.++++++|+|++++++++.+.+..++||||++ ++|.+++...
T Consensus        13 ~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~   91 (282)
T cd07829          13 GVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKR   91 (282)
T ss_pred             ceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhh
Confidence            89999998  589999998862         46779999999999999999999999999999999997 5999999875


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .  ..+++..++.++.+++.||.|||   ..+++|+||+|+||++++++.+||+|||+++.......   ......++..
T Consensus        92 ~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~  163 (282)
T cd07829          92 P--GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR---TYTHEVVTLW  163 (282)
T ss_pred             c--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc---ccCccccCcC
Confidence            3  34899999999999999999999   68999999999999999999999999999876533221   1223345778


Q ss_pred             ccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc-----cc---cccccCc---
Q 007261          488 YMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE-----AK---LSVLVDP---  555 (611)
Q Consensus       488 y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~-----~~---l~~~~d~---  555 (611)
                      |+|||.+.+. .++.++||||||+++|||++|+.|+......+.  ...+..........     ..   .......   
T Consensus       164 ~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (282)
T cd07829         164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ--LFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPP  241 (282)
T ss_pred             cCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHHHHhCCCcHHHHHhhcccccccccccccCc
Confidence            9999998766 889999999999999999999888765443221  11111111111000     00   0000000   


Q ss_pred             -cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          556 -NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       556 -~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                       ............+.+++.+||+.||++||++.+++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         242 KDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence             0000111235679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.4e-31  Score=278.11  Aligned_cols=243  Identities=23%  Similarity=0.353  Sum_probs=179.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccC------CeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD------GVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~E~~~~gsL~  401 (611)
                      |.||+|..  +|+.||||+++         ..+.+|+.++++++|+||+++++++...      ...++|+||+. .+|.
T Consensus        29 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  107 (342)
T cd07879          29 GSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQ  107 (342)
T ss_pred             eEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHH
Confidence            89999987  68999999985         2467899999999999999999998654      34699999996 4777


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      .++..     .+++..+..++.|++.||+|||   ..+++||||||+|||++.++.+||+|||+++.....      ...
T Consensus       108 ~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~------~~~  173 (342)
T cd07879         108 KIMGH-----PLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTG  173 (342)
T ss_pred             HHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC------CCC
Confidence            76532     3888999999999999999999   689999999999999999999999999998754221      123


Q ss_pred             cccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc-------cccccccc
Q 007261          482 AVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA-------EAKLSVLV  553 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-------~~~l~~~~  553 (611)
                      ..++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ + ..+.........       ........
T Consensus       174 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (342)
T cd07879         174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-L-TQILKVTGVPGPEFVQKLEDKAAKSYI  251 (342)
T ss_pred             ceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHHhcCCCCHHHHHHhcccchHHHH
Confidence            456888999999876 4688999999999999999999999976442211 1 111111000000       00000000


Q ss_pred             C--ccC-Cc----ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhchh
Q 007261          554 D--PNL-QA----NKKEIAHHLIMLCLACIAREPESRPSMAEVVST--LMKIQL  598 (611)
Q Consensus       554 d--~~l-~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~  598 (611)
                      +  +.. ..    .....+..+.+++.+||+.||++||++.|++.+  ++.++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         252 KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             hhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            0  000 00    011234568899999999999999999999965  666544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=2.2e-31  Score=256.71  Aligned_cols=251  Identities=22%  Similarity=0.311  Sum_probs=188.7

Q ss_pred             ceEEEEEE---c---CcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceecc-CCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII---N---GSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEH-DGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~---~---g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||+++-   +   ...+|||+++.         ...+|+.+++.++|||++.+..++.. +...+|++||.+. +|..
T Consensus        38 G~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~  116 (438)
T KOG0666|consen   38 GKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWH  116 (438)
T ss_pred             ceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHH
Confidence            89999965   2   23689999973         47899999999999999999999876 8889999999975 8999


Q ss_pred             HhhccCC--CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC----CcEEEeeecCccccccccCCc
Q 007261          403 WLHKKRY--PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN----LRAKLANFSFVRSAVREESGY  476 (611)
Q Consensus       403 ~l~~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~Dfgla~~~~~~~~~~  476 (611)
                      .++.++.  .+.++......|.+||+.|+.|||   ++=|+||||||.|||+..+    |++||+|||++|.....-...
T Consensus       117 II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl  193 (438)
T KOG0666|consen  117 IIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPL  193 (438)
T ss_pred             HHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhcccccc
Confidence            8876542  346888889999999999999999   6779999999999999777    999999999999876554444


Q ss_pred             ccccccccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChh-------hHHHHHHHHHHhcCCcc--
Q 007261          477 SSTKTAVGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEE-------ILLAEAVFSMVEGGNAE--  546 (611)
Q Consensus       477 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~-------~~l~~~~~~~~~~~~~~--  546 (611)
                      ......+.|.+|.|||.+.+. .|+++.||||.||+..||+|-.+.|.+...+.       ..-...++.++......  
T Consensus       194 ~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~W  273 (438)
T KOG0666|consen  194 ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDW  273 (438)
T ss_pred             ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccc
Confidence            456677889999999998775 59999999999999999999887776543220       11123334443322111  


Q ss_pred             ccccccc--------------Ccc-CCcC---hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          547 AKLSVLV--------------DPN-LQAN---KKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       547 ~~l~~~~--------------d~~-l~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      ..+...-              |+. +...   ...-+...++|+.++|..||.+|.|+++.+++.
T Consensus       274 p~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  274 PDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             hhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            1111110              000 0000   000122377899999999999999999998763

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=4.5e-31  Score=276.60  Aligned_cols=247  Identities=21%  Similarity=0.307  Sum_probs=184.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccC-----CeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHD-----GVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~  402 (611)
                      |.||++..  +|..||||.++.         .+.+|+.+++.++|+||+++++++...     ...++|+||+. ++|.+
T Consensus        19 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~   97 (337)
T cd07858          19 GIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQ   97 (337)
T ss_pred             eEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHH
Confidence            89999987  688999998752         456799999999999999999988644     35799999996 78999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++....   .+++.....++.|++.||.|||   ..+++||||||+||+++.++.+||+|||+++......   ......
T Consensus        98 ~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~  168 (337)
T cd07858          98 IIRSSQ---TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG---DFMTEY  168 (337)
T ss_pred             HHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc---cccccc
Confidence            887643   4899999999999999999999   6899999999999999999999999999987653221   112234


Q ss_pred             ccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccc-----------
Q 007261          483 VGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLS-----------  550 (611)
Q Consensus       483 ~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~-----------  550 (611)
                      .++..|+|||.+.. ..++.++||||||+++|||++|+.||...+..+.  ...+........ ...+.           
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  245 (337)
T cd07858         169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ--LKLITELLGSPS-EEDLGFIRNEKARRYI  245 (337)
T ss_pred             ccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH--HHHHHHHhCCCC-hHHhhhcCchhhhHHH
Confidence            57889999998765 5689999999999999999999999865432211  111111111000 00000           


Q ss_pred             ----cccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhchh
Q 007261          551 ----VLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST--LMKIQL  598 (611)
Q Consensus       551 ----~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~~  598 (611)
                          ...++........++.++.+++.+||+.+|++||++.|++++  +..+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         246 RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             HhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence                000111111122456778999999999999999999999987  555433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=254.43  Aligned_cols=241  Identities=21%  Similarity=0.372  Sum_probs=186.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecH--------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR--------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.|++.++  .|..+|||.+++        ++...++++..- +.|.||+.+|+|..+...++.||.|. ..++.+|+..
T Consensus       106 G~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C~ekLlkri  184 (391)
T KOG0983|consen  106 GQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TCAEKLLKRI  184 (391)
T ss_pred             cceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HHHHHHHHHh
Confidence            89999998  679999999973        455566666655 48999999999999999999999994 5677777764


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .  .++++.-.-++...+..||.||..  +.+|+|||+||+|||+|+.|.+|+||||.+-.....    .......|-+.
T Consensus       185 k--~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS----kAhtrsAGC~~  256 (391)
T KOG0983|consen  185 K--GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS----KAHTRSAGCAA  256 (391)
T ss_pred             c--CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc----cccccccCCcc
Confidence            4  337777777888999999999997  789999999999999999999999999998655332    23344578899


Q ss_pred             ccchhhhc---cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          488 YMAPEYME---YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       488 y~aPE~~~---~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      |||||.+.   ...|..++||||||+.|+||.||+.|+.....+-..+..    .+.          -..|.+.+. ...
T Consensus       257 YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk----vln----------~ePP~L~~~-~gF  321 (391)
T KOG0983|consen  257 YMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK----VLN----------EEPPLLPGH-MGF  321 (391)
T ss_pred             ccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH----HHh----------cCCCCCCcc-cCc
Confidence            99999985   456889999999999999999999998765443211111    111          111333332 237


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH-----HHhchhhhhhc
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST-----LMKIQLDVQRS  603 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~-----L~~i~~~~~~~  603 (611)
                      +..+.+++..||..|+.+||...+++++     .+.+..+..+|
T Consensus       322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~W  365 (391)
T KOG0983|consen  322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASW  365 (391)
T ss_pred             CHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHH
Confidence            7889999999999999999999999875     34444455555

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=8.2e-31  Score=270.72  Aligned_cols=246  Identities=22%  Similarity=0.301  Sum_probs=179.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccC--------CeEEEEEeecCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD--------GVFYLVYEFMENGS  399 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~lV~E~~~~gs  399 (611)
                      |.||+|..  +|+.+|||.+.         ..+.+|++++++++|+||+++++++...        ...++|+||+. ++
T Consensus        22 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~  100 (311)
T cd07866          22 GEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HD  100 (311)
T ss_pred             EEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cC
Confidence            89999998  68899999874         2467899999999999999999987443        35799999996 57


Q ss_pred             HHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc---
Q 007261          400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY---  476 (611)
Q Consensus       400 L~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~---  476 (611)
                      |...+....  ..+++..+..++.|+++||+|||   ..+++|+||||+||++++++.+||+|||+++.........   
T Consensus       101 l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  175 (311)
T cd07866         101 LSGLLENPS--VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG  175 (311)
T ss_pred             HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccC
Confidence            877776542  34899999999999999999999   6899999999999999999999999999987553322111   


Q ss_pred             -----ccccccccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc-----
Q 007261          477 -----SSTKTAVGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA-----  545 (611)
Q Consensus       477 -----~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-----  545 (611)
                           .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.......  ....+.........     
T Consensus       176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  253 (311)
T cd07866         176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID--QLHLIFKLCGTPTEETWPG  253 (311)
T ss_pred             CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChhhchh
Confidence                 111233567889999987654 58899999999999999999999886544322  11111111111000     


Q ss_pred             ccccccc----cCccCCcC----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          546 EAKLSVL----VDPNLQAN----KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       546 ~~~l~~~----~d~~l~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ...+...    ........    .......+.+++.+||+.||++|||+.|++.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         254 WRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             hhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            0000000    00011111    11233578899999999999999999998863

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.6e-31  Score=261.63  Aligned_cols=222  Identities=27%  Similarity=0.378  Sum_probs=182.2

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +++.+++|.+++          .+.+|+.++++++|+||+++++.+..++..++||||+++++|.+++..
T Consensus         7 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~   86 (250)
T cd05123           7 GKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK   86 (250)
T ss_pred             eEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHh
Confidence            89999988  588999999852          577899999999999999999999999999999999999999999986


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++.....++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++.......   .......++.
T Consensus        87 ~~---~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  157 (250)
T cd05123          87 EG---RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SRTNTFCGTP  157 (250)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC---CcccCCcCCc
Confidence            53   3899999999999999999999   6899999999999999999999999999987653321   1233456788


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|++||...+...+.++|+||||+++||+++|+.|+...+...     ....... .            . ...+...+.
T Consensus       158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~-~------------~-~~~~~~~~~  218 (250)
T cd05123         158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-----IYEKILK-D------------P-LRFPEFLSP  218 (250)
T ss_pred             cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHhc-C------------C-CCCCCCCCH
Confidence            9999999988889999999999999999999999986543311     1111111 0            0 011222356


Q ss_pred             HHHHHHHHhhccCCCCCCCHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAE  588 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~e  588 (611)
                      .+.+++.+||..||++||++.+
T Consensus       219 ~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         219 EARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHHhcCCHhhCCCccc
Confidence            7889999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.2e-30  Score=274.37  Aligned_cols=255  Identities=20%  Similarity=0.313  Sum_probs=187.3

Q ss_pred             hhHHHHHhhcCCCCCccc----ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccC
Q 007261          321 YEDLVVATENFSPKNMID----GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD  385 (611)
Q Consensus       321 ~~el~~at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~  385 (611)
                      ..++...+++|.....+|    |.||++..  +|+.||+|+++         +.+.+|+.++++++|+||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            345555666676655554    88999986  68899999985         2466799999999999999999987533


Q ss_pred             ------CeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 007261          386 ------GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK  459 (611)
Q Consensus       386 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k  459 (611)
                            ...++++|++ +++|.+++....    +++..+..++.|++.||+|||   +.+++||||||+||++++++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~~----l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQK----LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence                  3468888887 789998887543    899999999999999999999   68999999999999999999999


Q ss_pred             EeeecCccccccccCCcccccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHH
Q 007261          460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFS  538 (611)
Q Consensus       460 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~  538 (611)
                      |+|||+++....      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ +.. +..
T Consensus       161 l~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~-~~~  232 (345)
T cd07877         161 ILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKL-ILR  232 (345)
T ss_pred             Eecccccccccc------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHH
Confidence            999999875422      1223467889999998866 5688999999999999999999999865433221 111 111


Q ss_pred             HHhcCCcccccc---------------cccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          539 MVEGGNAEAKLS---------------VLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       539 ~~~~~~~~~~l~---------------~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .... .......               ..............+..+.+++.+|++.||.+||++.+++.+
T Consensus       233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         233 LVGT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhCC-CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            1000 0000000               000000000011234568899999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=1e-30  Score=274.47  Aligned_cols=244  Identities=19%  Similarity=0.294  Sum_probs=176.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccC--------------CeEEEEEeec
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHD--------------GVFYLVYEFM  395 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~--------------~~~~lV~E~~  395 (611)
                      |.||+|..  +|..||+|.+.       +.+.+|++++++++||||+++++++...              ...++||||+
T Consensus        19 g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~   98 (342)
T cd07854          19 GLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM   98 (342)
T ss_pred             EEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecc
Confidence            89999987  68899999884       3578899999999999999999876543              3579999999


Q ss_pred             CCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEeeecCccccccccC
Q 007261          396 ENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD-KNLRAKLANFSFVRSAVREES  474 (611)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~  474 (611)
                      + ++|.+++...    .+++...+.++.||+.||.|||   ..+++||||||+||+++ +++.+||+|||+++.......
T Consensus        99 ~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~  170 (342)
T cd07854          99 E-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS  170 (342)
T ss_pred             c-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccc
Confidence            7 5999888654    3888999999999999999999   68999999999999997 456789999999875432211


Q ss_pred             CcccccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc--------
Q 007261          475 GYSSTKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA--------  545 (611)
Q Consensus       475 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--------  545 (611)
                      .........++..|+|||.+.. ..++.++||||||+++|||++|+.||......+... . ..........        
T Consensus       171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~  248 (342)
T cd07854         171 HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ-L-ILESVPVVREEDRNELLN  248 (342)
T ss_pred             cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-H-HHHhcCCCChHHhhhhhh
Confidence            1111223457889999997654 568889999999999999999999997554322110 0 0000000000        


Q ss_pred             --ccccc-cccCccC--CcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          546 --EAKLS-VLVDPNL--QANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       546 --~~~l~-~~~d~~l--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        ..... ....+..  .......+.++.+++.+||+.||++||++.|++.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         249 VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence              00000 0000000  00011245678899999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=2.9e-30  Score=265.18  Aligned_cols=237  Identities=16%  Similarity=0.198  Sum_probs=169.7

Q ss_pred             ceEEEEEEc-----CcEEEEEEec---HHH---------------HHHHHHHHhcCCCceeeccceeccCC----eEEEE
Q 007261          339 GSVFRGIIN-----GSTVAIKCMR---RSI---------------SKEVNLLKKINHFNLINLFGACEHDG----VFYLV  391 (611)
Q Consensus       339 g~Vy~g~~~-----g~~vavK~~~---~~~---------------~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV  391 (611)
                      |.||+|...     +..+|+|...   ..+               ..+...+..++|+|++++++++....    ..+++
T Consensus        26 G~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~  105 (294)
T PHA02882         26 GCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFIL  105 (294)
T ss_pred             ceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCCceEEEEE
Confidence            899999983     3466777542   111               12233445568999999998765443    34778


Q ss_pred             EeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccccc
Q 007261          392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR  471 (611)
Q Consensus       392 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~  471 (611)
                      +|++. .++.+.+....   ..++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++....
T Consensus       106 ~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~  178 (294)
T PHA02882        106 LEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFII  178 (294)
T ss_pred             Eehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEEEEEcCCceeecc
Confidence            88774 47777766532   2567888899999999999999   68999999999999999999999999999976532


Q ss_pred             ccCC----cccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc
Q 007261          472 EESG----YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA  547 (611)
Q Consensus       472 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  547 (611)
                      ....    ........||+.|+|||.+.+..++.++||||||+++|||++|+.||...................      
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~------  252 (294)
T PHA02882        179 HGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIK------  252 (294)
T ss_pred             CCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHH------
Confidence            2111    011223468999999999999999999999999999999999999997653322111111111111      


Q ss_pred             ccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          548 KLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       548 ~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                         .+..+..  ....++..+.+++..||+.+|++||++.++.+.|
T Consensus       253 ---~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        253 ---RLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             ---Hhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence               0000100  0122356789999999999999999999999876

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=258.80  Aligned_cols=245  Identities=23%  Similarity=0.331  Sum_probs=200.5

Q ss_pred             ceEEEEEE--cCcEEEEEEecHHH----------HHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRRSI----------SKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~~----------~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.|-..+-  .|+.+|+|+++++.          ..|-++|+..+||.+..+--.|...+.+|+||||..||.|.-+|..
T Consensus       182 GKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr  261 (516)
T KOG0690|consen  182 GKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR  261 (516)
T ss_pred             ceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh
Confidence            77777665  78999999998642          3488899999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .+   .++.....-.-.+|..||.|||   +.+||.||||.+|.|+|.+|++||+||||++.....   ...++..+||+
T Consensus       262 er---~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~---g~t~kTFCGTP  332 (516)
T KOG0690|consen  262 ER---VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY---GDTTKTFCGTP  332 (516)
T ss_pred             hh---cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc---cceeccccCCh
Confidence            54   3676666778889999999999   689999999999999999999999999999865332   24667889999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||++....|....|+|.+||++|||++|+.||+..+.+..  .+.+   +. +          |   ...|..++.
T Consensus       333 EYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL--FeLI---l~-e----------d---~kFPr~ls~  393 (516)
T KOG0690|consen  333 EYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL--FELI---LM-E----------D---LKFPRTLSP  393 (516)
T ss_pred             hhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH--HHHH---Hh-h----------h---ccCCccCCH
Confidence            99999999999999999999999999999999999998765421  1111   00 0          0   011334556


Q ss_pred             HHHHHHHHhhccCCCCCC--CHHHHHHHHHhchhhhhhchhhhhhcC
Q 007261          567 HLIMLCLACIAREPESRP--SMAEVVSTLMKIQLDVQRSQTLLLERI  611 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP--s~~evl~~L~~i~~~~~~~~~~~~~~~  611 (611)
                      +...|+...|..||.+|.  ..+++.+....--.....|+..+.|+|
T Consensus       394 eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki  440 (516)
T KOG0690|consen  394 EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKI  440 (516)
T ss_pred             HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhcc
Confidence            677888999999999995  556777766666667788999988876

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.8e-30  Score=270.97  Aligned_cols=250  Identities=23%  Similarity=0.317  Sum_probs=183.9

Q ss_pred             HHhhcCCCCCccc----ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceecc-CCeEE
Q 007261          326 VATENFSPKNMID----GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEH-DGVFY  389 (611)
Q Consensus       326 ~at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~  389 (611)
                      ..+++|.....+|    |.||++..  +|+.||||++.         +.+.+|++++++++||||+++++++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            3444554444443    89999986  68899999863         357789999999999999999998865 56789


Q ss_pred             EEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccc
Q 007261          390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSA  469 (611)
Q Consensus       390 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~  469 (611)
                      +|+||+ +++|.++++...    +++.....++.|++.||.|||   ..+++||||+|+||++++++.+||+|||++...
T Consensus        87 lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLTSRP----LEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999999 579999887543    777888889999999999999   689999999999999999999999999998743


Q ss_pred             ccccCCcccccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc
Q 007261          470 VREESGYSSTKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK  548 (611)
Q Consensus       470 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  548 (611)
                      ..      ......++..|+|||.+.+ ..++.++||||||++++||++|+.||....... . ...+....... .++.
T Consensus       159 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~-~~~~~~~~~~~-~~~~  229 (328)
T cd07856         159 DP------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-Q-FSIITDLLGTP-PDDV  229 (328)
T ss_pred             CC------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-H-HHHHHHHhCCC-CHHH
Confidence            21      1122356788999998765 568999999999999999999999886543211 0 01111111000 0000


Q ss_pred             ccccc---------CccCC-c-----ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          549 LSVLV---------DPNLQ-A-----NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       549 l~~~~---------d~~l~-~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .....         .-... .     .....+..+.+++.+||+.+|++||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000         00000 0     011245789999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.5e-31  Score=272.68  Aligned_cols=229  Identities=27%  Similarity=0.398  Sum_probs=181.1

Q ss_pred             ceEEEEEE-cCcEEEEEEec---------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII-NGSTVAIKCMR---------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~---------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      ..||++.. +...+|+|++.         .-|.+|+..|.+| .|.+||+|++|-..++.+||||||= ..+|..+|++.
T Consensus       375 SkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~  453 (677)
T KOG0596|consen  375 SKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKK  453 (677)
T ss_pred             ceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhc
Confidence            57999988 45677888764         3488999999999 6999999999999999999999976 57999999986


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .. ....| .++.+..|++.++.++|   ..+|||.||||.|+|+-+ |.+||+|||.|.....+.. .......+||+.
T Consensus       454 ~~-~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT-sI~kdsQvGT~N  526 (677)
T KOG0596|consen  454 KS-IDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT-SIVKDSQVGTVN  526 (677)
T ss_pred             cC-CCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCcccc-ceeeccccCccc
Confidence            53 23445 56678899999999999   799999999999999864 7899999999987755432 234456789999


Q ss_pred             ccchhhhccC-----------CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCcc
Q 007261          488 YMAPEYMEYG-----------LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN  556 (611)
Q Consensus       488 y~aPE~~~~~-----------~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  556 (611)
                      ||+||.+...           ++++++||||+||+||+|+.|+.||..-..                 ...++..+.||.
T Consensus       527 YMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----------------~~aKl~aI~~P~  589 (677)
T KOG0596|consen  527 YMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----------------QIAKLHAITDPN  589 (677)
T ss_pred             ccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----------------HHHHHHhhcCCC
Confidence            9999988432           367899999999999999999999853211                 023455667764


Q ss_pred             CCcC-hH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          557 LQAN-KK-EIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       557 l~~~-~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..-+ +. ....++.++|+.||.+||.+||+..|++++
T Consensus       590 ~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  590 HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            4221 11 111238999999999999999999999975

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=7.3e-31  Score=274.98  Aligned_cols=226  Identities=27%  Similarity=0.380  Sum_probs=186.8

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      +.|..++.  .|..||||.+.+         .+.+|+++|+.++|||||+++.+......+|+||||+.+|.++++|.++
T Consensus        70 ~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~  149 (596)
T KOG0586|consen   70 AKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKH  149 (596)
T ss_pred             EEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhc
Confidence            78888876  789999999863         3678999999999999999999999999999999999999999999987


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      +.   +.......++.|+..|++|||   .+.|+|||||++||||+.+..+||+|||++......    ......+|++.
T Consensus       150 gr---~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~----~~lqt~cgspp  219 (596)
T KOG0586|consen  150 GR---MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG----LMLQTFCGSPP  219 (596)
T ss_pred             cc---chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc----ccccccCCCCC
Confidence            54   445777889999999999999   799999999999999999999999999998776433    34566889999


Q ss_pred             ccchhhhccCCC-CCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          488 YMAPEYMEYGLV-TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       488 y~aPE~~~~~~~-s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      |.|||++.+..+ .++.|+||+|++||-|+.|..||.+..-.+..          ......++         .-+..++.
T Consensus       220 yAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr----------~rvl~gk~---------rIp~~ms~  280 (596)
T KOG0586|consen  220 YAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR----------PRVLRGKY---------RIPFYMSC  280 (596)
T ss_pred             ccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc----------chheeeee---------cccceeec
Confidence            999999987664 68999999999999999999999765422100          00001111         01223445


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      ++.+++++++-.+|.+|++++++.++-
T Consensus       281 dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  281 DCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             hhHHHHHHhhccCccccCCHHHhhhhc
Confidence            677899999999999999999998864

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=268.66  Aligned_cols=236  Identities=22%  Similarity=0.329  Sum_probs=190.7

Q ss_pred             hcCCCCCccc----ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEE
Q 007261          329 ENFSPKNMID----GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVY  392 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  392 (611)
                      +.|.....+|    |.||....  .|+.+|.|.+.+          -..+|-.+|.+++.+.||.+--.|+.++.++||+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            3444444444    88998765  789999998842          2567999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       393 E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      ..|.||+|.-+|.+.+. ..++....+-.|.+|+.||++||   ..+||.|||||+|||+|+.|+++|+|+|||......
T Consensus       265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999988765 34888888899999999999999   789999999999999999999999999999877543


Q ss_pred             cCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccc
Q 007261          473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVL  552 (611)
Q Consensus       473 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  552 (611)
                      .    .....+||.+|||||++.++.|+...|.||+||+||||+.|+.||......  .-.+.+......          
T Consensus       341 ~----~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK--vk~eEvdrr~~~----------  404 (591)
T KOG0986|consen  341 K----PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK--VKREEVDRRTLE----------  404 (591)
T ss_pred             C----ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh--hhHHHHHHHHhc----------
Confidence            3    334559999999999999999999999999999999999999999654322  111122222211          


Q ss_pred             cCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHH
Q 007261          553 VDPNLQANKKEIAHHLIMLCLACIAREPESRPSMA  587 (611)
Q Consensus       553 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  587 (611)
                       |+  ...++..+++...++...|+.||++|-...
T Consensus       405 -~~--~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  405 -DP--EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             -ch--hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence             11  112456778888999999999999996443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=4.1e-30  Score=254.15  Aligned_cols=228  Identities=31%  Similarity=0.459  Sum_probs=186.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|+.  +|+.+++|++.        +.+.+|++.+++++|+|++++++++......++++||+++++|.+++....
T Consensus         3 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~   82 (244)
T smart00220        3 GKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG   82 (244)
T ss_pred             eEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc
Confidence            89999998  46899999984        467899999999999999999999999999999999999999999997653


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                      .   +++..+..++.+++.++.|||   ..+++|+||+|+||++++++.++|+|||++.......    ......++..|
T Consensus        83 ~---~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~  152 (244)
T smart00220       83 R---LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTPEY  152 (244)
T ss_pred             C---CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCcCC
Confidence            2   889999999999999999999   6899999999999999999999999999987654321    23345678899


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHH
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL  568 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l  568 (611)
                      ++||.+....++.++||||||+++++|++|..|+......+..     .........          .........+.++
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~-----~~~~~~~~~----------~~~~~~~~~~~~~  217 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLEL-----FKKIGKPKP----------PFPPPEWKISPEA  217 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-----HHHHhccCC----------CCccccccCCHHH
Confidence            9999999888999999999999999999999998653222211     111111100          0000001155678


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 007261          569 IMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       569 ~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      .+++.+||..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            99999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.4e-31  Score=254.21  Aligned_cols=256  Identities=24%  Similarity=0.382  Sum_probs=191.5

Q ss_pred             chhHHHHHhhcCCCCCcccceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhc-CCCceeeccceeccCCeEE
Q 007261          320 KYEDLVVATENFSPKNMIDGSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFY  389 (611)
Q Consensus       320 ~~~el~~at~~f~~~~~igg~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  389 (611)
                      +|+|+.+.|+....+.. -++|--.+.  +|..+|||++.       .++.+|++++.+. .|+||++|+.||+++..+|
T Consensus        74 ~F~d~YkLt~e~LGeGA-yasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY  152 (463)
T KOG0607|consen   74 KFEDMYKLTSELLGEGA-YASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY  152 (463)
T ss_pred             hHHHHHHhHHHHhcCcc-ceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence            35666666655422111 145554443  89999999985       4688999999999 6999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEEeeecCc
Q 007261          390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL---RAKLANFSFV  466 (611)
Q Consensus       390 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgla  466 (611)
                      ||||.|.||+|..++++..   .+++.+..++..+|+.||.|||   .++|.||||||+|||-.+-.   -+|||||.|.
T Consensus       153 LVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLg  226 (463)
T KOG0607|consen  153 LVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLG  226 (463)
T ss_pred             EEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccc
Confidence            9999999999999998764   3888999999999999999999   79999999999999996554   4799999987


Q ss_pred             cccccccCCc----ccccccccCCCccchhhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHH----
Q 007261          467 RSAVREESGY----SSTKTAVGTNGYMAPEYME-----YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA----  533 (611)
Q Consensus       467 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~----  533 (611)
                      .-......-.    ......+|+..|||||+..     ...|+.+.|.|||||+||-|++|..||.+..+.+..+.    
T Consensus       227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~  306 (463)
T KOG0607|consen  227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV  306 (463)
T ss_pred             cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence            5432211110    1123457888999999763     34688999999999999999999999987665432211    


Q ss_pred             -----HHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          534 -----EAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       534 -----~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                           ..++.-..++..+     +-    ..+....+.+..+++...+-.|+.+|-++.+++.
T Consensus       307 Cr~CQ~~LFesIQEGkYe-----FP----dkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  307 CRVCQNKLFESIQEGKYE-----FP----DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cHHHHHHHHHHHhccCCc-----CC----hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                 1111111111110     00    1124466778889999999999999999999887

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.3e-30  Score=271.89  Aligned_cols=237  Identities=26%  Similarity=0.397  Sum_probs=177.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCC------eEEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDG------VFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV~E~~~~gsL~  401 (611)
                      |.||++..  +|..||||++.         ..+.+|+.++++++|+||+++++++..+.      ..++||||+ +++|.
T Consensus        29 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~  107 (343)
T cd07880          29 GTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLG  107 (343)
T ss_pred             eEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHH
Confidence            88999987  68899999874         24678999999999999999999886543      458999999 78999


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +++...    .+++..+..++.|++.||+|||   ..+++||||||+||++++++.+||+|||++......      ...
T Consensus       108 ~~~~~~----~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~------~~~  174 (343)
T cd07880         108 KLMKHE----KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE------MTG  174 (343)
T ss_pred             HHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccccccccC------ccc
Confidence            888753    3889999999999999999999   689999999999999999999999999998754321      123


Q ss_pred             cccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhc-----------CCcc---
Q 007261          482 AVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEG-----------GNAE---  546 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~-----------~~~~---  546 (611)
                      ..++..|+|||.+.+ ..++.++|+||||+++++|++|+.||.......... . .......           ....   
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~  252 (343)
T cd07880         175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLM-E-IMKVTGTPSKEFVQKLQSEDAKNYV  252 (343)
T ss_pred             cccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-H-HHHhcCCCCHHHHHhhcchhHHHHH
Confidence            456889999999876 458899999999999999999999987554321110 0 0000000           0000   


Q ss_pred             cccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       547 ~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      ..+.......+.......+..+.+++.+|++.||++||++.+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         253 KKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000000000011234556889999999999999999999995

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.7e-30  Score=272.84  Aligned_cols=238  Identities=24%  Similarity=0.362  Sum_probs=179.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCe------EEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGV------FYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~lV~E~~~~gsL~  401 (611)
                      |.||+|..  ++..||||++.         +.+.+|+.++++++|+|++++.+++...+.      .++|+||+ +++|.
T Consensus        29 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~  107 (343)
T cd07851          29 GQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLN  107 (343)
T ss_pred             eEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHH
Confidence            89999998  57899999975         235679999999999999999998866554      89999999 67999


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +++...    .+++..+..++.|++.||.|||   ..+++|+||||+||++++++.+||+|||++......      ...
T Consensus       108 ~~~~~~----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~------~~~  174 (343)
T cd07851         108 NIVKCQ----KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE------MTG  174 (343)
T ss_pred             HHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccccccccc------ccC
Confidence            998763    3899999999999999999999   689999999999999999999999999998754322      223


Q ss_pred             cccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc-------cccccccc
Q 007261          482 AVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA-------EAKLSVLV  553 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-------~~~l~~~~  553 (611)
                      ..++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.  ...+.........       ......++
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~  252 (343)
T cd07851         175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ--LKRIMNLVGTPDEELLQKISSESARNYI  252 (343)
T ss_pred             CcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCCCHHHHhhccchhHHHHH
Confidence            457888999998865 4678999999999999999999999865443221  1111111100000       00000000


Q ss_pred             C-------ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          554 D-------PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       554 d-------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .       +.........+..+.+++.+||+.||++|||+.||+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         253 QSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            0       00000011235678999999999999999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.4e-30  Score=284.52  Aligned_cols=228  Identities=17%  Similarity=0.242  Sum_probs=162.9

Q ss_pred             HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC--CCccCHHHHHHHHHHHHHHHHHHhcCC
Q 007261          359 SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY--PEFVSWNCRFRIALDVAHGLHYLHNCT  436 (611)
Q Consensus       359 ~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~  436 (611)
                      .+.+|+.+|++++|+||+++++++...+..|+|+|++. ++|.+++.....  ...........|+.||+.||+|||   
T Consensus       209 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---  284 (501)
T PHA03210        209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---  284 (501)
T ss_pred             HHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---
Confidence            46789999999999999999999999999999999995 678887754321  122345667789999999999999   


Q ss_pred             CCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHH
Q 007261          437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI  516 (611)
Q Consensus       437 ~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ell  516 (611)
                      +.+|+||||||+|||++.++.+||+|||+++.......  .......||..|+|||.+.+..++.++|||||||++|||+
T Consensus       285 ~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  362 (501)
T PHA03210        285 DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML  362 (501)
T ss_pred             hCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHH
Confidence            68999999999999999999999999999976533221  1223357899999999999999999999999999999999


Q ss_pred             hCCCCCcCCCC-h-hhHHHHHHHHHH--hcCCc--ccccccccCc--------cCCcC--hHHHHHHHHHHHHHhhccCC
Q 007261          517 TGKEAAYKQDG-E-EILLAEAVFSMV--EGGNA--EAKLSVLVDP--------NLQAN--KKEIAHHLIMLCLACIAREP  580 (611)
Q Consensus       517 tG~~p~~~~~~-~-~~~l~~~~~~~~--~~~~~--~~~l~~~~d~--------~l~~~--~~~~~~~l~~l~~~Cl~~dP  580 (611)
                      +|+.++..... . ...+.+.+....  ....+  ...+...++.        .+...  .......+.+++.+||+.||
T Consensus       363 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP  442 (501)
T PHA03210        363 SHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDW  442 (501)
T ss_pred             HCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCc
Confidence            99865543222 1 111111111100  00000  0000000000        00000  01123457788999999999


Q ss_pred             CCCCCHHHHHHH
Q 007261          581 ESRPSMAEVVST  592 (611)
Q Consensus       581 ~~RPs~~evl~~  592 (611)
                      .+|||+.|++.+
T Consensus       443 ~~Rpsa~elL~h  454 (501)
T PHA03210        443 HLRPGAAELLAL  454 (501)
T ss_pred             ccCcCHHHHhhC
Confidence            999999999875

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=1.8e-30  Score=288.34  Aligned_cols=241  Identities=25%  Similarity=0.427  Sum_probs=178.0

Q ss_pred             cchhHHHHH-hhcCCCCCcccceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceecc---
Q 007261          319 YKYEDLVVA-TENFSPKNMIDGSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEH---  384 (611)
Q Consensus       319 ~~~~el~~a-t~~f~~~~~igg~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~---  384 (611)
                      -+|+|+... .++|       |.||+++.  ||..+|||++.        ..+.+|+.+|.+|+|||||+++..+.+   
T Consensus       479 ~DFEEL~lLGkGGF-------G~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~  551 (1351)
T KOG1035|consen  479 NDFEELELLGKGGF-------GSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA  551 (1351)
T ss_pred             hhhHHHHHhcCCCC-------ceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence            356676543 4556       99999986  99999999986        347789999999999999998632200   


Q ss_pred             --------------------------------------------------------------------------------
Q 007261          385 --------------------------------------------------------------------------------  384 (611)
Q Consensus       385 --------------------------------------------------------------------------------  384 (611)
                                                                                                      
T Consensus       552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S  631 (1351)
T KOG1035|consen  552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS  631 (1351)
T ss_pred             ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------C--------CeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHH
Q 007261          385 ----------------------------D--------GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG  428 (611)
Q Consensus       385 ----------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~g  428 (611)
                                                  +        ..+||-||||+...|.++++.+....  .....++++.+|++|
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEG  709 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHH
Confidence                                        0        12578899999888888887764321  356678899999999


Q ss_pred             HHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccc----cc----------c-CCcccccccccCCCccchhh
Q 007261          429 LHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV----RE----------E-SGYSSTKTAVGTNGYMAPEY  493 (611)
Q Consensus       429 L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~----~~----------~-~~~~~~~~~~gt~~y~aPE~  493 (611)
                      |.|+|   +.++|||||||.||++|++..+||+|||+|....    ..          . ......+..+||.-|+|||.
T Consensus       710 LaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  710 LAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            99999   6889999999999999999999999999998721    00          0 01113345689999999999


Q ss_pred             hccC---CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC---hHHHHHH
Q 007261          494 MEYG---LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN---KKEIAHH  567 (611)
Q Consensus       494 ~~~~---~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~---~~~~~~~  567 (611)
                      +.+.   .|+.|+|+||+|||++||+.   ||......    ...+.             .+.++.++..   ..+....
T Consensus       787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER----a~iL~-------------~LR~g~iP~~~~f~~~~~~~  846 (1351)
T KOG1035|consen  787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER----ASILT-------------NLRKGSIPEPADFFDPEHPE  846 (1351)
T ss_pred             hcccccccccchhhhHHHHHHHHHHhc---cCCchHHH----HHHHH-------------hcccCCCCCCcccccccchH
Confidence            9765   49999999999999999985   34322211    11111             1112222221   2333444


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      -..++.+++++||.+|||+.|++.
T Consensus       847 e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  847 EASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHHHhcCCCccCCCHHHHhh
Confidence            577999999999999999999986

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-31  Score=283.70  Aligned_cols=231  Identities=26%  Similarity=0.410  Sum_probs=182.3

Q ss_pred             ceEEEEEEcCcEEEEEEecHH----HHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC-CCc
Q 007261          339 GSVFRGIINGSTVAIKCMRRS----ISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY-PEF  412 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~~~----~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~  412 (611)
                      +.||+|.++|+.||||++-.+    ..+|+..|+.- +|||||++++.-.++...||..|.|. .+|.+++..... ...
T Consensus       524 t~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~  602 (903)
T KOG1027|consen  524 TVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEM  602 (903)
T ss_pred             cEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhh
Confidence            679999999999999999654    56899999998 79999999999999999999999994 799999987411 111


Q ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-----CCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-----NLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       413 l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      ..-...+.+..|++.||+|||   .-+||||||||.||||+.     ..+++|+|||+++....+.+.........||.+
T Consensus       603 ~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~G  679 (903)
T KOG1027|consen  603 QSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSG  679 (903)
T ss_pred             cccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCccc
Confidence            111344668889999999999   689999999999999965     357999999999988776665656677889999


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhC-CCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITG-KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      |+|||.+....-+...||||+||++|+.++| ..||...-..+...       +.+.   ..+..     +.... ++  
T Consensus       680 W~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI-------l~~~---~~L~~-----L~~~~-d~--  741 (903)
T KOG1027|consen  680 WQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI-------LTGN---YTLVH-----LEPLP-DC--  741 (903)
T ss_pred             ccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh-------hcCc---cceee-----eccCc-hH--
Confidence            9999999999889999999999999999997 56775443322111       1100   00000     11111 12  


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      +..+|+.+|++.+|..||++.+|+.
T Consensus       742 eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  742 EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            6788999999999999999999986

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=1.2e-29  Score=265.25  Aligned_cols=244  Identities=23%  Similarity=0.303  Sum_probs=177.3

Q ss_pred             ceEEEEEEc----CcEEEEEEec---------HHHHHHHHHHHhc-CCCceeeccceecc----CCeEEEEEeecCCCCH
Q 007261          339 GSVFRGIIN----GSTVAIKCMR---------RSISKEVNLLKKI-NHFNLINLFGACEH----DGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~~----g~~vavK~~~---------~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~lV~E~~~~gsL  400 (611)
                      |.||++...    +..||+|.++         +.+.+|+.+++++ +|+||+++++++..    ....++++||+. ++|
T Consensus        14 g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L   92 (332)
T cd07857          14 GIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADL   92 (332)
T ss_pred             eEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCH
Confidence            899999983    6689999875         2467799999999 59999999987532    245788999985 699


Q ss_pred             HHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC-cccc
Q 007261          401 SDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG-YSST  479 (611)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~  479 (611)
                      .+++....   .+++..++.++.||+.||+|||   ..+++||||||+|||+++++.+||+|||+++........ ....
T Consensus        93 ~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  166 (332)
T cd07857          93 HQIIRSGQ---PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM  166 (332)
T ss_pred             HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccc
Confidence            99987543   4899999999999999999999   689999999999999999999999999998765322111 1112


Q ss_pred             cccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccC----
Q 007261          480 KTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD----  554 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d----  554 (611)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... .+ ......+... ..+.+..+.+    
T Consensus       167 ~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~-~~~~~~~~~~-~~~~~~~~~~~~~~  243 (332)
T cd07857         167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QL-NQILQVLGTP-DEETLSRIGSPKAQ  243 (332)
T ss_pred             cCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HH-HHHHHHhCCC-CHHHHHhhhhhhHH
Confidence            23468899999998765 468999999999999999999998886544221 11 1111110000 0000000000    


Q ss_pred             -----------ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 -----------PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 -----------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                                 ..+..........+.+++.+||+.||++||++.+++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         244 NYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                       00000011124578899999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.7e-30  Score=269.66  Aligned_cols=224  Identities=22%  Similarity=0.311  Sum_probs=182.2

Q ss_pred             ceEEEEEE--cCcEEEEEEecHH---HHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCc
Q 007261          339 GSVFRGII--NGSTVAIKCMRRS---ISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEF  412 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~---~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~  412 (611)
                      +.|-++..  ++...++|++.+.   ..+|+.++... +||||+++.+.+.++.+.|+|||.+.++-|.+.+...+.   
T Consensus       336 s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~---  412 (612)
T KOG0603|consen  336 SAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE---  412 (612)
T ss_pred             cceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch---
Confidence            34444444  6778999999755   77888887777 899999999999999999999999999988887776542   


Q ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee-CCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL-DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       413 l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl-~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .. .++.+|+.+|+.|+.|||   ..++|||||||+|||+ ++.+.++|+|||.++.....      .....-|..|.||
T Consensus       413 ~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~------~~tp~~t~~y~AP  482 (612)
T KOG0603|consen  413 FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS------CDTPALTLQYVAP  482 (612)
T ss_pred             hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh------hcccchhhcccCh
Confidence            22 777889999999999999   6999999999999999 68899999999999866432      2344668899999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML  571 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l  571 (611)
                      |++....+++++|+||||++||+|++|+.|+.....+..     +...+.            .+   ......++...+|
T Consensus       483 Evl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-----i~~~i~------------~~---~~s~~vS~~AKdL  542 (612)
T KOG0603|consen  483 EVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-----IHTRIQ------------MP---KFSECVSDEAKDL  542 (612)
T ss_pred             hhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-----HHHhhc------------CC---ccccccCHHHHHH
Confidence            999999999999999999999999999999987765511     111111            01   1124567788999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHh
Q 007261          572 CLACIAREPESRPSMAEVVSTLMK  595 (611)
Q Consensus       572 ~~~Cl~~dP~~RPs~~evl~~L~~  595 (611)
                      +.+||+.||.+||+|.++..+-..
T Consensus       543 l~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  543 LQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHhccCChhhCcChhhhccCcch
Confidence            999999999999999999876544

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=1.2e-29  Score=287.80  Aligned_cols=123  Identities=24%  Similarity=0.446  Sum_probs=113.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|..  +++.||||+++          ..+.+|+.++..++|+||+++++++...+..||||||+++++|.+++..
T Consensus        18 g~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~   97 (669)
T cd05610          18 GKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI   97 (669)
T ss_pred             eEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh
Confidence            89999998  48899999986          3567899999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      ..   .+++...+.++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        98 ~~---~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          98 YG---YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            43   3788889999999999999999   5799999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=273.77  Aligned_cols=230  Identities=26%  Similarity=0.419  Sum_probs=189.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhc-CCCceeeccceec-----cCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKI-NHFNLINLFGACE-----HDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l-~H~niv~l~g~~~-----~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+++.  +|+.+|+|++.      .+...|.++|+.. +|||++.++|++.     .++++|||||||.+||..|++
T Consensus        33 gkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLV  112 (953)
T KOG0587|consen   33 GKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLV  112 (953)
T ss_pred             eeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHH
Confidence            77777765  89999999984      5677888999988 7999999999884     357899999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      +... ...+.|..+.-|+..++.||.|||   ...++|||||-.|||+++++.+||+|||++.....   .........|
T Consensus       113 Kn~~-g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds---T~grRnT~iG  185 (953)
T KOG0587|consen  113 KNTK-GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS---TVGRRNTFIG  185 (953)
T ss_pred             hhhc-ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeeec---ccccccCcCC
Confidence            8865 567999999999999999999999   78999999999999999999999999999876532   2334566789


Q ss_pred             CCCccchhhhcc-----CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc
Q 007261          485 TNGYMAPEYMEY-----GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA  559 (611)
Q Consensus       485 t~~y~aPE~~~~-----~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~  559 (611)
                      |+.|||||++..     .-|+.++|+||||++..||--|.+|+.++.....+                 +.....|...-
T Consensus       186 tP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-----------------F~IpRNPPPkL  248 (953)
T KOG0587|consen  186 TPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----------------FLIPRNPPPKL  248 (953)
T ss_pred             CcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-----------------ccCCCCCCccc
Confidence            999999999854     34778999999999999999999998766542211                 11111222222


Q ss_pred             C-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          560 N-KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       560 ~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      . +.....++.+++..||..|-++||++.+++++
T Consensus       249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            2 66778889999999999999999999999875

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=3.8e-29  Score=223.68  Aligned_cols=244  Identities=21%  Similarity=0.288  Sum_probs=188.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |+||+|+.  .++.||+|+++         ....+|+-+|+.++|.|||+++++...+...-||+|||. -+|..+....
T Consensus        16 gtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfdsl   94 (292)
T KOG0662|consen   16 GTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSL   94 (292)
T ss_pred             eeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHhc
Confidence            99999986  67899999987         358899999999999999999999999999999999995 5888888764


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .  ..++......++.|+++||.|+|   +.++.||||||.|.||+.||+.|++|||+++..+-.-   ......+.|.+
T Consensus        95 n--g~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv---rcysaevvtlw  166 (292)
T KOG0662|consen   95 N--GDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV---RCYSAEVVTLW  166 (292)
T ss_pred             C--CcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce---Eeeeceeeeee
Confidence            3  34888888999999999999999   6899999999999999999999999999999765432   23345678999


Q ss_pred             ccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCC--cccccccccCccCCcC----
Q 007261          488 YMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN--AEAKLSVLVDPNLQAN----  560 (611)
Q Consensus       488 y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--~~~~l~~~~d~~l~~~----  560 (611)
                      |.+|.++-+. .|+...|+||.||++.|+.....|.+...+.+..+.+.+ ..+....  .+..+..+-|-...+.    
T Consensus       167 yrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif-~~lg~p~ed~wps~t~lpdyk~yp~ypat  245 (292)
T KOG0662|consen  167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF-RLLGTPTEDQWPSMTKLPDYKPYPIYPAT  245 (292)
T ss_pred             ccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHH-HHhCCCccccCCccccCCCCcccCCcccc
Confidence            9999998765 589999999999999999986666555444433443332 3332221  1222333333221110    


Q ss_pred             ------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          561 ------KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       561 ------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                            -......=++++...+.-+|..|.++++.+++
T Consensus       246 tswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  246 TSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             chHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence                  11223345678888888899999999988764

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-30  Score=246.04  Aligned_cols=232  Identities=24%  Similarity=0.381  Sum_probs=179.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.|+|-..  .|...|||+++        +++..|.+...+- +.||||+++|.+..++..|+.||.|+ .||+.+-+..
T Consensus        78 G~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~v  156 (361)
T KOG1006|consen   78 GTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRV  156 (361)
T ss_pred             hhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHH
Confidence            89998877  78999999996        3567777765554 79999999999999999999999995 6777655421


Q ss_pred             --CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          408 --RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       408 --~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                        .....+++.-.-+|..-..+||.||..  ...|+|||+||+|||+|..|.+||||||.+-.....    .......|-
T Consensus       157 y~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S----iAkT~daGC  230 (361)
T KOG1006|consen  157 YSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS----IAKTVDAGC  230 (361)
T ss_pred             HHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH----HHhhhccCC
Confidence              011237777777788888999999986  678999999999999999999999999987654322    234456788


Q ss_pred             CCccchhhhcc--CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC---
Q 007261          486 NGYMAPEYMEY--GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN---  560 (611)
Q Consensus       486 ~~y~aPE~~~~--~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~---  560 (611)
                      ..|||||.+..  ..|..++||||||++|+|+.||+.|+...+.    ..+.+..++.+           ||.....   
T Consensus       231 rpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~g-----------dpp~l~~~~~  295 (361)
T KOG1006|consen  231 RPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVIG-----------DPPILLFDKE  295 (361)
T ss_pred             ccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHcC-----------CCCeecCccc
Confidence            89999999853  3489999999999999999999999865543    22222233221           1221111   


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          561 KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       561 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+.+..+..++..|+..|-..||+..++.++
T Consensus       296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            23466789999999999999999999998763

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=258.91  Aligned_cols=228  Identities=24%  Similarity=0.369  Sum_probs=184.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH-hhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW-LHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~  406 (611)
                      |.||-|+.  +|+.||||++.         ..+.+|+.||++++||.||.+...|+..+..+.|||.+. |+..++ |..
T Consensus       578 G~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GDMLEMILSs  656 (888)
T KOG4236|consen  578 GTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GDMLEMILSS  656 (888)
T ss_pred             eeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-chHHHHHHHh
Confidence            99999987  89999999985         357889999999999999999999999999999999995 555554 444


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEeeecCccccccccCCcccccccc
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN---LRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      ..  ..++.....-+..||+.||.|||   -++|+|+||||+|||+.+.   -.+||||||+||.++..    .-.+..+
T Consensus       657 Ek--gRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk----sFRrsVV  727 (888)
T KOG4236|consen  657 EK--GRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK----SFRRSVV  727 (888)
T ss_pred             hc--ccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchh----hhhhhhc
Confidence            32  34888877888999999999999   6899999999999999654   47999999999988654    2456789


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      ||+.|+|||+++...|...-|+||.||++|.-++|-.||....+  +  .+.+    .       -..++-|.  ....+
T Consensus       728 GTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--I--ndQI----Q-------NAaFMyPp--~PW~e  790 (888)
T KOG4236|consen  728 GTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--I--NDQI----Q-------NAAFMYPP--NPWSE  790 (888)
T ss_pred             CCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--h--hHHh----h-------ccccccCC--Cchhh
Confidence            99999999999999999999999999999999999999864322  1  1100    0       01111111  11456


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      .+.+..+|+...|+..-.+|-|.+..+.+-
T Consensus       791 is~~AidlIn~LLqVkm~kRysvdk~lsh~  820 (888)
T KOG4236|consen  791 ISPEAIDLINNLLQVKMRKRYSVDKSLSHP  820 (888)
T ss_pred             cCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence            777888999999999999999998877643

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=8.6e-29  Score=245.66  Aligned_cols=243  Identities=22%  Similarity=0.292  Sum_probs=184.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcC-C-C----ceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKIN-H-F----NLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~-H-~----niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.|-+...  .+..||||+++      ....-|+++|.++. + |    -+|.+.+||...++.|||+|.+ |-|+.++|
T Consensus       103 GkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFl  181 (415)
T KOG0671|consen  103 GKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFL  181 (415)
T ss_pred             cceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHh
Confidence            77777665  46799999997      34566999999993 2 2    3788999999999999999998 56999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC--------------------CCCcEEEeeec
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD--------------------KNLRAKLANFS  464 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~--------------------~~~~~kl~Dfg  464 (611)
                      ..+.. .+++...+..|+.|++++++|||   +.+++|-||||+|||+.                    ++..+||+|||
T Consensus       182 k~N~y-~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFG  257 (415)
T KOG0671|consen  182 KENNY-IPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFG  257 (415)
T ss_pred             ccCCc-cccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecC
Confidence            98754 45788899999999999999999   79999999999999993                    14458999999


Q ss_pred             CccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhH-HHHHH-------
Q 007261          465 FVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL-LAEAV-------  536 (611)
Q Consensus       465 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~-l~~~~-------  536 (611)
                      .|+......      ...+.|..|.|||++.+-.++..+||||+||+|.||.+|...|+..+..|-. +.+.+       
T Consensus       258 sAtf~~e~h------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~  331 (415)
T KOG0671|consen  258 SATFDHEHH------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSR  331 (415)
T ss_pred             CcceeccCc------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHH
Confidence            987653322      4567899999999999999999999999999999999999999887654411 11111       


Q ss_pred             -------HHHHhcCCc-------ccccccccCccCC-----cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          537 -------FSMVEGGNA-------EAKLSVLVDPNLQ-----ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       537 -------~~~~~~~~~-------~~~l~~~~d~~l~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                             ......+..       ..+++...++...     ...+.....+.+|+.++|..||.+|+|+.|++.+
T Consensus       332 mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  332 MIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence                   000000000       0011112222111     1134556779999999999999999999999864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=3e-28  Score=269.85  Aligned_cols=254  Identities=15%  Similarity=0.206  Sum_probs=163.7

Q ss_pred             hhcCCCCCccc----ceEEEEEE--c----CcEEEEEEecHHHHHHHHHHHhcC---CCceeeccce------eccCCeE
Q 007261          328 TENFSPKNMID----GSVFRGII--N----GSTVAIKCMRRSISKEVNLLKKIN---HFNLINLFGA------CEHDGVF  388 (611)
Q Consensus       328 t~~f~~~~~ig----g~Vy~g~~--~----g~~vavK~~~~~~~~E~~~l~~l~---H~niv~l~g~------~~~~~~~  388 (611)
                      .++|.....||    |.||+|++  +    +..||||++......|..+..+++   +.++..++..      +..+...
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEY  210 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCce
Confidence            34455555555    89999998  4    679999998754444444444443   3333333322      2456689


Q ss_pred             EEEEeecCCCCHHHHhhccCCCC-----------------ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCee
Q 007261          389 YLVYEFMENGSLSDWLHKKRYPE-----------------FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL  451 (611)
Q Consensus       389 ~lV~E~~~~gsL~~~l~~~~~~~-----------------~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NIL  451 (611)
                      +|||||+++++|.+++.......                 ......+..++.|++.||+|||   +.+|+||||||+|||
T Consensus       211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NIL  287 (566)
T PLN03225        211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNII  287 (566)
T ss_pred             EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHEE
Confidence            99999999999999997643110                 0112345579999999999999   689999999999999


Q ss_pred             eCC-CCcEEEeeecCccccccccCCcccccccccCCCccchhhhccC----------------------CCCCccchHHH
Q 007261          452 LDK-NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYG----------------------LVTPEMDTYAF  508 (611)
Q Consensus       452 l~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksDV~s~  508 (611)
                      +++ ++.+||+|||+++.......  .......+++.|+|||.+...                      .++.++|||||
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            986 58999999999975432211  123345788999999965322                      23456799999


Q ss_pred             HHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC-------hHHHHHHHHHHHHHhhccCCC
Q 007261          509 GVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN-------KKEIAHHLIMLCLACIAREPE  581 (611)
Q Consensus       509 Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~-------~~~~~~~l~~l~~~Cl~~dP~  581 (611)
                      ||+||||+++..+...   ....+...   +...+..........++.....       .+.......+|+.+||+.||+
T Consensus       366 GviL~el~~~~~~~~~---~~~~~~~~---l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        366 GLIFLQMAFPNLRSDS---NLIQFNRQ---LKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             HHHHHHHHhCcCCCch---HHHHHHHH---HHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            9999999987654321   11111110   1000100011111111111000       011123456899999999999


Q ss_pred             CCCCHHHHHHH
Q 007261          582 SRPSMAEVVST  592 (611)
Q Consensus       582 ~RPs~~evl~~  592 (611)
                      +|||+.|++++
T Consensus       440 kR~ta~e~L~H  450 (566)
T PLN03225        440 QRISAKAALAH  450 (566)
T ss_pred             cCCCHHHHhCC
Confidence            99999999986

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.8e-29  Score=248.45  Aligned_cols=235  Identities=20%  Similarity=0.390  Sum_probs=184.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------------HHHHHHHHHHHhcCCCceeeccceec-cCCeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------------RSISKEVNLLKKINHFNLINLFGACE-HDGVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------------~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~~~gsL~  401 (611)
                      ..||++..  ..+.||||+-.              +...+|.+|.+.|+||.||++|++|. +.+.+|-|+|||+|.+|+
T Consensus       477 SEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLD  556 (775)
T KOG1151|consen  477 SEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLD  556 (775)
T ss_pred             HHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchh
Confidence            68999976  67889999863              23567999999999999999999986 557789999999999999


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEeeecCcccccccc----C
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD---KNLRAKLANFSFVRSAVREE----S  474 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgla~~~~~~~----~  474 (611)
                      -+|+.++   .++.++...|+.||..||.||.. .+++|||-||||.|||+-   ..|.+||.||||++....+.    .
T Consensus       557 FYLKQhk---lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vd  632 (775)
T KOG1151|consen  557 FYLKQHK---LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVD  632 (775)
T ss_pred             HHHHhhh---hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCccc
Confidence            9999875   48999999999999999999985 478999999999999994   45889999999998765442    2


Q ss_pred             CcccccccccCCCccchhhhcc----CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHH-HHHHHHhcCCccccc
Q 007261          475 GYSSTKTAVGTNGYMAPEYMEY----GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE-AVFSMVEGGNAEAKL  549 (611)
Q Consensus       475 ~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~-~~~~~~~~~~~~~~l  549 (611)
                      +...+....||.+|++||.+.-    .+.+.|.||||.||++|.++.|+.||.........+.. .+...          
T Consensus       633 GmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA----------  702 (775)
T KOG1151|consen  633 GMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA----------  702 (775)
T ss_pred             ceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc----------
Confidence            2345667789999999998743    35788999999999999999999999765443222211 11000          


Q ss_pred             ccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       550 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      .+.   .++. -...+.+...++++||+..-++|....++..
T Consensus       703 tEV---qFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  703 TEV---QFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             eec---cCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            000   0000 1223456788999999999999988877654

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=5.4e-29  Score=233.74  Aligned_cols=246  Identities=22%  Similarity=0.341  Sum_probs=181.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceecc--------CCeEEEEEeecCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEH--------DGVFYLVYEFMENGS  399 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~--------~~~~~lV~E~~~~gs  399 (611)
                      |.||+++.  .|+.||+|+.-         ....+|+++|..++|+|++.++..|..        ...+||||++|+. +
T Consensus        31 geVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-D  109 (376)
T KOG0669|consen   31 GEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-D  109 (376)
T ss_pred             HHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-h
Confidence            88999876  57788988752         357899999999999999999998843        2458999999974 8


Q ss_pred             HHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC-Cccc
Q 007261          400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES-GYSS  478 (611)
Q Consensus       400 L~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~  478 (611)
                      |.-.|....  ..++...+.+++.++..||.|+|   ...|+|||+|+.|+||+.++.+||+|||+++....... ....
T Consensus       110 LaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kpr  184 (376)
T KOG0669|consen  110 LAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPR  184 (376)
T ss_pred             HHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCC
Confidence            888887653  34888899999999999999999   78999999999999999999999999999976543322 1122


Q ss_pred             ccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc-------ccc
Q 007261          479 TKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA-------KLS  550 (611)
Q Consensus       479 ~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~-------~l~  550 (611)
                      ....+.|.+|.+||.+.+ ..++++.|||..||++.||+++.+-+.+......  ...+..+...-..+-       .+-
T Consensus       185 ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq--l~~Is~LcGs~tkevWP~~d~lpL~  262 (376)
T KOG0669|consen  185 YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ--LHLISQLCGSITKEVWPNVDNLPLY  262 (376)
T ss_pred             cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH--HHHHHHHhccCCcccCCCcccchHH
Confidence            345677999999998765 5699999999999999999999877765443221  112222221111100       000


Q ss_pred             ccc--CccCCcC----------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          551 VLV--DPNLQAN----------KKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       551 ~~~--d~~l~~~----------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      .-+  .| +...          +-.-..+..+|+..++..||.+|+.+++++.+-
T Consensus       263 ~sie~eP-l~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  263 QSIELEP-LPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             HhccCCC-CCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            001  11 1100          001123577899999999999999999998753

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.2e-28  Score=243.44  Aligned_cols=218  Identities=25%  Similarity=0.442  Sum_probs=179.7

Q ss_pred             ceEEEEEEcC--cEEEEEEecHHH----------HHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGIING--STVAIKCMRRSI----------SKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~~g--~~vavK~~~~~~----------~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.|..+...|  +.+|||+++++.          ..|-++|.-. +-|.++++..+|..-+.+|+||||+.||+|--+++
T Consensus       363 GKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQ  442 (683)
T KOG0696|consen  363 GKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ  442 (683)
T ss_pred             ceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHH
Confidence            8888887744  579999998653          3466666665 67889999999999999999999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      +-+.   +.+...+-.|.+||-||-|||   +++|+.||||..|||+|.+|.+||+|||+++....+   ...++..+||
T Consensus       443 Q~Gk---FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~---~~TTkTFCGT  513 (683)
T KOG0696|consen  443 QVGK---FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD---GVTTKTFCGT  513 (683)
T ss_pred             Hhcc---cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC---CcceeeecCC
Confidence            7542   555667778999999999999   799999999999999999999999999999865433   2467788999


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+...+|+...|+|||||+||||+.|+.||.+.+.++..  .   ...             +.. ...+...+
T Consensus       514 PdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF--~---aI~-------------ehn-vsyPKslS  574 (683)
T KOG0696|consen  514 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF--Q---AIM-------------EHN-VSYPKSLS  574 (683)
T ss_pred             CcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH--H---HHH-------------Hcc-CcCccccc
Confidence            9999999999999999999999999999999999999877655421  1   111             111 12256677


Q ss_pred             HHHHHHHHHhhccCCCCCC
Q 007261          566 HHLIMLCLACIAREPESRP  584 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RP  584 (611)
                      .+...+++..+..+|.+|.
T Consensus       575 kEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  575 KEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HHHHHHHHHHhhcCCcccc
Confidence            7888899999999999995

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.95  E-value=6.9e-27  Score=253.04  Aligned_cols=249  Identities=20%  Similarity=0.259  Sum_probs=169.6

Q ss_pred             hhcCCCCCccc----ceEEEEEE------------------cCcEEEEEEec-------HHHH--------------HHH
Q 007261          328 TENFSPKNMID----GSVFRGII------------------NGSTVAIKCMR-------RSIS--------------KEV  364 (611)
Q Consensus       328 t~~f~~~~~ig----g~Vy~g~~------------------~g~~vavK~~~-------~~~~--------------~E~  364 (611)
                      .++|...++||    |.||+|.+                  ++..||||+++       ++|.              .|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            34566556665    89999964                  34579999975       1232              366


Q ss_pred             HHHHhcCCCce-----eeccceecc--------CCeEEEEEeecCCCCHHHHhhccCC---------------------C
Q 007261          365 NLLKKINHFNL-----INLFGACEH--------DGVFYLVYEFMENGSLSDWLHKKRY---------------------P  410 (611)
Q Consensus       365 ~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~  410 (611)
                      .++.+++|.++     ++++++|..        ++..+|||||+++++|.++|+....                     .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766554     678888753        3568999999999999999975311                     1


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA  490 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~a  490 (611)
                      ..++|..+..++.|++.||.|||   ..+++||||||+|||++.++.+||+|||+++......  ........+++.|+|
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~--~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI--NFNPLYGMLDPRYSP  378 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC--ccCccccCCCcceeC
Confidence            13567888999999999999999   6889999999999999999999999999986543221  111222345789999


Q ss_pred             hhhhccCCC----------------------CCccchHHHHHHHHHHHhCCC-CCcCCCChhhHHHH---H--HHHHHhc
Q 007261          491 PEYMEYGLV----------------------TPEMDTYAFGVVLLELITGKE-AAYKQDGEEILLAE---A--VFSMVEG  542 (611)
Q Consensus       491 PE~~~~~~~----------------------s~ksDV~s~Gvvl~elltG~~-p~~~~~~~~~~l~~---~--~~~~~~~  542 (611)
                      ||.+.....                      ..+.||||+||+++||++|.. |+.........+..   .  .+.....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            998754321                      235799999999999999875 44321110000000   0  0001000


Q ss_pred             CCcccccccccCccCCcChHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHH
Q 007261          543 GNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREP---ESRPSMAEVVST  592 (611)
Q Consensus       543 ~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~~  592 (611)
                      .        ..+  + ...+...+...+|+.+++..+|   .+|+|+.|+++|
T Consensus       459 ~--------~~~--~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        459 Q--------KYD--F-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             c--------CCC--c-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            0        000  0 0123345678889999999766   689999999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=4.1e-27  Score=215.34  Aligned_cols=182  Identities=21%  Similarity=0.381  Sum_probs=150.3

Q ss_pred             eEEEEEEcCcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc-CC
Q 007261          340 SVFRGIINGSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RY  409 (611)
Q Consensus       340 ~Vy~g~~~g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~  409 (611)
                      .+|+-..+|...|+|.++        ++..+|+++..+- ..|.+|.++|...+.+..++.||.|+ .||+.+-++. ..
T Consensus        63 ekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~  141 (282)
T KOG0984|consen   63 EKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKK  141 (282)
T ss_pred             hheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhc
Confidence            567777799999999996        3456677776665 79999999999999999999999995 6888776542 22


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                      ...+++.-.-+||..+..||.|||+  +..++|||+||+|||++.+|++|+||||.+-.....-    ......|-..||
T Consensus       142 g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi----Akt~daGCkpYm  215 (282)
T KOG0984|consen  142 GGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI----AKTMDAGCKPYM  215 (282)
T ss_pred             CCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh----HHHHhcCCCccC
Confidence            3458888888999999999999997  7889999999999999999999999999876553221    222346778899


Q ss_pred             chhhhcc----CCCCCccchHHHHHHHHHHHhCCCCCcCCCCh
Q 007261          490 APEYMEY----GLVTPEMDTYAFGVVLLELITGKEAAYKQDGE  528 (611)
Q Consensus       490 aPE~~~~----~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~  528 (611)
                      |||.+..    ..|+-|+||||||+++.||.+++.|+......
T Consensus       216 aPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  216 APERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             ChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence            9998853    36899999999999999999999998766544

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7e-28  Score=265.89  Aligned_cols=230  Identities=24%  Similarity=0.356  Sum_probs=181.4

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.|...+.  .++.+|.|++.+          -|..|-++|..-+.+-|+++.-.|.++.++|+|||||+||+|-.+|.+
T Consensus        89 GEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk  168 (1317)
T KOG0612|consen   89 GEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSK  168 (1317)
T ss_pred             ceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhh
Confidence            89998887  678999999864          377899999988999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .++..-..-++..|.-||.-||   +.|+|||||||+|||||..|++||+|||.+-....+  +.......+|||
T Consensus       169 ~~---~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d--G~V~s~~aVGTP  240 (1317)
T KOG0612|consen  169 FD---RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD--GTVRSSVAVGTP  240 (1317)
T ss_pred             cC---CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCCC--CcEEeccccCCC
Confidence            64   3776667778899999999999   799999999999999999999999999987554322  234456679999


Q ss_pred             Cccchhhhc----c-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcCh
Q 007261          487 GYMAPEYME----Y-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK  561 (611)
Q Consensus       487 ~y~aPE~~~----~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  561 (611)
                      .|++||++.    + +.|++.+|+||+||++|||+.|..|||...-     .+.....+....   .+      .++ ..
T Consensus       241 DYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl-----veTY~KIm~hk~---~l------~FP-~~  305 (1317)
T KOG0612|consen  241 DYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL-----VETYGKIMNHKE---SL------SFP-DE  305 (1317)
T ss_pred             CccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH-----HHHHHHHhchhh---hc------CCC-cc
Confidence            999999984    3 6799999999999999999999999986532     222222221110   00      011 12


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 007261          562 KEIAHHLIMLCLACIAREPESRPS---MAEVVST  592 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~  592 (611)
                      .+.+++..+||.+.+. +|+.|..   +.++-.+
T Consensus       306 ~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  306 TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            3367778888887654 6777877   7777654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=9.5e-26  Score=217.19  Aligned_cols=197  Identities=38%  Similarity=0.635  Sum_probs=172.6

Q ss_pred             ceEEEEEEc--CcEEEEEEecH--------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGIIN--GSTVAIKCMRR--------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++...  |+.+++|++..        .+.+|+..++.++|++++++++++......++++||+++++|.+++....
T Consensus         7 ~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~   86 (215)
T cd00180           7 GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE   86 (215)
T ss_pred             eEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc
Confidence            899999995  89999999852        47899999999999999999999999999999999999999999998753


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-NLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                        ..+++..+..++.++++++.+||   ..+++|+||+|.||+++. ++.++|+|||.+........   ......+...
T Consensus        87 --~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~  158 (215)
T cd00180          87 --GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGTPA  158 (215)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhhcccCCCC
Confidence              34889999999999999999999   679999999999999999 89999999999875533211   1233557788


Q ss_pred             ccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          488 YMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       488 y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      |++||.+... ..+.++|+|++|+++++|                                                  .
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------------~  188 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------------P  188 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------------H
Confidence            9999999887 889999999999999998                                                  3


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      .+.+++.+|++.||++||++.++++++
T Consensus       189 ~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         189 ELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            467899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.9e-27  Score=240.10  Aligned_cols=227  Identities=22%  Similarity=0.286  Sum_probs=185.2

Q ss_pred             ceEEEEEEcCcE--EEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGIINGST--VAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~~g~~--vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.|=....+++.  +|+|.+++          .+..|-.+|...+.|.||++|-.|.+....|+.||-|-||.|+..|++
T Consensus       434 GRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrd  513 (732)
T KOG0614|consen  434 GRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRD  513 (732)
T ss_pred             ceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhh
Confidence            788777776655  78998863          356789999999999999999999999999999999999999999998


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .+.   ++.....-++.-+.+|++|||   .++||.|||||+|+++|.+|-+||.|||+|+.....    ..+...+||+
T Consensus       514 Rg~---Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g----~KTwTFcGTp  583 (732)
T KOG0614|consen  514 RGS---FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG----RKTWTFCGTP  583 (732)
T ss_pred             cCC---cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC----CceeeecCCc
Confidence            753   666666778889999999999   799999999999999999999999999999987654    3567889999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|.|||.+.+...+.+.|.||||++++||++|++||...+....  ...+   +.+-          |  ....|.....
T Consensus       584 EYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt--Yn~I---LkGi----------d--~i~~Pr~I~k  646 (732)
T KOG0614|consen  584 EYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT--YNLI---LKGI----------D--KIEFPRRITK  646 (732)
T ss_pred             ccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH--HHHH---Hhhh----------h--hhhcccccch
Confidence            99999999999899999999999999999999999987654321  1111   1100          0  0112344556


Q ss_pred             HHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPS-----MAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs-----~~evl~~  592 (611)
                      ...+|+++.+..+|.+|..     +.+|-++
T Consensus       647 ~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  647 TATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             hHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence            6788999999999999975     4455444

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=2.4e-26  Score=213.23  Aligned_cols=241  Identities=17%  Similarity=0.324  Sum_probs=179.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec----HHHHHHHHHHHhcC-CCceeeccceeccC--CeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR----RSISKEVNLLKKIN-HFNLINLFGACEHD--GVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      +.||.|..  +++.++||+++    +.+.+|+.+|..|. ||||+.+++...+.  ..+.||+||+.+.+.......   
T Consensus        52 SEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t---  128 (338)
T KOG0668|consen   52 SEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT---  128 (338)
T ss_pred             hhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh---
Confidence            67999984  88999999996    57899999999996 99999999998764  568999999999887666543   


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN-LRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         ++...+.-.+.+++.||.|+|   +.||.|||+||.|++||.. -.++|+|+|||.......    .-...+.+..|
T Consensus       129 ---l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~----eYnVRVASRyf  198 (338)
T KOG0668|consen  129 ---LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK----EYNVRVASRYF  198 (338)
T ss_pred             ---hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCc----eeeeeeehhhc
Confidence               666777889999999999999   6999999999999999865 579999999998764432    22345667788


Q ss_pred             cchhhhc-cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHH--------HHHHhcCC--cccccccccCc--
Q 007261          489 MAPEYME-YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAV--------FSMVEGGN--AEAKLSVLVDP--  555 (611)
Q Consensus       489 ~aPE~~~-~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~--------~~~~~~~~--~~~~l~~~~d~--  555 (611)
                      ..||.+. ...|...-|+|||||+|.+|+..+.||+...+....+....        ...+..-.  ....+..++..  
T Consensus       199 KGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~  278 (338)
T KOG0668|consen  199 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHS  278 (338)
T ss_pred             CCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccc
Confidence            9999885 45688999999999999999999999986544322222111        11111000  00011111110  


Q ss_pred             ------cCCcCh-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          556 ------NLQANK-KEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       556 ------~l~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                            ....+. .-..++..+|+.+.|..|-.+|+|++|.+.+
T Consensus       279 rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  279 RKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             cccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence                  001111 1224778999999999999999999998864

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.4e-26  Score=221.71  Aligned_cols=234  Identities=19%  Similarity=0.377  Sum_probs=178.2

Q ss_pred             hcCCCCCccc-c---eEEEEEE--cCcEEEEEEecHHH----------HHHHHHHHhc-CCCceeeccceeccCCeEEEE
Q 007261          329 ENFSPKNMID-G---SVFRGII--NGSTVAIKCMRRSI----------SKEVNLLKKI-NHFNLINLFGACEHDGVFYLV  391 (611)
Q Consensus       329 ~~f~~~~~ig-g---~Vy~g~~--~g~~vavK~~~~~~----------~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  391 (611)
                      ++|..-..|| |   .|..+.+  ..+.+|+|++++++          ..|-.+..+- +||.+|-+..+|..+..+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            3444445555 3   3444444  56789999998654          3455566555 899999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccccc
Q 007261          392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR  471 (611)
Q Consensus       392 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~  471 (611)
                      .||++||+|--++.+.+.   ++.....-...+|+-||.|||   +.+|+.||||..|+|+|..|.+||.|+|+++....
T Consensus       330 ieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence            999999999777766542   777777788899999999999   79999999999999999999999999999986544


Q ss_pred             ccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcC--CCChhhHHHHHHHHHHhcCCccccc
Q 007261          472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKL  549 (611)
Q Consensus       472 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~--~~~~~~~l~~~~~~~~~~~~~~~~l  549 (611)
                      +.   ..+...+||+.|+|||.+++..|....|+|++||+++||+.|+.||.-  .+..+..-.+.++++.-+.    .+
T Consensus       404 ~g---d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek----qi  476 (593)
T KOG0695|consen  404 PG---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK----QI  476 (593)
T ss_pred             CC---cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh----cc
Confidence            32   356678999999999999999999999999999999999999999963  2222222223333333211    11


Q ss_pred             ccccCccCCcChHHHHHHHHHHHHHhhccCCCCCC
Q 007261          550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRP  584 (611)
Q Consensus       550 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP  584 (611)
                      +         -+...+-....+++.-|+.||.+|.
T Consensus       477 r---------iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  477 R---------IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             c---------ccceeehhhHHHHHHhhcCCcHHhc
Confidence            1         0222334455678888999999985

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-26  Score=219.75  Aligned_cols=232  Identities=24%  Similarity=0.411  Sum_probs=185.5

Q ss_pred             ceEEEEEEcCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |..|+|+|.|..++.|++.         ++|..|.-.|+.+.||||+.++|.|....++.++..||+.|||...|+....
T Consensus       204 gelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~  283 (448)
T KOG0195|consen  204 GELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTS  283 (448)
T ss_pred             cccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCcc
Confidence            9999999999999989874         5789999999999999999999999999999999999999999999998643


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                       -..+..+.+++|.++|+|++|||+. ++-|.---|.+..+++|++.+++|+= +-++...       ......-.+.||
T Consensus       284 -vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsf-------qe~gr~y~pawm  353 (448)
T KOG0195|consen  284 -VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF-------QEVGRAYSPAWM  353 (448)
T ss_pred             -EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeee-------eccccccCcccC
Confidence             4467788999999999999999974 34455557999999999999988751 1111111       111234567899


Q ss_pred             chhhhccCC---CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          490 APEYMEYGL---VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       490 aPE~~~~~~---~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      +||.++...   .-.++|+|||.++||||.|...||......+......+          +.++..+       +...+.
T Consensus       354 spealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial----------eglrv~i-------ppgis~  416 (448)
T KOG0195|consen  354 SPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL----------EGLRVHI-------PPGISR  416 (448)
T ss_pred             CHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh----------ccccccC-------CCCccH
Confidence            999997654   34579999999999999999999987766554433322          1122222       445667


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                      .+.+||.-|+..||.+||.++.++-.|++++
T Consensus       417 hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  417 HMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             HHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            8999999999999999999999999999875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-26  Score=224.11  Aligned_cols=232  Identities=24%  Similarity=0.322  Sum_probs=173.7

Q ss_pred             cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccC------CeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          347 NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD------GVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       347 ~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      .+++||+|++.         ++..+|..++..++|+||++++.+|.-.      .+.|+|||+|. .+|...+...    
T Consensus        40 ~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~e----  114 (369)
T KOG0665|consen   40 LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILME----  114 (369)
T ss_pred             ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHHh----
Confidence            67899999874         4677899999999999999999998543      35799999995 6898888732    


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                       ++-.....|..|++.|+.|||   +.+|+||||||+||++..+..+||.|||+|+.....    ......+.|..|.||
T Consensus       115 -lDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~----~~mtpyVvtRyyrap  186 (369)
T KOG0665|consen  115 -LDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD----FMMTPYVVTRYYRAP  186 (369)
T ss_pred             -cchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc----cccCchhheeeccCc
Confidence             666777889999999999999   799999999999999999999999999999865433    244556789999999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChh-----------------hHHHHHHHHHHhcCCccc---ccc-
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE-----------------ILLAEAVFSMVEGGNAEA---KLS-  550 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~-----------------~~l~~~~~~~~~~~~~~~---~l~-  550 (611)
                      |++.+-.+.+.+||||.||++.||++|+..|.+.+.-+                 ..+......+++ ..++.   .+. 
T Consensus       187 evil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~-~~~~y~~~~f~~  265 (369)
T KOG0665|consen  187 EVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE-NRPQYQAISFSE  265 (369)
T ss_pred             hheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh-cChHhhccchhh
Confidence            99988779999999999999999999998876432111                 001111111111 00010   111 


Q ss_pred             cccCccCCcC---hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          551 VLVDPNLQAN---KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       551 ~~~d~~l~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+-|..+...   ..-...-+.+++.+||-.||++|.|+++++++
T Consensus       266 ~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  266 LFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            1112111111   22233457889999999999999999999875

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=1.5e-25  Score=233.42  Aligned_cols=185  Identities=22%  Similarity=0.365  Sum_probs=153.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |+|..+.-  ....+|.|.+++          .++.|-+||..-+.+-||+||-.|.+++.+|+||||++||++-.+|-+
T Consensus       643 GeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr  722 (1034)
T KOG0608|consen  643 GEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR  722 (1034)
T ss_pred             ceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHH
Confidence            77877754  455789998874          246699999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccccccc-CC----------
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE-SG----------  475 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~-~~----------  475 (611)
                      .+   .+.+....-++.++..|+++.|   +.|+|||||||+|||||.+|.+||.||||+.-..+.. +.          
T Consensus       723 mg---IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~Rq  796 (1034)
T KOG0608|consen  723 MG---IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQ  796 (1034)
T ss_pred             hc---cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccccccCCCcccc
Confidence            64   2666666667889999999999   7999999999999999999999999999985332110 00          


Q ss_pred             ----------------------------cccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCC
Q 007261          476 ----------------------------YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDG  527 (611)
Q Consensus       476 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~  527 (611)
                                                  .......+||+.|+|||++....++..+|+||.||+|+||+.|+.||.....
T Consensus       797 DSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  797 DSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTP  876 (1034)
T ss_pred             ccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCC
Confidence                                        0011234699999999999999999999999999999999999999987655


Q ss_pred             hh
Q 007261          528 EE  529 (611)
Q Consensus       528 ~~  529 (611)
                      .+
T Consensus       877 ~~  878 (1034)
T KOG0608|consen  877 GE  878 (1034)
T ss_pred             Cc
Confidence            43

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=4.6e-26  Score=232.87  Aligned_cols=245  Identities=27%  Similarity=0.314  Sum_probs=186.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH------HHHHHHHHHHhcC------CCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR------SISKEVNLLKKIN------HFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~------H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      +.|.+|..  .|..||||+++.      .=.+|+++|++|+      --++++|+-.|....++|||||-+ .-+|.+.|
T Consensus       446 s~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevL  524 (752)
T KOG0670|consen  446 STVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVL  524 (752)
T ss_pred             eeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHH
Confidence            56777766  578999999973      3467999999994      358999999999999999999988 57999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeecCccccccccCCcccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN-LRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      +.-+....|.......++.|+.-||..|-   .-+|+|.||||.|||+++. ..+||||||.|..+...+-     ....
T Consensus       525 KKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei-----tPYL  596 (752)
T KOG0670|consen  525 KKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEI-----TPYL  596 (752)
T ss_pred             HHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccccccccccc-----cHHH
Confidence            98766666888999999999999999999   6789999999999999876 6789999999876654432     1223


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhH-HHHHH-----HHHHhcCCc------------
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL-LAEAV-----FSMVEGGNA------------  545 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~-l~~~~-----~~~~~~~~~------------  545 (611)
                      .+..|.|||.+.+-.|+...|+||.||+||||.||+..|.+.....+. +...+     ..++..+..            
T Consensus       597 VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~  676 (752)
T KOG0670|consen  597 VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFL  676 (752)
T ss_pred             HHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceE
Confidence            456799999999999999999999999999999999998876554321 11000     001100000            


Q ss_pred             -------c--c--ccccccC------------ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          546 -------E--A--KLSVLVD------------PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       546 -------~--~--~l~~~~d------------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                             .  +  .+...+.            +.+..+.......+.+|+..|+..||++|.+..+.+++
T Consensus       677 ~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  677 YIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             EEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence                   0  0  0011111            12233344566779999999999999999999998865

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=5.9e-25  Score=207.84  Aligned_cols=170  Identities=22%  Similarity=0.241  Sum_probs=129.0

Q ss_pred             CCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcc
Q 007261          398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS  477 (611)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  477 (611)
                      |+|.++++..+  ..++|..++.|+.|++.||+|||+   .+      ||+|||++.++.+|+  ||+++.....     
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----   62 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE-----   62 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc-----
Confidence            78999998643  349999999999999999999994   43      999999999999999  9998754321     


Q ss_pred             cccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccC
Q 007261          478 STKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNL  557 (611)
Q Consensus       478 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l  557 (611)
                         ...|++.|+|||.+.+..++.++||||||+++|||++|+.|+.........+.........           .++..
T Consensus        63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~  128 (176)
T smart00750       63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA-----------DDPRD  128 (176)
T ss_pred             ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc-----------CCccc
Confidence               1257899999999999999999999999999999999999986543322122111111110           00111


Q ss_pred             CcChHHHHH--HHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          558 QANKKEIAH--HLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       558 ~~~~~~~~~--~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      .........  ++.+++.+||+.||++||++.|+++++..+...
T Consensus       129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            111223333  699999999999999999999999999876543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=2.8e-26  Score=266.24  Aligned_cols=200  Identities=20%  Similarity=0.229  Sum_probs=140.9

Q ss_pred             HHhcCC-Cceeecccee-------ccCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCC
Q 007261          367 LKKINH-FNLINLFGAC-------EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDP  438 (611)
Q Consensus       367 l~~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~  438 (611)
                      .+.++| +||++++++|       .+.+.+++++||+ +++|.++|....  ..+++..++.++.||+.||+|||   +.
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~   99 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAH---SQ   99 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHH---hC
Confidence            345567 6888999988       2334678889988 569999997542  34899999999999999999999   68


Q ss_pred             CeEecCCCCCCeeeCCC-------------------CcEEEeeecCccccccccCC-------------cccccccccCC
Q 007261          439 GYVHKDISSGNILLDKN-------------------LRAKLANFSFVRSAVREESG-------------YSSTKTAVGTN  486 (611)
Q Consensus       439 ~ivH~Dlk~~NILl~~~-------------------~~~kl~Dfgla~~~~~~~~~-------------~~~~~~~~gt~  486 (611)
                      +|+||||||+||||+..                   +.+|++|||+++........             ........||+
T Consensus       100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence            99999999999999654                   44556666665432110000             00011235788


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|||||++.+..++.++|||||||+||||++|..|+.....   .    ......         ...++..    .....
T Consensus       180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~----~~~~~~---------~~~~~~~----~~~~~  239 (793)
T PLN00181        180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---T----MSSLRH---------RVLPPQI----LLNWP  239 (793)
T ss_pred             ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---H----HHHHHH---------hhcChhh----hhcCH
Confidence            99999999999999999999999999999998876532110   0    111100         0011111    11123


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ....++.+||+.+|.+||+|.|++++
T Consensus       240 ~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        240 KEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHHHhCCCChhhCcChHHHhhc
Confidence            45678899999999999999999874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-26  Score=220.52  Aligned_cols=244  Identities=23%  Similarity=0.365  Sum_probs=179.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccC-----CeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD-----GVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~  402 (611)
                      |.||....  +|+.||+|++.         +.+.+|+.+|..++|.|++..++...-.     .+.|.++|.|. .+|..
T Consensus        67 GVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHK  145 (449)
T KOG0664|consen   67 GVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHK  145 (449)
T ss_pred             eEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhh
Confidence            89998887  89999999985         4577899999999999999998866432     24688889884 57776


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      .+..   ++.++-....-+..||++||.|||   ..+|.||||||.|.|++.|-.+||||||+++.....+.  ..+...
T Consensus       146 IIVS---PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~--~hMTqE  217 (449)
T KOG0664|consen  146 IIVS---PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR--LNMTHE  217 (449)
T ss_pred             eecc---CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhhh--hhhHHH
Confidence            6654   355887888889999999999999   68999999999999999999999999999997654432  344556


Q ss_pred             ccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc-------cc----ccc
Q 007261          483 VGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA-------EA----KLS  550 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-------~~----~l~  550 (611)
                      +-|..|.|||.+.+. .|+.+.||||.||++.||+..+..|.....-+.  .+.+..++.....       ++    .++
T Consensus       218 VVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ--L~lItdLLGTPs~EaMr~ACEGAk~H~LR  295 (449)
T KOG0664|consen  218 VVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ--LQMIIDLLGTPSQEAMKYACEGAKNHVLR  295 (449)
T ss_pred             HHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH--HHHHHHHhCCCcHHHHHHHhhhhHHHhhc
Confidence            779999999998775 599999999999999999988877765443221  1222222221110       00    111


Q ss_pred             c-ccCccCC---c--ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          551 V-LVDPNLQ---A--NKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       551 ~-~~d~~l~---~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      . ...|.+.   .  .+..-..+...+...++..||+.|.+..+.+.++
T Consensus       296 ~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  296 AGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             cCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            0 1111111   1  1222233456677788999999999999988765

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=8.3e-26  Score=237.44  Aligned_cols=230  Identities=24%  Similarity=0.410  Sum_probs=189.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.|||++.  .|+..|||+++       .-...|+-+++..+|+|||.++|.+...+..|+.||||.+|+|.+.-+-.+ 
T Consensus        29 gdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tg-  107 (829)
T KOG0576|consen   29 GDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTG-  107 (829)
T ss_pred             cchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecc-
Confidence            89999987  78999999997       235679999999999999999999999999999999999999999887654 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                        ++++.++..++++...||+|||   ..+-+|||||-.|||+++.+.+|++|||.+-.+...   ....+...||+.||
T Consensus       108 --plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat---i~KrksfiGtpywm  179 (829)
T KOG0576|consen  108 --PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT---IAKRKSFIGTPYWM  179 (829)
T ss_pred             --cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh---hhhhhcccCCcccc
Confidence              4888899999999999999999   678899999999999999999999999987655322   23456778999999


Q ss_pred             chhhh---ccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          490 APEYM---EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       490 aPE~~---~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      |||+.   +.+.|..++|||+.|+...|+---..|.+.......     .+-+-         ....+|....+.....+
T Consensus       180 apEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~-----l~LmT---------kS~~qpp~lkDk~kws~  245 (829)
T KOG0576|consen  180 APEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA-----LFLMT---------KSGFQPPTLKDKTKWSE  245 (829)
T ss_pred             chhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH-----HHHhh---------ccCCCCCcccCCccchH
Confidence            99976   456799999999999999999888877665433221     11111         12233444444555677


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      .+-+|++.|+..+|.+||+++.+++
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhhee
Confidence            7899999999999999999998876

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.91  E-value=1e-23  Score=206.45  Aligned_cols=179  Identities=34%  Similarity=0.500  Sum_probs=155.6

Q ss_pred             ceEEEEEEc--CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGIIN--GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~~--g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++...  ++.+++|.+.        +.+.+|++.+++++|+|++++++++......++++||+++++|.+++....
T Consensus        13 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~   92 (225)
T smart00221       13 GKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKG   92 (225)
T ss_pred             eEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcc
Confidence            899999983  6899999985        256779999999999999999999999899999999999999999998754


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                      ..  +++.....++.+++.++.|||   ..+++|+||++.||+++.++.++|+|||++........  .......++..|
T Consensus        93 ~~--~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~  165 (225)
T smart00221       93 GK--LSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA--ALLKTVKGTPFY  165 (225)
T ss_pred             cC--CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc--ccccceeccCCc
Confidence            21  788999999999999999999   57999999999999999999999999999876543321  022345677889


Q ss_pred             cchhhh-ccCCCCCccchHHHHHHHHHHHhCCCCCcC
Q 007261          489 MAPEYM-EYGLVTPEMDTYAFGVVLLELITGKEAAYK  524 (611)
Q Consensus       489 ~aPE~~-~~~~~s~ksDV~s~Gvvl~elltG~~p~~~  524 (611)
                      ++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       166 ~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      166 LAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             CCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            999998 777788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=4.9e-24  Score=217.23  Aligned_cols=110  Identities=25%  Similarity=0.468  Sum_probs=94.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcC-----C---Cceeeccceecc----CCeEEEEEeecCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKIN-----H---FNLINLFGACEH----DGVFYLVYEFMENG  398 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~-----H---~niv~l~g~~~~----~~~~~lV~E~~~~g  398 (611)
                      .+||.+..  +.+.||+|+.+      +....||.+|++++     |   ..||+|+++|..    +.+.|||+|++ |-
T Consensus        92 STVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-Gd  170 (590)
T KOG1290|consen   92 STVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GD  170 (590)
T ss_pred             ceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hh
Confidence            78999977  67799999998      34678999999993     3   369999999965    45899999999 77


Q ss_pred             CHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 007261          399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL  452 (611)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl  452 (611)
                      +|..++..... +.++...+.+|+.||+.||.|||.  +-+|||-||||+|||+
T Consensus       171 nLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  171 NLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             HHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence            99999987644 348889999999999999999997  5699999999999999

>PRK06347 autolysin; Reviewed

Probab=99.91  E-value=5.7e-24  Score=230.84  Aligned_cols=167  Identities=19%  Similarity=0.202  Sum_probs=132.3

Q ss_pred             eeeeecCCCCCCHHHHHHhhCCChHhhhhhhCCCCCCCCCCCCCeEEEeeecccCC----------------Ccccccee
Q 007261           44 FLIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSG----------------LYYQANTS  107 (611)
Q Consensus        44 ~~~y~~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~vP~~~~c~~----------------~~~~~~~~  107 (611)
                      ...|++++ ||||+.||+.||+++.+|+++|++..  +.|.+||.|.||..-.-..                ........
T Consensus       405 ~~~ytVk~-GDTL~sIA~kygVSv~~L~~~N~l~s--~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~  481 (592)
T PRK06347        405 AKVYTVVK-GDSLWRIANNNKVTIANLKSWNNLKS--DFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKV  481 (592)
T ss_pred             ceeEEecC-CCCHHHHHHHhCCCHHHHHHHhCCCc--ceeccCcEEEEecCCccccccccccccccccccccccccccee
Confidence            35788866 99999999999999999999999865  6799999999996421100                00112357


Q ss_pred             EEEeecCCchhhhhHhhcCCCccHHHHHHhcCCCCCCCCCCceeeeeccCCCCCCcc-----ccCCeeEEEEEEccCCCC
Q 007261          108 FIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQ-----IVNGTKFLLTYLVSWGDS  182 (611)
Q Consensus       108 y~V~~~gdTl~~IA~~~~~~l~t~~~l~~~N~~~~~~l~~G~~l~ip~~~~~~~~~~-----~~~~~~~~~~y~v~~gdt  182 (611)
                      |+|++ |||||+||++|.   +++++|+++|++..+.|++||.|.||....-.....     .........+|+|++|||
T Consensus       482 YtVk~-GDTL~sIAkkyg---VSv~~L~~~N~l~s~~L~~GQ~L~Ip~~~~~s~~~t~~~s~~~~~~~~~~~Y~Vk~GDT  557 (592)
T PRK06347        482 YTVAK-GDSLWRIANNNK---VTIANLKSWNNLKSDFIYPGQKLKVSAGSTTNNTNTAKPSTNKPSNSTVKTYTVKKGDS  557 (592)
T ss_pred             eeecC-CCCHHHHHHHHC---CCHHHHHHhcCCCcccccCCcEEEEecCcccccccccCCccCCccCccceeeecCCCCc
Confidence            99999 999999997665   888999999998877899999999998643211000     011112356899999999


Q ss_pred             hhHHHhHhcCCHHHHHHhcCCCCCCCCcccceeeeec
Q 007261          183 VPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIP  219 (611)
Q Consensus       183 l~~Ia~~f~~~~~~l~~~N~~~~~~~~i~~g~~l~ip  219 (611)
                      ||+||++|||++++|++||+|.  ++.|++||.|.|+
T Consensus       558 L~sIA~KygvSv~~L~~~N~L~--~~~L~~GQ~L~I~  592 (592)
T PRK06347        558 LWAISRQYKTTVDNIKAWNKLT--SNMIHVGQKLTIK  592 (592)
T ss_pred             HHHHHHHhCCCHHHHHHhcCCC--cccCCCCCEEecC
Confidence            9999999999999999999995  4679999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.91  E-value=1.3e-24  Score=224.98  Aligned_cols=175  Identities=29%  Similarity=0.404  Sum_probs=152.0

Q ss_pred             ceEEEEEE--cCcEEEEEEecHH---------------HHHHHHHHHhcC---CCceeeccceeccCCeEEEEEeec-CC
Q 007261          339 GSVFRGII--NGSTVAIKCMRRS---------------ISKEVNLLKKIN---HFNLINLFGACEHDGVFYLVYEFM-EN  397 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~---------------~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~-~~  397 (611)
                      |.|+.+++  +...|+||.+.++               +..|+.||..++   |+||++++++|++++.+||+||-. ++
T Consensus       575 GkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~g  654 (772)
T KOG1152|consen  575 GKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEG  654 (772)
T ss_pred             ceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCC
Confidence            89999988  5678999998642               345999999997   999999999999999999999986 46


Q ss_pred             CCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcc
Q 007261          398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS  477 (611)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  477 (611)
                      .+|.+++..+..   +++.+..-|+.||+.|+++||   ..+|||||||-+|+.++.+|-+||+|||.+.....+     
T Consensus       655 IDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksg-----  723 (772)
T KOG1152|consen  655 IDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG-----  723 (772)
T ss_pred             cchhhhhhccCc---cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccchhhhcCC-----
Confidence            699999987643   899999999999999999999   799999999999999999999999999987654221     


Q ss_pred             cccccccCCCccchhhhccCCCC-CccchHHHHHHHHHHHhCCCCCcC
Q 007261          478 STKTAVGTNGYMAPEYMEYGLVT-PEMDTYAFGVVLLELITGKEAAYK  524 (611)
Q Consensus       478 ~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~s~Gvvl~elltG~~p~~~  524 (611)
                      .....+||..|.|||++.+.+|- ..-|||++|++||-++....|+++
T Consensus       724 pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  724 PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            23457899999999999988764 457999999999999988888764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.7e-24  Score=204.32  Aligned_cols=231  Identities=19%  Similarity=0.290  Sum_probs=171.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhc-CCCceeeccce-eccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKI-NHFNLINLFGA-CEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.+-.+..  ..+.+++|.+.      ++|.+|..---.| .|.||+.-|++ |+..+.+.+++||++.|+|.+-+...+
T Consensus        38 gkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G  117 (378)
T KOG1345|consen   38 GKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG  117 (378)
T ss_pred             eeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc
Confidence            66776666  45689999986      5777777665555 58999998874 667788899999999999999988765


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee-C-CCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL-D-KNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl-~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                          +.+....+++.|++.|+.|||   +.++||||||.+|||| + +..++||||||+.+..+..      .....-+.
T Consensus       118 ----igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t------V~~~~~~~  184 (378)
T KOG1345|consen  118 ----IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT------VKYLEYVN  184 (378)
T ss_pred             ----ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce------ehhhhhhc
Confidence                777888899999999999999   6899999999999999 3 3358999999998754322      12233456


Q ss_pred             Cccchhhhcc-----CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcCh
Q 007261          487 GYMAPEYMEY-----GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK  561 (611)
Q Consensus       487 ~y~aPE~~~~-----~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  561 (611)
                      .|.+||....     -...+.+|+|.||++++.++||+.|+......+...+++ ..+..+..          +.++...
T Consensus       185 ~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~-~~w~~rk~----------~~~P~~F  253 (378)
T KOG1345|consen  185 NYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEW-EQWLKRKN----------PALPKKF  253 (378)
T ss_pred             ccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHH-HHHhcccC----------ccCchhh
Confidence            7899997743     236788999999999999999999998544433333332 23332221          2233334


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      ...++.+.++.++-+.+++++|-...++.+..
T Consensus       254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  254 NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            45567788899999999999995555554443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.90  E-value=7.4e-24  Score=213.47  Aligned_cols=255  Identities=23%  Similarity=0.349  Sum_probs=185.7

Q ss_pred             hcCCCCCccc----ceEEEEEE-----cCcEEEEEEec-----HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEe
Q 007261          329 ENFSPKNMID----GSVFRGII-----NGSTVAIKCMR-----RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYE  393 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~-----~g~~vavK~~~-----~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  393 (611)
                      +.|...++||    ++||++++     ..+.||+|.+.     ..+.+|+++|..+ -+.||+++.+++...+...+|+|
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp  115 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP  115 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence            3444455554    78999876     35689999985     5688999999999 69999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeecCccccccc
Q 007261          394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN-LRAKLANFSFVRSAVRE  472 (611)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~~~~~~  472 (611)
                      |++.....+++..      ++...+....+.++.||.++|   ..|||||||||+|+|.+.. ++-.|.|||||......
T Consensus       116 ~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~  186 (418)
T KOG1167|consen  116 YFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY  186 (418)
T ss_pred             ccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence            9999999888875      567788889999999999999   7999999999999999865 67899999999721100


Q ss_pred             c------C--------------------------C---------cccccccccCCCccchhhh-ccCCCCCccchHHHHH
Q 007261          473 E------S--------------------------G---------YSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV  510 (611)
Q Consensus       473 ~------~--------------------------~---------~~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~s~Gv  510 (611)
                      .      .                          +         ........||++|.|||++ ..+..+++.||||.||
T Consensus       187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV  266 (418)
T KOG1167|consen  187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV  266 (418)
T ss_pred             hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence            0      0                          0         0011234699999999987 4567899999999999


Q ss_pred             HHHHHHhCCCCCcCCCChhhHHHHHH--------HHHH-hcCC--ccc--c----------cccc----cCc----cCCc
Q 007261          511 VLLELITGKEAAYKQDGEEILLAEAV--------FSMV-EGGN--AEA--K----------LSVL----VDP----NLQA  559 (611)
Q Consensus       511 vl~elltG~~p~~~~~~~~~~l~~~~--------~~~~-~~~~--~~~--~----------l~~~----~d~----~l~~  559 (611)
                      +++-+++++.||+....+-..+.+.+        .... ..+.  ...  .          +..+    +-+    ....
T Consensus       267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~  346 (418)
T KOG1167|consen  267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER  346 (418)
T ss_pred             eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence            99999999999987655421111111        0000 0000  000  0          0000    000    0000


Q ss_pred             --ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          560 --NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       560 --~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        ..+..+..+++|+.+|++.||.+|.|++|.+++
T Consensus       347 ~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  347 EIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence              122334478999999999999999999999875

>PRK06347 autolysin; Reviewed

Probab=99.90  E-value=7.5e-23  Score=222.13  Aligned_cols=171  Identities=20%  Similarity=0.217  Sum_probs=134.5

Q ss_pred             eeeeeecCCCCCCHHHHHHhhCCChHhhhhhhCCCCCCCCCCCCCeEEEeeecccCC-----------------Cccccc
Q 007261           43 GFLIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSG-----------------LYYQAN  105 (611)
Q Consensus        43 ~~~~y~~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~vP~~~~c~~-----------------~~~~~~  105 (611)
                      ....|+++. ||||+.||++||+++++|+++|++..  +.|.+||.|.||..-.-..                 ......
T Consensus       329 ~~~~Y~V~s-GDTL~~IA~rygvSv~eL~~~N~l~~--d~L~~Gq~L~VP~~~~~~~~~t~~~~~~~~~~~~~~~~~~~~  405 (592)
T PRK06347        329 NAKIYTVVK-GDSLWRIANNHKVTVANLKAWNNLKS--DFIYPGQKLKVSAGSTTSDTNTSKPSTGTSTSKPSTGTSTNA  405 (592)
T ss_pred             CceEEEeCC-CCCHHHHHHHhCCCHHHHHHHhCCCc--cccccCcEEEEeccccccccccccccccccccccccccccCc
Confidence            456688876 99999999999999999999999865  6899999999997421100                 001234


Q ss_pred             eeEEEeecCCchhhhhHhhcCCCccHHHHHHhcCCCCCCCCCCceeeeeccCCC------CCCcc-----ccCCeeEEEE
Q 007261          106 TSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCAC------PTSNQ-----IVNGTKFLLT  174 (611)
Q Consensus       106 ~~y~V~~~gdTl~~IA~~~~~~l~t~~~l~~~N~~~~~~l~~G~~l~ip~~~~~------~~~~~-----~~~~~~~~~~  174 (611)
                      ..|+|++ ||||+.||++|.   +++.+|+++|++..+.|.+||.|.||..-.-      +....     .+.......+
T Consensus       406 ~~ytVk~-GDTL~sIA~kyg---VSv~~L~~~N~l~s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~  481 (592)
T PRK06347        406 KVYTVVK-GDSLWRIANNNK---VTIANLKSWNNLKSDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKV  481 (592)
T ss_pred             eeEEecC-CCCHHHHHHHhC---CCHHHHHHHhCCCcceeccCcEEEEecCCccccccccccccccccccccccccccee
Confidence            5799999 999999997665   7889999999988778999999999975211      00000     0011122467


Q ss_pred             EEccCCCChhHHHhHhcCCHHHHHHhcCCCCCCCCcccceeeeecCCC
Q 007261          175 YLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTT  222 (611)
Q Consensus       175 y~v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~~~~~i~~g~~l~ip~~~  222 (611)
                      |+|+.|||||+||++||+++++|++||++.  ++.|++||.|.||...
T Consensus       482 YtVk~GDTL~sIAkkygVSv~~L~~~N~l~--s~~L~~GQ~L~Ip~~~  527 (592)
T PRK06347        482 YTVAKGDSLWRIANNNKVTIANLKSWNNLK--SDFIYPGQKLKVSAGS  527 (592)
T ss_pred             eeecCCCCHHHHHHHHCCCHHHHHHhcCCC--cccccCCcEEEEecCc
Confidence            999999999999999999999999999995  4579999999999765

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=99.85  E-value=9.9e-21  Score=202.09  Aligned_cols=159  Identities=20%  Similarity=0.196  Sum_probs=126.3

Q ss_pred             CCCHHHHHHhhCCChHhhhhhhCCCCCCCCCC-CC-CeEEEeeecccC-------C------------CccccceeEEEe
Q 007261           53 YDTVSSISNLTSSDPTELARVNNISNSAAALP-LD-KEVIVPVSCYCS-------G------------LYYQANTSFIIP  111 (611)
Q Consensus        53 g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~-~g-q~l~vP~~~~c~-------~------------~~~~~~~~y~V~  111 (611)
                      +.+|..||+++|+++++|+++|+... ...+. .| +.|+||....-.       +            ........|+|+
T Consensus       271 ~i~L~~iA~~~gvs~~eL~~LNP~~k-r~~t~p~g~~~llvP~~~~~~f~~~l~~~~~~~~~p~~~~~~~~~~~~~y~Vk  349 (456)
T PRK10783        271 QIELAQAAEMAGMSLTKLKTFNAGYK-RSTTAPSGPHYIMVPKKHADQLRESLASGEIAAVQSTLVADNTPLNSRSYKVR  349 (456)
T ss_pred             CcCHHHHHHHcCCCHHHHHHhCcccc-CCCcCCCCCeEEEecCchhhHHHHhhhhhhhhhcccccccccCcCCceEEEEC
Confidence            77999999999999999999998765 34443 34 778888753210       0            001124579999


Q ss_pred             ecCCchhhhhHhhcCCCccHHHHHHhcCCCCCCCCCCceeeeeccCCCCCCccccCCeeEEEEEEccCCCChhHHHhHhc
Q 007261          112 TIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPDISKRFN  191 (611)
Q Consensus       112 ~~gdTl~~IA~~~~~~l~t~~~l~~~N~~~~~~l~~G~~l~ip~~~~~~~~~~~~~~~~~~~~y~v~~gdtl~~Ia~~f~  191 (611)
                      + |||+++||+++.   ++.++|.++|++..+.|.+||+|.||..+.|..    .......++|+|++|||||+||++||
T Consensus       350 ~-GDTL~sIA~r~g---vs~~~L~~~N~l~~~~L~~Gq~L~Ip~~~~~~~----~~~~~~~~~Y~Vr~GDTL~sIA~kyg  421 (456)
T PRK10783        350 S-GDTLSGIASRLN---VSTKDLQQWNNLRGSKLKVGQTLTIGAGSSAQR----LANNSDSITYRVRKGDSLSSIAKRHG  421 (456)
T ss_pred             C-CCcHHHHHHHHC---cCHHHHHHHcCCCcccCCCCCEEEecCCccccc----ccccccceeEEeCCCCCHHHHHHHhC
Confidence            9 999999997654   777999999998877899999999998766532    11223357899999999999999999


Q ss_pred             CCHHHHHHhcCCCCCCCCcccceeeeecCCC
Q 007261          192 VSIESIVNANGFTEDDPLLFPFTTILIPLTT  222 (611)
Q Consensus       192 ~~~~~l~~~N~~~~~~~~i~~g~~l~ip~~~  222 (611)
                      |++++|++||++. .+ .|+|||+|.|++..
T Consensus       422 Vtv~~L~~~N~l~-~~-~L~pGq~L~l~v~~  450 (456)
T PRK10783        422 VNIKDVMRWNSDT-AK-NLQPGDKLTLFVKN  450 (456)
T ss_pred             CCHHHHHHhcCCC-CC-cCCCCCEEEEecCC
Confidence            9999999999986 45 89999999998765

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=7.9e-21  Score=201.10  Aligned_cols=220  Identities=25%  Similarity=0.400  Sum_probs=165.3

Q ss_pred             HHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 007261          367 LKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS  446 (611)
Q Consensus       367 l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk  446 (611)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+....  ..++|.-...+..+|+.||.|||+  ++-..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeec
Confidence            467899999999999999999999999999999999998743  459999999999999999999996  4444999999


Q ss_pred             CCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhccCC-------CCCccchHHHHHHHHHHHhCC
Q 007261          447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL-------VTPEMDTYAFGVVLLELITGK  519 (611)
Q Consensus       447 ~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~ksDV~s~Gvvl~elltG~  519 (611)
                      +.|+++|.++.+||+|||+...... ...........-...|.|||.+....       .+.+.||||||++++|+++.+
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~-~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEE-TAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccc-cccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            9999999999999999999765532 11111112223455799999997642       467899999999999999999


Q ss_pred             CCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          520 EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       520 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      .||......+.. .+.+.. ++.+.     ....-|.+... .+..+++..++.+||..+|++||+++++-..++.+...
T Consensus       156 ~~~~~~~~~~~~-~eii~~-~~~~~-----~~~~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  156 GPFDLRNLVEDP-DEIILR-VKKGG-----SNPFRPSIELL-NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             CccccccccCCh-HHHHHH-HHhcC-----CCCcCcchhhh-hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            999764333211 122222 22100     11111222111 14445789999999999999999999999998887664

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=6.3e-20  Score=190.95  Aligned_cols=152  Identities=19%  Similarity=0.239  Sum_probs=114.8

Q ss_pred             hcCCCCCccc----ceEEEEEE---cCcEEEEEEec------------HHHHHHHHHHHhcCCCceeeccceeccCCeEE
Q 007261          329 ENFSPKNMID----GSVFRGII---NGSTVAIKCMR------------RSISKEVNLLKKINHFNLINLFGACEHDGVFY  389 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~---~g~~vavK~~~------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  389 (611)
                      ++|.....||    |.||+|..   +|..||||++.            ..+.+|+++|++++|+|+++.+..+   +..+
T Consensus        18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~~   94 (365)
T PRK09188         18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKDG   94 (365)
T ss_pred             CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCcE
Confidence            3444444454    89999987   56778999852            2478999999999999998533222   4579


Q ss_pred             EEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCeeeCCCCcEEEeeecCccc
Q 007261          390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI-SSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       390 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dl-k~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      |||||+++++|... ...      .   ...++.+++.||.|||   +.+|+|||| ||+|||++.++.+||+|||+++.
T Consensus        95 LVmE~~~G~~L~~~-~~~------~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         95 LVRGWTEGVPLHLA-RPH------G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV  161 (365)
T ss_pred             EEEEccCCCCHHHh-Ccc------c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence            99999999999632 111      1   1457889999999999   689999999 99999999999999999999987


Q ss_pred             cccccCCcc-----cccccccCCCccchhhhcc
Q 007261          469 AVREESGYS-----STKTAVGTNGYMAPEYMEY  496 (611)
Q Consensus       469 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~  496 (611)
                      .........     ......++..|+|||.+..
T Consensus       162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            644322111     1135678889999999854

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.80  E-value=5.6e-18  Score=173.82  Aligned_cols=242  Identities=28%  Similarity=0.429  Sum_probs=181.9

Q ss_pred             ceEEEEEEcCcEEEEEEec----------HHHHHHHHHHHhcCCC-ceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGIINGSTVAIKCMR----------RSISKEVNLLKKINHF-NLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~----------~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++... ..+++|.+.          ..+.+|+.++..+.|+ +++++.+++......++++||+.+++|.+++...
T Consensus        14 ~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~   92 (384)
T COG0515          14 GEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKI   92 (384)
T ss_pred             eEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhc
Confidence            889999887 788999885          2477899999999888 7999999997777789999999999999777654


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeecCccccccccCCc---ccccccc
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL-RAKLANFSFVRSAVREESGY---SSTKTAV  483 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~~~~---~~~~~~~  483 (611)
                      .....+.......+..|++.++.|+|   ..+++|||+||+||+++..+ .++++|||+++.........   .......
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  169 (384)
T COG0515          93 GRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV  169 (384)
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccc
Confidence            31124788889999999999999999   68899999999999999998 79999999987544332211   1345678


Q ss_pred             cCCCccchhhhcc---CCCCCccchHHHHHHHHHHHhCCCCCcCCCCh--hhHHHHHHHHHHhcCCcccccccccCccCC
Q 007261          484 GTNGYMAPEYMEY---GLVTPEMDTYAFGVVLLELITGKEAAYKQDGE--EILLAEAVFSMVEGGNAEAKLSVLVDPNLQ  558 (611)
Q Consensus       484 gt~~y~aPE~~~~---~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~  558 (611)
                      ++..|++||.+.+   ...+...|+|++|++++++++|..|+......  .......+.....    . .......... 
T Consensus       170 ~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~~~~-  243 (384)
T COG0515         170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT----P-SLASPLSPSN-  243 (384)
T ss_pred             cccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC----c-ccccccCccc-
Confidence            9999999999987   68899999999999999999999996554431  1111111111100    0 0000000000 


Q ss_pred             cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        .......+.+++..|+..+|..|.++.+....
T Consensus       244 --~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         244 --PELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             --cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              02223567889999999999999999887765

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.78  E-value=1.1e-17  Score=173.87  Aligned_cols=242  Identities=19%  Similarity=0.216  Sum_probs=179.9

Q ss_pred             ceEEEEEEcC---cEEEEEEecH-------HHHHHHHHHHhcCC----Cceeecccee-ccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIING---STVAIKCMRR-------SISKEVNLLKKINH----FNLINLFGAC-EHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~g---~~vavK~~~~-------~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||.+....   ..+|+|....       .+..|..++..+.+    .++..+++.. ..+...++||+.+ |.+|.++
T Consensus        32 G~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl  110 (322)
T KOG1164|consen   32 GAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDL  110 (322)
T ss_pred             ceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHH
Confidence            9999999733   4688888753       47889999999963    5788888888 5777899999988 7899998


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-----CcEEEeeecCcc--ccccccCC-
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN-----LRAKLANFSFVR--SAVREESG-  475 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-----~~~kl~Dfgla~--~~~~~~~~-  475 (611)
                      ..... .+.++....++|+.|++.+|++||   +.+++||||||.|+++...     ..+.|.|||+++  ........ 
T Consensus       111 ~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~  186 (322)
T KOG1164|consen  111 RKRNP-PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGN  186 (322)
T ss_pred             HHhCC-CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcc
Confidence            87655 466899999999999999999999   7999999999999999765     469999999998  32222111 


Q ss_pred             ---ccc-ccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccc
Q 007261          476 ---YSS-TKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV  551 (611)
Q Consensus       476 ---~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  551 (611)
                         ... .....||..|.++....+...+.+.|+||++.++.|++.|..|+........  ...+.....        ..
T Consensus       187 ~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~~~~~~~--------~~  256 (322)
T KOG1164|consen  187 LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSKFEKDPR--------KL  256 (322)
T ss_pred             cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHHHHHHhh--------hh
Confidence               111 1234599999999999999999999999999999999999999865432211  011111100        00


Q ss_pred             ccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          552 LVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       552 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      ....    .....+.++.+++..+-..+..++|....+...|......
T Consensus       257 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  257 LTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             cccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            0000    1122334566666666678999999999999988776554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=1.5e-19  Score=200.05  Aligned_cols=215  Identities=15%  Similarity=0.209  Sum_probs=164.6

Q ss_pred             HHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 007261          360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG  439 (611)
Q Consensus       360 ~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~  439 (611)
                      +..|+.+-..++|+|++..+..+.+.....-+||||++ +|..++...   ..+...++-.++.|+..|+.|||   ..+
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h---~~G  440 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLH---SMG  440 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHH---hcC
Confidence            44567777788999999988888777666666999999 999999875   23777888889999999999999   799


Q ss_pred             eEecCCCCCCeeeCCCCcEEEeeecCccccccccC-CcccccccccCCCccchhhhccCCCCC-ccchHHHHHHHHHHHh
Q 007261          440 YVHKDISSGNILLDKNLRAKLANFSFVRSAVREES-GYSSTKTAVGTNGYMAPEYMEYGLVTP-EMDTYAFGVVLLELIT  517 (611)
Q Consensus       440 ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~-ksDV~s~Gvvl~ellt  517 (611)
                      +.|||+|++|+++..++.+||+|||.+........ .........|+..|+|||++.+..|.+ ..||||.|+++..|++
T Consensus       441 iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~  520 (601)
T KOG0590|consen  441 LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL  520 (601)
T ss_pred             ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec
Confidence            99999999999999999999999998865543322 123445678999999999999988876 5799999999999999


Q ss_pred             CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          518 GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       518 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      |+.||......+.....    .    ......  -+..........++.+...++.++|+.||.+|.++.+|++
T Consensus       521 ~~~~Wk~a~~~~~~~~~----~----~~~~~~--~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  521 GRFPWKVAKKSDNSFKT----N----NYSDQR--NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             CCCccccccccccchhh----h----cccccc--ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            99998755433221100    0    000000  0011111113456778889999999999999999999986

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.75  E-value=9.2e-19  Score=193.72  Aligned_cols=232  Identities=23%  Similarity=0.291  Sum_probs=165.2

Q ss_pred             eEEEEEEcCcEEEEEEec--------HHHHHHHHH--HHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          340 SVFRGIINGSTVAIKCMR--------RSISKEVNL--LKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       340 ~Vy~g~~~g~~vavK~~~--------~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      +|.+++.+...|+||++-        +.|.++++-  ...++|||.+++.-+-..+.-.|||-+|.. -+|.|.|...  
T Consensus        38 Kv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRlSTR--  114 (1431)
T KOG1240|consen   38 KVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRLSTR--  114 (1431)
T ss_pred             hhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhhccc--
Confidence            466777755559999983        235544333  444599999999988877888899999985 4899988765  


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc----cC
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV----GT  485 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~----gt  485 (611)
                       .++...+.+.|+.|++.||..+|   ..+|.|||||.+||||+.-..+.|+||.-.+...-.+..........    .-
T Consensus       115 -PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRR  190 (1431)
T KOG1240|consen  115 -PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRR  190 (1431)
T ss_pred             -hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCce
Confidence             45888888999999999999999   79999999999999999999999999998776554433222111111    22


Q ss_pred             CCccchhhhccC-----------CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHh-cCCccccccccc
Q 007261          486 NGYMAPEYMEYG-----------LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVE-GGNAEAKLSVLV  553 (611)
Q Consensus       486 ~~y~aPE~~~~~-----------~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~-~~~~~~~l~~~~  553 (611)
                      ..|+|||.+...           ..+++.||||+||++.||++-+.|.+.-       ...+.-.-. ....+..+..+-
T Consensus       191 tCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~aYr~~~~~~~e~~Le~Ie  263 (1431)
T KOG1240|consen  191 TCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLAYRSGNADDPEQLLEKIE  263 (1431)
T ss_pred             eeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHhHhccCccCHHHHHHhCc
Confidence            369999987431           2678999999999999999854443321       111110000 011112222222


Q ss_pred             CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       554 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      |.           .+++++..|++.||+.|-|+++.++.-..+
T Consensus       264 d~-----------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  264 DV-----------SLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             Cc-----------cHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence            22           478899999999999999999999875543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.75  E-value=2.4e-17  Score=161.39  Aligned_cols=243  Identities=16%  Similarity=0.168  Sum_probs=184.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec-----HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-----RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      |..|.|+.  ++++||||.-.     ..+..|....+.| ..++|...+-|-.++.+..||+|.+ |.||+|++.-++  
T Consensus        42 G~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~Cg--  118 (449)
T KOG1165|consen   42 GVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCG--  118 (449)
T ss_pred             eeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhc--
Confidence            88999975  99999999874     3678899999999 5689988887778888889999999 889999987764  


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-----CCcEEEeeecCccccccccCC----cccccc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-----NLRAKLANFSFVRSAVREESG----YSSTKT  481 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~Dfgla~~~~~~~~~----~~~~~~  481 (611)
                      +.++.+..+.+|.|++.-++|+|   .+.+|.|||||+|+||..     ...+.|+|||+|+........    +...+.
T Consensus       119 R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KS  195 (449)
T KOG1165|consen  119 RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKS  195 (449)
T ss_pred             CcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccc
Confidence            34899999999999999999999   689999999999999953     346899999999987655332    345566


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcCh
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK  561 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  561 (611)
                      ..||.+||+-....+.+.+.+.|.-|+|-+++..+.|..||.+.....  ..+. .+.+.......        .+....
T Consensus       196 LsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t--nK~k-YeKIGe~Kr~T--------~i~~Lc  264 (449)
T KOG1165|consen  196 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT--NKEK-YEKIGETKRST--------PIEVLC  264 (449)
T ss_pred             cccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc--hHHH-HHHhccccccC--------CHHHHH
Confidence            789999999999999999999999999999999999999998654321  0000 00000000000        011113


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      ...++++..-+.-.-..+-.+-|.-+-+...+..+..
T Consensus       265 ~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  265 EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            3456666666666666777778887766665555443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.75  E-value=9.7e-18  Score=157.44  Aligned_cols=238  Identities=18%  Similarity=0.208  Sum_probs=181.9

Q ss_pred             ceEEEEEE--cCcEEEEEEecH-----HHHHHHHHHHhcCC-CceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMRR-----SISKEVNLLKKINH-FNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      |.+|.|..  +|+.||||.-..     .+..|..+.+.|+| ..|..+..+..++..-.||||.+ |.||++.+.-..  
T Consensus        29 GdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~--  105 (341)
T KOG1163|consen   29 GDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCS--  105 (341)
T ss_pred             hheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHh--
Confidence            89999987  899999999863     57789999999965 57777778888888899999999 889999988654  


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEeeecCccccccccC----Ccccccccc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN---LRAKLANFSFVRSAVREES----GYSSTKTAV  483 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfgla~~~~~~~~----~~~~~~~~~  483 (611)
                      +.++.+..+.+|-|++.-++|+|   ..+++||||||+|+|..-+   ..+.++||||++.......    .+...+...
T Consensus       106 R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~lt  182 (341)
T KOG1163|consen  106 RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLT  182 (341)
T ss_pred             hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccc
Confidence            34888999999999999999999   6899999999999999644   5689999999987644322    234456678


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChh-hHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE-ILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      ||.+|.+-....+-..+.+.|+-|+|.+|..+-.|..||.+-.... ..-.+.+.        +.++..    .+.....
T Consensus       183 GTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~--------EkK~s~----~ie~LC~  250 (341)
T KOG1163|consen  183 GTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS--------EKKMST----PIEVLCK  250 (341)
T ss_pred             eeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH--------HhhcCC----CHHHHhC
Confidence            9999999888877788999999999999999999999998654321 11111111        111111    1111134


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      ..+.++...+.-|-..--++-|.-.-+-+...
T Consensus       251 G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  251 GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            55677788888888888888888766555443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=1.5e-17  Score=166.21  Aligned_cols=198  Identities=24%  Similarity=0.314  Sum_probs=142.0

Q ss_pred             CCCceeeccceecc---------------------------CCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHH
Q 007261          371 NHFNLINLFGACEH---------------------------DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIAL  423 (611)
Q Consensus       371 ~H~niv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~  423 (611)
                      +|||||+++++|.+                           ...+|+||.-++ -+|..+|....    .+.....-|..
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence            69999999987732                           235799999885 58999997654    56666677889


Q ss_pred             HHHHHHHHHhcCCCCCeEecCCCCCCeee--CCCC--cEEEeeecCccccccc--cCCcccc-cccccCCCccchhhhcc
Q 007261          424 DVAHGLHYLHNCTDPGYVHKDISSGNILL--DKNL--RAKLANFSFVRSAVRE--ESGYSST-KTAVGTNGYMAPEYMEY  496 (611)
Q Consensus       424 ~ia~gL~yLH~~~~~~ivH~Dlk~~NILl--~~~~--~~kl~Dfgla~~~~~~--~~~~~~~-~~~~gt~~y~aPE~~~~  496 (611)
                      |+++|+.|||   +.+|.|||+|++|||+  |++.  .+.|+|||.+-.....  ...+.+. -..-|.-.-||||....
T Consensus       349 QlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999   7999999999999999  4443  5789999976432211  1111111 12345667899998753


Q ss_pred             CC------CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          497 GL------VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       497 ~~------~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      ..      .-.|+|.|+.|-+.||+++...||+.....  .+..               +...+..+...++.++..+.+
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem--~L~~---------------r~Yqe~qLPalp~~vpp~~rq  488 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM--LLDT---------------RTYQESQLPALPSRVPPVARQ  488 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh--eech---------------hhhhhhhCCCCcccCChHHHH
Confidence            21      235899999999999999999999974321  1111               111223344556677788999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHH
Q 007261          571 LCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      ++...|++||.+|+|..-....|
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHH
Confidence            99999999999999876554433

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.72  E-value=2.6e-18  Score=178.71  Aligned_cols=177  Identities=27%  Similarity=0.411  Sum_probs=135.3

Q ss_pred             CeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecC
Q 007261          386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSF  465 (611)
Q Consensus       386 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl  465 (611)
                      ..+|+.|++|...+|.+||...+.....+|...+.++.|++.|++|      ++.+|+|+||.||+...+..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            3579999999999999999887777778999999999999999999      5789999999999999999999999999


Q ss_pred             ccccccccC---CcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHh
Q 007261          466 VRSAVREES---GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVE  541 (611)
Q Consensus       466 a~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  541 (611)
                      .........   .........||.+||+||.+.+..|+.|+||||||++|+||+. -..++..                 
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-----------------  465 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-----------------  465 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------------
Confidence            876543321   1223455689999999999999999999999999999999997 2222211                 


Q ss_pred             cCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 007261          542 GGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV  589 (611)
Q Consensus       542 ~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  589 (611)
                          ...+..+.|..+.+.....-..-+.|+.+++...|.+||++.+.
T Consensus       466 ----~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  466 ----IATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             ----HHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence                01112222333332211122234678999999999999955443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.71  E-value=2.9e-17  Score=157.09  Aligned_cols=123  Identities=23%  Similarity=0.192  Sum_probs=95.5

Q ss_pred             ceEEEEEE-cCcEEEEEEecHH----------------H-----------------HHHHHHHHhcCCCceeeccceecc
Q 007261          339 GSVFRGII-NGSTVAIKCMRRS----------------I-----------------SKEVNLLKKINHFNLINLFGACEH  384 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~~~----------------~-----------------~~E~~~l~~l~H~niv~l~g~~~~  384 (611)
                      |.||+|.. +|+.||||+++..                |                 .+|+..+.++.|+++.....+.. 
T Consensus        11 ~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~-   89 (190)
T cd05147          11 ANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILL-   89 (190)
T ss_pred             eEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEe-
Confidence            89999987 7999999998522                1                 23899999998777643322221 


Q ss_pred             CCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeec
Q 007261          385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS  464 (611)
Q Consensus       385 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg  464 (611)
                       ...+|||||+++++|.......   ..+++....+++.|++.+|.|||+  ..+|+||||||+|||++ ++.++|+|||
T Consensus        90 -~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~-~~~v~LiDFG  162 (190)
T cd05147          90 -KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH-DGKLYIIDVS  162 (190)
T ss_pred             -cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-CCcEEEEEcc
Confidence             2238999999988776543222   237889999999999999999932  67999999999999998 4789999999


Q ss_pred             Ccccc
Q 007261          465 FVRSA  469 (611)
Q Consensus       465 la~~~  469 (611)
                      ++...
T Consensus       163 ~a~~~  167 (190)
T cd05147         163 QSVEH  167 (190)
T ss_pred             ccccC
Confidence            98644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.70  E-value=3e-17  Score=159.28  Aligned_cols=159  Identities=15%  Similarity=0.141  Sum_probs=119.7

Q ss_pred             hhcCCCCCccc----ceEEEEEEcCcEEEEEEecH------H----------HHHHHHHHHhcCCCceeeccceeccC--
Q 007261          328 TENFSPKNMID----GSVFRGIINGSTVAIKCMRR------S----------ISKEVNLLKKINHFNLINLFGACEHD--  385 (611)
Q Consensus       328 t~~f~~~~~ig----g~Vy~g~~~g~~vavK~~~~------~----------~~~E~~~l~~l~H~niv~l~g~~~~~--  385 (611)
                      .++|.....++    |.||....++..+|||.++.      .          +.+|+..+.+++|++|....+++...  
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~  109 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER  109 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence            44444444443    88998777788999999962      1          46899999999999999998875532  


Q ss_pred             ------CeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 007261          386 ------GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK  459 (611)
Q Consensus       386 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k  459 (611)
                            +..+|||||++|.+|.++..       ++.    ....+++.+|..||   ..+++|||+||+||+++.++ ++
T Consensus       110 ~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        110 KTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             ccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence                  35899999999999988742       222    24569999999999   79999999999999999988 99


Q ss_pred             EeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHH
Q 007261          460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI  516 (611)
Q Consensus       460 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ell  516 (611)
                      |+|||..........               ...++....+..++|+|+||+++.-+.
T Consensus       175 liDfg~~~~~~e~~a---------------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKA---------------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhh---------------HHHHHHHhHhcccccccceeEeehHHH
Confidence            999998764421110               011333445667999999999987654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.69  E-value=1.3e-16  Score=152.95  Aligned_cols=122  Identities=20%  Similarity=0.204  Sum_probs=97.0

Q ss_pred             ceEEEEEE-cCcEEEEEEecHH---------------------------------HHHHHHHHHhcCCCceeeccceecc
Q 007261          339 GSVFRGII-NGSTVAIKCMRRS---------------------------------ISKEVNLLKKINHFNLINLFGACEH  384 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~~~---------------------------------~~~E~~~l~~l~H~niv~l~g~~~~  384 (611)
                      |.||+|.. +|+.||||+++..                                 +.+|...+.++.|+++.....+...
T Consensus        11 ~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~   90 (190)
T cd05145          11 ANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLK   90 (190)
T ss_pred             cEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEec
Confidence            89999987 6999999998631                                 2468899999999887443333322


Q ss_pred             CCeEEEEEeecCCCCHHH-HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeee
Q 007261          385 DGVFYLVYEFMENGSLSD-WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF  463 (611)
Q Consensus       385 ~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df  463 (611)
                        ..+|||||++++++.. .+...    .++.....+++.+++.++.+||+  ..+|+||||||+|||++ ++.++|+||
T Consensus        91 --~~~lVmE~~~g~~~~~~~l~~~----~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~~~~liDF  161 (190)
T cd05145          91 --KNVLVMEFIGDDGSPAPRLKDV----PLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DGKPYIIDV  161 (190)
T ss_pred             --CCEEEEEEecCCCchhhhhhhc----cCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CCCEEEEEc
Confidence              2489999999886543 34332    26778889999999999999993  28999999999999999 889999999


Q ss_pred             cCcccc
Q 007261          464 SFVRSA  469 (611)
Q Consensus       464 gla~~~  469 (611)
                      |++...
T Consensus       162 G~a~~~  167 (190)
T cd05145         162 SQAVEL  167 (190)
T ss_pred             ccceec
Confidence            998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=1.4e-16  Score=151.33  Aligned_cols=170  Identities=11%  Similarity=0.065  Sum_probs=127.6

Q ss_pred             ceEEEEEEcCcEEEEEEec-----------HHHHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGIINGSTVAIKCMR-----------RSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~-----------~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||.+...+..++.+.+.           ..+.+|+++|++|. |+++.+++++    +..+++|||++|.+|...+..
T Consensus        16 ~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~   91 (218)
T PRK12274         16 GRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR   91 (218)
T ss_pred             ceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh
Confidence            8899777788888877764           14788999999994 5888888886    346899999999998754321


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCeeeCCCCcEEEeeecCccccccccCC-----c----
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI-SSGNILLDKNLRAKLANFSFVRSAVREESG-----Y----  476 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dl-k~~NILl~~~~~~kl~Dfgla~~~~~~~~~-----~----  476 (611)
                      .          ...++.|++.+|.++|   ..+|+|||| ||.|||++.++.++|+|||++.........     .    
T Consensus        92 ~----------~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~  158 (218)
T PRK12274         92 G----------DLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLR  158 (218)
T ss_pred             h----------hHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHH
Confidence            1          1347789999999999   789999999 799999999999999999999754322110     0    


Q ss_pred             -ccccccccCCCccchhhhccC-CCC-CccchHHHHHHHHHHHhCCCCCcCC
Q 007261          477 -SSTKTAVGTNGYMAPEYMEYG-LVT-PEMDTYAFGVVLLELITGKEAAYKQ  525 (611)
Q Consensus       477 -~~~~~~~gt~~y~aPE~~~~~-~~s-~ksDV~s~Gvvl~elltG~~p~~~~  525 (611)
                       ........++.|++|+....- ..+ ...+.++-|.-+|.++|++.+...+
T Consensus       159 ~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        159 HLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence             001122357788888755332 333 5779999999999999999876544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.68  E-value=1.3e-17  Score=176.73  Aligned_cols=210  Identities=25%  Similarity=0.283  Sum_probs=164.9

Q ss_pred             HHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCC
Q 007261          360 ISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDP  438 (611)
Q Consensus       360 ~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~  438 (611)
                      ...|-.++..++ ||.+|++.-.+..+...+++++|..+|.|...+.....   ............++-+++++|   +.
T Consensus        43 t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh---~l  116 (612)
T KOG0603|consen   43 TKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVM---FDELDVAFYLAELALALDHLH---KL  116 (612)
T ss_pred             cccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcc---hh
Confidence            445778888886 99999999999999999999999999999988876542   455555567778999999999   79


Q ss_pred             CeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhC
Q 007261          439 GYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG  518 (611)
Q Consensus       439 ~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG  518 (611)
                      +++|||+|++||+++.+|.+++.|||+.+.......       .+||..|||||.+.  ......|.||||++++||+||
T Consensus       117 ~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg  187 (612)
T KOG0603|consen  117 GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTG  187 (612)
T ss_pred             HHHHhcccccceeecccCccccCCchhhhHhHhhhh-------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhC
Confidence            999999999999999999999999999987654332       28899999999998  457789999999999999999


Q ss_pred             CCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCH--HHHHHHHHhc
Q 007261          519 KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSM--AEVVSTLMKI  596 (611)
Q Consensus       519 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl~~L~~i  596 (611)
                      -.||..    +     .....+.              .-...+...+.....++..++..+|..|--.  ..+.++++.-
T Consensus       188 ~~pf~~----~-----~~~~Il~--------------~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~  244 (612)
T KOG0603|consen  188 TLPFGG----D-----TMKRILK--------------AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHE  244 (612)
T ss_pred             CCCCch----H-----HHHHHhh--------------hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccc
Confidence            999865    1     1111111              0112356677788889999999999999754  5666666555


Q ss_pred             hhhhhhchhhh
Q 007261          597 QLDVQRSQTLL  607 (611)
Q Consensus       597 ~~~~~~~~~~~  607 (611)
                      ......|+...
T Consensus       245 f~~~i~~~~l~  255 (612)
T KOG0603|consen  245 FFQSIDWNELE  255 (612)
T ss_pred             hheeeeHhhHh
Confidence            55555555433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.66  E-value=7.5e-16  Score=153.97  Aligned_cols=212  Identities=19%  Similarity=0.269  Sum_probs=135.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCC----------Cceeeccce---------eccC--
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINH----------FNLINLFGA---------CEHD--  385 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H----------~niv~l~g~---------~~~~--  385 (611)
                      +.||.++.  .|+.+|||++.          +++++|.-....+.+          -.++--++.         +...  
T Consensus        26 ~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~  105 (288)
T PF14531_consen   26 SIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPG  105 (288)
T ss_dssp             EEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECET
T ss_pred             eEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCC
Confidence            78999998  57999999984          345666555544322          111111111         1111  


Q ss_pred             -C-----eEEEEEeecCCCCHHHHhhc---c-CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC
Q 007261          386 -G-----VFYLVYEFMENGSLSDWLHK---K-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN  455 (611)
Q Consensus       386 -~-----~~~lV~E~~~~gsL~~~l~~---~-~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~  455 (611)
                       .     ..+++|+-+ .++|.+++..   . .....+....++.+..|+.+.+++||   ..+++|+||+|+|++++.+
T Consensus       106 ~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~~~nfll~~~  181 (288)
T PF14531_consen  106 QSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIKPENFLLDQD  181 (288)
T ss_dssp             TEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEE-TT
T ss_pred             Cccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecccceeeEEEcCC
Confidence             1     236788877 5799888653   1 11223556677888899999999999   6899999999999999999


Q ss_pred             CcEEEeeecCccccccccCCcccccccccCCCccchhhhcc--------CCCCCccchHHHHHHHHHHHhCCCCCcCCCC
Q 007261          456 LRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY--------GLVTPEMDTYAFGVVLLELITGKEAAYKQDG  527 (611)
Q Consensus       456 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~  527 (611)
                      |.++|+||+.....+...      .....+..|.+||....        -.++.+.|.|++|+++|.|++|+.|+.....
T Consensus       182 G~v~Lg~F~~~~r~g~~~------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~  255 (288)
T PF14531_consen  182 GGVFLGDFSSLVRAGTRY------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSP  255 (288)
T ss_dssp             S-EEE--GGGEEETTEEE------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGG
T ss_pred             CCEEEcChHHHeecCcee------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCc
Confidence            999999998765443211      11344578999997744        2578899999999999999999999875432


Q ss_pred             hhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCC
Q 007261          528 EEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESR  583 (611)
Q Consensus       528 ~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R  583 (611)
                      +..                      .+..+..+. +.++.+..|+..+|++||.+|
T Consensus       256 ~~~----------------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  256 EAD----------------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             GST----------------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccc----------------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            210                      001233445 788999999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=1.2e-15  Score=172.71  Aligned_cols=191  Identities=21%  Similarity=0.253  Sum_probs=148.5

Q ss_pred             HHHHHhhcCCCCCccc----ceEEEEEE-cCcEEEEEEecHHHHHH----HHHHHhcC---CCceeeccceeccCCeEEE
Q 007261          323 DLVVATENFSPKNMID----GSVFRGII-NGSTVAIKCMRRSISKE----VNLLKKIN---HFNLINLFGACEHDGVFYL  390 (611)
Q Consensus       323 el~~at~~f~~~~~ig----g~Vy~g~~-~g~~vavK~~~~~~~~E----~~~l~~l~---H~niv~l~g~~~~~~~~~l  390 (611)
                      +.....+.|.....+|    |+||+|.. +|+.||+|+-+..-.-|    .+++.||+   -+-|+.+.....-.+..+|
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            3444555566665665    89999987 89999999987422222    23344444   2345555555556677889


Q ss_pred             EEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-------CCCcEEEeee
Q 007261          391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD-------KNLRAKLANF  463 (611)
Q Consensus       391 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-------~~~~~kl~Df  463 (611)
                      |+||.+.|+|.+++...   +.++|.-.+.++.|+++-+++||   ..+|||+||||+|+||.       ++..++|+||
T Consensus       772 v~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEec
Confidence            99999999999999844   45999999999999999999999   78999999999999993       3456899999


Q ss_pred             cCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCC
Q 007261          464 SFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE  520 (611)
Q Consensus       464 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~  520 (611)
                      |.+-.......+ ...+..++|-.+-.+|...+..++...|-|.|.-+++.|+.|+.
T Consensus       846 G~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  846 GRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            988654332222 23455678999999999999999999999999999999999874

>PRK10345 hypothetical protein; Provisional

Probab=99.61  E-value=2.8e-15  Score=145.00  Aligned_cols=118  Identities=15%  Similarity=0.248  Sum_probs=92.7

Q ss_pred             ceEEEEEEcCcEEEEEEec-------HHHHHHHHHHHhc-----CCCceeeccceeccCC---e-EEEEEee--cCCCCH
Q 007261          339 GSVFRGIINGSTVAIKCMR-------RSISKEVNLLKKI-----NHFNLINLFGACEHDG---V-FYLVYEF--MENGSL  400 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~-------~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~lV~E~--~~~gsL  400 (611)
                      |.||....++.. +||++.       +++.+|+.+++++     +||||++++|++.++.   . ..+|+||  +++|+|
T Consensus        16 ~~Vy~hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL   94 (210)
T PRK10345         16 RKCYAHPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITL   94 (210)
T ss_pred             eEEEECCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhH
Confidence            789963334444 688875       3588999999999     5799999999998763   4 3478999  567999


Q ss_pred             HHHhhccCCCCccCHHHHHHHHHHHHHHH-HHHhcCCCCCeEecCCCCCCeeeCC----CCcEEEeeecCc
Q 007261          401 SDWLHKKRYPEFVSWNCRFRIALDVAHGL-HYLHNCTDPGYVHKDISSGNILLDK----NLRAKLANFSFV  466 (611)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~ia~~ia~gL-~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~Dfgla  466 (611)
                      .+++.+..    +++.  ..++.+++.++ +|||   +.+|+||||||+|||++.    ++.++|+||+.+
T Consensus        95 ~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         95 TEFAEQCR----YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHHHHccc----ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            99997643    4444  35677888888 9999   799999999999999974    348999995543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.61  E-value=3.8e-15  Score=145.09  Aligned_cols=119  Identities=17%  Similarity=0.298  Sum_probs=103.9

Q ss_pred             ceEEEEEEcCcEEEEEEec---------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIINGSTVAIKCMR---------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~---------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|.++|..|+||...               ..+.+|+.++..++|+++.....++...+..++||||++|++|.++
T Consensus        10 ~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~   89 (211)
T PRK14879         10 AEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDL   89 (211)
T ss_pred             EEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHH
Confidence            8999999999999999753               2366799999999999988777777777788999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      +....      + .+..++.+++.+|.+||   ..+++|+|++|.|||++ ++.++|+|||++..
T Consensus        90 ~~~~~------~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         90 INSNG------M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHhcc------H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            86532      2 77889999999999999   68999999999999999 78999999998753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.58  E-value=5.6e-15  Score=142.60  Aligned_cols=116  Identities=19%  Similarity=0.257  Sum_probs=97.8

Q ss_pred             ceEEEEEEcCcEEEEEEec---------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIINGSTVAIKCMR---------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~---------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|.++|..|++|...               .++.+|++++..++|+++.....++......++||||++|++|.++
T Consensus         8 ~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~   87 (199)
T TIGR03724         8 AIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDV   87 (199)
T ss_pred             EEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHH
Confidence            8999999999999999853               2355799999999888765555555556667899999999999998


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      +....    .      .++.+++.+|.+||   ..+++|+|++|.||+++ ++.++++|||+++.
T Consensus        88 ~~~~~----~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        88 IEEGN----D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             HhhcH----H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            86532    1      68899999999999   68999999999999999 89999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.55  E-value=1.8e-14  Score=142.65  Aligned_cols=120  Identities=22%  Similarity=0.213  Sum_probs=93.7

Q ss_pred             ceEEEEE---EcCcEEEEEEecH-------------------------------HHHHHHHHHHhcCCCc--eeecccee
Q 007261          339 GSVFRGI---INGSTVAIKCMRR-------------------------------SISKEVNLLKKINHFN--LINLFGAC  382 (611)
Q Consensus       339 g~Vy~g~---~~g~~vavK~~~~-------------------------------~~~~E~~~l~~l~H~n--iv~l~g~~  382 (611)
                      |.||+|.   .+|+.||||.++.                               .+.+|+..+.++.+.+  +.+++++ 
T Consensus        42 g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~-  120 (237)
T smart00090       42 ANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW-  120 (237)
T ss_pred             eeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe-
Confidence            8999998   2799999998752                               1357999999997532  3333432 


Q ss_pred             ccCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCCeeeCCCCcEEEe
Q 007261          383 EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG-YVHKDISSGNILLDKNLRAKLA  461 (611)
Q Consensus       383 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~-ivH~Dlk~~NILl~~~~~~kl~  461 (611)
                         ...+|||||+++++|..++....   .+.......++.|++.+|.+||   ..+ ++||||||+||+++ ++.++|+
T Consensus       121 ---~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIli~-~~~i~Li  190 (237)
T smart00090      121 ---RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNILVH-DGKVVII  190 (237)
T ss_pred             ---cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEEEE-CCCEEEE
Confidence               23489999999988877653321   2455566789999999999999   678 99999999999999 8899999


Q ss_pred             eecCcccc
Q 007261          462 NFSFVRSA  469 (611)
Q Consensus       462 Dfgla~~~  469 (611)
                      |||++...
T Consensus       191 DFg~a~~~  198 (237)
T smart00090      191 DVSQSVEL  198 (237)
T ss_pred             EChhhhcc
Confidence            99987643

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.55  E-value=1.6e-14  Score=160.53  Aligned_cols=115  Identities=20%  Similarity=0.234  Sum_probs=98.7

Q ss_pred             ceEEEEEEcCcEEEEEEec---------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIINGSTVAIKCMR---------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~---------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|.+.+..+++|+..               ..+.+|++++.+++|++++....++......++||||+++++|.++
T Consensus       347 g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~  426 (535)
T PRK09605        347 ADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDV  426 (535)
T ss_pred             EEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHH
Confidence            8999999977766665421               2467899999999999998887777777778999999999999998


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      +.           ....++.+++.+|.|||   +.+++||||||+|||+ +++.++|+|||+++.
T Consensus       427 l~-----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        427 LE-----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             HH-----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            86           24578999999999999   6899999999999999 678999999999865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.53  E-value=4.1e-14  Score=136.53  Aligned_cols=115  Identities=19%  Similarity=0.214  Sum_probs=92.2

Q ss_pred             ceEEEEEE-cCcEEEEEEecH-----------------------------HHHHHHHHHHhcCCCc--eeeccceeccCC
Q 007261          339 GSVFRGII-NGSTVAIKCMRR-----------------------------SISKEVNLLKKINHFN--LINLFGACEHDG  386 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~~-----------------------------~~~~E~~~l~~l~H~n--iv~l~g~~~~~~  386 (611)
                      |.||++.. +|+.||||+++.                             .+.+|+.++..+.|++  +...++    ..
T Consensus        29 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~----~~  104 (198)
T cd05144          29 SDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPID----WN  104 (198)
T ss_pred             eEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceee----cC
Confidence            88999988 799999997531                             2567888999998774  333433    23


Q ss_pred             eEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCc
Q 007261          387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV  466 (611)
Q Consensus       387 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla  466 (611)
                      ..++||||+++++|......         .....++.+++.++.++|   ..+++|+||||+||++++++.++|+|||++
T Consensus       105 ~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~~~~liDfg~~  172 (198)
T cd05144         105 RHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDEKIYIIDWPQM  172 (198)
T ss_pred             CceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCCcEEEEECCcc
Confidence            45899999999998765431         223568899999999999   689999999999999999999999999998


Q ss_pred             ccc
Q 007261          467 RSA  469 (611)
Q Consensus       467 ~~~  469 (611)
                      ...
T Consensus       173 ~~~  175 (198)
T cd05144         173 VST  175 (198)
T ss_pred             ccC
Confidence            644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.49  E-value=5.1e-14  Score=156.62  Aligned_cols=164  Identities=20%  Similarity=0.305  Sum_probs=118.7

Q ss_pred             HHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC------------cccccccccCCCccchhh
Q 007261          426 AHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG------------YSSTKTAVGTNGYMAPEY  493 (611)
Q Consensus       426 a~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~------------~~~~~~~~gt~~y~aPE~  493 (611)
                      +.+++|||   ..+|+|||+||+|.||+.-|.+|+.|||+.+........            ....+..+||+.|+|||+
T Consensus       153 vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV  229 (1205)
T KOG0606|consen  153 VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV  229 (1205)
T ss_pred             hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence            78999999   699999999999999999999999999998754322111            112345689999999999


Q ss_pred             hccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHH
Q 007261          494 MEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCL  573 (611)
Q Consensus       494 ~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~  573 (611)
                      +....|..-.|+|++|+++||.+-|..||++...++. +...+....               .+.+.......+..+++.
T Consensus       230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-fg~visd~i---------------~wpE~dea~p~Ea~dli~  293 (1205)
T KOG0606|consen  230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDDI---------------EWPEEDEALPPEAQDLIE  293 (1205)
T ss_pred             hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-Hhhhhhhhc---------------cccccCcCCCHHHHHHHH
Confidence            9999999999999999999999999999998766542 222221111               111112334456888999


Q ss_pred             HhhccCCCCCCCHHHHHHHHHhchhhhhhchhhhh
Q 007261          574 ACIAREPESRPSMAEVVSTLMKIQLDVQRSQTLLL  608 (611)
Q Consensus       574 ~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~  608 (611)
                      +.|+.+|..|--....++.-..=.....+|.-++.
T Consensus       294 ~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llR  328 (1205)
T KOG0606|consen  294 QLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLR  328 (1205)
T ss_pred             HHHHhChHhhcccchhhhhhhccceeecccchhhh
Confidence            99999999996444544444433334455554433

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=99.47  E-value=1.8e-13  Score=146.63  Aligned_cols=106  Identities=15%  Similarity=0.162  Sum_probs=90.7

Q ss_pred             eeeeecCCCCCCHHHHHHhhCCChHhhhhhhCCCCCCCCCCCCCeEEEeeecccCC-CccccceeEEEeecCCchhhhhH
Q 007261           44 FLIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSG-LYYQANTSFIIPTIYHTYFSIAN  122 (611)
Q Consensus        44 ~~~y~~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~vP~~~~c~~-~~~~~~~~y~V~~~gdTl~~IA~  122 (611)
                      ...|++++ ||||++||+.||+++.+|+++|++.+  +.|.+||.|.||.++.+.. ........|+|++ ||||++||+
T Consensus       343 ~~~y~Vk~-GDTL~sIA~r~gvs~~~L~~~N~l~~--~~L~~Gq~L~Ip~~~~~~~~~~~~~~~~Y~Vr~-GDTL~sIA~  418 (456)
T PRK10783        343 SRSYKVRS-GDTLSGIASRLNVSTKDLQQWNNLRG--SKLKVGQTLTIGAGSSAQRLANNSDSITYRVRK-GDSLSSIAK  418 (456)
T ss_pred             ceEEEECC-CCcHHHHHHHHCcCHHHHHHHcCCCc--ccCCCCCEEEecCCcccccccccccceeEEeCC-CCCHHHHHH
Confidence            45788877 99999999999999999999999876  7799999999998876642 2223346899999 999999997


Q ss_pred             hhcCCCccHHHHHHhcCCCCCCCCCCceeeeecc
Q 007261          123 NTYQGLSTCNILKHENNYSETSLDQGLTLRVPLR  156 (611)
Q Consensus       123 ~~~~~l~t~~~l~~~N~~~~~~l~~G~~l~ip~~  156 (611)
                      +|.   +|+++|+++|+...+.|.+||+|.|++.
T Consensus       419 kyg---Vtv~~L~~~N~l~~~~L~pGq~L~l~v~  449 (456)
T PRK10783        419 RHG---VNIKDVMRWNSDTAKNLQPGDKLTLFVK  449 (456)
T ss_pred             HhC---CCHHHHHHhcCCCCCcCCCCCEEEEecC
Confidence            665   8889999999987558999999999875

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.46  E-value=3.5e-13  Score=133.63  Aligned_cols=119  Identities=22%  Similarity=0.228  Sum_probs=95.8

Q ss_pred             ceEEEEEEcCcEEEEEEec--------------------HHHHHHHHHHHhcCCCce--eeccceeccC-C---eEEEEE
Q 007261          339 GSVFRGIINGSTVAIKCMR--------------------RSISKEVNLLKKINHFNL--INLFGACEHD-G---VFYLVY  392 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~--------------------~~~~~E~~~l~~l~H~ni--v~l~g~~~~~-~---~~~lV~  392 (611)
                      |+||+....+..++||.++                    ..+.+|+.++.+|+|+++  ++.+++...+ .   ..++||
T Consensus        46 gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~  125 (239)
T PRK01723         46 GTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILI  125 (239)
T ss_pred             ccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEE
Confidence            8999999999999998773                    135679999999988775  6667664432 2   235999


Q ss_pred             eecCC-CCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          393 EFMEN-GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       393 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      ||+++ .+|.+++....    ++..    .+.+++.+|.+||   ..+|+|+||||.|||++.++.++|+|||.++.
T Consensus       126 e~l~G~~~L~~~l~~~~----l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        126 ERIEGARDLVALLQEAP----LSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             EecCCCCCHHHHHhcCC----CCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            99997 69999986532    4433    3568999999999   79999999999999999999999999998764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=4.7e-14  Score=138.43  Aligned_cols=213  Identities=19%  Similarity=0.293  Sum_probs=146.5

Q ss_pred             HHHHhcCCCceeeccceeccCC-----eEEEEEeecCCCCHHHHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCC
Q 007261          365 NLLKKINHFNLINLFGACEHDG-----VFYLVYEFMENGSLSDWLHKKR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDP  438 (611)
Q Consensus       365 ~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~  438 (611)
                      .-|-++.|.|||++..++.+..     ...++.|||..|+|..+|++.+ ....+......+|+.||..||.|||++ .+
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            3455568999999999986543     4788999999999999998743 234577777888999999999999985 79


Q ss_pred             CeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC-cccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh
Q 007261          439 GYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG-YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT  517 (611)
Q Consensus       439 ~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt  517 (611)
                      +++|+++..+-|++..++-+|+.--.-.......... ........+-++|.+||+-.....+..+|||+||+..+||.-
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            9999999999999999999988532111000000000 011223346789999999888888889999999999999987


Q ss_pred             CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          518 GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       518 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                      +..........- ...+.+....         ..+-++.           -+.++..|++..|..||+|.+++.+...+.
T Consensus       278 lEiq~tnseS~~-~~ee~ia~~i---------~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  278 LEIQSTNSESKV-EVEENIANVI---------IGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             heeccCCCccee-ehhhhhhhhe---------eeccCcc-----------ccCcCcccccCCCCCCcchhhhhcCceeee
Confidence            765432222110 0000000000         0000111           133677899999999999999998766554


Q ss_pred             hh
Q 007261          598 LD  599 (611)
Q Consensus       598 ~~  599 (611)
                      ..
T Consensus       337 Vh  338 (458)
T KOG1266|consen  337 VH  338 (458)
T ss_pred             cc
Confidence            43

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.44  E-value=4.9e-13  Score=121.93  Aligned_cols=120  Identities=23%  Similarity=0.289  Sum_probs=103.5

Q ss_pred             ceEEEEEEcCcEEEEEEecH-----HHHHHHHHHHhcCC--CceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGIINGSTVAIKCMRR-----SISKEVNLLKKINH--FNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      +.||++..++..+++|..+.     ++.+|+.++..++|  .++.+++++....+..+++|||++++.+..+        
T Consensus        12 ~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------   83 (155)
T cd05120          12 NRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV--------   83 (155)
T ss_pred             cceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC--------
Confidence            78999999889999999863     58899999999976  5899999988888889999999988776543        


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                        ++.....++.+++.+|.+||.....+++|+|++|.||++++.+.+++.|||+++.
T Consensus        84 --~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          84 --SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             --CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence              4456677899999999999964446899999999999999999999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK13914 invasion associated secreted endopeptidase; Provisional

Probab=99.43  E-value=4.8e-13  Score=140.31  Aligned_cols=170  Identities=14%  Similarity=0.124  Sum_probs=96.8

Q ss_pred             eeeecCCCCCCHHHHHHhhCCChHhhhhhhCCCCCCCCCCCCCeEEEeeecccCC---------------CccccceeEE
Q 007261           45 LIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSG---------------LYYQANTSFI  109 (611)
Q Consensus        45 ~~y~~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~vP~~~~c~~---------------~~~~~~~~y~  109 (611)
                      -.|.+++ |||||.||++||+++++|+++|++..  +.|.+||.|.||-...-.-               ...+....-.
T Consensus        28 ~tytVq~-GDTLw~IA~~ygvtv~~I~~~N~l~~--~~I~~Gq~L~Ip~~~~~~~~~~~Vta~~LNVRsgps~s~~IIgs  104 (481)
T PRK13914         28 STVVVEA-GDTLWGIAQSKGTTVDAIKKANNLTT--DKIVPGQKLQVNEVAAAEKTEKSVSATWLNVRSGAGVDNSIITS  104 (481)
T ss_pred             ceEEECC-CCCHHHHHHHHCCCHHHHHHHhCCCc--ccccCCCEEEeCCCCcccccceeEecceEEEecCCCCCcceeee
Confidence            3477877 99999999999999999999999865  7899999999996542110               0111111222


Q ss_pred             EeecCCchhhhhH---hhc-----CC---CccHHHHHHhcCCCCCCCCCCceee--------eecc----------CC-C
Q 007261          110 IPTIYHTYFSIAN---NTY-----QG---LSTCNILKHENNYSETSLDQGLTLR--------VPLR----------CA-C  159 (611)
Q Consensus       110 V~~~gdTl~~IA~---~~~-----~~---l~t~~~l~~~N~~~~~~l~~G~~l~--------ip~~----------~~-~  159 (611)
                      |.. |+.+..+..   .++     .|   .+.-+-|...-...  .+..-|++.        -|..          .+ .
T Consensus       105 l~~-G~~V~Vl~~~~ngW~kI~~~~GktGwV~~~YLs~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (481)
T PRK13914        105 IKG-GTKVTVETTESNGWHKITYNDGKTGFVNGKYLTDKVTST--PVAPTQEVKKETTTQQAAPAAETKTEVKQTTQATT  181 (481)
T ss_pred             ecC-CCEEEEeecccCCeEEEEcCCCCEEEEecccccCCCccC--ccccchhhhhccccccccchhcccchhccCCcccC
Confidence            333 443333210   000     00   00000010000000  000000000        0000          00 0


Q ss_pred             CCC-----ccccCCeeEEEEEEccCCCChhHHHhHhcCCHHHHHHhcCCCCCCCCcccceeeeecCCC
Q 007261          160 PTS-----NQIVNGTKFLLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTT  222 (611)
Q Consensus       160 ~~~-----~~~~~~~~~~~~y~v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~~~~~i~~g~~l~ip~~~  222 (611)
                      |.+     +..........+|+|++|||||.||++||+++++|.+||++.  +..|++||.|.||...
T Consensus       182 ~~~~~~~~~~~~~~~~~a~tytVq~GDTL~sIAkrYgVtv~eI~~~N~l~--s~~L~pGQ~L~Ip~sa  247 (481)
T PRK13914        182 PAPKVAETKETPVVDQNATTHAVKSGDTIWALSVKYGVSVQDIMSWNNLS--SSSIYVGQKLAIKQTA  247 (481)
T ss_pred             CcccccccccCccccCCCeEEEECCCCCHHHHHHHHCCCHHHHHHhcCCC--ccccCCCCEEEecCCC
Confidence            000     000000012358999999999999999999999999999995  4679999999999654

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.33  E-value=4.4e-12  Score=120.99  Aligned_cols=119  Identities=22%  Similarity=0.286  Sum_probs=83.2

Q ss_pred             ceEEEEEE-cCcEEEEEEecHH---------H----------------------HHHHHHHHhcCCCc--eeeccceecc
Q 007261          339 GSVFRGII-NGSTVAIKCMRRS---------I----------------------SKEVNLLKKINHFN--LINLFGACEH  384 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~~~---------~----------------------~~E~~~l~~l~H~n--iv~l~g~~~~  384 (611)
                      |.||++.. +|+.||||+++..         +                      ..|...+.++.+..  +.+.+++   
T Consensus        11 g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~---   87 (187)
T cd05119          11 ADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL---   87 (187)
T ss_pred             eeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec---
Confidence            89999988 5999999987631         0                      23444444443322  2223322   


Q ss_pred             CCeEEEEEeecCCCCHHH-HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeee
Q 007261          385 DGVFYLVYEFMENGSLSD-WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF  463 (611)
Q Consensus       385 ~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df  463 (611)
                       ...++||||++++.+.. .+....    .. .....++.+++.++.++|.  ..+++|+||||+||+++ ++.++|+||
T Consensus        88 -~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~~~~liDf  158 (187)
T cd05119          88 -NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DGKVYIIDV  158 (187)
T ss_pred             -CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CCcEEEEEC
Confidence             23589999999854321 121111    11 4567899999999999993  28999999999999999 899999999


Q ss_pred             cCcccc
Q 007261          464 SFVRSA  469 (611)
Q Consensus       464 gla~~~  469 (611)
                      |.+...
T Consensus       159 g~a~~~  164 (187)
T cd05119         159 PQAVEI  164 (187)
T ss_pred             cccccc
Confidence            998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.29  E-value=4e-13  Score=149.24  Aligned_cols=212  Identities=23%  Similarity=0.306  Sum_probs=157.9

Q ss_pred             HHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCHHHHh-hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 007261          362 KEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG  439 (611)
Q Consensus       362 ~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l-~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~  439 (611)
                      .|..+-..+. |.|++.+++...+.+..++++||..++++.+-+ +....  ..+....-....|+..++.|+|.  ..+
T Consensus        69 ~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~--~~~  144 (601)
T KOG0590|consen   69 TETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHP--ENG  144 (601)
T ss_pred             ccccccccccccccccccCCccCCCcccccccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCc--ccc
Confidence            3555556665 999999999999999999999999999999888 43321  23344455688999999999994  578


Q ss_pred             eEecCCCCCCeeeCCCC-cEEEeeecCccccccccCCccccccccc-CCCccchhhhcc-CCCCCccchHHHHHHHHHHH
Q 007261          440 YVHKDISSGNILLDKNL-RAKLANFSFVRSAVREESGYSSTKTAVG-TNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELI  516 (611)
Q Consensus       440 ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~ell  516 (611)
                      +.|+||||+|.+++.++ ..+++|||+|.................| ++.|+|||...+ ....+..|+||.|+++.-++
T Consensus       145 ~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~  224 (601)
T KOG0590|consen  145 VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAML  224 (601)
T ss_pred             cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccc
Confidence            99999999999999999 9999999999877652223344455677 999999999877 45678899999999999999


Q ss_pred             hCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          517 TGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       517 tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      +|..|+............+    .+          .-+...............++..+++..+|..|.+.+++..
T Consensus       225 ~g~~p~~~~~~~~~~~~~~----~~----------~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  225 TGELPWDFPSRKDGRYSSW----KS----------NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cCCCCccccccccccceee----cc----------cccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence            9999987554332111100    00          0000001113344556777888899999999999888754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.28  E-value=1.4e-11  Score=132.76  Aligned_cols=124  Identities=21%  Similarity=0.263  Sum_probs=87.0

Q ss_pred             ceEEEEEE-cCcEEEEEEecH----H-------------------------------------------HHHHHHHHHhc
Q 007261          339 GSVFRGII-NGSTVAIKCMRR----S-------------------------------------------ISKEVNLLKKI  370 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~~----~-------------------------------------------~~~E~~~l~~l  370 (611)
                      |.||+|++ +|+.||||+.+.    .                                           |.+|...+.++
T Consensus       131 gQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~  210 (437)
T TIGR01982       131 AQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASEL  210 (437)
T ss_pred             hheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHH
Confidence            89999998 899999999752    1                                           22344444443


Q ss_pred             ----CCCceeeccceec-cCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHH-HHHHHhcCCCCCeEecC
Q 007261          371 ----NHFNLINLFGACE-HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAH-GLHYLHNCTDPGYVHKD  444 (611)
Q Consensus       371 ----~H~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~-gL~yLH~~~~~~ivH~D  444 (611)
                          +|.+-+.+-..+. .....+|||||++|++|.++.......  .   .+.+++..++. .+..+|   ..+++|+|
T Consensus       211 ~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~---~~g~~H~D  282 (437)
T TIGR01982       211 GENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVL---RDGFFHAD  282 (437)
T ss_pred             HHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHH---hCCceeCC
Confidence                1222233323222 234568999999999999887542211  2   23456766666 467888   68999999


Q ss_pred             CCCCCeeeCCCCcEEEeeecCccccc
Q 007261          445 ISSGNILLDKNLRAKLANFSFVRSAV  470 (611)
Q Consensus       445 lk~~NILl~~~~~~kl~Dfgla~~~~  470 (611)
                      +||.||+++++++++++|||++....
T Consensus       283 ~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       283 LHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCcccEEECCCCcEEEEeCCCeeECC
Confidence            99999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.23  E-value=1.3e-10  Score=124.92  Aligned_cols=226  Identities=18%  Similarity=0.257  Sum_probs=148.6

Q ss_pred             cCcEEEEEEecH-------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHH
Q 007261          347 NGSTVAIKCMRR-------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF  419 (611)
Q Consensus       347 ~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~  419 (611)
                      ++.+|.|...+.       ...+-++.|+.++||||++++..+..++..|||+|-+  -.|..++++..      -....
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~------~~~v~  107 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG------KEEVC  107 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH------HHHHH
Confidence            677777777652       2567788999999999999999999999999999998  47888887643      23444


Q ss_pred             HHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhccCCC
Q 007261          420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV  499 (611)
Q Consensus       420 ~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  499 (611)
                      -.+.||+.||.|||+  +.+++|++|.-..|+|++.|+.||++|.++........   .......-..|..|+.+.... 
T Consensus       108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCccc-
Confidence            567899999999997  67899999999999999999999999998754422211   011111223466676554332 


Q ss_pred             CCccchHHHHHHHHHHHhCCCCCcCCCCh-hhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhcc
Q 007261          500 TPEMDTYAFGVVLLELITGKEAAYKQDGE-EILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAR  578 (611)
Q Consensus       500 s~ksDV~s~Gvvl~elltG~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~  578 (611)
                       ...|.|-||+++||++.|..+....... +......+....+.              +...+..-+. ..+++..|...
T Consensus       182 -~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~--------------~~~~~~~r~n-~~~~~~~~~~~  245 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKK--------------LGATELKRPN-KLRFILECRLL  245 (690)
T ss_pred             -cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHH--------------hccccccccc-hhhHHHHHHhc
Confidence             3469999999999999993322111000 00000000000000              0000000111 45567777777


Q ss_pred             CCCCCCCHHHHHHHHHhchhhhhh
Q 007261          579 EPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       579 dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                      .+--|=.+-+++..|+.++.....
T Consensus       246 ~gff~n~fvd~~~fLeel~lks~~  269 (690)
T KOG1243|consen  246 GGFFRNDFVDTLLFLEELRLKSVE  269 (690)
T ss_pred             cccccchHHHHHHHHHhcccCcHH
Confidence            777777788888888777665443

>PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation []

Probab=99.15  E-value=2.8e-11  Score=86.32  Aligned_cols=43  Identities=30%  Similarity=0.527  Sum_probs=35.8

Q ss_pred             EEccCCCChhHHHhHhcCCHHHHHHhc-CCCCCCCCcccceeeeec
Q 007261          175 YLVSWGDSVPDISKRFNVSIESIVNAN-GFTEDDPLLFPFTTILIP  219 (611)
Q Consensus       175 y~v~~gdtl~~Ia~~f~~~~~~l~~~N-~~~~~~~~i~~g~~l~ip  219 (611)
                      |+|++|||+|+||++||++.++|++|| ++. . +.|++||.|.||
T Consensus         1 y~V~~gDtl~~IA~~~~~~~~~l~~~N~~~~-~-~~l~~G~~l~iP   44 (44)
T PF01476_consen    1 YTVQPGDTLWSIAKRYGISVDELMELNPNID-S-DNLQPGQKLCIP   44 (44)
T ss_dssp             EEE-TT--HHHHHHHTTS-HHHHHHHCCTTH-G-GCGGTTEEEEEC
T ss_pred             CEECcCCcHHHHHhhhhhhHhHHHHhcCCCC-c-ccCCCCCEEEeC
Confidence            899999999999999999999999999 874 3 349999999998

This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A.

>COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane]

Probab=99.15  E-value=4.9e-11  Score=105.85  Aligned_cols=112  Identities=17%  Similarity=0.279  Sum_probs=90.9

Q ss_pred             HHHhhCCChHhhhhhhCCCCCCCCCCCCCeEEEeeecccCCCccccceeEEEeecCCchhhhhHhhcCCCccHHHHHHhc
Q 007261           59 ISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANNTYQGLSTCNILKHEN  138 (611)
Q Consensus        59 Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~vP~~~~c~~~~~~~~~~y~V~~~gdTl~~IA~~~~~~l~t~~~l~~~N  138 (611)
                      ||..|++++.+|+.+|.+....+.+.+||.|.+|..           ..+.+.. +++.+..+..+.....         
T Consensus         1 ia~~~~~~v~~l~~~n~~~~~s~~i~~gq~l~~~~~-----------~~~~~~~-~~~~~~~~~~~~~~~~---------   59 (124)
T COG1388           1 IASKYGVSVKALKKANALTGKSDAIKPGQVLKIPGD-----------ISSTVNA-GQTLSSLSNKVSDSSS---------   59 (124)
T ss_pred             CcccccccHHHHHHHhcccCCCCccccCceEEccCC-----------ccccccc-ccccccccceeecccc---------
Confidence            578899999999999988732488999999999965           3577888 8999999965553221         


Q ss_pred             CCCCCCCCCCceeeeeccCCCCCCccccCCeeEEEEEEccCCCChhHHHhHhcCCHHHHHHhcCCCCCCCCcccceeeee
Q 007261          139 NYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILI  218 (611)
Q Consensus       139 ~~~~~~l~~G~~l~ip~~~~~~~~~~~~~~~~~~~~y~v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~~~~~i~~g~~l~i  218 (611)
                                                 ........+|+|+.||+|+.||++|++++.+|+++|++.  ++.+++||.|.+
T Consensus        60 ---------------------------~~~~~~~~~~~V~~gdtL~~Ia~~~~~tv~~l~~~n~l~--~~~i~~gq~l~~  110 (124)
T COG1388          60 ---------------------------ASKAPPVVTYTVKKGDTLSKIARKYGVTVAELKQLNNLS--SDKIKVGQKLKL  110 (124)
T ss_pred             ---------------------------ccccCCCceEEEecCCCHHHHHHHhCCCHHHHHHHhccC--CCceecCcEEEE
Confidence                                       000112357999999999999999999999999999995  449999999999


Q ss_pred             cC
Q 007261          219 PL  220 (611)
Q Consensus       219 p~  220 (611)
                      +.
T Consensus       111 ~~  112 (124)
T COG1388         111 PV  112 (124)
T ss_pred             ec
Confidence            86

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.10  E-value=2.8e-10  Score=106.56  Aligned_cols=115  Identities=21%  Similarity=0.197  Sum_probs=86.3

Q ss_pred             ceEEEEEEcCcEEEEEEecH------HHHHHHHHHHhcCCCcee-eccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGIINGSTVAIKCMRR------SISKEVNLLKKINHFNLI-NLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~~------~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      +.||+....|..+++|....      ++.+|+.+++.+.+.+++ +++.+..  ...++||||+++.++.+.  .     
T Consensus        12 ~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~--~-----   82 (170)
T cd05151          12 NKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE--D-----   82 (170)
T ss_pred             CceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc--c-----
Confidence            78999999999999999753      367899999999665544 3444432  235799999999887543  0     


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCT--DPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                       ..   ...++.+++++|+.||...  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        83 -~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          83 -FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             -cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence             11   1235678999999999522  22369999999999999 6689999999865

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.08  E-value=1.5e-10  Score=123.33  Aligned_cols=227  Identities=23%  Similarity=0.282  Sum_probs=162.5

Q ss_pred             ceEEEEEE----cCcEEEEEEec---------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII----NGSTVAIKCMR---------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~----~g~~vavK~~~---------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.+|.+..    ++..+|+|.-+         .+-.+|+....++ .|+|.++....+.+++..++-+|++. .+|..+.
T Consensus       130 ~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~  208 (524)
T KOG0601|consen  130 GSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYC  208 (524)
T ss_pred             ceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhh
Confidence            88998876    57789999853         2334677777777 59999999999999999999999994 7888888


Q ss_pred             hccCCCCccCHHHHHHHHHHHHH----HHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeecCccccccccCC--cc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAH----GLHYLHNCTDPGYVHKDISSGNILLDKN-LRAKLANFSFVRSAVREESG--YS  477 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~----gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~~~~~~~~~--~~  477 (611)
                      +....  .++.........+...    ||.++|   ...++|-|+||.||++.++ ...+++|||+..........  ..
T Consensus       209 ~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~  283 (524)
T KOG0601|consen  209 HTPCN--FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFK  283 (524)
T ss_pred             hcccc--cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcceeEEccCCcccccee
Confidence            76432  2444444455555555    999999   6899999999999999999 88999999998877554321  11


Q ss_pred             cccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccC
Q 007261          478 STKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNL  557 (611)
Q Consensus       478 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l  557 (611)
                      ......+...|++||... +.++...|+|++|.+..|..++.......-...                +..++....   
T Consensus       284 ~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~----------------W~~~r~~~i---  343 (524)
T KOG0601|consen  284 VSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS----------------WSQLRQGYI---  343 (524)
T ss_pred             eeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC----------------ccccccccC---
Confidence            223346788999999886 467899999999999999998876654321110                111111111   


Q ss_pred             CcC-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          558 QAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       558 ~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      ..+ ......++...+..+++.+|-.|++...+..
T Consensus       344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            111 1122334555888899999999998866553

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.03  E-value=4.5e-10  Score=122.64  Aligned_cols=76  Identities=22%  Similarity=0.234  Sum_probs=51.3

Q ss_pred             CeEEEEEeecCCCCHHHH--hhccCCCCccCHHHHHHHHHHHHHH-HHHHhcCCCCCeEecCCCCCCeeeCCCC----cE
Q 007261          386 GVFYLVYEFMENGSLSDW--LHKKRYPEFVSWNCRFRIALDVAHG-LHYLHNCTDPGYVHKDISSGNILLDKNL----RA  458 (611)
Q Consensus       386 ~~~~lV~E~~~~gsL~~~--l~~~~~~~~l~~~~~~~ia~~ia~g-L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~  458 (611)
                      ...+|||||++|+.|.++  +...+    .+.   ..++...+.. +.-++   ..+++|+|+||.||+++.++    ++
T Consensus       234 t~~VLvmE~i~G~~l~d~~~l~~~g----~d~---~~la~~~v~~~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i  303 (537)
T PRK04750        234 SETVMVMERMYGIPVSDVAALRAAG----TDM---KLLAERGVEVFFTQVF---RDGFFHADMHPGNIFVSYDPPENPRY  303 (537)
T ss_pred             CCceEEEeeecCccHHhHHHHHhcC----CCH---HHHHHHHHHHHHHHHH---hCCeeeCCCChHHeEEecCCCCCCeE
Confidence            345699999999999875  33222    111   1122222221 12223   47899999999999999988    99


Q ss_pred             EEeeecCcccccc
Q 007261          459 KLANFSFVRSAVR  471 (611)
Q Consensus       459 kl~Dfgla~~~~~  471 (611)
                      ++.|||++.....
T Consensus       304 ~llDFGivg~l~~  316 (537)
T PRK04750        304 IALDFGIVGSLNK  316 (537)
T ss_pred             EEEecceEEECCH
Confidence            9999999876543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.98  E-value=4.1e-09  Score=100.32  Aligned_cols=96  Identities=18%  Similarity=0.157  Sum_probs=70.4

Q ss_pred             HHHHHHHhcCC--CceeeccceeccCCeEEEEEeecCCCCHH-HHhhccCCCCccCHHHHHHHHHHHHHHHHHH-hcCCC
Q 007261          362 KEVNLLKKINH--FNLINLFGACEHDGVFYLVYEFMENGSLS-DWLHKKRYPEFVSWNCRFRIALDVAHGLHYL-HNCTD  437 (611)
Q Consensus       362 ~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~-~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~  437 (611)
                      +|+..|+++..  -++...+++    ...+|||||+.+..+. ..|++.    .++..+...+..+++.+|..| |   .
T Consensus        75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H---~  143 (197)
T cd05146          75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYK---E  143 (197)
T ss_pred             HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHH---h
Confidence            69999999843  345555543    3467999999765442 223322    144455667889999999999 6   6


Q ss_pred             CCeEecCCCCCCeeeCCCCcEEEeeecCcccc
Q 007261          438 PGYVHKDISSGNILLDKNLRAKLANFSFVRSA  469 (611)
Q Consensus       438 ~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~  469 (611)
                      .+++|+||++.|||++ ++.+.|+|||.+...
T Consensus       144 ~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         144 CNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence            8999999999999997 467999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.92  E-value=1e-09  Score=117.15  Aligned_cols=237  Identities=20%  Similarity=0.193  Sum_probs=163.4

Q ss_pred             hhcCCCCCccc----ceEEEEEE---cCcEEEEEEecHH---------HHHHHHHHHhc-CCCceeeccceeccCCeEEE
Q 007261          328 TENFSPKNMID----GSVFRGII---NGSTVAIKCMRRS---------ISKEVNLLKKI-NHFNLINLFGACEHDGVFYL  390 (611)
Q Consensus       328 t~~f~~~~~ig----g~Vy~g~~---~g~~vavK~~~~~---------~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  390 (611)
                      +..|.+-..|+    +.|++...   ++..+++|.+.+.         -..|+-+...+ .|.++++.+..+...+..|+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            44454444443    45555443   4667888877531         23466666666 68999998888888888889


Q ss_pred             EEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeecCcccc
Q 007261          391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN-LRAKLANFSFVRSA  469 (611)
Q Consensus       391 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~~~  469 (611)
                      --||++++++...+.-   ...++...++++..|++.++.++|   ++.++|+|+||+||++..+ +..++.|||.+...
T Consensus       344 p~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             chhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccc
Confidence            9999999998877632   233777788899999999999999   7999999999999999886 88999999987642


Q ss_pred             ccccCCcccccccccCCCc-cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc
Q 007261          470 VREESGYSSTKTAVGTNGY-MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK  548 (611)
Q Consensus       470 ~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  548 (611)
                      ...     .......+..| .+++......+-.+.|+||||..+.|.+++.........                     
T Consensus       418 ~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---------------------  471 (524)
T KOG0601|consen  418 AFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---------------------  471 (524)
T ss_pred             cee-----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---------------------
Confidence            111     11112223334 366667778889999999999999999998754322111                     


Q ss_pred             cccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       549 l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                      ...+........+. ....+..+.+.+...++..||.+.++..+..-.+
T Consensus       472 ~~~i~~~~~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  472 SLTIRSGDTPNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             ceeeecccccCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            00011111111112 2256677888888999999999988877655433

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.87  E-value=1.7e-08  Score=93.15  Aligned_cols=117  Identities=20%  Similarity=0.223  Sum_probs=89.8

Q ss_pred             ceEEEEEEcCcEEEEEEe-c--------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIINGSTVAIKCM-R--------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~-~--------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      ..+|.+.+-|..+.+|.= +              ..-.+|+.++.+++--.|.--+=+..+.....|+|||++|..|.+.
T Consensus        10 a~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~   89 (204)
T COG3642          10 AIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDA   89 (204)
T ss_pred             eeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHH
Confidence            568888887777777752 1              2356799999998654443333344556667899999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSA  469 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~  469 (611)
                      +....          ..++..+-.-+.-||   ..+|+|+||.++||++.... +.++||||+...
T Consensus        90 l~~~~----------~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          90 LEEAR----------PDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             HHhcc----------hHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            97652          346777888888899   79999999999999998765 999999998643

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.86  E-value=2.6e-08  Score=100.04  Aligned_cols=125  Identities=15%  Similarity=0.182  Sum_probs=94.7

Q ss_pred             ceEEEEEEcCcEEEEEEec--------H----------HHHHHHHHHHhcCCCc--eeeccceecc-----CCeEEEEEe
Q 007261          339 GSVFRGIINGSTVAIKCMR--------R----------SISKEVNLLKKINHFN--LINLFGACEH-----DGVFYLVYE  393 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~--------~----------~~~~E~~~l~~l~H~n--iv~l~g~~~~-----~~~~~lV~E  393 (611)
                      ..|++..++|+.+.||...        +          .+.+|...+.++...+  ....+++...     ....+||+|
T Consensus        36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            4577888899999999652        1          3778999998884333  3334444432     235789999


Q ss_pred             ecCCC-CHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-------CCcEEEeeecC
Q 007261          394 FMENG-SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-------NLRAKLANFSF  465 (611)
Q Consensus       394 ~~~~g-sL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-------~~~~kl~Dfgl  465 (611)
                      ++++. +|.+++..... ...+...+..++.+++..+.-||   ..+|+|+|++++|||++.       ++.+.++||+.
T Consensus       116 ~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        116 DLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             eCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            99876 89999864321 22455667789999999999999   799999999999999975       57899999997


Q ss_pred             cc
Q 007261          466 VR  467 (611)
Q Consensus       466 a~  467 (611)
                      ++
T Consensus       192 ~~  193 (268)
T PRK15123        192 AQ  193 (268)
T ss_pred             cc
Confidence            64

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.85  E-value=1e-08  Score=97.17  Aligned_cols=117  Identities=22%  Similarity=0.297  Sum_probs=78.5

Q ss_pred             eEEEEEE-cCcEEEEEEec---------------------------------HHHHHHHHHHHhcCCC--ceeeccceec
Q 007261          340 SVFRGII-NGSTVAIKCMR---------------------------------RSISKEVNLLKKINHF--NLINLFGACE  383 (611)
Q Consensus       340 ~Vy~g~~-~g~~vavK~~~---------------------------------~~~~~E~~~l~~l~H~--niv~l~g~~~  383 (611)
                      .||.|.. +|..+|||..+                                 ....+|.+.|.++..-  ++.+.+++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899987 78999999874                                 1245799999999655  445555442 


Q ss_pred             cCCeEEEEEeecC--CCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 007261          384 HDGVFYLVYEFME--NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYL-HNCTDPGYVHKDISSGNILLDKNLRAKL  460 (611)
Q Consensus       384 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~~ivH~Dlk~~NILl~~~~~~kl  460 (611)
                         ...|||||++  +..+..+....     ++......++.+++..+..+ |   ..+++|+||.+.|||++++ .+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEE
Confidence               2369999998  55554433322     11233456777888866664 6   7899999999999999988 9999


Q ss_pred             eeecCcccc
Q 007261          461 ANFSFVRSA  469 (611)
Q Consensus       461 ~Dfgla~~~  469 (611)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999987644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.84  E-value=3.1e-09  Score=119.17  Aligned_cols=196  Identities=20%  Similarity=0.218  Sum_probs=141.3

Q ss_pred             cCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 007261          370 INHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN  449 (611)
Q Consensus       370 l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~N  449 (611)
                      .+||-+++..--+.-....+|+++|+.+++|...|+....   .+..-.......+..+++|||   ...+.|+|++|.|
T Consensus       861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~  934 (1205)
T KOG0606|consen  861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDS  934 (1205)
T ss_pred             CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccc---cchhhcccccccc
Confidence            3457777666666667788999999999999999987642   232223345567788999999   4558999999999


Q ss_pred             eeeCCCCcEEEeeecCccccccc---------------------cCC-------cccccccccCCCccchhhhccCCCCC
Q 007261          450 ILLDKNLRAKLANFSFVRSAVRE---------------------ESG-------YSSTKTAVGTNGYMAPEYMEYGLVTP  501 (611)
Q Consensus       450 ILl~~~~~~kl~Dfgla~~~~~~---------------------~~~-------~~~~~~~~gt~~y~aPE~~~~~~~s~  501 (611)
                      .|...++..+++|||........                     ...       ........+|+.|.+||.+.+.....
T Consensus       935 ~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs 1014 (1205)
T KOG0606|consen  935 LLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGS 1014 (1205)
T ss_pred             hhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCC
Confidence            99999999999999843221110                     000       01123457899999999999999999


Q ss_pred             ccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCC
Q 007261          502 EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE  581 (611)
Q Consensus       502 ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~  581 (611)
                      .+|+|++|++++|.++|..||........     +....           -.+..+...+...+.+..+++...+..+|.
T Consensus      1015 ~ad~~~~g~~l~e~l~g~pp~na~tpq~~-----f~ni~-----------~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~ 1078 (1205)
T KOG0606|consen 1015 AADWWSSGVCLFEVLTGIPPFNAETPQQI-----FENIL-----------NRDIPWPEGPEEGSYEAQDLINRLLTEEPT 1078 (1205)
T ss_pred             cchhhhhhhhhhhhhcCCCCCCCcchhhh-----hhccc-----------cCCCCCCCCccccChhhhhhhhhhhccCch
Confidence            99999999999999999999876554321     01111           112223333555667778888888899999


Q ss_pred             CCCCHH
Q 007261          582 SRPSMA  587 (611)
Q Consensus       582 ~RPs~~  587 (611)
                      +|-.+.
T Consensus      1079 qr~~a~ 1084 (1205)
T KOG0606|consen 1079 QRLGAK 1084 (1205)
T ss_pred             hccCcc
Confidence            997765

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.82  E-value=4e-08  Score=90.17  Aligned_cols=127  Identities=21%  Similarity=0.251  Sum_probs=93.1

Q ss_pred             ceEEEEEEcCcEEEEEEe---------------cHHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCC-CCHHH
Q 007261          339 GSVFRGIINGSTVAIKCM---------------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN-GSLSD  402 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~---------------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~-gsL~~  402 (611)
                      +.|+++.+.|+...||.=               +++.++|+..|.+++--.|.--.-++.+...-.|+|||+++ .++.+
T Consensus        21 Arv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~  100 (229)
T KOG3087|consen   21 ARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKD  100 (229)
T ss_pred             eeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHH
Confidence            689999999999888853               14567899999998644443323344445555789999976 47888


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEEeeecCcccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL---RAKLANFSFVRSA  469 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgla~~~  469 (611)
                      ++.........+ .....++..|-+.+.-||   ...++|+||..+||++..++   .+.++|||++...
T Consensus       101 ~i~~~~~~~~~d-~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  101 FILSTMEDESED-EGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             HHHHHccCcccc-hhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            887654322222 223678889999999999   79999999999999996543   4589999997543

>PRK14125 cell division suppressor protein YneA; Provisional

Probab=98.82  E-value=6.1e-09  Score=87.83  Aligned_cols=50  Identities=16%  Similarity=0.259  Sum_probs=42.7

Q ss_pred             EEEEEccCCCChhHHHhHhcCC--------HHHHHHhcCCCCCCCCcccceeeeecCCCC
Q 007261          172 LLTYLVSWGDSVPDISKRFNVS--------IESIVNANGFTEDDPLLFPFTTILIPLTTE  223 (611)
Q Consensus       172 ~~~y~v~~gdtl~~Ia~~f~~~--------~~~l~~~N~~~~~~~~i~~g~~l~ip~~~~  223 (611)
                      ..+|+|++|||||+||++|+++        ++.|.+.|++.  ++.|+|||.|.||....
T Consensus        36 ~~~~tV~~GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~l~--~~~I~~Gq~L~IP~~~~   93 (103)
T PRK14125         36 YVEITVQEGDTLWALADQYAGKHHMAKNEFIEWVEDVNNLP--SGHIKAGDKLVIPVLKS   93 (103)
T ss_pred             cEEEEECCCCCHHHHHHHhCCCcCCCHHHHHHHHHHhcCCC--CCcCCCCCEEEEecCCC
Confidence            4679999999999999999876        56778889995  45799999999997764

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.78  E-value=4.1e-08  Score=95.90  Aligned_cols=126  Identities=21%  Similarity=0.326  Sum_probs=96.8

Q ss_pred             ceEEEEEEcC-cEEEEEEec--------HHHHHHHHHHHhcCC--CceeeccceeccC---CeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGIING-STVAIKCMR--------RSISKEVNLLKKINH--FNLINLFGACEHD---GVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~~g-~~vavK~~~--------~~~~~E~~~l~~l~H--~niv~l~g~~~~~---~~~~lV~E~~~~gsL~~~l  404 (611)
                      +.+|+....+ ..+++|...        ..+.+|..+++.+++  .++.+++.+....   +..++||||+++.+|.+.+
T Consensus        12 n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~   91 (223)
T cd05154          12 NLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRL   91 (223)
T ss_pred             ceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCC
Confidence            6899998854 899999875        257889999999965  3456677776654   3668999999998887655


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------------
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT------------------------------------------------  436 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~------------------------------------------------  436 (611)
                      ..    ..++..++..++.+++++|..||+..                                                
T Consensus        92 ~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (223)
T cd05154          92 LR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAH  167 (223)
T ss_pred             CC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhh
Confidence            32    12666777778888888888888521                                                


Q ss_pred             -----CCCeEecCCCCCCeeeCC--CCcEEEeeecCccc
Q 007261          437 -----DPGYVHKDISSGNILLDK--NLRAKLANFSFVRS  468 (611)
Q Consensus       437 -----~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgla~~  468 (611)
                           ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       168 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         168 LPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             CCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                 245799999999999998  66789999997653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.76  E-value=5.7e-07  Score=94.46  Aligned_cols=160  Identities=19%  Similarity=0.271  Sum_probs=122.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec---H----HHHHHHHHHHhcCCCceeeccceec----cCCeEEEEEeecCC-CCHHHHh
Q 007261          339 GSVFRGII--NGSTVAIKCMR---R----SISKEVNLLKKINHFNLINLFGACE----HDGVFYLVYEFMEN-GSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---~----~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~l  404 (611)
                      .+.|++.-  +|..+.+|++.   .    ....-++.++++.|.|+|++..++.    .+..+++||+|+++ ++|.+.-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            57888876  89999999993   1    2344688999999999999999886    34578999999986 6777765


Q ss_pred             hccCC------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          405 HKKRY------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       405 ~~~~~------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      .....            +...++...+.++.|+..||.++|   +.|+.-+-|.+++||++.+.+++|+..|.......+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            43211            123567888999999999999999   688999999999999999999999988875444322


Q ss_pred             cCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCC
Q 007261          473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA  521 (611)
Q Consensus       473 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p  521 (611)
                      .               .  |.+.+   -.+-|.-.||.+++.|.||...
T Consensus       447 ~---------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  447 P---------------T--EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             C---------------C--cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            1               0  11111   1256999999999999999764

>TIGR02899 spore_safA spore coat assembly protein SafA

Probab=98.74  E-value=1.2e-08  Score=72.38  Aligned_cols=43  Identities=30%  Similarity=0.543  Sum_probs=38.1

Q ss_pred             ccCCCChhHHHhHhcCCHHHHHHhcCCCCCCCCcccceeeeec
Q 007261          177 VSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIP  219 (611)
Q Consensus       177 v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~~~~~i~~g~~l~ip  219 (611)
                      |++|||||+||++|+++.++|.++|+.......+++||.|.||
T Consensus         1 v~~gdtl~~IA~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~ip   43 (44)
T TIGR02899         1 VQKGDTLWKIAKKYGVDFDELIQANPQLSNPNLIYPGMKIKIP   43 (44)
T ss_pred             CCCCCCHHHHHHHHCcCHHHHHHHhhcCCCCCCcCCCCEEecC
Confidence            6899999999999999999999999743155689999999997

in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.73  E-value=3.7e-09  Score=114.37  Aligned_cols=153  Identities=22%  Similarity=0.299  Sum_probs=107.0

Q ss_pred             HHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcc------cccccccCCCccchhhhcc
Q 007261          423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS------STKTAVGTNGYMAPEYMEY  496 (611)
Q Consensus       423 ~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~  496 (611)
                      .+++.||.|+|.  ..++||++|.|++|.++.++..||+.|+++...........      ..-.......|.|||++.+
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345699999997  78999999999999999999999999998765433211100      0111123457999999999


Q ss_pred             CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhh
Q 007261          497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACI  576 (611)
Q Consensus       497 ~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl  576 (611)
                      ...+.++|+||+|++++.+..|+.+.....+......              .-....+........+.+.++.+=+.+.+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--------------FSRNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhh--------------hhhcccccccccccccCcHHHHHHHHHHh
Confidence            8899999999999999999966655443322111000              00111122222224567788888899999


Q ss_pred             ccCCCCCCCHHHHHH
Q 007261          577 AREPESRPSMAEVVS  591 (611)
Q Consensus       577 ~~dP~~RPs~~evl~  591 (611)
                      ..++.-||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998877654

>PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation []

Probab=98.70  E-value=8.4e-09  Score=73.38  Aligned_cols=43  Identities=26%  Similarity=0.342  Sum_probs=34.2

Q ss_pred             EEEeecCCchhhhhHhhcCCCccHHHHHHhc-CCCCCCCCCCceeeee
Q 007261          108 FIIPTIYHTYFSIANNTYQGLSTCNILKHEN-NYSETSLDQGLTLRVP  154 (611)
Q Consensus       108 y~V~~~gdTl~~IA~~~~~~l~t~~~l~~~N-~~~~~~l~~G~~l~ip  154 (611)
                      |+|++ |||+|.||+++.   +++++|+++| .+....|.+||+|.||
T Consensus         1 y~V~~-gDtl~~IA~~~~---~~~~~l~~~N~~~~~~~l~~G~~l~iP   44 (44)
T PF01476_consen    1 YTVQP-GDTLWSIAKRYG---ISVDELMELNPNIDSDNLQPGQKLCIP   44 (44)
T ss_dssp             EEE-T-T--HHHHHHHTT---S-HHHHHHHCCTTHGGCGGTTEEEEEC
T ss_pred             CEECc-CCcHHHHHhhhh---hhHhHHHHhcCCCCcccCCCCCEEEeC
Confidence            89999 999999997664   8889999999 5556569999999998

This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A.

>cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation

Probab=98.62  E-value=5.5e-08  Score=68.98  Aligned_cols=45  Identities=33%  Similarity=0.584  Sum_probs=41.8

Q ss_pred             EEEccCCCChhHHHhHhcCCHHHHHHhcCCCCCCCCcccceeeeec
Q 007261          174 TYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIP  219 (611)
Q Consensus       174 ~y~v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~~~~~i~~g~~l~ip  219 (611)
                      +|+|++|||+++||++|+++..+|.++|+.. ....+.+|+.+.||
T Consensus         2 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~-~~~~~~~g~~l~ip   46 (46)
T cd00118           2 TYTVKKGDTLSSIAQRYGISVEELLKLNGLS-DPDNLQVGQKLKIP   46 (46)
T ss_pred             EEEECCCCCHHHHHHHHCcCHHHHHHHcCCC-CccccCCCCEEecC
Confidence            5999999999999999999999999999985 66789999999886

This domain may have a general peptidoglycan binding function.

>COG3858 Predicted glycosyl hydrolase [General function prediction only]

Probab=98.55  E-value=8.5e-08  Score=98.13  Aligned_cols=97  Identities=23%  Similarity=0.216  Sum_probs=81.2

Q ss_pred             eEEEeecCCchhhhhHhhcCCCccHHHHHHhcCCCCCCCCCCceeeeeccCCCCCCccccCCeeEEEEEEccCCCChhHH
Q 007261          107 SFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPDI  186 (611)
Q Consensus       107 ~y~V~~~gdTl~~IA~~~~~~l~t~~~l~~~N~~~~~~l~~G~~l~ip~~~~~~~~~~~~~~~~~~~~y~v~~gdtl~~I  186 (611)
                      .|.|++ ||+++.||+ +|.  .+...|...|....+.|.+||.+.||..               ...|.|++|||+++|
T Consensus         3 i~~~~p-g~~~~~i~~-~~~--~~~~~i~~~~~~~~d~~~~~q~~~v~~~---------------~~~y~~~~~d~~~Si   63 (423)
T COG3858           3 IHLVGP-GDSRLIIAV-YFP--YTNNRIVNGNDYTNDDLVDGQTFVVPPS---------------GHFYDVGPGDTLTSI   63 (423)
T ss_pred             EEEccC-Cceeeeehh-hcc--ccccccccccccccccccCceeEEECCc---------------ceEEEecCCcchhhh
Confidence            588999 999999995 554  5667776666665678999999999963               246999999999999


Q ss_pred             HhHhcCCHHHHHHhcCCCCCCCCcccceeeeecCCCC
Q 007261          187 SKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTE  223 (611)
Q Consensus       187 a~~f~~~~~~l~~~N~~~~~~~~i~~g~~l~ip~~~~  223 (611)
                      |++|||+.+.+...|... .+..+.+|-.+.+|-...
T Consensus        64 a~~~~vt~~~~~~m~~~~-~~~~l~~~~~l~~P~~~~   99 (423)
T COG3858          64 ARTVGVTQDSAAIMNFVI-CPGYLQYGLNLYIPSARK   99 (423)
T ss_pred             hhhhcCCHHHHHhhcccc-cccceeeeeEEeccCCCC
Confidence            999999999999999876 677889998888886653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.51  E-value=1.6e-06  Score=88.97  Aligned_cols=202  Identities=14%  Similarity=0.206  Sum_probs=132.4

Q ss_pred             EEEEEeecCCC-CHHHHhhc---cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeee
Q 007261          388 FYLVYEFMENG-SLSDWLHK---KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF  463 (611)
Q Consensus       388 ~~lV~E~~~~g-sL~~~l~~---~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df  463 (611)
                      ..+.|..+++- -...++.-   .+.-....|...++.+..+|.+.+-||   ..|.+-+|+.++|+|+.+++.+.|.|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcc
Confidence            56777777653 22233321   112234789999999999999999999   689999999999999999999999986


Q ss_pred             cCccccccccCCcccccccccCCCccchhhhc-----cCCCCCccchHHHHHHHHHHHhC-CCCCcCCCC-------hhh
Q 007261          464 SFVRSAVREESGYSSTKTAVGTNGYMAPEYME-----YGLVTPEMDTYAFGVVLLELITG-KEAAYKQDG-------EEI  530 (611)
Q Consensus       464 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~s~Gvvl~elltG-~~p~~~~~~-------~~~  530 (611)
                      ......    .........+|...|.+||.-.     +-.-+...|-|.+|+++++|+.| +.|+.+-..       .|.
T Consensus       162 Dsfqi~----~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~  237 (637)
T COG4248         162 DSFQIN----ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET  237 (637)
T ss_pred             cceeec----cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence            533222    1112334567889999999764     33456789999999999999886 777754211       111


Q ss_pred             HHHHHHHHHHhcCCcccccccccCccCCcC-hHHHHHHHHHHHHHhhcc--CCCCCCCHHHHHHHHHhchhhhhh
Q 007261          531 LLAEAVFSMVEGGNAEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAR--EPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       531 ~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                      ....-  .+...   ...-.... +..... ..-++..+..|..+|+..  ++.-|||++..+..|..++.++..
T Consensus       238 ~Ia~g--~f~ya---~~~~~g~~-p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         238 DIAHG--RFAYA---SDQRRGLK-PPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             hhhcc--eeeec---hhccCCCC-CCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence            11100  00000   00000011 111111 344566788888999875  467899999999999988877654

>PRK10871 nlpD lipoprotein NlpD; Provisional

Probab=98.50  E-value=1.1e-07  Score=96.17  Aligned_cols=48  Identities=19%  Similarity=0.105  Sum_probs=45.0

Q ss_pred             EEEccCCCChhHHHhHhcCCHHHHHHhcCCCCCCCCcccceeeeecCCC
Q 007261          174 TYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTT  222 (611)
Q Consensus       174 ~y~v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~~~~~i~~g~~l~ip~~~  222 (611)
                      +|+|++|||||.||.+||+++.+|.+||+|. ++..|++||.|.||...
T Consensus        62 ~y~Vk~GDTL~~IA~~~g~~~~~La~~N~l~-~p~~I~~GQ~L~i~~~~  109 (319)
T PRK10871         62 TYTVKKGDTLFYIAWITGNDFRDLAQRNNIQ-APYSLNVGQTLQVGNAS  109 (319)
T ss_pred             ceEECCCCHHHHHHHHHCcCHHHHHHhcCCC-CCccccCCCEEEeCCCC
Confidence            6999999999999999999999999999997 88899999999998543

>TIGR02907 spore_VI_D stage VI sporulation protein D

Probab=98.48  E-value=1.4e-07  Score=94.11  Aligned_cols=46  Identities=24%  Similarity=0.429  Sum_probs=42.9

Q ss_pred             EEEEEccCCCChhHHHhHhcCCHHHHHHhcCCCCCCCCcccceeeeec
Q 007261          172 LLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIP  219 (611)
Q Consensus       172 ~~~y~v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~~~~~i~~g~~l~ip  219 (611)
                      ..+|+|++|||||.||+|||++++.|+++|++.  ++.|++||+|+||
T Consensus       293 ~~~YiVq~GDTL~sIAkRYGVSV~~L~r~N~L~--~~~L~~GQ~L~IP  338 (338)
T TIGR02907       293 LRMCIVQEGDTIETIAERYEISVSQLIRHNQLE--DFEVNEGQILYIP  338 (338)
T ss_pred             cEEEEECCCCCHHHHHHHHCcCHHHHHHHhCCC--ccccCCCCEEEeC
Confidence            468999999999999999999999999999994  5789999999997

SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation.

>PRK14125 cell division suppressor protein YneA; Provisional

Probab=98.46  E-value=2.4e-07  Score=78.20  Aligned_cols=53  Identities=13%  Similarity=0.209  Sum_probs=42.6

Q ss_pred             cceeEEEeecCCchhhhhHhhcCC--Ccc---HHHHHHhcCCCCCCCCCCceeeeeccC
Q 007261          104 ANTSFIIPTIYHTYFSIANNTYQG--LST---CNILKHENNYSETSLDQGLTLRVPLRC  157 (611)
Q Consensus       104 ~~~~y~V~~~gdTl~~IA~~~~~~--l~t---~~~l~~~N~~~~~~l~~G~~l~ip~~~  157 (611)
                      ....|+|++ |||||+||++|...  ++.   ++.|++.|.+.++.|.+||+|.||..-
T Consensus        35 ~~~~~tV~~-GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~l~~~~I~~Gq~L~IP~~~   92 (103)
T PRK14125         35 QYVEITVQE-GDTLWALADQYAGKHHMAKNEFIEWVEDVNNLPSGHIKAGDKLVIPVLK   92 (103)
T ss_pred             CcEEEEECC-CCCHHHHHHHhCCCcCCCHHHHHHHHHHhcCCCCCcCCCCCEEEEecCC
Confidence            446899999 99999999776532  222   577888899987789999999999763

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.43  E-value=1.1e-06  Score=95.51  Aligned_cols=121  Identities=22%  Similarity=0.310  Sum_probs=80.4

Q ss_pred             ceEEEEEE-cCcEEEEEEecH-----------------------------------------------HHHHHHHHHHhc
Q 007261          339 GSVFRGII-NGSTVAIKCMRR-----------------------------------------------SISKEVNLLKKI  370 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~~-----------------------------------------------~~~~E~~~l~~l  370 (611)
                      |.||+|++ +|+.||||+.+.                                               ++.+|..-+.++
T Consensus       139 aQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~  218 (517)
T COG0661         139 AQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERF  218 (517)
T ss_pred             hhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHH
Confidence            89999999 599999999751                                               133455544444


Q ss_pred             C-----CCceeecccee-ccCCeEEEEEeecCCCCHHHHh--hccCCCCccCHHHHHHHHHHHHHH-HHHHhcCCCCCeE
Q 007261          371 N-----HFNLINLFGAC-EHDGVFYLVYEFMENGSLSDWL--HKKRYPEFVSWNCRFRIALDVAHG-LHYLHNCTDPGYV  441 (611)
Q Consensus       371 ~-----H~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l--~~~~~~~~l~~~~~~~ia~~ia~g-L~yLH~~~~~~iv  441 (611)
                      +     .+++ ++=.++ +-.+...|+|||++|-.+.+..  +..+    .+-+   .++..++++ +..+-   ..+++
T Consensus       219 ~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g----~d~k---~ia~~~~~~f~~q~~---~dgff  287 (517)
T COG0661         219 RENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG----IDRK---ELAELLVRAFLRQLL---RDGFF  287 (517)
T ss_pred             HHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcC----CCHH---HHHHHHHHHHHHHHH---hcCcc
Confidence            1     2332 222222 2345668999999999998874  4432    4422   233333332 11121   36899


Q ss_pred             ecCCCCCCeeeCCCCcEEEeeecCccccc
Q 007261          442 HKDISSGNILLDKNLRAKLANFSFVRSAV  470 (611)
Q Consensus       442 H~Dlk~~NILl~~~~~~kl~Dfgla~~~~  470 (611)
                      |.|.+|.||+++.++++-+.|||+.....
T Consensus       288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         288 HADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             ccCCCccceEEecCCcEEEEcCcceecCC
Confidence            99999999999999999999999976554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.41  E-value=2.8e-06  Score=82.36  Aligned_cols=104  Identities=23%  Similarity=0.262  Sum_probs=80.8

Q ss_pred             HHHHHHHHHHhcCC--CceeeccceeccC----CeEEEEEeecCCC-CHHHHhhccCCCCccCHHHHHHHHHHHHHHHHH
Q 007261          359 SISKEVNLLKKINH--FNLINLFGACEHD----GVFYLVYEFMENG-SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHY  431 (611)
Q Consensus       359 ~~~~E~~~l~~l~H--~niv~l~g~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~y  431 (611)
                      ...+|...+.+|..  -...+.+++....    ...+||+|++++. +|.+++.....   .+......++.+++..+.-
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHHH
Confidence            56788888888843  2344455554432    2458999999874 89999987432   4556677899999999999


Q ss_pred             HhcCCCCCeEecCCCCCCeeeCCCC---cEEEeeecCccc
Q 007261          432 LHNCTDPGYVHKDISSGNILLDKNL---RAKLANFSFVRS  468 (611)
Q Consensus       432 LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgla~~  468 (611)
                      ||   ..+|+|+|+++.|||++.+.   .+.++||+.++.
T Consensus       134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99   79999999999999999887   899999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>smart00257 LysM Lysin motif

Probab=98.30  E-value=9e-07  Score=61.82  Aligned_cols=44  Identities=27%  Similarity=0.450  Sum_probs=39.1

Q ss_pred             EEEccCCCChhHHHhHhcCCHHHHHHhcCCCCCCCCcccceeeee
Q 007261          174 TYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILI  218 (611)
Q Consensus       174 ~y~v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~~~~~i~~g~~l~i  218 (611)
                      +|+|++|||+|+||++|+++..+|.++|+.. ....+.+|+.+.+
T Consensus         1 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~-~~~~~~~g~~l~i   44 (44)
T smart00257        1 TYTVKKGDTLSSIARRYGISVSDLLELNNIL-DPDNLQVGQKLKI   44 (44)
T ss_pred             CeEeCCCCCHHHHHHHhCCCHHHHHHHcCCC-CccccCCCCEEeC
Confidence            4899999999999999999999999999964 6678999988754

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.28  E-value=5.2e-06  Score=81.33  Aligned_cols=115  Identities=19%  Similarity=0.193  Sum_probs=81.0

Q ss_pred             ceEEEEEE-cCcEEEEEEec-----------------------------HHHHHHHHHHHhcCCC--ceeeccceeccCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR-----------------------------RSISKEVNLLKKINHF--NLINLFGACEHDG  386 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~-----------------------------~~~~~E~~~l~~l~H~--niv~l~g~~~~~~  386 (611)
                      +.||.|.. +|.++|||.-+                             ....+|.++|.+|.-.  .+.+-+++    +
T Consensus       105 sdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----n  180 (304)
T COG0478         105 SDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW----N  180 (304)
T ss_pred             ceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc----c
Confidence            78999998 69999999753                             1246799999998543  55555443    3


Q ss_pred             eEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCc
Q 007261          387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV  466 (611)
Q Consensus       387 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla  466 (611)
                      ...+||||++|-.|...--        +-...-.++..|+.-+.-+-   ..++||+|+..-||+++++|.+.++||--+
T Consensus       181 RHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~  249 (304)
T COG0478         181 RHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGDIVVIDWPQA  249 (304)
T ss_pred             cceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCCEEEEeCccc
Confidence            4579999998866543321        11222234444555444444   478999999999999999999999999765


Q ss_pred             cc
Q 007261          467 RS  468 (611)
Q Consensus       467 ~~  468 (611)
                      ..
T Consensus       250 v~  251 (304)
T COG0478         250 VP  251 (304)
T ss_pred             cc
Confidence            43

>PRK13914 invasion associated secreted endopeptidase; Provisional

Probab=98.26  E-value=8.6e-07  Score=93.75  Aligned_cols=47  Identities=19%  Similarity=0.287  Sum_probs=43.2

Q ss_pred             EEEccCCCChhHHHhHhcCCHHHHHHhcCCCCCCCCcccceeeeecCCC
Q 007261          174 TYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTT  222 (611)
Q Consensus       174 ~y~v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~~~~~i~~g~~l~ip~~~  222 (611)
                      +|+|++|||||.||++||+++++|+++|++  .++.|++||.|.||...
T Consensus        29 tytVq~GDTLw~IA~~ygvtv~~I~~~N~l--~~~~I~~Gq~L~Ip~~~   75 (481)
T PRK13914         29 TVVVEAGDTLWGIAQSKGTTVDAIKKANNL--TTDKIVPGQKLQVNEVA   75 (481)
T ss_pred             eEEECCCCCHHHHHHHHCCCHHHHHHHhCC--CcccccCCCEEEeCCCC
Confidence            599999999999999999999999999999  55789999999999643

>PRK09902 hypothetical protein; Provisional

Probab=98.25  E-value=2e-05  Score=75.50  Aligned_cols=125  Identities=21%  Similarity=0.186  Sum_probs=96.2

Q ss_pred             ceEEEEEEcCcEEEEEEec-------------HHHHHHHHHHHhcCCC--ceeeccceecc-----CCeEEEEEeecCC-
Q 007261          339 GSVFRGIINGSTVAIKCMR-------------RSISKEVNLLKKINHF--NLINLFGACEH-----DGVFYLVYEFMEN-  397 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~-------------~~~~~E~~~l~~l~H~--niv~l~g~~~~-----~~~~~lV~E~~~~-  397 (611)
                      +.|++-.++|..+-+|...             ..|.+|+..|.+|..-  .+.+.. ++..     .-..+||+|-+++ 
T Consensus        32 SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~  110 (216)
T PRK09902         32 SGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGF  110 (216)
T ss_pred             ceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCC
Confidence            5788888888899999864             3688999999999532  244444 3321     1246899997754 


Q ss_pred             CCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc--EEEeeecCccc
Q 007261          398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR--AKLANFSFVRS  468 (611)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~Dfgla~~  468 (611)
                      -+|.+++.+... ...+...+..+..+++..+.-||   ..++.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       111 ~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        111 ISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             ccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            599999876432 23566777889999999999999   799999999999999986666  99999986553

>TIGR02899 spore_safA spore coat assembly protein SafA

Probab=98.21  E-value=2.2e-06  Score=60.63  Aligned_cols=41  Identities=24%  Similarity=0.210  Sum_probs=36.2

Q ss_pred             CCCCHHHHHHhhCCChHhhhhhhCC-CCCCCCCCCCCeEEEee
Q 007261           52 PYDTVSSISNLTSSDPTELARVNNI-SNSAAALPLDKEVIVPV   93 (611)
Q Consensus        52 ~g~tl~~Ia~~~~~~~~~l~~~N~~-~~~~~~l~~gq~l~vP~   93 (611)
                      +||||++||++||+++.+|+++|+. .+ ...+.+||.|.||.
T Consensus         3 ~gdtl~~IA~~~~~~~~~l~~~N~~~~~-~~~~~~g~~l~ip~   44 (44)
T TIGR02899         3 KGDTLWKIAKKYGVDFDELIQANPQLSN-PNLIYPGMKIKIPS   44 (44)
T ss_pred             CCCCHHHHHHHHCcCHHHHHHHhhcCCC-CCCcCCCCEEecCC
Confidence            3999999999999999999999974 44 57799999999983

in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins.

>COG3858 Predicted glycosyl hydrolase [General function prediction only]

Probab=98.12  E-value=2.2e-06  Score=87.92  Aligned_cols=111  Identities=20%  Similarity=0.097  Sum_probs=88.7

Q ss_pred             eeeecCCCCCCHHHHHHhhCCChHhhhhhhCCCCCCCCCCCCCeEEEeeecccCCCccccceeEEEeecCCchhhhhHhh
Q 007261           45 LIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVSCYCSGLYYQANTSFIIPTIYHTYFSIANNT  124 (611)
Q Consensus        45 ~~y~~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~vP~~~~c~~~~~~~~~~y~V~~~gdTl~~IA~~~  124 (611)
                      -++-++| ||++..||+.|+.+..+|...|.+.+  +.+.+||.+.||...          ..|.|++ |||+++||+++
T Consensus         2 ~i~~~~p-g~~~~~i~~~~~~~~~~i~~~~~~~~--d~~~~~q~~~v~~~~----------~~y~~~~-~d~~~Sia~~~   67 (423)
T COG3858           2 SIHLVGP-GDSRLIIAVYFPYTNNRIVNGNDYTN--DDLVDGQTFVVPPSG----------HFYDVGP-GDTLTSIARTV   67 (423)
T ss_pred             EEEEccC-Cceeeeehhhcccccccccccccccc--ccccCceeEEECCcc----------eEEEecC-Ccchhhhhhhh
Confidence            3556666 99999999999999999977777776  789999999999654          4799999 99999999766


Q ss_pred             cCCCccHHHHHHhcCCC-CCCCCCCceeeeeccCCCCCCccccCCeeEEEEEEccCCC
Q 007261          125 YQGLSTCNILKHENNYS-ETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGD  181 (611)
Q Consensus       125 ~~~l~t~~~l~~~N~~~-~~~l~~G~~l~ip~~~~~~~~~~~~~~~~~~~~y~v~~gd  181 (611)
                      +   +|.+.+...|... +..+.+|-.|.+|-....         ......|.....+
T Consensus        68 ~---vt~~~~~~m~~~~~~~~l~~~~~l~~P~~~~~---------~~~t~~~~~~~~~  113 (423)
T COG3858          68 G---VTQDSAAIMNFVICPGYLQYGLNLYIPSARKT---------DGETTAYYAPRPP  113 (423)
T ss_pred             c---CCHHHHHhhcccccccceeeeeEEeccCCCCC---------cceeEEEecCCCc
Confidence            6   8889999999776 668999999999964221         1234456666655

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.10  E-value=1.8e-05  Score=76.05  Aligned_cols=114  Identities=24%  Similarity=0.295  Sum_probs=76.6

Q ss_pred             ceEEEEEEcCcEEEEEEecHH----------------HHHHHHHHHhcCCC---ceeeccceec-----cCCeEEEEEee
Q 007261          339 GSVFRGIINGSTVAIKCMRRS----------------ISKEVNLLKKINHF---NLINLFGACE-----HDGVFYLVYEF  394 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~~~----------------~~~E~~~l~~l~H~---niv~l~g~~~-----~~~~~~lV~E~  394 (611)
                      -.|.+-..+|....+|..+.+                ..+++..+.+++..   ....++.+..     .....+|+|||
T Consensus        45 ~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EY  124 (229)
T PF06176_consen   45 NYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEY  124 (229)
T ss_pred             cEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEE
Confidence            345555669999999998632                23344444444322   2223232222     12345799999


Q ss_pred             cCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          395 MENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       395 ~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      ++|..|.++..       ++.    .++..+..++.-||   +.|++|+|.+|.|+++++++ ++++||+..+
T Consensus       125 IeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  125 IEGVELNDIED-------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             ecCeecccchh-------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence            99988766542       211    25567788899999   79999999999999998655 8999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.09  E-value=1.2e-05  Score=76.61  Aligned_cols=105  Identities=24%  Similarity=0.270  Sum_probs=82.5

Q ss_pred             HHHHHHHHhcCC-CceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 007261          361 SKEVNLLKKINH-FNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG  439 (611)
Q Consensus       361 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~  439 (611)
                      ..|..+|+.+.+ +++.+++|+|-+    ++|.||...+++...-..-..--..+|..|.+||.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358889999965 699999999953    579999987766432100000012689999999999999999999765566


Q ss_pred             eEecCCCCCCeeeCCCCcEEEeeecCcccc
Q 007261          440 YVHKDISSGNILLDKNLRAKLANFSFVRSA  469 (611)
Q Consensus       440 ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~  469 (611)
                      +.-.|++++|+-+++++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999876443

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK11198 LysM domain/BON superfamily protein; Provisional

Probab=98.08  E-value=3.6e-06  Score=76.54  Aligned_cols=46  Identities=26%  Similarity=0.416  Sum_probs=40.3

Q ss_pred             EEEEccCCCChhHHHhHhc---CCHHHHHHhcC--CCCCCCCcccceeeeec
Q 007261          173 LTYLVSWGDSVPDISKRFN---VSIESIVNANG--FTEDDPLLFPFTTILIP  219 (611)
Q Consensus       173 ~~y~v~~gdtl~~Ia~~f~---~~~~~l~~~N~--~~~~~~~i~~g~~l~ip  219 (611)
                      .+|+|++|||||+||++|.   .....|.++|+  +. ....|+|||+|.||
T Consensus        96 ~~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~-~~~~I~pGq~L~IP  146 (147)
T PRK11198         96 QFYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLK-SPDKIYPGQVLRIP  146 (147)
T ss_pred             eEEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCC-CcCCcCcCCEEecC
Confidence            4699999999999999985   34678999998  75 67789999999988

>cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation

Probab=98.04  E-value=8.5e-06  Score=57.41  Aligned_cols=45  Identities=24%  Similarity=0.398  Sum_probs=40.1

Q ss_pred             eeecCCCCCCHHHHHHhhCCChHhhhhhhCCCCCCCCCCCCCeEEEe
Q 007261           46 IFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVP   92 (611)
Q Consensus        46 ~y~~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~vP   92 (611)
                      .|++++ |||+++||+.||++..+|+++|+... ...+.+|+.|.||
T Consensus         2 ~~~v~~-gdt~~~ia~~~~~~~~~~~~~N~~~~-~~~~~~g~~l~ip   46 (46)
T cd00118           2 TYTVKK-GDTLSSIAQRYGISVEELLKLNGLSD-PDNLQVGQKLKIP   46 (46)
T ss_pred             EEEECC-CCCHHHHHHHHCcCHHHHHHHcCCCC-ccccCCCCEEecC
Confidence            466766 99999999999999999999999965 5789999999987

This domain may have a general peptidoglycan binding function.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.03  E-value=2.9e-05  Score=84.46  Aligned_cols=77  Identities=18%  Similarity=0.229  Sum_probs=52.0

Q ss_pred             CCeEEEEEeecCCCCHHHH--hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC----CCcE
Q 007261          385 DGVFYLVYEFMENGSLSDW--LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK----NLRA  458 (611)
Q Consensus       385 ~~~~~lV~E~~~~gsL~~~--l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~  458 (611)
                      .....|+||||+|..+.+.  +.+.+    ++...   ++..+.++...+=  ...|++|+|=+|.||+++.    ++++
T Consensus       274 st~RVLtME~~~G~~i~Dl~~i~~~g----i~~~~---i~~~l~~~~~~qI--f~~GffHaDPHPGNilv~~~~~~~~~i  344 (538)
T KOG1235|consen  274 STKRVLTMEYVDGIKINDLDAIDKRG----ISPHD---ILNKLVEAYLEQI--FKTGFFHADPHPGNILVRPNPEGDEEI  344 (538)
T ss_pred             CcceEEEEEecCCccCCCHHHHHHcC----CCHHH---HHHHHHHHHHHHH--HhcCCccCCCCCCcEEEecCCCCCccE
Confidence            3457899999999877654  44433    44443   3333333222211  1467999999999999983    6789


Q ss_pred             EEeeecCccccc
Q 007261          459 KLANFSFVRSAV  470 (611)
Q Consensus       459 kl~Dfgla~~~~  470 (611)
                      .+-|||+.....
T Consensus       345 vllDhGl~~~is  356 (538)
T KOG1235|consen  345 VLLDHGLYAVIS  356 (538)
T ss_pred             EEEccccccccc
Confidence            999999976553

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.97  E-value=5.4e-05  Score=75.35  Aligned_cols=129  Identities=14%  Similarity=0.106  Sum_probs=82.5

Q ss_pred             ceEEEEEEcCcEEEEEEecH----HHHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCHHHHh---------
Q 007261          339 GSVFRGIINGSTVAIKCMRR----SISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWL---------  404 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~~----~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l---------  404 (611)
                      ..||+...++..+.||....    ++.+|+.+++.+. +--+.+++++....+..++|||+++|.+|....         
T Consensus        13 ~~v~~~~~~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~   92 (244)
T cd05150          13 ATVYRLDGKNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLV   92 (244)
T ss_pred             CeEEEEcCCCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHH
Confidence            67899887778899999875    5889999999983 444556777776666789999999998776432         


Q ss_pred             ----------hccCC-CCccC--HHHHHHHHH--------------------HHHHHHHHHhc----CCCCCeEecCCCC
Q 007261          405 ----------HKKRY-PEFVS--WNCRFRIAL--------------------DVAHGLHYLHN----CTDPGYVHKDISS  447 (611)
Q Consensus       405 ----------~~~~~-~~~l~--~~~~~~ia~--------------------~ia~gL~yLH~----~~~~~ivH~Dlk~  447 (611)
                                |.... .....  +..++....                    .+...+..|-.    ...+.++|+|+.+
T Consensus        93 ~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~  172 (244)
T cd05150          93 DALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACL  172 (244)
T ss_pred             HHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCC
Confidence                      11100 00111  001110000                    01111222211    1135699999999


Q ss_pred             CCeeeCCCCcEEEeeecCcc
Q 007261          448 GNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       448 ~NILl~~~~~~kl~Dfgla~  467 (611)
                      .|||++++....|+||+.+.
T Consensus       173 ~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         173 PNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ccEEEeCCcEEEEEEccccc
Confidence            99999998888999999764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02907 spore_VI_D stage VI sporulation protein D

Probab=97.93  E-value=9.7e-06  Score=81.12  Aligned_cols=49  Identities=18%  Similarity=0.239  Sum_probs=43.5

Q ss_pred             cccceeEEEeecCCchhhhhHhhcCCCccHHHHHHhcCCCCCCCCCCceeeee
Q 007261          102 YQANTSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVP  154 (611)
Q Consensus       102 ~~~~~~y~V~~~gdTl~~IA~~~~~~l~t~~~l~~~N~~~~~~l~~G~~l~ip  154 (611)
                      +..+..|+|++ |||||.||++|.   ++++.|+++|++.++.|.+||.|.||
T Consensus       290 ~~~~~~YiVq~-GDTL~sIAkRYG---VSV~~L~r~N~L~~~~L~~GQ~L~IP  338 (338)
T TIGR02907       290 FTKLRMCIVQE-GDTIETIAERYE---ISVSQLIRHNQLEDFEVNEGQILYIP  338 (338)
T ss_pred             ccccEEEEECC-CCCHHHHHHHHC---cCHHHHHHHhCCCccccCCCCEEEeC
Confidence            44567899999 999999997665   88899999999887789999999998

SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.89  E-value=0.00014  Score=71.46  Aligned_cols=125  Identities=15%  Similarity=0.251  Sum_probs=75.2

Q ss_pred             ceEEEEEEcCcEEEEEEec-----HHHHHHHHHHHhcCCCc--eeeccceeccCCeEEEEEeecCCCC-HHHHh------
Q 007261          339 GSVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHFN--LINLFGACEHDGVFYLVYEFMENGS-LSDWL------  404 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~-----~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gs-L~~~l------  404 (611)
                      +.||+.  .|..+++|..+     .+..+|.++++.+..-+  +.+.+++....+...+|||+++|.. +...+      
T Consensus        15 ~~~y~~--~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~   92 (226)
T TIGR02172        15 GESYTH--KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSR   92 (226)
T ss_pred             cceeEe--cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHH
Confidence            678873  35567788875     36788999999986443  3566777777777889999998863 22111      


Q ss_pred             ---------------hccCCCCccCHHHHHH-HHH----------HHHH-HHHHHhc-CCCCCeEecCCCCCCeeeCCCC
Q 007261          405 ---------------HKKRYPEFVSWNCRFR-IAL----------DVAH-GLHYLHN-CTDPGYVHKDISSGNILLDKNL  456 (611)
Q Consensus       405 ---------------~~~~~~~~l~~~~~~~-ia~----------~ia~-gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~  456 (611)
                                     |....+ ......+.. +..          .+.. ...+|.. .....++|+|+.|.||++++++
T Consensus        93 ~~~l~~~la~~l~~lH~~~~~-~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~  171 (226)
T TIGR02172        93 LEEIAKIFAEMAKKLHSTKCD-TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG  171 (226)
T ss_pred             HHHHHHHHHHHHHHHhCCCCC-CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC
Confidence                           111000 011111000 000          0111 1222221 1134678999999999999888


Q ss_pred             cEEEeeecCcc
Q 007261          457 RAKLANFSFVR  467 (611)
Q Consensus       457 ~~kl~Dfgla~  467 (611)
                       +.|+||+.+.
T Consensus       172 -~~iIDwe~a~  181 (226)
T TIGR02172       172 -TYWIDLGDFG  181 (226)
T ss_pred             -cEEEechhcC
Confidence             9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK10871 nlpD lipoprotein NlpD; Provisional

Probab=97.87  E-value=1.3e-05  Score=81.09  Aligned_cols=48  Identities=25%  Similarity=0.264  Sum_probs=44.2

Q ss_pred             eeeecCCCCCCHHHHHHhhCCChHhhhhhhCCCCCCCCCCCCCeEEEeee
Q 007261           45 LIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVS   94 (611)
Q Consensus        45 ~~y~~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~vP~~   94 (611)
                      -+|++++ ||||+.||.+||+++.+|+++|++.+ +..|.+||.|.||.+
T Consensus        61 ~~y~Vk~-GDTL~~IA~~~g~~~~~La~~N~l~~-p~~I~~GQ~L~i~~~  108 (319)
T PRK10871         61 STYTVKK-GDTLFYIAWITGNDFRDLAQRNNIQA-PYSLNVGQTLQVGNA  108 (319)
T ss_pred             CceEECC-CCHHHHHHHHHCcCHHHHHHhcCCCC-CccccCCCEEEeCCC
Confidence            3688887 99999999999999999999999988 799999999999854

>PRK11198 LysM domain/BON superfamily protein; Provisional

Probab=97.80  E-value=3.7e-05  Score=69.96  Aligned_cols=48  Identities=21%  Similarity=0.331  Sum_probs=41.6

Q ss_pred             eeEEEeecCCchhhhhHhhcCCCccHHHHHHhcC--CC-CCCCCCCceeeee
Q 007261          106 TSFIIPTIYHTYFSIANNTYQGLSTCNILKHENN--YS-ETSLDQGLTLRVP  154 (611)
Q Consensus       106 ~~y~V~~~gdTl~~IA~~~~~~l~t~~~l~~~N~--~~-~~~l~~G~~l~ip  154 (611)
                      ..|+|++ |||||+||.++|..-..+.+|.++|+  +. ++.|.+||+|.||
T Consensus        96 ~~y~Vk~-GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP  146 (147)
T PRK11198         96 QFYTVKS-GDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP  146 (147)
T ss_pred             eEEEECC-CCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence            5799999 99999999888775566789999997  55 6679999999998

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.66  E-value=0.00045  Score=67.32  Aligned_cols=120  Identities=23%  Similarity=0.240  Sum_probs=79.2

Q ss_pred             ceEEEEEE-cCcEEEEEEecHH-------------------------------HHHHHHHHHhcC--CCceeeccceecc
Q 007261          339 GSVFRGII-NGSTVAIKCMRRS-------------------------------ISKEVNLLKKIN--HFNLINLFGACEH  384 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~~~-------------------------------~~~E~~~l~~l~--H~niv~l~g~~~~  384 (611)
                      ..||+|.- ++..+|||+++..                               ..+|+.-|.++.  +=.+.+-+++.  
T Consensus        62 A~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~--  139 (268)
T COG1718          62 ANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR--  139 (268)
T ss_pred             eEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec--
Confidence            57999876 7899999998611                               124666666652  22222233222  


Q ss_pred             CCeEEEEEeecCCCC-HHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeee
Q 007261          385 DGVFYLVYEFMENGS-LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF  463 (611)
Q Consensus       385 ~~~~~lV~E~~~~gs-L~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df  463 (611)
                        ...|||||+.... -.-.|+...    +.......+..++++.+.-|-.  ..++||+||..-|||+. ++.+.|+||
T Consensus       140 --~nVLvMEfIg~~g~pAP~LkDv~----~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~  210 (268)
T COG1718         140 --NNVLVMEFIGDDGLPAPRLKDVP----LELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDV  210 (268)
T ss_pred             --CCeEEEEeccCCCCCCCCcccCC----cCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCeEEEEEC
Confidence              3469999996431 111122211    2222455677788888888873  47999999999999999 889999999


Q ss_pred             cCcccc
Q 007261          464 SFVRSA  469 (611)
Q Consensus       464 gla~~~  469 (611)
                      |-|...
T Consensus       211 ~QaV~~  216 (268)
T COG1718         211 SQAVTI  216 (268)
T ss_pred             cccccc
Confidence            987654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.49  E-value=0.00092  Score=65.44  Aligned_cols=129  Identities=19%  Similarity=0.250  Sum_probs=75.0

Q ss_pred             ceEEEEEEcCcEEEEEEec-----HHHHHHHHHHHhcCCC--ceeeccceec---cCCeEEEEEeecCCCCHHH------
Q 007261          339 GSVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHF--NLINLFGACE---HDGVFYLVYEFMENGSLSD------  402 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~-----~~~~~E~~~l~~l~H~--niv~l~g~~~---~~~~~~lV~E~~~~gsL~~------  402 (611)
                      +.||+...++..+++|...     ..+.+|..+++.+...  .+.+++.++.   .....+++|+++++..+..      
T Consensus        11 n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~   90 (239)
T PF01636_consen   11 NRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQ   90 (239)
T ss_dssp             SEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHH
T ss_pred             eeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccc
Confidence            5799999977899999985     3577899999888433  3455665442   2345799999999988877      


Q ss_pred             ----------Hhh---ccC-CCCccCHHH---------HHHH------------HHHHHH-HHHHHhc----CCCCCeEe
Q 007261          403 ----------WLH---KKR-YPEFVSWNC---------RFRI------------ALDVAH-GLHYLHN----CTDPGYVH  442 (611)
Q Consensus       403 ----------~l~---~~~-~~~~l~~~~---------~~~i------------a~~ia~-gL~yLH~----~~~~~ivH  442 (611)
                                .+.   ... ......+..         ....            ...+.. .+..++.    .....++|
T Consensus        91 ~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~H  170 (239)
T PF01636_consen   91 RPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIH  170 (239)
T ss_dssp             HHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-
T ss_pred             cccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEE
Confidence                      111   110 001111110         0000            111222 2333332    13567999


Q ss_pred             cCCCCCCeeeC-CCCcEEEeeecCcc
Q 007261          443 KDISSGNILLD-KNLRAKLANFSFVR  467 (611)
Q Consensus       443 ~Dlk~~NILl~-~~~~~kl~Dfgla~  467 (611)
                      +|+.+.|||++ +++.+.|+||+.+.
T Consensus       171 gD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  171 GDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             eccccccceeeeccceeEEEecccce
Confidence            99999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>smart00257 LysM Lysin motif

Probab=97.47  E-value=0.00022  Score=49.37  Aligned_cols=43  Identities=23%  Similarity=0.349  Sum_probs=36.7

Q ss_pred             eecCCCCCCHHHHHHhhCCChHhhhhhhCCCCCCCCCCCCCeEEE
Q 007261           47 FKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIV   91 (611)
Q Consensus        47 y~~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~v   91 (611)
                      |++++ |||+++||+.|+++..+|.++|+... ...+.+|+.|.|
T Consensus         2 ~~v~~-gdt~~~ia~~~~~~~~~~~~~N~~~~-~~~~~~g~~l~i   44 (44)
T smart00257        2 YTVKK-GDTLSSIARRYGISVSDLLELNNILD-PDNLQVGQKLKI   44 (44)
T ss_pred             eEeCC-CCCHHHHHHHhCCCHHHHHHHcCCCC-ccccCCCCEEeC
Confidence            56655 99999999999999999999999655 477889998764

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.41  E-value=5.7e-05  Score=81.69  Aligned_cols=170  Identities=18%  Similarity=0.180  Sum_probs=117.6

Q ss_pred             ceEEEEEEcCc-EEEEEEecH--HHHHHHHHHHhcCCCc-eeeccceeccCCeEEEEEeecCCC-CHHHHhhccCCCCcc
Q 007261          339 GSVFRGIINGS-TVAIKCMRR--SISKEVNLLKKINHFN-LINLFGACEHDGVFYLVYEFMENG-SLSDWLHKKRYPEFV  413 (611)
Q Consensus       339 g~Vy~g~~~g~-~vavK~~~~--~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l  413 (611)
                      +++||.+-..+ ....+.+..  ...-++++|.+++||| .++.++-+..+...+++++++.++ +-..-...  ....+
T Consensus       256 tknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~--se~~~  333 (829)
T KOG0576|consen  256 TKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV--SEIAL  333 (829)
T ss_pred             cCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCCh--hhHhh
Confidence            56676655222 223454443  3455899999999999 778888888888899999999876 21111100  01113


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhh
Q 007261          414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEY  493 (611)
Q Consensus       414 ~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~  493 (611)
                      ...+...+...-.+++++||+   ..=+|+|    ||+..+ +..|..||+.........    ..+...+++.|+|||+
T Consensus       334 ~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~----~~~t~~~~~~~~~pev  401 (829)
T KOG0576|consen  334 EQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM----KPRTAIGTPEPLAPEV  401 (829)
T ss_pred             hhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc----ccccCCCCCCCCCchh
Confidence            333344456667789999994   3347888    776655 678999999876554332    3456778999999999


Q ss_pred             hccCCCCCccchHHHHHHHHHHHhCCCCC
Q 007261          494 MEYGLVTPEMDTYAFGVVLLELITGKEAA  522 (611)
Q Consensus       494 ~~~~~~s~ksDV~s~Gvvl~elltG~~p~  522 (611)
                      ...+.+..+-|+|++|+--.++--|-.|-
T Consensus       402 ~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  402 IQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             hcccccccCCCccCCCcchhhcCCCCCCC
Confidence            99999999999999998766766665553

>COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane]

Probab=97.31  E-value=0.00028  Score=62.36  Aligned_cols=50  Identities=24%  Similarity=0.377  Sum_probs=45.2

Q ss_pred             ceeeeeecCCCCCCHHHHHHhhCCChHhhhhhhCCCCCCCCCCCCCeEEEeee
Q 007261           42 QGFLIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVS   94 (611)
Q Consensus        42 ~~~~~y~~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~vP~~   94 (611)
                      ..+..|++++ ||||+.||+.||+++.+|+++|++.+  +.+.+||.|.+|..
T Consensus        64 ~~~~~~~V~~-gdtL~~Ia~~~~~tv~~l~~~n~l~~--~~i~~gq~l~~~~~  113 (124)
T COG1388          64 PPVVTYTVKK-GDTLSKIARKYGVTVAELKQLNNLSS--DKIKVGQKLKLPVS  113 (124)
T ss_pred             CCCceEEEec-CCCHHHHHHHhCCCHHHHHHHhccCC--CceecCcEEEEecc
Confidence            3467899987 99999999999999999999999988  49999999999973

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.30  E-value=0.00053  Score=79.18  Aligned_cols=195  Identities=19%  Similarity=0.198  Sum_probs=132.2

Q ss_pred             HHHHHHHhcCCCceeeccceeccCCeE----EEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCC
Q 007261          362 KEVNLLKKINHFNLINLFGACEHDGVF----YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTD  437 (611)
Q Consensus       362 ~E~~~l~~l~H~niv~l~g~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~  437 (611)
                      .|+..+.++.|+|++.+++|-..+...    .+..|++..-++...+....   .++....+.+..+...||.|+|.   
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~---  304 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHS---  304 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHH---
Confidence            477788888999999999887554332    34457788888888887653   37778888899999999999994   


Q ss_pred             CCeEecCCCCC---CeeeCCCCcEEEe--eecCccccccccCCcccccccccCCCccchhhhccCCCCC--ccchHHHHH
Q 007261          438 PGYVHKDISSG---NILLDKNLRAKLA--NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP--EMDTYAFGV  510 (611)
Q Consensus       438 ~~ivH~Dlk~~---NILl~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDV~s~Gv  510 (611)
                      ....|.-+..+   +...+..+...++  ||+..+.......    ......+..|.++|......+..  ..|+|.+|.
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~----~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK----SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCccc----chhhcCccccccccccccccchhhhhhHHHHHHH
Confidence            44555544444   4455666777777  8887665433321    22233455678888877665544  479999999


Q ss_pred             HHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 007261          511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV  590 (611)
Q Consensus       511 vl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  590 (611)
                      .+..+..|.........        .             ..+++    ..   ....+.+...+|+..++++|++..+++
T Consensus       381 l~~~~~~~~~i~~~~~~--------~-------------~~~l~----~~---~~~~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAV--------P-------------VSLLD----VL---STSELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             HHhhhhhcCcccccccc--------h-------------hhhhc----cc---cchhhhhhhhhhcchhhhhccchhhhh
Confidence            99999988754321110        0             00011    00   011466777899999999999999999


Q ss_pred             HHHH
Q 007261          591 STLM  594 (611)
Q Consensus       591 ~~L~  594 (611)
                      .+..
T Consensus       433 ~~~f  436 (1351)
T KOG1035|consen  433 THPF  436 (1351)
T ss_pred             hchh
Confidence            8754

>PLN02876 acyl-CoA dehydrogenase

Probab=97.27  E-value=0.0023  Score=75.19  Aligned_cols=61  Identities=13%  Similarity=0.384  Sum_probs=43.6

Q ss_pred             ceEEEEEEcC----cEEEEEEec--------HHHHHHHHHHHhcC-CCce--eeccceeccC---CeEEEEEeecCCCC
Q 007261          339 GSVFRGIING----STVAIKCMR--------RSISKEVNLLKKIN-HFNL--INLFGACEHD---GVFYLVYEFMENGS  399 (611)
Q Consensus       339 g~Vy~g~~~g----~~vavK~~~--------~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV~E~~~~gs  399 (611)
                      ..+|+-...+    ..+++|+..        ..+.+|+.+|+.+. |.++  .+++++|.+.   +..|+||||+++..
T Consensus        52 n~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~  130 (822)
T PLN02876         52 NPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI  130 (822)
T ss_pred             CceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence            4567665533    356677652        36789999999995 6664  7778887664   46789999998764

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.20  E-value=0.0021  Score=64.45  Aligned_cols=124  Identities=15%  Similarity=0.172  Sum_probs=72.6

Q ss_pred             ceEEEEEEcCcEEEEEEecH-------HHHHHHHHHHhcCCCcee-eccceeccCCeEEEEEeecCCCCHHHH-------
Q 007261          339 GSVFRGIINGSTVAIKCMRR-------SISKEVNLLKKINHFNLI-NLFGACEHDGVFYLVYEFMENGSLSDW-------  403 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~~-------~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL~~~-------  403 (611)
                      ..+|+...+|..+++|....       +..+|..+++.+....++ ++++.+.    -++||||++|..+...       
T Consensus        10 n~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~~   85 (256)
T TIGR02721        10 NRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALDL   85 (256)
T ss_pred             CCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCchh
Confidence            67888887888899987542       457899999999543332 3333332    3689999998665321       


Q ss_pred             ----------hhccCC-CCccCHHHHH-HHHHH---------HHHHHHHHhc-----CCCCCeEecCCCCCCeeeCCCCc
Q 007261          404 ----------LHKKRY-PEFVSWNCRF-RIALD---------VAHGLHYLHN-----CTDPGYVHKDISSGNILLDKNLR  457 (611)
Q Consensus       404 ----------l~~~~~-~~~l~~~~~~-~ia~~---------ia~gL~yLH~-----~~~~~ivH~Dlk~~NILl~~~~~  457 (611)
                                ||.... ...++...++ +...+         +..-+..+-.     .....++|+|+.+.||++++++ 
T Consensus        86 ~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-  164 (256)
T TIGR02721        86 LLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-  164 (256)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-
Confidence                      121111 1112222111 11101         1111222211     1134689999999999999877 


Q ss_pred             EEEeeecCcc
Q 007261          458 AKLANFSFVR  467 (611)
Q Consensus       458 ~kl~Dfgla~  467 (611)
                      +.|+||..+.
T Consensus       165 ~~lIDwE~a~  174 (256)
T TIGR02721       165 LKLIDWEYAS  174 (256)
T ss_pred             CEEEeccccC
Confidence            7899998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.15  E-value=0.0023  Score=63.29  Aligned_cols=31  Identities=23%  Similarity=0.532  Sum_probs=26.2

Q ss_pred             CCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          437 DPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       437 ~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      ...++|+|+.+.|||++++...-|+||+.+.
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            3558999999999999877666799999764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.05  E-value=0.0062  Score=62.51  Aligned_cols=62  Identities=15%  Similarity=0.144  Sum_probs=46.0

Q ss_pred             ceEEEEEEcCcEEEEEEecH-----HHHHHHHHHHhcCC---Cceeeccceecc---CCeEEEEEeecCCCCH
Q 007261          339 GSVFRGIINGSTVAIKCMRR-----SISKEVNLLKKINH---FNLINLFGACEH---DGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H---~niv~l~g~~~~---~~~~~lV~E~~~~gsL  400 (611)
                      +.||+-...+..+.+|..+.     .+..|.+.|+.|..   -.+.+++++|..   .+..+||||+++++++
T Consensus        28 ~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         28 AALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             eeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence            57888776555677777653     57889999999843   357788887754   3668999999998765

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=96.96  E-value=0.0064  Score=56.28  Aligned_cols=111  Identities=19%  Similarity=0.274  Sum_probs=75.6

Q ss_pred             ceEEEEEEcCcEEEEEEec-----HHHHHHHHHHHhcCCCceee-ccceeccCCeEEEEEeecCCCCHHHHhhccCCCCc
Q 007261          339 GSVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHFNLIN-LFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEF  412 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~  412 (611)
                      |.||.|.|.|..+|+|+-+     ..+..|+++|..+.-.++-+ ++.+-    .-++.|||+.|-.|.++-...     
T Consensus        36 s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~~~~~~~-----  106 (201)
T COG2112          36 SVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLGKLEIGG-----  106 (201)
T ss_pred             cEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchhhhhhcc-----
Confidence            7899999999999999986     46888999999987665543 23222    223559999988887765432     


Q ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC--CCeeeCCCCcEEEeeecCcc
Q 007261          413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS--GNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       413 l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~--~NILl~~~~~~kl~Dfgla~  467 (611)
                       +-...+    .+++.---|.   ..+|-|+.|.-  .||++.++ .+.|+||.-|+
T Consensus       107 -~rk~l~----~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At  154 (201)
T COG2112         107 -DRKHLL----RVLEKAYKLD---RLGIEHGELSRPWKNVLVNDR-DVYIIDFDSAT  154 (201)
T ss_pred             -cHHHHH----HHHHHHHHHH---HhccchhhhcCCceeEEecCC-cEEEEEccchh
Confidence             112222    3333322233   46788888874  56666555 99999999876

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.95  E-value=0.0082  Score=59.18  Aligned_cols=58  Identities=16%  Similarity=0.330  Sum_probs=39.0

Q ss_pred             ceEEEEEEc---CcEEEEEEecH------HHHHHHHHHHhcCCCc-eeeccceeccCCeEEEEEeecCCCCH
Q 007261          339 GSVFRGIIN---GSTVAIKCMRR------SISKEVNLLKKINHFN-LINLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~~---g~~vavK~~~~------~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      ..+|+....   +..+++|....      +..+|+.+++.+...+ ..++++.+. +   .++|||++|.++
T Consensus        12 N~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~l   79 (235)
T cd05157          12 NKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRTL   79 (235)
T ss_pred             ceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCcC
Confidence            578887764   57888997753      3357999999985433 344444332 2   479999998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.85  E-value=0.0073  Score=61.86  Aligned_cols=129  Identities=15%  Similarity=0.159  Sum_probs=78.4

Q ss_pred             ceEEEEEEcCcEEEEEEec----HHHHHHHHHHHhcCCCc--eeecccee------ccCCeEEEEEeecCCCCHHH----
Q 007261          339 GSVFRGIINGSTVAIKCMR----RSISKEVNLLKKINHFN--LINLFGAC------EHDGVFYLVYEFMENGSLSD----  402 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~----~~~~~E~~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~E~~~~gsL~~----  402 (611)
                      ..+|+...++..+++|+..    .+...|+.++..+.+.+  +.+.+...      ...+..++|+||++|..+..    
T Consensus        28 n~~y~v~~~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~  107 (296)
T cd05153          28 NTNYFVTTDSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAA  107 (296)
T ss_pred             cceEEEEeCCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHH
Confidence            4688887777789999875    34667898888884332  44444321      22345689999999876532    


Q ss_pred             Hh----------hcc--C--C----CCccCHHHHHH----------HHHHHHHHHHHHhc----CCCCCeEecCCCCCCe
Q 007261          403 WL----------HKK--R--Y----PEFVSWNCRFR----------IALDVAHGLHYLHN----CTDPGYVHKDISSGNI  450 (611)
Q Consensus       403 ~l----------~~~--~--~----~~~l~~~~~~~----------ia~~ia~gL~yLH~----~~~~~ivH~Dlk~~NI  450 (611)
                      .+          |..  .  .    .....|.....          ....+...+.++..    ....+++|+|+.|.||
T Consensus       108 ~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Ni  187 (296)
T cd05153         108 HCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNV  187 (296)
T ss_pred             HHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccE
Confidence            11          110  0  0    01123332210          11123334444442    1235799999999999


Q ss_pred             eeCCCCcEEEeeecCcc
Q 007261          451 LLDKNLRAKLANFSFVR  467 (611)
Q Consensus       451 Ll~~~~~~kl~Dfgla~  467 (611)
                      |++++....|.||+.+.
T Consensus       188 l~~~~~~~~iIDfe~a~  204 (296)
T cd05153         188 LFDGDELSGVIDFYFAC  204 (296)
T ss_pred             EEeCCceEEEeehhhhc
Confidence            99998778999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.82  E-value=0.013  Score=55.96  Aligned_cols=104  Identities=23%  Similarity=0.315  Sum_probs=75.6

Q ss_pred             ceEEEEEEcCcEEEEEEec----------------------------HHHHHHHHHHHhcC---CCce--eeccceeccC
Q 007261          339 GSVFRGIINGSTVAIKCMR----------------------------RSISKEVNLLKKIN---HFNL--INLFGACEHD  385 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~----------------------------~~~~~E~~~l~~l~---H~ni--v~l~g~~~~~  385 (611)
                      |.||+...+|..+|+|.++                            ..|..|.+...+|+   +.++  |+.+||..-.
T Consensus        52 ~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~  131 (207)
T PF13095_consen   52 GYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLT  131 (207)
T ss_pred             eEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEc
Confidence            7899999999999999943                            02556888877773   4566  9999987211


Q ss_pred             ------------------CeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 007261          386 ------------------GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS  447 (611)
Q Consensus       386 ------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~  447 (611)
                                        ....||.||++...            .+...    -+.+|.+-|..+|   ..+|+-+|+++
T Consensus       132 ~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~~~~---k~gI~~~Dv~~  192 (207)
T PF13095_consen  132 EDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLKILH---KLGIVPRDVKP  192 (207)
T ss_pred             hHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHHHHH---HCCeeeccCcc
Confidence                              12478888876533            12222    3456777888899   79999999999


Q ss_pred             CCeeeCCCCcEEEeeecCc
Q 007261          448 GNILLDKNLRAKLANFSFV  466 (611)
Q Consensus       448 ~NILl~~~~~~kl~Dfgla  466 (611)
                      .|..     .-||+|||.+
T Consensus       193 ~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  193 RNYR-----GGKLVDFSSS  206 (207)
T ss_pred             cccc-----CCEEEecccC
Confidence            9986     4589999853

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=96.73  E-value=0.022  Score=54.54  Aligned_cols=93  Identities=20%  Similarity=0.300  Sum_probs=66.2

Q ss_pred             HHHHHHHHHHhcC------CCceeeccceeccCCeEEEEEeecCC------CCHHHHhhccCCCCccCHHHHHHHHHHHH
Q 007261          359 SISKEVNLLKKIN------HFNLINLFGACEHDGVFYLVYEFMEN------GSLSDWLHKKRYPEFVSWNCRFRIALDVA  426 (611)
Q Consensus       359 ~~~~E~~~l~~l~------H~niv~l~g~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~ia~~ia  426 (611)
                      +..+|+.-...+.      +.+|.+++|+.+++.-..+|+|.+.+      -+|.+++....    ++. ...+...+..
T Consensus        57 ~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~~L~~f~  131 (199)
T PF10707_consen   57 QNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQALDEFK  131 (199)
T ss_pred             HHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHHHHHHHH
Confidence            4556777766665      78899999999999888999998753      36788886543    554 4444444444


Q ss_pred             HHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEee
Q 007261          427 HGLHYLHNCTDPGYVHKDISSGNILLDKNL----RAKLAN  462 (611)
Q Consensus       427 ~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~D  462 (611)
                      +   ||-   ...|+.+|++|.||++..+.    .+.|+|
T Consensus       132 ~---~l~---~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  132 R---YLL---DHHIVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             H---HHH---HcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence            4   444   46799999999999995432    466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF04225 OapA: Opacity-associated protein A LysM-like domain; InterPro: IPR007340 This entry includes the Haemophilus influenzae opacity-associated protein

Probab=96.56  E-value=0.0023  Score=52.23  Aligned_cols=41  Identities=27%  Similarity=0.341  Sum_probs=0.0

Q ss_pred             EEEccCCCChhHHHhHhcCCHHHHHHh-------cCCCCCCCCcccceeeee
Q 007261          174 TYLVSWGDSVPDISKRFNVSIESIVNA-------NGFTEDDPLLFPFTTILI  218 (611)
Q Consensus       174 ~y~v~~gdtl~~Ia~~f~~~~~~l~~~-------N~~~~~~~~i~~g~~l~i  218 (611)
                      +|+|++||||+.|=+++|++..+|.+.       +.|.    .|+|||.|-+
T Consensus         4 ~~~V~~GDtLs~iF~~~gls~~dl~~v~~~~~~~k~L~----~L~pGq~l~f   51 (85)
T PF04225_consen    4 EYTVKSGDTLSTIFRRAGLSASDLYAVLEADGEAKPLT----RLKPGQTLEF   51 (85)
T ss_dssp             EEE--TT--HHHHHHHTT--HHHHHHHHHHGGGT--GG----G--TT-EEEE
T ss_pred             EEEECCCCcHHHHHHHcCCCHHHHHHHHhccCccchHh----hCCCCCEEEE

This protein is required for efficient nasopharyngeal mucosal colonization, and its expression is associated with a distinctive transparent colony phenotype. OapA is thought to be a secreted protein, and its expression exhibits high-frequency phase variation [].; PDB: 2GU1_A.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	611
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-38
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-36
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-30
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-29
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-28
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-28
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-28
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-23
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-18
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-18
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-18
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-16
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-13
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-13
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-13
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		9e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-10
3soa_A	444	Full-Length Human Camkii Length = 444		4e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		8e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-07
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-07
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-07
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-07
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-07
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-07
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-07
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-07
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-07
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-07
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-06
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-06
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-06
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		9e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-05
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-04
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-04
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-04
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-04
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-04
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-04
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-04
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-04
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-04
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-04
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-04
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-04
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  155 bits (393), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 156/298 (52%), Gaps = 28/298 (9%)
Query: 316 LKFYKYEDLVVATENFSPKNMID----GSVFRG-IINGSTVAIKCMRR--------SISK 362
           LK +   +L VA++NFS KN++     G V++G + +G+ VA+K ++             
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQT 84
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEF---VSWNCRF 419
           EV ++    H NL+ L G C       LVY +M NGS++  L ++  PE    + W  R 
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER--PESQPPLDWPKRQ 142
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
           RIAL  A GL YLH+  DP  +H+D+ + NILLD+   A + +F   +  + +       
Sbjct: 143 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK--LMDYKDXHVX 200
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA---AYKQDGEEILLAEAV 536
               GT G++APEY+  G  + + D + +GV+LLELITG+ A   A   + ++++L    
Sbjct: 201 XAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML---- 256
Query: 537 FSMVEGGNAEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
              V+G   E KL  LVD +LQ N K E    LI + L C    P  RP M+EVV  L
Sbjct: 257 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 157/298 (52%), Gaps = 28/298 (9%)
Query: 316 LKFYKYEDLVVATENFSPKNMID----GSVFRG-IINGSTVAIKCMRRSISK-------- 362
           LK +   +L VA++NF  KN++     G V++G + +G  VA+K ++   ++        
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQT 76
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEF---VSWNCRF 419
           EV ++    H NL+ L G C       LVY +M NGS++  L ++  PE    + W  R 
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER--PESQPPLDWPKRQ 134
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
           RIAL  A GL YLH+  DP  +H+D+ + NILLD+   A + +F   +  + +       
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK--LMDYKDXHVX 192
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA---AYKQDGEEILLAEAV 536
               G  G++APEY+  G  + + D + +GV+LLELITG+ A   A   + ++++L + V
Sbjct: 193 XAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 537 FSMVEGGNAEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
             +++    E KL  LVD +LQ N K E    LI + L C    P  RP M+EVV  L
Sbjct: 253 KGLLK----EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  128 bits (322), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 145/289 (50%), Gaps = 29/289 (10%)
Query: 323 DLVVATENFSPKNMID----GSVFRGII-NGSTVAIKCMRRS---------ISKEVNLLK 368
           DL  AT NF  K +I     G V++G++ +G+ VA+K  RR+            E+  L 
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK--RRTPESSQGIEEFETEIETLS 90
Query: 369 KINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEF-VSWNCRFRIALDVAH 427
              H +L++L G C+      L+Y++MENG+L   L+    P   +SW  R  I +  A 
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 428 GLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV-GTN 486
           GLHYLH       +H+D+ S NILLD+N   K+ +F   +     E G +     V GT 
Sbjct: 151 GLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGT--ELGQTHLXXVVKGTL 205
Query: 487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL-LAEAVFSMVEGGNA 545
           GY+ PEY   G +T + D Y+FGVVL E++  + A  +    E++ LAE     VE  N 
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA---VESHN- 261
Query: 546 EAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
             +L  +VDPNL    + E         + C+A   E RPSM +V+  L
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 96/288 (33%), Positives = 143/288 (49%), Gaps = 27/288 (9%)
Query: 323 DLVVATENFSPKNMID----GSVFRGII-NGSTVAIKCMRRS---------ISKEVNLLK 368
           DL  AT NF  K +I     G V++G++ +G+ VA+K  RR+            E+  L 
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK--RRTPESSQGIEEFETEIETLS 90
Query: 369 KINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEF-VSWNCRFRIALDVAH 427
              H +L++L G C+      L+Y++MENG+L   L+    P   +SW  R  I +  A 
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 428 GLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG 487
           GLHYLH       +H+D+ S NILLD+N   K+ +F   +     +  +       GT G
Sbjct: 151 GLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXX-VVKGTLG 206
Query: 488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL-LAEAVFSMVEGGNAE 546
           Y+ PEY   G +T + D Y+FGVVL E++  + A  +    E++ LAE     VE  N  
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA---VESHN-N 262
Query: 547 AKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            +L  +VDPNL    + E         + C+A   E RPSM +V+  L
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 115/205 (56%), Gaps = 16/205 (7%)
Query: 339 GSVFRGIINGSTVAIKCM-----------RRSISKEVNLLKKINHFNLINLFGACEHDGV 387
           G V++G +N +TVA+K +           ++   +E+ ++ K  H NL+ L G       
Sbjct: 45  GVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 104
Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
             LVY +M NGSL D L        +SW+ R +IA   A+G+++LH   +  ++H+DI S
Sbjct: 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKS 161
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            NILLD+   AK+++F   R++ +       ++  VGT  YMAPE +  G +TP+ D Y+
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMXSRI-VGTTAYMAPEALR-GEITPKSDIYS 219
Query: 508 FGVVLLELITGKEAAYKQDGEEILL 532
           FGVVLLE+ITG  A  +    ++LL
Sbjct: 220 FGVVLLEIITGLPAVDEHREPQLLL 244

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  123 bits (308), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 114/205 (55%), Gaps = 16/205 (7%)
Query: 339 GSVFRGIINGSTVAIKCM-----------RRSISKEVNLLKKINHFNLINLFGACEHDGV 387
           G V++G +N +TVA+K +           ++   +E+ ++ K  H NL+ L G       
Sbjct: 45  GVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 104
Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
             LVY +M NGSL D L        +SW+ R +IA   A+G+++LH   +  ++H+DI S
Sbjct: 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKS 161
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            NILLD+   AK+++F   R++ +        +  VGT  YMAPE +  G +TP+ D Y+
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMXXRI-VGTTAYMAPEALR-GEITPKSDIYS 219
Query: 508 FGVVLLELITGKEAAYKQDGEEILL 532
           FGVVLLE+ITG  A  +    ++LL
Sbjct: 220 FGVVLLEIITGLPAVDEHREPQLLL 244

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  123 bits (308), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 114/205 (55%), Gaps = 16/205 (7%)
Query: 339 GSVFRGIINGSTVAIKCM-----------RRSISKEVNLLKKINHFNLINLFGACEHDGV 387
           G V++G +N +TVA+K +           ++   +E+ ++ K  H NL+ L G       
Sbjct: 39  GVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 98
Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
             LVY +M NGSL D L        +SW+ R +IA   A+G+++LH   +  ++H+DI S
Sbjct: 99  LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKS 155
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            NILLD+   AK+++F   R++ +        +  VGT  YMAPE +  G +TP+ D Y+
Sbjct: 156 ANILLDEAFTAKISDFGLARASEKFAQXVMXXRI-VGTTAYMAPEALR-GEITPKSDIYS 213
Query: 508 FGVVLLELITGKEAAYKQDGEEILL 532
           FGVVLLE+ITG  A  +    ++LL
Sbjct: 214 FGVVLLEIITGLPAVDEHREPQLLL 238

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 71/205 (34%), Positives = 112/205 (54%), Gaps = 16/205 (7%)
Query: 339 GSVFRGIINGSTVAIKCM-----------RRSISKEVNLLKKINHFNLINLFGACEHDGV 387
           G V++G +N +TVA+K +           ++   +E+ +  K  H NL+ L G       
Sbjct: 36  GVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDD 95
Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
             LVY +  NGSL D L        +SW+ R +IA   A+G+++LH   +  ++H+DI S
Sbjct: 96  LCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLH---ENHHIHRDIKS 152
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            NILLD+   AK+++F   R++ +       ++  VGT  Y APE +  G +TP+ D Y+
Sbjct: 153 ANILLDEAFTAKISDFGLARASEKFAQXVXXSRI-VGTTAYXAPEALR-GEITPKSDIYS 210
Query: 508 FGVVLLELITGKEAAYKQDGEEILL 532
           FGVVLLE+ITG  A  +    ++LL
Sbjct: 211 FGVVLLEIITGLPAVDEHREPQLLL 235

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 125/264 (47%), Gaps = 30/264 (11%)
Query: 339 GSVFRGIINGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V R   +GS VA+K +              +EV ++K++ H N++   GA        
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110
Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           +V E++  GSL   LHK    E +    R  +A DVA G++YLHN  +P  VH+++ S N
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPN 169
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           +L+DK    K+ +F   R    + S + S+K+A GT  +MAPE +       + D Y+FG
Sbjct: 170 LLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFG 226
Query: 510 VVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI 569
           V+L EL T ++     +  +++ A         G    +L +  + N Q         + 
Sbjct: 227 VILWELATLQQPWGNLNPAQVVAAV--------GFKCKRLEIPRNLNPQ---------VA 269
Query: 570 MLCLACIAREPESRPSMAEVVSTL 593
            +   C   EP  RPS A ++  L
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDLL 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 123/264 (46%), Gaps = 30/264 (11%)
Query: 339 GSVFRGIINGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V R   +GS VA+K +              +EV ++K++ H N++   GA        
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110
Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           +V E++  GSL   LHK    E +    R  +A DVA G++YLHN  +P  VH+D+ S N
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRDLKSPN 169
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           +L+DK    K+ +F   R    + S +  +K A GT  +MAPE +       + D Y+FG
Sbjct: 170 LLVDKKYTVKVCDFGLSRL---KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFG 226
Query: 510 VVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI 569
           V+L EL T ++     +  +++ A         G    +L +  + N Q         + 
Sbjct: 227 VILWELATLQQPWGNLNPAQVVAAV--------GFKCKRLEIPRNLNPQ---------VA 269
Query: 570 MLCLACIAREPESRPSMAEVVSTL 593
            +   C   EP  RPS A ++  L
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDLL 293

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 122/260 (46%), Gaps = 41/260 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 281 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 339
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       +A  +A G+ Y+       YVH+D+ 
Sbjct: 340 TEYMSKGSLLDFLKGETGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLR 390
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 391 AANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G       +   P       E   
Sbjct: 449 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERG-----YRMPCPP-------ECPE 491
Query: 567 HLIMLCLACIAREPESRPSM 586
            L  L   C  +EPE RP+ 
Sbjct: 492 SLHDLMCQCWRKEPEERPTF 511

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 122/260 (46%), Gaps = 41/260 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 256
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       +A  +A G+ Y+       YVH+D+ 
Sbjct: 257 TEYMSKGSLLDFLKGETGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLR 307
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 308 AANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G       +   P       E   
Sbjct: 366 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERG-----YRMPCPP-------ECPE 408
Query: 567 HLIMLCLACIAREPESRPSM 586
            L  L   C  +EPE RP+ 
Sbjct: 409 SLHDLMCQCWRKEPEERPTF 428

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 122/260 (46%), Gaps = 41/260 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 256
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       +A  +A G+ Y+       YVH+D+ 
Sbjct: 257 TEYMSKGSLLDFLKGETGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLR 307
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 308 AANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G       +   P       E   
Sbjct: 366 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERG-----YRMPCPP-------ECPE 408
Query: 567 HLIMLCLACIAREPESRPSM 586
            L  L   C  +EPE RP+ 
Sbjct: 409 SLHDLMCQCWRKEPEERPTF 428

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 120/259 (46%), Gaps = 41/259 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 25  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 83
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       +A  +A G+ Y+       YVH+D+ 
Sbjct: 84  TEYMSKGSLLDFLKGETGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLR 134
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 135 AANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G                   E   
Sbjct: 193 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERGYR------------MPCPPECPE 235
Query: 567 HLIMLCLACIAREPESRPS 585
            L  L   C  +EPE RP+
Sbjct: 236 SLHDLMCQCWRKEPEERPT 254

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 122/260 (46%), Gaps = 41/260 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 256
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       +A  +A G+ Y+       YVH+D+ 
Sbjct: 257 GEYMSKGSLLDFLKGETGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLR 307
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 308 AANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G       +   P       E   
Sbjct: 366 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERG-----YRMPCPP-------ECPE 408
Query: 567 HLIMLCLACIAREPESRPSM 586
            L  L   C  +EPE RP+ 
Sbjct: 409 SLHDLMCQCWRKEPEERPTF 428

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 129/266 (48%), Gaps = 39/266 (14%)
Query: 339 GSVFRGIINGST-VAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VA+K +++      +   E NL+K++ H  L+ L+     + + Y++
Sbjct: 33  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 91
Query: 392 YEFMENGSLSDWLHKKRYPEFV--SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            E+MENGSL D+L   + P  +  + N    +A  +A G+ ++    +  Y+H+D+ + N
Sbjct: 92  TEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAAN 145
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           IL+   L  K+A+F   R  + E++ Y++ + A     + APE + YG  T + D ++FG
Sbjct: 146 ILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 203
Query: 510 VVLLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
           ++L E++T     Y    + E I   E  + MV   N   +L                + 
Sbjct: 204 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL----------------YQ 247
Query: 568 LIMLCLACIAREPESRPSMAEVVSTL 593
           L+ LC       PE RP+   + S L
Sbjct: 248 LMRLCW---KERPEDRPTFDYLRSVL 270

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 120/259 (46%), Gaps = 41/259 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KKI H  L+ L+     + + Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSEEPI-YIV 90
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       +A  +A G+ Y+       YVH+D+ 
Sbjct: 91  TEYMSKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLR 141
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 142 AANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G                   E   
Sbjct: 200 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERGYR------------MPCPPECPE 242
Query: 567 HLIMLCLACIAREPESRPS 585
            L  L   C  ++PE RP+
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 129/266 (48%), Gaps = 39/266 (14%)
Query: 339 GSVFRGIINGST-VAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VA+K +++      +   E NL+K++ H  L+ L+     + + Y++
Sbjct: 37  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 95
Query: 392 YEFMENGSLSDWLHKKRYPEFV--SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            E+MENGSL D+L   + P  +  + N    +A  +A G+ ++    +  Y+H+D+ + N
Sbjct: 96  TEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAAN 149
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           IL+   L  K+A+F   R  + E++ Y++ + A     + APE + YG  T + D ++FG
Sbjct: 150 ILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 207
Query: 510 VVLLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
           ++L E++T     Y    + E I   E  + MV   N   +L                + 
Sbjct: 208 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL----------------YQ 251
Query: 568 LIMLCLACIAREPESRPSMAEVVSTL 593
           L+ LC       PE RP+   + S L
Sbjct: 252 LMRLCW---KERPEDRPTFDYLRSVL 274

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 129/266 (48%), Gaps = 39/266 (14%)
Query: 339 GSVFRGIINGST-VAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VA+K +++      +   E NL+K++ H  L+ L+     + + Y++
Sbjct: 32  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 90
Query: 392 YEFMENGSLSDWLHKKRYPEFV--SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            E+MENGSL D+L   + P  +  + N    +A  +A G+ ++    +  Y+H+D+ + N
Sbjct: 91  TEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAAN 144
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           IL+   L  K+A+F   R  + E++ Y++ + A     + APE + YG  T + D ++FG
Sbjct: 145 ILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 202
Query: 510 VVLLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
           ++L E++T     Y    + E I   E  + MV   N   +L                + 
Sbjct: 203 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL----------------YQ 246
Query: 568 LIMLCLACIAREPESRPSMAEVVSTL 593
           L+ LC       PE RP+   + S L
Sbjct: 247 LMRLCW---KERPEDRPTFDYLRSVL 269

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 121/259 (46%), Gaps = 41/259 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 90
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       +A  +A G+ Y+       YVH+D++
Sbjct: 91  TEYMSKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLA 141
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 142 AANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G                   E   
Sbjct: 200 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERGYR------------MPCPPECPE 242
Query: 567 HLIMLCLACIAREPESRPS 585
            L  L   C  ++PE RP+
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 120/259 (46%), Gaps = 41/259 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 23  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 81
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       +A  +A G+ Y+       YVH+D+ 
Sbjct: 82  TEYMSKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLR 132
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 133 AANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G                   E   
Sbjct: 191 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERGYR------------MPCPPECPE 233
Query: 567 HLIMLCLACIAREPESRPS 585
            L  L   C  ++PE RP+
Sbjct: 234 SLHDLMCQCWRKDPEERPT 252

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 129/266 (48%), Gaps = 39/266 (14%)
Query: 339 GSVFRGIINGST-VAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VA+K +++      +   E NL+K++ H  L+ L+     + + Y++
Sbjct: 22  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 80
Query: 392 YEFMENGSLSDWLHKKRYPEFV--SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            E+MENGSL D+L   + P  +  + N    +A  +A G+ ++    +  Y+H+D+ + N
Sbjct: 81  TEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAAN 134
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           IL+   L  K+A+F   R  + E++ Y++ + A     + APE + YG  T + D ++FG
Sbjct: 135 ILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 192
Query: 510 VVLLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
           ++L E++T     Y    + E I   E  + MV   N   +L                + 
Sbjct: 193 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL----------------YQ 236
Query: 568 LIMLCLACIAREPESRPSMAEVVSTL 593
           L+ LC       PE RP+   + S L
Sbjct: 237 LMRLCW---KERPEDRPTFDYLRSVL 259

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 126/264 (47%), Gaps = 35/264 (13%)
Query: 339 GSVFRGIINGST-VAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VA+K +++      +   E NL+K++ H  L+ L+     + + Y++
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 85
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E+MENGSL D+L      +    N    +A  +A G+ ++    +  Y+H+D+ + NIL
Sbjct: 86  TEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANIL 141
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           +   L  K+A+F   R  + E++ Y++ + A     + APE + YG  T + D ++FG++
Sbjct: 142 VSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 512 LLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI 569
           L E++T     Y    + E I   E  + MV   N   +L                + L+
Sbjct: 200 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL----------------YQLM 243
Query: 570 MLCLACIAREPESRPSMAEVVSTL 593
            LC       PE RP+   + S L
Sbjct: 244 RLCW---KERPEDRPTFDYLRSVL 264

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 122/259 (47%), Gaps = 41/259 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 29  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 87
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       ++  +A G+ Y+       YVH+D+ 
Sbjct: 88  TEYMNKGSLLDFLKGETGKYLRLPQLVD------MSAQIASGMAYVERMN---YVHRDLR 138
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 139 AANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G       +   P       E   
Sbjct: 197 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERG-----YRMPCPP-------ECPE 239
Query: 567 HLIMLCLACIAREPESRPS 585
            L  L   C  +EPE RP+
Sbjct: 240 SLHDLMCQCWRKEPEERPT 258

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 120/259 (46%), Gaps = 41/259 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 21  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 79
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       +A  +A G+ Y+       YVH+D+ 
Sbjct: 80  TEYMSKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLR 130
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 131 AANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G                   E   
Sbjct: 189 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERGYR------------MPCPPECPE 231
Query: 567 HLIMLCLACIAREPESRPS 585
            L  L   C  ++PE RP+
Sbjct: 232 SLHDLMCQCWRKDPEERPT 250

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 120/259 (46%), Gaps = 41/259 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 90
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       +A  +A G+ Y+       YVH+D+ 
Sbjct: 91  IEYMSKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLR 141
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 142 AANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G                   E   
Sbjct: 200 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERGYR------------MPCPPECPE 242
Query: 567 HLIMLCLACIAREPESRPS 585
            L  L   C  ++PE RP+
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 120/259 (46%), Gaps = 41/259 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 90
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       +A  +A G+ Y+       YVH+D+ 
Sbjct: 91  TEYMSKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLR 141
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 142 AANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G                   E   
Sbjct: 200 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERGYR------------MPCPPECPE 242
Query: 567 HLIMLCLACIAREPESRPS 585
            L  L   C  ++PE RP+
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 120/259 (46%), Gaps = 41/259 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 90
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       +A  +A G+ Y+       YVH+D+ 
Sbjct: 91  CEYMSKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLR 141
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 142 AANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G                   E   
Sbjct: 200 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERGYR------------MPCPPECPE 242
Query: 567 HLIMLCLACIAREPESRPS 585
            L  L   C  ++PE RP+
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 122/260 (46%), Gaps = 41/260 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 199 GEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 257
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       +A  +A G+ Y+       YVH+D+ 
Sbjct: 258 TEYMSKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLR 308
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 309 AANILVGENLVCKVADFGLGR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 366
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G       +   P       E   
Sbjct: 367 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERG-----YRMPCPP-------ECPE 409
Query: 567 HLIMLCLACIAREPESRPSM 586
            L  L   C  ++PE RP+ 
Sbjct: 410 SLHDLMCQCWRKDPEERPTF 429

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 122/259 (47%), Gaps = 41/259 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 29  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 87
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       ++  +A G+ Y+       YVH+D+ 
Sbjct: 88  TEYMNKGSLLDFLKGETGKYLRLPQLVD------MSAQIASGMAYVERMN---YVHRDLR 138
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ +++ + A     + APE   YG  T + D +
Sbjct: 139 AANILVGENLVCKVADFGLAR--LIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G       +   P       E   
Sbjct: 197 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERG-----YRMPCPP-------ECPE 239
Query: 567 HLIMLCLACIAREPESRPS 585
            L  L   C  +EPE RP+
Sbjct: 240 SLHDLMCQCWRKEPEERPT 258

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 129/266 (48%), Gaps = 39/266 (14%)
Query: 339 GSVFRGIINGST-VAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VA+K +++      +   E NL+K++ H  L+ L+     + + Y++
Sbjct: 23  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 81
Query: 392 YEFMENGSLSDWLHKKRYPEFV--SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            E+MENGSL D+L   + P  +  + N    +A  +A G+ ++    +  Y+H+++ + N
Sbjct: 82  TEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRNLRAAN 135
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           IL+   L  K+A+F   R  + E++ Y++ + A     + APE + YG  T + D ++FG
Sbjct: 136 ILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 193
Query: 510 VVLLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
           ++L E++T     Y    + E I   E  + MV   N   +L                + 
Sbjct: 194 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL----------------YQ 237
Query: 568 LIMLCLACIAREPESRPSMAEVVSTL 593
           L+ LC       PE RP+   + S L
Sbjct: 238 LMRLCW---KERPEDRPTFDYLRSVL 260

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 128/266 (48%), Gaps = 39/266 (14%)
Query: 339 GSVFRGIINGST-VAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VA+K +++      +   E NL+K++ H  L+ L+     + + Y++
Sbjct: 33  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 91
Query: 392 YEFMENGSLSDWLHKKRYPEFV--SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            E+MENGSL D+L   + P  +  + N    +A  +A G+ ++    +  Y+H+D+ + N
Sbjct: 92  TEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAAN 145
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           IL+   L  K+A+F   R  + E++  ++ + A     + APE + YG  T + D ++FG
Sbjct: 146 ILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 203
Query: 510 VVLLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
           ++L E++T     Y    + E I   E  + MV   N   +L                + 
Sbjct: 204 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL----------------YQ 247
Query: 568 LIMLCLACIAREPESRPSMAEVVSTL 593
           L+ LC       PE RP+   + S L
Sbjct: 248 LMRLCW---KERPEDRPTFDYLRSVL 270

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 41/259 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 90
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  G L D+L  +     R P+ V       +A  +A G+ Y+       YVH+D+ 
Sbjct: 91  MEYMSKGCLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLR 141
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 142 AANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G                   E   
Sbjct: 200 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERGYR------------MPCPPECPE 242
Query: 567 HLIMLCLACIAREPESRPS 585
            L  L   C  ++PE RP+
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 128/266 (48%), Gaps = 39/266 (14%)
Query: 339 GSVFRGIINGST-VAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VA+K +++      +   E NL+K++ H  L+ L+     + + Y++
Sbjct: 35  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 93
Query: 392 YEFMENGSLSDWLHKKRYPEFV--SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            E+MENGSL D+L   + P  +  + N    +A  +A G+ ++    +  Y+H+D+ + N
Sbjct: 94  TEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAAN 147
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           IL+   L  K+A+F   R  + E++  ++ + A     + APE + YG  T + D ++FG
Sbjct: 148 ILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 205
Query: 510 VVLLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
           ++L E++T     Y    + E I   E  + MV   N   +L                + 
Sbjct: 206 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL----------------YQ 249
Query: 568 LIMLCLACIAREPESRPSMAEVVSTL 593
           L+ LC       PE RP+   + S L
Sbjct: 250 LMRLCW---KERPEDRPTFDYLRSVL 272

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 41/259 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 90
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  G L D+L  +     R P+ V       +A  +A G+ Y+       YVH+D+ 
Sbjct: 91  TEYMSKGCLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLR 141
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D +
Sbjct: 142 AANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G                   E   
Sbjct: 200 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERGYR------------MPCPPECPE 242
Query: 567 HLIMLCLACIAREPESRPS 585
            L  L   C  ++PE RP+
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 128/266 (48%), Gaps = 39/266 (14%)
Query: 339 GSVFRGIINGST-VAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VA+K +++      +   E NL+K++ H  L+ L+     + + Y++
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 85
Query: 392 YEFMENGSLSDWLHKKRYPEFV--SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            E+MENGSL D+L   + P  +  + N    +A  +A G+ ++    +  Y+H+D+ + N
Sbjct: 86  TEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAAN 139
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           IL+   L  K+A+F   R  + E++  ++ + A     + APE + YG  T + D ++FG
Sbjct: 140 ILVSDTLSCKIADFGLAR--LIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197
Query: 510 VVLLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
           ++L E++T     Y    + E I   E  + MV   N   +L                + 
Sbjct: 198 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL----------------YQ 241
Query: 568 LIMLCLACIAREPESRPSMAEVVSTL 593
           L+ LC       PE RP+   + S L
Sbjct: 242 LMRLCW---KERPEDRPTFDYLRSVL 264

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 128/266 (48%), Gaps = 39/266 (14%)
Query: 339 GSVFRGIINGST-VAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VA+K +++      +   E NL+K++ H  L+ L+     + + Y++
Sbjct: 36  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 94
Query: 392 YEFMENGSLSDWLHKKRYPEFV--SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            E+MENGSL D+L   + P  +  + N    +A  +A G+ ++    +  Y+H+D+ + N
Sbjct: 95  TEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAAN 148
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           IL+   L  K+A+F   R  + E++  ++ + A     + APE + YG  T + D ++FG
Sbjct: 149 ILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 206
Query: 510 VVLLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
           ++L E++T     Y    + E I   E  + MV   N   +L                + 
Sbjct: 207 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL----------------YQ 250
Query: 568 LIMLCLACIAREPESRPSMAEVVSTL 593
           L+ LC       PE RP+   + S L
Sbjct: 251 LMRLCW---KERPEDRPTFDYLRSVL 273

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 128/266 (48%), Gaps = 39/266 (14%)
Query: 339 GSVFRGIINGST-VAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VA+K +++      +   E NL+K++ H  L+ L+     + + Y++
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 85
Query: 392 YEFMENGSLSDWLHKKRYPEFV--SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            E+MENGSL D+L   + P  +  + N    +A  +A G+ ++    +  Y+H+D+ + N
Sbjct: 86  TEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAAN 139
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           IL+   L  K+A+F   R  + E++  ++ + A     + APE + YG  T + D ++FG
Sbjct: 140 ILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197
Query: 510 VVLLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
           ++L E++T     Y    + E I   E  + MV   N   +L                + 
Sbjct: 198 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL----------------YQ 241
Query: 568 LIMLCLACIAREPESRPSMAEVVSTL 593
           L+ LC       PE RP+   + S L
Sbjct: 242 LMRLCW---KERPEDRPTFDYLRSVL 264

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 35/264 (13%)
Query: 339 GSVFRGIINGST-VAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VA+K +++      +   E NL+K++ H  L+ L+     + + Y++
Sbjct: 29  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 87
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E+MENGSL D+L      +    N    +A  +A G+ ++    +  Y+H+D+ + NIL
Sbjct: 88  TEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANIL 143
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           +   L  K+A+F   R  + E++  ++ + A     + APE + YG  T + D ++FG++
Sbjct: 144 VSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 201
Query: 512 LLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI 569
           L E++T     Y    + E I   E  + MV   N   +L                + L+
Sbjct: 202 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL----------------YQLM 245
Query: 570 MLCLACIAREPESRPSMAEVVSTL 593
            LC       PE RP+   + S L
Sbjct: 246 RLCW---KERPEDRPTFDYLRSVL 266

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 35/264 (13%)
Query: 339 GSVFRGIINGST-VAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VA+K +++      +   E NL+K++ H  L+ L+     + + Y++
Sbjct: 28  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 86
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E+MENGSL D+L      +    N    +A  +A G+ ++    +  Y+H+D+ + NIL
Sbjct: 87  TEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANIL 142
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           +   L  K+A+F   R  + E++  ++ + A     + APE + YG  T + D ++FG++
Sbjct: 143 VSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 200
Query: 512 LLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI 569
           L E++T     Y    + E I   E  + MV   N   +L                + L+
Sbjct: 201 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL----------------YQLM 244
Query: 570 MLCLACIAREPESRPSMAEVVSTL 593
            LC       PE RP+   + S L
Sbjct: 245 RLCW---KERPEDRPTFDYLRSVL 265

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 35/264 (13%)
Query: 339 GSVFRGIINGST-VAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VA+K +++      +   E NL+K++ H  L+ L+     + + Y++
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 85
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E+MENGSL D+L      +    N    +A  +A G+ ++    +  Y+H+D+ + NIL
Sbjct: 86  TEYMENGSLVDFLKTPSGIKLTI-NKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANIL 141
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           +   L  K+A+F   R  + E++  ++ + A     + APE + YG  T + D ++FG++
Sbjct: 142 VSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 512 LLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI 569
           L E++T     Y    + E I   E  + MV   N   +L                + L+
Sbjct: 200 LTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL----------------YQLM 243
Query: 570 MLCLACIAREPESRPSMAEVVSTL 593
            LC       PE RP+   + S L
Sbjct: 244 RLCW---KERPEDRPTFDYLRSVL 264

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 41/259 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 90
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       +A  +A G+ Y+       YVH+D+ 
Sbjct: 91  IEYMSKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLR 141
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++  ++ + A     + APE   YG  T + D +
Sbjct: 142 AANILVGENLVCKVADFGLAR--LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G                   E   
Sbjct: 200 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERGYR------------MPCPPECPE 242
Query: 567 HLIMLCLACIAREPESRPS 585
            L  L   C  ++PE RP+
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 118/259 (45%), Gaps = 41/259 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       +  +E  ++KK+ H  L+ L+     + +  +V
Sbjct: 22  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-XIV 80
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L  +     R P+ V       +A  +A G+ Y+       YVH+D+ 
Sbjct: 81  TEYMSKGSLLDFLKGETGKYLRLPQLVD------MAAQIASGMAYVERMN---YVHRDLR 131
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+ +NL  K+A+F   R  + E++  ++ + A     + APE   YG  T + D +
Sbjct: 132 AANILVGENLVCKVADFGLAR--LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL T     Y       ++   V   VE G                   E   
Sbjct: 190 SFGILLTELTTKGRVPYPG-----MVNREVLDQVERGYR------------MPCPPECPE 232
Query: 567 HLIMLCLACIAREPESRPS 585
            L  L   C  +EPE RP+
Sbjct: 233 SLHDLMCQCWRKEPEERPT 251

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 133/286 (46%), Gaps = 50/286 (17%)
Query: 342 FRGIINGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
            +G    +TVA+K ++        R +  E N+LK++NH ++I L+GAC  DG   L+ E
Sbjct: 47  LKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106
Query: 394 FMENGSLSDWLHKKR-------------------YPE--FVSWNCRFRIALDVAHGLHYL 432
           + + GSL  +L + R                   +P+   ++       A  ++ G+ YL
Sbjct: 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL 166
Query: 433 HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE 492
              +    VH+D+++ NIL+ +  + K+++F   R    E+S    ++  +    +MA E
Sbjct: 167 AEMS---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK-WMAIE 222
Query: 493 YMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVL 552
            +   + T + D ++FGV+L E++T     Y       +  E +F++++ G+   +    
Sbjct: 223 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-----IPPERLFNLLKTGHRMER---- 273
Query: 553 VDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL 598
             P+        +  +  L L C  +EP+ RP  A++   L K+ +
Sbjct: 274 --PD------NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 103/191 (53%), Gaps = 23/191 (12%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  N ST VA+K ++      ++  +E NL+K + H  L+ L+     +   Y++
Sbjct: 27  GEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYII 86
Query: 392 YEFMENGSLSDWLH-----KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L      K   P+ + ++ +      +A G+ Y+       Y+H+D+ 
Sbjct: 87  TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIER---KNYIHRDLR 137
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + N+L+ ++L  K+A+F   R  V E++ Y++ + A     + APE + +G  T + D +
Sbjct: 138 AANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVW 195
Query: 507 AFGVVLLELIT 517
           +FG++L E++T
Sbjct: 196 SFGILLYEIVT 206

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 132/286 (46%), Gaps = 50/286 (17%)
Query: 342 FRGIINGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
            +G    +TVA+K ++        R +  E N+LK++NH ++I L+GAC  DG   L+ E
Sbjct: 47  LKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106
Query: 394 FMENGSLSDWLHKKR-------------------YPE--FVSWNCRFRIALDVAHGLHYL 432
           + + GSL  +L + R                   +P+   ++       A  ++ G+ YL
Sbjct: 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL 166
Query: 433 HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE 492
                   VH+D+++ NIL+ +  + K+++F   R    E+S    ++  +    +MA E
Sbjct: 167 AEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK-WMAIE 222
Query: 493 YMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVL 552
            +   + T + D ++FGV+L E++T     Y       +  E +F++++ G+   +    
Sbjct: 223 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-----IPPERLFNLLKTGHRMER---- 273
Query: 553 VDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL 598
             P+        +  +  L L C  +EP+ RP  A++   L K+ +
Sbjct: 274 --PD------NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 135/306 (44%), Gaps = 64/306 (20%)
Query: 320 KYEDLVVATENFSPKNMIDGSVFRGIINGSTV----AIKCMR--------RSISKEVNLL 367
           K++D V+   NF       G V +  I    +    AIK M+        R  + E+ +L
Sbjct: 18  KFQD-VIGEGNF-------GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 69
Query: 368 KKINHF-NLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY----PEFVSWNCR---- 418
            K+ H  N+INL GACEH G  YL  E+  +G+L D+L K R     P F   N      
Sbjct: 70  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 129
Query: 419 -----FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSA---V 470
                   A DVA G+ YL   +   ++H+D+++ NIL+ +N  AK+A+F   R     V
Sbjct: 130 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 186
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
           ++  G    +       +MA E + Y + T   D +++GV+L E+++     Y      +
Sbjct: 187 KKTMGRLPVR-------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG----M 235
Query: 531 LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
             AE    + +G   E  L+                 +  L   C   +P  RPS A+++
Sbjct: 236 TCAELYEKLPQGYRLEKPLNC-------------DDEVYDLMRQCWREKPYERPSFAQIL 282
Query: 591 STLMKI 596
            +L ++
Sbjct: 283 VSLNRM 288

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 118/279 (42%), Gaps = 49/279 (17%)
Query: 339 GSVFRGIINGSTVAIKCMR-----------RSISKEVNLLKKINHFNLINLFGACEHDGV 387
           G V+R    G  VA+K  R            ++ +E  L   + H N+I L G C  +  
Sbjct: 21  GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80
Query: 388 FYLVYEFMENGSLSDWLHKKRYPE--FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
             LV EF   G L+  L  KR P    V+W      A+ +A G++YLH+      +H+D+
Sbjct: 81  LCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNYLHDEAIVPIIHRDL 134
Query: 446 SSGNILLDKNLR--------AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYG 497
            S NIL+ + +          K+ +F   R   R     ++  +A G   +MAPE +   
Sbjct: 135 KSSNILILQKVENGDLSNKILKITDFGLAREWHR-----TTKMSAAGAYAWMAPEVIRAS 189
Query: 498 LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNL 557
           + +   D +++GV+L EL+TG+      DG    LA A       G A  KL++ +    
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVPFRGIDG----LAVAY------GVAMNKLALPI---- 235
Query: 558 QANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                        L   C   +P SRPS   ++  L  I
Sbjct: 236 ---PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 132/286 (46%), Gaps = 50/286 (17%)
Query: 342 FRGIINGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
            +G    +TVA+K ++        R +  E N+LK++NH ++I L+GAC  DG   L+ E
Sbjct: 47  LKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106
Query: 394 FMENGSLSDWLHKKR-------------------YPE--FVSWNCRFRIALDVAHGLHYL 432
           + + GSL  +L + R                   +P+   ++       A  ++ G+ YL
Sbjct: 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL 166
Query: 433 HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE 492
                   VH+D+++ NIL+ +  + K+++F   R    E+S    ++  +    +MA E
Sbjct: 167 AEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK-WMAIE 222
Query: 493 YMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVL 552
            +   + T + D ++FGV+L E++T     Y       +  E +F++++ G+   +    
Sbjct: 223 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-----IPPERLFNLLKTGHRMER---- 273
Query: 553 VDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL 598
             P+        +  +  L L C  +EP+ RP  A++   L K+ +
Sbjct: 274 --PD------NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 135/306 (44%), Gaps = 64/306 (20%)
Query: 320 KYEDLVVATENFSPKNMIDGSVFRGIINGSTV----AIKCMR--------RSISKEVNLL 367
           K++D V+   NF       G V +  I    +    AIK M+        R  + E+ +L
Sbjct: 28  KFQD-VIGEGNF-------GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 79
Query: 368 KKINHF-NLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY----PEFVSWNCR---- 418
            K+ H  N+INL GACEH G  YL  E+  +G+L D+L K R     P F   N      
Sbjct: 80  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 419 -----FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSA---V 470
                   A DVA G+ YL   +   ++H+D+++ NIL+ +N  AK+A+F   R     V
Sbjct: 140 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 196
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
           ++  G    +       +MA E + Y + T   D +++GV+L E+++     Y      +
Sbjct: 197 KKTMGRLPVR-------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG----M 245
Query: 531 LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
             AE    + +G   E  L+                 +  L   C   +P  RPS A+++
Sbjct: 246 TCAELYEKLPQGYRLEKPLNC-------------DDEVYDLMRQCWREKPYERPSFAQIL 292
Query: 591 STLMKI 596
            +L ++
Sbjct: 293 VSLNRM 298

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 103/191 (53%), Gaps = 23/191 (12%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  N ST VA+K ++      ++  +E NL+K + H  L+ L+     +   Y++
Sbjct: 26  GEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 85
Query: 392 YEFMENGSLSDWLH-----KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            EFM  GSL D+L      K   P+ + ++ +      +A G+ Y+       Y+H+D+ 
Sbjct: 86  TEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIER---KNYIHRDLR 136
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + N+L+ ++L  K+A+F   R  V E++ Y++ + A     + APE + +G  T + + +
Sbjct: 137 AANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVW 194
Query: 507 AFGVVLLELIT 517
           +FG++L E++T
Sbjct: 195 SFGILLYEIVT 205

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 124/267 (46%), Gaps = 41/267 (15%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++       S  +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 23  GEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEEPI-YIV 81
Query: 392 YEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            E+M  GSL D+L        + P  V       +A  VA G+ Y+       Y+H+D+ 
Sbjct: 82  TEYMNKGSLLDFLKDGEGRALKLPNLVD------MAAQVAAGMAYIERMN---YIHRDLR 132
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           S NIL+   L  K+A+F   R  + E++  ++ + A     + APE   YG  T + D +
Sbjct: 133 SANILVGNGLICKIADFGLAR--LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG++L EL+T     Y       +    V   VE G    ++    D         I+ 
Sbjct: 191 SFGILLTELVTKGRVPYPG-----MNNREVLEQVERG---YRMPCPQD-------CPISL 235
Query: 567 HLIMLCLACIAREPESRPSMAEVVSTL 593
           H +M  + C  ++PE RP+   + S L
Sbjct: 236 HELM--IHCWKKDPEERPTFEYLQSFL 260

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 135/306 (44%), Gaps = 64/306 (20%)
Query: 320 KYEDLVVATENFSPKNMIDGSVFRGIINGSTV----AIKCMR--------RSISKEVNLL 367
           K++D V+   NF       G V +  I    +    AIK M+        R  + E+ +L
Sbjct: 25  KFQD-VIGEGNF-------GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 76
Query: 368 KKINHF-NLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY----PEFVSWNCR---- 418
            K+ H  N+INL GACEH G  YL  E+  +G+L D+L K R     P F   N      
Sbjct: 77  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 136
Query: 419 -----FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSA---V 470
                   A DVA G+ YL   +   ++H+++++ NIL+ +N  AK+A+F   R     V
Sbjct: 137 SSQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYV 193
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
           ++  G    +       +MA E + Y + T   D +++GV+L E+++     Y      +
Sbjct: 194 KKTMGRLPVR-------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG----M 242
Query: 531 LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
             AE    + +G   E  L+                 +  L   C   +P  RPS A+++
Sbjct: 243 TCAELYEKLPQGYRLEKPLNC-------------DDEVYDLMRQCWREKPYERPSFAQIL 289
Query: 591 STLMKI 596
            +L ++
Sbjct: 290 VSLNRM 295

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 117/257 (45%), Gaps = 30/257 (11%)
Query: 346 INGSTVAIKCMRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +N   VAIK +R          +E  ++ K++H  L+ L+G C       LV+EFME+G 
Sbjct: 29  LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 88
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           LSD+L  +R     +      + LDV  G+ YL   +    +H+D+++ N L+ +N   K
Sbjct: 89  LSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAS---VIHRDLAARNCLVGENQVIK 143
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +++F   R  + ++  Y+S+        + +PE   +   + + D ++FGV++ E+ +  
Sbjct: 144 VSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 201
Query: 520 EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIARE 579
           +  Y+        +E V  +  G         L  P L +       H+  +   C    
Sbjct: 202 KIPYENRSN----SEVVEDISTGFR-------LYKPRLAST------HVYQIMNHCWKER 244
Query: 580 PESRPSMAEVVSTLMKI 596
           PE RP+ + ++  L  I
Sbjct: 245 PEDRPAFSRLLRQLAAI 261

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 16/191 (8%)
Query: 339 GSVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGA-CEHDGVFYLVY 392
           G V  G   G+ VA+KC++     ++   E +++ ++ H NL+ L G   E  G  Y+V 
Sbjct: 26  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 85
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           E+M  GSL D+L + R    +  +C  + +LDV   + YL       +VH+D+++ N+L+
Sbjct: 86  EYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLV 141
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
            ++  AK+++F   + A       S+  T      + APE +     + + D ++FG++L
Sbjct: 142 SEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILL 195
Query: 513 LELITGKEAAY 523
            E+ +     Y
Sbjct: 196 WEIYSFGRVPY 206

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 117/257 (45%), Gaps = 30/257 (11%)
Query: 346 INGSTVAIKCMRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +N   VAIK +R          +E  ++ K++H  L+ L+G C       LV+EFME+G 
Sbjct: 29  LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 88
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           LSD+L  +R     +      + LDV  G+ YL        +H+D+++ N L+ +N   K
Sbjct: 89  LSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIK 143
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +++F   R  + ++  Y+S+        + +PE   +   + + D ++FGV++ E+ +  
Sbjct: 144 VSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 201
Query: 520 EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIARE 579
           +  Y+        +E V  +  G         L  P L +       H+  +   C    
Sbjct: 202 KIPYENRSN----SEVVEDISTGFR-------LYKPRLAST------HVYQIMNHCWKER 244
Query: 580 PESRPSMAEVVSTLMKI 596
           PE RP+ + ++  L +I
Sbjct: 245 PEDRPAFSRLLRQLAEI 261

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 117/257 (45%), Gaps = 30/257 (11%)
Query: 346 INGSTVAIKCMRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +N   VAIK +R          +E  ++ K++H  L+ L+G C       LV+EFME+G 
Sbjct: 27  LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           LSD+L  +R     +      + LDV  G+ YL        +H+D+++ N L+ +N   K
Sbjct: 87  LSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIK 141
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +++F   R  + ++  Y+S+        + +PE   +   + + D ++FGV++ E+ +  
Sbjct: 142 VSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 199
Query: 520 EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIARE 579
           +  Y+        +E V  +  G         L  P L +       H+  +   C    
Sbjct: 200 KIPYENRSN----SEVVEDISTGFR-------LYKPRLAST------HVYQIMNHCWKER 242
Query: 580 PESRPSMAEVVSTLMKI 596
           PE RP+ + ++  L +I
Sbjct: 243 PEDRPAFSRLLRQLAEI 259

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 117/257 (45%), Gaps = 30/257 (11%)
Query: 346 INGSTVAIKCMRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +N   VAIK +R          +E  ++ K++H  L+ L+G C       LV+EFME+G 
Sbjct: 32  LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           LSD+L  +R     +      + LDV  G+ YL        +H+D+++ N L+ +N   K
Sbjct: 92  LSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIK 146
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +++F   R  + ++  Y+S+        + +PE   +   + + D ++FGV++ E+ +  
Sbjct: 147 VSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 204
Query: 520 EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIARE 579
           +  Y+        +E V  +  G         L  P L +       H+  +   C    
Sbjct: 205 KIPYENRSN----SEVVEDISTGFR-------LYKPRLAST------HVYQIMNHCWRER 247
Query: 580 PESRPSMAEVVSTLMKI 596
           PE RP+ + ++  L +I
Sbjct: 248 PEDRPAFSRLLRQLAEI 264

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 16/191 (8%)
Query: 339 GSVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGA-CEHDGVFYLVY 392
           G V  G   G+ VA+KC++     ++   E +++ ++ H NL+ L G   E  G  Y+V 
Sbjct: 207 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           E+M  GSL D+L + R    +  +C  + +LDV   + YL       +VH+D+++ N+L+
Sbjct: 267 EYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLV 322
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
            ++  AK+++F   + A       S+  T      + APE +     + + D ++FG++L
Sbjct: 323 SEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 376
Query: 513 LELITGKEAAY 523
            E+ +     Y
Sbjct: 377 WEIYSFGRVPY 387

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 16/191 (8%)
Query: 339 GSVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGA-CEHDGVFYLVY 392
           G V  G   G+ VA+KC++     ++   E +++ ++ H NL+ L G   E  G  Y+V 
Sbjct: 20  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           E+M  GSL D+L + R    +  +C  + +LDV   + YL       +VH+D+++ N+L+
Sbjct: 80  EYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLV 135
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
            ++  AK+++F   + A       S+  T      + APE +     + + D ++FG++L
Sbjct: 136 SEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 189
Query: 513 LELITGKEAAY 523
            E+ +     Y
Sbjct: 190 WEIYSFGRVPY 200

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 16/191 (8%)
Query: 339 GSVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGA-CEHDGVFYLVY 392
           G V  G   G+ VA+KC++     ++   E +++ ++ H NL+ L G   E  G  Y+V 
Sbjct: 35  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           E+M  GSL D+L + R    +  +C  + +LDV   + YL       +VH+D+++ N+L+
Sbjct: 95  EYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLV 150
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
            ++  AK+++F   + A       S+  T      + APE +     + + D ++FG++L
Sbjct: 151 SEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 204
Query: 513 LELITGKEAAY 523
            E+ +     Y
Sbjct: 205 WEIYSFGRVPY 215

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 91
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E VS      +A  ++  + YL       ++H+D+++ N 
Sbjct: 92  ITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 147
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 148 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 205
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 206 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 247
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E VS      +A  ++  + YL       ++H+D+++ N 
Sbjct: 87  IIEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 142
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 143 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 201 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 119/254 (46%), Gaps = 30/254 (11%)
Query: 351 VAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD 402
           VAIK +        RR    E +++ + +H N+I+L G         +V E+MENGSL  
Sbjct: 53  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDT 112
Query: 403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLAN 462
           +L KK   +F        +   ++ G+ YL   +D GYVH+D+++ NIL++ NL  K+++
Sbjct: 113 FL-KKNDGQFTVIQL-VGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSD 167
Query: 463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAA 522
           F   R    +     +T+       + APE + +   T   D +++G+V+ E+++  E  
Sbjct: 168 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227
Query: 523 YKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPES 582
           Y +     +  + V   VE G    +L   +D             L  L L C  +E  S
Sbjct: 228 YWE-----MTNQDVIKAVEEG---YRLPSPMD---------CPAALYQLMLDCWQKERNS 270
Query: 583 RPSMAEVVSTLMKI 596
           RP   E+V+ L K+
Sbjct: 271 RPKFDEIVNMLDKL 284

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E VS      +A  ++  + YL       ++H+D+++ N 
Sbjct: 87  IIEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 142
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 143 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 201 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 121/272 (44%), Gaps = 47/272 (17%)
Query: 349 STVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGS 399
           + VA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+
Sbjct: 50  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 109
Query: 400 LSDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           L ++L  +R P             E +S       A  VA G+ YL    C     +H+D
Sbjct: 110 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC-----IHRD 164
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+ ++   K+A+F   R  +     Y  T        +MAPE +   + T + D
Sbjct: 165 LAARNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 223
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ T   + Y       +  E +F +++ G+   K S              
Sbjct: 224 VWSFGVLLWEIFTLGGSPYPG-----VPVEELFKLLKEGHRMDKPS------------NC 266
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            + L M+   C    P  RP+  ++V  L +I
Sbjct: 267 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 298

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E VS      +A  ++  + YL       ++H+D+++ N 
Sbjct: 87  ITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 142
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 143 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 201 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 121/272 (44%), Gaps = 47/272 (17%)
Query: 349 STVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGS 399
           + VA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+
Sbjct: 46  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 105
Query: 400 LSDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           L ++L  +R P             E +S       A  VA G+ YL    C     +H+D
Sbjct: 106 LREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC-----IHRD 160
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+ ++   K+A+F   R  +     Y  T        +MAPE +   + T + D
Sbjct: 161 LAARNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 219
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ T   + Y       +  E +F +++ G+   K S              
Sbjct: 220 VWSFGVLLWEIFTLGGSPYPG-----VPVEELFKLLKEGHRMDKPS------------NC 262
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            + L M+   C    P  RP+  ++V  L +I
Sbjct: 263 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 121/272 (44%), Gaps = 47/272 (17%)
Query: 349 STVAIKCMRRSISK--------EVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGS 399
           + VA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+
Sbjct: 102 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 161
Query: 400 LSDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           L ++L  +R P             E +S       A  VA G+ YL    C     +H+D
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC-----IHRD 216
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+ ++   K+A+F   R  +     Y  T        +MAPE +   + T + D
Sbjct: 217 LAARNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ T   + Y       +  E +F +++ G+   K S              
Sbjct: 276 VWSFGVLLWEIFTLGGSPYPG-----VPVEELFKLLKEGHRMDKPS------------NC 318
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            + L M+   C    P  RP+  ++V  L +I
Sbjct: 319 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 121/272 (44%), Gaps = 47/272 (17%)
Query: 349 STVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGS 399
           + VA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+
Sbjct: 53  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 112
Query: 400 LSDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           L ++L  +R P             E +S       A  VA G+ YL    C     +H+D
Sbjct: 113 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC-----IHRD 167
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+ ++   K+A+F   R  +     Y  T        +MAPE +   + T + D
Sbjct: 168 LAARNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 226
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ T   + Y       +  E +F +++ G+   K S              
Sbjct: 227 VWSFGVLLWEIFTLGGSPYPG-----VPVEELFKLLKEGHRMDKPS------------NC 269
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            + L M+   C    P  RP+  ++V  L +I
Sbjct: 270 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 301

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E VS      +A  ++  + YL       ++H+D+++ N 
Sbjct: 87  ITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 142
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 143 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 201 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 120/257 (46%), Gaps = 30/257 (11%)
Query: 346 INGSTVAIKCMRR-SISK-----EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +N   VAIK ++  S+S+     E  ++ K++H  L+ L+G C       LV+EFME+G 
Sbjct: 49  LNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 108
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           LSD+L  +R     +      + LDV  G+ YL        +H+D+++ N L+ +N   K
Sbjct: 109 LSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIK 163
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +++F   R  + ++  Y+S+        + +PE   +   + + D ++FGV++ E+ +  
Sbjct: 164 VSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 221
Query: 520 EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIARE 579
           +  Y+        +E V  +  G         L  P L +       H+  +   C    
Sbjct: 222 KIPYENRSN----SEVVEDISTGFR-------LYKPRLAST------HVYQIMNHCWKER 264
Query: 580 PESRPSMAEVVSTLMKI 596
           PE RP+ + ++  L +I
Sbjct: 265 PEDRPAFSRLLRQLAEI 281

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 121/272 (44%), Gaps = 47/272 (17%)
Query: 349 STVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGS 399
           + VA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 400 LSDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           L ++L  +R P             E +S       A  VA G+ YL    C     +H+D
Sbjct: 121 LREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC-----IHRD 175
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+ ++   K+A+F   R  +     Y  T        +MAPE +   + T + D
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 234
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ T   + Y       +  E +F +++ G+   K S              
Sbjct: 235 VWSFGVLLWEIFTLGGSPYPG-----VPVEELFKLLKEGHRMDKPS------------NC 277
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            + L M+   C    P  RP+  ++V  L +I
Sbjct: 278 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 121/272 (44%), Gaps = 47/272 (17%)
Query: 349 STVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGS 399
           + VA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+
Sbjct: 54  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 113
Query: 400 LSDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           L ++L  +R P             E +S       A  VA G+ YL    C     +H+D
Sbjct: 114 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC-----IHRD 168
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+ ++   K+A+F   R  +     Y  T        +MAPE +   + T + D
Sbjct: 169 LAARNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 227
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ T   + Y       +  E +F +++ G+   K S              
Sbjct: 228 VWSFGVLLWEIFTLGGSPYPG-----VPVEELFKLLKEGHRMDKPS------------NC 270
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            + L M+   C    P  RP+  ++V  L +I
Sbjct: 271 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 302

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 119/261 (45%), Gaps = 35/261 (13%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 25  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 84
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E VS      +A  ++  + YL       ++H+D+++ N 
Sbjct: 85  IIEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 140
Query: 451 LLDKNLRAKLANFSFVRSAVRE-ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           L+ +N   K+A+F   R    +  + ++  K  +    + APE + Y   + + D +AFG
Sbjct: 141 LVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIKSDVWAFG 197
Query: 510 VVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHL 568
           V+L E+ T   + Y                   G   +++  L++ + +  + E     +
Sbjct: 198 VLLWEIATYGMSPYP------------------GIDPSQVYELLEKDYRMERPEGCPEKV 239
Query: 569 IMLCLACIAREPESRPSMAEV 589
             L  AC    P  RPS AE+
Sbjct: 240 YELMRACWQWNPSDRPSFAEI 260

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 122/271 (45%), Gaps = 47/271 (17%)
Query: 350 TVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+L
Sbjct: 115 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 174
Query: 401 SDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDI 445
            ++L  +R P             E +++         +A G+ YL    C     +H+D+
Sbjct: 175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDL 229
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+L+ +N   K+A+F   R  +     Y  T        +MAPE +   + T + D 
Sbjct: 230 AARNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 288
Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV++ E+ T   + Y       +  E +F +++ G+   K          AN     
Sbjct: 289 WSFGVLMWEIFTLGGSPYPG-----IPVEELFKLLKEGHRMDK---------PAN---CT 331
Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           + L M+   C    P  RP+  ++V  L +I
Sbjct: 332 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 121/272 (44%), Gaps = 47/272 (17%)
Query: 349 STVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGS 399
           + VA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 400 LSDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           L ++L  +R P             E +S       A  VA G+ YL    C     +H+D
Sbjct: 121 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC-----IHRD 175
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+ ++   K+A+F   R  +     Y  T        +MAPE +   + T + D
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 234
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ T   + Y       +  E +F +++ G+   K S              
Sbjct: 235 VWSFGVLLWEIFTLGGSPYPG-----VPVEELFKLLKEGHRMDKPS------------NC 277
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            + L M+   C    P  RP+  ++V  L +I
Sbjct: 278 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 119/255 (46%), Gaps = 30/255 (11%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           +VAIK +        RR    E +++ + +H N+I L G         +V E+MENGSL 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
            +L +K   +F        +   +A G+ YL   +D GYVH+D+++ NIL++ NL  K++
Sbjct: 135 SFL-RKHDAQFTVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 189
Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
           +F   R    +     +T+       + +PE + Y   T   D +++G+VL E+++  E 
Sbjct: 190 DFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 522 AYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE 581
            Y +     +  + V   V+ G         + P +     +    L  L L C  ++  
Sbjct: 250 PYWE-----MSNQDVIKAVDEG-------YRLPPPM-----DCPAALYQLMLDCWQKDRN 292
Query: 582 SRPSMAEVVSTLMKI 596
           +RP   ++VS L K+
Sbjct: 293 NRPKFEQIVSILDKL 307

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/178 (37%), Positives = 88/178 (49%), Gaps = 25/178 (14%)
Query: 363 EVNLLKKINHFNLINLFGACEH----DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR 418
           EV  L  + H N++   GA +     D   +L+  F E GSLSD+L        VSWN  
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNEL 123
Query: 419 FRIALDVAHGLHYLH-------NCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR 471
             IA  +A GL YLH       +   P   H+DI S N+LL  NL A +A+F     A++
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL---ALK 180
Query: 472 EESGYSSTKT--AVGTNGYMAPEYMEYGL-----VTPEMDTYAFGVVLLELITGKEAA 522
            E+G S+  T   VGT  YMAPE +E  +         +D YA G+VL EL +   AA
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 91
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E V+      +A  ++  + YL       ++H+D+++ N 
Sbjct: 92  IIEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 147
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 148 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 205
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 206 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 247
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 25  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 84
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E VS      +A  ++  + YL       ++H+D+++ N 
Sbjct: 85  ITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 140
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   +++   A     + APE + Y   + + D +AFGV
Sbjct: 141 LVGENHLVKVADFGLSRLMTGD--TFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 198
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 199 LLWEIATYGMSPYP------------------GIDPSQVYELLEKDYRMERPEGCPEKVY 240
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 241 ELMRACWQWNPSDRPSFAEI 260

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 28  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 87
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E V+      +A  ++  + YL       ++H+D+++ N 
Sbjct: 88  ITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 143
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 144 LVGENHLVKVADFGLSRLMTGD--TYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 201
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 202 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 243
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 244 ELMRACWQWNPSDRPSFAEI 263

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 119/261 (45%), Gaps = 35/261 (13%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 25  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 84
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E VS      +A  ++  + YL       ++H+D+++ N 
Sbjct: 85  ITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 140
Query: 451 LLDKNLRAKLANFSFVRSAVRE-ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           L+ +N   K+A+F   R    +  + ++  K  +    + APE + Y   + + D +AFG
Sbjct: 141 LVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIKSDVWAFG 197
Query: 510 VVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHL 568
           V+L E+ T   + Y                   G   +++  L++ + +  + E     +
Sbjct: 198 VLLWEIATYGMSPYP------------------GIDPSQVYELLEKDYRMERPEGCPEKV 239
Query: 569 IMLCLACIAREPESRPSMAEV 589
             L  AC    P  RPS AE+
Sbjct: 240 YELMRACWQWNPSDRPSFAEI 260

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 91
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E V+      +A  ++  + YL       ++H+D+++ N 
Sbjct: 92  ITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 147
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 148 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 205
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 206 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 247
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 116/257 (45%), Gaps = 30/257 (11%)
Query: 346 INGSTVAIKCMRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +N   VAIK +R          +E  ++ K++H  L+ L+G C       LV EFME+G 
Sbjct: 30  LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           LSD+L  +R     +      + LDV  G+ YL        +H+D+++ N L+ +N   K
Sbjct: 90  LSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIK 144
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +++F   R  + ++  Y+S+        + +PE   +   + + D ++FGV++ E+ +  
Sbjct: 145 VSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 202
Query: 520 EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIARE 579
           +  Y+        +E V  +  G         L  P L +       H+  +   C    
Sbjct: 203 KIPYENRSN----SEVVEDISTGFR-------LYKPRLAST------HVYQIMNHCWRER 245
Query: 580 PESRPSMAEVVSTLMKI 596
           PE RP+ + ++  L +I
Sbjct: 246 PEDRPAFSRLLRQLAEI 262

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 88
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E V+      +A  ++  + YL       ++H+D+++ N 
Sbjct: 89  ITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 144
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 145 LVGENHLVKVADFGLSRLMTGD--TYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 202
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 203 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 244
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 245 ELMRACWQWNPSDRPSFAEI 264

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 122/271 (45%), Gaps = 47/271 (17%)
Query: 350 TVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+L
Sbjct: 56  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 115
Query: 401 SDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDI 445
            ++L  +R P             E +++         +A G+ YL    C     +H+D+
Sbjct: 116 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDL 170
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+L+ +N   K+A+F   R  +     Y  T        +MAPE +   + T + D 
Sbjct: 171 TARNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 229
Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV++ E+ T   + Y       +  E +F +++ G+   K          AN     
Sbjct: 230 WSFGVLMWEIFTLGGSPYPG-----IPVEELFKLLKEGHRMDK---------PAN---CT 272
Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           + L M+   C    P  RP+  ++V  L +I
Sbjct: 273 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 303

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 122/271 (45%), Gaps = 47/271 (17%)
Query: 350 TVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+L
Sbjct: 58  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 117
Query: 401 SDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDI 445
            ++L  +R P             E +++         +A G+ YL    C     +H+D+
Sbjct: 118 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDL 172
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+L+ +N   K+A+F   R  +     Y  T        +MAPE +   + T + D 
Sbjct: 173 AARNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 231
Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV++ E+ T   + Y       +  E +F +++ G+   K          AN     
Sbjct: 232 WSFGVLMWEIFTLGGSPYPG-----IPVEELFKLLKEGHRMDK---------PAN---CT 274
Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           + L M+   C    P  RP+  ++V  L +I
Sbjct: 275 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 305

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 47/271 (17%)
Query: 350 TVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 401 SDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDI 445
            ++L  +R P             E +++         +A G+ YL    C     +H+D+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDL 183
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+L+ +N   K+A+F   R  +     Y +T        +MAPE +   + T + D 
Sbjct: 184 AARNVLVTENNVMKIADFGLARD-INNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDV 242
Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV++ E+ T   + Y       +  E +F +++ G+   K          AN     
Sbjct: 243 WSFGVLMWEIFTLGGSPYPG-----IPVEELFKLLKEGHRMDK---------PAN---CT 285
Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           + L M+   C    P  RP+  ++V  L +I
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 119/255 (46%), Gaps = 30/255 (11%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           +VAIK +        RR    E +++ + +H N+I L G         +V E+MENGSL 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
            +L +K   +F        +   +A G+ YL   +D GYVH+D+++ NIL++ NL  K++
Sbjct: 135 SFL-RKHDAQFTVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 189
Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
           +F   R    +     +T+       + +PE + Y   T   D +++G+VL E+++  E 
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 522 AYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE 581
            Y +     +  + V   V+ G         + P +     +    L  L L C  ++  
Sbjct: 250 PYWE-----MSNQDVIKAVDEG-------YRLPPPM-----DCPAALYQLMLDCWQKDRN 292
Query: 582 SRPSMAEVVSTLMKI 596
           +RP   ++VS L K+
Sbjct: 293 NRPKFEQIVSILDKL 307

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 96/187 (51%), Gaps = 19/187 (10%)
Query: 347 NGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
            G  VA+K M       R  +  EV +++  +H N+++++ +       ++V EF+E G+
Sbjct: 69  TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGA 128
Query: 400 LSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           L+D + H +   E ++  C     L V   L YLHN    G +H+DI S +ILL  + R 
Sbjct: 129 LTDIVTHTRMNEEQIATVC-----LSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRI 180
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           KL++F F     +E       K  VGT  +MAPE +       E+D ++ G++++E+I G
Sbjct: 181 KLSDFGFCAQVSKE---VPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237
Query: 519 KEAAYKQ 525
           +   + +
Sbjct: 238 EPPYFNE 244

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E V+      +A  ++  + YL       ++H+D+++ N 
Sbjct: 87  ITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 142
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 143 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 201 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 31  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E V+      +A  ++  + YL       ++H+D+++ N 
Sbjct: 91  ITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 146
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 147 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 204
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 205 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 246
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 247 ELMRACWQWNPSDRPSFAEI 266

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 120/269 (44%), Gaps = 45/269 (16%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+    N  T VA+K M+       +   E N++K + H  L+ L      + + Y++
Sbjct: 29  GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YII 87
Query: 392 YEFMENGSLSDWLH-----KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            EFM  GSL D+L      K+  P+ + ++ +      +A G+ ++       Y+H+D+ 
Sbjct: 88  TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRN---YIHRDLR 138
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+  +L  K+A+F   R  V E++ Y++ + A     + APE + +G  T + D +
Sbjct: 139 AANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 196
Query: 507 AFGVVLLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
           +FG++L+E++T     Y    + E I   E  + M    N                    
Sbjct: 197 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC------------------- 237
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              L  + + C    PE RP+   + S L
Sbjct: 238 PEELYNIMMRCWKNRPEERPTFEYIQSVL 266

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 91
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E V+      +A  ++  + YL       ++H+D+++ N 
Sbjct: 92  ITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 147
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 148 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 205
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 206 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 247
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 122/271 (45%), Gaps = 47/271 (17%)
Query: 350 TVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+L
Sbjct: 61  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 120
Query: 401 SDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDI 445
            ++L  +R P             E +++         +A G+ YL    C     +H+D+
Sbjct: 121 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDL 175
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+L+ +N   K+A+F   R  +     Y  T        +MAPE +   + T + D 
Sbjct: 176 AARNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 234
Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV++ E+ T   + Y       +  E +F +++ G+   K          AN     
Sbjct: 235 WSFGVLMWEIFTLGGSPYPG-----IPVEELFKLLKEGHRMDK---------PAN---CT 277
Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           + L M+   C    P  RP+  ++V  L +I
Sbjct: 278 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 308

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 122/271 (45%), Gaps = 47/271 (17%)
Query: 350 TVAIKCMRRSISKE--------VNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K ++   ++E        + ++K I  H N+INL GAC  DG  Y++ E+   G+L
Sbjct: 69  TVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 401 SDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDI 445
            ++L  +R P             E +++         +A G+ YL    C     +H+D+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDL 183
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+L+ +N   K+A+F   R  +     Y  T        +MAPE +   + T + D 
Sbjct: 184 AARNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 242
Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV++ E+ T   + Y       +  E +F +++ G+   K          AN     
Sbjct: 243 WSFGVLMWEIFTLGGSPYPG-----IPVEELFKLLKEGHRMDK---------PAN---CT 285
Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           + L M+   C    P  RP+  ++V  L +I
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E V+      +A  ++  + YL       ++H+D+++ N 
Sbjct: 87  ITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 142
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 143 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 201 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 119/255 (46%), Gaps = 30/255 (11%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           +VAIK +        RR    E +++ + +H N+I L G         +V E+MENGSL 
Sbjct: 73  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 132
Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
            +L +K   +F        +   +A G+ YL   +D GYVH+D+++ NIL++ NL  K++
Sbjct: 133 SFL-RKHDAQFTVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 187
Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
           +F   R    +     +T+       + +PE + Y   T   D +++G+VL E+++  E 
Sbjct: 188 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 247
Query: 522 AYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE 581
            Y +     +  + V   V+ G         + P +     +    L  L L C  ++  
Sbjct: 248 PYWE-----MSNQDVIKAVDEG-------YRLPPPM-----DCPAALYQLMLDCWQKDRN 290
Query: 582 SRPSMAEVVSTLMKI 596
           +RP   ++VS L K+
Sbjct: 291 NRPKFEQIVSILDKL 305

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 119/255 (46%), Gaps = 30/255 (11%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           +VAIK +        RR    E +++ + +H N+I L G         +V E+MENGSL 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
            +L +K   +F        +   +A G+ YL   +D GYVH+D+++ NIL++ NL  K++
Sbjct: 135 SFL-RKHDAQFTVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 189
Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
           +F   R    +     +T+       + +PE + Y   T   D +++G+VL E+++  E 
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 522 AYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE 581
            Y +     +  + V   V+ G         + P +     +    L  L L C  ++  
Sbjct: 250 PYWE-----MSNQDVIKAVDEG-------YRLPPPM-----DCPAALYQLMLDCWQKDRN 292
Query: 582 SRPSMAEVVSTLMKI 596
           +RP   ++VS L K+
Sbjct: 293 NRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 119/255 (46%), Gaps = 30/255 (11%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           +VAIK +        RR    E +++ + +H N+I L G         +V E+MENGSL 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
            +L +K   +F        +   +A G+ YL   +D GYVH+D+++ NIL++ NL  K++
Sbjct: 135 SFL-RKHDAQFTVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 189
Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
           +F   R    +     +T+       + +PE + Y   T   D +++G+VL E+++  E 
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 522 AYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE 581
            Y +     +  + V   V+ G         + P +     +    L  L L C  ++  
Sbjct: 250 PYWE-----MSNQDVIKAVDEG-------YRLPPPM-----DCPAALYQLMLDCWQKDRN 292
Query: 582 SRPSMAEVVSTLMKI 596
           +RP   ++VS L K+
Sbjct: 293 NRPKFEQIVSILDKL 307

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 119/255 (46%), Gaps = 30/255 (11%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           +VAIK +        RR    E +++ + +H N+I L G         +V E+MENGSL 
Sbjct: 46  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 105
Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
            +L +K   +F        +   +A G+ YL   +D GYVH+D+++ NIL++ NL  K++
Sbjct: 106 SFL-RKHDAQFTVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 160
Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
           +F   R    +     +T+       + +PE + Y   T   D +++G+VL E+++  E 
Sbjct: 161 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 220
Query: 522 AYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE 581
            Y +     +  + V   V+ G         + P +     +    L  L L C  ++  
Sbjct: 221 PYWE-----MSNQDVIKAVDEG-------YRLPPPM-----DCPAALYQLMLDCWQKDRN 263
Query: 582 SRPSMAEVVSTLMKI 596
           +RP   ++VS L K+
Sbjct: 264 NRPKFEQIVSILDKL 278

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 119/255 (46%), Gaps = 30/255 (11%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           +VAIK +        RR    E +++ + +H N+I L G         +V E+MENGSL 
Sbjct: 63  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 122
Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
            +L +K   +F        +   +A G+ YL   +D GYVH+D+++ NIL++ NL  K++
Sbjct: 123 SFL-RKHDAQFTVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 177
Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
           +F   R    +     +T+       + +PE + Y   T   D +++G+VL E+++  E 
Sbjct: 178 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 237
Query: 522 AYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE 581
            Y +     +  + V   V+ G         + P +     +    L  L L C  ++  
Sbjct: 238 PYWE-----MSNQDVIKAVDEG-------YRLPPPM-----DCPAALYQLMLDCWQKDRN 280
Query: 582 SRPSMAEVVSTLMKI 596
           +RP   ++VS L K+
Sbjct: 281 NRPKFEQIVSILDKL 295

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 119/255 (46%), Gaps = 30/255 (11%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           +VAIK +        RR    E +++ + +H N+I L G         +V E+MENGSL 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
            +L +K   +F        +   +A G+ YL   +D GYVH+D+++ NIL++ NL  K++
Sbjct: 135 SFL-RKHDAQFTVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 189
Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
           +F   R    +     +T+       + +PE + Y   T   D +++G+VL E+++  E 
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 522 AYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE 581
            Y +     +  + V   V+ G         + P +     +    L  L L C  ++  
Sbjct: 250 PYWE-----MSNQDVIKAVDEG-------YRLPPPM-----DCPAALYQLMLDCWQKDRN 292
Query: 582 SRPSMAEVVSTLMKI 596
           +RP   ++VS L K+
Sbjct: 293 NRPKFEQIVSILDKL 307

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 122/272 (44%), Gaps = 47/272 (17%)
Query: 349 STVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGS 399
           + VA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 400 LSDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           L ++L  +R P             E +S       A  VA G+ YL    C     +H+D
Sbjct: 121 LREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC-----IHRD 175
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+ ++   K+A+F   R     +    +T   +    +MAPE +   + T + D
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVK-WMAPEALFDRIYTHQSD 234
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ T   + Y       +  E +F +++ G+   K S              
Sbjct: 235 VWSFGVLLWEIFTLGGSPYPG-----VPVEELFKLLKEGHRMDKPS------------NC 277
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            + L M+   C    P  RP+  ++V  L +I
Sbjct: 278 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 129/274 (47%), Gaps = 40/274 (14%)
Query: 339 GSVFRGIINGST------VAIKCMRRSISK--------EVNLLKKINHFNLINLFGACEH 384
           G V++G++  S+      VAIK ++   ++        E  ++ + +H N+I L G    
Sbjct: 58  GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
                ++ E+MENG+L  +L +K   EF        +   +A G+ YL N     YVH+D
Sbjct: 118 YKPMMIITEYMENGALDKFLREKD-GEFSVLQL-VGMLRGIAAGMKYLANMN---YVHRD 172
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVRE-ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           +++ NIL++ NL  K+++F   R    + E+ Y+++   +    + APE + Y   T   
Sbjct: 173 LAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR-WTAPEAISYRKFTSAS 231
Query: 504 DTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK 562
           D ++FG+V+ E++T G+   ++    E++ A          N   +L   +D        
Sbjct: 232 DVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---------NDGFRLPTPMD-------- 274
Query: 563 EIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                +  L + C  +E   RP  A++VS L K+
Sbjct: 275 -CPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 40  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 99
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E V+      +A  ++  + YL       ++H+D+++ N 
Sbjct: 100 ITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 155
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 156 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 213
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 214 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 255
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 256 ELMRACWQWNPSDRPSFAEI 275

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 88
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E V+      +A  ++  + YL       ++H+D+++ N 
Sbjct: 89  ITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 144
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 145 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 202
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 203 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 244
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 245 ELMRACWQWNPSDRPSFAEI 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 88
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E V+      +A  ++  + YL       ++H+D+++ N 
Sbjct: 89  ITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 144
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 145 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 202
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 203 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 244
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 245 ELMRACWQWNPSDRPSFAEI 264

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 119/256 (46%), Gaps = 40/256 (15%)
Query: 351 VAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD 402
           VAIK +        RR    E +++ + +H N+I L G      +  +V E+MENGSL  
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 403 WL--HKKRYP--EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           +L  H  ++   + V       +   V  G+ YL   +D GYVH+D+++ N+L+D NL  
Sbjct: 140 FLRTHDGQFTIMQLVG------MLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVC 190
Query: 459 KLANFSFVRSAVRE-ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+++F   R    + ++ Y++T   +    + APE + +   +   D ++FGVV+ E++ 
Sbjct: 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIR-WTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
Query: 518 GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIA 577
             E  Y      +   + + S+ EG    A +                H L  L L C  
Sbjct: 250 YGERPYWN----MTNRDVISSVEEGYRLPAPMGC-------------PHALHQLMLDCWH 292
Query: 578 REPESRPSMAEVVSTL 593
           ++   RP  +++VS L
Sbjct: 293 KDRAQRPRFSQIVSVL 308

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 119/255 (46%), Gaps = 30/255 (11%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           +VAIK +        RR    E +++ + +H N+I L G         +V E+MENGSL 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
            +L +K   +F        +   +A G+ YL   +D GYVH+D+++ NIL++ NL  K++
Sbjct: 135 SFL-RKHDAQFTVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 189
Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
           +F   R    +     +T+       + +PE + Y   T   D +++G+VL E+++  E 
Sbjct: 190 DFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 522 AYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE 581
            Y +     +  + V   V+ G         + P +     +    L  L L C  ++  
Sbjct: 250 PYWE-----MSNQDVIKAVDEG-------YRLPPPM-----DCPAALYQLMLDCWQKDRN 292
Query: 582 SRPSMAEVVSTLMKI 596
           +RP   ++VS L K+
Sbjct: 293 NRPKFEQIVSILDKL 307

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 120/269 (44%), Gaps = 45/269 (16%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+    N  T VA+K M+       +   E N++K + H  L+ L      + + Y++
Sbjct: 202 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YII 260
Query: 392 YEFMENGSLSDWLH-----KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            EFM  GSL D+L      K+  P+ + ++ +      +A G+ ++       Y+H+D+ 
Sbjct: 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRN---YIHRDLR 311
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+  +L  K+A+F   R  V E++ Y++ + A     + APE + +G  T + D +
Sbjct: 312 AANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 507 AFGVVLLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
           +FG++L+E++T     Y    + E I   E  + M    N                    
Sbjct: 370 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC------------------- 410
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              L  + + C    PE RP+   + S L
Sbjct: 411 PEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 123/271 (45%), Gaps = 47/271 (17%)
Query: 350 TVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 401 SDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDI 445
            ++L  +R P             E +++         +A G+ YL    C     +H+D+
Sbjct: 129 REYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDL 183
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+L+ +N   K+A+F   R     +    +T   +    +MAPE +   + T + D 
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVK-WMAPEALFDRVYTHQSDV 242
Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV++ E+ T   + Y       +  E +F +++ G+   K          AN     
Sbjct: 243 WSFGVLMWEIFTLGGSPYPG-----IPVEELFKLLKEGHRMDK---------PAN---CT 285
Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           + L M+   C    P  RP+  ++V  L +I
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 123/271 (45%), Gaps = 47/271 (17%)
Query: 350 TVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 401 SDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDI 445
            ++L  +R P             E +++         +A G+ YL    C     +H+D+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDL 183
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+L+ +N   K+A+F   R     +    +T   +    +MAPE +   + T + D 
Sbjct: 184 AARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVK-WMAPEALFDRVYTHQSDV 242
Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV++ E+ T   + Y       +  E +F +++ G+   K          AN     
Sbjct: 243 WSFGVLMWEIFTLGGSPYPG-----IPVEELFKLLKEGHRMDK---------PAN---CT 285
Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           + L M+   C    P  RP+  ++V  L +I
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 122/271 (45%), Gaps = 47/271 (17%)
Query: 350 TVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 401 SDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDI 445
            ++L  +R P             E +++         +A G+ YL    C     +H+D+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDL 183
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+L+ +N   ++A+F   R  +     Y  T        +MAPE +   + T + D 
Sbjct: 184 AARNVLVTENNVMRIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 242
Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV++ E+ T   + Y       +  E +F +++ G+   K          AN     
Sbjct: 243 WSFGVLMWEIFTLGGSPYPG-----IPVEELFKLLKEGHRMDK---------PAN---CT 285
Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           + L M+   C    P  RP+  ++V  L +I
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 234 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E VS      +A  ++  + YL       ++H+++++ N 
Sbjct: 294 ITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNC 349
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 350 LVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 407
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 408 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 449
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 450 ELMRACWQWNPSDRPSFAEI 469

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 119/261 (45%), Gaps = 35/261 (13%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 91
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E V+      +A  ++  + YL       ++H+D+++ N 
Sbjct: 92  ITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 147
Query: 451 LLDKNLRAKLANFSFVRSAVRE-ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           L+ +N   K+A+F   R    +  + ++  K  +    + APE + Y   + + D +AFG
Sbjct: 148 LVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIKSDVWAFG 204
Query: 510 VVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHL 568
           V+L E+ T   + Y                   G   +++  L++ + +  + E     +
Sbjct: 205 VLLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKV 246
Query: 569 IMLCLACIAREPESRPSMAEV 589
             L  AC    P  RPS AE+
Sbjct: 247 YELMRACWQWNPSDRPSFAEI 267

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 114/255 (44%), Gaps = 38/255 (14%)
Query: 351 VAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD 402
           VAIK +        RR    E +++ + +H N+I L G      +  +V E+MENGSL  
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 403 WL--HKKRYP--EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           +L  H  ++   + V       +   V  G+ YL   +D GYVH+D+++ N+L+D NL  
Sbjct: 140 FLRTHDGQFTIMQLVG------MLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVC 190
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           K+++F   R    +     +T        + APE + +   +   D ++FGVV+ E++  
Sbjct: 191 KVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAY 250
Query: 519 KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAR 578
            E  Y      +   + + S+ EG    A +                H L  L L C  +
Sbjct: 251 GERPYWN----MTNRDVISSVEEGYRLPAPMGC-------------PHALHQLMLDCWHK 293
Query: 579 EPESRPSMAEVVSTL 593
           +   RP  +++VS L
Sbjct: 294 DRAQRPRFSQIVSVL 308

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 100/187 (53%), Gaps = 19/187 (10%)
Query: 340 SVFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           S+  G   G T  I+  +    +EV ++  +NH N++ L+G   +     +V EF+  G 
Sbjct: 51  SLILGDSEGETEMIEKFQE-FQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGD 107
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL---LDKN- 455
           L   L  K +P  + W+ + R+ LD+A G+ Y+ N  +P  VH+D+ S NI    LD+N 
Sbjct: 108 LYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENA 164
Query: 456 -LRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM--EYGLVTPEMDTYAFGVVL 512
            + AK+A+FS  + +V   SG       +G   +MAPE +  E    T + DTY+F ++L
Sbjct: 165 PVCAKVADFSLSQQSVHSVSGL------LGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218
Query: 513 LELITGK 519
             ++TG+
Sbjct: 219 YTILTGE 225

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 119/261 (45%), Gaps = 35/261 (13%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 28  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 87
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E V+      +A  ++  + YL       ++H+D+++ N 
Sbjct: 88  IIEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 143
Query: 451 LLDKNLRAKLANFSFVRSAVRE-ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           L+ +N   K+A+F   R    +  + ++  K  +    + APE + Y   + + D +AFG
Sbjct: 144 LVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIKSDVWAFG 200
Query: 510 VVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHL 568
           V+L E+ T   + Y                   G   +++  L++ + +  + E     +
Sbjct: 201 VLLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKV 242
Query: 569 IMLCLACIAREPESRPSMAEV 589
             L  AC    P  RPS AE+
Sbjct: 243 YELMRACWQWNPSDRPSFAEI 263

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 119/255 (46%), Gaps = 30/255 (11%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           +VAIK +        RR    E +++ + +H N+I L G         +V E+MENGSL 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
            +L +K   +F        +   +A G+ YL   +D G+VH+D+++ NIL++ NL  K++
Sbjct: 135 SFL-RKHDAQFTVIQL-VGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVS 189
Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
           +F   R    +     +T+       + +PE + Y   T   D +++G+VL E+++  E 
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 522 AYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE 581
            Y +     +  + V   V+ G         + P +     +    L  L L C  ++  
Sbjct: 250 PYWE-----MSNQDVIKAVDEG-------YRLPPPM-----DCPAALYQLMLDCWQKDRN 292
Query: 582 SRPSMAEVVSTLMKI 596
           +RP   ++VS L K+
Sbjct: 293 NRPKFEQIVSILDKL 307

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 118/255 (46%), Gaps = 30/255 (11%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           +VAIK +        RR    E +++ + +H N+I L G         +V E MENGSL 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
            +L +K   +F        +   +A G+ YL   +D GYVH+D+++ NIL++ NL  K++
Sbjct: 135 SFL-RKHDAQFTVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 189
Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
           +F   R    +     +T+       + +PE + Y   T   D +++G+VL E+++  E 
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 522 AYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE 581
            Y +     +  + V   V+ G         + P +     +    L  L L C  ++  
Sbjct: 250 PYWE-----MSNQDVIKAVDEG-------YRLPPPM-----DCPAALYQLMLDCWQKDRN 292
Query: 582 SRPSMAEVVSTLMKI 596
           +RP   ++VS L K+
Sbjct: 293 NRPKFEQIVSILDKL 307

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 113/241 (46%), Gaps = 42/241 (17%)
Query: 310 SNLDRGLKFYKYEDLVVATENFS-----------PKNMID-----GSVFRGII------- 346
           S +D G +   ++  VV  E F            P+ ++D     G    GI+       
Sbjct: 9   SGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKH 68
Query: 347 NGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +G  VA+K M       R  +  EV +++   HFN++ ++ +       +++ EF++ G+
Sbjct: 69  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128
Query: 400 LSDWLHKKRY-PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           L+D + + R   E ++  C       V   L YLH     G +H+DI S +ILL  + R 
Sbjct: 129 LTDIVSQVRLNEEQIATVCE-----AVLQALAYLHA---QGVIHRDIKSDSILLTLDGRV 180
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           KL++F F     ++       K  VGT  +MAPE +   L   E+D ++ G++++E++ G
Sbjct: 181 KLSDFGFCAQISKD---VPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
Query: 519 K 519
           +
Sbjct: 238 E 238

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 120/272 (44%), Gaps = 47/272 (17%)
Query: 349 STVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGS 399
           + VA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++ E+   G+
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 400 LSDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           L ++L  +  P             E +S       A  VA G+ YL    C     +H+D
Sbjct: 121 LREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC-----IHRD 175
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+ ++   K+A+F   R  +     Y  T        +MAPE +   + T + D
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 234
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ T   + Y       +  E +F +++ G+   K S              
Sbjct: 235 VWSFGVLLWEIFTLGGSPYPG-----VPVEELFKLLKEGHRMDKPS------------NC 277
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            + L M+   C    P  RP+  ++V  L +I
Sbjct: 278 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 118/255 (46%), Gaps = 30/255 (11%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           +VAIK +        RR    E +++ + +H N+I L G         +V E MENGSL 
Sbjct: 46  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 105
Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
            +L +K   +F        +   +A G+ YL   +D GYVH+D+++ NIL++ NL  K++
Sbjct: 106 SFL-RKHDAQFTVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVS 160
Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
           +F   R    +     +T+       + +PE + Y   T   D +++G+VL E+++  E 
Sbjct: 161 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 220
Query: 522 AYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE 581
            Y +     +  + V   V+ G         + P +     +    L  L L C  ++  
Sbjct: 221 PYWE-----MSNQDVIKAVDEG-------YRLPPPM-----DCPAALYQLMLDCWQKDRN 263
Query: 582 SRPSMAEVVSTLMKI 596
           +RP   ++VS L K+
Sbjct: 264 NRPKFEQIVSILDKL 278

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 94/187 (50%), Gaps = 19/187 (10%)
Query: 347 NGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +G  VA+K M       R  +  EV +++   H N++ ++ +       ++V EF+E G+
Sbjct: 53  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 112
Query: 400 LSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           L+D + H +   E ++  C     L V   L  LH     G +H+DI S +ILL  + R 
Sbjct: 113 LTDIVTHTRMNEEQIAAVC-----LAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRV 164
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           KL++F F     +E       K  VGT  +MAPE +      PE+D ++ G++++E++ G
Sbjct: 165 KLSDFGFCAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 221
Query: 519 KEAAYKQ 525
           +   + +
Sbjct: 222 EPPYFNE 228

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 94/187 (50%), Gaps = 19/187 (10%)
Query: 347 NGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +G  VA+K M       R  +  EV +++   H N++ ++ +       ++V EF+E G+
Sbjct: 175 SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 234
Query: 400 LSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           L+D + H +   E ++  C     L V   L  LH     G +H+DI S +ILL  + R 
Sbjct: 235 LTDIVTHTRMNEEQIAAVC-----LAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRV 286
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           KL++F F     +E       K  VGT  +MAPE +      PE+D ++ G++++E++ G
Sbjct: 287 KLSDFGFCAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343
Query: 519 KEAAYKQ 525
           +   + +
Sbjct: 344 EPPYFNE 350

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 124/271 (45%), Gaps = 33/271 (12%)
Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V++G  +G  VA+K ++         ++   EV +L+K  H N++   G    D +  
Sbjct: 50  GTVYKGKWHGD-VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNL-A 107
Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           +V ++ E  SL   LH +   +F  +     IA   A G+ YLH       +H+D+ S N
Sbjct: 108 IVTQWCEGSSLYKHLHVQE-TKFQMFQL-IDIARQTAQGMDYLHA---KNIIHRDMKSNN 162
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP---EMDTY 506
           I L + L  K+ +F       R  SG    +   G+  +MAPE +      P   + D Y
Sbjct: 163 IFLHEGLTVKIGDFGLATVKSRW-SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVY 221
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           ++G+VL EL+TG E  Y      I   + +  MV  G A   LS L     +A K+ +A 
Sbjct: 222 SYGIVLYELMTG-ELPY----SHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVAD 276
Query: 567 HLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
                   C+ +  E RP   +++S++  +Q
Sbjct: 277 --------CVKKVKEERPLFPQILSSIELLQ 299

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 122/271 (45%), Gaps = 47/271 (17%)
Query: 350 TVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K ++   ++        E+ ++K I  H N+I+L GAC  DG  Y++ E+   G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNL 128
Query: 401 SDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDI 445
            ++L  +R P             E +++         +A G+ YL    C     +H+D+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDL 183
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+L+ +N   K+A+F   R  +     Y  T        +MAPE +   + T + D 
Sbjct: 184 AARNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 242
Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV++ E+ T   + Y       +  E +F +++ G+   K          AN     
Sbjct: 243 WSFGVLMWEIFTLGGSPYPG-----IPVEELFKLLKEGHRMDK---------PAN---CT 285
Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           + L M+   C    P  RP+  ++V  L +I
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 94/187 (50%), Gaps = 19/187 (10%)
Query: 347 NGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +G  VA+K M       R  +  EV +++   H N++ ++ +       ++V EF+E G+
Sbjct: 55  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 114
Query: 400 LSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           L+D + H +   E ++  C     L V   L  LH     G +H+DI S +ILL  + R 
Sbjct: 115 LTDIVTHTRMNEEQIAAVC-----LAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRV 166
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           KL++F F     +E       K  VGT  +MAPE +      PE+D ++ G++++E++ G
Sbjct: 167 KLSDFGFCAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 223
Query: 519 KEAAYKQ 525
           +   + +
Sbjct: 224 EPPYFNE 230

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 121/271 (44%), Gaps = 47/271 (17%)
Query: 350 TVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K ++   ++        E+ ++K I  H N+I L GAC  DG  Y++ E+   G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNL 128
Query: 401 SDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDI 445
            ++L  +R P             E +++         +A G+ YL    C     +H+D+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDL 183
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+L+ +N   K+A+F   R  +     Y  T        +MAPE +   + T + D 
Sbjct: 184 AARNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 242
Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV++ E+ T   + Y       +  E +F +++ G+   K          AN     
Sbjct: 243 WSFGVLMWEIFTLGGSPYPG-----IPVEELFKLLKEGHRMDK---------PAN---CT 285
Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           + L M+   C    P  RP+  ++V  L +I
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 121/271 (44%), Gaps = 47/271 (17%)
Query: 350 TVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++  +   G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNL 128
Query: 401 SDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDI 445
            ++L  +R P             E +++         +A G+ YL    C     +H+D+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDL 183
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+L+ +N   K+A+F   R  +     Y  T        +MAPE +   + T + D 
Sbjct: 184 AARNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 242
Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV++ E+ T   + Y       +  E +F +++ G+   K          AN     
Sbjct: 243 WSFGVLMWEIFTLGGSPYPG-----IPVEELFKLLKEGHRMDK---------PAN---CT 285
Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           + L M+   C    P  RP+  ++V  L +I
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 94/187 (50%), Gaps = 19/187 (10%)
Query: 347 NGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +G  VA+K M       R  +  EV +++   H N++ ++ +       ++V EF+E G+
Sbjct: 44  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103
Query: 400 LSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           L+D + H +   E ++  C     L V   L  LH     G +H+DI S +ILL  + R 
Sbjct: 104 LTDIVTHTRMNEEQIAAVC-----LAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRV 155
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           KL++F F     +E       K  VGT  +MAPE +      PE+D ++ G++++E++ G
Sbjct: 156 KLSDFGFCAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
Query: 519 KEAAYKQ 525
           +   + +
Sbjct: 213 EPPYFNE 219

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 94/187 (50%), Gaps = 19/187 (10%)
Query: 347 NGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +G  VA+K M       R  +  EV +++   H N++ ++ +       ++V EF+E G+
Sbjct: 48  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 107
Query: 400 LSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           L+D + H +   E ++  C     L V   L  LH     G +H+DI S +ILL  + R 
Sbjct: 108 LTDIVTHTRMNEEQIAAVC-----LAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRV 159
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           KL++F F     +E       K  VGT  +MAPE +      PE+D ++ G++++E++ G
Sbjct: 160 KLSDFGFCAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 216
Query: 519 KEAAYKQ 525
           +   + +
Sbjct: 217 EPPYFNE 223

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 120/256 (46%), Gaps = 32/256 (12%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
            VAIK +        RR    E +++ + +H N+++L G         +V EFMENG+L 
Sbjct: 73  AVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALD 132
Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
            +L +K   +F        +   +A G+ YL    D GYVH+D+++ NIL++ NL  K++
Sbjct: 133 AFL-RKHDGQFTVIQL-VGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVS 187
Query: 462 NFSFVRSAVRE-ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE 520
           +F   R    + E+ Y++T   +    + APE ++Y   T   D +++G+V+ E+++  E
Sbjct: 188 DFGLSRVIEDDPEAVYTTTGGKIPVR-WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 246
Query: 521 AAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREP 580
             Y       +  + V   +E G    +L   +D             L  L L C  +E 
Sbjct: 247 RPYWD-----MSNQDVIKAIEEGY---RLPAPMD---------CPAGLHQLMLDCWQKER 289
Query: 581 ESRPSMAEVVSTLMKI 596
             RP   ++V  L K+
Sbjct: 290 AERPKFEQIVGILDKM 305

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 94/187 (50%), Gaps = 19/187 (10%)
Query: 347 NGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +G  VA+K M       R  +  EV +++   H N++ ++ +       ++V EF+E G+
Sbjct: 98  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 157
Query: 400 LSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           L+D + H +   E ++  C     L V   L  LH     G +H+DI S +ILL  + R 
Sbjct: 158 LTDIVTHTRMNEEQIAAVC-----LAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRV 209
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           KL++F F     +E       K  VGT  +MAPE +      PE+D ++ G++++E++ G
Sbjct: 210 KLSDFGFCAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266
Query: 519 KEAAYKQ 525
           +   + +
Sbjct: 267 EPPYFNE 273

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 121/271 (44%), Gaps = 47/271 (17%)
Query: 350 TVAIKCMRRSISK--------EVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K ++   ++        E+ ++K I  H N+INL GAC  DG  Y++  +   G+L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNL 128
Query: 401 SDWLHKKRYP-------------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDI 445
            ++L  +R P             E +++         +A G+ YL    C     +H+D+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDL 183
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+L+ +N   K+A+F   R  +     Y  T        +MAPE +   + T + D 
Sbjct: 184 AARNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 242
Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV++ E+ T   + Y       +  E +F +++ G+   K          AN     
Sbjct: 243 WSFGVLMWEIFTLGGSPYPG-----IPVEELFKLLKEGHRMDK---------PAN---CT 285
Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           + L M+   C    P  RP+  ++V  L +I
Sbjct: 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 99/187 (52%), Gaps = 19/187 (10%)
Query: 340 SVFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           S+  G   G T  I+  +    +EV ++  +NH N++ L+G   +     +V EF+  G 
Sbjct: 51  SLILGDSEGETEMIEKFQ-EFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGD 107
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL---LDKN- 455
           L   L  K +P  + W+ + R+ LD+A G+ Y+ N  +P  VH+D+ S NI    LD+N 
Sbjct: 108 LYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENA 164
Query: 456 -LRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM--EYGLVTPEMDTYAFGVVL 512
            + AK+A+F   + +V   SG       +G   +MAPE +  E    T + DTY+F ++L
Sbjct: 165 PVCAKVADFGLSQQSVHSVSGL------LGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218
Query: 513 LELITGK 519
             ++TG+
Sbjct: 219 YTILTGE 225

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 273 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 332
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    E V+      +A  ++  + YL       ++H+++++ N 
Sbjct: 333 ITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNC 388
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 389 LVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 446
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHHLI 569
           +L E+ T   + Y                   G   +++  L++ + +  + E     + 
Sbjct: 447 LLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRMERPEGCPEKVY 488
Query: 570 MLCLACIAREPESRPSMAEV 589
            L  AC    P  RPS AE+
Sbjct: 489 ELMRACWQWNPSDRPSFAEI 508

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 112/246 (45%), Gaps = 34/246 (13%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           RR    E +++ + +H N+I+L G         ++ E+MENGSL  +L K         +
Sbjct: 53  RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN--------D 104
Query: 417 CRFRIA------LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
            RF +         +  G+ YL   +D  YVH+D+++ NIL++ NL  K+++F   R   
Sbjct: 105 GRFTVIQLVGMLRGIGSGMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLE 161
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
            +     +T+       + APE + Y   T   D +++G+V+ E+++  E  Y       
Sbjct: 162 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD----- 216
Query: 531 LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
           +  + V   +E G         + P +      IA H +M  L C  +E   RP   ++V
Sbjct: 217 MSNQDVIKAIEEG-------YRLPPPMDC---PIALHQLM--LDCWQKERSDRPKFGQIV 264
Query: 591 STLMKI 596
           + L K+
Sbjct: 265 NMLDKL 270

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 112/246 (45%), Gaps = 34/246 (13%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           RR    E +++ + +H N+I+L G         ++ E+MENGSL  +L K         +
Sbjct: 59  RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN--------D 110
Query: 417 CRFRIA------LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
            RF +         +  G+ YL   +D  YVH+D+++ NIL++ NL  K+++F   R   
Sbjct: 111 GRFTVIQLVGMLRGIGSGMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLE 167
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
            +     +T+       + APE + Y   T   D +++G+V+ E+++  E  Y       
Sbjct: 168 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD----- 222
Query: 531 LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
           +  + V   +E G         + P +      IA H +M  L C  +E   RP   ++V
Sbjct: 223 MSNQDVIKAIEEG-------YRLPPPMDC---PIALHQLM--LDCWQKERSDRPKFGQIV 270
Query: 591 STLMKI 596
           + L K+
Sbjct: 271 NMLDKL 276

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 99/187 (52%), Gaps = 19/187 (10%)
Query: 340 SVFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           S+  G   G T  I+  +    +EV ++  +NH N++ L+G   +     +V EF+  G 
Sbjct: 51  SLILGDSEGETEMIEKFQ-EFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGD 107
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL---LDKN- 455
           L   L  K +P  + W+ + R+ LD+A G+ Y+ N  +P  VH+D+ S NI    LD+N 
Sbjct: 108 LYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENA 164
Query: 456 -LRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM--EYGLVTPEMDTYAFGVVL 512
            + AK+A+F   + +V   SG       +G   +MAPE +  E    T + DTY+F ++L
Sbjct: 165 PVCAKVADFGTSQQSVHSVSGL------LGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218
Query: 513 LELITGK 519
             ++TG+
Sbjct: 219 YTILTGE 225

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 31/258 (12%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+      TVA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 46  GEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYI 105
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           V E+M  G+L D+L +    E V+      +A  ++  + YL       ++H+D+++ N 
Sbjct: 106 VTEYMPYGNLLDYLRECNREE-VTAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNC 161
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R    +   Y++   A     + APE + Y   + + D +AFGV
Sbjct: 162 LVGENHVVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGV 219
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM 570
           +L E+ T   + Y      I L++ V+ ++E G        +  P     K      +  
Sbjct: 220 LLWEIATYGMSPYPG----IDLSQ-VYDLLEKGYR------MEQPEGCPPK------VYE 262
Query: 571 LCLACIAREPESRPSMAE 588
           L  AC    P  RPS AE
Sbjct: 263 LMRACWKWSPADRPSFAE 280

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 123/257 (47%), Gaps = 34/257 (13%)
Query: 351 VAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD 402
           VAIK +        RR    E +++ + +H N+I+L G         ++ EFMENGSL  
Sbjct: 64  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 123
Query: 403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLAN 462
           +L ++   +F        +   +A G+ YL    D  YVH+D+++ NIL++ NL  K+++
Sbjct: 124 FL-RQNDGQFTVIQL-VGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSD 178
Query: 463 FSFVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           F   R  + +++   +  +A+G      + APE ++Y   T   D +++G+V+ E+++  
Sbjct: 179 FGLSR-FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 237
Query: 520 EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIARE 579
           E  Y       +  + V + +E    + +L   +D             L  L L C  ++
Sbjct: 238 ERPYWD-----MTNQDVINAIE---QDYRLPPPMD---------CPSALHQLMLDCWQKD 280
Query: 580 PESRPSMAEVVSTLMKI 596
              RP   ++V+TL K+
Sbjct: 281 RNHRPKFGQIVNTLDKM 297

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 118/264 (44%), Gaps = 30/264 (11%)
Query: 339 GSVFRGIINGSTVAIKCM-----RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           G V +       VAIK +     R++   E+  L ++NH N++ L+GAC +     LV E
Sbjct: 23  GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVME 80
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL- 452
           + E GSL + LH      + +        L  + G+ YLH+      +H+D+   N+LL 
Sbjct: 81  YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV 140
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
                 K+ +F    +A   ++  ++ K   G+  +MAPE  E    + + D +++G++L
Sbjct: 141 AGGTVLKICDFG---TACDIQTHMTNNK---GSAAWMAPEVFEGSNYSEKCDVFSWGIIL 194
Query: 513 LELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLC 572
            E+IT ++   +  G    +  AV +                P L  N  +    L+  C
Sbjct: 195 WEVITRRKPFDEIGGPAFRIMWAVHNGTR-------------PPLIKNLPKPIESLMTRC 241
Query: 573 LACIAREPESRPSMAEVVSTLMKI 596
               +++P  RPSM E+V  +  +
Sbjct: 242 W---SKDPSQRPSMEEIVKIMTHL 262

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 117/255 (45%), Gaps = 30/255 (11%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           +VAIK +        RR    E +++ + +H N+I L G         +V E MENGSL 
Sbjct: 75  SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
            +L +K   +F        +   +A G+ YL   +D G VH+D+++ NIL++ NL  K++
Sbjct: 135 SFL-RKHDAQFTVIQL-VGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVS 189
Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
           +F   R    +     +T+       + +PE + Y   T   D +++G+VL E+++  E 
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 522 AYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE 581
            Y +     +  + V   V+ G         + P +     +    L  L L C  ++  
Sbjct: 250 PYWE-----MSNQDVIKAVDEG-------YRLPPPM-----DCPAALYQLMLDCWQKDRN 292
Query: 582 SRPSMAEVVSTLMKI 596
           +RP   ++VS L K+
Sbjct: 293 NRPKFEQIVSILDKL 307

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 118/264 (44%), Gaps = 30/264 (11%)
Query: 339 GSVFRGIINGSTVAIKCM-----RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           G V +       VAIK +     R++   E+  L ++NH N++ L+GAC +     LV E
Sbjct: 22  GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVME 79
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL- 452
           + E GSL + LH      + +        L  + G+ YLH+      +H+D+   N+LL 
Sbjct: 80  YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV 139
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
                 K+ +F    +A   ++  ++ K   G+  +MAPE  E    + + D +++G++L
Sbjct: 140 AGGTVLKICDFG---TACDIQTHMTNNK---GSAAWMAPEVFEGSNYSEKCDVFSWGIIL 193
Query: 513 LELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLC 572
            E+IT ++   +  G    +  AV +                P L  N  +    L+  C
Sbjct: 194 WEVITRRKPFDEIGGPAFRIMWAVHNGTR-------------PPLIKNLPKPIESLMTRC 240
Query: 573 LACIAREPESRPSMAEVVSTLMKI 596
               +++P  RPSM E+V  +  +
Sbjct: 241 W---SKDPSQRPSMEEIVKIMTHL 261

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 91/186 (48%), Gaps = 20/186 (10%)
Query: 343 RGIINGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R I+ G  VA+K + ++         + +EV ++K +NH N++ LF   E +   YLV E
Sbjct: 27  RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 86
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
           +   G + D+L    + +      +FR    +   + Y   C     VH+D+ + N+LLD
Sbjct: 87  YASGGEVFDYLVAHGWMKEKEARAKFR---QIVSAVQY---CHQKFIVHRDLKAENLLLD 140
Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME-YGLVTPEMDTYAFGVVL 512
            ++  K+A+F F      E +  +   T  G+  Y APE  +      PE+D ++ GV+L
Sbjct: 141 ADMNIKIADFGF----SNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 196
Query: 513 LELITG 518
             L++G
Sbjct: 197 YTLVSG 202

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 111/246 (45%), Gaps = 34/246 (13%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           RR    E +++ + +H N+I+L G         ++ E+MENGSL  +L K         +
Sbjct: 74  RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN--------D 125
Query: 417 CRFRIA------LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
            RF +         +  G+ YL   +D   VH+D+++ NIL++ NL  K+++F   R   
Sbjct: 126 GRFTVIQLVGMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLE 182
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
            +     +T+       + APE + Y   T   D +++G+V+ E+++  E  Y       
Sbjct: 183 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD----- 237
Query: 531 LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
           +  + V   +E G         + P +      IA H +M  L C  +E   RP   ++V
Sbjct: 238 MSNQDVIKAIEEG-------YRLPPPMDC---PIALHQLM--LDCWQKERSDRPKFGQIV 285
Query: 591 STLMKI 596
           + L K+
Sbjct: 286 NMLDKL 291

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 36/255 (14%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK--KRYPEFVS 414
           +R+  KEV +++ + H N++   G    D     + E+++ G+L   +     +YP    
Sbjct: 51  QRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP---- 106
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
           W+ R   A D+A G+ YLH+      +H+D++S N L+ +N    +A+F   R  V E++
Sbjct: 107 WSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163
Query: 475 ---GYSSTK--------TAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAY 523
              G  S K        T VG   +MAPE +       ++D ++FG+VL E+I       
Sbjct: 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG------ 217
Query: 524 KQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESR 583
           + + +   L     +M  G N    L     PN   +          + + C   +PE R
Sbjct: 218 RVNADPDYLPR---TMDFGLNVRGFLDRYCPPNCPPS-------FFPITVRCCDLDPEKR 267
Query: 584 PSMAEVVSTLMKIQL 598
           PS  ++   L  +++
Sbjct: 268 PSFVKLEHWLETLRM 282

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 339 GSVFRGIINGSTVAIKCM----RRSISKEVNLLKK--INHFNLINLFGACEHDGV----- 387
           G V++  +    VA+K      ++S   E  +     + H NL+  F A E  G      
Sbjct: 29  GCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQ-FIAAEKRGSNLEVE 87
Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHN----CTDPGY--- 440
            +L+  F + GSL+D+L        ++WN    +A  ++ GL YLH     C   G+   
Sbjct: 88  LWLITAFHDKGSLTDYLKGN----IITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPS 143
Query: 441 -VHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY--SSTKTAVGTNGYMAPEYMEYG 497
             H+D  S N+LL  +L A LA+F     AVR E G     T   VGT  YMAPE +E  
Sbjct: 144 IAHRDFKSKNVLLKSDLTAVLADFGL---AVRFEPGKPPGDTHGQVGTRRYMAPEVLEGA 200
Query: 498 L-----VTPEMDTYAFGVVLLELITGKEAA 522
           +         +D YA G+VL EL++  +AA
Sbjct: 201 INFQRDAFLRIDMYAMGLVLWELVSRCKAA 230

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 112/256 (43%), Gaps = 43/256 (16%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH----------K 406
           R+   +E  LL  + H +++  +G C       +V+E+M++G L+ +L           +
Sbjct: 59  RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAE 118
Query: 407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV 466
              P  ++ +    IA  +A G+ YL       +VH+D+++ N L+ +NL  K+ +F   
Sbjct: 119 GNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS 175
Query: 467 RSAVREESGYSSTKTAVGTNG-----YMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKE 520
           R        YS+    VG +      +M PE + Y   T E D ++ GVVL E+ T GK+
Sbjct: 176 RDV------YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229
Query: 521 AAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREP 580
             Y+    E+     +  + +G        VL  P      +     +  L L C  REP
Sbjct: 230 PWYQLSNNEV-----IECITQG-------RVLQRP------RTCPQEVYELMLGCWQREP 271
Query: 581 ESRPSMAEVVSTLMKI 596
             R ++  + + L  +
Sbjct: 272 HMRKNIKGIHTLLQNL 287

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 90/186 (48%), Gaps = 20/186 (10%)
Query: 343 RGIINGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R I+ G  VA+K + ++         + +EV ++K +NH N++ LF   E +   YLV E
Sbjct: 34  RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 93
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
           +   G + D+L      +      +FR    +   + Y   C     VH+D+ + N+LLD
Sbjct: 94  YASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQY---CHQKFIVHRDLKAENLLLD 147
Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME-YGLVTPEMDTYAFGVVL 512
            ++  K+A+F F      E +  +   T  G+  Y APE  +      PE+D ++ GV+L
Sbjct: 148 ADMNIKIADFGF----SNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 513 LELITG 518
             L++G
Sbjct: 204 YTLVSG 209

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 89/186 (47%), Gaps = 20/186 (10%)
Query: 343 RGIINGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R I+ G  VAIK + ++         + +EV ++K +NH N++ LF   E +   YL+ E
Sbjct: 32  RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 91
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
           +   G + D+L      +      +FR    +   + Y   C     VH+D+ + N+LLD
Sbjct: 92  YASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQY---CHQKRIVHRDLKAENLLLD 145
Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME-YGLVTPEMDTYAFGVVL 512
            ++  K+A+F F      E +      T  G+  Y APE  +      PE+D ++ GV+L
Sbjct: 146 ADMNIKIADFGF----SNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 201
Query: 513 LELITG 518
             L++G
Sbjct: 202 YTLVSG 207

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 90/186 (48%), Gaps = 20/186 (10%)
Query: 343 RGIINGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R I+ G  VA+K + ++         + +EV ++K +NH N++ LF   E +   YLV E
Sbjct: 34  RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 93
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
           +   G + D+L      +      +FR    +   + Y   C     VH+D+ + N+LLD
Sbjct: 94  YASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQY---CHQKFIVHRDLKAENLLLD 147
Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME-YGLVTPEMDTYAFGVVL 512
            ++  K+A+F F      E +  +   T  G+  Y APE  +      PE+D ++ GV+L
Sbjct: 148 ADMNIKIADFGF----SNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 513 LELITG 518
             L++G
Sbjct: 204 YTLVSG 209

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 109/214 (50%), Gaps = 22/214 (10%)
Query: 347 NGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
           +G   A+K ++++  K         E ++L  +NH  ++ L  A + +G  YL+ +F+  
Sbjct: 55  SGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRG 114
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
           G L   L K+    F   + +F +A ++A GL +LH+    G +++D+   NILLD+   
Sbjct: 115 GDLFTRLSKEVM--FTEEDVKFYLA-ELALGLDHLHSL---GIIYRDLKPENILLDEEGH 168
Query: 458 AKLANFSFVRSAV-REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI 516
            KL +F   + A+  E+  YS      GT  YMAPE +     +   D +++GV++ E++
Sbjct: 169 IKLTDFGLSKEAIDHEKKAYS----FCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEML 224
Query: 517 TGKEAAYKQDGEE--ILLAEAVFSMVEGGNAEAK 548
           TG      +D +E   L+ +A   M +  + EA+
Sbjct: 225 TGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQ 258

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 90/186 (48%), Gaps = 20/186 (10%)
Query: 343 RGIINGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R I+ G  VA++ + ++         + +EV ++K +NH N++ LF   E +   YLV E
Sbjct: 34  RHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 93
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
           +   G + D+L      +      +FR    +   + Y   C     VH+D+ + N+LLD
Sbjct: 94  YASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQY---CHQKFIVHRDLKAENLLLD 147
Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME-YGLVTPEMDTYAFGVVL 512
            ++  K+A+F F      E +  +   T  G+  Y APE  +      PE+D ++ GV+L
Sbjct: 148 ADMNIKIADFGF----SNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 513 LELITG 518
             L++G
Sbjct: 204 YTLVSG 209

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 112/256 (43%), Gaps = 46/256 (17%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL--HKKRYPEFVS 414
           R+   +E  LL  + H +++  +G C       +V+E+M++G L+ +L  H       V 
Sbjct: 61  RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 415 WNCR-----------FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF 463
              R             IA  +A G+ YL       +VH+D+++ N L+  NL  K+ +F
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDF 177
Query: 464 SFVRSAVREESGYSSTKTAVGTNG-----YMAPEYMEYGLVTPEMDTYAFGVVLLELIT- 517
              R        YS+    VG +      +M PE + Y   T E D ++FGV+L E+ T 
Sbjct: 178 GMSRDV------YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 231
Query: 518 GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIA 577
           GK+  ++    E+     +  + +G        VL  P +    KE+      + L C  
Sbjct: 232 GKQPWFQLSNTEV-----IECITQG-------RVLERPRV--CPKEVYD----VMLGCWQ 273
Query: 578 REPESRPSMAEVVSTL 593
           REP+ R ++ E+   L
Sbjct: 274 REPQQRLNIKEIYKIL 289

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 90/186 (48%), Gaps = 20/186 (10%)
Query: 343 RGIINGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R ++ G  VA+K + ++         + +EV ++K +NH N++ LF   E +   YLV E
Sbjct: 35  RHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVME 94
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
           +   G + D+L      +      +FR    +   + Y   C     VH+D+ + N+LLD
Sbjct: 95  YASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQY---CHQKYIVHRDLKAENLLLD 148
Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME-YGLVTPEMDTYAFGVVL 512
            ++  K+A+F F      E +  +   T  G+  Y APE  +      PE+D ++ GV+L
Sbjct: 149 GDMNIKIADFGF----SNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 204
Query: 513 LELITG 518
             L++G
Sbjct: 205 YTLVSG 210

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 45/278 (16%)
Query: 339 GSVFRGIING-------STVAIKC------MRRSIS--KEVNLLKKINHFNLINLFGACE 383
           G V+ G+  G       + VAIK       MR  I    E +++K+ N  +++ L G   
Sbjct: 39  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEF--------VSWNCRFRIALDVAHGLHYLHNC 435
                 ++ E M  G L  +L   R PE          S +   ++A ++A G+ YL+  
Sbjct: 99  QGQPTLVIMELMTRGDLKSYLRSLR-PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN 157
Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME 495
               +VH+D+++ N ++ ++   K+ +F   R  + E   Y      +    +M+PE ++
Sbjct: 158 K---FVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMSPESLK 213
Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
            G+ T   D ++FGVVL E+ T  E  Y+                 G + E  L  +++ 
Sbjct: 214 DGVFTTYSDVWSFGVVLWEIATLAEQPYQ-----------------GLSNEQVLRFVMEG 256
Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            L          L  L   C    P+ RPS  E++S++
Sbjct: 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 118/278 (42%), Gaps = 45/278 (16%)
Query: 339 GSVFRGIING-------STVAIKC------MRRSIS--KEVNLLKKINHFNLINLFGACE 383
           G V+ G+  G       + VAIK       MR  I    E +++K+ N  +++ L G   
Sbjct: 24  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 83
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEF--------VSWNCRFRIALDVAHGLHYLHNC 435
                 ++ E M  G L  +L   R PE          S +   ++A ++A G+ YL+  
Sbjct: 84  QGQPTLVIMELMTRGDLKSYLRSLR-PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN 142
Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME 495
               +VH+D+++ N ++ ++   K+ +F   R     +      K  +    +M+PE ++
Sbjct: 143 K---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMSPESLK 198
Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
            G+ T   D ++FGVVL E+ T  E  Y                 +G + E  L  +++ 
Sbjct: 199 DGVFTTYSDVWSFGVVLWEIATLAEQPY-----------------QGLSNEQVLRFVMEG 241
Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            L          L+ L   C    P+ RPS  E++S++
Sbjct: 242 GLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSI 279

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 126/258 (48%), Gaps = 36/258 (13%)
Query: 351 VAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD 402
           VAIK +        RR    E +++ + +H N+I+L G         ++ EFMENGSL  
Sbjct: 38  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 97
Query: 403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLAN 462
           +L ++   +F        +   +A G+ YL    D  YVH+ +++ NIL++ NL  K+++
Sbjct: 98  FL-RQNDGQFTVIQL-VGMLRGIAAGMKYL---ADMNYVHRALAARNILVNSNLVCKVSD 152
Query: 463 FSFVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           F   R  + +++   +  +A+G      + APE ++Y   T   D +++G+V+ E+++  
Sbjct: 153 FGLSR-FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 211
Query: 520 EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD-PNLQANKKEIAHHLIMLCLACIAR 578
           E  Y       +  + V + +E    + +L   +D P+        A H +ML   C  +
Sbjct: 212 ERPYWD-----MTNQDVINAIE---QDYRLPPPMDCPS--------ALHQLML--DCWQK 253
Query: 579 EPESRPSMAEVVSTLMKI 596
           +   RP   ++V+TL K+
Sbjct: 254 DRNHRPKFGQIVNTLDKM 271

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 110/258 (42%), Gaps = 35/258 (13%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH------ 405
           A +  R+   +E  LL  + H +++  FG C       +V+E+M +G L+ +L       
Sbjct: 53  ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 112
Query: 406 ------KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
                 +   P  +       +A  VA G+ YL       +VH+D+++ N L+ + L  K
Sbjct: 113 KLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVK 169
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-G 518
           + +F   R     +      +T +    +M PE + Y   T E D ++FGVVL E+ T G
Sbjct: 170 IGDFGMSRDIYSTDYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFTYG 228
Query: 519 KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAR 578
           K+  Y+         EA+  + +G   E   +    P + A  +            C  R
Sbjct: 229 KQPWYQLSN-----TEAIDCITQGRELERPRA--CPPEVYAIMR-----------GCWQR 270
Query: 579 EPESRPSMAEVVSTLMKI 596
           EP+ R S+ +V + L  +
Sbjct: 271 EPQQRHSIKDVHARLQAL 288

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 45/278 (16%)
Query: 339 GSVFRGIING-------STVAIKC------MRRSIS--KEVNLLKKINHFNLINLFGACE 383
           G V+ G+  G       + VAIK       MR  I    E +++K+ N  +++ L G   
Sbjct: 30  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 89
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEF--------VSWNCRFRIALDVAHGLHYLHNC 435
                 ++ E M  G L  +L   R PE          S +   ++A ++A G+ YL+  
Sbjct: 90  QGQPTLVIMELMTRGDLKSYLRSLR-PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN 148
Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME 495
               +VH+D+++ N ++ ++   K+ +F   R  + E   Y      +    +M+PE ++
Sbjct: 149 K---FVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMSPESLK 204
Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
            G+ T   D ++FGVVL E+ T  E  Y                 +G + E  L  +++ 
Sbjct: 205 DGVFTTYSDVWSFGVVLWEIATLAEQPY-----------------QGLSNEQVLRFVMEG 247
Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            L          L  L   C    P+ RPS  E++S++
Sbjct: 248 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 285

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 45/278 (16%)
Query: 339 GSVFRGIING-------STVAIKC------MRRSIS--KEVNLLKKINHFNLINLFGACE 383
           G V+ G+  G       + VAIK       MR  I    E +++K+ N  +++ L G   
Sbjct: 32  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 91
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEF--------VSWNCRFRIALDVAHGLHYLHNC 435
                 ++ E M  G L  +L   R PE          S +   ++A ++A G+ YL+  
Sbjct: 92  QGQPTLVIMELMTRGDLKSYLRSLR-PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN 150
Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME 495
               +VH+D+++ N ++ ++   K+ +F   R  + E   Y      +    +M+PE ++
Sbjct: 151 K---FVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMSPESLK 206
Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
            G+ T   D ++FGVVL E+ T  E  Y                 +G + E  L  +++ 
Sbjct: 207 DGVFTTYSDVWSFGVVLWEIATLAEQPY-----------------QGLSNEQVLRFVMEG 249
Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            L          L  L   C    P+ RPS  E++S++
Sbjct: 250 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 110/258 (42%), Gaps = 35/258 (13%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH------ 405
           A +  R+   +E  LL  + H +++  FG C       +V+E+M +G L+ +L       
Sbjct: 59  ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 118
Query: 406 ------KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
                 +   P  +       +A  VA G+ YL       +VH+D+++ N L+ + L  K
Sbjct: 119 KLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVK 175
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-G 518
           + +F   R     +      +T +    +M PE + Y   T E D ++FGVVL E+ T G
Sbjct: 176 IGDFGMSRDIYSTDYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFTYG 234
Query: 519 KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAR 578
           K+  Y+         EA+  + +G   E   +    P + A  +            C  R
Sbjct: 235 KQPWYQLSN-----TEAIDCITQGRELERPRA--CPPEVYAIMR-----------GCWQR 276
Query: 579 EPESRPSMAEVVSTLMKI 596
           EP+ R S+ +V + L  +
Sbjct: 277 EPQQRHSIKDVHARLQAL 294

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 110/258 (42%), Gaps = 35/258 (13%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH------ 405
           A +  R+   +E  LL  + H +++  FG C       +V+E+M +G L+ +L       
Sbjct: 82  ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 141
Query: 406 ------KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
                 +   P  +       +A  VA G+ YL       +VH+D+++ N L+ + L  K
Sbjct: 142 KLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVK 198
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-G 518
           + +F   R     +      +T +    +M PE + Y   T E D ++FGVVL E+ T G
Sbjct: 199 IGDFGMSRDIYSTDYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257
Query: 519 KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAR 578
           K+  Y+         EA+  + +G   E   +    P + A  +            C  R
Sbjct: 258 KQPWYQLSN-----TEAIDCITQGRELERPRA--CPPEVYAIMR-----------GCWQR 299
Query: 579 EPESRPSMAEVVSTLMKI 596
           EP+ R S+ +V + L  +
Sbjct: 300 EPQQRHSIKDVHARLQAL 317

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 45/278 (16%)
Query: 339 GSVFRGIING-------STVAIKC------MRRSIS--KEVNLLKKINHFNLINLFGACE 383
           G V+ G+  G       + VAIK       MR  I    E +++K+ N  +++ L G   
Sbjct: 26  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 85
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEF--------VSWNCRFRIALDVAHGLHYLHNC 435
                 ++ E M  G L  +L   R PE          S +   ++A ++A G+ YL+  
Sbjct: 86  QGQPTLVIMELMTRGDLKSYLRSLR-PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN 144
Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME 495
               +VH+D+++ N ++ ++   K+ +F   R  + E   Y      +    +M+PE ++
Sbjct: 145 K---FVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMSPESLK 200
Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
            G+ T   D ++FGVVL E+ T  E  Y                 +G + E  L  +++ 
Sbjct: 201 DGVFTTYSDVWSFGVVLWEIATLAEQPY-----------------QGLSNEQVLRFVMEG 243
Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            L          L  L   C    P+ RPS  E++S++
Sbjct: 244 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 45/278 (16%)
Query: 339 GSVFRGIING-------STVAIKC------MRRSIS--KEVNLLKKINHFNLINLFGACE 383
           G V+ G+  G       + VAIK       MR  I    E +++K+ N  +++ L G   
Sbjct: 32  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 91
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEF--------VSWNCRFRIALDVAHGLHYLHNC 435
                 ++ E M  G L  +L   R PE          S +   ++A ++A G+ YL+  
Sbjct: 92  QGQPTLVIMELMTRGDLKSYLRSLR-PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN 150
Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME 495
               +VH+D+++ N ++ ++   K+ +F   R  + E   Y      +    +M+PE ++
Sbjct: 151 K---FVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMSPESLK 206
Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
            G+ T   D ++FGVVL E+ T  E  Y                 +G + E  L  +++ 
Sbjct: 207 DGVFTTYSDVWSFGVVLWEIATLAEQPY-----------------QGLSNEQVLRFVMEG 249
Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            L          L  L   C    P+ RPS  E++S++
Sbjct: 250 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 45/278 (16%)
Query: 339 GSVFRGIING-------STVAIKC------MRRSIS--KEVNLLKKINHFNLINLFGACE 383
           G V+ G+  G       + VAIK       MR  I    E +++K+ N  +++ L G   
Sbjct: 33  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 92
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEF--------VSWNCRFRIALDVAHGLHYLHNC 435
                 ++ E M  G L  +L   R PE          S +   ++A ++A G+ YL+  
Sbjct: 93  QGQPTLVIMELMTRGDLKSYLRSLR-PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN 151
Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME 495
               +VH+D+++ N ++ ++   K+ +F   R  + E   Y      +    +M+PE ++
Sbjct: 152 K---FVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMSPESLK 207
Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
            G+ T   D ++FGVVL E+ T  E  Y                 +G + E  L  +++ 
Sbjct: 208 DGVFTTYSDVWSFGVVLWEIATLAEQPY-----------------QGLSNEQVLRFVMEG 250
Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            L          L  L   C    P+ RPS  E++S++
Sbjct: 251 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 113/269 (42%), Gaps = 55/269 (20%)
Query: 339 GSVFRGIINGST-VAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+    N  T VA+K M+       +   E N++K + H  L+ L      + + Y++
Sbjct: 196 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YII 254
Query: 392 YEFMENGSLSDWLH-----KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            EFM  GSL D+L      K+  P+ + ++ +      +A G+ ++       Y+H+D+ 
Sbjct: 255 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRN---YIHRDLR 305
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + NIL+  +L  K+A+F   R   +    ++            APE + +G  T + D +
Sbjct: 306 AANILVSASLVCKIADFGLARVGAKFPIKWT------------APEAINFGSFTIKSDVW 353
Query: 507 AFGVVLLELITGKEAAYK--QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
           +FG++L+E++T     Y    + E I   E  + M    N                    
Sbjct: 354 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC------------------- 394
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              L  + + C    PE RP+   + S L
Sbjct: 395 PEELYNIMMRCWKNRPEERPTFEYIQSVL 423

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 45/278 (16%)
Query: 339 GSVFRGIING-------STVAIKC------MRRSIS--KEVNLLKKINHFNLINLFGACE 383
           G V+ G+  G       + VAIK       MR  I    E +++K+ N  +++ L G   
Sbjct: 61  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 120
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEF--------VSWNCRFRIALDVAHGLHYLHNC 435
                 ++ E M  G L  +L   R PE          S +   ++A ++A G+ YL+  
Sbjct: 121 QGQPTLVIMELMTRGDLKSYLRSLR-PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN 179
Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME 495
               +VH+D+++ N ++ ++   K+ +F   R  + E   Y      +    +M+PE ++
Sbjct: 180 K---FVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMSPESLK 235
Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
            G+ T   D ++FGVVL E+ T  E  Y                 +G + E  L  +++ 
Sbjct: 236 DGVFTTYSDVWSFGVVLWEIATLAEQPY-----------------QGLSNEQVLRFVMEG 278
Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            L          L  L   C    P+ RPS  E++S++
Sbjct: 279 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 316

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 12/188 (6%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           ++  +T+ ++   R+   E ++L ++NH  ++ L  A + +G  YL+ +F+  G L   L
Sbjct: 59  VLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL 117
Query: 405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS 464
            K+    F   + +F +A ++A  L +LH+    G +++D+   NILLD+    KL +F 
Sbjct: 118 SKEVM--FTEEDVKFYLA-ELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFG 171
Query: 465 FVRSAV-REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAY 523
             + ++  E+  YS      GT  YMAPE +     T   D ++FGV++ E++TG     
Sbjct: 172 LSKESIDHEKKAYS----FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227
Query: 524 KQDGEEIL 531
            +D +E +
Sbjct: 228 GKDRKETM 235

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 117/278 (42%), Gaps = 45/278 (16%)
Query: 339 GSVFRGIING-------STVAIKC------MRRSIS--KEVNLLKKINHFNLINLFGACE 383
           G V+ G+  G       + VAIK       MR  I    E +++K+ N  +++ L G   
Sbjct: 33  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 92
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEF--------VSWNCRFRIALDVAHGLHYLHNC 435
                 ++ E M  G L  +L   R PE          S +   ++A ++A G+ YL+  
Sbjct: 93  QGQPTLVIMELMTRGDLKSYLRSLR-PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN 151
Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME 495
               +VH+D+++ N ++ ++   K+ +F   R     +      K  +    +M+PE ++
Sbjct: 152 K---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMSPESLK 207
Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
            G+ T   D ++FGVVL E+ T  E  Y                 +G + E  L  +++ 
Sbjct: 208 DGVFTTYSDVWSFGVVLWEIATLAEQPY-----------------QGLSNEQVLRFVMEG 250
Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            L          L  L   C    P+ RPS  E++S++
Sbjct: 251 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 45/278 (16%)
Query: 339 GSVFRGIING-------STVAIKC------MRRSIS--KEVNLLKKINHFNLINLFGACE 383
           G V+ G+  G       + VAIK       MR  I    E +++K+ N  +++ L G   
Sbjct: 26  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 85
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEF--------VSWNCRFRIALDVAHGLHYLHNC 435
                 ++ E M  G L  +L   R PE          S +   ++A ++A G+ YL+  
Sbjct: 86  QGQPTLVIMELMTRGDLKSYLRSLR-PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN 144
Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME 495
               +VH+D+++ N  + ++   K+ +F   R  + E   Y      +    +M+PE ++
Sbjct: 145 K---FVHRDLAARNCXVAEDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMSPESLK 200
Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
            G+ T   D ++FGVVL E+ T  E  Y                 +G + E  L  +++ 
Sbjct: 201 DGVFTTYSDVWSFGVVLWEIATLAEQPY-----------------QGLSNEQVLRFVMEG 243
Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            L          L+ L   C    P+ RPS  E++S++
Sbjct: 244 GLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 19/197 (9%)
Query: 349 STVAIKCMRRSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK 407
           S   ++ +R +  KEV++L+K++ H N+I L    E +  F+LV++ M+ G L D+L +K
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK 118
Query: 408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR 467
                       R  L+V   LH L+       VH+D+   NILLD ++  KL +F F  
Sbjct: 119 VTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF-- 170
Query: 468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGL------VTPEMDTYAFGVVLLELITGKEA 521
            + + + G    ++  GT  Y+APE +E  +         E+D ++ GV++  L+ G   
Sbjct: 171 -SCQLDPG-EKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
Query: 522 AYKQDGEEILLAEAVFS 538
            + +  +++L+   + S
Sbjct: 229 FWHR--KQMLMLRMIMS 243

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 343 RGIINGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R I+ G  VAIK + ++         + +EV ++K +NH N++ LF   E +   YL+ E
Sbjct: 35  RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
           +   G + D+L      +      +FR    +   + Y   C     VH+D+ + N+LLD
Sbjct: 95  YASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQY---CHQKRIVHRDLKAENLLLD 148
Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME-YGLVTPEMDTYAFGVVL 512
            ++  K+A+F F      E +         G   Y APE  +      PE+D ++ GV+L
Sbjct: 149 ADMNIKIADFGF----SNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204
Query: 513 LELITG 518
             L++G
Sbjct: 205 YTLVSG 210

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 89/187 (47%), Gaps = 22/187 (11%)
Query: 343 RGIINGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R I+ G  VA+K + ++         + +EV ++K +NH N++ LF   E +   YLV E
Sbjct: 34  RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 93
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
           +   G + D+L      +      +FR    +   + Y   C     VH+D+ + N+LLD
Sbjct: 94  YASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQY---CHQKFIVHRDLKAENLLLD 147
Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAV-GTNGYMAPEYME-YGLVTPEMDTYAFGVV 511
            ++  K+A+F F       E  + +   A  G   Y APE  +      PE+D ++ GV+
Sbjct: 148 ADMNIKIADFGF-----SNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVI 202
Query: 512 LLELITG 518
           L  L++G
Sbjct: 203 LYTLVSG 209

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 12/188 (6%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           ++  +T+ ++   R+   E ++L ++NH  ++ L  A + +G  YL+ +F+  G L   L
Sbjct: 59  VLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL 117
Query: 405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS 464
            K+    F   + +F +A ++A  L +LH+    G +++D+   NILLD+    KL +F 
Sbjct: 118 SKEVM--FTEEDVKFYLA-ELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFG 171
Query: 465 FVRSAV-REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAY 523
             + ++  E+  YS      GT  YMAPE +     T   D ++FGV++ E++TG     
Sbjct: 172 LSKESIDHEKKAYS----FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227
Query: 524 KQDGEEIL 531
            +D +E +
Sbjct: 228 GKDRKETM 235

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 12/188 (6%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           ++  +T+ ++   R+   E ++L ++NH  ++ L  A + +G  YL+ +F+  G L   L
Sbjct: 60  VLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL 118
Query: 405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS 464
            K+    F   + +F +A ++A  L +LH+    G +++D+   NILLD+    KL +F 
Sbjct: 119 SKEVM--FTEEDVKFYLA-ELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFG 172
Query: 465 FVRSAV-REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAY 523
             + ++  E+  YS      GT  YMAPE +     T   D ++FGV++ E++TG     
Sbjct: 173 LSKESIDHEKKAYS----FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 228
Query: 524 KQDGEEIL 531
            +D +E +
Sbjct: 229 GKDRKETM 236

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 118/264 (44%), Gaps = 38/264 (14%)
Query: 357 RRSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP----- 410
           + ++  E+ ++  +  H N++NL GAC H G   ++ E+   G L ++L +KR P     
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYS 152
Query: 411 --------EFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDISSGNILLDKNLRAKL 460
                   E +S       +  VA G+ +L   NC     +H+D+++ N+LL     AK+
Sbjct: 153 YNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKI 207
Query: 461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE 520
            +F   R  +  +S Y     A     +MAPE +   + T + D +++G++L E+ +   
Sbjct: 208 GDFGLARD-IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 266
Query: 521 AAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREP 580
             Y      IL+    + +V+ G   A+ +                ++  +  AC A EP
Sbjct: 267 NPYPG----ILVNSKFYKLVKDGYQMAQPAF------------APKNIYSIMQACWALEP 310
Query: 581 ESRPSMAEVVSTLMKIQLDVQRSQ 604
             RP+  ++ S L +   + +R +
Sbjct: 311 THRPTFQQICSFLQEQAQEDRRER 334

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 19/197 (9%)
Query: 349 STVAIKCMRRSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK 407
           S   ++ +R +  KEV++L+K++ H N+I L    E +  F+LV++ M+ G L D+L +K
Sbjct: 46  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK 105
Query: 408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR 467
                       R  L+V   LH L+       VH+D+   NILLD ++  KL +F F  
Sbjct: 106 VTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF-- 157
Query: 468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGL------VTPEMDTYAFGVVLLELITGKEA 521
            + + + G    +   GT  Y+APE +E  +         E+D ++ GV++  L+ G   
Sbjct: 158 -SCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215
Query: 522 AYKQDGEEILLAEAVFS 538
            + +  +++L+   + S
Sbjct: 216 FWHR--KQMLMLRMIMS 230

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 117/278 (42%), Gaps = 45/278 (16%)
Query: 339 GSVFRGIING-------STVAIKC------MRRSIS--KEVNLLKKINHFNLINLFGACE 383
           G V+ G+  G       + VAIK       MR  I    E +++K+ N  +++ L G   
Sbjct: 39  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFV--------SWNCRFRIALDVAHGLHYLHNC 435
                 ++ E M  G L  +L   R P           S +   ++A ++A G+ YL+  
Sbjct: 99  QGQPTLVIMELMTRGDLKSYLRSLR-PAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN 157
Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME 495
               +VH+D+++ N ++ ++   K+ +F   R  + E   Y      +    +M+PE ++
Sbjct: 158 K---FVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMSPESLK 213
Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
            G+ T   D ++FGVVL E+ T  E  Y                 +G + E  L  +++ 
Sbjct: 214 DGVFTTYSDVWSFGVVLWEIATLAEQPY-----------------QGLSNEQVLRFVMEG 256
Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            L          L  L   C    P+ RPS  E++S++
Sbjct: 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 116/257 (45%), Gaps = 36/257 (14%)
Query: 354 KCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFV 413
           K +++   +E+ LLK++ H NL+NL   C+    +YLV+EF+++  L D    + +P  +
Sbjct: 65  KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL---ELFPNGL 121
Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
            +    +    + +G+ +   C     +H+DI   NIL+ ++   KL +F F R+     
Sbjct: 122 DYQVVQKYLFQIINGIGF---CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178
Query: 474 SGYSSTKTAVGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE 529
             Y      V T  Y APE +    +YG     +D +A G ++ E+  G E  +  D + 
Sbjct: 179 EVYDDE---VATRWYRAPELLVGDVKYG---KAVDVWAIGCLVTEMFMG-EPLFPGDSD- 230
Query: 530 ILLAEAVFSMVEGGNAEAKLSVLVDPN----------------LQANKKEIAHHLIMLCL 573
             + +    M+  GN   +   L + N                L+    +++  +I L  
Sbjct: 231 --IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAK 288
Query: 574 ACIAREPESRPSMAEVV 590
            C+  +P+ RP  AE++
Sbjct: 289 KCLHIDPDKRPFCAELL 305

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 121/263 (46%), Gaps = 39/263 (14%)
Query: 350 TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGAC-EHDGVFYLVYEFMENGS 399
           TVA+K ++        R++  E+ +L  I +H N++NL GAC +  G   ++ EF + G+
Sbjct: 59  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118
Query: 400 LSDWLHKKR---------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           LS +L  KR         Y +F++       +  VA G+ +L +      +H+D+++ NI
Sbjct: 119 LSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRK---XIHRDLAARNI 175
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           LL +    K+ +F   R  + ++  Y     A     +MAPE +   + T + D ++FGV
Sbjct: 176 LLSEKNVVKIXDFGLARD-IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 234
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM 570
           +L E+ +   + Y   G +I   E    + EG    A       P+    +      +  
Sbjct: 235 LLWEIFSLGASPYP--GVKI-DEEFXRRLKEGTRMRA-------PDYTTPE------MYQ 278
Query: 571 LCLACIAREPESRPSMAEVVSTL 593
             L C   EP  RP+ +E+V  L
Sbjct: 279 TMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 120/294 (40%), Gaps = 50/294 (17%)
Query: 321 YEDLVVATENFSPKNMIDGSVFRGII--NGSTVAIKCMRRSIS--------KEVNLLKKI 370
           +EDLV+  E     N   G VF G +  + + VA+K  R ++         +E  +LK+ 
Sbjct: 113 HEDLVLG-EQIGRGNF--GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169
Query: 371 NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIAL------D 424
           +H N++ L G C      Y+V E ++ G    +L  +          R R+        D
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--------GARLRVKTLLQMVGD 221
Query: 425 VAHGLHYLHN-CTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV 483
            A G+ YL + C     +H+D+++ N L+ +    K+++F   R         S     V
Sbjct: 222 AAAGMEYLESKCC----IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQV 277
Query: 484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGG 543
               + APE + YG  + E D ++FG++L E  +   + Y       L  +     VE G
Sbjct: 278 PVK-WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN-----LSNQQTREFVEKG 331
Query: 544 NAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
                   L  P L  +       +  L   C A EP  RPS + +   L  I+
Sbjct: 332 GR------LPCPELCPDA------VFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 25/203 (12%)
Query: 351 VAIKCMRR--------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD 402
           VAIKC+ +        S+  E+ +L KI H N++ L    E  G  YL+ + +  G L D
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL---LDKNLRAK 459
            + +K    F +     R+   V   + YLH   D G VH+D+   N+L   LD++ +  
Sbjct: 106 RIVEKG---FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +++F   +    E+ G S   TA GT GY+APE +     +  +D ++ GV+   L+ G 
Sbjct: 160 ISDFGLSK---MEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215
Query: 520 EAAYKQDG----EEILLAEAVFS 538
              Y ++     E+IL AE  F 
Sbjct: 216 PPFYDENDAKLFEQILKAEYEFD 238

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 117/278 (42%), Gaps = 45/278 (16%)
Query: 339 GSVFRGIING-------STVAIKC------MRRSIS--KEVNLLKKINHFNLINLFGACE 383
           G V+ G+  G       + VAIK       MR  I    E +++K+ N  +++ L G   
Sbjct: 29  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 88
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFV--------SWNCRFRIALDVAHGLHYLHNC 435
                 ++ E M  G L  +L   R P           S +   ++A ++A G+ YL+  
Sbjct: 89  QGQPTLVIMELMTRGDLKSYLRSLR-PAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN 147
Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME 495
               +VH+D+++ N ++ ++   K+ +F   R  + E   Y      +    +M+PE ++
Sbjct: 148 K---FVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMSPESLK 203
Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
            G+ T   D ++FGVVL E+ T  E  Y                 +G + E  L  +++ 
Sbjct: 204 DGVFTTYSDVWSFGVVLWEIATLAEQPY-----------------QGLSNEQVLRFVMEG 246
Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            L          L  L   C    P+ RPS  E++S++
Sbjct: 247 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 284

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 19/197 (9%)
Query: 349 STVAIKCMRRSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK 407
           S   ++ +R +  KEV++L+K++ H N+I L    E +  F+LV++ M+ G L D+L +K
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK 118
Query: 408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR 467
                       R  L+V   LH L+       VH+D+   NILLD ++  KL +F F  
Sbjct: 119 VTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF-- 170
Query: 468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGL------VTPEMDTYAFGVVLLELITGKEA 521
            + + + G    +   GT  Y+APE +E  +         E+D ++ GV++  L+ G   
Sbjct: 171 -SCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
Query: 522 AYKQDGEEILLAEAVFS 538
            + +  +++L+   + S
Sbjct: 229 FWHR--KQMLMLRMIMS 243

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 25/202 (12%)
Query: 351 VAIKCMRR--------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD 402
           VAIKC+ +        S+  E+ +L KI H N++ L    E  G  YL+ + +  G L D
Sbjct: 46  VAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL---LDKNLRAK 459
            + +K    F +     R+   V   + YLH   D G VH+D+   N+L   LD++ +  
Sbjct: 106 RIVEKG---FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +++F   +    E+ G S   TA GT GY+APE +     +  +D ++ GV+   L+ G 
Sbjct: 160 ISDFGLSK---MEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215
Query: 520 EAAYKQDG----EEILLAEAVF 537
              Y ++     E+IL AE  F
Sbjct: 216 PPFYDENDAKLFEQILKAEYEF 237

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 20/186 (10%)
Query: 343 RGIINGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R I+ G  VA++ + ++         + +EV ++K +NH N++ LF   E +   YLV E
Sbjct: 34  RHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVME 93
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
           +   G + D+L      +      +FR    +   + Y   C     VH+D+ + N+LLD
Sbjct: 94  YASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQY---CHQKFIVHRDLKAENLLLD 147
Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME-YGLVTPEMDTYAFGVVL 512
            ++  K+A+F F      E +  +      G+  Y APE  +      PE+D ++ GV+L
Sbjct: 148 ADMNIKIADFGF----SNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 513 LELITG 518
             L++G
Sbjct: 204 YTLVSG 209

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 89/176 (50%), Gaps = 12/176 (6%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD-W 403
           +I+   V  K  + S+ +EV LLK+++H N++ L+   E  G FYLV E    G L D  
Sbjct: 58  VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI 117
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF 463
           + +KR+ E  +     RI   V  G+ Y+H       VH+D+   N+LL+   ++K AN 
Sbjct: 118 ISRKRFSEVDA----ARIIRQVLSGITYMHKNK---IVHRDLKPENLLLES--KSKDANI 168
Query: 464 SFVRSAVREE-SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
             +   +          K  +GT  Y+APE + +G    + D ++ GV+L  L++G
Sbjct: 169 RIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 223

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 25/202 (12%)
Query: 351 VAIKCMRR--------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD 402
           VAIKC+ +        S+  E+ +L KI H N++ L    E  G  YL+ + +  G L D
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL---LDKNLRAK 459
            + +K    F +     R+   V   + YLH   D G VH+D+   N+L   LD++ +  
Sbjct: 106 RIVEKG---FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +++F   +    E+ G S   TA GT GY+APE +     +  +D ++ GV+   L+ G 
Sbjct: 160 ISDFGLSK---MEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215
Query: 520 EAAYKQDG----EEILLAEAVF 537
              Y ++     E+IL AE  F
Sbjct: 216 PPFYDENDAKLFEQILKAEYEF 237

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 25/202 (12%)
Query: 351 VAIKCMRR--------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD 402
           VAIKC+ +        S+  E+ +L KI H N++ L    E  G  YL+ + +  G L D
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL---LDKNLRAK 459
            + +K    F +     R+   V   + YLH   D G VH+D+   N+L   LD++ +  
Sbjct: 106 RIVEKG---FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +++F   +    E+ G S   TA GT GY+APE +     +  +D ++ GV+   L+ G 
Sbjct: 160 ISDFGLSK---MEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215
Query: 520 EAAYKQDG----EEILLAEAVF 537
              Y ++     E+IL AE  F
Sbjct: 216 PPFYDENDAKLFEQILKAEYEF 237

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 90/176 (51%), Gaps = 12/176 (6%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD-W 403
           +I+   V  K  + S+ +EV LLK+++H N++ L+   E  G FYLV E    G L D  
Sbjct: 81  VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI 140
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD-KNLRAKLAN 462
           + +KR+ E  +     RI   V  G+ Y+H       VH+D+   N+LL+ K+  A +  
Sbjct: 141 ISRKRFSEVDA----ARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRI 193
Query: 463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
             F  S   E S     K  +GT  Y+APE + +G    + D ++ GV+L  L++G
Sbjct: 194 IDFGLSTHFEAS--KKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 90/176 (51%), Gaps = 12/176 (6%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD-W 403
           +I+   V  K  + S+ +EV LLK+++H N++ L+   E  G FYLV E    G L D  
Sbjct: 82  VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI 141
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD-KNLRAKLAN 462
           + +KR+ E  +     RI   V  G+ Y+H       VH+D+   N+LL+ K+  A +  
Sbjct: 142 ISRKRFSEVDA----ARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRI 194
Query: 463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
             F  S   E S     K  +GT  Y+APE + +G    + D ++ GV+L  L++G
Sbjct: 195 IDFGLSTHFEAS--KKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 247

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 134/304 (44%), Gaps = 61/304 (20%)
Query: 316 LKFYKYEDLVVATENFSPKNMIDGSVFRGIING-----STVAIKCM--------RRSISK 362
           + + K E+++ A E         G V RG +       S VAIK +        RR    
Sbjct: 15  VSYVKIEEVIGAGEF--------GEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLS 66
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           E +++ +  H N+I L G   +     ++ EFMENG+L  +L           + +F + 
Sbjct: 67  EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLN--------DGQFTVI 118
Query: 423 ------LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                   +A G+ YL   +   YVH+D+++ NIL++ NL  K+++F   R  + E S  
Sbjct: 119 QLVGMLRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSR-FLEENSSD 174
Query: 477 SSTKTAVGTN---GYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILL 532
            +  +++G      + APE + +   T   D +++G+V+ E+++ G+   +    ++++ 
Sbjct: 175 PTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVI- 233
Query: 533 AEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST 592
                      NA  +   L  P       +    L  L L C  ++  +RP   +VVS 
Sbjct: 234 -----------NAIEQDYRLPPP------PDCPTSLHQLMLDCWQKDRNARPRFPQVVSA 276
Query: 593 LMKI 596
           L K+
Sbjct: 277 LDKM 280

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 120/294 (40%), Gaps = 50/294 (17%)
Query: 321 YEDLVVATENFSPKNMIDGSVFRGII--NGSTVAIKCMRRSIS--------KEVNLLKKI 370
           +EDLV+  E     N   G VF G +  + + VA+K  R ++         +E  +LK+ 
Sbjct: 113 HEDLVLG-EQIGRGNF--GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169
Query: 371 NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIAL------D 424
           +H N++ L G C      Y+V E ++ G    +L  +          R R+        D
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--------GARLRVKTLLQMVGD 221
Query: 425 VAHGLHYLHN-CTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV 483
            A G+ YL + C     +H+D+++ N L+ +    K+++F   R         S     V
Sbjct: 222 AAAGMEYLESKCC----IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV 277
Query: 484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGG 543
               + APE + YG  + E D ++FG++L E  +   + Y       L  +     VE G
Sbjct: 278 PVK-WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN-----LSNQQTREFVEKG 331
Query: 544 NAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
                   L  P L  +       +  L   C A EP  RPS + +   L  I+
Sbjct: 332 GR------LPCPELCPDA------VFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 90/176 (51%), Gaps = 12/176 (6%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD-W 403
           +I+   V  K  + S+ +EV LLK+++H N++ L+   E  G FYLV E    G L D  
Sbjct: 64  VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI 123
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD-KNLRAKLAN 462
           + +KR+ E  +     RI   V  G+ Y+H       VH+D+   N+LL+ K+  A +  
Sbjct: 124 ISRKRFSEVDA----ARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRI 176
Query: 463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
             F  S   E S     K  +GT  Y+APE + +G    + D ++ GV+L  L++G
Sbjct: 177 IDFGLSTHFEAS--KKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 229

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 17/195 (8%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK-KRYPEFV 413
            +R  I +E+ +L + N   ++  +GA   DG   +  E M+ GSL   L + KR PE +
Sbjct: 56  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI 115
Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
                 ++++ V  GL YL        +H+D+   NIL++     KL +F      +   
Sbjct: 116 LG----KVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 167
Query: 474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA 533
              S   + VGT  YMAPE ++    + + D ++ G+ L+EL  G+      D +E+   
Sbjct: 168 ---SMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKEL--- 221
Query: 534 EAVFS--MVEGGNAE 546
           EA+F   +V+G   E
Sbjct: 222 EAIFGRPVVDGEEGE 236

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 134/304 (44%), Gaps = 61/304 (20%)
Query: 316 LKFYKYEDLVVATENFSPKNMIDGSVFRGIING-----STVAIKCM--------RRSISK 362
           + + K E+++ A E         G V RG +       S VAIK +        RR    
Sbjct: 13  VSYVKIEEVIGAGEF--------GEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLS 64
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           E +++ +  H N+I L G   +     ++ EFMENG+L  +L           + +F + 
Sbjct: 65  EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLN--------DGQFTVI 116
Query: 423 ------LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                   +A G+ YL   +   YVH+D+++ NIL++ NL  K+++F   R  + E S  
Sbjct: 117 QLVGMLRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSR-FLEENSSD 172
Query: 477 SSTKTAVGTN---GYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILL 532
            +  +++G      + APE + +   T   D +++G+V+ E+++ G+   +    ++++ 
Sbjct: 173 PTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVI- 231
Query: 533 AEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST 592
                      NA  +   L  P       +    L  L L C  ++  +RP   +VVS 
Sbjct: 232 -----------NAIEQDYRLPPP------PDCPTSLHQLMLDCWQKDRNARPRFPQVVSA 274
Query: 593 LMKI 596
           L K+
Sbjct: 275 LDKM 278

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 121/263 (46%), Gaps = 39/263 (14%)
Query: 350 TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGAC-EHDGVFYLVYEFMENGS 399
           TVA+K ++        R++  E+ +L  I +H N++NL GAC +  G   ++ EF + G+
Sbjct: 59  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118
Query: 400 LSDWLHKKR---------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           LS +L  KR         Y +F++       +  VA G+ +L +      +H+D+++ NI
Sbjct: 119 LSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRK---XIHRDLAARNI 175
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           LL +    K+ +F   R  + ++  Y     A     +MAPE +   + T + D ++FGV
Sbjct: 176 LLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 234
Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM 570
           +L E+ +   + Y   G +I   E    + EG    A       P+    +      +  
Sbjct: 235 LLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE------MYQ 278
Query: 571 LCLACIAREPESRPSMAEVVSTL 593
             L C   EP  RP+ +E+V  L
Sbjct: 279 TMLDCWHGEPSQRPTFSELVEHL 301

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 117/270 (43%), Gaps = 33/270 (12%)
Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V++G  +G  VA+K +          ++   EV +L+K  H N++ LF          
Sbjct: 38  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLA 95
Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           +V ++ E  SL   LH               IA   A G+ YLH  +    +H+D+ S N
Sbjct: 96  IVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNN 150
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP---EMDTY 506
           I L ++   K+ +F       R  SG    +   G+  +MAPE +      P   + D Y
Sbjct: 151 IFLHEDNTVKIGDFGLATEKSRW-SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVY 209
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           AFG+VL EL+TG +  Y      I   + +  MV  G+        + P+L   +     
Sbjct: 210 AFGIVLYELMTG-QLPY----SNINNRDQIIEMVGRGS--------LSPDLSKVRSNCPK 256
Query: 567 HLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            +  L   C+ ++ + RPS   +++ + ++
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 87/187 (46%), Gaps = 22/187 (11%)
Query: 343 RGIINGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R I+ G  VA+K + ++         + +EV + K +NH N++ LF   E +   YLV E
Sbjct: 34  RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXE 93
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
           +   G + D+L      +      +FR    +   + Y   C     VH+D+ + N+LLD
Sbjct: 94  YASGGEVFDYLVAHGRXKEKEARAKFR---QIVSAVQY---CHQKFIVHRDLKAENLLLD 147
Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAV-GTNGYMAPEYME-YGLVTPEMDTYAFGVV 511
            +   K+A+F F       E  + +   A  G   Y APE  +      PE+D ++ GV+
Sbjct: 148 ADXNIKIADFGF-----SNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVI 202
Query: 512 LLELITG 518
           L  L++G
Sbjct: 203 LYTLVSG 209

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 117/270 (43%), Gaps = 33/270 (12%)
Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V++G  +G  VA+K +          ++   EV +L+K  H N++ LF          
Sbjct: 26  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLA 83
Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           +V ++ E  SL   LH               IA   A G+ YLH  +    +H+D+ S N
Sbjct: 84  IVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNN 138
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP---EMDTY 506
           I L ++   K+ +F       R  SG    +   G+  +MAPE +      P   + D Y
Sbjct: 139 IFLHEDNTVKIGDFGLATVKSRW-SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVY 197
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           AFG+VL EL+TG +  Y      I   + +  MV  G+        + P+L   +     
Sbjct: 198 AFGIVLYELMTG-QLPY----SNINNRDQIIEMVGRGS--------LSPDLSKVRSNCPK 244
Query: 567 HLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            +  L   C+ ++ + RPS   +++ + ++
Sbjct: 245 RMKRLMAECLKKKRDERPSFPRILAEIEEL 274

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 116/259 (44%), Gaps = 34/259 (13%)
Query: 350 TVAIKCMRRSI----------SKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +VA+KC++  +           +EVN +  ++H NLI L+G      +  +V E    GS
Sbjct: 42  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGS 100
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           L D L K +    +    R+  A+ VA G+ YL +     ++H+D+++ N+LL      K
Sbjct: 101 LLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVK 155
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-G 518
           + +F  +R+  + +  Y   +       + APE ++    +   DT+ FGV L E+ T G
Sbjct: 156 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 215
Query: 519 KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAR 578
           +E     +G +IL              + +   L  P      ++    +  + + C A 
Sbjct: 216 QEPWIGLNGSQIL-----------HKIDKEGERLPRP------EDCPQDIYNVMVQCWAH 258
Query: 579 EPESRPSMAEVVSTLMKIQ 597
           +PE RP+   +   L++ Q
Sbjct: 259 KPEDRPTFVALRDFLLEAQ 277

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 37/269 (13%)
Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V++G  +G  VA+K +          ++   EV +L+K  H N++ LF          
Sbjct: 42  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLA 99
Query: 390 LVYEFMENGSLSDWLH--KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +V ++ E  SL   LH  + ++ E +       IA   A G+ YLH  +    +H+D+ S
Sbjct: 100 IVTQWCEGSSLYHHLHIIETKF-EMIKL---IDIARQTAQGMDYLHAKS---IIHRDLKS 152
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP---EMD 504
            NI L ++L  K+ +F       R  SG    +   G+  +MAPE +      P   + D
Sbjct: 153 NNIFLHEDLTVKIGDFGLATEKSRW-SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 211
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            YAFG+VL EL+TG+      +  +    + +F +  G          + P+L   +   
Sbjct: 212 VYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRG---------YLSPDLSKVRSNC 258
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +  L   C+ ++ + RP   ++++++
Sbjct: 259 PKAMKRLMAECLKKKRDERPLFPQILASI 287

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 32/202 (15%)
Query: 339 GSVFRGIINGSTVAIKCM----RRSISKEVNLLKKI--NHFNLINLFGACEHD-GVF--- 388
           G V+RG   G  VA+K       RS  +E  + + +   H N++    A   D G +   
Sbjct: 43  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 102
Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH-----NCTDPGYVHK 443
           +LV ++ E+GSL D+L+  RY   V+     ++AL  A GL +LH         P   H+
Sbjct: 103 WLVSDYHEHGSLFDYLN--RYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 158
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA----VGTNGYMAPEY------ 493
           D+ S NIL+ KN    +A+      AVR +S   +   A    VGT  YMAPE       
Sbjct: 159 DLKSKNILVKKNGTCCIADLGL---AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 215
Query: 494 MEYGLVTPEMDTYAFGVVLLEL 515
           M++       D YA G+V  E+
Sbjct: 216 MKHFESFKRADIYAMGLVFWEI 237

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 32/202 (15%)
Query: 339 GSVFRGIINGSTVAIKCM----RRSISKEVNLLKKI--NHFNLINLFGACEHD-GVF--- 388
           G V+RG   G  VA+K       RS  +E  + + +   H N++    A   D G +   
Sbjct: 56  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115
Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH-----NCTDPGYVHK 443
           +LV ++ E+GSL D+L+  RY   V+     ++AL  A GL +LH         P   H+
Sbjct: 116 WLVSDYHEHGSLFDYLN--RYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA----VGTNGYMAPEY------ 493
           D+ S NIL+ KN    +A+      AVR +S   +   A    VGT  YMAPE       
Sbjct: 172 DLKSKNILVKKNGTCCIADLGL---AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 228
Query: 494 MEYGLVTPEMDTYAFGVVLLEL 515
           M++       D YA G+V  E+
Sbjct: 229 MKHFESFKRADIYAMGLVFWEI 250

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 42/234 (17%)
Query: 320 KYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLI--- 376
           +YE +V        K   D  V + I  G+   ++ +R   S++V  +K ++ F +I   
Sbjct: 59  RYEKIVKKIRGLQMKAE-DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRS 117
Query: 377 ---------------------NLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVS- 414
                                 LF A + D   Y+V E+M  G L + +     PE  + 
Sbjct: 118 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK 177
Query: 415 -WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
            +     +ALD  H +         G +H+D+   N+LLDK+   KLA+F        +E
Sbjct: 178 FYTAEVVLALDAIHSM---------GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DE 226
Query: 474 SGYSSTKTAVGTNGYMAPEYMEY----GLVTPEMDTYAFGVVLLELITGKEAAY 523
           +G     TAVGT  Y++PE ++     G    E D ++ GV L E++ G    Y
Sbjct: 227 TGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 280

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 117/270 (43%), Gaps = 33/270 (12%)
Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V++G  +G  VA+K +          ++   EV +L+K  H N++ LF          
Sbjct: 38  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTAPQLA 95
Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           +V ++ E  SL   LH               IA   A G+ YLH  +    +H+D+ S N
Sbjct: 96  IVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNN 150
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP---EMDTY 506
           I L ++   K+ +F       R  SG    +   G+  +MAPE +      P   + D Y
Sbjct: 151 IFLHEDNTVKIGDFGLATEKSRW-SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVY 209
Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           AFG+VL EL+TG +  Y      I   + +  MV  G+        + P+L   +     
Sbjct: 210 AFGIVLYELMTG-QLPY----SNINNRDQIIEMVGRGS--------LSPDLSKVRSNCPK 256
Query: 567 HLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            +  L   C+ ++ + RPS   +++ + ++
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 37/269 (13%)
Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V++G  +G  VA+K +          ++   EV +L+K  H N++ LF          
Sbjct: 50  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLA 107
Query: 390 LVYEFMENGSLSDWLH--KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +V ++ E  SL   LH  + ++ E +       IA   A G+ YLH  +    +H+D+ S
Sbjct: 108 IVTQWCEGSSLYHHLHIIETKF-EMIKL---IDIARQTAQGMDYLHAKS---IIHRDLKS 160
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP---EMD 504
            NI L ++L  K+ +F       R  SG    +   G+  +MAPE +      P   + D
Sbjct: 161 NNIFLHEDLTVKIGDFGLATEKSRW-SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 219
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            YAFG+VL EL+TG+      +  +    + +F +  G          + P+L   +   
Sbjct: 220 VYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRG---------YLSPDLSKVRSNC 266
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +  L   C+ ++ + RP   ++++++
Sbjct: 267 PKAMKRLMAECLKKKRDERPLFPQILASI 295

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 32/202 (15%)
Query: 339 GSVFRGIINGSTVAIKCM----RRSISKEVNLLKKI--NHFNLINLFGACEHD-GVF--- 388
           G V+RG   G  VA+K       RS  +E  + + +   H N++    A   D G +   
Sbjct: 17  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76
Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH-----NCTDPGYVHK 443
           +LV ++ E+GSL D+L+  RY   V+     ++AL  A GL +LH         P   H+
Sbjct: 77  WLVSDYHEHGSLFDYLN--RYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA----VGTNGYMAPEY------ 493
           D+ S NIL+ KN    +A+      AVR +S   +   A    VGT  YMAPE       
Sbjct: 133 DLKSKNILVKKNGTCCIADLGL---AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 189
Query: 494 MEYGLVTPEMDTYAFGVVLLEL 515
           M++       D YA G+V  E+
Sbjct: 190 MKHFESFKRADIYAMGLVFWEI 211

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 37/269 (13%)
Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V++G  +G  VA+K +          ++   EV +L+K  H N++ LF          
Sbjct: 22  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLA 79
Query: 390 LVYEFMENGSLSDWLH--KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +V ++ E  SL   LH  + ++ E +       IA   A G+ YLH  +    +H+D+ S
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKF-EMIK---LIDIARQTAQGMDYLHAKS---IIHRDLKS 132
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP---EMD 504
            NI L ++L  K+ +F       R  SG    +   G+  +MAPE +      P   + D
Sbjct: 133 NNIFLHEDLTVKIGDFGLATEKSRW-SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            YAFG+VL EL+TG+      +  +    + +F +  G          + P+L   +   
Sbjct: 192 VYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRG---------YLSPDLSKVRSNC 238
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +  L   C+ ++ + RP   ++++++
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASI 267

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 116/235 (49%), Gaps = 30/235 (12%)
Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRI 421
           +E   + K++H  L+  +G C  +   Y+V E++ NG L ++L  + + + +  +    +
Sbjct: 52  QEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEM 109
Query: 422 ALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
             DV  G+ +L +     ++H+D+++ N L+D++L  K+++F   R  + ++  Y S+  
Sbjct: 110 CYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ--YVSS-- 162
Query: 482 AVGTN---GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFS 538
            VGT     + APE   Y   + + D +AFG+++ E+ +  +  Y    +    +E V  
Sbjct: 163 -VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY----DLYTNSEVVLK 217
Query: 539 MVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
           + +G         L  P+L ++       +  +  +C    PE RP+  +++S++
Sbjct: 218 VSQGHR-------LYRPHLASDT------IYQIMYSCWHELPEKRPTFQQLLSSI 259

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 123/295 (41%), Gaps = 53/295 (17%)
Query: 339 GSVFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLI-----NLFGACEHDGV------ 387
           G V+RG+ +G +VA+K    S   E +  ++   +N +     N+ G    D        
Sbjct: 22  GEVWRGLWHGESVAVKIF--SSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTSRNSST 79
Query: 388 -FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH-----NCTDPGYV 441
             +L+  + E+GSL D+L ++     ++     R+A+  A GL +LH         P   
Sbjct: 80  QLWLITHYHEHGSLYDFLQRQTLEPHLA----LRLAVSAACGLAHLHVEIFGTQGKPAIA 135
Query: 442 HKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS----STKTAVGTNGYMAPEYMEYG 497
           H+D  S N+L+  NL+  +A+      AV    G           VGT  YMAPE ++  
Sbjct: 136 HRDFKSRNVLVKSNLQCCIADLGL---AVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQ 192
Query: 498 LVT------PEMDTYAFGVVLLE-----LITGKEAAYKQDGEEILLAEAVFSMVEGGNAE 546
           + T         D +AFG+VL E     ++ G    Y+    +++  +  F        +
Sbjct: 193 IRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSFE-------D 245
Query: 547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIARE-----PESRPSMAEVVSTLMKI 596
            K  V VD         +A   ++  LA + RE     P +R +   +  TL KI
Sbjct: 246 MKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKI 300

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 32/202 (15%)
Query: 339 GSVFRGIINGSTVAIKCM----RRSISKEVNLLKKI--NHFNLINLFGACEHD-GVF--- 388
           G V+RG   G  VA+K       RS  +E  + + +   H N++    A   D G +   
Sbjct: 18  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 77
Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH-----NCTDPGYVHK 443
           +LV ++ E+GSL D+L+  RY   V+     ++AL  A GL +LH         P   H+
Sbjct: 78  WLVSDYHEHGSLFDYLN--RYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 133
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA----VGTNGYMAPEY------ 493
           D+ S NIL+ KN    +A+      AVR +S   +   A    VGT  YMAPE       
Sbjct: 134 DLKSKNILVKKNGTCCIADLGL---AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 190
Query: 494 MEYGLVTPEMDTYAFGVVLLEL 515
           M++       D YA G+V  E+
Sbjct: 191 MKHFESFKRADIYAMGLVFWEI 212

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 113/263 (42%), Gaps = 44/263 (16%)
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH---------- 405
           M+    +E  L+ + ++ N++ L G C       L++E+M  G L+++L           
Sbjct: 93  MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 152
Query: 406 -------KKRY----PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK 454
                  + R     P  +S   +  IA  VA G+ YL   ++  +VH+D+++ N L+ +
Sbjct: 153 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGE 209
Query: 455 NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLE 514
           N+  K+A+F   R+    +   +    A+    +M PE + Y   T E D +A+GVVL E
Sbjct: 210 NMVVKIADFGLSRNIYSADYYKADGNDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWE 268
Query: 515 LIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCL 573
           + + G +  Y    EE++                    + D N+ A  +     L  L  
Sbjct: 269 IFSYGLQPYYGMAHEEVIY------------------YVRDGNILACPENCPLELYNLMR 310
Query: 574 ACIAREPESRPSMAEVVSTLMKI 596
            C ++ P  RPS   +   L ++
Sbjct: 311 LCWSKLPADRPSFCSIHRILQRM 333

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 41/265 (15%)
Query: 350 TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGAC-EHDGVFYLVYEFMENGS 399
           TVA+K ++        R++  E+ +L  I +H N++NL GAC +  G   ++ EF + G+
Sbjct: 61  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 120
Query: 400 LSDWLHKKR-----------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           LS +L  KR           Y +F++       +  VA G+ +L +      +H+D+++ 
Sbjct: 121 LSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRK---XIHRDLAAR 177
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           NILL +    K+ +F   R   ++          +    +MAPE +   + T + D ++F
Sbjct: 178 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK-WMAPETIFDRVYTIQSDVWSF 236
Query: 509 GVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL 568
           GV+L E+ +   + Y   G +I   E    + EG    A       P+    +      +
Sbjct: 237 GVLLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE------M 280
Query: 569 IMLCLACIAREPESRPSMAEVVSTL 593
               L C   EP  RP+ +E+V  L
Sbjct: 281 YQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 119/266 (44%), Gaps = 34/266 (12%)
Query: 350 TVAIKCMRRSI----------SKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +VA+KC++  +           +EVN +  ++H NLI L+G      +  +V E    GS
Sbjct: 48  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGS 106
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           L D L K +    +    R+  A+ VA G+ YL +     ++H+D+++ N+LL      K
Sbjct: 107 LLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVK 161
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-G 518
           + +F  +R+  + +  Y   +       + APE ++    +   DT+ FGV L E+ T G
Sbjct: 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 221
Query: 519 KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAR 578
           +E     +G +IL              + +   L  P      ++    +  + + C A 
Sbjct: 222 QEPWIGLNGSQIL-----------HKIDKEGERLPRP------EDCPQDIYNVMVQCWAH 264
Query: 579 EPESRPSMAEVVSTLMKIQLDVQRSQ 604
           +PE RP+   +   L++ Q    R++
Sbjct: 265 KPEDRPTFVALRDFLLEAQPTDMRAE 290

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 32/202 (15%)
Query: 339 GSVFRGIINGSTVAIKCM----RRSISKEVNLLKKI--NHFNLINLFGACEHD-GVF--- 388
           G V+RG   G  VA+K       RS  +E  + + +   H N++    A   D G +   
Sbjct: 23  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 82
Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH-----NCTDPGYVHK 443
           +LV ++ E+GSL D+L+  RY   V+     ++AL  A GL +LH         P   H+
Sbjct: 83  WLVSDYHEHGSLFDYLN--RYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 138
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA----VGTNGYMAPEY------ 493
           D+ S NIL+ KN    +A+      AVR +S   +   A    VGT  YMAPE       
Sbjct: 139 DLKSKNILVKKNGTCCIADLGL---AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 195
Query: 494 MEYGLVTPEMDTYAFGVVLLEL 515
           M++       D YA G+V  E+
Sbjct: 196 MKHFESFKRADIYAMGLVFWEI 217

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 88/176 (50%), Gaps = 12/176 (6%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD-W 403
           +I+   V  K  + S+ +EV LLK+++H N+  L+   E  G FYLV E    G L D  
Sbjct: 58  VISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEI 117
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD-KNLRAKLAN 462
           + +KR+ E  +     RI   V  G+ Y H       VH+D+   N+LL+ K+  A +  
Sbjct: 118 ISRKRFSEVDA----ARIIRQVLSGITYXHKNK---IVHRDLKPENLLLESKSKDANIRI 170
Query: 463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
             F  S   E S     K  +GT  Y+APE + +G    + D ++ GV+L  L++G
Sbjct: 171 IDFGLSTHFEAS--KKXKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 223

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 37/269 (13%)
Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V++G  +G  VA+K +          ++   EV +L+K  H N++ LF          
Sbjct: 49  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLA 106
Query: 390 LVYEFMENGSLSDWLH--KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +V ++ E  SL   LH  + ++ E +       IA   A G+ YLH  +    +H+D+ S
Sbjct: 107 IVTQWCEGSSLYHHLHIIETKF-EMIKL---IDIARQTAQGMDYLHAKS---IIHRDLKS 159
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP---EMD 504
            NI L ++L  K+ +F       R  SG    +   G+  +MAPE +      P   + D
Sbjct: 160 NNIFLHEDLTVKIGDFGLATVKSRW-SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 218
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            YAFG+VL EL+TG+      +  +    + +F +  G          + P+L   +   
Sbjct: 219 VYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRG---------YLSPDLSKVRSNC 265
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +  L   C+ ++ + RP   ++++++
Sbjct: 266 PKAMKRLMAECLKKKRDERPLFPQILASI 294

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 116/258 (44%), Gaps = 32/258 (12%)
Query: 357 RRSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           + ++  E+ ++  +  H N++NL GAC H G   ++ E+   G L ++L +K   +    
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 152
Query: 416 NCR-------FRIALDVAHGLHYL--HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV 466
           + R          +  VA G+ +L   NC     +H+D+++ N+LL     AK+ +F   
Sbjct: 153 DGRPLELRDLLHFSSQVAQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLA 207
Query: 467 RSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQD 526
           R  +  +S Y     A     +MAPE +   + T + D +++G++L E+ +     Y   
Sbjct: 208 RD-IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG- 265
Query: 527 GEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSM 586
              IL+    + +V+ G   A+ +                ++  +  AC A EP  RP+ 
Sbjct: 266 ---ILVNSKFYKLVKDGYQMAQPAF------------APKNIYSIMQACWALEPTHRPTF 310
Query: 587 AEVVSTLMKIQLDVQRSQ 604
            ++ S L +   + +R +
Sbjct: 311 QQICSFLQEQAQEDRRER 328

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 116/259 (44%), Gaps = 34/259 (13%)
Query: 350 TVAIKCMRRSI----------SKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +VA+KC++  +           +EVN +  ++H NLI L+G      +  +V E    GS
Sbjct: 38  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGS 96
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           L D L K +    +    R+  A+ VA G+ YL +     ++H+D+++ N+LL      K
Sbjct: 97  LLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVK 151
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-G 518
           + +F  +R+  + +  Y   +       + APE ++    +   DT+ FGV L E+ T G
Sbjct: 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 211
Query: 519 KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAR 578
           +E     +G +IL              + +   L  P      ++    +  + + C A 
Sbjct: 212 QEPWIGLNGSQIL-----------HKIDKEGERLPRP------EDCPQDIYNVMVQCWAH 254
Query: 579 EPESRPSMAEVVSTLMKIQ 597
           +PE RP+   +   L++ Q
Sbjct: 255 KPEDRPTFVALRDFLLEAQ 273

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 116/259 (44%), Gaps = 34/259 (13%)
Query: 350 TVAIKCMRRSI----------SKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +VA+KC++  +           +EVN +  ++H NLI L+G      +  +V E    GS
Sbjct: 42  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGS 100
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           L D L K +    +    R+  A+ VA G+ YL +     ++H+D+++ N+LL      K
Sbjct: 101 LLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVK 155
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-G 518
           + +F  +R+  + +  Y   +       + APE ++    +   DT+ FGV L E+ T G
Sbjct: 156 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 215
Query: 519 KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAR 578
           +E     +G +IL              + +   L  P      ++    +  + + C A 
Sbjct: 216 QEPWIGLNGSQIL-----------HKIDKEGERLPRP------EDCPQDIYNVMVQCWAH 258
Query: 579 EPESRPSMAEVVSTLMKIQ 597
           +PE RP+   +   L++ Q
Sbjct: 259 KPEDRPTFVALRDFLLEAQ 277

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 11/168 (6%)
Query: 371 NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
           NH  L  LF   +     + V EF+  G L   + K R   F     RF  A ++   L 
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARF-YAAEIISALM 138
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           +LH   D G +++D+   N+LLD     KLA+F   +  +       +T T  GT  Y+A
Sbjct: 139 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI---CNGVTTATFCGTPDYIA 192
Query: 491 PEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFS 538
           PE ++  L  P +D +A GV+L E++ G  A ++ + E+ L  EA+ +
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCG-HAPFEAENEDDLF-EAILN 238

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 32/202 (15%)
Query: 339 GSVFRGIINGSTVAIKCM----RRSISKEVNLLKKI--NHFNLINLFGACEHD-GVF--- 388
           G V+RG   G  VA+K       RS  +E  + + +   H N++    A   D G +   
Sbjct: 20  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 79
Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH-----NCTDPGYVHK 443
           +LV ++ E+GSL D+L+  RY   V+     ++AL  A GL +LH         P   H+
Sbjct: 80  WLVSDYHEHGSLFDYLN--RYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 135
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA----VGTNGYMAPEY------ 493
           D+ S NIL+ KN    +A+      AVR +S   +   A    VGT  YMAPE       
Sbjct: 136 DLKSKNILVKKNGTCCIADLGL---AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 192
Query: 494 MEYGLVTPEMDTYAFGVVLLEL 515
           M++       D YA G+V  E+
Sbjct: 193 MKHFESFKRADIYAMGLVFWEI 214

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 37/269 (13%)
Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V++G  +G  VA+K +          ++   EV +L+K  H N++ LF          
Sbjct: 27  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLA 84
Query: 390 LVYEFMENGSLSDWLH--KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +V ++ E  SL   LH  + ++ E +       IA   A G+ YLH  +    +H+D+ S
Sbjct: 85  IVTQWCEGSSLYHHLHIIETKF-EMIK---LIDIARQTAQGMDYLHAKS---IIHRDLKS 137
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP---EMD 504
            NI L ++L  K+ +F       R  SG    +   G+  +MAPE +      P   + D
Sbjct: 138 NNIFLHEDLTVKIGDFGLATVKSRW-SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 196
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            YAFG+VL EL+TG+      +  +    + +F +  G          + P+L   +   
Sbjct: 197 VYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRG---------YLSPDLSKVRSNC 243
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +  L   C+ ++ + RP   ++++++
Sbjct: 244 PKAMKRLMAECLKKKRDERPLFPQILASI 272

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 121/269 (44%), Gaps = 47/269 (17%)
Query: 350 TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGAC-EHDGVFYLVYEFMENGS 399
           TVA+K ++        R++  E+ +L  I +H N++NL GAC +  G   ++ EF + G+
Sbjct: 59  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118
Query: 400 LSDWLHKKR-------------YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           LS +L  KR             Y +F++       +  VA G+ +L    C     +H+D
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRD 173
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ NILL +    K+ +F   R  + ++  Y     A     +MAPE +   + T + D
Sbjct: 174 LAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 232
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ +   + Y   G +I   E    + EG    A       P+    +   
Sbjct: 233 VWSFGVLLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE--- 279
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +    L C   EP  RP+ +E+V  L
Sbjct: 280 ---MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 37/269 (13%)
Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V++G  +G  VA+K +          ++   EV +L+K  H N++ LF          
Sbjct: 50  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLA 107
Query: 390 LVYEFMENGSLSDWLH--KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +V ++ E  SL   LH  + ++ E +       IA   A G+ YLH  +    +H+D+ S
Sbjct: 108 IVTQWCEGSSLYHHLHIIETKF-EMIKL---IDIARQTAQGMDYLHAKS---IIHRDLKS 160
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP---EMD 504
            NI L ++L  K+ +F       R  SG    +   G+  +MAPE +      P   + D
Sbjct: 161 NNIFLHEDLTVKIGDFGLATVKSRW-SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 219
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            YAFG+VL EL+TG+      +  +    + +F +  G          + P+L   +   
Sbjct: 220 VYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRG---------YLSPDLSKVRSNC 266
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +  L   C+ ++ + RP   ++++++
Sbjct: 267 PKAMKRLMAECLKKKRDERPLFPQILASI 295

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 91/177 (51%), Gaps = 16/177 (9%)
Query: 359 SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD-WLHKKRYPEFVSWNC 417
           +I +EV LLKK++H N++ LF   E    FY+V E    G L D  + +KR+ E  +   
Sbjct: 67  TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--- 123
Query: 418 RFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSAVREES 474
             RI   V  G+ Y+H       VH+D+   NILL   +K+   K+ +F    S   +++
Sbjct: 124 -ARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGL--STCFQQN 177
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
             +  K  +GT  Y+APE +  G    + D ++ GV+L  L++G    Y ++  +IL
Sbjct: 178 --TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 37/269 (13%)
Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V++G  +G  VA+K +          ++   EV +L+K  H N++ LF          
Sbjct: 24  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLA 81
Query: 390 LVYEFMENGSLSDWLH--KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +V ++ E  SL   LH  + ++ E +       IA   A G+ YLH  +    +H+D+ S
Sbjct: 82  IVTQWCEGSSLYHHLHIIETKF-EMIK---LIDIARQTAQGMDYLHAKS---IIHRDLKS 134
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP---EMD 504
            NI L ++L  K+ +F       R  SG    +   G+  +MAPE +      P   + D
Sbjct: 135 NNIFLHEDLTVKIGDFGLATVKSRW-SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 193
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            YAFG+VL EL+TG+      +  +    + +F +  G          + P+L   +   
Sbjct: 194 VYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRG---------YLSPDLSKVRSNC 240
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +  L   C+ ++ + RP   ++++++
Sbjct: 241 PKAMKRLMAECLKKKRDERPLFPQILASI 269

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 91/177 (51%), Gaps = 16/177 (9%)
Query: 359 SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD-WLHKKRYPEFVSWNC 417
           +I +EV LLKK++H N++ LF   E    FY+V E    G L D  + +KR+ E  +   
Sbjct: 67  TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--- 123
Query: 418 RFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSAVREES 474
             RI   V  G+ Y+H       VH+D+   NILL   +K+   K+ +F    S   +++
Sbjct: 124 -ARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGL--STCFQQN 177
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
             +  K  +GT  Y+APE +  G    + D ++ GV+L  L++G    Y ++  +IL
Sbjct: 178 --TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 37/269 (13%)
Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V++G  +G  VA+K +          ++   EV +L+K  H N++ LF          
Sbjct: 22  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLA 79
Query: 390 LVYEFMENGSLSDWLH--KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +V ++ E  SL   LH  + ++ E +       IA   A G+ YLH  +    +H+D+ S
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKF-EMIK---LIDIARQTAQGMDYLHAKS---IIHRDLKS 132
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP---EMD 504
            NI L ++L  K+ +F       R  SG    +   G+  +MAPE +      P   + D
Sbjct: 133 NNIFLHEDLTVKIGDFGLATVKSRW-SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            YAFG+VL EL+TG+      +  +    + +F +  G          + P+L   +   
Sbjct: 192 VYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRG---------YLSPDLSKVRSNC 238
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +  L   C+ ++ + RP   ++++++
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASI 267

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 121/269 (44%), Gaps = 47/269 (17%)
Query: 350 TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGAC-EHDGVFYLVYEFMENGS 399
           TVA+K ++        R++  E+ +L  I +H N++NL GAC +  G   ++ EF + G+
Sbjct: 96  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 155
Query: 400 LSDWLHKKR-------------YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           LS +L  KR             Y +F++       +  VA G+ +L    C     +H+D
Sbjct: 156 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRD 210
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ NILL +    K+ +F   R  + ++  Y     A     +MAPE +   + T + D
Sbjct: 211 LAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 269
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ +   + Y   G +I   E    + EG    A       P+    +   
Sbjct: 270 VWSFGVLLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE--- 316
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +    L C   EP  RP+ +E+V  L
Sbjct: 317 ---MYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 116/259 (44%), Gaps = 34/259 (13%)
Query: 350 TVAIKCMRRSI----------SKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +VA+KC++  +           +EVN +  ++H NLI L+G      +  +V E    GS
Sbjct: 38  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGS 96
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           L D L K +    +    R+  A+ VA G+ YL +     ++H+D+++ N+LL      K
Sbjct: 97  LLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVK 151
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-G 518
           + +F  +R+  + +  Y   +       + APE ++    +   DT+ FGV L E+ T G
Sbjct: 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 211
Query: 519 KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAR 578
           +E     +G +IL              + +   L  P      ++    +  + + C A 
Sbjct: 212 QEPWIGLNGSQIL-----------HKIDKEGERLPRP------EDCPQDIYNVMVQCWAH 254
Query: 579 EPESRPSMAEVVSTLMKIQ 597
           +PE RP+   +   L++ Q
Sbjct: 255 KPEDRPTFVALRDFLLEAQ 273

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 85/163 (52%), Gaps = 10/163 (6%)
Query: 358 RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNC 417
           +   +EV+   +++H N++++    E D  +YLV E++E  +LS+++ +   P  +S + 
Sbjct: 56  KRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGP--LSVDT 112
Query: 418 RFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS 477
                  +  G+ + H   D   VH+DI   NIL+D N   K+ +F   ++    E+  +
Sbjct: 113 AINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLT 167
Query: 478 STKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLELITGK 519
            T   +GT  Y +PE  + G  T E  D Y+ G+VL E++ G+
Sbjct: 168 QTNHVLGTVQYFSPEQAK-GEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/249 (23%), Positives = 112/249 (44%), Gaps = 32/249 (12%)
Query: 357 RRSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           + ++  E+ ++  +  H N++NL GAC H G   ++ E+   G L ++L +K   +    
Sbjct: 85  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 144
Query: 416 NCR-------FRIALDVAHGLHYL--HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV 466
           + R          +  VA G+ +L   NC     +H+D+++ N+LL     AK+ +F   
Sbjct: 145 DGRPLELRDLLHFSSQVAQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLA 199
Query: 467 RSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQD 526
           R  +  +S Y     A     +MAPE +   + T + D +++G++L E+ +     Y   
Sbjct: 200 RD-IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG- 257
Query: 527 GEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSM 586
              IL+    + +V+ G   A+ +                ++  +  AC A EP  RP+ 
Sbjct: 258 ---ILVNSKFYKLVKDGYQMAQPAF------------APKNIYSIMQACWALEPTHRPTF 302
Query: 587 AEVVSTLMK 595
            ++ S L +
Sbjct: 303 QQICSFLQE 311

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 84/179 (46%), Gaps = 14/179 (7%)
Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     L+ E++  G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL D+L K +  E +      +    +  G+ YL       Y+H+D+++ NIL++   R 
Sbjct: 99  SLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 153
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+ +F   +   +++  +   +       + APE +     +   D ++FGVVL EL T
Sbjct: 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 112/246 (45%), Gaps = 41/246 (16%)
Query: 347 NGSTVAIKCMRRSISKEVNLLKKINHFN-------------LINLFGACEHDGVFYLVYE 393
           NG   A+K +++ I   V  LK++ H N             +I ++G  +     +++ +
Sbjct: 30  NGRYYAMKVLKKEI---VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86
Query: 394 FMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           ++E G L   L K +R+P  V+   +F  A +V   L YLH+      +++D+   NILL
Sbjct: 87  YIEGGELFSLLRKSQRFPNPVA---KF-YAAEVCLALEYLHSKD---IIYRDLKPENILL 139
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
           DKN   K+ +F F +           T    GT  Y+APE +        +D ++FG+++
Sbjct: 140 DKNGHIKITDFGFAKYVP------DVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILI 193
Query: 513 LELITGKEAAYKQDG----EEILLAEAVFSMVEGGNAEAKLSVLVD-------PNLQANK 561
            E++ G    Y  +     E+IL AE  F      + +  LS L+         NLQ   
Sbjct: 194 YEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGT 253
Query: 562 KEIAHH 567
           +++ +H
Sbjct: 254 EDVKNH 259

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 121/269 (44%), Gaps = 47/269 (17%)
Query: 350 TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGAC-EHDGVFYLVYEFMENGS 399
           TVA+K ++        R++  E+ +L  I +H N++NL GAC +  G   ++ EF + G+
Sbjct: 61  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 120
Query: 400 LSDWLHKKR-------------YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           LS +L  KR             Y +F++       +  VA G+ +L    C     +H+D
Sbjct: 121 LSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRD 175
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ NILL +    K+ +F   R  + ++  Y     A     +MAPE +   + T + D
Sbjct: 176 LAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 234
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ +   + Y   G +I   E    + EG    A       P+    +   
Sbjct: 235 VWSFGVLLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE--- 281
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +    L C   EP  RP+ +E+V  L
Sbjct: 282 ---MYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 37/269 (13%)
Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V++G  +G  VA+K +          ++   EV +L+K  H N++ LF          
Sbjct: 27  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLA 84
Query: 390 LVYEFMENGSLSDWLH--KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +V ++ E  SL   LH  + ++ E +       IA   A G+ YLH  +    +H+D+ S
Sbjct: 85  IVTQWCEGSSLYHHLHIIETKF-EMIK---LIDIARQTAQGMDYLHAKS---IIHRDLKS 137
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP---EMD 504
            NI L ++L  K+ +F       R  SG    +   G+  +MAPE +      P   + D
Sbjct: 138 NNIFLHEDLTVKIGDFGLATVKSRW-SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 196
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            YAFG+VL EL+TG+      +  +    + +F +  G          + P+L   +   
Sbjct: 197 VYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRG---------YLSPDLSKVRSNC 243
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +  L   C+ ++ + RP   ++++++
Sbjct: 244 PKAMKRLMAECLKKKRDERPLFPQILASI 272

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 82/166 (49%), Gaps = 13/166 (7%)
Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRI 421
           +E +++   N   ++ LF A + D   Y+V E+M  G L + +     PE   W  RF  
Sbjct: 118 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE--KW-ARFYT 174
Query: 422 ALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
           A +V   L  +H+    G++H+D+   N+LLDK+   KLA+F       +E  G     T
Sbjct: 175 A-EVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--GMVRCDT 228
Query: 482 AVGTNGYMAPEYMEY----GLVTPEMDTYAFGVVLLELITGKEAAY 523
           AVGT  Y++PE ++     G    E D ++ GV L E++ G    Y
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 91/177 (51%), Gaps = 16/177 (9%)
Query: 359 SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD-WLHKKRYPEFVSWNC 417
           +I +EV LLKK++H N++ LF   E    FY+V E    G L D  + +KR+ E  +   
Sbjct: 67  TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-- 124
Query: 418 RFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSAVREES 474
             RI   V  G+ Y+H       VH+D+   NILL   +K+   K+ +F    S   +++
Sbjct: 125 --RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGL--STCFQQN 177
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
             +  K  +GT  Y+APE +  G    + D ++ GV+L  L++G    Y ++  +IL
Sbjct: 178 --TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 82/166 (49%), Gaps = 13/166 (7%)
Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRI 421
           +E +++   N   ++ LF A + D   Y+V E+M  G L + +     PE   W  RF  
Sbjct: 123 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE--KW-ARFYT 179
Query: 422 ALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
           A +V   L  +H+    G++H+D+   N+LLDK+   KLA+F       +E  G     T
Sbjct: 180 A-EVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--GMVRCDT 233
Query: 482 AVGTNGYMAPEYMEY----GLVTPEMDTYAFGVVLLELITGKEAAY 523
           AVGT  Y++PE ++     G    E D ++ GV L E++ G    Y
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 279

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 114/277 (41%), Gaps = 43/277 (15%)
Query: 339 GSVFRGIINGST-------VAIKCMRRSISK--------EVNLLKKINHFNLINLFGACE 383
           G V+ G ++G         VA+K +    S+        E  ++ K+NH N++   G   
Sbjct: 59  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSL 118
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++      +A D+A G  YL    +  
Sbjct: 119 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENH 175
Query: 440 YVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
           ++H+DI++ N LL        AK+ +F   R   R  S Y     A+    +M PE    
Sbjct: 176 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWMPPEAFME 234
Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
           G+ T + DT++FGV+L E+ +     Y     +    E +  +  GG         +DP 
Sbjct: 235 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTSGGR--------MDP- 281
Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                K     +  +   C   +PE RP+ A ++  +
Sbjct: 282 ----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 82/166 (49%), Gaps = 13/166 (7%)
Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRI 421
           +E +++   N   ++ LF A + D   Y+V E+M  G L + +     PE   W  RF  
Sbjct: 123 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE--KW-ARFYT 179
Query: 422 ALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
           A +V   L  +H+    G++H+D+   N+LLDK+   KLA+F       +E  G     T
Sbjct: 180 A-EVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--GMVRCDT 233
Query: 482 AVGTNGYMAPEYMEY----GLVTPEMDTYAFGVVLLELITGKEAAY 523
           AVGT  Y++PE ++     G    E D ++ GV L E++ G    Y
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 279

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 121/269 (44%), Gaps = 47/269 (17%)
Query: 350 TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGAC-EHDGVFYLVYEFMENGS 399
           TVA+K ++        R++  E+ +L  I +H N++NL GAC +  G   ++ EF + G+
Sbjct: 50  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGN 109
Query: 400 LSDWLHKKR-------------YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           LS +L  KR             Y +F++       +  VA G+ +L    C     +H+D
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRD 164
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ NILL +    K+ +F   R  + ++  Y     A     +MAPE +   + T + D
Sbjct: 165 LAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 223
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ +   + Y   G +I   E    + EG    A       P+    +   
Sbjct: 224 VWSFGVLLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE--- 270
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +    L C   EP  RP+ +E+V  L
Sbjct: 271 ---MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 37/269 (13%)
Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V++G  +G  VA+K +          ++   EV +L+K  H N++ LF          
Sbjct: 22  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTAPQLA 79
Query: 390 LVYEFMENGSLSDWLH--KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +V ++ E  SL   LH  + ++ E +       IA   A G+ YLH  +    +H+D+ S
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKF-EMIK---LIDIARQTAQGMDYLHAKS---IIHRDLKS 132
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP---EMD 504
            NI L ++L  K+ +F       R  SG    +   G+  +MAPE +      P   + D
Sbjct: 133 NNIFLHEDLTVKIGDFGLATVKSRW-SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            YAFG+VL EL+TG+      +  +    + +F +  G          + P+L   +   
Sbjct: 192 VYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRG---------YLSPDLSKVRSNC 238
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +  L   C+ ++ + RP   ++++++
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASI 267

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 116/262 (44%), Gaps = 36/262 (13%)
Query: 357 RRSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY-----P 410
           + ++  E+ ++  +  H N++NL GAC H G   ++ E+   G L ++L +K       P
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 411 EFVSWNCR------FRIALDVAHGLHYL--HNCTDPGYVHKDISSGNILLDKNLRAKLAN 462
            F   N           +  VA G+ +L   NC     +H+D+++ N+LL     AK+ +
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGD 207
Query: 463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAA 522
           F   R  +  +S Y     A     +MAPE +   + T + D +++G++L E+ +     
Sbjct: 208 FGLARD-IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
Query: 523 YKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPES 582
           Y      IL+    + +V+ G   A+ +                ++  +  AC A EP  
Sbjct: 267 YPG----ILVNSKFYKLVKDGYQMAQPAF------------APKNIYSIMQACWALEPTH 310
Query: 583 RPSMAEVVSTLMKIQLDVQRSQ 604
           RP+  ++ S L +   + +R +
Sbjct: 311 RPTFQQICSFLQEQAQEDRRER 332

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 121/269 (44%), Gaps = 47/269 (17%)
Query: 350 TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGAC-EHDGVFYLVYEFMENGS 399
           TVA+K ++        R++  E+ +L  I +H N++NL GAC +  G   ++ EF + G+
Sbjct: 50  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGN 109
Query: 400 LSDWLHKKR-------------YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           LS +L  KR             Y +F++       +  VA G+ +L    C     +H+D
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRD 164
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ NILL +    K+ +F   R  + ++  Y     A     +MAPE +   + T + D
Sbjct: 165 LAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 223
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ +   + Y   G +I   E    + EG    A       P+    +   
Sbjct: 224 VWSFGVLLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE--- 270
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +    L C   EP  RP+ +E+V  L
Sbjct: 271 ---MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 114/277 (41%), Gaps = 43/277 (15%)
Query: 339 GSVFRGIINGST-------VAIKCMRRSISK--------EVNLLKKINHFNLINLFGACE 383
           G V+ G ++G         VA+K +    S+        E  ++ K+NH N++   G   
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSL 104
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++      +A D+A G  YL    +  
Sbjct: 105 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENH 161
Query: 440 YVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
           ++H+DI++ N LL        AK+ +F   R   R  S Y     A+    +M PE    
Sbjct: 162 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWMPPEAFME 220
Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
           G+ T + DT++FGV+L E+ +     Y     +    E +  +  GG         +DP 
Sbjct: 221 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTSGGR--------MDP- 267
Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                K     +  +   C   +PE RP+ A ++  +
Sbjct: 268 ----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 116/262 (44%), Gaps = 36/262 (13%)
Query: 357 RRSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY-----P 410
           + ++  E+ ++  +  H N++NL GAC H G   ++ E+   G L ++L +K       P
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 411 EFVSWNCR------FRIALDVAHGLHYL--HNCTDPGYVHKDISSGNILLDKNLRAKLAN 462
            F   N           +  VA G+ +L   NC     +H+D+++ N+LL     AK+ +
Sbjct: 153 AFAIANSTLSTRDLLHFSSQVAQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGD 207
Query: 463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAA 522
           F   R  +  +S Y     A     +MAPE +   + T + D +++G++L E+ +     
Sbjct: 208 FGLARD-IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
Query: 523 YKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPES 582
           Y      IL+    + +V+ G   A+ +                ++  +  AC A EP  
Sbjct: 267 YPG----ILVNSKFYKLVKDGYQMAQPAF------------APKNIYSIMQACWALEPTH 310
Query: 583 RPSMAEVVSTLMKIQLDVQRSQ 604
           RP+  ++ S L +   + +R +
Sbjct: 311 RPTFQQICSFLQEQAQEDRRER 332

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 107/248 (43%), Gaps = 30/248 (12%)
Query: 347 NGSTVAIKCMRRSI----------SKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME 396
            G   A+K +R+ +            E  +L+   H  L  L  A +       V E+  
Sbjct: 32  TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 91
Query: 397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
            G L  + H  R   F     RF  A ++   L YLH+      V++DI   N++LDK+ 
Sbjct: 92  GGEL--FFHLSRERVFTEERARFYGA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDG 145
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI 516
             K+ +F   +  +   S  ++ KT  GT  Y+APE +E       +D +  GVV+ E++
Sbjct: 146 HIKITDFGLCKEGI---SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 202
Query: 517 TGKEAAYKQDGEE----ILLAEAVFSMVEGGNAEAKLSVLV--DPNLQ-----ANKKEIA 565
            G+   Y QD E     IL+ E  F       A++ L+ L+  DP  +     ++ KE+ 
Sbjct: 203 CGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 262
Query: 566 HHLIMLCL 573
            H   L +
Sbjct: 263 EHRFFLSI 270

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 107/248 (43%), Gaps = 30/248 (12%)
Query: 347 NGSTVAIKCMRRSI----------SKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME 396
            G   A+K +R+ +            E  +L+   H  L  L  A +       V E+  
Sbjct: 29  TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 88
Query: 397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
            G L  + H  R   F     RF  A ++   L YLH+      V++DI   N++LDK+ 
Sbjct: 89  GGEL--FFHLSRERVFTEERARFYGA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDG 142
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI 516
             K+ +F   +  +   S  ++ KT  GT  Y+APE +E       +D +  GVV+ E++
Sbjct: 143 HIKITDFGLCKEGI---SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 517 TGKEAAYKQDGEE----ILLAEAVFSMVEGGNAEAKLSVLV--DPNLQ-----ANKKEIA 565
            G+   Y QD E     IL+ E  F       A++ L+ L+  DP  +     ++ KE+ 
Sbjct: 200 CGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
Query: 566 HHLIMLCL 573
            H   L +
Sbjct: 260 EHRFFLSI 267

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     L+ E++  G
Sbjct: 38  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 97
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL D+L K +  E +      +    +  G+ YL       Y+H+D+++ NIL++   R 
Sbjct: 98  SLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 152
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+ +F   +   +++      +       + APE +     +   D ++FGVVL EL T
Sbjct: 153 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     L+ E++  G
Sbjct: 37  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 96
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL D+L K +  E +      +    +  G+ YL       Y+H+D+++ NIL++   R 
Sbjct: 97  SLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 151
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+ +F   +   +++      +       + APE +     +   D ++FGVVL EL T
Sbjct: 152 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 84/179 (46%), Gaps = 14/179 (7%)
Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     L+ E++  G
Sbjct: 40  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 99
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL D+L K +  E +      +    +  G+ YL       Y+H+++++ NIL++   R 
Sbjct: 100 SLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRNLATRNILVENENRV 154
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+ +F   +   +++  Y   +       + APE +     +   D ++FGVVL EL T
Sbjct: 155 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     L+ E++  G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL D+L K +  E +      +    +  G+ YL       Y+H+D+++ NIL++   R 
Sbjct: 99  SLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 153
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+ +F   +   +++      +       + APE +     +   D ++FGVVL EL T
Sbjct: 154 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 119/268 (44%), Gaps = 46/268 (17%)
Query: 350 TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGAC-EHDGVFYLVYEFMENGS 399
           TVA+K ++        R++  E+ +L  I +H N++NL GAC +  G   ++ EF + G+
Sbjct: 60  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 119
Query: 400 LSDWLHKKR------------YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDI 445
           LS +L  KR            Y +F++       +  VA G+ +L    C     +H+D+
Sbjct: 120 LSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRDL 174
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ NILL +    K+ +F   R   ++          +    +MAPE +   + T + D 
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK-WMAPETIFDRVYTIQSDV 233
Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV+L E+ +   + Y   G +I   E    + EG    A       P+    +    
Sbjct: 234 WSFGVLLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE---- 279
Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTL 593
             +    L C   EP  RP+ +E+V  L
Sbjct: 280 --MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     L+ E++  G
Sbjct: 43  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 102
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL D+L K +  E +      +    +  G+ YL       Y+H+D+++ NIL++   R 
Sbjct: 103 SLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 157
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+ +F   +   +++      +       + APE +     +   D ++FGVVL EL T
Sbjct: 158 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 107/248 (43%), Gaps = 30/248 (12%)
Query: 347 NGSTVAIKCMRRSI----------SKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME 396
            G   A+K +R+ +            E  +L+   H  L  L  A +       V E+  
Sbjct: 29  TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 88
Query: 397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
            G L  + H  R   F     RF  A ++   L YLH+      V++DI   N++LDK+ 
Sbjct: 89  GGEL--FFHLSRERVFTEERARFYGA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDG 142
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI 516
             K+ +F   +  +   S  ++ KT  GT  Y+APE +E       +D +  GVV+ E++
Sbjct: 143 HIKITDFGLCKEGI---SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 517 TGKEAAYKQDGEE----ILLAEAVFSMVEGGNAEAKLSVLV--DPNLQ-----ANKKEIA 565
            G+   Y QD E     IL+ E  F       A++ L+ L+  DP  +     ++ KE+ 
Sbjct: 200 CGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
Query: 566 HHLIMLCL 573
            H   L +
Sbjct: 260 EHRFFLSI 267

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     L+ E++  G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL D+L K +  E +      +    +  G+ YL       Y+H+D+++ NIL++   R 
Sbjct: 99  SLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 153
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+ +F   +   +++      +       + APE +     +   D ++FGVVL EL T
Sbjct: 154 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     L+ E++  G
Sbjct: 46  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 105
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL D+L K +  E +      +    +  G+ YL       Y+H+D+++ NIL++   R 
Sbjct: 106 SLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 160
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+ +F   +   +++      +       + APE +     +   D ++FGVVL EL T
Sbjct: 161 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     L+ E++  G
Sbjct: 70  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL D+L K +  E +      +    +  G+ YL       Y+H+D+++ NIL++   R 
Sbjct: 130 SLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 184
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+ +F   +   +++      +       + APE +     +   D ++FGVVL EL T
Sbjct: 185 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     L+ E++  G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL D+L K +  E +      +    +  G+ YL       Y+H+D+++ NIL++   R 
Sbjct: 102 SLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 156
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+ +F   +   +++      +       + APE +     +   D ++FGVVL EL T
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     L+ E++  G
Sbjct: 44  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 103
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL D+L K +  E +      +    +  G+ YL       Y+H+D+++ NIL++   R 
Sbjct: 104 SLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 158
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+ +F   +   +++      +       + APE +     +   D ++FGVVL EL T
Sbjct: 159 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 94/191 (49%), Gaps = 21/191 (10%)
Query: 339 GSVFRG--IINGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V+    +  G  VAI+ M       +  I  E+ ++++  + N++N   +       +
Sbjct: 34  GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93
Query: 390 LVYEFMENGSLSDWLHKKRYPEF-VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +V E++  GSL+D + +    E  ++  CR     +    L +LH+      +H+DI S 
Sbjct: 94  VVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQ---VIHRDIKSD 145
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           NILL  +   KL +F F      E+S  S   T VGT  +MAPE +      P++D ++ 
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRS---TMVGTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 509 GVVLLELITGK 519
           G++ +E+I G+
Sbjct: 203 GIMAIEMIEGE 213

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     L+ E++  G
Sbjct: 45  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 104
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL D+L K +  E +      +    +  G+ YL       Y+H+D+++ NIL++   R 
Sbjct: 105 SLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 159
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+ +F   +   +++      +       + APE +     +   D ++FGVVL EL T
Sbjct: 160 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 43/277 (15%)
Query: 339 GSVFRGIINGST-------VAIKCMRRSISK--------EVNLLKKINHFNLINLFGACE 383
           G V+ G ++G         VA+K +    S+        E  ++ K NH N++   G   
Sbjct: 61  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 120
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++      +A D+A G  YL    +  
Sbjct: 121 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENH 177
Query: 440 YVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
           ++H+DI++ N LL        AK+ +F   R   R  S Y     A+    +M PE    
Sbjct: 178 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWMPPEAFME 236
Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
           G+ T + DT++FGV+L E+ +     Y     +    E +  +  GG         +DP 
Sbjct: 237 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTSGGR--------MDP- 283
Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                K     +  +   C   +PE RP+ A ++  +
Sbjct: 284 ----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 316

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 43/277 (15%)
Query: 339 GSVFRGIINGST-------VAIKCMRRSISK--------EVNLLKKINHFNLINLFGACE 383
           G V+ G ++G         VA+K +    S+        E  ++ K NH N++   G   
Sbjct: 51  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 110
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++      +A D+A G  YL    +  
Sbjct: 111 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENH 167
Query: 440 YVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
           ++H+DI++ N LL        AK+ +F   R   R  S Y     A+    +M PE    
Sbjct: 168 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWMPPEAFME 226
Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
           G+ T + DT++FGV+L E+ +     Y     +    E +  +  GG         +DP 
Sbjct: 227 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTSGGR--------MDP- 273
Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                K     +  +   C   +PE RP+ A ++  +
Sbjct: 274 ----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 306

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 119/269 (44%), Gaps = 47/269 (17%)
Query: 350 TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGAC-EHDGVFYLVYEFMENGS 399
           TVA+K ++        R++  E+ +L  I +H N++NL GAC +  G   ++ EF + G+
Sbjct: 59  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118
Query: 400 LSDWLHKKR-------------YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           LS +L  KR             Y +F++       +  VA G+ +L    C     +H+D
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRD 173
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ NILL +    K+ +F   R   ++          +    +MAPE +   + T + D
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK-WMAPETIFDRVYTIQSD 232
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ +   + Y   G +I   E    + EG    A       P+    +   
Sbjct: 233 VWSFGVLLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE--- 279
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +    L C   EP  RP+ +E+V  L
Sbjct: 280 ---MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 16/194 (8%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYPEFV 413
            +R  I +E+ +L + N   ++  +GA   DG   +  E M+ GSL   L K  R PE +
Sbjct: 108 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI 167
Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
                 ++++ V  GL YL        +H+D+   NIL++     KL +F      +   
Sbjct: 168 LG----KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 219
Query: 474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA 533
              S   + VGT  YM+PE ++    + + D ++ G+ L+E+  G+      D +E+   
Sbjct: 220 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--- 273
Query: 534 EAVFS-MVEGGNAE 546
           E +F   VEG  AE
Sbjct: 274 ELMFGCQVEGDAAE 287

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     L+ E++  G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL D+L K +  E +      +    +  G+ YL       Y+H+D+++ NIL++   R 
Sbjct: 117 SLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 171
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+ +F   +   +++      +       + APE +     +   D ++FGVVL EL T
Sbjct: 172 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 43/277 (15%)
Query: 339 GSVFRGIINGST-------VAIKCMRRSISK--------EVNLLKKINHFNLINLFGACE 383
           G V+ G ++G         VA+K +    S+        E  ++ K NH N++   G   
Sbjct: 59  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 118
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++      +A D+A G  YL    +  
Sbjct: 119 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENH 175
Query: 440 YVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
           ++H+DI++ N LL        AK+ +F   R   R  S Y     A+    +M PE    
Sbjct: 176 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWMPPEAFME 234
Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
           G+ T + DT++FGV+L E+ +     Y     +    E +  +  GG         +DP 
Sbjct: 235 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTSGGR--------MDP- 281
Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                K     +  +   C   +PE RP+ A ++  +
Sbjct: 282 ----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 43/277 (15%)
Query: 339 GSVFRGIINGST-------VAIKCMRRSISK--------EVNLLKKINHFNLINLFGACE 383
           G V+ G ++G         VA+K +    S+        E  ++ K NH N++   G   
Sbjct: 71  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 130
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++      +A D+A G  YL    +  
Sbjct: 131 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENH 187
Query: 440 YVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
           ++H+DI++ N LL        AK+ +F   R   R  S Y     A+    +M PE    
Sbjct: 188 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWMPPEAFME 246
Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
           G+ T + DT++FGV+L E+ +     Y     +    E +  +  GG         +DP 
Sbjct: 247 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTSGGR--------MDP- 293
Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                K     +  +   C   +PE RP+ A ++  +
Sbjct: 294 ----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 326

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 43/277 (15%)
Query: 339 GSVFRGIINGST-------VAIKCMRRSISK--------EVNLLKKINHFNLINLFGACE 383
           G V+ G ++G         VA+K +    S+        E  ++ K NH N++   G   
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 104
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++      +A D+A G  YL    +  
Sbjct: 105 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENH 161
Query: 440 YVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
           ++H+DI++ N LL        AK+ +F   R   R  S Y     A+    +M PE    
Sbjct: 162 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWMPPEAFME 220
Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
           G+ T + DT++FGV+L E+ +     Y     +    E +  +  GG         +DP 
Sbjct: 221 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTSGGR--------MDP- 267
Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                K     +  +   C   +PE RP+ A ++  +
Sbjct: 268 ----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 43/277 (15%)
Query: 339 GSVFRGIINGST-------VAIKCMRRSISK--------EVNLLKKINHFNLINLFGACE 383
           G V+ G ++G         VA+K +    S+        E  ++ K NH N++   G   
Sbjct: 36  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 95
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++      +A D+A G  YL    +  
Sbjct: 96  QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENH 152
Query: 440 YVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
           ++H+DI++ N LL        AK+ +F   R   R  S Y     A+    +M PE    
Sbjct: 153 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWMPPEAFME 211
Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
           G+ T + DT++FGV+L E+ +     Y     +    E +  +  GG         +DP 
Sbjct: 212 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTSGGR--------MDP- 258
Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                K     +  +   C   +PE RP+ A ++  +
Sbjct: 259 ----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 291

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     L+ E++  G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL D+L K +  E +      +    +  G+ YL       Y+H+D+++ NIL++   R 
Sbjct: 117 SLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 171
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+ +F   +   +++      +       + APE +     +   D ++FGVVL EL T
Sbjct: 172 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     L+ EF+  G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYG 101
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL ++L K  + E +      +    +  G+ YL       Y+H+D+++ NIL++   R 
Sbjct: 102 SLREYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 156
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+ +F   +   +++      +       + APE +     +   D ++FGVVL EL T
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 88/180 (48%), Gaps = 15/180 (8%)
Query: 348 GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDG--VFYLVYEFMEN 397
           G  VA+K ++          + KE+ +L+ + H N++   G C  DG     L+ EF+ +
Sbjct: 50  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
           GSL ++L K +    ++   + + A+ +  G+ YL +     YVH+D+++ N+L++   +
Sbjct: 110 GSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 164
Query: 458 AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
            K+ +F   ++   ++   +          + APE +         D ++FGV L EL+T
Sbjct: 165 VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 43/277 (15%)
Query: 339 GSVFRGIINGST-------VAIKCMRRSISK--------EVNLLKKINHFNLINLFGACE 383
           G V+ G ++G         VA+K +    S+        E  ++ K NH N++   G   
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++      +A D+A G  YL    +  
Sbjct: 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENH 160
Query: 440 YVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
           ++H+DI++ N LL        AK+ +F   R   R  S Y     A+    +M PE    
Sbjct: 161 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWMPPEAFME 219
Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
           G+ T + DT++FGV+L E+ +     Y     +    E +  +  GG         +DP 
Sbjct: 220 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTSGGR--------MDP- 266
Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                K     +  +   C   +PE RP+ A ++  +
Sbjct: 267 ----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 43/277 (15%)
Query: 339 GSVFRGIINGST-------VAIKCMRRSISK--------EVNLLKKINHFNLINLFGACE 383
           G V+ G ++G         VA+K +    S+        E  ++ K NH N++   G   
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++      +A D+A G  YL    +  
Sbjct: 104 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENH 160
Query: 440 YVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
           ++H+DI++ N LL        AK+ +F   R   R  S Y     A+    +M PE    
Sbjct: 161 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWMPPEAFME 219
Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
           G+ T + DT++FGV+L E+ +     Y     +    E +  +  GG         +DP 
Sbjct: 220 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTSGGR--------MDP- 266
Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                K     +  +   C   +PE RP+ A ++  +
Sbjct: 267 ----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 119/269 (44%), Gaps = 47/269 (17%)
Query: 350 TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGAC-EHDGVFYLVYEFMENGS 399
           TVA+K ++        R++  E+ +L  I +H N++NL GAC +  G   ++ EF + G+
Sbjct: 59  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118
Query: 400 LSDWLHKKR-------------YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           LS +L  KR             Y +F++       +  VA G+ +L    C     +H+D
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRD 173
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ NILL +    K+ +F   R   ++          +    +MAPE +   + T + D
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLK-WMAPETIFDRVYTIQSD 232
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ +   + Y   G +I   E    + EG    A       P+    +   
Sbjct: 233 VWSFGVLLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE--- 279
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +    L C   EP  RP+ +E+V  L
Sbjct: 280 ---MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 43/277 (15%)
Query: 339 GSVFRGIINGST-------VAIKCMRRSISK--------EVNLLKKINHFNLINLFGACE 383
           G V+ G ++G         VA+K +    S+        E  ++ K NH N++   G   
Sbjct: 59  GEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSL 118
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++      +A D+A G  YL    +  
Sbjct: 119 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENH 175
Query: 440 YVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
           ++H+DI++ N LL        AK+ +F   R   R  S Y     A+    +M PE    
Sbjct: 176 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWMPPEAFME 234
Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
           G+ T + DT++FGV+L E+ +     Y     +    E +  +  GG         +DP 
Sbjct: 235 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTSGGR--------MDP- 281
Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                K     +  +   C   +PE RP+ A ++  +
Sbjct: 282 ----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 119/269 (44%), Gaps = 47/269 (17%)
Query: 350 TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGAC-EHDGVFYLVYEFMENGS 399
           TVA+K ++        R++  E+ +L  I +H N++NL GAC +  G   ++ EF + G+
Sbjct: 50  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 109
Query: 400 LSDWLHKKR-------------YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           LS +L  KR             Y +F++       +  VA G+ +L    C     +H+D
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRD 164
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ NILL +    K+ +F   R   ++          +    +MAPE +   + T + D
Sbjct: 165 LAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK-WMAPETIFDRVYTIQSD 223
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ +   + Y   G +I   E    + EG    A       P+    +   
Sbjct: 224 VWSFGVLLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE--- 270
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +    L C   EP  RP+ +E+V  L
Sbjct: 271 ---MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 95/195 (48%), Gaps = 20/195 (10%)
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHK 443
           HD + + V E+   G L  + H  R   F     RF  A ++   L YLH  ++   V++
Sbjct: 220 HDRLCF-VMEYANGGEL--FFHLSRERVFSEDRARFYGA-EIVSALDYLH--SEKNVVYR 273
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           D+   N++LDK+   K+ +F   +  +++ +   + KT  GT  Y+APE +E       +
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYLAPEVLEDNDYGRAV 330
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEE----ILLAEAVFSMVEGGNAEAKLSVLV--DPNL 557
           D +  GVV+ E++ G+   Y QD E+    IL+ E  F    G  A++ LS L+  DP  
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQ 390
Query: 558 Q-----ANKKEIAHH 567
           +      + KEI  H
Sbjct: 391 RLGGGSEDAKEIMQH 405

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 88/180 (48%), Gaps = 15/180 (8%)
Query: 348 GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDG--VFYLVYEFMEN 397
           G  VA+K ++          + KE+ +L+ + H N++   G C  DG     L+ EF+ +
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
           GSL ++L K +    ++   + + A+ +  G+ YL +     YVH+D+++ N+L++   +
Sbjct: 98  GSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 152
Query: 458 AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
            K+ +F   ++   ++   +          + APE +         D ++FGV L EL+T
Sbjct: 153 VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 122/273 (44%), Gaps = 37/273 (13%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 43  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 102
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ YL       +VH+D
Sbjct: 103 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKYL---ASKKFVHRD 157
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN-GYMAPEYMEYGLVTPEM 503
           +++ N +LD+    K+A+F   R    +E      KT       +MA E ++    T + 
Sbjct: 158 LAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKS 217
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    +   
Sbjct: 218 DVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRR-------LLQPEYCPDP-- 264
Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
               L  + L C   + E RPS +E+VS +  I
Sbjct: 265 ----LYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 41/275 (14%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 63  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 122
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ YL       +VH+D
Sbjct: 123 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKYL---ASKKFVHRD 177
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGLVTP 501
           +++ N +LD+    K+A+F   R    +E  Y S     G      +MA E ++    T 
Sbjct: 178 LAARNCMLDEKFTVKVADFGLARDMYDKE--YYSVHNKTGAKLPVKWMALESLQTQKFTT 235
Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK 561
           + D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    + 
Sbjct: 236 KSDVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRR-------LLQPEYCPDP 284
Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                 L  + L C   + E RPS +E+VS +  I
Sbjct: 285 ------LYEVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 119/269 (44%), Gaps = 47/269 (17%)
Query: 350 TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGAC-EHDGVFYLVYEFMENGS 399
           TVA+K ++        R++  E+ +L  I +H N++NL GAC +  G   ++ EF + G+
Sbjct: 50  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGN 109
Query: 400 LSDWLHKKR-------------YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKD 444
           LS +L  KR             Y +F++       +  VA G+ +L    C     +H+D
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRD 164
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ NILL +    K+ +F   R   ++          +    +MAPE +   + T + D
Sbjct: 165 LAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK-WMAPETIFDRVYTIQSD 223
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++FGV+L E+ +   + Y   G +I   E    + EG    A       P+    +   
Sbjct: 224 VWSFGVLLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE--- 270
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTL 593
              +    L C   EP  RP+ +E+V  L
Sbjct: 271 ---MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 14/179 (7%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EVN+L++I H N+I L    E+     L+ E +  G L D+L +K   E ++ +
Sbjct: 52  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK---ESLTED 108
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
              +    +  G+HYLH+       H D+   NI LLDKN+   R KL +F     A + 
Sbjct: 109 EATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI---AHKI 162
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
           E+G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G      +  +E L
Sbjct: 163 EAG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL 220

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 16/194 (8%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYPEFV 413
            +R  I +E+ +L + N   ++  +GA   DG   +  E M+ GSL   L K  R PE +
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI 105
Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
                 ++++ V  GL YL        +H+D+   NIL++     KL +F      +   
Sbjct: 106 LG----KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157
Query: 474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA 533
              S   + VGT  YM+PE ++    + + D ++ G+ L+E+  G+      D +E+   
Sbjct: 158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--- 211
Query: 534 EAVFS-MVEGGNAE 546
           E +F   VEG  AE
Sbjct: 212 ELMFGCQVEGDAAE 225

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 44/221 (19%)
Query: 329 ENFSPKNMID---GSVFRGIIN---GSTVAIKCM---------------RRSISKEVNLL 367
           + + PK++I     SV R  ++   G   A+K M               R +  +E ++L
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 368 KKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVA 426
           +++  H ++I L  + E     +LV++ M  G L D+L +K     +S      I   + 
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA---LSEKETRSIMRSLL 210
Query: 427 HGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN 486
             + +LH       VH+D+   NILLD N++ +L++F F   +   E G    +   GT 
Sbjct: 211 EAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGF---SCHLEPG-EKLRELCGTP 263
Query: 487 GYMAPEYME---------YGLVTPEMDTYAFGVVLLELITG 518
           GY+APE ++         YG    E+D +A GV+L  L+ G
Sbjct: 264 GYLAPEILKCSMDETHPGYG---KEVDLWACGVILFTLLAG 301

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 16/194 (8%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYPEFV 413
            +R  I +E+ +L + N   ++  +GA   DG   +  E M+ GSL   L K  R PE +
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI 105
Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
                 ++++ V  GL YL        +H+D+   NIL++     KL +F      +   
Sbjct: 106 LG----KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157
Query: 474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA 533
              S   + VGT  YM+PE ++    + + D ++ G+ L+E+  G+      D +E+   
Sbjct: 158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--- 211
Query: 534 EAVFS-MVEGGNAE 546
           E +F   VEG  AE
Sbjct: 212 ELMFGCQVEGDAAE 225

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 41/275 (14%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 44  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 103
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ YL       +VH+D
Sbjct: 104 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKYL---ASKKFVHRD 158
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGLVTP 501
           +++ N +LD+    K+A+F   R    +E  Y S     G      +MA E ++    T 
Sbjct: 159 LAARNCMLDEKFTVKVADFGLARDMYDKE--YYSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK 561
           + D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    + 
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRR-------LLQPEYCPDP 265
Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                 L  + L C   + E RPS +E+VS +  I
Sbjct: 266 ------LYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 91/189 (48%), Gaps = 19/189 (10%)
Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            V E+   G L  + H  R   F     RF  A ++   L YLH  ++   V++D+   N
Sbjct: 228 FVMEYANGGEL--FFHLSRERVFSEDRARFYGA-EIVSALDYLH--SEKNVVYRDLKLEN 282
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           ++LDK+   K+ +F   +  +++ +   + KT  GT  Y+APE +E       +D +  G
Sbjct: 283 LMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 339
Query: 510 VVLLELITGKEAAYKQDGEE----ILLAEAVFSMVEGGNAEAKLSVLV--DPNLQ----- 558
           VV+ E++ G+   Y QD E+    IL+ E  F    G  A++ LS L+  DP  +     
Sbjct: 340 VVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGS 399
Query: 559 ANKKEIAHH 567
            + KEI  H
Sbjct: 400 EDAKEIMQH 408

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 14/179 (7%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EVN+L++I H N+I L    E+     L+ E +  G L D+L +K   E ++ +
Sbjct: 59  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK---ESLTED 115
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
              +    +  G+HYLH+       H D+   NI LLDKN+   R KL +F     A + 
Sbjct: 116 EATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI---AHKI 169
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
           E+G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G      +  +E L
Sbjct: 170 EAG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL 227

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 41/275 (14%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 62  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 121
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ YL       +VH+D
Sbjct: 122 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKYL---ASKKFVHRD 176
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGLVTP 501
           +++ N +LD+    K+A+F   R    +E  Y S     G      +MA E ++    T 
Sbjct: 177 LAARNCMLDEKFTVKVADFGLARDMYDKE--YYSVHNKTGAKLPVKWMALESLQTQKFTT 234
Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK 561
           + D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    + 
Sbjct: 235 KSDVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRR-------LLQPEYCPDP 283
Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                 L  + L C   + E RPS +E+VS +  I
Sbjct: 284 ------LYEVMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 41/275 (14%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 39  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ YL       +VH+D
Sbjct: 99  EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKYL---ASKKFVHRD 153
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGLVTP 501
           +++ N +LD+    K+A+F   R    +E  Y S     G      +MA E ++    T 
Sbjct: 154 LAARNCMLDEKFTVKVADFGLARDMYDKE--YYSVHNKTGAKLPVKWMALESLQTQKFTT 211
Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK 561
           + D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    + 
Sbjct: 212 KSDVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRR-------LLQPEYCPDP 260
Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                 L  + L C   + E RPS +E+VS +  I
Sbjct: 261 ------LYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 41/275 (14%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 36  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 95
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ YL       +VH+D
Sbjct: 96  EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKYL---ASKKFVHRD 150
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGLVTP 501
           +++ N +LD+    K+A+F   R    +E  Y S     G      +MA E ++    T 
Sbjct: 151 LAARNCMLDEKFTVKVADFGLARDMYDKE--YYSVHNKTGAKLPVKWMALESLQTQKFTT 208
Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK 561
           + D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    + 
Sbjct: 209 KSDVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRR-------LLQPEYCPDP 257
Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                 L  + L C   + E RPS +E+VS +  I
Sbjct: 258 ------LYEVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 17/181 (9%)
Query: 347 NGSTVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFME 396
            G  VA+K +        R    +E+++L+ + H ++I   G CE  G     LV E++ 
Sbjct: 59  TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP 118
Query: 397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
            GSL D+L +      +        A  +  G+ YLH      Y+H+D+++ N+LLD + 
Sbjct: 119 LGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDR 171
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI 516
             K+ +F   ++       Y   +       + APE ++        D ++FGV L EL+
Sbjct: 172 LVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231
Query: 517 T 517
           T
Sbjct: 232 T 232

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 112/252 (44%), Gaps = 50/252 (19%)
Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL--------HKKRYPEFV 413
           KE+  + + +H N+++ + +       +LV + +  GS+ D +        HK    +  
Sbjct: 57  KEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDES 116
Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS--------- 464
           +     R   +V  GL YLH     G +H+D+ +GNILL ++   ++A+F          
Sbjct: 117 TIATILR---EVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 170
Query: 465 -FVRSAVREESGYSSTKTAVGTNGYMAPEYME----YGLVTPEMDTYAFGVVLLELITGK 519
              R+ VR        KT VGT  +MAPE ME    Y     + D ++FG+  +EL TG 
Sbjct: 171 DITRNKVR--------KTFVGTPCWMAPEVMEQVRGYDF---KADIWSFGITAIELATGA 219
Query: 520 EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV-DPNLQANKKEIAHHLIMLCLACIAR 578
              +K    ++L       M+   N    L   V D  +     +    +I LCL    +
Sbjct: 220 APYHKYPPMKVL-------MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCL---QK 269
Query: 579 EPESRPSMAEVV 590
           +PE RP+ AE++
Sbjct: 270 DPEKRPTAAELL 281

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 14/179 (7%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EVN+L++I H N+I L    E+     L+ E +  G L D+L +K   E ++ +
Sbjct: 73  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK---ESLTED 129
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
              +    +  G+HYLH+       H D+   NI LLDKN+   R KL +F     A + 
Sbjct: 130 EATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI---AHKI 183
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
           E+G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G      +  +E L
Sbjct: 184 EAG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL 241

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 41/275 (14%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 43  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 102
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ YL       +VH+D
Sbjct: 103 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKYL---ASKKFVHRD 157
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGLVTP 501
           +++ N +LD+    K+A+F   R    +E  Y S     G      +MA E ++    T 
Sbjct: 158 LAARNCMLDEKFTVKVADFGLARDMYDKE--YYSVHNKTGAKLPVKWMALESLQTQKFTT 215
Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK 561
           + D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    + 
Sbjct: 216 KSDVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRR-------LLQPEYCPDP 264
Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                 L  + L C   + E RPS +E+VS +  I
Sbjct: 265 ------LYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 41/275 (14%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 44  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 103
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ YL       +VH+D
Sbjct: 104 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKYL---ASKKFVHRD 158
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGLVTP 501
           +++ N +LD+    K+A+F   R    +E  Y S     G      +MA E ++    T 
Sbjct: 159 LAARNCMLDEKFTVKVADFGLARDMYDKE--YYSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK 561
           + D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    + 
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRR-------LLQPEYCPDP 265
Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                 L  + L C   + E RPS +E+VS +  I
Sbjct: 266 ------LYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 16/194 (8%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYPEFV 413
            +R  I +E+ +L + N   ++  +GA   DG   +  E M+ GSL   L K  R PE +
Sbjct: 73  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI 132
Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
                 ++++ V  GL YL        +H+D+   NIL++     KL +F      +   
Sbjct: 133 LG----KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 184
Query: 474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA 533
              S   + VGT  YM+PE ++    + + D ++ G+ L+E+  G+      D +E+   
Sbjct: 185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--- 238
Query: 534 EAVFS-MVEGGNAE 546
           E +F   VEG  AE
Sbjct: 239 ELMFGCQVEGDAAE 252

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 113/270 (41%), Gaps = 41/270 (15%)
Query: 343 RGIING---STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           R II G   + VA+K +  S S         E +++K     +++ L G         +V
Sbjct: 39  RDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 98
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCR--------FRIALDVAHGLHYLHNCTDPGYVHK 443
            E M +G L  +L   R PE  +   R         ++A ++A G+ YL+      +VH+
Sbjct: 99  MELMAHGDLKSYLRSLR-PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHR 154
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           D+++ N ++  +   K+ +F   R  + E + Y      +    +MAPE ++ G+ T   
Sbjct: 155 DLAARNCMVAHDFTVKIGDFGMTRD-IYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSS 213
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGVVL E+ +  E  Y                 +G + E  L  ++D         
Sbjct: 214 DMWSFGVVLWEITSLAEQPY-----------------QGLSNEQVLKFVMDGGYLDQPDN 256
Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTL 593
               +  L   C    P+ RP+  E+V+ L
Sbjct: 257 CPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 16/194 (8%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYPEFV 413
            +R  I +E+ +L + N   ++  +GA   DG   +  E M+ GSL   L K  R PE +
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI 105
Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
                 ++++ V  GL YL        +H+D+   NIL++     KL +F      +   
Sbjct: 106 LG----KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157
Query: 474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA 533
              S   + VGT  YM+PE ++    + + D ++ G+ L+E+  G+      D +E+   
Sbjct: 158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--- 211
Query: 534 EAVFS-MVEGGNAE 546
           E +F   VEG  AE
Sbjct: 212 ELMFGCQVEGDAAE 225

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 16/194 (8%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYPEFV 413
            +R  I +E+ +L + N   ++  +GA   DG   +  E M+ GSL   L K  R PE +
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI 105
Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
                 ++++ V  GL YL        +H+D+   NIL++     KL +F      +   
Sbjct: 106 LG----KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157
Query: 474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA 533
              S   + VGT  YM+PE ++    + + D ++ G+ L+E+  G+      D +E+   
Sbjct: 158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--- 211
Query: 534 EAVFS-MVEGGNAE 546
           E +F   VEG  AE
Sbjct: 212 ELMFGCQVEGDAAE 225

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 41/275 (14%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 41  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 100
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ YL       +VH+D
Sbjct: 101 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKYL---ASKKFVHRD 155
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGLVTP 501
           +++ N +LD+    K+A+F   R    +E  Y S     G      +MA E ++    T 
Sbjct: 156 LAARNCMLDEKFTVKVADFGLARDMYDKE--YYSVHNKTGAKLPVKWMALESLQTQKFTT 213
Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK 561
           + D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    + 
Sbjct: 214 KSDVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRR-------LLQPEYCPDP 262
Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                 L  + L C   + E RPS +E+VS +  I
Sbjct: 263 ------LYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 118/266 (44%), Gaps = 34/266 (12%)
Query: 350 TVAIKCMRRSIS----------KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +VA+KC++  +           +EVN +  ++H NLI L+G      +  +V E    GS
Sbjct: 48  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGS 106
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           L D L K +    +    R+  A+ VA G+ YL +     ++H+D+++ N+LL      K
Sbjct: 107 LLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVK 161
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-G 518
           + +F  +R+  + +      +       + APE ++    +   DT+ FGV L E+ T G
Sbjct: 162 IGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 221
Query: 519 KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAR 578
           +E     +G +IL              + +   L  P      ++    +  + + C A 
Sbjct: 222 QEPWIGLNGSQIL-----------HKIDKEGERLPRP------EDCPQDIYNVMVQCWAH 264
Query: 579 EPESRPSMAEVVSTLMKIQLDVQRSQ 604
           +PE RP+   +   L++ Q    R++
Sbjct: 265 KPEDRPTFVALRDFLLEAQPTDMRAE 290

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 41/275 (14%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 42  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 101
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ YL       +VH+D
Sbjct: 102 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKYL---ASKKFVHRD 156
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGLVTP 501
           +++ N +LD+    K+A+F   R    +E  Y S     G      +MA E ++    T 
Sbjct: 157 LAARNCMLDEKFTVKVADFGLARDMYDKE--YYSVHNKTGAKLPVKWMALESLQTQKFTT 214
Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK 561
           + D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    + 
Sbjct: 215 KSDVWSFGVLLWELMTRGAPPYP----DVNTFDITVYLLQGRR-------LLQPEYCPDP 263
Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                 L  + L C   + E RPS +E+VS +  I
Sbjct: 264 ------LYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 43/277 (15%)
Query: 339 GSVFRGIINGST-------VAIKCMRRSISK--------EVNLLKKINHFNLINLFGACE 383
           G V+ G ++G         VA+K +    S+        E  ++ K NH N++   G   
Sbjct: 85  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++      +A D+A G  YL    +  
Sbjct: 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENH 201
Query: 440 YVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
           ++H+DI++ N LL        AK+ +F   R   R    Y     A+    +M PE    
Sbjct: 202 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-GYYRKGGCAMLPVKWMPPEAFME 260
Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
           G+ T + DT++FGV+L E+ +     Y     +    E +  +  GG         +DP 
Sbjct: 261 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTSGGR--------MDP- 307
Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                K     +  +   C   +PE RP+ A ++  +
Sbjct: 308 ----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 112/252 (44%), Gaps = 50/252 (19%)
Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL--------HKKRYPEFV 413
           KE+  + + +H N+++ + +       +LV + +  GS+ D +        HK    +  
Sbjct: 62  KEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDES 121
Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS--------- 464
           +     R   +V  GL YLH     G +H+D+ +GNILL ++   ++A+F          
Sbjct: 122 TIATILR---EVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175
Query: 465 -FVRSAVREESGYSSTKTAVGTNGYMAPEYME----YGLVTPEMDTYAFGVVLLELITGK 519
              R+ VR        KT VGT  +MAPE ME    Y     + D ++FG+  +EL TG 
Sbjct: 176 DITRNKVR--------KTFVGTPCWMAPEVMEQVRGYDF---KADIWSFGITAIELATGA 224
Query: 520 EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV-DPNLQANKKEIAHHLIMLCLACIAR 578
              +K    ++L       M+   N    L   V D  +     +    +I LCL    +
Sbjct: 225 APYHKYPPMKVL-------MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCL---QK 274
Query: 579 EPESRPSMAEVV 590
           +PE RP+ AE++
Sbjct: 275 DPEKRPTAAELL 286

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 115/259 (44%), Gaps = 34/259 (13%)
Query: 350 TVAIKCMRRSI----------SKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           +VA+KC++  +           +EVN +  ++H NLI L+G      +  +V E    GS
Sbjct: 38  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGS 96
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           L D L K +    +    R+  A+ VA G+ YL +     ++H+D+++ N+LL      K
Sbjct: 97  LLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVK 151
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-G 518
           + +F  +R+  + +      +       + APE ++    +   DT+ FGV L E+ T G
Sbjct: 152 IGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 211
Query: 519 KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAR 578
           +E     +G +IL              + +   L  P      ++    +  + + C A 
Sbjct: 212 QEPWIGLNGSQIL-----------HKIDKEGERLPRP------EDCPQDIYNVMVQCWAH 254
Query: 579 EPESRPSMAEVVSTLMKIQ 597
           +PE RP+   +   L++ Q
Sbjct: 255 KPEDRPTFVALRDFLLEAQ 273

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 112/270 (41%), Gaps = 41/270 (15%)
Query: 343 RGIING---STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           R II G   + VA+K +  S S         E +++K     +++ L G         +V
Sbjct: 39  RDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 98
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCR--------FRIALDVAHGLHYLHNCTDPGYVHK 443
            E M +G L  +L   R PE  +   R         ++A ++A G+ YL+      +VH+
Sbjct: 99  MELMAHGDLKSYLRSLR-PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHR 154
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           D+++ N ++  +   K+ +F   R  + E   Y      +    +MAPE ++ G+ T   
Sbjct: 155 DLAARNCMVAHDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSS 213
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGVVL E+ +  E  Y                 +G + E  L  ++D         
Sbjct: 214 DMWSFGVVLWEITSLAEQPY-----------------QGLSNEQVLKFVMDGGYLDQPDN 256
Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTL 593
               +  L   C    P+ RP+  E+V+ L
Sbjct: 257 CPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 106/248 (42%), Gaps = 30/248 (12%)
Query: 347 NGSTVAIKCMRRSI----------SKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME 396
            G   A+K +R+ +            E  +L+   H  L  L  A +       V E+  
Sbjct: 29  TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 88
Query: 397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
            G L  + H  R   F     RF  A ++   L YLH+      V++DI   N++LDK+ 
Sbjct: 89  GGEL--FFHLSRERVFTEERARFYGA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDG 142
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI 516
             K+ +F   +  +   S  ++ K   GT  Y+APE +E       +D +  GVV+ E++
Sbjct: 143 HIKITDFGLCKEGI---SDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 517 TGKEAAYKQDGEE----ILLAEAVFSMVEGGNAEAKLSVLV--DPNLQ-----ANKKEIA 565
            G+   Y QD E     IL+ E  F       A++ L+ L+  DP  +     ++ KE+ 
Sbjct: 200 CGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
Query: 566 HHLIMLCL 573
            H   L +
Sbjct: 260 EHRFFLSI 267

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 106/248 (42%), Gaps = 30/248 (12%)
Query: 347 NGSTVAIKCMRRSI----------SKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME 396
            G   A+K +R+ +            E  +L+   H  L  L  A +       V E+  
Sbjct: 29  TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 88
Query: 397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
            G L  + H  R   F     RF  A ++   L YLH+      V++DI   N++LDK+ 
Sbjct: 89  GGEL--FFHLSRERVFTEERARFYGA-EIVSALEYLHSRD---VVYRDIKLENLMLDKDG 142
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI 516
             K+ +F   +  +   S  ++ K   GT  Y+APE +E       +D +  GVV+ E++
Sbjct: 143 HIKITDFGLCKEGI---SDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 517 TGKEAAYKQDGEE----ILLAEAVFSMVEGGNAEAKLSVLV--DPNLQ-----ANKKEIA 565
            G+   Y QD E     IL+ E  F       A++ L+ L+  DP  +     ++ KE+ 
Sbjct: 200 CGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
Query: 566 HHLIMLCL 573
            H   L +
Sbjct: 260 EHRFFLSI 267

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 107/252 (42%), Gaps = 30/252 (11%)
Query: 343 RGIINGSTVAIKCMRRSI----------SKEVNLLKKINHFNLINLFGACEHDGVFYLVY 392
           R    G   A+K +R+ +            E  +L+   H  L  L  A +       V 
Sbjct: 30  REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 89
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           E+   G L  + H  R   F     RF  A ++   L YLH+      V++DI   N++L
Sbjct: 90  EYANGGEL--FFHLSRERVFTEERARFYGA-EIVSALEYLHSRD---VVYRDIKLENLML 143
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
           DK+   K+ +F   +  +   S  ++ K   GT  Y+APE +E       +D +  GVV+
Sbjct: 144 DKDGHIKITDFGLCKEGI---SDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 200
Query: 513 LELITGKEAAYKQDGEE----ILLAEAVFSMVEGGNAEAKLSVLV--DPNLQ-----ANK 561
            E++ G+   Y QD E     IL+ E  F       A++ L+ L+  DP  +     ++ 
Sbjct: 201 YEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA 260
Query: 562 KEIAHHLIMLCL 573
           KE+  H   L +
Sbjct: 261 KEVMEHRFFLSI 272

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 93/191 (48%), Gaps = 21/191 (10%)
Query: 339 GSVFRG--IINGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V+    +  G  VAI+ M       +  I  E+ ++++  + N++N   +       +
Sbjct: 34  GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93
Query: 390 LVYEFMENGSLSDWLHKKRYPEF-VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +V E++  GSL+D + +    E  ++  CR     +    L +LH+      +H+DI S 
Sbjct: 94  VVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQ---VIHRDIKSD 145
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           NILL  +   KL +F F      E+S  S     VGT  +MAPE +      P++D ++ 
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSEM---VGTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 509 GVVLLELITGK 519
           G++ +E+I G+
Sbjct: 203 GIMAIEMIEGE 213

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 43/277 (15%)
Query: 339 GSVFRGIINGST-------VAIKCMRRSISK--------EVNLLKKINHFNLINLFGACE 383
           G V+ G ++G         VA+K +    S+        E  ++ K NH N++   G   
Sbjct: 62  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 121
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++      +A D+A G  YL    +  
Sbjct: 122 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENH 178
Query: 440 YVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
           ++H+DI++ N LL        AK+ +F   R   R    Y     A+    +M PE    
Sbjct: 179 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-GYYRKGGCAMLPVKWMPPEAFME 237
Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
           G+ T + DT++FGV+L E+ +     Y     +    E +  +  GG         +DP 
Sbjct: 238 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTSGGR--------MDP- 284
Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                K     +  +   C   +PE RP+ A ++  +
Sbjct: 285 ----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 317

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 93/191 (48%), Gaps = 21/191 (10%)
Query: 339 GSVFRG--IINGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V+    +  G  VAI+ M       +  I  E+ ++++  + N++N   +       +
Sbjct: 34  GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93
Query: 390 LVYEFMENGSLSDWLHKKRYPEF-VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +V E++  GSL+D + +    E  ++  CR     +    L +LH+      +H+DI S 
Sbjct: 94  VVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQ---VIHRDIKSD 145
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           NILL  +   KL +F F      E+S  S     VGT  +MAPE +      P++D ++ 
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSXM---VGTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 509 GVVLLELITGK 519
           G++ +E+I G+
Sbjct: 203 GIMAIEMIEGE 213

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 113/277 (40%), Gaps = 43/277 (15%)
Query: 339 GSVFRGIINGST-------VAIKCMRRSISK--------EVNLLKKINHFNLINLFGACE 383
           G V+ G ++G         VA+K +    S+        E  ++ K NH N++   G   
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 104
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++      +A D+A G  YL    +  
Sbjct: 105 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENH 161
Query: 440 YVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
           ++H+DI++ N LL        AK+ +F   +   R  S Y     A+    +M PE    
Sbjct: 162 FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRA-SYYRKGGCAMLPVKWMPPEAFME 220
Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
           G+ T + DT++FGV+L E+ +     Y     +    E +  +  GG         +DP 
Sbjct: 221 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFVTSGGR--------MDP- 267
Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                K     +  +   C   +PE RP+ A ++  +
Sbjct: 268 ----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 107/252 (42%), Gaps = 30/252 (11%)
Query: 343 RGIINGSTVAIKCMRRSI----------SKEVNLLKKINHFNLINLFGACEHDGVFYLVY 392
           R    G   A+K +R+ +            E  +L+   H  L  L  A +       V 
Sbjct: 25  REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           E+   G L  + H  R   F     RF  A ++   L YLH+      V++DI   N++L
Sbjct: 85  EYANGGEL--FFHLSRERVFTEERARFYGA-EIVSALEYLHS---RDVVYRDIKLENLML 138
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
           DK+   K+ +F   +  +   S  ++ K   GT  Y+APE +E       +D +  GVV+
Sbjct: 139 DKDGHIKITDFGLCKEGI---SDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195
Query: 513 LELITGKEAAYKQDGEE----ILLAEAVFSMVEGGNAEAKLSVLV--DPNLQ-----ANK 561
            E++ G+   Y QD E     IL+ E  F       A++ L+ L+  DP  +     ++ 
Sbjct: 196 YEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 562 KEIAHHLIMLCL 573
           KE+  H   L +
Sbjct: 256 KEVMEHRFFLSI 267

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 90/189 (47%), Gaps = 19/189 (10%)
Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            V E+   G L  + H  R   F     RF  A ++   L YLH  ++   V++D+   N
Sbjct: 87  FVMEYANGGEL--FFHLSRERVFSEDRARFYGA-EIVSALDYLH--SEKNVVYRDLKLEN 141
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           ++LDK+   K+ +F   +  +++ +   + K   GT  Y+APE +E       +D +  G
Sbjct: 142 LMLDKDGHIKITDFGLCKEGIKDGA---TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLG 198
Query: 510 VVLLELITGKEAAYKQDGEE----ILLAEAVFSMVEGGNAEAKLSVLV--DPNLQ----- 558
           VV+ E++ G+   Y QD E+    IL+ E  F    G  A++ LS L+  DP  +     
Sbjct: 199 VVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGS 258
Query: 559 ANKKEIAHH 567
            + KEI  H
Sbjct: 259 EDAKEIMQH 267

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 90/189 (47%), Gaps = 19/189 (10%)
Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            V E+   G L  + H  R   F     RF  A ++   L YLH  ++   V++D+   N
Sbjct: 85  FVMEYANGGEL--FFHLSRERVFSEDRARFYGA-EIVSALDYLH--SEKNVVYRDLKLEN 139
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           ++LDK+   K+ +F   +  +++ +   + K   GT  Y+APE +E       +D +  G
Sbjct: 140 LMLDKDGHIKITDFGLCKEGIKDGA---TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLG 196
Query: 510 VVLLELITGKEAAYKQDGEE----ILLAEAVFSMVEGGNAEAKLSVLV--DPNLQ----- 558
           VV+ E++ G+   Y QD E+    IL+ E  F    G  A++ LS L+  DP  +     
Sbjct: 197 VVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGS 256
Query: 559 ANKKEIAHH 567
            + KEI  H
Sbjct: 257 EDAKEIMQH 265

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 93/191 (48%), Gaps = 21/191 (10%)
Query: 339 GSVFRG--IINGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V+    +  G  VAI+ M       +  I  E+ ++++  + N++N   +       +
Sbjct: 35  GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 94
Query: 390 LVYEFMENGSLSDWLHKKRYPEF-VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +V E++  GSL+D + +    E  ++  CR     +    L +LH+      +H+DI S 
Sbjct: 95  VVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQ---VIHRDIKSD 146
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           NILL  +   KL +F F      E+S  S     VGT  +MAPE +      P++D ++ 
Sbjct: 147 NILLGMDGSVKLTDFGFCAQITPEQSKRSXM---VGTPYWMAPEVVTRKAYGPKVDIWSL 203
Query: 509 GVVLLELITGK 519
           G++ +E+I G+
Sbjct: 204 GIMAIEMIEGE 214

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 111/270 (41%), Gaps = 41/270 (15%)
Query: 343 RGIING---STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           R II G   + VA+K +  S S         E +++K     +++ L G         +V
Sbjct: 39  RDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 98
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCR--------FRIALDVAHGLHYLHNCTDPGYVHK 443
            E M +G L  +L   R PE  +   R         ++A ++A G+ YL+      +VH+
Sbjct: 99  MELMAHGDLKSYLRSLR-PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHR 154
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           D+++ N ++  +   K+ +F   R     +      K  +    +MAPE ++ G+ T   
Sbjct: 155 DLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMAPESLKDGVFTTSS 213
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGVVL E+ +  E  Y                 +G + E  L  ++D         
Sbjct: 214 DMWSFGVVLWEITSLAEQPY-----------------QGLSNEQVLKFVMDGGYLDQPDN 256
Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTL 593
               +  L   C    P+ RP+  E+V+ L
Sbjct: 257 CPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 87/180 (48%), Gaps = 10/180 (5%)
Query: 341 VFRGIINGSTVAIKC-MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           VF G I   ++ +K   R  +S E+++ + + H +++   G  E +   ++V E     S
Sbjct: 44  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 103
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           L + LHK+R         R+ +   +  G  YLH       +H+D+  GN+ L+++L  K
Sbjct: 104 LLE-LHKRRK-ALTEPEARYYLR-QIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVK 157
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           + +F     A + E      KT  GT  Y+APE +     + E+D ++ G ++  L+ GK
Sbjct: 158 IGDFGL---ATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 112/270 (41%), Gaps = 41/270 (15%)
Query: 343 RGIING---STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           R II G   + VA+K +  S S         E +++K     +++ L G         +V
Sbjct: 38  RDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 97
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCR--------FRIALDVAHGLHYLHNCTDPGYVHK 443
            E M +G L  +L   R PE  +   R         ++A ++A G+ YL+      +VH+
Sbjct: 98  MELMAHGDLKSYLRSLR-PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHR 153
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           D+++ N ++  +   K+ +F   R  + E   Y      +    +MAPE ++ G+ T   
Sbjct: 154 DLAARNCMVAHDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSS 212
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGVVL E+ +  E  Y                 +G + E  L  ++D         
Sbjct: 213 DMWSFGVVLWEITSLAEQPY-----------------QGLSNEQVLKFVMDGGYLDQPDN 255
Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTL 593
               +  L   C    P+ RP+  E+V+ L
Sbjct: 256 CPERVTDLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 82/179 (45%), Gaps = 14/179 (7%)
Query: 348 GSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMENG 398
           G  VA+K ++       R   +E+ +LK + H N++   G C   G     L+ E++  G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL D+L    + E +      +    +  G+ YL       Y+H+D+++ NIL++   R 
Sbjct: 102 SLRDYLQA--HAERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 156
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
           K+ +F   +   +++      +       + APE +     +   D ++FGVVL EL T
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 123/273 (45%), Gaps = 37/273 (13%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 45  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 104
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ +L       +VH+D
Sbjct: 105 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKFL---ASKKFVHRD 159
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN-GYMAPEYMEYGLVTPEM 503
           +++ N +LD+    K+A+F   R  + +E      KT       +MA E ++    T + 
Sbjct: 160 LAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 219
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    +   
Sbjct: 220 DVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRR-------LLQPEYCPDP-- 266
Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
               L  + L C   + E RPS +E+VS +  I
Sbjct: 267 ----LYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 87/180 (48%), Gaps = 10/180 (5%)
Query: 341 VFRGIINGSTVAIKC-MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           VF G I   ++ +K   R  +S E+++ + + H +++   G  E +   ++V E     S
Sbjct: 48  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 107
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           L + LHK+R         R+ +   +  G  YLH       +H+D+  GN+ L+++L  K
Sbjct: 108 LLE-LHKRRK-ALTEPEARYYLR-QIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVK 161
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           + +F     A + E      KT  GT  Y+APE +     + E+D ++ G ++  L+ GK
Sbjct: 162 IGDFGL---ATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 218

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 90/189 (47%), Gaps = 19/189 (10%)
Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            V E+   G L  + H  R   F     RF  A ++   L YLH  ++   V++D+   N
Sbjct: 86  FVMEYANGGEL--FFHLSRERVFSEDRARFYGA-EIVSALDYLH--SEKNVVYRDLKLEN 140
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           ++LDK+   K+ +F   +  +++ +   + K   GT  Y+APE +E       +D +  G
Sbjct: 141 LMLDKDGHIKITDFGLCKEGIKDGA---TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLG 197
Query: 510 VVLLELITGKEAAYKQDGEE----ILLAEAVFSMVEGGNAEAKLSVLV--DPNLQ----- 558
           VV+ E++ G+   Y QD E+    IL+ E  F    G  A++ LS L+  DP  +     
Sbjct: 198 VVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGS 257
Query: 559 ANKKEIAHH 567
            + KEI  H
Sbjct: 258 EDAKEIMQH 266

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 94/191 (49%), Gaps = 21/191 (10%)
Query: 339 GSVFRG--IINGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V+    +  G  VAI+ M       +  I  E+ ++++  + N++N   +       +
Sbjct: 35  GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 94
Query: 390 LVYEFMENGSLSDWLHKKRYPEF-VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +V E++  GSL+D + +    E  ++  CR     +    L +LH+      +H++I S 
Sbjct: 95  VVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQ---VIHRNIKSD 146
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           NILL  +   KL +F F      E+S  S   T VGT  +MAPE +      P++D ++ 
Sbjct: 147 NILLGMDGSVKLTDFGFCAQITPEQSKRS---TMVGTPYWMAPEVVTRKAYGPKVDIWSL 203
Query: 509 GVVLLELITGK 519
           G++ +E+I G+
Sbjct: 204 GIMAIEMIEGE 214

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/252 (21%), Positives = 121/252 (48%), Gaps = 30/252 (11%)
Query: 351 VAIKCMRR-SISK-----EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           VAIK ++  S+S+     E  ++  ++H  L+ L+G C      +++ E+M NG L ++L
Sbjct: 36  VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 95
Query: 405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS 464
            + R+  F +      +  DV   + YL +     ++H+D+++ N L++     K+++F 
Sbjct: 96  REMRH-RFQTQQL-LEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFG 150
Query: 465 FVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYK 524
             R  + +E  Y+S++ +     +  PE + Y   + + D +AFGV++ E+ +  +  Y+
Sbjct: 151 LSRYVLDDE--YTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208
Query: 525 QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRP 584
           +           F+  E     A+   L  P+L + K      +  +  +C   + + RP
Sbjct: 209 R-----------FTNSETAEHIAQGLRLYRPHLASEK------VYTIMYSCWHEKADERP 251
Query: 585 SMAEVVSTLMKI 596
           +   ++S ++ +
Sbjct: 252 TFKILLSNILDV 263

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 111/270 (41%), Gaps = 41/270 (15%)
Query: 343 RGIING---STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           R II G   + VA+K +  S S         E +++K     +++ L G         +V
Sbjct: 36  RDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 95
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCR--------FRIALDVAHGLHYLHNCTDPGYVHK 443
            E M +G L  +L   R PE  +   R         ++A ++A G+ YL+      +VH+
Sbjct: 96  MELMAHGDLKSYLRSLR-PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHR 151
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           D+++ N ++  +   K+ +F   R     +      K  +    +MAPE ++ G+ T   
Sbjct: 152 DLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMAPESLKDGVFTTSS 210
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGVVL E+ +  E  Y                 +G + E  L  ++D         
Sbjct: 211 DMWSFGVVLWEITSLAEQPY-----------------QGLSNEQVLKFVMDGGYLDQPDN 253
Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTL 593
               +  L   C    P+ RP+  E+V+ L
Sbjct: 254 CPERVTDLMRMCWQFNPKMRPTFLEIVNLL 283

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 87/180 (48%), Gaps = 10/180 (5%)
Query: 341 VFRGIINGSTVAIKC-MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           VF G I   ++ +K   R  +S E+++ + + H +++   G  E +   ++V E     S
Sbjct: 44  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 103
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           L + LHK+R         R+ +   +  G  YLH       +H+D+  GN+ L+++L  K
Sbjct: 104 LLE-LHKRRK-ALTEPEARYYLR-QIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVK 157
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           + +F     A + E      KT  GT  Y+APE +     + E+D ++ G ++  L+ GK
Sbjct: 158 IGDFGL---ATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 120/278 (43%), Gaps = 56/278 (20%)
Query: 339 GSVFRGI--INGSTVAIKCMR---RSISKEVNLLKKINHFNLINLFGACEHDGV------ 387
           G VF+    I+G T  IK ++       +EV  L K++H N+++  G    DG       
Sbjct: 25  GQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCW--DGFDYDPET 82
Query: 388 ------------FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNC 435
                        ++  EF + G+L  W+ K+R  E +       +   +  G+ Y+H+ 
Sbjct: 83  SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHS- 140
Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME 495
                +++D+   NI L    + K+ +F  V ++++ +     +K   GT  YM+PE + 
Sbjct: 141 --KKLINRDLKPSNIFLVDTKQVKIGDFGLV-TSLKNDGKRXRSK---GTLRYMSPEQIS 194
Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
                 E+D YA G++L EL+   + A++       L + + S +               
Sbjct: 195 SQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDI--------------- 239
Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
               +KKE       L    ++++PE RP+ +E++ TL
Sbjct: 240 ---FDKKEKT-----LLQKLLSKKPEDRPNTSEILRTL 269

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 115/262 (43%), Gaps = 37/262 (14%)
Query: 335 NMIDGSVFRGIINGSTVAIKC-MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           +M    VF G +   ++ +K   +  +S E+ + K +++ +++   G  E D   Y+V E
Sbjct: 63  DMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLE 122
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
                SL + LHK+R         R+ +   +  G+ YLHN      +H+D+  GN+ L+
Sbjct: 123 ICRRRSLLE-LHKRRK-AVTEPEARYFMRQTI-QGVQYLHNNR---VIHRDLKLGNLFLN 176
Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLL 513
            ++  K+ +F     A + E      KT  GT  Y+APE +     + E+D ++ G +L 
Sbjct: 177 DDMDVKIGDFGL---ATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILY 233
Query: 514 ELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCL 573
            L+ GK        E   L E                      ++ N+  +  H+  +  
Sbjct: 234 TLLVGKPPF-----ETSCLKETYI------------------RIKKNEYSVPRHINPVAS 270
Query: 574 ACIAR----EPESRPSMAEVVS 591
           A I R    +P  RPS+AE+++
Sbjct: 271 ALIRRMLHADPTLRPSVAELLT 292

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 110/270 (40%), Gaps = 41/270 (15%)
Query: 343 RGIING---STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           R II G   + VA+K +  S S         E +++K     +++ L G         +V
Sbjct: 39  RDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 98
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCR--------FRIALDVAHGLHYLHNCTDPGYVHK 443
            E M +G L  +L   R PE  +   R         ++A ++A G+ YL+      +VH+
Sbjct: 99  MELMAHGDLKSYLRSLR-PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHR 154
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           D+++ N ++  +   K+ +F   R     +      K  +    +MAPE ++ G+ T   
Sbjct: 155 DLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMAPESLKDGVFTTSS 213
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGVVL E+ +  E  Y                 +G + E  L  ++D         
Sbjct: 214 DMWSFGVVLWEITSLAEQPY-----------------QGLSNEQVLKFVMDGGYLDQPDN 256
Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTL 593
               +  L   C    P  RP+  E+V+ L
Sbjct: 257 CPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 75/160 (46%), Gaps = 20/160 (12%)
Query: 375 LINLFGACEHDGVFYLVYEFMENGSLSDWLHK--KRYPEFVS--WNCRFRIALDVAHGLH 430
           +  L  A + D   YLV ++   G L   L K   R PE ++  +     IA+D  H LH
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           Y         VH+DI   NIL+D N   +LA+F      +  E G   +  AVGT  Y++
Sbjct: 196 Y---------VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYIS 244
Query: 491 PEYMEY-----GLVTPEMDTYAFGVVLLELITGKEAAYKQ 525
           PE ++      G   PE D ++ GV + E++ G+   Y +
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 122/273 (44%), Gaps = 37/273 (13%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 42  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 101
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ +L       +VH+D
Sbjct: 102 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKFL---ASKKFVHRD 156
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN-GYMAPEYMEYGLVTPEM 503
           +++ N +LD+    K+A+F   R    +E      KT       +MA E ++    T + 
Sbjct: 157 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 216
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    +   
Sbjct: 217 DVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRR-------LLQPEYCPDP-- 263
Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
               L  + L C   + E RPS +E+VS +  I
Sbjct: 264 ----LYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 112/262 (42%), Gaps = 38/262 (14%)
Query: 339 GSVFRGIINGS--TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G VF+GI N +   VAIK +           I +E+ +L + +   +   +G+   D   
Sbjct: 41  GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 100
Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +++ E++  GS  D L     P  +       I  ++  GL YLH+      +H+DI + 
Sbjct: 101 WIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAA 153
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           N+LL ++   KLA+F         +       T VGT  +MAPE ++      + D ++ 
Sbjct: 154 NVLLSEHGEVKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 210
Query: 509 GVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL 568
           G+  +EL  G E  + +     L    V  ++   N          P L+ N    +  L
Sbjct: 211 GITAIELARG-EPPHSE-----LHPMKVLFLIPKNNP---------PTLEGN---YSKPL 252
Query: 569 IMLCLACIAREPESRPSMAEVV 590
                AC+ +EP  RP+  E++
Sbjct: 253 KEFVEACLNKEPSFRPTAKELL 274

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 122/273 (44%), Gaps = 37/273 (13%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 44  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 103
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ +L       +VH+D
Sbjct: 104 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKFL---ASKKFVHRD 158
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN-GYMAPEYMEYGLVTPEM 503
           +++ N +LD+    K+A+F   R    +E      KT       +MA E ++    T + 
Sbjct: 159 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 218
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    +   
Sbjct: 219 DVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRR-------LLQPEYCPDP-- 265
Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
               L  + L C   + E RPS +E+VS +  I
Sbjct: 266 ----LYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 112/262 (42%), Gaps = 38/262 (14%)
Query: 339 GSVFRGIINGS--TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G VF+GI N +   VAIK +           I +E+ +L + +   +   +G+   D   
Sbjct: 21  GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 80
Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +++ E++  GS  D L     P  +       I  ++  GL YLH+      +H+DI + 
Sbjct: 81  WIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAA 133
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           N+LL ++   KLA+F         +       T VGT  +MAPE ++      + D ++ 
Sbjct: 134 NVLLSEHGEVKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 190
Query: 509 GVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL 568
           G+  +EL  G E  + +     L    V  ++   N          P L+ N    +  L
Sbjct: 191 GITAIELARG-EPPHSE-----LHPMKVLFLIPKNNP---------PTLEGN---YSKPL 232
Query: 569 IMLCLACIAREPESRPSMAEVV 590
                AC+ +EP  RP+  E++
Sbjct: 233 KEFVEACLNKEPSFRPTAKELL 254

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 122/273 (44%), Gaps = 37/273 (13%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 49  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 108
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ +L       +VH+D
Sbjct: 109 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKFL---ASKKFVHRD 163
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN-GYMAPEYMEYGLVTPEM 503
           +++ N +LD+    K+A+F   R    +E      KT       +MA E ++    T + 
Sbjct: 164 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 223
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    +   
Sbjct: 224 DVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRR-------LLQPEYCPDP-- 270
Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
               L  + L C   + E RPS +E+VS +  I
Sbjct: 271 ----LYEVMLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 122/273 (44%), Gaps = 37/273 (13%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 44  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 103
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ +L       +VH+D
Sbjct: 104 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKFL---ASKKFVHRD 158
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN-GYMAPEYMEYGLVTPEM 503
           +++ N +LD+    K+A+F   R    +E      KT       +MA E ++    T + 
Sbjct: 159 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 218
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    +   
Sbjct: 219 DVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRR-------LLQPEYCPDP-- 265
Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
               L  + L C   + E RPS +E+VS +  I
Sbjct: 266 ----LYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 122/273 (44%), Gaps = 37/273 (13%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 103 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ +L       +VH+D
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKFL---ASKKFVHRD 217
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN-GYMAPEYMEYGLVTPEM 503
           +++ N +LD+    K+A+F   R    +E      KT       +MA E ++    T + 
Sbjct: 218 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 277
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    +   
Sbjct: 278 DVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRR-------LLQPEYCPDP-- 324
Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
               L  + L C   + E RPS +E+VS +  I
Sbjct: 325 ----LYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 122/273 (44%), Gaps = 37/273 (13%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +++     I C  +S+++            E  ++K  +H N+++L G C   
Sbjct: 45  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 104
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +   V     F   L VA G+ +L       +VH+D
Sbjct: 105 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF--GLQVAKGMKFL---ASKKFVHRD 159
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN-GYMAPEYMEYGLVTPEM 503
           +++ N +LD+    K+A+F   R    +E      KT       +MA E ++    T + 
Sbjct: 160 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 219
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGV+L EL+T     Y     ++   +    +++G         L+ P    +   
Sbjct: 220 DVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRR-------LLQPEYCPDP-- 266
Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
               L  + L C   + E RPS +E+VS +  I
Sbjct: 267 ----LYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 348 GSTVAIKCMRR--------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           G   A+KC+ +        SI  E+ +L+KI H N++ L    E     YLV + +  G 
Sbjct: 47  GKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGE 106
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNL 456
           L D + +K +      +   R  LD  + LH +      G VH+D+   N+L    D+  
Sbjct: 107 LFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRM------GIVHRDLKPENLLYYSQDEES 160
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI 516
           +  +++F   +     E       TA GT GY+APE +     +  +D ++ GV+   L+
Sbjct: 161 KIMISDFGLSKM----EGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 216
Query: 517 TGKEAAYKQDG----EEILLAEAVF 537
            G    Y ++     E+IL AE  F
Sbjct: 217 CGYPPFYDENDSKLFEQILKAEYEF 241

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 83/181 (45%), Gaps = 17/181 (9%)
Query: 347 NGSTVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDG--VFYLVYEFME 396
            G  VA+K +        R    +E+++L+ + H ++I   G CE  G     LV E++ 
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
            GSL D+L +      +        A  +  G+ YLH+     Y+H+++++ N+LLD + 
Sbjct: 102 LGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHS---QHYIHRNLAARNVLLDNDR 154
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI 516
             K+ +F   ++       Y   +       + APE ++        D ++FGV L EL+
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214
Query: 517 T 517
           T
Sbjct: 215 T 215

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/289 (21%), Positives = 123/289 (42%), Gaps = 65/289 (22%)
Query: 339 GSVFRGI--INGSTVAIKCMR---RSISKEVNLLKKINHFNLINLFG------------- 380
           G VF+    I+G T  I+ ++       +EV  L K++H N+++  G             
Sbjct: 26  GQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSD 85
Query: 381 ----ACEHD------------GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALD 424
               + ++D               ++  EF + G+L  W+ K+R  E +       +   
Sbjct: 86  DSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQ 144
Query: 425 VAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG 484
           +  G+ Y+H+      +H+D+   NI L    + K+ +F  V ++++ +   + +K   G
Sbjct: 145 ITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLV-TSLKNDGKRTRSK---G 197
Query: 485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN 544
           T  YM+PE +       E+D YA G++L EL+   + A++       L + + S +    
Sbjct: 198 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDI---- 253
Query: 545 AEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                          +KKE       L    ++++PE RP+ +E++ TL
Sbjct: 254 --------------FDKKEKT-----LLQKLLSKKPEDRPNTSEILRTL 283

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 82/176 (46%), Gaps = 12/176 (6%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYPEFV 413
            +R  I +E+ +L + N   ++  +GA   DG   +  E M+ GSL   L K  R PE +
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI 105
Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
                 ++++ V  GL YL        +H+D+   NIL++     KL +F      +   
Sbjct: 106 LG----KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157
Query: 474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE 529
              S   + VGT  YM+PE ++    + + D ++ G+ L+E+  G+      D +E
Sbjct: 158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 17/181 (9%)
Query: 347 NGSTVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDG--VFYLVYEFME 396
            G  VA+K +        R    +E+++L+ + H ++I   G CE  G     LV E++ 
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
            GSL D+L +      +        A  +  G+ YLH      Y+H+++++ N+LLD + 
Sbjct: 102 LGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHA---QHYIHRNLAARNVLLDNDR 154
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI 516
             K+ +F   ++       Y   +       + APE ++        D ++FGV L EL+
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214
Query: 517 T 517
           T
Sbjct: 215 T 215

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 86/180 (47%), Gaps = 10/180 (5%)
Query: 341 VFRGIINGSTVAIKC-MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           VF G I   ++ +K   R  +S E+++ + + H +++   G  E +   ++V E     S
Sbjct: 66  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 125
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           L + LHK+R         R+ +   +  G  YLH       +H+D+  GN+ L+++L  K
Sbjct: 126 LLE-LHKRRK-ALTEPEARYYLR-QIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVK 179
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           + +F     A + E      K   GT  Y+APE +     + E+D ++ G ++  L+ GK
Sbjct: 180 IGDFGL---ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 236

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 33/198 (16%)
Query: 339 GSVF--RGIINGSTVAIK---------CMRRSISKEVNLLKKINHFNLINLFGACEHDGV 387
           G VF  R    G  VAIK          +++   +E+ +LK++ H NL+NL         
Sbjct: 17  GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR 76
Query: 388 FYLVYEFMENGSLSDWLHKKR-YPEFVSWNCRFRI--ALDVAHGLHYLHNCTDPGYVHKD 444
            +LV+E+ ++  L +    +R  PE +  +  ++   A++  H     HNC     +H+D
Sbjct: 77  LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK----HNC-----IHRD 127
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----EYGLVT 500
           +   NIL+ K+   KL +F F R        Y      V T  Y +PE +    +YG   
Sbjct: 128 VKPENILITKHSVIKLCDFGFARLLTGPSDYYDD---EVATRWYRSPELLVGDTQYG--- 181
Query: 501 PEMDTYAFGVVLLELITG 518
           P +D +A G V  EL++G
Sbjct: 182 PPVDVWAIGCVFAELLSG 199

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 84/192 (43%), Gaps = 36/192 (18%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGV------FYLV 391
            G+ VAIK + R            +E+ LLK + H N+I L      D        FYLV
Sbjct: 49  TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
             FM         H+K   + + +     +   +  GL Y+H     G +H+D+  GN+ 
Sbjct: 109 MPFMGTDLGKLMKHEKLGEDRIQF-----LVYQMLKGLRYIHAA---GIIHRDLKPGNLA 160
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE----YMEYGLVTPEMDTYA 507
           ++++   K+ +F   R A  E  G       V T  Y APE    +M Y   T  +D ++
Sbjct: 161 VNEDCELKILDFGLARQADSEMXG------XVVTRWYRAPEVILNWMRY---TQTVDIWS 211
Query: 508 FGVVLLELITGK 519
            G ++ E+ITGK
Sbjct: 212 VGCIMAEMITGK 223

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 124/265 (46%), Gaps = 31/265 (11%)
Query: 339 GSVFRGIINGS-TVAIKCMRR-SISK-----EVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V  G   G   VAIK ++  S+S+     E  ++  ++H  L+ L+G C      +++
Sbjct: 18  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E+M NG L ++L + R+  F +      +  DV   + YL +     ++H+D+++ N L
Sbjct: 78  TEYMANGCLLNYLREMRH-RFQTQQL-LEMCKDVCEAMEYLES---KQFLHRDLAARNCL 132
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           ++     K+++F   R  + +E  Y+S+  +     +  PE + Y   + + D +AFGV+
Sbjct: 133 VNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 190
Query: 512 LLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML 571
           + E+ +  +  Y++           F+  E     A+   L  P+L + K      +  +
Sbjct: 191 MWEIYSLGKMPYER-----------FTNSETAEHIAQGLRLYRPHLASEK------VYTI 233
Query: 572 CLACIAREPESRPSMAEVVSTLMKI 596
             +C   + + RP+   ++S ++ +
Sbjct: 234 MYSCWHEKADERPTFKILLSNILDV 258

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/271 (22%), Positives = 125/271 (46%), Gaps = 43/271 (15%)
Query: 339 GSVFRGIINGS-TVAIKCMRR-SISK-----EVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V  G   G   VAIK ++  S+S+     E  ++  ++H  L+ L+G C      +++
Sbjct: 22  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 81
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFR------IALDVAHGLHYLHNCTDPGYVHKDI 445
            E+M NG L ++L + R+        RF+      +  DV   + YL +     ++H+D+
Sbjct: 82  TEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDL 130
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N L++     K+++F   R  + +E  Y+S+  +     +  PE + Y   + + D 
Sbjct: 131 AARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 188
Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           +AFGV++ E+ +  +  Y++           F+  E     A+   L  P+L + K    
Sbjct: 189 WAFGVLMWEIYSLGKMPYER-----------FTNSETAEHIAQGLRLYRPHLASEK---- 233
Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
             +  +  +C   + + RP+   ++S ++ +
Sbjct: 234 --VYTIMYSCWHEKADERPTFKILLSNILDV 262

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 86/180 (47%), Gaps = 10/180 (5%)
Query: 341 VFRGIINGSTVAIKC-MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGS 399
           VF G I   ++ +K   R  +S E+++ + + H +++   G  E +   ++V E     S
Sbjct: 68  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127
Query: 400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
           L + LHK+R         R+ +   +  G  YLH       +H+D+  GN+ L+++L  K
Sbjct: 128 LLE-LHKRRK-ALTEPEARYYLR-QIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVK 181
Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           + +F     A + E      K   GT  Y+APE +     + E+D ++ G ++  L+ GK
Sbjct: 182 IGDFGL---ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/252 (21%), Positives = 120/252 (47%), Gaps = 30/252 (11%)
Query: 351 VAIKCMRR-SISK-----EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           VAIK ++  S+S+     E  ++  ++H  L+ L+G C      +++ E+M NG L ++L
Sbjct: 51  VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 110
Query: 405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS 464
            + R+  F +      +  DV   + YL +     ++H+D+++ N L++     K+++F 
Sbjct: 111 REMRH-RFQTQQL-LEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFG 165
Query: 465 FVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYK 524
             R  + +E  Y+S+  +     +  PE + Y   + + D +AFGV++ E+ +  +  Y+
Sbjct: 166 LSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223
Query: 525 QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRP 584
           +           F+  E     A+   L  P+L + K      +  +  +C   + + RP
Sbjct: 224 R-----------FTNSETAEHIAQGLRLYRPHLASEK------VYTIMYSCWHEKADERP 266
Query: 585 SMAEVVSTLMKI 596
           +   ++S ++ +
Sbjct: 267 TFKILLSNILDV 278

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/258 (21%), Positives = 121/258 (46%), Gaps = 42/258 (16%)
Query: 351 VAIKCMRR-SISK-----EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           VAIK ++  S+S+     E  ++  ++H  L+ L+G C      +++ E+M NG L ++L
Sbjct: 36  VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 95
Query: 405 HKKRYPEFVSWNCRFR------IALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
            + R+        RF+      +  DV   + YL +     ++H+D+++ N L++     
Sbjct: 96  REMRH--------RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVV 144
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           K+++F   R  + +E  Y+S+  +     +  PE + Y   + + D +AFGV++ E+ + 
Sbjct: 145 KVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 202
Query: 519 KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAR 578
            +  Y++           F+  E     A+   L  P+L + K      +  +  +C   
Sbjct: 203 GKMPYER-----------FTNSETAEHIAQGLRLYRPHLASEK------VYTIMYSCWHE 245
Query: 579 EPESRPSMAEVVSTLMKI 596
           + + RP+   ++S ++ +
Sbjct: 246 KADERPTFKILLSNILDV 263

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 111/270 (41%), Gaps = 41/270 (15%)
Query: 343 RGIING---STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           R II G   + VA+K +  S S         E +++K     +++ L G         +V
Sbjct: 39  RDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 98
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCR--------FRIALDVAHGLHYLHNCTDPGYVHK 443
            E M +G L  +L   R PE  +   R         ++A ++A G+ YL+      +VH+
Sbjct: 99  MELMAHGDLKSYLRSLR-PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHR 154
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           ++++ N ++  +   K+ +F   R  + E   Y      +    +MAPE ++ G+ T   
Sbjct: 155 NLAARNCMVAHDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSS 213
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGVVL E+ +  E  Y                 +G + E  L  ++D         
Sbjct: 214 DMWSFGVVLWEITSLAEQPY-----------------QGLSNEQVLKFVMDGGYLDQPDN 256
Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTL 593
               +  L   C    P  RP+  E+V+ L
Sbjct: 257 CPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 123/279 (44%), Gaps = 54/279 (19%)
Query: 343 RGIINGSTVAIKCMRRSISK----------EVNLLKKINHFNLINLFGACEHDG----VF 388
           R + +   VA+K +R  +++          E      +NH  ++ ++   E +     + 
Sbjct: 32  RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91
Query: 389 YLVYEFMENGSLSDWLH------KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
           Y+V E+++  +L D +H       KR  E ++  C+          L++ H     G +H
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ---------ALNFSHQN---GIIH 139
Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA--VGTNGYMAPEYMEYGLVT 500
           +D+   NI++      K+ +F   R+    +SG S T+TA  +GT  Y++PE      V 
Sbjct: 140 RDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQYLSPEQARGDSVD 197
Query: 501 PEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN 560
              D Y+ G VL E++TG E  +  D  + +               A   V  DP   + 
Sbjct: 198 ARSDVYSLGCVLYEVLTG-EPPFTGDSPDSV---------------AYQHVREDPIPPSA 241
Query: 561 KKE-IAHHLIMLCLACIAREPESR-PSMAEVVSTLMKIQ 597
           + E ++  L  + L  +A+ PE+R  + AE+ + L+++ 
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 88/192 (45%), Gaps = 37/192 (19%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLF------GACEHDGVFYLV 391
           +G  VAIK + R            +E+ LLK + H N+I L        +  +   FYLV
Sbjct: 66  SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
             FM+       L K    EF     ++ +   +  GL Y+H+    G VH+D+  GN+ 
Sbjct: 126 MPFMQTD-----LQKIMGMEFSEEKIQY-LVYQMLKGLKYIHSA---GVVHRDLKPGNLA 176
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE----YMEYGLVTPEMDTYA 507
           ++++   K+ +F   R A  E +GY      V T  Y APE    +M Y      +D ++
Sbjct: 177 VNEDCELKILDFGLARHADAEMTGY------VVTRWYRAPEVILSWMHYNQT---VDIWS 227
Query: 508 FGVVLLELITGK 519
            G ++ E++TGK
Sbjct: 228 VGCIMAEMLTGK 239

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 35/204 (17%)
Query: 339 GSVFRG--IINGSTVAIKCM------RRSISKEVNLLKKINHF-NLINLFGAC------E 383
           G V++G  +  G   AIK M         I +E+N+LKK +H  N+   +GA        
Sbjct: 38  GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97
Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
            D   +LV EF   GS++D +   +      E++++ CR     ++  GL +LH      
Sbjct: 98  MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-----EILRGLSHLHQHK--- 149
Query: 440 YVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EY 496
            +H+DI   N+LL +N   KL +F     + + +       T +GT  +MAPE +   E 
Sbjct: 150 VIHRDIKGQNVLLTENAEVKLVDFGV---SAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 206
Query: 497 GLVTPEM--DTYAFGVVLLELITG 518
              T +   D ++ G+  +E+  G
Sbjct: 207 PDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 111/270 (41%), Gaps = 41/270 (15%)
Query: 343 RGIING---STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           R II G   + VA+K +  S S         E +++K     +++ L G         +V
Sbjct: 40  RDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 99
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCR--------FRIALDVAHGLHYLHNCTDPGYVHK 443
            E M +G L  +L   R PE  +   R         ++A ++A G+ YL+      +VH+
Sbjct: 100 MELMAHGDLKSYLRSLR-PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHR 155
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           ++++ N ++  +   K+ +F   R  + E   Y      +    +MAPE ++ G+ T   
Sbjct: 156 NLAARNCMVAHDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSS 214
Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGVVL E+ +  E  Y                 +G + E  L  ++D         
Sbjct: 215 DMWSFGVVLWEITSLAEQPY-----------------QGLSNEQVLKFVMDGGYLDQPDN 257
Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTL 593
               +  L   C    P  RP+  E+V+ L
Sbjct: 258 CPERVTDLMRMCWQFNPNMRPTFLEIVNLL 287

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 86/181 (47%), Gaps = 10/181 (5%)
Query: 340 SVFRGIINGSTVAIKC-MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENG 398
            VF G I   ++ +K   R  +S E+++ + + H +++   G  E +   ++V E     
Sbjct: 41  EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 100
Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           SL + LHK+R         R+ +   +  G  YLH       +H+D+  GN+ L+++L  
Sbjct: 101 SLLE-LHKRRK-ALTEPEARYYLR-QIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEV 154
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           K+ +F     A + E      K   GT  Y+APE +     + E+D ++ G ++  L+ G
Sbjct: 155 KIGDFGL---ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211
Query: 519 K 519
           K
Sbjct: 212 K 212

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 114/262 (43%), Gaps = 37/262 (14%)
Query: 335 NMIDGSVFRGIINGSTVAIKC-MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           +M    VF G +   ++ +K   +  +S E+ + K +++ +++   G  E D   Y+V E
Sbjct: 63  DMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLE 122
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
                SL + LHK+R         R+ +   +  G+ YLHN      +H+D+  GN+ L+
Sbjct: 123 ICRRRSLLE-LHKRRK-AVTEPEARYFMRQTI-QGVQYLHNNR---VIHRDLKLGNLFLN 176
Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLL 513
            ++  K+ +F     A + E      K   GT  Y+APE +     + E+D ++ G +L 
Sbjct: 177 DDMDVKIGDFGL---ATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILY 233
Query: 514 ELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCL 573
            L+ GK        E   L E                      ++ N+  +  H+  +  
Sbjct: 234 TLLVGKPPF-----ETSCLKETYI------------------RIKKNEYSVPRHINPVAS 270
Query: 574 ACIAR----EPESRPSMAEVVS 591
           A I R    +P  RPS+AE+++
Sbjct: 271 ALIRRMLHADPTLRPSVAELLT 292

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 127/280 (45%), Gaps = 38/280 (13%)
Query: 281 HKRRRDEAARKDG---------KREKKRNLPEDFLVSVSNL-------DRGLKFYKYEDL 324
           H +RR +    DG           +K R +P D  V  S         D+ L F K ++L
Sbjct: 279 HPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKL-FLKRDNL 337
Query: 325 VVATENFSPKNMIDGSVFRGIINGST----VAIKCMRRSISK--------EVNLLKKINH 372
           ++A       N   GSV +G+         VAIK +++   K        E  ++ ++++
Sbjct: 338 LIADIELGCGNF--GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 395
Query: 373 FNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYL 432
             ++ L G C+ + +  LV E    G L  +L  KR  E +  +    +   V+ G+ YL
Sbjct: 396 PYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYL 452
Query: 433 HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE 492
               +  +VH+++++ N+LL     AK+++F   ++   ++S Y++         + APE
Sbjct: 453 E---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509
Query: 493 YMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQ-DGEEIL 531
            + +   +   D +++GV + E ++  +  YK+  G E++
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 549

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/258 (21%), Positives = 121/258 (46%), Gaps = 42/258 (16%)
Query: 351 VAIKCMRR-SISK-----EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           VAIK ++  S+S+     E  ++  ++H  L+ L+G C      +++ E+M NG L ++L
Sbjct: 42  VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 101
Query: 405 HKKRYPEFVSWNCRFR------IALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
            + R+        RF+      +  DV   + YL +     ++H+D+++ N L++     
Sbjct: 102 REMRH--------RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVV 150
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           K+++F   R  + +E  Y+S+  +     +  PE + Y   + + D +AFGV++ E+ + 
Sbjct: 151 KVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 208
Query: 519 KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAR 578
            +  Y++           F+  E     A+   L  P+L + K      +  +  +C   
Sbjct: 209 GKMPYER-----------FTNSETAEHIAQGLRLYRPHLASEK------VYTIMYSCWHE 251
Query: 579 EPESRPSMAEVVSTLMKI 596
           + + RP+   ++S ++ +
Sbjct: 252 KADERPTFKILLSNILDV 269

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 15/186 (8%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL-SDW 403
           IIN   ++ +  ++ + +E  + + + H N++ L  +   +G  YL+++ +  G L  D 
Sbjct: 54  IINTKKLSARDHQK-LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI 112
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA---KL 460
           + ++ Y E  + +C  +I   V H       C   G VH+D+   N+LL   L+    KL
Sbjct: 113 VAREYYSEADASHCIQQILEAVLH-------CHQMGVVHRDLKPENLLLASKLKGAAVKL 165
Query: 461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE 520
           A+F     A+  E    +     GT GY++PE +        +D +A GV+L  L+ G  
Sbjct: 166 ADFGL---AIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 222
Query: 521 AAYKQD 526
             + +D
Sbjct: 223 PFWDED 228

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 114/262 (43%), Gaps = 37/262 (14%)
Query: 335 NMIDGSVFRGIINGSTVAIKC-MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           +M    VF G +   ++ +K   +  +S E+ + K +++ +++   G  E D   Y+V E
Sbjct: 63  DMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLE 122
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
                SL + LHK+R         R+ +   +  G+ YLHN      +H+D+  GN+ L+
Sbjct: 123 ICRRRSLLE-LHKRRK-AVTEPEARYFMRQTI-QGVQYLHNNR---VIHRDLKLGNLFLN 176
Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLL 513
            ++  K+ +F     A + E      K   GT  Y+APE +     + E+D ++ G +L 
Sbjct: 177 DDMDVKIGDFGL---ATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILY 233
Query: 514 ELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCL 573
            L+ GK        E   L E                      ++ N+  +  H+  +  
Sbjct: 234 TLLVGKPPF-----ETSCLKETYI------------------RIKKNEYSVPRHINPVAS 270
Query: 574 ACIAR----EPESRPSMAEVVS 591
           A I R    +P  RPS+AE+++
Sbjct: 271 ALIRRMLHADPTLRPSVAELLT 292

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 114/262 (43%), Gaps = 37/262 (14%)
Query: 335 NMIDGSVFRGIINGSTVAIKC-MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           +M    VF G +   ++ +K   +  +S E+ + K +++ +++   G  E D   Y+V E
Sbjct: 47  DMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLE 106
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
                SL + LHK+R         R+ +   +  G+ YLHN      +H+D+  GN+ L+
Sbjct: 107 ICRRRSLLE-LHKRRK-AVTEPEARYFMRQTI-QGVQYLHNNR---VIHRDLKLGNLFLN 160
Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLL 513
            ++  K+ +F     A + E      K   GT  Y+APE +     + E+D ++ G +L 
Sbjct: 161 DDMDVKIGDFGL---ATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILY 217
Query: 514 ELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCL 573
            L+ GK        E   L E                      ++ N+  +  H+  +  
Sbjct: 218 TLLVGKPPF-----ETSCLKETYI------------------RIKKNEYSVPRHINPVAS 254
Query: 574 ACIAR----EPESRPSMAEVVS 591
           A I R    +P  RPS+AE+++
Sbjct: 255 ALIRRMLHADPTLRPSVAELLT 276

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 111/262 (42%), Gaps = 38/262 (14%)
Query: 339 GSVFRGIINGS--TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G VF+GI N +   VAIK +           I +E+ +L + +   +   +G+   D   
Sbjct: 36  GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95
Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +++ E++  GS  D L     P  +       I  ++  GL YLH+      +H+DI + 
Sbjct: 96  WIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAA 148
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           N+LL ++   KLA+F         +         VGT  +MAPE ++      + D ++ 
Sbjct: 149 NVLLSEHGEVKLADFGVAGQLTDTQI---KRNXFVGTPFWMAPEVIKQSAYDSKADIWSL 205
Query: 509 GVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL 568
           G+  +EL  G E  + +     L    V  ++   N          P L+ N    +  L
Sbjct: 206 GITAIELARG-EPPHSE-----LHPMKVLFLIPKNNP---------PTLEGN---YSKPL 247
Query: 569 IMLCLACIAREPESRPSMAEVV 590
                AC+ +EP  RP+  E++
Sbjct: 248 KEFVEACLNKEPSFRPTAKELL 269

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 91/191 (47%), Gaps = 23/191 (12%)
Query: 346 INGSTVAIKCMRRS-------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENG 398
           + G   A+KC+++S       +  E+ +LKKI H N++ L    E    +YLV + +  G
Sbjct: 32  LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGG 91
Query: 399 SLSD-WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DK 454
            L D  L +  Y E         +   V   + YLH   + G VH+D+   N+L    ++
Sbjct: 92  ELFDRILERGVYTE----KDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEE 144
Query: 455 NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLE 514
           N +  + +F   +    E++G  S  TA GT GY+APE +     +  +D ++ GV+   
Sbjct: 145 NSKIMITDFGLSK---MEQNGIMS--TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYI 199
Query: 515 LITGKEAAYKQ 525
           L+ G    Y++
Sbjct: 200 LLCGYPPFYEE 210

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 56/276 (20%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K +        R ++  E+ +L  + NH N++NL GAC   G   ++ E+   G L
Sbjct: 73  TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 132
Query: 401 SDWLHKKRYPEFVSWNCRFRI----------------ALDVAHGLHYL--HNCTDPGYVH 442
            ++L +KR   F+       I                +  VA G+ +L   NC     +H
Sbjct: 133 LNFLRRKR-DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC-----IH 186
Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           +D+++ NILL      K+ +F   R  ++ +S Y     A     +MAPE +   + T E
Sbjct: 187 RDLAARNILLTHGRITKICDFGLARD-IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 245
Query: 503 MDTYAFGVVLLELITGKEAAYKQ---DGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA 559
            D +++G+ L EL +   + Y     D +   + +  F M+   +A A++  ++      
Sbjct: 246 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK----- 300
Query: 560 NKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
                          C   +P  RP+  ++V  + K
Sbjct: 301 --------------TCWDADPLKRPTFKQIVQLIEK 322

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 56/276 (20%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K +        R ++  E+ +L  + NH N++NL GAC   G   ++ E+   G L
Sbjct: 55  TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 114
Query: 401 SDWLHKKRYPEFVSWNCRFRI----------------ALDVAHGLHYL--HNCTDPGYVH 442
            ++L +KR   F+       I                +  VA G+ +L   NC     +H
Sbjct: 115 LNFLRRKR-DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC-----IH 168
Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           +D+++ NILL      K+ +F   R  ++ +S Y     A     +MAPE +   + T E
Sbjct: 169 RDLAARNILLTHGRITKICDFGLARD-IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 227
Query: 503 MDTYAFGVVLLELITGKEAAYKQ---DGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA 559
            D +++G+ L EL +   + Y     D +   + +  F M+   +A A++  ++      
Sbjct: 228 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK----- 282
Query: 560 NKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
                          C   +P  RP+  ++V  + K
Sbjct: 283 --------------TCWDADPLKRPTFKQIVQLIEK 304

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 329 ENFSPKNMIDGSVFRGII------NGSTVAIKC----------MRRSISKEVNLLKKINH 372
           E+F   N++    F G+        G  VAIK           M + +  EV +  ++ H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 373 FNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYL 432
            +++ L+   E     YLV E   NG ++ +L K R   F     R      +  G+ YL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEAR-HFMHQIITGMLYL 128
Query: 433 HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE 492
           H+    G +H+D++  N+LL +N+  K+A+F     A + +  +    T  GT  Y++PE
Sbjct: 129 HS---HGILHRDLTLSNLLLTRNMNIKIADFGL---ATQLKMPHEKHYTLCGTPNYISPE 182
Query: 493 YMEYGLVTPEMDTYAFGVVLLELITGK 519
                    E D ++ G +   L+ G+
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 56/276 (20%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K +        R ++  E+ +L  + NH N++NL GAC   G   ++ E+   G L
Sbjct: 78  TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 137
Query: 401 SDWLHKKRYPEFVSWNCRFRI----------------ALDVAHGLHYL--HNCTDPGYVH 442
            ++L +KR   F+       I                +  VA G+ +L   NC     +H
Sbjct: 138 LNFLRRKR-DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC-----IH 191
Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           +D+++ NILL      K+ +F   R  ++ +S Y     A     +MAPE +   + T E
Sbjct: 192 RDLAARNILLTHGRITKICDFGLARD-IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 250
Query: 503 MDTYAFGVVLLELITGKEAAYKQ---DGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA 559
            D +++G+ L EL +   + Y     D +   + +  F M+   +A A++  ++      
Sbjct: 251 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK----- 305
Query: 560 NKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
                          C   +P  RP+  ++V  + K
Sbjct: 306 --------------TCWDADPLKRPTFKQIVQLIEK 327

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 89/190 (46%), Gaps = 15/190 (7%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL-SDW 403
           IIN   ++ +  ++ + +E  + + + H N++ L  +   +G  YLV++ +  G L  D 
Sbjct: 36  IINTKKLSARDHQK-LEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDI 94
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD---KNLRAKL 460
           + ++ Y E  + +C  +I   V H       C   G VH+D+   N+LL    K    KL
Sbjct: 95  VAREYYSEADASHCIQQILEAVLH-------CHQMGVVHRDLKPENLLLASKCKGAAVKL 147
Query: 461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE 520
           A+F     A+  +    +     GT GY++PE +        +D +A GV+L  L+ G  
Sbjct: 148 ADFGL---AIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYP 204
Query: 521 AAYKQDGEEI 530
             + +D  ++
Sbjct: 205 PFWDEDQHKL 214

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 122/278 (43%), Gaps = 38/278 (13%)
Query: 339 GSVFRGII--NGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++GI    G TV    AIK +  +   + N        ++  ++H +L+ L G C  
Sbjct: 29  GTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 88
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             +  LV + M +G L +++H+ +  + +         + +A G+ YL        VH+D
Sbjct: 89  PTI-QLVTQLMPHGCLLEYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRD 142
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   R    +E  Y++    +    +MA E + Y   T + D
Sbjct: 143 LAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK-WMALECIHYRKFTHQSD 201
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   +    +  ++E G        L  P +       
Sbjct: 202 VWSYGVTIWELMTFGGKPY--DG---IPTREIPDLLEKGER------LPQPPI------C 244
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E+ +   ++  D QR
Sbjct: 245 TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQR 282

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 111/262 (42%), Gaps = 38/262 (14%)
Query: 339 GSVFRGIINGS--TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G VF+GI N +   VAIK +           I +E+ +L + +   +   +G+   D   
Sbjct: 21  GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 80
Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +++ E++  GS  D L     P  +       I  ++  GL YLH+      +H+DI + 
Sbjct: 81  WIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAA 133
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           N+LL ++   KLA+F         +         VGT  +MAPE ++      + D ++ 
Sbjct: 134 NVLLSEHGEVKLADFGVAGQLTDTQI---KRNXFVGTPFWMAPEVIKQSAYDSKADIWSL 190
Query: 509 GVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL 568
           G+  +EL  G E  + +     L    V  ++   N          P L+ N    +  L
Sbjct: 191 GITAIELARG-EPPHSE-----LHPMKVLFLIPKNNP---------PTLEGN---YSKPL 232
Query: 569 IMLCLACIAREPESRPSMAEVV 590
                AC+ +EP  RP+  E++
Sbjct: 233 KEFVEACLNKEPSFRPTAKELL 254

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 56/276 (20%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K +        R ++  E+ +L  + NH N++NL GAC   G   ++ E+   G L
Sbjct: 71  TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 130
Query: 401 SDWLHKKRYPEFVSWNCRFRI----------------ALDVAHGLHYL--HNCTDPGYVH 442
            ++L +KR   F+       I                +  VA G+ +L   NC     +H
Sbjct: 131 LNFLRRKR-DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC-----IH 184
Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           +D+++ NILL      K+ +F   R  ++ +S Y     A     +MAPE +   + T E
Sbjct: 185 RDLAARNILLTHGRITKICDFGLARD-IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 243
Query: 503 MDTYAFGVVLLELITGKEAAYKQ---DGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA 559
            D +++G+ L EL +   + Y     D +   + +  F M+   +A A++  ++      
Sbjct: 244 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK----- 298
Query: 560 NKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
                          C   +P  RP+  ++V  + K
Sbjct: 299 --------------TCWDADPLKRPTFKQIVQLIEK 320

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 95/191 (49%), Gaps = 21/191 (10%)
Query: 339 GSVFRGI--INGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           GSV++ I    G  VAIK +      + I KE++++++ +  +++  +G+   +   ++V
Sbjct: 43  GSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E+   GS+SD +  +   + ++ +    I      GL YLH       +H+DI +GNIL
Sbjct: 103 MEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNIL 157
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---YGLVTPEMDTYAF 508
           L+    AKLA+F     A +     +     +GT  +MAPE ++   Y  V    D ++ 
Sbjct: 158 LNTEGHAKLADFGV---AGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVA---DIWSL 211
Query: 509 GVVLLELITGK 519
           G+  +E+  GK
Sbjct: 212 GITAIEMAEGK 222

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 80/181 (44%), Gaps = 17/181 (9%)
Query: 347 NGSTVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDG--VFYLVYEFME 396
            G  VA+K +        R    +E+ +L+ + H +++   G CE  G     LV E++ 
Sbjct: 37  TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 96
Query: 397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
            GSL D+L +      V        A  +  G+ YLH      Y+H+ +++ N+LLD + 
Sbjct: 97  LGSLRDYLPR----HCVGLAQLLLFAQQICEGMAYLHA---QHYIHRALAARNVLLDNDR 149
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI 516
             K+ +F   ++       Y   +       + APE ++        D ++FGV L EL+
Sbjct: 150 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 209
Query: 517 T 517
           T
Sbjct: 210 T 210

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 12/166 (7%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYPEFV 413
            +R  I +E+ +L + N   ++  +GA   DG   +  E M+ GSL   L K  R PE +
Sbjct: 65  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI 124
Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
                 ++++ V  GL YL        +H+D+   NIL++     KL +F      +   
Sbjct: 125 LG----KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 176
Query: 474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
              S   + VGT  YM+PE ++    + + D ++ G+ L+E+  G+
Sbjct: 177 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/308 (22%), Positives = 131/308 (42%), Gaps = 61/308 (19%)
Query: 311 NLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMR---------RSIS 361
           N   G+ F +   L    EN S      G +++G   G+ + +K ++         R  +
Sbjct: 2   NKHSGIDFKQLNFLTKLNENHS------GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFN 55
Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFY--LVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +E   L+  +H N++ + GAC+     +  L+  +M  GSL + LH+      V  +   
Sbjct: 56  EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAV 114
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA----NFSFVRSAVREESG 475
           + ALD+A G+ +LH   +P      ++S ++++D+++ A+++     FSF          
Sbjct: 115 KFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSF---------- 163
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPE------MDTYAFGVVLLELITGKEAAYKQDGEE 529
              +   +    ++APE ++     PE       D ++F V+L EL+T           E
Sbjct: 164 --QSPGRMYAPAWVAPEALQK---KPEDTNRRSADMWSFAVLLWELVT----------RE 208
Query: 530 ILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
           +  A+         N E  + V ++         I+ H+  L   C+  +P  RP    +
Sbjct: 209 VPFADL-------SNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMI 261
Query: 590 VSTLMKIQ 597
           V  L K+Q
Sbjct: 262 VPILEKMQ 269

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 80/181 (44%), Gaps = 17/181 (9%)
Query: 347 NGSTVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDG--VFYLVYEFME 396
            G  VA+K +        R    +E+ +L+ + H +++   G CE  G     LV E++ 
Sbjct: 36  TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 95
Query: 397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
            GSL D+L +      V        A  +  G+ YLH      Y+H+ +++ N+LLD + 
Sbjct: 96  LGSLRDYLPR----HCVGLAQLLLFAQQICEGMAYLHA---QHYIHRALAARNVLLDNDR 148
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI 516
             K+ +F   ++       Y   +       + APE ++        D ++FGV L EL+
Sbjct: 149 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 208
Query: 517 T 517
           T
Sbjct: 209 T 209

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 122/278 (43%), Gaps = 38/278 (13%)
Query: 339 GSVFRGII--NGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++GI    G TV    AIK +  +   + N        ++  ++H +L+ L G C  
Sbjct: 52  GTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 111
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             +  LV + M +G L +++H+ +  + +         + +A G+ YL        VH+D
Sbjct: 112 PTI-QLVTQLMPHGCLLEYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRD 165
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   R    +E  Y++    +    +MA E + Y   T + D
Sbjct: 166 LAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK-WMALECIHYRKFTHQSD 224
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   +    +  ++E G        L  P +       
Sbjct: 225 VWSYGVTIWELMTFGGKPY--DG---IPTREIPDLLEKGER------LPQPPI------C 267
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E+ +   ++  D QR
Sbjct: 268 TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQR 305

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 117/276 (42%), Gaps = 56/276 (20%)
Query: 350 TVAIKCM--------RRSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           TVA+K +        R ++  E+ +L  + NH N++NL GAC   G   ++ E+   G L
Sbjct: 78  TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 137
Query: 401 SDWLHKKRYPEFVSWNCRFRI----------------ALDVAHGLHYL--HNCTDPGYVH 442
            ++L +KR   F+       I                +  VA G+ +L   NC     +H
Sbjct: 138 LNFLRRKR-DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC-----IH 191
Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           +D+++ NILL      K+ +F   R  ++ +S Y     A     +MAPE +   + T E
Sbjct: 192 RDLAARNILLTHGRITKICDFGLARH-IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 250
Query: 503 MDTYAFGVVLLELITGKEAAYKQ---DGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA 559
            D +++G+ L EL +   + Y     D +   + +  F M+   +A A++  ++      
Sbjct: 251 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK----- 305
Query: 560 NKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
                          C   +P  RP+  ++V  + K
Sbjct: 306 --------------TCWDADPLKRPTFKQIVQLIEK 327

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 10/187 (5%)
Query: 345 IINGSTVAIKCMRRSISKEVN-LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW 403
           ++    +  K   + I  E N LLK + H  L+ L  + +     Y V +++  G L  +
Sbjct: 70  VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL--F 127
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF 463
            H +R   F+    RF  A ++A  L YLH+      V++D+   NILLD      L +F
Sbjct: 128 YHLQRERCFLEPRARFYAA-EIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDF 183
Query: 464 SFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAY 523
              +  +   S   +T T  GT  Y+APE +        +D +  G VL E++ G    Y
Sbjct: 184 GLCKENIEHNS---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240
Query: 524 KQDGEEI 530
            ++  E+
Sbjct: 241 SRNTAEM 247

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 109/227 (48%), Gaps = 21/227 (9%)
Query: 318 FYKYEDLVVATENFSPKNMIDGSVFRGIINGST----VAIKCMRRSISK--------EVN 365
           F K ++L++A       N   GSV +G+         VAIK +++   K        E  
Sbjct: 5   FLKRDNLLIADIELGCGNF--GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 62
Query: 366 LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDV 425
           ++ ++++  ++ L G C+ + +  LV E    G L  +L  KR  E +  +    +   V
Sbjct: 63  IMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQV 119
Query: 426 AHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT 485
           + G+ YL    +  +VH+D+++ N+LL     AK+++F   ++   ++S Y++       
Sbjct: 120 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176
Query: 486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQ-DGEEIL 531
             + APE + +   +   D +++GV + E ++  +  YK+  G E++
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 223

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 12/166 (7%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYPEFV 413
            +R  I +E+ +L + N   ++  +GA   DG   +  E M+ GSL   L K  R PE +
Sbjct: 49  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI 108
Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
                 ++++ V  GL YL        +H+D+   NIL++     KL +F      + E 
Sbjct: 109 LG----KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEM 162
Query: 474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +        VGT  YM+PE ++    + + D ++ G+ L+E+  G+
Sbjct: 163 A-----NEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 90/186 (48%), Gaps = 16/186 (8%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL-SDW 403
           IIN   ++ +  ++ + +E  + +K+ H N++ L  + + +   YLV++ +  G L  D 
Sbjct: 38  IINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 96
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKL 460
           + ++ Y E  + +C  +I   +A+       C   G VH+++   N+LL    K    KL
Sbjct: 97  VAREFYSEADASHCIQQILESIAY-------CHSNGIVHRNLKPENLLLASKAKGAAVKL 149
Query: 461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE 520
           A+F         E+ +       GT GY++PE ++    +  +D +A GV+L  L+ G  
Sbjct: 150 ADFGLAIEVNDSEAWHGFA----GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205
Query: 521 AAYKQD 526
             + +D
Sbjct: 206 PFWDED 211

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 107/241 (44%), Gaps = 31/241 (12%)
Query: 346 INGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFM 395
           + G  VA+K + R           I +E+  LK   H ++I L+         ++V E++
Sbjct: 39  LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV 98
Query: 396 ENGSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK 454
             G L D++ K  R  E  S     R+   +  G+ Y H       VH+D+   N+LLD 
Sbjct: 99  SGGELFDYICKNGRLDEKESR----RLFQQILSGVDYCHRHM---VVHRDLKPENVLLDA 151
Query: 455 NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVT-PEMDTYAFGVVLL 513
           ++ AK+A+F    S +  +  +   + + G+  Y APE +   L   PE+D ++ GV+L 
Sbjct: 152 HMNAKIADFGL--SNMMSDGEF--LRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILY 207
Query: 514 ELITGKEAAYKQDGEEIL---LAEAVFSMVEGGNAEA----KLSVLVDPNLQANKKEIAH 566
            L+ G    +  D    L   + + +F   +  N       K  + VDP  +A  K+I  
Sbjct: 208 ALLCGT-LPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266
Query: 567 H 567
           H
Sbjct: 267 H 267

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 95/196 (48%), Gaps = 25/196 (12%)
Query: 339 GSVFR-----GIINGSTVAIKCMRRSI-----------SKEVNLLKKINHFNLINLFGAC 382
           G VF+     G   G   A+K +++++             E N+L+++ H  +++L  A 
Sbjct: 31  GKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90
Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
           +  G  YL+ E++  G L  ++  +R   F+     F +A +++  L +LH     G ++
Sbjct: 91  QTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLA-EISMALGHLHQ---KGIIY 144
Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           +D+   NI+L+     KL +F   + ++ +    + T T  GT  YMAPE +        
Sbjct: 145 RDLKPENIMLNHQGHVKLTDFGLCKESIHDG---TVTHTFCGTIEYMAPEILMRSGHNRA 201
Query: 503 MDTYAFGVVLLELITG 518
           +D ++ G ++ +++TG
Sbjct: 202 VDWWSLGALMYDMLTG 217

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 121/271 (44%), Gaps = 54/271 (19%)
Query: 351 VAIKCMRRSISK----------EVNLLKKINHFNLINLFGACEHDG----VFYLVYEFME 396
           VA+K +R  +++          E      +NH  ++ ++   E +     + Y+V E+++
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVD 99
Query: 397 NGSLSDWLH------KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
             +L D +H       KR  E ++  C+   AL+ +H           G +H+D+   NI
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQ---ALNFSH---------QNGIIHRDVKPANI 147
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTA--VGTNGYMAPEYMEYGLVTPEMDTYAF 508
           ++      K+ +F   R+    +SG S T+TA  +GT  Y++PE      V    D Y+ 
Sbjct: 148 MISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 509 GVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHH 567
           G VL E++T         GE     ++  S+       A   V  DP   + + E ++  
Sbjct: 206 GCVLYEVLT---------GEPPFTGDSPVSV-------AYQHVREDPIPPSARHEGLSAD 249
Query: 568 LIMLCLACIAREPESR-PSMAEVVSTLMKIQ 597
           L  + L  +A+ PE+R  + AE+ + L+++ 
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 123/279 (44%), Gaps = 54/279 (19%)
Query: 343 RGIINGSTVAIKCMRRSISK----------EVNLLKKINHFNLINLFGACEHD----GVF 388
           R + +   VA+K +R  +++          E      +NH  ++ ++   E +     + 
Sbjct: 32  RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91
Query: 389 YLVYEFMENGSLSDWLH------KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
           Y+V E+++  +L D +H       KR  E ++  C+          L++ H     G +H
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ---------ALNFSHQN---GIIH 139
Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA--VGTNGYMAPEYMEYGLVT 500
           +D+   NI++      K+ +F   R+    +SG S T+TA  +GT  Y++PE      V 
Sbjct: 140 RDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQYLSPEQARGDSVD 197
Query: 501 PEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN 560
              D Y+ G VL E++T         GE     ++  S+       A   V  DP   + 
Sbjct: 198 ARSDVYSLGCVLYEVLT---------GEPPFTGDSPVSV-------AYQHVREDPIPPSA 241
Query: 561 KKE-IAHHLIMLCLACIAREPESR-PSMAEVVSTLMKIQ 597
           + E ++  L  + L  +A+ PE+R  + AE+ + L+++ 
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 90/186 (48%), Gaps = 16/186 (8%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL-SDW 403
           IIN   ++ +  ++ + +E  + +K+ H N++ L  + + +   YLV++ +  G L  D 
Sbjct: 61  IINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 119
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKL 460
           + ++ Y E  + +C  +I   +A+       C   G VH+++   N+LL    K    KL
Sbjct: 120 VAREFYSEADASHCIQQILESIAY-------CHSNGIVHRNLKPENLLLASKAKGAAVKL 172
Query: 461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE 520
           A+F         E+ +       GT GY++PE ++    +  +D +A GV+L  L+ G  
Sbjct: 173 ADFGLAIEVNDSEAWHG----FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228
Query: 521 AAYKQD 526
             + +D
Sbjct: 229 PFWDED 234

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 87/184 (47%), Gaps = 21/184 (11%)
Query: 346 INGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFM 395
           + G  VA+K + R           I +E+  LK   H ++I L+        F++V E++
Sbjct: 34  LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93
Query: 396 ENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN 455
             G L D++ K    E +      R+   +   + Y H       VH+D+   N+LLD +
Sbjct: 94  SGGELFDYICKHGRVEEMEAR---RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAH 147
Query: 456 LRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL-VTPEMDTYAFGVVLLE 514
           + AK+A+F    S +  +  +   +T+ G+  Y APE +   L   PE+D ++ GV+L  
Sbjct: 148 MNAKIADFGL--SNMMSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYA 203
Query: 515 LITG 518
           L+ G
Sbjct: 204 LLCG 207

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 8/164 (4%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGAC--EHDGVFYLVYEFMENGSLSDWLHK-KRYPEFV 413
           ++ +  EVNLL+++ H N++  +       +   Y+V E+ E G L+  + K  +  +++
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGY--VHKDISSGNILLDKNLRAKLANFSFVRSAVR 471
                 R+   +   L   H  +D G+  +H+D+   N+ LD     KL +F   R    
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLEL 515
           + S     KT VGT  YM+PE M       + D ++ G +L EL
Sbjct: 169 DTS---FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 90/186 (48%), Gaps = 16/186 (8%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL-SDW 403
           IIN   ++ +  ++ + +E  + +K+ H N++ L  + + +   YLV++ +  G L  D 
Sbjct: 37  IINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 95
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKL 460
           + ++ Y E  + +C  +I   +A+       C   G VH+++   N+LL    K    KL
Sbjct: 96  VAREFYSEADASHCIQQILESIAY-------CHSNGIVHRNLKPENLLLASKAKGAAVKL 148
Query: 461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE 520
           A+F         E+ +       GT GY++PE ++    +  +D +A GV+L  L+ G  
Sbjct: 149 ADFGLAIEVNDSEAWHGFA----GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 204
Query: 521 AAYKQD 526
             + +D
Sbjct: 205 PFWDED 210

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 90/184 (48%), Gaps = 29/184 (15%)
Query: 357 RRSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP---EF 412
           R ++  E+ ++ ++ +H N++NL GAC   G  YL++E+   G L ++L  KR     + 
Sbjct: 92  REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 151
Query: 413 VSWNCRFRI-----------------ALDVAHGLHYLH--NCTDPGYVHKDISSGNILLD 453
           + +  + R+                 A  VA G+ +L   +C     VH+D+++ N+L+ 
Sbjct: 152 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC-----VHRDLAARNVLVT 206
Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLL 513
                K+ +F   R  +  +S Y     A     +MAPE +  G+ T + D +++G++L 
Sbjct: 207 HGKVVKICDFGLARD-IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265
Query: 514 ELIT 517
           E+ +
Sbjct: 266 EIFS 269

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/262 (22%), Positives = 114/262 (43%), Gaps = 45/262 (17%)
Query: 357 RRSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-------- 407
           + ++  E+ ++  +  H N++NL GAC H G   ++ E+   G L ++L +K        
Sbjct: 78  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPS 137
Query: 408 ----RYPEFVSWNCRFRIAL--------DVAHGLHYL--HNCTDPGYVHKDISSGNILLD 453
               + PE +       + L         VA G+ +L   NC     +H+D+++ N+LL 
Sbjct: 138 LAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC-----IHRDVAARNVLLT 192
Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLL 513
               AK+ +F   R  +  +S Y     A     +MAPE +   + T + D +++G++L 
Sbjct: 193 NGHVAKIGDFGLARD-IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 251
Query: 514 ELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCL 573
           E+ +     Y      IL+    + +V+ G   A+ +                ++  +  
Sbjct: 252 EIFSLGLNPYPG----ILVNSKFYKLVKDGYQMAQPAF------------APKNIYSIMQ 295
Query: 574 ACIAREPESRPSMAEVVSTLMK 595
           AC A EP  RP+  ++ S L +
Sbjct: 296 ACWALEPTHRPTFQQICSFLQE 317

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 90/186 (48%), Gaps = 16/186 (8%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL-SDW 403
           IIN   ++ +  ++ + +E  + +K+ H N++ L  + + +   YLV++ +  G L  D 
Sbjct: 38  IINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 96
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKL 460
           + ++ Y E  + +C  +I   +A+       C   G VH+++   N+LL    K    KL
Sbjct: 97  VAREFYSEADASHCIQQILESIAY-------CHSNGIVHRNLKPENLLLASKAKGAAVKL 149
Query: 461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE 520
           A+F         E+ +       GT GY++PE ++    +  +D +A GV+L  L+ G  
Sbjct: 150 ADFGLAIEVNDSEAWHGFA----GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205
Query: 521 AAYKQD 526
             + +D
Sbjct: 206 PFWDED 211

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/255 (21%), Positives = 120/255 (47%), Gaps = 36/255 (14%)
Query: 351 VAIKCMRR-SISK-----EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           VAIK ++  S+S+     E  ++  ++H  L+ L+G C      +++ E+M NG L ++L
Sbjct: 51  VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 110
Query: 405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS 464
            + R+  F +      +  DV   + YL +     ++H+D+++ N L++     K+++F 
Sbjct: 111 REMRH-RFQTQQL-LEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFG 165
Query: 465 FVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
             R  + +E       ++VG+     +  PE + Y   + + D +AFGV++ E+ +  + 
Sbjct: 166 LSRYVLDDEE-----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
Query: 522 AYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPE 581
            Y++           F+  E     A+   L  P+L + K      +  +  +C   + +
Sbjct: 221 PYER-----------FTNSETAEHIAQGLRLYRPHLASEK------VYTIMYSCWHEKAD 263
Query: 582 SRPSMAEVVSTLMKI 596
            RP+   ++S ++ +
Sbjct: 264 ERPTFKILLSNILDV 278

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/277 (22%), Positives = 117/277 (42%), Gaps = 50/277 (18%)
Query: 343 RGIINGSTVAIKCMRRSISK----------EVNLLKKINHFNLINLFGACEHD----GVF 388
           R + +   VA+K +R  +++          E      +NH  ++ ++   E +     + 
Sbjct: 32  RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91
Query: 389 YLVYEFMENGSLSDWLH------KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
           Y+V E+++  +L D +H       KR  E ++  C+          L++ H     G +H
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ---------ALNFSHQN---GIIH 139
Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           +D+   NIL+      K+ +F   R+     +    T   +GT  Y++PE      V   
Sbjct: 140 RDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDAR 199
Query: 503 MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK 562
            D Y+ G VL E++T         GE     ++  S+       A   V  DP   + + 
Sbjct: 200 SDVYSLGCVLYEVLT---------GEPPFTGDSPVSV-------AYQHVREDPIPPSARH 243
Query: 563 E-IAHHLIMLCLACIAREPESR-PSMAEVVSTLMKIQ 597
           E ++  L  + L  +A+ PE+R  + AE+ + L+++ 
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 87/186 (46%), Gaps = 15/186 (8%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL-SDW 403
           IIN   ++ +  ++ + +E  + + + H N++ L  +   +G  YLV++ +  G L  D 
Sbjct: 36  IINTKKLSARDHQK-LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI 94
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKL 460
           + ++ Y E  + +C  +I   V H       C   G VH+D+   N+LL    K    KL
Sbjct: 95  VAREYYSEADASHCIQQILESVNH-------CHLNGIVHRDLKPENLLLASKSKGAAVKL 147
Query: 461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE 520
           A+F     A+  +    +     GT GY++PE +        +D +A GV+L  L+ G  
Sbjct: 148 ADFGL---AIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYP 204
Query: 521 AAYKQD 526
             + +D
Sbjct: 205 PFWDED 210

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 120/271 (44%), Gaps = 54/271 (19%)
Query: 351 VAIKCMRRSISK----------EVNLLKKINHFNLINLFGACEHDG----VFYLVYEFME 396
           VA+K +R  +++          E      +NH  ++ ++   E +     + Y+V E+++
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 397 NGSLSDWLH------KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
             +L D +H       KR  E ++  C+          L++ H     G +H+D+   NI
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQ---------ALNFSHQN---GIIHRDVKPANI 147
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTA--VGTNGYMAPEYMEYGLVTPEMDTYAF 508
           ++      K+ +F   R+    +SG S T+TA  +GT  Y++PE      V    D Y+ 
Sbjct: 148 MISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 509 GVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHH 567
           G VL E++T         GE     ++  S+       A   V  DP   + + E ++  
Sbjct: 206 GCVLYEVLT---------GEPPFTGDSPVSV-------AYQHVREDPIPPSARHEGLSAD 249
Query: 568 LIMLCLACIAREPESR-PSMAEVVSTLMKIQ 597
           L  + L  +A+ PE+R  + AE+ + L+++ 
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 37/192 (19%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLF------GACEHDGVFYLV 391
           +G  VAIK + R            +E+ LLK + H N+I L        +  +   FYLV
Sbjct: 48  SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
             FM+       L K    +F     ++ +   +  GL Y+H+    G VH+D+  GN+ 
Sbjct: 108 MPFMQTD-----LQKIMGLKFSEEKIQY-LVYQMLKGLKYIHSA---GVVHRDLKPGNLA 158
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE----YMEYGLVTPEMDTYA 507
           ++++   K+ +F   R A  E +GY      V T  Y APE    +M Y      +D ++
Sbjct: 159 VNEDCELKILDFGLARHADAEMTGY------VVTRWYRAPEVILSWMHYNQT---VDIWS 209
Query: 508 FGVVLLELITGK 519
            G ++ E++TGK
Sbjct: 210 VGCIMAEMLTGK 221

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 87/186 (46%), Gaps = 15/186 (8%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL-SDW 403
           IIN   ++ +  ++ + +E  + + + H N++ L  +   +G  YLV++ +  G L  D 
Sbjct: 36  IINTKKLSARDHQK-LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI 94
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKL 460
           + ++ Y E  + +C  +I   V H       C   G VH+D+   N+LL    K    KL
Sbjct: 95  VAREYYSEADASHCIQQILESVNH-------CHLNGIVHRDLKPENLLLASKSKGAAVKL 147
Query: 461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE 520
           A+F     A+  +    +     GT GY++PE +        +D +A GV+L  L+ G  
Sbjct: 148 ADFGL---AIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYP 204
Query: 521 AAYKQD 526
             + +D
Sbjct: 205 PFWDED 210

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/189 (22%), Positives = 93/189 (49%), Gaps = 12/189 (6%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVS 414
            ++  +  E N+++++++  ++ + G CE +  + LV E  E G L+ +L + R+   V 
Sbjct: 412 ALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH---VK 467
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
                 +   V+ G+ YL       +VH+D+++ N+LL     AK+++F   ++   +E+
Sbjct: 468 DKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
            Y +         + APE + Y   + + D ++FGV++ E  +  +  Y+      +   
Sbjct: 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-----MKGS 579
Query: 535 AVFSMVEGG 543
            V +M+E G
Sbjct: 580 EVTAMLEKG 588

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/189 (22%), Positives = 94/189 (49%), Gaps = 12/189 (6%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVS 414
            ++  +  E N+++++++  ++ + G CE +  + LV E  E G L+ +L + R+   V 
Sbjct: 54  ALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH---VK 109
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
                 +   V+ G+ YL    +  +VH+D+++ N+LL     AK+++F   ++   +E+
Sbjct: 110 DKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
            Y +         + APE + Y   + + D ++FGV++ E  +  +  Y+      +   
Sbjct: 167 XYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-----MKGS 221
Query: 535 AVFSMVEGG 543
            V +M+E G
Sbjct: 222 EVTAMLEKG 230

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/189 (22%), Positives = 93/189 (49%), Gaps = 12/189 (6%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVS 414
            ++  +  E N+++++++  ++ + G CE +  + LV E  E G L+ +L + R+   V 
Sbjct: 413 ALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH---VK 468
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
                 +   V+ G+ YL       +VH+D+++ N+LL     AK+++F   ++   +E+
Sbjct: 469 DKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 525
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
            Y +         + APE + Y   + + D ++FGV++ E  +  +  Y+      +   
Sbjct: 526 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-----MKGS 580
Query: 535 AVFSMVEGG 543
            V +M+E G
Sbjct: 581 EVTAMLEKG 589

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 121/271 (44%), Gaps = 54/271 (19%)
Query: 351 VAIKCMRRSISK----------EVNLLKKINHFNLINLFGACEHDG----VFYLVYEFME 396
           VA+K +R  +++          E      +NH  ++ ++   E +     + Y+V E+++
Sbjct: 57  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 116
Query: 397 NGSLSDWLH------KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
             +L D +H       KR  E ++  C+   AL+ +H           G +H+D+   NI
Sbjct: 117 GVTLRDIVHTEGPMTPKRAIEVIADACQ---ALNFSH---------QNGIIHRDVKPANI 164
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTA--VGTNGYMAPEYMEYGLVTPEMDTYAF 508
           ++      K+ +F   R+    +SG S T+TA  +GT  Y++PE      V    D Y+ 
Sbjct: 165 MISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 222
Query: 509 GVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE-IAHH 567
           G VL E++T         GE     ++  S+       A   V  DP   + + E ++  
Sbjct: 223 GCVLYEVLT---------GEPPFTGDSPVSV-------AYQHVREDPIPPSARHEGLSAD 266
Query: 568 LIMLCLACIAREPESR-PSMAEVVSTLMKIQ 597
           L  + L  +A+ PE+R  + AE+ + L+++ 
Sbjct: 267 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 297

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 88/194 (45%), Gaps = 26/194 (13%)
Query: 339 GSVFRGIINGS--TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G VF+GI N +   VAIK +           I +E+ +L + +   +   +G+       
Sbjct: 37  GEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKL 96
Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIAL---DVAHGLHYLHNCTDPGYVHKDI 445
           +++ E++  GS  D L    + EF       +IA    ++  GL YLH+      +H+DI
Sbjct: 97  WIIMEYLGGGSALDLLRAGPFDEF-------QIATMLKEILKGLDYLHSEKK---IHRDI 146
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
            + N+LL +    KLA+F         +       T VGT  +MAPE ++      + D 
Sbjct: 147 KAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIQQSAYDSKADI 203
Query: 506 YAFGVVLLELITGK 519
           ++ G+  +EL  G+
Sbjct: 204 WSLGITAIELAKGE 217

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 32/202 (15%)
Query: 339 GSVFRGIINGSTVAIKCM----RRSISKEVNLLKKI--NHFNLINLFGA---CEHDGV-F 388
           G V+RG   G  VA+K       +S  +E  L   +   H N++    +     H     
Sbjct: 22  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81
Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH-----NCTDPGYVHK 443
           +L+  + E GSL D+L   +     + +C  RI L +A GL +LH         P   H+
Sbjct: 82  WLITHYHEMGSLYDYL---QLTTLDTVSC-LRIVLSIASGLAHLHIEIFGTQGKPAIAHR 137
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA----VGTNGYMAPEYMEYGLV 499
           D+ S NIL+ KN +  +A+      AV      +         VGT  YMAPE ++  + 
Sbjct: 138 DLKSKNILVKKNGQCCIADLGL---AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQ 194
Query: 500 T------PEMDTYAFGVVLLEL 515
                    +D +AFG+VL E+
Sbjct: 195 VDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/189 (22%), Positives = 94/189 (49%), Gaps = 12/189 (6%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVS 414
            ++  +  E N+++++++  ++ + G CE +  + LV E  E G L+ +L + R+   V 
Sbjct: 70  ALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH---VK 125
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
                 +   V+ G+ YL    +  +VH+D+++ N+LL     AK+++F   ++   +E+
Sbjct: 126 DKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
            Y +         + APE + Y   + + D ++FGV++ E  +  +  Y+      +   
Sbjct: 183 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-----MKGS 237
Query: 535 AVFSMVEGG 543
            V +M+E G
Sbjct: 238 EVTAMLEKG 246

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/189 (22%), Positives = 94/189 (49%), Gaps = 12/189 (6%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVS 414
            ++  +  E N+++++++  ++ + G CE +  + LV E  E G L+ +L + R+   V 
Sbjct: 70  ALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH---VK 125
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
                 +   V+ G+ YL    +  +VH+D+++ N+LL     AK+++F   ++   +E+
Sbjct: 126 DKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
            Y +         + APE + Y   + + D ++FGV++ E  +  +  Y+      +   
Sbjct: 183 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-----MKGS 237
Query: 535 AVFSMVEGG 543
            V +M+E G
Sbjct: 238 EVTAMLEKG 246

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 79/159 (49%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRK--IGSFDETCTRF 136
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 137 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 191
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
            + VGT  Y++PE +     +   D +A G ++ +L+ G
Sbjct: 192 NSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 32/202 (15%)
Query: 339 GSVFRGIINGSTVAIKCM----RRSISKEVNLLKKI--NHFNLINLFGA---CEHDGV-F 388
           G V+RG   G  VA+K       +S  +E  L   +   H N++    +     H     
Sbjct: 51  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 110
Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH-----NCTDPGYVHK 443
           +L+  + E GSL D+L   +     + +C  RI L +A GL +LH         P   H+
Sbjct: 111 WLITHYHEMGSLYDYL---QLTTLDTVSC-LRIVLSIASGLAHLHIEIFGTQGKPAIAHR 166
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA----VGTNGYMAPEYMEYGLV 499
           D+ S NIL+ KN +  +A+      AV      +         VGT  YMAPE ++  + 
Sbjct: 167 DLKSKNILVKKNGQCCIADLGL---AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQ 223
Query: 500 T------PEMDTYAFGVVLLEL 515
                    +D +AFG+VL E+
Sbjct: 224 VDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 32/202 (15%)
Query: 339 GSVFRGIINGSTVAIKCM----RRSISKEVNLLKKI--NHFNLINLFGA---CEHDGV-F 388
           G V+RG   G  VA+K       +S  +E  L   +   H N++    +     H     
Sbjct: 22  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81
Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH-----NCTDPGYVHK 443
           +L+  + E GSL D+L   +     + +C  RI L +A GL +LH         P   H+
Sbjct: 82  WLITHYHEMGSLYDYL---QLTTLDTVSC-LRIVLSIASGLAHLHIEIFGTQGKPAIAHR 137
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA----VGTNGYMAPEYMEYGLV 499
           D+ S NIL+ KN +  +A+      AV      +         VGT  YMAPE ++  + 
Sbjct: 138 DLKSKNILVKKNGQCCIADLGL---AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQ 194
Query: 500 T------PEMDTYAFGVVLLEL 515
                    +D +AFG+VL E+
Sbjct: 195 VDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 88/186 (47%), Gaps = 15/186 (8%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL-SDW 403
           IIN   ++ +  ++ + +E  + + + H N++ L  +   +G  YL+++ +  G L  D 
Sbjct: 43  IINTKKLSARDHQK-LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI 101
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA---KL 460
           + ++ Y E  + +C  +I   V H       C   G VH+++   N+LL   L+    KL
Sbjct: 102 VAREYYSEADASHCIQQILEAVLH-------CHQMGVVHRNLKPENLLLASKLKGAAVKL 154
Query: 461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE 520
           A+F     A+  E    +     GT GY++PE +        +D +A GV+L  L+ G  
Sbjct: 155 ADFGL---AIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211
Query: 521 AAYKQD 526
             + +D
Sbjct: 212 PFWDED 217

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 339 GSVFRG-IINGSTVAIKCMRRSISK------------EVNLLKKINHFNLINLFG-ACEH 384
           G V+ G  I+ +   I+C  +S+S+            E  L++ +NH N++ L G     
Sbjct: 35  GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G+ +++  +M +G L  ++   +    V     F   L VA G+ YL    +  +VH+D
Sbjct: 95  EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQVARGMEYL---AEQKFVHRD 149
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAV-REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           +++ N +LD++   K+A+F   R  + RE       + A     + A E ++    T + 
Sbjct: 150 LAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKS 209
Query: 504 DTYAFGVVLLELITGKEAAYKQ 525
           D ++FGV+L EL+T     Y+ 
Sbjct: 210 DVWSFGVLLWELLTRGAPPYRH 231

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/189 (22%), Positives = 94/189 (49%), Gaps = 12/189 (6%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVS 414
            ++  +  E N+++++++  ++ + G CE +  + LV E  E G L+ +L + R+   V 
Sbjct: 68  ALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH---VK 123
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
                 +   V+ G+ YL    +  +VH+D+++ N+LL     AK+++F   ++   +E+
Sbjct: 124 DKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 180
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
            Y +         + APE + Y   + + D ++FGV++ E  +  +  Y+      +   
Sbjct: 181 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-----MKGS 235
Query: 535 AVFSMVEGG 543
            V +M+E G
Sbjct: 236 EVTAMLEKG 244

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 33  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 92
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 93  STV-QLIMQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 146
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 147 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 205
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 206 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 248
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 249 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 286

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 54  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 113
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 114 STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 167
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 168 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 226
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 227 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 269
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 270 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 307

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 111/260 (42%), Gaps = 34/260 (13%)
Query: 339 GSVF--RGIINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDG 386
           G+V+  R + N   VAIK M  S          I KEV  L+K+ H N I   G    + 
Sbjct: 68  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127
Query: 387 VFYLVYEFMENGSLSDWL--HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             +LV E+   GS SD L  HKK   E V        AL    GL YLH+      +H+D
Sbjct: 128 TAWLVMEYCL-GSASDLLEVHKKPLQE-VEIAAVTHGAL---QGLAYLHSHN---MIHRD 179
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEY---MEYGLVTP 501
           + +GNILL +    KL +F          S  +     VGT  +MAPE    M+ G    
Sbjct: 180 VKAGNILLSEPGLVKLGDFG-------SASIMAPANXFVGTPYWMAPEVILAMDEGQYDG 232
Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEIL--LAEAVFSMVEGGNAEAKLSVLVDPNLQA 559
           ++D ++ G+  +EL   K   +  +    L  +A+     ++ G+        VD  LQ 
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 292
Query: 560 NKKEIAHHLIMLCLACIARE 579
             ++     ++L    + RE
Sbjct: 293 IPQDRPTSEVLLKHRFVLRE 312

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 30  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 89
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 90  STV-QLIMQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 143
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 144 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 202
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 203 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 245
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 246 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 283

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 60/110 (54%), Gaps = 6/110 (5%)
Query: 422 ALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
           A ++  GL +LH+    G V++D+   NILLDK+   K+A+F   +  +    G + T  
Sbjct: 124 AAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM---LGDAKTNX 177
Query: 482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
             GT  Y+APE +        +D ++FGV+L E++ G+   + QD EE+ 
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR-----YPE 411
           R    +EV +L  + H N++    + E +G  Y+V ++ E G L   ++ ++       +
Sbjct: 67  REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQ 126
Query: 412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR 471
            + W  +  +AL   H         D   +H+DI S NI L K+   +L +F   R    
Sbjct: 127 ILDWFVQICLALKHVH---------DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-- 175
Query: 472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
             S     +  +GT  Y++PE  E      + D +A G VL EL T K A
Sbjct: 176 -NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 30  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 89
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 90  STV-QLIMQLMPFGXLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 143
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 144 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 202
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 203 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 245
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 246 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 283

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGAC--EHDGVFYLVYEFMENGSLSDWLHK-KRYPEFV 413
           ++ +  EVNLL+++ H N++  +       +   Y+V E+ E G L+  + K  +  +++
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGY--VHKDISSGNILLDKNLRAKLANFSFVRSAVR 471
                 R+   +   L   H  +D G+  +H+D+   N+ LD     KL +F   R    
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLEL 515
           +E      K  VGT  YM+PE M       + D ++ G +L EL
Sbjct: 169 DED---FAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 60/110 (54%), Gaps = 6/110 (5%)
Query: 422 ALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
           A ++  GL +LH+    G V++D+   NILLDK+   K+A+F   +  +    G + T  
Sbjct: 125 AAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM---LGDAKTNE 178
Query: 482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
             GT  Y+APE +        +D ++FGV+L E++ G+   + QD EE+ 
Sbjct: 179 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 228

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/189 (22%), Positives = 94/189 (49%), Gaps = 12/189 (6%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVS 414
            ++  +  E N+++++++  ++ + G CE +  + LV E  E G L+ +L + R+   V 
Sbjct: 54  ALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH---VK 109
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
                 +   V+ G+ YL    +  +VH+D+++ N+LL     AK+++F   ++   +E+
Sbjct: 110 DKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
            Y +         + APE + Y   + + D ++FGV++ E  +  +  Y+      +   
Sbjct: 167 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-----MKGS 221
Query: 535 AVFSMVEGG 543
            V +M+E G
Sbjct: 222 EVTAMLEKG 230

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 29  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 89  STV-QLITQLMPFGXLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 142
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 201
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 202 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 244
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 282

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 29  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 89  STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 142
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 201
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 202 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 244
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 282

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 78/159 (49%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 80  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 137
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 138 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 192
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
            + VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 193 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/189 (22%), Positives = 94/189 (49%), Gaps = 12/189 (6%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVS 414
            ++  +  E N+++++++  ++ + G CE +  + LV E  E G L+ +L + R+   V 
Sbjct: 60  ALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH---VK 115
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
                 +   V+ G+ YL    +  +VH+D+++ N+LL     AK+++F   ++   +E+
Sbjct: 116 DKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
            Y +         + APE + Y   + + D ++FGV++ E  +  +  Y+      +   
Sbjct: 173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-----MKGS 227
Query: 535 AVFSMVEGG 543
            V +M+E G
Sbjct: 228 EVTAMLEKG 236

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 36  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 95
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 96  STV-QLIMQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 149
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 150 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 208
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 209 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 251
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 252 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 289

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 29  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 89  STV-QLIMQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 142
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 201
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 202 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 244
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 282

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 29  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 89  STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 142
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 201
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 202 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 244
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 282

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/189 (22%), Positives = 94/189 (49%), Gaps = 12/189 (6%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVS 414
            ++  +  E N+++++++  ++ + G CE +  + LV E  E G L+ +L + R+   V 
Sbjct: 50  ALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH---VK 105
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
                 +   V+ G+ YL    +  +VH+D+++ N+LL     AK+++F   ++   +E+
Sbjct: 106 DKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
            Y +         + APE + Y   + + D ++FGV++ E  +  +  Y+      +   
Sbjct: 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-----MKGS 217
Query: 535 AVFSMVEGG 543
            V +M+E G
Sbjct: 218 EVTAMLEKG 226

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 111/260 (42%), Gaps = 34/260 (13%)
Query: 339 GSVF--RGIINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDG 386
           G+V+  R + N   VAIK M  S          I KEV  L+K+ H N I   G    + 
Sbjct: 29  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88
Query: 387 VFYLVYEFMENGSLSDWL--HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             +LV E+   GS SD L  HKK   E V        AL    GL YLH+      +H+D
Sbjct: 89  TAWLVMEYC-LGSASDLLEVHKKPLQE-VEIAAVTHGAL---QGLAYLHSHN---MIHRD 140
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEY---MEYGLVTP 501
           + +GNILL +    KL +F          S  +     VGT  +MAPE    M+ G    
Sbjct: 141 VKAGNILLSEPGLVKLGDFG-------SASIMAPANXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEIL--LAEAVFSMVEGGNAEAKLSVLVDPNLQA 559
           ++D ++ G+  +EL   K   +  +    L  +A+     ++ G+        VD  LQ 
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253
Query: 560 NKKEIAHHLIMLCLACIARE 579
             ++     ++L    + RE
Sbjct: 254 IPQDRPTSEVLLKHRFVLRE 273

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 31  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 90
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 91  STV-QLIMQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 144
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 145 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 203
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 204 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 246
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 247 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 284

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 35  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 94
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 95  STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 148
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 149 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 207
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 208 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 250
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 251 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 288

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 31  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 90
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 91  STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 144
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 145 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 203
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 204 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 246
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 247 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 284

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 36  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 95
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 96  STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 149
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 150 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 208
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 209 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 251
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 252 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 289

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/189 (22%), Positives = 94/189 (49%), Gaps = 12/189 (6%)
Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVS 414
            ++  +  E N+++++++  ++ + G CE +  + LV E  E G L+ +L + R+   V 
Sbjct: 48  ALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH---VK 103
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
                 +   V+ G+ YL    +  +VH+D+++ N+LL     AK+++F   ++   +E+
Sbjct: 104 DKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 160
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
            Y +         + APE + Y   + + D ++FGV++ E  +  +  Y+      +   
Sbjct: 161 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-----MKGS 215
Query: 535 AVFSMVEGG 543
            V +M+E G
Sbjct: 216 EVTAMLEKG 224

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 32  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 91
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 92  STV-QLIMQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 145
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 146 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 204
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 205 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 247
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 248 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 285

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 57  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 114
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 115 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 169
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 170 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 32  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 91
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 92  STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 145
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 146 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 204
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 205 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 247
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 248 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 285

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 32  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 91
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 92  STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 145
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 146 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 204
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 205 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 247
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 248 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 285

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 56  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 113
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 114 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 168
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 169 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 54  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 111
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 112 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 166
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 167 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++LK+I H N+I L    E+     L+ E +  G L D+L +K   E ++  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEE 114
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   + +G++YLH+       H D+   NI LLD+N+   R K+ +F     A + 
Sbjct: 115 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKI 168
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           + G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 169 DFG-NEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 134
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 135 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 189
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 190 NAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 36  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 95
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 96  STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 149
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 150 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 208
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 209 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 251
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 252 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 289

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 26  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 85
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 86  STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAEGMNYLE---DRRLVHRD 139
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 140 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 198
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 199 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 241
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 242 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 279

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 55  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 112
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 113 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 167
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 168 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGAC--EHDGVFYLVYEFMENGSLSDWLHK-KRYPEFV 413
           ++ +  EVNLL+++ H N++  +       +   Y+V E+ E G L+  + K  +  +++
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGY--VHKDISSGNILLDKNLRAKLANFSFVRSAVR 471
                 R+   +   L   H  +D G+  +H+D+   N+ LD     KL +F   R    
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLEL 515
           + S     K  VGT  YM+PE M       + D ++ G +L EL
Sbjct: 169 DTS---FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 78/159 (49%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 76  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 133
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 134 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 188
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
            + VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 189 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 15/152 (9%)
Query: 371 NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
           NH  L+ L    + +   + V E++  G L    H +R  +    + RF  A +++  L+
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALN 167
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           YLH   + G +++D+   N+LLD     KL ++   +  +R      +T T  GT  Y+A
Sbjct: 168 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIA 221
Query: 491 PEYM---EYGLVTPEMDTYAFGVVLLELITGK 519
           PE +   +YG     +D +A GV++ E++ G+
Sbjct: 222 PEILRGEDYGF---SVDWWALGVLMFEMMAGR 250

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 23  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 82
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 83  STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 136
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 137 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 195
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 196 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 238
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 239 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 276

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 134
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 135 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 189
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 190 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 94/196 (47%), Gaps = 25/196 (12%)
Query: 339 GSVFR-----GIINGSTVAIKCMRRSI-----------SKEVNLLKKINHFNLINLFGAC 382
           G VF+     G   G   A+K +++++             E N+L+++ H  +++L  A 
Sbjct: 31  GKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90
Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
           +  G  YL+ E++  G L  ++  +R   F+     F +A +++  L +LH     G ++
Sbjct: 91  QTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLA-EISMALGHLHQ---KGIIY 144
Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           +D+   NI+L+     KL +F   + ++ +    + T    GT  YMAPE +        
Sbjct: 145 RDLKPENIMLNHQGHVKLTDFGLCKESIHDG---TVTHXFCGTIEYMAPEILMRSGHNRA 201
Query: 503 MDTYAFGVVLLELITG 518
           +D ++ G ++ +++TG
Sbjct: 202 VDWWSLGALMYDMLTG 217

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 134
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 135 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 189
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 190 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 134
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 135 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 189
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 190 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 136
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 137 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 191
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 192 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 136
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 137 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 191
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 192 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 80  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 137
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 138 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 192
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 193 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 136
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 137 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 191
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 192 NXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 136
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 137 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 191
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 192 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 346 INGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFM 395
           + G  VA+K + R           I +E+  LK   H ++I L+        F++V E++
Sbjct: 34  LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93
Query: 396 ENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN 455
             G L D++ K    E +      R+   +   + Y H       VH+D+   N+LLD +
Sbjct: 94  SGGELFDYICKHGRVEEMEAR---RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAH 147
Query: 456 LRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL-VTPEMDTYAFGVVLLE 514
           + AK+A+F    S +  +  +   + + G+  Y APE +   L   PE+D ++ GV+L  
Sbjct: 148 MNAKIADFGL--SNMMSDGEF--LRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYA 203
Query: 515 LITG 518
           L+ G
Sbjct: 204 LLCG 207

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 115/256 (44%), Gaps = 23/256 (8%)
Query: 339 GSVFRGI--INGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVF 388
            +V++G+    G  VA+K ++         +  +E++L+K++ H N++ L+     +   
Sbjct: 19  ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKL 78
Query: 389 YLVYEFMENGSLSDWLHKKRY---PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
            LV+EFM+N  L  ++  +     P  +  N        +  GL +   C +   +H+D+
Sbjct: 79  TLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF---CHENKILHRDL 134
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE-YMEYGLVTPEMD 504
              N+L++K  + KL +F   R+     + +SS    V T  Y AP+  M     +  +D
Sbjct: 135 KPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVVTLWYRAPDVLMGSRTYSTSID 191
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++ G +L E+ITGK      + EE L  + +F ++   N     SV   P    N ++ 
Sbjct: 192 IWSCGCILAEMITGKPLFPGTNDEEQL--KLIFDIMGTPNESLWPSVTKLPKYNPNIQQR 249
Query: 565 AHHLIMLCLACIAREP 580
               +   L    +EP
Sbjct: 250 PPRDLRQVLQPHTKEP 265

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 136
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 137 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 191
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 192 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 84  VTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 141
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 142 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 196
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 197 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 106/253 (41%), Gaps = 24/253 (9%)
Query: 358 RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNC 417
           + + +E+ L K + H N++   G+   +G   +  E +  GSLS  L  K  P   +   
Sbjct: 64  QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 123
Query: 418 RFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS 477
                  +  GL YLH   D   VH+DI   N+L+  N  + +   S   ++ R      
Sbjct: 124 IGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLI--NTYSGVLKISDFGTSKRLAGINP 178
Query: 478 STKTAVGTNGYMAPEYMEYGL--VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEA 535
            T+T  GT  YMAPE ++ G        D ++ G  ++E+ TGK   Y+       L E 
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE-------LGEP 231
Query: 536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAE-VVSTLM 594
             +M + G  +      V P +  +    A   I   L C   +P+ R    + +V   +
Sbjct: 232 QAAMFKVGMFK------VHPEIPESMSAEAKAFI---LKCFEPDPDKRACANDLLVDEFL 282
Query: 595 KIQLDVQRSQTLL 607
           K+    +++Q  L
Sbjct: 283 KVSSKKKKTQPKL 295

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 82  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 139
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 140 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 194
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 195 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 61  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 118
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 119 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 173
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 174 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 33  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 92
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 93  STV-QLIMQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 146
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 147 LAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 205
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 206 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 248
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 249 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 286

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 123/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 39  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 98
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 99  STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 152
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 153 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 211
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 212 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 254
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+   C   + +SRP   E++    K+  D QR
Sbjct: 255 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQR 292

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 31  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 90
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 91  STV-QLIMQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 144
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 145 LAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 203
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 204 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 246
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 247 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 284

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++LK+I H N+I L    E+     L+ E +  G L D+L +K   E ++  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEE 114
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   + +G++YLH+       H D+   NI LLD+N+   R K+ +F     A + 
Sbjct: 115 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKI 168
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           + G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 169 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++E +++ +++H   + L+   + D   Y    + +NG L  ++ K     F     RF
Sbjct: 76  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRF 133
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
             A ++   L YLH     G +H+D+   NILL++++  ++ +F   +  +  ES  +  
Sbjct: 134 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARA 188
Query: 480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
              VGT  Y++PE +         D +A G ++ +L+ G
Sbjct: 189 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++LK+I H N+I L    E+     L+ E +  G L D+L +K   E ++  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEE 114
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   + +G++YLH+       H D+   NI LLD+N+   R K+ +F     A + 
Sbjct: 115 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKI 168
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           + G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 169 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++LK+I H N+I L    E+     L+ E +  G L D+L +K   E ++  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEE 114
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   + +G++YLH+       H D+   NI LLD+N+   R K+ +F     A + 
Sbjct: 115 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKI 168
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           + G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 169 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++LK+I H N+I L    E+     L+ E +  G L D+L +K   E ++  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEE 114
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   + +G++YLH+       H D+   NI LLD+N+   R K+ +F     A + 
Sbjct: 115 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKI 168
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           + G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 169 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 29  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 89  STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 142
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 143 LAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 201
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 202 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 244
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 282

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++LK+I H N+I L    E+     L+ E +  G L D+L +K   E ++  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEE 114
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   + +G++YLH+       H D+   NI LLD+N+   R K+ +F     A + 
Sbjct: 115 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKI 168
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           + G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 169 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++LK+I H N+I L    E+     L+ E +  G L D+L +K   E ++  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEE 114
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   + +G++YLH+       H D+   NI LLD+N+   R K+ +F     A + 
Sbjct: 115 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKI 168
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           + G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 169 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++LK+I H N+I L    E+     L+ E +  G L D+L +K   E ++  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEE 114
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   + +G++YLH+       H D+   NI LLD+N+   R K+ +F     A + 
Sbjct: 115 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKI 168
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           + G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 169 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 123/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 32  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 91
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 92  STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 145
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 146 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 204
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 205 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 247
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+   C   + +SRP   E++    K+  D QR
Sbjct: 248 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQR 285

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++LK+I H N+I L    E+     L+ E +  G L D+L +K   E ++  
Sbjct: 57  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEE 113
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   + +G++YLH+       H D+   NI LLD+N+   R K+ +F     A + 
Sbjct: 114 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKI 167
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           + G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 168 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++LK+I H N+I L    E+     L+ E +  G L D+L +K   E ++  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEE 114
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   + +G++YLH+       H D+   NI LLD+N+   R K+ +F     A + 
Sbjct: 115 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKI 168
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           + G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 169 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++LK+I H N+I L    E+     L+ E +  G L D+L +K   E ++  
Sbjct: 57  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEE 113
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   + +G++YLH+       H D+   NI LLD+N+   R K+ +F     A + 
Sbjct: 114 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKI 167
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           + G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 168 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++LK+I H N+I L    E+     L+ E +  G L D+L +K   E ++  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEE 114
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   + +G++YLH+       H D+   NI LLD+N+   R K+ +F     A + 
Sbjct: 115 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKI 168
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           + G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 169 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 36  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 95
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 96  STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 149
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 150 LAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 208
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 209 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 251
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 252 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 289

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 123/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 29  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 89  STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 142
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 201
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 202 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 244
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+   C   + +SRP   E++    K+  D QR
Sbjct: 245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQR 282

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 9/144 (6%)
Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
            Y V E++  G L    H ++   F   +  F  A ++A GL +L +    G +++D+  
Sbjct: 417 LYFVMEYVNGGDLM--YHIQQVGRFKEPHAVF-YAAEIAIGLFFLQS---KGIIYRDLKL 470
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            N++LD     K+A+F   +  + +     +TK   GT  Y+APE + Y      +D +A
Sbjct: 471 DNVMLDSEGHIKIADFGMCKENIWDGV---TTKXFCGTPDYIAPEIIAYQPYGKSVDWWA 527
Query: 508 FGVVLLELITGKEAAYKQDGEEIL 531
           FGV+L E++ G+     +D +E+ 
Sbjct: 528 FGVLLYEMLAGQAPFEGEDEDELF 551

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++LK+I H N+I L    E+     L+ E +  G L D+L +K   E ++  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEE 114
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   + +G++YLH+       H D+   NI LLD+N+   R K+ +F     A + 
Sbjct: 115 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKI 168
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           + G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 169 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 87/189 (46%), Gaps = 18/189 (9%)
Query: 352 AIKCMRRSISK-----EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK 406
           A+K +++++ K     E+ +L +++H N+I L    E      LV E +  G L D + +
Sbjct: 82  ALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE 141
Query: 407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK---NLRAKLANF 463
           K Y    S          +   + YLH   + G VH+D+   N+L      +   K+A+F
Sbjct: 142 KGY---YSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADF 195
Query: 464 SFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAY 523
               S + E       KT  GT GY APE +      PE+D ++ G++   L+ G E  Y
Sbjct: 196 GL--SKIVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251
Query: 524 KQDGEEILL 532
            + G++ + 
Sbjct: 252 DERGDQFMF 260

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 72/143 (50%), Gaps = 9/143 (6%)
Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           Y V E++  G L    H ++   F   +  F  A ++A GL +L +    G +++D+   
Sbjct: 97  YFVMEYVNGGDLM--YHIQQVGRFKEPHAVF-YAAEIAIGLFFLQS---KGIIYRDLKLD 150
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           N++LD     K+A+F   +  + +     +TK   GT  Y+APE + Y      +D +AF
Sbjct: 151 NVMLDSEGHIKIADFGMCKENIWDGV---TTKXFCGTPDYIAPEIIAYQPYGKSVDWWAF 207
Query: 509 GVVLLELITGKEAAYKQDGEEIL 531
           GV+L E++ G+     +D +E+ 
Sbjct: 208 GVLLYEMLAGQAPFEGEDEDELF 230

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 108/248 (43%), Gaps = 34/248 (13%)
Query: 343 RGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD 402
           +G  +     I+     I  E++LLK ++H N+I LF   E    FYLV EF E G L +
Sbjct: 76  KGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE 135
Query: 403 W-LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD-KN--LRA 458
             +++ ++ E  + N    I   +  G+ YLH       VH+DI   NILL+ KN  L  
Sbjct: 136 QIINRHKFDECDAAN----IMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI 188
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           K+ +F       ++       +  +GT  Y+APE ++      + D ++ GV++  L+ G
Sbjct: 189 KIVDFGLSSFFSKD----YKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCG 243
Query: 519 KEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLA---- 574
                 Q+ ++I+        VE G          D N   N  + A  LI L L     
Sbjct: 244 YPPFGGQNDQDII------KKVEKG------KYYFDFNDWKNISDEAKELIKLMLTYDYN 291
Query: 575 --CIAREP 580
             C A E 
Sbjct: 292 KRCTAEEA 299

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 18/188 (9%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW-LHKKRYPEFVSWNCR 418
             +E+ ++K ++H N+I L+   E +   YLV E    G L +  +HK+ + E    +  
Sbjct: 53  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE----SDA 108
Query: 419 FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESG 475
            RI  DV   + Y H        H+D+   N L      +   KL +F     A R + G
Sbjct: 109 ARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGL---AARFKPG 162
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA-- 533
               +T VGT  Y++P+ +E GL  PE D ++ GV++  L+ G          E++L   
Sbjct: 163 -KMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIR 220
Query: 534 EAVFSMVE 541
           E  F+  E
Sbjct: 221 EGTFTFPE 228

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 90/190 (47%), Gaps = 15/190 (7%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL-SDW 403
           IIN   ++ +  ++ + +E  + + + H N++ L  +   +G  YLV++ +  G L  D 
Sbjct: 63  IINTKKLSARDHQK-LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI 121
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD---KNLRAKL 460
           + ++ Y E  + +C  +I   V H +H  H+      VH+D+   N+LL    K    KL
Sbjct: 122 VAREYYSEADASHCIHQILESVNH-IHQ-HDI-----VHRDLKPENLLLASKCKGAAVKL 174
Query: 461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE 520
           A+F        E+  +       GT GY++PE +        +D +A GV+L  L+ G  
Sbjct: 175 ADFGLAIEVQGEQQAWFGF---AGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYP 231
Query: 521 AAYKQDGEEI 530
             + +D  ++
Sbjct: 232 PFWDEDQHKL 241

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 18/188 (9%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW-LHKKRYPEFVSWNCR 418
             +E+ ++K ++H N+I L+   E +   YLV E    G L +  +HK+ + E    +  
Sbjct: 70  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE----SDA 125
Query: 419 FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESG 475
            RI  DV   + Y H        H+D+   N L      +   KL +F     A R + G
Sbjct: 126 ARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGL---AARFKPG 179
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA-- 533
               +T VGT  Y++P+ +E GL  PE D ++ GV++  L+ G          E++L   
Sbjct: 180 -KMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIR 237
Query: 534 EAVFSMVE 541
           E  F+  E
Sbjct: 238 EGTFTFPE 245

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 123/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 31  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 90
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 91  STV-QLIMQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 144
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 145 LAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 203
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 204 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 246
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+   C   + +SRP   E++    K+  D QR
Sbjct: 247 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQR 284

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++LK+I H N+I L    E+     L+ E +  G L D+L +K   E ++  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEK---ESLTEE 114
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   + +G++YLH+       H D+   NI LLD+N+   R K+ +F     A + 
Sbjct: 115 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKI 168
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           + G +  K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 169 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 76/172 (44%), Gaps = 34/172 (19%)
Query: 358 RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME---------NGSLSDWLHKKR 408
           R+  +E+ LL++++H N+I L  A  H     LV++FME         N  +    H K 
Sbjct: 57  RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA 116
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
           Y             L    GL YLH       +H+D+   N+LLD+N   KLA+F   +S
Sbjct: 117 Y------------MLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELI 516
                  Y      V T  Y APE +     YG+    +D +A G +L EL+
Sbjct: 162 FGSPNRAYXHQ---VVTRWYRAPELLFGARMYGV---GVDMWAVGCILAELL 207

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 123/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AIK +R + S + N        ++  +++ ++  L G C  
Sbjct: 31  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 90
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 91  STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 144
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 145 LAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 203
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 204 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 246
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+   C   + +SRP   E++    K+  D QR
Sbjct: 247 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQR 284

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 12/220 (5%)
Query: 358 RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNC 417
           + + +E+ L K + H N++   G+   +G   +  E +  GSLS  L  K  P   +   
Sbjct: 50  QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 109
Query: 418 RFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS 477
                  +  GL YLH   D   VH+DI   N+L+  N  + +   S   ++ R      
Sbjct: 110 IGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLI--NTYSGVLKISDFGTSKRLAGINP 164
Query: 478 STKTAVGTNGYMAPEYMEYGL--VTPEMDTYAFGVVLLELITGKEAAYK-QDGEEILLAE 534
            T+T  GT  YMAPE ++ G        D ++ G  ++E+ TGK   Y+  + +  +   
Sbjct: 165 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV 224
Query: 535 AVF----SMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM 570
            +F     + E  +AEAK  +L       +K+  A+ L++
Sbjct: 225 GMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 264

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 28/158 (17%)
Query: 381 ACEHDGVFYLVYEFMENGSLSDWLHK--KRYPEFVSWNCRFRI-----ALDVAHGLHYLH 433
           A + +   YLV ++   G L   L K   + PE ++   RF I     A+D  H LHY  
Sbjct: 142 AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMA---RFYIGEMVLAIDSIHQLHY-- 196
Query: 434 NCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR-EESGYSSTKTAVGTNGYMAPE 492
                  VH+DI   N+LLD N   +LA+F    S ++  + G   +  AVGT  Y++PE
Sbjct: 197 -------VHRDIKPDNVLLDVNGHIRLADFG---SCLKMNDDGTVQSSVAVGTPDYISPE 246
Query: 493 YME-----YGLVTPEMDTYAFGVVLLELITGKEAAYKQ 525
            ++      G   PE D ++ GV + E++ G+   Y +
Sbjct: 247 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 284

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 123/278 (44%), Gaps = 38/278 (13%)
Query: 339 GSVFRG--IINGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++G  I  G  V    AI  +R + S + N        ++  +++ ++  L G C  
Sbjct: 63  GTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 122
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++  + + + +         + +A G++YL    D   VH+D
Sbjct: 123 STV-QLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRD 176
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +    EE  Y +    V    +MA E + + + T + D
Sbjct: 177 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRIYTHQSD 235
Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y  DG   + A  + S++E G        L  P +       
Sbjct: 236 VWSYGVTVWELMTFGSKPY--DG---IPASEISSILEKGER------LPQPPI------C 278
Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
              + M+ + C   + +SRP   E++    K+  D QR
Sbjct: 279 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 316

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 28/158 (17%)
Query: 381 ACEHDGVFYLVYEFMENGSLSDWLHK--KRYPEFVSWNCRFRI-----ALDVAHGLHYLH 433
           A + +   YLV ++   G L   L K   + PE ++   RF I     A+D  H LHY  
Sbjct: 158 AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMA---RFYIGEMVLAIDSIHQLHY-- 212
Query: 434 NCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR-EESGYSSTKTAVGTNGYMAPE 492
                  VH+DI   N+LLD N   +LA+F    S ++  + G   +  AVGT  Y++PE
Sbjct: 213 -------VHRDIKPDNVLLDVNGHIRLADFG---SCLKMNDDGTVQSSVAVGTPDYISPE 262
Query: 493 YME-----YGLVTPEMDTYAFGVVLLELITGKEAAYKQ 525
            ++      G   PE D ++ GV + E++ G+   Y +
Sbjct: 263 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 300

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++L+++ H N+I L    E+     L+ E +  G L D+L +K   E +S  
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSEE 115
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   +  G++YLH        H D+   NI LLDKN+     KL +F         
Sbjct: 116 EATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--- 169
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           E G    K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 170 EDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++L+++ H N+I L    E+     L+ E +  G L D+L +K   E +S  
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSEE 115
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   +  G++YLH        H D+   NI LLDKN+     KL +F         
Sbjct: 116 EATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--- 169
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           E G    K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 170 EDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 14/166 (8%)
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL-HKKRYPEFVS 414
           M   + +E++ LK + H ++I L+          +V E+   G L D++  KKR  E   
Sbjct: 52  MHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTE--- 107
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
            +   R    +   + Y H       VH+D+   N+LLD NL  K+A+F    S +  + 
Sbjct: 108 -DEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGL--SNIMTDG 161
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVT-PEMDTYAFGVVLLELITGK 519
            +   KT+ G+  Y APE +   L   PE+D ++ G+VL  ++ G+
Sbjct: 162 NF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++L+++ H N+I L    E+     L+ E +  G L D+L +K   E +S  
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSEE 115
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   +  G++YLH        H D+   NI LLDKN+     KL +F         
Sbjct: 116 EATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--- 169
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           E G    K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 170 EDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++L+++ H N+I L    E+     L+ E +  G L D+L +K   E +S  
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSEE 115
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   +  G++YLH        H D+   NI LLDKN+     KL +F         
Sbjct: 116 EATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--- 169
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           E G    K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 170 EDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 130/286 (45%), Gaps = 56/286 (19%)
Query: 339 GSVFRG--IINGSTVAIK-CMR-----------RSISKEVNLLKKINHFNLINLFGACEH 384
           G+V +G  I  G ++ I  C++           ++++  +  +  ++H +++ L G C  
Sbjct: 45  GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG 104
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
                LV +++  GSL D  H +++   +         + +A G++YL    + G VH++
Sbjct: 105 SS-LQLVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRN 158
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESG--YSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           +++ N+LL    + ++A+F        ++    YS  KT +    +MA E + +G  T +
Sbjct: 159 LAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK---WMALESIHFGKYTHQ 215
Query: 503 MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV----------- 551
            D +++GV + EL+T     Y      + LAE V  ++E G   A+  +           
Sbjct: 216 SDVWSYGVTVWELMTFGAEPYAG----LRLAE-VPDLLEKGERLAQPQICTIDVYMVMVK 270
Query: 552 --LVDPNLQANKKEIAHHLIMLCLACIAREP--------ESRPSMA 587
             ++D N++   KE+A+    +     AR+P        ES P +A
Sbjct: 271 CWMIDENIRPTFKELANEFTRM-----ARDPPRYLVIKRESGPGIA 311

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++L+++ H N+I L    E+     L+ E +  G L D+L +K   E +S  
Sbjct: 59  REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSEE 115
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   +  G++YLH        H D+   NI LLDKN+     KL +F         
Sbjct: 116 EATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--- 169
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           E G    K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 170 EDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 14/166 (8%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           R  I +EV++L+++ H N+I L    E+     L+ E +  G L D+L +K   E +S  
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSEE 115
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI-LLDKNL---RAKLANFSFVRSAVRE 472
                   +  G++YLH        H D+   NI LLDKN+     KL +F         
Sbjct: 116 EATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--- 169
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           E G    K   GT  ++APE + Y  +  E D ++ GV+   L++G
Sbjct: 170 EDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 130/286 (45%), Gaps = 56/286 (19%)
Query: 339 GSVFRG--IINGSTVAIK-CMR-----------RSISKEVNLLKKINHFNLINLFGACEH 384
           G+V +G  I  G ++ I  C++           ++++  +  +  ++H +++ L G C  
Sbjct: 27  GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG 86
Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
                LV +++  GSL D  H +++   +         + +A G++YL    + G VH++
Sbjct: 87  SS-LQLVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRN 140
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESG--YSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           +++ N+LL    + ++A+F        ++    YS  KT +    +MA E + +G  T +
Sbjct: 141 LAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK---WMALESIHFGKYTHQ 197
Query: 503 MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV----------- 551
            D +++GV + EL+T     Y      + LAE V  ++E G   A+  +           
Sbjct: 198 SDVWSYGVTVWELMTFGAEPYAG----LRLAE-VPDLLEKGERLAQPQICTIDVYMVMVK 252
Query: 552 --LVDPNLQANKKEIAHHLIMLCLACIAREP--------ESRPSMA 587
             ++D N++   KE+A+    +     AR+P        ES P +A
Sbjct: 253 CWMIDENIRPTFKELANEFTRM-----ARDPPRYLVIKRESGPGIA 293

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/181 (22%), Positives = 76/181 (41%), Gaps = 24/181 (13%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGV------------FYLVYEFMENGSLSDWL 404
           R  + +EV  L K+ H  ++  F A                   Y+  +     +L DW+
Sbjct: 47  REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM 106
Query: 405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS 464
           + +   E    +    I L +A  + +LH+    G +H+D+   NI    +   K+ +F 
Sbjct: 107 NGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFG 163
Query: 465 FVRSAVREES---------GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLEL 515
            V +  ++E           Y+     VGT  YM+PE +     + ++D ++ G++L EL
Sbjct: 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
Query: 516 I 516
           +
Sbjct: 224 L 224

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 114/262 (43%), Gaps = 34/262 (12%)
Query: 341 VFRG--IINGSTVAIKCM----------RRSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           V+R   +++G  VA+K +          R    KE++LLK++NH N+I  + +   D   
Sbjct: 48  VYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107
Query: 389 YLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
            +V E  + G LS  + H K+    +     ++  + +   L ++H+      +H+DI  
Sbjct: 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKP 164
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            N+ +      KL +    R      S  ++  + VGT  YM+PE +       + D ++
Sbjct: 165 ANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 221
Query: 508 FGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
            G +L E+   +   Y   G+++ L    +S+ +      K+     P L ++    +  
Sbjct: 222 LGCLLYEMAALQSPFY---GDKMNL----YSLCK------KIEQCDYPPLPSD--HYSEE 266
Query: 568 LIMLCLACIAREPESRPSMAEV 589
           L  L   CI  +PE RP +  V
Sbjct: 267 LRQLVNMCINPDPEKRPDVTYV 288

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 72/144 (50%), Gaps = 9/144 (6%)
Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
            Y V E++  G L    H ++  +F      F  A +++ GL +LH     G +++D+  
Sbjct: 95  LYFVMEYVNGGDL--MYHIQQVGKFKEPQAVF-YAAEISIGLFFLHKR---GIIYRDLKL 148
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            N++LD     K+A+F   +  + +     +T+   GT  Y+APE + Y      +D +A
Sbjct: 149 DNVMLDSEGHIKIADFGMCKEHMMDGV---TTREFCGTPDYIAPEIIAYQPYGKSVDWWA 205
Query: 508 FGVVLLELITGKEAAYKQDGEEIL 531
           +GV+L E++ G+     +D +E+ 
Sbjct: 206 YGVLLYEMLAGQPPFDGEDEDELF 229

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 24/185 (12%)
Query: 347 NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDG--VFYLVYEFMEN 397
            G+ VA+K ++       R   +E+ +LK ++   ++   G     G     LV E++ +
Sbjct: 38  TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS 97
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIAL---DVAHGLHYL--HNCTDPGYVHKDISSGNILL 452
           G L D+L + R     S     R+ L    +  G+ YL    C     VH+D+++ NIL+
Sbjct: 98  GCLRDFLQRHRARLDAS-----RLLLYSSQICKGMEYLGSRRC-----VHRDLAARNILV 147
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
           +     K+A+F   +    ++  Y   +       + APE +   + + + D ++FGVVL
Sbjct: 148 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 207
Query: 513 LELIT 517
            EL T
Sbjct: 208 YELFT 212

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 84/169 (49%), Gaps = 12/169 (7%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           IIN   +A   M+  I +E++ L+ + H ++I L+   +      +V E+  N  L D++
Sbjct: 36  IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYI 94
Query: 405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS 464
            ++   + +S     R    +   + Y H       VH+D+   N+LLD++L  K+A+F 
Sbjct: 95  VQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFG 148
Query: 465 FVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVT-PEMDTYAFGVVL 512
              S +  +  +   KT+ G+  Y APE +   L   PE+D ++ GV+L
Sbjct: 149 L--SNIMTDGNF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 193

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 106/269 (39%), Gaps = 25/269 (9%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL----SDWLHKKRYPEF 412
           + ++ KE+  +  + H  L+NL  A E D    ++YEFM  G L    +D  +K    E 
Sbjct: 198 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA 257
Query: 413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE 472
           V +         V  GL ++H      YVH D+   NI+       +L    F  +A  +
Sbjct: 258 VEY------MRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL- 531
                S K   GT  + APE  E   V    D ++ GV+   L++G      ++ +E L 
Sbjct: 309 PK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 366
Query: 532 --------LAEAVFSMV-EGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPES 582
                   + ++ FS + E G    +  +L DPN +    +   H  +       R+ + 
Sbjct: 367 NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426
Query: 583 RPSMAEVVSTLMKIQLDVQRSQTLLLERI 611
             S    +   +K + D        L RI
Sbjct: 427 PSSRYTKIRDSIKTKYDAWPEPLPPLGRI 455

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/264 (23%), Positives = 113/264 (42%), Gaps = 33/264 (12%)
Query: 347 NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDG--VFYLVYEFMEN 397
            G+ VA+K ++       R   +E+ +LK ++   ++   G     G     LV E++ +
Sbjct: 39  TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS 98
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIAL---DVAHGLHYL--HNCTDPGYVHKDISSGNILL 452
           G L D+L + R     S     R+ L    +  G+ YL    C     VH+D+++ NIL+
Sbjct: 99  GCLRDFLQRHRARLDAS-----RLLLYSSQICKGMEYLGSRRC-----VHRDLAARNILV 148
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
           +     K+A+F   +    ++  Y   +       + APE +   + + + D ++FGVVL
Sbjct: 149 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 208
Query: 513 LELITGKEAAYKQDGEEILL---AEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI 569
            EL T  + +     E + +      V ++        +   L  P   A   E+ H L+
Sbjct: 209 YELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPP--ACPAEV-HELM 265
Query: 570 MLCLACIAREPESRPSMAEVVSTL 593
            LC    A  P+ RPS + +   L
Sbjct: 266 KLCW---APSPQDRPSFSALGPQL 286

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 84/169 (49%), Gaps = 12/169 (7%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           IIN   +A   M+  I +E++ L+ + H ++I L+   +      +V E+  N  L D++
Sbjct: 40  IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYI 98
Query: 405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS 464
            ++   + +S     R    +   + Y H       VH+D+   N+LLD++L  K+A+F 
Sbjct: 99  VQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFG 152
Query: 465 FVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL-VTPEMDTYAFGVVL 512
              S +  +  +   KT+ G+  Y APE +   L   PE+D ++ GV+L
Sbjct: 153 L--SNIMTDGNF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 197

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 84/169 (49%), Gaps = 12/169 (7%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           IIN   +A   M+  I +E++ L+ + H ++I L+   +      +V E+  N  L D++
Sbjct: 45  IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYI 103
Query: 405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS 464
            ++   + +S     R    +   + Y H       VH+D+   N+LLD++L  K+A+F 
Sbjct: 104 VQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFG 157
Query: 465 FVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVT-PEMDTYAFGVVL 512
              S +  +  +   KT+ G+  Y APE +   L   PE+D ++ GV+L
Sbjct: 158 L--SNIMTDGNF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 202

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 24/185 (12%)
Query: 347 NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDG--VFYLVYEFMEN 397
            G+ VA+K ++       R   +E+ +LK ++   ++   G     G     LV E++ +
Sbjct: 51  TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS 110
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIAL---DVAHGLHYL--HNCTDPGYVHKDISSGNILL 452
           G L D+L + R     S     R+ L    +  G+ YL    C     VH+D+++ NIL+
Sbjct: 111 GCLRDFLQRHRARLDAS-----RLLLYSSQICKGMEYLGSRRC-----VHRDLAARNILV 160
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
           +     K+A+F   +    ++  Y   +       + APE +   + + + D ++FGVVL
Sbjct: 161 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220
Query: 513 LELIT 517
            EL T
Sbjct: 221 YELFT 225

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 84/169 (49%), Gaps = 12/169 (7%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           IIN   +A   M+  I +E++ L+ + H ++I L+   +      +V E+  N  L D++
Sbjct: 46  IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYI 104
Query: 405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS 464
            ++   + +S     R    +   + Y H       VH+D+   N+LLD++L  K+A+F 
Sbjct: 105 VQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFG 158
Query: 465 FVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVT-PEMDTYAFGVVL 512
              S +  +  +   KT+ G+  Y APE +   L   PE+D ++ GV+L
Sbjct: 159 L--SNIMTDGNF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 203

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 106/269 (39%), Gaps = 25/269 (9%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL----SDWLHKKRYPEF 412
           + ++ KE+  +  + H  L+NL  A E D    ++YEFM  G L    +D  +K    E 
Sbjct: 92  KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA 151
Query: 413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE 472
           V +         V  GL ++H      YVH D+   NI+       +L    F  +A  +
Sbjct: 152 VEY------MRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 202
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL- 531
                S K   GT  + APE  E   V    D ++ GV+   L++G      ++ +E L 
Sbjct: 203 PK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 260
Query: 532 --------LAEAVFSMV-EGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPES 582
                   + ++ FS + E G    +  +L DPN +    +   H  +       R+ + 
Sbjct: 261 NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 320
Query: 583 RPSMAEVVSTLMKIQLDVQRSQTLLLERI 611
             S    +   +K + D        L RI
Sbjct: 321 PSSRYTKIRDSIKTKYDAWPEPLPPLGRI 349

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 120/282 (42%), Gaps = 46/282 (16%)
Query: 339 GSVFRGII--NGSTV----AIKCMRRSISKEVN--------LLKKINHFNLINLFGACEH 384
           G+V++GI   +G  V    AIK +R + S + N        ++  +    +  L G C  
Sbjct: 31  GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLT 90
Query: 385 DGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
             V  LV + M  G L D + + R      + ++W       + +A G+ YL +      
Sbjct: 91  STV-QLVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYLEDVR---L 140
Query: 441 VHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVT 500
           VH+D+++ N+L+      K+ +F   R    +E+ Y +    V    +MA E +     T
Sbjct: 141 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK-WMALESILRRRFT 199
Query: 501 PEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN 560
            + D +++GV + EL+T     Y  DG   + A  +  ++E G        L  P +   
Sbjct: 200 HQSDVWSYGVTVWELMTFGAKPY--DG---IPAREIPDLLEKGER------LPQPPI--- 245
Query: 561 KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
                  + M+ + C   + E RP   E+VS   ++  D QR
Sbjct: 246 ---CTIDVYMIMVKCWMIDSECRPRFRELVSEFSRMARDPQR 284

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 347 NGSTVAIKCMRRSISKEVN---------LLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
            G  +A+K MRRS +KE N         +LK  +   ++  FG    +   ++  E M  
Sbjct: 49  TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-- 106
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
           G+ ++ L KKR    +      ++ + +   L+YL      G +H+D+   NILLD+  +
Sbjct: 107 GTCAEKL-KKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQ 163
Query: 458 AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP-----EMDTYAFGVVL 512
            KL +F      V ++    +   + G   YMAPE ++    T        D ++ G+ L
Sbjct: 164 IKLCDFGISGRLVDDK----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219
Query: 513 LELITGK 519
           +EL TG+
Sbjct: 220 VELATGQ 226

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 25/191 (13%)
Query: 341 VFRGIINGSTVAI---KCMRRSISKEVNLLKKINHFNLINL---FGACEHDGV--FYLVY 392
           VF  + +G TV I     + + + +E+ LL   +H N++ L   F   E   +   YLV 
Sbjct: 54  VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVT 113
Query: 393 EFMENGSLSDWLHKKRY---PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           E M    L+  +H +R    P+ + +   + I L    GLH LH   + G VH+D+  GN
Sbjct: 114 ELMRT-DLAQVIHDQRIVISPQHIQY-FMYHILL----GLHVLH---EAGVVHRDLHPGN 164
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEY-MEYGLVTPEMDTYAF 508
           ILL  N    + +F+      RE++  ++    V    Y APE  M++   T  +D ++ 
Sbjct: 165 ILLADNNDITICDFNL----AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSA 220
Query: 509 GVVLLELITGK 519
           G V+ E+   K
Sbjct: 221 GCVMAEMFNRK 231

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/249 (22%), Positives = 104/249 (41%), Gaps = 26/249 (10%)
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +R    +E   +++ +H +++ L G    + V +++ E    G L  +L  ++Y   +  
Sbjct: 51  VREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS--LDL 107
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
                 A  ++  L YL +     +VH+DI++ N+L+  N   KL +F   R    E+S 
Sbjct: 108 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDST 162
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEA 535
           Y           +MAPE + +   T   D + FGV + E++      ++      +    
Sbjct: 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-----VKNND 217
Query: 536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
           V   +E G       + + PN           L  L   C A +P  RP   E+ + L  
Sbjct: 218 VIGRIENGE-----RLPMPPNCPPT-------LYSLMTKCWAYDPSRRPRFTELKAQLST 265
Query: 596 IQLDVQRSQ 604
           I L+ +++Q
Sbjct: 266 I-LEEEKAQ 273

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 352 AIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD 402
           AIK +R++         + +EV +LK ++H N++ L+   E    +YLV E  + G L D
Sbjct: 66  AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125
Query: 403 -WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRA 458
             +H+ ++ E  +      I   V  G+ YLH       VH+D+   N+LL   +K+   
Sbjct: 126 EIIHRMKFNEVDA----AVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALI 178
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           K+ +F    SAV E       K  +GT  Y+APE +       + D ++ GV+L  L+ G
Sbjct: 179 KIVDFGL--SAVFENQ--KKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAG 233
Query: 519 KEAAYKQDGEEILL----AEAVFSMVEGGNAEAKLSVLVDPNLQ-------ANKKEIAHH 567
                 Q  +EIL      +  F   E  N       L+   LQ       + ++ + H 
Sbjct: 234 YPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293
Query: 568 LIMLCLACIAREPE-SRPSMAEVVSTLMKIQLDVQRSQTLLL 608
            I     C  +E     PS+A  +  + K Q   + +Q  LL
Sbjct: 294 WIKEM--CSKKESGIELPSLANAIENMRKFQNSQKLAQAALL 333

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/249 (22%), Positives = 104/249 (41%), Gaps = 26/249 (10%)
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +R    +E   +++ +H +++ L G    + V +++ E    G L  +L  ++Y   +  
Sbjct: 82  VREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS--LDL 138
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
                 A  ++  L YL +     +VH+DI++ N+L+  N   KL +F   R    E+S 
Sbjct: 139 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDST 193
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEA 535
           Y           +MAPE + +   T   D + FGV + E++      ++      +    
Sbjct: 194 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-----VKNND 248
Query: 536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
           V   +E G       + + PN           L  L   C A +P  RP   E+ + L  
Sbjct: 249 VIGRIENGE-----RLPMPPNCPPT-------LYSLMTKCWAYDPSRRPRFTELKAQLST 296
Query: 596 IQLDVQRSQ 604
           I L+ +++Q
Sbjct: 297 I-LEEEKAQ 304

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 25/191 (13%)
Query: 341 VFRGIINGSTVAI---KCMRRSISKEVNLLKKINHFNLINL---FGACEHDGV--FYLVY 392
           VF  + +G TV I     + + + +E+ LL   +H N++ L   F   E   +   YLV 
Sbjct: 54  VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVT 113
Query: 393 EFMENGSLSDWLHKKRY---PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           E M    L+  +H +R    P+ + +   + I L    GLH LH   + G VH+D+  GN
Sbjct: 114 ELMRT-DLAQVIHDQRIVISPQHIQY-FMYHILL----GLHVLH---EAGVVHRDLHPGN 164
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEY-MEYGLVTPEMDTYAF 508
           ILL  N    + +F+      RE++  ++    V    Y APE  M++   T  +D ++ 
Sbjct: 165 ILLADNNDITICDFNL----AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSA 220
Query: 509 GVVLLELITGK 519
           G V+ E+   K
Sbjct: 221 GCVMAEMFNRK 231

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/249 (22%), Positives = 104/249 (41%), Gaps = 26/249 (10%)
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +R    +E   +++ +H +++ L G    + V +++ E    G L  +L  ++Y   +  
Sbjct: 57  VREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS--LDL 113
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
                 A  ++  L YL +     +VH+DI++ N+L+  N   KL +F   R    E+S 
Sbjct: 114 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDST 168
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEA 535
           Y           +MAPE + +   T   D + FGV + E++      ++      +    
Sbjct: 169 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-----VKNND 223
Query: 536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
           V   +E G       + + PN           L  L   C A +P  RP   E+ + L  
Sbjct: 224 VIGRIENGE-----RLPMPPNCPPT-------LYSLMTKCWAYDPSRRPRFTELKAQLST 271
Query: 596 IQLDVQRSQ 604
           I L+ +++Q
Sbjct: 272 I-LEEEKAQ 279

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/249 (22%), Positives = 104/249 (41%), Gaps = 26/249 (10%)
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +R    +E   +++ +H +++ L G    + V +++ E    G L  +L  ++Y   +  
Sbjct: 56  VREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS--LDL 112
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
                 A  ++  L YL +     +VH+DI++ N+L+  N   KL +F   R    E+S 
Sbjct: 113 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDST 167
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEA 535
           Y           +MAPE + +   T   D + FGV + E++      ++      +    
Sbjct: 168 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-----VKNND 222
Query: 536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
           V   +E G       + + PN           L  L   C A +P  RP   E+ + L  
Sbjct: 223 VIGRIENGE-----RLPMPPNCPPT-------LYSLMTKCWAYDPSRRPRFTELKAQLST 270
Query: 596 IQLDVQRSQ 604
           I L+ +++Q
Sbjct: 271 I-LEEEKAQ 278

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/249 (22%), Positives = 104/249 (41%), Gaps = 26/249 (10%)
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +R    +E   +++ +H +++ L G    + V +++ E    G L  +L  ++Y   +  
Sbjct: 59  VREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS--LDL 115
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
                 A  ++  L YL +     +VH+DI++ N+L+  N   KL +F   R    E+S 
Sbjct: 116 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDST 170
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEA 535
           Y           +MAPE + +   T   D + FGV + E++      ++      +    
Sbjct: 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-----VKNND 225
Query: 536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
           V   +E G       + + PN           L  L   C A +P  RP   E+ + L  
Sbjct: 226 VIGRIENGE-----RLPMPPNCPPT-------LYSLMTKCWAYDPSRRPRFTELKAQLST 273
Query: 596 IQLDVQRSQ 604
           I L+ +++Q
Sbjct: 274 I-LEEEKAQ 281

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 40/206 (19%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSISK--------EVNLLKKINHFNLINL------FGAC 382
           G V R I    G  VAIK  R+ +S         E+ ++KK+NH N+++           
Sbjct: 29  GYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 88
Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNC------RFRIAL-DVAHGLHYLHNC 435
             + +  L  E+ E G L  +L++         NC        R  L D++  L YLH  
Sbjct: 89  APNDLPLLAMEYCEGGDLRKYLNQFE-------NCCGLKEGPIRTLLSDISSALRYLH-- 139
Query: 436 TDPGYVHKDISSGNILLD---KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE 492
            +   +H+D+   NI+L    + L  K+ +  + +     + G   T+  VGT  Y+APE
Sbjct: 140 -ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTE-FVGTLQYLAPE 194
Query: 493 YMEYGLVTPEMDTYAFGVVLLELITG 518
            +E    T  +D ++FG +  E ITG
Sbjct: 195 LLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 40/206 (19%)
Query: 339 GSVFRGIIN--GSTVAIKCMRRSISK--------EVNLLKKINHFNLINL------FGAC 382
           G V R I    G  VAIK  R+ +S         E+ ++KK+NH N+++           
Sbjct: 28  GYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87
Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNC------RFRIAL-DVAHGLHYLHNC 435
             + +  L  E+ E G L  +L++         NC        R  L D++  L YLH  
Sbjct: 88  APNDLPLLAMEYCEGGDLRKYLNQFE-------NCCGLKEGPIRTLLSDISSALRYLH-- 138
Query: 436 TDPGYVHKDISSGNILLD---KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE 492
            +   +H+D+   NI+L    + L  K+ +  + +     + G   T+  VGT  Y+APE
Sbjct: 139 -ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTE-FVGTLQYLAPE 193
Query: 493 YMEYGLVTPEMDTYAFGVVLLELITG 518
            +E    T  +D ++FG +  E ITG
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 102/234 (43%), Gaps = 24/234 (10%)
Query: 288 AARKDGKREKKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGII 346
           A+++  +  KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +
Sbjct: 18  ASKQKNEESKKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL 72
Query: 347 NGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK 406
             + V        + +EV +   + H N++ L+G        YL+ E+   G++   L K
Sbjct: 73  EKAGV-----EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 127
Query: 407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV 466
                 +S     R A  +    + L  C     +H+DI   N+LL      K+A+F + 
Sbjct: 128 ------LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 181
Query: 467 RSAVREESGYSSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
             A       SS +T + GT  Y+ PE +E  +   ++D ++ GV+  E + GK
Sbjct: 182 VHAP------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 84/185 (45%), Gaps = 24/185 (12%)
Query: 347 NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFMEN 397
            G+ VA+K ++       R   +E+ +LK ++   ++   G     G     LV E++ +
Sbjct: 35  TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPS 94
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIAL---DVAHGLHYL--HNCTDPGYVHKDISSGNILL 452
           G L D+L + R     S     R+ L    +  G+ YL    C     VH+D+++ NIL+
Sbjct: 95  GCLRDFLQRHRARLDAS-----RLLLYSSQICKGMEYLGSRRC-----VHRDLAARNILV 144
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
           +     K+A+F   +    ++      +       + APE +   + + + D ++FGVVL
Sbjct: 145 ESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 204
Query: 513 LELIT 517
            EL T
Sbjct: 205 YELFT 209

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 84/181 (46%), Gaps = 24/181 (13%)
Query: 353 IKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK--KRYP 410
           + C R    +E ++L   +   +  L  A + +   YLV E+   G L   L K  +R P
Sbjct: 105 VSCFR----EERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP 160
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
             ++   RF +A ++   +  +H     GYVH+DI   NILLD+    +LA+F    S +
Sbjct: 161 AEMA---RFYLA-EIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG---SCL 210
Query: 471 R-EESGYSSTKTAVGTNGYMAPEYME-------YGLVTPEMDTYAFGVVLLELITGKEAA 522
           +    G   +  AVGT  Y++PE ++        G   PE D +A GV   E+  G+   
Sbjct: 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
Query: 523 Y 523
           Y
Sbjct: 271 Y 271

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 339 GSVFRGII---NGST--VAIKCMR------RSISK---EVNLLKKINHFNLINLFGAC-- 382
           GSV  G +   +G++  VA+K M+      R I +   E   +K  +H N+I L G C  
Sbjct: 48  GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107
Query: 383 -EHDGV--FYLVYEFMENGSLSDWLHKKRY---PEFVSWNCRFRIALDVAHGLHYLHNCT 436
               G+    ++  FM+ G L  +L   R    P+ +      +  +D+A G+ YL N  
Sbjct: 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-- 165
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
              ++H+D+++ N +L  ++   +A+F   +  +     Y   + A     ++A E +  
Sbjct: 166 -RNFLHRDLAARNCMLRDDMTVCVADFGLSKK-IYSGDYYRQGRIAKMPVKWIAIESLAD 223
Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAY 523
            + T + D +AFGV + E+ T     Y
Sbjct: 224 RVYTSKSDVWAFGVTMWEIATRGMTPY 250

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 45/213 (21%)
Query: 339 GSVFRGIINGSTVAIKCM----RRSISKEVNLLKK--INHFNLINLFGACEH---DGV-- 387
           G+V++G ++   VA+K      R++   E N+ +   + H N+       E    DG   
Sbjct: 27  GAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86
Query: 388 FYLVYEFMENGSLSDWL--HKKRYPEFVSWNCRFRIALDVAHGLHYLH------NCTDPG 439
           + LV E+  NGSL  +L  H         W    R+A  V  GL YLH      +   P 
Sbjct: 87  YLLVMEYYPNGSLXKYLSLHTS------DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA 140
Query: 440 YVHKDISSGNILL---------DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
             H+D++S N+L+         D  L  +L     VR    + +  S     VGT  YMA
Sbjct: 141 ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE----VGTIRYMA 196
Query: 491 PEYMEYGL-------VTPEMDTYAFGVVLLELI 516
           PE +E  +          ++D YA G++  E+ 
Sbjct: 197 PEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 98/241 (40%), Gaps = 25/241 (10%)
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +R    +E   +++ +H +++ L G    + V +++ E    G L  +L  ++Y   +  
Sbjct: 54  VREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS--LDL 110
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
                 A  ++  L YL +     +VH+DI++ N+L+  N   KL +F   R    E+S 
Sbjct: 111 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDST 165
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEA 535
           Y           +MAPE + +   T   D + FGV + E++      ++      +    
Sbjct: 166 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-----VKNND 220
Query: 536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
           V   +E G       + + PN           L  L   C A +P  RP   E+ + L  
Sbjct: 221 VIGRIENGE-----RLPMPPNCPPT-------LYSLMTKCWAYDPSRRPRFTELKAQLST 268
Query: 596 I 596
           I
Sbjct: 269 I 269

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 98/241 (40%), Gaps = 25/241 (10%)
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +R    +E   +++ +H +++ L G    + V +++ E    G L  +L  ++Y   +  
Sbjct: 54  VREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS--LDL 110
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
                 A  ++  L YL +     +VH+DI++ N+L+  N   KL +F   R    E+S 
Sbjct: 111 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDST 165
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEA 535
           Y           +MAPE + +   T   D + FGV + E++      ++      +    
Sbjct: 166 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-----VKNND 220
Query: 536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
           V   +E G       + + PN           L  L   C A +P  RP   E+ + L  
Sbjct: 221 VIGRIENGE-----RLPMPPNCPPT-------LYSLMTKCWAYDPSRRPRFTELKAQLST 268
Query: 596 I 596
           I
Sbjct: 269 I 269

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 102/234 (43%), Gaps = 24/234 (10%)
Query: 288 AARKDGKREKKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGII 346
           A+++  +  KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +
Sbjct: 9   ASKQKNEESKKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL 63
Query: 347 NGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK 406
             + V        + +EV +   + H N++ L+G        YL+ E+   G++   L K
Sbjct: 64  EKAGV-----EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 118
Query: 407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV 466
                 +S     R A  +    + L  C     +H+DI   N+LL      K+A+F + 
Sbjct: 119 ------LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 172
Query: 467 RSAVREESGYSSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
             A       SS +T + GT  Y+ PE +E  +   ++D ++ GV+  E + GK
Sbjct: 173 VHAP------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 44/213 (20%)
Query: 339 GSVFRGIING-------STVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACE 383
           G V++G + G         VAIK +        R     E  L  ++ H N++ L G   
Sbjct: 40  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99
Query: 384 HDGVFYLVYEFMENGSLSDWLHKK-------------------RYPEFVSWNCRFRIALD 424
            D    +++ +  +G L ++L  +                     P+FV       +   
Sbjct: 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV------HLVAQ 153
Query: 425 VAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG 484
           +A G+ YL   +    VHKD+++ N+L+   L  K+++    R  V     Y     ++ 
Sbjct: 154 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE-VYAADYYKLLGNSLL 209
Query: 485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
              +MAPE + YG  + + D +++GVVL E+ +
Sbjct: 210 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 18/184 (9%)
Query: 346 INGSTVAIKC--MRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
           +    VA+K   M+R+      I KE+ + K +NH N++  +G      + YL  E+   
Sbjct: 30  VTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 89
Query: 398 GSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
           G L D +      PE  +     R    +  G+ YLH     G  H+DI   N+LLD+  
Sbjct: 90  GELFDRIEPDIGMPEPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERD 142
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLEL 515
             K+++F    +  R  +         GT  Y+APE ++      E +D ++ G+VL  +
Sbjct: 143 NLKISDFGLA-TVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201
Query: 516 ITGK 519
           + G+
Sbjct: 202 LAGE 205

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 18/184 (9%)
Query: 346 INGSTVAIKC--MRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
           +    VA+K   M+R+      I KE+ + K +NH N++  +G      + YL  E+   
Sbjct: 29  VTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 88
Query: 398 GSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
           G L D +      PE  +     R    +  G+ YLH     G  H+DI   N+LLD+  
Sbjct: 89  GELFDRIEPDIGMPEPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERD 141
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLEL 515
             K+++F    +  R  +         GT  Y+APE ++      E +D ++ G+VL  +
Sbjct: 142 NLKISDFGLA-TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200
Query: 516 ITGK 519
           + G+
Sbjct: 201 LAGE 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 18/184 (9%)
Query: 346 INGSTVAIKC--MRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
           +    VA+K   M+R+      I KE+ + K +NH N++  +G      + YL  E+   
Sbjct: 29  VTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 88
Query: 398 GSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
           G L D +      PE  +     R    +  G+ YLH     G  H+DI   N+LLD+  
Sbjct: 89  GELFDRIEPDIGMPEPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERD 141
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLEL 515
             K+++F    +  R  +         GT  Y+APE ++      E +D ++ G+VL  +
Sbjct: 142 NLKISDFGLA-TVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200
Query: 516 ITGK 519
           + G+
Sbjct: 201 LAGE 204

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 77/176 (43%), Gaps = 20/176 (11%)
Query: 347 NGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW--- 403
           N   ++IK        E+ ++  I +   +   G   +    Y++YE+MEN S+  +   
Sbjct: 77  NNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY 136
Query: 404 --LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
             +  K Y  F+       I   V +   Y+HN  +    H+D+   NIL+DKN R KL+
Sbjct: 137 FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLS 194
Query: 462 NFSFVRSAVREESGYSSTKTAVGTNG---YMAPEYM--EYGLVTPEMDTYAFGVVL 512
           +F         ES Y   K   G+ G   +M PE+   E      ++D ++ G+ L
Sbjct: 195 DFG--------ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 44/213 (20%)
Query: 339 GSVFRGIING-------STVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACE 383
           G V++G + G         VAIK +        R     E  L  ++ H N++ L G   
Sbjct: 23  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 82
Query: 384 HDGVFYLVYEFMENGSLSDWLHKK-------------------RYPEFVSWNCRFRIALD 424
            D    +++ +  +G L ++L  +                     P+FV       +   
Sbjct: 83  KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV------HLVAQ 136
Query: 425 VAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG 484
           +A G+ YL   +    VHKD+++ N+L+   L  K+++    R  V     Y     ++ 
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE-VYAADYYKLLGNSLL 192
Query: 485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT 517
              +MAPE + YG  + + D +++GVVL E+ +
Sbjct: 193 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 106/249 (42%), Gaps = 27/249 (10%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD-W 403
           II  S+V       ++  EV +LK+++H N++ L+   E    +YLV E    G L D  
Sbjct: 53  IIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI 112
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF 463
           + ++++ E  +      I   V  G  YLH       VH+D+   N+LL+   R  L   
Sbjct: 113 ILRQKFSEVDA----AVIMKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKI 165
Query: 464 -SFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAA 522
             F  SA  E  G    K  +GT  Y+APE +       + D ++ GV+L  L+ G    
Sbjct: 166 VDFGLSAHFEVGG--KMKERLGTAYYIAPEVLRKK-YDEKCDVWSCGVILYILLCGYPPF 222
Query: 523 YKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPES 582
             Q  +EIL        VE G    K S   DP       + A  L+ L L     EP  
Sbjct: 223 GGQTDQEIL------KRVEKG----KFS--FDPPDWTQVSDEAKQLVKLMLTY---EPSK 267
Query: 583 RPSMAEVVS 591
           R S  E ++
Sbjct: 268 RISAEEALN 276

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 9/168 (5%)
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           E  +L+K+N   +++L  A E      LV   M  G L   ++      F      F  A
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF-YA 292
Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
            ++  GL  LH       V++D+   NILLD +   ++++      AV    G  + K  
Sbjct: 293 AEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGL---AVHVPEG-QTIKGR 345
Query: 483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
           VGT GYMAPE ++    T   D +A G +L E+I G ++ ++Q  ++I
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG-QSPFQQRKKKI 392

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 119/279 (42%), Gaps = 30/279 (10%)
Query: 297 KKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKC 355
           KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V    
Sbjct: 3   KKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---- 53
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
               + +EV +   + H N++ L+G        YL+ E+   G++   L K      +S 
Sbjct: 54  -EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSK 106
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
               R A  +    + L  C     +H+DI   N+LL      K+ANF +   A      
Sbjct: 107 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP----- 161
Query: 476 YSSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEI 530
            SS +T + GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I
Sbjct: 162 -SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 220
Query: 531 LLAEAVFSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
              E  F       A   +S L+  +P+ +   +E+  H
Sbjct: 221 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 259

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 28/200 (14%)
Query: 339 GSVFRGIINGSTVAIKCM----RRSISKEVNLLKKI--NHFNLINLFGACEHDGV----- 387
           G V+ G   G  VA+K        S  +E  + + +   H N++  F A +  G      
Sbjct: 51  GEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILG-FIAADIKGTGSWTQ 109
Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHN-----CTDPGYVH 442
            YL+ ++ ENGSL D+L        +      ++A     GL +LH         P   H
Sbjct: 110 LYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH 165
Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYS-STKTAVGTNGYMAPEYMEYGLVTP 501
           +D+ S NIL+ KN    +A+       + + +       T VGT  YM PE ++  L   
Sbjct: 166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN 225
Query: 502 EM------DTYAFGVVLLEL 515
                   D Y+FG++L E+
Sbjct: 226 HFQSYIMADMYSFGLILWEV 245

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 18/184 (9%)
Query: 346 INGSTVAIKC--MRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
           +    VA+K   M+R+      I KE+ + K +NH N++  +G      + YL  E+   
Sbjct: 29  VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 88
Query: 398 GSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
           G L D +      PE  +     R    +  G+ YLH     G  H+DI   N+LLD+  
Sbjct: 89  GELFDRIEPDIGMPEPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERD 141
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLEL 515
             K+++F    +  R  +         GT  Y+APE ++      E +D ++ G+VL  +
Sbjct: 142 NLKISDFGLA-TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200
Query: 516 ITGK 519
           + G+
Sbjct: 201 LAGE 204

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 83/169 (49%), Gaps = 20/169 (11%)
Query: 359 SISKEVNLLKKINHFNLINLFGAC--EHDGVFYLVYEFMENG--SLSDWLHKKRYP--EF 412
           ++ KE+ LL+++ H N+I L      E     Y+V E+   G   + D + +KR+P  + 
Sbjct: 52  NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA 111
Query: 413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE 472
             + C+      +  GL YLH+    G VHKDI  GN+LL      K++    V  A+  
Sbjct: 112 HGYFCQ------LIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALG-VAEALHP 161
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVT---PEMDTYAFGVVLLELITG 518
            +   + +T+ G+  +  PE +  GL T    ++D ++ GV L  + TG
Sbjct: 162 FAADDTCRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYP 410
           A+ C   +I KE+ + K +NH N++  +G      + YL  E+   G L D +      P
Sbjct: 44  AVDCPE-NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 102
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
           E  +     R    +  G+ YLH     G  H+DI   N+LLD+    K+++F    +  
Sbjct: 103 EPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA-TVF 154
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLELITGK 519
           R  +         GT  Y+APE ++      E +D ++ G+VL  ++ G+
Sbjct: 155 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYP 410
           A+ C   +I KE+ + K +NH N++  +G      + YL  E+   G L D +      P
Sbjct: 44  AVDCPE-NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 102
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
           E  +     R    +  G+ YLH     G  H+DI   N+LLD+    K+++F    +  
Sbjct: 103 EPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA-TVF 154
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLELITGK 519
           R  +         GT  Y+APE ++      E +D ++ G+VL  ++ G+
Sbjct: 155 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 9/168 (5%)
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           E  +L+K+N   +++L  A E      LV   M  G L   ++      F      F  A
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF-YA 292
Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
            ++  GL  LH       V++D+   NILLD +   ++++      AV    G  + K  
Sbjct: 293 AEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGL---AVHVPEG-QTIKGR 345
Query: 483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
           VGT GYMAPE ++    T   D +A G +L E+I G ++ ++Q  ++I
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG-QSPFQQRKKKI 392

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYP 410
           A+ C   +I KE+ + K +NH N++  +G      + YL  E+   G L D +      P
Sbjct: 45  AVDC-PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 103
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
           E  +     R    +  G+ YLH     G  H+DI   N+LLD+    K+++F    +  
Sbjct: 104 EPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA-TVF 155
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLELITGK 519
           R  +         GT  Y+APE ++      E +D ++ G+VL  ++ G+
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYP 410
           A+ C   +I KE+ + K +NH N++  +G      + YL  E+   G L D +      P
Sbjct: 45  AVDC-PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 103
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
           E  +     R    +  G+ YLH     G  H+DI   N+LLD+    K+++F    +  
Sbjct: 104 EPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA-TVF 155
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLELITGK 519
           R  +         GT  Y+APE ++      E +D ++ G+VL  ++ G+
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYP 410
           A+ C   +I KE+ + K +NH N++  +G      + YL  E+   G L D +      P
Sbjct: 45  AVDC-PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 103
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
           E  +     R    +  G+ YLH     G  H+DI   N+LLD+    K+++F    +  
Sbjct: 104 EPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA-TVF 155
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLELITGK 519
           R  +         GT  Y+APE ++      E +D ++ G+VL  ++ G+
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYP 410
           A+ C   +I KE+ + K +NH N++  +G      + YL  E+   G L D +      P
Sbjct: 45  AVDCPE-NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 103
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
           E  +     R    +  G+ YLH     G  H+DI   N+LLD+    K+++F    +  
Sbjct: 104 EPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA-TVF 155
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLELITGK 519
           R  +         GT  Y+APE ++      E +D ++ G+VL  ++ G+
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYP 410
           A+ C   +I KE+ + K +NH N++  +G      + YL  E+   G L D +      P
Sbjct: 44  AVDC-PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 102
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
           E  +     R    +  G+ YLH     G  H+DI   N+LLD+    K+++F    +  
Sbjct: 103 EPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA-TVF 154
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLELITGK 519
           R  +         GT  Y+APE ++      E +D ++ G+VL  ++ G+
Sbjct: 155 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 119/279 (42%), Gaps = 30/279 (10%)
Query: 297 KKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKC 355
           KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V    
Sbjct: 4   KKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--- 55
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
               + +EV +   + H N++ L+G        YL+ E+   G++   L K      +S 
Sbjct: 56  --HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSK 107
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
               R A  +    + L  C     +H+DI   N+LL      K+ANF +   A      
Sbjct: 108 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP----- 162
Query: 476 YSSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEI 530
            SS +T + GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I
Sbjct: 163 -SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221
Query: 531 LLAEAVFSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
              E  F       A   +S L+  +P+ +   +E+  H
Sbjct: 222 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 84/191 (43%), Gaps = 20/191 (10%)
Query: 339 GSVFRGIINGS--TVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G V++GI N +   VAIK +           I +E+ +L + +   +   FG+       
Sbjct: 33  GEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSYLKSTKL 92
Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +++ E++  GS  D L     P  +       I  ++  GL YLH+      +H+DI + 
Sbjct: 93  WIIMEYLGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSERK---IHRDIKAA 145
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           N+LL +    KLA+F         +         VGT  +MAPE ++      + D ++ 
Sbjct: 146 NVLLSEQGDVKLADFGVAGQLTDTQI---KRNXFVGTPFWMAPEVIKQSAYDFKADIWSL 202
Query: 509 GVVLLELITGK 519
           G+  +EL  G+
Sbjct: 203 GITAIELAKGE 213

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 18/184 (9%)
Query: 346 INGSTVAIKC--MRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
           +    VA+K   M+R+      I KE+ + K +NH N++  +G      + YL  E+   
Sbjct: 29  VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 88
Query: 398 GSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
           G L D +      PE  +     R    +  G+ YLH     G  H+DI   N+LLD+  
Sbjct: 89  GELFDRIEPDIGMPEPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERD 141
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLEL 515
             K+++F    +  R  +         GT  Y+APE ++      E +D ++ G+VL  +
Sbjct: 142 NLKISDFGLA-TVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200
Query: 516 ITGK 519
           + G+
Sbjct: 201 LAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYP 410
           A+ C   +I KE+ + K +NH N++  +G      + YL  E+   G L D +      P
Sbjct: 43  AVDCPE-NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 101
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
           E  +     R    +  G+ YLH     G  H+DI   N+LLD+    K+++F    +  
Sbjct: 102 EPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA-TVF 153
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLELITGK 519
           R  +         GT  Y+APE ++      E +D ++ G+VL  ++ G+
Sbjct: 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYP 410
           A+ C   +I KE+ + K +NH N++  +G      + YL  E+   G L D +      P
Sbjct: 44  AVDC-PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 102
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
           E  +     R    +  G+ YLH     G  H+DI   N+LLD+    K+++F    +  
Sbjct: 103 EPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA-TVF 154
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLELITGK 519
           R  +         GT  Y+APE ++      E +D ++ G+VL  ++ G+
Sbjct: 155 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 18/184 (9%)
Query: 346 INGSTVAIKC--MRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
           +    VA+K   M+R+      I KE+ + K +NH N++  +G      + YL  E+   
Sbjct: 29  VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 88
Query: 398 GSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
           G L D +      PE  +     R    +  G+ YLH     G  H+DI   N+LLD+  
Sbjct: 89  GELFDRIEPDIGMPEPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERD 141
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLEL 515
             K+++F    +  R  +         GT  Y+APE ++      E +D ++ G+VL  +
Sbjct: 142 NLKISDFGLA-TVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200
Query: 516 ITGK 519
           + G+
Sbjct: 201 LAGE 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYP 410
           A+ C   +I KE+ + K +NH N++  +G      + YL  E+   G L D +      P
Sbjct: 44  AVDC-PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 102
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
           E  +     R    +  G+ YLH     G  H+DI   N+LLD+    K+++F    +  
Sbjct: 103 EPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA-TVF 154
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLELITGK 519
           R  +         GT  Y+APE ++      E +D ++ G+VL  ++ G+
Sbjct: 155 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYP 410
           A+ C   +I KE+ + K +NH N++  +G      + YL  E+   G L D +      P
Sbjct: 45  AVDC-PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 103
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
           E  +     R    +  G+ YLH     G  H+DI   N+LLD+    K+++F    +  
Sbjct: 104 EPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA-TVF 155
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLELITGK 519
           R  +         GT  Y+APE ++      E +D ++ G+VL  ++ G+
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 18/184 (9%)
Query: 346 INGSTVAIKC--MRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
           +    VA+K   M+R+      I KE+ + K +NH N++  +G      + YL  E+   
Sbjct: 29  VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 88
Query: 398 GSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL 456
           G L D +      PE  +     R    +  G+ YLH     G  H+DI   N+LLD+  
Sbjct: 89  GELFDRIEPDIGMPEPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERD 141
Query: 457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLEL 515
             K+++F    +  R  +         GT  Y+APE ++      E +D ++ G+VL  +
Sbjct: 142 NLKISDFGLA-TVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200
Query: 516 ITGK 519
           + G+
Sbjct: 201 LAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYP 410
           A+ C   +I KE+ + K +NH N++  +G      + YL  E+   G L D +      P
Sbjct: 44  AVDC-PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 102
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
           E  +     R    +  G+ YLH     G  H+DI   N+LLD+    K+++F    +  
Sbjct: 103 EPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA-TVF 154
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLELITGK 519
           R  +         GT  Y+APE ++      E +D ++ G+VL  ++ G+
Sbjct: 155 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYP 410
           A+ C   +I KE+ + K +NH N++  +G      + YL  E+   G L D +      P
Sbjct: 45  AVDC-PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 103
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
           E  +     R    +  G+ YLH     G  H+DI   N+LLD+    K+++F    +  
Sbjct: 104 EPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA-TVF 155
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLELITGK 519
           R  +         GT  Y+APE ++      E +D ++ G+VL  ++ G+
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/241 (21%), Positives = 98/241 (40%), Gaps = 25/241 (10%)
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +R    +E   +++ +H +++ L G    + V +++ E    G L  +L  +++   +  
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFS--LDL 490
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
                 A  ++  L YL +     +VH+DI++ N+L+  N   KL +F   R    E+S 
Sbjct: 491 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDST 545
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEA 535
           Y           +MAPE + +   T   D + FGV + E++      ++      +    
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-----VKNND 600
Query: 536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
           V   +E G       + + PN           L  L   C A +P  RP   E+ + L  
Sbjct: 601 VIGRIENGE-----RLPMPPNCPPT-------LYSLMTKCWAYDPSRRPRFTELKAQLST 648
Query: 596 I 596
           I
Sbjct: 649 I 649

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 83/172 (48%), Gaps = 28/172 (16%)
Query: 362 KEVNLLKKINHFNLINLFGACEHD--------GVFYLVYEFMEN---GSLSDWLHKKRYP 410
           +E+ +L+ + H N++NL   C           G  YLV++F E+   G LS+ L K    
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 125
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS-A 469
           E        R+   + +GL+Y+H       +H+D+ + N+L+ ++   KLA+F   R+ +
Sbjct: 126 EIK------RVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFS 176
Query: 470 VREESGYSSTKTAVGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELIT 517
           + + S  +     V T  Y  PE +    +YG   P +D +  G ++ E+ T
Sbjct: 177 LAKNSQPNRYXNRVVTLWYRPPELLLGERDYG---PPIDLWGAGCIMAEMWT 225

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 24/225 (10%)
Query: 297 KKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKC 355
           KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V    
Sbjct: 6   KKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---- 56
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
               + +EV +   + H N++ L+G        YL+ E+   G +   L K      +S 
Sbjct: 57  -EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK------LSK 109
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
               R A  +    + L  C     +H+DI   N+LL      K+A+F +   A      
Sbjct: 110 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----- 164
Query: 476 YSSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
            SS +T + GT  Y+ PE +E  +   ++D ++ GV+  E + GK
Sbjct: 165 -SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 106/249 (42%), Gaps = 27/249 (10%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD-W 403
           II  S+V       ++  EV +LK+++H N++ L+   E    +YLV E    G L D  
Sbjct: 36  IIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI 95
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF 463
           + ++++ E  +      I   V  G  YLH       VH+D+   N+LL+   R  L   
Sbjct: 96  ILRQKFSEVDA----AVIMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKI 148
Query: 464 -SFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAA 522
             F  SA  E  G    K  +GT  Y+APE +       + D ++ GV+L  L+ G    
Sbjct: 149 VDFGLSAHFEVGG--KMKERLGTAYYIAPEVLRKK-YDEKCDVWSCGVILYILLCGYPPF 205
Query: 523 YKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPES 582
             Q  +EIL        VE G    K S   DP       + A  L+ L L     EP  
Sbjct: 206 GGQTDQEIL------KRVEKG----KFS--FDPPDWTQVSDEAKQLVKLMLTY---EPSK 250
Query: 583 RPSMAEVVS 591
           R S  E ++
Sbjct: 251 RISAEEALN 259

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 83/172 (48%), Gaps = 28/172 (16%)
Query: 362 KEVNLLKKINHFNLINLFGACEHD--------GVFYLVYEFMEN---GSLSDWLHKKRYP 410
           +E+ +L+ + H N++NL   C           G  YLV++F E+   G LS+ L K    
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 125
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS-A 469
           E        R+   + +GL+Y+H       +H+D+ + N+L+ ++   KLA+F   R+ +
Sbjct: 126 EIK------RVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFS 176
Query: 470 VREESGYSSTKTAVGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELIT 517
           + + S  +     V T  Y  PE +    +YG   P +D +  G ++ E+ T
Sbjct: 177 LAKNSQPNRYXNRVVTLWYRPPELLLGERDYG---PPIDLWGAGCIMAEMWT 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 83/172 (48%), Gaps = 28/172 (16%)
Query: 362 KEVNLLKKINHFNLINLFGACEHD--------GVFYLVYEFMEN---GSLSDWLHKKRYP 410
           +E+ +L+ + H N++NL   C           G  YLV++F E+   G LS+ L K    
Sbjct: 65  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS-A 469
           E        R+   + +GL+Y+H       +H+D+ + N+L+ ++   KLA+F   R+ +
Sbjct: 125 EIK------RVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFS 175
Query: 470 VREESGYSSTKTAVGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELIT 517
           + + S  +     V T  Y  PE +    +YG   P +D +  G ++ E+ T
Sbjct: 176 LAKNSQPNRYXNRVVTLWYRPPELLLGERDYG---PPIDLWGAGCIMAEMWT 224

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 77/168 (45%), Gaps = 19/168 (11%)
Query: 358 RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNC 417
           R++ KE+ +++ + H  L+NL+ + + +   ++V + +  G L    H ++   F     
Sbjct: 60  RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEETV 117
Query: 418 RFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS 477
           +  I  ++   L YL N      +H+D+   NILLD++    + +F+      RE    +
Sbjct: 118 KLFIC-ELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----T 169
Query: 478 STKTAVGTNGYMAPEYME------YGLVTPEMDTYAFGVVLLELITGK 519
              T  GT  YMAPE         Y      +D ++ GV   EL+ G+
Sbjct: 170 QITTMAGTKPYMAPEMFSSRKGAGYSFA---VDWWSLGVTAYELLRGR 214

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR-----YPEFVS 414
           + +E ++   + H +++ L      DG+ Y+V+EFM+   L   + K+      Y E V+
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSAVR 471
            +   +I       L  L  C D   +H+D+   N+LL   + +   KL +F    +   
Sbjct: 133 SHYMRQI-------LEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGV--AIQL 183
Query: 472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
            ESG  +    VGT  +MAPE ++       +D +  GV+L  L++G
Sbjct: 184 GESGLVAGGR-VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 101/235 (42%), Gaps = 24/235 (10%)
Query: 358 RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL-HKKRYPEFVSWN 416
             I  E+ +LK ++H N+I +F   E     Y+V E  E G L + +   +   + +S  
Sbjct: 65  EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL-DKNLRAKLANFSFVRSAVREESG 475
               +   + + L Y H+      VHKD+   NIL  D +  + +    F  + + +   
Sbjct: 125 YVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEA 535
           +S+   A GT  YMAPE  +   VT + D ++ GVV+  L+TG         EE+     
Sbjct: 182 HST--NAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV----- 233
Query: 536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
                       + +   +PN     + +    + L    + ++PE RPS A+V+
Sbjct: 234 -----------QQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 116/273 (42%), Gaps = 24/273 (8%)
Query: 302 PEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSIS 361
           P  + +    + R L   K+ ++ +A E  S   +    +F+  +  + V        + 
Sbjct: 2   PRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-----EHQLR 56
Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRI 421
           +EV +   + H N++ L+G        YL+ E+   G++   L K      +S     R 
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRT 110
Query: 422 ALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
           A  +    + L  C     +H+DI   N+LL      K+A+F +   A       SS +T
Sbjct: 111 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP------SSRRT 164
Query: 482 AV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEILLAEAV 536
            + GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I   E  
Sbjct: 165 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 224
Query: 537 FSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
           F       A   +S L+  +P+ +   +E+  H
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 121/285 (42%), Gaps = 44/285 (15%)
Query: 297 KKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCM 356
           K++   EDF     ++ R L   K+ ++ +A E  S   +    +F+  +  + V     
Sbjct: 6   KRQWTLEDF-----DIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE---- 56
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK-KRYPEFVSW 415
              + +EV +   + H N++ L+G        YL+ E+   G++   L K  R+ E    
Sbjct: 57  -HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQ--- 112
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
               R A  +    + L  C     +H+DI   N+LL  N   K+A+F +   A      
Sbjct: 113 ----RTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAP----- 163
Query: 476 YSSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG----KEAAYKQDGEEI 530
            SS +T + GT  Y+ PE +E  +   ++D ++ GV+  E + G    +   Y++    I
Sbjct: 164 -SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRI 222
Query: 531 LLAEAVFS--MVEGG----------NAEAKLS---VLVDPNLQAN 560
              E  F   + EG           NA  +L+   VL  P ++AN
Sbjct: 223 SRVEFTFPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 22/233 (9%)
Query: 288 AARKDGKREKKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGII 346
           A+++  +  KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +
Sbjct: 18  ASKQKNEESKKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL 72
Query: 347 NGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK 406
             + V        + +EV +   + H N++ L+G        YL+ E+   G++   L K
Sbjct: 73  EKAGV-----EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 127
Query: 407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV 466
                 +S     R A  +    + L  C     +H+DI   N+LL      K+A+F + 
Sbjct: 128 ------LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 181
Query: 467 RSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
             A       S      GT  Y+ PE +E  +   ++D ++ GV+  E + GK
Sbjct: 182 VHAPS-----SRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 42/284 (14%)
Query: 297 KKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCM 356
           K++   EDF     ++ R L   K+ ++ +A E  S   +    +F+  +  + V     
Sbjct: 6   KRQWTLEDF-----DIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE---- 56
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK-KRYPEFVSW 415
              + +EV +   + H N++ L+G        YL+ E+   G++   L K  R+ E    
Sbjct: 57  -HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQ--- 112
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
               R A  +    + L  C     +H+DI   N+LL  N   K+A+F +   +V   S 
Sbjct: 113 ----RTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW---SVHAPS- 164
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG----KEAAYKQDGEEIL 531
            S   T  GT  Y+ PE +E  +   ++D ++ GV+  E + G    +   Y++    I 
Sbjct: 165 -SRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRIS 223
Query: 532 LAEAVFS--MVEGG----------NAEAKLS---VLVDPNLQAN 560
             E  F   + EG           NA  +L+   VL  P ++AN
Sbjct: 224 RVEFTFPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 78/177 (44%), Gaps = 37/177 (20%)
Query: 358 RSISKEVNLLKKINHFNLINLFG------ACEHDGVFYLVYEFM--------ENGSLSDW 403
           R   +E+ LLK + H N+I L        + E     YLV   M        ++ +LSD 
Sbjct: 72  RRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSD- 130
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF 463
                  E V +     +   +  GL Y+H+    G +H+D+   N+ ++++   ++ +F
Sbjct: 131 -------EHVQF-----LVYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDSELRILDF 175
Query: 464 SFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
              R A  E +GY      V T  Y APE M  +      +D ++ G ++ EL+ GK
Sbjct: 176 GLARQADEEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/271 (22%), Positives = 116/271 (42%), Gaps = 44/271 (16%)
Query: 339 GSVFRGIINGST-----VAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHD 385
           G V+ G+          VA+K  ++  +         E  ++K ++H +++ L G  E +
Sbjct: 22  GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 81
Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH--NCTDPGYVHK 443
              +++ E    G L  +L + +    V     +  +L +   + YL   NC     VH+
Sbjct: 82  PT-WIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQICKAMAYLESINC-----VHR 133
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           DI+  NIL+      KL +F   R  + +E  Y ++ T +    +M+PE + +   T   
Sbjct: 134 DIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIK-WMSPESINFRRFTTAS 191
Query: 504 DTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK 562
           D + F V + E+++ GK+  +  + ++++       ++E G+   K      P+L     
Sbjct: 192 DVWMFAVCMWEILSFGKQPFFWLENKDVI------GVLEKGDRLPK------PDL----- 234
Query: 563 EIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                L  L   C   +P  RP   E+V +L
Sbjct: 235 -CPPVLYTLMTRCWDYDPSDRPRFTELVCSL 264

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 21/177 (11%)
Query: 356 MRRSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVS 414
           +R  + +EV +L +   H N++ L    E +  FYLV+E M  GS+   +HK+R+   + 
Sbjct: 53  IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE 112
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR---AKLANFSFVRSAVR 471
            +    +  DVA  L +LHN    G  H+D+   NIL +   +    K+ +F  + S ++
Sbjct: 113 ASV---VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFD-LGSGIK 165
Query: 472 EESGYSSTK-----TAVGTNGYMAPEYM-----EYGLVTPEMDTYAFGVVLLELITG 518
                S        T  G+  YMAPE +     E  +     D ++ GV+L  L++G
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 21/177 (11%)
Query: 356 MRRSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVS 414
           +R  + +EV +L +   H N++ L    E +  FYLV+E M  GS+   +HK+R+   + 
Sbjct: 53  IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE 112
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR---AKLANFSFVRSAVR 471
            +    +  DVA  L +LHN    G  H+D+   NIL +   +    K+ +F  + S ++
Sbjct: 113 ASV---VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFG-LGSGIK 165
Query: 472 EESGYSSTK-----TAVGTNGYMAPEYM-----EYGLVTPEMDTYAFGVVLLELITG 518
                S        T  G+  YMAPE +     E  +     D ++ GV+L  L++G
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/162 (20%), Positives = 74/162 (45%), Gaps = 15/162 (9%)
Query: 367 LKKINHFNLINLFGACEHDG---VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIAL 423
           +++++ F+  N  G  +        Y+  +     +L DW++++   E         I +
Sbjct: 112 IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 424 DVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES--------- 474
            +A  + +LH+    G +H+D+   NI    +   K+ +F  V +  ++E          
Sbjct: 172 QIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELI 516
            Y++    VGT  YM+PE +     + ++D ++ G++L EL+
Sbjct: 229 AYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 119/279 (42%), Gaps = 30/279 (10%)
Query: 297 KKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKC 355
           KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V    
Sbjct: 4   KKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---- 54
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
               + +EV +   + H N++ L+G        YL+ E+   G++   L K      +S 
Sbjct: 55  -EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSK 107
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
               R A  +    + L  C     +H+DI   N+LL      K+A+F +   A      
Sbjct: 108 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----- 162
Query: 476 YSSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEI 530
            SS +T + GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I
Sbjct: 163 -SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221
Query: 531 LLAEAVFSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
              E  F       A   +S L+  +P+ +   +E+  H
Sbjct: 222 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/271 (22%), Positives = 116/271 (42%), Gaps = 44/271 (16%)
Query: 339 GSVFRGIINGST-----VAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHD 385
           G V+ G+          VA+K  ++  +         E  ++K ++H +++ L G  E +
Sbjct: 38  GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 97
Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH--NCTDPGYVHK 443
              +++ E    G L  +L + +    V     +  +L +   + YL   NC     VH+
Sbjct: 98  PT-WIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQICKAMAYLESINC-----VHR 149
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           DI+  NIL+      KL +F   R  + +E  Y ++ T +    +M+PE + +   T   
Sbjct: 150 DIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIK-WMSPESINFRRFTTAS 207
Query: 504 DTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK 562
           D + F V + E+++ GK+  +  + ++++       ++E G+   K      P+L     
Sbjct: 208 DVWMFAVCMWEILSFGKQPFFWLENKDVI------GVLEKGDRLPK------PDL----- 250
Query: 563 EIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                L  L   C   +P  RP   E+V +L
Sbjct: 251 -CPPVLYTLMTRCWDYDPSDRPRFTELVCSL 280

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 116/273 (42%), Gaps = 24/273 (8%)
Query: 302 PEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSIS 361
           P  + +    + R L   K+ ++ +A E  S   +    +F+  +  + V        + 
Sbjct: 2   PRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-----EHQLR 56
Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRI 421
           +EV +   + H N++ L+G        YL+ E+   G++   L K      +S     R 
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRT 110
Query: 422 ALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
           A  +    + L  C     +H+DI   N+LL      K+A+F +   A       SS +T
Sbjct: 111 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP------SSRRT 164
Query: 482 AV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEILLAEAV 536
            + GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I   E  
Sbjct: 165 ELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 224
Query: 537 FSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
           F       A   +S L+  +P+ +   +E+  H
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 19/183 (10%)
Query: 347 NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
            G  VA+K +R          +  +E++LLK+++H N+++L      +    LV+EFME 
Sbjct: 44  QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK 103
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                   KK   E  +     +I + +   L  + +C     +H+D+   N+L++ +  
Sbjct: 104 DL------KKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA 157
Query: 458 AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE-YMEYGLVTPEMDTYAFGVVLLELI 516
            KLA+F   R+       Y+     V T  Y AP+  M     +  +D ++ G +  E+I
Sbjct: 158 LKLADFGLARAFGIPVRSYTH---EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214
Query: 517 TGK 519
           TGK
Sbjct: 215 TGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 19/183 (10%)
Query: 347 NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
            G  VA+K +R          +  +E++LLK+++H N+++L      +    LV+EFME 
Sbjct: 44  QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK 103
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                   KK   E  +     +I + +   L  + +C     +H+D+   N+L++ +  
Sbjct: 104 DL------KKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA 157
Query: 458 AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE-YMEYGLVTPEMDTYAFGVVLLELI 516
            KLA+F   R+       Y+     V T  Y AP+  M     +  +D ++ G +  E+I
Sbjct: 158 LKLADFGLARAFGIPVRSYTH---EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214
Query: 517 TGK 519
           TGK
Sbjct: 215 TGK 217

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 116/278 (41%), Gaps = 28/278 (10%)
Query: 297 KKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKC 355
           KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V    
Sbjct: 2   KKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---- 52
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
               + +EV +   + H N++ L+G        YL+ E+   G++   L K      +S 
Sbjct: 53  -EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSK 105
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
               R A  +    + L  C     +H+DI   N+LL      K+A+F +   A      
Sbjct: 106 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 161
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEIL 531
            S   T  GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I 
Sbjct: 162 -SRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220
Query: 532 LAEAVFSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
             E  F       A   +S L+  +P+ +   +E+  H
Sbjct: 221 RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 30/226 (13%)
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH--KKRYPEFVSWNCRFR 420
           E  +L K++   +++L  A E      LV   M  G +   ++   +  P F      F 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 421 IALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTK 480
            A  +  GL +LH       +++D+   N+LLD +   ++++      AV  ++G + TK
Sbjct: 295 TA-QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGL---AVELKAGQTKTK 347
Query: 481 TAVGTNGYMAPEYM---EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVF 537
              GT G+MAPE +   EY      +D +A GV L E+I  +   ++  GE++       
Sbjct: 348 GYAGTPGFMAPELLLGEEYDF---SVDYFALGVTLYEMIAAR-GPFRARGEKV------- 396
Query: 538 SMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESR 583
                 N E K  VL       +K   A      C A + ++PE R
Sbjct: 397 -----ENKELKQRVLEQAVTYPDKFSPASK--DFCEALLQKDPEKR 435

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 30/226 (13%)
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH--KKRYPEFVSWNCRFR 420
           E  +L K++   +++L  A E      LV   M  G +   ++   +  P F      F 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 421 IALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTK 480
            A  +  GL +LH       +++D+   N+LLD +   ++++      AV  ++G + TK
Sbjct: 295 TA-QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGL---AVELKAGQTKTK 347
Query: 481 TAVGTNGYMAPEYM---EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVF 537
              GT G+MAPE +   EY      +D +A GV L E+I  +   ++  GE++       
Sbjct: 348 GYAGTPGFMAPELLLGEEYDF---SVDYFALGVTLYEMIAAR-GPFRARGEKV------- 396
Query: 538 SMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESR 583
                 N E K  VL       +K   A      C A + ++PE R
Sbjct: 397 -----ENKELKQRVLEQAVTYPDKFSPASK--DFCEALLQKDPEKR 435

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 30/226 (13%)
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH--KKRYPEFVSWNCRFR 420
           E  +L K++   +++L  A E      LV   M  G +   ++   +  P F      F 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 421 IALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTK 480
            A  +  GL +LH       +++D+   N+LLD +   ++++      AV  ++G + TK
Sbjct: 295 TA-QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGL---AVELKAGQTKTK 347
Query: 481 TAVGTNGYMAPEYM---EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVF 537
              GT G+MAPE +   EY      +D +A GV L E+I  +   ++  GE++       
Sbjct: 348 GYAGTPGFMAPELLLGEEYDF---SVDYFALGVTLYEMIAAR-GPFRARGEKV------- 396
Query: 538 SMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESR 583
                 N E K  VL       +K   A      C A + ++PE R
Sbjct: 397 -----ENKELKQRVLEQAVTYPDKFSPASK--DFCEALLQKDPEKR 435

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 30/226 (13%)
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH--KKRYPEFVSWNCRFR 420
           E  +L K++   +++L  A E      LV   M  G +   ++   +  P F      F 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 421 IALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTK 480
            A  +  GL +LH       +++D+   N+LLD +   ++++      AV  ++G + TK
Sbjct: 295 TA-QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGL---AVELKAGQTKTK 347
Query: 481 TAVGTNGYMAPEYM---EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVF 537
              GT G+MAPE +   EY      +D +A GV L E+I  +   ++  GE++       
Sbjct: 348 GYAGTPGFMAPELLLGEEYDF---SVDYFALGVTLYEMIAAR-GPFRARGEKV------- 396
Query: 538 SMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESR 583
                 N E K  VL       +K   A      C A + ++PE R
Sbjct: 397 -----ENKELKQRVLEQAVTYPDKFSPASK--DFCEALLQKDPEKR 435

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 24/225 (10%)
Query: 297 KKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKC 355
           KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V    
Sbjct: 6   KKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---- 56
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
               + +EV +   + H N++ L+G        YL+ E+   G++   L K      +S 
Sbjct: 57  -EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSK 109
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
               R A  +    + L  C     +H+DI   N+LL      K+A+F +   A      
Sbjct: 110 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----- 164
Query: 476 YSSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
            SS +T + GT  Y+ PE +E  +   ++D ++ GV+  E + GK
Sbjct: 165 -SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/271 (22%), Positives = 116/271 (42%), Gaps = 44/271 (16%)
Query: 339 GSVFRGIINGST-----VAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHD 385
           G V+ G+          VA+K  ++  +         E  ++K ++H +++ L G  E +
Sbjct: 26  GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85
Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH--NCTDPGYVHK 443
              +++ E    G L  +L + +    V     +  +L +   + YL   NC     VH+
Sbjct: 86  PT-WIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQICKAMAYLESINC-----VHR 137
Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           DI+  NIL+      KL +F   R  + +E  Y ++ T +    +M+PE + +   T   
Sbjct: 138 DIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIK-WMSPESINFRRFTTAS 195
Query: 504 DTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK 562
           D + F V + E+++ GK+  +  + ++++       ++E G+   K      P+L     
Sbjct: 196 DVWMFAVCMWEILSFGKQPFFWLENKDVI------GVLEKGDRLPK------PDL----- 238
Query: 563 EIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                L  L   C   +P  RP   E+V +L
Sbjct: 239 -CPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 37/177 (20%)
Query: 358 RSISKEVNLLKKINHFNLINLFG------ACEHDGVFYLVYEFM--------ENGSLSDW 403
           R   +E+ LLK + H N+I L        + E     YLV   M        +  +LSD 
Sbjct: 64  RRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSD- 122
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF 463
                  E V +     +   +  GL Y+H+    G +H+D+   N+ ++++   ++ +F
Sbjct: 123 -------EHVQF-----LVYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 167
Query: 464 SFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
              R A  E +GY      V T  Y APE M  +      +D ++ G ++ EL+ GK
Sbjct: 168 GLARQADEEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 123/285 (43%), Gaps = 42/285 (14%)
Query: 297 KKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKC 355
           KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V    
Sbjct: 4   KKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--- 55
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK------KRY 409
               + +EV +   + H N++ L+G        YL+ E+   G++   L K      +R 
Sbjct: 56  --HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSA 469
             +++         ++A+ L Y   C     +H+DI   N+LL      K+A+F +   A
Sbjct: 114 ATYIT---------ELANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 161
Query: 470 VREESGYSSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYK 524
                  SS +T + GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y+
Sbjct: 162 P------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215
Query: 525 QDGEEILLAEAVFSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
           +  + I   E  F       A   +S L+  +P+ +   +E+  H
Sbjct: 216 ETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/307 (22%), Positives = 130/307 (42%), Gaps = 53/307 (17%)
Query: 320 KYEDLVVATENFSPKNMID----GSVFRGII---NGS--TVAIKCMRRSIS--------- 361
           K ED+++  + F+   M+     GSV    +   +GS   VA+K ++  I          
Sbjct: 14  KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL 73
Query: 362 KEVNLLKKINHFNLINLFG------ACEHDGVFYLVYEFMENGSLSDWLHKKRY---PEF 412
           +E   +K+ +H ++  L G      A     +  ++  FM++G L  +L   R    P  
Sbjct: 74  REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE 472
           +      R  +D+A G+ YL   +   ++H+D+++ N +L +++   +A+F   R     
Sbjct: 134 LPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILL 532
           +       + +    ++A E +   L T   D +AFGV + E++T  +  Y   G E   
Sbjct: 191 DYYRQGCASKLPVK-WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA--GIE--- 244
Query: 533 AEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST 592
                      NAE   + L+  N      E    +  L   C + +P+ RPS      T
Sbjct: 245 -----------NAEI-YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSF-----T 287
Query: 593 LMKIQLD 599
            ++++L+
Sbjct: 288 CLRMELE 294

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 119/279 (42%), Gaps = 30/279 (10%)
Query: 297 KKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKC 355
           KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V    
Sbjct: 1   KKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--- 52
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
               + +EV +   + H N++ L+G        YL+ E+   G++   L K      +S 
Sbjct: 53  --HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSK 104
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
               R A  +    + L  C     +H+DI   N+LL      K+A+F +   A      
Sbjct: 105 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----- 159
Query: 476 YSSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEI 530
            SS +T + GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I
Sbjct: 160 -SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218
Query: 531 LLAEAVFSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
              E  F       A   +S L+  +P+ +   +E+  H
Sbjct: 219 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 35/224 (15%)
Query: 303 EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISK 362
           EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V        + +
Sbjct: 11  EDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-----EHQLRR 60
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK------KRYPEFVSWN 416
           EV +   + H N++ L+G        YL+ E+   G++   L K      +R   +++  
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-- 118
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                  ++A+ L Y   C     +H+DI   N+LL      K+A+F +   A       
Sbjct: 119 -------ELANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP------ 162
Query: 477 SSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           SS + A+ GT  Y+ PE +E  +   ++D ++ GV+  E + GK
Sbjct: 163 SSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 320 KYEDLVVATENFSPKNM---IDGSVFRGIINGSTVAIKCM-------RRSISKEVNLLKK 369
           K+ED+   T     +     + G+V   + NG   A+K +       R  + +EV  L +
Sbjct: 9   KFEDMYKLTSELLGEGAYAKVQGAV--SLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQ 66
Query: 370 IN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR--FRIALDVA 426
              + N++ L    E D  FYLV+E ++ GS+   + K+++     +N R   R+  DVA
Sbjct: 67  CQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH-----FNEREASRVVRDVA 121
Query: 427 HGLHYLHNCTDPGYVHKDISSGNILLDKNLR---AKLANFSFVRSAVREESGYSST---- 479
             L +LH     G  H+D+   NIL +   +    K+ +F          S    T    
Sbjct: 122 AALDFLHT---KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPEL 178
Query: 480 KTAVGTNGYMAPEYMEY-----GLVTPEMDTYAFGVVLLELITG 518
            T  G+  YMAPE +E             D ++ GVVL  +++G
Sbjct: 179 TTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 119/279 (42%), Gaps = 30/279 (10%)
Query: 297 KKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKC 355
           KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V    
Sbjct: 2   KKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---- 52
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
               + +EV +   + H N++ L+G        YL+ E+   G++   L K      +S 
Sbjct: 53  -EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSK 105
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
               R A  +    + L  C     +H+DI   N+LL      K+A+F +   A      
Sbjct: 106 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----- 160
Query: 476 YSSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEI 530
            SS +T + GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I
Sbjct: 161 -SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219
Query: 531 LLAEAVFSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
              E  F       A   +S L+  +P+ +   +E+  H
Sbjct: 220 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M    L++ +  ++       + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 107 HLM-GADLNNIVKXQK---LTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 159 NEDXELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 213 MAELLTGR 220

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/272 (23%), Positives = 116/272 (42%), Gaps = 29/272 (10%)
Query: 303 EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISK 362
           EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V        + +
Sbjct: 7   EDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-----HQLRR 56
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           EV +   + H N++ L+G        YL+ E+   G++   L K      +S     R A
Sbjct: 57  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTA 110
Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
             +    + L  C     +H+DI   N+LL      K+A+F +   A       SS +T 
Sbjct: 111 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP------SSRRTT 164
Query: 483 V-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEILLAEAVF 537
           + GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I   E  F
Sbjct: 165 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 224
Query: 538 SMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
                  A   +S L+  +P+ +   +E+  H
Sbjct: 225 PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 256

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E+M  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    K+A+F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 26/228 (11%)
Query: 303 EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISK 362
           EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V        + +
Sbjct: 8   EDF-----EIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGV-----EHQLRR 57
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           EV +   + H N++ L+G        YL+ E+   G++   L K      +S     R A
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQK------LSKFDEQRTA 111
Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
             +    + L  C     +H+DI   N+LL      K+A+F +   A       SS + A
Sbjct: 112 TYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAP------SSRRAA 165
Query: 483 V-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EAAYKQD 526
           + GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA   QD
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQD 213

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E+M  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    K+A+F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 119/279 (42%), Gaps = 30/279 (10%)
Query: 297 KKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKC 355
           KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V    
Sbjct: 6   KKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---- 56
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
               + +EV +   + H N++ L+G        YL+ E+   G++   L K      +S 
Sbjct: 57  -EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSK 109
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
               R A  +    + L  C     +H+DI   N+LL      K+A+F +   A      
Sbjct: 110 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----- 164
Query: 476 YSSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEI 530
            SS +T + GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I
Sbjct: 165 -SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223
Query: 531 LLAEAVFSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
              E  F       A   +S L+  +P+ +   +E+  H
Sbjct: 224 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 262

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 15/177 (8%)
Query: 348 GSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACE--HDGVFYLVYEFMENGSLSDWLH 405
           G  +  +     + +E+ +LKK++H N++ L    +  ++   Y+V+E +  G + +   
Sbjct: 71  GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 130
Query: 406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSF 465
            K   E      RF    D+  G+ YLH       +H+DI   N+L+ ++   K+A+F  
Sbjct: 131 LKPLSED---QARFYFQ-DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 466 VRSAVREESGYSSTKTAVGTNGYMAPEYMEYG---LVTPEMDTYAFGVVLLELITGK 519
                  ++  S+T   VGT  +MAPE +           +D +A GV L   + G+
Sbjct: 184 SNEFKGSDALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 53  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 113 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 164
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 165 VNEDCELKILDFGLARHTADEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 218
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 219 IMAELLTGR 227

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 119/279 (42%), Gaps = 30/279 (10%)
Query: 297 KKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKC 355
           KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V    
Sbjct: 2   KKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---- 52
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
               + +EV +   + H N++ L+G        YL+ E+   G++   L K      +S 
Sbjct: 53  -EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSK 105
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
               R A  +    + L  C     +H+DI   N+LL      K+A+F +   A      
Sbjct: 106 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAP----- 160
Query: 476 YSSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEI 530
            SS +T + GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I
Sbjct: 161 -SSRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219
Query: 531 LLAEAVFSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
              E  F       A   +S L+  +P+ +   +E+  H
Sbjct: 220 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 53  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 113 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 164
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 165 VNEDCELKILDFGLARHTADEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 218
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 219 IMAELLTGR 227

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 352 AIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-RYP 410
           A+ C   +I KE+ +   +NH N++  +G      + YL  E+   G L D +      P
Sbjct: 45  AVDC-PENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 103
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
           E  +     R    +  G+ YLH     G  H+DI   N+LLD+    K+++F    +  
Sbjct: 104 EPDA----QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA-TVF 155
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLELITGK 519
           R  +         GT  Y+APE ++      E +D ++ G+VL  ++ G+
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 87/194 (44%), Gaps = 36/194 (18%)
Query: 345 IINGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFY 389
           + +G  +A+K + R            +E+ LLK + H N+I L        + E     Y
Sbjct: 73  VKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVY 132
Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           LV   M    L++ +  ++       + +F I   +  GL Y+H+      +H+D+   N
Sbjct: 133 LVTHLM-GADLNNIVKCQK---LTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSN 184
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE----YMEYGLVTPEMDT 505
           + ++++   K+ +F   R    E +GY      V T  Y APE    +M Y +    +D 
Sbjct: 185 LAVNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNMT---VDI 235
Query: 506 YAFGVVLLELITGK 519
           ++ G ++ EL+TG+
Sbjct: 236 WSVGCIMAELLTGR 249

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 53  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 113 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 164
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 165 VNEDCELKILDFGLARHTADEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 218
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 219 IMAELLTGR 227

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 118/279 (42%), Gaps = 30/279 (10%)
Query: 297 KKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKC 355
           KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V    
Sbjct: 6   KKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---- 56
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
               + +EV +   + H N++ L+G        YL+ E+   G++   L K      +S 
Sbjct: 57  -EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSK 109
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
               R A  +    + L  C     +H+DI   N+LL      K+A+F +   A      
Sbjct: 110 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----- 164
Query: 476 YSSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEI 530
            SS +T + GT  Y+ PE +E      ++D ++ GV+  E + GK   EA  Y++  + I
Sbjct: 165 -SSRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223
Query: 531 LLAEAVFSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
              E  F       A   +S L+  +P+ +   +E+  H
Sbjct: 224 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPXLREVLEH 262

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/241 (21%), Positives = 97/241 (40%), Gaps = 25/241 (10%)
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +R    +E   +++ +H +++ L G    + V +++ E    G L  +L  +++   +  
Sbjct: 54  VREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFS--LDL 110
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
                 A  ++  L YL +     +VH+DI++ N+L+      KL +F   R    E+S 
Sbjct: 111 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYM--EDST 165
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEA 535
           Y           +MAPE + +   T   D + FGV + E++      ++      +    
Sbjct: 166 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-----VKNND 220
Query: 536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
           V   +E G       + + PN           L  L   C A +P  RP   E+ + L  
Sbjct: 221 VIGRIENGE-----RLPMPPNCPPT-------LYSLMTKCWAYDPSRRPRFTELKAQLST 268
Query: 596 I 596
           I
Sbjct: 269 I 269

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M    L++ +  ++       + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 107 HLM-GADLNNIVKXQK---LTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 213 MAELLTGR 220

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/272 (23%), Positives = 116/272 (42%), Gaps = 29/272 (10%)
Query: 303 EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISK 362
           EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V        + +
Sbjct: 12  EDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-----EHQLRR 61
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           EV +   + H N++ L+G        YL+ E+   G++   L K      +S     R A
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTA 115
Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
             +    + L  C     +H+DI   N+LL      K+A+F +   A       SS +T 
Sbjct: 116 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP------SSRRTT 169
Query: 483 V-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEILLAEAVF 537
           + GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I   E  F
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 229
Query: 538 SMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
                  A   +S L+  +P+ +   +E+  H
Sbjct: 230 PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 261

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/272 (23%), Positives = 116/272 (42%), Gaps = 29/272 (10%)
Query: 303 EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISK 362
           EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V        + +
Sbjct: 8   EDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-----HQLRR 57
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           EV +   + H N++ L+G        YL+ E+   G++   L K      +S     R A
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTA 111
Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
             +    + L  C     +H+DI   N+LL      K+A+F +   A       SS +T 
Sbjct: 112 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP------SSRRTX 165
Query: 483 V-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEILLAEAVF 537
           + GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I   E  F
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 225
Query: 538 SMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
                  A   +S L+  +P+ +   +E+  H
Sbjct: 226 PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 120/278 (43%), Gaps = 41/278 (14%)
Query: 303 EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISK 362
           EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V        + +
Sbjct: 8   EDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-----EHQLRR 57
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK------KRYPEFVSWN 416
           EV +   + H N++ L+G        YL+ E+   G++   L K      +R   +++  
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-- 115
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                  ++A+ L Y   C     +H+DI   N+LL      K+A+F +   A       
Sbjct: 116 -------ELANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP------ 159
Query: 477 SSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEIL 531
           SS + A+ GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I 
Sbjct: 160 SSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 219
Query: 532 LAEAVFSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
             E  F       A   +S L+  +P+ +   +E+  H
Sbjct: 220 RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 31/222 (13%)
Query: 359 SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK------KRYPEF 412
            + +EV +   + H N++ L+G        YL+ E+   G++   L K      +R   +
Sbjct: 51  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 110
Query: 413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE 472
           ++         ++A+ L Y   C     +H+DI   N+LL      K+A+F +   A   
Sbjct: 111 IT---------ELANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 156
Query: 473 ESGYSSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDG 527
               SS +T + GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  
Sbjct: 157 ----SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 212
Query: 528 EEILLAEAVFSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
           + I   E  F       A   +S L+  +P+ +   +E+  H
Sbjct: 213 KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 254

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/241 (21%), Positives = 97/241 (40%), Gaps = 25/241 (10%)
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +R    +E   +++ +H +++ L G    + V +++ E    G L  +L  +++   +  
Sbjct: 54  VREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFS--LDL 110
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
                 A  ++  L YL +     +VH+DI++ N+L+  N   KL +F   R    E+S 
Sbjct: 111 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDST 165
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEA 535
                       +MAPE + +   T   D + FGV + E++      ++      +    
Sbjct: 166 XXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-----VKNND 220
Query: 536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
           V   +E G       + + PN           L  L   C A +P  RP   E+ + L  
Sbjct: 221 VIGRIENGE-----RLPMPPNCPPT-------LYSLMTKCWAYDPSRRPRFTELKAQLST 268
Query: 596 I 596
           I
Sbjct: 269 I 269

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 120/278 (43%), Gaps = 41/278 (14%)
Query: 303 EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISK 362
           EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V        + +
Sbjct: 8   EDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-----EHQLRR 57
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK------KRYPEFVSWN 416
           EV +   + H N++ L+G        YL+ E+   G++   L K      +R   +++  
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-- 115
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                  ++A+ L Y   C     +H+DI   N+LL      K+A+F +   A       
Sbjct: 116 -------ELANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP------ 159
Query: 477 SSTKTAV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEIL 531
           SS +T + GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I 
Sbjct: 160 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 219
Query: 532 LAEAVFSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
             E  F       A   +S L+  +P+ +   +E+  H
Sbjct: 220 RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/241 (21%), Positives = 97/241 (40%), Gaps = 25/241 (10%)
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +R    +E   +++ +H +++ L G    + V +++ E    G L  +L  +++   +  
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFS--LDL 490
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
                 A  ++  L YL +     +VH+DI++ N+L+      KL +F   R    E+S 
Sbjct: 491 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYM--EDST 545
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEA 535
           Y           +MAPE + +   T   D + FGV + E++      ++      +    
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-----VKNND 600
Query: 536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
           V   +E G       + + PN           L  L   C A +P  RP   E+ + L  
Sbjct: 601 VIGRIENGE-----RLPMPPNCPPT-------LYSLMTKCWAYDPSRRPRFTELKAQLST 648
Query: 596 I 596
           I
Sbjct: 649 I 649

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 22/224 (9%)
Query: 297 KKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKC 355
           KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V    
Sbjct: 6   KKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---- 56
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
               + +EV +   + H N++ L+G        YL+ E+   G +   L K      +S 
Sbjct: 57  -EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK------LSK 109
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
               R A  +    + L  C     +H+DI   N+LL      K+A+F +   A      
Sbjct: 110 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 165
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
            S      GT  Y+ PE +E  +   ++D ++ GV+  E + GK
Sbjct: 166 -SRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 78/164 (47%), Gaps = 11/164 (6%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +  +  E++++ +++H NLI L+ A E      LV E+++ G L D +  + Y   ++  
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--LTEL 187
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL-LDKNLRA-KLANFSFVRSAVREES 474
                   +  G+ ++H       +H D+   NIL ++++ +  K+ +F   R     E 
Sbjct: 188 DTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                K   GT  ++APE + Y  V+   D ++ GV+   L++G
Sbjct: 244 ---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 28/172 (16%)
Query: 362 KEVNLLKKINHFNLINLFGACEHDGV--------FYLVYEFMEN---GSLSDWLHKKRYP 410
           +E+ +L+ + H N++NL   C              YLV++F E+   G LS+ L K    
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLS 125
Query: 411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS-A 469
           E        R+   + +GL+Y+H       +H+D+ + N+L+ ++   KLA+F   R+ +
Sbjct: 126 EIK------RVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFS 176
Query: 470 VREESGYSSTKTAVGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELIT 517
           + + S  +     V T  Y  PE +    +YG   P +D +  G ++ E+ T
Sbjct: 177 LAKNSQPNRYXNRVVTLWYRPPELLLGERDYG---PPIDLWGAGCIMAEMWT 225

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 37/177 (20%)
Query: 358 RSISKEVNLLKKINHFNLINLFG------ACEHDGVFYLVYEFM--------ENGSLSDW 403
           R   +E+ LLK + H N+I L        + E     YLV   M        +  +LSD 
Sbjct: 72  RRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSD- 130
Query: 404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF 463
                  E V +     +   +  GL Y+H+    G +H+D+   N+ ++++   ++ +F
Sbjct: 131 -------EHVQF-----LVYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDSELRILDF 175
Query: 464 SFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
              R A  E +GY      V T  Y APE M  +      +D ++ G ++ EL+ GK
Sbjct: 176 GLARQADEEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 111/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 22  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 81
Query: 382 CEHDGVFYLVYEFME-----------NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E ME            G+L + L +  +     W         V   + 
Sbjct: 82  FERPDSFVLILERMEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 128
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 129 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 181
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 228
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 229 --------QRVSSE-CQHLIRWCLAL---RPSDRPTFEEI 256

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 57  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 116
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 117 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 168
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 169 NEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 222
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 223 MAELLTGR 230

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 42  TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 102 THLMG----ADLNNIVKCAKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 153
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 154 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 207
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 208 IMAELLTGR 216

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 112 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 163
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 164 NEDXELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 217
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 218 MAELLTGR 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 107 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 213 MAELLTGR 220

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M    L++ +  ++       + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 107 HLM-GADLNNIVKSQK---LTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 159 NEDSELKILDFGLCRHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 213 MAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 112 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 163
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 164 NEDXELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 217
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 218 MAELLTGR 225

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 39/227 (17%)
Query: 325 VVATENFSPKNMID----GSVF--RGIINGSTVAIKCMRRSIS---------KEVNLLKK 369
           +V  ENF     I     G V+  R  + G  VA+K +R             +E++LLK+
Sbjct: 3   LVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 370 INHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG- 428
           +NH N++ L      +   YLV+EF+               +F+  +    I L +    
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSY 112
Query: 429 ----LHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG 484
               L  L  C     +H+D+   N+L++     KLA+F   R+       Y+     V 
Sbjct: 113 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV 169
Query: 485 TNGYMAPEYM---EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGE 528
           T  Y APE +   +Y   +  +D ++ G +  E++T + A +  D E
Sbjct: 170 TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 213

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 66  TGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 125
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 126 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 177
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 178 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 231
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 232 IMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 66  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 125
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 126 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 177
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 178 NEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 231
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 232 MAELLTGR 239

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 103 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 154
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 155 NEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 208
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 209 MAELLTGR 216

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 46  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 106 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 157
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL-VTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M   +     +D ++ G 
Sbjct: 158 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNAMHYNQTVDIWSVGC 211
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 212 IMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 107 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 213 MAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 46  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 106 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 157
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 158 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 211
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 212 IMAELLTGR 220

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 115/278 (41%), Gaps = 28/278 (10%)
Query: 297 KKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKC 355
           KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V    
Sbjct: 3   KKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---- 53
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
               + +EV +   + H N++ L+G        YL+ E+   G++   L K      +S 
Sbjct: 54  -EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSK 106
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
               R A  +    + L  C     +H+DI   N+LL      K+A+F +   A      
Sbjct: 107 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 162
Query: 476 YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEIL 531
            S      GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I 
Sbjct: 163 -SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 221
Query: 532 LAEAVFSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
             E  F       A   +S L+  +P+ +   +E+  H
Sbjct: 222 RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 259

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 84/201 (41%), Gaps = 29/201 (14%)
Query: 343 RGIINGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R             +E++LLK++NH N++ L      +   YLV+E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 83  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 132
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE-YMEYGLVTPEMDTYA 507
           N+L++     KLA+F   R+       Y+     V T  Y APE  +     +  +D ++
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYTH---EVVTLWYRAPEILLGXKYYSTAVDIWS 189
Query: 508 FGVVLLELITGKEAAYKQDGE 528
            G +  E++T + A +  D E
Sbjct: 190 LGCIFAEMVT-RRALFPGDSE 209

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 46  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 106 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 157
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 158 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 211
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 212 IMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 46  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 106 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 157
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 158 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 211
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 212 IMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 53  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 113 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 164
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 165 NEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 218
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 219 MAELLTGR 226

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 107 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 213 MAELLTGR 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 107 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 213 MAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 53  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 113 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 164
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 165 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 218
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 219 IMAELLTGR 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 58  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 117
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 118 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 169
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 170 NEDXELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 223
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 224 MAELLTGR 231

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 112 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 163
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 164 NEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 217
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 218 MAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 46  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 105
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 106 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 157
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 158 NEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 211
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 212 MAELLTGR 219

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 86/201 (42%), Gaps = 29/201 (14%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 30  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 89
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+           +   +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 90  FLH----------QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 139
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE-YMEYGLVTPEMDTYA 507
           N+L++     KLA+F   R+       Y+     V T  Y APE  +     +  +D ++
Sbjct: 140 NLLINTEGAIKLADFGLARAFGVPVRTYTH---EVVTLWYRAPEILLGXKYYSTAVDIWS 196
Query: 508 FGVVLLELITGKEAAYKQDGE 528
            G +  E++T + A +  D E
Sbjct: 197 LGCIFAEMVT-RRALFPGDSE 216

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 48  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 107
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 108 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 159
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 160 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 213
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 214 IMAELLTGR 222

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 46  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 106 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 157
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 158 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 211
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 212 IMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 48  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 107
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 108 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 159
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 160 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 213
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 214 IMAELLTGR 222

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 109 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 160
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 161 NEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 214
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 215 MAELLTGR 222

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 26/187 (13%)
Query: 345 IINGSTVAIKCMRRS-----ISKEVNLLKKINHFNLI---NLFGACEHDGVFYLVYEFME 396
           II+    AI   R +     +  E+ +LKK+NH  +I   N F A +    +Y+V E ME
Sbjct: 42  IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED----YYIVLELME 97
Query: 397 NGSLSD-WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN 455
            G L D  +  KR  E       +++ L V     YLH   + G +H+D+   N+LL   
Sbjct: 98  GGELFDKVVGNKRLKEATCKLYFYQMLLAV----QYLH---ENGIIHRDLKPENVLLSSQ 150
Query: 456 LRAKLANFS-FVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLV--TPEMDTYAFGVV 511
               L   + F  S +  E+  S  +T  GT  Y+APE +   G       +D ++ GV+
Sbjct: 151 EEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
Query: 512 LLELITG 518
           L   ++G
Sbjct: 209 LFICLSG 215

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 107 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 159 NEDCELKILDFYLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 213 MAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 43  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 102
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 103 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 154
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 155 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 208
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 209 IMAELLTGR 217

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 58  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 117
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 118 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 169
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 170 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 223
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 224 IMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 58  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 117
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 118 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 169
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 170 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 223
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 224 IMAELLTGR 232

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R             +E++LLK++NH N++ L      +   YLV+E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 83  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQ 132
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y+     V T  Y APE +   +Y   +  +D 
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYTH---EVVTLWYRAPEILLGCKY--YSTAVDI 187
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 188 WSLGCIFAEMVT-RRALFPGDSE 209

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 66  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 125
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 126 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 177
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 178 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 231
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 232 IMAELLTGR 240

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 26/187 (13%)
Query: 345 IINGSTVAIKCMRRS-----ISKEVNLLKKINHFNLI---NLFGACEHDGVFYLVYEFME 396
           II+    AI   R +     +  E+ +LKK+NH  +I   N F A +    +Y+V E ME
Sbjct: 48  IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED----YYIVLELME 103
Query: 397 NGSLSD-WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN 455
            G L D  +  KR  E       +++ L V     YLH   + G +H+D+   N+LL   
Sbjct: 104 GGELFDKVVGNKRLKEATCKLYFYQMLLAV----QYLH---ENGIIHRDLKPENVLLSSQ 156
Query: 456 LRAKLANFS-FVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLV--TPEMDTYAFGVV 511
               L   + F  S +  E+  S  +T  GT  Y+APE +   G       +D ++ GV+
Sbjct: 157 EEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 214
Query: 512 LLELITG 518
           L   ++G
Sbjct: 215 LFICLSG 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 26/187 (13%)
Query: 345 IINGSTVAIKCMRRS-----ISKEVNLLKKINHFNLI---NLFGACEHDGVFYLVYEFME 396
           II+    AI   R +     +  E+ +LKK+NH  +I   N F A +    +Y+V E ME
Sbjct: 41  IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED----YYIVLELME 96
Query: 397 NGSLSD-WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN 455
            G L D  +  KR  E       +++ L V     YLH   + G +H+D+   N+LL   
Sbjct: 97  GGELFDKVVGNKRLKEATCKLYFYQMLLAV----QYLH---ENGIIHRDLKPENVLLSSQ 149
Query: 456 LRAKLANFS-FVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLV--TPEMDTYAFGVV 511
               L   + F  S +  E+  S  +T  GT  Y+APE +   G       +D ++ GV+
Sbjct: 150 EEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 207
Query: 512 LLELITG 518
           L   ++G
Sbjct: 208 LFICLSG 214

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 26/187 (13%)
Query: 345 IINGSTVAIKCMRRS-----ISKEVNLLKKINHFNLI---NLFGACEHDGVFYLVYEFME 396
           II+    AI   R +     +  E+ +LKK+NH  +I   N F A +    +Y+V E ME
Sbjct: 42  IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED----YYIVLELME 97
Query: 397 NGSLSD-WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN 455
            G L D  +  KR  E       +++ L V     YLH   + G +H+D+   N+LL   
Sbjct: 98  GGELFDKVVGNKRLKEATCKLYFYQMLLAV----QYLH---ENGIIHRDLKPENVLLSSQ 150
Query: 456 LRAKLANFS-FVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLV--TPEMDTYAFGVV 511
               L   + F  S +  E+  S  +T  GT  Y+APE +   G       +D ++ GV+
Sbjct: 151 EEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
Query: 512 LLELITG 518
           L   ++G
Sbjct: 209 LFICLSG 215

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 65  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 124
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 125 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 176
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 177 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 230
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 231 IMAELLTGR 239

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 26/187 (13%)
Query: 345 IINGSTVAIKCMRRS-----ISKEVNLLKKINHFNLI---NLFGACEHDGVFYLVYEFME 396
           II+    AI   R +     +  E+ +LKK+NH  +I   N F A +    +Y+V E ME
Sbjct: 42  IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED----YYIVLELME 97
Query: 397 NGSLSDW-LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN 455
            G L D  +  KR  E       +++ L V     YLH   + G +H+D+   N+LL   
Sbjct: 98  GGELFDKVVGNKRLKEATCKLYFYQMLLAV----QYLH---ENGIIHRDLKPENVLLSSQ 150
Query: 456 LRAKLANFS-FVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLV--TPEMDTYAFGVV 511
               L   + F  S +  E+  S  +T  GT  Y+APE +   G       +D ++ GV+
Sbjct: 151 EEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
Query: 512 LLELITG 518
           L   ++G
Sbjct: 209 LFICLSG 215

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 42  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 102 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 153
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 154 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 207
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 208 IMAELLTGR 216

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 52  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 111
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 112 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 163
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 164 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 217
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 218 IMAELLTGR 226

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R             +E++LLK++NH N++ L      +   YLV+E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 394 FMENGSLSDWLHKKR-----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           F+    L D++          P   S+         +  GL + H+      +H+D+   
Sbjct: 83  FLHQ-DLKDFMDASALTGIPLPLIKSY------LFQLLQGLAFCHSHR---VLHRDLKPE 132
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 187
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 188 WSLGCIFAEMVT-RRALFPGDSE 209

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 51  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 110
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 111 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 162
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 163 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 216
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 217 IMAELLTGR 225

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 57  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 116
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 117 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 168
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 169 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 222
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 223 IMAELLTGR 231

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 80/167 (47%), Gaps = 14/167 (8%)
Query: 357 RRSISKEVN-LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +R  ++E+  LL+   H N+I L    +     Y+V E M+ G L D + +++   F S 
Sbjct: 59  KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK---FFSE 115
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL-LDKNLRA---KLANFSFVRSAVR 471
                +   +   + YLH     G VH+D+   NIL +D++      ++ +F F +  +R
Sbjct: 116 REASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-LR 171
Query: 472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
            E+G     T   T  ++APE +E        D ++ GV+L  ++TG
Sbjct: 172 AENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 43  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 102
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 103 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 154
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 155 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 208
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 209 IMAELLTGR 217

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 22  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 82  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 131
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y+     V T  Y APE +   +Y   +  +D 
Sbjct: 132 NLLINTEGAIKLADFGLARAFGVPVRTYTH---EVVTLWYRAPEILLGCKY--YSTAVDI 186
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 187 WSLGCIFAEMVT-RRALFPGDSE 208

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 69  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 128
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 129 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 180
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 181 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 234
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 235 IMAELLTGR 243

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 44  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 103
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 104 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 155
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 156 VNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 209
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 210 IMAELLTGR 218

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 24  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 83
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 84  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 133
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y+     V T  Y APE +   +Y   +  +D 
Sbjct: 134 NLLINTEGAIKLADFGLARAFGVPVRTYTH---EVVTLWYRAPEILLGCKY--YSTAVDI 188
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 189 WSLGCIFAEMVT-RRALFPGDSE 210

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 83  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 132
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y+     V T  Y APE +   +Y   +  +D 
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYTH---EVVTLWYRAPEILLGCKY--YSTAVDI 187
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 188 WSLGCIFAEMVT-RRALFPGDSE 209

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 22  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 82  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 131
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y+     V T  Y APE +   +Y   +  +D 
Sbjct: 132 NLLINTEGAIKLADFGLARAFGVPVRTYTH---EVVTLWYRAPEILLGCKY--YSTAVDI 186
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 187 WSLGCIFAEMVT-RRALFPGDSE 208

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 109 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 160
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 161 NEDSELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 214
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 215 MAELLTGR 222

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 103/237 (43%), Gaps = 35/237 (14%)
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW---LHKKRYPEFVSWNCRF 419
           E+ +L   +H  ++ L GA  HDG  +++ EF   G++      L +      +   CR 
Sbjct: 58  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR- 116
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
                +   L++LH+      +H+D+ +GN+L+      +LA+F     + +        
Sbjct: 117 ----QMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGV---SAKNLKTLQKR 166
Query: 480 KTAVGTNGYMAPEYM--EYGLVTP---EMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
            + +GT  +MAPE +  E    TP   + D ++ G+ L+E+   +   ++ +   +LL  
Sbjct: 167 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-- 224
Query: 535 AVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVS 591
                        K++    P L    K        L +A + + PE+RPS A+++ 
Sbjct: 225 -------------KIAKSDPPTLLTPSKWSVEFRDFLKIA-LDKNPETRPSAAQLLE 267

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R             +E++LLK++NH N++ L      +   YLV+E
Sbjct: 30  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 89
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+           +   +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 90  FLH----------QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 139
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y+     V T  Y APE +   +Y   +  +D 
Sbjct: 140 NLLINTEGAIKLADFGLARAFGVPVRTYTH---EVVTLWYRAPEILLGCKY--YSTAVDI 194
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 195 WSLGCIFAEMVT-RRALFPGDSE 216

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 119/284 (41%), Gaps = 40/284 (14%)
Query: 297 KKRNLP-EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKC 355
           KKR    EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V    
Sbjct: 4   KKRQWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--- 55
Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK------KRY 409
               + +EV +   + H N++ L+G        YL+ E+   G++   L K      +R 
Sbjct: 56  --HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSA 469
             +++         ++A+ L Y   C     +H+DI   N+LL      K+A+F +   A
Sbjct: 114 ATYIT---------ELANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 161
Query: 470 VREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQ 525
                  S      GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++
Sbjct: 162 PS-----SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216
Query: 526 DGEEILLAEAVFSMVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
             + I   E  F       A   +S L+  +P+ +   +E+  H
Sbjct: 217 TYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    K+A+F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 113 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 164
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 165 NEDSELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 218
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 219 MAELLTGR 226

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 113 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 164
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 165 NEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 218
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 219 MAELLTGR 226

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 83  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 132
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y+     V T  Y APE +   +Y   +  +D 
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYTH---EVVTLWYRAPEILLGCKY--YSTAVDI 187
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 188 WSLGCIFAEMVT-RRALFPGDSE 209

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 18/167 (10%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR-----YPEFVS 414
           + +E ++   + H +++ L      DG+ Y+V+EFM+   L   + K+      Y E V+
Sbjct: 75  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 134
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSAVR 471
            +   +I       L  L  C D   +H+D+    +LL   + +   KL  F    +   
Sbjct: 135 SHYMRQI-------LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV--AIQL 185
Query: 472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
            ESG  +    VGT  +MAPE ++       +D +  GV+L  L++G
Sbjct: 186 GESGLVAGGR-VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 103/237 (43%), Gaps = 35/237 (14%)
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW---LHKKRYPEFVSWNCRF 419
           E+ +L   +H  ++ L GA  HDG  +++ EF   G++      L +      +   CR 
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR- 124
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
                +   L++LH+      +H+D+ +GN+L+      +LA+F     + +        
Sbjct: 125 ----QMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGV---SAKNLKTLQKR 174
Query: 480 KTAVGTNGYMAPEYM--EYGLVTP---EMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
            + +GT  +MAPE +  E    TP   + D ++ G+ L+E+   +   ++ +   +LL  
Sbjct: 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-- 232
Query: 535 AVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVS 591
                        K++    P L    K        L +A + + PE+RPS A+++ 
Sbjct: 233 -------------KIAKSDPPTLLTPSKWSVEFRDFLKIA-LDKNPETRPSAAQLLE 275

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 394 FMENGSLSDWLHKKR-----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           F+ +  L D++          P   S+         +  GL + H+      +H+D+   
Sbjct: 86  FL-SMDLKDFMDASALTGIPLPLIKSY------LFQLLQGLAFCHSHR---VLHRDLKPQ 135
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 136 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 190
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 191 WSLGCIFAEMVT-RRALFPGDSE 212

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 99  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 155
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 156 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 211
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                    +T T  GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 212 VK------GATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 23  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 82
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 83  FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 129
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 130 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 182
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 229
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 230 --------QRVSSE-CQHLIRWCLAL---RPSDRPTFEEI 257

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 18/167 (10%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR-----YPEFVS 414
           + +E ++   + H +++ L      DG+ Y+V+EFM+   L   + K+      Y E V+
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSAVR 471
            +   +I       L  L  C D   +H+D+    +LL   + +   KL  F    +   
Sbjct: 133 SHYMRQI-------LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV--AIQL 183
Query: 472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
            ESG  +    VGT  +MAPE ++       +D +  GV+L  L++G
Sbjct: 184 GESGLVAGGR-VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R             +E++LLK++NH N++ L      +   YLV+E
Sbjct: 25  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 84
Query: 394 FMENGSLSDWLHKKR-----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           F+ +  L D++          P   S+         +  GL + H+      +H+D+   
Sbjct: 85  FL-SMDLKDFMDASALTGIPLPLIKSY------LFQLLQGLAFCHSHR---VLHRDLKPQ 134
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 135 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 189
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 190 WSLGCIFAEMVT-RRALFPGDSE 211

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 81/189 (42%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 46  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 106 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 157
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+  F   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 158 VNEDCELKILGFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 211
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 212 IMAELLTGR 220

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 22  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 81
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 82  FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 128
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 129 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 181
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 228
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 229 --------QRVSSE-CQHLIRWCLAL---RPSDRPTFEEI 256

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 81/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 129
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 130 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 181
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E  GY      V T  Y APE M  +      +D ++ G +
Sbjct: 182 NEDCELKILDFGLARHTDDEMXGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 235
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 236 MAELLTGR 243

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 112/271 (41%), Gaps = 27/271 (9%)
Query: 303 EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISK 362
           EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V        + +
Sbjct: 8   EDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-----HQLRR 57
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           EV +   + H N++ L+G        YL+ E+   G++   L K      +S     R A
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTA 111
Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
             +    + L  C     +H+DI   N+LL      K+A+F +   A       S     
Sbjct: 112 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRXXL 166
Query: 483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEILLAEAVFS 538
            GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I   E  F 
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226
Query: 539 MVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
                 A   +S L+  +P+ +   +E+  H
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEH 257

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 107 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +G+      V T  Y APE M  +      +D ++ G +
Sbjct: 159 NEDCELKILDFGLARHTDDEMAGF------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 213 MAELLTGR 220

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 18  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 78  FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 124
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 125 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 177
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 224
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 225 --------QRVSSE-CQHLIRWCLAL---RPSDRPTFEEI 252

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 107 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +G+      V T  Y APE M  +      +D ++ G +
Sbjct: 159 NEDCELKILDFGLARHTDDEMAGF------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 213 MAELLTGR 220

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 81/206 (39%), Gaps = 55/206 (26%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR- 418
           I  EV L+KK++H N+  L+   E +    LV E    G L D L+   + +  +  C  
Sbjct: 75  IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV--FIDDSTGKCAM 132
Query: 419 ------------------------FRIALDVAH--------------GLHYLHNCTDPGY 440
                                   FR +LD                  LHYLHN    G 
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGI 189
Query: 441 VHKDISSGNILL--DKNLRAKLANFSFVRSAVREESG-YSSTKTAVGTNGYMAPEYM--- 494
            H+DI   N L   +K+   KL +F   +   +  +G Y    T  GT  ++APE +   
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249
Query: 495 --EYGLVTPEMDTYAFGVVLLELITG 518
              YG   P+ D ++ GV+L  L+ G
Sbjct: 250 NESYG---PKCDAWSAGVLLHLLLMG 272

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 112/271 (41%), Gaps = 27/271 (9%)
Query: 303 EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGIINGSTVAIKCMRRSISK 362
           EDF      + R L   K+ ++ +A E  S   +    +F+  +  + V        + +
Sbjct: 11  EDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-----EHQLRR 60
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           EV +   + H N++ L+G        YL+ E+   G++   L K      +S     R A
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTA 114
Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
             +    + L  C     +H+DI   N+LL      K+A+F +   A       S     
Sbjct: 115 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRDDL 169
Query: 483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EA-AYKQDGEEILLAEAVFS 538
            GT  Y+ PE +E  +   ++D ++ GV+  E + GK   EA  Y++  + I   E  F 
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 229
Query: 539 MVEGGNAEAKLSVLV--DPNLQANKKEIAHH 567
                 A   +S L+  +P+ +   +E+  H
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEH 260

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 37  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 96
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 97  FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 143
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 144 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 196
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 197 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 243
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 244 --------QRVSXE-CQHLIRWCLAL---RPSDRPTFEEI 271

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 50  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 109
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 110 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 156
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 157 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 209
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F        +   
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFRQRVSSECQ--- 264
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                            HLI  CLA     P  RP+  E+
Sbjct: 265 -----------------HLIRWCLAL---RPSDRPTFEEI 284

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 37  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 96
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 97  FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 143
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 144 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 196
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F        +   
Sbjct: 197 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFRQRVSSECQ--- 251
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                            HLI  CLA     P  RP+  E+
Sbjct: 252 -----------------HLIRWCLAL---RPSDRPTFEEI 271

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R             +E++LLK++NH N++ L      +   YLV+E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 86  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 135
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 136 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 190
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 191 WSLGCIFAEMVT-RRALFPGDSE 212

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R             +E++LLK++NH N++ L      +   YLV+E
Sbjct: 25  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 84
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 85  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 134
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 135 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 189
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 190 WSLGCIFAEMVT-RRALFPGDSE 211

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 23  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 82
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 83  FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 129
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 130 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 182
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 229
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 230 --------QRVSSE-CQHLIRWCLAL---RPSDRPTFEEI 257

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKINHF--NLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 38  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 97
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 98  FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 144
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 145 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 197
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 244
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 245 --------QRVSSE-CQHLIRWCLAL---RPSDRPTFEEI 272

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 21  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 80
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 81  FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 127
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 128 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 180
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 181 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 227
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 228 --------QRVSSE-CQHLIRWCLAL---RPSDRPTFEEI 255

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R             +E++LLK++NH N++ L      +   YLV+E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 83  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 132
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 187
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 188 WSLGCIFAEMVT-RRALFPGDSE 209

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 26/187 (13%)
Query: 345 IINGSTVAIKCMRRS-----ISKEVNLLKKINHFNLI---NLFGACEHDGVFYLVYEFME 396
           II+    AI   R +     +  E+ +LKK+NH  +I   N F A +    +Y+V E ME
Sbjct: 181 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED----YYIVLELME 236
Query: 397 NGSLSD-WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN 455
            G L D  +  KR  E       +++ L V     YLH   + G +H+D+   N+LL   
Sbjct: 237 GGELFDKVVGNKRLKEATCKLYFYQMLLAV----QYLH---ENGIIHRDLKPENVLLSSQ 289
Query: 456 LRAKLANFS-FVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLV--TPEMDTYAFGVV 511
               L   + F  S +  E+  S  +T  GT  Y+APE +   G       +D ++ GV+
Sbjct: 290 EEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 347
Query: 512 LLELITG 518
           L   ++G
Sbjct: 348 LFICLSG 354

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 103 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 154
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E +G+      V T  Y APE M  +      +D ++ G +
Sbjct: 155 NEDCELKILDFGLARHTDDEMAGF------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 208
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 209 MAELLTGR 216

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 38  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 97
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 98  FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 144
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 145 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 197
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 244
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 245 --------QRVSXE-CQHLIRWCLAL---RPSDRPTFEEI 272

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 25  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 84
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 85  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 134
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 135 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 189
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 190 WSLGCIFAEMVT-RRALFPGDSE 211

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 83  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 132
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 187
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 188 WSLGCIFAEMVT-RRALFPGDSE 209

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 105/230 (45%), Gaps = 29/230 (12%)
Query: 357 RRSISKEVN-LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +R  S+E+  LL+   H N+I L    +     YLV E M  G L D + ++++  F   
Sbjct: 64  KRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF--FSER 121
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL-LDKNLRA---KLANFSFVRSAVR 471
              F +   +   + YLH+    G VH+D+   NIL +D++      ++ +F F +  +R
Sbjct: 122 EASF-VLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ-LR 176
Query: 472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA---AYKQDGE 528
            E+G     T   T  ++APE ++        D ++ G++L  ++ G            E
Sbjct: 177 AENGL--LMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE 234
Query: 529 EIL--LAEAVFSMVEGGN-------AEAKLSVL--VDPNLQANKKEIAHH 567
           EIL  +    F++  GGN       A+  +S +  VDP+ +   K++  H
Sbjct: 235 EILTRIGSGKFTL-SGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQH 283

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 22  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 82  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 131
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 132 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 186
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 187 WSLGCIFAEMVT-RRALFPGDSE 208

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 26/187 (13%)
Query: 345 IINGSTVAIKCMRRS-----ISKEVNLLKKINHFNLI---NLFGACEHDGVFYLVYEFME 396
           II+    AI   R +     +  E+ +LKK+NH  +I   N F A +    +Y+V E ME
Sbjct: 167 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED----YYIVLELME 222
Query: 397 NGSLSDW-LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN 455
            G L D  +  KR  E       +++ L V     YLH   + G +H+D+   N+LL   
Sbjct: 223 GGELFDKVVGNKRLKEATCKLYFYQMLLAV----QYLH---ENGIIHRDLKPENVLLSSQ 275
Query: 456 LRAKLANFS-FVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLV--TPEMDTYAFGVV 511
               L   + F  S +  E+  S  +T  GT  Y+APE +   G       +D ++ GV+
Sbjct: 276 EEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
Query: 512 LLELITG 518
           L   ++G
Sbjct: 334 LFICLSG 340

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 65  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 124
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 125 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 171
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 172 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 224
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 225 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 271
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 272 --------QRVSXE-CQHLIRWCLAL---RPSDRPTFEEI 299

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 83  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 132
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 187
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 188 WSLGCIFAEMVT-RRALFPGDSE 209

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 22  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 82  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 131
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 132 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 186
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 187 WSLGCIFAEMVT-RRALFPGDSE 208

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R             +E++LLK++NH N++ L      +   YLV+E
Sbjct: 24  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 83
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 84  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 133
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 134 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 188
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 189 WSLGCIFAEMVT-RRALFPGDSE 210

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 65/132 (49%), Gaps = 16/132 (12%)
Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            + + M  G L    H  ++  F   + RF  A ++  GL ++HN      V++D+   N
Sbjct: 268 FILDLMNGGDLH--YHLSQHGVFSEADMRF-YAAEIILGLEHMHNRF---VVYRDLKPAN 321
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTK--TAVGTNGYMAPEYMEYGLV-TPEMDTY 506
           ILLD++   ++++             +S  K   +VGT+GYMAPE ++ G+      D +
Sbjct: 322 ILLDEHGHVRISDLGLA-------CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 374
Query: 507 AFGVVLLELITG 518
           + G +L +L+ G
Sbjct: 375 SLGCMLFKLLRG 386

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKINHF--NLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 57  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 163
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 164 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 216
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 263
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 264 --------QRVSSE-CQHLIRWCLAL---RPSDRPTFEEI 291

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 23  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 82
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 83  FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 129
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 130 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 182
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 229
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 230 --------QRVSSE-CQHLIRWCLAL---RPSDRPTFEEI 257

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 65/132 (49%), Gaps = 16/132 (12%)
Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            + + M  G L    H  ++  F   + RF  A ++  GL ++HN      V++D+   N
Sbjct: 269 FILDLMNGGDLH--YHLSQHGVFSEADMRF-YAAEIILGLEHMHNRF---VVYRDLKPAN 322
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTK--TAVGTNGYMAPEYMEYGLV-TPEMDTY 506
           ILLD++   ++++             +S  K   +VGT+GYMAPE ++ G+      D +
Sbjct: 323 ILLDEHGHVRISDLGLA-------CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 375
Query: 507 AFGVVLLELITG 518
           + G +L +L+ G
Sbjct: 376 SLGCMLFKLLRG 387

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+           +   +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 86  FLH----------QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 135
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 136 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 190
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 191 WSLGCIFAEMVT-RRALFPGDSE 212

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 65/132 (49%), Gaps = 16/132 (12%)
Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            + + M  G L    H  ++  F   + RF  A ++  GL ++HN      V++D+   N
Sbjct: 269 FILDLMNGGDLH--YHLSQHGVFSEADMRF-YAAEIILGLEHMHNRF---VVYRDLKPAN 322
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTK--TAVGTNGYMAPEYMEYGLV-TPEMDTY 506
           ILLD++   ++++             +S  K   +VGT+GYMAPE ++ G+      D +
Sbjct: 323 ILLDEHGHVRISDLGLA-------CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 375
Query: 507 AFGVVLLELITG 518
           + G +L +L+ G
Sbjct: 376 SLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 65/132 (49%), Gaps = 16/132 (12%)
Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            + + M  G L    H  ++  F   + RF  A ++  GL ++HN      V++D+   N
Sbjct: 269 FILDLMNGGDLH--YHLSQHGVFSEADMRF-YAAEIILGLEHMHNRF---VVYRDLKPAN 322
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTK--TAVGTNGYMAPEYMEYGLV-TPEMDTY 506
           ILLD++   ++++             +S  K   +VGT+GYMAPE ++ G+      D +
Sbjct: 323 ILLDEHGHVRISDLGLA-------CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 375
Query: 507 AFGVVLLELITG 518
           + G +L +L+ G
Sbjct: 376 SLGCMLFKLLRG 387

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 27  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 86
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+           +   +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 87  FLH----------QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 136
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 137 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 191
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 192 WSLGCIFAEMVT-RRALFPGDSE 213

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 38  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 97
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 98  FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 144
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 145 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 197
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 244
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 245 --------QRVSXE-CQHLIRWCLAL---RPXDRPTFEEI 272

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R             +E++LLK++NH N++ L      +   YLV+E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+           +   +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 83  FLH----------QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 132
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 187
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 188 WSLGCIFAEMVT-RRALFPGDSE 209

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 65  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 124
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 125 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 171
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 172 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 224
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 225 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 271
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 272 --------QRVSSE-CQHLIRWCLAL---RPSDRPTFEEI 299

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +    H +R
Sbjct: 64  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRR 120
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 121 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 176
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T T  GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 177 VK------GRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 7/159 (4%)
Query: 375 LINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHN 434
           +INL    E+     L+ E+   G +   L      E VS N   R+   +  G++YLH 
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFS-LCLPELAEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 435 CTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS-STKTAVGTNGYMAPEY 493
                 VH D+   NILL       L +   V   +  + G++   +  +GT  Y+APE 
Sbjct: 150 ---NNIVHLDLKPQNILLSSIY--PLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI 204
Query: 494 MEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILL 532
           + Y  +T   D +  G++   L+T       +D +E  L
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL 243

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 46  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 106 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 157
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ ++   R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 158 VNEDCELKILDYGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 211
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 212 IMAELLTGR 220

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 79  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR 135
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 136 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 191
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T T  GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 192 VK------GRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 96/244 (39%), Gaps = 59/244 (24%)
Query: 360 ISKEVNLLKKIN--HFNLINLFGACEHDGVFYLVYE-----------FMENGSLSDWLHK 406
           +  EV LLKK++     +I L    E    F L+ E             E G+L + L +
Sbjct: 101 VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 160
Query: 407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV 466
             +     W         V   + + HNC   G +H+DI   NIL+D N R +L    F 
Sbjct: 161 SFF-----WQ--------VLEAVRHCHNC---GVLHRDIKDENILIDLN-RGELKLIDFG 203
Query: 467 RSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQ 525
             A+ +++ Y+      GT  Y  PE++ Y          ++ G++L +++ G +  ++ 
Sbjct: 204 SGALLKDTVYTDFD---GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEH 259
Query: 526 DGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPS 585
           D EEI+  +  F        +                    HLI  CLA     P  RP+
Sbjct: 260 D-EEIIRGQVFFRQRVSSECQ--------------------HLIRWCLAL---RPSDRPT 295
Query: 586 MAEV 589
             E+
Sbjct: 296 FEEI 299

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 25  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 84
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 85  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPE 134
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 135 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 189
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 190 WSLGCIFAEMVT-RRALFPGDSE 211

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 107/243 (44%), Gaps = 38/243 (15%)
Query: 359 SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR 418
           S  +  +++ K++H +L+  +G C       LV EF++ GSL  +L K +    + W  +
Sbjct: 58  SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--K 115
Query: 419 FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS 478
             +A  +A  +H+L   T    +H ++ + NILL +    K  N  F++ +   + G S 
Sbjct: 116 LEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLS---DPGISI 169
Query: 479 T---KTAVGTN-GYMAPEYME----YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
           T   K  +     ++ PE +E      L T   D ++FG  L E+ +G        G++ 
Sbjct: 170 TVLPKDILQERIPWVPPECIENPKNLNLAT---DKWSFGTTLWEICSG--------GDKP 218
Query: 531 LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
           L A          +++ KL    D +     K  A  L  L   C+  EP+ RPS   ++
Sbjct: 219 LSAL---------DSQRKLQFYEDRHQLPAPK--AAELANLINNCMDYEPDHRPSFRAII 267
Query: 591 STL 593
             L
Sbjct: 268 RDL 270

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 21/165 (12%)
Query: 362 KEVNLLKKINHFNLINLFG------ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +E+ LLK + H N+I L        + E     YLV   M     +D  +  +  +    
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDD 137
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG 475
           + +F I   +  GL Y+H+      +H+D+   N+ ++++   K+ +F   R    E +G
Sbjct: 138 HVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 193
Query: 476 YSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
           Y      V T  Y APE M  +      +D ++ G ++ EL+TG+
Sbjct: 194 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 24  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 83
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+           +   +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 84  FLH----------QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 133
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 134 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 188
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 189 WSLGCIFAEMVT-RRALFPGDSE 210

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 375 LINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHN 434
           L+ L  A + +   +L+ +++  G L  + H  +   F     +  +  ++   L +LH 
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVG-EIVLALEHLHK 177
Query: 435 CTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM 494
               G +++DI   NILLD N    L +F   +  V +E+         GT  YMAP+ +
Sbjct: 178 L---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET--ERAYDFCGTIEYMAPDIV 232
Query: 495 EYGLVTPE--MDTYAFGVVLLELITGKEAAYKQDGEE 529
             G    +  +D ++ GV++ EL+TG  + +  DGE+
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGA-SPFTVDGEK 268

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 105/230 (45%), Gaps = 29/230 (12%)
Query: 357 RRSISKEVN-LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +R  S+E+  LL+   H N+I L    +     YLV E M  G L D + ++++  F   
Sbjct: 64  KRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF--FSER 121
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL-LDKNLRA---KLANFSFVRSAVR 471
              F +   +   + YLH+    G VH+D+   NIL +D++      ++ +F F +  +R
Sbjct: 122 EASF-VLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ-LR 176
Query: 472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA---AYKQDGE 528
            E+G     T   T  ++APE ++        D ++ G++L  ++ G            E
Sbjct: 177 AENGL--LMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE 234
Query: 529 EIL--LAEAVFSMVEGGN-------AEAKLSVL--VDPNLQANKKEIAHH 567
           EIL  +    F++  GGN       A+  +S +  VDP+ +   K++  H
Sbjct: 235 EILTRIGSGKFTL-SGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQH 283

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 24  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 83
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 84  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPE 133
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 134 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 188
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 189 WSLGCIFAEMVT-RRALFPGDSE 210

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKINHF--NLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 70  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 129
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 130 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 176
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 177 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 229
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 230 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 276
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 277 --------QRVSXE-CQHLIRWCLAL---RPSDRPTFEEI 304

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 51  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 110
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 111 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 157
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 158 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 210
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIGGQVFFR----------- 257
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 258 --------QRVSSE-CQHLIRWCLAL---RPSDRPTFEEI 285

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E   V Y  LV +++  
Sbjct: 44  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPE 103
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 104 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 160
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 161 VLKLCDFGSAKQLVRGEPNVSX----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 215
Query: 515 LITGK 519
           L+ G+
Sbjct: 216 LLLGQ 220

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 51  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 110
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 111 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 157
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 158 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 210
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIGGQVFFR----------- 257
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 258 --------QRVSSE-CQHLIRWCLAL---RPSDRPTFEEI 285

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 18  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 78  FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 124
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 125 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 177
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIGGQVFFR----------- 224
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 225 --------QRVSSE-CQHLIRWCLAL---RPSDRPTFEEI 252

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 45  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 104
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 105 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 151
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 152 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 204
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 205 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 251
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 252 --------QRVSXE-CQHLIRWCLAL---RPSDRPTFEEI 279

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 107/243 (44%), Gaps = 38/243 (15%)
Query: 359 SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR 418
           S  +  +++ K++H +L+  +G C       LV EF++ GSL  +L K +    + W  +
Sbjct: 58  SFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--K 115
Query: 419 FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS 478
             +A  +A  +H+L   T    +H ++ + NILL +    K  N  F++ +   + G S 
Sbjct: 116 LEVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLS---DPGISI 169
Query: 479 T---KTAVGTN-GYMAPEYME----YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
           T   K  +     ++ PE +E      L T   D ++FG  L E+ +G        G++ 
Sbjct: 170 TVLPKDILQERIPWVPPECIENPKNLNLAT---DKWSFGTTLWEICSG--------GDKP 218
Query: 531 LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
           L A          +++ KL    D +     K  A  L  L   C+  EP+ RPS   ++
Sbjct: 219 LSAL---------DSQRKLQFYEDRHQLPAPK--AAELANLINNCMDYEPDHRPSFRAII 267
Query: 591 STL 593
             L
Sbjct: 268 RDL 270

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 50  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 109
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 110 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 156
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 157 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 209
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIGGQVFFR----------- 256
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 257 --------QRVSSE-CQHLIRWCLAL---RPSDRPTFEEI 284

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+     +          F+  +    I L +        L  L  C     +H+D+   
Sbjct: 86  FLHQDLKT----------FMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 135
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D 
Sbjct: 136 NLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDI 190
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 191 WSLGCIFAEMVT-RRALFPGDSE 212

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 28/186 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA------CEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK +NH N+I+L          E     YLV 
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           E M + +L   +H +   E +S+     +   +  G+ +LH+    G +H+D+   NI++
Sbjct: 109 ELM-DANLCQVIHMELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVV 159
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
             +   K+ +F   R+A    + +  T   V T  Y APE +        +D ++ G ++
Sbjct: 160 KSDCTLKILDFGLARTAC---TNFMMTPYVV-TRYYRAPEVILGMGYAANVDIWSVGCIM 215
Query: 513 LELITG 518
            EL+ G
Sbjct: 216 GELVKG 221

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 50  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 109
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 110 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 156
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 157 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 209
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIGGQVFFR----------- 256
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 257 --------QRVSSE-CQHLIRWCLAL---RPSDRPTFEEI 284

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 51  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 110
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 111 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 157
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 158 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 210
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIGGQVFFR----------- 257
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 258 --------QRVSXE-CQHLIRWCLAL---RPSDRPTFEEI 285

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 50  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 109
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 110 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 156
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 157 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 209
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIGGQVFFR----------- 256
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 257 --------QRVSXE-CQHLIRWCLAL---RPSDRPTFEEI 284

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/175 (22%), Positives = 74/175 (42%), Gaps = 13/175 (7%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           ++  S +  + +   + +E+ +   + H N++ ++         YL+ EF   G L   L
Sbjct: 47  VLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL 106
Query: 405 HKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF 463
            K  R+ E  S         ++A  LHY   C +   +H+DI   N+L+      K+A+F
Sbjct: 107 QKHGRFDEQRSAT----FMEELADALHY---CHERKVIHRDIKPENLLMGYKGELKIADF 159
Query: 464 SFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
            +   A          +   GT  Y+ PE +E      ++D +  GV+  E + G
Sbjct: 160 GWSVHAPS-----LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/175 (22%), Positives = 74/175 (42%), Gaps = 13/175 (7%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           ++  S +  + +   + +E+ +   + H N++ ++         YL+ EF   G L   L
Sbjct: 46  VLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL 105
Query: 405 HKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF 463
            K  R+ E  S         ++A  LHY   C +   +H+DI   N+L+      K+A+F
Sbjct: 106 QKHGRFDEQRSAT----FMEELADALHY---CHERKVIHRDIKPENLLMGYKGELKIADF 158
Query: 464 SFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
            +   A          +   GT  Y+ PE +E      ++D +  GV+  E + G
Sbjct: 159 GWSVHAPS-----LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 51  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 110
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W         V   + 
Sbjct: 111 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQ--------VLEAVR 157
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
           + HNC   G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 158 HCHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 210
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIGGQVFFR----------- 257
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 258 --------QRVSXE-CQHLIRWCLAL---RPSDRPTFEEI 285

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 27/200 (13%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 394 F--MENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
           F  M+     D       P  +  +  F++      GL + H+      +H+D+   N+L
Sbjct: 86  FLSMDLKKFMDASALTGIPLPLIKSYLFQL----LQGLAFCHSHR---VLHRDLKPENLL 138
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDTYAF 508
           ++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D ++ 
Sbjct: 139 INTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDIWSL 193
Query: 509 GVVLLELITGKEAAYKQDGE 528
           G +  E++T + A +  D E
Sbjct: 194 GCIFAEMVT-RRALFPGDSE 212

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 37/203 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG-- 380
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I L    
Sbjct: 33  GSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVF 92
Query: 381 ----ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
               + E     Y+V E M + +LS  +  +   E +S+     +   +  G+ +LH+  
Sbjct: 93  TPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-----LLYQMLVGIKHLHSA- 145
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 146 --GIIHRDLKPSNIVVKSDATLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 198
Query: 496 YGLVTPEMDTYAFGVVLLELITG 518
                  +D ++ GV++ E+I G
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 27/200 (13%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 24  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 83
Query: 394 F--MENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
           F  M+     D       P  +  +  F++      GL + H+      +H+D+   N+L
Sbjct: 84  FLSMDLKKFMDASALTGIPLPLIKSYLFQL----LQGLAFCHSHR---VLHRDLKPENLL 136
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDTYAF 508
           ++     KLA+F   R+       Y      V T  Y APE +   +Y   +  +D ++ 
Sbjct: 137 INTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTAVDIWSL 191
Query: 509 GVVLLELITGKEAAYKQDGE 528
           G +  E++T + A +  D E
Sbjct: 192 GCIFAEMVT-RRALFPGDSE 210

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 30/207 (14%)
Query: 394 FMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDISS 447
           F E+ SLSD   ++     Y E ++       +  VA G+ +L    C     +H+D+++
Sbjct: 173 FQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVARGMEFLSSRKC-----IHRDLAA 227
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            NILL +N   K+ +F   R   +         T +    +MAPE +   + + + D ++
Sbjct: 228 RNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLK-WMAPESIFDKIYSTKSDVWS 286
Query: 508 FGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH- 566
           +GV+L E+ +   + Y      + + E   S +  G             ++    E +  
Sbjct: 287 YGVLLWEIFSLGGSPYPG----VQMDEDFCSRLREG-------------MRMRAPEYSTP 329
Query: 567 HLIMLCLACIAREPESRPSMAEVVSTL 593
            +  + L C  R+P+ RP  AE+V  L
Sbjct: 330 EIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 28/186 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA------CEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK +NH N+I+L          E     YLV 
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 106
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           E M + +L   +H +   E +S+     +   +  G+ +LH+    G +H+D+   NI++
Sbjct: 107 ELM-DANLCQVIHMELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVV 157
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
             +   K+ +F   R+A    + +  T   V T  Y APE +        +D ++ G ++
Sbjct: 158 KSDCTLKILDFGLARTA---STNFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIM 213
Query: 513 LELITG 518
            EL+ G
Sbjct: 214 GELVKG 219

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 84/184 (45%), Gaps = 30/184 (16%)
Query: 351 VAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVYEFM 395
           VAIK + R            +E+ L+K +NH N+I L        + E     Y+V E M
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 396 ENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN 455
            + +LS  +  +   E +S+     +   +  G+ +LH+    G +H+D+   NI++  +
Sbjct: 112 -DANLSQVIQMELDHERMSY-----LLYQMLVGIKHLHSA---GIIHRDLKPSNIVVKSD 162
Query: 456 LRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLE 514
              K+ +F   R+A     G S   T  V T  Y APE +        +D ++ GV++ E
Sbjct: 163 ATLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGE 217
Query: 515 LITG 518
           +I G
Sbjct: 218 MIKG 221

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 85/203 (41%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+  +R             +E++LLK++NH N++ L      +   YLV+E
Sbjct: 23  RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 83  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 132
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y+     V T  Y APE +   +Y   +  +D 
Sbjct: 133 NLLINTEGAIKLADFGLARAFGVPVRTYTH---EVVTLWYRAPEILLGCKY--YSTAVDI 187
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 188 WSLGCIFAEMVT-RRALFPGDSE 209

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 85/203 (41%), Gaps = 33/203 (16%)
Query: 343 RGIINGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+  +R             +E++LLK++NH N++ L      +   YLV+E
Sbjct: 22  RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG-----LHYLHNCTDPGYVHKDISSG 448
           F+               +F+  +    I L +        L  L  C     +H+D+   
Sbjct: 82  FLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 131
Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDT 505
           N+L++     KLA+F   R+       Y+     V T  Y APE +   +Y   +  +D 
Sbjct: 132 NLLINTEGAIKLADFGLARAFGVPVRTYTH---EVVTLWYRAPEILLGCKY--YSTAVDI 186
Query: 506 YAFGVVLLELITGKEAAYKQDGE 528
           ++ G +  E++T + A +  D E
Sbjct: 187 WSLGCIFAEMVT-RRALFPGDSE 208

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFAEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 81/189 (42%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 46  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 106 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 157
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +F   R    E +G       V T  Y APE M  +      +D ++ G 
Sbjct: 158 VNEDCELKILDFGLARHTDDEMTG------XVATRWYRAPEIMLNWMHYNQTVDIWSVGC 211
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 212 IMAELLTGR 220

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +    H +R
Sbjct: 73  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRR 129
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 130 IGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 185
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 186 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 39/206 (18%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 22  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 394 --------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
                   FM+  +L+        P   S+         +  GL + H+      +H+D+
Sbjct: 82  HVHQDLKTFMDASALTG----IPLPLIKSY------LFQLLQGLAFCHSHR---VLHRDL 128
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPE 502
              N+L++     KLA+F   R+       Y+     V T  Y APE +   +Y   +  
Sbjct: 129 KPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVVTLWYRAPEILLGCKY--YSTA 183
Query: 503 MDTYAFGVVLLELITGKEAAYKQDGE 528
           +D ++ G +  E++T + A +  D E
Sbjct: 184 VDIWSLGCIFAEMVT-RRALFPGDSE 208

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 13/170 (7%)
Query: 354 KCMRRSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEF 412
           K M  +  KE+  LK    H N++ L          +LV E +  G L + + KK++  F
Sbjct: 46  KRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--F 103
Query: 413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSA 469
                 + I   +   + ++H   D G VH+D+   N+L    + NL  K+ +F F R  
Sbjct: 104 SETEASY-IMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159
Query: 470 VREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
             +       KT   T  Y APE +         D ++ GV+L  +++G+
Sbjct: 160 PPDNQ---PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +    H +R
Sbjct: 71  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRR 127
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 128 IGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 183
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 184 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 99  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 155
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 156 IGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 211
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 212 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 74/280 (26%)
Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 18  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77
Query: 382 CEHDGVFYLVYE-----------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLH 430
            E    F L+ E             E G+L + L +  +     W             L 
Sbjct: 78  FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-----WQV-----------LE 121
Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA 490
            + +C + G +H+DI   NIL+D N R +L    F   A+ +++ Y+      GT  Y  
Sbjct: 122 AVRHCHNXGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDTVYTDFD---GTRVYSP 177
Query: 491 PEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
           PE++ Y          ++ G++L +++ G +  ++ D EEI+  +  F            
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCG-DIPFEHD-EEIIRGQVFFR----------- 224
Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                   Q    E   HLI  CLA     P  RP+  E+
Sbjct: 225 --------QRVSXE-CQHLIRWCLAL---RPSDRPTFEEI 252

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +    H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +    H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +    H +R
Sbjct: 79  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRR 135
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 136 IGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 191
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 192 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 76/170 (44%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E+   G +    H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+++D+    K+ +F F + 
Sbjct: 135 IGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 81/189 (42%), Gaps = 30/189 (15%)
Query: 347 NGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLV 391
            G  VA+K + R            +E+ LLK + H N+I L        + E     YLV
Sbjct: 46  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ 
Sbjct: 106 THLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLA 157
Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGV 510
           ++++   K+ +    R    E +GY      V T  Y APE M  +      +D ++ G 
Sbjct: 158 VNEDCELKILDAGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGC 211
Query: 511 VLLELITGK 519
           ++ EL+TG+
Sbjct: 212 IMAELLTGR 220

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 126
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 127 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 178
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +F   R    E  G       V T  Y APE M  +      +D ++ G +
Sbjct: 179 NEDCELKILDFGLARHTDDEMXG------XVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 232
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 233 MAELLTGR 240

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 79  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 135
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 136 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 191
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 192 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           E+++L   +H N++ L  A  ++   +++ EF   G++   + +   P  ++ +    + 
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVC 141
Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
                 L+YLH   D   +H+D+ +GNIL   +   KLA+F       R         + 
Sbjct: 142 KQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR---XIQRRDSF 195
Query: 483 VGTNGYMAPEYM--EYGLVTP---EMDTYAFGVVLLEL 515
           +GT  +MAPE +  E     P   + D ++ G+ L+E+
Sbjct: 196 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           E+++L   +H N++ L  A  ++   +++ EF   G++   + +   P  ++ +    + 
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVC 141
Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
                 L+YLH   D   +H+D+ +GNIL   +   KLA+F       R         + 
Sbjct: 142 KQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR---TIQRRDSF 195
Query: 483 VGTNGYMAPEYM--EYGLVTP---EMDTYAFGVVLLEL 515
           +GT  +MAPE +  E     P   + D ++ G+ L+E+
Sbjct: 196 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 394 FMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDISS 447
           F+E  SLSD   ++     Y +F++       +  VA G+ +L    C     +H+D+++
Sbjct: 172 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRDLAA 226
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            NILL +    K+ +F   R  + ++  Y     A     +MAPE +   + T + D ++
Sbjct: 227 RNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 285
Query: 508 FGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
           FGV+L E+ +   + Y   G +I   E    + EG    A       P+    +      
Sbjct: 286 FGVLLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE------ 329
Query: 568 LIMLCLACIAREPESRPSMAEVVSTL 593
           +    L C   EP  RP+ +E+V  L
Sbjct: 330 MYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 79  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR 135
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 136 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 191
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 192 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +    H +R
Sbjct: 71  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRR 127
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 128 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 183
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 184 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 79  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR 135
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 136 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 191
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 192 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  + + +N   L+ L  + + +   Y+V E+   G +  + H +R
Sbjct: 79  KVVKLKQIEHTLN-EKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEM--FSHLRR 135
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    K+A+F F + 
Sbjct: 136 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKR 191
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 192 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 79  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR 135
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 136 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 191
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 192 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 81/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 107 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +    R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 159 NEDCELKILDRGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 213 MAELLTGR 220

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 54/283 (19%)
Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G V+ G  +G  VAI+ +          ++  +EV   ++  H N++   GAC       
Sbjct: 47  GQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105
Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           ++    +  +L   +   +    +  N   +IA ++  G+ YLH     G +HKD+ S N
Sbjct: 106 IITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKN 160
Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY---MAPEYMEYGLVTPEM--- 503
           +  D N +  + +F     +   ++G    K  +  NG+   +APE +    ++P+    
Sbjct: 161 VFYD-NGKVVITDFGLFSISGVLQAGRREDKLRI-QNGWLCHLAPEIIRQ--LSPDTEED 216
Query: 504 --------DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
                   D +A G +  EL   +E  +K        AEA+   +  G         + P
Sbjct: 217 KLPFSKHSDVFALGTIWYEL-HAREWPFKTQP-----AEAIIWQMGTG---------MKP 261
Query: 556 NLQ--ANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           NL      KEI+     + L C A E E RP+  +++  L K+
Sbjct: 262 NLSQIGMGKEISD----ILLFCWAFEQEERPTFTKLMDMLEKL 300

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +    H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +    H +R
Sbjct: 79  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRR 135
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 136 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 191
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 192 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E+   G +  + H +R
Sbjct: 79  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR 135
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+++D+    K+ +F F + 
Sbjct: 136 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKR 191
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 192 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +    H +R
Sbjct: 65  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRR 121
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 122 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDEQGYIQVTDFGFAKR 177
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 178 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 99  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR 155
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 156 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 211
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 212 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E+   G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+++D+    K+ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 394 FMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDISS 447
           F+E  SLSD   ++     Y +F++       +  VA G+ +L    C     +H+D+++
Sbjct: 174 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRDLAA 228
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            NILL +    K+ +F   R  + ++  Y     A     +MAPE +   + T + D ++
Sbjct: 229 RNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 287
Query: 508 FGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
           FGV+L E+ +   + Y   G +I   E    + EG    A       P+    +      
Sbjct: 288 FGVLLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE------ 331
Query: 568 LIMLCLACIAREPESRPSMAEVVSTL 593
           +    L C   EP  RP+ +E+V  L
Sbjct: 332 MYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 81/188 (43%), Gaps = 30/188 (15%)
Query: 348 GSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG------ACEHDGVFYLVY 392
           G  VA+K + R            +E+ LLK + H N+I L        + E     YLV 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
             M     +D  +  +  +    + +F I   +  GL Y+H+      +H+D+   N+ +
Sbjct: 107 HLMG----ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVV 511
           +++   K+ +    R    E +GY      V T  Y APE M  +      +D ++ G +
Sbjct: 159 NEDCELKILDGGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 212
Query: 512 LLELITGK 519
           + EL+TG+
Sbjct: 213 MAELLTGR 220

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 394 FMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDISS 447
           F+E  SLSD   ++     Y +F++       +  VA G+ +L    C     +H+D+++
Sbjct: 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRDLAA 221
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            NILL +    K+ +F   R  + ++  Y     A     +MAPE +   + T + D ++
Sbjct: 222 RNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 280
Query: 508 FGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
           FGV+L E+ +   + Y   G +I   E    + EG    A       P+    +      
Sbjct: 281 FGVLLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE------ 324
Query: 568 LIMLCLACIAREPESRPSMAEVVSTL 593
           +    L C   EP  RP+ +E+V  L
Sbjct: 325 MYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 52  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 111
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 112 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 168
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 169 VLKLCDFGSAKQLVRGEPNVSX----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 223
Query: 515 LITGK 519
           L+ G+
Sbjct: 224 LLLGQ 228

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 394 FMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDISS 447
           F+E  SLSD   ++     Y +F++       +  VA G+ +L    C     +H+D+++
Sbjct: 165 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRDLAA 219
Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            NILL +    K+ +F   R  + ++  Y     A     +MAPE +   + T + D ++
Sbjct: 220 RNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 278
Query: 508 FGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
           FGV+L E+ +   + Y   G +I   E    + EG    A       P+    +      
Sbjct: 279 FGVLLWEIFSLGASPYP--GVKI-DEEFCRRLKEGTRMRA-------PDYTTPE------ 322
Query: 568 LIMLCLACIAREPESRPSMAEVVSTL 593
           +    L C   EP  RP+ +E+V  L
Sbjct: 323 MYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 14/167 (8%)
Query: 357 RRSISKEVN-LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSW 415
           +R  ++E+  LL+   H N+I L    +     Y+V E  + G L D + +++   F S 
Sbjct: 59  KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK---FFSE 115
Query: 416 NCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL-LDKNLRA---KLANFSFVRSAVR 471
                +   +   + YLH     G VH+D+   NIL +D++      ++ +F F +  +R
Sbjct: 116 REASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-LR 171
Query: 472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
            E+G     T   T  ++APE +E        D ++ GV+L   +TG
Sbjct: 172 AENGL--LXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 63  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 122
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 123 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 179
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 180 VLKLCDFGSAKQLVRGEPNVSX----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 234
Query: 515 LITGK 519
           L+ G+
Sbjct: 235 LLLGQ 239

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 39/206 (18%)
Query: 343 RGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           R  + G  VA+K +R          +  +E++LLK++NH N++ L      +   YLV+E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 394 --------FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
                   FM+  +L+        P   S+         +  GL + H+      +H+D+
Sbjct: 86  HVDQDLKKFMDASALTG----IPLPLIKSY------LFQLLQGLAFCHSHR---VLHRDL 132
Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EYGLVTPE 502
              N+L++     KLA+F   R+       Y      V T  Y APE +   +Y   +  
Sbjct: 133 KPQNLLINTEGAIKLADFGLARAFGVPVRTYXH---EVVTLWYRAPEILLGCKY--YSTA 187
Query: 503 MDTYAFGVVLLELITGKEAAYKQDGE 528
           +D ++ G +  E++T + A +  D E
Sbjct: 188 VDIWSLGCIFAEMVT-RRALFPGDSE 212

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 78  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 137
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 138 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 194
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 195 VLKLCDFGSAKQLVRGEPNVSX----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 249
Query: 515 LITGK 519
           L+ G+
Sbjct: 250 LLLGQ 254

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 56  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 115
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 116 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 172
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 173 VLKLCDFGSAKQLVRGEPNVSX----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 227
Query: 515 LITGK 519
           L+ G+
Sbjct: 228 LLLGQ 232

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 56  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 115
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 116 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 172
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 173 VLKLCDFGSAKQLVRGEPNVSX----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 227
Query: 515 LITGK 519
           L+ G+
Sbjct: 228 LLLGQ 232

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 83/193 (43%), Gaps = 29/193 (15%)
Query: 339 GSVFRGIINGSTVAIKCMRR------------SISKEVNLLKKINHFNLINLFGACEHDG 386
           G+VF+   N  T  I  ++R            S  +E+ LLK++ H N++ L      D 
Sbjct: 16  GTVFKAK-NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74
Query: 387 VFYLVYEFMENG--SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
              LV+EF +       D  +    PE V           +  GL + H+      +H+D
Sbjct: 75  KLTLVFEFCDQDLKKYFDSCNGDLDPEIVK-----SFLFQLLKGLGFCHS---RNVLHRD 126
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYG--LVTPE 502
           +   N+L+++N   KLANF   R+       YS+    V T  Y  P+ + +G  L +  
Sbjct: 127 LKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVVTLWYRPPDVL-FGAKLYSTS 182
Query: 503 MDTYAFGVVLLEL 515
           +D ++ G +  EL
Sbjct: 183 IDMWSAGCIFAEL 195

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 73/158 (46%), Gaps = 13/158 (8%)
Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
           E+++L   +H N++ L  A  ++   +++ EF   G++   + +   P  ++ +    + 
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVC 141
Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
                 L+YLH   D   +H+D+ +GNIL   +   KLA+F       R           
Sbjct: 142 KQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR---XIQRRDXF 195
Query: 483 VGTNGYMAPEYM--EYGLVTP---EMDTYAFGVVLLEL 515
           +GT  +MAPE +  E     P   + D ++ G+ L+E+
Sbjct: 196 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 45  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 104
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 105 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 161
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 162 VLKLCDFGSAKQLVRGEPNVSX----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 216
Query: 515 LITGK 519
           L+ G+
Sbjct: 217 LLLGQ 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 44  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 103
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 104 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 160
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 161 VLKLCDFGSAKQLVRGEPNVSX----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 215
Query: 515 LITGK 519
           L+ G+
Sbjct: 216 LLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 44  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 103
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 104 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 160
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 161 VLKLCDFGSAKQLVRGEPNVSX----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 215
Query: 515 LITGK 519
           L+ G+
Sbjct: 216 LLLGQ 220

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 72  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 131
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 132 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 188
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 189 VLKLCDFGSAKQLVRGEPNVSY----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 243
Query: 515 LITGK 519
           L+ G+
Sbjct: 244 LLLGQ 248

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 48  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 107
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 108 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 164
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 165 VLKLCDFGSAKQLVRGEPNVSX----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 219
Query: 515 LITGK 519
           L+ G+
Sbjct: 220 LLLGQ 224

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+++D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLIIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ ++  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 57  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 116
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 117 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 173
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 174 VLKLCDFGSAKQLVRGEPNVSY----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 228
Query: 515 LITGK 519
           L+ G+
Sbjct: 229 LLLGQ 233

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 78  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 137
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 138 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 194
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 195 VLKLCDFGSAKQLVRGEPNVS----YICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 249
Query: 515 LITGK 519
           L+ G+
Sbjct: 250 LLLGQ 254

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 80  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 139
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 140 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 196
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 197 VLKLCDFGSAKQLVRGEPNVS----YICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 251
Query: 515 LITGK 519
           L+ G+
Sbjct: 252 LLLGQ 256

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 37/203 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG-- 380
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I L    
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVF 92
Query: 381 ----ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
               + E     Y+V E M + +LS  +  +   E +S+     +   +  G+ +LH+  
Sbjct: 93  TPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-----LLYQMLVGIKHLHSA- 145
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 146 --GIIHRDLKPSNIVVKSDATLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 198
Query: 496 YGLVTPEMDTYAFGVVLLELITG 518
                  +D ++ G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 82  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 141
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 142 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 198
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 199 VLKLCDFGSAKQLVRGEPNVS----YICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 253
Query: 515 LITGK 519
           L+ G+
Sbjct: 254 LLLGQ 258

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 78/180 (43%), Gaps = 23/180 (12%)
Query: 345 IINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           ++  S +  + +   + +E+ +   ++H N++ L+         YL+ E+   G L   L
Sbjct: 55  VLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL 114
Query: 405 HKKRYPEFVSWNCRF------RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
            K         +C F       I  ++A  L Y   C     +H+DI   N+LL      
Sbjct: 115 QK---------SCTFDEQRTATIMEELADALMY---CHGKKVIHRDIKPENLLLGLKGEL 162
Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           K+A+F +   +V   S     KT  GT  Y+ PE +E  +   ++D +  GV+  EL+ G
Sbjct: 163 KIADFGW---SVHAPS--LRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 49  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 108
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 109 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 165
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 166 VLKLCDFGSAKQLVRGEPNVSY----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 220
Query: 515 LITGK 519
           L+ G+
Sbjct: 221 LLLGQ 225

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 76/170 (44%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L  L  + + +   Y+V E+   G +  + H +R
Sbjct: 79  KVVKLKQIEHTLN-EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR 135
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+++D+    K+ +F F + 
Sbjct: 136 IGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKR 191
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 192 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 37/203 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG-- 380
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I L    
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVF 92
Query: 381 ----ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
               + E     Y+V E M + +LS  +  +   E +S+     +   +  G+ +LH+  
Sbjct: 93  TPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 145
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 146 --GIIHRDLKPSNIVVKSDATLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 198
Query: 496 YGLVTPEMDTYAFGVVLLELITG 518
                  +D ++ G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 78/342 (22%), Positives = 140/342 (40%), Gaps = 71/342 (20%)
Query: 282 KRRRDEAARKDGKREKKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSV 341
           KR+R     K G++ +  N+P +F  S+ NL             V +E           V
Sbjct: 5   KRKRGSRGGKKGRKSRIANIP-NFEQSLKNL-------------VVSEKILGYGSSGTVV 50
Query: 342 FRGIINGSTVAIKCMRRSISK----EVNLL-KKINHFNLINLFGACEHDGVFYLVYEFME 396
           F+G   G  VA+K M          E+ LL +  +H N+I  + +   D   Y+  E   
Sbjct: 51  FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC- 109
Query: 397 NGSLSDWLHKKRYPEFVSWNCRFR-----IAL--DVAHGLHYLHNCTDPGYVHKDISSGN 449
           N +L D +  K   +    N + +     I+L   +A G+ +LH+      +H+D+   N
Sbjct: 110 NLNLQDLVESKNVSD---ENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQN 163
Query: 450 ILLD-------------KNLRAKLANFSFVRSAVREESGYSSTKTAV----GTNGYMAPE 492
           IL+              +NLR  +++F   +     +SG    +  +    GT+G+ APE
Sbjct: 164 ILVSTSSRFTADQQTGAENLRILISDFGLCKKL---DSGQXXFRXNLNNPSGTSGWRAPE 220
Query: 493 YMEYGL---VTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAK 548
            +E      +T  +D ++ G V   +++ GK     +   E  +   +FS+ E       
Sbjct: 221 LLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDE------- 273
Query: 549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
           +  L D +L A   ++   +       I  +P  RP+  +V+
Sbjct: 274 MKCLHDRSLIAEATDLISQM-------IDHDPLKRPTAMKVL 308

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 123 SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 182
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 183 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 239
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 240 VLKLCDFGSAKQLVRGEPNVS----YICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 294
Query: 515 LITGK 519
           L+ G+
Sbjct: 295 LLLGQ 299

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCM---RRSISKEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK +   +R  ++E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 44  SGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 103
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 104 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 160
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 161 VLKLCDFGSAKQLVRGEPNVSY----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 215
Query: 515 LITGK 519
           L+ G+
Sbjct: 216 LLLGQ 220

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 78/342 (22%), Positives = 140/342 (40%), Gaps = 71/342 (20%)
Query: 282 KRRRDEAARKDGKREKKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSV 341
           KR+R     K G++ +  N+P +F  S+ NL             V +E           V
Sbjct: 5   KRKRGSRGGKKGRKSRIANIP-NFEQSLKNL-------------VVSEKILGYGSSGTVV 50
Query: 342 FRGIINGSTVAIKCMRRSISK----EVNLL-KKINHFNLINLFGACEHDGVFYLVYEFME 396
           F+G   G  VA+K M          E+ LL +  +H N+I  + +   D   Y+  E   
Sbjct: 51  FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC- 109
Query: 397 NGSLSDWLHKKRYPEFVSWNCRFR-----IAL--DVAHGLHYLHNCTDPGYVHKDISSGN 449
           N +L D +  K   +    N + +     I+L   +A G+ +LH+      +H+D+   N
Sbjct: 110 NLNLQDLVESKNVSD---ENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQN 163
Query: 450 ILLD-------------KNLRAKLANFSFVRSAVREESGYSSTKTAV----GTNGYMAPE 492
           IL+              +NLR  +++F   +     +SG    +  +    GT+G+ APE
Sbjct: 164 ILVSTSSRFTADQQTGAENLRILISDFGLCKKL---DSGQXXFRXNLNNPSGTSGWRAPE 220
Query: 493 YMEYGL---VTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAK 548
            +E      +T  +D ++ G V   +++ GK     +   E  +   +FS+ E       
Sbjct: 221 LLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDE------- 273
Query: 549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
           +  L D +L A   ++   +       I  +P  RP+  +V+
Sbjct: 274 MKCLHDRSLIAEATDLISQM-------IDHDPLKRPTAMKVL 308

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E+   G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+++D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 37/203 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG-- 380
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I L    
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92
Query: 381 ----ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
               + E     Y+V E M + +LS  +  +   E +S+     +   +  G+ +LH+  
Sbjct: 93  TPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 145
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 146 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 198
Query: 496 YGLVTPEMDTYAFGVVLLELITG 518
                  +D ++ G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 76/170 (44%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L  L  + + +   Y+V E+   G +  + H +R
Sbjct: 79  KVVKLKQIEHTLN-EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR 135
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+++D+    K+ +F F + 
Sbjct: 136 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKR 191
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 192 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 76/170 (44%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L  L  + + +   Y+V E+   G +  + H +R
Sbjct: 79  KVVKLKQIEHTLN-EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR 135
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+++D+    K+ +F F + 
Sbjct: 136 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKR 191
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 192 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 123/287 (42%), Gaps = 61/287 (21%)
Query: 341 VFRGIINGSTVAIKCMRRSISK----EVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFM 395
           VF+G   G  VA+K M          E+ LL + + H N+I  + +   D   Y+  E  
Sbjct: 32  VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91
Query: 396 ENGSLSDWLHKKRYPEFVSWNCRFR-----IAL--DVAHGLHYLHNCTDPGYVHKDISSG 448
            N +L D +  K   +    N + +     I+L   +A G+ +LH+      +H+D+   
Sbjct: 92  -NLNLQDLVESKNVSD---ENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQ 144
Query: 449 NILLD-------------KNLRAKLANFSFVRSAVREESGYSSTKTAV----GTNGYMAP 491
           NIL+              +NLR  +++F   +   + +SG SS +T +    GT+G+ AP
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGLCK---KLDSGQSSFRTNLNNPSGTSGWRAP 201
Query: 492 EYMEYG-------LVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGG 543
           E +E          +T  +D ++ G V   +++ GK     +   E  +   +FS+ E  
Sbjct: 202 ELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDE-- 259
Query: 544 NAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
                +  L D +L A   ++   +       I  +P  RP+  +V+
Sbjct: 260 -----MKCLHDRSLIAEATDLISQM-------IDHDPLKRPTAMKVL 294

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 37/203 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG-- 380
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I L    
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92
Query: 381 ----ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
               + E     Y+V E M + +LS  +  +   E +S+     +   +  G+ +LH+  
Sbjct: 93  TPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 145
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 146 --GIIHRDLKPSNIVVKSDATLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 198
Query: 496 YGLVTPEMDTYAFGVVLLELITG 518
                  +D ++ G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 83/193 (43%), Gaps = 29/193 (15%)
Query: 339 GSVFRGIINGSTVAIKCMRR------------SISKEVNLLKKINHFNLINLFGACEHDG 386
           G+VF+   N  T  I  ++R            S  +E+ LLK++ H N++ L      D 
Sbjct: 16  GTVFKAK-NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74
Query: 387 VFYLVYEFMENG--SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
              LV+EF +       D  +    PE V           +  GL + H+      +H+D
Sbjct: 75  KLTLVFEFCDQDLKKYFDSCNGDLDPEIVK-----SFLFQLLKGLGFCHS---RNVLHRD 126
Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYG--LVTPE 502
           +   N+L+++N   KLA+F   R+       YS+    V T  Y  P+ + +G  L +  
Sbjct: 127 LKPQNLLINRNGELKLADFGLARAFGIPVRCYSA---EVVTLWYRPPDVL-FGAKLYSTS 182
Query: 503 MDTYAFGVVLLEL 515
           +D ++ G +  EL
Sbjct: 183 IDMWSAGCIFAEL 195

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA- 381
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I+L    
Sbjct: 33  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVF 92
Query: 382 -----CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                 E     YLV E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 93  TPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSY-----LLYQMLXGIKHLHSA- 145
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 146 --GIIHRDLKPSNIVVKSDXTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 198
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+AP  +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 29/201 (14%)
Query: 339 GSVF--RGIINGST-VAIKCMR---------RSISKEVNLLKKINHF---NLINLFGAC- 382
           G VF  R + NG   VA+K +R          S  +EV +L+ +  F   N++ LF  C 
Sbjct: 25  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84
Query: 383 ----EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDP 438
               + +    LV+E ++   L+ +L K   P   +   +  +   +  GL +LH+    
Sbjct: 85  VSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK-DMMFQLLRGLDFLHSHR-- 140
Query: 439 GYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL 498
             VH+D+   NIL+  + + KLA+F   R      S   +  + V T  Y APE +    
Sbjct: 141 -VVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVVTLWYRAPEVLLQSS 195
Query: 499 VTPEMDTYAFGVVLLELITGK 519
               +D ++ G +  E+   K
Sbjct: 196 YATPVDLWSVGCIFAEMFRRK 216

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 32/199 (16%)
Query: 343 RGIINGSTVAIKCM----------RRSISKEVNLLKKINHFNLI---NLFGACEHDGVF- 388
           R  + G  VAIK +          +R++ +E+ +LK   H N+I   ++       G F 
Sbjct: 75  RRRLTGQQVAIKKIPNAFDVVTNAKRTL-RELKILKHFKHDNIIAIKDILRPTVPYGEFK 133
Query: 389 --YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
             Y+V + ME+  L   +H  +       + R+ +   +  GL Y+H+      +H+D+ 
Sbjct: 134 SVYVVLDLMES-DLHQIIHSSQ--PLTLEHVRYFL-YQLLRGLKYMHSAQ---VIHRDLK 186
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYM----EYGLVTP 501
             N+L+++N   K+ +F   R      + +    T  V T  Y APE M    EY   T 
Sbjct: 187 PSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEY---TQ 243
Query: 502 EMDTYAFGVVLLELITGKE 520
            +D ++ G +  E++  ++
Sbjct: 244 AIDLWSVGCIFGEMLARRQ 262

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 84/207 (40%), Gaps = 23/207 (11%)
Query: 362 KEVNLLKKINHFNLINLFGACEHDGV-----FYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +E+ +LK   H N+I +F     D        Y++ E M+       LH+    + +S +
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDD 112
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR----SAV-- 470
                       +  LH       +H+D+   N+L++ N   K+ +F   R    SA   
Sbjct: 113 HIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 471 REESGYSSTKT-AVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGE 528
            E +G  S  T  V T  Y APE M      +  MD ++ G +L EL   +     +D  
Sbjct: 170 SEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR 229
Query: 529 EILLAEAVFSMVEGGNAEAKLSVLVDP 555
             LL   +F ++   +++  L  +  P
Sbjct: 230 HQLL--LIFGIIGTPHSDNDLRCIESP 254

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 84/207 (40%), Gaps = 23/207 (11%)
Query: 362 KEVNLLKKINHFNLINLFGACEHDGV-----FYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +E+ +LK   H N+I +F     D        Y++ E M+       LH+    + +S +
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDD 112
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR----SAV-- 470
                       +  LH       +H+D+   N+L++ N   K+ +F   R    SA   
Sbjct: 113 HIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 471 REESGYSSTKTA-VGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGE 528
            E +G  S  T  V T  Y APE M      +  MD ++ G +L EL   +     +D  
Sbjct: 170 SEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR 229
Query: 529 EILLAEAVFSMVEGGNAEAKLSVLVDP 555
             LL   +F ++   +++  L  +  P
Sbjct: 230 HQLL--LIFGIIGTPHSDNDLRCIESP 254

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 87/188 (46%), Gaps = 25/188 (13%)
Query: 324 LVVATENFSPKNMI----DGS-VFRGIINGSTVAIK-----CMRRSISKEVNLLKKIN-H 372
           ++V   +F PK+++    +G+ V+RG+ +   VA+K     C   +  +EV LL++ + H
Sbjct: 19  VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA-DREVQLLRESDEH 77
Query: 373 FNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR-FRIALDVAHGLHY 431
            N+I  F   E D  F  +   +   +L +++ +K   +F         +      GL +
Sbjct: 78  PNVIRYF-CTEKDRQFQYIAIELCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAH 133
Query: 432 LHNCTDPGYVHKDISSGNILLD-----KNLRAKLANFSFVRSAVREESGYSSTKTAVGTN 486
           LH+      VH+D+   NIL+        ++A +++F   +        +S      GT 
Sbjct: 134 LHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 487 GYMAPEYM 494
           G++APE +
Sbjct: 191 GWIAPEML 198

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 29/201 (14%)
Query: 339 GSVF--RGIINGST-VAIKCMR---------RSISKEVNLLKKINHF---NLINLFGAC- 382
           G VF  R + NG   VA+K +R          S  +EV +L+ +  F   N++ LF  C 
Sbjct: 25  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84
Query: 383 ----EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDP 438
               + +    LV+E ++   L+ +L K   P   +   +  +   +  GL +LH+    
Sbjct: 85  VSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK-DMMFQLLRGLDFLHSHR-- 140
Query: 439 GYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL 498
             VH+D+   NIL+  + + KLA+F   R      S   +  + V T  Y APE +    
Sbjct: 141 -VVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVVTLWYRAPEVLLQSS 195
Query: 499 VTPEMDTYAFGVVLLELITGK 519
               +D ++ G +  E+   K
Sbjct: 196 YATPVDLWSVGCIFAEMFRRK 216

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 32/199 (16%)
Query: 343 RGIINGSTVAIKCM----------RRSISKEVNLLKKINHFNLI---NLFGACEHDGVF- 388
           R  + G  VAIK +          +R++ +E+ +LK   H N+I   ++       G F 
Sbjct: 74  RRRLTGQQVAIKKIPNAFDVVTNAKRTL-RELKILKHFKHDNIIAIKDILRPTVPYGEFK 132
Query: 389 --YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
             Y+V + ME+  L   +H  +       + R+ +   +  GL Y+H+      +H+D+ 
Sbjct: 133 SVYVVLDLMES-DLHQIIHSSQ--PLTLEHVRYFL-YQLLRGLKYMHSAQ---VIHRDLK 185
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYM----EYGLVTP 501
             N+L+++N   K+ +F   R      + +    T  V T  Y APE M    EY   T 
Sbjct: 186 PSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEY---TQ 242
Query: 502 EMDTYAFGVVLLELITGKE 520
            +D ++ G +  E++  ++
Sbjct: 243 AIDLWSVGCIFGEMLARRQ 261

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 29/201 (14%)
Query: 339 GSVF--RGIINGST-VAIKCMR---------RSISKEVNLLKKINHF---NLINLFGAC- 382
           G VF  R + NG   VA+K +R          S  +EV +L+ +  F   N++ LF  C 
Sbjct: 25  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84
Query: 383 ----EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDP 438
               + +    LV+E ++   L+ +L K   P   +   +  +   +  GL +LH+    
Sbjct: 85  VSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK-DMMFQLLRGLDFLHSHR-- 140
Query: 439 GYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL 498
             VH+D+   NIL+  + + KLA+F   R      S   +  + V T  Y APE +    
Sbjct: 141 -VVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVVTLWYRAPEVLLQSS 195
Query: 499 VTPEMDTYAFGVVLLELITGK 519
               +D ++ G +  E+   K
Sbjct: 196 YATPVDLWSVGCIFAEMFRRK 216

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 31/176 (17%)
Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFY--LVYEFMENGSLSDWLHKKR----YPEFVSW 415
           +E  +LKK+NH N++ LF   E     +  L+ EF   GSL   L +       PE    
Sbjct: 56  REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE---- 111
Query: 416 NCRFRIAL-DVAHGLHYLHNCTDPGYVHKDISSGNILL----DKNLRAKLANFSFVRSAV 470
              F I L DV  G+++L    + G VH++I  GNI+     D     KL +F     A 
Sbjct: 112 -SEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF----GAA 163
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPE--------MDTYAFGVVLLELITG 518
           RE        +  GT  Y+ P+  E  ++  +        +D ++ GV      TG
Sbjct: 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 61/283 (21%), Positives = 112/283 (39%), Gaps = 50/283 (17%)
Query: 341 VFRGIINGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGAC------EHDGV 387
           +  G+ +G   A+K +       R    +E ++ +  NH N++ L   C      +H+  
Sbjct: 47  LVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA- 105
Query: 388 FYLVYEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            +L+  F + G+L + + + K    F++ +    + L +  GL  +H     GY H+D+ 
Sbjct: 106 -WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLK 161
Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG------TNGYMAPEYM---EYG 497
             NILL    +  L +   +  A     G     T         T  Y APE      + 
Sbjct: 162 PTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHC 221
Query: 498 LVTPEMDTYAFGVVLLELITGKEAAYK---QDGEEILLAEAVFSMVEGGNAEAKLSVLVD 554
           ++    D ++ G VL  ++ G E  Y    Q G+ + LA            + +LS+   
Sbjct: 222 VIDERTDVWSLGCVLYAMMFG-EGPYDMVFQKGDSVALA-----------VQNQLSIPQS 269
Query: 555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
           P   +        L  L  + +  +P  RP +  ++S L  +Q
Sbjct: 270 PRHSSA-------LWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 34/218 (15%)
Query: 326 VATENFSPKNMID----GSVF--RGIINGSTVAIKCMRR---------SISKEVNLLKKI 370
           +AT  + P   I     G+V+  R   +G  VA+K +R          S  +EV LL+++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 371 NHF---NLINLFGAC-----EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
             F   N++ L   C     + +    LV+E ++   L  +L K   P   +   +  + 
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DLM 118
Query: 423 LDVAHGLHYLH-NCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
                GL +LH NC     VH+D+   NIL+      KLA+F   R      S   +   
Sbjct: 119 RQFLRGLDFLHANCI----VHRDLKPENILVTSGGTVKLADFGLARIY----SYQMALDP 170
Query: 482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
            V T  Y APE +        +D ++ G +  E+   K
Sbjct: 171 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 76/170 (44%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E+   G +  + H +R
Sbjct: 78  KVVKLKEIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+++D+    K+ +F   + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGLAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 34/218 (15%)
Query: 326 VATENFSPKNMID----GSVF--RGIINGSTVAIKCMRR---------SISKEVNLLKKI 370
           +AT  + P   I     G+V+  R   +G  VA+K +R          S  +EV LL+++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 371 NHF---NLINLFGAC-----EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
             F   N++ L   C     + +    LV+E ++   L  +L K   P   +   +  + 
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DLM 118
Query: 423 LDVAHGLHYLH-NCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
                GL +LH NC     VH+D+   NIL+      KLA+F   R      S   +   
Sbjct: 119 RQFLRGLDFLHANCI----VHRDLKPENILVTSGGTVKLADFGLARIY----SYQMALAP 170
Query: 482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
            V T  Y APE +        +D ++ G +  E+   K
Sbjct: 171 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 37/203 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG-- 380
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I L    
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92
Query: 381 ----ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
               + E     Y+V E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 93  TPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 145
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 146 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPEVVTRYYRAPEVIL 198
Query: 496 YGLVTPEMDTYAFGVVLLELITG 518
                  +D ++ G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E++  G +  + H +R
Sbjct: 78  KVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+L+D+    ++ +F F + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT   +APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 11/177 (6%)
Query: 357 RRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           + ++  E++++ +++H  LINL  A E      L+ EF+  G L D +  + Y   +S  
Sbjct: 92  KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEA 149
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD--KNLRAKLANFSFVRSAVREES 474
                      GL ++H  +    VH DI   NI+ +  K    K+ +F        +E 
Sbjct: 150 EVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205
Query: 475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL 531
                K    T  + APE ++   V    D +A GV+   L++G      +D  E L
Sbjct: 206 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 259

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 37/203 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG-- 380
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I L    
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92
Query: 381 ----ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
               + E     Y+V E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 93  TPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 145
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 146 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 198
Query: 496 YGLVTPEMDTYAFGVVLLELITG 518
                  +D ++ G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 37/203 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG-- 380
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I L    
Sbjct: 34  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 93
Query: 381 ----ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
               + E     Y+V E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 94  TPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 146
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 147 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 199
Query: 496 YGLVTPEMDTYAFGVVLLELITG 518
                  +D ++ G ++ E+I G
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 37/203 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG-- 380
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I L    
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92
Query: 381 ----ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
               + E     Y+V E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 93  TPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 145
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 146 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 198
Query: 496 YGLVTPEMDTYAFGVVLLELITG 518
                  +D ++ G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA- 381
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I+L    
Sbjct: 33  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 92
Query: 382 -----CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                 E     YLV E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 93  TPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSY-----LLYQMLXGIKHLHSA- 145
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 146 --GIIHRDLKPSNIVVKSDXTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 198
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 14/164 (8%)
Query: 362 KEVNLLKKINHFNLINL-----FGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +E+ +L +  H N+I +         E     Y+V + ME       L+K    + +S +
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 128
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                   +  GL Y+H+      +H+D+   N+LL+     K+ +F   R A  +    
Sbjct: 129 HICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 477 SSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
                 V T  Y APE M      T  +D ++ G +L E+++ +
Sbjct: 186 GFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 14/164 (8%)
Query: 362 KEVNLLKKINHFNLINL-----FGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +E+ +L +  H N+I +         E     Y+V + ME       L+K    + +S +
Sbjct: 75  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 129
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                   +  GL Y+H+      +H+D+   N+LL+     K+ +F   R A  +    
Sbjct: 130 HICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 186
Query: 477 SSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
                 V T  Y APE M      T  +D ++ G +L E+++ +
Sbjct: 187 GFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 34/218 (15%)
Query: 326 VATENFSPKNMID----GSVF--RGIINGSTVAIKCMRR---------SISKEVNLLKKI 370
           +AT  + P   I     G+V+  R   +G  VA+K +R          S  +EV LL+++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 371 NHF---NLINLFGAC-----EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIA 422
             F   N++ L   C     + +    LV+E ++   L  +L K   P   +   +  + 
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DLM 118
Query: 423 LDVAHGLHYLH-NCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
                GL +LH NC     VH+D+   NIL+      KLA+F   R    + + +     
Sbjct: 119 RQFLRGLDFLHANCI----VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP---- 170
Query: 482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
            V T  Y APE +        +D ++ G +  E+   K
Sbjct: 171 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCMRRSIS---KEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK + +  +   +E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 44  SGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPA 103
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 104 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 160
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 161 VLKLCDFGSAKQLVRGEPNVSX----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 215
Query: 515 LITGK 519
           L+ G+
Sbjct: 216 LLLGQ 220

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA- 381
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I+L    
Sbjct: 26  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85
Query: 382 -----CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                 E     YLV E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 86  TPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSY-----LLYQMLXGIKHLHSA- 138
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 139 --GIIHRDLKPSNIVVKSDXTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 191
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 26/190 (13%)
Query: 346 INGSTVAIK----------CMRRSISKEVNLLKKINHFNLINL-----FGACEHDGVFYL 390
           +N   VAIK          C R    +E+ +L +  H N+I +         E     Y+
Sbjct: 46  VNKVRVAIKKISPFEHQTYCQR--TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 103
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           V + ME       L+K    + +S +        +  GL Y+H+      +H+D+   N+
Sbjct: 104 VQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNL 155
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFG 509
           LL+     K+ +F   R A  +          V T  Y APE M      T  +D ++ G
Sbjct: 156 LLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 215
Query: 510 VVLLELITGK 519
            +L E+++ +
Sbjct: 216 CILAEMLSNR 225

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 83/208 (39%), Gaps = 25/208 (12%)
Query: 362 KEVNLLKKINHFNLINLFGACEHDGV-----FYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +E+ +LK   H N+I +F     D        Y++ E M+       LH+    + +S +
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDD 112
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                       +  LH       +H+D+   N+L++ N   K+ +F   R  + E +  
Sbjct: 113 HIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR-IIDESAAD 168
Query: 477 SSTKTA--------VGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDG 527
           +S  T         V T  Y APE M      +  MD ++ G +L EL   +     +D 
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
Query: 528 EEILLAEAVFSMVEGGNAEAKLSVLVDP 555
              LL   +F ++   +++  L  +  P
Sbjct: 229 RHQLL--LIFGIIGTPHSDNDLRCIESP 254

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA- 381
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I+L    
Sbjct: 33  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVF 92
Query: 382 -----CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                 E     YLV E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 93  TPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 145
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 146 --GIIHRDLKPSNIVVKSDXTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 198
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 26/190 (13%)
Query: 346 INGSTVAIK----------CMRRSISKEVNLLKKINHFNLINL-----FGACEHDGVFYL 390
           +N   VAIK          C R    +E+ +L +  H N+I +         E     Y+
Sbjct: 46  VNKVRVAIKKISPFEHQTYCQR--TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 103
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           V + ME       L+K    + +S +        +  GL Y+H+      +H+D+   N+
Sbjct: 104 VQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNL 155
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFG 509
           LL+     K+ +F   R A  +          V T  Y APE M      T  +D ++ G
Sbjct: 156 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 215
Query: 510 VVLLELITGK 519
            +L E+++ +
Sbjct: 216 CILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 26/190 (13%)
Query: 346 INGSTVAIK----------CMRRSISKEVNLLKKINHFNLINL-----FGACEHDGVFYL 390
           +N   VAIK          C R    +E+ +L +  H N+I +         E     Y+
Sbjct: 46  VNKVRVAIKKISPFEHQTYCQR--TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 103
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           V + ME       L+K    + +S +        +  GL Y+H+      +H+D+   N+
Sbjct: 104 VQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNL 155
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFG 509
           LL+     K+ +F   R A  +          V T  Y APE M      T  +D ++ G
Sbjct: 156 LLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 215
Query: 510 VVLLELITGK 519
            +L E+++ +
Sbjct: 216 CILAEMLSNR 225

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 74/176 (42%), Gaps = 31/176 (17%)
Query: 362 KEVNLLKKINHFNLINLFGACEHDGVFY--LVYEFMENGSLSDWLHKKR----YPEFVSW 415
           +E  +LKK+NH N++ LF   E     +  L+ EF   GSL   L +       PE    
Sbjct: 56  REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE---- 111
Query: 416 NCRFRIAL-DVAHGLHYLHNCTDPGYVHKDISSGNILL----DKNLRAKLANFSFVRSAV 470
              F I L DV  G+++L    + G VH++I  GNI+     D     KL +F     A 
Sbjct: 112 -SEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF----GAA 163
Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPE--------MDTYAFGVVLLELITG 518
           RE           GT  Y+ P+  E  ++  +        +D ++ GV      TG
Sbjct: 164 RELEDDEQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 26/190 (13%)
Query: 346 INGSTVAIK----------CMRRSISKEVNLLKKINHFNLINL-----FGACEHDGVFYL 390
           +N   VAIK          C R    +E+ +L +  H N+I +         E     Y+
Sbjct: 46  VNKVRVAIKKISPFEHQTYCQR--TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 103
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           V + ME       L+K    + +S +        +  GL Y+H+      +H+D+   N+
Sbjct: 104 VQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNL 155
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFG 509
           LL+     K+ +F   R A  +          V T  Y APE M      T  +D ++ G
Sbjct: 156 LLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 215
Query: 510 VVLLELITGK 519
            +L E+++ +
Sbjct: 216 CILAEMLSNR 225

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCMRRSIS---KEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK + +  +   +E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 44  SGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 103
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 104 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 160
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 161 VLKLCDFGSAKQLVRGEPNVSY----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 215
Query: 515 LITGK 519
           L+ G+
Sbjct: 216 LLLGQ 220

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 26/190 (13%)
Query: 346 INGSTVAIK----------CMRRSISKEVNLLKKINHFNLINL-----FGACEHDGVFYL 390
           +N   VAIK          C R    +E+ +L +  H N+I +         E     Y+
Sbjct: 54  VNKVRVAIKKISPFEHQTYCQR--TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 111
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           V + ME       L+K    + +S +        +  GL Y+H+      +H+D+   N+
Sbjct: 112 VQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNL 163
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFG 509
           LL+     K+ +F   R A  +          V T  Y APE M      T  +D ++ G
Sbjct: 164 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 223
Query: 510 VVLLELITGK 519
            +L E+++ +
Sbjct: 224 CILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 26/190 (13%)
Query: 346 INGSTVAIK----------CMRRSISKEVNLLKKINHFNLINL-----FGACEHDGVFYL 390
           +N   VAIK          C R    +E+ +L +  H N+I +         E     Y+
Sbjct: 46  VNKVRVAIKKISPFEHQTYCQR--TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 103
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           V + ME       L+K    + +S +        +  GL Y+H+      +H+D+   N+
Sbjct: 104 VQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNL 155
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFG 509
           LL+     K+ +F   R A  +          V T  Y APE M      T  +D ++ G
Sbjct: 156 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 215
Query: 510 VVLLELITGK 519
            +L E+++ +
Sbjct: 216 CILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 26/190 (13%)
Query: 346 INGSTVAIK----------CMRRSISKEVNLLKKINHFNLINL-----FGACEHDGVFYL 390
           +N   VAIK          C R    +E+ +L +  H N+I +         E     Y+
Sbjct: 48  VNKVRVAIKKISPFEHQTYCQR--TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 105
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           V + ME       L+K    + +S +        +  GL Y+H+      +H+D+   N+
Sbjct: 106 VQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNL 157
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFG 509
           LL+     K+ +F   R A  +          V T  Y APE M      T  +D ++ G
Sbjct: 158 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 217
Query: 510 VVLLELITGK 519
            +L E+++ +
Sbjct: 218 CILAEMLSNR 227

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 347 NGSTVAIKCMRRSIS---KEVNLLKKINHFNLINL----FGACEHDGVFY--LVYEFMEN 397
           +G  VAIK + +  +   +E+ +++K++H N++ L    + + E     Y  LV +++  
Sbjct: 44  SGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 103
Query: 398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
                  H  R  + +           +   L Y+H+    G  H+DI   N+LLD +  
Sbjct: 104 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 160
Query: 458 A-KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TPEMDTYAFGVVLLE 514
             KL +F   +  VR E   S     + +  Y APE + +G    T  +D ++ G VL E
Sbjct: 161 VLKLCDFGSAKQLVRGEPNVSY----ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAE 215
Query: 515 LITGK 519
           L+ G+
Sbjct: 216 LLLGQ 220

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/265 (21%), Positives = 111/265 (41%), Gaps = 47/265 (17%)
Query: 347 NGSTVAIKCMRRSISKEVN---------LLKKINHFNLINLFGACEHDGVFYLVYEFMEN 397
           +G  +A+K +R ++ ++           +++  +   ++  +GA   +G  ++  E M  
Sbjct: 46  SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST 105
Query: 398 GSLSDWLHKKRYP---EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK 454
               D  +K  Y    + +      +I L     L++L    +   +H+DI   NILLD+
Sbjct: 106 SF--DKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDR 161
Query: 455 NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME-------YGLVTPEMDTYA 507
           +   KL +F      V      + T+ A G   YMAPE ++       Y + +   D ++
Sbjct: 162 SGNIKLCDFGISGQLV---DSIAKTRDA-GCRPYMAPERIDPSASRQGYDVRS---DVWS 214
Query: 508 FGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN--KKEIA 565
            G+ L EL TG+    K +     + + +  +V+G           DP   +N  ++E +
Sbjct: 215 LGITLYELATGRFPYPKWNS----VFDQLTQVVKG-----------DPPQLSNSEEREFS 259
Query: 566 HHLIMLCLACIAREPESRPSMAEVV 590
              I     C+ ++   RP   E++
Sbjct: 260 PSFINFVNLCLTKDESKRPKYKELL 284

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 114/276 (41%), Gaps = 62/276 (22%)
Query: 339 GSVFRG--IINGSTVAIKCMRR-------------SISKEVNLLKKIN----HFNLINLF 379
           G+VF G  + +   VAIK + R             +   EV LL K+     H  +I L 
Sbjct: 45  GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104
Query: 380 GACEHDGVFYLVYEF-MENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDP 438
              E    F LV E  +    L D++ +K         C F         +  + +C   
Sbjct: 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF------GQVVAAIQHCHSR 158
Query: 439 GYVHKDISSGNILLD-KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM--- 494
           G VH+DI   NIL+D +   AKL +F     A+  +  Y+      GT  Y  PE++   
Sbjct: 159 GVVHRDIKDENILIDLRRGCAKLIDFG--SGALLHDEPYTDFD---GTRVYSPPEWISRH 213
Query: 495 EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD 554
           +Y  +      ++ G++L +++ G +  +++D +EIL AE  F               V 
Sbjct: 214 QYHALP--ATVWSLGILLYDMVCG-DIPFERD-QEILEAELHF------------PAHVS 257
Query: 555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
           P+  A           L   C+A +P SRPS+ E++
Sbjct: 258 PDCCA-----------LIRRCLAPKPSSRPSLEEIL 282

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 26/190 (13%)
Query: 346 INGSTVAIK----------CMRRSISKEVNLLKKINHFNLINL-----FGACEHDGVFYL 390
           +N   VAIK          C R    +E+ +L +  H N+I +         E     Y+
Sbjct: 66  VNKVRVAIKKISPFEHQTYCQR--TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 123
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           V + ME       L+K    + +S +        +  GL Y+H+      +H+D+   N+
Sbjct: 124 VQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNL 175
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFG 509
           LL+     K+ +F   R A  +          V T  Y APE M      T  +D ++ G
Sbjct: 176 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 235
Query: 510 VVLLELITGK 519
            +L E+++ +
Sbjct: 236 CILAEMLSNR 245

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA- 381
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I+L    
Sbjct: 33  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVF 92
Query: 382 -----CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                 E     YLV E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 93  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 145
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 146 --GIIHRDLKPSNIVVKSDXTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 198
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 76/182 (41%), Gaps = 16/182 (8%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +  E+++ K  NH N++        D   ++V  FM  GS  D +       F+      
Sbjct: 57  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT----HFMDGMNEL 112
Query: 420 RIAL---DVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKL----ANFSFVRSAVRE 472
            IA     V   L Y+H+    GYVH+ + + +IL+  + +  L    +N S +    R+
Sbjct: 113 AIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ 169
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGL--VTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
              +   K +V    +++PE ++  L     + D Y+ G+   EL  G          ++
Sbjct: 170 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 229
Query: 531 LL 532
           LL
Sbjct: 230 LL 231

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 14/164 (8%)
Query: 362 KEVNLLKKINHFNLINL-----FGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +E+ +L +  H N+I +         E     Y+V + ME       L+K    + +S +
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 128
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                   +  GL Y+H+      +H+D+   N+LL+     K+ +F   R A  +    
Sbjct: 129 HICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 185
Query: 477 SSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
                 V T  Y APE M      T  +D ++ G +L E+++ +
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 14/164 (8%)
Query: 362 KEVNLLKKINHFNLINL-----FGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +E+ +L +  H N+I +         E     Y+V + ME       L+K    + +S +
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 128
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                   +  GL Y+H+      +H+D+   N+LL+     K+ +F   R A  +    
Sbjct: 129 HICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 477 SSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
                 V T  Y APE M      T  +D ++ G +L E+++ +
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 14/164 (8%)
Query: 362 KEVNLLKKINHFNLINL-----FGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +E+ +L +  H N+I +         E     Y+V + ME       L+K    + +S +
Sbjct: 68  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 122
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                   +  GL Y+H+      +H+D+   N+LL+     K+ +F   R A  +    
Sbjct: 123 HICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 179
Query: 477 SSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
                 V T  Y APE M      T  +D ++ G +L E+++ +
Sbjct: 180 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 37/221 (16%)
Query: 326 VATENFSPKNMID----GSVF--RGIINGSTVAIKCMRR------------SISKEVNLL 367
           +AT  + P   I     G+V+  R   +G  VA+K +R             S  +EV LL
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 368 KKINHF---NLINLFGAC-----EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +++  F   N++ L   C     + +    LV+E ++   L  +L K   P   +   + 
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK- 123
Query: 420 RIALDVAHGLHYLH-NCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS 478
            +      GL +LH NC     VH+D+   NIL+      KLA+F   R      S   +
Sbjct: 124 DLMRQFLRGLDFLHANCI----VHRDLKPENILVTSGGTVKLADFGLARIY----SYQMA 175
Query: 479 TKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
               V T  Y APE +        +D ++ G +  E+   K
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 14/164 (8%)
Query: 362 KEVNLLKKINHFNLINL-----FGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +E+ +L +  H N+I +         E     Y+V + ME       L+K    + +S +
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 128
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                   +  GL Y+H+      +H+D+   N+LL+     K+ +F   R A  +    
Sbjct: 129 HICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 185
Query: 477 SSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
                 V T  Y APE M      T  +D ++ G +L E+++ +
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA- 381
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I+L    
Sbjct: 71  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 130
Query: 382 -----CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                 E     YLV E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 131 TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 183
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 184 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 236
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 14/164 (8%)
Query: 362 KEVNLLKKINHFNLINL-----FGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +E+ +L +  H N+I +         E     Y+V + ME       L+K    + +S +
Sbjct: 75  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 129
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                   +  GL Y+H+      +H+D+   N+LL+     K+ +F   R A  +    
Sbjct: 130 HICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 186
Query: 477 SSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
                 V T  Y APE M      T  +D ++ G +L E+++ +
Sbjct: 187 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 14/164 (8%)
Query: 362 KEVNLLKKINHFNLINL-----FGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +E+ +L +  H N+I +         E     Y+V + ME       L+K    + +S +
Sbjct: 68  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 122
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                   +  GL Y+H+      +H+D+   N+LL+     K+ +F   R A  +    
Sbjct: 123 HICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 179
Query: 477 SSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
                 V T  Y APE M      T  +D ++ G +L E+++ +
Sbjct: 180 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 76/182 (41%), Gaps = 16/182 (8%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           +  E+++ K  NH N++        D   ++V  FM  GS  D +       F+      
Sbjct: 73  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT----HFMDGMNEL 128
Query: 420 RIAL---DVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKL----ANFSFVRSAVRE 472
            IA     V   L Y+H+    GYVH+ + + +IL+  + +  L    +N S +    R+
Sbjct: 129 AIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ 185
Query: 473 ESGYSSTKTAVGTNGYMAPEYMEYGL--VTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
              +   K +V    +++PE ++  L     + D Y+ G+   EL  G          ++
Sbjct: 186 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 245
Query: 531 LL 532
           LL
Sbjct: 246 LL 247

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 14/164 (8%)
Query: 362 KEVNLLKKINHFNLINL-----FGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +E+ +L +  H N+I +         E     Y+V + ME       L+K    + +S +
Sbjct: 76  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 130
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                   +  GL Y+H+      +H+D+   N+LL+     K+ +F   R A  +    
Sbjct: 131 HICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 187
Query: 477 SSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
                 V T  Y APE M      T  +D ++ G +L E+++ +
Sbjct: 188 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 14/164 (8%)
Query: 362 KEVNLLKKINHFNLINL-----FGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +E+ +L +  H N+I +         E     Y+V + ME       L+K    + +S +
Sbjct: 67  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 121
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                   +  GL Y+H+      +H+D+   N+LL+     K+ +F   R A  +    
Sbjct: 122 HICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 178
Query: 477 SSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
                 V T  Y APE M      T  +D ++ G +L E+++ +
Sbjct: 179 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 14/164 (8%)
Query: 362 KEVNLLKKINHFNLINL-----FGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +E+ +L +  H N+I +         E     Y+V + ME       L+K    + +S +
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSND 128
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                   +  GL Y+H+      +H+D+   N+LL+     K+ +F   R A  +    
Sbjct: 129 HICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 477 SSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
                 V T  Y APE M      T  +D ++ G +L E+++ +
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 10/158 (6%)
Query: 360 ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF 419
           ++ E+ +L ++ H N+I +    E+ G F LV E   +G L  +    R+P        +
Sbjct: 76  VTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASY 134
Query: 420 RIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST 479
            I   +   + YL        +H+DI   NI++ ++   KL +F    SA   E G    
Sbjct: 135 -IFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFG---SAAYLERG-KLF 186
Query: 480 KTAVGTNGYMAPE-YMEYGLVTPEMDTYAFGVVLLELI 516
            T  GT  Y APE  M      PE++ ++ GV L  L+
Sbjct: 187 YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/170 (21%), Positives = 76/170 (44%), Gaps = 13/170 (7%)
Query: 349 STVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR 408
             V +K +  +++ E  +L+ +N   L+ L  + + +   Y+V E+   G +  + H +R
Sbjct: 78  KVVKLKEIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR 134
Query: 409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS 468
              F   + RF  A  +     YLH+      +++D+   N+++D+    ++ +F   + 
Sbjct: 135 IGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGLAKR 190
Query: 469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
                     T    GT  Y+APE +        +D +A GV++ E+  G
Sbjct: 191 VK------GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 78/180 (43%), Gaps = 30/180 (16%)
Query: 362 KEVNLLKKIN-HFNLINLFGA--CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR 418
           +E+ +L +++ H N++NL      ++D   YLV+++ME       LH       +    +
Sbjct: 57  REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHK 111
Query: 419 FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS 478
             +   +   + YLH+    G +H+D+   NILL+     K+A+F   RS V      ++
Sbjct: 112 QYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 479 TKTA------------------VGTNGYMAPEYMEYGL-VTPEMDTYAFGVVLLELITGK 519
              +                  V T  Y APE +      T  +D ++ G +L E++ GK
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA- 381
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I+L    
Sbjct: 34  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 93
Query: 382 -----CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                 E     YLV E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 94  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 146
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 147 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 199
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 200 GMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA- 381
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I+L    
Sbjct: 32  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 91
Query: 382 -----CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                 E     YLV E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 92  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 144
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 145 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 197
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 198 GMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA- 381
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I+L    
Sbjct: 33  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 92
Query: 382 -----CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                 E     YLV E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 93  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 145
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 146 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 198
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA- 381
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I+L    
Sbjct: 33  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 92
Query: 382 -----CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                 E     YLV E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 93  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 145
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 146 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 198
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA- 381
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I+L    
Sbjct: 27  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 86
Query: 382 -----CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                 E     YLV E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 87  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 139
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 140 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 192
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA- 381
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I+L    
Sbjct: 27  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 86
Query: 382 -----CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                 E     YLV E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 87  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 139
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 140 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 192
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA- 381
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I+L    
Sbjct: 26  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85
Query: 382 -----CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                 E     YLV E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 86  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 138
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 139 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 191
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 14/164 (8%)
Query: 362 KEVNLLKKINHFNLINL-----FGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +E+ +L +  H N+I +         E     Y+V + ME       L+K    + +S +
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKCQHLSND 128
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                   +  GL Y+H+      +H+D+   N+LL+     K+ +F   R A  +    
Sbjct: 129 HICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 477 SSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
                 V T  Y APE M      T  +D ++ G +L E+++ +
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA- 381
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I+L    
Sbjct: 34  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 93
Query: 382 -----CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                 E     YLV E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 94  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 146
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 147 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 199
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 200 GMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 72/164 (43%), Gaps = 14/164 (8%)
Query: 362 KEVNLLKKINHFNLI---NLFGACEHDGV--FYLVYEFMENGSLSDWLHKKRYPEFVSWN 416
           +E+ +L +  H N+I   ++  A   + +   Y+V + ME       L+K    + +S +
Sbjct: 90  REIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETD-----LYKLLKSQQLSND 144
Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
                   +  GL Y+H+      +H+D+   N+L++     K+ +F   R A  E    
Sbjct: 145 HICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHT 201
Query: 477 SSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGK 519
                 V T  Y APE M      T  +D ++ G +L E+++ +
Sbjct: 202 GFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGA- 381
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I+L    
Sbjct: 71  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 130
Query: 382 -----CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                 E     YLV E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 131 TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 183
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 184 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 236
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 37/203 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG-- 380
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I L    
Sbjct: 35  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 94
Query: 381 ----ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
               + E     Y+V E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 95  TPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 147
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S      V T  Y APE + 
Sbjct: 148 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMVPFVVTRYYRAPEVIL 200
Query: 496 YGLVTPEMDTYAFGVVLLELITG 518
                  +D ++ G ++ E+I G
Sbjct: 201 GMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 76/190 (40%), Gaps = 26/190 (13%)
Query: 346 INGSTVAIK----------CMRRSISKEVNLLKKINHFNLINL-----FGACEHDGVFYL 390
           +N   VAIK          C R    +E+ +L    H N+I +         E     Y+
Sbjct: 48  VNKVRVAIKKISPFEHQTYCQR--TLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYI 105
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           V + ME       L+K    + +S +        +  GL Y+H+      +H+D+   N+
Sbjct: 106 VQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNL 157
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFG 509
           LL+     K+ +F   R A  +          V T  Y APE M      T  +D ++ G
Sbjct: 158 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 217
Query: 510 VVLLELITGK 519
            +L E+++ +
Sbjct: 218 CILAEMLSNR 227

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 31/193 (16%)
Query: 351 VAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL 404
           VA+K + R      ++ +E+   + + H N++             +V E+   G L + +
Sbjct: 47  VAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 106
Query: 405 -HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL--RAKLA 461
            +  R+ E      RF     ++ G+ Y H        H+D+   N LLD +   R K+A
Sbjct: 107 CNAGRFSED---EARFFFQQLIS-GVSYAHAMQ---VAHRDLKLENTLLDGSPAPRLKIA 159
Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EY-GLVTPEMDTYAFGVVLLELIT 517
           +F + +++V     +S  K+AVGT  Y+APE +   EY G V    D ++ GV L  ++ 
Sbjct: 160 DFGYSKASVL----HSQPKSAVGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLV 212
Query: 518 GKEAAYK-QDGEE 529
           G   AY  +D EE
Sbjct: 213 G---AYPFEDPEE 222

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/196 (21%), Positives = 84/196 (42%), Gaps = 37/196 (18%)
Query: 342 FRGIINGSTVAIKCMRRSI-SKEVNLL--------KKINHFNLINLFGACEHDGVFYLVY 392
            R + +G  +A+K +R ++ S+E   L        + ++    +  +GA   +G  ++  
Sbjct: 70  MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 129
Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           E M+      +       + +  +   +IA+ +   L +LH+      +H+D+   N+L+
Sbjct: 130 ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLI 187
Query: 453 DKNLRAKLANFSFVRSAVREESGY---SSTKTA-VGTNGYMAPEYMEYGLVTPEM----- 503
           +   + K+ +F          SGY   S  KT   G   YMAPE      + PE+     
Sbjct: 188 NALGQVKMCDFGI--------SGYLVDSVAKTIDAGCKPYMAPER-----INPELNQKGY 234
Query: 504 ----DTYAFGVVLLEL 515
               D ++ G+ ++EL
Sbjct: 235 SVKSDIWSLGITMIEL 250

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG-- 380
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I L    
Sbjct: 27  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 86
Query: 381 ----ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
               + E     Y+V E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 87  TPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 139
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 140 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 192
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 193 GMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG-- 380
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I L    
Sbjct: 38  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 97
Query: 381 ----ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
               + E     Y+V E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 98  TPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 150
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   T  V T  Y APE + 
Sbjct: 151 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVIL 203
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 204 GMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 76/190 (40%), Gaps = 26/190 (13%)
Query: 346 INGSTVAIK----------CMRRSISKEVNLLKKINHFNLINL-----FGACEHDGVFYL 390
           +N   VAIK          C R    +E+ +L    H N+I +         E     Y+
Sbjct: 48  VNKVRVAIKKISPFEHQTYCQR--TLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYI 105
Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           V + ME       L+K    + +S +        +  GL Y+H+      +H+D+   N+
Sbjct: 106 VQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNL 157
Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFG 509
           LL+     K+ +F   R A  +          V T  Y APE M      T  +D ++ G
Sbjct: 158 LLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 217
Query: 510 VVLLELITGK 519
            +L E+++ +
Sbjct: 218 CILAEMLSNR 227

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 31/203 (15%)
Query: 341 VFRGIINGSTVAIKCMRRSISKEVNLLKKI------NHFNLINLFGACEHDGVFYLVYEF 394
           + R  +    VA+K + R  + + N+ ++I       H N++             ++ E+
Sbjct: 38  LMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97
Query: 395 MENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
              G L + + +  R+ E      RF     +  G+ Y H+       H+D+   N LLD
Sbjct: 98  ASGGELYERICNAGRFSED---EARFFFQ-QLLSGVSYCHSMQ---ICHRDLKLENTLLD 150
Query: 454 KNL--RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EY-GLVTPEMDTYA 507
            +   R K+ +F + +S+V     +S  K+ VGT  Y+APE +   EY G +    D ++
Sbjct: 151 GSPAPRLKICDFGYSKSSVL----HSQPKSTVGTPAYIAPEVLLRQEYDGKIA---DVWS 203
Query: 508 FGVVLLELITGKEAAYK-QDGEE 529
            GV L  ++ G   AY  +D EE
Sbjct: 204 CGVTLYVMLVG---AYPFEDPEE 223

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG-- 380
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I L    
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92
Query: 381 ----ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
               + E     Y+V E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 93  TPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 145
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS-STKTAVGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   +  V T  Y APE + 
Sbjct: 146 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMEPEVVTRYYRAPEVIL 198
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/239 (21%), Positives = 101/239 (42%), Gaps = 35/239 (14%)
Query: 362 KEVNLLKKINHFNLINLF--------------GACEHDGVFYLVYEFMENGSLSDWLHKK 407
           +E+ ++++++H N++ +F              G+       Y+V E+ME   L++ L + 
Sbjct: 57  REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQG 115
Query: 408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD-KNLRAKLANFSFV 466
                +  + R      +  GL Y+H+      +H+D+   N+ ++ ++L  K+ +F   
Sbjct: 116 ---PLLEEHARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLA 168
Query: 467 RSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP-----EMDTYAFGVVLLELITGKEA 521
           R      S        + T  Y +P      L++P      +D +A G +  E++TGK  
Sbjct: 169 RIMDPHYSHKGHLSEGLVTKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224
Query: 522 -AYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIARE 579
            A   + E++ L      +V   + +  LSV+  P    N     H  +   L  I+RE
Sbjct: 225 FAGAHELEQMQLILESIPVVHEEDRQELLSVI--PVYIRNDMTEPHKPLTQLLPGISRE 281

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 339 GSVFRGIINGS-------TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFG-- 380
           GS  +GI+  +        VAIK + R            +E+ L+K +NH N+I L    
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92
Query: 381 ----ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
               + E     Y+V E M + +L   +  +   E +S+     +   +  G+ +LH+  
Sbjct: 93  TPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA- 145
Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS-STKTAVGTNGYMAPEYME 495
             G +H+D+   NI++  +   K+ +F   R+A     G S   +  V T  Y APE + 
Sbjct: 146 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFMMEPEVVTRYYRAPEVIL 198
Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
                  +D ++ G ++ E++  K
Sbjct: 199 GMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 27/148 (18%)
Query: 339 GSVFRGI--INGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGV 387
           G V++ I  +   TVAIK +R          +  +EV+LLK++ H N+I L     H+  
Sbjct: 48  GEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107
Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHN--CTDPGYVHKDI 445
            +L++E+ EN  L  ++ K   P+ VS          + +G+++ H+  C     +H+D+
Sbjct: 108 LHLIFEYAEN-DLKKYMDKN--PD-VSMRVIKSFLYQLINGVNFCHSRRC-----LHRDL 158
Query: 446 SSGNILL-----DKNLRAKLANFSFVRS 468
              N+LL      +    K+ +F   R+
Sbjct: 159 KPQNLLLSVSDASETPVLKIGDFGLARA 186

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	611
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-81
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-80
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-79
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-68
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-59
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-59
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-56
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-53
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-53
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-52
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-52
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-52
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-50
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-49
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-49
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-48
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-36
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	1e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-35
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-34
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-34
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-32
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-32
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-32
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-32
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-32
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-32
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-32
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-31
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-31
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-31
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-31
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-31
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-31
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-31
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	9e-31
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-30
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-30
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-30
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-30
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-30
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-30
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-30
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-30
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-30
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-30
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-30
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-30
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-30
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-29
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-29
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-29
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-29
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-29
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-29
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-29
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-28
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-28
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-28
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-28
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-28
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-28
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-28
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-27
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-27
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-27
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-27
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-27
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-26
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-24
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-23
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-23
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-23
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-22
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-22
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-22
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-22
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-21
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-20
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-20
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-20
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-20
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-19
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-19
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-19
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-19
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-19
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-19
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-19
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-18
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-18
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-18
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-18
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-18
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-17
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-17
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-16
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-16
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-16
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-15
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-15
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-13
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-08
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-12
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-12
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-12
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-12
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-11
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-11
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-11
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-11
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-11
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-10
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-10
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-08
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	2e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-04
1y7m_A	164	Hypothetical protein BSU14040; surface mutagenesis	3e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-04
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	7e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  257 bits (658), Expect = 4e-81
 Identities = 86/311 (27%), Positives = 144/311 (46%), Gaps = 30/311 (9%)

Query: 308 SVSNLDRGLKFYKYEDLVVATENFSPKNMID----------GSVFRGIINGSTVAIKCMR 357
           S+   D     + + +L   T NF  + +            G V++G +N +TVA+K + 
Sbjct: 4   SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLA 63

Query: 358 RSISK-----------EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK 406
             +             E+ ++ K  H NL+ L G         LVY +M NGSL D L  
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123

Query: 407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV 466
                 +SW+ R +IA   A+G+++LH   +  ++H+DI S NILLD+   AK+++F   
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLA 180

Query: 467 RSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQD 526
           R++ +      +++  VGT  YMAPE +  G +TP+ D Y+FGVVLLE+ITG  A  +  
Sbjct: 181 RASEKFAQTVMTSR-IVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR 238

Query: 527 GEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSM 586
             ++LL        E       +   +D  +          +  +   C+  +   RP +
Sbjct: 239 EPQLLLDIKEEIEDEEK----TIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI 294

Query: 587 AEVVSTLMKIQ 597
            +V   L ++ 
Sbjct: 295 KKVQQLLQEMT 305

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  254 bits (651), Expect = 6e-80
 Identities = 105/326 (32%), Positives = 150/326 (46%), Gaps = 26/326 (7%)

Query: 294 KREKKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMID----GSVFRGII-NG 348
           K  K  N   D L S   +          DL  AT NF  K +I     G V++G++ +G
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63

Query: 349 STVAIKCMRRSISK--------EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           + VA+K  R   S         E+  L    H +L++L G C+      L+Y++MENG+L
Sbjct: 64  AKVALK-RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122

Query: 401 SDWLHKKRYPEFV-SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
              L+    P    SW  R  I +  A GLHYLH       +H+D+ S NILLD+N   K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPK 179

Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           + +F   +     +  + ST    GT GY+ PEY   G +T + D Y+FGVVL E++  +
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVK-GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

Query: 520 EAA-YKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIA 577
            A       E + LAE        G  E     +VDPNL    + E         + C+A
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQ----IVDPNLADKIRPESLRKFGDTAVKCLA 294

Query: 578 REPESRPSMAEVVSTLMKIQLDVQRS 603
              E RPSM +V+  L +  L +Q S
Sbjct: 295 LSSEDRPSMGDVLWKL-EYALRLQES 319

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  252 bits (646), Expect = 3e-79
 Identities = 102/297 (34%), Positives = 162/297 (54%), Gaps = 26/297 (8%)

Query: 316 LKFYKYEDLVVATENFSPKNMID----GSVFRGII-NGSTVAIKCMRRSISK-------- 362
           LK +   +L VA++NFS KN++     G V++G + +G+ VA+K ++   ++        
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 363 EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFV-SWNCRFRI 421
           EV ++    H NL+ L G C       LVY +M NGS++  L ++   +    W  R RI
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 422 ALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT 481
           AL  A GL YLH+  DP  +H+D+ + NILLD+   A + +F   +    +++  +   T
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---T 193

Query: 482 AV-GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK---EAAYKQDGEEILLAEAVF 537
           AV GT G++APEY+  G  + + D + +GV+LLELITG+   + A   + ++++L + V 
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253

Query: 538 SMVEGGNAEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
            +++      KL  LVD +LQ N K E    LI + L C    P  RP M+EVV  L
Sbjct: 254 GLLKEK----KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  223 bits (569), Expect = 6e-68
 Identities = 86/312 (27%), Positives = 125/312 (40%), Gaps = 45/312 (14%)

Query: 321 YEDLVVATENFSPKNMID----GSVFRGIINGSTVAIKCMRRSIS------KEVNLLKKI 370
            E+L   +       +      G V++  +    VA+K              EV  L  +
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGM 75

Query: 371 NHFNLINLFGACEHD----GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVA 426
            H N++   GA +         +L+  F E GSLSD+L        VSWN    IA  +A
Sbjct: 76  KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMA 131

Query: 427 HGLHYLH-------NCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS-- 477
            GL YLH       +   P   H+DI S N+LL  NL A +A+F     A++ E+G S  
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL---ALKFEAGKSAG 188

Query: 478 STKTAVGTNGYMAPEYMEYGLVTPE-----MDTYAFGVVLLELITGKEAAYKQDGEEILL 532
            T   VGT  YMAPE +E  +         +D YA G+VL EL +   AA     E +L 
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248

Query: 533 AEAVFSMVEGGNAEAKLSVLV-----DPNLQAN--KKEIAHHLIMLCLACIAREPESRPS 585
            E     +    +   +  +V      P L+    K      L      C   + E+R S
Sbjct: 249 FEE---EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 586 MAEVVSTLMKIQ 597
              V   + ++Q
Sbjct: 306 AGCVGERITQMQ 317

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  201 bits (513), Expect = 1e-59
 Identities = 62/327 (18%), Positives = 121/327 (37%), Gaps = 44/327 (13%)

Query: 321 YEDLVVATENFSPKNMID----GSVFRGIINGSTVAIKCM----RRSIS--KEVNLLKKI 370
             +  +  +N     +I     G+V++G ++   VA+K      R++    K +  +  +
Sbjct: 5   ASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLM 64

Query: 371 NHFNLINLFGACEHDGV-----FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDV 425
            H N+       E         + LV E+  NGSL  +L          W    R+A  V
Sbjct: 65  EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSV 120

Query: 426 AHGLHYLHN------CTDPGYVHKDISSGNILLDKNLRAKLANFSFVR-----SAVREES 474
             GL YLH          P   H+D++S N+L+  +    +++F           VR   
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180

Query: 475 GYSSTKTAVGTNGYMAPEYMEYGL-------VTPEMDTYAFGVVLLELITGKEAAYKQDG 527
             ++  + VGT  YMAPE +E  +          ++D YA G++  E+       +  + 
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240

Query: 528 -EEILLAEAVFSMVEGGNAEAKLSVLVD------PNLQANKKEIAHHLIMLCLACIAREP 580
             E  +A            + ++ V  +      P            L      C  ++ 
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300

Query: 581 ESRPSMAEVVSTLMKIQLDVQRSQTLL 607
           E+R +       + ++ +  +R++++ 
Sbjct: 301 EARLTAQXAEERMAELMMIWERNKSVS 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  198 bits (506), Expect = 6e-59
 Identities = 76/268 (28%), Positives = 126/268 (47%), Gaps = 30/268 (11%)

Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V R   +GS VA+K +              +EV ++K++ H N++   GA        
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           +V E++  GSL   LHK    E +    R  +A DVA G++YLHN   P  VH+++ S N
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPN 169

Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           +L+DK    K+ +F   R    + S + S+K+A GT  +MAPE +       + D Y+FG
Sbjct: 170 LLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFG 226

Query: 510 VVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI 569
           V+L EL T ++  +      +  A+ V ++        +L +   P      + +   + 
Sbjct: 227 VILWELATLQQ-PW----GNLNPAQVVAAVGFKC---KRLEI---P------RNLNPQVA 269

Query: 570 MLCLACIAREPESRPSMAEVVSTLMKIQ 597
            +   C   EP  RPS A ++  L  + 
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  192 bits (489), Expect = 2e-56
 Identities = 62/271 (22%), Positives = 112/271 (41%), Gaps = 30/271 (11%)

Query: 339 GSVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           G V +       VAIK +      ++   E+  L ++NH N++ L+GAC +     LV E
Sbjct: 22  GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVME 79

Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
           + E GSL + LH      + +        L  + G+ YLH+      +H+D+   N+LL 
Sbjct: 80  YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV 139

Query: 454 KNLR-AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
                 K+ +F             +      G+  +MAPE  E    + + D +++G++L
Sbjct: 140 AGGTVLKICDFGTACDI------QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIIL 193

Query: 513 LELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLC 572
            E+IT ++  +    E    A  +   V  G    +  +          K +   +  L 
Sbjct: 194 WEVITRRK-PFD---EIGGPAFRIMWAVHNG---TRPPL---I------KNLPKPIESLM 237

Query: 573 LACIAREPESRPSMAEVVSTLMKIQLDVQRS 603
             C +++P  RPSM E+V  +  +      +
Sbjct: 238 TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  183 bits (466), Expect = 1e-53
 Identities = 68/277 (24%), Positives = 109/277 (39%), Gaps = 45/277 (16%)

Query: 339 GSVFRGIINGSTVAIKCMRRSIS-----------KEVNLLKKINHFNLINLFGACEHDGV 387
           G V+R    G  VA+K  R               +E  L   + H N+I L G C  +  
Sbjct: 21  GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
             LV EF   G L+  L  KR    +  +     A+ +A G++YLH+      +H+D+ S
Sbjct: 81  LCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKS 136

Query: 448 GNILLDK--------NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV 499
            NIL+ +        N   K+ +F   R     E   ++  +A G   +MAPE +   + 
Sbjct: 137 SNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWMAPEVIRASMF 191

Query: 500 TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA 559
           +   D +++GV+L EL+TG+   +      I      + +         L +   P    
Sbjct: 192 SKGSDVWSYGVLLWELLTGEV-PF----RGIDGLAVAYGVAMNK---LALPI---P---- 236

Query: 560 NKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                      L   C   +P SRPS   ++  L  I
Sbjct: 237 --STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  181 bits (462), Expect = 4e-53
 Identities = 57/273 (20%), Positives = 116/273 (42%), Gaps = 41/273 (15%)

Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGAC--EHDGV 387
           G +++G   G+ + +K ++         R  ++E   L+  +H N++ + GAC       
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
             L+  +M  GSL + LH+      V  +   + ALD+A G+ +LH   +P      ++S
Sbjct: 84  PTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNS 141

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---YGLVTPEMD 504
            ++++D+++ A+++      S          +   +    ++APE ++           D
Sbjct: 142 RSVMIDEDMTARISMADVKFSF--------QSPGRMYAPAWVAPEALQKKPEDTNRRSAD 193

Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++F V+L EL+T +   +     ++   E    +   G     L   + P        I
Sbjct: 194 MWSFAVLLWELVTREV-PF----ADLSNMEIGMKVALEG-----LRPTIPPG-------I 236

Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
           + H+  L   C+  +P  RP    +V  L K+Q
Sbjct: 237 SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  181 bits (461), Expect = 2e-52
 Identities = 59/283 (20%), Positives = 113/283 (39%), Gaps = 41/283 (14%)

Query: 339 GSVFRGIINGST--VAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G   +     +   + +K +       +R+  KEV +++ + H N++   G    D    
Sbjct: 24  GQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            + E+++ G+L   +          W+ R   A D+A G+ YLH+      +H+D++S N
Sbjct: 84  FITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHN 138

Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYS-----------STKTAVGTNGYMAPEYMEYGL 498
            L+ +N    +A+F   R  V E++                 T VG   +MAPE +    
Sbjct: 139 CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS 198

Query: 499 VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ 558
              ++D ++FG+VL E+I    A       + L     F +   G  +        P+  
Sbjct: 199 YDEKVDVFSFGIVLCEIIGRVNADP-----DYLPRTMDFGLNVRGFLDRYCPPNCPPSF- 252

Query: 559 ANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ 601
                    + + C      +PE RPS  ++   L  +++ + 
Sbjct: 253 -------FPITVRCC---DLDPEKRPSFVKLEHWLETLRMHLA 285

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  180 bits (458), Expect = 3e-52
 Identities = 65/271 (23%), Positives = 113/271 (41%), Gaps = 33/271 (12%)

Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V++G  +G  VA+K +          ++   EV +L+K  H N++   G         
Sbjct: 38  GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 95

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           +V ++ E  SL   LH               IA   A G+ YLH       +H+D+ S N
Sbjct: 96  IVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNN 150

Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE---YMEYGLVTPEMDTY 506
           I L ++   K+ +F          SG    +   G+  +MAPE     +    + + D Y
Sbjct: 151 IFLHEDNTVKIGDFGLAT-EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVY 209

Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           AFG+VL EL+TG+   Y      I   + +  MV  G+          P+L   +     
Sbjct: 210 AFGIVLYELMTGQL-PY----SNINNRDQIIEMVGRGSLS--------PDLSKVRSNCPK 256

Query: 567 HLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
            +  L   C+ ++ + RPS   +++ + ++ 
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRILAEIEELA 287

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  178 bits (452), Expect = 6e-51
 Identities = 66/287 (22%), Positives = 106/287 (36%), Gaps = 35/287 (12%)

Query: 339 GSVFRGIINGSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGV----F 388
           G V+ G   G  VA+K    +         E+     + H N++    A           
Sbjct: 51  GEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH-----NCTDPGYVHK 443
           YL+ ++ ENGSL D+L        +      ++A     GL +LH         P   H+
Sbjct: 111 YLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166

Query: 444 DISSGNILLDKNLRAKLANFSF-VRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           D+ S NIL+ KN    +A+    V+             T VGT  YM PE ++  L    
Sbjct: 167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNH 226

Query: 503 ------MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
                  D Y+FG++L E+     +    +  ++   + V S     + E    ++    
Sbjct: 227 FQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP---SYEDMREIVCIKK 283

Query: 557 L------QANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
           L      + +  E    +  L   C A  P SR +   V  TL K+ 
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  176 bits (447), Expect = 3e-50
 Identities = 68/289 (23%), Positives = 113/289 (39%), Gaps = 39/289 (13%)

Query: 339 GSVFRGIINGSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGV----F 388
           G V+RG   G  VA+K              E+     + H N++    A   D       
Sbjct: 56  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTD-----PGYVHK 443
           +LV ++ E+GSL D+L++      V+     ++AL  A GL +LH         P   H+
Sbjct: 116 WLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171

Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA----VGTNGYMAPEYMEYGLV 499
           D+ S NIL+ KN    +A+      AVR +S   +   A    VGT  YMAPE ++  + 
Sbjct: 172 DLKSKNILVKKNGTCCIADLGL---AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 228

Query: 500 TPE------MDTYAFGVVLLELITGKEAA-----YKQDGEEILLAEAVFSMVEGGNAEAK 548
                     D YA G+V  E+            Y+    +++ ++     +     E K
Sbjct: 229 MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK 288

Query: 549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
           L   +    Q+   E    +  +   C      +R +   +  TL ++ 
Sbjct: 289 LRPNIPNRWQSC--EALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  172 bits (439), Expect = 1e-49
 Identities = 71/281 (25%), Positives = 124/281 (44%), Gaps = 49/281 (17%)

Query: 339 GSVFRGI--INGSTVAIKCMR--------------RSISKEVNLLKKINHFNLINLFGAC 382
           G V +G    + S VAIK +               +   +EV ++  +NH N++ L+G  
Sbjct: 33  GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92

Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
            +     +V EF+  G L   L  K +P  + W+ + R+ LD+A G+ Y+ N   P  VH
Sbjct: 93  HNP--PRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQNQN-PPIVH 147

Query: 443 KDISSGNILLDK-----NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE--YME 495
           +D+ S NI L        + AK+A+F   + +V       S    +G   +MAPE    E
Sbjct: 148 RDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH------SVSGLLGNFQWMAPETIGAE 201

Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
               T + DTY+F ++L  ++TG+    +    +I       +M+        +     P
Sbjct: 202 EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINMIREEGLRPTIPEDCPP 257

Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            L+        ++I LC    + +P+ RP  + +V  L ++
Sbjct: 258 RLR--------NVIELCW---SGDPKKRPHFSYIVKELSEL 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  173 bits (440), Expect = 2e-49
 Identities = 58/279 (20%), Positives = 109/279 (39%), Gaps = 44/279 (15%)

Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G V+ G  +G  VAI+ +          ++  +EV   ++  H N++   GAC       
Sbjct: 47  GQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           ++    +  +L   +   +    +  N   +IA ++  G+ YLH     G +HKD+ S N
Sbjct: 106 IITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKN 160

Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTK--TAVGTNGYMAPEYMEYGLVTPEM---- 503
           +  D   +  + +F     +   ++G    K     G   ++APE +       E     
Sbjct: 161 VFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLP 219

Query: 504 -----DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ 558
                D +A G +  EL   +   +K        AEA+   +  G    K ++     + 
Sbjct: 220 FSKHSDVFALGTIWYELHAREW-PFKT-----QPAEAIIWQMGTGM---KPNL---SQIG 267

Query: 559 ANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
             K+     +  + L C A E E RP+  +++  L K+ 
Sbjct: 268 MGKE-----ISDILLFCWAFEQEERPTFTKLMDMLEKLP 301

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  169 bits (429), Expect = 5e-48
 Identities = 64/286 (22%), Positives = 109/286 (38%), Gaps = 35/286 (12%)

Query: 339 GSVFRGIINGSTVAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDG----VF 388
           G V+RG   G  VA+K              E+     + H N++    +           
Sbjct: 22  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH-----NCTDPGYVHK 443
           +L+  + E GSL D+L        +      RI L +A GL +LH         P   H+
Sbjct: 82  WLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHR 137

Query: 444 DISSGNILLDKNLRAKLANF--SFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP 501
           D+ S NIL+ KN +  +A+   + + S    +    +    VGT  YMAPE ++  +   
Sbjct: 138 DLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN-PRVGTKRYMAPEVLDETIQVD 196

Query: 502 E------MDTYAFGVVLLELITGKEA-----AYKQDGEEILLAEAVFSMVEGGNAEAKLS 550
                  +D +AFG+VL E+     +      YK    +++  +  F  +       +  
Sbjct: 197 CFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR 256

Query: 551 VLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
             +     ++       L  L   C  + P +R +   +  TL KI
Sbjct: 257 PNIPNRWFSD--PTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  137 bits (346), Expect = 2e-36
 Identities = 64/314 (20%), Positives = 122/314 (38%), Gaps = 56/314 (17%)

Query: 294 KREKKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMIDGSVFRGI--INGSTV 351
           +R ++++  E+       +    +F K++  +    +F        +V++G+       V
Sbjct: 3   ERNQQQDDIEELETKAVGMSNDGRFLKFDIEI-GRGSF-------KTVYKGLDTETTVEV 54

Query: 352 AIKCM---------RRSISKEVNLLKKINHFNLINLFGA----CEHDGVFYLVYEFMENG 398
           A   +         R+   +E  +LK + H N++  + +     +      LV E M +G
Sbjct: 55  AWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSG 114

Query: 399 SLSDWLHK-KRYPEFV--SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD-K 454
           +L  +L + K     V  SW CR      +  GL +LH    P  +H+D+   NI +   
Sbjct: 115 TLKTYLKRFKVMKIKVLRSW-CR-----QILKGLQFLHTR-TPPIIHRDLKCDNIFITGP 167

Query: 455 NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLE 514
               K+ +       +      S  K  +GT  +MAPE  E       +D YAFG+ +LE
Sbjct: 168 TGSVKIGDL-----GLATLKRASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLE 221

Query: 515 LITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLA 574
           + T +    +        A  ++  V  G   A    +  P ++         +I  C+ 
Sbjct: 222 MATSEYPYSECQN-----AAQIYRRVTSGVKPASFDKVAIPEVK--------EIIEGCI- 267

Query: 575 CIAREPESRPSMAE 588
              +  + R S+ +
Sbjct: 268 --RQNKDERYSIKD 279

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212

 Score =  132 bits (332), Expect = 1e-35
 Identities = 43/211 (20%), Positives = 75/211 (35%), Gaps = 20/211 (9%)

Query: 38  NRPCQGFLIFKSQPPYDTVSSISNLTSSDPT--------ELARVNNISNSAAALPLDKEV 89
              C   L         T+S I+   +S            + R N+       + +   V
Sbjct: 2   RTSCPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRV 61

Query: 90  IVPVSCYCS-GLYYQANTSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQG 148
           +VP  C C  G +   N S+ +     TY  +A + Y  L+T   L+  N +  T++   
Sbjct: 62  LVPFPCECQPGDFLGHNFSYSVRQ-EDTYERVAISNYANLTTMESLQARNPFPATNIPLS 120

Query: 149 LTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDP 208
            TL V + C+C   +         +TY +   DS+  I++   VS + +   N       
Sbjct: 121 ATLNVLVNCSCGDESV-SKDFGLFVTYPLRPEDSLSSIARSSGVSADILQRYNPGVN--- 176

Query: 209 LLFPFTTILIPLTTEPLSSQTIIHYPPPPSS 239
                  + +P      +      +PP  SS
Sbjct: 177 FNSGNGIVYVPGRDPNGA------FPPFKSS 201

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  137 bits (347), Expect = 3e-35
 Identities = 64/271 (23%), Positives = 117/271 (43%), Gaps = 47/271 (17%)

Query: 339 GSVFRGIINGSTVAIKCMRRSIS-----KEVNLLKKINHFNLINLFGAC-EHDGVFYLVY 392
           G V  G   G+ VA+KC++   +      E +++ ++ H NL+ L G   E  G  Y+V 
Sbjct: 207 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266

Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           E+M  GSL D+L + R    +  +C  + +LDV   + YL       +VH+D+++ N+L+
Sbjct: 267 EYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLV 322

Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
            ++  AK+++F   + A   +      K  V    + APE +     + + D ++FG++L
Sbjct: 323 SEDNVAKVSDFGLTKEASSTQDT---GKLPV---KWTAPEALREKKFSTKSDVWSFGILL 376

Query: 513 LELITGKEAAYKQDGEEILLAEAVFSMVEGG-------NAEAKLSVLVDPNLQANKKEIA 565
            E+ +     Y      I L + V   VE G            +                
Sbjct: 377 WEIYSFGRVPY----PRIPLKD-VVPRVEKGYKMDAPDGCPPAV---------------- 415

Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            + +M    C   +  +RP+  ++   L  I
Sbjct: 416 -YDVM--KNCWHLDAATRPTFLQLREQLEHI 443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  136 bits (345), Expect = 1e-34
 Identities = 67/273 (24%), Positives = 121/273 (44%), Gaps = 45/273 (16%)

Query: 339 GSVFRGIINGST--VAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+    +  VA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 234 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293

Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L ++   + VS      +A  ++  + YL       ++H+++++ N 
Sbjct: 294 ITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNC 349

Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
           L+ +N   K+A+F   R  +     Y++   A     + APE + Y   + + D +AFGV
Sbjct: 350 LVGENHLVKVADFGLSR--LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 407

Query: 511 VLLELITGKEAAYKQDGEEILLAEAVFSMVEGG-------NAEAKLSVLVDPNLQANKKE 563
           +L E+ T   + Y      I L++ V+ ++E             K+              
Sbjct: 408 LLWEIATYGMSPY----PGIDLSQ-VYELLEKDYRMERPEGCPEKV-------------- 448

Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
              + +M   AC    P  RPS AE+      +
Sbjct: 449 ---YELM--RACWQWNPSDRPSFAEIHQAFETM 476

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  133 bits (337), Expect = 2e-34
 Identities = 61/281 (21%), Positives = 106/281 (37%), Gaps = 57/281 (20%)

Query: 339 GSVFRGIINGST--VAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHDGVF 388
           G VF G +      VA+K  R ++         +E  +LK+ +H N++ L G C      
Sbjct: 128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           Y+V E ++ G    +L  +     +      ++  D A G+ YL        +H+D+++ 
Sbjct: 188 YIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAAR 242

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY-----MAPEYMEYGLVTPEM 503
           N L+ +    K+++F   R     +  Y     A G          APE + YG  + E 
Sbjct: 243 NCLVTEKNVLKISDFGMSR--EEADGVY----AASGGLRQVPVKWTAPEALNYGRYSSES 296

Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGG-------NAEAKLSVLVDPN 556
           D ++FG++L E  +   + Y      +   +     VE G            +       
Sbjct: 297 DVWSFGILLWETFSLGASPY----PNLSNQQ-TREFVEKGGRLPCPELCPDAV------- 344

Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
                       +M    C A EP  RPS + +   L  I+
Sbjct: 345 ----------FRLM--EQCWAYEPGQRPSFSTIYQELQSIR 373

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  129 bits (326), Expect = 9e-34
 Identities = 64/271 (23%), Positives = 114/271 (42%), Gaps = 47/271 (17%)

Query: 339 GSVFRGIINGSTVAIK-----CMRRSISKEVNLLKKINHFNLINLFGAC-EHDGVFYLVY 392
           G V  G   G+ VA+K        ++   E +++ ++ H NL+ L G   E  G  Y+V 
Sbjct: 35  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94

Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           E+M  GSL D+L + R    +  +C  + +LDV   + YL       +VH+D+++ N+L+
Sbjct: 95  EYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLV 150

Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
            ++  AK+++F   + A   +      K  V    + APE +     + + D ++FG++L
Sbjct: 151 SEDNVAKVSDFGLTKEASSTQDT---GKLPV---KWTAPEALREKKFSTKSDVWSFGILL 204

Query: 513 LELITGKEAAYKQDGEEILLAEAVFSMVEGG-------NAEAKLSVLVDPNLQANKKEIA 565
            E+ +     Y      I L + V   VE G            +                
Sbjct: 205 WEIYSFGRVPY----PRIPLKD-VVPRVEKGYKMDAPDGCPPAV---------------- 243

Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            + +M    C   +   RPS  ++   L  I
Sbjct: 244 -YEVM--KNCWHLDAAMRPSFLQLREQLEHI 271

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  131 bits (330), Expect = 5e-33
 Identities = 75/272 (27%), Positives = 123/272 (45%), Gaps = 45/272 (16%)

Query: 339 GSVFRGIINGST-VAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++          +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 256

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E+M  GSL D+L K    +++       +A  +A G+ Y+       YVH+D+ + NIL
Sbjct: 257 TEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANIL 312

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           + +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D ++FG++
Sbjct: 313 VGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 370

Query: 512 LLELITGKEAAYKQDGEEILLAEAVFSMVEGG-------NAEAKLSVLVDPNLQANKKEI 564
           L EL T     Y      ++  E V   VE G            L               
Sbjct: 371 LTELTTKGRVPY----PGMVNRE-VLDQVERGYRMPCPPECPESL--------------- 410

Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
             H +M    C  +EPE RP+   + + L   
Sbjct: 411 --HDLM--CQCWRKEPEERPTFEYLQAFLEDY 438

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  131 bits (332), Expect = 7e-33
 Identities = 75/272 (27%), Positives = 123/272 (45%), Gaps = 45/272 (16%)

Query: 339 GSVFRGIINGST-VAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++          +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 281 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 339

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E+M  GSL D+L K    +++       +A  +A G+ Y+       YVH+D+ + NIL
Sbjct: 340 TEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANIL 395

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           + +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D ++FG++
Sbjct: 396 VGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 453

Query: 512 LLELITGKEAAYKQDGEEILLAEAVFSMVEGG-------NAEAKLSVLVDPNLQANKKEI 564
           L EL T     Y      ++  E V   VE G            L               
Sbjct: 454 LTELTTKGRVPY----PGMVNRE-VLDQVERGYRMPCPPECPESL--------------- 493

Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
             H +M    C  +EPE RP+   + + L   
Sbjct: 494 --HDLM--CQCWRKEPEERPTFEYLQAFLEDY 521

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  128 bits (323), Expect = 9e-33
 Identities = 59/265 (22%), Positives = 102/265 (38%), Gaps = 42/265 (15%)

Query: 339 GSVFRG--IINGSTVAIKCM---------RRSISKEVNLLKKINHFNLINLFGACEHDGV 387
           G         +G    IK +         R    +EV +L  + H N++    + E +G 
Sbjct: 38  GKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS 97

Query: 388 FYLVYEFMENGSLSDWLHKKR---YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
            Y+V ++ E G L   ++ ++   + E           + +   L ++H   D   +H+D
Sbjct: 98  LYIVMDYCEGGDLFKRINAQKGVLFQEDQIL----DWFVQICLALKHVH---DRKILHRD 150

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           I S NI L K+   +L +F   R      S     +  +GT  Y++PE  E      + D
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIARVL---NSTVELARACIGTPYYLSPEICENKPYNNKSD 207

Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +A G VL EL T K A          +   V  ++ G  +   +S+    +L+      
Sbjct: 208 IWALGCVLYELCTLKHAFEAGS-----MKNLVLKIISG--SFPPVSLHYSYDLR------ 254

Query: 565 AHHLIMLCLACIAREPESRPSMAEV 589
              L+        R P  RPS+  +
Sbjct: 255 --SLVSQLF---KRNPRDRPSVNSI 274

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (326), Expect = 1e-32
 Identities = 53/264 (20%), Positives = 105/264 (39%), Gaps = 38/264 (14%)

Query: 341 VFRGIINGSTVAIKCMRRS----ISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFM 395
           V+RG+ +   VA+K +         +EV LL++ + H N+I  F   +     Y+  E  
Sbjct: 41  VYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100

Query: 396 ENGSLSDWLHKK--RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL- 452
              +L +++ +K   +           +      GL +LH+      VH+D+   NIL+ 
Sbjct: 101 A-ATLQEYVEQKDFAHLGLEPIT----LLQQTTSGLAHLHSL---NIVHRDLKPHNILIS 152

Query: 453 ----DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---YGLVTPEMDT 505
                  ++A +++F   +        +S      GT G++APE +        T  +D 
Sbjct: 153 MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDI 212

Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++ G V   +I+     + +  +          ++   + +         + + ++  IA
Sbjct: 213 FSAGCVFYYVISEGSHPFGKSLQRQA-----NILLGACSLDC-------LHPEKHEDVIA 260

Query: 566 HHLIMLCLACIAREPESRPSMAEV 589
             LI      IA +P+ RPS   V
Sbjct: 261 RELIE---KMIAMDPQKRPSAKHV 281

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  125 bits (317), Expect = 2e-32
 Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 45/272 (16%)

Query: 339 GSVFRGIINGST-VAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VA+K +++          E NL+K++ H  L+ L+     + + Y++
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 85

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E+MENGSL D+L K      ++ N    +A  +A G+ ++    +  Y+H+D+ + NIL
Sbjct: 86  TEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANIL 141

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           +   L  K+A+F   R  + E++ Y++ + A     + APE + YG  T + D ++FG++
Sbjct: 142 VSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199

Query: 512 LLELITGKEAAYKQDGEEILLAEAVFSMVEGG-------NAEAKLSVLVDPNLQANKKEI 564
           L E++T     Y      +   E V   +E G       N   +L               
Sbjct: 200 LTEIVTHGRIPY----PGMTNPE-VIQNLERGYRMVRPDNCPEEL--------------- 239

Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
             + +M    C    PE RP+   + S L   
Sbjct: 240 --YQLM--RLCWKERPEDRPTFDYLRSVLEDF 267

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  125 bits (316), Expect = 3e-32
 Identities = 71/291 (24%), Positives = 120/291 (41%), Gaps = 60/291 (20%)

Query: 339 GSVFRGIING-------STVAIK-------CMRRSISKEVNLLKKINHFNLINLFGACEH 384
           G VF               VA+K         R+   +E  LL  + H +++  +G C  
Sbjct: 29  GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD 88

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFR-------------IALDVAHGLHY 431
                +V+E+M++G L+ +L        +  + + R             IA  +A G+ Y
Sbjct: 89  GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVY 148

Query: 432 LHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG---- 487
           L       +VH+D+++ N L+  NL  K+ +F   R      + Y      VG +     
Sbjct: 149 L---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV--YSTDY----YRVGGHTMLPI 199

Query: 488 -YMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNA 545
            +M PE + Y   T E D ++FGV+L E+ T GK+  ++    E      V   +  G  
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------VIECITQGR- 252

Query: 546 EAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                VL  P  +   KE+  + +M  L C  REP+ R ++ E+   L  +
Sbjct: 253 -----VLERP--RVCPKEV--YDVM--LGCWQREPQQRLNIKEIYKILHAL 292

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  124 bits (313), Expect = 3e-32
 Identities = 66/277 (23%), Positives = 115/277 (41%), Gaps = 55/277 (19%)

Query: 339 GSVFRGIINGST-VAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V  G       VAIK +R          +E  ++ K++H  L+ L+G C       LV
Sbjct: 22  GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            EFME+G LSD+L  +R     +      + LDV  G+ YL    +   +H+D+++ N L
Sbjct: 82  TEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCL 136

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYMEYGLVTPEMDTY 506
           + +N   K+++F   R     +  Y+S+     T       + +PE   +   + + D +
Sbjct: 137 VGENQVIKVSDFGMTR--FVLDDQYTSS-----TGTKFPVKWASPEVFSFSRYSSKSDVW 189

Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGG-------NAEAKLSVLVDPNLQA 559
           +FGV++ E+ +  +  Y    E    +E V   +  G        A   +          
Sbjct: 190 SFGVLMWEVFSEGKIPY----ENRSNSE-VVEDISTGFRLYKPRLASTHV---------- 234

Query: 560 NKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                  + IM    C    PE RP+ + ++  L +I
Sbjct: 235 -------YQIM--NHCWRERPEDRPAFSRLLRQLAEI 262

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  125 bits (316), Expect = 4e-32
 Identities = 61/291 (20%), Positives = 113/291 (38%), Gaps = 58/291 (19%)

Query: 339 GSVFRGIINGS------TVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEH 384
           G V     + +       VA+K ++            +E+++L+ + H ++I   G CE 
Sbjct: 45  GKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104

Query: 385 DGV--FYLVYEFMENGSLSDWLHKKR--YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
            G     LV E++  GSL D+L +      + + +      A  +  G+ YLH      Y
Sbjct: 105 AGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAYLHAQ---HY 155

Query: 441 VHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYME 495
           +H+D+++ N+LLD +   K+ +F   ++       Y      V  +G     + APE ++
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-----VREDGDSPVFWYAPECLK 210

Query: 496 YGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLA--------EAVFSMVEGGNAE 546
                   D ++FGV L EL+T    +         L+           +  ++E G   
Sbjct: 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE-- 268

Query: 547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
                L  P       E+  + +M    C   E   RP+   ++  L  + 
Sbjct: 269 ----RLPRP--DKCPAEV--YHLM--KNCWETEASFRPTFENLIPILKTVH 309

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  125 bits (317), Expect = 5e-32
 Identities = 66/287 (22%), Positives = 115/287 (40%), Gaps = 57/287 (19%)

Query: 339 GSVFRGIING-------STVAIKCMRRSIS--------KEVNLLKKI-NHFNLINLFGAC 382
           G V      G         VA+K ++ +           E+ ++  +  H N++NL GAC
Sbjct: 60  GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119

Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR-----------FRIALDVAHGLHY 431
            H G   ++ E+   G L ++L +K                         +  VA G+ +
Sbjct: 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179

Query: 432 LHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG---- 487
           L        +H+D+++ N+LL     AK+ +F   R  +  +S Y      V  N     
Sbjct: 180 L---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD-IMNDSNYI-----VKGNARLPV 230

Query: 488 -YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE 546
            +MAPE +   + T + D +++G++L E+ +     Y      IL+    + +V+ G   
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG----ILVNSKFYKLVKDGY-- 284

Query: 547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                +  P      K I  + IM   AC A EP  RP+  ++ S L
Sbjct: 285 ----QMAQP--AFAPKNI--YSIM--QACWALEPTHRPTFQQICSFL 321

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  124 bits (313), Expect = 5e-32
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 55/278 (19%)

Query: 339 GSVFRGIINGST--VAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V+ G+    +  VA+K ++          KE  ++K+I H NL+ L G C  +  FY+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86

Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           + EFM  G+L D+L +    + VS      +A  ++  + YL       ++H+D+++ N 
Sbjct: 87  ITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNC 142

Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYMEYGLVTPEMDT 505
           L+ +N   K+A+F   R  +     Y++              + APE + Y   + + D 
Sbjct: 143 LVGENHLVKVADFGLSR--LMTGDTYTAH-----AGAKFPIKWTAPESLAYNKFSIKSDV 195

Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGG-------NAEAKLSVLVDPNLQ 558
           +AFGV+L E+ T   + Y      I L++ V+ ++E             K+         
Sbjct: 196 WAFGVLLWEIATYGMSPY----PGIDLSQ-VYELLEKDYRMERPEGCPEKV--------- 241

Query: 559 ANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                   + +M   AC    P  RPS AE+      +
Sbjct: 242 --------YELM--RACWQWNPSDRPSFAEIHQAFETM 269

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  122 bits (309), Expect = 1e-31
 Identities = 60/275 (21%), Positives = 116/275 (42%), Gaps = 51/275 (18%)

Query: 339 GSVFRGIINGST-VAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V  G   G   VA+K ++          +E   + K++H  L+  +G C  +   Y+V
Sbjct: 22  GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E++ NG L ++L        +  +    +  DV  G+ +L       ++H+D+++ N L
Sbjct: 82  TEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCL 136

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGLVTPEMDTYAF 508
           +D++L  K+++F   R     +  Y S+    GT     + APE   Y   + + D +AF
Sbjct: 137 VDRDLCVKVSDFGMTR--YVLDDQYVSSV---GTKFPVKWSAPEVFHYFKYSSKSDVWAF 191

Query: 509 GVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGG-------NAEAKLSVLVDPNLQANK 561
           G+++ E+ +  +  Y    +    +E V   V  G        A   +            
Sbjct: 192 GILMWEVFSLGKMPY----DLYTNSE-VVLKVSQGHRLYRPHLASDTI------------ 234

Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                + IM   +C    PE RP+  +++S++  +
Sbjct: 235 -----YQIM--YSCWHELPEKRPTFQQLLSSIEPL 262

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  123 bits (310), Expect = 2e-31
 Identities = 61/297 (20%), Positives = 119/297 (40%), Gaps = 60/297 (20%)

Query: 339 GSVFRGIING------STVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHD 385
           GSV     +         VA+K ++       R   +E+ +LK + H N++   G C   
Sbjct: 24  GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83

Query: 386 GV--FYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
           G     L+ E++  GSL D+L K +    + + + +         +  G+ YL       
Sbjct: 84  GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQICKGMEYLGTK---R 134

Query: 440 YVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYM 494
           Y+H+D+++ NIL++   R K+ +F   +   +++  +          G     + APE +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK-----EPGESPIFWYAPESL 189

Query: 495 EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI----------LLAEAVFSMVEGGN 544
                +   D ++FGVVL EL T  E +     E +          ++   +  +++   
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 249

Query: 545 AEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ 601
              +L     P       EI  ++IM    C       RPS  ++   + +I+ ++ 
Sbjct: 250 ---RL-----PRPDGCPDEI--YMIM--TECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  122 bits (309), Expect = 2e-31
 Identities = 56/275 (20%), Positives = 113/275 (41%), Gaps = 51/275 (18%)

Query: 339 GSVFRGIINGST-VAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V  G   G   VAIK ++          +E  ++  ++H  L+ L+G C      +++
Sbjct: 38  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E+M NG L ++L + R+           +  DV   + YL       ++H+D+++ N L
Sbjct: 98  TEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCL 152

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGLVTPEMDTYAF 508
           ++     K+++F   R     +  Y+S+    G+     +  PE + Y   + + D +AF
Sbjct: 153 VNDQGVVKVSDFGLSR--YVLDDEYTSSV---GSKFPVRWSPPEVLMYSKFSSKSDIWAF 207

Query: 509 GVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGG-------NAEAKLSVLVDPNLQANK 561
           GV++ E+ +  +  Y    E    +E     +  G        A  K+            
Sbjct: 208 GVLMWEIYSLGKMPY----ERFTNSE-TAEHIAQGLRLYRPHLASEKV------------ 250

Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                + IM   +C   + + RP+   ++S ++ +
Sbjct: 251 -----YTIM--YSCWHEKADERPTFKILLSNILDV 278

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  123 bits (311), Expect = 2e-31
 Identities = 73/301 (24%), Positives = 130/301 (43%), Gaps = 71/301 (23%)

Query: 339 GSVFRGIING-------STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACE 383
           G V +            +TVA+K ++ + S         E N+LK++NH ++I L+GAC 
Sbjct: 37  GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF---------------------RIA 422
            DG   L+ E+ + GSL  +L + R                                  A
Sbjct: 97  QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFA 156

Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
             ++ G+ YL    +   VH+D+++ NIL+ +  + K+++F   R  V EE  Y      
Sbjct: 157 WQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD-VYEEDSYV----- 207

Query: 483 VGTNG-----YMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAV 536
             + G     +MA E +   + T + D ++FGV+L E++T G         E       +
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER------L 261

Query: 537 FSMVEGGNAEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMK 595
           F++++ G+       +  P    N  +E+  + +M  L C  +EP+ RP  A++   L K
Sbjct: 262 FNLLKTGH------RMERP---DNCSEEM--YRLM--LQCWKQEPDKRPVFADISKDLEK 308

Query: 596 I 596
           +
Sbjct: 309 M 309

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  123 bits (311), Expect = 2e-31
 Identities = 77/290 (26%), Positives = 125/290 (43%), Gaps = 62/290 (21%)

Query: 339 GSVFRGIING----STVAIKCMRRSIS--------KEVNLLKKI-NHFNLINLFGACEHD 385
           G V +  I         AIK M+   S         E+ +L K+ +H N+INL GACEH 
Sbjct: 39  GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98

Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF-------------RIALDVAHGLHYL 432
           G  YL  E+  +G+L D+L K R  E                       A DVA G+ YL
Sbjct: 99  GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158

Query: 433 HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG----- 487
              +   ++H+D+++ NIL+ +N  AK+A+F       R +  Y        T G     
Sbjct: 159 ---SQKQFIHRDLAARNILVGENYVAKIADFGL----SRGQEVYVKK-----TMGRLPVR 206

Query: 488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA 547
           +MA E + Y + T   D +++GV+L E+++     Y       +    ++  +  G    
Sbjct: 207 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-----MTCAELYEKLPQGY--- 258

Query: 548 KLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
               L  P    N   E+  + +M    C   +P  RPS A+++ +L ++
Sbjct: 259 ---RLEKP---LNCDDEV--YDLM--RQCWREKPYERPSFAQILVSLNRM 298

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  122 bits (309), Expect = 3e-31
 Identities = 58/267 (21%), Positives = 90/267 (33%), Gaps = 51/267 (19%)

Query: 339 GSVFRGI--INGSTVAIKCM---------RRSISKEVNLLKKI-NHFNLINLFGACEHDG 386
           G VF+     +G   A+K           R     EV   +K+  H   + L  A E  G
Sbjct: 71  GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130

Query: 387 VFYLVYEFMENGSLSDWLHK--KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           + YL  E     SL           PE   W        D    L +LH     G VH D
Sbjct: 131 ILYLQTELCG-PSLQQHCEAWGASLPEAQVWG----YLRDTLLALAHLH---SQGLVHLD 182

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME--YGLVTPE 502
           +   NI L    R KL +F  +           + +   G   YMAPE ++  YG     
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLVEL----GTAGAGEVQEGDPRYMAPELLQGSYG---TA 235

Query: 503 MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK 562
            D ++ G+ +LE+    E  +          E    + +G      L       L +   
Sbjct: 236 ADVFSLGLTILEVACNMELPHG--------GEGWQQLRQG-----YLPPEFTAGLSSE-- 280

Query: 563 EIAHHLIMLCLACIAREPESRPSMAEV 589
                ++++ L     +P+ R +   +
Sbjct: 281 --LRSVLVMML---EPDPKLRATAEAL 302

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  122 bits (309), Expect = 4e-31
 Identities = 62/292 (21%), Positives = 115/292 (39%), Gaps = 60/292 (20%)

Query: 339 GSVFRGIING------STVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHD 385
           GSV     +         VA+K ++       R   +E+ +LK + H N++   G C   
Sbjct: 55  GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114

Query: 386 GV--FYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
           G     L+ E++  GSL D+L K +    + + + +         +  G+ YL       
Sbjct: 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQICKGMEYLG---TKR 165

Query: 440 YVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYM 494
           Y+H+D+++ NIL++   R K+ +F   +   +++  Y          G     + APE +
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK-----EPGESPIFWYAPESL 220

Query: 495 EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI----------LLAEAVFSMVEGGN 544
                +   D ++FGVVL EL T  E +     E +          ++   +  +++   
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280

Query: 545 AEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                  L  P       EI  ++IM    C       RPS  ++   + +I
Sbjct: 281 ------RLPRP--DGCPDEI--YMIM--TECWNNNVNQRPSFRDLALRVDQI 320

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  122 bits (308), Expect = 4e-31
 Identities = 56/292 (19%), Positives = 113/292 (38%), Gaps = 60/292 (20%)

Query: 339 GSVFRGII------NGSTVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEH 384
           G V            G  VA+K ++            KE+ +L+ + H N++   G C  
Sbjct: 35  GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 94

Query: 385 DGV--FYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDP 438
           DG     L+ EF+ +GSL ++L K +      + + +      A+ +  G+ YL      
Sbjct: 95  DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY------AVQICKGMDYLG---SR 145

Query: 439 GYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEY 493
            YVH+D+++ N+L++   + K+ +F   ++   ++  Y+        +      + APE 
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK-----DDRDSPVFWYAPEC 200

Query: 494 MEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLA--------EAVFSMVEGGN 544
           +         D ++FGV L EL+T     +        ++           + + ++ G 
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK 260

Query: 545 AEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                  L  P       E+  + +M    C   +P +R S   ++     +
Sbjct: 261 ------RLPCP--PNCPDEV--YQLM--RKCWEFQPSNRTSFQNLIEGFEAL 300

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  122 bits (308), Expect = 5e-31
 Identities = 66/295 (22%), Positives = 117/295 (39%), Gaps = 63/295 (21%)

Query: 339 GSVFRGIING-------STVAIKCMRRSIS--------KEVNLLKKI-NHFNLINLFGAC 382
           G V      G        TVA+K ++ S           E+ +L  + NH N++NL GAC
Sbjct: 37  GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96

Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR---------------FRIALDVAH 427
              G   ++ E+   G L ++L +KR     S                      +  VA 
Sbjct: 97  TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156

Query: 428 GLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG 487
           G+ +L        +H+D+++ NILL      K+ +F   R  ++ +S Y         N 
Sbjct: 157 GMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD-IKNDSNYVVK-----GNA 207

Query: 488 -----YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEG 542
                +MAPE +   + T E D +++G+ L EL +   + Y      + +    + M++ 
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY----PGMPVDSKFYKMIKE 263

Query: 543 GNAEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           G        ++ P    +   E+  + IM    C   +P  RP+  ++V  + K 
Sbjct: 264 GF------RMLSP---EHAPAEM--YDIM--KTCWDADPLKRPTFKQIVQLIEKQ 305

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  121 bits (306), Expect = 9e-31
 Identities = 67/289 (23%), Positives = 118/289 (40%), Gaps = 55/289 (19%)

Query: 339 GSVFRGIING-------STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACE 383
           G V+ G+  G       + VAIK +  + S         E +++K+ N  +++ L G   
Sbjct: 39  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR-------FRIALDVAHGLHYLHNCT 436
                 ++ E M  G L  +L   R     +            ++A ++A G+ YL+   
Sbjct: 99  QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--- 155

Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY-----MAP 491
              +VH+D+++ N ++ ++   K+ +F   R  + E   Y       G  G      M+P
Sbjct: 156 ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYR-----KGGKGLLPVRWMSP 209

Query: 492 EYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV 551
           E ++ G+ T   D ++FGVVL E+ T  E  Y+      L  E V   V  G       +
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-----LSNEQVLRFVMEGG------L 258

Query: 552 LVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD 599
           L  P    N    +    +M    C    P+ RPS  E++S++ +    
Sbjct: 259 LDKP---DNCPDML--FELM--RMCWQYNPKMRPSFLEIISSIKEEMEP 300

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  121 bits (307), Expect = 9e-31
 Identities = 62/287 (21%), Positives = 123/287 (42%), Gaps = 56/287 (19%)

Query: 339 GSVFRGIINGS------TVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEH 384
           G+V++G+           VAIK +R + S         E  ++  +++ ++  L G C  
Sbjct: 29  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRY----PEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
             V  L+ + M  G L D++ + +        ++W       + +A G++YL +      
Sbjct: 89  STV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RL 138

Query: 441 VHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYME 495
           VH+D+++ N+L+      K+ +F   +  +  E             G     +MA E + 
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAK-LLGAEEKEYHA-----EGGKVPIKWMALESIL 192

Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
           + + T + D +++GV + EL+T     Y    + I  +E + S++E G    +L     P
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPY----DGIPASE-ISSILEKGE---RL-----P 239

Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR 602
                  ++  ++IM    C   + +SRP   E++    K+  D QR
Sbjct: 240 QPPICTIDV--YMIM--RKCWMIDADSRPKFRELIIEFSKMARDPQR 282

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  121 bits (305), Expect = 1e-30
 Identities = 61/286 (21%), Positives = 113/286 (39%), Gaps = 55/286 (19%)

Query: 339 GSVFRGIINGS-----TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGAC-- 382
           GSV  G +         VA+K M+   S          E   +K  +H N+I L G C  
Sbjct: 48  GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107

Query: 383 ---EHDGVFYLVYEFMENGSLSDWLHKKRY---PEFVSWNCRFRIALDVAHGLHYLHNCT 436
              +      ++  FM+ G L  +L   R    P+ +      +  +D+A G+ YL   +
Sbjct: 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---S 164

Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAP 491
           +  ++H+D+++ N +L  ++   +A+F   +  +     Y       G        ++A 
Sbjct: 165 NRNFLHRDLAARNCMLRDDMTVCVADFGLSKK-IYSGDYYR-----QGRIAKMPVKWIAI 218

Query: 492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLS 550
           E +   + T + D +AFGV + E+ T G          E      ++  +  G+      
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------MYDYLLHGH------ 266

Query: 551 VLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            L  P  +    E+  + IM    C   +P  RP+ + +   L K+
Sbjct: 267 RLKQP--EDCLDEL--YEIMYS--CWRTDPLDRPTFSVLRLQLEKL 306

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  120 bits (304), Expect = 1e-30
 Identities = 59/271 (21%), Positives = 109/271 (40%), Gaps = 48/271 (17%)

Query: 339 GSVFRG--IINGSTVAIKCM----------RRSISKEVNLLKKINHFNLINLFGACEHDG 386
             V+R   +++G  VA+K +          R    KE++LLK++NH N+I  + +   D 
Sbjct: 46  SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105

Query: 387 VFYLVYEFMENGSLSDWL-----HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYV 441
              +V E  + G LS  +      K+  PE   W       + +   L ++H       +
Sbjct: 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK----YFVQLCSALEHMH---SRRVM 158

Query: 442 HKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---YGL 498
           H+DI   N+ +      KL +    R      S  ++  + VGT  YM+PE +    Y  
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYMSPERIHENGYNF 215

Query: 499 VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ 558
            +   D ++ G +L E+   + + +  D   +    ++   +E  +     S      L+
Sbjct: 216 KS---DIWSLGCLLYEMAALQ-SPFYGDKMNLY---SLCKKIEQCDYPPLPSDHYSEELR 268

Query: 559 ANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                    L+ +C+     +PE RP +  V
Sbjct: 269 --------QLVNMCI---NPDPEKRPDVTYV 288

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  120 bits (303), Expect = 2e-30
 Identities = 60/282 (21%), Positives = 116/282 (41%), Gaps = 55/282 (19%)

Query: 339 GSVFRGIINGS-----TVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGAC-EH 384
           G V+ G            AIK + R           +E  L++ +NH N++ L G     
Sbjct: 35  GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94

Query: 385 DGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
           +G+ +++  +M +G L  ++   +      + +S        L VA G+ YL    +  +
Sbjct: 95  EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS------FGLQVARGMEYL---AEQKF 145

Query: 441 VHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYME 495
           VH+D+++ N +LD++   K+A+F   R  + +   YS  +     +      + A E ++
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARD-ILDREYYSVQQ---HRHARLPVKWTALESLQ 201

Query: 496 YGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD 554
               T + D ++FGV+L EL+T G       D  +      +   +  G        L  
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD------LTHFLAQGR------RLPQ 249

Query: 555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           P  +     +  + +M    C   +P  RP+   +V  + +I
Sbjct: 250 P--EYCPDSL--YQVM--QQCWEADPAVRPTFRVLVGEVEQI 285

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  120 bits (304), Expect = 2e-30
 Identities = 72/290 (24%), Positives = 115/290 (39%), Gaps = 59/290 (20%)

Query: 339 GSVFRGIING-------STVAIK-------CMRRSISKEVNLLKKINHFNLINLFGACEH 384
           G VF    +          VA+K         R+   +E  LL  + H +++  FG C  
Sbjct: 55  GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE 114

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR------------FRIALDVAHGLHYL 432
                +V+E+M +G L+ +L        +                   +A  VA G+ YL
Sbjct: 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL 174

Query: 433 HNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG----- 487
                  +VH+D+++ N L+ + L  K+ +F   R        YS+    VG        
Sbjct: 175 ---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI------YSTDYYRVGGRTMLPIR 225

Query: 488 YMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAE 546
           +M PE + Y   T E D ++FGVVL E+ T GK+  Y+    E          +  G   
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE------AIDCITQGR-- 277

Query: 547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                L  P  +A   E+  + IM    C  REP+ R S+ +V + L  +
Sbjct: 278 ----ELERP--RACPPEV--YAIM--RGCWQREPQQRHSIKDVHARLQAL 317

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  120 bits (303), Expect = 2e-30
 Identities = 61/287 (21%), Positives = 116/287 (40%), Gaps = 56/287 (19%)

Query: 339 GSVFRGIINGS-----TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGAC-- 382
           GSV    +         VA+K ++  I          +E   +K+ +H ++  L G    
Sbjct: 37  GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96

Query: 383 ----EHDGVFYLVYEFMENGSLSDWLHKKRYPE---FVSWNCRFRIALDVAHGLHYLHNC 435
                   +  ++  FM++G L  +L   R  E    +      R  +D+A G+ YL   
Sbjct: 97  SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL--- 153

Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMA 490
           +   ++H+D+++ N +L +++   +A+F   R  +     Y       G        ++A
Sbjct: 154 SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK-IYSGDYYR-----QGCASKLPVKWLA 207

Query: 491 PEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL 549
            E +   L T   D +AFGV + E++T G+      +  E      +++ + GGN     
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------IYNYLIGGN----- 256

Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
             L  P      +E+  + +M    C + +P+ RPS   +   L  I
Sbjct: 257 -RLKQP--PECMEEV--YDLMYQ--CWSADPKQRPSFTCLRMELENI 296

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  119 bits (301), Expect = 3e-30
 Identities = 64/284 (22%), Positives = 124/284 (43%), Gaps = 55/284 (19%)

Query: 339 GSVFRGIINGS----TVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHD 385
           G+V +G         TVA+K ++   +          E N+++++++  ++ + G CE +
Sbjct: 31  GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE 90

Query: 386 GVFYLVYEFMENGSLSDWLHKKRY---PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
               LV E  E G L+ +L + R+      +           V+ G+ YL       +VH
Sbjct: 91  SW-MLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMKYLEES---NFVH 140

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYMEYG 497
           +D+++ N+LL     AK+++F   ++   +E+ Y +      T+G     + APE + Y 
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ-----THGKWPVKWYAPECINYY 195

Query: 498 LVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN 556
             + + D ++FGV++ E  + G++      G E      V +M+E G    ++       
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGE---RM-----GC 241

Query: 557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV 600
                +E+  + +M    C   + E+RP  A V   L     DV
Sbjct: 242 PAGCPREM--YDLM--NLCWTYDVENRPGFAAVELRLRNYYYDV 281

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  120 bits (303), Expect = 3e-30
 Identities = 72/296 (24%), Positives = 123/296 (41%), Gaps = 66/296 (22%)

Query: 339 GSVFRGIING---------STVAIKCMRRSIS--------KEVNLLKKI-NHFNLINLFG 380
           G V      G          TVA+K ++   +         E+ ++K I  H N+INL G
Sbjct: 49  GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108

Query: 381 ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR-------------FRIALDVAH 427
           AC  DG  Y++ E+   G+L ++L  +R P                           +A 
Sbjct: 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 168

Query: 428 GLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG 487
           G+ YL        +H+D+++ N+L+ +N   K+A+F   R  +     Y        TNG
Sbjct: 169 GMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD-INNIDYYK-----KTTNG 219

Query: 488 -----YMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVE 541
                +MAPE +   + T + D ++FGV++ E+ T G         EE      +F +++
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------LFKLLK 273

Query: 542 GGNAEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            G+       +  P   AN   E+  +++M    C    P  RP+  ++V  L +I
Sbjct: 274 EGH------RMDKP---ANCTNEL--YMMM--RDCWHAVPSQRPTFKQLVEDLDRI 316

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  120 bits (303), Expect = 3e-30
 Identities = 64/299 (21%), Positives = 115/299 (38%), Gaps = 66/299 (22%)

Query: 339 GSVFRGIING-------STVAIKCMRRSIS--------KEVNLLKKI-NHFNLINLFGAC 382
           G V      G         VA+K ++             E+ ++ ++ +H N++NL GAC
Sbjct: 59  GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118

Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFR--------------------IA 422
              G  YL++E+   G L ++L  KR                                 A
Sbjct: 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 178

Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
             VA G+ +L        VH+D+++ N+L+      K+ +F   R  +  +S Y      
Sbjct: 179 YQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD-IMSDSNYVVR--- 231

Query: 483 VGTNG-----YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVF 537
              N      +MAPE +  G+ T + D +++G++L E+ +     Y      I +    +
Sbjct: 232 --GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY----PGIPVDANFY 285

Query: 538 SMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            +++ G        +  P      +EI  ++IM   +C A +   RPS   + S L   
Sbjct: 286 KLIQNGF------KMDQP--FYATEEI--YIIM--QSCWAFDSRKRPSFPNLTSFLGCQ 332

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  120 bits (302), Expect = 4e-30
 Identities = 61/291 (20%), Positives = 113/291 (38%), Gaps = 59/291 (20%)

Query: 339 GSVFRGIINGS------TVAIKCMRRSIS-------KEVNLLKKINHFNLINLFGACEHD 385
           GSV     +         VA+K ++ S         +E+ +LK ++   ++   G     
Sbjct: 37  GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96

Query: 386 GV--FYLVYEFMENGSLSDWLHKKRY----PEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
           G     LV E++ +G L D+L + R        + +      +  +  G+ YL +     
Sbjct: 97  GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY------SSQICKGMEYLGSR---R 147

Query: 440 YVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYM 494
            VH+D+++ NIL++     K+A+F   +    ++  Y          G     + APE +
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR-----EPGQSPIFWYAPESL 202

Query: 495 EYGLVTPEMDTYAFGVVLLELIT---------GKEAAYKQDGEEILLAEAVFSMVEGGNA 545
              + + + D ++FGVVL EL T          +         ++     +  ++E G  
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ- 261

Query: 546 EAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                 L  P   A   E+  H +M    C A  P+ RPS + +   L  +
Sbjct: 262 -----RLPAP--PACPAEV--HELM--KLCWAPSPQDRPSFSALGPQLDML 301

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  122 bits (308), Expect = 4e-30
 Identities = 68/272 (25%), Positives = 116/272 (42%), Gaps = 45/272 (16%)

Query: 339 GSVFRGIINGST-VAIKCMRRSIS------KEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+    N  T VA+K M+           E N++K + H  L+ L      + + Y++
Sbjct: 202 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YII 260

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            EFM  GSL D+L K               +  +A G+ ++       Y+H+D+ + NIL
Sbjct: 261 TEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANIL 316

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           +  +L  K+A+F   R  V E++ Y++ + A     + APE + +G  T + D ++FG++
Sbjct: 317 VSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGIL 374

Query: 512 LLELITGKEAAYKQDGEEILLAEAVFSMVEGG-------NAEAKLSVLVDPNLQANKKEI 564
           L+E++T     Y      +   E V   +E G       N   +L               
Sbjct: 375 LMEIVTYGRIPY----PGMSNPE-VIRALERGYRMPRPENCPEEL--------------- 414

Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
             + IM  + C    PE RP+   + S L   
Sbjct: 415 --YNIM--MRCWKNRPEERPTFEYIQSVLDDF 442

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  119 bits (300), Expect = 4e-30
 Identities = 56/289 (19%), Positives = 108/289 (37%), Gaps = 65/289 (22%)

Query: 339 GSVF--RGIINGSTVAIKCMRRS------ISKEVNLLKKINHFNLINLFGA--------- 381
           G V   R  ++    AIK +R +      I  EV LL  +NH  ++  + A         
Sbjct: 20  GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79

Query: 382 ----CEHDGVFYLVYEFMENGSLSDWLHKKRY--PEFVSWNCRFRIALDVAHGLHYLHNC 435
                +     ++  E+ ENG+L D +H +         W    R+   +   L Y+H+ 
Sbjct: 80  PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----RLFRQILEALSYIHSQ 135

Query: 436 TDPGYVHKDISSGNILLDKNLRAKLANF-----------SFVRSAVREESGYSSTKTAVG 484
              G +H+D+   NI +D++   K+ +F                +        +  +A+G
Sbjct: 136 ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG 192

Query: 485 TNGYMAPEYME----YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMV 540
           T  Y+A E ++    Y     ++D Y+ G++  E+I       ++          +   +
Sbjct: 193 TAMYVATEVLDGTGHYN---EKIDMYSLGIIFFEMIYPFSTGMERV--------NILKKL 241

Query: 541 EGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
              + E        P+   NK ++   +I L +     +P  RP    +
Sbjct: 242 RSVSIE------FPPDFDDNKMKVEKKIIRLLI---DHDPNKRPGARTL 281

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  120 bits (304), Expect = 5e-30
 Identities = 72/296 (24%), Positives = 123/296 (41%), Gaps = 66/296 (22%)

Query: 339 GSVFRGIING---------STVAIKCMRRSIS--------KEVNLLKKI-NHFNLINLFG 380
           G V      G          TVA+K ++   +         E+ ++K I  H N+INL G
Sbjct: 95  GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154

Query: 381 ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR-------------FRIALDVAH 427
           AC  DG  Y++ E+   G+L ++L  +R P                           +A 
Sbjct: 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 214

Query: 428 GLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG 487
           G+ YL        +H+D+++ N+L+ +N   K+A+F   R  +     Y        TNG
Sbjct: 215 GMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD-INNIDYYK-----KTTNG 265

Query: 488 -----YMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVE 541
                +MAPE +   + T + D ++FGV++ E+ T G         EE      +F +++
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------LFKLLK 319

Query: 542 GGNAEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            G+       +  P   AN   E+  +++M    C    P  RP+  ++V  L +I
Sbjct: 320 EGH------RMDKP---ANCTNEL--YMMM--RDCWHAVPSQRPTFKQLVEDLDRI 362

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  118 bits (298), Expect = 5e-30
 Identities = 61/278 (21%), Positives = 112/278 (40%), Gaps = 64/278 (23%)

Query: 339 GSVFRG--IINGSTVAIKCM---RRSISKEVNLLKKINHFNLINLFGA------------ 381
           G VF+    I+G T  IK +        +EV  L K++H N+++  G             
Sbjct: 25  GQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84

Query: 382 ----CEHDGVFYLVYEFMENGSLSDWLHKKR---YPEFVSWNCRFRIALDVAHGLHYLHN 434
                      ++  EF + G+L  W+ K+R     + ++      +   +  G+ Y+H 
Sbjct: 85  KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL----ELFEQITKGVDYIH- 139

Query: 435 CTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM 494
                 +++D+   NI L    + K+ +F  V S             + GT  YM+PE +
Sbjct: 140 --SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL----KNDGKRTRSKGTLRYMSPEQI 193

Query: 495 E---YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV 551
               YG    E+D YA G++L EL+   + A++            F+ +  G     +S 
Sbjct: 194 SSQDYG---KEVDLYALGLILAELLHVCDTAFE--------TSKFFTDLRDG----IISD 238

Query: 552 LVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
           + D   +         L+   L   +++PE RP+ +E+
Sbjct: 239 IFDKKEK--------TLLQKLL---SKKPEDRPNTSEI 265

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  119 bits (300), Expect = 8e-30
 Identities = 66/289 (22%), Positives = 111/289 (38%), Gaps = 55/289 (19%)

Query: 339 GSVFRGIING-------STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACE 383
           G V+ G ++G         VA+K +    S         E  ++ K NH N++   G   
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++      +A D+A G  YL    +  
Sbjct: 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENH 160

Query: 440 YVHKDISSGNILLDK---NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY-----MAP 491
           ++H+DI++ N LL        AK+ +F   R      + Y       G         M P
Sbjct: 161 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRASY----YRKGGCAMLPVKWMPP 214

Query: 492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLS 550
           E    G+ T + DT++FGV+L E+ + G      +  +E      V   V  G       
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEFVTSGG------ 262

Query: 551 VLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD 599
            +  P  +     +  + IM    C   +PE RP+ A ++  +     D
Sbjct: 263 RMDPP--KNCPGPV--YRIM--TQCWQHQPEDRPNFAIILERIEYCTQD 305

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  118 bits (298), Expect = 8e-30
 Identities = 64/282 (22%), Positives = 120/282 (42%), Gaps = 55/282 (19%)

Query: 339 GSVFRGIINGS-----TVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +  +       A+K + R            E  ++K  +H N+++L G C   
Sbjct: 39  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98

Query: 385 DGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
           +G   +V  +M++G L +++  +       + +         L VA G+ YL       +
Sbjct: 99  EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQVAKGMKYL---ASKKF 149

Query: 441 VHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYME 495
           VH+D+++ N +LD+    K+A+F   R  + ++  YS       T       +MA E ++
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNK---TGAKLPVKWMALESLQ 205

Query: 496 YGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD 554
               T + D ++FGV+L EL+T G       +  +      +   +  G        L+ 
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGR------RLLQ 253

Query: 555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           P  +     +  + +M  L C   + E RPS +E+VS +  I
Sbjct: 254 P--EYCPDPL--YEVM--LKCWHPKAEMRPSFSELVSRISAI 289

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  118 bits (297), Expect = 8e-30
 Identities = 57/283 (20%), Positives = 118/283 (41%), Gaps = 61/283 (21%)

Query: 339 GSVFRGIINGST----VAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHDG 386
           GSV +G+         VAIK +++           +E  ++ ++++  ++ L G C+ + 
Sbjct: 24  GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA 83

Query: 387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
           +  LV E    G L  +L  KR  E +  +    +   V+ G+ YL    +  +VH+D++
Sbjct: 84  L-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLA 137

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYMEYGLVTP 501
           + N+LL     AK+++F   ++   ++S Y++      + G     + APE + +   + 
Sbjct: 138 ARNVLLVNRHYAKISDFGLSKALGADDSYYTAR-----SAGKWPLKWYAPECINFRKFSS 192

Query: 502 EMDTYAFGVVLLELITGKEAAYKQ-DGEEILLAEAVFSMVEGG-------NAEAKLSVLV 553
             D +++GV + E ++  +  YK+  G E++      + +E G           +L    
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------AFIEQGKRMECPPECPPEL---- 242

Query: 554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                        + +M    C   + E RP    V   +   
Sbjct: 243 -------------YALM--SDCWIYKWEDRPDFLTVEQRMRAC 270

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  118 bits (297), Expect = 9e-30
 Identities = 61/289 (21%), Positives = 110/289 (38%), Gaps = 61/289 (21%)

Query: 339 GSVFRGIING-------STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACE 383
           G V++G + G         VAIK ++             E  L  ++ H N++ L G   
Sbjct: 23  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 82

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFR-------------IALDVAHGLH 430
            D    +++ +  +G L ++L  +     V      R             +   +A G+ 
Sbjct: 83  KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME 142

Query: 431 YLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG--- 487
           YL   +    VHKD+++ N+L+   L  K+++    R  V     Y      +  N    
Sbjct: 143 YL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE-VYAADYYK-----LLGNSLLP 193

Query: 488 --YMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGN 544
             +MAPE + YG  + + D +++GVVL E+ + G +       ++      V  M+    
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------VVEMIRNRQ 247

Query: 545 AEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
                 VL  P        +  + +M  + C    P  RP   ++ S L
Sbjct: 248 ------VLPCP--DDCPAWV--YALM--IECWNEFPSRRPRFKDIHSRL 284

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  119 bits (300), Expect = 1e-29
 Identities = 71/300 (23%), Positives = 121/300 (40%), Gaps = 69/300 (23%)

Query: 339 GSVFRGIING-------STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACE 383
           G VF+    G       + VA+K ++   S        +E  L+ + ++ N++ L G C 
Sbjct: 61  GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFR---------------------IA 422
                 L++E+M  G L+++L         S +                         IA
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180

Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
             VA G+ YL   ++  +VH+D+++ N L+ +N+  K+A+F   R+ +     Y      
Sbjct: 181 RQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN-IYSADYYK----- 231

Query: 483 VGTNGY-----MAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAV 536
              N       M PE + Y   T E D +A+GVVL E+ + G +  Y    EE      V
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE------V 285

Query: 537 FSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
              V  GN      +L  P  +    E+  + +M    C ++ P  RPS   +   L ++
Sbjct: 286 IYYVRDGN------ILACP--ENCPLEL--YNLM--RLCWSKLPADRPSFCSIHRILQRM 333

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  118 bits (297), Expect = 2e-29
 Identities = 66/294 (22%), Positives = 117/294 (39%), Gaps = 62/294 (21%)

Query: 339 GSVFRGIING-------STVAIKCMRRSIS--------KEVNLLKKI-NHFNLINLFGAC 382
           G V      G        TVA+K ++   +         E+ +L  I +H N++NL GAC
Sbjct: 41  GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100

Query: 383 -EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFR-------------IALDVAHG 428
            +  G   ++ EF + G+LS +L  KR                          +  VA G
Sbjct: 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160

Query: 429 LHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG- 487
           + +L        +H+D+++ NILL +    K+ +F   R  + ++  Y         +  
Sbjct: 161 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYV-----RKGDAR 211

Query: 488 ----YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGG 543
               +MAPE +   + T + D ++FGV+L E+ +   + Y      + + E     ++ G
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRRLKEG 267

Query: 544 NAEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                   +  P        E+  +  M  L C   EP  RP+ +E+V  L  +
Sbjct: 268 T------RMRAP---DYTTPEM--YQTM--LDCWHGEPSQRPTFSELVEHLGNL 308

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  118 bits (298), Expect = 2e-29
 Identities = 67/289 (23%), Positives = 112/289 (38%), Gaps = 55/289 (19%)

Query: 339 GSVFRGIING-------STVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACE 383
           G V+ G ++G         VA+K +    S         E  ++ K NH N++   G   
Sbjct: 85  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                +++ E M  G L  +L + R     P  ++      +A D+A G  YL    +  
Sbjct: 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENH 201

Query: 440 YVHKDISSGNILLDK---NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY-----MAP 491
           ++H+DI++ N LL        AK+ +F   R      +GY       G         M P
Sbjct: 202 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRAGY----YRKGGCAMLPVKWMPP 255

Query: 492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLS 550
           E    G+ T + DT++FGV+L E+ + G      +  +E      V   V  G       
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEFVTSGG------ 303

Query: 551 VLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD 599
            +  P  +     +  + IM    C   +PE RP+ A ++  +     D
Sbjct: 304 RMDPP--KNCPGPV--YRIM--TQCWQHQPEDRPNFAIILERIEYCTQD 346

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  119 bits (299), Expect = 2e-29
 Identities = 61/323 (18%), Positives = 113/323 (34%), Gaps = 61/323 (18%)

Query: 339 GSVFRGI--INGSTVAIKCM---------RRSISKEVNLLKKINHFNLINLFGACEHDGV 387
            +V        G  V ++ +            +  E+++ K  NH N++        D  
Sbjct: 41  MTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
            ++V  FM  GS  D L    + + ++      I   V   L Y+H+    GYVH+ + +
Sbjct: 101 LWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKA 156

Query: 448 GNILLDKNLRAKLANF----SFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--TP 501
            +IL+  + +  L+      S +    R+   +   K +V    +++PE ++  L     
Sbjct: 157 SHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA 216

Query: 502 EMDTYAFGVVLLELITGK-----------------------EAAYKQDGEEILLAEAVFS 538
           + D Y+ G+   EL  G                                EE+ ++ +   
Sbjct: 217 KSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSV 276

Query: 539 MVEGGNAEAKLSVLVDPNLQANKKEIA-------HHLIMLCLACIAREPESRPSMAEVVS 591
              G +     S     N  +             HH +  CL    R P++RPS     S
Sbjct: 277 ANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL---QRNPDARPS----AS 329

Query: 592 TLMK---IQLDVQRSQTLLLERI 611
           TL+     +   +R+   L E +
Sbjct: 330 TLLNHSFFKQIKRRASEALPELL 352

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  118 bits (298), Expect = 3e-29
 Identities = 72/296 (24%), Positives = 124/296 (41%), Gaps = 66/296 (22%)

Query: 339 GSVFRGIING---------STVAIKCMRRSIS--------KEVNLLKKI-NHFNLINLFG 380
           G V      G         + VA+K ++   +         E+ ++K I  H N+INL G
Sbjct: 83  GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 142

Query: 381 ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR-------------FRIALDVAH 427
           AC  DG  Y++ E+   G+L ++L  +R P                        A  VA 
Sbjct: 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 202

Query: 428 GLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG 487
           G+ YL        +H+D+++ N+L+ ++   K+A+F   R  +     Y        TNG
Sbjct: 203 GMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD-IHHIDYYK-----KTTNG 253

Query: 488 -----YMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVE 541
                +MAPE +   + T + D ++FGV+L E+ T G         EE      +F +++
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLK 307

Query: 542 GGNAEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            G+       +  P   +N   E+  +++M    C    P  RP+  ++V  L +I
Sbjct: 308 EGH------RMDKP---SNCTNEL--YMMM--RDCWHAVPSQRPTFKQLVEDLDRI 350

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  116 bits (293), Expect = 6e-29
 Identities = 41/189 (21%), Positives = 72/189 (38%), Gaps = 15/189 (7%)

Query: 339 GSVFRGI--INGSTVAIKCMR--RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEF 394
           G V R      G   A+K +R      +E+     ++   ++ L+GA        +  E 
Sbjct: 72  GEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131

Query: 395 MENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
           +E GSL   +      PE  +             GL YLH       +H D+ + N+LL 
Sbjct: 132 LEGGSLGQLIKQMGCLPEDRALY----YLGQALEGLEYLHTR---RILHGDVKADNVLLS 184

Query: 454 KN-LRAKLANF--SFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGV 510
            +  RA L +F  +             +     GT  +MAPE +       ++D ++   
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCC 244

Query: 511 VLLELITGK 519
           ++L ++ G 
Sbjct: 245 MMLHMLNGC 253

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  116 bits (293), Expect = 7e-29
 Identities = 64/288 (22%), Positives = 128/288 (44%), Gaps = 50/288 (17%)

Query: 339 GSVFRGIINGS------TVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEH 384
           G+V++G+           VAIK +R + S         E  ++  +++ ++  L G C  
Sbjct: 29  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRY----PEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
             V  L+ + M  G L D++ + +        ++W       + +A G++YL +      
Sbjct: 89  STV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RL 138

Query: 441 VHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST--KTAVGTNGYMAPEYMEYGL 498
           VH+D+++ N+L+      K+ +F   +    EE  Y +   K  +    +MA E + + +
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI---KWMALESILHRI 195

Query: 499 VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ 558
            T + D +++GV + EL+T     Y    + I  +E + S++E G    +L     P   
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPY----DGIPASE-ISSILEKGE---RL-----PQPP 242

Query: 559 ANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQTL 606
               ++  ++IM  + C   + +SRP   E++    K+  D QR   +
Sbjct: 243 ICTIDV--YMIM--VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 286

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  116 bits (292), Expect = 8e-29
 Identities = 55/298 (18%), Positives = 116/298 (38%), Gaps = 70/298 (23%)

Query: 339 GSVFRGIINGS------TVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEH 384
           G+V +G+           V IK +               +  +  ++H +++ L G C  
Sbjct: 27  GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG 86

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRY----PEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
             +  LV +++  GSL D + + R        ++W       + +A G++YL    + G 
Sbjct: 87  SSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYLE---EHGM 136

Query: 441 VHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYME 495
           VH+++++ N+LL    + ++A+F      +  +           +       +MA E + 
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVAD-LLPPDDKQLLY-----SEAKTPIKWMALESIH 190

Query: 496 YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGG-------NAEAK 548
           +G  T + D +++GV + EL+T     Y      + LAE V  ++E G            
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEPY----AGLRLAE-VPDLLEKGERLAQPQICTID 245

Query: 549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQTL 606
           +                 +++M  + C   +   RP+  E+ +   ++  D  R   +
Sbjct: 246 V-----------------YMVM--VKCWMIDENIRPTFKELANEFTRMARDPPRYLVI 284

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  115 bits (290), Expect = 1e-28
 Identities = 57/296 (19%), Positives = 103/296 (34%), Gaps = 54/296 (18%)

Query: 339 GSVF--RGIINGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGV-- 387
             V    G+ +G   A+K +       R    +E ++ +  NH N++ L   C  +    
Sbjct: 43  SYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102

Query: 388 --FYLVYEFMENGSLSDWL-----HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
              +L+  F + G+L + +           E         + L +  GL  +H     GY
Sbjct: 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL----WLLLGICRGLEAIH---AKGY 155

Query: 441 VHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST------KTAVGTNGYMAPEYM 494
            H+D+   NILL    +  L +   +  A     G               T  Y APE  
Sbjct: 156 AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELF 215

Query: 495 E---YGLVTPEMDTYAFGVVLLELITGKEA--AYKQDGEEILLAEAVFSMVEGGNAEAKL 549
               + ++    D ++ G VL  ++ G+       Q G+ + LA            + +L
Sbjct: 216 SVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-----------VQNQL 264

Query: 550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQT 605
           S+   P   +        L+   +     +P  RP +  ++S L  +Q       T
Sbjct: 265 SIPQSPRHSSA----LWQLLNSMM---TVDPHQRPHIPLLLSQLEALQPPAPGQHT 313

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  116 bits (293), Expect = 1e-28
 Identities = 67/279 (24%), Positives = 124/279 (44%), Gaps = 51/279 (18%)

Query: 339 GSVFRGIINGST-----VAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHD 385
           G V  G +   +     VAIK ++   +         E +++ + +H N+I L G     
Sbjct: 59  GEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118

Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
               +V E+MENGSL  +L K    +F +      +   +A G+ YL   +D GYVH+D+
Sbjct: 119 KPVMIVTEYMENGSLDSFLRKHD-AQF-TVIQLVGMLRGIASGMKYL---SDMGYVHRDL 173

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ NIL++ NL  K+++F   R    +     +T+       + +PE + Y   T   D 
Sbjct: 174 AARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233

Query: 506 YAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGG-------NAEAKLSVLVDPNL 557
           +++G+VL E+++ G+   ++   ++      V   V+ G       +  A L        
Sbjct: 234 WSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLPPPMDCPAAL-------- 279

Query: 558 QANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                    + +M  L C  ++  +RP   ++VS L K+
Sbjct: 280 ---------YQLM--LDCWQKDRNNRPKFEQIVSILDKL 307

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  114 bits (287), Expect = 2e-28
 Identities = 57/271 (21%), Positives = 99/271 (36%), Gaps = 45/271 (16%)

Query: 339 GSVF--RGIINGSTVAIKCM---------RRSISKEVNLLKKINHFNLINLFGA--CEHD 385
           G     R   +G  +  K +         ++ +  EVNLL+++ H N++  +       +
Sbjct: 20  GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 79

Query: 386 GVFYLVYEFMENGSLSDWL-----HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
              Y+V E+ E G L+  +      ++   E        R+   +   L   H  +D G+
Sbjct: 80  TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL----RVMTQLTLALKECHRRSDGGH 135

Query: 441 --VHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL 498
             +H+D+   N+ LD     KL +F   R         S  KT VGT  YM+PE M    
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKTFVGTPYYMSPEQMNRMS 192

Query: 499 VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ 558
              + D ++ G +L EL            +E+         +  G    ++       L 
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------AGKIREGKFR-RIPYRYSDELN 245

Query: 559 ANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                    +I   L     +   RPS+ E+
Sbjct: 246 --------EIITRML---NLKDYHRPSVEEI 265

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  116 bits (292), Expect = 2e-28
 Identities = 62/282 (21%), Positives = 118/282 (41%), Gaps = 55/282 (19%)

Query: 339 GSVFRGIINGS-----TVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +  +       A+K + R            E  ++K  +H N+++L G C   
Sbjct: 103 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162

Query: 385 DGVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
           +G   +V  +M++G L +++  +       + +         L VA G+ +L       +
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQVAKGMKFL---ASKKF 213

Query: 441 VHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYME 495
           VH+D+++ N +LD+    K+A+F   R     +  + S      T       +MA E ++
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHN--KTGAKLPVKWMALESLQ 269

Query: 496 YGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD 554
               T + D ++FGV+L EL+T G       +  +      +   +  G        L+ 
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGR------RLLQ 317

Query: 555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           P  +     +  + +M  L C   + E RPS +E+VS +  I
Sbjct: 318 P--EYCPDPL--YEVM--LKCWHPKAEMRPSFSELVSRISAI 353

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  114 bits (287), Expect = 2e-28
 Identities = 67/291 (23%), Positives = 124/291 (42%), Gaps = 57/291 (19%)

Query: 339 GSVFRGIINGST-----VAIKCMRRSIS----------KEVNLLKKINHFNLINLFGACE 383
           G V RG  +  +     VA+KC++  +           +EVN +  ++H NLI L+G   
Sbjct: 32  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRY----PEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
              +  +V E    GSL D L K +          +      A+ VA G+ YL +     
Sbjct: 92  TPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGMGYLESK---R 141

Query: 440 YVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYM 494
           ++H+D+++ N+LL      K+ +F  +R+  + +  Y         +      + APE +
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ-----EHRKVPFAWCAPESL 196

Query: 495 EYGLVTPEMDTYAFGVVLLELITGKEAAYKQ-DGEEILLAEAVFSMVEGGNAEAKLSVLV 553
           +    +   DT+ FGV L E+ T  +  +   +G +IL        ++          L 
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HKIDKEGE-----RLP 245

Query: 554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQ 604
            P  +   ++I  + +M  + C A +PE RP+   +   L++ Q    R++
Sbjct: 246 RP--EDCPQDI--YNVM--VQCWAHKPEDRPTFVALRDFLLEAQPTDMRAE 290

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  113 bits (286), Expect = 3e-28
 Identities = 54/285 (18%), Positives = 99/285 (34%), Gaps = 60/285 (21%)

Query: 339 GSVF--RGIINGSTVAIK--------CMRRSISKEVNLLKKINHFNLINLFGACEHD--- 385
           G VF  +  ++    AIK          R  + +EV  L K+ H  ++  F A       
Sbjct: 19  GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78

Query: 386 ---------GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                       Y+  +     +L DW++ +   E    +    I L +A  + +LH+  
Sbjct: 79  EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK- 137

Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVR---------SAVREESGYSSTKTAVGTNG 487
             G +H+D+   NI    +   K+ +F  V          + +     Y+     VGT  
Sbjct: 138 --GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKL 195

Query: 488 YMAPEYME---YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN 544
           YM+PE +    Y     ++D ++ G++L EL+       ++      +    F       
Sbjct: 196 YMSPEQIHGNSYS---HKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKF------- 245

Query: 545 AEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                     P L   K    + ++   L+     P  RP    +
Sbjct: 246 ----------PPLFTQKYPCEYVMVQDMLS---PSPMERPEAINI 277

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  113 bits (284), Expect = 5e-28
 Identities = 54/288 (18%), Positives = 111/288 (38%), Gaps = 72/288 (25%)

Query: 339 GSVFRGIINGST-----VAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHD 385
           G V+ G+          VA+K  ++  +         E  ++K ++H +++ L G  E +
Sbjct: 26  GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85

Query: 386 GVFYLVYEFMENGSLSDWLHKKRY----PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYV 441
              +++ E    G L  +L + +        V +      +L +   + YL +      V
Sbjct: 86  PT-WIIMELYPYGELGHYLERNKNSLKVLTLVLY------SLQICKAMAYLESI---NCV 135

Query: 442 HKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYMEY 496
           H+DI+  NIL+      KL +F   R  + +E  Y ++             +M+PE + +
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASV------TRLPIKWMSPESINF 188

Query: 497 GLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGG-------NAEAK 548
              T   D + F V + E+++ GK+  +  + ++++       ++E G            
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI------GVLEKGDRLPKPDLCPPV 242

Query: 549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           L                 + +M    C   +P  RP   E+V +L  +
Sbjct: 243 L-----------------YTLM--TRCWDYDPSDRPRFTELVCSLSDV 271

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  114 bits (287), Expect = 5e-28
 Identities = 59/275 (21%), Positives = 105/275 (38%), Gaps = 50/275 (18%)

Query: 339 GSVFRGI-INGSTVAIKCMRR---------SISKEVNLLKKINHFNL--INLFGACEHDG 386
             VF+ +       AIK +           S   E+  L K+   +   I L+     D 
Sbjct: 23  SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82

Query: 387 VFYLVYEFMENGSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
             Y+V E   N  L+ WL KK           R     ++   +H +H     G VH D+
Sbjct: 83  YIYMVMEC-GNIDLNSWLKKKKSIDP----WERKSYWKNMLEAVHTIHQH---GIVHSDL 134

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE-----------YM 494
              N L+      KL +F      ++ ++      + VGT  YM PE             
Sbjct: 135 KPANFLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 192

Query: 495 EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD 554
               ++P+ D ++ G +L  +  GK   ++Q   +I     + ++++  N E +   + +
Sbjct: 193 SKSKISPKSDVWSLGCILYYMTYGK-TPFQQIINQI---SKLHAIID-PNHEIEFPDIPE 247

Query: 555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
            +LQ         ++  CL    R+P+ R S+ E+
Sbjct: 248 KDLQ--------DVLKCCL---KRDPKQRISIPEL 271

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  113 bits (286), Expect = 5e-28
 Identities = 69/283 (24%), Positives = 122/283 (43%), Gaps = 58/283 (20%)

Query: 339 GSVFRGIINGST------VAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEH 384
           G V++G++  S+      VAIK ++   +         E  ++ + +H N+I L G    
Sbjct: 58  GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
                ++ E+MENG+L  +L +K      S      +   +A G+ YL    +  YVH+D
Sbjct: 118 YKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYL---ANMNYVHRD 172

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN---GYMAPEYMEYGLVTP 501
           +++ NIL++ NL  K+++F   R     E    +T T  G      + APE + Y   T 
Sbjct: 173 LAARNILVNSNLVCKVSDFGLSRVL---EDDPEATYTTSGGKIPIRWTAPEAISYRKFTS 229

Query: 502 EMDTYAFGVVLLELITGKEAAYKQ-DGEEILLAEAVFSMVEGG-------NAEAKLSVLV 553
             D ++FG+V+ E++T  E  Y +    E      V   +  G       +  + +    
Sbjct: 230 ASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDGFRLPTPMDCPSAI---- 279

Query: 554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                        + +M  + C  +E   RP  A++VS L K+
Sbjct: 280 -------------YQLM--MQCWQQERARRPKFADIVSILDKL 307

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  113 bits (285), Expect = 5e-28
 Identities = 63/288 (21%), Positives = 100/288 (34%), Gaps = 47/288 (16%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS--------ISKEVNLLKKINHFNLINLFGACEHDG-- 386
            +VFRG     G   AIK               +E  +LKK+NH N++ LF   E     
Sbjct: 23  ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82

Query: 387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
              L+ EF   GSL   L +      +  +    +  DV  G+++L      G VH++I 
Sbjct: 83  HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIK 139

Query: 447 SGNILL----DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--- 499
            GNI+     D     KL +F       RE        +  GT  Y+ P+  E  ++   
Sbjct: 140 PGNIMRVIGEDGQSVYKLTDFGA----ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKD 195

Query: 500 -----TPEMDTYAFGVVLLELITG-------------KEAAYKQDGEEILLAEAVFSMVE 541
                   +D ++ GV      TG             KE  YK    +   A +     E
Sbjct: 196 HQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAE 255

Query: 542 GGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
            G  +    + V  +L    + +   ++   L     + E      + 
Sbjct: 256 NGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL---EADQEKCWGFDQF 300

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  113 bits (285), Expect = 6e-28
 Identities = 69/284 (24%), Positives = 115/284 (40%), Gaps = 61/284 (21%)

Query: 339 GSVFRGIINGS-----TVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHD 385
           G V  G +         VAIK ++   +         E +++ + +H N+I L G     
Sbjct: 63  GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122

Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
            +  +V E+MENGSL  +L         +      +   V  G+ YL   +D GYVH+D+
Sbjct: 123 RLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYL---SDLGYVHRDL 177

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYMEYGLVT 500
           ++ N+L+D NL  K+++F   R    +     +T     T G     + APE + +   +
Sbjct: 178 AARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT-----TGGKIPIRWTAPEAIAFRTFS 232

Query: 501 PEMDTYAFGVVLLELITGKEAAYKQ-DGEEILLAEAVFSMVEGG-------NAEAKLSVL 552
              D ++FGVV+ E++   E  Y      +      V S VE G            L   
Sbjct: 233 SASDVWSFGVVMWEVLAYGERPYWNMTNRD------VISSVEEGYRLPAPMGCPHAL--- 283

Query: 553 VDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                         H +M  L C  ++   RP  +++VS L  +
Sbjct: 284 --------------HQLM--LDCWHKDRAQRPRFSQIVSVLDAL 311

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  112 bits (283), Expect = 1e-27
 Identities = 59/275 (21%), Positives = 106/275 (38%), Gaps = 50/275 (18%)

Query: 339 GSVFRGI-INGSTVAIKCMRR---------SISKEVNLLKKINHFNL--INLFGACEHDG 386
             VF+ +       AIK +           S   E+  L K+   +   I L+     D 
Sbjct: 42  SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101

Query: 387 VFYLVYEFMENGSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
             Y+V E   N  L+ WL KK        W  +     ++   +H +H     G VH D+
Sbjct: 102 YIYMVMEC-GNIDLNSWLKKKKSIDP---WERKS-YWKNMLEAVHTIHQH---GIVHSDL 153

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE-----------YM 494
              N L+      KL +F      ++ ++      + VGT  YM PE             
Sbjct: 154 KPANFLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 211

Query: 495 EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD 554
               ++P+ D ++ G +L  +  GK   ++Q   +I     + ++++  N E +   + +
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGK-TPFQQIINQI---SKLHAIID-PNHEIEFPDIPE 266

Query: 555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
            +LQ         ++  CL    R+P+ R S+ E+
Sbjct: 267 KDLQ--------DVLKCCL---KRDPKQRISIPEL 290

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  114 bits (288), Expect = 1e-27
 Identities = 57/279 (20%), Positives = 108/279 (38%), Gaps = 47/279 (16%)

Query: 341 VFRGIINGSTVAIKCMRRS----ISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFM 395
           VF+G   G  VA+K M          E+ LL +  +H N+I  + +   D   Y+  E  
Sbjct: 32  VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91

Query: 396 ENGSLSDWL-HKKRYPEFVSWNCRF---RIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
              +L D +  K    E +     +    +   +A G+ +LH+      +H+D+   NIL
Sbjct: 92  N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNIL 147

Query: 452 LD-------------KNLRAKLANFSFVRSAVREESGYSST-KTAVGTNGYMAPEYMEYG 497
           +              +NLR  +++F   +     +S + +      GT+G+ APE +E  
Sbjct: 148 VSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEES 207

Query: 498 LV-------TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLS 550
                    T  +D ++ G V   +++  +  +   G++      +            L 
Sbjct: 208 NNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF---GDKYSRESNII------RGIFSLD 258

Query: 551 VLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
            +   + ++   E A  LI      I  +P  RP+  +V
Sbjct: 259 EMKCLHDRSLIAE-ATDLIS---QMIDHDPLKRPTAMKV 293

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  114 bits (286), Expect = 1e-27
 Identities = 58/275 (21%), Positives = 105/275 (38%), Gaps = 50/275 (18%)

Query: 339 GSVFRGI-INGSTVAIKCMRR---------SISKEVNLLKKINHFNL--INLFGACEHDG 386
             VF+ +       AIK +           S   E+  L K+   +   I L+     D 
Sbjct: 70  SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129

Query: 387 VFYLVYEFMENGSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
             Y+V E   N  L+ WL KK        W  +     ++   +H +H     G VH D+
Sbjct: 130 YIYMVMEC-GNIDLNSWLKKKKSIDP---WERK-SYWKNMLEAVHTIHQH---GIVHSDL 181

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE-----------YM 494
              N L+      KL +F      ++ ++      + VG   YM PE             
Sbjct: 182 KPANFLIVDG-MLKLIDFGIAN-QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGK 239

Query: 495 EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD 554
               ++P+ D ++ G +L  +  GK   ++Q   +I     + ++++  N E +   + +
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGK-TPFQQIINQI---SKLHAIID-PNHEIEFPDIPE 294

Query: 555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
            +LQ         ++  CL    R+P+ R S+ E+
Sbjct: 295 KDLQ--------DVLKCCL---KRDPKQRISIPEL 318

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  111 bits (280), Expect = 2e-27
 Identities = 60/288 (20%), Positives = 109/288 (37%), Gaps = 72/288 (25%)

Query: 339 GSVFRGIINGS-----TVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHD 385
           G V +GI          VAIK  +   S        +E   +++ +H +++ L G    +
Sbjct: 29  GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 88

Query: 386 GVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYV 441
            V +++ E    G L  +L  ++        + +      A  ++  L YL       +V
Sbjct: 89  PV-WIIMELCTLGELRSFLQVRKYSLDLASLILY------AYQLSTALAYL---ESKRFV 138

Query: 442 HKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG-----YMAPEYMEY 496
           H+DI++ N+L+  N   KL +F   R  + + + Y ++K      G     +MAPE + +
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASK------GKLPIKWMAPESINF 191

Query: 497 GLVTPEMDTYAFGVVLLELITGKEAAYK-QDGEEILLAEAVFSMVEGG-------NAEAK 548
              T   D + FGV + E++      ++     +      V   +E G       N    
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMPPNCPPT 245

Query: 549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           L                 + +M    C A +P  RP   E+ + L  I
Sbjct: 246 L-----------------YSLM--TKCWAYDPSRRPRFTELKAQLSTI 274

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  116 bits (291), Expect = 2e-27
 Identities = 59/283 (20%), Positives = 110/283 (38%), Gaps = 62/283 (21%)

Query: 339 GSVFRGIINGS-----TVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHD 385
           G V +GI          VAIK  +   S        +E   +++ +H +++ L G    +
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 463

Query: 386 GVFYLVYEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYV 441
            V +++ E    G L  +L  ++        + +      A  ++  L YL +     +V
Sbjct: 464 PV-WIIMELCTLGELRSFLQVRKFSLDLASLILY------AYQLSTALAYLESK---RFV 513

Query: 442 HKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP 501
           H+DI++ N+L+  N   KL +F   R  + + + Y ++K  +    +MAPE + +   T 
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIK-WMAPESINFRRFTS 571

Query: 502 EMDTYAFGVVLLELITGKEAAYK-QDGEEILLAEAVFSMVEGG-------NAEAKLSVLV 553
             D + FGV + E++      ++     +      V   +E G       N    L    
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMPPNCPPTL---- 621

Query: 554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                        + +M    C A +P  RP   E+ + L  I
Sbjct: 622 -------------YSLM--TKCWAYDPSRRPRFTELKAQLSTI 649

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  110 bits (278), Expect = 3e-27
 Identities = 52/288 (18%), Positives = 98/288 (34%), Gaps = 72/288 (25%)

Query: 339 GSVFRGI--INGSTVAIKCM---------RRSISKEVNLLKKI-NHFNLINLFGACEHDG 386
           GSVF+ +  ++G   AIK            ++  +EV     +  H +++  F A   D 
Sbjct: 25  GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84

Query: 387 VFYLVYEFMENGSLSDWL-----HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYV 441
              +  E+   GSL+D +         + E    +    + L V  GL Y+H+      V
Sbjct: 85  HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD----LLLQVGRGLRYIHSM---SLV 137

Query: 442 HKDISSGNILLDKN-------------------LRAKLANFSFVRSAVREESGYSSTKTA 482
           H DI   NI + +                    +  K+ +   V          SS +  
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-------SSPQVE 190

Query: 483 VGTNGYMAPE-YMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVE 541
            G + ++A E   E     P+ D +A  + ++     +              +    + +
Sbjct: 191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR--------NGDQWHEIRQ 242

Query: 542 GGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
           G     +L     P +     +    L+ + +     +PE RPS   +
Sbjct: 243 G-----RL-----PRIPQVLSQEFTELLKVMI---HPDPERRPSAMAL 277

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  111 bits (279), Expect = 3e-27
 Identities = 44/196 (22%), Positives = 71/196 (36%), Gaps = 26/196 (13%)

Query: 339 GSVFRG--IINGSTVAIKCMRRSISKEVNLLK----------KINHFNLINLFGACEHDG 386
           G V+     +    VA+K M  ++S +               ++   +++ +    E DG
Sbjct: 48  GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107

Query: 387 VFYLVYEFMENGSLSDWLHKKR---YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHK 443
             Y+    +    L+  L ++     P  V       I   +   L   H     G  H+
Sbjct: 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAV------AIVRQIGSALDAAH---AAGATHR 158

Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           D+   NIL+  +  A L +F    +    +   +     VGT  YMAPE       T   
Sbjct: 159 DVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHATYRA 216

Query: 504 DTYAFGVVLLELITGK 519
           D YA   VL E +TG 
Sbjct: 217 DIYALTCVLYECLTGS 232

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  112 bits (282), Expect = 5e-27
 Identities = 64/296 (21%), Positives = 102/296 (34%), Gaps = 47/296 (15%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS--------ISKEVNLLKKINHFNLINLFGACEHDG-- 386
            +VFRG     G   AIK               +E  +LKK+NH N++ LF   E     
Sbjct: 23  ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82

Query: 387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
              L+ EF   GSL   L +      +  +    +  DV  G+++L      G VH++I 
Sbjct: 83  HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIK 139

Query: 447 SGNILL----DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV--- 499
            GNI+     D     KL +F       RE        +  GT  Y+ P+  E  ++   
Sbjct: 140 PGNIMRVIGEDGQSVYKLTDFGA----ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKD 195

Query: 500 -----TPEMDTYAFGVVLLELITG-------------KEAAYKQDGEEILLAEAVFSMVE 541
                   +D ++ GV      TG             KE  YK    +   A +     E
Sbjct: 196 HQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAE 255

Query: 542 GGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
            G  +    + V  +L    + +   ++   L     + E      +  +    I 
Sbjct: 256 NGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL---EADQEKCWGFDQFFAETSDIL 308

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  110 bits (277), Expect = 5e-27
 Identities = 56/288 (19%), Positives = 114/288 (39%), Gaps = 53/288 (18%)

Query: 339 GSVFRG--IINGSTVAIKCMRRSISKEVNLLKK----------INHFNLINLFGACEHDG 386
            +V+     I    VAIK +     ++   LK+          ++H N++++    E D 
Sbjct: 25  STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84

Query: 387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            +YLV E++E  +LS+++        +S +        +  G+ + H+      VH+DI 
Sbjct: 85  CYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM---RIVHRDIK 138

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
             NIL+D N   K+ +F   ++    E+  + T   +GT  Y +PE  +        D Y
Sbjct: 139 PQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIY 196

Query: 507 AFGVVLLELITGK---------EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNL 557
           + G+VL E++ G+           A K   + +                  ++  V  + 
Sbjct: 197 SIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV----------------PNVTTDVRKD- 239

Query: 558 QANKKEIAHHLIMLCLACIAREPESRP-SMAEVVSTLMKIQLDVQRSQ 604
                 I   L  + L    ++  +R  ++ E+   L  +  + + ++
Sbjct: 240 ------IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  110 bits (276), Expect = 5e-27
 Identities = 60/263 (22%), Positives = 106/263 (40%), Gaps = 36/263 (13%)

Query: 339 GSVFRGI--INGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G V+ G    N   +AIK +        + + +E+ L K + H N++   G+   +G   
Sbjct: 36  GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFR-IALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +  E +  GSLS  L + ++                +  GL YLH+      VH+DI   
Sbjct: 96  IFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGD 151

Query: 449 NILLD-KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE--YMEYGLVTPEMDT 505
           N+L++  +   K+++F    ++ R       T+T  GT  YMAPE             D 
Sbjct: 152 NVLINTYSGVLKISDFG---TSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADI 208

Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++ G  ++E+ TGK   + + GE      A+F +   G  +        P +  +    A
Sbjct: 209 WSLGCTIIEMATGK-PPFYELGEPQ---AAMFKV---GMFKVH------PEIPESMSAEA 255

Query: 566 HHLIMLCLACIAREPESRPSMAE 588
              I+ C      +P+ R    +
Sbjct: 256 KAFILKCF---EPDPDKRACAND 275

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  110 bits (277), Expect = 6e-27
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 33/205 (16%)

Query: 339 GSVFRGII--NGSTVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVF 388
             V           VAIK +           + KE+  + + +H N+++ + +       
Sbjct: 29  AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFR---IAL---DVAHGLHYLHNCTDPGYVH 442
           +LV + +  GS+ D + K    +    +       IA    +V  GL YLH     G +H
Sbjct: 89  WLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIH 144

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSA----VREESGYSSTKTAVGTNGYMAPEYME--- 495
           +D+ +GNILL ++   ++A+F    SA      + +     KT VGT  +MAPE ME   
Sbjct: 145 RDVKAGNILLGEDGSVQIADFGV--SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR 202

Query: 496 -YGLVTPEMDTYAFGVVLLELITGK 519
            Y     + D ++FG+  +EL TG 
Sbjct: 203 GYD---FKADIWSFGITAIELATGA 224

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  110 bits (277), Expect = 7e-27
 Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 27/194 (13%)

Query: 339 GSVFRGIIN--GSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G V        G  VA+K M       R  +  EV +++   HFN++ ++ +       +
Sbjct: 59  GIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELW 118

Query: 390 LVYEFMENGSLSDWLHKKRYPEF-VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           ++ EF++ G+L+D + + R  E  ++  C       V   L YLH     G +H+DI S 
Sbjct: 119 VLMEFLQGGALTDIVSQVRLNEEQIATVCE-----AVLQALAYLHA---QGVIHRDIKSD 170

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE---YMEYGLVTPEMDT 505
           +ILL  + R KL++F F     +        K+ VGT  +MAPE      Y     E+D 
Sbjct: 171 SILLTLDGRVKLSDFGF---CAQISKDVPKRKSLVGTPYWMAPEVISRSLYA---TEVDI 224

Query: 506 YAFGVVLLELITGK 519
           ++ G++++E++ G+
Sbjct: 225 WSLGIMVIEMVDGE 238

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  114 bits (286), Expect = 8e-27
 Identities = 55/279 (19%), Positives = 118/279 (42%), Gaps = 37/279 (13%)

Query: 339 GSVFRGIINGST----VAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHDG 386
           GSV +G+         VAIK +++           +E  ++ ++++  ++ L G C+ + 
Sbjct: 350 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA 409

Query: 387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
           +  LV E    G L  +L  KR  E +  +    +   V+ G+ YL    +  +VH++++
Sbjct: 410 L-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLA 463

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           + N+LL     AK+++F   ++   ++S Y++         + APE + +   +   D +
Sbjct: 464 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 523

Query: 507 AFGVVLLELITGKEAAY-KQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++GV + E ++  +  Y K  G E++      + +E G    ++             E+ 
Sbjct: 524 SYGVTMWEALSYGQKPYKKMKGPEVM------AFIEQGK---RM-----ECPPECPPEL- 568

Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQ 604
            + +M    C   + E RP    V   +      +    
Sbjct: 569 -YALM--SDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  109 bits (275), Expect = 1e-26
 Identities = 52/194 (26%), Positives = 93/194 (47%), Gaps = 27/194 (13%)

Query: 339 GSVFRGII--NGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V+  +    G  VAI+ M       +  I  E+ ++++  + N++N   +       +
Sbjct: 34  GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93

Query: 390 LVYEFMENGSLSDWLHKKRYPEF-VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +V E++  GSL+D + +    E  ++  CR     +    L +LH+      +H+DI S 
Sbjct: 94  VVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHS---NQVIHRDIKSD 145

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE---YMEYGLVTPEMDT 505
           NILL  +   KL +F F     +     S   T VGT  +MAPE      YG   P++D 
Sbjct: 146 NILLGMDGSVKLTDFGF---CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG---PKVDI 199

Query: 506 YAFGVVLLELITGK 519
           ++ G++ +E+I G+
Sbjct: 200 WSLGIMAIEMIEGE 213

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  108 bits (272), Expect = 2e-26
 Identities = 50/192 (26%), Positives = 89/192 (46%), Gaps = 22/192 (11%)

Query: 339 GSVFRGIIN--GSTVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G VF+GI N     VAIK +           I +E+ +L + +   +   +G+   D   
Sbjct: 36  GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95

Query: 389 YLVYEFMENGSLSDWLHKKRYPE-FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +++ E++  GS  D L      E  ++   R     ++  GL YLH+      +H+DI +
Sbjct: 96  WIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE---KKIHRDIKA 147

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
            N+LL ++   KLA+F    +    ++      T VGT  +MAPE ++      + D ++
Sbjct: 148 ANVLLSEHGEVKLADFGV--AGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 204

Query: 508 FGVVLLELITGK 519
            G+  +EL  G+
Sbjct: 205 LGITAIELARGE 216

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  108 bits (271), Expect = 2e-26
 Identities = 50/285 (17%), Positives = 106/285 (37%), Gaps = 58/285 (20%)

Query: 339 GSVFRGIINGS---------TVAIKCMRRSIS-------KEVNLLKKINHFNLINLFGAC 382
             +F+G+              V +K + ++         +  +++ K++H +L+  +G C
Sbjct: 22  TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC 81

Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
                  LV EF++ GSL  +L K +    + W  +  +A  +A  +H+L    +   +H
Sbjct: 82  VCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFL---EENTLIH 136

Query: 443 KDISSGNILLDK--------NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM 494
            ++ + NILL +            KL++     + + ++              ++ PE +
Sbjct: 137 GNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP-------WVPPECI 189

Query: 495 EYGLV-TPEMDTYAFGVVLLELITGKEAAYKQ-DGEEILLAEAVFSMVEGGNAEAKLSVL 552
           E         D ++FG  L E+ +G +      D +            E  +   +L   
Sbjct: 190 ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR------KLQFYEDRH---QLPAP 240

Query: 553 VDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
               L           ++    C+  EP+ RPS   ++  L  + 
Sbjct: 241 KAAEL---------ANLI--NNCMDYEPDHRPSFRAIIRDLNSLF 274

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  111 bits (279), Expect = 8e-26
 Identities = 57/278 (20%), Positives = 97/278 (34%), Gaps = 37/278 (13%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS--------ISKEVNLLKKINHFNLINLF------GAC 382
           G V R I    G  VAIK  R+            E+ ++KK+NH N+++           
Sbjct: 28  GYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87

Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
             + +  L  E+ E G L  +L++      +       +  D++  L YLH       +H
Sbjct: 88  APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIH 144

Query: 443 KDISSGNILLDKN---LRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV 499
           +D+   NI+L      L  K+ +  + +   + E         VGT  Y+APE +E    
Sbjct: 145 RDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL----CTEFVGTLQYLAPELLEQKKY 200

Query: 500 TPEMDTYAFGVVLLELITGK--------EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV 551
           T  +D ++FG +  E ITG            +     E      V      G  +    +
Sbjct: 201 TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVL 260

Query: 552 LVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
               +L           +   L         R +  + 
Sbjct: 261 PTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQN 295

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  106 bits (265), Expect = 5e-25
 Identities = 59/290 (20%), Positives = 104/290 (35%), Gaps = 55/290 (18%)

Query: 339 GSVFRGI--INGSTVAIKCM--------RRSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G VF+     +G  +A K +        R  I +E+ +L + N   ++  +GA   DG  
Sbjct: 47  GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106

Query: 389 YLVYEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
            +  E M+ GSL   L K  R PE +      ++++ V  GL YL        +H+D+  
Sbjct: 107 SICMEHMDGGSLDQVLKKAGRIPEQIL----GKVSIAVIKGLTYLR--EKHKIMHRDVKP 160

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGY---SSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
            NIL++     KL +F          SG    S   + VGT  YM+PE ++    + + D
Sbjct: 161 SNILVNSRGEIKLCDFGV--------SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 212

Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++ G+ L+E+  G+         + L       +                 L     + 
Sbjct: 213 IWSMGLSLVEMAVGR-YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271

Query: 565 AHHLIMLCL--------------------------ACIAREPESRPSMAE 588
              + +  L                           C+ + P  R  + +
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  104 bits (262), Expect = 6e-25
 Identities = 53/285 (18%), Positives = 114/285 (40%), Gaps = 56/285 (19%)

Query: 339 GSVFRG--IINGSTVAIKCMRRSISKEVNLLKK----------INHFNLINLFGACEHDG 386
             V     + +   VA+K +R  ++++ +   +          +NH  ++ ++   E + 
Sbjct: 26  SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85

Query: 387 ----VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
               + Y+V E+++  +L D +H +     ++      +  D    L++ H     G +H
Sbjct: 86  PAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQN---GIIH 139

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           +D+   NI++      K+ +F   R+     +  + T   +GT  Y++PE      V   
Sbjct: 140 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR 199

Query: 503 MDTYAFGVVLLELITGK---------EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV 553
            D Y+ G VL E++TG+           AY+   E+                        
Sbjct: 200 SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP----------------------- 236

Query: 554 DPNLQANKKEIAHHLIMLCLACIAREPESRP-SMAEVVSTLMKIQ 597
                A  + ++  L  + L  +A+ PE+R  + AE+ + L+++ 
Sbjct: 237 -IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  104 bits (261), Expect = 2e-24
 Identities = 38/269 (14%), Positives = 77/269 (28%), Gaps = 55/269 (20%)

Query: 343 RGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFME--NG 398
           R +          +        +L+K      +I +        V   + +Y  M+    
Sbjct: 128 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 187

Query: 399 SLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
           +  + L       + +  + R ++ L V   L  LH+    G VH  +   +I+LD+   
Sbjct: 188 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGG 244

Query: 458 AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-----------EYGLVTPEMDTY 506
             L  F  +           +   +  + G+  PE                L+T   D +
Sbjct: 245 VFLTGFEHLVRD-------GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAW 297

Query: 507 AFGVVLLELITGK---EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           A G+V+  +                 +  +E +F   +      +               
Sbjct: 298 ALGLVIYWIWCADLPIT-----KDAALGGSEWIFRSCKNIPQPVR--------------- 337

Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVST 592
               L+   L       E R    + + T
Sbjct: 338 ---ALLEGFL---RYPKEDRLLPLQAMET 360

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  101 bits (253), Expect = 1e-23
 Identities = 49/191 (25%), Positives = 92/191 (48%), Gaps = 21/191 (10%)

Query: 339 GSVFRG--IINGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           GSV++      G  VAIK +      + I KE++++++ +  +++  +G+   +   ++V
Sbjct: 43  GSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102

Query: 392 YEFMENGSLSDWLHKKRYP---EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
            E+   GS+SD +  +      + ++   +         GL YLH       +H+DI +G
Sbjct: 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQ-----STLKGLEYLHF---MRKIHRDIKAG 154

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           NILL+    AKLA+F     A +     +   T +GT  +MAPE ++        D ++ 
Sbjct: 155 NILLNTEGHAKLADFGV---AGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSL 211

Query: 509 GVVLLELITGK 519
           G+  +E+  GK
Sbjct: 212 GITAIEMAEGK 222

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 46/194 (23%), Positives = 88/194 (45%), Gaps = 25/194 (12%)

Query: 339 GSVF--RGIINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDG 386
           G+V+  R   +   +A+K + ++          + +EV +   + H N++ L+G      
Sbjct: 23  GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82

Query: 387 VFYLVYEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
             YL+ E+   G++   L K  ++ E  +         ++A+ L Y H+      +H+DI
Sbjct: 83  RVYLILEYAPLGTVYRELQKLSKFDEQRT----ATYITELANALSYCHSK---RVIHRDI 135

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
              N+LL      K+A+F +   +V   S  S      GT  Y+ PE +E  +   ++D 
Sbjct: 136 KPENLLLGSAGELKIADFGW---SVHAPS--SRRTDLCGTLDYLPPEMIEGRMHDEKVDL 190

Query: 506 YAFGVVLLELITGK 519
           ++ GV+  E + GK
Sbjct: 191 WSLGVLCYEFLVGK 204

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  102 bits (254), Expect = 2e-23
 Identities = 38/260 (14%), Positives = 75/260 (28%), Gaps = 38/260 (14%)

Query: 343 RGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGV--FYLVYEFME--NG 398
           R +          +        +L+K      +I +        V   + +Y  M+    
Sbjct: 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 192

Query: 399 SLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
           +  + L       + +  + R ++ L V   L  LH+    G VH  +   +I+LD+   
Sbjct: 193 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGG 249

Query: 458 AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY-----GLVTPEMDTYAFGVVL 512
             L  F  +       S  S            A   + +      L+T   DT+  G+ +
Sbjct: 250 VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307

Query: 513 LELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLC 572
             +          D   +  +E +F   +      +                   L+   
Sbjct: 308 YWIWCAD-LPNTDD-AALGGSEWIFRSCKNIPQPVR------------------ALLEGF 347

Query: 573 LACIAREPESRPSMAEVVST 592
           L       E R    + + T
Sbjct: 348 L---RYPKEDRLLPLQAMET 364

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  100 bits (249), Expect = 5e-23
 Identities = 28/302 (9%), Positives = 61/302 (20%), Gaps = 72/302 (23%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS----------ISKEVNLLKKINHFN---------LIN 377
             VF           A+K               + +      ++   +         L+ 
Sbjct: 76  SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135

Query: 378 LFGACEHDGV-----------------FYLVYEFMENGSLSDWLHK----KRYPEFVSWN 416
              A                       + L+        L            +       
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGIL 194

Query: 417 CRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY 476
               +   +      L      G VH   +  N+ +  + R  L + S +          
Sbjct: 195 ALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG------ 245

Query: 477 SSTKTAVGTNGYMAPEYM--EYGLVTPEMDTYAFGVVLLELITGK----EAAYKQDGEEI 530
           +    +     Y   E++       T  ++ +  G+ +  +               G   
Sbjct: 246 TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305

Query: 531 LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
             +  V                +         +    LI   L     +   R    E +
Sbjct: 306 RPSLRVPGTDS-----------LAFGSCTPLPDFVKTLIGRFL---NFDRRRRLLPLEAM 351

Query: 591 ST 592
            T
Sbjct: 352 ET 353

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 98.2 bits (245), Expect = 8e-23
 Identities = 41/201 (20%), Positives = 83/201 (41%), Gaps = 34/201 (16%)

Query: 339 GSVFRGI--INGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G V++      G+  A K +             E+ +L   +H  ++ L GA  HDG  +
Sbjct: 33  GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92

Query: 390 LVYEFMENGSLSDWLHKKRYP---EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
           ++ EF   G++   + +         +   CR      +   L++LH+      +H+D+ 
Sbjct: 93  IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR-----QMLEALNFLHSK---RIIHRDLK 144

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM--------EYGL 498
           +GN+L+      +LA+F     + +         + +GT  +MAPE +         Y  
Sbjct: 145 AGNVLMTLEGDIRLADFGV---SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD- 200

Query: 499 VTPEMDTYAFGVVLLELITGK 519
              + D ++ G+ L+E+   +
Sbjct: 201 --YKADIWSLGITLIEMAQIE 219

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 99.3 bits (247), Expect = 1e-22
 Identities = 31/223 (13%), Positives = 64/223 (28%), Gaps = 31/223 (13%)

Query: 339 GSVFRGI-------INGSTVAIKCMRRSISKEV-------NLLKKINHFNLINLFGACEH 384
             V+           N     +K  + +   E          LK       +  + A   
Sbjct: 79  AQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEF--VSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
                LV E    G+L + ++  +      +        A+ + + +  +H+C     +H
Sbjct: 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIH 195

Query: 443 KDISSGNILL-----------DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP 491
            DI   N +L           D +    L +            G +       T+G+   
Sbjct: 196 GDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG-TIFTAKCETSGFQCV 254

Query: 492 EYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAE 534
           E +       ++D +     +  ++ G     K +G E     
Sbjct: 255 EMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 23/188 (12%)

Query: 343 RGIINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVY 392
           R   N   +A+K + +S          + +E+ +   + H N++ ++         YL+ 
Sbjct: 34  REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93

Query: 393 EFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
           EF   G L   L K  R+ E  S      +  ++A  LHY H       +H+DI   N+L
Sbjct: 94  EFAPRGELYKELQKHGRFDEQRS---ATFME-ELADALHYCHER---KVIHRDIKPENLL 146

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           +      K+A+F +  S           +T  GT  Y+ PE +E      ++D +  GV+
Sbjct: 147 MGYKGELKIADFGW--SVHAPS---LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVL 201

Query: 512 LLELITGK 519
             E + G 
Sbjct: 202 CYEFLVGM 209

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 58/292 (19%), Positives = 96/292 (32%), Gaps = 59/292 (20%)

Query: 339 GSVF--RGIINGSTVAIK-------CMRRSISKEVNLLKKI-NHFNLINLFGAC-----E 383
             V+  + + +G   A+K          R+I +EV  +KK+  H N++    A      E
Sbjct: 42  AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101

Query: 384 HDGVFYLVYEFME--NGSLSDWL----HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTD 437
            D          E   G L ++L     +             +I       + ++H    
Sbjct: 102 SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL----KIFYQTCRAVQHMHRQKP 157

Query: 438 PGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTK---------TAVGTNGY 488
           P  +H+D+   N+LL      KL +F    +         S +         T   T  Y
Sbjct: 158 P-IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMY 216

Query: 489 MAPEYME---YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA 545
             PE ++      +  + D +A G +L  L   +                 F   E G  
Sbjct: 217 RTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP---------------F---EDGAK 258

Query: 546 EAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
              ++          +  + H LI   L      PE R S+AEVV  L +I 
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSLIRAML---QVNPEERLSIAEVVHQLQEIA 307

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 97.3 bits (242), Expect = 3e-22
 Identities = 50/326 (15%), Positives = 111/326 (34%), Gaps = 34/326 (10%)

Query: 275 SIVLFHHKRRRDEAARKDGKREKKRNLPEDFLVSVSNLDRGLKFY--KYEDLVVATENFS 332
            +    +K      A K  +   +    E  +  V  L +       +Y +  + T    
Sbjct: 21  VVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80

Query: 333 PKNMIDGSVFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVY 392
            +  +D    +       ++      + S ++  +   +  N +            Y+  
Sbjct: 81  WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140

Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           +     +L DW++++   E         I + +A  + +LH+    G +H+D+   NI  
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFF 197

Query: 453 DKNLRAKLANF---------SFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
             +   K+ +F            ++ +     Y++    VGT  YM+PE +     + ++
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257

Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++ G++L EL+           E + +                +  L  P L   K  
Sbjct: 258 DIFSLGLILFELLYSFSTQM----ERVRIIT-------------DVRNLKFPLLFTQKYP 300

Query: 564 IAHHLIMLCLACIAREPESRPSMAEV 589
             H ++   L   +  P  RP   ++
Sbjct: 301 QEHMMVQDML---SPSPTERPEATDI 323

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 98.6 bits (246), Expect = 3e-22
 Identities = 62/264 (23%), Positives = 108/264 (40%), Gaps = 57/264 (21%)

Query: 295 REKKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMID-------------GSV 341
           + K+R L  +  +++S      K + + DL V  ++  PK + D             G V
Sbjct: 94  KGKRRPLNNNSEIALS--LSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEV 151

Query: 342 FRGI--INGSTVAIKCMRRS---------------ISKEVNLLKKINHFNLINLFGACEH 384
                      VAI+ + +                +  E+ +LKK+NH  +I +    + 
Sbjct: 152 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211

Query: 385 DGVFYLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHK 443
           +   Y+V E ME G L D +   KR  E     C+      +   + YLH     G +H+
Sbjct: 212 EDY-YIVLELMEGGELFDKVVGNKRLKEA---TCK-LYFYQMLLAVQYLHEN---GIIHR 263

Query: 444 DISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE------YM 494
           D+   N+LL   +++   K+ +F    S +  E+  S  +T  GT  Y+APE        
Sbjct: 264 DLKPENVLLSSQEEDCLIKITDFGH--SKILGET--SLMRTLCGTPTYLAPEVLVSVGTA 319

Query: 495 EYGLVTPEMDTYAFGVVLLELITG 518
            Y      +D ++ GV+L   ++G
Sbjct: 320 GYN---RAVDCWSLGVILFICLSG 340

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  100 bits (250), Expect = 3e-22
 Identities = 47/197 (23%), Positives = 73/197 (37%), Gaps = 33/197 (16%)

Query: 339 GSVFRG---IINGSTVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEH--- 384
           G ++      +NG  V +K +  S           E   L ++ H +++ +F   EH   
Sbjct: 94  GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153

Query: 385 --DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
             D V Y+V E++   SL     +K               L++   L YLH     G V+
Sbjct: 154 HGDPVGYIVMEYVGGQSLKRSKGQKLPVAEA-----IAYLLEILPALSYLH---SIGLVY 205

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
            D+   NI+L +  + KL +   V          +S     GT G+ APE +     T  
Sbjct: 206 NDLKPENIMLTEE-QLKLIDLGAVSRI-------NSFGYLYGTPGFQAPEIVR-TGPTVA 256

Query: 503 MDTYAFGVVLLELITGK 519
            D Y  G  L  L    
Sbjct: 257 TDIYTVGRTLAALTLDL 273

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 96.3 bits (240), Expect = 8e-22
 Identities = 58/203 (28%), Positives = 86/203 (42%), Gaps = 42/203 (20%)

Query: 339 GSVFRGI--INGSTVAIKCM----------RRSISKEVNLLKKINHFNLINLFGACEHDG 386
           G+V+      N   VAIK M           + I KEV  L+K+ H N I   G    + 
Sbjct: 68  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127

Query: 387 VFYLVYEFMENGSLSDWLHKKRYP---EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHK 443
             +LV E+   GS SD L   + P     ++             GL YLH+      +H+
Sbjct: 128 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTH-----GALQGLAYLHS---HNMIHR 178

Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSST----KTAVGTNGYMAPE---YMEY 496
           D+ +GNILL +    KL +F           G +S      + VGT  +MAPE    M+ 
Sbjct: 179 DVKAGNILLSEPGLVKLGDF-----------GSASIMAPANSFVGTPYWMAPEVILAMDE 227

Query: 497 GLVTPEMDTYAFGVVLLELITGK 519
           G    ++D ++ G+  +EL   K
Sbjct: 228 GQYDGKVDVWSLGITCIELAERK 250

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 43/197 (21%), Positives = 81/197 (41%), Gaps = 22/197 (11%)

Query: 334 KNMIDGSVFRGIINGSTVAIKCMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE 393
           K++++        N   ++IK        E+ ++  I +   +   G   +    Y++YE
Sbjct: 64  KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYE 123

Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRF------RIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +MEN S+  +       +  ++ C         I   V +   Y+HN  +    H+D+  
Sbjct: 124 YMENDSILKFDEYFFVLD-KNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKP 180

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME-----YGLVTPE 502
            NIL+DKN R KL++F    S    +      K + GT  +M PE+        G    +
Sbjct: 181 SNILMDKNGRVKLSDFGE--SEYMVD---KKIKGSRGTYEFMPPEFFSNESSYNG---AK 232

Query: 503 MDTYAFGVVLLELITGK 519
           +D ++ G+ L  +    
Sbjct: 233 VDIWSLGICLYVMFYNV 249

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 93.6 bits (233), Expect = 4e-21
 Identities = 62/272 (22%), Positives = 104/272 (38%), Gaps = 52/272 (19%)

Query: 339 GSVFRGI--INGSTVAIKCMRRSISKEVN---------LLKKINHFNLINLFGACEHDGV 387
           G V++      G  +A+K MRRS +KE N         +LK  +   ++  FG    +  
Sbjct: 39  GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
            ++  E M   +      KKR    +      ++ + +   L+YL      G +H+D+  
Sbjct: 99  VFIAMELMGTCAEKL---KKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKP 153

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGY---SSTKTA-VGTNGYMAPEYMEYGLVTPEM 503
            NILLD+  + KL +F          SG       K    G   YMAPE ++    T   
Sbjct: 154 SNILLDERGQIKLCDFGI--------SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205

Query: 504 -----DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ 558
                D ++ G+ L+EL TG +  YK    +    E +  +++    E        P L 
Sbjct: 206 YDIRADVWSLGISLVELATG-QFPYKNCKTDF---EVLTKVLQE---EP-------PLLP 251

Query: 559 ANKK--EIAHHLIMLCLACIAREPESRPSMAE 588
            +          +  CL    ++   RP   +
Sbjct: 252 GHMGFSGDFQSFVKDCL---TKDHRKRPKYNK 280

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 94.4 bits (235), Expect = 1e-20
 Identities = 65/266 (24%), Positives = 108/266 (40%), Gaps = 42/266 (15%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGV 387
           G V      +     AIK +R++         + +EV +LK ++H N++ L+   E    
Sbjct: 51  GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110

Query: 388 FYLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
           +YLV E  + G L D + H+ ++ E  +      I   V  G+ YLH       VH+D+ 
Sbjct: 111 YYLVMECYKGGELFDEIIHRMKFNEVDA----AVIIKQVLSGVTYLHKH---NIVHRDLK 163

Query: 447 SGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
             N+LL   +K+   K+ +F     +   E+     K  +GT  Y+APE +       + 
Sbjct: 164 PENLLLESKEKDALIKIVDFGL---SAVFENQ-KKMKERLGTAYYIAPEVLR-KKYDEKC 218

Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++ GV+L  L+ G      Q  +EI         VE G          + +  A K  
Sbjct: 219 DVWSIGVILFILLAGYPPFGGQTDQEI------LRKVEKGKYTFDSPEWKNVSEGA-K-- 269

Query: 564 IAHHLIMLCLACIAREPESRPSMAEV 589
               LI   L     + + R S  + 
Sbjct: 270 ---DLIKQML---QFDSQRRISAQQA 289

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 48/198 (24%), Positives = 87/198 (43%), Gaps = 30/198 (15%)

Query: 339 GSVF--RGIINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDG 386
             V+    I  G  VAIK + +           +  EV +  ++ H +++ L+   E   
Sbjct: 25  AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84

Query: 387 VFYLVYEFMENGSLSDWLHK--KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             YLV E   NG ++ +L    K + E  +          +  G+ YLH+    G +H+D
Sbjct: 85  YVYLVLEMCHNGEMNRYLKNRVKPFSENEAR----HFMHQIITGMLYLHSH---GILHRD 137

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---YGLVTP 501
           ++  N+LL +N+  K+A+F     A + +  +    T  GT  Y++PE      +G    
Sbjct: 138 LTLSNLLLTRNMNIKIADFGL---ATQLKMPHEKHYTLCGTPNYISPEIATRSAHG---L 191

Query: 502 EMDTYAFGVVLLELITGK 519
           E D ++ G +   L+ G+
Sbjct: 192 ESDVWSLGCMFYTLLIGR 209

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 93.2 bits (232), Expect = 3e-20
 Identities = 69/267 (25%), Positives = 109/267 (40%), Gaps = 43/267 (16%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDG 386
           G V      I G   A+K + +           + +EV LLK+++H N++ L+   E  G
Sbjct: 40  GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99

Query: 387 VFYLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
            FYLV E    G L D +  +KR+ E  +     RI   V  G+ Y+H       VH+D+
Sbjct: 100 YFYLVGEVYTGGELFDEIISRKRFSEVDA----ARIIRQVLSGITYMHKN---KIVHRDL 152

Query: 446 SSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
              N+LL    K+   ++ +F     +   E+     K  +GT  Y+APE +  G    +
Sbjct: 153 KPENLLLESKSKDANIRIIDFGL---STHFEAS-KKMKDKIGTAYYIAPEVLH-GTYDEK 207

Query: 503 MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK 562
            D ++ GV+L  L++G       +  +I         VE G    +L      +  A K 
Sbjct: 208 CDVWSTGVILYILLSGCPPFNGANEYDI------LKKVEKGKYTFELPQWKKVSESA-K- 259

Query: 563 EIAHHLIMLCLACIAREPESRPSMAEV 589
                LI   L      P  R S  + 
Sbjct: 260 ----DLIRKML---TYVPSMRISARDA 279

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 93.7 bits (233), Expect = 3e-20
 Identities = 56/260 (21%), Positives = 94/260 (36%), Gaps = 32/260 (12%)

Query: 280 HHKRRRDEAARKDGKREKKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMID- 338
             +R+R      D + +  R          + +    K Y  + + +  ++      I  
Sbjct: 104 GDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHE 163

Query: 339 -------GSVFRGI--INGSTVAIKCMRRS-------ISKEVNLLKKINHFNLINLFGAC 382
                  G V R      G+  A K +          + KE+  +  + H  L+NL  A 
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223

Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKR--YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
           E D    ++YEFM  G L + +  +     E  +          V  GL ++H      Y
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA----VEYMRQVCKGLCHMHEN---NY 276

Query: 441 VHKDISSGNILL--DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL 498
           VH D+   NI+    ++   KL +F         +    S K   GT  + APE  E   
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGL---TAHLDPK-QSVKVTTGTAEFAAPEVAEGKP 332

Query: 499 VTPEMDTYAFGVVLLELITG 518
           V    D ++ GV+   L++G
Sbjct: 333 VGYYTDMWSVGVLSYILLSG 352

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 43/172 (25%), Positives = 78/172 (45%), Gaps = 21/172 (12%)

Query: 356 MRRSISKEVNLLKKINHFNLINLFGACEH--DGVFYLVYEFMENGSLSDWLHKKRYPEFV 413
               + +E+ +LKK++H N++ L    +   +   Y+V+E +  G + +    K   E  
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138

Query: 414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREE 473
           +    F+   D+  G+ YLH       +H+DI   N+L+ ++   K+A+F    S   + 
Sbjct: 139 AR-FYFQ---DLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGV--SNEFKG 189

Query: 474 SGYSSTKTAVGTNGYMAPE-----YMEY-GLVTPEMDTYAFGVVLLELITGK 519
           S  +     VGT  +MAPE        + G     +D +A GV L   + G+
Sbjct: 190 SD-ALLSNTVGTPAFMAPESLSETRKIFSG---KALDVWAMGVTLYCFVFGQ 237

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 89.2 bits (222), Expect = 8e-20
 Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 43/203 (21%)

Query: 339 GSVFRGI--INGSTVAIKC----------------MRRSISKEVNLLKKIN-HFNLINLF 379
             V R I        A+K                 +R +  KEV++L+K++ H N+I L 
Sbjct: 31  SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90

Query: 380 GACEHDGVFYLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDP 438
              E +  F+LV++ M+ G L D+L  K    E  +     R  L+V   +  LH     
Sbjct: 91  DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MRALLEV---ICALHKL--- 143

Query: 439 GYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE------ 492
             VH+D+   NILLD ++  KL +F F   + + + G    +   GT  Y+APE      
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGF---SCQLDPG-EKLREVCGTPSYLAPEIIECSM 199

Query: 493 ---YMEYGLVTPEMDTYAFGVVL 512
              +  YG    E+D ++ GV++
Sbjct: 200 NDNHPGYG---KEVDMWSTGVIM 219

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 35/205 (17%)

Query: 339 GSVFRGI--INGSTVAIKCM------RRSISKEVNLLKKI-NHFNLINLFGA------CE 383
           G V++G     G   AIK M         I +E+N+LKK  +H N+   +GA        
Sbjct: 38  GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEF----VSWNCRFRIALDVAHGLHYLHNCTDPG 439
            D   +LV EF   GS++D +   +        +++ CR     ++  GL +LH      
Sbjct: 98  MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-----EILRGLSHLHQ---HK 149

Query: 440 YVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV 499
            +H+DI   N+LL +N   KL +F     + + +       T +GT  +MAPE +     
Sbjct: 150 VIHRDIKGQNVLLTENAEVKLVDFGV---SAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 206

Query: 500 TPEM-----DTYAFGVVLLELITGK 519
                    D ++ G+  +E+  G 
Sbjct: 207 PDATYDFKSDLWSLGITAIEMAEGA 231

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 53/275 (19%), Positives = 102/275 (37%), Gaps = 57/275 (20%)

Query: 339 GSVFRGI--INGSTVAIKCMRRSISKEVN---------LLKKINHFNLINLFGACEHDGV 387
           G V +     +G  +A+K +R +++ +            ++ ++    +  +GA   +G 
Sbjct: 21  GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80

Query: 388 FYLVYEFMENGSLSDWL-----HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
            ++  E M + SL  +        +  PE +      +IA+ +   L +LH+      +H
Sbjct: 81  VWICMELM-DTSLDKFYKQVIDKGQTIPEDILG----KIAVSIVKALEHLHS--KLSVIH 133

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGY---SSTK-TAVGTNGYMAPEYMEYGL 498
           +D+   N+L++   + K+ +F          SGY      K    G   YMAPE +   L
Sbjct: 134 RDVKPSNVLINALGQVKMCDFGI--------SGYLVDDVAKDIDAGCKPYMAPERINPEL 185

Query: 499 VTPEMDTYA----FGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD 554
                   +     G+ ++EL   +   Y   G      + +  +VE             
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILR-FPYDSWGTPF---QQLKQVVEEP----------S 231

Query: 555 PNLQANK-KEIAHHLIMLCLACIAREPESRPSMAE 588
           P L A+K           CL    +  + RP+  E
Sbjct: 232 PQLPADKFSAEFVDFTSQCL---KKNSKERPTYPE 263

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 67/277 (24%), Positives = 108/277 (38%), Gaps = 64/277 (23%)

Query: 339 GSVFRG--IINGSTVAIKCMRRS-------------ISKEVNLLKKINHF--NLINLFGA 381
           GSV+ G  + +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 57  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116

Query: 382 CEHDGVFYLVYEFMEN-GSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
            E    F L+ E  E    L D++  +    E +    R      V   + + HNC   G
Sbjct: 117 FERPDSFVLILERPEPVQDLFDFITERGALQEEL---AR-SFFWQVLEAVRHCHNC---G 169

Query: 440 YVHKDISSGNILLDKN-LRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL 498
            +H+DI   NIL+D N    KL +F     A+ +++ Y       GT  Y  PE++ Y  
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGS--GALLKDTVY---TDFDGTRVYSPPEWIRYHR 224

Query: 499 VT-PEMDTYAFGVVLLELITGK---EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD 554
                   ++ G++L +++ G    E       EEI+         +  ++E +      
Sbjct: 225 YHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEII--RGQVFFRQRVSSECQ------ 271

Query: 555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVS 591
                       HLI  CL   A  P  RP+  E+ +
Sbjct: 272 ------------HLIRWCL---ALRPSDRPTFEEIQN 293

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 36/199 (18%), Positives = 78/199 (39%), Gaps = 37/199 (18%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V R +   +  T   K ++        + KE+++L    H N+++L  + E      +
Sbjct: 19  GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78

Query: 391 VYEFMENGSLSDWLHKK--RYPEFVSWNCRFRIALDVAH-------GLHYLHNCTDPGYV 441
           ++EF+    + + ++       E            ++          L +LH+       
Sbjct: 79  IFEFISGLDIFERINTSAFELNE-----------REIVSYVHQVCEALQFLHSH---NIG 124

Query: 442 HKDISSGNILL--DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV 499
           H DI   NI+    ++   K+  F     A + + G  + +       Y APE  ++ +V
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQ---ARQLKPG-DNFRLLFTAPEYYAPEVHQHDVV 180

Query: 500 TPEMDTYAFGVVLLELITG 518
           +   D ++ G ++  L++G
Sbjct: 181 STATDMWSLGTLVYVLLSG 199

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 41/188 (21%), Positives = 78/188 (41%), Gaps = 21/188 (11%)

Query: 343 RGIINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVY 392
                    A K + +S          +S E+++ + + H +++   G  E +   ++V 
Sbjct: 35  SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94

Query: 393 EFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
           E     SL +    +K   E  +          +  G  YLH       +H+D+  GN+ 
Sbjct: 95  ELCRRRSLLELHKRRKALTEPEAR----YYLRQIVLGCQYLHR---NRVIHRDLKLGNLF 147

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           L+++L  K+ +F    +   E  G    K   GT  Y+APE +     + E+D ++ G +
Sbjct: 148 LNEDLEVKIGDFGL--ATKVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCI 204

Query: 512 LLELITGK 519
           +  L+ GK
Sbjct: 205 MYTLLVGK 212

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 90.2 bits (224), Expect = 2e-19
 Identities = 55/260 (21%), Positives = 94/260 (36%), Gaps = 37/260 (14%)

Query: 280 HHKRRRDEAARKDGKREKKRNLPEDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNMID- 338
                    ++  GK +  +    D        +   K Y  + + V   +      I  
Sbjct: 3   GSHHHHHHGSKVRGKYDGPKINDYDKFY-----EDIWKKYVPQPVEVKQGSVYDYYDILE 57

Query: 339 -------GSVFRGI--INGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGAC 382
                  G V R +    G     K +       + ++  E++++ +++H  LINL  A 
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117

Query: 383 EHDGVFYLVYEFMENGSLSDWLHKK--RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
           E      L+ EF+  G L D +  +  +  E    N   R A +   GL ++H       
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY-MRQACE---GLKHMHEH---SI 170

Query: 441 VHKDISSGNILL--DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL 498
           VH DI   NI+    K    K+ +F     A +        K    T  + APE ++   
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGL---ATKLNPD-EIVKVTTATAEFAAPEIVDREP 226

Query: 499 VTPEMDTYAFGVVLLELITG 518
           V    D +A GV+   L++G
Sbjct: 227 VGFYTDMWAIGVLGYVLLSG 246

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 41/188 (21%), Positives = 78/188 (41%), Gaps = 21/188 (11%)

Query: 343 RGIINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVY 392
                    A K + +S          +S E+++ + + H +++   G  E +   ++V 
Sbjct: 61  SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120

Query: 393 EFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
           E     SL +    +K   E  +          +  G  YLH       +H+D+  GN+ 
Sbjct: 121 ELCRRRSLLELHKRRKALTEPEAR----YYLRQIVLGCQYLHR---NRVIHRDLKLGNLF 173

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           L+++L  K+ +F    +   E  G    K   GT  Y+APE +     + E+D ++ G +
Sbjct: 174 LNEDLEVKIGDFGL--ATKVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCI 230

Query: 512 LLELITGK 519
           +  L+ GK
Sbjct: 231 MYTLLVGK 238

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 40/206 (19%)

Query: 339 GSVFRGI--INGSTVAIKCMR--------RSISKEVN-LLKKINHFNLINLFGACEHDGV 387
           GSV + +   +G  +A+K +R        + +  +++ +++  +   ++  +GA   +G 
Sbjct: 36  GSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95

Query: 388 FYLVYEFMENGSLSDWLHK------KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYV 441
            ++  E M + S   +            PE +      +I L     L++L    +   +
Sbjct: 96  CWICMELM-STSFDKFYKYVYSVLDDVIPEEILG----KITLATVKALNHLKE--NLKII 148

Query: 442 HKDISSGNILLDKNLRAKLANFSFVRSAVREESGY---SSTKT-AVGTNGYMAPEYMEYG 497
           H+DI   NILLD++   KL +F          SG    S  KT   G   YMAPE ++  
Sbjct: 149 HRDIKPSNILLDRSGNIKLCDFGI--------SGQLVDSIAKTRDAGCRPYMAPERIDPS 200

Query: 498 LVTPEMDTYA----FGVVLLELITGK 519
                 D  +     G+ L EL TG+
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGR 226

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 89.4 bits (222), Expect = 3e-19
 Identities = 54/196 (27%), Positives = 86/196 (43%), Gaps = 29/196 (14%)

Query: 352 AIKCMRRS--ISK--------EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           A+K + +   I +        E +++   N   ++ LF A + D   Y+V E+M  G L 
Sbjct: 98  AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV 157

Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
           + +     PE  +   RF  A +V   L  +H+    G++H+D+   N+LLDK+   KLA
Sbjct: 158 NLMSNYDVPEKWA---RFYTA-EVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLA 210

Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPE-------YMEYGLVTPEMDTYAFGVVLLE 514
           +F         + G     TAVGT  Y++PE          YG    E D ++ GV L E
Sbjct: 211 DFGT--CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG---RECDWWSVGVFLYE 265

Query: 515 LITGKEAAYKQDGEEI 530
           ++ G    Y       
Sbjct: 266 MLVGDTPFYADSLVGT 281

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 29/263 (11%), Positives = 56/263 (21%), Gaps = 62/263 (23%)

Query: 339 GSVFRG--IINGSTVAIKCMRRSIS----------KEVNLLKKINHFNLINLFGACEHDG 386
              ++         VA+  +                    L +I+   +  +        
Sbjct: 45  LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA 104

Query: 387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
              +V E++  GSL +       P         R    +A      H     G       
Sbjct: 105 GGLVVAEWIRGGSLQEVADTSPSPVGAI-----RAMQSLAAAADAAH---RAGVALSIDH 156

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
              + +  +    LA                           M           P+ D  
Sbjct: 157 PSRVRVSIDGDVVLAYP-----------------------ATMPD-------ANPQDDIR 186

Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
             G  L  L+        + G    LA A           A +   +   + A       
Sbjct: 187 GIGASLYALLVN-RWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA------- 238

Query: 567 HLIMLCLACIAREPESRPSMAEV 589
               +    +  +   R +   +
Sbjct: 239 ----VAARSVQGDGGIRSASTLL 257

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 87.2 bits (217), Expect = 3e-19
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 31/200 (15%)

Query: 339 GSVFRGI--INGSTVAIKCM-------------RRSISKEVNLLKKINHFNLINLFGACE 383
             V +      G   A K +             R  I +EVN+L++I H N+I L    E
Sbjct: 19  AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE 78

Query: 384 HDGVFYLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
           +     L+ E +  G L D+L  K+   E  +     +  LD   G+HYLH+       H
Sbjct: 79  NKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-LKQILD---GVHYLHSK---RIAH 131

Query: 443 KDISSGNILL----DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL 498
            D+   NI+L      N R KL +F     A + E+G +  K   GT  ++APE + Y  
Sbjct: 132 FDLKPENIMLLDKNVPNPRIKLIDFGI---AHKIEAG-NEFKNIFGTPEFVAPEIVNYEP 187

Query: 499 VTPEMDTYAFGVVLLELITG 518
           +  E D ++ GV+   L++G
Sbjct: 188 LGLEADMWSIGVITYILLSG 207

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 49/200 (24%), Positives = 80/200 (40%), Gaps = 31/200 (15%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKINHFNLINLFGACE 383
             V +      G   A K +++              I +EV++L+++ H N+I L    E
Sbjct: 26  AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE 85

Query: 384 HDGVFYLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
           +     L+ E +  G L D+L  K+   E             +  G++YLH        H
Sbjct: 86  NRTDVVLILELVSGGELFDFLAQKESLSEE---EAT-SFIKQILDGVNYLHTK---KIAH 138

Query: 443 KDISSGNILL----DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL 498
            D+   NI+L          KL +F     A   E G    K   GT  ++APE + Y  
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGL---AHEIEDG-VEFKNIFGTPEFVAPEIVNYEP 194

Query: 499 VTPEMDTYAFGVVLLELITG 518
           +  E D ++ GV+   L++G
Sbjct: 195 LGLEADMWSIGVITYILLSG 214

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 88.2 bits (219), Expect = 4e-19
 Identities = 49/200 (24%), Positives = 80/200 (40%), Gaps = 31/200 (15%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKINHFNLINLFGACE 383
             V +      G   A K +++              I +EV++L+++ H N+I L    E
Sbjct: 26  AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85

Query: 384 HDGVFYLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
           +     L+ E +  G L D+L  K+   E             +  G++YLH        H
Sbjct: 86  NRTDVVLILELVSGGELFDFLAQKESLSEE---EAT-SFIKQILDGVNYLHTK---KIAH 138

Query: 443 KDISSGNILL----DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL 498
            D+   NI+L          KL +F     A   E G    K   GT  ++APE + Y  
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGL---AHEIEDG-VEFKNIFGTPEFVAPEIVNYEP 194

Query: 499 VTPEMDTYAFGVVLLELITG 518
           +  E D ++ GV+   L++G
Sbjct: 195 LGLEADMWSIGVITYILLSG 214

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 86.9 bits (216), Expect = 5e-19
 Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 25/187 (13%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS-------ISKEVNLLKKINHFNLINLFGACEHDGVFY 389
             VF     + G   A+KC+++S       +  E+ +LKKI H N++ L    E    +Y
Sbjct: 23  SEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82

Query: 390 LVYEFMENGSLSDW-LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           LV + +  G L D  L +  Y E  +      +   V   + YLH     G VH+D+   
Sbjct: 83  LVMQLVSGGELFDRILERGVYTEKDA----SLVIQQVLSAVKYLHEN---GIVHRDLKPE 135

Query: 449 NILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           N+L    ++N +  + +F     +  E++G     TA GT GY+APE +     +  +D 
Sbjct: 136 NLLYLTPEENSKIMITDFGL---SKMEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDC 190

Query: 506 YAFGVVL 512
           ++ GV+ 
Sbjct: 191 WSIGVIT 197

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 86.5 bits (215), Expect = 5e-19
 Identities = 51/191 (26%), Positives = 85/191 (44%), Gaps = 31/191 (16%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGV 387
           G V +    I     A+K + ++         I +EV LLKK++H N++ LF   E    
Sbjct: 36  GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95

Query: 388 FYLVYEFMENGSLSDW-LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
           FY+V E    G L D  + +KR+ E  +     +        + Y+H       VH+D+ 
Sbjct: 96  FYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSG---ITYMHKH---NIVHRDLK 148

Query: 447 SGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME--YGLVTP 501
             NILL   +K+   K+ +F     +   +   +  K  +GT  Y+APE +   Y     
Sbjct: 149 PENILLESKEKDCDIKIIDFGL---STCFQQN-TKMKDRIGTAYYIAPEVLRGTYD---E 201

Query: 502 EMDTYAFGVVL 512
           + D ++ GV+L
Sbjct: 202 KCDVWSAGVIL 212

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 89.0 bits (221), Expect = 7e-19
 Identities = 69/278 (24%), Positives = 110/278 (39%), Gaps = 66/278 (23%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGV 387
           G V +    I     A+K + ++         I +EV LLKK++H N++ LF   E    
Sbjct: 36  GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95

Query: 388 FYLVYEFMENGSLSDW-LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
           FY+V E    G L D  + +KR+ E  +     RI   V  G+ Y+H       VH+D+ 
Sbjct: 96  FYIVGELYTGGELFDEIIKRKRFSEHDA----ARIIKQVFSGITYMHKH---NIVHRDLK 148

Query: 447 SGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
             NILL   +K+   K+ +F     +   +   +  K  +GT  Y+APE +  G    + 
Sbjct: 149 PENILLESKEKDCDIKIIDFGL---STCFQQN-TKMKDRIGTAYYIAPEVLR-GTYDEKC 203

Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN------------AEAKLSV 551
           D ++ GV+L  L++G    Y ++  +I         VE G              +AK   
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDI------LKRVETGKYAFDLPQWRTISDDAK--- 254

Query: 552 LVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                           LI   L      P  R +  + 
Sbjct: 255 ---------------DLIRKML---TFHPSLRITATQC 274

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 69/277 (24%), Positives = 102/277 (36%), Gaps = 66/277 (23%)

Query: 339 GSVFRG--IINGSTVAIKCMRRS-------------ISKEVNLLKKIN----HFNLINLF 379
           G+VF G  + +   VAIK + R+                EV LL K+     H  +I L 
Sbjct: 45  GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104

Query: 380 GACEHDGVFYLVYEFMENGS-LSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTD 437
              E    F LV E       L D++  K    E      R      V   + + H+   
Sbjct: 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP---SR-CFFGQVVAAIQHCHSR-- 158

Query: 438 PGYVHKDISSGNILLD-KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY 496
            G VH+DI   NIL+D +   AKL +F     A+  +  Y       GT  Y  PE++  
Sbjct: 159 -GVVHRDIKDENILIDLRRGCAKLIDFGS--GALLHDEPY---TDFDGTRVYSPPEWISR 212

Query: 497 GLVT-PEMDTYAFGVVLLELITGK---EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVL 552
                     ++ G++L +++ G    E       +EIL  EA        + +      
Sbjct: 213 HQYHALPATVWSLGILLYDMVCGDIPFE-----RDQEIL--EAELHFPAHVSPDCC---- 261

Query: 553 VDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                          LI  CL   A +P SRPS+ E+
Sbjct: 262 --------------ALIRRCL---APKPSSRPSLEEI 281

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 86.1 bits (214), Expect = 9e-19
 Identities = 44/189 (23%), Positives = 84/189 (44%), Gaps = 26/189 (13%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGV 387
             V R +    G   A K +            + +E  + +K+ H N++ L  + + +  
Sbjct: 20  SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 79

Query: 388 FYLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            YLV++ +  G L + +  ++ Y E  + +C  +  L+    + Y H+    G VH+++ 
Sbjct: 80  HYLVFDLVTGGELFEDIVAREFYSEADASHC-IQQILES---IAYCHSN---GIVHRNLK 132

Query: 447 SGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
             N+LL    K    KLA+F     A+       +     GT GY++PE ++    +  +
Sbjct: 133 PENLLLASKAKGAAVKLADFGL---AIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPV 188

Query: 504 DTYAFGVVL 512
           D +A GV+L
Sbjct: 189 DIWACGVIL 197

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 87.2 bits (216), Expect = 9e-19
 Identities = 55/237 (23%), Positives = 78/237 (32%), Gaps = 59/237 (24%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS------------ISKEVNLLKKINHFNLINLFGACEH 384
           G V   I     +  AIK M ++            I  EV L+KK++H N+  L+   E 
Sbjct: 40  GVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF------------------------- 419
           +    LV E    G L D L+                                       
Sbjct: 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE 159

Query: 420 ------------RIALDVAHGLHYLHNCTDPGYVHKDISSGNILL--DKNLRAKLANFSF 465
                        I   +   LHYLHN    G  H+DI   N L   +K+   KL +F  
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGL 216

Query: 466 -VRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL--VTPEMDTYAFGVVLLELITGK 519
                      Y    T  GT  ++APE +        P+ D ++ GV+L  L+ G 
Sbjct: 217 SKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 86.5 bits (215), Expect = 9e-19
 Identities = 46/194 (23%), Positives = 88/194 (45%), Gaps = 21/194 (10%)

Query: 339 GSVF--RGIINGSTVAIKCMR-RSISK---------EVNLLKKINHFNLINLFGACEHDG 386
            +V   R +      AIK +  R I K         E +++ +++H   + L+   + D 
Sbjct: 44  STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 103

Query: 387 VFYLVYEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
             Y    + +NG L  ++ K   + E  +   RF  A ++   L YLH     G +H+D+
Sbjct: 104 KLYFGLSYAKNGELLKYIRKIGSFDETCT---RFYTA-EIVSALEYLHGK---GIIHRDL 156

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
              NILL++++  ++ +F   +  +  ES  +   + VGT  Y++PE +         D 
Sbjct: 157 KPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDL 215

Query: 506 YAFGVVLLELITGK 519
           +A G ++ +L+ G 
Sbjct: 216 WALGCIIYQLVAGL 229

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 53/188 (28%), Positives = 87/188 (46%), Gaps = 26/188 (13%)

Query: 345 IINGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFM 395
           I+ G  VAIK + ++         + +EV ++K +NH N++ LF   E +   YL+ E+ 
Sbjct: 37  ILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96

Query: 396 ENGSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK 454
             G + D+L    R  E  +   R      +   + Y H       VH+D+ + N+LLD 
Sbjct: 97  SGGEVFDYLVAHGRMKEKEA---R-SKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDA 149

Query: 455 NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---YGLVTPEMDTYAFGVV 511
           ++  K+A+F F  S      G        G   Y APE  +   Y    PE+D ++ GV+
Sbjct: 150 DMNIKIADFGF--SNEFTVGGK--LDAFCGAPPYAAPELFQGKKY--DGPEVDVWSLGVI 203

Query: 512 LLELITGK 519
           L  L++G 
Sbjct: 204 LYTLVSGS 211

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 88.2 bits (219), Expect = 1e-18
 Identities = 69/289 (23%), Positives = 107/289 (37%), Gaps = 77/289 (26%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS--------------------ISKEVNLLKKINHFNLI 376
           G V         S  AIK +++S                    I  E++LLK ++H N+I
Sbjct: 50  GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109

Query: 377 NLFGACEHDGVFYLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNC 435
            LF   E    FYLV EF E G L + + ++ ++ E  +      I   +  G+ YLH  
Sbjct: 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA----ANIMKQILSGICYLHKH 165

Query: 436 TDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE 492
                VH+DI   NILL   +  L  K+ +F     +          +  +GT  Y+APE
Sbjct: 166 ---NIVHRDIKPENILLENKNSLLNIKIVDFGL---SSFFSKD-YKLRDRLGTAYYIAPE 218

Query: 493 YMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN-------- 544
            ++      + D ++ GV++  L+ G      Q+ ++I         VE G         
Sbjct: 219 VLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI------IKKVEKGKYYFDFNDW 271

Query: 545 ----AEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                EAK                   LI L L     +   R +  E 
Sbjct: 272 KNISDEAK------------------ELIKLML---TYDYNKRCTAEEA 299

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 42/201 (20%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS---------------ISKEVNLLKKINHFNLINLFGA 381
           G V           VAIK + +                +  E+ +LKK+NH  +I +   
Sbjct: 24  GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 83

Query: 382 CEHDGVFYLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
            + +   Y+V E ME G L D +   KR  E     C+      +   + YLH     G 
Sbjct: 84  FDAEDY-YIVLELMEGGELFDKVVGNKRLKEA---TCK-LYFYQMLLAVQYLHEN---GI 135

Query: 441 VHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE----- 492
           +H+D+   N+LL   +++   K+ +F    S +  E+  S  +T  GT  Y+APE     
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGH--SKILGET--SLMRTLCGTPTYLAPEVLVSV 191

Query: 493 -YMEYGLVTPEMDTYAFGVVL 512
               Y      +D ++ GV+L
Sbjct: 192 GTAGYN---RAVDCWSLGVIL 209

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 87.4 bits (217), Expect = 2e-18
 Identities = 42/189 (22%), Positives = 81/189 (42%), Gaps = 25/189 (13%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGV 387
             V R +  + G   A   +            + +E  + + + H N++ L  +   +G 
Sbjct: 25  SVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84

Query: 388 FYLVYEFMENGSLSDW-LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            YL+++ +  G L +  + ++ Y E  + +C  +  L+    + + H     G VH+++ 
Sbjct: 85  HYLIFDLVTGGELFEDIVAREYYSEADASHC-IQQILEA---VLHCHQM---GVVHRNLK 137

Query: 447 SGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
             N+LL    K    KLA+F     A+  E    +     GT GY++PE +        +
Sbjct: 138 PENLLLASKLKGAAVKLADFGL---AIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPV 194

Query: 504 DTYAFGVVL 512
           D +A GV+L
Sbjct: 195 DLWACGVIL 203

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 44/189 (23%), Positives = 84/189 (44%), Gaps = 26/189 (13%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGACEHDGV 387
             V R +    G   A K +            + +E  + +K+ H N++ L  + + +  
Sbjct: 43  SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 102

Query: 388 FYLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
            YLV++ +  G L + +  ++ Y E  + +C  +  L+    + Y H+    G VH+++ 
Sbjct: 103 HYLVFDLVTGGELFEDIVAREFYSEADASHC-IQQILES---IAYCHSN---GIVHRNLK 155

Query: 447 SGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
             N+LL    K    KLA+F     A+       +     GT GY++PE ++    +  +
Sbjct: 156 PENLLLASKAKGAAVKLADFGL---AIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPV 211

Query: 504 DTYAFGVVL 512
           D +A GV+L
Sbjct: 212 DIWACGVIL 220

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 42/195 (21%), Positives = 72/195 (36%), Gaps = 23/195 (11%)

Query: 339 GSVFRGI--INGSTVAIKCM---------RRSISKEVNLLKKINHF-NLINLFGACEHDG 386
             V + I    G   A K +         R  I  E+ +L+       +INL    E+  
Sbjct: 43  AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102

Query: 387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
              L+ E+   G +      +        +   R+   +  G++YLH       VH D+ 
Sbjct: 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVI-RLIKQILEGVYYLHQN---NIVHLDLK 158

Query: 447 SGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
             NILL         K+ +F     + +        +  +GT  Y+APE + Y  +T   
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGM---SRKIGHA-CELREIMGTPEYLAPEILNYDPITTAT 214

Query: 504 DTYAFGVVLLELITG 518
           D +  G++   L+T 
Sbjct: 215 DMWNIGIIAYMLLTH 229

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 47/189 (24%), Positives = 80/189 (42%), Gaps = 29/189 (15%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS-------ISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G V   +        A K + +          +E+ ++K ++H N+I L+   E +   Y
Sbjct: 23  GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82

Query: 390 LVYEFMENGSLSDW-LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           LV E    G L +  +HK+ + E  +     +  L     + Y H        H+D+   
Sbjct: 83  LVMELCTGGELFERVVHKRVFRESDAARI-MKDVLSA---VAYCHKL---NVAHRDLKPE 135

Query: 449 NILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME--YGLVTPEM 503
           N L      +   KL +F     A R + G    +T VGT  Y++P+ +E  YG   PE 
Sbjct: 136 NFLFLTDSPDSPLKLIDFGL---AARFKPG-KMMRTKVGTPYYVSPQVLEGLYG---PEC 188

Query: 504 DTYAFGVVL 512
           D ++ GV++
Sbjct: 189 DEWSAGVMM 197

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 42/202 (20%)

Query: 339 GSVFRGI--INGSTVAIKC---------------MRRSISKEVNLLKKI-NHFNLINLFG 380
             V R +    G   A+K                +R +  +E ++L+++  H ++I L  
Sbjct: 108 SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167

Query: 381 ACEHDGVFYLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
           + E     +LV++ M  G L D+L  K    E  + +   R  L+    + +LH      
Sbjct: 168 SYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI-MRSLLEA---VSFLHAN---N 220

Query: 440 YVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE------- 492
            VH+D+   NILLD N++ +L++F F   +   E G    +   GT GY+APE       
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGF---SCHLEPG-EKLRELCGTPGYLAPEILKCSMD 276

Query: 493 --YMEYGLVTPEMDTYAFGVVL 512
             +  YG    E+D +A GV+L
Sbjct: 277 ETHPGYG---KEVDLWACGVIL 295

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 39/197 (19%)

Query: 345 IINGSTVAIKCMRRS---------------ISKEVNLLKKINHFNLINLFGACEHDGVFY 389
                 V +K +++                ++ E+ +L ++ H N+I +    E+ G F 
Sbjct: 46  KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105

Query: 390 LVYEFMENGS-LSDWL-HKKRYPEFVSWNCR--FRIALDVAHGLHYLHNCTDPGYVHKDI 445
           LV E   +G  L  ++    R  E +       FR    +   + YL        +H+DI
Sbjct: 106 LVMEKHGSGLDLFAFIDRHPRLDEPL---ASYIFR---QLVSAVGYLRL---KDIIHRDI 156

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---Y-GLVTP 501
              NI++ ++   KL +F    +A  E        T  GT  Y APE +    Y G   P
Sbjct: 157 KDENIVIAEDFTIKLIDFGS--AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRG---P 209

Query: 502 EMDTYAFGVVLLELITG 518
           E++ ++ GV L  L+  
Sbjct: 210 ELEMWSLGVTLYTLVFE 226

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 85.5 bits (212), Expect = 4e-18
 Identities = 44/191 (23%), Positives = 82/191 (42%), Gaps = 20/191 (10%)

Query: 339 GSVFRGI--INGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G V +      G  +A K +       +  +  E++++ +++H NLI L+ A E      
Sbjct: 103 GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV 162

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           LV E+++ G L D +  + Y      +        +  G+ ++H       +H D+   N
Sbjct: 163 LVMEYVDGGELFDRIIDESY-NLTELDTI-LFMKQICEGIRHMHQM---YILHLDLKPEN 217

Query: 450 ILL--DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
           IL       + K+ +F     A R +      K   GT  ++APE + Y  V+   D ++
Sbjct: 218 ILCVNRDAKQIKIIDFGL---ARRYKPR-EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWS 273

Query: 508 FGVVLLELITG 518
            GV+   L++G
Sbjct: 274 VGVIAYMLLSG 284

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 83.5 bits (207), Expect = 7e-18
 Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 29/194 (14%)

Query: 345 IINGSTVAIKCMRRS-----------ISKEVNLLKKINHFNLINLFG--ACEHDGVFYLV 391
                  A+K +++            + KE+ LL+++ H N+I L      E     Y+V
Sbjct: 27  SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86

Query: 392 YEFMENGS--LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
            E+   G   + D + +KR+P   +    F   +D   GL YLH+    G VHKDI  GN
Sbjct: 87  MEYCVCGMQEMLDSVPEKRFPVCQAHGY-FCQLID---GLEYLHSQ---GIVHKDIKPGN 139

Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSST-KTAVGTNGYMAPEYMEYGLVT---PEMDT 505
           +LL      K++      +          T +T+ G+  +  PE +  GL T    ++D 
Sbjct: 140 LLLTTGGTLKISALGV--AEALHPFAADDTCRTSQGSPAFQPPE-IANGLDTFSGFKVDI 196

Query: 506 YAFGVVLLELITGK 519
           ++ GV L  + TG 
Sbjct: 197 WSAGVTLYNITTGL 210

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 83.8 bits (208), Expect = 8e-18
 Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 45/207 (21%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKINHFNLINLFGACE 383
             V +      G   A K +++              I +EV++LK+I H N+I L    E
Sbjct: 25  AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 84

Query: 384 HDGVFYLVYEFMENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAH-------GLHYLHNC 435
           +     L+ E +  G L D+L  K+   E            +          G++YLH+ 
Sbjct: 85  NKTDVILILELVAGGELFDFLAEKESLTE-----------EEATEFLKQILNGVYYLHSL 133

Query: 436 TDPGYVHKDISSGNILL----DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP 491
                 H D+   NI+L        R K+ +F     A + + G +  K   GT  ++AP
Sbjct: 134 ---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKIDFG-NEFKNIFGTPEFVAP 186

Query: 492 EYMEYGLVTPEMDTYAFGVVLLELITG 518
           E + Y  +  E D ++ GV+   L++G
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG 213

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 47/199 (23%), Positives = 80/199 (40%), Gaps = 38/199 (19%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS------------ISKEVNLLKKINHFNLINLFGACEH 384
             V R I    G   A+K +  +            + +E ++   + H +++ L      
Sbjct: 38  SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS 97

Query: 385 DGVFYLVYEFMENGSLSDWLHKK-----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
           DG+ Y+V+EFM+   L   + K+      Y E V+ +   R  L+    L Y H+     
Sbjct: 98  DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY-MRQILEA---LRYCHDN---N 150

Query: 440 YVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE---Y 493
            +H+D+    +LL   + +   KL  F     A++           VGT  +MAPE    
Sbjct: 151 IIHRDVKPHCVLLASKENSAPVKLGGFGV---AIQLGESGLVAGGRVGTPHFMAPEVVKR 207

Query: 494 MEYGLVTPEMDTYAFGVVL 512
             YG     +D +  GV+L
Sbjct: 208 EPYG---KPVDVWGCGVIL 223

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 48/185 (25%), Positives = 81/185 (43%), Gaps = 22/185 (11%)

Query: 339 GSVFRGI--INGSTVAIKCMRRSISK-----EVNLLKKINHFNLINLFGACEHDGVFYLV 391
             V+R          A+K +++++ K     E+ +L +++H N+I L    E      LV
Sbjct: 67  SIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126

Query: 392 YEFMENGSLSDW-LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
            E +  G L D  + K  Y E  + +   +  L+    + YLH     G VH+D+   N+
Sbjct: 127 LELVTGGELFDRIVEKGYYSERDAADA-VKQILEA---VAYLHEN---GIVHRDLKPENL 179

Query: 451 LL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
           L      +   K+A+F     +   E      KT  GT GY APE +      PE+D ++
Sbjct: 180 LYATPAPDAPLKIADFGL---SKIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWS 235

Query: 508 FGVVL 512
            G++ 
Sbjct: 236 VGIIT 240

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 52/198 (26%), Positives = 82/198 (41%), Gaps = 30/198 (15%)

Query: 339 GSVFRGI--INGSTVAIKCMRRSISK--------EVNLLKKINHFNLINLFGACEHDGVF 388
           G V       +G    IK + +  S+        E+ +LK ++H N+I +F   E     
Sbjct: 36  GDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM 95

Query: 389 YLVYEFMENGSLSDWL-----HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHK 443
           Y+V E  E G L + +       K   E        +  ++    L Y H+      VHK
Sbjct: 96  YIVMETCEGGELLERIVSAQARGKALSEGYVAEL-MKQMMNA---LAYFHSQ---HVVHK 148

Query: 444 DISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVT 500
           D+   NIL      +   K+ +F     A   +S    +  A GT  YMAPE  +  + T
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGL---AELFKSD-EHSTNAAGTALYMAPEVFKRDV-T 203

Query: 501 PEMDTYAFGVVLLELITG 518
            + D ++ GVV+  L+TG
Sbjct: 204 FKCDIWSAGVVMYFLLTG 221

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 80.7 bits (200), Expect = 4e-17
 Identities = 48/190 (25%), Positives = 80/190 (42%), Gaps = 30/190 (15%)

Query: 345 IINGSTVAIKCMRRS--------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME 396
            +    VA+K +           I KE+ + K +NH N++  +G      + YL  E+  
Sbjct: 29  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88

Query: 397 NGSLSDWL-HKKRYPEFVSWNCRFR--IALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
            G L D +      PE  +    F   +A     G+ YLH     G  H+DI   N+LLD
Sbjct: 89  GGELFDRIEPDIGMPEPDAQRF-FHQLMA-----GVVYLHG---IGITHRDIKPENLLLD 139

Query: 454 KNLRAKLANFSFVRSAVREESGYSST-KTAVGTNGYMAPEYM---EY-GLVTPEMDTYAF 508
           +    K+++F    + V   +          GT  Y+APE +   E+       +D ++ 
Sbjct: 140 ERDNLKISDFGL--ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---EPVDVWSC 194

Query: 509 GVVLLELITG 518
           G+VL  ++ G
Sbjct: 195 GIVLTAMLAG 204

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 82.9 bits (205), Expect = 5e-17
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 28/211 (13%)

Query: 339 GSVF--RGIINGSTVAIKCMRRS--ISK--------EVNLLKKINHFNLINLFGACEHDG 386
           G V   +        A+K + +   + +        E ++L   +   +  L  A + D 
Sbjct: 88  GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147

Query: 387 VFYLVYEFMENGSLSDWLHK--KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             YLV ++   G L   L K   R PE ++   RF +A ++   +  +H      YVH+D
Sbjct: 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMA---RFYLA-EMVIAIDSVHQL---HYVHRD 200

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE---YMEYGLV-- 499
           I   NIL+D N   +LA+F         E G   +  AVGT  Y++PE    ME G    
Sbjct: 201 IKPDNILMDMNGHIRLADFGS--CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY 258

Query: 500 TPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
            PE D ++ GV + E++ G+   Y +   E 
Sbjct: 259 GPECDWWSLGVCMYEMLYGETPFYAESLVET 289

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 80.7 bits (200), Expect = 5e-17
 Identities = 51/190 (26%), Positives = 88/190 (46%), Gaps = 29/190 (15%)

Query: 345 IINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEF 394
            + G  VA+K + R           I +E+  LK   H ++I L+        F++V E+
Sbjct: 33  QLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92

Query: 395 MENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
           +  G L D++    R  E  +    F+    +   + Y H       VH+D+   N+LLD
Sbjct: 93  VSGGELFDYICKHGRVEEMEARRL-FQ---QILSAVDYCHR---HMVVHRDLKPENVLLD 145

Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---Y-GLVTPEMDTYAFG 509
            ++ AK+A+F    S +  +  +   +T+ G+  Y APE +    Y G   PE+D ++ G
Sbjct: 146 AHMNAKIADFGL--SNMMSDGEF--LRTSCGSPNYAAPEVISGRLYAG---PEVDIWSCG 198

Query: 510 VVLLELITGK 519
           V+L  L+ G 
Sbjct: 199 VILYALLCGT 208

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 42/190 (22%), Positives = 73/190 (38%), Gaps = 31/190 (16%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS----ISKEVNLLKKI-NHFNLINLFGACEHDGVFYLV 391
               + +   +    A+K + +       KE+  LK    H N++ L          +LV
Sbjct: 25  SICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRF------RIALDVAHGLHYLHNCTDPGYVHKDI 445
            E +  G L + + KK++         F       I   +   + ++H+    G VH+D+
Sbjct: 85  MELLNGGELFERIKKKKH---------FSETEASYIMRKLVSAVSHMHDV---GVVHRDL 132

Query: 446 SSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
              N+L    + NL  K+ +F F   A  +       KT   T  Y APE +        
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGF---ARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDES 189

Query: 503 MDTYAFGVVL 512
            D ++ GV+L
Sbjct: 190 CDLWSLGVIL 199

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 82.1 bits (203), Expect = 8e-17
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 22/200 (11%)

Query: 352 AIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           A+K ++               E  +L+   H  L  L  + +       V E+   G L 
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 236

Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
             L ++R   F     RF  A ++   L YLH+  +   V++D+   N++LDK+   K+ 
Sbjct: 237 FHLSRER--VFSEDRARFYGA-EIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKIT 291

Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
           +F   +  +++ +   + KT  GT  Y+APE +E       +D +  GVV+ E++ G+  
Sbjct: 292 DFGLCKEGIKDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

Query: 522 AYKQDGEE----ILLAEAVF 537
            Y QD E+    IL+ E  F
Sbjct: 349 FYNQDHEKLFELILMEEIRF 368

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 52/271 (19%), Positives = 97/271 (35%), Gaps = 48/271 (17%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS--ISKEVNLLKKI-NHFNLINLFGACE----HDGVFY 389
           G V        G   A+K +  S    +EV+   +     +++ +    E          
Sbjct: 43  GKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           ++ E ME G L   + ++    F        I  D+   + +LH+       H+D+   N
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAA-EIMRDIGTAIQFLHSH---NIAHRDVKPEN 158

Query: 450 ILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           +L    +K+   KL +F F   A        + +T   T  Y+APE +         D +
Sbjct: 159 LLYTSKEKDAVLKLTDFGF---AKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMW 213

Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE------AKLSVLVDPNLQAN 560
           + GV++  L+ G    Y   G+ I  +  +   +  G         +++S          
Sbjct: 214 SLGVIMYILLCGFPPFYSNTGQAI--SPGMKRRIRLGQYGFPNPEWSEVS---------- 261

Query: 561 KKEIAHHLI--MLCLACIAREPESRPSMAEV 589
             E A  LI  +L       +P  R ++ + 
Sbjct: 262 --EDAKQLIRLLLK-----TDPTERLTITQF 285

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 43/193 (22%), Positives = 76/193 (39%), Gaps = 37/193 (19%)

Query: 339 GSVFRGI--INGSTVAIKCM---RRSISKEVNLLKK-INHFNLINLFGACEHDGVFYLVY 392
               R I        A+K +   +R  ++E+ +L +   H N+I L    +     Y+V 
Sbjct: 36  SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95

Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRF------RIALDVAHGLHYLHNCTDPGYVHKDIS 446
           E M+ G L D + ++++         F       +   +   + YLH     G VH+D+ 
Sbjct: 96  ELMKGGELLDKILRQKF---------FSEREASAVLFTITKTVEYLHAQ---GVVHRDLK 143

Query: 447 SGNILL----DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---YGLV 499
             NIL           ++ +F F   A +  +      T   T  ++APE +E   Y   
Sbjct: 144 PSNILYVDESGNPESIRICDFGF---AKQLRAENGLLMTPCYTANFVAPEVLERQGYD-- 198

Query: 500 TPEMDTYAFGVVL 512
               D ++ GV+L
Sbjct: 199 -AACDIWSLGVLL 210

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 55/201 (27%), Positives = 84/201 (41%), Gaps = 34/201 (16%)

Query: 352 AIKCMRRS--ISK--------EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           A+K M +   + +        E ++L   +   +  L  A + +   YLV E+   G L 
Sbjct: 90  AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149

Query: 402 DWLHK--KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
             L K  +R P  ++   RF +A ++   +  +H     GYVH+DI   NILLD+    +
Sbjct: 150 TLLSKFGERIPAEMA---RFYLA-EIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIR 202

Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPE----------YMEYGLVTPEMDTYAFG 509
           LA+F           G   +  AVGT  Y++PE             YG   PE D +A G
Sbjct: 203 LADFGS--CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYG---PECDWWALG 257

Query: 510 VVLLELITGKEAAYKQDGEEI 530
           V   E+  G+   Y     E 
Sbjct: 258 VFAYEMFYGQTPFYADSTAET 278

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 48/190 (25%), Positives = 80/190 (42%), Gaps = 30/190 (15%)

Query: 345 IINGSTVAIKCMRRS--------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME 396
            +    VA+K +           I KE+ + K +NH N++  +G      + YL  E+  
Sbjct: 29  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88

Query: 397 NGSLSDWL-HKKRYPEFVSWNCRFR--IALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
            G L D +      PE  +    F   +A     G+ YLH     G  H+DI   N+LLD
Sbjct: 89  GGELFDRIEPDIGMPEPDAQRF-FHQLMA-----GVVYLHG---IGITHRDIKPENLLLD 139

Query: 454 KNLRAKLANFSFVRSAVREESGYSST-KTAVGTNGYMAPEYM---EY-GLVTPEMDTYAF 508
           +    K+++F    + V   +          GT  Y+APE +   E+       +D ++ 
Sbjct: 140 ERDNLKISDFGL--ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---EPVDVWSC 194

Query: 509 GVVLLELITG 518
           G+VL  ++ G
Sbjct: 195 GIVLTAMLAG 204

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 53/196 (27%), Positives = 82/196 (41%), Gaps = 27/196 (13%)

Query: 339 GSVFRG--IINGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLFGACEHDGV 387
           G VF+      G  VAIK    S            E+ +LK++ H NL+NL         
Sbjct: 17  GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR 76

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
            +LV+E+ ++ ++   L   RY   V  +    I       +++ H       +H+D+  
Sbjct: 77  LHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKP 130

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE----YMEYGLVTPEM 503
            NIL+ K+   KL +F F R        Y      V T  Y +PE      +YG   P +
Sbjct: 131 ENILITKHSVIKLCDFGFARLLTGPSDYYDDE---VATRWYRSPELLVGDTQYG---PPV 184

Query: 504 DTYAFGVVLLELITGK 519
           D +A G V  EL++G 
Sbjct: 185 DVWAIGCVFAELLSGV 200

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 27/196 (13%)

Query: 339 GSVFRG--IINGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLFGACEHDGV 387
           G V +      G  VAIK    S            E+ LLK++ H NL+NL   C+    
Sbjct: 39  GMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
           +YLV+EF+++ ++ D L  + +P  + +    +    + +G+ + H+      +H+DI  
Sbjct: 99  WYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKP 152

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE----YMEYGLVTPEM 503
            NIL+ ++   KL +F F R+       Y      V T  Y APE     ++YG     +
Sbjct: 153 ENILVSQSGVVKLCDFGFARTLAAPGEVYDDE---VATRWYRAPELLVGDVKYG---KAV 206

Query: 504 DTYAFGVVLLELITGK 519
           D +A G ++ E+  G+
Sbjct: 207 DVWAIGCLVTEMFMGE 222

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 80.6 bits (199), Expect = 4e-16
 Identities = 50/178 (28%), Positives = 77/178 (43%), Gaps = 18/178 (10%)

Query: 352 AIKCMRRSISK----------EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           A K + +   K          E  +L+K+N   +++L  A E      LV   M  G L 
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272

Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
             ++      F      F  A ++  GL  LH       V++D+   NILLD +   +++
Sbjct: 273 FHIYHMGQAGFPEARAVFYAA-EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRIS 328

Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +      AV    G  + K  VGT GYMAPE ++    T   D +A G +L E+I G+
Sbjct: 329 DLGL---AVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 79.1 bits (195), Expect = 1e-15
 Identities = 45/180 (25%), Positives = 78/180 (43%), Gaps = 19/180 (10%)

Query: 352 AIKCMRRSISK----------EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           A K + +   K          E  +L K++   +++L  A E      LV   M  G + 
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273

Query: 402 DWLHK--KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
             ++   +  P F      F  A  +  GL +LH       +++D+   N+LLD +   +
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVR 329

Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +++      AV  ++G + TK   GT G+MAPE +        +D +A GV L E+I  +
Sbjct: 330 ISDLGL---AVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 78.7 bits (194), Expect = 1e-15
 Identities = 52/190 (27%), Positives = 88/190 (46%), Gaps = 29/190 (15%)

Query: 345 IINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEF 394
            + G  VA+K + R           I +E+  LK   H ++I L+         ++V E+
Sbjct: 38  ELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97

Query: 395 MENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
           +  G L D++    R  E  S    F+    +  G+ Y H       VH+D+   N+LLD
Sbjct: 98  VSGGELFDYICKNGRLDEKESRRL-FQ---QILSGVDYCHR---HMVVHRDLKPENVLLD 150

Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---Y-GLVTPEMDTYAFG 509
            ++ AK+A+F    S +  +  +   +T+ G+  Y APE +    Y G   PE+D ++ G
Sbjct: 151 AHMNAKIADFGL--SNMMSDGEF--LRTSCGSPNYAAPEVISGRLYAG---PEVDIWSSG 203

Query: 510 VVLLELITGK 519
           V+L  L+ G 
Sbjct: 204 VILYALLCGT 213

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 42/187 (22%), Positives = 79/187 (42%), Gaps = 25/187 (13%)

Query: 347 NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME 396
                A+K M           R++ KE+ +++ + H  L+NL+ + + +   ++V + + 
Sbjct: 39  TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLL 98

Query: 397 NGSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN 455
            G L   L +   + E      +  I  ++   L YL N      +H+D+   NILLD++
Sbjct: 99  GGDLRYHLQQNVHFKEETV---KLFIC-ELVMALDYLQNQ---RIIHRDMKPDNILLDEH 151

Query: 456 LRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV---TPEMDTYAFGVVL 512
               + +F+            +   T  GT  YMAPE          +  +D ++ GV  
Sbjct: 152 GHVHITDFNIAA----MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTA 207

Query: 513 LELITGK 519
            EL+ G+
Sbjct: 208 YELLRGR 214

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 51/205 (24%), Positives = 79/205 (38%), Gaps = 46/205 (22%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS-------ISKEVNLLKKI-NHFNLINLFGACEHDGVF 388
             V   I  I     A+K + +        + +EV +L +   H N++ L    E +  F
Sbjct: 27  ARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRF------RIALDVAHGLHYLHNCTDPGYVH 442
           YLV+E M  GS+   +HK+R+         F       +  DVA  L +LHN    G  H
Sbjct: 87  YLVFEKMRGGSILSHIHKRRH---------FNELEASVVVQDVASALDFLHNK---GIAH 134

Query: 443 KDISSGNILL---DKNLRAKLANF----SFVRSAVREESGYSSTKTAVGTNGYMAPE--- 492
           +D+   NIL    ++    K+ +F        +            T  G+  YMAPE   
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194

Query: 493 -----YMEYGLVTPEMDTYAFGVVL 512
                   Y       D ++ GV+L
Sbjct: 195 AFSEEASIYD---KRCDLWSLGVIL 216

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 77.6 bits (191), Expect = 5e-15
 Identities = 45/196 (22%), Positives = 83/196 (42%), Gaps = 28/196 (14%)

Query: 352 AIKCMR-RSISK---------EVNLLKKINHFN---LINLFGACEHDGVFYLVYEFMENG 398
           A+KC+  + I           E  +L  ++  +   ++ +  A         + + M  G
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277

Query: 399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
            L   L +     F   + RF  A ++  GL ++HN      V++D+   NILLD++   
Sbjct: 278 DLHYHLSQHG--VFSEADMRFYAA-EIILGLEHMHNR---FVVYRDLKPANILLDEHGHV 331

Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV-TPEMDTYAFGVVLLELIT 517
           ++++      A            +VGT+GYMAPE ++ G+      D ++ G +L +L+ 
Sbjct: 332 RISDLGL---ACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386

Query: 518 GK---EAAYKQDGEEI 530
           G         +D  EI
Sbjct: 387 GHSPFRQHKTKDKHEI 402

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 55/192 (28%), Positives = 89/192 (46%), Gaps = 37/192 (19%)

Query: 347 NGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLF------GACEHDGVFYLV 391
           +G  VAIK + R             E+ LLK + H N+I L        +  +   FYLV
Sbjct: 48  SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
             FM+    +D L K    +F     ++ +   +  GL Y+H+    G VH+D+  GN+ 
Sbjct: 108 MPFMQ----TD-LQKIMGLKFSEEKIQY-LVYQMLKGLKYIHSA---GVVHRDLKPGNLA 158

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE----YMEYGLVTPEMDTYA 507
           ++++   K+ +F   R A  E +GY      V T  Y APE    +M Y      +D ++
Sbjct: 159 VNEDCELKILDFGLARHADAEMTGY------VVTRWYRAPEVILSWMHY---NQTVDIWS 209

Query: 508 FGVVLLELITGK 519
            G ++ E++TGK
Sbjct: 210 VGCIMAEMLTGK 221

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 51/190 (26%), Positives = 86/190 (45%), Gaps = 30/190 (15%)

Query: 345 IINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEF 394
                 VA+K + R           + +E++ LK + H ++I L+          +V E+
Sbjct: 31  YKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90

Query: 395 MENGSLSDWL-HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
              G L D++  KKR  E       F+    +   + Y H       VH+D+   N+LLD
Sbjct: 91  A-GGELFDYIVEKKRMTEDEGRRF-FQ---QIICAIEYCHR---HKIVHRDLKPENLLLD 142

Query: 454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---Y-GLVTPEMDTYAFG 509
            NL  K+A+F    S +  +  +   KT+ G+  Y APE +    Y G   PE+D ++ G
Sbjct: 143 DNLNVKIADFGL--SNIMTDGNF--LKTSCGSPNYAAPEVINGKLYAG---PEVDVWSCG 195

Query: 510 VVLLELITGK 519
           +VL  ++ G+
Sbjct: 196 IVLYVMLVGR 205

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 75.5 bits (186), Expect = 8e-15
 Identities = 46/190 (24%), Positives = 82/190 (43%), Gaps = 32/190 (16%)

Query: 347 NGSTVAIKCMRRSISK---------EVNLLKKINHFNLI---NLFGACEHDGVF---YLV 391
               VAIK + R             E+ L+K +NH N+I   N+F   +    F   Y+V
Sbjct: 49  LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E M+  +L   +  +   E +S+     +   +  G+ +LH+    G +H+D+   NI+
Sbjct: 109 MELMDA-NLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIV 159

Query: 452 LDKNLRAKLANFSFVRSAVREE--SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           +  +   K+ +F   R+A      + Y      V T  Y APE +        +D ++ G
Sbjct: 160 VKSDCTLKILDFGLARTAGTSFMMTPY------VVTRYYRAPEVILGMGYKENVDIWSVG 213

Query: 510 VVLLELITGK 519
            ++ E+I G 
Sbjct: 214 CIMGEMIKGG 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 73.5 bits (181), Expect = 4e-14
 Identities = 48/193 (24%), Positives = 83/193 (43%), Gaps = 38/193 (19%)

Query: 347 NGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLF------GACEHDGVFYLV 391
            G  VA+K + R             E+ LLK + H N+I L        + E     YLV
Sbjct: 53  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112

Query: 392 YEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
              M     +D L+   +  +    + +F +   +  GL Y+H+      +H+D+   N+
Sbjct: 113 THLMG----AD-LNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSA---DIIHRDLKPSNL 163

Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE----YMEYGLVTPEMDTY 506
            ++++   K+ +F   R    E +GY      V T  Y APE    +M Y      +D +
Sbjct: 164 AVNEDCELKILDFGLARHTADEMTGY------VATRWYRAPEIMLNWMHY---NQTVDIW 214

Query: 507 AFGVVLLELITGK 519
           + G ++ EL+TG+
Sbjct: 215 SVGCIMAELLTGR 227

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 45/205 (21%), Positives = 87/205 (42%), Gaps = 26/205 (12%)

Query: 339 GSVF--RGIINGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDG 386
           G V   +   +G+  A+K + +              E  +L+ +N   L+ L  + + + 
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114

Query: 387 VFYLVYEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
             Y+V E++  G +   L +  R+ E  +   RF  A  +     YLH+      +++D+
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHA---RFYAA-QIVLTFEYLHSL---DLIYRDL 167

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
              N+L+D+    ++ +F F   A R +     T T  GT   +APE +        +D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGF---AKRVK---GRTWTLCGTPEALAPEIILSKGYNKAVDW 221

Query: 506 YAFGVVLLELITGKEAAYKQDGEEI 530
           +A GV++ E+  G    +     +I
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQI 246

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 72.4 bits (178), Expect = 7e-14
 Identities = 58/193 (30%), Positives = 89/193 (46%), Gaps = 38/193 (19%)

Query: 347 NGSTVAIKCMRRSISK---------EVNLLKKINHFNLINL---FGACEHDGVF---YLV 391
            G+ VAIK + R             E+ LLK + H N+I L   F   E    F   YLV
Sbjct: 49  TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108

Query: 392 YEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
             FM     +D L K  ++ +      +F +   +  GL Y+H     G +H+D+  GN+
Sbjct: 109 MPFMG----TD-LGKLMKHEKLGEDRIQF-LVYQMLKGLRYIHAA---GIIHRDLKPGNL 159

Query: 451 LLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE----YMEYGLVTPEMDTY 506
            ++++   K+ +F   R A  E +GY      V T  Y APE    +M Y   T  +D +
Sbjct: 160 AVNEDCELKILDFGLARQADSEMTGY------VVTRWYRAPEVILNWMRY---TQTVDIW 210

Query: 507 AFGVVLLELITGK 519
           + G ++ E+ITGK
Sbjct: 211 SVGCIMAEMITGK 223

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 40/193 (20%), Positives = 69/193 (35%), Gaps = 34/193 (17%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS--ISKEVNLLKKI-NHFNLINLFGACE----HDGVFY 389
           G V +          A+K ++      +EV L  +     +++ +    E          
Sbjct: 76  GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135

Query: 390 LVYEFMENGSLSDWLHKKRYPEF----VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
           +V E ++ G L   +  +    F     S      I   +   + YLH+       H+D+
Sbjct: 136 IVMECLDGGELFSRIQDRGDQAFTEREAS-----EIMKSIGEAIQYLHSI---NIAHRDV 187

Query: 446 SSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYME---YGLV 499
              N+L      N   KL +F F   A    S  +S  T   T  Y+APE +    Y   
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGF---AKETTSH-NSLTTPCYTPYYVAPEVLGPEKYD-- 241

Query: 500 TPEMDTYAFGVVL 512
               D ++ GV++
Sbjct: 242 -KSCDMWSLGVIM 253

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 43/191 (22%), Positives = 79/191 (41%), Gaps = 31/191 (16%)

Query: 343 RGIINGSTVAIKCMRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME 396
           R  +    VA+K + R       + +E+   + + H N++             ++ E+  
Sbjct: 40  RDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99

Query: 397 NGSLSDWL-HKKRYPEFVSWNCRFR--IALDVAHGLHYLHNCTDPGYVHKDISSGNILLD 453
            G L + + +  R+ E  +    F+  ++     G+ Y H+       H+D+   N LLD
Sbjct: 100 GGELYERICNAGRFSEDEARFF-FQQLLS-----GVSYCHS---MQICHRDLKLENTLLD 150

Query: 454 KN--LRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---EY-GLVTPEMDTYA 507
            +   R K+ +F +  S           K+ VGT  Y+APE +   EY G      D ++
Sbjct: 151 GSPAPRLKICDFGY--SKSSVLHSQ--PKSTVGTPAYIAPEVLLRQEYDG---KIADVWS 203

Query: 508 FGVVLLELITG 518
            GV L  ++ G
Sbjct: 204 CGVTLYVMLVG 214

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 46/193 (23%), Positives = 81/193 (41%), Gaps = 38/193 (19%)

Query: 347 NGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLF------GACEHDGVFYLV 391
               VAIK + R             E+ L+K +NH N+I+L          E     YLV
Sbjct: 86  LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E M+  +L   +  +   E +S+     +   +  G+ +LH+    G +H+D+   NI+
Sbjct: 146 MELMDA-NLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIV 196

Query: 452 LDKNLRAKLANFSFVRSAVREE--SGYSSTKTAVGTNGYMAPEYM---EYGLVTPEMDTY 506
           +  +   K+ +F   R+A      + Y      V T  Y APE +    Y      +D +
Sbjct: 197 VKSDCTLKILDFGLARTAGTSFMMTPY------VVTRYYRAPEVILGMGY---KENVDIW 247

Query: 507 AFGVVLLELITGK 519
           + G ++ E++  K
Sbjct: 248 SVGCIMGEMVRHK 260

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 23/200 (11%)

Query: 352 AIKCMRRSI---SKEV-------NLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS 401
           A+K +R+ +     EV        +L+   H  L  L  A +       V E+   G L 
Sbjct: 34  AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93

Query: 402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA 461
             L ++R   F     RF  A ++   L YLH+      V++DI   N++LDK+   K+ 
Sbjct: 94  FHLSRERV--FTEERARFYGA-EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKIT 147

Query: 462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA 521
           +F   +  + + +   + KT  GT  Y+APE +E       +D +  GVV+ E++ G+  
Sbjct: 148 DFGLCKEGISDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

Query: 522 AYKQDGEE----ILLAEAVF 537
            Y QD E     IL+ E  F
Sbjct: 205 FYNQDHERLFELILMEEIRF 224

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 69.1 bits (170), Expect = 6e-13
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 32/196 (16%)

Query: 339 GSVF--RGIINGSTVAIKCMRRSI---SKEV-------NLLKKINHFNLINLFGACEHDG 386
           G V   R   NG   A+K +++ I    K+V        +L  + H  +I ++G  +   
Sbjct: 20  GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 79

Query: 387 VFYLVYEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
             +++ +++E G L   L K +R+P  V+   +F  A +V   L YLH+      +++D+
Sbjct: 80  QIFMIMDYIEGGELFSLLRKSQRFPNPVA---KFYAA-EVCLALEYLHSK---DIIYRDL 132

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE---YMEYGLVTPE 502
              NILLDKN   K+ +F F   A         T T  GT  Y+APE      Y      
Sbjct: 133 KPENILLDKNGHIKITDFGF---AKYVP---DVTYTLCGTPDYIAPEVVSTKPYN---KS 183

Query: 503 MDTYAFGVVLLELITG 518
           +D ++FG+++ E++ G
Sbjct: 184 IDWWSFGILIYEMLAG 199

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 68.7 bits (169), Expect = 7e-13
 Identities = 43/192 (22%), Positives = 95/192 (49%), Gaps = 24/192 (12%)

Query: 352 AIKCMRRSI----SKEV-------NLLKKINH-FNLINLFGACEHDGVFYLVYEFMENGS 399
           A+K +++++    +K+        N+L+++ H F +++L  A +  G  YL+ E++  G 
Sbjct: 49  AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF-IVDLIYAFQTGGKLYLILEYLSGGE 107

Query: 400 LSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA 458
           L   L +   + E  +    F +A +++  L +LH     G +++D+   NI+L+     
Sbjct: 108 LFMQLEREGIFMEDTA---CFYLA-EISMALGHLHQK---GIIYRDLKPENIMLNHQGHV 160

Query: 459 KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG 518
           KL +F   + ++ + +    T T  GT  YMAPE +        +D ++ G ++ +++TG
Sbjct: 161 KLTDFGLCKESIHDGT---VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

Query: 519 KEAAYKQDGEEI 530
                 ++ ++ 
Sbjct: 218 APPFTGENRKKT 229

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 69.7 bits (171), Expect = 8e-13
 Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 54/211 (25%)

Query: 339 GSVFRGII--NGSTVAIKCMR---RSISKEVNLLKKINHFNLINLF------GACEHDGV 387
           G V++  +  +G  VAIK +    R  ++E+ +++K++H N++ L       G  + +  
Sbjct: 68  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127

Query: 388 FYLVYEFMENGSLSDWLHK--KRYPEFVSWNCRFRIALDVAH----------GLHYLHNC 435
             LV +++        +++  + Y        R +  L V +           L Y+H+ 
Sbjct: 128 LNLVLDYVP----ET-VYRVARHYS-------RAKQTLPVIYVKLYMYQLFRSLAYIHSF 175

Query: 436 TDPGYVHKDISSGNILLDKNLRA-KLANFSFVRSAVREES--GYSSTKTAVGTNGYMAPE 492
              G  H+DI   N+LLD +    KL +F   +  VR E    Y      + +  Y APE
Sbjct: 176 ---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY------ICSRYYRAPE 226

Query: 493 YM----EYGLVTPEMDTYAFGVVLLELITGK 519
            +    +Y   T  +D ++ G VL EL+ G+
Sbjct: 227 LIFGATDY---TSSIDVWSAGCVLAELLLGQ 254

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 68.7 bits (169), Expect = 9e-13
 Identities = 52/190 (27%), Positives = 95/190 (50%), Gaps = 22/190 (11%)

Query: 352 AIKCMRRS--ISK-------EVNLLKKINH-FNLINLFGACEHDGVFYLVYEFMENGSLS 401
           A+K ++++    +       E ++L ++NH F ++ L  A + +G  YL+ +F+  G L 
Sbjct: 56  AMKVLKKATLKVRDRVRTKMERDILVEVNHPF-IVKLHYAFQTEGKLYLILDFLRGGDLF 114

Query: 402 DWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKL 460
             L K   + E      +F +A ++A  L +LH+    G +++D+   NILLD+    KL
Sbjct: 115 TRLSKEVMFTEEDV---KFYLA-ELALALDHLHSL---GIIYRDLKPENILLDEEGHIKL 167

Query: 461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE 520
            +F   + ++  E       +  GT  YMAPE +     T   D ++FGV++ E++TG  
Sbjct: 168 TDFGLSKESIDHEKK---AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224

Query: 521 AAYKQDGEEI 530
               +D +E 
Sbjct: 225 PFQGKDRKET 234

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 69.2 bits (169), Expect = 9e-13
 Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 28/211 (13%)

Query: 392 YEFMENGSLSDWLHKKR----YPEFVSWNCRFRIALDVAHGLHYL--HNCTDPGYVHKDI 445
             F+E  SLSD   ++     Y +F++       +  VA G+ +L    C     +H+D+
Sbjct: 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRDL 219

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ NILL +    K+ +F   R  + ++  Y     A     +MAPE +   + T + D 
Sbjct: 220 AARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 278

Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV+L E+ +   + Y      + + E     ++ G        +  P       E+ 
Sbjct: 279 WSFGVLLWEIFSLGASPY----PGVKIDEEFCRRLKEGT------RMRAP--DYTTPEM- 325

Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            +  M  L C   EP  RP+ +E+V  L  +
Sbjct: 326 -YQTM--LDCWHGEPSQRPTFSELVEHLGNL 353

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 17/87 (19%)

Query: 339 GSVFRGIING-------STVAIKCMRRSIS--------KEVNLLKKI-NHFNLINLFGAC 382
           G V      G        TVA+K ++   +         E+ +L  I +H N++NL GAC
Sbjct: 36  GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 95

Query: 383 -EHDGVFYLVYEFMENGSLSDWLHKKR 408
            +  G   ++ EF + G+LS +L  KR
Sbjct: 96  TKPGGPLMVIVEFCKFGNLSTYLRSKR 122

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 42/201 (20%), Positives = 84/201 (41%), Gaps = 33/201 (16%)

Query: 339 GSVFRG--IINGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLFGACEHDGV 387
           G V++    +   TVAIK +R    +         EV+LLK++ H N+I L     H+  
Sbjct: 48  GEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
            +L++E+ EN  L  ++ K   P+      +      + +G+++ H       +H+D+  
Sbjct: 108 LHLIFEYAEN-DLKKYMDKN--PDVSMRVIK-SFLYQLINGVNFCH---SRRCLHRDLKP 160

Query: 448 GNILLDKNLRA-----KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----EYGL 498
            N+LL  +  +     K+ +F   R+       ++     + T  Y  PE +     Y  
Sbjct: 161 QNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE---IITLWYRPPEILLGSRHYS- 216

Query: 499 VTPEMDTYAFGVVLLELITGK 519
               +D ++   +  E++   
Sbjct: 217 --TSVDIWSIACIWAEMLMKT 235

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 47/201 (23%), Positives = 86/201 (42%), Gaps = 24/201 (11%)

Query: 352 AIKCMRRSI---SKEVN--------LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           A+K +++ +     +V         L        L  L    +     Y V E++  G L
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429

Query: 401 SDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKL 460
              + +     F   +  F  A ++A GL +L      G +++D+   N++LD     K+
Sbjct: 430 MYHIQQVG--RFKEPHAVFYAA-EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKI 483

Query: 461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE 520
           A+F   +  + +     +TKT  GT  Y+APE + Y      +D +AFGV+L E++ G+ 
Sbjct: 484 ADFGMCKENIWDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540

Query: 521 AAYKQDGEE----ILLAEAVF 537
               +D +E    I+     +
Sbjct: 541 PFEGEDEDELFQSIMEHNVAY 561

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 48/233 (20%), Positives = 91/233 (39%), Gaps = 41/233 (17%)

Query: 311 NLDRGLKFYKYEDLVVA---TENFSPKNMID----GSVFRGI--INGSTVAIKCMRRSIS 361
           N  R  +++ YE  VV     +++     +       VF  I   N   V +K ++    
Sbjct: 15  NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK 74

Query: 362 K----EVNLLKKI-NHFNLINLFGACEHDGVF--YLVYEFMENGSLSDWLHKKRYPEFVS 414
           K    E+ +L+ +    N+I L    +        LV+E + N        K+ Y     
Sbjct: 75  KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF-----KQLYQTLTD 129

Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRA-KLANFSFVRSAV--R 471
           ++ RF +  ++   L Y H+    G +H+D+   N+++D   R  +L ++         +
Sbjct: 130 YDIRFYM-YEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185

Query: 472 EESGYSSTKTAVGTNGYMAPE----YMEYGLVTPEMDTYAFGVVLLELITGKE 520
           E +        V +  +  PE    Y  Y      +D ++ G +L  +I  KE
Sbjct: 186 EYNVR------VASRYFKGPELLVDYQMY---DYSLDMWSLGCMLASMIFRKE 229

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 45/200 (22%), Positives = 76/200 (38%), Gaps = 48/200 (24%)

Query: 347 NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLF-----GACEHDGVFYLVYE 393
           N   VAIK +         +   +E+ +L +  H N+I +         E     Y+V +
Sbjct: 51  NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 110

Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAH----------GLHYLHNCTDPGYVHK 443
            ME    +D L+K      +         L   H          GL Y+H+      +H+
Sbjct: 111 LME----TD-LYK-----LLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHR 152

Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE----YMEYGLV 499
           D+   N+LL+     K+ +F   R A  +          V T  Y APE       Y   
Sbjct: 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY--- 209

Query: 500 TPEMDTYAFGVVLLELITGK 519
           T  +D ++ G +L E+++ +
Sbjct: 210 TKSIDIWSVGCILAEMLSNR 229

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 67.6 bits (166), Expect = 3e-12
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 26/202 (12%)

Query: 352 AIKCMRRSI---SKEVN--------LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           A+K +++ +     +V         L    NH  L  LF   +     + V EF+  G L
Sbjct: 52  AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111

Query: 401 SDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
              + K +R+ E  +   RF  A ++   L +LH+    G +++D+   N+LLD     K
Sbjct: 112 MFHIQKSRRFDEARA---RFYAA-EIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCK 164

Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           LA+F   +  +       +T T  GT  Y+APE ++  L  P +D +A GV+L E++ G 
Sbjct: 165 LADFGMCKEGICNGV---TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

Query: 520 EAAYKQDGEE----ILLAEAVF 537
                ++ ++    IL  E V+
Sbjct: 222 APFEAENEDDLFEAILNDEVVY 243

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 46/207 (22%), Positives = 76/207 (36%), Gaps = 55/207 (26%)

Query: 347 NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLF-----GACEHDGVFYLVYE 393
            G  VAIK +             +E+ +LK   H N+I +F      + E+    Y++ E
Sbjct: 35  TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQE 94

Query: 394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAH----------GLHYLHNCTDPGYVHK 443
            M+    +D LH+      +S        L   H           +  LH       +H+
Sbjct: 95  LMQ----TD-LHR-----VISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHR 136

Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-------VGTNGYMAPE---- 492
           D+   N+L++ N   K+ +F   R      +  S            V T  Y APE    
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196

Query: 493 YMEYGLVTPEMDTYAFGVVLLELITGK 519
             +Y   +  MD ++ G +L EL   +
Sbjct: 197 SAKY---SRAMDVWSCGCILAELFLRR 220

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 67.2 bits (165), Expect = 3e-12
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 26/202 (12%)

Query: 352 AIKCMRRSI---SKEVN--------LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           AIK +++ +     +V         L     H  L ++F   +     + V E++  G L
Sbjct: 46  AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL 105

Query: 401 SDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
              +    ++    +    F  A ++  GL +LH+    G V++D+   NILLDK+   K
Sbjct: 106 MYHIQSCHKFDLSRA---TFYAA-EIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIK 158

Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +A+F   +  +  ++    T T  GT  Y+APE +        +D ++FGV+L E++ G+
Sbjct: 159 IADFGMCKENMLGDA---KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

Query: 520 EAAYKQDGEE----ILLAEAVF 537
              + QD EE    I +    +
Sbjct: 216 SPFHGQDEEELFHSIRMDNPFY 237

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 45/206 (21%), Positives = 82/206 (39%), Gaps = 32/206 (15%)

Query: 339 GSVFRG----IINGSTVAIKCMRR-----SISKEVNLLKKINHFNLINLFGACEH--DGV 387
           G V++       +    A+K +       S  +E+ LL+++ H N+I+L        D  
Sbjct: 35  GHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRK 94

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRF------RIALDVAHGLHYLHNCTDPGYV 441
            +L++++ E+  L   +   R  +      +        +   +  G+HYLH       +
Sbjct: 95  VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVL 150

Query: 442 HKDISSGNILLDKNLRA----KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM--- 494
           H+D+   NIL+          K+A+  F R         +     V T  Y APE +   
Sbjct: 151 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 210

Query: 495 -EYGLVTPEMDTYAFGVVLLELITGK 519
             Y   T  +D +A G +  EL+T +
Sbjct: 211 RHY---TKAIDIWAIGCIFAELLTSE 233

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 33/201 (16%)

Query: 339 GSVFRG--IINGSTVAIKCMR------------RSISKEVNLLKKINHFNLINLFGACEH 384
            +V++G     G  VA+K ++            R    E++L+K++ H N++ L+     
Sbjct: 19  ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKELKHENIVRLYDVIHT 74

Query: 385 DGVFYLVYEFMEN--GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
           +    LV+EFM+N      D       P  +  N        +  GL + H   +   +H
Sbjct: 75  ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILH 131

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----EYGL 498
           +D+   N+L++K  + KL +F   R+     + +SS    V T  Y AP+ +     Y  
Sbjct: 132 RDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE---VVTLWYRAPDVLMGSRTYS- 187

Query: 499 VTPEMDTYAFGVVLLELITGK 519
               +D ++ G +L E+ITGK
Sbjct: 188 --TSIDIWSCGCILAEMITGK 206

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 66.4 bits (163), Expect = 4e-12
 Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 46/205 (22%)

Query: 339 GSVFRGI-INGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLFGACEHDGVF 388
           G V++     G  VA+K +R              E++LLK+++H N+++L      +   
Sbjct: 35  GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAH----------GLHYLHNCTDP 438
            LV+EFME   L   L + +              L  +           G+ + H     
Sbjct: 95  TLVFEFMEK-DLKKVLDENKTG------------LQDSQIKIYLYQLLRGVAHCH---QH 138

Query: 439 GYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---- 494
             +H+D+   N+L++ +   KLA+F   R+       Y+     V T  Y AP+ +    
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE---VVTLWYRAPDVLMGSK 195

Query: 495 EYGLVTPEMDTYAFGVVLLELITGK 519
           +Y      +D ++ G +  E+ITGK
Sbjct: 196 KYS---TSVDIWSIGCIFAEMITGK 217

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 66.2 bits (162), Expect = 7e-12
 Identities = 48/204 (23%), Positives = 75/204 (36%), Gaps = 50/204 (24%)

Query: 348 GSTVAIKCMRRSISK------------------EVNLLKKINHFNLINLF-----GACEH 384
           G  VAIK +  ++S                   E+ LL   +H N++ L           
Sbjct: 46  GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA 105

Query: 385 DGVFYLVYEFMENGSLSDWLH---KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYV 441
               YLV E M     +D L      +       + ++     +  GLH LH     G V
Sbjct: 106 MHKLYLVTELMR----TD-LAQVIHDQRIVISPQHIQY-FMYHILLGLHVLHEA---GVV 156

Query: 442 HKDISSGNILLDKNLRAKLANFSFVRSAVREE--SGYSSTKTAVGTNGYMAPE----YME 495
           H+D+  GNILL  N    + +F+  R    +   + Y      V    Y APE    +  
Sbjct: 157 HRDLHPGNILLADNNDITICDFNLAREDTADANKTHY------VTHRWYRAPELVMQFKG 210

Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
           +   T  +D ++ G V+ E+   K
Sbjct: 211 F---TKLVDMWSAGCVMAEMFNRK 231

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 66.1 bits (162), Expect = 7e-12
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 59/218 (27%)

Query: 339 GSVFRG--IINGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLFGAC----- 382
           G VF+      G  VA+K +     K         E+ +L+ + H N++NL   C     
Sbjct: 31  GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 90

Query: 383 ---EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAH----------GL 429
                 G  YLV++F E+  L+  L                    ++           GL
Sbjct: 91  PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK------------FTLSEIKRVMQMLLNGL 137

Query: 430 HYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF----SFVRSAVREESGYSSTKTAVGT 485
           +Y+H       +H+D+ + N+L+ ++   KLA+F    +F  +   + + Y++    V T
Sbjct: 138 YYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR---VVT 191

Query: 486 NGYMAPEYM----EYGLVTPEMDTYAFGVVLLELITGK 519
             Y  PE +    +YG   P +D +  G ++ E+ T  
Sbjct: 192 LWYRPPELLLGERDYG---PPIDLWGAGCIMAEMWTRS 226

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 66.2 bits (162), Expect = 8e-12
 Identities = 46/185 (24%), Positives = 85/185 (45%), Gaps = 28/185 (15%)

Query: 352 AIKCMRRS--ISK---------EVNLLKKINH--FNLINLFGACEHDGVFYLVYEFMENG 398
           A+K ++++  + K         E  +L+ I    F L+ L  A + +   +L+ +++  G
Sbjct: 86  AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF-LVTLHYAFQTETKLHLILDYINGG 144

Query: 399 SLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR 457
            L   L + +R+ E      +  +  ++   L +LH     G +++DI   NILLD N  
Sbjct: 145 ELFTHLSQRERFTEHEV---QIYVG-EIVLALEHLHKL---GIIYRDIKLENILLDSNGH 197

Query: 458 AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE---YMEYGLVTPEMDTYAFGVVLLE 514
             L +F   +  V +E+         GT  YMAP+     + G     +D ++ GV++ E
Sbjct: 198 VVLTDFGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYE 254

Query: 515 LITGK 519
           L+TG 
Sbjct: 255 LLTGA 259

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 66.1 bits (162), Expect = 8e-12
 Identities = 50/191 (26%), Positives = 84/191 (43%), Gaps = 22/191 (11%)

Query: 352 AIKCMRRSI---SKEVN--------LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           A+K +++      KE          LLK + H  L+ L  + +     Y V +++  G L
Sbjct: 67  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126

Query: 401 SDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
              L + + + E  +   RF  A ++A  L YLH+      V++D+   NILLD      
Sbjct: 127 FYHLQRERCFLEPRA---RFYAA-EIASALGYLHSL---NIVYRDLKPENILLDSQGHIV 179

Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           L +F   +  +   S   +T T  GT  Y+APE +        +D +  G VL E++ G 
Sbjct: 180 LTDFGLCKENIEHNS---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

Query: 520 EAAYKQDGEEI 530
              Y ++  E+
Sbjct: 237 PPFYSRNTAEM 247

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 65.2 bits (160), Expect = 1e-11
 Identities = 47/208 (22%), Positives = 75/208 (36%), Gaps = 47/208 (22%)

Query: 339 GSVFRG--IINGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLFGACEHDGV 387
           G+VF+         VA+K +R              E+ LLK++ H N++ L      D  
Sbjct: 16  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAH----------GLHYLHNCTD 437
             LV+EF +   L  +                   LD             GL + H    
Sbjct: 76  LTLVFEFCDQ-DLKKYFDSCNGD------------LDPEIVKSFLFQLLKGLGFCH---S 119

Query: 438 PGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM--- 494
              +H+D+   N+L+++N   KLANF   R+       YS+    V T  Y  P+ +   
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE---VVTLWYRPPDVLFGA 176

Query: 495 -EYGLVTPEMDTYAFGVVLLELITGKEA 521
             Y      +D ++ G +  EL      
Sbjct: 177 KLYS---TSIDMWSAGCIFAELANAGRP 201

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 64.8 bits (159), Expect = 1e-11
 Identities = 43/195 (22%), Positives = 83/195 (42%), Gaps = 26/195 (13%)

Query: 339 GSVFRGIIN-GSTVAIKCMRRSISK---------EVNLLKKINHFNLINLFGACEHDGVF 388
           G V++   N G T A+K +R              E+++LK++ H N++ L+         
Sbjct: 16  GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
            LV+E ++   L   L         S   +    L + +G+ Y H   D   +H+D+   
Sbjct: 76  VLVFEHLDQ-DLKKLLDVCEGG-LESVTAK-SFLLQLLNGIAYCH---DRRVLHRDLKPQ 129

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----EYGLVTPEMD 504
           N+L+++    K+A+F   R+       Y+     + T  Y AP+ +    +Y      +D
Sbjct: 130 NLLINREGELKIADFGLARAFGIPVRKYTHE---IVTLWYRAPDVLMGSKKYS---TTID 183

Query: 505 TYAFGVVLLELITGK 519
            ++ G +  E++ G 
Sbjct: 184 IWSVGCIFAEMVNGT 198

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 64.9 bits (159), Expect = 1e-11
 Identities = 44/195 (22%), Positives = 84/195 (43%), Gaps = 26/195 (13%)

Query: 339 GSVFRG--IINGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVF 388
            +V++G   +  + VA+K +R         +  +EV+LLK + H N++ L      +   
Sbjct: 16  ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 75

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
            LV+E+++   L  +L           N +      +  GL Y H       +H+D+   
Sbjct: 76  TLVFEYLDK-DLKQYLDDCGNI-INMHNVK-LFLFQLLRGLAYCH---RQKVLHRDLKPQ 129

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----EYGLVTPEMD 504
           N+L+++    KLA+F   R+       Y +    V T  Y  P+ +    +Y     ++D
Sbjct: 130 NLLINERGELKLADFGLARAKSIPTKTYDNE---VVTLWYRPPDILLGSTDYS---TQID 183

Query: 505 TYAFGVVLLELITGK 519
            +  G +  E+ TG+
Sbjct: 184 MWGVGCIFYEMATGR 198

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 46/210 (21%), Positives = 87/210 (41%), Gaps = 53/210 (25%)

Query: 339 GSVFRGIINGS-TVAIKCMR---RSISKEVNLLKKINHFNLINLF------GACEHDGVF 388
           G VF+  +  S  VAIK +    R  ++E+ +++ + H N+++L       G  + +   
Sbjct: 54  GVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113

Query: 389 YLVYEFMENGSLSDWLHK--KRYPEFVSWNCRFRIALDVAH----------GLHYLHNCT 436
            LV E++        +++  + Y        + +  + +             L Y+H+  
Sbjct: 114 NLVLEYVP----ET-VYRASRHYA-------KLKQTMPMLLIKLYMYQLLRSLAYIHSI- 160

Query: 437 DPGYVHKDISSGNILLDKNLRA-KLANFSFVRSAVREES--GYSSTKTAVGTNGYMAPEY 493
             G  H+DI   N+LLD      KL +F   +  +  E    Y      + +  Y APE 
Sbjct: 161 --GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY------ICSRYYRAPEL 212

Query: 494 M----EYGLVTPEMDTYAFGVVLLELITGK 519
           +     Y   T  +D ++ G V+ EL+ G+
Sbjct: 213 IFGATNY---TTNIDIWSTGCVMAELMQGQ 239

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 48/202 (23%), Positives = 89/202 (44%), Gaps = 26/202 (12%)

Query: 352 AIKCMRRSI---SKEVN--------LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           A+K +++ +     +V         L        L  L    +     Y V E++  G L
Sbjct: 49  AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108

Query: 401 SDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
              + +  R+ E  +    F  A ++A GL +L +    G +++D+   N++LD     K
Sbjct: 109 MYHIQQVGRFKEPHA---VFYAA-EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK 161

Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +A+F   +  + +     +TKT  GT  Y+APE + Y      +D +AFGV+L E++ G+
Sbjct: 162 IADFGMCKENIWDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

Query: 520 EAAYKQDGEE----ILLAEAVF 537
                +D +E    I+     +
Sbjct: 219 APFEGEDEDELFQSIMEHNVAY 240

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 41/179 (22%), Positives = 85/179 (47%), Gaps = 20/179 (11%)

Query: 352 AIKCMRRSI---SKEVN--------LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           A+K +++ +    ++++          +  NH  L+ L    + +   + V E++  G L
Sbjct: 38  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97

Query: 401 SDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKL 460
              + ++R  +    + RF  A +++  L+YLH     G +++D+   N+LLD     KL
Sbjct: 98  MFHMQRQR--KLPEEHARFYSA-EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKL 151

Query: 461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
            ++   +  +R      +T T  GT  Y+APE +        +D +A GV++ E++ G+
Sbjct: 152 TDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 58/212 (27%), Positives = 87/212 (41%), Gaps = 56/212 (26%)

Query: 339 GSVFRG--IINGSTVAIKCMR---RSISK---------EVNLLKKINHFNLINLFGACEH 384
            +V++         VAIK ++   RS +K         E+ LL++++H N+I L  A  H
Sbjct: 24  ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAH----------GLHYLHN 434
                LV++FME   L   +                  L  +H          GL YLH 
Sbjct: 84  KSNISLVFDFMET-DLEVIIKDNSLV------------LTPSHIKAYMLMTLQGLEYLHQ 130

Query: 435 CTDPGYVHKDISSGNILLDKNLRAKLANFSFVR---SAVREESGYSSTKTAVGTNGYMAP 491
                 +H+D+   N+LLD+N   KLA+F   +   S  R    Y+     V T  Y AP
Sbjct: 131 H---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YTHQ---VVTRWYRAP 181

Query: 492 EYM----EYGLVTPEMDTYAFGVVLLELITGK 519
           E +     YG     +D +A G +L EL+   
Sbjct: 182 ELLFGARMYG---VGVDMWAVGCILAELLLRV 210

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 63.5 bits (155), Expect = 6e-11
 Identities = 40/179 (22%), Positives = 85/179 (47%), Gaps = 20/179 (11%)

Query: 352 AIKCMRRSI---SKEVN--------LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSL 400
           A++ +++ +    ++++          +  NH  L+ L    + +   + V E++  G L
Sbjct: 81  AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140

Query: 401 SDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKL 460
              + ++R  +    + RF  A +++  L+YLH     G +++D+   N+LLD     KL
Sbjct: 141 MFHMQRQR--KLPEEHARFYSA-EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKL 194

Query: 461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
            ++   +  +R      +T T  GT  Y+APE +        +D +A GV++ E++ G+
Sbjct: 195 TDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 62.3 bits (152), Expect = 9e-11
 Identities = 44/212 (20%), Positives = 82/212 (38%), Gaps = 45/212 (21%)

Query: 339 GSVFRGI--INGSTVAIK---------CMRRSISKEVNLLKKINHFNLINLF-------- 379
           G VF  +       VAIK                +E+ ++++++H N++ +F        
Sbjct: 25  GLVFSAVDNDCDKRVAIKKIVLTDPQSVKH--ALREIKIIRRLDHDNIVKVFEILGPSGS 82

Query: 380 ------GACEHDGVFYLVYEFMENGSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYL 432
                 G+       Y+V E+ME    +D L         +  + R      +  GL Y+
Sbjct: 83  QLTDDVGSLTELNSVYIVQEYME----TD-LANVLEQGPLLEEHARL-FMYQLLRGLKYI 136

Query: 433 HNCTDPGYVHKDISSGNILLD-KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP 491
           H+      +H+D+   N+ ++ ++L  K+ +F   R      S        + T  Y +P
Sbjct: 137 HSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSP 193

Query: 492 E----YMEYGLVTPEMDTYAFGVVLLELITGK 519
                   Y   T  +D +A G +  E++TGK
Sbjct: 194 RLLLSPNNY---TKAIDMWAAGCIFAEMLTGK 222

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 47/206 (22%), Positives = 80/206 (38%), Gaps = 37/206 (17%)

Query: 339 GSVFRG--IINGSTVAIKCMRRSISK------------EVNLLKKIN---HFNLINLF-- 379
           G+V++     +G  VA+K +R                 EV LL+++    H N++ L   
Sbjct: 23  GTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82

Query: 380 ---GACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT 436
                 + +    LV+E ++   L  +L K   P   +   +  +      GL +LH   
Sbjct: 83  CATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DLMRQFLRGLDFLH--- 137

Query: 437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM-- 494
               VH+D+   NIL+      KLA+F   R     +   +     V T  Y APE +  
Sbjct: 138 ANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTPV---VVTLWYRAPEVLLQ 193

Query: 495 -EYGLVTPEMDTYAFGVVLLELITGK 519
             Y      +D ++ G +  E+   K
Sbjct: 194 STYA---TPVDMWSVGCIFAEMFRRK 216

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 35/204 (17%)

Query: 339 GSVFRGI---INGSTVAIKCMRRSISK---------EVNLLKKIN---HFNLINLF---- 379
           G VF+       G  VA+K +R    +         EV +L+ +    H N++ LF    
Sbjct: 25  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84

Query: 380 -GACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDP 438
               + +    LV+E ++   L+ +L K   P   +   +  +   +  GL +LH     
Sbjct: 85  VSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK-DMMFQLLRGLDFLH---SH 139

Query: 439 GYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM---E 495
             VH+D+   NIL+  + + KLA+F   R     +   +S    V T  Y APE +    
Sbjct: 140 RVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSV---VVTLWYRAPEVLLQSS 195

Query: 496 YGLVTPEMDTYAFGVVLLELITGK 519
           Y      +D ++ G +  E+   K
Sbjct: 196 YA---TPVDLWSVGCIFAEMFRRK 216

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 61.2 bits (149), Expect = 4e-10
 Identities = 42/214 (19%), Positives = 80/214 (37%), Gaps = 54/214 (25%)

Query: 339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLF------GACE 383
           G+V  G     G +VAIK +        R +   +  L  ++H N++ L       G  +
Sbjct: 37  GTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSYFYTLGERD 95

Query: 384 HDGVF-YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAH----------GLHYL 432
              ++  +V E++        LH+           R ++A                +  L
Sbjct: 96  RRDIYLNVVMEYVP----DT-LHR-----CCRNYYRRQVAPPPILIKVFLFQLIRSIGCL 145

Query: 433 HNCTDPGYVHKDISSGNILLDK-NLRAKLANFSFVRSAVREES--GYSSTKTAVGTNGYM 489
           H  +     H+DI   N+L+++ +   KL +F   +     E    Y      + +  Y 
Sbjct: 146 HLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY------ICSRYYR 198

Query: 490 APEYM----EYGLVTPEMDTYAFGVVLLELITGK 519
           APE +     Y   T  +D ++ G +  E++ G+
Sbjct: 199 APELIFGNQHY---TTAVDIWSVGCIFAEMMLGE 229

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 61.4 bits (148), Expect = 7e-10
 Identities = 63/401 (15%), Positives = 113/401 (28%), Gaps = 104/401 (25%)

Query: 159 CPTSNQIVNGTKFLLTYLVSWGDSVPDISKRFNVSIESIVNA-NGFTEDDP----LL--- 210
           C +   ++   + LL  +     S  D S    + I SI        +  P    LL   
Sbjct: 192 CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL 251

Query: 211 ----------FPFT-TILIPLTT------EPLSSQTIIHYPPPPSSPIVPTRK-YNQTSS 252
                     F  +  IL+  TT      + LS+ T  H        +            
Sbjct: 252 NVQNAKAWNAFNLSCKILL--TTRFKQVTDFLSAATTTHIS------LDHHSMTLTPDEV 303

Query: 253 RGIYL-WVGIGI--------GISLLVICFVLSIVLFHHKRRRDEAARKDG-KREKKRNLP 302
           + + L ++              +   +    SI+    +  RD  A  D  K      L 
Sbjct: 304 KSLLLKYLDCRPQDLPREVLTTNPRRL----SII---AESIRDGLATWDNWKHVNCDKLT 356

Query: 303 EDFLVSVSNLDRGLKFYKYEDLVVATENFSPKNM-IDGSVFRGII--NGST-----VAIK 354
                S++ L+       ++ L V    F P +  I   +   +I  +        V  K
Sbjct: 357 TIIESSLNVLEPAEYRKMFDRLSV----F-PPSAHIPTILL-SLIWFDVIKSDVMVVVNK 410

Query: 355 CMRRSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK---RYPE 411
             + S      L++K    + I++          YL  +       +  LH+     Y  
Sbjct: 411 LHKYS------LVEKQPKESTISI-----PS--IYLELKVKLENEYA--LHRSIVDHYNI 455

Query: 412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR 471
             ++     +         Y H     G+ H   +  +       R    +F F+   +R
Sbjct: 456 PKTF-DSDDLIPPYLDQYFYSH----IGH-HLK-NIEHPERMTLFRMVFLDFRFLEQKIR 508

Query: 472 EESGYSSTKTAVGTNGYMAP------EYMEYGLVTPEMDTY 506
                    TA   +G +         Y  Y  +      Y
Sbjct: 509 ------HDSTAWNASGSILNTLQQLKFYKPY--ICDNDPKY 541

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 60.1 bits (146), Expect = 9e-10
 Identities = 43/226 (19%), Positives = 73/226 (32%), Gaps = 67/226 (29%)

Query: 347 NGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLF-----GACEHDGVFYLVY 392
               VAIK + R             E+ +L ++    +I L+              Y+V 
Sbjct: 50  TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109

Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAH----------GLHYLHNCTDPGYVH 442
           E  +    SD L K           +  I L   H          G +++H     G +H
Sbjct: 110 EIAD----SD-LKKL---------FKTPIFLTEEHIKTILYNLLLGENFIHES---GIIH 152

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-------------------V 483
           +D+   N LL+++   K+ +F   R+   E+                            V
Sbjct: 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHV 212

Query: 484 GTNGYMAPE----YMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQ 525
            T  Y APE       Y   T  +D ++ G +  EL+   ++    
Sbjct: 213 VTRWYRAPELILLQENY---TKSIDIWSTGCIFAELLNMLQSHIND 255

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 33/184 (17%), Positives = 66/184 (35%), Gaps = 41/184 (22%)

Query: 347 NGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLF-----GACEHDGVFYLVY 392
               VAIK + R             E+ +L ++NH +++ +         E     Y+V 
Sbjct: 77  EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136

Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAH----------GLHYLHNCTDPGYVH 442
           E  +    SD   K           R  + L   H          G+ Y+H+    G +H
Sbjct: 137 EIAD----SD-FKKL---------FRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILH 179

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           +D+   N L++++   K+ +F   R+    E+G S    +   +      +     +  +
Sbjct: 180 RDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQ 239

Query: 503 MDTY 506
           +  +
Sbjct: 240 LTGH 243

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 51/221 (23%), Positives = 87/221 (39%), Gaps = 73/221 (33%)

Query: 347 NGSTVAIKCMRRSISK---------EVNLLKKIN-HFNLINLFGAC--EHDGVFYLVYEF 394
            G  VA+K +  +            E+ +L +++ H N++NL      ++D   YLV+++
Sbjct: 33  TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY 92

Query: 395 MENGSLSDWLHKKRYPEFVSWNCRFRI----ALDVAH----------GLHYLHNCTDPGY 440
           ME    +D LH               +     L+  H           + YLH+    G 
Sbjct: 93  ME----TD-LH--------------AVIRANILEPVHKQYVVYQLIKVIKYLHSG---GL 130

Query: 441 VHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA------------------ 482
           +H+D+   NILL+     K+A+F   RS V      ++   +                  
Sbjct: 131 LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDY 190

Query: 483 VGTNGYMAPE----YMEYGLVTPEMDTYAFGVVLLELITGK 519
           V T  Y APE      +Y   T  +D ++ G +L E++ GK
Sbjct: 191 VATRWYRAPEILLGSTKY---TKGIDMWSLGCILGEILCGK 228

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 56.0 bits (134), Expect = 1e-08
 Identities = 36/213 (16%), Positives = 56/213 (26%), Gaps = 65/213 (30%)

Query: 339 GSVFRGIINGSTVAIKCMR---------------RSISKEVNLLKKI---------NHFN 374
           G VF+ I + + VAIK +                  I  E+ + K++             
Sbjct: 34  GEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93

Query: 375 LINLFGACEHDGVF------------------------------YLVYEFMENGSLSDWL 404
            I L       G +                              ++V EF   G   + +
Sbjct: 94  FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQM 153

Query: 405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS 464
             K      S      I   +   L          + H+D+  GN+LL K    KL    
Sbjct: 154 RTK----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTL 207

Query: 465 FVRSAVREESGYSSTKTAVGTNGYMAPEYMEYG 497
             +S+     G       V    Y        G
Sbjct: 208 NGKSSTIPSCGLQ-----VSIIDYTLSRLERDG 235

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 77

 Score = 50.6 bits (121), Expect = 2e-08
 Identities = 16/57 (28%), Positives = 30/57 (52%), Gaps = 1/57 (1%)

Query: 173 LTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQT 229
           L + +  GD++  ++ ++ V++E I  AN    +D  +F   T+ IP+ TEP     
Sbjct: 16  LEHQLEPGDTLAGLALKYGVTMEQIKRANRLYTND-SIFLKKTLYIPILTEPRDLFN 71

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 26/139 (18%), Positives = 48/139 (34%), Gaps = 16/139 (11%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS--ISKEVNLLKKI-NHFNLINLFGACE----HDGVFY 389
           G V +          A+K ++      +EV L  +     +++ +    E          
Sbjct: 32  GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           +V E ++ G L   +  +    F        I   +   + YLH+       H+D+   N
Sbjct: 92  IVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHSI---NIAHRDVKPEN 147

Query: 450 ILL---DKNLRAKLANFSF 465
           +L      N   KL +F F
Sbjct: 148 LLYTSKRPNAILKLTDFGF 166

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 48/241 (19%), Positives = 84/241 (34%), Gaps = 82/241 (34%)

Query: 339 GSVFRGIIN--GSTVAIK---CMRRSISKEVNLLKKINHFNLINL---FGACEHDGVF-- 388
           G V        G   A+K      R  ++E++++K ++H N+I L   F     +     
Sbjct: 21  GIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80

Query: 389 ---------------------------------YLVYEFMENGSLSDWLHKKRYPEFVSW 415
                                             ++ E++        LHK      +  
Sbjct: 81  QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP----DT-LHK-----VLKS 130

Query: 416 NCRFRIALDVAH----------GLHYLHNCTDPGYVHKDISSGNILLD-KNLRAKLANFS 464
             R   ++ +             + ++H+    G  H+DI   N+L++ K+   KL +F 
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFG 187

Query: 465 FVRSAVREES--GYSSTKTAVGTNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELITG 518
             +  +  E    Y      + +  Y APE M    EY   TP +D ++ G V  ELI G
Sbjct: 188 SAKKLIPSEPSVAY------ICSRFYRAPELMLGATEY---TPSIDLWSIGCVFGELILG 238

Query: 519 K 519
           K
Sbjct: 239 K 239

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 41/203 (20%), Positives = 80/203 (39%), Gaps = 43/203 (21%)

Query: 347 NGSTVAIKC------MRRSISKEVNLLKKIN-----------HFNLINLFGACEHDGVFY 389
           N + VA+K          +   E+ LL+++N             +++ L     H G   
Sbjct: 43  NNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 102

Query: 390 ----LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
               +V+E +   +L   + K  +        + +I+  +  GL Y+H     G +H DI
Sbjct: 103 VHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK-QISKQLLLGLDYMH--RRCGIIHTDI 158

Query: 446 SSGNILLDKNLRA------KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE---YMEY 496
              N+L++           K+A+     +A   +  Y+++   + T  Y +PE      +
Sbjct: 159 KPENVLMEIVDSPENLIQIKIADLG---NACWYDEHYTNS---IQTREYRSPEVLLGAPW 212

Query: 497 GLVTPEMDTYAFGVVLLELITGK 519
           G      D ++   ++ ELITG 
Sbjct: 213 G---CGADIWSTACLIFELITGD 232

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 42/197 (21%), Positives = 78/197 (39%), Gaps = 27/197 (13%)

Query: 339 GSVFRGI--INGSTVAIK------CMRRSISKEVNLLKKINH------FNLINLFGACEH 384
           G V +         VA+K         R  ++E+ +L+ +         N+I++      
Sbjct: 111 GQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
                + +E +   +L + + K ++  F     R + A  +   L  LH       +H D
Sbjct: 171 RNHICMTFELLSM-NLYELIKKNKFQGFSLPLVR-KFAHSILQCLDALHKN---RIIHCD 225

Query: 445 ISSGNILLDKNLRA--KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           +   NILL +  R+  K+ +F    S+  E        T + +  Y APE +        
Sbjct: 226 LKPENILLKQQGRSGIKVIDFG---SSCYEHQRVY---TYIQSRFYRAPEVILGARYGMP 279

Query: 503 MDTYAFGVVLLELITGK 519
           +D ++ G +L EL+TG 
Sbjct: 280 IDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 47.8 bits (114), Expect = 6e-06
 Identities = 43/200 (21%), Positives = 76/200 (38%), Gaps = 31/200 (15%)

Query: 339 GSVFRGI--INGSTVAIK------CMRRSISKEVNLLKKINH------FNLINLFGACEH 384
           G V +    +    VAIK              EV LL+ +N       + +++L      
Sbjct: 68  GQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
                LV+E +   +L D L    +        R + A  +   L +L    +   +H D
Sbjct: 128 RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTR-KFAQQMCTALLFLAT-PELSIIHCD 184

Query: 445 ISSGNILLDKNLRA--KLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE---YMEYGLV 499
           +   NILL    R+  K+ +F    S+ +           + +  Y +PE    M Y   
Sbjct: 185 LKPENILLCNPKRSAIKIVDFG---SSCQLGQRIY---QYIQSRFYRSPEVLLGMPYD-- 236

Query: 500 TPEMDTYAFGVVLLELITGK 519
              +D ++ G +L+E+ TG+
Sbjct: 237 -LAIDMWSLGCILVEMHTGE 255

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 47.6 bits (113), Expect = 7e-06
 Identities = 33/124 (26%), Positives = 49/124 (39%), Gaps = 30/124 (24%)

Query: 351 VAIK------CMRRSISKEVNLLKKINHFN-----------LINLFGACEHDGVFY---- 389
           VA+K          +   E+ LLK + + +           L++ F   +  GV      
Sbjct: 65  VAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF---KISGVNGTHIC 121

Query: 390 LVYEFMENG-SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           +V+E +  G  L  W+ K  Y        + +I   V  GL YLH  T    +H DI   
Sbjct: 122 MVFEVL--GHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLDYLH--TKCRIIHTDIKPE 176

Query: 449 NILL 452
           NILL
Sbjct: 177 NILL 180

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 48/216 (22%), Positives = 77/216 (35%), Gaps = 43/216 (19%)

Query: 339 GSVFRGI--INGSTVAIK------CMRRSISKEVNLLKKINH-----FNLINLFGACEHD 385
           G V       N    A+K         RS   E ++LKKI +      N++   G   + 
Sbjct: 49  GRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108

Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
               L++E +   SL + + +  Y  F   + +    +++   L+YL         H D+
Sbjct: 109 DHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIK-LYCIEILKALNYLRKM---SLTHTDL 163

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV-----G--------------TN 486
              NILLD     K        +  ++   Y +  T +     G              T 
Sbjct: 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTR 223

Query: 487 GYMAPE---YMEYGLVTPEMDTYAFGVVLLELITGK 519
            Y APE    + +       D ++FG VL EL TG 
Sbjct: 224 QYRAPEVILNLGWD---VSSDMWSFGCVLAELYTGS 256

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 33/167 (19%), Positives = 57/167 (34%), Gaps = 23/167 (13%)

Query: 339 GSVFRG--IINGSTVAIKCMRR-----SISKEVNLLKKINHFNLI-NLFGACEHDGVFYL 390
           G ++ G  I  G  VAIK          +  E  + K +     I  +           +
Sbjct: 23  GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82

Query: 391 VYEFMENG-SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           V E +  G SL D L      +F S      +A  +   + Y+H+     ++H+D+   N
Sbjct: 83  VMELL--GPSLED-LFNFCSRKF-SLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDN 135

Query: 450 ILLDKNLRAK---LANFSFVRSAVREESG----YSSTKTAVGTNGYM 489
            L+    +     + +F   +      +     Y   K   GT  Y 
Sbjct: 136 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 43/212 (20%), Positives = 72/212 (33%), Gaps = 39/212 (18%)

Query: 339 GSVFR---GIINGSTVAIKC------MRRSISKEVNLLKKINH------FNLINLFGACE 383
           G V          S VA+K        R +   E+N+LKKI        F  + +     
Sbjct: 33  GKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHK 443
             G   + +E +   +  ++L +  +  +   + R  +A  + H L +LH        H 
Sbjct: 93  FHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVR-HMAYQLCHALRFLHEN---QLTHT 147

Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGY-------SSTK------TAVGTNGYMA 490
           D+   NIL   +    L N          ++         S+T       T V T  Y  
Sbjct: 148 DLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRP 207

Query: 491 PE---YMEYGLVTPEMDTYAFGVVLLELITGK 519
           PE    + +       D ++ G +L E   G 
Sbjct: 208 PEVILELGWA---QPCDVWSIGCILFEYYRGF 236

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 44/212 (20%), Positives = 79/212 (37%), Gaps = 39/212 (18%)

Query: 339 GSVFRGI---INGSTVAIKC------MRRSISKEVNLLKKINH------FNLINLFGACE 383
           G V   I     G  VA+K          +   E+ +L+ +N       F  + +    E
Sbjct: 28  GKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHK 443
           H G   +V+E +   S  D++ +  +  F   + R ++A  +   +++LH+       H 
Sbjct: 88  HHGHICIVFELLGL-STYDFIKENGFLPFRLDHIR-KMAYQICKSVNFLHSN---KLTHT 142

Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGY-------SSTK------TAVGTNGYMA 490
           D+   NIL  ++   +  N    R      +         S+T       T V T  Y A
Sbjct: 143 DLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRA 202

Query: 491 PE---YMEYGLVTPEMDTYAFGVVLLELITGK 519
           PE    + +       D ++ G +L+E   G 
Sbjct: 203 PEVILALGWS---QPCDVWSIGCILIEYYLGF 231

>1y7m_A Hypothetical protein BSU14040; surface mutagenesis, cysteine proteases, cell WALL catabolism, structural genomics, PSI; 2.05A {Bacillus subtilis subsp} SCOP: b.160.1.1 d.7.1.1 Length = 164

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 17/60 (28%), Positives = 29/60 (48%), Gaps = 2/60 (3%)

Query: 172 LLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTEPLSSQTII 231
           +LTY V  GD++  I+  F +S  +++ AN        L    +I+IP   +P +    I
Sbjct: 1   MLTYQVKQGDTLNSIAADFRISTAALLQANP--SLQAGLTAGQSIVIPGLPDPYTIPYHI 58

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 33/167 (19%), Positives = 58/167 (34%), Gaps = 23/167 (13%)

Query: 339 GSVFRG--IINGSTVAIKCMRR-----SISKEVNLLKKINHFNLI-NLFGACEHDGVFYL 390
           G ++ G  I     VAIK          +  E  + + +     I N+           L
Sbjct: 21  GEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80

Query: 391 VYEFMENG-SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           V + +  G SL D L      +  S      +A  + + + ++H+     ++H+DI   N
Sbjct: 81  VMDLL--GPSLED-LFNFCSRKL-SLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDN 133

Query: 450 ILLDKNLRAK---LANFSFVRSAVREESG----YSSTKTAVGTNGYM 489
            L+    RA    + +F   +      +     Y   K   GT  Y 
Sbjct: 134 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1 Length = 48

 Score = 36.7 bits (86), Expect = 7e-04
 Identities = 13/34 (38%), Positives = 21/34 (61%)

Query: 173 LTYLVSWGDSVPDISKRFNVSIESIVNANGFTED 206
           +TY V  GDS+  I+KR  V+I+ ++  N  T +
Sbjct: 3   ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDTAN 36

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	611
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.98
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.79
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	99.79
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.61
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.39
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	99.35
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	99.33
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	99.19
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	99.16
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	99.1
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.08
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.89
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	98.89
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.8
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	98.7
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	98.68
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.56
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.26
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.16
4a1k_A	165	Putative L, D-transpeptidase YKUD; transferase, pe	98.08
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.07
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.89
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.68
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.65
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.58
4a1k_A	165	Putative L, D-transpeptidase YKUD; transferase, pe	97.49
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.05
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.93
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	96.82
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.72
3slu_A	371	M23 peptidase domain protein; outer membrane, hydr	96.69
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.38
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.94
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.89
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	95.84
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	95.82
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.61
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.6
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.58
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.46
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.2
3slu_A	371	M23 peptidase domain protein; outer membrane, hydr	93.95
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	93.76
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	93.73
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.57
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	91.42
3mes_A	424	Choline kinase; malaria, structural genomics, stru	90.9
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	88.4

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.6e-52  Score=422.62  Aligned_cols=239  Identities=26%  Similarity=0.513  Sum_probs=199.8

Q ss_pred             ceEEEEEE-------cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII-------NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|++       +|..||||+++       ++|.+|+++|++++|||||+++|+|.+++..+||||||++|+|.++|
T Consensus        27 G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l  106 (299)
T 4asz_A           27 GKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL  106 (299)
T ss_dssp             CCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred             cEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHH
Confidence            99999986       36789999995       46899999999999999999999999999999999999999999999


Q ss_pred             hccC----------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC
Q 007261          405 HKKR----------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES  474 (611)
Q Consensus       405 ~~~~----------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~  474 (611)
                      +..+          ....++|.++++|+.|||.||+|||   +++|+||||||+||||++++.+||+|||+|+.......
T Consensus       107 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  183 (299)
T 4asz_A          107 RAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY  183 (299)
T ss_dssp             HHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC
T ss_pred             HhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEECCcccceecCCCCc
Confidence            8642          2356999999999999999999999   58999999999999999999999999999986543321


Q ss_pred             CcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCccccccccc
Q 007261          475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV  553 (611)
Q Consensus       475 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  553 (611)
                       ........||+.|||||.+.++.++.++|||||||+||||+| |+.||......+.     ...... +          
T Consensus       184 -~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~-----~~~i~~-~----------  246 (299)
T 4asz_A          184 -YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-----IECITQ-G----------  246 (299)
T ss_dssp             -EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----HHHHHH-T----------
T ss_pred             -eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----HHHHHc-C----------
Confidence             223344578999999999999999999999999999999999 8999876544321     111111 1          


Q ss_pred             CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       554 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                        .....+..++.++.+|+.+||+.||++||||.||++.|+++...
T Consensus       247 --~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          247 --RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence              11112344667899999999999999999999999999987654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-51  Score=417.48  Aligned_cols=242  Identities=26%  Similarity=0.471  Sum_probs=194.1

Q ss_pred             ceEEEEEEcCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|++.+ .||||+++         ++|.+|+.+|++++|||||+++|+|.+ +..+||||||++|+|.++|+... 
T Consensus        50 G~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~-  126 (307)
T 3omv_A           50 GTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQE-  126 (307)
T ss_dssp             SEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSC-
T ss_pred             cEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcC-
Confidence            9999999866 59999985         468899999999999999999999865 56899999999999999998654 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                       ..++|..+++|+.|||.||+|||   +.+|+||||||+||||++++.+||+|||+|+....... ........||+.||
T Consensus       127 -~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~-~~~~~~~~GT~~ym  201 (307)
T 3omv_A          127 -TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG-SQQVEQPTGSVLWM  201 (307)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------------CCCCTTSC
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc-ceeecccccCCCcc
Confidence             34999999999999999999999   58999999999999999999999999999986543221 22344568999999


Q ss_pred             chhhhcc---CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          490 APEYMEY---GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       490 aPE~~~~---~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      |||++.+   +.|+.++|||||||+||||+||+.||.........     ...+..+        ...|.+...+.+++.
T Consensus       202 APE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~-----~~~~~~~--------~~~p~~~~~~~~~~~  268 (307)
T 3omv_A          202 APEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI-----IFMVGRG--------YASPDLSKLYKNCPK  268 (307)
T ss_dssp             CHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-----HHHHHTT--------CCCCCSTTSCTTSCH
T ss_pred             CHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH-----HHHHhcC--------CCCCCcccccccchH
Confidence            9999863   46899999999999999999999999765543221     1112111        122333333445677


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                      .+.+|+.+||+.||++||||.||+++|+.++....
T Consensus       269 ~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          269 AMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             HHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            89999999999999999999999999998876543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.1e-51  Score=420.26  Aligned_cols=236  Identities=22%  Similarity=0.435  Sum_probs=197.6

Q ss_pred             ceEEEEEE-------cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII-------NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|.+       +++.||||+++        ++|.+|+.+|++++|||||+++|+|.+++..+||||||++|+|.++
T Consensus        40 G~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~  119 (308)
T 4gt4_A           40 GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF  119 (308)
T ss_dssp             CEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHH
T ss_pred             cEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHH
Confidence            99999987       35689999985        4699999999999999999999999999999999999999999999


Q ss_pred             hhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccc
Q 007261          404 LHKKRY-------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV  470 (611)
Q Consensus       404 l~~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~  470 (611)
                      |+....             ...++|..+++|+.|||.||+|||   +.+|+||||||+||||++++.+||+|||+++...
T Consensus       120 L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~  196 (308)
T 4gt4_A          120 LVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY  196 (308)
T ss_dssp             HHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGG
T ss_pred             HHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCEEECCcccceecc
Confidence            975321             235899999999999999999999   5889999999999999999999999999998764


Q ss_pred             cccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCccccc
Q 007261          471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKL  549 (611)
Q Consensus       471 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l  549 (611)
                      .... ........||+.|||||.+.++.++.++|||||||+||||+| |+.||......+.      ...+..+      
T Consensus       197 ~~~~-~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~------~~~i~~~------  263 (308)
T 4gt4_A          197 AADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV------VEMIRNR------  263 (308)
T ss_dssp             GGGC-BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH------HHHHHTT------
T ss_pred             CCCc-eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcC------
Confidence            4322 223445679999999999999999999999999999999999 7888876543321      1112111      


Q ss_pred             ccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       550 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                            ...+.+.+++.++.+|+.+||+.||++||||.||+++|+.+
T Consensus       264 ------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          264 ------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                  11122445677899999999999999999999999999865

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.3e-51  Score=423.93  Aligned_cols=239  Identities=26%  Similarity=0.491  Sum_probs=192.3

Q ss_pred             ceEEEEEE-------cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII-------NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|++       ++..||||+++       ++|.+|+++|++++|||||+++|+|.+++..+||||||++|+|.++|
T Consensus        55 G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l  134 (329)
T 4aoj_A           55 GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL  134 (329)
T ss_dssp             EEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred             cEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHH
Confidence            99999987       36789999995       46899999999999999999999999999999999999999999999


Q ss_pred             hccCC------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          405 HKKRY------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       405 ~~~~~------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      +....            ...++|.++++|+.|||.||+|||   +.+|+||||||+||||++++.+||+|||+++.....
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~  211 (329)
T 4aoj_A          135 RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST  211 (329)
T ss_dssp             HTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             HhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEEEcccccceeccCC
Confidence            86432            245999999999999999999999   588999999999999999999999999999866433


Q ss_pred             cCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCccccccc
Q 007261          473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV  551 (611)
Q Consensus       473 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  551 (611)
                      .. ........||+.|||||++.+..++.++|||||||+||||+| |+.||......+.     +.....+.        
T Consensus       212 ~~-~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~-----~~~i~~g~--------  277 (329)
T 4aoj_A          212 DY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-----IDCITQGR--------  277 (329)
T ss_dssp             ---------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH-----HHHHHHTC--------
T ss_pred             Cc-ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH-----HHHHHcCC--------
Confidence            21 223345679999999999999999999999999999999999 8999876543321     11111111        


Q ss_pred             ccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          552 LVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       552 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                           ....+..+++++.+|+.+||+.||++||||.||+++|+.+...
T Consensus       278 -----~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          278 -----ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -----CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence                 0112334567899999999999999999999999999988654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.7e-49  Score=414.51  Aligned_cols=258  Identities=26%  Similarity=0.443  Sum_probs=205.6

Q ss_pred             hHHHHHhhcCCCCCccc----ceEEEEEEcC-------cEEEEEEec--------HHHHHHHHHHHhcCC-Cceeeccce
Q 007261          322 EDLVVATENFSPKNMID----GSVFRGIING-------STVAIKCMR--------RSISKEVNLLKKINH-FNLINLFGA  381 (611)
Q Consensus       322 ~el~~at~~f~~~~~ig----g~Vy~g~~~g-------~~vavK~~~--------~~~~~E~~~l~~l~H-~niv~l~g~  381 (611)
                      ++.++..++|.....||    |.||+|.+.+       +.||||+++        ++|.+|+.+|.+++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            33444445565555665    8999999743       579999985        358899999999965 999999999


Q ss_pred             eccC-CeEEEEEeecCCCCHHHHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 007261          382 CEHD-GVFYLVYEFMENGSLSDWLHKKRY-------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS  447 (611)
Q Consensus       382 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~  447 (611)
                      |.+. +..+||||||++|+|.++|+....             ...++|..++.++.|||.||+|||   +.+|+||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~  213 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA  213 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCc
Confidence            9764 568999999999999999976421             345899999999999999999999   68999999999


Q ss_pred             CCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCC
Q 007261          448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQD  526 (611)
Q Consensus       448 ~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~  526 (611)
                      +|||+++++.+||+|||+|+....... ........||+.|||||++.+..++.++|||||||+||||+| |+.||....
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999987644322 223445678999999999999999999999999999999998 899987654


Q ss_pred             ChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          527 GEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       527 ~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      ..+..     ...+..+.            ....+..++.++.+++.+||+.||++||||.||+++|+++....
T Consensus       293 ~~~~~-----~~~i~~g~------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          293 IDEEF-----CRRLKEGT------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             CSHHH-----HHHHHHTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHH-----HHHHHcCC------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            33221     11111111            11123345677999999999999999999999999999876543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.9e-48  Score=398.49  Aligned_cols=248  Identities=25%  Similarity=0.362  Sum_probs=190.1

Q ss_pred             ceEEEEEEcCcEEEEEEecH----HHH--HHHHHHHhcCCCceeeccceeccCC----eEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGIINGSTVAIKCMRR----SIS--KEVNLLKKINHFNLINLFGACEHDG----VFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~~----~~~--~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|+++|+.||||+++.    ++.  .|+..+.+++|||||+++|+|.+++    ..|||||||++|+|.++|+...
T Consensus        17 G~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~   96 (303)
T 3hmm_A           17 GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT   96 (303)
T ss_dssp             SEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC
T ss_pred             eEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCC
Confidence            99999999999999999962    333  4566667889999999999997653    6899999999999999998754


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc-cccccc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNC-----TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY-SSTKTA  482 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~-----~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~  482 (611)
                          ++|..+++++.|++.||+|||+.     ..++|+||||||+||||++++.+||+|||+++......... ......
T Consensus        97 ----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~  172 (303)
T 3hmm_A           97 ----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR  172 (303)
T ss_dssp             ----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC----
T ss_pred             ----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccc
Confidence                89999999999999999999953     13489999999999999999999999999998764432211 123346


Q ss_pred             ccCCCccchhhhccC------CCCCccchHHHHHHHHHHHhCCCCCcCCCChh----------hHHHHHHHHHHhcCCcc
Q 007261          483 VGTNGYMAPEYMEYG------LVTPEMDTYAFGVVLLELITGKEAAYKQDGEE----------ILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~------~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~----------~~l~~~~~~~~~~~~~~  546 (611)
                      .||+.|||||++.+.      .++.++|||||||+||||+||+.|+......+          ... ..+.....     
T Consensus       173 ~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~~~-----  246 (303)
T 3hmm_A          173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV-EEMRKVVC-----  246 (303)
T ss_dssp             -CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH-HHHHHHHT-----
T ss_pred             cccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH-HHHHHHHh-----
Confidence            799999999999754      46789999999999999999987764322111          001 11111111     


Q ss_pred             cccccccCccCCcC--hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          547 AKLSVLVDPNLQAN--KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       547 ~~l~~~~d~~l~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                         ....+|.+...  ..+++..+.+|+.+||+.||++||||.||++.|+++..+
T Consensus       247 ---~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          247 ---EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             ---TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ---cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence               11122333322  235677899999999999999999999999999988654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-48  Score=402.81  Aligned_cols=242  Identities=21%  Similarity=0.254  Sum_probs=197.8

Q ss_pred             ceEEEEEE--cCcEEEEEEecHH--HHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccC
Q 007261          339 GSVFRGII--NGSTVAIKCMRRS--ISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVS  414 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~--~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~  414 (611)
                      |.||+|+.  +|+.||||+++.+  ..+|+.+|++++|||||++++++.+++..|||||||++|+|.++|+..+   .++
T Consensus        72 G~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~---~l~  148 (336)
T 4g3f_A           72 GEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG---CLP  148 (336)
T ss_dssp             EEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS---SCC
T ss_pred             eEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC---CCC
Confidence            89999998  6899999999743  4579999999999999999999999999999999999999999998753   499


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeecCccccccccCCc--ccccccccCCCccch
Q 007261          415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL-RAKLANFSFVRSAVREESGY--SSTKTAVGTNGYMAP  491 (611)
Q Consensus       415 ~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~~~~--~~~~~~~gt~~y~aP  491 (611)
                      +..++.++.||+.||+|||   +.+|+||||||+||||+.++ .+||+|||+|+.........  ......+||+.||||
T Consensus       149 e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAP  225 (336)
T 4g3f_A          149 EDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP  225 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCH
T ss_pred             HHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCH
Confidence            9999999999999999999   68999999999999999987 69999999998764332211  123345799999999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML  571 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l  571 (611)
                      |++.+..++.++|||||||+||||++|+.||......+...     ......           +.+...+..++..+.+|
T Consensus       226 E~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-----~i~~~~-----------~~~~~~~~~~s~~~~~l  289 (336)
T 4g3f_A          226 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-----KIASEP-----------PPIREIPPSCAPLTAQA  289 (336)
T ss_dssp             HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH-----HHHHSC-----------CGGGGSCTTSCHHHHHH
T ss_pred             HHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-----HHHcCC-----------CCchhcCccCCHHHHHH
Confidence            99999999999999999999999999999997655433211     111111           11111233456778999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          572 CLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       572 ~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                      +.+||+.||++|||+.|++++|.+.......
T Consensus       290 i~~~L~~dP~~R~sa~el~~~l~~~l~~~~~  320 (336)
T 4g3f_A          290 IQEGLRKEPVHRASAMELRRKVGKALQEVGG  320 (336)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred             HHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence            9999999999999999999999887665443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-48  Score=404.79  Aligned_cols=229  Identities=24%  Similarity=0.382  Sum_probs=192.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+++.  +|+.||||+++         +.+.+|+.+|++++|||||++++++.+++..|||||||++|+|.++|...
T Consensus        38 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~  117 (350)
T 4b9d_A           38 GKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ  117 (350)
T ss_dssp             -CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT
T ss_pred             eEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHc
Confidence            99999998  68999999985         35889999999999999999999999999999999999999999999765


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      + ...+++...+.|+.||+.||+|||   +.+|+||||||+||||++++.+||+|||+|+......   ......+||+.
T Consensus       118 ~-~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~---~~~~~~~GT~~  190 (350)
T 4b9d_A          118 K-GVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV---ELARACIGTPY  190 (350)
T ss_dssp             T-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH---HHHHHHHSCCT
T ss_pred             C-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc---ccccccCCCcc
Confidence            3 234788999999999999999999   6899999999999999999999999999998653321   12345679999


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHH
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH  567 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  567 (611)
                      |||||.+.+..|+.++|||||||+||||++|+.||......+.     +.......             ....+..++.+
T Consensus       191 YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-----~~~i~~~~-------------~~~~~~~~s~~  252 (350)
T 4b9d_A          191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL-----VLKIISGS-------------FPPVSLHYSYD  252 (350)
T ss_dssp             TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHTC-------------CCCCCTTSCHH
T ss_pred             ccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-----HHHHHcCC-------------CCCCCccCCHH
Confidence            9999999999999999999999999999999999976543321     11222211             11112334567


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.+|+.+||+.||++|||+.|++++
T Consensus       253 ~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          253 LRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcC
Confidence            8999999999999999999999874

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6e-48  Score=399.63  Aligned_cols=228  Identities=27%  Similarity=0.471  Sum_probs=193.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|+.  +|+.||||+++       +.+.+|+.+|++++|||||+++++|.+++..|||||||++|+|.+++...+ 
T Consensus        88 G~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~-  166 (346)
T 4fih_A           88 GIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-  166 (346)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHSC-
T ss_pred             eEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcCC-
Confidence            99999998  68999999985       358899999999999999999999999999999999999999999998653 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                         +++..+..++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+|+......   ......+||+.||
T Consensus       167 ---l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~---~~~~~~~GTp~Ym  237 (346)
T 4fih_A          167 ---MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---PRRKSLVGTPYWM  237 (346)
T ss_dssp             ---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS---CCBCCCCSCGGGC
T ss_pred             ---CCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC---CcccccccCcCcC
Confidence               899999999999999999999   6899999999999999999999999999998664332   2345678999999


Q ss_pred             chhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          490 APEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       490 aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      |||++.+..|+.++|||||||+||||++|+.||......+.     .......          ..+.+ .....++.++.
T Consensus       238 APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-----~~~i~~~----------~~~~~-~~~~~~s~~~~  301 (346)
T 4fih_A          238 APELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-----MKMIRDN----------LPPRL-KNLHKVSPSLK  301 (346)
T ss_dssp             CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHS----------SCCCC-SCGGGSCHHHH
T ss_pred             CHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-----HHHHHcC----------CCCCC-CccccCCHHHH
Confidence            99999999999999999999999999999999976543221     1111111          01111 12334567889


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 007261          570 MLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +|+.+||+.||++|||+.|++++
T Consensus       302 dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          302 GFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcC
Confidence            99999999999999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.8e-47  Score=385.74  Aligned_cols=226  Identities=22%  Similarity=0.398  Sum_probs=183.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceecc----CCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEH----DGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|..  +|..||||++.         +.|.+|+.+|++++|||||+++++|.+    ++..|||||||++|+|.++
T Consensus        40 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~  119 (290)
T 3fpq_A           40 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY  119 (290)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHH
T ss_pred             cEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHH
Confidence            99999998  68899999984         358899999999999999999999864    3568999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeCC-CCcEEEeeecCccccccccCCccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG--YVHKDISSGNILLDK-NLRAKLANFSFVRSAVREESGYSSTK  480 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~  480 (611)
                      |+...   .+++..+..|+.||+.||+|||   +.+  |+||||||+||||+. ++.+||+|||+|+....     ....
T Consensus       120 l~~~~---~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-----~~~~  188 (290)
T 3fpq_A          120 LKRFK---VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-----SFAK  188 (290)
T ss_dssp             HHHHS---SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-----TSBE
T ss_pred             HHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-----CccC
Confidence            98753   4899999999999999999999   455  999999999999984 79999999999975322     2334


Q ss_pred             ccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC
Q 007261          481 TAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN  560 (611)
Q Consensus       481 ~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~  560 (611)
                      ..+||+.|||||.+.+ .++.++|||||||+||||+||+.||.........     ...+..+...        +.   .
T Consensus       189 ~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~-----~~~i~~~~~~--------~~---~  251 (290)
T 3fpq_A          189 AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRVTSGVKP--------AS---F  251 (290)
T ss_dssp             ESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----HHHHTTTCCC--------GG---G
T ss_pred             CcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH-----HHHHHcCCCC--------CC---C
Confidence            5689999999998865 6999999999999999999999999765433211     1111111100        00   1


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          561 KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       561 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +...++++.+|+.+||+.||++|||+.|++++
T Consensus       252 ~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            12234568899999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.7e-47  Score=401.25  Aligned_cols=228  Identities=27%  Similarity=0.464  Sum_probs=193.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|..  +|+.||||+++       +.+.+|+.+|++++|||||+++++|.+++.+|||||||++|+|.++++..+ 
T Consensus       165 G~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~~-  243 (423)
T 4fie_A          165 GIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-  243 (423)
T ss_dssp             CEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHSC-
T ss_pred             cEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhccC-
Confidence            99999998  68999999985       458899999999999999999999999999999999999999999998654 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                         +++..+..++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+|+......   ......+||+.||
T Consensus       244 ---l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~---~~~~~~~GTp~Ym  314 (423)
T 4fie_A          244 ---MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---PRRKSLVGTPYWM  314 (423)
T ss_dssp             ---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC---CCBCCCEECTTTC
T ss_pred             ---CCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC---ccccccccCcCcC
Confidence               899999999999999999999   6899999999999999999999999999998664332   2345678999999


Q ss_pred             chhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          490 APEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       490 aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      |||++.+..|+.++|||||||+||||++|+.||......+..     .......          .+.+ .....++.++.
T Consensus       315 APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-----~~i~~~~----------~~~~-~~~~~~s~~~~  378 (423)
T 4fie_A          315 APELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-----KMIRDNL----------PPRL-KNLHKVSPSLK  378 (423)
T ss_dssp             CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHSC----------CCCC-SCTTSSCHHHH
T ss_pred             CHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-----HHHHcCC----------CCCC-cccccCCHHHH
Confidence            999999999999999999999999999999999765433211     1111110          1111 11233556789


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 007261          570 MLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +|+.+||+.||++|||+.|++++
T Consensus       379 dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          379 GFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcC
Confidence            99999999999999999999885

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.2e-47  Score=387.57  Aligned_cols=227  Identities=19%  Similarity=0.347  Sum_probs=191.1

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+++.  +|+.||||++++          .+.+|+++|++++|||||++++++.+++..|||||||++|+|.+++.+
T Consensus        46 g~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~  125 (311)
T 4aw0_A           46 STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK  125 (311)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH
Confidence            89999998  789999999852          477899999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .+   .+++.....++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+....... .......+||+
T Consensus       126 ~~---~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~~~GTp  198 (311)
T 4aw0_A          126 IG---SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANSFVGTA  198 (311)
T ss_dssp             HS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT-CCCBCCCCSCG
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC-cccccCcccCc
Confidence            53   3899999999999999999999   68999999999999999999999999999987643221 22345578999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|||||.+.+..++.++||||+||+||||++|+.||...+..+.     ........           ..+   +...+.
T Consensus       199 ~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-----~~~i~~~~-----------~~~---p~~~s~  259 (311)
T 4aw0_A          199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI-----FAKIIKLE-----------YDF---PEKFFP  259 (311)
T ss_dssp             GGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHTC-----------CCC---CTTCCH
T ss_pred             ccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHcCC-----------CCC---CcccCH
Confidence            99999999999999999999999999999999999976543221     11111111           011   123456


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      ++.+|+.+||+.||++|||+.|++.
T Consensus       260 ~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          260 KARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             HHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             HHHHHHHHHccCCHhHCcChHHHcC
Confidence            7889999999999999999998753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.8e-46  Score=377.58  Aligned_cols=224  Identities=23%  Similarity=0.357  Sum_probs=179.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||+++          ..+.+|+.+|++++|||||++++++.+++..||||||+ +|+|.+++.+
T Consensus        27 g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~  105 (275)
T 3hyh_A           27 GKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQ  105 (275)
T ss_dssp             CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHH
Confidence            89999987  68999999984          35789999999999999999999999999999999999 6899999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++.....++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+.....    .......||+
T Consensus       106 ~~---~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~~GT~  175 (275)
T 3hyh_A          106 RD---KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG----NFLKTSCGSP  175 (275)
T ss_dssp             SC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------------------C
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC----CccCCeeECc
Confidence            53   4999999999999999999999   689999999999999999999999999999865332    2334568999


Q ss_pred             CccchhhhccCCC-CCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          487 GYMAPEYMEYGLV-TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       487 ~y~aPE~~~~~~~-s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      .|||||.+.+..+ +.++||||+||+||||++|+.||......+.     ...... +.          ..   .+...+
T Consensus       176 ~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~-----~~~i~~-~~----------~~---~p~~~s  236 (275)
T 3hyh_A          176 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL-----FKNISN-GV----------YT---LPKFLS  236 (275)
T ss_dssp             TTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHH-TC----------CC---CCTTSC
T ss_pred             ccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHc-CC----------CC---CCCCCC
Confidence            9999999988776 5799999999999999999999976443221     111111 10          00   112345


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .++.+|+.+||+.||++|||+.|++++
T Consensus       237 ~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          237 PGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            678899999999999999999999875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.5e-46  Score=383.29  Aligned_cols=225  Identities=25%  Similarity=0.361  Sum_probs=181.7

Q ss_pred             ceEEEEEE-----cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII-----NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~-----~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+++.     .++.||||+++         ..+.+|+++|++++|||||++++++.+++..|||||||++|+|.+++
T Consensus        38 g~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l  117 (304)
T 3ubd_A           38 GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL  117 (304)
T ss_dssp             CEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHH
T ss_pred             eEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHH
Confidence            89999986     36789999985         25788999999999999999999999999999999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      .+.+   .+++.....++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+......   .......|
T Consensus       118 ~~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~---~~~~~~~G  188 (304)
T 3ubd_A          118 SKEV---MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---KKAYSFCG  188 (304)
T ss_dssp             HHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--------CCCCSCCC
T ss_pred             HhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC---cccccccc
Confidence            8754   3899999999999999999999   6899999999999999999999999999998653322   23345689


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      |+.|||||.+.+..++.++|||||||+||||++|+.||...+..+.     ........           .   ..+..+
T Consensus       189 T~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-----~~~i~~~~-----------~---~~p~~~  249 (304)
T 3ubd_A          189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-----MTMILKAK-----------L---GMPQFL  249 (304)
T ss_dssp             CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHCC-----------C---CCCTTS
T ss_pred             CcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH-----HHHHHcCC-----------C---CCCCcC
Confidence            9999999999999999999999999999999999999976543321     11111110           0   112234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSM-----AEVVS  591 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~-----~evl~  591 (611)
                      +.++.+|+.+||+.||++|||+     +|+++
T Consensus       250 s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            5678999999999999999984     56654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1e-45  Score=378.20  Aligned_cols=231  Identities=22%  Similarity=0.390  Sum_probs=176.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCC------------eEEEEEeecC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDG------------VFYLVYEFME  396 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~------------~~~lV~E~~~  396 (611)
                      |.||+|+.  +|+.||||+++        +.+.+|+.+|++++|||||++++++.+.+            ..|+|||||+
T Consensus        19 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~   98 (299)
T 4g31_A           19 GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCR   98 (299)
T ss_dssp             -EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCC
T ss_pred             eEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCC
Confidence            89999998  68999999985        35789999999999999999999986443            3799999999


Q ss_pred             CCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc
Q 007261          397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY  476 (611)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  476 (611)
                      +|+|.+++..........+..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.........
T Consensus        99 gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~  175 (299)
T 4g31_A           99 KENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ  175 (299)
T ss_dssp             SCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCCCC----------
T ss_pred             CCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccCccceecCCCcccc
Confidence            9999999987655445677888999999999999999   6899999999999999999999999999998764432111


Q ss_pred             ---------ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc
Q 007261          477 ---------SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA  547 (611)
Q Consensus       477 ---------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  547 (611)
                               ......+||+.|||||.+.+..|+.++|||||||+||||++   ||....  +  ....+....       
T Consensus       176 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~--~~~~~~~~~-------  241 (299)
T 4g31_A          176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--E--RVRTLTDVR-------  241 (299)
T ss_dssp             ----------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--H--HHHHHHHHH-------
T ss_pred             ccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--H--HHHHHHHHh-------
Confidence                     11234579999999999999999999999999999999996   553211  1  111111111       


Q ss_pred             ccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          548 KLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       548 ~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                            +.............+.+|+.+||+.||++|||+.|++++
T Consensus       242 ------~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          242 ------NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             ------TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                  111122233445567889999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-42  Score=363.80  Aligned_cols=245  Identities=20%  Similarity=0.287  Sum_probs=186.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceecc------CCeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEH------DGVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~~lV~E~~~~gsL~  401 (611)
                      |.||+|..  +|+.||||+++         +.+.+|+.+|++++|||||++++++..      .+..|||||||+ |+|.
T Consensus        68 G~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~  146 (398)
T 4b99_A           68 GVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLH  146 (398)
T ss_dssp             CEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHH
T ss_pred             eEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHH
Confidence            89999998  69999999985         346789999999999999999998753      467899999996 7899


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC-Cccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES-GYSSTK  480 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~  480 (611)
                      +++...+   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....... ......
T Consensus       147 ~~i~~~~---~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~  220 (398)
T 4b99_A          147 QIIHSSQ---PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMT  220 (398)
T ss_dssp             HHHTSSS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCC
T ss_pred             HHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccc
Confidence            9997653   4999999999999999999999   68999999999999999999999999999986543211 122344


Q ss_pred             ccccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc-------ccc-
Q 007261          481 TAVGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK-------LSV-  551 (611)
Q Consensus       481 ~~~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~-------l~~-  551 (611)
                      ..+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+.  ...+............       ... 
T Consensus       221 ~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~--l~~I~~~~g~p~~~~~~~~~~~~~~~~  298 (398)
T 4b99_A          221 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ--LQLIMMVLGTPSPAVIQAVGAERVRAY  298 (398)
T ss_dssp             SSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCGGGTC-----CHHHH
T ss_pred             cceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhcCCCChHHhhhhhhhhhhhh
Confidence            57899999999998765 579999999999999999999999976554322  2222222211110000       000 


Q ss_pred             --ccCccCCcC----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          552 --LVDPNLQAN----KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       552 --~~d~~l~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        .+.+.....    ....+.++.+|+.+||..||++|||+.|++++
T Consensus       299 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          299 IQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             HHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              000010000    11235678899999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.7e-41  Score=346.05  Aligned_cols=275  Identities=31%  Similarity=0.534  Sum_probs=225.2

Q ss_pred             CccccchhHHHHHhhcCCCC------Cccc----ceEEEEEEcCcEEEEEEec-----------HHHHHHHHHHHhcCCC
Q 007261          315 GLKFYKYEDLVVATENFSPK------NMID----GSVFRGIINGSTVAIKCMR-----------RSISKEVNLLKKINHF  373 (611)
Q Consensus       315 ~~~~~~~~el~~at~~f~~~------~~ig----g~Vy~g~~~g~~vavK~~~-----------~~~~~E~~~l~~l~H~  373 (611)
                      ....|.++++..++++|...      ..||    |.||+|..+++.||||++.           +.+.+|+.++++++||
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            34668999999999999987      6665    8999999999999999874           3578999999999999


Q ss_pred             ceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC
Q 007261          374 NLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD  453 (611)
Q Consensus       374 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~  453 (611)
                      ||+++++++.+.+..++||||+++|+|.+++........++|..++.++.|++.||.|||   +.+++||||||+|||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence            999999999999999999999999999999986544456999999999999999999999   68999999999999999


Q ss_pred             CCCcEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHH
Q 007261          454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA  533 (611)
Q Consensus       454 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~  533 (611)
                      +++.+||+|||+++....... ........||+.|+|||.+.+ .++.++||||||+++|||++|+.||......... .
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~  244 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQ-TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-L  244 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSS-CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT-T
T ss_pred             CCCcEEEeecccccccccccc-cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH-H
Confidence            999999999999876543221 122334578999999998865 5899999999999999999999998765433211 1


Q ss_pred             HHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          534 EAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       534 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      ........   ....+...+++.+...+...+..+.+++.+||+.||.+||++.+++++|+++..
T Consensus       245 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          245 DIKEEIED---EEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHT---TSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHhhh---hhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            11111111   122334455555655677888999999999999999999999999999998864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.3e-41  Score=352.58  Aligned_cols=277  Identities=37%  Similarity=0.611  Sum_probs=228.3

Q ss_pred             CccccchhHHHHHhhcCCCCCccc----ceEEEEEE-cCcEEEEEEecH--------HHHHHHHHHHhcCCCceeeccce
Q 007261          315 GLKFYKYEDLVVATENFSPKNMID----GSVFRGII-NGSTVAIKCMRR--------SISKEVNLLKKINHFNLINLFGA  381 (611)
Q Consensus       315 ~~~~~~~~el~~at~~f~~~~~ig----g~Vy~g~~-~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~  381 (611)
                      ..+.|++.++...+++|.....||    |.||+|.. +|+.||||+++.        .+.+|+.++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            456789999999999999999887    89999987 688999999852        57899999999999999999999


Q ss_pred             eccCCeEEEEEeecCCCCHHHHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 007261          382 CEHDGVFYLVYEFMENGSLSDWLHKKR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKL  460 (611)
Q Consensus       382 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl  460 (611)
                      +...+..++||||+++|+|.+++.... ....++|..+..++.|++.||+|||+.+.++++||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999998754 2345999999999999999999999633349999999999999999999999


Q ss_pred             eeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCC---CChhhHHHHHHH
Q 007261          461 ANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQ---DGEEILLAEAVF  537 (611)
Q Consensus       461 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~---~~~~~~l~~~~~  537 (611)
                      +|||+++.......  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...   .........++ 
T Consensus       176 ~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-  252 (326)
T 3uim_A          176 GDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV-  252 (326)
T ss_dssp             CCCSSCEECCSSSS--CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH-
T ss_pred             ccCccccccCcccc--cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH-
Confidence            99999986543221  2334456899999999999999999999999999999999999998521   11112222222 


Q ss_pred             HHHhcCCcccccccccCccCCcC-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          538 SMVEGGNAEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       538 ~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                         ........+....+..+... ....+..+.+++.+||+.||.+|||+.||+++|+...
T Consensus       253 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          253 ---KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             ---TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             ---HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence               22222344555566655544 6788899999999999999999999999999998643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.9e-42  Score=357.84  Aligned_cols=254  Identities=21%  Similarity=0.326  Sum_probs=188.3

Q ss_pred             hcCCCCCccc----ceEEEEEE-----cCcEEEEEEec-----HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEe
Q 007261          329 ENFSPKNMID----GSVFRGII-----NGSTVAIKCMR-----RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYE  393 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~-----~g~~vavK~~~-----~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  393 (611)
                      +.|.....||    |.||+|+.     .++.||||.+.     .++.+|+++|+.+ +|||||++++++.+++..|||||
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE  100 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP  100 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence            3454445554    89999976     36789999985     3578899999998 79999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeecCccccccc
Q 007261          394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN-LRAKLANFSFVRSAVRE  472 (611)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~~~~~~  472 (611)
                      |+++|+|.+++..      +++.....++.||+.||+|||   +.+|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus       101 ~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A          101 YLEHESFLDILNS------LSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             CCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             CCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            9999999999942      888999999999999999999   6899999999999999877 79999999999754322


Q ss_pred             cCC-------------------------cccccccccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCC
Q 007261          473 ESG-------------------------YSSTKTAVGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQD  526 (611)
Q Consensus       473 ~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~  526 (611)
                      ...                         .......+||+.|+|||++.+. .++.++||||+||+++||++|+.||+...
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            110                         0112345799999999998765 58999999999999999999999998765


Q ss_pred             ChhhHHHHHHHHHHhc---------CC---------cccccccc------cC---ccC----------CcChHHHHHHHH
Q 007261          527 GEEILLAEAVFSMVEG---------GN---------AEAKLSVL------VD---PNL----------QANKKEIAHHLI  569 (611)
Q Consensus       527 ~~~~~l~~~~~~~~~~---------~~---------~~~~l~~~------~d---~~l----------~~~~~~~~~~l~  569 (611)
                      .+...+... ......         ..         +.......      .+   +..          .......++++.
T Consensus       252 ~~~~~l~~I-~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~  330 (361)
T 4f9c_A          252 DDLTALAQI-MTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY  330 (361)
T ss_dssp             SHHHHHHHH-HHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred             CHHHHHHHH-HHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence            543222211 111100         00         00000000      00   000          000123456788


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 007261          570 MLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +|+.+||+.||++|||++|++++
T Consensus       331 DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          331 DLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHCcCChhHCcCHHHHhcC
Confidence            99999999999999999999864

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.6e-41  Score=351.37  Aligned_cols=273  Identities=33%  Similarity=0.549  Sum_probs=221.3

Q ss_pred             cchhHHHHHhhcCCCCCccc----ceEEEEEE-cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCC
Q 007261          319 YKYEDLVVATENFSPKNMID----GSVFRGII-NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDG  386 (611)
Q Consensus       319 ~~~~el~~at~~f~~~~~ig----g~Vy~g~~-~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~  386 (611)
                      +.+.++..++++|.....+|    |.||+|.+ +|+.||||++.       +.+.+|+.++++++||||+++++++.+++
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            44455566777888777776    89999998 58999999875       46889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHhhccCC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecC
Q 007261          387 VFYLVYEFMENGSLSDWLHKKRY-PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSF  465 (611)
Q Consensus       387 ~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl  465 (611)
                      ..++||||+++|+|.+++..... ...++|..++.++.|++.||+|||   ..+++||||||+|||++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999999976542 235899999999999999999999   58999999999999999999999999999


Q ss_pred             ccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChh-hHHHHHHHHHHhcCC
Q 007261          466 VRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE-ILLAEAVFSMVEGGN  544 (611)
Q Consensus       466 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~  544 (611)
                      ++....... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .....+......   
T Consensus       186 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---  261 (321)
T 2qkw_B          186 SKKGTELDQ-THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN---  261 (321)
T ss_dssp             CEECSSSSC-CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT---
T ss_pred             ccccccccc-cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc---
Confidence            876432221 112234568999999999999999999999999999999999999987654332 122222222222   


Q ss_pred             cccccccccCccCCcC-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          545 AEAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       545 ~~~~l~~~~d~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                       ...+...+++.+... ....+..+.+++.+||+.||++|||+.|++++|+.+...
T Consensus       262 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          262 -NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             -TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence             233445556655544 678889999999999999999999999999999987653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.1e-41  Score=374.96  Aligned_cols=229  Identities=24%  Similarity=0.339  Sum_probs=191.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  +|+.||||+++       +.+.+|+.+|++++|||||++++++.+++..|||||||++|+|.++|.... 
T Consensus       171 g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~-  249 (573)
T 3uto_A          171 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-  249 (573)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTT-
T ss_pred             eEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhC-
Confidence            89999998  78999999985       357889999999999999999999999999999999999999999997543 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC--CcEEEeeecCccccccccCCcccccccccCCC
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN--LRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                       ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.+  +.+||+|||+++.....    ......+||+.
T Consensus       250 -~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~----~~~~~~~GT~~  321 (573)
T 3uto_A          250 -NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK----QSVKVTTGTAE  321 (573)
T ss_dssp             -SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT----SEEEEECSSGG
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC----CceeeeEECcc
Confidence             34899999999999999999999   6899999999999999854  89999999999876432    23345689999


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc-ChHHHHH
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA-NKKEIAH  566 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~-~~~~~~~  566 (611)
                      |||||++.+..|+.++|||||||+||||++|+.||......+.     ........           ..+.. ....++.
T Consensus       322 y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-----~~~i~~~~-----------~~~~~~~~~~~s~  385 (573)
T 3uto_A          322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-----LRNVKSCD-----------WNMDDSAFSGISE  385 (573)
T ss_dssp             GCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-----HHHHHTTC-----------CCCCSGGGTTSCH
T ss_pred             ccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-----HHHHHhCC-----------CCCCcccccCCCH
Confidence            9999999999999999999999999999999999976554322     11111110           00111 1233556


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ++.+|+.+||+.||.+|||+.|++++
T Consensus       386 ~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          386 DGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcC
Confidence            78899999999999999999999874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.5e-41  Score=372.26  Aligned_cols=227  Identities=20%  Similarity=0.285  Sum_probs=184.2

Q ss_pred             ceEEEEEE--cCcEEEEEEecHH----------HHH---HHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMRRS----------ISK---EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~~----------~~~---E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+++.  +|+.||||++++.          +.+   ++.+++.++|||||+++++|.+.+.+|||||||+||+|.++
T Consensus       203 G~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~  282 (689)
T 3v5w_A          203 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH  282 (689)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHH
Confidence            89999998  7899999999632          233   35666777999999999999999999999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      |...+   .+++.....++.||+.||+|||   +.+|+||||||+||||+.+|.+||+|||+|+.....     .....+
T Consensus       283 l~~~~---~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~-----~~~t~~  351 (689)
T 3v5w_A          283 LSQHG---VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASV  351 (689)
T ss_dssp             HHHHC---CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----CCCSCC
T ss_pred             HHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCCC-----CCCCcc
Confidence            98754   3899999999999999999999   799999999999999999999999999999865322     234568


Q ss_pred             cCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          484 GTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       484 gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      ||+.|||||++.. ..|+.++|||||||+||||++|+.||......+..  .........           ..   ..+.
T Consensus       352 GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~--~i~~~i~~~-----------~~---~~p~  415 (689)
T 3v5w_A          352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTM-----------AV---ELPD  415 (689)
T ss_dssp             SCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH--HHHHHHHHC-----------CC---CCCT
T ss_pred             CCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHhhcCC-----------CC---CCCc
Confidence            9999999999964 57999999999999999999999999764332211  111111110           00   1123


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRPS-----MAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~  592 (611)
                      ..+.++.+|+.+||+.||.+|++     +.||+++
T Consensus       416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            35667899999999999999998     6776654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.9e-40  Score=341.86  Aligned_cols=248  Identities=29%  Similarity=0.457  Sum_probs=193.3

Q ss_pred             cCCCCCccc----ceEEEEEEcCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecC
Q 007261          330 NFSPKNMID----GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME  396 (611)
Q Consensus       330 ~f~~~~~ig----g~Vy~g~~~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  396 (611)
                      +|.....||    |.||++..+|+.||||++.         +.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        38 ~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  117 (309)
T 3p86_A           38 DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS  117 (309)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred             HceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCC
Confidence            344444444    8999999999999999984         357889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeCCCCcEEEeeecCccccccccC
Q 007261          397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG--YVHKDISSGNILLDKNLRAKLANFSFVRSAVREES  474 (611)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~  474 (611)
                      +|+|.+++........+++..++.++.|++.||+|||   +.+  |+||||||+|||++.++.+||+|||+++.....  
T Consensus       118 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--  192 (309)
T 3p86_A          118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST--  192 (309)
T ss_dssp             TCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred             CCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc--
Confidence            9999999987543345899999999999999999999   577  999999999999999999999999998754322  


Q ss_pred             CcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccC
Q 007261          475 GYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD  554 (611)
Q Consensus       475 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d  554 (611)
                       ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..     .......           
T Consensus       193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~-----~~~~~~~-----------  255 (309)
T 3p86_A          193 -FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV-----AAVGFKC-----------  255 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-----HHHHHSC-----------
T ss_pred             -ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhcC-----------
Confidence             12234567899999999999999999999999999999999999998765433211     1111000           


Q ss_pred             ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       555 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                       .....+..++..+.+|+.+||+.||++|||+.++++.|+.+..+.
T Consensus       256 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          256 -KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             -CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence             001112334567899999999999999999999999999887654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=341.26  Aligned_cols=243  Identities=24%  Similarity=0.414  Sum_probs=195.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  +|..||+|++.       +.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++.... 
T Consensus        24 g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-  102 (310)
T 3s95_A           24 GQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD-  102 (310)
T ss_dssp             EEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCC-
T ss_pred             EEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhcc-
Confidence            89999998  58899999874       468899999999999999999999999999999999999999999998743 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc-----------cc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY-----------SS  478 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-----------~~  478 (611)
                       ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.........           ..
T Consensus       103 -~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~  178 (310)
T 3s95_A          103 -SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK  178 (310)
T ss_dssp             -TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------------------
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccccccccccc
Confidence             34899999999999999999999   6899999999999999999999999999997654332111           01


Q ss_pred             ccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCC
Q 007261          479 TKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ  558 (611)
Q Consensus       479 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~  558 (611)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|..|+..................             +..  
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~-------------~~~--  243 (310)
T 3s95_A          179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-------------DRY--  243 (310)
T ss_dssp             -CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH-------------HHT--
T ss_pred             ccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc-------------ccc--
Confidence            12457999999999999999999999999999999999999887654322111000000000             000  


Q ss_pred             cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          559 ANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                       .+..++..+.+++.+||+.||++|||+.|+++.|++++.....
T Consensus       244 -~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          244 -CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             -CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             -CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence             0122345688999999999999999999999999999876543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.7e-40  Score=348.31  Aligned_cols=241  Identities=27%  Similarity=0.482  Sum_probs=197.1

Q ss_pred             ceEEEEEEc---------CcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCH
Q 007261          339 GSVFRGIIN---------GSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~~---------g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      |.||+|.+.         +..||||+++        +++.+|+.+++++ +||||++++++|.+++..|+||||+++|+|
T Consensus        95 g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L  174 (370)
T 2psq_A           95 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  174 (370)
T ss_dssp             SEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             eeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCH
Confidence            899999862         3479999985        3578899999999 899999999999999999999999999999


Q ss_pred             HHHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          401 SDWLHKKRY-------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       401 ~~~l~~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      .+++.....             ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       175 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  251 (370)
T 2psq_A          175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR  251 (370)
T ss_dssp             HHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCSSCE
T ss_pred             HHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEECCCCCEEEccccCCc
Confidence            999987542             235899999999999999999999   6899999999999999999999999999998


Q ss_pred             ccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcc
Q 007261          468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       468 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  546 (611)
                      ....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+..      ..+..+.  
T Consensus       252 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~------~~~~~~~--  322 (370)
T 2psq_A          252 DINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------KLLKEGH--  322 (370)
T ss_dssp             ETTCCCT-TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH------HHHHTTC--
T ss_pred             ccCcccc-eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH------HHHhcCC--
Confidence            6543221 122334567889999999999999999999999999999999 88888765443211      1111110  


Q ss_pred             cccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       547 ~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                                ....+..++.++.+++.+||+.||++||++.|+++.|+++.....
T Consensus       323 ----------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          323 ----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence                      111123455679999999999999999999999999999876543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=344.82  Aligned_cols=241  Identities=27%  Similarity=0.463  Sum_probs=194.8

Q ss_pred             ceEEEEEE-----cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII-----NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~-----~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|.+     .+..||||+++        +.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++.
T Consensus        63 g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  142 (325)
T 3kul_A           63 GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR  142 (325)
T ss_dssp             EEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHH
T ss_pred             cEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHH
Confidence            89999998     24469999986        358889999999999999999999999999999999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...  ..+++..++.++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++................+|
T Consensus       143 ~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t  217 (325)
T 3kul_A          143 THD--GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP  217 (325)
T ss_dssp             TTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CC
T ss_pred             hcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCc
Confidence            653  34899999999999999999999   6899999999999999999999999999998764433222233344567


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      ..|+|||.+.+..++.++||||||+++|||++ |+.||......+.     ...... +.            ....+..+
T Consensus       218 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-----~~~~~~-~~------------~~~~~~~~  279 (325)
T 3kul_A          218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-----ISSVEE-GY------------RLPAPMGC  279 (325)
T ss_dssp             GGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-----HHHHHT-TC------------CCCCCTTC
T ss_pred             ccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-----HHHHHc-CC------------CCCCCCCc
Confidence            88999999999999999999999999999999 8888876543321     111111 10            01112345


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                      +..+.+|+.+||+.||++||++.|+++.|+.+......
T Consensus       280 ~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence            56789999999999999999999999999998776544

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.5e-40  Score=340.94  Aligned_cols=245  Identities=33%  Similarity=0.407  Sum_probs=193.6

Q ss_pred             ceEEEEEEcCcEEEEEEecH------HHHHHHHHHHhcCCCceeeccceeccC----CeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGIINGSTVAIKCMRR------SISKEVNLLKKINHFNLINLFGACEHD----GVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~~------~~~~E~~~l~~l~H~niv~l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|.+.|+.||||+++.      .+.+|+.++++++||||+++++++...    ...++||||+++|+|.++++...
T Consensus        38 g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~  117 (322)
T 3soc_A           38 GCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV  117 (322)
T ss_dssp             CEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC
T ss_pred             eEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC
Confidence            89999999999999999852      355688899999999999999999764    34799999999999999998753


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCC----------CeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDP----------GYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS  478 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~----------~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  478 (611)
                          ++|..++.++.|++.||+|||   +.          +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus       118 ----~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~-~~~  189 (322)
T 3soc_A          118 ----VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS-AGD  189 (322)
T ss_dssp             ----BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSC-CCC
T ss_pred             ----CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccC-ccc
Confidence                899999999999999999999   56          999999999999999999999999999976543322 122


Q ss_pred             ccccccCCCccchhhhcc-----CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhH-H---------HHHHHHHHhcC
Q 007261          479 TKTAVGTNGYMAPEYMEY-----GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL-L---------AEAVFSMVEGG  543 (611)
Q Consensus       479 ~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~-l---------~~~~~~~~~~~  543 (611)
                      .....||+.|+|||.+.+     ..++.++||||||+++|||++|+.||......... .         .........  
T Consensus       190 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  267 (322)
T 3soc_A          190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV--  267 (322)
T ss_dssp             CTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHT--
T ss_pred             cccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhh--
Confidence            334578999999999986     35667899999999999999999998764332110 0         001111111  


Q ss_pred             CcccccccccCccCCcC--hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          544 NAEAKLSVLVDPNLQAN--KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       544 ~~~~~l~~~~d~~l~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                            .....+.+...  ....+.++.+|+.+||+.||++|||+.|+++.|++++..
T Consensus       268 ------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          268 ------HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             ------TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                  11111222221  235667799999999999999999999999999998764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.9e-40  Score=349.51  Aligned_cols=248  Identities=27%  Similarity=0.478  Sum_probs=188.2

Q ss_pred             hcCCCCCccc----ceEEEEEEc-----CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEE
Q 007261          329 ENFSPKNMID----GSVFRGIIN-----GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV  391 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~~-----g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  391 (611)
                      ++|.....||    |.||+|...     +..||||.++        +++.+|+.++++++||||+++++++.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            3555555665    899999863     5679999985        3588999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccccc
Q 007261          392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR  471 (611)
Q Consensus       392 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~  471 (611)
                      |||+++|+|.++++...  ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       125 ~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            99999999999998653  34899999999999999999999   58999999999999999999999999999986643


Q ss_pred             ccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccc
Q 007261          472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLS  550 (611)
Q Consensus       472 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~  550 (611)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.      ...+..+.      
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~------~~~i~~~~------  267 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV------IKAVDEGY------  267 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH------HHHHHTTE------
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCC------
Confidence            3222222233345778999999999999999999999999999998 8988876543221      11111110      


Q ss_pred             cccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          551 VLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       551 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                            ....+..++..+.+++.+||+.||++||++.+|++.|+++...
T Consensus       268 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          268 ------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             ------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence                  0011223456789999999999999999999999999998654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.6e-39  Score=332.94  Aligned_cols=237  Identities=24%  Similarity=0.419  Sum_probs=195.2

Q ss_pred             cCCCCCccc----ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecC
Q 007261          330 NFSPKNMID----GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME  396 (611)
Q Consensus       330 ~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  396 (611)
                      .|.....||    |.||++..  +|+.||||++.       +.+.+|+.++++++||||+++++++..++..++||||++
T Consensus        21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  100 (297)
T 3fxz_A           21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (297)
T ss_dssp             TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence            344444454    89999986  78899999984       457899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc
Q 007261          397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY  476 (611)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  476 (611)
                      +|+|.+++....    +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   
T Consensus       101 ~~~L~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  170 (297)
T 3fxz_A          101 GGSLTDVVTETC----MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---  170 (297)
T ss_dssp             TCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---
T ss_pred             CCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc---
Confidence            999999998753    889999999999999999999   5899999999999999999999999999987654322   


Q ss_pred             ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCcc
Q 007261          477 SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN  556 (611)
Q Consensus       477 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  556 (611)
                      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..     .........           
T Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----~~~~~~~~~-----------  234 (297)
T 3fxz_A          171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATNGTP-----------  234 (297)
T ss_dssp             CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHHCSC-----------
T ss_pred             cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhCCCC-----------
Confidence            2234467999999999999999999999999999999999999999765433211     111111100           


Q ss_pred             CCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       557 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ....+...+..+.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            011133456678999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.7e-39  Score=332.28  Aligned_cols=245  Identities=27%  Similarity=0.402  Sum_probs=190.2

Q ss_pred             ceEEEEEEcCcEEEEEEec----HHHHHHHHHHHh--cCCCceeeccceecc----CCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGIINGSTVAIKCMR----RSISKEVNLLKK--INHFNLINLFGACEH----DGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~----~~~~~E~~~l~~--l~H~niv~l~g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|.++|+.||||++.    ..+.+|.+++..  ++||||+++++++..    ....++||||+++|+|.++++.. 
T Consensus        22 g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-  100 (301)
T 3q4u_A           22 GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-  100 (301)
T ss_dssp             EEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC-
T ss_pred             cEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc-
Confidence            8999999999999999986    345667777777  799999999998643    35689999999999999999654 


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc-cccccc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCT-----DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY-SSTKTA  482 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~  482 (611)
                         .+++..+++++.|++.||+|||+..     +.+|+||||||+|||++.++.+||+|||+++......... ......
T Consensus       101 ---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  177 (301)
T 3q4u_A          101 ---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR  177 (301)
T ss_dssp             ---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCC
T ss_pred             ---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccccccccc
Confidence               3899999999999999999999321     4789999999999999999999999999997654332211 112344


Q ss_pred             ccCCCccchhhhccC------CCCCccchHHHHHHHHHHHhC----------CCCCcCCCChhhHHHHHHHHHHhcCCcc
Q 007261          483 VGTNGYMAPEYMEYG------LVTPEMDTYAFGVVLLELITG----------KEAAYKQDGEEILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~------~~s~ksDV~s~Gvvl~elltG----------~~p~~~~~~~~~~l~~~~~~~~~~~~~~  546 (611)
                      .||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||............. .......   
T Consensus       178 ~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~-~~~~~~~---  253 (301)
T 3q4u_A          178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM-RKVVCVD---  253 (301)
T ss_dssp             CCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHH-HHHHTTS---
T ss_pred             ccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhh-hHHHhcc---
Confidence            799999999999876      455799999999999999999          77776543322111111 1111111   


Q ss_pred             cccccccCccCCc--ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          547 AKLSVLVDPNLQA--NKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       547 ~~l~~~~d~~l~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                           ...+.+..  .....+..+.+|+.+||+.||++|||+.|+++.|+++
T Consensus       254 -----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          254 -----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             -----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence                 01111111  1346778899999999999999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.6e-39  Score=335.15  Aligned_cols=251  Identities=24%  Similarity=0.427  Sum_probs=203.2

Q ss_pred             cccchhHHHHHhhcCC----------CCCccc----ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCC
Q 007261          317 KFYKYEDLVVATENFS----------PKNMID----GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHF  373 (611)
Q Consensus       317 ~~~~~~el~~at~~f~----------~~~~ig----g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~  373 (611)
                      ..++++++..+++.+.          ....||    |.||+|..  +|+.||||+++       +.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            3477788888876532          233454    89999998  68999999985       4588999999999999


Q ss_pred             ceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC
Q 007261          374 NLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD  453 (611)
Q Consensus       374 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~  453 (611)
                      ||+++++++...+..++||||+++|+|.+++....    +++..+..++.|++.||+|||   +.+++||||||+|||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCC----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEC
Confidence            99999999999999999999999999999997643    899999999999999999999   58999999999999999


Q ss_pred             CCCcEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHH
Q 007261          454 KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA  533 (611)
Q Consensus       454 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~  533 (611)
                      .++.+||+|||+++......   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.   
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~---  249 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDV---PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---  249 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSS---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---
T ss_pred             CCCcEEEeeeeeeeecccCc---cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence            99999999999987654322   123456799999999999999999999999999999999999999976543221   


Q ss_pred             HHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          534 EAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       534 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                        ........          .+.+ ......+..+.+++.+||+.||++|||+.|++++-
T Consensus       250 --~~~~~~~~----------~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  296 (321)
T 2c30_A          250 --MKRLRDSP----------PPKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP  296 (321)
T ss_dssp             --HHHHHHSS----------CCCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             --HHHHhcCC----------CCCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence              11111111          1111 11223456789999999999999999999999863

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.4e-39  Score=352.91  Aligned_cols=234  Identities=24%  Similarity=0.475  Sum_probs=194.4

Q ss_pred             ceEEEEEEcCcEEEEEEec-----HHHHHHHHHHHhcCCCceeeccceeccCC-eEEEEEeecCCCCHHHHhhccCCCCc
Q 007261          339 GSVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGACEHDG-VFYLVYEFMENGSLSDWLHKKRYPEF  412 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~  412 (611)
                      |.||+|.++|+.||||+++     +.+.+|+.+|++++||||+++++++...+ ..++||||+++|+|.+++.... ...
T Consensus       207 g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~-~~~  285 (450)
T 1k9a_A          207 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSV  285 (450)
T ss_dssp             EEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHC-TTT
T ss_pred             eeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcC-CCC
Confidence            8999999999999999996     46899999999999999999999986654 7999999999999999998753 234


Q ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchh
Q 007261          413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE  492 (611)
Q Consensus       413 l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE  492 (611)
                      +++..++.++.||+.||+|||   +.+++||||||+|||+++++.+||+|||+++.....      .....++..|+|||
T Consensus       286 ~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------~~~~~~~~~y~aPE  356 (450)
T 1k9a_A          286 LGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------QDTGKLPVKWTAPE  356 (450)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------------CCCTTTSCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc------ccCCCCCcceeCHH
Confidence            789999999999999999999   689999999999999999999999999998754221      12235788999999


Q ss_pred             hhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHH
Q 007261          493 YMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML  571 (611)
Q Consensus       493 ~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l  571 (611)
                      .+.+..++.++||||||++||||++ |+.|+......+..      ..+..+.            ....+..++..+.+|
T Consensus       357 ~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~------~~i~~~~------------~~~~p~~~~~~l~~l  418 (450)
T 1k9a_A          357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------PRVEKGY------------KMDAPDGCPPAVYDV  418 (450)
T ss_dssp             HHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH------HHHHTTC------------CCCCCTTCCHHHHHH
T ss_pred             HhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHcCC------------CCCCCCcCCHHHHHH
Confidence            9999999999999999999999998 99888765443321      1111110            111233456789999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          572 CLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       572 ~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      +.+||+.||++|||+.++++.|+++....
T Consensus       419 i~~cl~~dp~~Rpt~~~l~~~L~~i~~~~  447 (450)
T 1k9a_A          419 MKNCWHLDAATRPTFLQLREQLEHIRTHE  447 (450)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence            99999999999999999999999987653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-39  Score=328.58  Aligned_cols=236  Identities=27%  Similarity=0.514  Sum_probs=195.4

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||++.. ++..||+|+++      +++.+|+.++++++||||+++++++.+++..++||||+++++|.+++....  .
T Consensus        24 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~  101 (269)
T 4hcu_A           24 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--G  101 (269)
T ss_dssp             CEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTT--T
T ss_pred             cEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcC--c
Confidence            89999998 78899999985      468899999999999999999999999999999999999999999997654  3


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......  ........++..|+||
T Consensus       102 ~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aP  176 (269)
T 4hcu_A          102 LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASP  176 (269)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH--HHSTTSTTCCGGGCCH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc--cccccCcccccccCCH
Confidence            4899999999999999999999   6899999999999999999999999999987653321  1222344567789999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+.+..++.++||||||+++|||++ |+.||......+.     ...... ..            ....+...+..+.+
T Consensus       177 E~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~-----~~~~~~-~~------------~~~~~~~~~~~~~~  238 (269)
T 4hcu_A          177 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDIST-GF------------RLYKPRLASTHVYQ  238 (269)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----HHHHHT-TC------------CCCCCTTSCHHHHH
T ss_pred             HHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH-----HHHHhc-Cc------------cCCCCCcCCHHHHH
Confidence            99999999999999999999999999 8888765443221     111111 00            00112223566899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      ++.+||+.||++||++.|++++|+++...
T Consensus       239 li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          239 IMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            99999999999999999999999998764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.1e-40  Score=349.87  Aligned_cols=237  Identities=25%  Similarity=0.438  Sum_probs=193.3

Q ss_pred             ceEEEEEE--cCcEEEEEEecH--------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMRR--------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|.+  +|+.||||.++.        ++.+|+.+|++++||||++++++|..++..++||||+++|+|.+++....
T Consensus       128 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~  207 (377)
T 3cbl_A          128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG  207 (377)
T ss_dssp             EEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG
T ss_pred             CeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC
Confidence            89999999  588999999852        47789999999999999999999999999999999999999999998643


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                        ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++....... ........++..|
T Consensus       208 --~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~-~~~~~~~~~~~~y  281 (377)
T 3cbl_A          208 --ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY-AASGGLRQVPVKW  281 (377)
T ss_dssp             --GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE-ECCSSCCEEEGGG
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce-eecCCCCCCCcCc
Confidence              34899999999999999999999   68999999999999999999999999999875432211 0111223356789


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHH
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH  567 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  567 (611)
                      +|||.+.++.++.++||||||+++|||++ |..|+......+.      ...+..+.            ....+..++..
T Consensus       282 ~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~------~~~~~~~~------------~~~~~~~~~~~  343 (377)
T 3cbl_A          282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT------REFVEKGG------------RLPCPELCPDA  343 (377)
T ss_dssp             SCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH------HHHHHTTC------------CCCCCTTCCHH
T ss_pred             CCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCC------------CCCCCCCCCHH
Confidence            99999999999999999999999999998 8888765543221      11221111            01112334567


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          568 LIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      +.+|+.+||+.||++|||+.++++.|+++...
T Consensus       344 l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            89999999999999999999999999988653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-40  Score=341.26  Aligned_cols=241  Identities=28%  Similarity=0.517  Sum_probs=194.9

Q ss_pred             ceEEEEEEcC-------cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIING-------STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~g-------~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++...+       ..||||+++        +.+.+|+.++++++||||+++++++.+++..++||||+++|+|.++
T Consensus        61 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  140 (343)
T 1luf_A           61 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF  140 (343)
T ss_dssp             CEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred             eeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHH
Confidence            8999999854       789999985        3578899999999999999999999999999999999999999999


Q ss_pred             hhccCC---------------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 007261          404 LHKKRY---------------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLAN  462 (611)
Q Consensus       404 l~~~~~---------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D  462 (611)
                      +.....                     ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus       141 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~D  217 (343)
T 1luf_A          141 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIAD  217 (343)
T ss_dssp             HHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             HHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEECCCCeEEEee
Confidence            987421                     145899999999999999999999   68999999999999999999999999


Q ss_pred             ecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHh
Q 007261          463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVE  541 (611)
Q Consensus       463 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  541 (611)
                      ||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.     ......
T Consensus       218 fg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-----~~~~~~  291 (343)
T 1luf_A          218 FGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV-----IYYVRD  291 (343)
T ss_dssp             CSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----HHHHHT
T ss_pred             cCCCcccccCcc-ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHH-----HHHHhC
Confidence            999876533221 122334567889999999999999999999999999999999 8888876543321     111111


Q ss_pred             cCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          542 GGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       542 ~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                       +            .....+..++..+.+++.+||+.||++||++.++++.|+++.....
T Consensus       292 -~------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          292 -G------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             -T------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             -C------------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence             1            1111123445678999999999999999999999999999876543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.4e-39  Score=330.70  Aligned_cols=245  Identities=23%  Similarity=0.415  Sum_probs=190.3

Q ss_pred             ceEEEEEE------cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceecc--CCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII------NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEH--DGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~------~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++.+      +|+.||||+++       +.+.+|+.++++++||||+++++++..  ....++||||+++|+|.++
T Consensus        24 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  103 (295)
T 3ugc_A           24 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY  103 (295)
T ss_dssp             EEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHH
T ss_pred             EEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHH
Confidence            89999985      57899999985       467899999999999999999999854  3568999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      +....  ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++................
T Consensus       104 l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  178 (295)
T 3ugc_A          104 LQKHK--ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE  178 (295)
T ss_dssp             HHHCG--GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTT
T ss_pred             HHhcc--cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCC
Confidence            98753  34899999999999999999999   68999999999999999999999999999986644332223334456


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChh----------hHHHHHHHHHHhcCCccccccccc
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE----------ILLAEAVFSMVEGGNAEAKLSVLV  553 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~----------~~l~~~~~~~~~~~~~~~~l~~~~  553 (611)
                      ++..|+|||.+.+..++.++||||||+++|||++|..|+.......          ............            
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------  246 (295)
T 3ugc_A          179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK------------  246 (295)
T ss_dssp             CGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH------------
T ss_pred             CccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh------------
Confidence            7788999999999999999999999999999999998875322110          000001111111            


Q ss_pred             CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       554 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      .......+..++.++.+++.+||+.||++|||+.|+++.|+++....
T Consensus       247 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          247 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            11111223455678999999999999999999999999999987654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.5e-39  Score=336.16  Aligned_cols=225  Identities=24%  Similarity=0.379  Sum_probs=188.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|..  +|+.||||++.         +.+.+|+.+|++++||||+++++++...+..++||||+++|+|.+++...
T Consensus        29 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  108 (328)
T 3fe3_A           29 AKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH  108 (328)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc
Confidence            89999997  78999999985         24678999999999999999999999999999999999999999999775


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....    .......||+.
T Consensus       109 ~---~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~  178 (328)
T 3fe3_A          109 G---RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG----GKLDAFCGAPP  178 (328)
T ss_dssp             C---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS----CGGGTTSSSGG
T ss_pred             C---CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC----CccccccCCcc
Confidence            3   3899999999999999999999   689999999999999999999999999998765322    12345679999


Q ss_pred             ccchhhhccCCCC-CccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          488 YMAPEYMEYGLVT-PEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       488 y~aPE~~~~~~~s-~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      |+|||.+.+..+. .++||||||+++|||++|+.||......+.     ...... +..             ..+...+.
T Consensus       179 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~i~~-~~~-------------~~p~~~s~  239 (328)
T 3fe3_A          179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL-----RERVLR-GKY-------------RIPFYMST  239 (328)
T ss_dssp             GCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHH-CCC-------------CCCTTSCH
T ss_pred             eeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH-----HHHHHh-CCC-------------CCCCCCCH
Confidence            9999999887765 799999999999999999999976543221     111111 100             01122456


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+.+|+.+||+.||.+|||+.|++++
T Consensus       240 ~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          240 DCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             HHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            68899999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.2e-39  Score=324.97  Aligned_cols=236  Identities=23%  Similarity=0.461  Sum_probs=193.6

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||++.. ++..||||+++      +++.+|+.++++++||||+++++++.+++..++||||+++++|.+++....  .
T Consensus        22 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~   99 (268)
T 3sxs_A           22 GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG--K   99 (268)
T ss_dssp             EEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG--G
T ss_pred             ceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC--C
Confidence            89999998 45689999985      468899999999999999999999999999999999999999999998753  3


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......  ........+|..|+||
T Consensus       100 ~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aP  174 (268)
T 3sxs_A          100 GLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ--YVSSVGTKFPVKWSAP  174 (268)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC--EEECCSCCCCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh--hhcccCCCcCcccCCH
Confidence            4899999999999999999999   6899999999999999999999999999987653322  1222334567789999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+.+..++.++||||||+++|||++ |+.||......+..     .......       ...      .+...+..+.+
T Consensus       175 E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-----~~~~~~~-------~~~------~~~~~~~~l~~  236 (268)
T 3sxs_A          175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-----LKVSQGH-------RLY------RPHLASDTIYQ  236 (268)
T ss_dssp             HHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-----HHHHTTC-------CCC------CCTTSCHHHHH
T ss_pred             HHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH-----HHHHcCC-------CCC------CCCcChHHHHH
Confidence            99999899999999999999999999 88888655433211     1111100       000      11223457899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      ++.+||+.||++|||+.|++++|+.+...
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          237 IMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            99999999999999999999999988764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=330.90  Aligned_cols=238  Identities=25%  Similarity=0.442  Sum_probs=188.8

Q ss_pred             ceEEEEEEcCcEEEEEEec-----HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCcc
Q 007261          339 GSVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFV  413 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l  413 (611)
                      |.||++.+.++.||||.++     +.+.+|+.++++++||||+++++++.+  ..++||||+++|+|.+++........+
T Consensus        22 g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~   99 (307)
T 2eva_A           22 GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYY   99 (307)
T ss_dssp             SEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECC
T ss_pred             ceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCcc
Confidence            8999999999999999985     468899999999999999999999874  378999999999999999876543457


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc-EEEeeecCccccccccCCcccccccccCCCccchh
Q 007261          414 SWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR-AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE  492 (611)
Q Consensus       414 ~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~-~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE  492 (611)
                      ++..++.++.|++.||+|||+....+++||||||+|||++.++. +||+|||++......      .....||+.|+|||
T Consensus       100 ~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE  173 (307)
T 2eva_A          100 TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------MTNNKGSAAWMAPE  173 (307)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------------CCTTSSCHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc------cccCCCCCceEChh
Confidence            89999999999999999999533378999999999999988886 799999998754321      22346899999999


Q ss_pred             hhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHH
Q 007261          493 YMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLC  572 (611)
Q Consensus       493 ~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~  572 (611)
                      .+.+..++.++||||||+++|||++|+.||...........   ..... +.            .......++..+.+++
T Consensus       174 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~-~~------------~~~~~~~~~~~l~~li  237 (307)
T 2eva_A          174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHN-GT------------RPPLIKNLPKPIESLM  237 (307)
T ss_dssp             HHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH---HHHHT-TC------------CCCCBTTCCHHHHHHH
T ss_pred             hhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH---HHHhc-CC------------CCCcccccCHHHHHHH
Confidence            99999999999999999999999999999875543322111   11111 10            0111223456788999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          573 LACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       573 ~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      .+||+.||++|||+.|+++.|+.+....
T Consensus       238 ~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          238 TRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             HHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            9999999999999999999999887543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.9e-39  Score=329.50  Aligned_cols=242  Identities=22%  Similarity=0.379  Sum_probs=192.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|..||+|.+.          +.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++..
T Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~  104 (294)
T 4eqm_A           25 STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES  104 (294)
T ss_dssp             EEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred             EEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHh
Confidence            89999987  68899999873          3578899999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......  ........||+
T Consensus       105 ~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~gt~  176 (294)
T 4eqm_A          105 HG---PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS--LTQTNHVLGTV  176 (294)
T ss_dssp             HC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---------------CC
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc--ccccCccccCc
Confidence            53   3899999999999999999999   6899999999999999999999999999997653221  12233457899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||......+..     .........         ..........+.
T Consensus       177 ~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-----~~~~~~~~~---------~~~~~~~~~~~~  242 (294)
T 4eqm_A          177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-----IKHIQDSVP---------NVTTDVRKDIPQ  242 (294)
T ss_dssp             SSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-----HHHHSSCCC---------CHHHHSCTTSCH
T ss_pred             cccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhhccCC---------CcchhcccCCCH
Confidence            999999999999999999999999999999999999765433211     111111100         000011223456


Q ss_pred             HHHHHHHHhhccCCCCCC-CHHHHHHHHHhchhhhhh
Q 007261          567 HLIMLCLACIAREPESRP-SMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~~  602 (611)
                      .+.+++.+||+.||++|| ++.++.+.|..+......
T Consensus       243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~  279 (294)
T 4eqm_A          243 SLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA  279 (294)
T ss_dssp             HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred             HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence            789999999999999998 999999999987654433

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.8e-39  Score=354.56  Aligned_cols=237  Identities=27%  Similarity=0.489  Sum_probs=196.7

Q ss_pred             ceEEEEEEc--CcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGIIN--GSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~~--g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      |.||+|.+.  +..||||.++      ++|.+|+.+|++++||||++++++|...+..+|||||+++|+|.+++.... .
T Consensus       234 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~  312 (495)
T 1opk_A          234 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-R  312 (495)
T ss_dssp             SSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSC-T
T ss_pred             eEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcC-c
Confidence            899999994  7899999986      468899999999999999999999999999999999999999999998753 2


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA  490 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~a  490 (611)
                      ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  ........++..|+|
T Consensus       313 ~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~y~a  387 (495)
T 1opk_A          313 QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA  387 (495)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC--EECCTTCCCCGGGCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc--eeecCCCcCCcceeC
Confidence            45899999999999999999999   6899999999999999999999999999998653221  122233456788999


Q ss_pred             hhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          491 PEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       491 PE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      ||.+.+..++.++||||||++||||++ |+.|+......+.      ...+..+.            ....+..++..+.
T Consensus       388 PE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~------~~~~~~~~------------~~~~~~~~~~~l~  449 (495)
T 1opk_A          388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDY------------RMERPEGCPEKVY  449 (495)
T ss_dssp             HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH------HHHHHTTC------------CCCCCTTCCHHHH
T ss_pred             HhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCC------------CCCCCCCCCHHHH
Confidence            999999999999999999999999999 8888866543321      11111110            0111334567789


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          570 MLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      +|+.+||+.||++|||+.+|++.|+.+...
T Consensus       450 ~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          450 ELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             HHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999999998654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.4e-39  Score=341.89  Aligned_cols=257  Identities=25%  Similarity=0.442  Sum_probs=202.1

Q ss_pred             hHHHHHhhcCCCCCccc----ceEEEEEE-------cCcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccce
Q 007261          322 EDLVVATENFSPKNMID----GSVFRGII-------NGSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGA  381 (611)
Q Consensus       322 ~el~~at~~f~~~~~ig----g~Vy~g~~-------~g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~  381 (611)
                      .+.....++|.....||    |.||+|.+       +++.||||+++        +.+.+|+.++.++ +||||++++++
T Consensus        15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~   94 (359)
T 3vhe_A           15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   94 (359)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence            34444455666555565    89999985       34789999985        2488999999999 89999999999


Q ss_pred             eccCC-eEEEEEeecCCCCHHHHhhccCC---------------------------------------------------
Q 007261          382 CEHDG-VFYLVYEFMENGSLSDWLHKKRY---------------------------------------------------  409 (611)
Q Consensus       382 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------  409 (611)
                      +.+.+ ..++||||+++|+|.++++....                                                   
T Consensus        95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence            88754 48999999999999999986532                                                   


Q ss_pred             ------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcc
Q 007261          410 ------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS  477 (611)
Q Consensus       410 ------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  477 (611)
                                  ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~  250 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YV  250 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CE
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-ch
Confidence                        122899999999999999999999   58999999999999999999999999999976533222 22


Q ss_pred             cccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCcc
Q 007261          478 STKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN  556 (611)
Q Consensus       478 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  556 (611)
                      ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+...     .......            
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-----~~~~~~~------------  313 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-----RRLKEGT------------  313 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-----HHHHHTC------------
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH-----HHHHcCC------------
Confidence            3344568899999999999999999999999999999998 999987655433211     1111110            


Q ss_pred             CCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       557 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      ....+...+.++.+++.+||+.||++|||+.|++++|+++...
T Consensus       314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            0011223456789999999999999999999999999988754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-38  Score=324.38  Aligned_cols=250  Identities=23%  Similarity=0.319  Sum_probs=196.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCC--eEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDG--VFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|..  +|+.||||+++        +.+.+|+.++++++||||+++++++....  ..++||||+++|+|.+++..
T Consensus        23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  102 (319)
T 4euu_A           23 ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE  102 (319)
T ss_dssp             EEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHS
T ss_pred             eEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHH
Confidence            89999998  48999999985        35778999999999999999999987654  78999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee----CCCCcEEEeeecCccccccccCCccccccc
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL----DKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ......+++..++.++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++......    .....
T Consensus       103 ~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~----~~~~~  175 (319)
T 4euu_A          103 PSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSL  175 (319)
T ss_dssp             GGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC----CBCCC
T ss_pred             hccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC----ceeec
Confidence            654445999999999999999999999   6899999999999999    888899999999998654322    22345


Q ss_pred             ccCCCccchhhhc--------cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc--ccccccc
Q 007261          483 VGTNGYMAPEYME--------YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA--EAKLSVL  552 (611)
Q Consensus       483 ~gt~~y~aPE~~~--------~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--~~~l~~~  552 (611)
                      .||..|+|||.+.        +..++.++||||||+++|||++|+.||......... .............  ...+...
T Consensus       176 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~~  254 (319)
T 4euu_A          176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMYKIITGKPSGAISGVQKA  254 (319)
T ss_dssp             CSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC-HHHHHHHHHHCCTTCCEEEECS
T ss_pred             ccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh-HHHHHHHhcCCCcccchhhhcc
Confidence            6899999999986        578999999999999999999999999755433211 1112222221110  0000000


Q ss_pred             cC------ccC---CcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          553 VD------PNL---QANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       553 ~d------~~l---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      ..      +.+   ..........+.+++.+||+.||++|||+.|++++..+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          255 ENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             TTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            00      011   122567888999999999999999999999999998753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.9e-39  Score=324.68  Aligned_cols=232  Identities=28%  Similarity=0.478  Sum_probs=182.2

Q ss_pred             ceEEEEEEcCcEEEEEEec-----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGIINGSTVAIKCMR-----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~-----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|.+.|+.||||+++           +.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++...
T Consensus        21 g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  100 (271)
T 3dtc_A           21 GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK  100 (271)
T ss_dssp             EEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS
T ss_pred             eEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC
Confidence            8999999999999999985           35778999999999999999999999999999999999999999999654


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC--------CCcEEEeeecCccccccccCCcccc
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK--------NLRAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~--------~~~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                          .+++..++.++.|++.||+|||+....+++||||||+|||++.        ++.+||+|||+++.....     ..
T Consensus       101 ----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~  171 (271)
T 3dtc_A          101 ----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-----TK  171 (271)
T ss_dssp             ----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------
T ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccc-----cc
Confidence                3899999999999999999999522123999999999999986        778999999998754322     12


Q ss_pred             cccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc
Q 007261          480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA  559 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~  559 (611)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........     ........            ...
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~~~------------~~~  234 (271)
T 3dtc_A          172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA-----YGVAMNKL------------ALP  234 (271)
T ss_dssp             ----CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-----HHHHTSCC------------CCC
T ss_pred             cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HhhhcCCC------------CCC
Confidence            2456899999999999999999999999999999999999999765433211     11111100            001


Q ss_pred             ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          560 NKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      .+..++..+.+++.+||+.||++|||+.|++++|++|
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1233456789999999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.2e-39  Score=326.10  Aligned_cols=236  Identities=22%  Similarity=0.428  Sum_probs=194.4

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||++.+ ++..||||+++      +++.+|+.++++++||||+++++++.+++..++||||+++++|.+++....  .
T Consensus        38 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~  115 (283)
T 3gen_A           38 GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR--H  115 (283)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGG--G
T ss_pred             ceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhc--c
Confidence            89999998 55689999986      468899999999999999999999999999999999999999999998743  2


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......  ........+|+.|+||
T Consensus       116 ~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aP  190 (283)
T 3gen_A          116 RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPP  190 (283)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH--HHSTTSTTSCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc--cccccCCccCcccCCH
Confidence            4899999999999999999999   6899999999999999999999999999987653321  1122334567889999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+.+..++.++||||||+++|||++ |+.||......+.     ........             ....+...+..+.+
T Consensus       191 E~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-----~~~~~~~~-------------~~~~~~~~~~~l~~  252 (283)
T 3gen_A          191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----AEHIAQGL-------------RLYRPHLASEKVYT  252 (283)
T ss_dssp             HHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----HHHHHTTC-------------CCCCCTTCCHHHHH
T ss_pred             HHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-----HHHHhccc-------------CCCCCCcCCHHHHH
Confidence            99999999999999999999999998 8888876543221     11111110             00011223467889


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      ++.+||+.||++|||+.|++++|.++..+
T Consensus       253 li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          253 IMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            99999999999999999999999988764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-38  Score=326.61  Aligned_cols=260  Identities=25%  Similarity=0.380  Sum_probs=195.8

Q ss_pred             hhcCCCCCccc----ceEEEEEEcCcEEEEEEecH----HHHHHHHHHHhc--CCCceeeccceeccC----CeEEEEEe
Q 007261          328 TENFSPKNMID----GSVFRGIINGSTVAIKCMRR----SISKEVNLLKKI--NHFNLINLFGACEHD----GVFYLVYE  393 (611)
Q Consensus       328 t~~f~~~~~ig----g~Vy~g~~~g~~vavK~~~~----~~~~E~~~l~~l--~H~niv~l~g~~~~~----~~~~lV~E  393 (611)
                      .++|.....||    |.||+|..+|+.||||++..    .+.+|.+++..+  +||||+++++++...    ...++|||
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e  115 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD  115 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEEC
T ss_pred             ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEe
Confidence            34555555565    89999999999999999852    355566666655  999999999998776    78999999


Q ss_pred             ecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT-----DPGYVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      |+++|+|.++++...    +++..++.++.|++.||+|||+..     .++++||||||+|||++.++.+||+|||+++.
T Consensus       116 ~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~  191 (337)
T 3mdy_A          116 YHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK  191 (337)
T ss_dssp             CCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccCCCcHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCcee
Confidence            999999999997653    899999999999999999999410     12999999999999999999999999999976


Q ss_pred             cccccCCc-ccccccccCCCccchhhhccCCCCCc------cchHHHHHHHHHHHhC----------CCCCcCCCChhhH
Q 007261          469 AVREESGY-SSTKTAVGTNGYMAPEYMEYGLVTPE------MDTYAFGVVLLELITG----------KEAAYKQDGEEIL  531 (611)
Q Consensus       469 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k------sDV~s~Gvvl~elltG----------~~p~~~~~~~~~~  531 (611)
                      ........ .......||+.|+|||.+.+...+.+      +||||||+++|||++|          +.|+.........
T Consensus       192 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~  271 (337)
T 3mdy_A          192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS  271 (337)
T ss_dssp             CC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             eccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc
Confidence            54332211 11234579999999999988776665      9999999999999999          5555433222111


Q ss_pred             HHHHHHHHHhcCCcccccccccCccCCcC--hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          532 LAEAVFSMVEGGNAEAKLSVLVDPNLQAN--KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       532 l~~~~~~~~~~~~~~~~l~~~~d~~l~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      ... .......        ....+.....  ...++.++.+++.+||+.||++|||+.|++++|+++..+.
T Consensus       272 ~~~-~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          272 YED-MREIVCI--------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             HHH-HHHHHTT--------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             hhh-hHHHHhh--------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            111 1111110        0111122111  3478889999999999999999999999999999987754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.5e-40  Score=355.47  Aligned_cols=237  Identities=25%  Similarity=0.467  Sum_probs=193.6

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||+|.+ ++..||||+++      +.+.+|+.+|++++||||+++++++. ++..++||||+++|+|.++++... ..
T Consensus       202 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~-~~  279 (454)
T 1qcf_A          202 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDE-GS  279 (454)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHH-HH
T ss_pred             eEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhcc-CC
Confidence            89999999 57789999986      46899999999999999999999987 567899999999999999998642 12


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  ........++..|+||
T Consensus       280 ~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~y~aP  354 (454)
T 1qcf_A          280 KQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAP  354 (454)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH--HHTTCSSSSCGGGSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc--eeccCCCcccccccCH
Confidence            3788999999999999999999   5899999999999999999999999999998653221  1122334567889999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+..+.++.++||||||++||||++ |+.||......+..     ..... +.            ....+..++..+.+
T Consensus       355 E~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~-----~~i~~-~~------------~~~~~~~~~~~l~~  416 (454)
T 1qcf_A          355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-----RALER-GY------------RMPRPENCPEELYN  416 (454)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-----HHHHH-TC------------CCCCCTTSCHHHHH
T ss_pred             HHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH-----HHHHc-CC------------CCCCCCCCCHHHHH
Confidence            99999999999999999999999999 88888765433211     11111 10            01112345677999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      |+.+||+.||++|||+.+|++.|+.+....
T Consensus       417 li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          417 IMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             HHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            999999999999999999999999986543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-39  Score=339.70  Aligned_cols=242  Identities=28%  Similarity=0.478  Sum_probs=197.6

Q ss_pred             ceEEEEEEc---------CcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCH
Q 007261          339 GSVFRGIIN---------GSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~~---------g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      |.||++...         +..||||+++        +.+.+|+++++++ +||||++++++|..++..++||||+++|+|
T Consensus        83 g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L  162 (382)
T 3tt0_A           83 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  162 (382)
T ss_dssp             EEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             eEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcH
Confidence            899999863         2579999985        3578899999999 999999999999999999999999999999


Q ss_pred             HHHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          401 SDWLHKKRY-------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       401 ~~~l~~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      .+++.....             ...+++..++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~  239 (382)
T 3tt0_A          163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR  239 (382)
T ss_dssp             HHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSCSCCC
T ss_pred             HHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEcCCCcEEEcccCccc
Confidence            999987542             235899999999999999999999   5899999999999999999999999999998


Q ss_pred             ccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcc
Q 007261          468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       468 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  546 (611)
                      ....... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.|+......+      +...+....  
T Consensus       240 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~--  310 (382)
T 3tt0_A          240 DIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGH--  310 (382)
T ss_dssp             CSSCCCT-TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHTTC--
T ss_pred             ccccccc-cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCC--
Confidence            6543221 123344567889999999999999999999999999999999 888886554322      111221111  


Q ss_pred             cccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       547 ~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                                ....+..++.++.+++.+||+.||++|||+.||+++|+++......
T Consensus       311 ----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          311 ----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             ----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             ----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence                      0011223456789999999999999999999999999998775544

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-39  Score=340.62  Aligned_cols=240  Identities=26%  Similarity=0.437  Sum_probs=194.0

Q ss_pred             ceEEEEEE-------cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII-------NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|.+       ++..||||+++        .++.+|+.++++++||||+++++++...+..++||||+++|+|.++
T Consensus        85 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~  164 (367)
T 3l9p_A           85 GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF  164 (367)
T ss_dssp             SCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHH
T ss_pred             EEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHH
Confidence            89999985       35589999985        3578899999999999999999999999999999999999999999


Q ss_pred             hhccCC----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEEeeecCccccccccCCc
Q 007261          404 LHKKRY----PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL---RAKLANFSFVRSAVREESGY  476 (611)
Q Consensus       404 l~~~~~----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgla~~~~~~~~~~  476 (611)
                      +...+.    ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++   .+||+|||+++....... .
T Consensus       165 l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~-~  240 (367)
T 3l9p_A          165 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-Y  240 (367)
T ss_dssp             HHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSS-C
T ss_pred             HHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccc-c
Confidence            987532    235899999999999999999999   68999999999999999554   599999999976533221 1


Q ss_pred             ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCc
Q 007261          477 SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP  555 (611)
Q Consensus       477 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  555 (611)
                      .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+.      ......+.           
T Consensus       241 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~------~~~i~~~~-----------  303 (367)
T 3l9p_A          241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV------LEFVTSGG-----------  303 (367)
T ss_dssp             TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH------HHHHHTTC-----------
T ss_pred             ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCC-----------
Confidence            23334567899999999999999999999999999999998 8888865543221      11111111           


Q ss_pred             cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       556 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                       ....+..++..+.+|+.+||+.||++||++.+|+++|+.+....
T Consensus       304 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          304 -RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             -CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence             01112334567899999999999999999999999999887654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.8e-39  Score=332.50  Aligned_cols=248  Identities=22%  Similarity=0.393  Sum_probs=196.9

Q ss_pred             ceEEEEEE------cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceecc--CCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII------NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEH--DGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~------~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||++.+      +|+.||||+++        +.+.+|+.++++++||||+++++++.+  ....++||||+++|+|.+
T Consensus        45 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~  124 (318)
T 3lxp_A           45 GKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD  124 (318)
T ss_dssp             EEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHH
T ss_pred             eEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHH
Confidence            89998876      67899999986        347899999999999999999999976  467899999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++....    +++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...............
T Consensus       125 ~l~~~~----~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  197 (318)
T 3lxp_A          125 YLPRHS----IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG  197 (318)
T ss_dssp             HGGGSC----CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---C
T ss_pred             HHhhCC----CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCC
Confidence            998754    899999999999999999999   6899999999999999999999999999998765433222334455


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhh---------HHHHHHHHHHhcCCccccccccc
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI---------LLAEAVFSMVEGGNAEAKLSVLV  553 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~---------~l~~~~~~~~~~~~~~~~l~~~~  553 (611)
                      .++..|+|||.+.+..++.++||||||+++|||++|+.|+........         ............           
T Consensus       198 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------  266 (318)
T 3lxp_A          198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER-----------  266 (318)
T ss_dssp             CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT-----------
T ss_pred             CCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc-----------
Confidence            678889999999999999999999999999999999999864321110         000111111111           


Q ss_pred             CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhhchh
Q 007261          554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQT  605 (611)
Q Consensus       554 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~  605 (611)
                       ......+..++..+.+|+.+||+.||++|||+.|+++.|+++........|
T Consensus       267 -~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p  317 (318)
T 3lxp_A          267 -GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP  317 (318)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred             -ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence             111112334567899999999999999999999999999999887766544

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.3e-39  Score=322.14  Aligned_cols=231  Identities=24%  Similarity=0.403  Sum_probs=190.6

Q ss_pred             ceEEEEEEcCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccC--CeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD--GVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|.++|+.||||+++         +.+.+|+.++++++||||+++++++.+.  +..++||||+++|+|.+++...
T Consensus        24 g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  103 (271)
T 3kmu_A           24 GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG  103 (271)
T ss_dssp             EEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSC
T ss_pred             ceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhc
Confidence            8999999999999999985         3588999999999999999999999876  7889999999999999999875


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG--YVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      . ...+++..++.++.|++.||+|||   +.+  ++||||||+|||++.++.++|+|||++....        .....+|
T Consensus       104 ~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--------~~~~~~t  171 (271)
T 3kmu_A          104 T-NFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--------SPGRMYA  171 (271)
T ss_dssp             S-SCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--------CTTCBSC
T ss_pred             c-cCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec--------ccCccCC
Confidence            3 235899999999999999999999   567  9999999999999999999999999865421        2235689


Q ss_pred             CCccchhhhccCCCCC---ccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          486 NGYMAPEYMEYGLVTP---EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~---ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      +.|+|||.+.+..++.   ++||||||+++|||++|+.||......+..     ........         .+   ..+.
T Consensus       172 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~~~---------~~---~~~~  234 (271)
T 3kmu_A          172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-----MKVALEGL---------RP---TIPP  234 (271)
T ss_dssp             GGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-----HHHHHSCC---------CC---CCCT
T ss_pred             ccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-----HHHHhcCC---------CC---CCCC
Confidence            9999999998765554   799999999999999999998765433211     11111110         01   1123


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          563 EIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      .++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          235 GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            345678999999999999999999999999998764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-38  Score=331.88  Aligned_cols=240  Identities=26%  Similarity=0.464  Sum_probs=188.0

Q ss_pred             ceEEEEEEcC------cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGIING------STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~~g------~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|....      ..||||.++        .++.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++
T Consensus        58 g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  137 (333)
T 1mqb_A           58 GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL  137 (333)
T ss_dssp             SEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHH
T ss_pred             eEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHH
Confidence            8999998732      359999985        35788999999999999999999999999999999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ....  ..+++..++.++.||+.||+|||   +.+++||||||+|||++.++.+||+|||+++................+
T Consensus       138 ~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  212 (333)
T 1mqb_A          138 REKD--GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI  212 (333)
T ss_dssp             HHTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CC
T ss_pred             HhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCc
Confidence            8653  34899999999999999999999   589999999999999999999999999999865433222222233456


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      |..|+|||.+.+..++.++||||||+++|||++ |+.||......+.      ...+..+.            ....+..
T Consensus       213 ~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~------~~~~~~~~------------~~~~~~~  274 (333)
T 1mqb_A          213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV------MKAINDGF------------RLPTPMD  274 (333)
T ss_dssp             CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTTC------------CCCCCTT
T ss_pred             cccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH------HHHHHCCC------------cCCCccc
Confidence            788999999999999999999999999999999 9988865543221      11111110            0111223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                      ++..+.+++.+||+.||++||++.++++.|+++.....
T Consensus       275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          275 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            45678999999999999999999999999998876443

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.1e-39  Score=333.70  Aligned_cols=237  Identities=24%  Similarity=0.433  Sum_probs=188.4

Q ss_pred             ceEEEEEE--cCc----EEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGS----TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~----~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.+  +|+    .||+|.++        +.+.+|+.++++++||||++++++|.+.. .++|+||+++|+|.+++
T Consensus        29 g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l  107 (327)
T 3poz_A           29 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV  107 (327)
T ss_dssp             EEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHH
T ss_pred             eEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHH
Confidence            89999997  444    46888874        35888999999999999999999998765 78999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ....  ..+++..++.|+.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... ........+
T Consensus       108 ~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~  181 (327)
T 3poz_A          108 REHK--DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-EYHAEGGKV  181 (327)
T ss_dssp             HHST--TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC--------CC
T ss_pred             HhcC--CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc-cccccCCCc
Confidence            8754  34899999999999999999999   58999999999999999999999999999986543322 122234456


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      |..|+|||.+.+..++.++||||||+++|||++ |+.||......+..      ..+....            ....+..
T Consensus       182 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~~~------------~~~~~~~  243 (327)
T 3poz_A          182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------SILEKGE------------RLPQPPI  243 (327)
T ss_dssp             CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH------HHHHTTC------------CCCCCTT
T ss_pred             cccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH------HHHHcCC------------CCCCCcc
Confidence            889999999999999999999999999999999 89888765543321      1111110            0111223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      ++..+.+++.+||+.||++||++.|++++|+++..+.
T Consensus       244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          244 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence            4567899999999999999999999999999886643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-39  Score=334.33  Aligned_cols=254  Identities=23%  Similarity=0.446  Sum_probs=200.1

Q ss_pred             hhcCCCCCccc----ceEEEEEE-------cCcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCe
Q 007261          328 TENFSPKNMID----GSVFRGII-------NGSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGV  387 (611)
Q Consensus       328 t~~f~~~~~ig----g~Vy~g~~-------~g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  387 (611)
                      .++|.....||    |.||+|..       ++..||||+++        +.+.+|+.+++++ +||||+++++++...+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            34555555554    89999996       34589999985        3578999999999 99999999999999999


Q ss_pred             EEEEEeecCCCCHHHHhhccCCC--------------------CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 007261          388 FYLVYEFMENGSLSDWLHKKRYP--------------------EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS  447 (611)
Q Consensus       388 ~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~  447 (611)
                      .++||||+++|+|.+++......                    ..+++..++.++.||+.||+|||   ..+|+||||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp  200 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA  200 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCh
Confidence            99999999999999999875321                    34799999999999999999999   68999999999


Q ss_pred             CCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCC
Q 007261          448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQD  526 (611)
Q Consensus       448 ~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~  526 (611)
                      +|||++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCcc-ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            999999999999999999976543321 222334567889999999999999999999999999999998 888887654


Q ss_pred             ChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          527 GEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       527 ~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                      .....     ......+.         .   ...+..++..+.+|+.+||+.||.+|||+.|++++|+.+.....+
T Consensus       280 ~~~~~-----~~~~~~~~---------~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          280 VDANF-----YKLIQNGF---------K---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             CSHHH-----HHHHHTTC---------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             cHHHH-----HHHHhcCC---------C---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence            43211     11111110         0   011223456789999999999999999999999999998765443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-38  Score=328.53  Aligned_cols=238  Identities=28%  Similarity=0.521  Sum_probs=195.0

Q ss_pred             ceEEEEEE-------cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII-------NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++..       ++..||||+++        +.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.++
T Consensus        37 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  116 (314)
T 2ivs_A           37 GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF  116 (314)
T ss_dssp             SEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred             eeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHH
Confidence            89999986       34789999985        3577899999999999999999999999999999999999999999


Q ss_pred             hhccCC---------------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 007261          404 LHKKRY---------------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLAN  462 (611)
Q Consensus       404 l~~~~~---------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D  462 (611)
                      +.....                     ...+++..++.++.||+.||+|||   +.+++||||||+|||+++++.+||+|
T Consensus       117 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~NIli~~~~~~kl~D  193 (314)
T 2ivs_A          117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISD  193 (314)
T ss_dssp             HHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTEEEECC
T ss_pred             HHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccchheEEEcCCCCEEEcc
Confidence            987532                     134899999999999999999999   58999999999999999999999999


Q ss_pred             ecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHh
Q 007261          463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVE  541 (611)
Q Consensus       463 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  541 (611)
                      ||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+..      ....
T Consensus       194 fg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~------~~~~  266 (314)
T 2ivs_A          194 FGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF------NLLK  266 (314)
T ss_dssp             CTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH------HHHH
T ss_pred             cccccccccccc-ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHhh
Confidence            999976543321 122334567888999999999999999999999999999999 88888765543211      1111


Q ss_pred             cCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          542 GGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       542 ~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      ...            ....+..++..+.+++.+||+.||++||++.|++++|+++..
T Consensus       267 ~~~------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          267 TGH------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             TTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCC------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            110            011123345678999999999999999999999999998765

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.5e-39  Score=331.11  Aligned_cols=231  Identities=21%  Similarity=0.420  Sum_probs=185.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCC----------------------
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDG----------------------  386 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~----------------------  386 (611)
                      |.||+|+.  +|+.||||+++        +.+.+|+.+|++++||||++++++|.+..                      
T Consensus        20 g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   99 (332)
T 3qd2_B           20 GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPL   99 (332)
T ss_dssp             SEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------------
T ss_pred             eEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccc
Confidence            89999998  68999999985        46889999999999999999999885432                      


Q ss_pred             -----------------------------------eEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHH
Q 007261          387 -----------------------------------VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHY  431 (611)
Q Consensus       387 -----------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~y  431 (611)
                                                         ..++||||+++|+|.+++.........++..++.++.||+.||+|
T Consensus       100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~  179 (332)
T 3qd2_B          100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF  179 (332)
T ss_dssp             --------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHH
T ss_pred             cCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHH
Confidence                                               389999999999999999987655567888899999999999999


Q ss_pred             HhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC---------cccccccccCCCccchhhhccCCCCCc
Q 007261          432 LHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG---------YSSTKTAVGTNGYMAPEYMEYGLVTPE  502 (611)
Q Consensus       432 LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~s~k  502 (611)
                      ||   +.+|+||||||+|||++.++.+||+|||+++........         ........||+.|+|||.+.+..++.+
T Consensus       180 LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  256 (332)
T 3qd2_B          180 LH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK  256 (332)
T ss_dssp             HH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTH
T ss_pred             HH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcch
Confidence            99   689999999999999999999999999999866443211         112234579999999999999999999


Q ss_pred             cchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCC
Q 007261          503 MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPES  582 (611)
Q Consensus       503 sDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~  582 (611)
                      +||||||+++|||++|..|+...       ........             ..............+.+++.+||+.||++
T Consensus       257 ~Di~slG~il~el~~~~~~~~~~-------~~~~~~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~  316 (332)
T 3qd2_B          257 VDIFSLGLILFELLYSFSTQMER-------VRIITDVR-------------NLKFPLLFTQKYPQEHMMVQDMLSPSPTE  316 (332)
T ss_dssp             HHHHHHHHHHHHHHSCCCCHHHH-------HHHHHHHH-------------TTCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred             hhHHHHHHHHHHHHHcCCChhHH-------HHHHHHhh-------------ccCCCcccccCChhHHHHHHHHccCCCCc
Confidence            99999999999999987653210       11111111             11112223455667899999999999999


Q ss_pred             CCCHHHHHHH
Q 007261          583 RPSMAEVVST  592 (611)
Q Consensus       583 RPs~~evl~~  592 (611)
                      ||++.|++++
T Consensus       317 Rps~~~~l~~  326 (332)
T 3qd2_B          317 RPEATDIIEN  326 (332)
T ss_dssp             SCCHHHHHHS
T ss_pred             CCCHHHHhhc
Confidence            9999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=356.49  Aligned_cols=240  Identities=23%  Similarity=0.444  Sum_probs=192.2

Q ss_pred             ceEEEEEE----cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII----NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~----~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|.+    ++..||||+++        +++.+|+.+|++++|||||+++++|.. +..++||||+++|+|.+++..
T Consensus       350 G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~  428 (613)
T 2ozo_A          350 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG  428 (613)
T ss_dssp             SEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTT
T ss_pred             cEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhh
Confidence            99999987    34579999985        468899999999999999999999976 568999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..  ..+++..++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++................+++
T Consensus       429 ~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~  503 (613)
T 2ozo_A          429 KR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL  503 (613)
T ss_dssp             CT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CC
T ss_pred             cc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCcc
Confidence            53  45899999999999999999999   58999999999999999999999999999987643332222233345678


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      .|+|||.+.+..++.++||||||++||||++ |+.||......+..      ..+..+.            ....+..++
T Consensus       504 ~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~------~~i~~~~------------~~~~p~~~~  565 (613)
T 2ozo_A          504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------AFIEQGK------------RMECPPECP  565 (613)
T ss_dssp             TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH------HHHHTTC------------CCCCCTTCC
T ss_pred             ceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH------HHHHcCC------------CCCCCCcCC
Confidence            9999999999999999999999999999998 99998776554321      1121111            111233456


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                      .++.+|+.+||+.||++||++.+|++.|+.+..+...
T Consensus       566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          566 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence            7899999999999999999999999999988765443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.4e-38  Score=333.02  Aligned_cols=229  Identities=22%  Similarity=0.317  Sum_probs=189.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++..  +|..||+|.++             ..+.+|+.+|++++||||+++++++.+.+..++||||+++|+|.++
T Consensus        26 g~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~  105 (361)
T 2yab_A           26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDF  105 (361)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHH
Confidence            89999998  68999999985             3578999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEeeecCccccccccCCcccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL----RAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      +....   .+++..+..++.||+.||.|||   +.+|+||||||+|||+++++    .+||+|||+++......    ..
T Consensus       106 l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~----~~  175 (361)
T 2yab_A          106 LAQKE---SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EF  175 (361)
T ss_dssp             HTTCS---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC----CC
T ss_pred             HHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC----cc
Confidence            97643   4899999999999999999999   58999999999999998877    79999999997654321    23


Q ss_pred             cccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc
Q 007261          480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA  559 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~  559 (611)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|..||......+.     .........       .+++   .
T Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-----~~~i~~~~~-------~~~~---~  240 (361)
T 2yab_A          176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----LANITAVSY-------DFDE---E  240 (361)
T ss_dssp             CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-----HHHHHTTCC-------CCCH---H
T ss_pred             ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcCC-------CCCc---h
Confidence            446799999999999999999999999999999999999999976543321     111111100       0000   0


Q ss_pred             ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          560 NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .....+..+.+|+.+||..||++|||+.|++++
T Consensus       241 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          241 FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            012345678999999999999999999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.3e-38  Score=330.07  Aligned_cols=226  Identities=24%  Similarity=0.358  Sum_probs=189.0

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||++++          .+.+|+.+|++++||||+++++++.+.+..++||||+++|+|.+++..
T Consensus        19 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~   98 (337)
T 1o6l_A           19 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR   98 (337)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh
Confidence            89999998  689999999963          367899999999999999999999999999999999999999999986


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .+   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||+
T Consensus        99 ~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~~gt~  169 (337)
T 1o6l_A           99 ER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTP  169 (337)
T ss_dssp             HS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT---CCBCCCEECG
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC---CcccccccCh
Confidence            53   3899999999999999999999   6899999999999999999999999999987543221   2334567999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||......+.     ........           ..   .+...+.
T Consensus       170 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----~~~i~~~~-----------~~---~p~~~s~  230 (337)
T 1o6l_A          170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----FELILMEE-----------IR---FPRTLSP  230 (337)
T ss_dssp             GGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHCC-----------CC---CCTTSCH
T ss_pred             hhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH-----HHHHHcCC-----------CC---CCCCCCH
Confidence            99999999999999999999999999999999999976543221     11111110           00   1123456


Q ss_pred             HHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      ++.+|+.+||+.||++||     ++.|++++
T Consensus       231 ~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            789999999999999999     89998875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.2e-38  Score=318.35  Aligned_cols=230  Identities=29%  Similarity=0.519  Sum_probs=188.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||++..  +++.||||++.              +.+.+|+.++++++||||+++++++.+..  ++||||+++|+|.+
T Consensus        33 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~  110 (287)
T 4f0f_A           33 GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYH  110 (287)
T ss_dssp             SCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHH
T ss_pred             eeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHH
Confidence            89999998  78899999983              46889999999999999999999997765  69999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeCCCCc-----EEEeeecCccccccccCC
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG--YVHKDISSGNILLDKNLR-----AKLANFSFVRSAVREESG  475 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivH~Dlk~~NILl~~~~~-----~kl~Dfgla~~~~~~~~~  475 (611)
                      ++....  ..+++..++.++.|++.||+|||   ..+  ++||||||+|||++.++.     +||+|||+++....    
T Consensus       111 ~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~----  181 (287)
T 4f0f_A          111 RLLDKA--HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----  181 (287)
T ss_dssp             HHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS----
T ss_pred             HHhccc--CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc----
Confidence            987653  35899999999999999999999   577  999999999999988776     99999999874422    


Q ss_pred             cccccccccCCCccchhhh--ccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccccc
Q 007261          476 YSSTKTAVGTNGYMAPEYM--EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV  553 (611)
Q Consensus       476 ~~~~~~~~gt~~y~aPE~~--~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  553 (611)
                        ......+|+.|+|||.+  ....++.++||||||+++|||++|+.||.............   .....         .
T Consensus       182 --~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---~~~~~---------~  247 (287)
T 4f0f_A          182 --SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM---IREEG---------L  247 (287)
T ss_dssp             --CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH---HHHSC---------C
T ss_pred             --cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH---HhccC---------C
Confidence              23345789999999998  45567899999999999999999999997655443222111   11111         0


Q ss_pred             CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       554 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      .+   ..+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       248 ~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          248 RP---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CC---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            01   11234456789999999999999999999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8e-39  Score=325.39  Aligned_cols=239  Identities=28%  Similarity=0.482  Sum_probs=197.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      |.||+|..  ++..||||.++      +.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++.... .
T Consensus        27 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~  105 (288)
T 3kfa_A           27 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-R  105 (288)
T ss_dssp             CSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCC-T
T ss_pred             eeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcc-c
Confidence            89999998  48899999986      468899999999999999999999999999999999999999999998753 2


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA  490 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~a  490 (611)
                      ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......  ........+++.|+|
T Consensus       106 ~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~~y~a  180 (288)
T 3kfa_A          106 QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA  180 (288)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS--SEEETTEEECGGGCC
T ss_pred             CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc--cccccCCccccCcCC
Confidence            45899999999999999999999   6899999999999999999999999999987654322  123334556888999


Q ss_pred             hhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          491 PEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       491 PE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      ||.+.+..++.++||||||+++|||++ |..|+.........  .    ......            ....+..++..+.
T Consensus       181 PE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~--~----~~~~~~------------~~~~~~~~~~~l~  242 (288)
T 3kfa_A          181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--E----LLEKDY------------RMERPEGCPEKVY  242 (288)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--H----HHHTTC------------CCCCCTTCCHHHH
T ss_pred             hhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--H----HHhccC------------CCCCCCCCCHHHH
Confidence            999999999999999999999999999 88887655433211  1    111100            0111233456789


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          570 MLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                      +++.+||+.||.+|||+.|+++.|+.+.....
T Consensus       243 ~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          243 ELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            99999999999999999999999999877544

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.4e-39  Score=332.51  Aligned_cols=250  Identities=24%  Similarity=0.410  Sum_probs=186.0

Q ss_pred             hcCCCCCccc----ceEEEEEEc--Cc---EEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeE--
Q 007261          329 ENFSPKNMID----GSVFRGIIN--GS---TVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVF--  388 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~~--g~---~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~--  388 (611)
                      ++|.....+|    |.||+|...  +.   .||||+++         +.+.+|+.++++++||||+++++++......  
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            3444444454    899999873  32   79999985         3578899999999999999999999876654  


Q ss_pred             ----EEEEeecCCCCHHHHhhccCC---CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 007261          389 ----YLVYEFMENGSLSDWLHKKRY---PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA  461 (611)
Q Consensus       389 ----~lV~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~  461 (611)
                          ++||||+++|+|.+++.....   ...+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl~  179 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVA  179 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEEe
Confidence                999999999999999975422   225899999999999999999999   5899999999999999999999999


Q ss_pred             eecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHH
Q 007261          462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMV  540 (611)
Q Consensus       462 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  540 (611)
                      |||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+..     ....
T Consensus       180 Dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-----~~~~  253 (323)
T 3qup_A          180 DFGLSRKIYSGDY-YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY-----NYLI  253 (323)
T ss_dssp             CCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----HHHH
T ss_pred             ecccccccccccc-ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH-----HHHh
Confidence            9999976543221 122233456788999999999999999999999999999999 88888765443321     1111


Q ss_pred             hcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          541 EGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       541 ~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      . .            .....+..++..+.+++.+||+.||++|||+.++++.|+++....
T Consensus       254 ~-~------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          254 G-G------------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             T-T------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             c-C------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            1 0            111112334567899999999999999999999999999987643

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.4e-38  Score=322.82  Aligned_cols=236  Identities=23%  Similarity=0.398  Sum_probs=181.7

Q ss_pred             ceEEEEEEc-----CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGIIN-----GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~~-----g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|...     +..||||.++        +.+.+|+.++++++||||+++++++. ++..++||||+++|+|.+++.
T Consensus        29 g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~  107 (281)
T 1mp8_A           29 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ  107 (281)
T ss_dssp             SEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHH
T ss_pred             eeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHH
Confidence            899999872     4579999975        35788999999999999999999985 456789999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...  ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......  ........++
T Consensus       108 ~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~  180 (281)
T 1mp8_A          108 VRK--YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLP  180 (281)
T ss_dssp             HTT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------------------CC
T ss_pred             hcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCccc--ccccccCCCc
Confidence            653  34899999999999999999999   5899999999999999999999999999997654322  1122334567


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      +.|+|||.+.+..++.++||||||+++|||++ |..||......+..     ..... ..            ....+..+
T Consensus       181 ~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~-----~~i~~-~~------------~~~~~~~~  242 (281)
T 1mp8_A          181 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-----GRIEN-GE------------RLPMPPNC  242 (281)
T ss_dssp             GGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----HHHHT-TC------------CCCCCTTC
T ss_pred             ccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH-----HHHHc-CC------------CCCCCCCC
Confidence            88999999999999999999999999999997 88888765443221     11111 10            01112334


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      +..+.+++.+||+.||++||++.|+++.|+++..+.
T Consensus       243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            567899999999999999999999999999987653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-38  Score=330.03  Aligned_cols=231  Identities=19%  Similarity=0.296  Sum_probs=190.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      |.||++..  +|..||+|.++      ..+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++....  
T Consensus        19 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--   96 (321)
T 1tki_A           19 GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA--   96 (321)
T ss_dssp             EEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS--
T ss_pred             eEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcC--
Confidence            89999998  68899999985      357889999999999999999999999999999999999999999997653  


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC--CCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK--NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                      ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.  ++.+||+|||+++......    ......+|+.|
T Consensus        97 ~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y  169 (321)
T 1tki_A           97 FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEY  169 (321)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC----EEEEEESCGGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC----ccccccCChhh
Confidence            34899999999999999999999   689999999999999987  7899999999997653321    23345789999


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHH
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL  568 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l  568 (611)
                      +|||.+.+..++.++||||||+++|||++|+.||......+.     ..........       .+   .......+.++
T Consensus       170 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~i~~~~~~-------~~---~~~~~~~s~~~  234 (321)
T 1tki_A          170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-----IENIMNAEYT-------FD---EEAFKEISIEA  234 (321)
T ss_dssp             SCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHHTCCC-------CC---HHHHTTSCHHH
T ss_pred             cCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-----HHHHHcCCCC-------CC---hhhhccCCHHH
Confidence            999999998899999999999999999999999976543321     1111111100       00   00012345678


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          569 IMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       569 ~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      .+|+.+||+.||++|||+.|++++-
T Consensus       235 ~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          235 MDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCh
Confidence            9999999999999999999999854

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-38  Score=321.38  Aligned_cols=240  Identities=24%  Similarity=0.447  Sum_probs=196.4

Q ss_pred             ceEEEEEE----cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII----NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~----~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|.+    ++..||||+++        +.+.+|+.++++++||||+++++++ ..+..++||||+++++|.+++..
T Consensus        24 g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~  102 (287)
T 1u59_A           24 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG  102 (287)
T ss_dssp             EEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTT
T ss_pred             eeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh
Confidence            89999986    57789999985        3578899999999999999999999 45668999999999999999975


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..  ..+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++................+|+
T Consensus       103 ~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~  177 (287)
T 1u59_A          103 KR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL  177 (287)
T ss_dssp             CT--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCG
T ss_pred             CC--ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccc
Confidence            43  34899999999999999999999   68999999999999999999999999999986644332222333445688


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      .|+|||.+.+..++.++||||||+++|||++ |+.||......+..      .....+.            ....+..++
T Consensus       178 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~i~~~~------------~~~~~~~~~  239 (287)
T 1u59_A          178 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------AFIEQGK------------RMECPPECP  239 (287)
T ss_dssp             GGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH------HHHHTTC------------CCCCCTTCC
T ss_pred             cccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH------HHHhcCC------------cCCCCCCcC
Confidence            9999999998899999999999999999998 99998765543211      1111110            011123455


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                      ..+.+++.+||+.||++||++.+++++|+++..+...
T Consensus       240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence            6799999999999999999999999999998776543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.3e-37  Score=324.45  Aligned_cols=261  Identities=25%  Similarity=0.377  Sum_probs=201.9

Q ss_pred             HhhcCCCCCccc----ceEEEEEEcCcEEEEEEec----HHHHHHHHHHHh--cCCCceeeccceeccCC----eEEEEE
Q 007261          327 ATENFSPKNMID----GSVFRGIINGSTVAIKCMR----RSISKEVNLLKK--INHFNLINLFGACEHDG----VFYLVY  392 (611)
Q Consensus       327 at~~f~~~~~ig----g~Vy~g~~~g~~vavK~~~----~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~  392 (611)
                      ..++|.....+|    |.||+|..+|+.||||+++    ..+.+|.+++..  ++||||+++++++....    ..++||
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~  119 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS  119 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred             ccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEE
Confidence            345666666665    8999999999999999986    357789999988  69999999999998765    799999


Q ss_pred             eecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT-----DPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       393 E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      ||+++|+|.+++....    +++..++.++.|++.||+|||...     +.+++||||||+|||++.++.+||+|||+++
T Consensus       120 e~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~  195 (342)
T 1b6c_B          120 DYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  195 (342)
T ss_dssp             CCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eecCCCcHHHHHhccC----ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCce
Confidence            9999999999998653    899999999999999999999311     3789999999999999999999999999997


Q ss_pred             ccccccCCc-ccccccccCCCccchhhhccC------CCCCccchHHHHHHHHHHHhC----------CCCCcCCCChhh
Q 007261          468 SAVREESGY-SSTKTAVGTNGYMAPEYMEYG------LVTPEMDTYAFGVVLLELITG----------KEAAYKQDGEEI  530 (611)
Q Consensus       468 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~s~Gvvl~elltG----------~~p~~~~~~~~~  530 (611)
                      ......... .......||+.|+|||.+.+.      .++.++||||||+++|||++|          ..||........
T Consensus       196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  275 (342)
T 1b6c_B          196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  275 (342)
T ss_dssp             EEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc
Confidence            654332111 123445789999999999765      234689999999999999999          667765432221


Q ss_pred             HHHHHHHHHHhcCCcccccccccCccCCc--ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          531 LLAEAVFSMVEGGNAEAKLSVLVDPNLQA--NKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       531 ~l~~~~~~~~~~~~~~~~l~~~~d~~l~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      ...........         ....+.+..  ...++...+.+|+.+||+.||++|||+.||+++|+++..+.
T Consensus       276 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          276 SVEEMRKVVCE---------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             CHHHHHHHHTT---------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cHHHHHHHHHH---------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            11111111111         111122221  13467788999999999999999999999999999987653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=332.08  Aligned_cols=250  Identities=22%  Similarity=0.353  Sum_probs=186.3

Q ss_pred             ceEEEEEEcCcEEEEEEec----HHHHHHHHH--HHhcCCCceeecccee-----ccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGIINGSTVAIKCMR----RSISKEVNL--LKKINHFNLINLFGAC-----EHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~----~~~~~E~~~--l~~l~H~niv~l~g~~-----~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|+.+|+.||||+++    ..+..|.++  +..++||||+++++.+     ......++||||+++|+|.+++...
T Consensus        27 g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~  106 (336)
T 3g2f_A           27 GAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH  106 (336)
T ss_dssp             EEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC
T ss_pred             eEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc
Confidence            8999999999999999986    344455554  4458999999999744     3344679999999999999999876


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCC---------CeEecCCCCCCeeeCCCCcEEEeeecCccccccccC----
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDP---------GYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES----  474 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~---------~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~----  474 (611)
                      .    .++..++.++.||+.||+|||   ..         +|+||||||+|||++.++.+||+|||+++.......    
T Consensus       107 ~----~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~  179 (336)
T 3g2f_A          107 T----SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG  179 (336)
T ss_dssp             C----BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---
T ss_pred             c----cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCcc
Confidence            4    689999999999999999999   45         999999999999999999999999999976543211    


Q ss_pred             -CcccccccccCCCccchhhhcc-------CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhh---HH---------HH
Q 007261          475 -GYSSTKTAVGTNGYMAPEYMEY-------GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI---LL---------AE  534 (611)
Q Consensus       475 -~~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~---~l---------~~  534 (611)
                       .........||+.|+|||.+.+       ..++.++||||||+++|||++|+.|++.......   ..         ..
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  259 (336)
T 3g2f_A          180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFE  259 (336)
T ss_dssp             ------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHH
T ss_pred             ccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHH
Confidence             1112234579999999999976       4567899999999999999999888765432110   00         00


Q ss_pred             HHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          535 AVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       535 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      .........    .....+.... ......+..+.+|+.+||+.||++|||+.|+++.|+++...-
T Consensus       260 ~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          260 DMQVLVSRE----KQRPKFPEAW-KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             HHHHHHTTS----CCCCCCCTTC-CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             HHHhhhccc----ccCCCCCccc-ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence            111111110    0011111111 113356778999999999999999999999999999987543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.1e-37  Score=323.92  Aligned_cols=243  Identities=14%  Similarity=0.162  Sum_probs=196.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec-----HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-----RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      |.||+|..  +|+.||||++.     ..+.+|+.+++++ +||||+++++++..++..++||||+ +++|.+++....  
T Consensus        23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--   99 (330)
T 2izr_A           23 GELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD--   99 (330)
T ss_dssp             TSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--
T ss_pred             ceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcC--
Confidence            89999996  78999999985     3588999999999 9999999999999999999999999 999999998752  


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc-----EEEeeecCccccccccCC----cccccc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR-----AKLANFSFVRSAVREESG----YSSTKT  481 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~Dfgla~~~~~~~~~----~~~~~~  481 (611)
                      ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.     +||+|||+++........    ......
T Consensus       100 ~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~  176 (330)
T 2izr_A          100 RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS  176 (330)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCC
Confidence            35999999999999999999999   589999999999999999887     999999999865433221    112345


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhh-HHHHHHHHHHhcCCcccccccccCccCCcC
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI-LLAEAVFSMVEGGNAEAKLSVLVDPNLQAN  560 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~  560 (611)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. .....+.......    .    . ..+   
T Consensus       177 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~----~----~-~~~---  244 (330)
T 2izr_A          177 LTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT----P----I-EVL---  244 (330)
T ss_dssp             CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS----C----H-HHH---
T ss_pred             cCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC----C----H-HHH---
Confidence            6799999999999999999999999999999999999999987543321 1111111110000    0    0 000   


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          561 KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       561 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      ....+ ++.+++.+||+.||.+||++.+|++.|+++....
T Consensus       245 ~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          245 CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            01123 7999999999999999999999999998876543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.6e-39  Score=347.79  Aligned_cols=237  Identities=30%  Similarity=0.487  Sum_probs=188.7

Q ss_pred             ceEEEEEEc-CcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGIIN-GSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~~-g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||+|.+. +..||||+++      +++.+|+.+|++++||||+++++++.+ +..++||||+++|+|.+++.... ..
T Consensus       198 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~-~~  275 (452)
T 1fmk_A          198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GK  275 (452)
T ss_dssp             CEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHH-HT
T ss_pred             eEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcC-CC
Confidence            899999995 4679999986      468999999999999999999999976 67899999999999999997532 13


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++......  ........++..|+||
T Consensus       276 ~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~~~~~y~aP  350 (452)
T 1fmk_A          276 YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAP  350 (452)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------------CCGGGSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc--eecccCCcccccccCH
Confidence            4899999999999999999999   6899999999999999999999999999998654321  1222334567899999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+.++.++.++||||||++||||++ |+.|+......+.      ...+..+.            ....+..++..+.+
T Consensus       351 E~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~------~~~i~~~~------------~~~~~~~~~~~l~~  412 (452)
T 1fmk_A          351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGY------------RMPCPPECPESLHD  412 (452)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHHHHTTC------------CCCCCTTSCHHHHH
T ss_pred             hHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCC------------CCCCCCCCCHHHHH
Confidence            99999999999999999999999999 8888865543221      11111110            01112345677899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      ++.+||+.||++|||+.+|++.|+.+....
T Consensus       413 li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          413 LMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence            999999999999999999999999886543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-38  Score=327.81  Aligned_cols=228  Identities=23%  Similarity=0.340  Sum_probs=189.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++..  +|..||||+++             ..+.+|+.+|++++||||+++++++.+.+..++||||+++|+|.++
T Consensus        25 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  104 (326)
T 2y0a_A           25 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF  104 (326)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred             eEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHH
Confidence            89999998  58899999884             3578999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEeeecCccccccccCCcccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL----RAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      +...   ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++    .+||+|||+++......    ..
T Consensus       105 l~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~----~~  174 (326)
T 2y0a_A          105 LAEK---ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EF  174 (326)
T ss_dssp             HTTS---SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS----CC
T ss_pred             HHhc---CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC----cc
Confidence            9764   34899999999999999999999   68999999999999999887    89999999997653221    22


Q ss_pred             cccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc
Q 007261          480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA  559 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~  559 (611)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..     .......           .....
T Consensus       175 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-----~~~~~~~-----------~~~~~  238 (326)
T 2y0a_A          175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-----ANVSAVN-----------YEFED  238 (326)
T ss_dssp             CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-----HHHHHTC-----------CCCCH
T ss_pred             ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-----HHHHhcC-----------CCcCc
Confidence            3457999999999999999999999999999999999999999765432211     1111100           00000


Q ss_pred             C-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          560 N-KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       560 ~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      . ....+..+.+|+.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0 12345678899999999999999999999974

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-38  Score=319.17  Aligned_cols=236  Identities=27%  Similarity=0.507  Sum_probs=194.4

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||++.. ++..||+|+++      +++.+|+.++++++||||+++++++.+++..++||||+++++|.+++....  .
T Consensus        22 g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~   99 (267)
T 3t9t_A           22 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR--G   99 (267)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTT--T
T ss_pred             eeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCc--c
Confidence            89999998 77899999986      468899999999999999999999999999999999999999999998753  3


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++......  ........++..|+||
T Consensus       100 ~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~y~aP  174 (267)
T 3t9t_A          100 LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASP  174 (267)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH--HHSTTSTTCCGGGCCH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc--ccccccccccccccCh
Confidence            4899999999999999999999   6899999999999999999999999999987653221  1122334567889999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+.+..++.++||||||+++|||++ |+.||......+.     ...... +.     .       ...+...+..+.+
T Consensus       175 E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----~~~i~~-~~-----~-------~~~~~~~~~~l~~  236 (267)
T 3t9t_A          175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDIST-GF-----R-------LYKPRLASTHVYQ  236 (267)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----HHHHHT-TC-----C-------CCCCTTSCHHHHH
T ss_pred             hhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH-----HHHHhc-CC-----c-------CCCCccCcHHHHH
Confidence            99998999999999999999999999 7888765443221     111111 10     0       0011223567899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      ++.+||+.||++||++.+++++|+++..+
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          237 IMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999999998763

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=9.8e-38  Score=318.80  Aligned_cols=244  Identities=17%  Similarity=0.146  Sum_probs=197.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec-----HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-----RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      |.||+|..  +|+.||||++.     ..+.+|+.+++++ +|+|++++++++.++...++||||+ +++|.+++....  
T Consensus        24 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--  100 (298)
T 1csn_A           24 GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG--  100 (298)
T ss_dssp             CEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--
T ss_pred             EEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhc--
Confidence            89999996  78999999985     3588999999999 8999999999999999999999999 999999998753  


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc-----EEEeeecCccccccccCC----cccccc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR-----AKLANFSFVRSAVREESG----YSSTKT  481 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~Dfgla~~~~~~~~~----~~~~~~  481 (611)
                      ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.     +||+|||+++........    ......
T Consensus       101 ~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  177 (298)
T 1csn_A          101 RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN  177 (298)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccC
Confidence            34899999999999999999999   689999999999999987776     999999999866433221    112345


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChh-hHHHHHHHHHHhcCCcccccccccCccCCcC
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE-ILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN  560 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~  560 (611)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ......+.......    .        ....
T Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~--------~~~~  245 (298)
T 1csn_A          178 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST----P--------LREL  245 (298)
T ss_dssp             CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS----C--------HHHH
T ss_pred             CCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc----c--------HHHH
Confidence            679999999999999999999999999999999999999997654321 11111111111000    0        0000


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          561 KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       561 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      ...++..+.+++.+||+.||++||++.+|++.|+++....
T Consensus       246 ~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~  285 (298)
T 1csn_A          246 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  285 (298)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence            1134567899999999999999999999999999987654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.4e-38  Score=329.75  Aligned_cols=224  Identities=25%  Similarity=0.369  Sum_probs=187.2

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|..  +|+.||||++.+          .+.+|+.+++.++||||+++++++...+..++||||+ +|+|.+++..
T Consensus        23 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~  101 (336)
T 3h4j_B           23 GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVE  101 (336)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHH
Confidence            89999998  788999999853          4778999999999999999999999999999999999 7899999876


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..++.++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||++.......    ......||+
T Consensus       102 ~~---~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~----~~~~~~gt~  171 (336)
T 3h4j_B          102 KK---RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----FLKTSCGSP  171 (336)
T ss_dssp             HC---SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB----TTCCCTTST
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc----ccccccCCc
Confidence            53   3899999999999999999999   5899999999999999999999999999987653321    234457999


Q ss_pred             CccchhhhccCCC-CCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          487 GYMAPEYMEYGLV-TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       487 ~y~aPE~~~~~~~-s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      .|+|||.+.+..+ ++++||||||+++|||++|+.||......+                   +...+.......+...+
T Consensus       172 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------------------~~~~i~~~~~~~p~~~s  232 (336)
T 3h4j_B          172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-------------------LFKKVNSCVYVMPDFLS  232 (336)
T ss_dssp             TTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-------------------CBCCCCSSCCCCCTTSC
T ss_pred             CcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-------------------HHHHHHcCCCCCcccCC
Confidence            9999999988776 789999999999999999999997543221                   01111111111233456


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+.+|+.+||+.||.+|||+.|++++
T Consensus       233 ~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          233 PGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            678999999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6e-39  Score=331.86  Aligned_cols=254  Identities=24%  Similarity=0.433  Sum_probs=200.3

Q ss_pred             HHHHHhhcCCCCCccc----ceEEEEEEc-------CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceec
Q 007261          323 DLVVATENFSPKNMID----GSVFRGIIN-------GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACE  383 (611)
Q Consensus       323 el~~at~~f~~~~~ig----g~Vy~g~~~-------g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~  383 (611)
                      ++....++|.....||    |.||+|...       +..||||.++        ..+.+|+.++++++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            3334445555555554    899999864       5789999985        24788999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHhhccC-------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC
Q 007261          384 HDGVFYLVYEFMENGSLSDWLHKKR-------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL  456 (611)
Q Consensus       384 ~~~~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~  456 (611)
                      +.+..++||||+++|+|.+++...+       ....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCC
Confidence            9999999999999999999997632       1234789999999999999999999   58999999999999999999


Q ss_pred             cEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHH
Q 007261          457 RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEA  535 (611)
Q Consensus       457 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~  535 (611)
                      .+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+......+.     
T Consensus       176 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-----  249 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-----  249 (322)
T ss_dssp             CEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-----
T ss_pred             eEEECcCccccccccccc-cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH-----
Confidence            999999999876543221 122334567889999999999999999999999999999999 7777765433221     


Q ss_pred             HHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          536 VFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       536 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      ...... +            .....+..++..+.+++.+||+.||++|||+.|++++|+++..
T Consensus       250 ~~~~~~-~------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          250 LRFVME-G------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHT-T------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHc-C------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            111111 1            1111123445678999999999999999999999999988644

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.7e-38  Score=326.78  Aligned_cols=241  Identities=24%  Similarity=0.425  Sum_probs=196.1

Q ss_pred             ceEEEEEE-------cCcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII-------NGSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||++.+       ++..||||+++        +.+.+|+.+++++ +||||+++++++.+++..++||||+++|+|.+
T Consensus        37 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  116 (313)
T 1t46_A           37 GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN  116 (313)
T ss_dssp             EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred             cceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHH
Confidence            89999986       35789999985        3578999999999 99999999999999999999999999999999


Q ss_pred             HhhccCC---------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          403 WLHKKRY---------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       403 ~l~~~~~---------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      ++.....               ...+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus       117 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  193 (313)
T 1t46_A          117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR  193 (313)
T ss_dssp             HHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETTTEEEECCCGGGS
T ss_pred             HHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEcCCCCEEEccccccc
Confidence            9987542               124899999999999999999999   5899999999999999999999999999987


Q ss_pred             ccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcc
Q 007261          468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       468 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  546 (611)
                      ....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... .    .......  
T Consensus       194 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~----~~~~~~~--  265 (313)
T 1t46_A          194 DIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-Y----KMIKEGF--  265 (313)
T ss_dssp             CTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-H----HHHHHTC--
T ss_pred             ccccccc-ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH-H----HHhccCC--
Confidence            6543321 122334557889999999999999999999999999999999 88888765443221 1    1111110  


Q ss_pred             cccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       547 ~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                         ..       ..+...+..+.+++.+||+.||.+|||+.|++++|+++..+.
T Consensus       266 ---~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          266 ---RM-------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             ---CC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ---CC-------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence               00       012234567899999999999999999999999999887654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.9e-38  Score=338.23  Aligned_cols=230  Identities=21%  Similarity=0.343  Sum_probs=189.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.+|+|++.         +.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++...
T Consensus        25 g~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~  104 (444)
T 3soa_A           25 SVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR  104 (444)
T ss_dssp             CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHC
T ss_pred             eEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHc
Confidence            89999987  78999999984         34789999999999999999999999999999999999999999999875


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEeeecCccccccccCCccccccccc
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD---KNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      .   .+++..+..++.||+.||.|||   +.+|+||||||+|||++   +++.+||+|||+++......   .......|
T Consensus       105 ~---~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~~g  175 (444)
T 3soa_A          105 E---YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ---QAWFGFAG  175 (444)
T ss_dssp             S---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC---CBCCCSCS
T ss_pred             C---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC---ceeecccC
Confidence            3   4899999999999999999999   68999999999999998   56889999999997654322   22334679


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      |+.|+|||.+.+..++.++||||||+++|||++|+.||......+..     ..... +..     ....+.    ....
T Consensus       176 t~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~-----~~i~~-~~~-----~~~~~~----~~~~  240 (444)
T 3soa_A          176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY-----QQIKA-GAY-----DFPSPE----WDTV  240 (444)
T ss_dssp             CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----HHHHH-TCC-----CCCTTT----TTTS
T ss_pred             CcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH-----HHHHh-CCC-----CCCccc----cccC
Confidence            99999999999999999999999999999999999999765433211     11111 100     000111    1234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.++.+|+.+||+.||++|||+.|++++
T Consensus       241 s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          241 TPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            5678999999999999999999999985

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4e-38  Score=331.71  Aligned_cols=239  Identities=21%  Similarity=0.381  Sum_probs=192.8

Q ss_pred             hcCCCCCccc----ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEe
Q 007261          329 ENFSPKNMID----GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYE  393 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  393 (611)
                      ++|.....||    |.||++..  +|..||+|+++         +.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            3444444554    89999998  68899999985         357789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEeeecCccccc
Q 007261          394 FMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN---LRAKLANFSFVRSAV  470 (611)
Q Consensus       394 ~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfgla~~~~  470 (611)
                      |+++|+|.+++....   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.+   +.+||+|||+++...
T Consensus       109 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          109 LVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             CCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             cCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999999997653   4899999999999999999999   5899999999999999865   459999999997654


Q ss_pred             cccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccc
Q 007261          471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLS  550 (611)
Q Consensus       471 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~  550 (611)
                      ...    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.     ...... +...    
T Consensus       183 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----~~~i~~-~~~~----  248 (362)
T 2bdw_A          183 DSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-----YAQIKA-GAYD----  248 (362)
T ss_dssp             TCC----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHH-TCCC----
T ss_pred             CCc----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHh-CCCC----
Confidence            221    22346799999999999999999999999999999999999999976543221     111111 1000    


Q ss_pred             cccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          551 VLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       551 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                       ..    .......+.++.+|+.+||+.||++||++.|++++
T Consensus       249 -~~----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 -YP----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -CC----TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -CC----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             00    01122345678999999999999999999999876

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.4e-38  Score=330.25  Aligned_cols=249  Identities=22%  Similarity=0.358  Sum_probs=194.3

Q ss_pred             ceEEEEEE------cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceec--cCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII------NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACE--HDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~------~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++.+      +|..||||+++       +.+.+|+.++++++||||+++++++.  +....++||||+++++|.++
T Consensus        37 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  116 (327)
T 3lxl_A           37 GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF  116 (327)
T ss_dssp             EEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHH
T ss_pred             eEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHH
Confidence            89999985      57899999985       35889999999999999999999886  55678999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      +....  ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++................
T Consensus       117 l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  191 (327)
T 3lxl_A          117 LQRHR--ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ  191 (327)
T ss_dssp             HHHHG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCC
T ss_pred             HHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCC
Confidence            98743  24899999999999999999999   68999999999999999999999999999986644333223334456


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhH---------HHHHHHHHHhcCCcccccccccC
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL---------LAEAVFSMVEGGNAEAKLSVLVD  554 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~---------l~~~~~~~~~~~~~~~~l~~~~d  554 (611)
                      +|..|+|||.+.+..++.++||||||+++|||++|+.|+.........         ..........            .
T Consensus       192 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~  259 (327)
T 3lxl_A          192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE------------E  259 (327)
T ss_dssp             SCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH------------T
T ss_pred             ccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh------------c
Confidence            888899999999999999999999999999999999998643221100         0001111111            1


Q ss_pred             ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhhch
Q 007261          555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQ  604 (611)
Q Consensus       555 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~~  604 (611)
                      ......+..++..+.+|+.+||+.||++|||+.|++++|+++......+.
T Consensus       260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  309 (327)
T 3lxl_A          260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE  309 (327)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred             ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence            11111234456779999999999999999999999999999877655443

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.9e-38  Score=333.05  Aligned_cols=248  Identities=14%  Similarity=0.215  Sum_probs=189.7

Q ss_pred             ceEEEEEEc-------CcEEEEEEecH---HHH---------------HHHHHHHhcCCCceeeccceeccC----CeEE
Q 007261          339 GSVFRGIIN-------GSTVAIKCMRR---SIS---------------KEVNLLKKINHFNLINLFGACEHD----GVFY  389 (611)
Q Consensus       339 g~Vy~g~~~-------g~~vavK~~~~---~~~---------------~E~~~l~~l~H~niv~l~g~~~~~----~~~~  389 (611)
                      |.||+|.+.       ++.||||++..   .+.               .|+..+..++|+||+++++++...    ...+
T Consensus        49 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~  128 (364)
T 3op5_A           49 GCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRF  128 (364)
T ss_dssp             CEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEE
T ss_pred             eEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEE
Confidence            899999882       46899999752   223               345556667799999999998764    4589


Q ss_pred             EEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC--CCCcEEEeeecCcc
Q 007261          390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD--KNLRAKLANFSFVR  467 (611)
Q Consensus       390 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~Dfgla~  467 (611)
                      |||||+ +++|.+++....  ..+++..++.|+.||+.||+|||   ..+|+||||||+|||++  .++.+||+|||+++
T Consensus       129 lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~  202 (364)
T 3op5_A          129 MIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY  202 (364)
T ss_dssp             EEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSCTTCEEECCCTTCE
T ss_pred             EEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCCCCeEEEEECCcce
Confidence            999999 999999998753  34999999999999999999999   58999999999999999  88999999999997


Q ss_pred             ccccccCCc----ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcC
Q 007261          468 SAVREESGY----SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGG  543 (611)
Q Consensus       468 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  543 (611)
                      .........    .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.................    
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~----  278 (364)
T 3op5_A          203 RYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRY----  278 (364)
T ss_dssp             ESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHH----
T ss_pred             ecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHh----
Confidence            654332111    112344599999999999999999999999999999999999999985433322111111111    


Q ss_pred             CcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          544 NAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       544 ~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                        ...+..++++.+..  ..++.++.+++.+||+.||++||++.+|++.|+++....
T Consensus       279 --~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          279 --RENIASLMDKCFPA--ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             --HHCHHHHHHHHSCT--TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             --hhhHHHHHHHhccc--ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence              11122222222211  223567899999999999999999999999999876643

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1e-38  Score=325.61  Aligned_cols=239  Identities=25%  Similarity=0.452  Sum_probs=194.0

Q ss_pred             ceEEEEEE----cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII----NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~----~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|.+    .+..||||+++         +.+.+|+.++++++||||+++++++ ..+..++||||+++++|.+++.
T Consensus        31 g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~  109 (291)
T 1xbb_A           31 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ  109 (291)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHH
T ss_pred             eeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHH
Confidence            89999976    36789999985         3578899999999999999999999 5667899999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++................++
T Consensus       110 ~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  183 (291)
T 1xbb_A          110 QNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP  183 (291)
T ss_dssp             HCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCC
T ss_pred             hCc---CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCC
Confidence            753   3899999999999999999999   5899999999999999999999999999998664433222223334567


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      ..|+|||.+.+..++.++||||||+++|||++ |+.||......+.      ........            ....+..+
T Consensus       184 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~------------~~~~~~~~  245 (291)
T 1xbb_A          184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------TAMLEKGE------------RMGCPAGC  245 (291)
T ss_dssp             GGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHHHHTTC------------CCCCCTTC
T ss_pred             ceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH------HHHHHcCC------------CCCCCCCC
Confidence            88999999998889999999999999999999 9999876543321      11111111            01112345


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                      +..+.+++.+||+.||++||++.++++.|+++......
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence            56799999999999999999999999999998776554

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-38  Score=326.27  Aligned_cols=242  Identities=21%  Similarity=0.405  Sum_probs=193.1

Q ss_pred             ceEEEEEE------cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccC--CeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII------NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHD--GVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~------~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~~gsL~~  402 (611)
                      |.||++.+      +|+.||||+++        ..+.+|+.++++++||||+++++++...  ...++||||+++|+|.+
T Consensus        35 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~  114 (302)
T 4e5w_A           35 GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE  114 (302)
T ss_dssp             EEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHH
T ss_pred             eEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHH
Confidence            89999985      67899999986        4578999999999999999999999876  66899999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++....  ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...............
T Consensus       115 ~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  189 (302)
T 4e5w_A          115 YLPKNK--NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDR  189 (302)
T ss_dssp             HHHHHT--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCT
T ss_pred             HHHhcc--ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCC
Confidence            997653  34899999999999999999999   6899999999999999999999999999998765443322334456


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCCh---------hhHHHHHHHHHHhcCCccccccccc
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGE---------EILLAEAVFSMVEGGNAEAKLSVLV  553 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~---------~~~l~~~~~~~~~~~~~~~~l~~~~  553 (611)
                      .+|..|+|||.+.+..++.++||||||+++|||++|+.|+......         .......+.....            
T Consensus       190 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------  257 (302)
T 4e5w_A          190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK------------  257 (302)
T ss_dssp             TCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH------------
T ss_pred             CCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh------------
Confidence            7888899999999999999999999999999999999875322100         0000011111111            


Q ss_pred             CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       554 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                      .......+..++..+.+|+.+||+.||.+|||+.|+++.|+++.
T Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            11111123345677999999999999999999999999998864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.1e-38  Score=327.31  Aligned_cols=231  Identities=22%  Similarity=0.330  Sum_probs=189.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++..  +|+.||||+++        +.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++....
T Consensus        21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  100 (323)
T 3tki_A           21 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI  100 (323)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTT
T ss_pred             EEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcC
Confidence            89999988  68899999984        357899999999999999999999999999999999999999999997643


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... ........||+.|
T Consensus       101 ---~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y  173 (323)
T 3tki_A          101 ---GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPY  173 (323)
T ss_dssp             ---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-ECCBCSCCSCGGG
T ss_pred             ---CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc-ccccCCCccCcCc
Confidence               4899999999999999999999   68999999999999999999999999999976532221 1223456799999


Q ss_pred             cchhhhccCCC-CCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHH
Q 007261          489 MAPEYMEYGLV-TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH  567 (611)
Q Consensus       489 ~aPE~~~~~~~-s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  567 (611)
                      +|||.+.+..+ +.++||||||+++|||++|+.||............+    .....            ........+..
T Consensus       174 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~----~~~~~------------~~~~~~~~~~~  237 (323)
T 3tki_A          174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----KEKKT------------YLNPWKKIDSA  237 (323)
T ss_dssp             SCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH----HTTCT------------TSTTGGGSCHH
T ss_pred             cCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH----hcccc------------cCCccccCCHH
Confidence            99999987765 779999999999999999999997655432222111    11000            00112334567


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.+|+.+||+.||++|||+.|++++
T Consensus       238 ~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          238 PLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhhC
Confidence            8899999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.3e-38  Score=356.73  Aligned_cols=237  Identities=26%  Similarity=0.461  Sum_probs=190.7

Q ss_pred             ceEEEEEE----cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII----NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~----~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|.+    .+..||||+++         +++.+|+.+|++++|||||+++++|.. +..++||||+++|+|.+++.
T Consensus       383 G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~  461 (635)
T 4fl3_A          383 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ  461 (635)
T ss_dssp             EEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH
T ss_pred             EEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHh
Confidence            89999976    35789999986         358899999999999999999999965 45789999999999999997


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..++.|+.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++................+|
T Consensus       462 ~~~---~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t  535 (635)
T 4fl3_A          462 QNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP  535 (635)
T ss_dssp             HCT---TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------C
T ss_pred             hCC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCc
Confidence            653   4899999999999999999999   5899999999999999999999999999998764433322333445678


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      ..|+|||.+.+..++.++||||||++||||++ |+.||......+.      ...+..+.            ....+..+
T Consensus       536 ~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~------~~~i~~~~------------~~~~p~~~  597 (635)
T 4fl3_A          536 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------TAMLEKGE------------RMGCPAGC  597 (635)
T ss_dssp             GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHHHHTTC------------CCCCCTTC
T ss_pred             eeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCC------------CCCCCCCC
Confidence            89999999999999999999999999999998 9999876554321      11222111            11113345


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      +.++.+|+.+||+.||++||++.+|++.|+++..+.
T Consensus       598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            678999999999999999999999999999887654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.5e-38  Score=322.37  Aligned_cols=239  Identities=26%  Similarity=0.478  Sum_probs=182.2

Q ss_pred             ceEEEEEEcCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|.+.+ .||||+++         +.+.+|+.++++++||||+++++++. ....++||||+++++|.+++.... 
T Consensus        38 g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-  114 (289)
T 3og7_A           38 GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASE-  114 (289)
T ss_dssp             EEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHTTC--
T ss_pred             eEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEEecCCCcHHHHHhhcc-
Confidence            8999998755 59999985         35889999999999999999999764 556799999999999999997653 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                       ..+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++....... ........||+.|+
T Consensus       115 -~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~  189 (289)
T 3og7_A          115 -TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWM  189 (289)
T ss_dssp             ---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-------------------CCCTTC
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccc-cccccccCCCcccc
Confidence             34899999999999999999999   68999999999999999999999999999875432211 12233457899999


Q ss_pred             chhhhc---cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          490 APEYME---YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       490 aPE~~~---~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      |||.+.   +..++.++||||||+++|||++|+.||......+..     ........        ..+.+......++.
T Consensus       190 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~~~--------~~~~~~~~~~~~~~  256 (289)
T 3og7_A          190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEMVGRGS--------LSPDLSKVRSNCPK  256 (289)
T ss_dssp             CHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH-----HHHHHHTS--------CCCCTTSSCTTSCH
T ss_pred             CchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH-----HHHhcccc--------cCcchhhccccCCH
Confidence            999986   667889999999999999999999999765544321     11111111        11112222334567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      .+.+|+.+||+.||++|||+.|+++.|+++..
T Consensus       257 ~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          257 RMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            89999999999999999999999999998764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9e-38  Score=318.69  Aligned_cols=244  Identities=22%  Similarity=0.314  Sum_probs=189.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.||||+++         ..+.+|+.++++++||||+++++++.+++..++||||+++ +|.+++...
T Consensus        16 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   94 (292)
T 3o0g_A           16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC   94 (292)
T ss_dssp             SEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHT
T ss_pred             eEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhC
Confidence            89999998  68899999985         4578899999999999999999999999999999999975 666666553


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......+|+.
T Consensus        95 ~--~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~t~~  166 (292)
T 3o0g_A           95 N--GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSAEVVTLW  166 (292)
T ss_dssp             T--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC---SCCCSCCSCGG
T ss_pred             C--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc---ccccCCccccC
Confidence            2  34899999999999999999999   5899999999999999999999999999997653221   23344578999


Q ss_pred             ccchhhhccCC-CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc--cccccc----------C
Q 007261          488 YMAPEYMEYGL-VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA--KLSVLV----------D  554 (611)
Q Consensus       488 y~aPE~~~~~~-~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~--~l~~~~----------d  554 (611)
                      |+|||.+.+.. ++.++||||||+++|||++|+.|++........+.. +...........  ......          .
T Consensus       167 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (292)
T 3o0g_A          167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR-IFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT  245 (292)
T ss_dssp             GCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH-HHHHHCCCCTTTCTTGGGSTTCCCCCCCCTT
T ss_pred             CcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHH-HHHHhCCCChhhhhhhcccccccccccccCC
Confidence            99999997765 899999999999999999999997765544333222 222222111100  000000          0


Q ss_pred             ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+.......+..+.+|+.+||+.||++|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          246 TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            01111123456778999999999999999999999874

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.9e-38  Score=332.92  Aligned_cols=226  Identities=19%  Similarity=0.352  Sum_probs=183.5

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+++.  +|+.||||++++          .+.+|..++.++ +||||+++++++.+++..++||||+++|+|..++.
T Consensus        66 G~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~  145 (396)
T 4dc2_A           66 AKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ  145 (396)
T ss_dssp             EEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHH
Confidence            89999998  678999999863          367899999887 89999999999999999999999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ..+   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||
T Consensus       146 ~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~---~~~~~~~gt  216 (396)
T 4dc2_A          146 RQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGT  216 (396)
T ss_dssp             HHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT---CCBCCCCBC
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC---CccccccCC
Confidence            753   3899999999999999999999   6899999999999999999999999999997533221   234456899


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhh---HHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI---LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||......+.   .....+........             ...+.
T Consensus       217 ~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------------~~~p~  283 (396)
T 4dc2_A          217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------------IRIPR  283 (396)
T ss_dssp             GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-------------CCCCT
T ss_pred             cccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-------------cCCCC
Confidence            999999999999999999999999999999999999964322110   00111111111110             01122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCH
Q 007261          563 EIAHHLIMLCLACIAREPESRPSM  586 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~  586 (611)
                      ..+.++.+|+.+||+.||++||++
T Consensus       284 ~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          284 SLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             cCCHHHHHHHHHHhcCCHhHcCCC
Confidence            345678899999999999999996

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.7e-38  Score=324.69  Aligned_cols=241  Identities=23%  Similarity=0.434  Sum_probs=184.7

Q ss_pred             ceEEEEEEc-----CcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCC-----eEEEEEeecCCCC
Q 007261          339 GSVFRGIIN-----GSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDG-----VFYLVYEFMENGS  399 (611)
Q Consensus       339 g~Vy~g~~~-----g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E~~~~gs  399 (611)
                      |.||+|...     +..||||.++         +.+.+|+.++++++||||+++++++.+.+     ..++||||+++|+
T Consensus        48 g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~  127 (313)
T 3brb_A           48 GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD  127 (313)
T ss_dssp             CCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCB
T ss_pred             eEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCC
Confidence            899999872     3479999985         34788999999999999999999997654     3599999999999


Q ss_pred             HHHHhhccC---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc
Q 007261          400 LSDWLHKKR---YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY  476 (611)
Q Consensus       400 L~~~l~~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  476 (611)
                      |.+++....   ....+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++....... .
T Consensus       128 L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~  203 (313)
T 3brb_A          128 LHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY-Y  203 (313)
T ss_dssp             HHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECSCSCC----------
T ss_pred             HHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEeecCcceecccccc-c
Confidence            999995432   2346999999999999999999999   68999999999999999999999999999876543221 1


Q ss_pred             ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCc
Q 007261          477 SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP  555 (611)
Q Consensus       477 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  555 (611)
                      .......+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+..  .   .... +            
T Consensus       204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--~---~~~~-~------------  265 (313)
T 3brb_A          204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY--D---YLLH-G------------  265 (313)
T ss_dssp             -------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--H---HHHT-T------------
T ss_pred             CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH--H---HHHc-C------------
Confidence            22334457889999999999999999999999999999999 77777655433211  1   1111 1            


Q ss_pred             cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       556 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                      .....+..++..+.+++.+||+.||++||++.+++++|+++.....
T Consensus       266 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            0111123345678999999999999999999999999999876543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-37  Score=320.90  Aligned_cols=243  Identities=23%  Similarity=0.325  Sum_probs=188.5

Q ss_pred             ceEEEEEE-cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII-NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++.. +|+.||||+++         ..+.+|+.++++++||||+++++++.+++..++||||++ |+|.+++....
T Consensus        35 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~  113 (311)
T 3niz_A           35 GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENK  113 (311)
T ss_dssp             CEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCT
T ss_pred             eEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhcc
Confidence            89999998 78999999985         357789999999999999999999999999999999997 58888887654


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                        ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......+|+.|
T Consensus       114 --~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y  185 (311)
T 3niz_A          114 --TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV---RSYTHEVVTLWY  185 (311)
T ss_dssp             --TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC---C---CCCCCCTT
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc---ccccCCcccCCc
Confidence              34899999999999999999999   6899999999999999999999999999997653221   223445789999


Q ss_pred             cchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc-----cccccC---ccCCc
Q 007261          489 MAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK-----LSVLVD---PNLQA  559 (611)
Q Consensus       489 ~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~-----l~~~~d---~~l~~  559 (611)
                      +|||.+.+ ..++.++||||||+++|||++|+.||......+.  ...+............     +....+   .....
T Consensus       186 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (311)
T 3niz_A          186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEK  263 (311)
T ss_dssp             CCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCC
T ss_pred             CCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHHCCCChHHhhhhhccchhhhcccccccC
Confidence            99999876 5689999999999999999999999976554432  1222222221111100     000000   00000


Q ss_pred             C-----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          560 N-----KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       560 ~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .     ....+.++.+|+.+||+.||++|||+.|++++
T Consensus       264 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          264 KPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             CCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            0     12234678899999999999999999999874

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.8e-38  Score=328.58  Aligned_cols=232  Identities=22%  Similarity=0.345  Sum_probs=187.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGSTVAIKCMR------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||++..  +|+.||||+++            +.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++
T Consensus        38 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l  117 (351)
T 3c0i_A           38 SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI  117 (351)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHH
Confidence            89999988  68999999984            34789999999999999999999999999999999999999999888


Q ss_pred             hccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc---EEEeeecCccccccccCCccccc
Q 007261          405 HKKR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR---AKLANFSFVRSAVREESGYSSTK  480 (611)
Q Consensus       405 ~~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfgla~~~~~~~~~~~~~~  480 (611)
                      .... ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.   +||+|||+++......   ....
T Consensus       118 ~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~  191 (351)
T 3c0i_A          118 VKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG---LVAG  191 (351)
T ss_dssp             HHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS---CBCC
T ss_pred             HHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC---eeec
Confidence            6532 2335899999999999999999999   689999999999999986654   9999999997654322   1233


Q ss_pred             ccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC
Q 007261          481 TAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN  560 (611)
Q Consensus       481 ~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~  560 (611)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||.....  .    ...........       .++   ..
T Consensus       192 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~----~~~~i~~~~~~-------~~~---~~  255 (351)
T 3c0i_A          192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--R----LFEGIIKGKYK-------MNP---RQ  255 (351)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--H----HHHHHHHTCCC-------CCH---HH
T ss_pred             CCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--H----HHHHHHcCCCC-------CCc---cc
Confidence            45799999999999999999999999999999999999999976421  1    11111111100       000   00


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          561 KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       561 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ....+.++.+|+.+||+.||++||++.|++++
T Consensus       256 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          256 WSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            12345678999999999999999999999874

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.5e-38  Score=329.73  Aligned_cols=230  Identities=23%  Similarity=0.391  Sum_probs=177.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec-----HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||++..  +++.||||+++     +.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++....   
T Consensus        67 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---  143 (349)
T 2w4o_A           67 SIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG---  143 (349)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS---
T ss_pred             EEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcC---
Confidence            89999998  57899999986     347789999999999999999999999999999999999999999997653   


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK---NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                      .+++..++.++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++.....    .......||+.|
T Consensus       144 ~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y  216 (349)
T 2w4o_A          144 YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ----VLMKTVCGTPGY  216 (349)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------------CGGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc----cccccccCCCCc
Confidence            4899999999999999999999   589999999999999975   899999999998765322    123345789999


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHH
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL  568 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l  568 (611)
                      +|||.+.+..++.++||||||+++|||++|+.||......+..+.    .......      ....    ......+..+
T Consensus       217 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----~i~~~~~------~~~~----~~~~~~~~~~  282 (349)
T 2w4o_A          217 CAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR----RILNCEY------YFIS----PWWDEVSLNA  282 (349)
T ss_dssp             SCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHH----HHHTTCC------CCCT----TTTTTSCHHH
T ss_pred             cCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHH----HHHhCCC------ccCC----chhhhCCHHH
Confidence            999999999999999999999999999999999976655432211    1111100      0011    1122345678


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHH
Q 007261          569 IMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       569 ~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+|+.+||+.||++|||+.|++++
T Consensus       283 ~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          283 KDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHccCChhhCcCHHHHhcC
Confidence            899999999999999999999974

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=9.3e-39  Score=332.16  Aligned_cols=252  Identities=24%  Similarity=0.427  Sum_probs=198.5

Q ss_pred             hcCCCCCccc----ceEEEEEEc--C-----cEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeE
Q 007261          329 ENFSPKNMID----GSVFRGIIN--G-----STVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVF  388 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~~--g-----~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  388 (611)
                      ++|.....+|    |.||+|...  |     ..||+|.++        +.+.+|+.+++++ +||||+++++++.+.+..
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            3444444454    899999973  2     379999985        3478999999999 899999999999999999


Q ss_pred             EEEEeecCCCCHHHHhhccC-----------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc
Q 007261          389 YLVYEFMENGSLSDWLHKKR-----------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR  457 (611)
Q Consensus       389 ~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~  457 (611)
                      ++||||+++|+|.+++....           ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~  202 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHV  202 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGGE
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCCe
Confidence            99999999999999997532           1234799999999999999999999   589999999999999999999


Q ss_pred             EEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHH
Q 007261          458 AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAV  536 (611)
Q Consensus       458 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~  536 (611)
                      +||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |..|+.........     
T Consensus       203 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-----  276 (333)
T 2i1m_A          203 AKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF-----  276 (333)
T ss_dssp             EEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-----
T ss_pred             EEECccccccccccccc-eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-----
Confidence            99999999986543321 222334567889999999999999999999999999999999 88887655433211     


Q ss_pred             HHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          537 FSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       537 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                      ........         .   ...+...+..+.+++.+||+.||.+|||+.|+++.|+++.....
T Consensus       277 ~~~~~~~~---------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  329 (333)
T 2i1m_A          277 YKLVKDGY---------Q---MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR  329 (333)
T ss_dssp             HHHHHHTC---------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHhcCC---------C---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence            11111110         0   00112234678999999999999999999999999998876543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.3e-38  Score=340.91  Aligned_cols=252  Identities=21%  Similarity=0.337  Sum_probs=200.5

Q ss_pred             chhHHHHHhhcCCCCCccc----ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceec
Q 007261          320 KYEDLVVATENFSPKNMID----GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACE  383 (611)
Q Consensus       320 ~~~el~~at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~  383 (611)
                      .+.++...+++|.....||    |.||++..  +|+.||||++++          .+.+|..++.+++||||++++++|.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            3445555667777777776    89999998  578999999963          2788999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeee
Q 007261          384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF  463 (611)
Q Consensus       384 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df  463 (611)
                      +++..|||||||++|+|.+++....  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcch
Confidence            9999999999999999999998742  34899999999999999999999   689999999999999999999999999


Q ss_pred             cCccccccccCCcccccccccCCCccchhhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHH
Q 007261          464 SFVRSAVREESGYSSTKTAVGTNGYMAPEYME-----YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFS  538 (611)
Q Consensus       464 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~  538 (611)
                      |+++......  ........||+.|+|||++.     .+.++.++|||||||++|||++|+.||......+..  ..+..
T Consensus       220 Gla~~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~--~~i~~  295 (437)
T 4aw2_A          220 GSCLKLMEDG--TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY--GKIMN  295 (437)
T ss_dssp             TTCEECCTTS--CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHT
T ss_pred             hhhhhcccCC--CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH--Hhhhh
Confidence            9997654322  12233467999999999987     567999999999999999999999999865433221  11111


Q ss_pred             HHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 007261          539 MVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPES--RPSMAEVVST  592 (611)
Q Consensus       539 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  592 (611)
                      ...      .   +   .........+.++.+|+.+||..+|++  ||++.|++++
T Consensus       296 ~~~------~---~---~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          296 HKE------R---F---QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHH------H---C---CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ccc------c---c---cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            000      0   0   011111224567889999999888888  9999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5e-38  Score=327.12  Aligned_cols=241  Identities=27%  Similarity=0.493  Sum_probs=194.5

Q ss_pred             ceEEEEEE---------cCcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCH
Q 007261          339 GSVFRGII---------NGSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~---------~g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      |.||++..         ++..||||+++        +.+.+|+.+++++ +||||+++++++.+++..++||||+++|+|
T Consensus        49 g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L  128 (334)
T 2pvf_A           49 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  128 (334)
T ss_dssp             CEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBH
T ss_pred             eeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcH
Confidence            89999986         35689999985        3478899999999 999999999999999999999999999999


Q ss_pred             HHHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          401 SDWLHKKRY-------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       401 ~~~l~~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      .+++.....             ...+++..++.++.||+.||.|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus       129 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~  205 (334)
T 2pvf_A          129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR  205 (334)
T ss_dssp             HHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             HHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEEcCCCCEEEccccccc
Confidence            999987542             134899999999999999999999   5899999999999999999999999999997


Q ss_pred             ccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcc
Q 007261          468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       468 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  546 (611)
                      ....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......+.      ...+..+.  
T Consensus       206 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~--  276 (334)
T 2pvf_A          206 DINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------FKLLKEGH--  276 (334)
T ss_dssp             ECTTTSS-EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH------HHHHHHTC--
T ss_pred             ccccccc-ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH------HHHHhcCC--
Confidence            6543221 122334467889999999998899999999999999999999 8888865543221      11111110  


Q ss_pred             cccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       547 ~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                                ....+..++..+.+++.+||+.||.+||++.|+++.|+++.....
T Consensus       277 ----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          277 ----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             ----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence                      001122345678999999999999999999999999999876543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=6.2e-38  Score=331.57  Aligned_cols=230  Identities=22%  Similarity=0.349  Sum_probs=188.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|..  +|..||+|+++       +.+.+|+.+|++++||||+++++++.+.+..+|||||+++|+|.+++.... 
T Consensus       103 g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-  181 (373)
T 2x4f_A          103 GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES-  181 (373)
T ss_dssp             -CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTG-
T ss_pred             EEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC-
Confidence            89999988  68899999985       358899999999999999999999999999999999999999999997643 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee--CCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL--DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl--~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                       ..+++..++.++.||+.||+|||   +.+|+||||||+|||+  +.++.+||+|||+++......    ......||+.
T Consensus       182 -~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~~  253 (373)
T 2x4f_A          182 -YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE----KLKVNFGTPE  253 (373)
T ss_dssp             -GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC----BCCCCCSSCT
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc----ccccccCCCc
Confidence             34899999999999999999999   6899999999999999  677899999999998654322    2234569999


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHH
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH  567 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  567 (611)
                      |+|||.+.+..++.++||||||+++|||++|+.||......+.     ..........      +.    .......+.+
T Consensus       254 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~i~~~~~~------~~----~~~~~~~~~~  318 (373)
T 2x4f_A          254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET-----LNNILACRWD------LE----DEEFQDISEE  318 (373)
T ss_dssp             TCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHHTCCC------SC----SGGGTTSCHH
T ss_pred             EeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhccCC------CC----hhhhccCCHH
Confidence            9999999999999999999999999999999999976543321     1112111100      00    0112234567


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.+|+.+||+.||.+||++.|++++
T Consensus       319 ~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          319 AKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcC
Confidence            8999999999999999999999984

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=324.25  Aligned_cols=227  Identities=23%  Similarity=0.363  Sum_probs=182.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------------------------------HHHHHHHHHHHhcCCCceeeccceec
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------------------------------RSISKEVNLLKKINHFNLINLFGACE  383 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------------------------------~~~~~E~~~l~~l~H~niv~l~g~~~  383 (611)
                      |.||++..  +|+.||||+++                                 +.+.+|+.++++++||||+++++++.
T Consensus        27 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  106 (298)
T 2zv2_A           27 GVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLD  106 (298)
T ss_dssp             CEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             EEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            89999987  68899999984                                 23678999999999999999999997


Q ss_pred             c--CCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 007261          384 H--DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLA  461 (611)
Q Consensus       384 ~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~  461 (611)
                      +  ++..++||||+++++|.+++..    ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus       107 ~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  179 (298)
T 2zv2_A          107 DPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIA  179 (298)
T ss_dssp             CSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             cCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCCEEEe
Confidence            6  5789999999999999886543    34899999999999999999999   5899999999999999999999999


Q ss_pred             eecCccccccccCCcccccccccCCCccchhhhccCC---CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHH
Q 007261          462 NFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL---VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFS  538 (611)
Q Consensus       462 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~  538 (611)
                      |||+++......   .......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||........     ...
T Consensus       180 Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~  251 (298)
T 2zv2_A          180 DFGVSNEFKGSD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL-----HSK  251 (298)
T ss_dssp             CCTTCEECSSSS---CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHH
T ss_pred             cCCCcccccccc---ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH-----HHH
Confidence            999997654322   1233457999999999997655   47889999999999999999999875432211     111


Q ss_pred             HHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          539 MVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       539 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ... ..    ..   .+    .....+..+.+++.+||+.||++||++.|++++
T Consensus       252 ~~~-~~----~~---~~----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          252 IKS-QA----LE---FP----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HHH-CC----CC---CC----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             Hhc-cc----CC---CC----CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            111 00    00   00    012244678999999999999999999999764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-38  Score=329.12  Aligned_cols=237  Identities=23%  Similarity=0.437  Sum_probs=188.3

Q ss_pred             ceEEEEEE--cCcE----EEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGST----VAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~~----vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.+  +|+.    ||+|.+.        ..+.+|+.++++++||||+++++++. ++..++||||+++|+|.+++
T Consensus        27 g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l  105 (325)
T 3kex_A           27 GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHV  105 (325)
T ss_dssp             CEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHH
T ss_pred             ceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHH
Confidence            89999998  4443    8888874        34678999999999999999999986 45688999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ....  ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... ........+
T Consensus       106 ~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~  179 (325)
T 3kex_A          106 RQHR--GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK-QLLYSEAKT  179 (325)
T ss_dssp             HSSG--GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT-CCC-----C
T ss_pred             HHcc--ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcccc-cccccCCCC
Confidence            8653  35889999999999999999999   58999999999999999999999999999987643322 122344567


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      +..|+|||.+.+..++.++||||||+++|||++ |+.||......+..      ........            ...+..
T Consensus       180 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------~~~~~~~~------------~~~~~~  241 (325)
T 3kex_A          180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP------DLLEKGER------------LAQPQI  241 (325)
T ss_dssp             CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH------HHHHTTCB------------CCCCTT
T ss_pred             cccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH------HHHHcCCC------------CCCCCc
Confidence            889999999999999999999999999999999 99998765443211      11111110            001112


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      ++..+.+++.+||+.||++||++.|++++|.++....
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            3345788999999999999999999999999986644

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=332.09  Aligned_cols=235  Identities=23%  Similarity=0.387  Sum_probs=187.4

Q ss_pred             cCCCCCccc----ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEE
Q 007261          330 NFSPKNMID----GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVY  392 (611)
Q Consensus       330 ~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  392 (611)
                      +|.....||    |.||++..  +|+.||||++++          .+.+|..++..+ +||||+++++++.+.+..|+||
T Consensus        24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~  103 (353)
T 3txo_A           24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM  103 (353)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence            344444444    89999998  688999999974          256799999988 7999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       393 E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      ||+++|+|.+++...+   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       104 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          104 EFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            9999999999998753   3899999999999999999999   689999999999999999999999999999754322


Q ss_pred             cCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccc
Q 007261          473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVL  552 (611)
Q Consensus       473 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  552 (611)
                      .   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.     .........        
T Consensus       178 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-----~~~i~~~~~--------  241 (353)
T 3txo_A          178 G---VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL-----FEAILNDEV--------  241 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHCCC--------
T ss_pred             C---ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH-----HHHHHcCCC--------
Confidence            1   233456799999999999998999999999999999999999999976544321     111111100        


Q ss_pred             cCccCCcChHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 007261          553 VDPNLQANKKEIAHHLIMLCLACIAREPESRPSM------AEVVST  592 (611)
Q Consensus       553 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~  592 (611)
                            ..+...+..+.+|+.+||+.||++||++      .|++++
T Consensus       242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          242 ------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             ------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                  0112245668899999999999999998      666653

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=100.00  E-value=3.4e-37  Score=295.23  Aligned_cols=177  Identities=22%  Similarity=0.328  Sum_probs=157.6

Q ss_pred             Ccc-eeeeeecCCCCCCHHHHHHhhCCCh--------Hhhhhhh-CCCCCCCCCCCCCeEEEeeecccCC-CccccceeE
Q 007261           40 PCQ-GFLIFKSQPPYDTVSSISNLTSSDP--------TELARVN-NISNSAAALPLDKEVIVPVSCYCSG-LYYQANTSF  108 (611)
Q Consensus        40 ~c~-~~~~y~~~~~g~tl~~Ia~~~~~~~--------~~l~~~N-~~~~~~~~l~~gq~l~vP~~~~c~~-~~~~~~~~y  108 (611)
                      +|+ +|+.|++++ ||||+.||++||+++        ++|+++| ++.+ ++.|.+||.|+||.+|.|.. .+......|
T Consensus         4 ~C~~a~~~Y~V~~-GDTL~~IA~~~~vsv~~~~~~~~~~I~~~Np~l~~-~~~l~~Gq~L~IP~~~~~~~~~~~~~~~~Y   81 (212)
T 4eby_A            4 SCPLALASYYLEN-GTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKD-KDRIQMGSRVLVPFPCECQPGDFLGHNFSY   81 (212)
T ss_dssp             CCSCEEEEEECCT-TCCHHHHHHHTCCSSSCCCSSCCHHHHTTCTTCSC-TTSCCTTCEEEEEECCEEETTTEEEEEEEE
T ss_pred             CCccceEEEEeCC-CCCHHHHHHHHCCCchhccccCHHHHHHhccCCCC-cCccCCCCEEEEeccccccCCccccCceEE
Confidence            799 999999987 999999999999999        9999999 8876 68999999999999999974 456667899


Q ss_pred             EEeecCCchhhhhHhhcCCCccHHHHHHhcCCCCCCCCCCceeeeeccCCCCCCccccCCeeEEEEEEccCCCChhHHHh
Q 007261          109 IIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPDISK  188 (611)
Q Consensus       109 ~V~~~gdTl~~IA~~~~~~l~t~~~l~~~N~~~~~~l~~G~~l~ip~~~~~~~~~~~~~~~~~~~~y~v~~gdtl~~Ia~  188 (611)
                      +|++ |||||.||++.|.+++++++|+++|++.++.|.+||+|.||..|+|++. +.+.+....++|+|++|||||+||+
T Consensus        82 ~V~~-GDTL~~IA~~~y~~lvt~~~L~~~N~~~~~~l~~Gq~L~IP~~~~~~~~-~~~~~~~~~~~Y~V~~GDTL~~IA~  159 (212)
T 4eby_A           82 SVRQ-EDTYERVAISNYANLTTMESLQARNPFPATNIPLSATLNVLVNCSCGDE-SVSKDFGLFVTYPLRPEDSLSSIAR  159 (212)
T ss_dssp             ECCT-TCCHHHHHHTTTTTSSCHHHHHHHCCSCTTCCCTTCEEEEEEECCCCCT-TTCSSCCCEEEEECCTTCCHHHHHH
T ss_pred             EecC-CCcHHHHHHHhcCCCCCHHHHHHhcCCCcccCCCCCEEEEcCCCcCCCc-ccccCCCCeEEEEECCCCcHHHHHH
Confidence            9999 9999999976888999999999999977888999999999999999765 3444556678999999999999999


Q ss_pred             HhcCCHHHHHHhcCCCCCCCCcccceeeeecCCCC
Q 007261          189 RFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTE  223 (611)
Q Consensus       189 ~f~~~~~~l~~~N~~~~~~~~i~~g~~l~ip~~~~  223 (611)
                      +||+++++|++||++. + ..+.+|+ |+||.+..
T Consensus       160 ~fgvsv~~L~~~N~~~-~-~~~~~g~-l~IP~~~~  191 (212)
T 4eby_A          160 SSGVSADILQRYNPGV-N-FNSGNGI-VYVPGRDP  191 (212)
T ss_dssp             HHTSCHHHHHHHSTTC-C-TTSCSSE-EEEECCCT
T ss_pred             HHCcCHHHHHHhcCCC-c-cCCCCCE-EEecCCCC
Confidence            9999999999999985 3 4566666 99998884

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-38  Score=325.69  Aligned_cols=232  Identities=22%  Similarity=0.323  Sum_probs=183.6

Q ss_pred             hcCCCCCccc----ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEE
Q 007261          329 ENFSPKNMID----GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVY  392 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  392 (611)
                      ++|.....||    |.||+|..  +|+.||||++.         ..+..|+..+.++ +|+||++++++|.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            4565555665    89999998  68999999874         1344566666665 9999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       393 E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      ||+ +++|.+++....  ..++|..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            999 779999988754  34999999999999999999999   578999999999999999999999999998765332


Q ss_pred             cCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccc
Q 007261          473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVL  552 (611)
Q Consensus       473 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  552 (611)
                      .    ......||+.|+|||.+.+ .++.++||||||+++|||++|..++.....         ...+...         
T Consensus       211 ~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~~~~~~~---------  267 (311)
T 3p1a_A          211 G----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------WQQLRQG---------  267 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------HHHHTTT---------
T ss_pred             C----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HHHHhcc---------
Confidence            1    2334568999999999876 789999999999999999999877653211         0111110         


Q ss_pred             cCccCCcC-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          553 VDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       553 ~d~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                         ..... +...+.++.+++.+||+.||++|||+.|++++
T Consensus       268 ---~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          268 ---YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             ---CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ---CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence               01111 22345779999999999999999999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-37  Score=322.10  Aligned_cols=223  Identities=23%  Similarity=0.362  Sum_probs=187.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||+|++++          .+.+|..+++.++||||+++++++.+.+..++||||+++|+|.+++..
T Consensus        20 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~   99 (318)
T 1fot_A           20 GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK   99 (318)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH
Confidence            89999998  689999999863          356799999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....      ......||+
T Consensus       100 ~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~------~~~~~~gt~  167 (318)
T 1fot_A          100 SQ---RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCGTP  167 (318)
T ss_dssp             TS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS------CBCCCCSCT
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC------ccccccCCc
Confidence            53   3899999999999999999999   68999999999999999999999999999976432      223467999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||......+.     .........           .   .+...+.
T Consensus       168 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~i~~~~~-----------~---~p~~~~~  228 (318)
T 1fot_A          168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNAEL-----------R---FPPFFNE  228 (318)
T ss_dssp             TTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHHCCC-----------C---CCTTSCH
T ss_pred             cccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCCC-----------C---CCCCCCH
Confidence            99999999999999999999999999999999999976543221     111111100           0   1123456


Q ss_pred             HHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      ++.+++.+||+.||++||     ++.|++++
T Consensus       229 ~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            788999999999999999     88888764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2e-38  Score=338.74  Aligned_cols=246  Identities=24%  Similarity=0.355  Sum_probs=196.4

Q ss_pred             HHHHHhhcCCCCCccc----ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCC
Q 007261          323 DLVVATENFSPKNMID----GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDG  386 (611)
Q Consensus       323 el~~at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~  386 (611)
                      ++....++|.....||    |.||++..  +|+.||+|++++          .+.+|+.+++.++||||++++++|.+++
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            3444455666555665    89999998  688999999864          2678999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCc
Q 007261          387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV  466 (611)
Q Consensus       387 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla  466 (611)
                      ..|+||||+++|+|.++++...    +++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~~----~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEecccee
Confidence            9999999999999999998653    888999999999999999999   689999999999999999999999999999


Q ss_pred             cccccccCCcccccccccCCCccchhhhccCC----CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhc
Q 007261          467 RSAVREESGYSSTKTAVGTNGYMAPEYMEYGL----VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEG  542 (611)
Q Consensus       467 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  542 (611)
                      +......  ........||+.|+|||.+.+..    ++.++||||||++||||++|+.||......+..  ..+..... 
T Consensus       216 ~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~--~~i~~~~~-  290 (410)
T 3v8s_A          216 MKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY--SKIMNHKN-  290 (410)
T ss_dssp             EECCTTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHTHHH-
T ss_pred             EeeccCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH--HHHHhccc-
Confidence            7653321  12334568999999999997655    889999999999999999999999865433211  11111000 


Q ss_pred             CCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 007261          543 GNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPES--RPSMAEVVST  592 (611)
Q Consensus       543 ~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  592 (611)
                           .+   .-+    .....+.++.+|+.+||..+|.+  ||++.||+++
T Consensus       291 -----~~---~~p----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          291 -----SL---TFP----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             -----HC---CCC----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             -----cc---cCC----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                 00   000    01124567889999999999988  9999999876

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.1e-38  Score=319.60  Aligned_cols=234  Identities=25%  Similarity=0.485  Sum_probs=187.2

Q ss_pred             ceEEEEEEcCcEEEEEEec-----HHHHHHHHHHHhcCCCceeeccceeccC-CeEEEEEeecCCCCHHHHhhccCCCCc
Q 007261          339 GSVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGACEHD-GVFYLVYEFMENGSLSDWLHKKRYPEF  412 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~  412 (611)
                      |.||++..+|+.||||.++     +.+.+|+.++++++||||+++++++.+. +..++||||+++|+|.+++.... ...
T Consensus        35 g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~  113 (278)
T 1byg_A           35 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSV  113 (278)
T ss_dssp             CEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHH-HHH
T ss_pred             ceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc-ccc
Confidence            8999999999999999986     4688999999999999999999987554 57899999999999999997642 123


Q ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchh
Q 007261          413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE  492 (611)
Q Consensus       413 l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE  492 (611)
                      +++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....      .....++..|+|||
T Consensus       114 ~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~------~~~~~~~~~y~aPE  184 (278)
T 1byg_A          114 LGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------QDTGKLPVKWTAPE  184 (278)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------------------CCTTTSCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc------ccCCCccccccCHH
Confidence            788999999999999999999   689999999999999999999999999998754322      12345788999999


Q ss_pred             hhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHH
Q 007261          493 YMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML  571 (611)
Q Consensus       493 ~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l  571 (611)
                      .+.+..++.++||||||+++|||++ |+.|+......+..      .....+.            ....+..++..+.++
T Consensus       185 ~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~------~~~~~~~------------~~~~~~~~~~~l~~l  246 (278)
T 1byg_A          185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------PRVEKGY------------KMDAPDGCPPAVYEV  246 (278)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH------HHHTTTC------------CCCCCTTCCHHHHHH
T ss_pred             HhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHhcCC------------CCCCcccCCHHHHHH
Confidence            9999999999999999999999998 88888655433211      1111110            011123345678999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          572 CLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       572 ~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      +.+||+.||++||++.|+++.|+++....
T Consensus       247 i~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          247 MKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence            99999999999999999999999987653

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.3e-38  Score=318.43  Aligned_cols=237  Identities=22%  Similarity=0.415  Sum_probs=188.8

Q ss_pred             ceEEEEEEcC-----cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGIING-----STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~~g-----~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|.+.+     ..||||.++        +.+.+|+.++++++||||+++++++.++ ..++||||+++++|.+++.
T Consensus        26 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~  104 (281)
T 3cc6_A           26 GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLE  104 (281)
T ss_dssp             SEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHH
T ss_pred             eeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHH
Confidence            8999998732     359999985        3578899999999999999999998754 4689999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...  ..+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++.......  .......++
T Consensus       105 ~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~  177 (281)
T 3cc6_A          105 RNK--NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY--YKASVTRLP  177 (281)
T ss_dssp             HHT--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----------CCCCC
T ss_pred             hcc--ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccccc--cccccCCCC
Confidence            753  34899999999999999999999   68999999999999999999999999999876543221  122334568


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      ..|+|||.+.+..++.++||||||+++|||++ |+.||......+..  ..   ......             ...+..+
T Consensus       178 ~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~--~~---~~~~~~-------------~~~~~~~  239 (281)
T 3cc6_A          178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI--GV---LEKGDR-------------LPKPDLC  239 (281)
T ss_dssp             GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH--HH---HHHTCC-------------CCCCTTC
T ss_pred             cceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH--HH---HhcCCC-------------CCCCCCC
Confidence            89999999999999999999999999999998 99998765443321  11   111000             0112234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                      +..+.+++.+||+.||++||++.|++++|+++.....
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  276 (281)
T 3cc6_A          240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK  276 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence            5678999999999999999999999999999876543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-38  Score=331.04  Aligned_cols=241  Identities=25%  Similarity=0.420  Sum_probs=181.5

Q ss_pred             ceEEEEEE--c-C--cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceecc-CCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--N-G--STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEH-DGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~-g--~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.+  + +  ..||||.++        +++.+|+.++++++||||++++++|.. ++..++||||+++|+|.+++
T Consensus       103 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l  182 (373)
T 3c1x_A          103 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI  182 (373)
T ss_dssp             SEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHH
T ss_pred             eEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHH
Confidence            89999987  2 2  368999985        458899999999999999999998754 56789999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC-cccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG-YSSTKTAV  483 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~  483 (611)
                      ....  ..+++..++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++........ ........
T Consensus       183 ~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~  257 (373)
T 3c1x_A          183 RNET--HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK  257 (373)
T ss_dssp             HCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------------------
T ss_pred             hhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCC
Confidence            8653  34889999999999999999999   689999999999999999999999999999865332211 11223345


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCC-CCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK-EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      ++..|+|||.+.+..++.++||||||+++|||++|+ .|+......+..  .   .... +.            ....+.
T Consensus       258 ~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~--~---~~~~-~~------------~~~~p~  319 (373)
T 3c1x_A          258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--V---YLLQ-GR------------RLLQPE  319 (373)
T ss_dssp             CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH--H---HHHT-TC------------CCCCCT
T ss_pred             CcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH--H---HHHc-CC------------CCCCCC
Confidence            778899999999999999999999999999999954 555443332211  1   1111 10            011123


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          563 EIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                      .++..+.+++.+||+.||++||++.|+++.|+++......
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence            3456789999999999999999999999999998776543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3e-37  Score=318.95  Aligned_cols=245  Identities=23%  Similarity=0.423  Sum_probs=189.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  +|+.||||+++        ..+.+|+.++++++||||+++++++.+++..++||||++ |+|.+++....
T Consensus        19 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~   97 (317)
T 2pmi_A           19 ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRT   97 (317)
T ss_dssp             CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhcc
Confidence            89999987  68999999985        468899999999999999999999999999999999998 69999987532


Q ss_pred             ---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          409 ---YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       409 ---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                         ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......+|
T Consensus        98 ~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~t  171 (317)
T 2pmi_A           98 VGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV---NTFSSEVVT  171 (317)
T ss_dssp             SSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC---CCCCCCCSC
T ss_pred             ccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc---ccCCCCccc
Confidence               2345899999999999999999999   6899999999999999999999999999997653221   122345789


Q ss_pred             CCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc--cccccc--cCccC---
Q 007261          486 NGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE--AKLSVL--VDPNL---  557 (611)
Q Consensus       486 ~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--~~l~~~--~d~~l---  557 (611)
                      +.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.  ...+..........  ......  ..+..   
T Consensus       172 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (317)
T 2pmi_A          172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ--LKLIFDIMGTPNESLWPSVTKLPKYNPNIQQR  249 (317)
T ss_dssp             CTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCC
T ss_pred             ccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCChhHhhhhhhhhhcccccccc
Confidence            99999999876 4689999999999999999999999976544321  12222222111100  000000  00000   


Q ss_pred             -Cc---------ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          558 -QA---------NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       558 -~~---------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                       ..         .....+.++.+|+.+||+.||++|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          250 PPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             CCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence             00         011235678999999999999999999999874

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.7e-38  Score=318.38  Aligned_cols=236  Identities=28%  Similarity=0.508  Sum_probs=191.1

Q ss_pred             ceEEEEEEc-CcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGIIN-GSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~~-g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||+|... +..||||.++      +.+.+|++++++++||||+++++++.. +..++||||+++++|.+++.... ..
T Consensus        27 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~-~~  104 (279)
T 1qpc_A           27 GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPS-GI  104 (279)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHH-HH
T ss_pred             eEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCC-CC
Confidence            899999984 5689999986      468899999999999999999999874 45889999999999999997542 12


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++......  ........++..|+||
T Consensus       105 ~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aP  179 (279)
T 1qpc_A          105 KLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTAP  179 (279)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC--EECCTTCCCCTTTSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc--cccccCCCCccCccCh
Confidence            4899999999999999999999   6899999999999999999999999999987654321  1222344567889999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+.+..++.++||||||+++|||++ |+.|+......+.     ...... +.            ....+..++..+.+
T Consensus       180 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-----~~~~~~-~~------------~~~~~~~~~~~l~~  241 (279)
T 1qpc_A          180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-----IQNLER-GY------------RMVRPDNCPEELYQ  241 (279)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----HHHHHT-TC------------CCCCCTTCCHHHHH
T ss_pred             hhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH-----HHHHhc-cc------------CCCCcccccHHHHH
Confidence            99998899999999999999999999 8888765443221     111111 10            00112234567899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      ++.+||+.||++|||+.++++.|+++...
T Consensus       242 li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          242 LMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            99999999999999999999999988654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.2e-38  Score=325.18  Aligned_cols=255  Identities=25%  Similarity=0.444  Sum_probs=200.4

Q ss_pred             HHhhcCCCCCccc----ceEEEEEE-------cCcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccC
Q 007261          326 VATENFSPKNMID----GSVFRGII-------NGSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHD  385 (611)
Q Consensus       326 ~at~~f~~~~~ig----g~Vy~g~~-------~g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~  385 (611)
                      ...++|.....+|    |.||++.+       +++.||||+++        +.+.+|+.++.++ +||||+++++++...
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            3345555555554    89999985       34789999985        3578899999999 799999999998765


Q ss_pred             C-eEEEEEeecCCCCHHHHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCee
Q 007261          386 G-VFYLVYEFMENGSLSDWLHKKRY-------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL  451 (611)
Q Consensus       386 ~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NIL  451 (611)
                      + ..++||||+++|+|.+++.....             ...+++..++.++.|++.||.|||   +.+++||||||+|||
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil  180 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL  180 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEE
Confidence            4 58999999999999999987542             123889999999999999999999   589999999999999


Q ss_pred             eCCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhh
Q 007261          452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEI  530 (611)
Q Consensus       452 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~  530 (611)
                      ++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             ECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence            99999999999999976543221 122334567889999999999999999999999999999998 8888866543322


Q ss_pred             HHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          531 LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       531 ~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                      ..     .....+.            ....+...+..+.+++.+||+.||.+|||+.|++++|+.+.....
T Consensus       260 ~~-----~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          260 FC-----RRLKEGT------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             HH-----HHHHHTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HH-----HHhccCc------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            11     1111110            001112245678999999999999999999999999999876543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.9e-38  Score=351.25  Aligned_cols=236  Identities=30%  Similarity=0.489  Sum_probs=192.9

Q ss_pred             ceEEEEEEc-CcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGIIN-GSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~~-g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||+|.+. +..||||+++      ++|.+|+.+|++++|+||+++++++.+ +..+|||||+++|+|.++|.... ..
T Consensus       281 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-~~  358 (535)
T 2h8h_A          281 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GK  358 (535)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHH-HT
T ss_pred             eEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcC-CC
Confidence            899999995 4679999986      468999999999999999999999976 67899999999999999997532 13


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.|+.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++......  ........++..|+||
T Consensus       359 ~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~y~aP  433 (535)
T 2h8h_A          359 YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAP  433 (535)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH--HHTTCSTTSCGGGSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc--eecccCCcCcccccCH
Confidence            4899999999999999999999   6899999999999999999999999999998653221  1122334567889999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+.++.++.++||||||++||||++ |+.||......+.      ...+..+.            ....+..++..+.+
T Consensus       434 E~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~------~~~i~~~~------------~~~~~~~~~~~l~~  495 (535)
T 2h8h_A          434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGY------------RMPCPPECPESLHD  495 (535)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH------HHHHHTTC------------CCCCCTTCCHHHHH
T ss_pred             HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCC------------CCCCCCCCCHHHHH
Confidence            99999999999999999999999999 8888865543221      11111110            01112345667899


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      |+.+||+.||++|||+.+|++.|+.+...
T Consensus       496 li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          496 LMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            99999999999999999999999988654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.3e-37  Score=317.06  Aligned_cols=243  Identities=21%  Similarity=0.348  Sum_probs=185.3

Q ss_pred             ceEEEEEE-cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII-NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++.. +|+.||||+++         ..+.+|+.++++++||||+++++++.+++..++||||+++ +|.+++....
T Consensus        16 g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~   94 (288)
T 1ob3_A           16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCE   94 (288)
T ss_dssp             EEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTST
T ss_pred             EEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcc
Confidence            89999998 58899999984         4578999999999999999999999999999999999975 9999997653


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                        ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......+|+.|
T Consensus        95 --~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~t~~y  166 (288)
T 1ob3_A           95 --GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEIVTLWY  166 (288)
T ss_dssp             --TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------------CCCTT
T ss_pred             --cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc---cccccccccccc
Confidence              34899999999999999999999   6899999999999999999999999999987653221   122345689999


Q ss_pred             cchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc--ccc--cccCccC------
Q 007261          489 MAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA--KLS--VLVDPNL------  557 (611)
Q Consensus       489 ~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~--~l~--~~~d~~l------  557 (611)
                      +|||.+.+ ..++.++||||||+++|||++|+.||......+. + ..+...........  ...  ...++..      
T Consensus       167 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (288)
T 1ob3_A          167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-L-MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL  244 (288)
T ss_dssp             CCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H-HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCC
T ss_pred             cCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHHHHCCCChhhchhhhcccccccccccccCc
Confidence            99999876 4589999999999999999999999876543321 1 12222221111000  000  0011111      


Q ss_pred             --CcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          558 --QANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       558 --~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        .......+.++.+|+.+||+.||++|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence              01122356678999999999999999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.8e-38  Score=330.55  Aligned_cols=227  Identities=22%  Similarity=0.352  Sum_probs=185.8

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||+|++.+          .+.+|+.+|++++||||+++++++.+.+..++||||+++|+|.+++..
T Consensus        29 G~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~  108 (384)
T 4fr4_A           29 GKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ  108 (384)
T ss_dssp             CCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT
T ss_pred             eEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh
Confidence            89999998  678999999852          467899999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....    .......||+
T Consensus       109 ~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~----~~~~~~~gt~  178 (384)
T 4fr4_A          109 NV---HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTK  178 (384)
T ss_dssp             TC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT----CCBCCCCSCG
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC----CceeccCCCc
Confidence            53   3899999999999999999999   689999999999999999999999999999765322    2334567999


Q ss_pred             Cccchhhhcc---CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          487 GYMAPEYMEY---GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       487 ~y~aPE~~~~---~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      .|+|||.+..   ..++.++||||||+++|||++|+.||.........  ........ .             ....+..
T Consensus       179 ~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--~~~~~~~~-~-------------~~~~p~~  242 (384)
T 4fr4_A          179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK--EIVHTFET-T-------------VVTYPSA  242 (384)
T ss_dssp             GGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH--HHHHHHHH-C-------------CCCCCTT
T ss_pred             cccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH--HHHHHHhh-c-------------ccCCCCc
Confidence            9999999864   45899999999999999999999999754432211  11111111 0             0111223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRPS-MAEVVS  591 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs-~~evl~  591 (611)
                      .+..+.+|+.+||+.||.+||+ +.++++
T Consensus       243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            4567899999999999999998 666654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4e-38  Score=320.37  Aligned_cols=231  Identities=23%  Similarity=0.398  Sum_probs=186.4

Q ss_pred             ceEEEEEE--cC-------cEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NG-------STVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g-------~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||+|..  ++       ..||+|+++       +.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+
T Consensus        22 g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  101 (289)
T 4fvq_A           22 TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT  101 (289)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHH
T ss_pred             ceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHH
Confidence            89999987  33       479999985       458899999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc--------EEEeeecCccccccccC
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR--------AKLANFSFVRSAVREES  474 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~--------~kl~Dfgla~~~~~~~~  474 (611)
                      ++....  ..+++..++.++.||+.||.|||   +.+++||||||+|||++.++.        +||+|||++.....   
T Consensus       102 ~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~---  173 (289)
T 4fvq_A          102 YLKKNK--NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP---  173 (289)
T ss_dssp             HHHHTG--GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC---
T ss_pred             HHHhCC--CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccC---
Confidence            998753  34899999999999999999999   689999999999999998887        99999999865422   


Q ss_pred             CcccccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccccc
Q 007261          475 GYSSTKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV  553 (611)
Q Consensus       475 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  553 (611)
                          .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..........     ......   ..    .
T Consensus       174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-----~~~~~~---~~----~  237 (289)
T 4fvq_A          174 ----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-----QFYEDR---HQ----L  237 (289)
T ss_dssp             ----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-----HHHHTT---CC----C
T ss_pred             ----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-----HHhhcc---CC----C
Confidence                123457889999999987 779999999999999999999777665544332111     111100   00    0


Q ss_pred             CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       554 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      .       ...+.++.+++.+||+.||++|||+.|++++|+++....
T Consensus       238 ~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          238 P-------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             C-------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             C-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            0       111345788999999999999999999999999987643

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.4e-37  Score=320.04  Aligned_cols=243  Identities=22%  Similarity=0.378  Sum_probs=187.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|..||||+++          .++.+|+.++++++||||+++++++..++..++||||+++|+|.+++..
T Consensus        46 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  125 (310)
T 2wqm_A           46 SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH  125 (310)
T ss_dssp             CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHH
T ss_pred             ceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHH
Confidence            89999997  78999999875          3578899999999999999999999999999999999999999999975


Q ss_pred             cC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          407 KR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       407 ~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      .. ....+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++......   .......++
T Consensus       126 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~  199 (310)
T 2wqm_A          126 FKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGT  199 (310)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC---------------------C
T ss_pred             hcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC---ccccccCCC
Confidence            21 2345899999999999999999999   6899999999999999999999999999987553221   122345689


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      ..|+|||.+.+..++.++||||||+++|||++|+.||.........+..   .... ..    .     +..  .....+
T Consensus       200 ~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~-~~----~-----~~~--~~~~~~  264 (310)
T 2wqm_A          200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---KIEQ-CD----Y-----PPL--PSDHYS  264 (310)
T ss_dssp             CSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHH---HHHT-TC----S-----CCC--CTTTSC
T ss_pred             eeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHH---Hhhc-cc----C-----CCC--cccccC
Confidence            9999999999999999999999999999999999998754432211111   1111 10    0     000  012345


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                      .++.+++.+||+.||++||++.++++.|+++......
T Consensus       265 ~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          265 EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence            6789999999999999999999999999999886554

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-37  Score=315.33  Aligned_cols=243  Identities=23%  Similarity=0.377  Sum_probs=194.0

Q ss_pred             ceEEEEEE--cCc---EEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeE-EEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGS---TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVF-YLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~---~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.+  ++.   .||+|.++        +.+.+|+.++++++||||+++++++.+.+.. ++||||+.+|+|.+++
T Consensus        35 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~  114 (298)
T 3pls_A           35 GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI  114 (298)
T ss_dssp             EEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHH
T ss_pred             ceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHH
Confidence            89999987  332   79999985        3578999999999999999999999766554 9999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC-Ccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES-GYSSTKTAV  483 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~  483 (611)
                      ....  ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++....... .........
T Consensus       115 ~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  189 (298)
T 3pls_A          115 RSPQ--RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR  189 (298)
T ss_dssp             HCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTT
T ss_pred             hccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCC
Confidence            8743  34899999999999999999999   58999999999999999999999999999975533221 112334456


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      ++..|+|||.+.+..++.++||||||+++|||++|+.|++........ ..    ......            ....+..
T Consensus       190 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~-~~----~~~~~~------------~~~~~~~  252 (298)
T 3pls_A          190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL-TH----FLAQGR------------RLPQPEY  252 (298)
T ss_dssp             CGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH-HH----HHHTTC------------CCCCCTT
T ss_pred             CCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH-HH----HhhcCC------------CCCCCcc
Confidence            788999999999999999999999999999999977776654433211 11    111110            0111223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhhc
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRS  603 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~  603 (611)
                      .+..+.+++.+||+.||.+|||+.++++.|+++.......
T Consensus       253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          253 CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence            4567899999999999999999999999999988765543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.5e-37  Score=317.81  Aligned_cols=240  Identities=25%  Similarity=0.412  Sum_probs=187.9

Q ss_pred             ceEEEEEEc-----CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceec-cCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGIIN-----GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACE-HDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~~-----g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|...     +..||+|.++        +.+.+|+.++++++||||++++++|. .++..++||||+++|+|.+++
T Consensus        39 g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l  118 (298)
T 3f66_A           39 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI  118 (298)
T ss_dssp             EEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHH
T ss_pred             ceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHH
Confidence            899999862     2258999985        35788999999999999999999864 556789999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC-cccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG-YSSTKTAV  483 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~  483 (611)
                      ....  ..+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++........ ........
T Consensus       119 ~~~~--~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~  193 (298)
T 3f66_A          119 RNET--HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK  193 (298)
T ss_dssp             HCTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CC
T ss_pred             Hhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCC
Confidence            7643  34899999999999999999999   689999999999999999999999999999765432211 12233456


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      +|+.|+|||.+.+..++.++||||||+++|||++|+.|++.........    ..... .            .....+..
T Consensus       194 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~----~~~~~-~------------~~~~~~~~  256 (298)
T 3f66_A          194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT----VYLLQ-G------------RRLLQPEY  256 (298)
T ss_dssp             BCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH----HHHHT-T------------CCCCCCTT
T ss_pred             CCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH----HHHhc-C------------CCCCCCcc
Confidence            7789999999999999999999999999999999666554433221111    11111 0            00111223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      ++..+.+++.+||+.||++||++.|+++.|+++....
T Consensus       257 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            4467899999999999999999999999999987654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-37  Score=324.60  Aligned_cols=252  Identities=25%  Similarity=0.332  Sum_probs=193.2

Q ss_pred             HHHHHhhcCCCCCccc----ceEEEEEE--cCcEEEEEEec------------HHHHHHHHHHHhcCCCceeeccceecc
Q 007261          323 DLVVATENFSPKNMID----GSVFRGII--NGSTVAIKCMR------------RSISKEVNLLKKINHFNLINLFGACEH  384 (611)
Q Consensus       323 el~~at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~------------~~~~~E~~~l~~l~H~niv~l~g~~~~  384 (611)
                      ++....++|.....||    |.||++..  ++..||+|+++            +.+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            3445566666666665    89999988  67899999985            347789999999999999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHhhccC-------------------------------------CCCccCHHHHHHHHHHHHH
Q 007261          385 DGVFYLVYEFMENGSLSDWLHKKR-------------------------------------YPEFVSWNCRFRIALDVAH  427 (611)
Q Consensus       385 ~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~ia~~ia~  427 (611)
                      .+..++||||+++|+|.+++....                                     ....+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            999999999999999999996310                                     0112457778899999999


Q ss_pred             HHHHHhcCCCCCeEecCCCCCCeeeCCCC--cEEEeeecCccccccccCC-cccccccccCCCccchhhhcc--CCCCCc
Q 007261          428 GLHYLHNCTDPGYVHKDISSGNILLDKNL--RAKLANFSFVRSAVREESG-YSSTKTAVGTNGYMAPEYMEY--GLVTPE  502 (611)
Q Consensus       428 gL~yLH~~~~~~ivH~Dlk~~NILl~~~~--~~kl~Dfgla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~k  502 (611)
                      ||+|||   +.+|+||||||+|||++.++  .+||+|||+++........ ........||+.|+|||.+.+  ..++.+
T Consensus       180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999   58999999999999998776  8999999999865432211 112345678999999999865  678999


Q ss_pred             cchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCC
Q 007261          503 MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPES  582 (611)
Q Consensus       503 sDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~  582 (611)
                      +||||||+++|||++|+.||......+.     ..........      ...    ......+..+.+|+.+||+.||.+
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~~~~~~~~------~~~----~~~~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADT-----ISQVLNKKLC------FEN----PNYNVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHCCCC------TTS----GGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHH-----HHHHHhcccc------cCC----cccccCCHHHHHHHHHHcCCChhH
Confidence            9999999999999999999976543321     1122211110      000    112234567899999999999999


Q ss_pred             CCCHHHHHHH
Q 007261          583 RPSMAEVVST  592 (611)
Q Consensus       583 RPs~~evl~~  592 (611)
                      ||++.|++++
T Consensus       322 Rps~~~~l~h  331 (345)
T 3hko_A          322 RFDAMRALQH  331 (345)
T ss_dssp             SCCHHHHHHS
T ss_pred             CCCHHHHhcC
Confidence            9999999874

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-37  Score=330.15  Aligned_cols=230  Identities=22%  Similarity=0.309  Sum_probs=189.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  +|+.||+|++.       ..+.+|+.+|++++||||+++++++.+++..++||||+++|+|.+++.... 
T Consensus        65 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-  143 (387)
T 1kob_A           65 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-  143 (387)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT-
T ss_pred             EEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhc-
Confidence            89999998  68899999985       357889999999999999999999999999999999999999999997643 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC--CCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK--NLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                       ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++......    ......||+.
T Consensus       144 -~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~----~~~~~~gt~~  215 (387)
T 1kob_A          144 -YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAE  215 (387)
T ss_dssp             -CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS----CEEEECSSGG
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc----ceeeeccCCC
Confidence             34899999999999999999999   689999999999999974  4789999999998654321    2234578999


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHH
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH  567 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  567 (611)
                      |+|||.+.+..++.++||||||+++|||++|+.||......+.     .........       ..++   ......+.+
T Consensus       216 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-----~~~i~~~~~-------~~~~---~~~~~~s~~  280 (387)
T 1kob_A          216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-----LQNVKRCDW-------EFDE---DAFSSVSPE  280 (387)
T ss_dssp             GCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-----HHHHHHCCC-------CCCS---STTTTSCHH
T ss_pred             ccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCCC-------CCCc---cccccCCHH
Confidence            9999999999999999999999999999999999976543221     111111100       0111   112234567


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.+|+.+||+.||++|||+.|++++
T Consensus       281 ~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          281 AKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhhC
Confidence            8999999999999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=321.51  Aligned_cols=245  Identities=24%  Similarity=0.429  Sum_probs=194.0

Q ss_pred             ceEEEEEE------cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCC--eEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII------NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDG--VFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~------~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++.+      +|+.||||+++       +.+.+|+.++++++||||+++++++...+  ..++||||+++++|.++
T Consensus        55 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  134 (326)
T 2w1i_A           55 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY  134 (326)
T ss_dssp             EEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHH
T ss_pred             eEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHH
Confidence            89999985      57899999985       36889999999999999999999987654  68999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      +....  ..+++..++.++.|++.||+|||   ..+++||||||+|||++.++.+||+|||+++................
T Consensus       135 l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~  209 (326)
T 2w1i_A          135 LQKHK--ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE  209 (326)
T ss_dssp             HHHST--TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCS
T ss_pred             HHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCC
Confidence            98754  34899999999999999999999   68999999999999999999999999999986644322222233456


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChh----------hHHHHHHHHHHhcCCccccccccc
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE----------ILLAEAVFSMVEGGNAEAKLSVLV  553 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~----------~~l~~~~~~~~~~~~~~~~l~~~~  553 (611)
                      ++..|+|||.+.+..++.++||||||+++|||++|..|+......-          ......+...+...          
T Consensus       210 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------  279 (326)
T 2w1i_A          210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN----------  279 (326)
T ss_dssp             CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT----------
T ss_pred             CceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC----------
Confidence            7788999999998889999999999999999999998875321100          00011111111110          


Q ss_pred             CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       554 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                        .....+..++.++.+++.+||+.||++||++.|+++.|++++...
T Consensus       280 --~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          280 --GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence              011113345677999999999999999999999999999988754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.5e-37  Score=313.64  Aligned_cols=229  Identities=21%  Similarity=0.374  Sum_probs=187.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|..||+|++.         +.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++...
T Consensus        20 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~   99 (284)
T 3kk8_A           20 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR   99 (284)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH
T ss_pred             eEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhc
Confidence            89999988  58899999985         34678999999999999999999999999999999999999999998765


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc---EEEeeecCccccccccCCccccccccc
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR---AKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      .   .+++..+..++.|++.||.|||   +.+++||||||+|||++.++.   +||+|||++.......    ......+
T Consensus       100 ~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~  169 (284)
T 3kk8_A          100 E---FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAG  169 (284)
T ss_dssp             S---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC----BCCCSCS
T ss_pred             C---CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc----cccCCCC
Confidence            3   4899999999999999999999   689999999999999976655   9999999987653221    2234578


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      |+.|+|||.+.+..++.++||||||+++|||++|+.||......+..     ..... +..     ....    ......
T Consensus       170 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~~~-~~~-----~~~~----~~~~~~  234 (284)
T 3kk8_A          170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-----AQIKA-GAY-----DYPS----PEWDTV  234 (284)
T ss_dssp             CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHHH-TCC-----CCCT----TTTTTS
T ss_pred             CcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH-----HHHHh-ccc-----cCCc----hhhccc
Confidence            99999999999999999999999999999999999999765433211     11111 100     0000    111234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +..+.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          235 TPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            5678899999999999999999999985

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.1e-37  Score=327.08  Aligned_cols=250  Identities=20%  Similarity=0.295  Sum_probs=188.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.||||+++         +.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++...
T Consensus        41 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  120 (389)
T 3gni_B           41 MTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH  120 (389)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT
T ss_pred             eEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhh
Confidence            78999998  58999999985         34678999999999999999999999999999999999999999999875


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC----Ccccccccc
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES----GYSSTKTAV  483 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~----~~~~~~~~~  483 (611)
                      .. ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++........    .........
T Consensus       121 ~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~  196 (389)
T 3gni_B          121 FM-DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV  196 (389)
T ss_dssp             CT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCT
T ss_pred             cc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccccccccccccccc
Confidence            32 34899999999999999999999   68999999999999999999999999998865432211    111223347


Q ss_pred             cCCCccchhhhcc--CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHH---HHHhcCC-cccc---------
Q 007261          484 GTNGYMAPEYMEY--GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVF---SMVEGGN-AEAK---------  548 (611)
Q Consensus       484 gt~~y~aPE~~~~--~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~---~~~~~~~-~~~~---------  548 (611)
                      ||..|+|||.+.+  ..++.++||||||+++|||++|+.||......+........   ....... ....         
T Consensus       197 gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (389)
T 3gni_B          197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSV  276 (389)
T ss_dssp             TTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------------------------
T ss_pred             ccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccc
Confidence            8999999999987  67999999999999999999999999765544322111000   0000000 0000         


Q ss_pred             ----cccc----------cCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          549 ----LSVL----------VDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       549 ----l~~~----------~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                          +...          .+......+...+..+.+|+.+||+.||++|||+.|++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          277 ANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -----------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                0000          0000001123455779999999999999999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-37  Score=326.25  Aligned_cols=223  Identities=20%  Similarity=0.283  Sum_probs=187.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||++++          .+.+|+.++++++||||+++++++.+.+..|+||||+++|+|.+++..
T Consensus        55 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~  134 (350)
T 1rdq_E           55 GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR  134 (350)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred             cEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH
Confidence            89999998  689999999853          466799999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....      ......||+
T Consensus       135 ~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~------~~~~~~gt~  202 (350)
T 1rdq_E          135 IG---RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTP  202 (350)
T ss_dssp             HC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS------CBCCCEECG
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccC------CcccccCCc
Confidence            53   3899999999999999999999   68999999999999999999999999999986532      123457899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||......+.     ........     .         ..+...+.
T Consensus       203 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----~~~i~~~~-----~---------~~p~~~~~  263 (350)
T 1rdq_E          203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-----YEKIVSGK-----V---------RFPSHFSS  263 (350)
T ss_dssp             GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHCC-----C---------CCCTTCCH
T ss_pred             cccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH-----HHHHHcCC-----C---------CCCCCCCH
Confidence            99999999999999999999999999999999999976543221     11111110     0         01123456


Q ss_pred             HHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPS-----MAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs-----~~evl~~  592 (611)
                      .+.+++.+||+.||.+||+     +.|++++
T Consensus       264 ~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            7899999999999999998     7777764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.2e-38  Score=328.41  Aligned_cols=225  Identities=27%  Similarity=0.410  Sum_probs=186.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +|+.||||++++          .+..|..++..+ +||||+++++++.+.+..|+||||+++|+|.+++.
T Consensus        31 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~  110 (345)
T 1xjd_A           31 GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ  110 (345)
T ss_dssp             SEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence            89999998  688999999964          256789999887 99999999999999999999999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||
T Consensus       111 ~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~~gt  181 (345)
T 1xjd_A          111 SCH---KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD---AKTNTFCGT  181 (345)
T ss_dssp             HHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT---CCBCCCCSC
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC---CcccCCCCC
Confidence            753   3899999999999999999999   5899999999999999999999999999987543221   234456799


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||......+.  .   ..... ..          +..   +...+
T Consensus       182 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~---~~i~~-~~----------~~~---p~~~s  242 (345)
T 1xjd_A          182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--F---HSIRM-DN----------PFY---PRWLE  242 (345)
T ss_dssp             GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H---HHHHH-CC----------CCC---CTTSC
T ss_pred             cccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH--H---HHHHh-CC----------CCC---CcccC
Confidence            999999999999999999999999999999999999976543321  1   11111 10          011   12245


Q ss_pred             HHHHHHHHHhhccCCCCCCCHH-HHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMA-EVVS  591 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~-evl~  591 (611)
                      .++.+|+.+||+.||++||++. ++++
T Consensus       243 ~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          243 KEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             HHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence            6788999999999999999997 6654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-37  Score=323.17  Aligned_cols=239  Identities=30%  Similarity=0.520  Sum_probs=192.6

Q ss_pred             ceEEEEEE--cCcE--EEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGST--VAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~--vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +|..  ||||.++        +.+.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.+++.
T Consensus        39 g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  118 (327)
T 1fvr_A           39 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR  118 (327)
T ss_dssp             CEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH
T ss_pred             ceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHH
Confidence            89999987  5654  4999885        3578899999999 99999999999999999999999999999999998


Q ss_pred             ccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          406 KKR-------------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       406 ~~~-------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      ...             ....+++..++.++.||+.||.|||   +.+++||||||+|||++.++.+||+|||+++.....
T Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~  195 (327)
T 1fvr_A          119 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY  195 (327)
T ss_dssp             TTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE
T ss_pred             hcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeEEEcccCcCcccccc
Confidence            653             1245899999999999999999999   689999999999999999999999999998743221


Q ss_pred             cCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCccccccc
Q 007261          473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV  551 (611)
Q Consensus       473 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~  551 (611)
                          .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.      ...+..+.       
T Consensus       196 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~------~~~~~~~~-------  258 (327)
T 1fvr_A          196 ----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKLPQGY-------  258 (327)
T ss_dssp             ----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHGGGTC-------
T ss_pred             ----ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH------HHHhhcCC-------
Confidence                12233456889999999998889999999999999999998 9999876543221      11111110       


Q ss_pred             ccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          552 LVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       552 ~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                           ....+..++..+.+++.+||+.||.+||++.|++++|.++......
T Consensus       259 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          259 -----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence                 0111223456789999999999999999999999999998775443

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.9e-38  Score=324.44  Aligned_cols=238  Identities=24%  Similarity=0.432  Sum_probs=185.9

Q ss_pred             ceEEEEEE--cCc----EEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGS----TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~----~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.+  +|+    .||+|.++        +.+.+|+.++++++||||+++++++.... .++|+||+++|+|.+++
T Consensus        29 g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l  107 (327)
T 3lzb_A           29 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV  107 (327)
T ss_dssp             EEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHH
T ss_pred             eEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHH
Confidence            89999997  454    36778763        46889999999999999999999998765 78999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ....  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........ .......+
T Consensus       108 ~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~~~  181 (327)
T 3lzb_A          108 REHK--DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YHAEGGKV  181 (327)
T ss_dssp             HHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-----------------CC
T ss_pred             HhcC--CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc-ccccCCCc
Confidence            8754  34899999999999999999999   689999999999999999999999999999865433221 12233456


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      |..|+|||.+.+..++.++||||||+++|||++ |+.||......+..      ..+....            ....+..
T Consensus       182 t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~------~~~~~~~------------~~~~~~~  243 (327)
T 3lzb_A          182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------SILEKGE------------RLPQPPI  243 (327)
T ss_dssp             CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH------HHHHTTC------------CCCCCTT
T ss_pred             cccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH------HHHHcCC------------CCCCCcc
Confidence            788999999999999999999999999999999 89888765543321      1111110            0111223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                      ++..+.+++.+||+.||.+||++.|+++.|+++.....
T Consensus       244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  281 (327)
T 3lzb_A          244 CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ  281 (327)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence            45578999999999999999999999999999876543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.7e-38  Score=327.76  Aligned_cols=225  Identities=27%  Similarity=0.421  Sum_probs=185.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|..  +|+.||||++.          +++.+|+.++++++||||+++++++..++..++||||++ |+|.+++..
T Consensus        68 g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~  146 (348)
T 1u5q_A           68 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV  146 (348)
T ss_dssp             EEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH
T ss_pred             EEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHH
Confidence            89999997  78999999984          357899999999999999999999999999999999997 789888865


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....       .....||+
T Consensus       147 ~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-------~~~~~gt~  214 (348)
T 1u5q_A          147 HK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANSFVGTP  214 (348)
T ss_dssp             HT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-------BCCCCSCG
T ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-------CCcccCCc
Confidence            43  34899999999999999999999   58999999999999999999999999999875432       23457899


Q ss_pred             Cccchhhhc---cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          487 GYMAPEYME---YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       487 ~y~aPE~~~---~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      .|+|||.+.   .+.++.++||||||+++|||++|+.||......+.     .........          +...  ...
T Consensus       215 ~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-----~~~~~~~~~----------~~~~--~~~  277 (348)
T 1u5q_A          215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNES----------PALQ--SGH  277 (348)
T ss_dssp             GGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCC----------CCCC--CTT
T ss_pred             ceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcCC----------CCCC--CCC
Confidence            999999984   57799999999999999999999999876543221     112222111          0110  122


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      .+..+.+++.+||+.||++|||+.+++++.
T Consensus       278 ~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          278 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            345688999999999999999999998754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.9e-38  Score=325.55  Aligned_cols=239  Identities=22%  Similarity=0.402  Sum_probs=180.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCC----eEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDG----VFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~E~~~~gsL~~  402 (611)
                      |.||++..  +|+.||||+++          ..+.+|+.++++++||||+++++++....    ..++||||+++|+|.+
T Consensus        26 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~  105 (311)
T 3ork_A           26 SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD  105 (311)
T ss_dssp             EEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHH
T ss_pred             EEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHH
Confidence            89999997  78899999985          24778999999999999999999986543    3599999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++....   .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...............
T Consensus       106 ~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  179 (311)
T 3ork_A          106 IVHTEG---PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV  179 (311)
T ss_dssp             HHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC----------------
T ss_pred             HHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccccccccccccc
Confidence            998653   3899999999999999999999   5899999999999999999999999999998654433222333445


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..     .........        .+.  ....
T Consensus       180 ~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-----~~~~~~~~~--------~~~--~~~~  244 (311)
T 3ork_A          180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-----YQHVREDPI--------PPS--ARHE  244 (311)
T ss_dssp             --CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----HHHHHCCCC--------CHH--HHST
T ss_pred             CcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhcCCCC--------Ccc--cccC
Confidence            7899999999999999999999999999999999999999765433211     111111100        000  0012


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHH-HHHHhchh
Q 007261          563 EIAHHLIMLCLACIAREPESRPSMAEVV-STLMKIQL  598 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl-~~L~~i~~  598 (611)
                      ..+.++.+++.+||+.||++||++.+++ ..|.++..
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            2456789999999999999999666554 55555433

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=324.36  Aligned_cols=249  Identities=13%  Similarity=0.170  Sum_probs=192.4

Q ss_pred             ceEEEEEE-----cCcEEEEEEecH------------------HHHHHHHHHHhcCCCceeeccceecc----CCeEEEE
Q 007261          339 GSVFRGII-----NGSTVAIKCMRR------------------SISKEVNLLKKINHFNLINLFGACEH----DGVFYLV  391 (611)
Q Consensus       339 g~Vy~g~~-----~g~~vavK~~~~------------------~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV  391 (611)
                      |.||+|..     .+..+|||++..                  .+.+|+..++.++||||+++++++..    ....++|
T Consensus        51 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv  130 (345)
T 2v62_A           51 GLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV  130 (345)
T ss_dssp             -CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEE
T ss_pred             eEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEE
Confidence            89999998     457899999741                  25567888888999999999999877    7789999


Q ss_pred             EeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC--cEEEeeecCcccc
Q 007261          392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL--RAKLANFSFVRSA  469 (611)
Q Consensus       392 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~--~~kl~Dfgla~~~  469 (611)
                      |||+ +++|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++  .+||+|||+++..
T Consensus       131 ~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~  203 (345)
T 2v62_A          131 MERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY  203 (345)
T ss_dssp             EECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTSEEECCCTTCEES
T ss_pred             Eecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceec
Confidence            9999 999999998754   5899999999999999999999   58999999999999998887  9999999999765


Q ss_pred             ccccCC----cccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc
Q 007261          470 VREESG----YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA  545 (611)
Q Consensus       470 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  545 (611)
                      ......    ........||..|+|||.+.+..++.++||||||+++|||++|+.||.................... ..
T Consensus       204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~  282 (345)
T 2v62_A          204 CPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDE-LP  282 (345)
T ss_dssp             SGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHT-TT
T ss_pred             ccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhccc-cc
Confidence            433211    1112445799999999999999999999999999999999999999965333222221111111110 00


Q ss_pred             ccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          546 EAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       546 ~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                       ..+.....      ...++.++.+++.+||+.||++||++.+|++.|+++......
T Consensus       283 -~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  332 (345)
T 2v62_A          283 -QSVLKWAP------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGP  332 (345)
T ss_dssp             -HHHHHHSC------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCC
T ss_pred             -HHHHhhcc------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccC
Confidence             00000000      013456799999999999999999999999999987654443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.3e-38  Score=335.14  Aligned_cols=251  Identities=24%  Similarity=0.357  Sum_probs=197.6

Q ss_pred             chhHHHHHhhcCCCCCccc----ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceec
Q 007261          320 KYEDLVVATENFSPKNMID----GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACE  383 (611)
Q Consensus       320 ~~~el~~at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~  383 (611)
                      .++++....++|.....||    |.||++..  +|+.||||++++          .+.+|..++.+++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            3445555566776666665    89999998  689999999963          2678999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeee
Q 007261          384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANF  463 (611)
Q Consensus       384 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df  463 (611)
                      +.+..||||||+++|+|.+++...+  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeec
Confidence            9999999999999999999998753  24899999999999999999999   689999999999999999999999999


Q ss_pred             cCccccccccCCcccccccccCCCccchhhhc-------cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHH
Q 007261          464 SFVRSAVREESGYSSTKTAVGTNGYMAPEYME-------YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAV  536 (611)
Q Consensus       464 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~  536 (611)
                      |+++.......  .......||+.|+|||.+.       ...++.++|||||||++|||++|+.||......+..  ..+
T Consensus       207 Gla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~--~~i  282 (412)
T 2vd5_A          207 GSCLKLRADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY--GKI  282 (412)
T ss_dssp             TTCEECCTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHH
T ss_pred             hhheeccCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH--HHH
Confidence            99976543221  1233467999999999987       457899999999999999999999999765543211  111


Q ss_pred             HHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 007261          537 FSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESR---PSMAEVVST  592 (611)
Q Consensus       537 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~  592 (611)
                      .....      .+      .+.......+.++.+|+.+||. +|.+|   |++.|++++
T Consensus       283 ~~~~~------~~------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          283 VHYKE------HL------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HTHHH------HC------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             Hhccc------Cc------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            11000      00      0011122345678999999999 99998   588888764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.5e-37  Score=322.36  Aligned_cols=226  Identities=19%  Similarity=0.352  Sum_probs=182.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+++.  +|+.||||++++          .+.+|..++.++ +||||+++++++.+.+..|+||||+++|+|.+++.
T Consensus        23 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~  102 (345)
T 3a8x_A           23 AKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ  102 (345)
T ss_dssp             EEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence            89999998  588999999863          367899999998 89999999999999999999999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||
T Consensus       103 ~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~---~~~~~~~gt  173 (345)
T 3a8x_A          103 RQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGT  173 (345)
T ss_dssp             HHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT---CCBCCCCSC
T ss_pred             HcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC---CcccccCCC
Confidence            753   3899999999999999999999   5899999999999999999999999999987543221   233456899


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhh---HHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI---LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||........   ..............          .   ..+.
T Consensus       174 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~---~~p~  240 (345)
T 3a8x_A          174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------I---RIPR  240 (345)
T ss_dssp             GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----------C---CCCT
T ss_pred             ccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----------C---CCCC
Confidence            999999999999999999999999999999999999965322110   00111111111110          0   0122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCH
Q 007261          563 EIAHHLIMLCLACIAREPESRPSM  586 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~  586 (611)
                      ..+..+.+|+.+||+.||.+||++
T Consensus       241 ~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          241 SLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCHHHHHHHHHHhcCCHhHCCCC
Confidence            345678899999999999999995

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.8e-37  Score=328.24  Aligned_cols=251  Identities=24%  Similarity=0.321  Sum_probs=198.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCC--eEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDG--VFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|..  +|+.||||+++        +.+.+|++++++++||||+++++++...+  ..++||||+++|+|.+++..
T Consensus        23 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  102 (396)
T 4eut_A           23 ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE  102 (396)
T ss_dssp             EEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTS
T ss_pred             eEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHh
Confidence            89999998  48999999986        35678999999999999999999987654  78999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee----CCCCcEEEeeecCccccccccCCccccccc
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL----DKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ......+++..++.++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++......    .....
T Consensus       103 ~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~----~~~~~  175 (396)
T 4eut_A          103 PSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSL  175 (396)
T ss_dssp             GGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG----GSSCS
T ss_pred             hhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC----ccccc
Confidence            654445999999999999999999999   6899999999999999    888889999999997654322    22345


Q ss_pred             ccCCCccchhhhcc--------CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccc---c
Q 007261          483 VGTNGYMAPEYMEY--------GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLS---V  551 (611)
Q Consensus       483 ~gt~~y~aPE~~~~--------~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~---~  551 (611)
                      .||..|+|||.+.+        ..++.++||||||+++|||++|+.||......... .+......... +...+.   .
T Consensus       176 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~-~~~~~~~~~~~-p~~~~~~~~~  253 (396)
T 4eut_A          176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMYKIITGK-PSGAISGVQK  253 (396)
T ss_dssp             SSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC-HHHHHHHHHSC-CTTCCEEEEC
T ss_pred             cCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch-HHHHHHHhcCC-Ccccchhhee
Confidence            78999999999865        56788999999999999999999999754432211 12222222221 111110   0


Q ss_pred             ccC---------ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          552 LVD---------PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       552 ~~d---------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      ..+         +............+.+++.+||+.||++||++.|+++.+.++..
T Consensus       254 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          254 AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             ccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            000         11112256788899999999999999999999999999988755

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.3e-37  Score=327.65  Aligned_cols=231  Identities=19%  Similarity=0.272  Sum_probs=178.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      |.||++..  +|+.||||+++      ..+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++....  
T Consensus        34 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--  111 (361)
T 3uc3_A           34 GVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG--  111 (361)
T ss_dssp             SSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--
T ss_pred             EEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC--
Confidence            89999998  68899999985      468899999999999999999999999999999999999999999997653  


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc--EEEeeecCccccccccCCcccccccccCCCc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR--AKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                       .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.  +||+|||+++.....    .......||+.|
T Consensus       112 -~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y  183 (361)
T 3uc3_A          112 -RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAY  183 (361)
T ss_dssp             -SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------------------CTT
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc----CCCCCCcCCCCc
Confidence             3899999999999999999999   689999999999999987765  999999998743222    123345799999


Q ss_pred             cchhhhccCCCCCc-cchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHH
Q 007261          489 MAPEYMEYGLVTPE-MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH  567 (611)
Q Consensus       489 ~aPE~~~~~~~s~k-sDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  567 (611)
                      +|||.+.+..++.+ +||||||+++|||++|+.||........ ....+........           .. ......+..
T Consensus       184 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~~-----------~~-~~~~~~s~~  250 (361)
T 3uc3_A          184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVKY-----------SI-PDDIRISPE  250 (361)
T ss_dssp             SCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTTCC-----------CC-CTTSCCCHH
T ss_pred             CChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcCCC-----------CC-CCcCCCCHH
Confidence            99999988887666 8999999999999999999976443221 1111222211100           00 001123467


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.+|+.+||+.||++|||+.|++++
T Consensus       251 ~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          251 CCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHccCChhHCcCHHHHHhC
Confidence            8899999999999999999999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2e-37  Score=313.92  Aligned_cols=225  Identities=22%  Similarity=0.327  Sum_probs=185.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  ++..||||++.          ..+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++..
T Consensus        23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~  102 (279)
T 3fdn_A           23 GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK  102 (279)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH
T ss_pred             eEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHh
Confidence            89999998  56789999984          2477899999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++......     ......+++
T Consensus       103 ~~---~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~  171 (279)
T 3fdn_A          103 LS---KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTL  171 (279)
T ss_dssp             HS---SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC-------------CCCC
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-----cccccCCCC
Confidence            53   3899999999999999999999   689999999999999999999999999987544322     223457899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||......+..     ..... ..          .   ..+...+.
T Consensus       172 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~-~~----------~---~~~~~~~~  232 (279)
T 3fdn_A          172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-----KRISR-VE----------F---TFPDFVTE  232 (279)
T ss_dssp             TTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----HHHHH-TC----------C---CCCTTSCH
T ss_pred             CccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH-----HHHHh-CC----------C---CCCCcCCH
Confidence            999999999999999999999999999999999998755432211     11111 00          0   01122446


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      .+.+|+.+||+.||++||++.|++++-
T Consensus       233 ~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          233 GARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             HHHHHHHHHhccChhhCCCHHHHhhCc
Confidence            688999999999999999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.9e-38  Score=339.28  Aligned_cols=227  Identities=23%  Similarity=0.356  Sum_probs=182.5

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||+++.          .+.+|+.++++++||||++++++|.+.+..++||||+++|+|.+++..
T Consensus       162 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~  241 (446)
T 4ejn_A          162 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR  241 (446)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH
T ss_pred             EEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh
Confidence            89999997  688999999863          356799999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++.+||+|||+++......   .......||+
T Consensus       242 ~~---~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~~gt~  313 (446)
T 4ejn_A          242 ER---VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKTFCGTP  313 (446)
T ss_dssp             HS---CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--------CCSSSCG
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC---cccccccCCc
Confidence            53   48999999999999999999993  2789999999999999999999999999987543221   2334567999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||++||||++|+.||......+.     .........           .   .+...+.
T Consensus       314 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----~~~i~~~~~-----------~---~p~~~~~  374 (446)
T 4ejn_A          314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----FELILMEEI-----------R---FPRTLGP  374 (446)
T ss_dssp             GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHCCC-----------C---CCTTSCH
T ss_pred             cccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-----HHHHHhCCC-----------C---CCccCCH
Confidence            99999999999999999999999999999999999976543321     111111100           0   1122456


Q ss_pred             HHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      ++.+|+.+||+.||.+||     ++.|++++
T Consensus       375 ~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            789999999999999999     99999874

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-37  Score=312.76  Aligned_cols=227  Identities=24%  Similarity=0.399  Sum_probs=167.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||++.          +.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++..
T Consensus        25 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  104 (278)
T 3cok_A           25 AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN  104 (278)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT
T ss_pred             eEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh
Confidence            89999997  78999999985          3477899999999999999999999999999999999999999999986


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..  ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......   .......+|+
T Consensus       105 ~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~  176 (278)
T 3cok_A          105 RV--KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH---EKHYTLCGTP  176 (278)
T ss_dssp             CS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----------------
T ss_pred             cc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC---CcceeccCCC
Confidence            53  34899999999999999999999   5899999999999999999999999999987653222   1223456899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||......+..                  ........ ..+...+.
T Consensus       177 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------------------~~~~~~~~-~~~~~~~~  237 (278)
T 3cok_A          177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------------------NKVVLADY-EMPSFLSI  237 (278)
T ss_dssp             ---------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------------CCSSCC-CCCTTSCH
T ss_pred             CcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------------------HHHhhccc-CCccccCH
Confidence            999999999989999999999999999999999998754432210                  00000000 11223456


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ++.+++.+||+.||++||++.+++++
T Consensus       238 ~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          238 EAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            78899999999999999999999874

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-37  Score=336.06  Aligned_cols=225  Identities=25%  Similarity=0.417  Sum_probs=188.4

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|..  +|+.||||++++          .+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++..
T Consensus        30 g~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~  109 (476)
T 2y94_A           30 GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK  109 (476)
T ss_dssp             SCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS
T ss_pred             eEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh
Confidence            89999998  689999999852          467899999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......    ......||+
T Consensus       110 ~~---~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~----~~~~~~gt~  179 (476)
T 2y94_A          110 NG---RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSP  179 (476)
T ss_dssp             SS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC----CBCCCCSCS
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc----cccccCCCc
Confidence            43   4899999999999999999999   6899999999999999999999999999998653321    234467999


Q ss_pred             CccchhhhccCCC-CCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          487 GYMAPEYMEYGLV-TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       487 ~y~aPE~~~~~~~-s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      .|+|||.+.+..+ +.++||||||+++|||++|+.||........     ...... +.             ...+...+
T Consensus       180 ~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-----~~~i~~-~~-------------~~~p~~~s  240 (476)
T 2y94_A          180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL-----FKKICD-GI-------------FYTPQYLN  240 (476)
T ss_dssp             TTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH-----HHHHHT-TC-------------CCCCTTCC
T ss_pred             CeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH-----HHHHhc-CC-------------cCCCccCC
Confidence            9999999988765 6899999999999999999999976544321     111111 10             00122234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .++.+|+.+||+.||++|||+.|++++
T Consensus       241 ~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          241 PSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            578899999999999999999999974

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.5e-37  Score=324.18  Aligned_cols=226  Identities=23%  Similarity=0.391  Sum_probs=186.1

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +|+.||||++++          .+.+|..++..+ +||||+++++++.+.+..|+||||+++|+|.+++.
T Consensus        34 g~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~  113 (353)
T 2i0e_A           34 GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ  113 (353)
T ss_dssp             EEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHH
Confidence            89999998  467899999964          356799999888 89999999999999999999999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ..+   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||
T Consensus       114 ~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~~gt  184 (353)
T 2i0e_A          114 QVG---RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG---VTTKTFCGT  184 (353)
T ss_dssp             HHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT---CCBCCCCSC
T ss_pred             hcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC---cccccccCC
Confidence            753   3899999999999999999999   6899999999999999999999999999997543221   234456799


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||......+.     ........           .   ..+...+
T Consensus       185 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-----~~~i~~~~-----------~---~~p~~~s  245 (353)
T 2i0e_A          185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----FQSIMEHN-----------V---AYPKSMS  245 (353)
T ss_dssp             GGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHCC-----------C---CCCTTSC
T ss_pred             ccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH-----HHHHHhCC-----------C---CCCCCCC
Confidence            999999999999999999999999999999999999976543221     11111110           0   0122345


Q ss_pred             HHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPS-----MAEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs-----~~evl~~  592 (611)
                      .++.+|+.+||+.||++||+     +.|++++
T Consensus       246 ~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          246 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            67899999999999999996     4666553

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.9e-37  Score=313.14  Aligned_cols=253  Identities=16%  Similarity=0.181  Sum_probs=196.5

Q ss_pred             hcCCCCCccc----ceEEEEEE--cCcEEEEEEec-----HHHHHHHHHHHhcCCCceeecccee-ccCCeEEEEEeecC
Q 007261          329 ENFSPKNMID----GSVFRGII--NGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGAC-EHDGVFYLVYEFME  396 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E~~~  396 (611)
                      ++|.....||    |.||+|..  +|+.||||++.     ..+.+|+.++++++|++++..++.+ ...+..++||||+ 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence            3444444444    89999996  78899999864     4688999999999988877777766 5677889999999 


Q ss_pred             CCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEeeecCcccccccc
Q 007261          397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSAVREE  473 (611)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~~~~~  473 (611)
                      +++|.+++....  ..+++..++.++.|++.||.|||   +.+|+||||||+|||+   ++++.+||+|||+++......
T Consensus        88 ~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           88 GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            999999998643  34899999999999999999999   6899999999999999   788999999999998654432


Q ss_pred             CC----cccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChh--hHHHHHHHHHHhcCCccc
Q 007261          474 SG----YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE--ILLAEAVFSMVEGGNAEA  547 (611)
Q Consensus       474 ~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~  547 (611)
                      ..    ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.......  .............     
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  237 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-----  237 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-----
Confidence            21    122345678999999999999999999999999999999999999997643321  1111111111100     


Q ss_pred             ccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          548 KLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       548 ~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                              .........+..+.+++.+||+.||++||++.++++.|+++....
T Consensus       238 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          238 --------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             --------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             --------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence                    000001123567999999999999999999999999999987754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.8e-37  Score=315.17  Aligned_cols=253  Identities=23%  Similarity=0.319  Sum_probs=192.0

Q ss_pred             hcCCCCCccc----ceEEEEEE--cCcEEEEEEec------------HHHHHHHHHHHhcC---CCceeeccceeccCC-
Q 007261          329 ENFSPKNMID----GSVFRGII--NGSTVAIKCMR------------RSISKEVNLLKKIN---HFNLINLFGACEHDG-  386 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~------------~~~~~E~~~l~~l~---H~niv~l~g~~~~~~-  386 (611)
                      ++|.....||    |.||++..  +|+.||||+++            ..+.+|+.++++++   ||||++++++|.... 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            3444444444    89999996  78999999985            36778998888875   999999999997654 


Q ss_pred             ----eEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 007261          387 ----VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLAN  462 (611)
Q Consensus       387 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D  462 (611)
                          ..++||||++ |+|.+++..... ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           89 DREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             SSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             CCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEee
Confidence                5899999996 699999987642 34899999999999999999999   58899999999999999999999999


Q ss_pred             ecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhc
Q 007261          463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEG  542 (611)
Q Consensus       463 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  542 (611)
                      ||+++.....    .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||......+.  ...+......
T Consensus       164 fg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~  237 (308)
T 3g33_A          164 FGLARIYSYQ----MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIGL  237 (308)
T ss_dssp             CSCTTTSTTC----CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH--HHHHHHHHCC
T ss_pred             CccccccCCC----cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCC
Confidence            9998765322    123446789999999999999999999999999999999999999876544322  1222222211


Q ss_pred             CCcccccc------cccCccCCcC----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          543 GNAEAKLS------VLVDPNLQAN----KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       543 ~~~~~~l~------~~~d~~l~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ........      ..+.+.....    ..+.+..+.+|+.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            11000000      0000000000    12345678999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.4e-37  Score=315.11  Aligned_cols=234  Identities=24%  Similarity=0.472  Sum_probs=189.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec---HHHHHHHHHHHhcCCCceeeccceecc----------------CCeEEEEEeecCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR---RSISKEVNLLKKINHFNLINLFGACEH----------------DGVFYLVYEFMEN  397 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---~~~~~E~~~l~~l~H~niv~l~g~~~~----------------~~~~~lV~E~~~~  397 (611)
                      |.||++..  +|+.||||.++   ..+.+|+.++++++||||+++++++..                ....++||||+++
T Consensus        25 g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~  104 (284)
T 2a19_B           25 GQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDK  104 (284)
T ss_dssp             CCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCS
T ss_pred             eEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCC
Confidence            89999998  58999999986   568899999999999999999998854                4458999999999


Q ss_pred             CCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcc
Q 007261          398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS  477 (611)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  477 (611)
                      |+|.+++.... ...+++..++.++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++......    
T Consensus       105 ~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----  176 (284)
T 2a19_B          105 GTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG----  176 (284)
T ss_dssp             CBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS----
T ss_pred             CCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc----
Confidence            99999997642 235899999999999999999999   5899999999999999999999999999987654322    


Q ss_pred             cccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccC
Q 007261          478 STKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNL  557 (611)
Q Consensus       478 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l  557 (611)
                      ......+++.|+|||.+.+..++.++||||||+++|||++|..|+....       ... ......            .+
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~~~-~~~~~~------------~~  236 (284)
T 2a19_B          177 KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------KFF-TDLRDG------------II  236 (284)
T ss_dssp             CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------HHH-HHHHTT------------CC
T ss_pred             cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------HHH-HHhhcc------------cc
Confidence            2234568999999999999999999999999999999999998864211       111 111110            01


Q ss_pred             CcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhhc
Q 007261          558 QANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRS  603 (611)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~~  603 (611)
                         +...+..+.+++.+||+.||++||++.|++++|..+..+....
T Consensus       237 ---~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~  279 (284)
T 2a19_B          237 ---SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN  279 (284)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred             ---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence               1123356789999999999999999999999999987765543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2e-37  Score=321.85  Aligned_cols=226  Identities=22%  Similarity=0.362  Sum_probs=180.6

Q ss_pred             ceEEEEEE-----cCcEEEEEEecH-----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII-----NGSTVAIKCMRR-----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||++..     +|+.||+|++++           .+.+|+.+|++++||||+++++++..++..++||||+++|+|.+
T Consensus        31 g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  110 (327)
T 3a62_A           31 GKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFM  110 (327)
T ss_dssp             EEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHH
T ss_pred             EEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHH
Confidence            89999986     678999999852           35679999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++....   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++......   ......
T Consensus       111 ~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~  181 (327)
T 3a62_A          111 QLEREG---IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG---TVTHTF  181 (327)
T ss_dssp             HHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC-------------CTT
T ss_pred             HHHhCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC---cccccc
Confidence            998653   3888999999999999999999   5899999999999999999999999999987543221   123445


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.     ........           .   ..+.
T Consensus       182 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~i~~~~-----------~---~~p~  242 (327)
T 3a62_A          182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-----IDKILKCK-----------L---NLPP  242 (327)
T ss_dssp             SSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHTC-----------C---CCCT
T ss_pred             CCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHhCC-----------C---CCCC
Confidence            789999999999999999999999999999999999999976543221     11111110           0   0112


Q ss_pred             HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      ..+..+.+++.+||+.||++||     ++.|++++
T Consensus       243 ~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            3456789999999999999999     67777764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.6e-37  Score=320.72  Aligned_cols=235  Identities=21%  Similarity=0.324  Sum_probs=170.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec----HHHHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR----RSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||++..  +|+.||||++.    ..+.+|+.+++++. ||||+++++++.+++..++||||+++|+|.+++....   
T Consensus        25 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---  101 (325)
T 3kn6_A           25 SICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK---  101 (325)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCS---
T ss_pred             eEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcC---
Confidence            89999998  58899999986    35778999999996 9999999999999999999999999999999998753   


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEEeeecCccccccccCCcccccccccCCCc
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL---RAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                      .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++   .+||+|||+++......   .......+|+.|
T Consensus       102 ~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y  175 (325)
T 3kn6_A          102 HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN---QPLKTPCFTLHY  175 (325)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC---CcccccCCCcCc
Confidence            4899999999999999999999   68999999999999997665   89999999997543322   223345689999


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhh-HHHHHHHHHHhcCCcccccccccCccCCcC-hHHHHH
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI-LLAEAVFSMVEGGNAEAKLSVLVDPNLQAN-KKEIAH  566 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~  566 (611)
                      +|||.+.+..++.++||||||+++|||++|+.||........ .....+......+.          ...... ....+.
T Consensus       176 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~----------~~~~~~~~~~~s~  245 (325)
T 3kn6_A          176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD----------FSFEGEAWKNVSQ  245 (325)
T ss_dssp             --------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC----------CCCCSHHHHTSCH
T ss_pred             cCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC----------CCCCcccccCCCH
Confidence            999999999999999999999999999999999975432210 00011111111110          001111 234567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ++.+|+.+||+.||++|||+.|++++
T Consensus       246 ~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          246 EAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             HHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            89999999999999999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.5e-37  Score=318.85  Aligned_cols=229  Identities=22%  Similarity=0.319  Sum_probs=188.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++..  +|+.||||.++             ..+.+|+.++++++||||+++++++.+++..++||||+++++|.++
T Consensus        26 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  105 (321)
T 2a2a_A           26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDF  105 (321)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred             EEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHH
Confidence            89999998  68899999984             3488999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEeeecCccccccccCCcccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL----RAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      +....   .+++..++.++.|++.||+|||   +.+++||||||+|||++.++    .+||+|||+++......    ..
T Consensus       106 l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~  175 (321)
T 2a2a_A          106 LAQKE---SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EF  175 (321)
T ss_dssp             HHTCS---CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC----CC
T ss_pred             HHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc----cc
Confidence            98643   4899999999999999999999   58999999999999999888    79999999997654321    22


Q ss_pred             cccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc
Q 007261          480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA  559 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~  559 (611)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.     .........       ..++   .
T Consensus       176 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~i~~~~~-------~~~~---~  240 (321)
T 2a2a_A          176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----LANITSVSY-------DFDE---E  240 (321)
T ss_dssp             CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-----HHHHHTTCC-------CCCH---H
T ss_pred             cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHhccc-------ccCh---h
Confidence            345689999999999999999999999999999999999999976543221     111111000       0000   0


Q ss_pred             ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          560 NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .....+..+.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            012345678999999999999999999999974

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.5e-37  Score=322.34  Aligned_cols=241  Identities=26%  Similarity=0.443  Sum_probs=191.5

Q ss_pred             ceEEEEEE-------cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII-------NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|.+       ++..||||.+.        .++.+|+.++++++||||+++++++.+.+..++||||+++|+|.++
T Consensus        44 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  123 (327)
T 2yfx_A           44 GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSF  123 (327)
T ss_dssp             SCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHH
T ss_pred             eeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHH
Confidence            89999984       46689999984        3578899999999999999999999999999999999999999999


Q ss_pred             hhccCC----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeecCccccccccCCc
Q 007261          404 LHKKRY----PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK---NLRAKLANFSFVRSAVREESGY  476 (611)
Q Consensus       404 l~~~~~----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~  476 (611)
                      +.....    ...+++..++.++.|++.||.|||   +.+++||||||+|||++.   +..+||+|||+++....... .
T Consensus       124 l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~-~  199 (327)
T 2yfx_A          124 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY-Y  199 (327)
T ss_dssp             HHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-----
T ss_pred             HHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEECccccccccccccc-c
Confidence            987532    235899999999999999999999   689999999999999984   45699999999875433221 1


Q ss_pred             ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCc
Q 007261          477 SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP  555 (611)
Q Consensus       477 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  555 (611)
                      .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.      ......+.           
T Consensus       200 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~-----------  262 (327)
T 2yfx_A          200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV------LEFVTSGG-----------  262 (327)
T ss_dssp             --CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH------HHHHHTTC-----------
T ss_pred             ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH------HHHHhcCC-----------
Confidence            22234567889999999999999999999999999999998 8888765443221      11111110           


Q ss_pred             cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       556 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                       ....+..++..+.+++.+||+.||.+||++.+++++|+.+.....
T Consensus       263 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          263 -RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence             011122345678999999999999999999999999998876543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-37  Score=318.53  Aligned_cols=239  Identities=20%  Similarity=0.271  Sum_probs=183.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||+++          +.+.+|+.++++++||||+++++++..++..++||||+++++|.+++..
T Consensus        48 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  127 (309)
T 2h34_A           48 GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR  127 (309)
T ss_dssp             SEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH
T ss_pred             eeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh
Confidence            89999997  68899999985          3477899999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++.......  ........+++
T Consensus       128 ~~---~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~  199 (309)
T 2h34_A          128 QG---PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK--LTQLGNTVGTL  199 (309)
T ss_dssp             HC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC------------------CCG
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc--cccccccCCCc
Confidence            53   3899999999999999999999   5899999999999999999999999999987653321  11223456899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||......      ...........          .....+..++.
T Consensus       200 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~----------~~~~~~~~~~~  263 (309)
T 2h34_A          200 YYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------VMGAHINQAIP----------RPSTVRPGIPV  263 (309)
T ss_dssp             GGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH------HHHHHHHSCCC----------CGGGTSTTCCT
T ss_pred             CccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------HHHHHhccCCC----------CccccCCCCCH
Confidence            999999999999999999999999999999999998654321      11111111100          00111233455


Q ss_pred             HHHHHHHHhhccCCCCCC-CHHHHHHHHHhchhhhh
Q 007261          567 HLIMLCLACIAREPESRP-SMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~~~~~  601 (611)
                      .+.+++.+||+.||++|| ++.++++.|+++.....
T Consensus       264 ~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          264 AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            788999999999999999 99999999998766543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.7e-37  Score=326.29  Aligned_cols=258  Identities=24%  Similarity=0.296  Sum_probs=195.3

Q ss_pred             hhHHHHHhhcCCCCCccc----ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcC-----CCceeeccceec
Q 007261          321 YEDLVVATENFSPKNMID----GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKIN-----HFNLINLFGACE  383 (611)
Q Consensus       321 ~~el~~at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~-----H~niv~l~g~~~  383 (611)
                      +.+.....++|.....||    |.||++..  +|+.||||+++      +.+..|+.++++++     ||||+++++++.
T Consensus        27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            333333345555555554    89999998  78899999986      35677999999996     999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---------
Q 007261          384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK---------  454 (611)
Q Consensus       384 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---------  454 (611)
                      ..+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.         
T Consensus       107 ~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~  181 (360)
T 3llt_A          107 YYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLIT  181 (360)
T ss_dssp             ETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred             ECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccc
Confidence            999999999999 9999999987542 34899999999999999999999   689999999999999976         


Q ss_pred             ----------------CCcEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhC
Q 007261          455 ----------------NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG  518 (611)
Q Consensus       455 ----------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG  518 (611)
                                      ++.+||+|||+++....      ......||+.|+|||.+.+..++.++||||||+++|||++|
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  255 (360)
T 3llt_A          182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG  255 (360)
T ss_dssp             EECTTTCCEEEEEEESCCCEEECCCTTCEETTS------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred             hhcccccccccccccCCCCEEEEeccCceecCC------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence                            78999999999975432      12345789999999999999999999999999999999999


Q ss_pred             CCCCcCCCChhhHHHHHHHHHHhcCCccccc--------ccccC--------ccCCcC--------------hHHHHHHH
Q 007261          519 KEAAYKQDGEEILLAEAVFSMVEGGNAEAKL--------SVLVD--------PNLQAN--------------KKEIAHHL  568 (611)
Q Consensus       519 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l--------~~~~d--------~~l~~~--------------~~~~~~~l  568 (611)
                      +.||......+.  ...+..... ..+...+        ....+        +.....              .....+.+
T Consensus       256 ~~pf~~~~~~~~--~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          256 SLLFRTHEHMEH--LAMMESIIQ-PIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             SCSCCCSSHHHH--HHHHHHHTC-CCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             CCCCCCCcHHHH--HHHHHHhcC-CCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            999976543321  111111111 0000000        00000        000000              01112568


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHH
Q 007261          569 IMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       569 ~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+|+.+||+.||++|||+.|++++
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHhcCChhhCCCHHHHhcC
Confidence            899999999999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.2e-37  Score=321.98  Aligned_cols=247  Identities=13%  Similarity=0.150  Sum_probs=196.6

Q ss_pred             hcCCCCCccc----ceEEEEE-------EcCcEEEEEEec----HHHHHHHHHHHhcC---CCceeeccceeccCCeEEE
Q 007261          329 ENFSPKNMID----GSVFRGI-------INGSTVAIKCMR----RSISKEVNLLKKIN---HFNLINLFGACEHDGVFYL  390 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~-------~~g~~vavK~~~----~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~l  390 (611)
                      +.|.....||    |.||+|.       ..++.||||+++    .++.+|+.++.+++   |+||+++++++..++..+|
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l  144 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL  144 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence            3444444444    8999993       268899999996    46788999998886   9999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccC--CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-----------CCc
Q 007261          391 VYEFMENGSLSDWLHKKR--YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-----------NLR  457 (611)
Q Consensus       391 V~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-----------~~~  457 (611)
                      ||||+++|+|.+++....  ....++|..++.|+.||+.||+|||   +.+|+||||||+|||++.           ++.
T Consensus       145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~  221 (365)
T 3e7e_A          145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG  221 (365)
T ss_dssp             EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred             EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccccCC
Confidence            999999999999997532  2345999999999999999999999   689999999999999998           899


Q ss_pred             EEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHH
Q 007261          458 AKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVF  537 (611)
Q Consensus       458 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~  537 (611)
                      +||+|||+++....... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.......        
T Consensus       222 ~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------  292 (365)
T 3e7e_A          222 LALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--------  292 (365)
T ss_dssp             EEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--------
T ss_pred             EEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--------
Confidence            99999999975432211 223345679999999999999999999999999999999999999986443211        


Q ss_pred             HHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHhchhhhhh
Q 007261          538 SMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESR-PSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       538 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~i~~~~~~  602 (611)
                               ..+...+    ...  ...+.+.+++..|++.+|.+| |++.++.+.|+++......
T Consensus       293 ---------~~~~~~~----~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~  343 (365)
T 3e7e_A          293 ---------CKPEGLF----RRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT  343 (365)
T ss_dssp             ---------EEECSCC----TTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred             ---------eeechhc----ccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence                     1111111    111  124567789999999999999 6888999988887665433

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.5e-37  Score=310.79  Aligned_cols=227  Identities=23%  Similarity=0.353  Sum_probs=186.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|..  ++..||+|++.       +.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.... 
T Consensus        23 g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-  101 (277)
T 3f3z_A           23 GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR-  101 (277)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-
T ss_pred             EEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC-
Confidence            89999998  56789999985       468899999999999999999999999999999999999999999998753 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                        .+++..++.++.|++.||+|||   +.+++||||||+|||+   +.++.+||+|||++.......    ......+|+
T Consensus       102 --~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~t~  172 (277)
T 3f3z_A          102 --VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMRTKVGTP  172 (277)
T ss_dssp             --SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS----CBCCCCSCT
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc----chhccCCCC
Confidence              3899999999999999999999   6899999999999999   888999999999987653221    234457899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc-ChHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA-NKKEIA  565 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~-~~~~~~  565 (611)
                      .|+|||.+.+. ++.++||||||+++|||++|+.||......+..     ........           .... .....+
T Consensus       173 ~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~~~-----------~~~~~~~~~~~  235 (277)
T 3f3z_A          173 YYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM-----LKIREGTF-----------TFPEKDWLNVS  235 (277)
T ss_dssp             TTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHHHCCC-----------CCCHHHHTTSC
T ss_pred             CccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH-----HHHHhCCC-----------CCCchhhhcCC
Confidence            99999998754 899999999999999999999999765433211     11111100           0000 011345


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+.+++.+||+.||++||++.|++++
T Consensus       236 ~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          236 PQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            678999999999999999999999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.8e-37  Score=328.59  Aligned_cols=234  Identities=21%  Similarity=0.351  Sum_probs=181.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec--HHHHHHHHHHHhc-CCCceeeccceecc----CCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--RSISKEVNLLKKI-NHFNLINLFGACEH----DGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  +|+.||||+++  ..+.+|+.++.++ +||||+++++++..    ++..||||||+++|+|.+++.... 
T Consensus        76 g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-  154 (400)
T 1nxk_A           76 GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-  154 (400)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC--
T ss_pred             eEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhC-
Confidence            89999998  68899999996  5678899988655 89999999998865    567899999999999999998753 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeecCccccccccCCcccccccccCC
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK---NLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ...+++..+..|+.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++.....    .......||+
T Consensus       155 ~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~  227 (400)
T 1nxk_A          155 DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCYTP  227 (400)
T ss_dssp             --CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---------------C
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCCC----CccccCCCCC
Confidence            245899999999999999999999   589999999999999998   789999999999865322    1234567899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhH--HHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL--LAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~--l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      .|+|||++.+..++.++|||||||++|||++|+.||.........  ....+   .. +..     .+..+    ....+
T Consensus       228 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i---~~-~~~-----~~~~~----~~~~~  294 (400)
T 1nxk_A          228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---RM-GQY-----EFPNP----EWSEV  294 (400)
T ss_dssp             TTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH---HH-TCC-----CCCTT----TTTTS
T ss_pred             CccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH---Hc-Ccc-----cCCCc----ccccC
Confidence            999999999999999999999999999999999999765432210  11111   00 000     00000    11235


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      +.++.+|+.+||+.||++|||+.|++++-
T Consensus       295 s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          295 SEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            56789999999999999999999999864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-37  Score=316.72  Aligned_cols=240  Identities=28%  Similarity=0.475  Sum_probs=187.4

Q ss_pred             ceEEEEEEc---Cc--EEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIIN---GS--TVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~---g~--~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|.++   +.  .||||+++          +.+.+|+.++++++||||+++++++.... .++||||+++++|.++
T Consensus        32 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~  110 (291)
T 1u46_A           32 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDR  110 (291)
T ss_dssp             CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHH
T ss_pred             eeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHH
Confidence            899999862   33  69999885          35778999999999999999999998765 7899999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      +....  ..+++..++.++.|++.||.|||   +.+++|+||||+|||++.++.+||+|||+++................
T Consensus       111 l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  185 (291)
T 1u46_A          111 LRKHQ--GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK  185 (291)
T ss_dssp             HHHHG--GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----
T ss_pred             HHhcc--CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCC
Confidence            98653  34899999999999999999999   58999999999999999999999999999886644332222334456


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      ++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.     .........            ....+.
T Consensus       186 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----~~~~~~~~~------------~~~~~~  248 (291)
T 1u46_A          186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LHKIDKEGE------------RLPRPE  248 (291)
T ss_dssp             CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----HHHHHTSCC------------CCCCCT
T ss_pred             CCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH-----HHHHHccCC------------CCCCCc
Confidence            7889999999998889999999999999999999 8988876543221     111111110            001122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          563 EIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                      .++..+.+++.+||+.||++||++.++++.|.++.....
T Consensus       249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  287 (291)
T 1u46_A          249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM  287 (291)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence            345678999999999999999999999999998876443

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.1e-37  Score=313.14  Aligned_cols=244  Identities=16%  Similarity=0.178  Sum_probs=192.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec-----HHHHHHHHHHHhcCCCceeecccee-ccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGAC-EHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      |.||+|..  +|+.||||++.     +.+.+|+.++++++|++++..++++ ..++..++||||+ +++|.+++....  
T Consensus        23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--   99 (296)
T 3uzp_A           23 GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS--   99 (296)
T ss_dssp             EEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--
T ss_pred             eEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhc--
Confidence            89999996  78999999975     4689999999999988877777665 5667889999999 999999998543  


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEeeecCccccccccCC----cccccccc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESG----YSSTKTAV  483 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~~~~~~~----~~~~~~~~  483 (611)
                      ..+++..++.++.|++.||+|||   +.+++||||||+|||+   ++++.+||+|||+++........    ........
T Consensus       100 ~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~  176 (296)
T 3uzp_A          100 RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT  176 (296)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccc
Confidence            34899999999999999999999   6899999999999999   48899999999999865443221    11234567


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChh--hHHHHHHHHHHhcCCcccccccccCccCCcCh
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE--ILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK  561 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  561 (611)
                      ||+.|+|||.+.+..++.++||||||+++|||++|+.||.......  ..+...........             .....
T Consensus       177 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~  243 (296)
T 3uzp_A          177 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-------------IEVLC  243 (296)
T ss_dssp             SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-------------HHHHT
T ss_pred             cccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-------------hHHHH
Confidence            9999999999999999999999999999999999999997643221  11111111111000             00001


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                      ..++..+.+++.+||+.||++||++.++++.|+++.....
T Consensus       244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence            2235678999999999999999999999999999876543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.6e-37  Score=311.74  Aligned_cols=232  Identities=26%  Similarity=0.429  Sum_probs=187.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|..  ++..||||.++       +.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.....
T Consensus        36 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~  115 (295)
T 2clq_A           36 GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG  115 (295)
T ss_dssp             SEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTC
T ss_pred             EEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhcc
Confidence            89999998  67899999974       4588999999999999999999999999999999999999999999987654


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                      ...+++..+..++.|++.||.|||   +.+++|+||||+|||++. ++.+||+|||+++......   .......|+..|
T Consensus       116 ~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y  189 (295)
T 2clq_A          116 PLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN---PCTETFTGTLQY  189 (295)
T ss_dssp             CCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--------CCCCCCGGG
T ss_pred             CCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC---CcccccCCCccc
Confidence            455788999999999999999999   589999999999999987 8999999999987653221   122345789999


Q ss_pred             cchhhhccCC--CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          489 MAPEYMEYGL--VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       489 ~aPE~~~~~~--~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      +|||.+.+..  ++.++||||||+++|||++|+.||.............  ....           ..+.   .+...+.
T Consensus       190 ~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~-----------~~~~---~~~~~~~  253 (295)
T 2clq_A          190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV--GMFK-----------VHPE---IPESMSA  253 (295)
T ss_dssp             CCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH--HHHC-----------CCCC---CCTTSCH
T ss_pred             cChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh--cccc-----------cccc---ccccCCH
Confidence            9999997654  8899999999999999999999987544332211110  0000           0111   1223456


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ++.+++.+||+.||++||++.|++++
T Consensus       254 ~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          254 EAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcC
Confidence            78899999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-37  Score=313.83  Aligned_cols=230  Identities=27%  Similarity=0.385  Sum_probs=181.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++..  +|..||+|++.        +.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++....
T Consensus        36 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  115 (285)
T 3is5_A           36 GDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQ  115 (285)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHH
T ss_pred             eEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhh
Confidence            89999998  68899999985        357899999999999999999999999999999999999999999986531


Q ss_pred             -CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEeeecCccccccccCCccccccccc
Q 007261          409 -YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       409 -~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                       ....+++..++.++.|++.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++......    ......+
T Consensus       116 ~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~  188 (285)
T 3is5_A          116 ARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE----HSTNAAG  188 (285)
T ss_dssp             HHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--------------CT
T ss_pred             hcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc----cCcCccc
Confidence             1245899999999999999999999   6899999999999999   556889999999997653321    2334578


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      |+.|+|||.+. +.++.++||||||+++|||++|+.||......+...     .... .          .+.........
T Consensus       189 t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~-----~~~~-~----------~~~~~~~~~~~  251 (285)
T 3is5_A          189 TALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ-----KATY-K----------EPNYAVECRPL  251 (285)
T ss_dssp             TGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HHHH-C----------CCCCCC--CCC
T ss_pred             ccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh-----hhcc-C----------CcccccccCcC
Confidence            99999999986 568999999999999999999999997654332111     1110 0          00111111113


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +..+.+|+.+||+.||++|||+.|++++
T Consensus       252 ~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          252 TPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            4568899999999999999999999864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.8e-37  Score=320.96  Aligned_cols=250  Identities=17%  Similarity=0.199  Sum_probs=194.4

Q ss_pred             ceEEEEEEc----------CcEEEEEEecH--HHHHHHHHHHhcCCCceee---------------ccceecc-CCeEEE
Q 007261          339 GSVFRGIIN----------GSTVAIKCMRR--SISKEVNLLKKINHFNLIN---------------LFGACEH-DGVFYL  390 (611)
Q Consensus       339 g~Vy~g~~~----------g~~vavK~~~~--~~~~E~~~l~~l~H~niv~---------------l~g~~~~-~~~~~l  390 (611)
                      |.||+|...          ++.||||.++.  .+.+|+.++++++||||++               +++++.. ++..++
T Consensus        56 g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  135 (352)
T 2jii_A           56 GILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFL  135 (352)
T ss_dssp             EEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEE
T ss_pred             eEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEE
Confidence            899999873          67899999974  5999999999999999998               4555554 678999


Q ss_pred             EEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC--cEEEeeecCccc
Q 007261          391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL--RAKLANFSFVRS  468 (611)
Q Consensus       391 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~--~~kl~Dfgla~~  468 (611)
                      ||||+ +++|.+++.... ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++  .+||+|||+++.
T Consensus       136 v~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~  210 (352)
T 2jii_A          136 VLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR  210 (352)
T ss_dssp             EEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBC
T ss_pred             EecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCCCCceEEEecCcceee
Confidence            99999 999999998752 234999999999999999999999   58999999999999999998  999999999976


Q ss_pred             cccccCCc----ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCC
Q 007261          469 AVREESGY----SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN  544 (611)
Q Consensus       469 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  544 (611)
                      ........    .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....................  
T Consensus       211 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--  288 (352)
T 2jii_A          211 YCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDK--  288 (352)
T ss_dssp             SSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHS--
T ss_pred             ccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCC--
Confidence            54332111    122345789999999999999999999999999999999999999986543222222222222111  


Q ss_pred             cccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          545 AEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       545 ~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                          ...+.+....  ....+..+.+++.+||+.||++||++.++++.|+++.....
T Consensus       289 ----~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          289 ----PGPFVGPCGH--WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             ----CCCEECTTSC--EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ----hhhhhhhccc--cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence                1111111110  11234678999999999999999999999999999876543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=321.81  Aligned_cols=219  Identities=22%  Similarity=0.378  Sum_probs=184.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCC-CH
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENG-SL  400 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g-sL  400 (611)
                      |.||++..  +|+.||||+++.               .+.+|+.++++++||||+++++++.+.+..++||||+.+| +|
T Consensus        38 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l  117 (335)
T 3dls_A           38 GFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDL  117 (335)
T ss_dssp             CSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBH
T ss_pred             EEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccH
Confidence            89999987  788999999863               3567999999999999999999999999999999999777 99


Q ss_pred             HHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccc
Q 007261          401 SDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTK  480 (611)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  480 (611)
                      .+++....   .+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++......    ...
T Consensus       118 ~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~----~~~  187 (335)
T 3dls_A          118 FAFIDRHP---RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK----LFY  187 (335)
T ss_dssp             HHHHHTCC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTC----CBC
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCC----cee
Confidence            99998753   3899999999999999999999   6899999999999999999999999999997654322    223


Q ss_pred             ccccCCCccchhhhccCCC-CCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc
Q 007261          481 TAVGTNGYMAPEYMEYGLV-TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA  559 (611)
Q Consensus       481 ~~~gt~~y~aPE~~~~~~~-s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~  559 (611)
                      ...||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......                    ......     
T Consensus       188 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------------~~~~~~-----  242 (335)
T 3dls_A          188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------------VEAAIH-----  242 (335)
T ss_dssp             EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------------TTTCCC-----
T ss_pred             ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------------HhhccC-----
Confidence            4578999999999988776 78999999999999999999998642110                    000010     


Q ss_pred             ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          560 NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+...+.++.+|+.+||+.||++|||+.|++++
T Consensus       243 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            011245678999999999999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-37  Score=323.05  Aligned_cols=229  Identities=24%  Similarity=0.381  Sum_probs=179.2

Q ss_pred             ceEEEEEE-cCcEEEEEEec---------HHHHHHHHHHHhcCC--CceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII-NGSTVAIKCMR---------RSISKEVNLLKKINH--FNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~---------~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++.. +++.||||+++         +.+.+|+.+|.+++|  +||+++++++.+++..++||| +.+|+|.+++..
T Consensus        23 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~  101 (343)
T 3dbq_A           23 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK  101 (343)
T ss_dssp             EEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH
T ss_pred             eEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHh
Confidence            89999987 68899999985         457889999999976  999999999999999999999 558899999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..+..++.||+.||+|||   +.+|+||||||+|||++ ++.+||+|||+++....... ........||+
T Consensus       102 ~~---~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~  173 (343)
T 3dbq_A          102 KK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT-SVVKDSQVGTV  173 (343)
T ss_dssp             SC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------------CCCC
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc-cccCCCCcCCc
Confidence            53   4899999999999999999999   68999999999999997 57899999999986543321 11233457999


Q ss_pred             Cccchhhhcc-----------CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCc
Q 007261          487 GYMAPEYMEY-----------GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP  555 (611)
Q Consensus       487 ~y~aPE~~~~-----------~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  555 (611)
                      .|+|||.+.+           ..++.++||||||+++|||++|+.||.........    ......             +
T Consensus       174 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~-------------~  236 (343)
T 3dbq_A          174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK----LHAIID-------------P  236 (343)
T ss_dssp             SSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----HHHHHC-------------T
T ss_pred             CcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH----HHHHhc-------------C
Confidence            9999999865           67899999999999999999999999754432111    111111             1


Q ss_pred             cCCc-ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          556 NLQA-NKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       556 ~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      .... .+...+..+.+|+.+||+.||.+|||+.|++++-
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence            1111 1122245688999999999999999999999764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=312.82  Aligned_cols=243  Identities=23%  Similarity=0.331  Sum_probs=184.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.||||++.         +.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++...
T Consensus        17 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~   96 (311)
T 4agu_A           17 GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ   96 (311)
T ss_dssp             EEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTS
T ss_pred             eEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhh
Confidence            89999998  58999999873         35778999999999999999999999999999999999999999988765


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .   .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......   .......+|..
T Consensus        97 ~---~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~  167 (311)
T 4agu_A           97 R---GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS---DYYDDEVATRW  167 (311)
T ss_dssp             S---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---------------GG
T ss_pred             c---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc---cccCCCcCCcc
Confidence            3   3899999999999999999999   6899999999999999999999999999997654222   12234578999


Q ss_pred             ccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc--------cccc--ccccCcc
Q 007261          488 YMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA--------EAKL--SVLVDPN  556 (611)
Q Consensus       488 y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--------~~~l--~~~~d~~  556 (611)
                      |+|||.+.+ ..++.++||||||+++|||++|+.||......+..  ..+.........        ....  ....++.
T Consensus       168 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T 4agu_A          168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL--YLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPE  245 (311)
T ss_dssp             GCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCS
T ss_pred             ccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhcccccccccccccccccccCcCCCcc
Confidence            999999876 67899999999999999999999998765543321  111111110000        0000  0011111


Q ss_pred             CCcC----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          557 LQAN----KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       557 l~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ....    ....+..+.+|+.+||+.||++|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          246 DMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             SCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000    12345678999999999999999999999875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.3e-37  Score=326.82  Aligned_cols=243  Identities=23%  Similarity=0.351  Sum_probs=186.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHH-HHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNL-LKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+++.  ++..||||++++          .+.+|..+ ++.++||||+++++++.+.+..|+||||+++|+|.+++.
T Consensus        52 g~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~  131 (373)
T 2r5t_A           52 GKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ  131 (373)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred             eEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence            89999998  578999999853          24456665 566899999999999999999999999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||
T Consensus       132 ~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~---~~~~~~~gt  202 (373)
T 2r5t_A          132 RER---CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---STTSTFCGT  202 (373)
T ss_dssp             HHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC---CCCCSBSCC
T ss_pred             hcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccCC---CccccccCC
Confidence            753   3888999999999999999999   6899999999999999999999999999997543221   234456799


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||......+.     ........     +      .+   +...+
T Consensus       203 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-----~~~i~~~~-----~------~~---~~~~~  263 (373)
T 2r5t_A          203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-----YDNILNKP-----L------QL---KPNIT  263 (373)
T ss_dssp             CCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH-----HHHHHHSC-----C------CC---CSSSC
T ss_pred             ccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-----HHHHHhcc-----c------CC---CCCCC
Confidence            999999999999999999999999999999999999976543221     11111110     0      00   12234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHh-chhhhhhchhhhhh
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVSTLMK-IQLDVQRSQTLLLE  609 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~-i~~~~~~~~~~~~~  609 (611)
                      ..+.+|+.+||+.||.+||++.+.++.+.+ --....+|+.+..+
T Consensus       264 ~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~  308 (373)
T 2r5t_A          264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINK  308 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTT
T ss_pred             HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhC
Confidence            568899999999999999998654443332 22234456555443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.2e-37  Score=310.60  Aligned_cols=228  Identities=24%  Similarity=0.371  Sum_probs=185.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++..  +|+.||+|.++             +.+.+|+.++++++||||+++++++.+.+..++||||+++++|.++
T Consensus        19 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   98 (283)
T 3bhy_A           19 AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDF   98 (283)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred             eEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHH
Confidence            89999998  58899999874             3588999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEeeecCccccccccCCcccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL----RAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      +....   .+++..++.++.|++.||.|||   +.+++||||||+||+++.++    .+||+|||++.......    ..
T Consensus        99 l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~----~~  168 (283)
T 3bhy_A           99 LAEKE---SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EF  168 (283)
T ss_dssp             HHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---------
T ss_pred             HHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC----cc
Confidence            97643   3899999999999999999999   68999999999999998877    89999999987653321    22


Q ss_pred             cccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc
Q 007261          480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA  559 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~  559 (611)
                      ....+++.|+|||.+.+..++.++||||||+++|||++|+.||......+.     ...... ..          .....
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~-~~----------~~~~~  232 (283)
T 3bhy_A          169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-----LTNISA-VN----------YDFDE  232 (283)
T ss_dssp             ---CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHT-TC----------CCCCH
T ss_pred             cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-----HHHhHh-cc----------cCCcc
Confidence            345689999999999999999999999999999999999999876543221     111111 00          00000


Q ss_pred             -ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          560 -NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       560 -~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                       .....+..+.+++.+||+.||++||++.|++++
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          233 EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence             012345678999999999999999999999984

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.2e-37  Score=323.42  Aligned_cols=243  Identities=23%  Similarity=0.379  Sum_probs=188.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++..  +|..||+|+++        +.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++....
T Consensus        47 g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  126 (360)
T 3eqc_A           47 GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG  126 (360)
T ss_dssp             CEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS
T ss_pred             eEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC
Confidence            89999998  58899999985        357899999999999999999999999999999999999999999998753


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         .+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++.....     ......||+.|
T Consensus       127 ---~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~gt~~y  196 (360)
T 3eqc_A          127 ---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSY  196 (360)
T ss_dssp             ---SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-----C----CCCCTT
T ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-----cccCCCCCCCe
Confidence               38999999999999999999994  238999999999999999999999999998754322     22345789999


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCC----------------------c-
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN----------------------A-  545 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~----------------------~-  545 (611)
                      +|||.+.+..++.++||||||+++|||++|+.||......+.....  ........                      . 
T Consensus       197 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (360)
T 3eqc_A          197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF--GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPP  274 (360)
T ss_dssp             CCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHH--C------------------------------C
T ss_pred             ECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh--cccccccCCCCCCCcccCCCcccccccCCCCc
Confidence            9999999999999999999999999999999999765543321110  00000000                      0 


Q ss_pred             ---ccccccccCccCCcC-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          546 ---EAKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       546 ---~~~l~~~~d~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                         ...+........... ....+.++.+|+.+||+.||++|||+.|++++-
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          275 MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             CCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             ccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence               000000000000111 123456789999999999999999999999853

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2e-37  Score=319.57  Aligned_cols=238  Identities=25%  Similarity=0.382  Sum_probs=182.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++..  +|+.||||+++       ..+.+|+.++.++ +||||+++++++.+++..++||||+++|+|.+++....
T Consensus        27 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  106 (316)
T 2ac3_A           27 ARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR  106 (316)
T ss_dssp             EEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS
T ss_pred             EEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC
Confidence            89999987  78999999984       4688999999995 79999999999999999999999999999999998753


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc---EEEeeecCccccccccCC----cccccc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR---AKLANFSFVRSAVREESG----YSSTKT  481 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfgla~~~~~~~~~----~~~~~~  481 (611)
                         .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.   +||+|||+++........    ......
T Consensus       107 ---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  180 (316)
T 2ac3_A          107 ---HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT  180 (316)
T ss_dssp             ---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------------------
T ss_pred             ---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccccccccc
Confidence               3899999999999999999999   589999999999999998776   999999998755322110    111223


Q ss_pred             cccCCCccchhhhcc-----CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhH---------HHHHHHHHHhcCCccc
Q 007261          482 AVGTNGYMAPEYMEY-----GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL---------LAEAVFSMVEGGNAEA  547 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~-----~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~---------l~~~~~~~~~~~~~~~  547 (611)
                      ..||+.|+|||.+..     ..++.++||||||+++|||++|+.||......+..         ....+......+..  
T Consensus       181 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--  258 (316)
T 2ac3_A          181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY--  258 (316)
T ss_dssp             -CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCC--
T ss_pred             ccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCc--
Confidence            468999999999875     56899999999999999999999999765432100         00111111111100  


Q ss_pred             ccccccCccCCcC-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          548 KLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       548 ~l~~~~d~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                              ..... ....+..+.+|+.+||+.||++|||+.|++++
T Consensus       259 --------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          259 --------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             --------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                    00000 11245678999999999999999999999985

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.4e-37  Score=309.72  Aligned_cols=224  Identities=22%  Similarity=0.324  Sum_probs=187.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  ++..||||++.          ..+.+|++++++++||||+++++++.+.+..++||||+++|+|.+++..
T Consensus        28 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  107 (284)
T 2vgo_A           28 GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK  107 (284)
T ss_dssp             EEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH
T ss_pred             eEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh
Confidence            89999998  57899999984          3477899999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......     ......++.
T Consensus       108 ~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~  176 (284)
T 2vgo_A          108 HG---RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTL  176 (284)
T ss_dssp             HS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-----CBCCCCSCG
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-----ccccccCCC
Confidence            53   3899999999999999999999   689999999999999999999999999998654321     223457899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||......+.     ...... .          +...   +...+.
T Consensus       177 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~-~----------~~~~---~~~~~~  237 (284)
T 2vgo_A          177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-----HRRIVN-V----------DLKF---PPFLSD  237 (284)
T ss_dssp             GGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHT-T----------CCCC---CTTSCH
T ss_pred             CcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-----HHHHhc-c----------ccCC---CCcCCH
Confidence            99999999999999999999999999999999999875543221     111111 0          0011   122446


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+.+++.+||+.||.+||++.|++++
T Consensus       238 ~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          238 GSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             HHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            78899999999999999999999874

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.4e-37  Score=318.47  Aligned_cols=231  Identities=23%  Similarity=0.351  Sum_probs=186.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||+++         ..+.+|+.++.++ +||||+++++++.+.+..++||||+++|+|.+++..
T Consensus        43 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  122 (327)
T 3lm5_A           43 AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP  122 (327)
T ss_dssp             EEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSS
T ss_pred             eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHH
Confidence            89999998  58999999985         4688999999999 579999999999999999999999999999999865


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeecCccccccccCCcccccccc
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK---NLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      .. ...+++..++.++.|++.||+|||   ..+|+||||||+|||++.   ++.+||+|||+++......    ......
T Consensus       123 ~~-~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~----~~~~~~  194 (327)
T 3lm5_A          123 EL-AEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC----ELREIM  194 (327)
T ss_dssp             CC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-------------C
T ss_pred             hc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc----cccccc
Confidence            42 245899999999999999999999   689999999999999998   7899999999998653321    223457


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      ||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...     .......          .........
T Consensus       195 gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-----~i~~~~~----------~~~~~~~~~  259 (327)
T 3lm5_A          195 GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL-----NISQVNV----------DYSEETFSS  259 (327)
T ss_dssp             CCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HHHHTCC----------CCCTTTTTT
T ss_pred             CCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH-----HHHhccc----------ccCchhhcc
Confidence            8999999999999999999999999999999999999997654432211     1111000          000111233


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+..+.+++.+||+.||++|||+.|++++
T Consensus       260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          260 VSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            45678899999999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.3e-36  Score=320.62  Aligned_cols=241  Identities=26%  Similarity=0.459  Sum_probs=192.4

Q ss_pred             HhhcCCCCCccc----ceEEEEEE--cCcEEEEEEec---------------HHHHHHHHHHHhc-CCCceeeccceecc
Q 007261          327 ATENFSPKNMID----GSVFRGII--NGSTVAIKCMR---------------RSISKEVNLLKKI-NHFNLINLFGACEH  384 (611)
Q Consensus       327 at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~---------------~~~~~E~~~l~~l-~H~niv~l~g~~~~  384 (611)
                      ..++|.....||    |.||++..  +|+.||||+++               +.+.+|+.+++++ +||||+++++++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            345566556665    89999998  58999999874               2467899999999 89999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeec
Q 007261          385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFS  464 (611)
Q Consensus       385 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg  464 (611)
                      .+..++||||+++++|.+++....   .+++..+..++.||+.||.|||   +.+++|+||||+|||++.++.+||+|||
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecC
Confidence            999999999999999999998653   3899999999999999999999   5899999999999999999999999999


Q ss_pred             CccccccccCCcccccccccCCCccchhhhcc------CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHH
Q 007261          465 FVRSAVREESGYSSTKTAVGTNGYMAPEYMEY------GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFS  538 (611)
Q Consensus       465 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~  538 (611)
                      ++.......    ......||+.|+|||.+.+      ..++.++||||||+++|||++|+.||........  .   ..
T Consensus       246 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~---~~  316 (365)
T 2y7j_A          246 FSCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM--L---RM  316 (365)
T ss_dssp             TCEECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H---HH
T ss_pred             cccccCCCc----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH--H---HH
Confidence            987654322    2344678999999999863      3588999999999999999999999875433211  1   11


Q ss_pred             HHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          539 MVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       539 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ...... .     ...+    .....+..+.+++.+||+.||++||++.|++++
T Consensus       317 i~~~~~-~-----~~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          317 IMEGQY-Q-----FSSP----EWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHTCC-C-----CCHH----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhCCC-C-----CCCc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111100 0     0000    011234668999999999999999999999874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.6e-36  Score=328.19  Aligned_cols=239  Identities=22%  Similarity=0.280  Sum_probs=179.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccC------CeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD------GVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~E~~~~gsL~  401 (611)
                      |.||++..  +|+.||||++.         +.+.+|+.+|+.++||||+++++++...      ...||||||+++ +|.
T Consensus        76 g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~  154 (464)
T 3ttj_A           76 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLC  154 (464)
T ss_dssp             CEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHH
T ss_pred             eEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHH
Confidence            89999987  68899999985         3577899999999999999999998544      467999999975 577


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +.+...     +++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....    .....
T Consensus       155 ~~~~~~-----l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~----~~~~~  222 (464)
T 3ttj_A          155 QVIQME-----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTP  222 (464)
T ss_dssp             HHHTSC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C----CCC--
T ss_pred             HHHhhc-----CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC----cccCC
Confidence            776532     889999999999999999999   589999999999999999999999999999865432    12344


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc---------------
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE---------------  546 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~---------------  546 (611)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.+..+.  ...+...+.....+               
T Consensus       223 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~--~~~i~~~lg~p~~~~~~~~~~~~~~~~~~  300 (464)
T 3ttj_A          223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPEFMKKLQPTVRNYVEN  300 (464)
T ss_dssp             --CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHHHTTSCHHHHHHHTT
T ss_pred             CcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHHcchhhhhHhhc
Confidence            6789999999999999999999999999999999999999976543321  11111111111000               


Q ss_pred             ------cccccccCccC----CcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          547 ------AKLSVLVDPNL----QANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       547 ------~~l~~~~d~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                            ..+...+...+    .......+..+.+|+.+||+.||++|||+.|++++
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          301 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             SCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                  00000010000    01122346789999999999999999999999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.1e-37  Score=315.55  Aligned_cols=234  Identities=23%  Similarity=0.356  Sum_probs=186.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceec--cCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACE--HDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +|+.||+|.++         +.+.+|+.++++++||||+++++++.  .....++||||+++++|.+++.
T Consensus        20 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   99 (279)
T 2w5a_A           20 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT   99 (279)
T ss_dssp             SEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHH
T ss_pred             cEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHH
Confidence            89999998  68899999985         35788999999999999999999874  4678999999999999999997


Q ss_pred             ccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccc
Q 007261          406 KKR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPG-----YVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       406 ~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~-----ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      ... ....+++..++.++.|++.||+|||+   .+     ++||||||+|||++.++.+||+|||+++......   ...
T Consensus       100 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~---~~~  173 (279)
T 2w5a_A          100 KGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT---SFA  173 (279)
T ss_dssp             HHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C---HHH
T ss_pred             hhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc---ccc
Confidence            642 23458999999999999999999994   55     9999999999999999999999999987653221   112


Q ss_pred             cccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc
Q 007261          480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA  559 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~  559 (611)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+.  .   ..... +.            ...
T Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~---~~i~~-~~------------~~~  235 (279)
T 2w5a_A          174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--A---GKIRE-GK------------FRR  235 (279)
T ss_dssp             HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H---HHHHH-TC------------CCC
T ss_pred             cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH--H---HHHhh-cc------------ccc
Confidence            335689999999999998999999999999999999999999876543221  1   11111 10            001


Q ss_pred             ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          560 NKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      .+...+.++.+++.+||+.||++||++.|+++++...
T Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence            1223456789999999999999999999999876543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.1e-37  Score=318.28  Aligned_cols=245  Identities=21%  Similarity=0.288  Sum_probs=190.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceec----cCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACE----HDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||++..  +|+.||||++.       +.+.+|+.++++++||||+++++++.    .....++||||+++|+|.+++.
T Consensus        43 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  122 (317)
T 2buj_A           43 SYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE  122 (317)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHH
T ss_pred             eEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHH
Confidence            89999997  78999999874       45789999999999999999999986    3457899999999999999997


Q ss_pred             ccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc------cc
Q 007261          406 KKR-YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY------SS  478 (611)
Q Consensus       406 ~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~------~~  478 (611)
                      ... ....+++..++.++.|++.||.|||   ..+++||||||+|||++.++.+||+|||+++.........      ..
T Consensus       123 ~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  199 (317)
T 2buj_A          123 RLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD  199 (317)
T ss_dssp             HHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHH
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccc
Confidence            631 2345899999999999999999999   5799999999999999999999999999987543211110      01


Q ss_pred             ccccccCCCccchhhhccCC---CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCc
Q 007261          479 TKTAVGTNGYMAPEYMEYGL---VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP  555 (611)
Q Consensus       479 ~~~~~gt~~y~aPE~~~~~~---~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  555 (611)
                      .....||+.|+|||.+....   ++.++||||||+++|||++|+.||............    .....     .      
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~-----~------  264 (317)
T 2buj_A          200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----AVQNQ-----L------  264 (317)
T ss_dssp             HHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH----HHHCC------------
T ss_pred             cccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH----Hhhcc-----C------
Confidence            12345799999999987543   789999999999999999999998531110000000    01000     0      


Q ss_pred             cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhhh
Q 007261          556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQR  602 (611)
Q Consensus       556 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~  602 (611)
                       ........+..+.+++.+||+.||.+||++.+++++|+.+......
T Consensus       265 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          265 -SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             -CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence             0011123456789999999999999999999999999998765443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.3e-37  Score=321.22  Aligned_cols=234  Identities=22%  Similarity=0.338  Sum_probs=187.1

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEF  412 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~  412 (611)
                      |.||++..  +|+.||||++++   +..+|++++.++ +||||+++++++.+++..|+||||+++|+|.+++....   .
T Consensus        36 g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~---~  112 (342)
T 2qr7_A           36 SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK---F  112 (342)
T ss_dssp             EEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT---T
T ss_pred             EEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC---C
Confidence            89999998  688999999964   467899999998 79999999999999999999999999999999997653   4


Q ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC----CcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN----LRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       413 l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                      +++..+..++.||+.||+|||   +.+|+||||||+|||+.++    +.+||+|||+++......   .......+|+.|
T Consensus       113 ~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y  186 (342)
T 2qr7_A          113 FSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN---GLLMTPCYTANF  186 (342)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT---CCBCCSSCCSSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC---CceeccCCCccc
Confidence            899999999999999999999   6899999999999998443    359999999998654322   123446789999


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHH
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL  568 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l  568 (611)
                      +|||.+.+..++.++||||||+++|||++|+.||........  .+....... +..    .  ..   .......+.++
T Consensus       187 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~i~~-~~~----~--~~---~~~~~~~s~~~  254 (342)
T 2qr7_A          187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP--EEILARIGS-GKF----S--LS---GGYWNSVSDTA  254 (342)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH--HHHHHHHHH-CCC----C--CC---STTTTTSCHHH
T ss_pred             cCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH--HHHHHHHcc-CCc----c--cC---ccccccCCHHH
Confidence            999999888899999999999999999999999975432211  111111111 110    0  00   01123355678


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          569 IMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       569 ~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      .+|+.+||+.||++||++.|++++-
T Consensus       255 ~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          255 KDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             HHHHHHHCCCChhHCcCHHHHhcCC
Confidence            9999999999999999999998753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.7e-37  Score=313.81  Aligned_cols=228  Identities=27%  Similarity=0.462  Sum_probs=189.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  +|+.||||+++        +.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++... 
T Consensus        36 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-  114 (303)
T 3a7i_A           36 GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-  114 (303)
T ss_dssp             SEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTS-
T ss_pred             eEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcC-
Confidence            89999987  68899999985        46889999999999999999999999999999999999999999999754 


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         .+++..++.++.|++.||.|||   ..+++|+||||+|||++.++.+||+|||++.......   .......++..|
T Consensus       115 ---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y  185 (303)
T 3a7i_A          115 ---PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---IKRNTFVGTPFW  185 (303)
T ss_dssp             ---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB---CCBCCCCSCGGG
T ss_pred             ---CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc---cccCccCCCcCc
Confidence               3899999999999999999999   5899999999999999999999999999987654322   123345789999


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHH
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL  568 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l  568 (611)
                      +|||.+.+..++.++||||||+++|||++|+.|+......+..     ..... ..         .+.+   ....+..+
T Consensus       186 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~-~~---------~~~~---~~~~~~~l  247 (303)
T 3a7i_A          186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL-----FLIPK-NN---------PPTL---EGNYSKPL  247 (303)
T ss_dssp             CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHH-SC---------CCCC---CSSCCHHH
T ss_pred             cCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH-----HHhhc-CC---------CCCC---ccccCHHH
Confidence            9999999999999999999999999999999998754432211     11111 10         0111   12234568


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          569 IMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       569 ~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      .+++.+||+.||++||++.|++++..
T Consensus       248 ~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          248 KEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhhChh
Confidence            99999999999999999999998643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.2e-37  Score=325.89  Aligned_cols=229  Identities=23%  Similarity=0.373  Sum_probs=179.8

Q ss_pred             ceEEEEEE-cCcEEEEEEec---------HHHHHHHHHHHhcC--CCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII-NGSTVAIKCMR---------RSISKEVNLLKKIN--HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~---------~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++.. +|+.||||+++         ..+.+|+.+|++++  ||||+++++++..++..++||| +.+++|.+++..
T Consensus        70 g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~  148 (390)
T 2zmd_A           70 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK  148 (390)
T ss_dssp             EEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH
T ss_pred             eEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh
Confidence            89999987 68899999984         35789999999996  5999999999999999999999 568999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..++.++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++....... ........||+
T Consensus       149 ~~---~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~  220 (390)
T 2zmd_A          149 KK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT-SVVKDSQVGAV  220 (390)
T ss_dssp             CS---SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----------CCSCCCG
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc-cccCCCCCcCC
Confidence            53   4888999999999999999999   68999999999999995 58999999999986543221 11234567999


Q ss_pred             Cccchhhhcc-----------CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCc
Q 007261          487 GYMAPEYMEY-----------GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP  555 (611)
Q Consensus       487 ~y~aPE~~~~-----------~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  555 (611)
                      .|+|||++.+           ..++.++|||||||+||||++|+.||.........    +........         ..
T Consensus       221 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~----~~~~~~~~~---------~~  287 (390)
T 2zmd_A          221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK----LHAIIDPNH---------EI  287 (390)
T ss_dssp             GGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH----HHHHHCTTS---------CC
T ss_pred             CccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH----HHHHhCccc---------cC
Confidence            9999999865           46899999999999999999999999754432111    111111100         00


Q ss_pred             cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       556 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..   +...+..+.+|+.+||+.||++||++.|++++
T Consensus       288 ~~---~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          288 EF---PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             CC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CC---CccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            01   11124568899999999999999999999875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.2e-36  Score=307.95  Aligned_cols=226  Identities=22%  Similarity=0.394  Sum_probs=182.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceecc----CCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEH----DGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|..  ++..||+|.++         +.+.+|+.++++++||||+++++++..    +...++||||+++|+|.++
T Consensus        40 g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  119 (290)
T 1t4h_A           40 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY  119 (290)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHH
T ss_pred             eEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHH
Confidence            89999998  67789999985         347889999999999999999998754    4668999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeC-CCCcEEEeeecCccccccccCCccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG--YVHKDISSGNILLD-KNLRAKLANFSFVRSAVREESGYSSTK  480 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~  480 (611)
                      +....   .+++..++.++.|++.||.|||   ..+  ++||||||+|||++ +++.+||+|||++......     ...
T Consensus       120 l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-----~~~  188 (290)
T 1t4h_A          120 LKRFK---VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAK  188 (290)
T ss_dssp             HHHHS---SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-----SBE
T ss_pred             HHHcc---CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc-----ccc
Confidence            98753   3899999999999999999999   566  99999999999998 7899999999998654321     223


Q ss_pred             ccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC
Q 007261          481 TAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN  560 (611)
Q Consensus       481 ~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~  560 (611)
                      ...||+.|+|||.+. +.++.++||||||+++|||++|+.||..........     .....+....           ..
T Consensus       189 ~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-----~~~~~~~~~~-----------~~  251 (290)
T 1t4h_A          189 AVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-----RRVTSGVKPA-----------SF  251 (290)
T ss_dssp             ESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-----HHHTTTCCCG-----------GG
T ss_pred             cccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH-----HHHhccCCcc-----------cc
Confidence            456899999999887 459999999999999999999999997654432211     1111110000           01


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          561 KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       561 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +...+.++.+++.+||+.||++|||+.|++++
T Consensus       252 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            12223568999999999999999999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.4e-36  Score=327.12  Aligned_cols=246  Identities=18%  Similarity=0.304  Sum_probs=175.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceecc-----CCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEH-----DGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||++..  +|+.||||++.         +.+.+|+.+|++++||||+++++++..     ....|+||||+ +|+|.+
T Consensus        67 g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~  145 (458)
T 3rp9_A           67 GHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKK  145 (458)
T ss_dssp             -CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHH
T ss_pred             eEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhh
Confidence            89999987  68899999984         357789999999999999999999843     35799999998 579999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc------
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY------  476 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~------  476 (611)
                      ++....   .+++..+..++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++.........      
T Consensus       146 ~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  219 (458)
T 3rp9_A          146 LFRTPV---YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS  219 (458)
T ss_dssp             HHHSSC---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC--
T ss_pred             hcccCC---CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccC
Confidence            997653   4899999999999999999999   5899999999999999999999999999998654321110      


Q ss_pred             ------------------ccccccccCCCccchhhh-ccCCCCCccchHHHHHHHHHHHh-----------CCCCCcCCC
Q 007261          477 ------------------SSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELIT-----------GKEAAYKQD  526 (611)
Q Consensus       477 ------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~s~Gvvl~ellt-----------G~~p~~~~~  526 (611)
                                        ......+||+.|+|||++ ....++.++|||||||+||||++           |+.+|.+..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~  299 (458)
T 3rp9_A          220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS  299 (458)
T ss_dssp             -------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---
T ss_pred             ccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCc
Confidence                              122345789999999976 56679999999999999999999           444443322


Q ss_pred             Ch------------------hhHHHHHHHHHHhcCCccccccc-----------cc----CccCCcChHHHHHHHHHHHH
Q 007261          527 GE------------------EILLAEAVFSMVEGGNAEAKLSV-----------LV----DPNLQANKKEIAHHLIMLCL  573 (611)
Q Consensus       527 ~~------------------~~~l~~~~~~~~~~~~~~~~l~~-----------~~----d~~l~~~~~~~~~~l~~l~~  573 (611)
                      ..                  .......+...+..... +.+..           .+    ...+.......+.++.+|+.
T Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~  378 (458)
T 3rp9_A          300 CFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSE-EDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLK  378 (458)
T ss_dssp             -----------------CHHHHHHHHHHHHHHCCCCH-HHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHH
T ss_pred             cccccccccccccccccccCCHHHHHHHHHHcCCCCH-HHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHH
Confidence            10                  01111111222111110 00000           00    00011111234667899999


Q ss_pred             HhhccCCCCCCCHHHHHHH
Q 007261          574 ACIAREPESRPSMAEVVST  592 (611)
Q Consensus       574 ~Cl~~dP~~RPs~~evl~~  592 (611)
                      +||..||++|||+.|++++
T Consensus       379 ~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          379 RMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             HHSCSSTTTSCCHHHHHHS
T ss_pred             HHhccCccccCCHHHHhcC
Confidence            9999999999999999985

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.3e-36  Score=306.93  Aligned_cols=231  Identities=22%  Similarity=0.330  Sum_probs=188.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++..  +|+.||||+++        +.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++... 
T Consensus        21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-   99 (276)
T 2yex_A           21 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-   99 (276)
T ss_dssp             SEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-
T ss_pred             cEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhc-
Confidence            89999998  68899999985        35788999999999999999999999999999999999999999998754 


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                        ..+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++........ ........++..|
T Consensus       100 --~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y  173 (276)
T 2yex_A          100 --IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPY  173 (276)
T ss_dssp             --TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-ECCBCCCCSCGGG
T ss_pred             --cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc-hhcccCCccccCc
Confidence              34899999999999999999999   68999999999999999999999999999876532211 1123445789999


Q ss_pred             cchhhhccCCC-CCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHH
Q 007261          489 MAPEYMEYGLV-TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH  567 (611)
Q Consensus       489 ~aPE~~~~~~~-s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  567 (611)
                      +|||.+.+..+ +.++||||||+++|||++|+.||............+    .....            ........+..
T Consensus       174 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~------------~~~~~~~~~~~  237 (276)
T 2yex_A          174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----KEKKT------------YLNPWKKIDSA  237 (276)
T ss_dssp             CCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH----HTTCT------------TSTTGGGSCHH
T ss_pred             cChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh----hhccc------------ccCchhhcCHH
Confidence            99999987665 779999999999999999999997655432222111    11000            00112234567


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          238 PLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHHHCCCCchhCCCHHHHhcC
Confidence            8899999999999999999999874

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.5e-37  Score=338.53  Aligned_cols=231  Identities=25%  Similarity=0.317  Sum_probs=189.4

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||++++          .+.+|+.+|++++||||+++++++.+++..|+||||+++|+|.+++..
T Consensus       198 G~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~  277 (576)
T 2acx_A          198 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH  277 (576)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHS
T ss_pred             EEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHh
Confidence            89999998  689999999853          367899999999999999999999999999999999999999999986


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .. ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......    ......||+
T Consensus       278 ~~-~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~----~~~~~~GT~  349 (576)
T 2acx_A          278 MG-QAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTV  349 (576)
T ss_dssp             SS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC----CEECCCSCG
T ss_pred             cC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccCc----cccccCCCc
Confidence            53 234899999999999999999999   5899999999999999999999999999997653321    223457999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++|||||||++|||++|+.||........ . ..+........          .   ..+...+.
T Consensus       350 ~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~-~~i~~~i~~~~----------~---~~p~~~s~  414 (576)
T 2acx_A          350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-R-EEVERLVKEVP----------E---EYSERFSP  414 (576)
T ss_dssp             GGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-H-HHHHHHHHHCC----------C---CCCTTSCH
T ss_pred             cccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-H-HHHHHHhhccc----------c---cCCccCCH
Confidence            99999999999999999999999999999999999976543210 0 11111111000          0   01223456


Q ss_pred             HHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      ++.+|+.+||+.||.+||     ++.|++++
T Consensus       415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          415 QARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             HHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            789999999999999999     77888764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.1e-37  Score=311.98  Aligned_cols=223  Identities=22%  Similarity=0.368  Sum_probs=181.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||+++         .++.+|+..+.++ +||||+++++++.+++..++||||+++|+|.+++..
T Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  104 (289)
T 1x8b_A           25 GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISE  104 (289)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH
T ss_pred             eEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHh
Confidence            89999998  68999999985         3577899999999 999999999999999999999999999999999986


Q ss_pred             cCC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-------------------CCcEEEeeecCc
Q 007261          407 KRY-PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-------------------NLRAKLANFSFV  466 (611)
Q Consensus       407 ~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-------------------~~~~kl~Dfgla  466 (611)
                      ... ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.                   ...+||+|||++
T Consensus       105 ~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~  181 (289)
T 1x8b_A          105 NYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV  181 (289)
T ss_dssp             HHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC--------------------CCCEEECCCTTC
T ss_pred             hcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccc
Confidence            421 234899999999999999999999   589999999999999984                   448999999998


Q ss_pred             cccccccCCcccccccccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc
Q 007261          467 RSAVREESGYSSTKTAVGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA  545 (611)
Q Consensus       467 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  545 (611)
                      ......       ....+|..|+|||.+.+. .++.++||||||+++|||++|..++.....        ...... +  
T Consensus       182 ~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--------~~~~~~-~--  243 (289)
T 1x8b_A          182 TRISSP-------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--------WHEIRQ-G--  243 (289)
T ss_dssp             EETTCS-------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--------HHHHHT-T--
T ss_pred             cccCCc-------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--------HHHHHc-C--
Confidence            765322       234589999999999765 567899999999999999999877643211        011111 0  


Q ss_pred             ccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          546 EAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       546 ~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                                .....+...+..+.+++.+||+.||++|||+.|++++
T Consensus       244 ----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          244 ----------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             ----------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ----------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence                      1111122345678999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.1e-37  Score=318.17  Aligned_cols=237  Identities=24%  Similarity=0.303  Sum_probs=172.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcC-CCceeecccee--------ccCCeEEEEEeecCCCCH
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKIN-HFNLINLFGAC--------EHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~-H~niv~l~g~~--------~~~~~~~lV~E~~~~gsL  400 (611)
                      |.||++..  +|+.||||++.       +.+.+|+.++.++. ||||+++++++        ......++||||++ |+|
T Consensus        42 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L  120 (337)
T 3ll6_A           42 AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQL  120 (337)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEH
T ss_pred             eEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCH
Confidence            89999998  78999999883       45788999999995 99999999988        34456899999995 799


Q ss_pred             HHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc--
Q 007261          401 SDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG--YVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY--  476 (611)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~--  476 (611)
                      .+++........+++..++.++.||+.||+|||   ..+  ++||||||+|||++.++.+||+|||+++.........  
T Consensus       121 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  197 (337)
T 3ll6_A          121 VEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS  197 (337)
T ss_dssp             HHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-----
T ss_pred             HHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCccccc
Confidence            999976433455999999999999999999999   567  9999999999999999999999999998654322110  


Q ss_pred             -------ccccccccCCCccchhhh---ccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc
Q 007261          477 -------SSTKTAVGTNGYMAPEYM---EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       477 -------~~~~~~~gt~~y~aPE~~---~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  546 (611)
                             .......+|+.|+|||.+   .+..++.++||||||+++|||++|+.||........         ..     
T Consensus       198 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---------~~-----  263 (337)
T 3ll6_A          198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI---------VN-----  263 (337)
T ss_dssp             --------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             ccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh---------hc-----
Confidence                   011234689999999998   567789999999999999999999999864332110         00     


Q ss_pred             cccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       547 ~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      .......       ....+..+.+|+.+||+.||++||++.|++++|..+....
T Consensus       264 ~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          264 GKYSIPP-------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             --CCCCT-------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CcccCCc-------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            0000000       1112234788999999999999999999999999987643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-36  Score=323.30  Aligned_cols=243  Identities=23%  Similarity=0.346  Sum_probs=182.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcC-CCceeeccceeccC--CeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKIN-HFNLINLFGACEHD--GVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||++..  +|+.||||++.         ..+.+|+.+++++. ||||+++++++...  ...|+|||||+ |+|.+++
T Consensus        23 g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~  101 (388)
T 3oz6_A           23 GIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVI  101 (388)
T ss_dssp             -CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHH
Confidence            89999987  68999999884         34678999999996 99999999998644  47899999997 6999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC----------
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES----------  474 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~----------  474 (611)
                      ...    .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......          
T Consensus       102 ~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~  174 (388)
T 3oz6_A          102 RAN----ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN  174 (388)
T ss_dssp             HHT----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC
T ss_pred             HcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccc
Confidence            874    3889999999999999999999   68999999999999999999999999999986532110          


Q ss_pred             --------CcccccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc
Q 007261          475 --------GYSSTKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA  545 (611)
Q Consensus       475 --------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  545 (611)
                              .........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.  ...+.........
T Consensus       175 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~p~~  252 (388)
T 3oz6_A          175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ--LERIIGVIDFPSN  252 (388)
T ss_dssp             ---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCH
T ss_pred             ccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCH
Confidence                    0112234579999999999876 6789999999999999999999999976543321  1122222211110


Q ss_pred             cccccccc------------------CccCCcCh-------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          546 EAKLSVLV------------------DPNLQANK-------------KEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       546 ~~~l~~~~------------------d~~l~~~~-------------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                       ..+....                  ........             ..++..+.+|+.+||+.||++|||+.|++++
T Consensus       253 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          253 -EDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             -HHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             -HHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence             0000000                  00000000             0235678999999999999999999999987

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.6e-36  Score=310.93  Aligned_cols=230  Identities=24%  Similarity=0.411  Sum_probs=190.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec-----HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||+|..  +|+.||||.+.     ..+.+|+.++++++||||+++++++...+..++||||+++++|.+++....  .
T Consensus        43 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~  120 (314)
T 3com_A           43 GSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN--K  120 (314)
T ss_dssp             CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT--C
T ss_pred             eEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcC--C
Confidence            89999998  48999999985     568899999999999999999999999999999999999999999997532  3


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .+++..++.++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||++.......   .......++..|+||
T Consensus       121 ~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aP  194 (314)
T 3com_A          121 TLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM---AKRNTVIGTPFWMAP  194 (314)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB---SCBCCCCSCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc---cccCccCCCCCccCh
Confidence            4899999999999999999999   6899999999999999999999999999987653321   123345789999999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML  571 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l  571 (611)
                      |.+.+..++.++||||||+++|||++|+.||........     .........          +. ...+...+..+.++
T Consensus       195 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~----------~~-~~~~~~~~~~l~~l  258 (314)
T 3com_A          195 EVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-----IFMIPTNPP----------PT-FRKPELWSDNFTDF  258 (314)
T ss_dssp             HHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCC----------CC-CSSGGGSCHHHHHH
T ss_pred             hhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHhcCCC----------cc-cCCcccCCHHHHHH
Confidence            999999999999999999999999999999875443221     111111100          00 01123345678999


Q ss_pred             HHHhhccCCCCCCCHHHHHHH
Q 007261          572 CLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       572 ~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.+||+.||.+||++.+++++
T Consensus       259 i~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          259 VKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             HHHHTCSCTTTSCCHHHHTTS
T ss_pred             HHHHccCChhhCcCHHHHHhC
Confidence            999999999999999999874

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=6.5e-37  Score=318.11  Aligned_cols=242  Identities=21%  Similarity=0.320  Sum_probs=179.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.||||+++         ..+.+|+.++++++||||+++++++.+++..++||||++ |+|.+++...
T Consensus        48 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~  126 (329)
T 3gbz_A           48 GEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKN  126 (329)
T ss_dssp             SEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHC
T ss_pred             eEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhc
Confidence            89999987  78899999985         246789999999999999999999999999999999997 5999999876


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee-----CCCCcEEEeeecCccccccccCCccccccc
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL-----DKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl-----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      .   .+++..++.++.||+.||+|||   +.+|+||||||+|||+     ++++.+||+|||+++......   ......
T Consensus       127 ~---~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~  197 (329)
T 3gbz_A          127 P---DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI---RQFTHE  197 (329)
T ss_dssp             T---TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC------------
T ss_pred             C---CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc---cccCCC
Confidence            4   3899999999999999999999   5899999999999999     555669999999997653221   223345


Q ss_pred             ccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc-----ccccccC--
Q 007261          483 VGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA-----KLSVLVD--  554 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~-----~l~~~~d--  554 (611)
                      .+|..|+|||.+.+. .++.++||||||+++|||++|+.||......+. +. .+...........     .+.....  
T Consensus       198 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (329)
T 3gbz_A          198 IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-LF-KIFEVLGLPDDTTWPGVTALPDWKQSF  275 (329)
T ss_dssp             --CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH-HHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             cCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-HH-HHHHHhCCCchhhhhhhhhhhhhhhhh
Confidence            679999999999774 489999999999999999999999876543322 11 1111111111000     0000000  


Q ss_pred             ccCCcC------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 PNLQAN------KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 ~~l~~~------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.....      ....+.++.+|+.+||+.||++|||+.|++++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          276 PKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             CCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            000111      11245678999999999999999999999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.2e-36  Score=316.27  Aligned_cols=243  Identities=24%  Similarity=0.396  Sum_probs=184.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.||||++.         +.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++...
T Consensus        39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~  118 (331)
T 4aaa_A           39 GMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP  118 (331)
T ss_dssp             SSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHST
T ss_pred             EEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhc
Confidence            89999998  48899999973         34678999999999999999999999999999999999999999887654


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .   .+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++......   .......++..
T Consensus       119 ~---~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~t~~  189 (331)
T 4aaa_A          119 N---GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---EVYDDEVATRW  189 (331)
T ss_dssp             T---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC---------------CCCCCT
T ss_pred             c---CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc---cccCCCcCCcc
Confidence            3   3899999999999999999999   6899999999999999999999999999987653322   12334578999


Q ss_pred             ccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc--------ccccccccCccCC
Q 007261          488 YMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA--------EAKLSVLVDPNLQ  558 (611)
Q Consensus       488 y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--------~~~l~~~~d~~l~  558 (611)
                      |+|||.+.+. .++.++||||||+++|||++|+.||......+.. ... .........        .........+...
T Consensus       190 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (331)
T 4aaa_A          190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL-YHI-MMCLGNLIPRHQELFNKNPVFAGVRLPEIK  267 (331)
T ss_dssp             TCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHH-HHHHCSCCHHHHHHHHHCGGGTTCCCCCCS
T ss_pred             ccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHH-HHHhCCCChhhhhHhhhccccccccCcccc
Confidence            9999999775 7899999999999999999999998765443221 111 111100000        0000001111111


Q ss_pred             cC------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 AN------KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 ~~------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..      ...++..+.+|+.+||+.||++|||+.|++++
T Consensus       268 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          268 EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             SCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            10      12346789999999999999999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.3e-36  Score=311.86  Aligned_cols=228  Identities=24%  Similarity=0.413  Sum_probs=187.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  +|+.||||.++       ..+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.... 
T Consensus        23 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-  101 (304)
T 2jam_A           23 SEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG-  101 (304)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-
T ss_pred             ceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC-
Confidence            89999998  68999999985       347899999999999999999999999999999999999999999997653 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                        .+++..+..++.|++.||.|||   +.+++||||||+|||+   ++++.+||+|||+++.....     ......|++
T Consensus       102 --~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~  171 (304)
T 2jam_A          102 --VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTP  171 (304)
T ss_dssp             --CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-----TTHHHHSCC
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-----ccccccCCC
Confidence              3899999999999999999999   5899999999999999   78899999999998654221     223346899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||......+.     .........      ....    ......+.
T Consensus       172 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~i~~~~~------~~~~----~~~~~~~~  236 (304)
T 2jam_A          172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL-----FEKIKEGYY------EFES----PFWDDISE  236 (304)
T ss_dssp             CBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHCCC------CCCT----TTTTTSCH
T ss_pred             CccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHcCCC------CCCc----cccccCCH
Confidence            99999999999999999999999999999999999876543221     111111100      0000    11223456


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+.+++.+||+.||++||++.|++++
T Consensus       237 ~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          237 SAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             HHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            78999999999999999999999974

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1e-36  Score=327.32  Aligned_cols=239  Identities=21%  Similarity=0.353  Sum_probs=181.2

Q ss_pred             hcCCCCCccc----ceEEEEEE--cCcEEEEEEecH---------------HHHHHHHHHHhcCCCceeeccceeccCCe
Q 007261          329 ENFSPKNMID----GSVFRGII--NGSTVAIKCMRR---------------SISKEVNLLKKINHFNLINLFGACEHDGV  387 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~~---------------~~~~E~~~l~~l~H~niv~l~g~~~~~~~  387 (611)
                      ++|.....||    |.||+|..  +|+.||||++..               .+.+|+.+|++++||||+++++++.. +.
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~  213 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED  213 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence            4454444554    89999998  678999999853               36789999999999999999999854 55


Q ss_pred             EEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEeeec
Q 007261          388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN---LRAKLANFS  464 (611)
Q Consensus       388 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfg  464 (611)
                      .++||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.+   +.+||+|||
T Consensus       214 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             EEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             eEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecc
Confidence            799999999999999887653   4899999999999999999999   5899999999999999654   459999999


Q ss_pred             CccccccccCCcccccccccCCCccchhhhc---cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHh
Q 007261          465 FVRSAVREESGYSSTKTAVGTNGYMAPEYME---YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVE  541 (611)
Q Consensus       465 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  541 (611)
                      +++.....    .......||+.|+|||.+.   ...++.++||||||+++|||++|+.||......... ..    ...
T Consensus       288 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-~~----~i~  358 (419)
T 3i6u_A          288 HSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-KD----QIT  358 (419)
T ss_dssp             TTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH-HH----HHH
T ss_pred             cceecCCC----ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH-HH----HHh
Confidence            99865322    2234567999999999985   367888999999999999999999999764432211 11    111


Q ss_pred             cCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          542 GGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       542 ~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+..         ..........+..+.+|+.+||+.||++||++.|++++
T Consensus       359 ~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          359 SGKY---------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             TTCC---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cCCC---------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0000         00000112345678999999999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.8e-37  Score=328.55  Aligned_cols=228  Identities=17%  Similarity=0.223  Sum_probs=175.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHH---HHHhcCCCceeecc-------ceeccCC----------
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVN---LLKKINHFNLINLF-------GACEHDG----------  386 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~---~l~~l~H~niv~l~-------g~~~~~~----------  386 (611)
                      |.||+|..  +|+.||||+++          +.+.+|+.   ++++++||||++++       +++.+.+          
T Consensus        87 g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (377)
T 3byv_A           87 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD  166 (377)
T ss_dssp             EEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC---
T ss_pred             EEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccC
Confidence            89999996  68999999985          45789994   55555899999999       4444332          


Q ss_pred             -------eEEEEEeecCCCCHHHHhhccCC----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC
Q 007261          387 -------VFYLVYEFMENGSLSDWLHKKRY----PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN  455 (611)
Q Consensus       387 -------~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~  455 (611)
                             ..+|||||+ +|+|.+++.....    ...+++..++.|+.||+.||+|||   +.+|+||||||+|||++.+
T Consensus       167 ~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~  242 (377)
T 3byv_A          167 ERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQR  242 (377)
T ss_dssp             ---CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTT
T ss_pred             CCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCC
Confidence                   278999999 6899999986421    123557888999999999999999   5899999999999999999


Q ss_pred             CcEEEeeecCccccccccCCcccccccccCCCccchhhhccC-----------CCCCccchHHHHHHHHHHHhCCCCCcC
Q 007261          456 LRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYG-----------LVTPEMDTYAFGVVLLELITGKEAAYK  524 (611)
Q Consensus       456 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDV~s~Gvvl~elltG~~p~~~  524 (611)
                      +.+||+|||+++....      ......| +.|+|||.+.+.           .++.++||||||+++|||++|+.||..
T Consensus       243 ~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~  315 (377)
T 3byv_A          243 GGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK  315 (377)
T ss_dssp             CCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CCEEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcc
Confidence            9999999999985322      2234566 999999999887           899999999999999999999999864


Q ss_pred             CCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhchhhh
Q 007261          525 QDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVS--TLMKIQLDV  600 (611)
Q Consensus       525 ~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~i~~~~  600 (611)
                      ....+                  ....+.. .    ...++..+.+|+.+||+.||++||++.|+++  .+..+....
T Consensus       316 ~~~~~------------------~~~~~~~-~----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~  370 (377)
T 3byv_A          316 DAALG------------------GSEWIFR-S----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL  370 (377)
T ss_dssp             ----C------------------CSGGGGS-S----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred             ccccc------------------chhhhhh-h----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence            43211                  0111111 0    1123467889999999999999999999997  445544443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-36  Score=316.80  Aligned_cols=253  Identities=24%  Similarity=0.342  Sum_probs=190.0

Q ss_pred             hcCCCCCccc----ceEEEEEE--cCcEEEEEEec------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEE
Q 007261          329 ENFSPKNMID----GSVFRGII--NGSTVAIKCMR------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYL  390 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  390 (611)
                      ++|.....+|    |.||++..  +|+.||||+++            +.+.+|+.++++++||||+++++++.+.+..++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            3444444444    89999998  58899999985            246789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccc
Q 007261          391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV  470 (611)
Q Consensus       391 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~  470 (611)
                      ||||+++ +|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        90 v~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             EEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             EEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            9999975 8999987653  34888899999999999999999   6889999999999999999999999999987653


Q ss_pred             cccCCcccccccccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc--
Q 007261          471 REESGYSSTKTAVGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA--  547 (611)
Q Consensus       471 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~--  547 (611)
                      ...   .......+|+.|+|||.+.+. .++.++||||||+++|||++|..|+......+ .+ ..+...........  
T Consensus       164 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~-~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          164 SPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QL-TRIFETLGTPTEEQWP  238 (346)
T ss_dssp             SCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH-HHHHHHHCCCCTTTSS
T ss_pred             CCc---ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HH-HHHHHHcCCCChhhhh
Confidence            322   223446789999999998654 58999999999999999999998876554322 11 12222211111000  


Q ss_pred             ccccccC----ccCCcC-----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          548 KLSVLVD----PNLQAN-----KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       548 ~l~~~~d----~~l~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ......+    ......     ....+..+.+|+.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000000    000000     12345779999999999999999999999975

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.7e-36  Score=307.93  Aligned_cols=226  Identities=20%  Similarity=0.342  Sum_probs=188.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||+|++.          ..+.+|+.++++++||||+++++++.+++..++||||+++++|.+++..
T Consensus        29 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  108 (294)
T 2rku_A           29 AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR  108 (294)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred             EEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh
Confidence            89999998  57899999974          3477899999999999999999999999999999999999999999876


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......   .......+++
T Consensus       109 ~~---~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~  179 (294)
T 2rku_A          109 RK---ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---ERKKVLCGTP  179 (294)
T ss_dssp             HC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT---CCBCCCCSCC
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc---cccccccCCC
Confidence            53   3899999999999999999999   5899999999999999999999999999987653221   1233457899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||......+.     ........           .   ..+...+.
T Consensus       180 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~-----------~---~~~~~~~~  240 (294)
T 2rku_A          180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-----YLRIKKNE-----------Y---SIPKHINP  240 (294)
T ss_dssp             SSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHTTC-----------C---CCCTTSCH
T ss_pred             CcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHhhcc-----------C---CCccccCH
Confidence            99999999999999999999999999999999999876543221     11111100           0   01123345


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+.+++.+||+.||++||++.|++++
T Consensus       241 ~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          241 VAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhhC
Confidence            68899999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.8e-36  Score=311.94  Aligned_cols=241  Identities=17%  Similarity=0.286  Sum_probs=187.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec----HHHHHHHHHHHhcC-CCceeeccceecc--CCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR----RSISKEVNLLKKIN-HFNLINLFGACEH--DGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  +|+.||||+++    +.+.+|+.++++++ ||||+++++++.+  ....++||||+++++|.+++..   
T Consensus        50 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---  126 (330)
T 3nsz_A           50 SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---  126 (330)
T ss_dssp             EEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG---
T ss_pred             eEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh---
Confidence            89999987  78899999986    57889999999996 9999999999987  6778999999999999999853   


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeecCccccccccCCcccccccccCCCc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL-RAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         +++..+..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+++......    ......++..|
T Consensus       127 ---~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~~~y  196 (330)
T 3nsz_A          127 ---LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASRYF  196 (330)
T ss_dssp             ---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC----CCCSCCSCGGG
T ss_pred             ---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC----ccccccccccc
Confidence               788999999999999999999   68999999999999999776 89999999997653322    23345789999


Q ss_pred             cchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHH--------HHHhcCCc--cccccc------
Q 007261          489 MAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVF--------SMVEGGNA--EAKLSV------  551 (611)
Q Consensus       489 ~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~--------~~~~~~~~--~~~l~~------  551 (611)
                      +|||.+.+ ..++.++||||||+++|||++|+.||.........+.....        ........  ...+..      
T Consensus       197 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (330)
T 3nsz_A          197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHS  276 (330)
T ss_dssp             CCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCC
T ss_pred             cChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhcc
Confidence            99999877 67999999999999999999999999765544222211111        11110000  000000      


Q ss_pred             --ccCccCCc-ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          552 --LVDPNLQA-NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       552 --~~d~~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        ..+..... .....+.++.+|+.+||+.||++|||+.|++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          277 RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              00000011 123356789999999999999999999999874

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.6e-37  Score=308.05  Aligned_cols=225  Identities=26%  Similarity=0.422  Sum_probs=178.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|..  +|+.||||.++.          .+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++..
T Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  104 (276)
T 2h6d_A           25 GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK  104 (276)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred             eEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc
Confidence            89999998  689999999852          467899999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..++.++.|++.||.|||   +.+++|+||||+|||++.++.+||+|||++.......    ......+++
T Consensus       105 ~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~  174 (276)
T 2h6d_A          105 HG---RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSP  174 (276)
T ss_dssp             HC---SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---------------
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc----ceecccCCc
Confidence            53   3899999999999999999999   5899999999999999999999999999987653321    223456899


Q ss_pred             CccchhhhccCCC-CCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          487 GYMAPEYMEYGLV-TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       487 ~y~aPE~~~~~~~-s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      .|+|||.+.+..+ +.++||||||+++|||++|+.||......+.     . .....+.             ...+...+
T Consensus       175 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~-~~~~~~~-------------~~~~~~~~  235 (276)
T 2h6d_A          175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL-----F-KKIRGGV-------------FYIPEYLN  235 (276)
T ss_dssp             --CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----H-HHHHHCC-------------CCCCTTSC
T ss_pred             cccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-----H-HHhhcCc-------------ccCchhcC
Confidence            9999999987765 6899999999999999999999865433211     1 1111110             00112234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+.+++.+||+.||++|||+.|++++
T Consensus       236 ~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          236 RSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            568899999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.2e-36  Score=315.02  Aligned_cols=226  Identities=20%  Similarity=0.342  Sum_probs=188.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +++.||+|++.          +.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++..
T Consensus        55 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  134 (335)
T 2owb_A           55 AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR  134 (335)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc
Confidence            89999998  57899999974          3477899999999999999999999999999999999999999999876


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......|+.
T Consensus       135 ~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~  205 (335)
T 2owb_A          135 RK---ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---ERKKVLCGTP  205 (335)
T ss_dssp             HC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT---CCBCCCCSCC
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc---ccccccCCCc
Confidence            53   3899999999999999999999   5899999999999999999999999999987653222   1233457899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||......+.     ........           ..   .+...+.
T Consensus       206 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~-----------~~---~~~~~~~  266 (335)
T 2owb_A          206 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-----YLRIKKNE-----------YS---IPKHINP  266 (335)
T ss_dssp             SSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHHTC-----------CC---CCTTSCH
T ss_pred             cccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-----HHHHhcCC-----------CC---CCccCCH
Confidence            99999999999999999999999999999999999876543221     11111100           00   0122345


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+.+|+.+||+.||++||++.|++++
T Consensus       267 ~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          267 VAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcC
Confidence            68899999999999999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-37  Score=322.71  Aligned_cols=232  Identities=23%  Similarity=0.325  Sum_probs=185.8

Q ss_pred             ceEEEEEE-----cCcEEEEEEec-----------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII-----NGSTVAIKCMR-----------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~-----~g~~vavK~~~-----------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  401 (611)
                      |.||++..     +|+.||||+++           ..+.+|+.+++++ +||||+++++++..++..++||||+++|+|.
T Consensus        68 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  147 (355)
T 1vzo_A           68 GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF  147 (355)
T ss_dssp             EEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred             EEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHH
Confidence            89999987     68899999985           3467799999999 7999999999999999999999999999999


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +++....   .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.......  .....
T Consensus       148 ~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~  219 (355)
T 1vzo_A          148 THLSQRE---RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET--ERAYD  219 (355)
T ss_dssp             HHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG--GGGCG
T ss_pred             HHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC--CcccC
Confidence            9998753   3899999999999999999999   58999999999999999999999999999976533221  22334


Q ss_pred             cccCCCccchhhhcc--CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc
Q 007261          482 AVGTNGYMAPEYMEY--GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA  559 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~--~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~  559 (611)
                      ..||+.|+|||.+.+  ..++.++||||||+++|||++|+.||........ ............           +   .
T Consensus       220 ~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~-----------~---~  284 (355)
T 1vzo_A          220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSE-----------P---P  284 (355)
T ss_dssp             GGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCC-----------C---C
T ss_pred             cccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhccC-----------C---C
Confidence            579999999999985  3478999999999999999999999875433211 111111111100           0   1


Q ss_pred             ChHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 007261          560 NKKEIAHHLIMLCLACIAREPESRP-----SMAEVVSTL  593 (611)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L  593 (611)
                      .+...+..+.+|+.+||+.||++||     ++.|++++.
T Consensus       285 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          285 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            1223456788999999999999999     999998764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.6e-36  Score=325.62  Aligned_cols=252  Identities=15%  Similarity=0.189  Sum_probs=196.5

Q ss_pred             cCCCCCccc----ceEEEEEE--cCcEEEEEEec-----HHHHHHHHHHHhcCC-CceeeccceeccCCeEEEEEeecCC
Q 007261          330 NFSPKNMID----GSVFRGII--NGSTVAIKCMR-----RSISKEVNLLKKINH-FNLINLFGACEHDGVFYLVYEFMEN  397 (611)
Q Consensus       330 ~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~  397 (611)
                      +|.....||    |.||+|..  +|+.||||+++     .++.+|+++++.++| +++..+..++...+..+|||||+ +
T Consensus         8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g   86 (483)
T 3sv0_A            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G   86 (483)
T ss_dssp             TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence            444555554    89999997  68999999875     468899999999976 55555666667788899999999 9


Q ss_pred             CCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEeeecCccccccccC
Q 007261          398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSAVREES  474 (611)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~~~~~~  474 (611)
                      ++|.+++....  ..+++..++.|+.||+.||+|||   ..+|+||||||+||||   +.++.+||+|||+++.......
T Consensus        87 ~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           87 PSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             CCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence            99999998643  34999999999999999999999   6899999999999999   6889999999999986644322


Q ss_pred             C----cccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChh-hHHHHHHHHHHhcCCccccc
Q 007261          475 G----YSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE-ILLAEAVFSMVEGGNAEAKL  549 (611)
Q Consensus       475 ~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~l  549 (611)
                      .    ........||..|+|||.+.+..++.++||||||++||||++|+.||....... ......+.....        
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------  233 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------  233 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH--------
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc--------
Confidence            1    122335679999999999999999999999999999999999999998654422 111111111100        


Q ss_pred             ccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          550 SVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       550 ~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      ...    +......++.++.+|+.+||+.||++||++.+|++.|+++...
T Consensus       234 ~~~----~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          234 ATS----IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             HSC----HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccc----HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            000    0000123356789999999999999999999999999988653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.7e-36  Score=333.72  Aligned_cols=227  Identities=21%  Similarity=0.285  Sum_probs=185.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||++++          .+.+|+.+|++++||||+++++++.+.+..|+||||+++|+|.+++..
T Consensus       199 G~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~  278 (543)
T 3c4z_A          199 GEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYN  278 (543)
T ss_dssp             SEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT
T ss_pred             eEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHH
Confidence            89999998  689999999953          366799999999999999999999999999999999999999999976


Q ss_pred             cCC-CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          407 KRY-PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       407 ~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ... ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||
T Consensus       279 ~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~---~~~~~~~GT  352 (543)
T 3c4z_A          279 VDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGT  352 (543)
T ss_dssp             SSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC---CCBCCCCSC
T ss_pred             hhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC---cccccccCC
Confidence            432 345899999999999999999999   6899999999999999999999999999998654322   123345899


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+.+..++.++|||||||++|||++|+.||....... .............              ...+...+
T Consensus       353 ~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~~~~--------------~~~p~~~s  417 (543)
T 3c4z_A          353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVLEQA--------------VTYPDKFS  417 (543)
T ss_dssp             TTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHHHCC--------------CCCCTTSC
T ss_pred             ccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHhhcc--------------cCCCcccC
Confidence            99999999999999999999999999999999999997653211 0111111111110              01122345


Q ss_pred             HHHHHHHHHhhccCCCCCCCH
Q 007261          566 HHLIMLCLACIAREPESRPSM  586 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~  586 (611)
                      ..+.+|+.+||+.||++||++
T Consensus       418 ~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          418 PASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCC
T ss_pred             HHHHHHHHHhccCCHhHCCCC
Confidence            678899999999999999976

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-36  Score=316.18  Aligned_cols=237  Identities=24%  Similarity=0.378  Sum_probs=185.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccC------CeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD------GVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~E~~~~gsL~  401 (611)
                      |.||+|..  +|+.||||++.         +.+.+|+.+|++++||||+++++++...      ...|+||||+ +++|.
T Consensus        39 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~  117 (367)
T 1cm8_A           39 GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLG  117 (367)
T ss_dssp             -CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHH
T ss_pred             eEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHH
Confidence            89999998  68999999983         3577899999999999999999998765      3469999999 88999


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +++....    +++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....      ...
T Consensus       118 ~~~~~~~----l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~------~~~  184 (367)
T 1cm8_A          118 KLMKHEK----LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTG  184 (367)
T ss_dssp             HHHHHCC----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS------CCS
T ss_pred             HHHhcCC----CCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccccccc------cCc
Confidence            9998743    889999999999999999999   689999999999999999999999999999865321      234


Q ss_pred             cccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc------------
Q 007261          482 AVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK------------  548 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~------------  548 (611)
                      ..+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||......+.  ...+........ .+.            
T Consensus       185 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~~~-~~~~~~~~~~~~~~~  261 (367)
T 1cm8_A          185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPP-AEFVQRLQSDEAKNY  261 (367)
T ss_dssp             SCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCC-HHHHHTCSCHHHHHH
T ss_pred             CcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCC-HHHHHHhhhHHHHHH
Confidence            578999999999877 6799999999999999999999999976543321  111111111100 000            


Q ss_pred             ---cccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          549 ---LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       549 ---l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                         +.......+.......+..+.+|+.+||+.||++|||+.|++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          262 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence               00001111111123345678999999999999999999999984

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.5e-36  Score=329.49  Aligned_cols=228  Identities=27%  Similarity=0.424  Sum_probs=185.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.||||++.         ..+.+|+.+|++++||||+++++++.+.+..++||||+++|+|.+++...
T Consensus        36 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  115 (486)
T 3mwu_A           36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR  115 (486)
T ss_dssp             SEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc
Confidence            89999998  68899999985         35788999999999999999999999999999999999999999998765


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEeeecCccccccccCCccccccccc
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD---KNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      .   .+++..+..++.||+.||.|||   +.+|+||||||+|||++   .++.+||+|||+++.....    .......|
T Consensus       116 ~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~g  185 (486)
T 3mwu_A          116 K---RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN----TKMKDRIG  185 (486)
T ss_dssp             S---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--------CCTT
T ss_pred             C---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC----CccCCCcC
Confidence            3   3899999999999999999999   68999999999999995   4568999999998765322    12344579


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      |+.|+|||.+.+ .++.++||||||+++|||++|+.||......+.     ...... +...      .+   .......
T Consensus       186 t~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~i~~-~~~~------~~---~~~~~~~  249 (486)
T 3mwu_A          186 TAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-----LKRVET-GKYA------FD---LPQWRTI  249 (486)
T ss_dssp             GGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHH-TCCC------SC---SGGGGGS
T ss_pred             CCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHh-CCCC------CC---CcccCCC
Confidence            999999999875 589999999999999999999999976544321     111111 1000      00   0112334


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +..+.+|+.+||+.||.+|||+.|++++
T Consensus       250 s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          250 SDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            5678999999999999999999999985

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.7e-36  Score=329.91  Aligned_cols=228  Identities=25%  Similarity=0.354  Sum_probs=185.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  ++..||||+++         ..+.+|+.++++++||||++++++|.+.+..++||||+++|+|.+++...
T Consensus        51 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~  130 (494)
T 3lij_A           51 GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR  130 (494)
T ss_dssp             -EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc
Confidence            89999998  68899999985         35788999999999999999999999999999999999999999998765


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEeeecCccccccccCCccccccccc
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN---LRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      .   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.+   +.+||+|||+++......    ......|
T Consensus       131 ~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~~~g  200 (494)
T 3lij_A          131 M---KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK----KMKERLG  200 (494)
T ss_dssp             S---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB----CBCCCCS
T ss_pred             C---CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc----cccccCC
Confidence            3   3899999999999999999999   5899999999999999764   559999999997654321    2344679


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      |+.|+|||.+. +.++.++||||||+++|||++|+.||......+.     .........      ....+.    ....
T Consensus       201 t~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~i~~~~~------~~~~~~----~~~~  264 (494)
T 3lij_A          201 TAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-----LRKVEKGKY------TFDSPE----WKNV  264 (494)
T ss_dssp             CTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHTCC------CCCSGG----GTTS
T ss_pred             CcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCCC------CCCchh----cccC
Confidence            99999999986 5699999999999999999999999976554321     111111110      000111    1234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +..+.+|+.+||+.||.+|||+.|++++
T Consensus       265 s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          265 SEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            5678899999999999999999999875

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3e-36  Score=317.02  Aligned_cols=260  Identities=23%  Similarity=0.311  Sum_probs=191.3

Q ss_pred             hhHHHHHhhcCCCCCccc----ceEEEEEE-cCcEEEEEEec------------------HHHHHHHHHHHhcCCCceee
Q 007261          321 YEDLVVATENFSPKNMID----GSVFRGII-NGSTVAIKCMR------------------RSISKEVNLLKKINHFNLIN  377 (611)
Q Consensus       321 ~~el~~at~~f~~~~~ig----g~Vy~g~~-~g~~vavK~~~------------------~~~~~E~~~l~~l~H~niv~  377 (611)
                      +.++....++|.....||    |.||+|.. +|..||||++.                  +.+.+|+.++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            456677777887777776    89999987 78899999873                  46889999999999999999


Q ss_pred             ccceec-----cCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 007261          378 LFGACE-----HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL  452 (611)
Q Consensus       378 l~g~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl  452 (611)
                      +++++.     .....++||||++ |+|.+++....  ..+++..+..++.||+.||.|||   ..+|+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence            999983     3457899999997 78999887643  35899999999999999999999   5899999999999999


Q ss_pred             CCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhH
Q 007261          453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL  531 (611)
Q Consensus       453 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~  531 (611)
                      +.++.+||+|||+++.....    .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. 
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-  242 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTAD----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ-  242 (362)
T ss_dssp             CTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred             cCCCCEEEEecCcccccccc----cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-
Confidence            99999999999998754322    12334578999999999876 6799999999999999999999999976543321 


Q ss_pred             HHHHHHHHHhcCCcc-----------cccccccCccCC----cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          532 LAEAVFSMVEGGNAE-----------AKLSVLVDPNLQ----ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       532 l~~~~~~~~~~~~~~-----------~~l~~~~d~~l~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                       ...+..........           ..+.........    ......+..+.+|+.+||+.||++|||+.|++++
T Consensus       243 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          243 -LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             -HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence             11111111111100           000000000000    0112335678999999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.2e-36  Score=318.18  Aligned_cols=241  Identities=21%  Similarity=0.335  Sum_probs=189.3

Q ss_pred             ceEEEEEEcCcEEEEEEec------------------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEee
Q 007261          339 GSVFRGIINGSTVAIKCMR------------------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEF  394 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~------------------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  394 (611)
                      |.||++..+|+.||||++.                        ..+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        45 g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  124 (348)
T 2pml_X           45 NKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEY  124 (348)
T ss_dssp             CCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEEC
T ss_pred             eEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEec
Confidence            8999999999999999984                        5678999999999999999999999999999999999


Q ss_pred             cCCCCHHHH------hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          395 MENGSLSDW------LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       395 ~~~gsL~~~------l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      +++|+|.++      +... ....+++..++.++.|++.||.|||+  ..+++||||||+|||++.++.+||+|||++..
T Consensus       125 ~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  201 (348)
T 2pml_X          125 MENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEY  201 (348)
T ss_dssp             CTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             cCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcCCCcEEEeccccccc
Confidence            999999998      5442 13469999999999999999999993  28999999999999999999999999999876


Q ss_pred             cccccCCcccccccccCCCccchhhhccC-CCCC-ccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc
Q 007261          469 AVREESGYSSTKTAVGTNGYMAPEYMEYG-LVTP-EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       469 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  546 (611)
                      ....     ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||.........     ......+...
T Consensus       202 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~i~~~~~~  271 (348)
T 2pml_X          202 MVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL-----FNNIRTKNIE  271 (348)
T ss_dssp             CBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH-----HHHHTSCCCC
T ss_pred             cccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-----HHHHhccCcC
Confidence            5322     23446789999999999877 6666 999999999999999999999765542211     1111111110


Q ss_pred             cc--cccccCc----cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          547 AK--LSVLVDP----NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       547 ~~--l~~~~d~----~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..  ......+    .........+..+.+|+.+||+.||.+||++.|++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          272 YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             CCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00  0000000    0000113456788999999999999999999999984

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4e-36  Score=307.02  Aligned_cols=229  Identities=26%  Similarity=0.408  Sum_probs=186.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------------HHHHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------------RSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGS  399 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------------~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs  399 (611)
                      |.||++..  +|+.||||+++                +.+.+|+.+++++. ||||+++++++..++..++||||+++++
T Consensus        31 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  110 (298)
T 1phk_A           31 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE  110 (298)
T ss_dssp             EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred             eEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCc
Confidence            89999998  68899999973                34678999999995 9999999999999999999999999999


Q ss_pred             HHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccc
Q 007261          400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       400 L~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      |.+++....   .+++..++.++.||+.||.|||   +.+++|+||||+||+++.++.+||+|||++.......    ..
T Consensus       111 L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~----~~  180 (298)
T 1phk_A          111 LFDYLTEKV---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KL  180 (298)
T ss_dssp             HHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC----CB
T ss_pred             HHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCc----cc
Confidence            999998753   4899999999999999999999   6899999999999999999999999999987653321    23


Q ss_pred             cccccCCCccchhhhc------cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccccc
Q 007261          480 KTAVGTNGYMAPEYME------YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV  553 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~------~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  553 (611)
                      ....+++.|+|||.+.      ...++.++||||||+++|||++|+.|+......+.     ......... .     ..
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~-~-----~~  249 (298)
T 1phk_A          181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-----LRMIMSGNY-Q-----FG  249 (298)
T ss_dssp             CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHTCC-C-----CC
T ss_pred             ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH-----HHHHhcCCc-c-----cC
Confidence            3457899999999885      45688999999999999999999999876543221     111111100 0     00


Q ss_pred             CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       554 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                          .......+..+.+++.+||+.||++||++.|++++
T Consensus       250 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          250 ----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             ----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ----cccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence                01123456678999999999999999999999863

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.7e-37  Score=312.33  Aligned_cols=242  Identities=25%  Similarity=0.391  Sum_probs=176.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc-
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK-  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~-  407 (611)
                      |.||++..  +|+.||||.+.        +++.+|+.++++++||||+++++++...+..++||||+++++|.+++... 
T Consensus        29 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  108 (303)
T 2vwi_A           29 AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIV  108 (303)
T ss_dssp             CCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHH
T ss_pred             eEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHh
Confidence            89999986  78899999885        34678999999999999999999999999999999999999999999741 


Q ss_pred             ----CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC--Ccccccc
Q 007261          408 ----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES--GYSSTKT  481 (611)
Q Consensus       408 ----~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~--~~~~~~~  481 (611)
                          .....+++..++.++.||+.||.|||   ..+++||||||+|||++.++.+||+|||++........  .......
T Consensus       109 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  185 (303)
T 2vwi_A          109 AKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT  185 (303)
T ss_dssp             HTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-------------
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcc
Confidence                12345899999999999999999999   58999999999999999999999999999875533211  1112234


Q ss_pred             cccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC
Q 007261          482 AVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN  560 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~  560 (611)
                      ..+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..........     ....... ........++..   
T Consensus       186 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~~~-~~~~~~~~~~~~---  256 (303)
T 2vwi_A          186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-----LTLQNDP-PSLETGVQDKEM---  256 (303)
T ss_dssp             --CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-----HHHTSSC-CCTTC-----CC---
T ss_pred             cCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH-----HHhccCC-Cccccccccchh---
Confidence            578999999999876 568999999999999999999999987655433211     1111110 000000111111   


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          561 KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       561 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ....+..+.+++.+||+.||.+||++.|++++
T Consensus       257 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          257 LKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            12234578899999999999999999999874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.3e-37  Score=315.62  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=188.7

Q ss_pred             hcCCCCCccc----ceEEEEEEcCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeec
Q 007261          329 ENFSPKNMID----GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFM  395 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  395 (611)
                      ++|.....||    |.||+|...+. +|+|+++         +.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        33 ~~~~~~~~lg~G~~g~V~~~~~~~~-~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~  111 (319)
T 2y4i_B           33 EQLEIGELIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC  111 (319)
T ss_dssp             SCEECCCBCCCSSSSEEEEEEESSS-EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred             HHeEEeeEeccCCceEEEEEEEcCe-EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence            3344444454    89999998664 9999985         34778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC-
Q 007261          396 ENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES-  474 (611)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-  474 (611)
                      ++++|.+++....  ..+++..++.++.||+.||+|||   +.+++||||||+|||++ ++.+||+|||+++....... 
T Consensus       112 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          112 KGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             CSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred             cCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence            9999999998753  34899999999999999999999   58999999999999998 67999999999875432211 


Q ss_pred             -CcccccccccCCCccchhhhcc---------CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCC
Q 007261          475 -GYSSTKTAVGTNGYMAPEYMEY---------GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN  544 (611)
Q Consensus       475 -~~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  544 (611)
                       .........|+..|+|||.+.+         ..++.++||||||+++|||++|+.||.........     ....... 
T Consensus       186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~~-  259 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-----WQMGTGM-  259 (319)
T ss_dssp             --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH-----HHHHTTC-
T ss_pred             ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHhccCC-
Confidence             1122334568999999999864         45788999999999999999999998765433211     1111110 


Q ss_pred             cccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          545 AEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       545 ~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                               .+...  ....+.++.+++.+||+.||++||++.++++.|+++.....
T Consensus       260 ---------~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          260 ---------KPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             ---------CCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             ---------CCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence                     01110  11233458899999999999999999999999999877543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6e-37  Score=317.69  Aligned_cols=242  Identities=21%  Similarity=0.341  Sum_probs=183.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH--------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMRR--------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  +|+.||||+++.        .+.+|+.++++++||||+++++++.+++..++||||++ |+|.+++....
T Consensus        16 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   94 (324)
T 3mtl_A           16 ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG   94 (324)
T ss_dssp             EEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTT
T ss_pred             EEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcC
Confidence            89999998  688999999862        24469999999999999999999999999999999997 69999998754


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                        ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......   .......+|+.|
T Consensus        95 --~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y  166 (324)
T 3mtl_A           95 --NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT---KTYDNEVVTLWY  166 (324)
T ss_dssp             --TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------------CGGG
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc---cccccccCcccc
Confidence              35899999999999999999999   6899999999999999999999999999987543221   122345689999


Q ss_pred             cchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccccc---------CccCC
Q 007261          489 MAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV---------DPNLQ  558 (611)
Q Consensus       489 ~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~---------d~~l~  558 (611)
                      +|||.+.+ ..++.++||||||+++|||++|+.||......+.  ...+.......... ......         .+...
T Consensus       167 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  243 (324)
T 3mtl_A          167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ--LHFIFRILGTPTEE-TWPGILSNEEFKTYNYPKYR  243 (324)
T ss_dssp             CCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTT-TSTTGGGCHHHHHTCCCCCC
T ss_pred             cChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChH-hchhhhcchhhccccccccc
Confidence            99999876 5689999999999999999999999976554321  22222222211110 000000         00000


Q ss_pred             cC-----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 AN-----KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 ~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..     ....+..+.+|+.+||+.||++|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          244 AEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             CCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             chhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00     12345678999999999999999999999874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.7e-36  Score=340.09  Aligned_cols=229  Identities=24%  Similarity=0.393  Sum_probs=188.8

Q ss_pred             cCCCCCccc----ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEE
Q 007261          330 NFSPKNMID----GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVY  392 (611)
Q Consensus       330 ~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  392 (611)
                      +|.....||    |.||++..  +|+.||||++++          .+..|..++..+ +||||+++++++.+.+..||||
T Consensus       342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~  421 (674)
T 3pfq_A          342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  421 (674)
T ss_dssp             TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred             ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence            344444454    89999998  678999999974          356789999888 7999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       393 E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      ||+++|+|.+++...+   .+++..++.++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++.....
T Consensus       422 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          422 EYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             eCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            9999999999998753   3899999999999999999999   689999999999999999999999999999854322


Q ss_pred             cCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccc
Q 007261          473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVL  552 (611)
Q Consensus       473 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  552 (611)
                      .   .......||+.|+|||++.+..++.++||||||++||||++|+.||......+.     ........         
T Consensus       496 ~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~-----~~~i~~~~---------  558 (674)
T 3pfq_A          496 G---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----FQSIMEHN---------  558 (674)
T ss_dssp             T---CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHSSC---------
T ss_pred             C---cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH-----HHHHHhCC---------
Confidence            2   234556899999999999999999999999999999999999999976543321     11111110         


Q ss_pred             cCccCCcChHHHHHHHHHHHHHhhccCCCCCCCH
Q 007261          553 VDPNLQANKKEIAHHLIMLCLACIAREPESRPSM  586 (611)
Q Consensus       553 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  586 (611)
                           ...+...+.++.+|+.+||+.||++||++
T Consensus       559 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          559 -----VAYPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             -----CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence                 01122355678999999999999999997

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.8e-36  Score=307.81  Aligned_cols=230  Identities=19%  Similarity=0.358  Sum_probs=184.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|..  +|..||+|.+.       ..+.+|+.++++++||||+++++++..++..++||||+++++|.+++.... 
T Consensus        33 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-  111 (302)
T 2j7t_A           33 GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-  111 (302)
T ss_dssp             CCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHT-
T ss_pred             eEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhc-
Confidence            89999998  48899999985       457889999999999999999999999999999999999999999987643 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                       ..+++..++.++.|++.||.|||   ..+++||||||+|||++.++.+||+|||++.......   .......++..|+
T Consensus       112 -~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~  184 (302)
T 2j7t_A          112 -RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL---QKRDSFIGTPYWM  184 (302)
T ss_dssp             -SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH---HC-----CCGGGC
T ss_pred             -cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc---cccccccCChhhc
Confidence             34899999999999999999999   5899999999999999999999999999875432211   1223356899999


Q ss_pred             chhhh-----ccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          490 APEYM-----EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       490 aPE~~-----~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      |||.+     ....++.++||||||+++|||++|+.|+......+.     .........           .....+...
T Consensus       185 aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~-----------~~~~~~~~~  248 (302)
T 2j7t_A          185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAKSDP-----------PTLLTPSKW  248 (302)
T ss_dssp             CHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCC-----------CCCSSGGGS
T ss_pred             CCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-----HHHHhccCC-----------cccCCcccc
Confidence            99998     467789999999999999999999999876543221     111111110           001112344


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +..+.+++.+||+.||++|||+.+++++
T Consensus       249 ~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          249 SVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            5678999999999999999999999874

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-37  Score=316.52  Aligned_cols=243  Identities=25%  Similarity=0.434  Sum_probs=186.1

Q ss_pred             HHhhcCCCCCccc----ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhc-CCCceeeccceecc------CC
Q 007261          326 VATENFSPKNMID----GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKI-NHFNLINLFGACEH------DG  386 (611)
Q Consensus       326 ~at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l-~H~niv~l~g~~~~------~~  386 (611)
                      ...+.|.....||    |.||+|..  +|+.||||++.      ..+.+|+.+++++ +||||+++++++..      .+
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            3344554445554    89999998  78999999985      5688999999999 89999999999876      56


Q ss_pred             eEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCc
Q 007261          387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFV  466 (611)
Q Consensus       387 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla  466 (611)
                      ..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||   ..+++|+||||+|||++.++.+||+|||++
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             eEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence            8899999999999999998653 235889999999999999999999   589999999999999999999999999998


Q ss_pred             cccccccCCcccccccccCCCccchhhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHh
Q 007261          467 RSAVREESGYSSTKTAVGTNGYMAPEYME-----YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVE  541 (611)
Q Consensus       467 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  541 (611)
                      .......   .......+++.|+|||.+.     ...++.++||||||+++|||++|+.||........     ......
T Consensus       177 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~  248 (326)
T 2x7f_A          177 AQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLIPR  248 (326)
T ss_dssp             C----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHH
T ss_pred             eecCcCc---cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-----HHHhhc
Confidence            7653221   1223456899999999986     56789999999999999999999999865543221     111111


Q ss_pred             cCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          542 GGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       542 ~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ...          +..  .....+..+.+++.+||+.||.+||++.+++++
T Consensus       249 ~~~----------~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          249 NPA----------PRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             SCC----------CCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             Ccc----------ccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            110          000  012234578899999999999999999999984

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-36  Score=320.35  Aligned_cols=254  Identities=22%  Similarity=0.307  Sum_probs=188.1

Q ss_pred             hcCCCCCccc----ceEEEEEE--cCcEEEEEEecH---HHHHHHHHHHhcCCCceeeccceecc---------------
Q 007261          329 ENFSPKNMID----GSVFRGII--NGSTVAIKCMRR---SISKEVNLLKKINHFNLINLFGACEH---------------  384 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~---------------  384 (611)
                      ++|.....||    |.||++..  +|+.||||++..   ...+|+.+|+.++||||+++++++..               
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~   86 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH   86 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence            3444444444    89999988  789999999863   35689999999999999999999843               


Q ss_pred             -----------------------CCeEEEEEeecCCCCHHHHhhcc-CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 007261          385 -----------------------DGVFYLVYEFMENGSLSDWLHKK-RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGY  440 (611)
Q Consensus       385 -----------------------~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~i  440 (611)
                                             ....++||||++ |+|.+.+... .....+++..+..++.||+.||+|||   +.+|
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~gi  162 (383)
T 3eb0_A           87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGI  162 (383)
T ss_dssp             -----------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTE
T ss_pred             ccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCcC
Confidence                                   334899999998 6888877642 12245899999999999999999999   6899


Q ss_pred             EecCCCCCCeeeC-CCCcEEEeeecCccccccccCCcccccccccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhC
Q 007261          441 VHKDISSGNILLD-KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITG  518 (611)
Q Consensus       441 vH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG  518 (611)
                      +||||||+|||++ .++.+||+|||+++......    ......+|+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus       163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  238 (383)
T 3eb0_A          163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE----PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG  238 (383)
T ss_dssp             ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS----CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC----CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence            9999999999997 68999999999998653322    22345689999999998765 489999999999999999999


Q ss_pred             CCCCcCCCChhhHHHHHHHHHHhcCCccc------ccccccCccCCc------ChHHHHHHHHHHHHHhhccCCCCCCCH
Q 007261          519 KEAAYKQDGEEILLAEAVFSMVEGGNAEA------KLSVLVDPNLQA------NKKEIAHHLIMLCLACIAREPESRPSM  586 (611)
Q Consensus       519 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~------~l~~~~d~~l~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~  586 (611)
                      +.||......+. + ..+.........+.      ......-+....      .+...+..+.+|+.+||+.||++|||+
T Consensus       239 ~~pf~~~~~~~~-~-~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  316 (383)
T 3eb0_A          239 KPLFSGETSIDQ-L-VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP  316 (383)
T ss_dssp             SCSSCCSSHHHH-H-HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             CCCCCCCChHHH-H-HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            999976544332 1 11111111111000      000000011110      122345678999999999999999999


Q ss_pred             HHHHHH
Q 007261          587 AEVVST  592 (611)
Q Consensus       587 ~evl~~  592 (611)
                      .|++++
T Consensus       317 ~e~l~h  322 (383)
T 3eb0_A          317 YEAMAH  322 (383)
T ss_dssp             HHHHTS
T ss_pred             HHHhcC
Confidence            999863

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.2e-36  Score=330.96  Aligned_cols=228  Identities=26%  Similarity=0.387  Sum_probs=187.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||++.          ..+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++..
T Consensus        40 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  119 (484)
T 3nyv_A           40 GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS  119 (484)
T ss_dssp             EEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT
T ss_pred             EEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh
Confidence            89999998  68999999984          3588999999999999999999999999999999999999999999976


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee---CCCCcEEEeeecCccccccccCCcccccccc
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL---DKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      ..   .+++..++.++.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++......    ......
T Consensus       120 ~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~  189 (484)
T 3nyv_A          120 RK---RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK----KMKDKI  189 (484)
T ss_dssp             CS---CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC----SHHHHT
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc----ccccCC
Confidence            53   4899999999999999999999   5899999999999999   567899999999987653221    233457


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      ||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+.     ........ ..     .   . ......
T Consensus       190 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~i~~~~-~~-----~---~-~~~~~~  253 (484)
T 3nyv_A          190 GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI-----LKKVEKGK-YT-----F---E-LPQWKK  253 (484)
T ss_dssp             TGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHCC-CC-----C---C-SGGGGG
T ss_pred             CCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHcCC-CC-----C---C-Cccccc
Confidence            9999999999876 699999999999999999999999976543321     11111111 00     0   0 011234


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+..+.+|+.+||+.||.+|||+.|++++
T Consensus       254 ~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          254 VSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            56678999999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.9e-36  Score=314.00  Aligned_cols=243  Identities=21%  Similarity=0.306  Sum_probs=187.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccC-----CeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHD-----GVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++..  +|..||||++.        +.+.+|+.++++++||||+++++++...     ...++||||++ |+|.++
T Consensus        41 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~  119 (364)
T 3qyz_A           41 GMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKL  119 (364)
T ss_dssp             EEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHH
T ss_pred             eEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHH
Confidence            89999987  68899999985        4578899999999999999999998654     46899999997 699999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      +....    +++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++................
T Consensus       120 l~~~~----~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  192 (364)
T 3qyz_A          120 LKTQH----LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV  192 (364)
T ss_dssp             HHHCC----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCC
T ss_pred             HHhCC----CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccc
Confidence            97653    899999999999999999999   68999999999999999999999999999986644332222234557


Q ss_pred             cCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccc-----------
Q 007261          484 GTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV-----------  551 (611)
Q Consensus       484 gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~-----------  551 (611)
                      ||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+..  ..+........ .+.+..           
T Consensus       193 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~i~~~~~~~~-~~~~~~~~~~~~~~~~~  269 (364)
T 3qyz_A          193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL--NHILGILGSPS-QEDLNCIINLKARNYLL  269 (364)
T ss_dssp             SCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH--HHHHHHHCSCC-HHHHHTCCCHHHHHHHH
T ss_pred             cccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH--HHHHHHhCCCC-HHHHHHhhhhhHHHHHH
Confidence            9999999998754 45899999999999999999999998765543321  11222111111 000000           


Q ss_pred             -ccCccCCc---ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          552 -LVDPNLQA---NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       552 -~~d~~l~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                       ........   .....+..+.+|+.+||+.||++|||+.|++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          270 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             TSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             00000000   012235678999999999999999999999974

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.2e-36  Score=320.46  Aligned_cols=250  Identities=20%  Similarity=0.288  Sum_probs=176.4

Q ss_pred             ceEEEEEE----cCcEEEEEEec-----HHHHHHHHHHHhcCCCceeecccee--ccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII----NGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGAC--EHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~----~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~--~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..    ++..||||+++     ..+.+|+.+|++++||||+++++++  ..+...++||||++ |+|.+++...
T Consensus        35 g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~  113 (405)
T 3rgf_A           35 GHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFH  113 (405)
T ss_dssp             -EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHH
T ss_pred             eEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHh
Confidence            89999996    36789999986     4688999999999999999999999  45778999999996 5888888642


Q ss_pred             C------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee----CCCCcEEEeeecCccccccccCCcc
Q 007261          408 R------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL----DKNLRAKLANFSFVRSAVREESGYS  477 (611)
Q Consensus       408 ~------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgla~~~~~~~~~~~  477 (611)
                      .      ....+++..++.++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++..........
T Consensus       114 ~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  190 (405)
T 3rgf_A          114 RASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA  190 (405)
T ss_dssp             HHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------
T ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccc
Confidence            1      1234899999999999999999999   5899999999999999    7789999999999986643322223


Q ss_pred             cccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChh-------hHHHHHHHHHHhcCCcc--c
Q 007261          478 STKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE-------ILLAEAVFSMVEGGNAE--A  547 (611)
Q Consensus       478 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~-------~~l~~~~~~~~~~~~~~--~  547 (611)
                      ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......       ......+...+......  .
T Consensus       191 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~  270 (405)
T 3rgf_A          191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWE  270 (405)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCG
T ss_pred             cCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcc
Confidence            3345678999999999987 458999999999999999999999997554321       11112222222111100  0


Q ss_pred             ccccc----------cCccCCcC-hH--------HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          548 KLSVL----------VDPNLQAN-KK--------EIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       548 ~l~~~----------~d~~l~~~-~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+...          ........ ..        ..+..+.+|+.+||+.||.+|||+.|++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          271 DIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             GGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000          00000000 00        014568899999999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.1e-36  Score=312.93  Aligned_cols=245  Identities=21%  Similarity=0.301  Sum_probs=185.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceecc--------CCeEEEEEeecCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEH--------DGVFYLVYEFMENGS  399 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~--------~~~~~lV~E~~~~gs  399 (611)
                      |.||++..  +|+.||||++.         ..+.+|+.++++++||||+++++++..        .+..++||||++ |+
T Consensus        31 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~  109 (351)
T 3mi9_A           31 GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HD  109 (351)
T ss_dssp             TSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCS-EE
T ss_pred             cEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccC-CC
Confidence            89999998  68899999874         357899999999999999999999876        456899999997 58


Q ss_pred             HHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC-Cccc
Q 007261          400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES-GYSS  478 (611)
Q Consensus       400 L~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~  478 (611)
                      |.+.+....  ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus       110 l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  184 (351)
T 3mi9_A          110 LAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR  184 (351)
T ss_dssp             HHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCC
T ss_pred             HHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccc
Confidence            888887643  34899999999999999999999   68999999999999999999999999999976542221 1222


Q ss_pred             ccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccc-----
Q 007261          479 TKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVL-----  552 (611)
Q Consensus       479 ~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~-----  552 (611)
                      .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.  ...+......... ......     
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~-~~~~~~~~~~~  261 (351)
T 3mi9_A          185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ--LALISQLCGSITP-EVWPNVDNYEL  261 (351)
T ss_dssp             CCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCT-TTSTTGGGCGG
T ss_pred             cCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCh-hhccccccchh
Confidence            344678999999999876 4589999999999999999999999876543321  1222222211110 000000     


Q ss_pred             ------cCccCCcChHH-----HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          553 ------VDPNLQANKKE-----IAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       553 ------~d~~l~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                            ...........     .+..+.+|+.+||+.||++|||+.|++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          262 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             GTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence                  00000000111     13568899999999999999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=8.4e-36  Score=315.07  Aligned_cols=241  Identities=22%  Similarity=0.272  Sum_probs=177.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCC------eEEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDG------VFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV~E~~~~gsL~  401 (611)
                      |.||++..  +|+.||||++.         +.+.+|+.+++.++||||+++++++...+      ..++||||++ |+|.
T Consensus        39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  117 (371)
T 2xrw_A           39 GIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLC  117 (371)
T ss_dssp             EEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHH
T ss_pred             EEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHH
Confidence            89999987  68899999985         34778999999999999999999987654      7899999997 5788


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +++...     +++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....    .....
T Consensus       118 ~~~~~~-----~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~----~~~~~  185 (371)
T 2xrw_A          118 QVIQME-----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTP  185 (371)
T ss_dssp             HHHHSC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC----------------
T ss_pred             HHHhhc-----cCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccccccc----cccCC
Confidence            888632     889999999999999999999   589999999999999999999999999999765322    12334


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHH------------------HHHHhcC
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAV------------------FSMVEGG  543 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~------------------~~~~~~~  543 (611)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. +...+                  .......
T Consensus       186 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (371)
T 2xrw_A          186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKKLQPTVRTYVENR  264 (371)
T ss_dssp             ----CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCCCHHHHTTSCHHHHHHHHSS
T ss_pred             ceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHhhhHHHHHHhhC
Confidence            5789999999999999999999999999999999999999976543221 11100                  0000000


Q ss_pred             Cc--cccccccc----CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          544 NA--EAKLSVLV----DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       544 ~~--~~~l~~~~----d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      ..  ...+....    -+.........+..+.+|+.+||+.||++|||+.|++++-
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          265 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             ccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence            00  00000000    0111111334577899999999999999999999999853

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.2e-36  Score=321.22  Aligned_cols=246  Identities=20%  Similarity=0.326  Sum_probs=179.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccC-----CeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD-----GVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~  402 (611)
                      |.||++..  +|+.||||+++         +.+.+|+.+|++++||||+++++++...     ...|+||||++ |+|.+
T Consensus        40 g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~  118 (432)
T 3n9x_A           40 GYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKK  118 (432)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHH
T ss_pred             EEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHH
Confidence            89999988  68899999985         3578899999999999999999998765     57999999996 69999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc------
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY------  476 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~------  476 (611)
                      ++...   ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.........      
T Consensus       119 ~~~~~---~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  192 (432)
T 3n9x_A          119 LFKTP---IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE  192 (432)
T ss_dssp             HHHSS---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------
T ss_pred             HHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccccccccccc
Confidence            99865   34899999999999999999999   5899999999999999999999999999998654322110      


Q ss_pred             -------------ccccccccCCCccchhhh-ccCCCCCccchHHHHHHHHHHHhCCCCCc----------CCCCh----
Q 007261          477 -------------SSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGKEAAY----------KQDGE----  528 (611)
Q Consensus       477 -------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~s~Gvvl~elltG~~p~~----------~~~~~----  528 (611)
                                   .......||+.|+|||.+ ....++.++|||||||++|||++|..|+.          .....    
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~  272 (432)
T 3n9x_A          193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLS  272 (432)
T ss_dssp             ------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC--
T ss_pred             ccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccC
Confidence                         123456789999999986 56679999999999999999998544332          11110    


Q ss_pred             ------------hhHHHHHHHHHHhcCCcccccccc-----------cCccCCcC----hHHHHHHHHHHHHHhhccCCC
Q 007261          529 ------------EILLAEAVFSMVEGGNAEAKLSVL-----------VDPNLQAN----KKEIAHHLIMLCLACIAREPE  581 (611)
Q Consensus       529 ------------~~~l~~~~~~~~~~~~~~~~l~~~-----------~d~~l~~~----~~~~~~~l~~l~~~Cl~~dP~  581 (611)
                                  .......+...+.... .+.+..+           ........    ....+..+.+|+.+||+.||+
T Consensus       273 ~~~~~~~~~~~~~~~ql~~i~~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~  351 (432)
T 3n9x_A          273 PDRNSKKVHEKSNRDQLNIIFNIIGTPT-EDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPN  351 (432)
T ss_dssp             --------CHHHHHHHHHHHHHHHCSCC-HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTT
T ss_pred             cccccccccccchHHHHHHHHHhcCCCC-HHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcc
Confidence                        0111111122221111 0000000           00000000    123467789999999999999


Q ss_pred             CCCCHHHHHHH
Q 007261          582 SRPSMAEVVST  592 (611)
Q Consensus       582 ~RPs~~evl~~  592 (611)
                      +|||+.|++++
T Consensus       352 ~R~ta~e~L~H  362 (432)
T 3n9x_A          352 KRITIDQALDH  362 (432)
T ss_dssp             TSCCHHHHHTC
T ss_pred             cCCCHHHHhcC
Confidence            99999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.2e-36  Score=328.45  Aligned_cols=228  Identities=27%  Similarity=0.400  Sum_probs=186.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME  396 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  396 (611)
                      |.||++..  ++..||||+++                    +.+.+|+.+|++++||||+++++++.+.+..++||||++
T Consensus        50 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  129 (504)
T 3q5i_A           50 GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYE  129 (504)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             eEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCC
Confidence            89999998  67899999974                    246789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC---cEEEeeecCcccccccc
Q 007261          397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL---RAKLANFSFVRSAVREE  473 (611)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgla~~~~~~~  473 (611)
                      +|+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++   .+||+|||+++..... 
T Consensus       130 gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-  202 (504)
T 3q5i_A          130 GGELFEQIINRH---KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-  202 (504)
T ss_dssp             TCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT-
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC-
Confidence            999999997653   3899999999999999999999   58999999999999998776   6999999999765332 


Q ss_pred             CCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccccc
Q 007261          474 SGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV  553 (611)
Q Consensus       474 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  553 (611)
                         .......||+.|+|||.+. +.++.++||||||+++|||++|+.||......+.     ...... +...      .
T Consensus       203 ---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~i~~-~~~~------~  266 (504)
T 3q5i_A          203 ---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI-----IKKVEK-GKYY------F  266 (504)
T ss_dssp             ---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHH-CCCC------C
T ss_pred             ---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHc-CCCC------C
Confidence               1234467999999999987 4699999999999999999999999976544321     111111 1000      0


Q ss_pred             CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       554 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +   .......+.++.+|+.+||+.||.+|||+.|++++
T Consensus       267 ~---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          267 D---FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             C---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             C---ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            0   00012345678999999999999999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.6e-36  Score=311.38  Aligned_cols=229  Identities=23%  Similarity=0.370  Sum_probs=181.8

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  401 (611)
                      |.||++..  +|+.||||++..               .+.+|+.++++++||||+++++++..+. .++||||+++++|.
T Consensus        24 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~  102 (322)
T 2ycf_A           24 GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELF  102 (322)
T ss_dssp             EEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETH
T ss_pred             EEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHH
Confidence            89999998  678999999742               3678999999999999999999997665 89999999999999


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc---EEEeeecCccccccccCCccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR---AKLANFSFVRSAVREESGYSS  478 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfgla~~~~~~~~~~~~  478 (611)
                      +++....   .+++..++.++.||+.||.|||   +.+++||||||+|||++.++.   +||+|||+++.....    ..
T Consensus       103 ~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~  172 (322)
T 2ycf_A          103 DKVVGNK---RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SL  172 (322)
T ss_dssp             HHHSTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC----HH
T ss_pred             HHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccc----cc
Confidence            9997643   4899999999999999999999   689999999999999987654   999999998765322    12


Q ss_pred             ccccccCCCccchhhhc---cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCc
Q 007261          479 TKTAVGTNGYMAPEYME---YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP  555 (611)
Q Consensus       479 ~~~~~gt~~y~aPE~~~---~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  555 (611)
                      .....||+.|+|||.+.   ...++.++||||||+++|||++|+.||......... ...+   .. +..         .
T Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~---~~-~~~---------~  238 (322)
T 2ycf_A          173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-KDQI---TS-GKY---------N  238 (322)
T ss_dssp             HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH-HHHH---HH-TCC---------C
T ss_pred             cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH-HHHH---Hh-Ccc---------c
Confidence            23456899999999874   567899999999999999999999998765432211 1111   00 000         0


Q ss_pred             cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       556 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .........+..+.+++.+||+.||++||++.|++++
T Consensus       239 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          239 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            0000012345678999999999999999999999863

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.2e-36  Score=323.51  Aligned_cols=244  Identities=23%  Similarity=0.343  Sum_probs=181.3

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---HHHHHHHHHHhcCCCceeeccceecc------CCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---SISKEVNLLKKINHFNLINLFGACEH------DGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|..  +|+.||||++.+   ...+|+++|++++||||++++++|..      ....++||||+++ +|.+.+...
T Consensus        68 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~  146 (420)
T 1j1b_A           68 GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHY  146 (420)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHH
Confidence            89999998  689999999863   34579999999999999999998843      2246799999975 676666431


Q ss_pred             -CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeecCccccccccCCcccccccccC
Q 007261          408 -RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN-LRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       408 -~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                       .....+++..++.++.||+.||+|||   +.+|+||||||+|||++.+ +.+||+|||+++......    ......+|
T Consensus       147 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~----~~~~~~~t  219 (420)
T 1j1b_A          147 SRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICS  219 (420)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC----CCCSCCSC
T ss_pred             hhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC----CceeeeeC
Confidence             12345999999999999999999999   6899999999999999965 678999999998654322    22345789


Q ss_pred             CCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc------cccccccCccCC
Q 007261          486 NGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE------AKLSVLVDPNLQ  558 (611)
Q Consensus       486 ~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~------~~l~~~~d~~l~  558 (611)
                      +.|+|||++.+. .++.++|||||||+||||++|+.||......+. +... ...+.....+      .....+..+.+.
T Consensus       220 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~-l~~i-~~~lg~p~~~~~~~~~~~~~~~~~p~~~  297 (420)
T 1j1b_A          220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEI-IKVLGTPTREQIREMNPNYTEFKFPQIK  297 (420)
T ss_dssp             TTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH-HHHHCSCCHHHHHHHCSCCCCCCCCCCC
T ss_pred             CCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-HHHhCCCCHHHHHhhChhhhhhccCccC
Confidence            999999998764 799999999999999999999999976543321 1111 1111111000      000111111111


Q ss_pred             cC------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 AN------KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 ~~------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..      +...+.++.+|+.+||+.||++||++.|++++
T Consensus       298 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          298 AHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            11      12335678999999999999999999999874

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.5e-36  Score=305.23  Aligned_cols=230  Identities=19%  Similarity=0.311  Sum_probs=172.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.||||+++.         .+.++...++.++||||+++++++.+++..++||||++ |+|.+++...
T Consensus        21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~   99 (290)
T 3fme_A           21 GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQV   99 (290)
T ss_dssp             EEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHH
T ss_pred             eEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHH
Confidence            89999998  789999999862         23345555777899999999999999999999999997 5998887652


Q ss_pred             -CCCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          408 -RYPEFVSWNCRFRIALDVAHGLHYLHNCTDP-GYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       408 -~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                       .....+++..++.++.|++.||+|||   .. +++||||||+|||++.++.+||+|||+++......    ......||
T Consensus       100 ~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~t  172 (290)
T 3fme_A          100 IDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV----AKDIDAGC  172 (290)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------------------CCC
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc----cccccCCC
Confidence             12245999999999999999999999   45 99999999999999999999999999987653322    22334689


Q ss_pred             CCccchhhh----ccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcCh
Q 007261          486 NGYMAPEYM----EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK  561 (611)
Q Consensus       486 ~~y~aPE~~----~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  561 (611)
                      +.|+|||.+    .+..++.++||||||+++|||++|+.||.........+    .........            ....
T Consensus       173 ~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~------------~~~~  236 (290)
T 3fme_A          173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL----KQVVEEPSP------------QLPA  236 (290)
T ss_dssp             CCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH----HHHHHSCCC------------CCCT
T ss_pred             ccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH----HHHhccCCC------------Cccc
Confidence            999999996    56678999999999999999999999987544332221    112211110            0011


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          562 KEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ...+..+.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            2345678999999999999999999999984

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.4e-36  Score=340.27  Aligned_cols=245  Identities=23%  Similarity=0.391  Sum_probs=192.6

Q ss_pred             hcCCCCCccc----ceEEEEEEc-----CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEE
Q 007261          329 ENFSPKNMID----GSVFRGIIN-----GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLV  391 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~~-----g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  391 (611)
                      +.|.....||    |.||+|.+.     +..||||.++        +.+.+|+.++++++||||+++++++. ++..++|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence            4444444454    899999882     4579999975        45889999999999999999999985 4568999


Q ss_pred             EeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccccc
Q 007261          392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVR  471 (611)
Q Consensus       392 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~  471 (611)
                      |||+++|+|.+++....  ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       469 ~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          469 MELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             EECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             EEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            99999999999998653  34899999999999999999999   58999999999999999999999999999986533


Q ss_pred             ccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccc
Q 007261          472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLS  550 (611)
Q Consensus       472 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~  550 (611)
                      ..  ........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.     ........       
T Consensus       544 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-----~~~i~~~~-------  609 (656)
T 2j0j_A          544 ST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-----IGRIENGE-------  609 (656)
T ss_dssp             ------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----HHHHHHTC-------
T ss_pred             Cc--ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH-----HHHHHcCC-------
Confidence            22  112234456789999999999999999999999999999997 8888865543321     11111110       


Q ss_pred             cccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          551 VLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       551 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                            ....+..++..+.+++.+||+.||++||++.|+++.|+++...
T Consensus       610 ------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          610 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                  0111233456789999999999999999999999999998654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-35  Score=303.63  Aligned_cols=239  Identities=22%  Similarity=0.303  Sum_probs=186.0

Q ss_pred             hcCCCCCccc----ceEEEEEE--cCcEEEEEEec-----------HHHHHHHHHHHhcCCCceeecccee--ccCCeEE
Q 007261          329 ENFSPKNMID----GSVFRGII--NGSTVAIKCMR-----------RSISKEVNLLKKINHFNLINLFGAC--EHDGVFY  389 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~-----------~~~~~E~~~l~~l~H~niv~l~g~~--~~~~~~~  389 (611)
                      ++|.....+|    |.||++..  +|..||||+++           ..+.+|+.++++++||||+++++++  .+....+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            3455555554    89999998  67899999985           2467899999999999999999998  4456789


Q ss_pred             EEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcccc
Q 007261          390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSA  469 (611)
Q Consensus       390 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~  469 (611)
                      +||||++++ |.+++.... ...+++..++.++.||+.||.|||   +.+++||||||+|||++.++.+||+|||++...
T Consensus        85 lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            999999876 878777643 245899999999999999999999   589999999999999999999999999998765


Q ss_pred             ccccCCcccccccccCCCccchhhhccCC--CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc
Q 007261          470 VREESGYSSTKTAVGTNGYMAPEYMEYGL--VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA  547 (611)
Q Consensus       470 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  547 (611)
                      ..... ........++..|+|||.+.+..  ++.++||||||+++|||++|+.||......+.     ...... ..   
T Consensus       160 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~i~~-~~---  229 (305)
T 2wtk_C          160 HPFAA-DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-----FENIGK-GS---  229 (305)
T ss_dssp             CTTCS-SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHH-CC---
T ss_pred             Ccccc-ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-----HHHHhc-CC---
Confidence            32211 12234456899999999987643  47899999999999999999999875442211     111111 10   


Q ss_pred             ccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          548 KLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       548 ~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                                ...+..++..+.+++.+||+.||++|||+.|++++
T Consensus       230 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 ----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                      00112345678899999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.8e-36  Score=317.20  Aligned_cols=243  Identities=21%  Similarity=0.282  Sum_probs=186.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcC--------CCceeeccceec----cCCeEEEEEeecCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKIN--------HFNLINLFGACE----HDGVFYLVYEFMENG  398 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~--------H~niv~l~g~~~----~~~~~~lV~E~~~~g  398 (611)
                      |.||++..  +|+.||||+++      +.+.+|+.++++++        |+||+++++++.    .....++||||+ ++
T Consensus        51 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~  129 (397)
T 1wak_A           51 STVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GH  129 (397)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CC
T ss_pred             eeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-Cc
Confidence            89999987  68899999986      45778999999995        788999999987    566899999999 66


Q ss_pred             CHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeeeCCCC---------------------
Q 007261          399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDP-GYVHKDISSGNILLDKNL---------------------  456 (611)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~ivH~Dlk~~NILl~~~~---------------------  456 (611)
                      +|.+++.... ...+++..++.++.||+.||+|||   +. +|+||||||+|||++.++                     
T Consensus       130 ~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~  205 (397)
T 1wak_A          130 HLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP  205 (397)
T ss_dssp             BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHHHHHC----------
T ss_pred             cHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCC
Confidence            7777766542 245899999999999999999999   46 899999999999999775                     


Q ss_pred             ----------------------------cEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHH
Q 007261          457 ----------------------------RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF  508 (611)
Q Consensus       457 ----------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~  508 (611)
                                                  .+||+|||+++.....      .....||+.|+|||.+.+..++.++|||||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  279 (397)
T 1wak_A          206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVLIGSGYNTPADIWST  279 (397)
T ss_dssp             -----------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHHHTSCCCTHHHHHHH
T ss_pred             CCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhhcCCCCCcHHHHHHH
Confidence                                        8999999998765322      234578999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCcCCCChh----hHHHHHHHHHHhcCCc---------c------cccccccCcc----------CCc
Q 007261          509 GVVLLELITGKEAAYKQDGEE----ILLAEAVFSMVEGGNA---------E------AKLSVLVDPN----------LQA  559 (611)
Q Consensus       509 Gvvl~elltG~~p~~~~~~~~----~~l~~~~~~~~~~~~~---------~------~~l~~~~d~~----------l~~  559 (611)
                      |++||||++|+.||......+    ......+.........         .      ..+..+.+..          ...
T Consensus       280 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (397)
T 1wak_A          280 ACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYE  359 (397)
T ss_dssp             HHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSC
T ss_pred             HHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcc
Confidence            999999999999997654332    1111122222111000         0      0000000000          011


Q ss_pred             ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          560 NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+...+..+.+|+.+||+.||++|||+.|++++
T Consensus       360 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          360 WSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            246677889999999999999999999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=306.02  Aligned_cols=244  Identities=20%  Similarity=0.332  Sum_probs=180.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeecccee--------------ccCCeEEEEEeec
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGAC--------------EHDGVFYLVYEFM  395 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~--------------~~~~~~~lV~E~~  395 (611)
                      |.||+|..  +|+.||||++.       +.+.+|+.++++++||||+++++++              .+....++||||+
T Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~  104 (320)
T 2i6l_A           25 GLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM  104 (320)
T ss_dssp             -CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECC
T ss_pred             eEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeecc
Confidence            89999998  48899999884       4578899999999999999999887              3446889999999


Q ss_pred             CCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEeeecCccccccccC
Q 007261          396 ENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD-KNLRAKLANFSFVRSAVREES  474 (611)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~  474 (611)
                      + |+|.+++...    .+++..++.++.|++.||+|||   +.+++||||||+|||++ +++.+||+|||+++.......
T Consensus       105 ~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  176 (320)
T 2i6l_A          105 E-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS  176 (320)
T ss_dssp             S-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC-----
T ss_pred             C-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcc
Confidence            7 6999999754    3889999999999999999999   68999999999999997 567999999999986543222


Q ss_pred             CcccccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc--cc---
Q 007261          475 GYSSTKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE--AK---  548 (611)
Q Consensus       475 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--~~---  548 (611)
                      .........++..|+|||.+.. ..++.++||||||+++|||++|+.||......+..  ..+..........  ..   
T Consensus       177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  254 (320)
T 2i6l_A          177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM--QLILESIPVVHEEDRQELLS  254 (320)
T ss_dssp             ---CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHSCCCCHHHHHHHHT
T ss_pred             cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcCCCchhhhhhhhh
Confidence            2222334567899999998865 67899999999999999999999999765432211  1111100000000  00   


Q ss_pred             -c----cc-ccCccCC--cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          549 -L----SV-LVDPNLQ--ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       549 -l----~~-~~d~~l~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                       +    .. ...+...  ......+.++.+++.+||+.||++||++.|++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          255 VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence             0    00 0000000  0012346779999999999999999999999874

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4e-35  Score=315.82  Aligned_cols=179  Identities=23%  Similarity=0.349  Sum_probs=156.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhc------CCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKI------NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|..  +|+.||||+++      +.+.+|+.+++.+      +|+||+++++++...+..++||||+. ++|.+++
T Consensus       111 g~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l  189 (429)
T 3kvw_A          111 GQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELI  189 (429)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHH
Confidence            89999988  57899999995      3567799998887      57799999999999999999999996 7999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc--EEEeeecCccccccccCCccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR--AKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ..... ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.  +||+|||+++....      .....
T Consensus       190 ~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~------~~~~~  259 (429)
T 3kvw_A          190 KKNKF-QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ------RVYTY  259 (429)
T ss_dssp             HHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC------CCCSS
T ss_pred             HhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccceecCC------ccccc
Confidence            87542 34899999999999999999999   589999999999999999987  99999999865422      22345


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCCh
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGE  528 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~  528 (611)
                      .+|+.|+|||++.+..++.++|||||||+||||++|+.||......
T Consensus       260 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  305 (429)
T 3kvw_A          260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG  305 (429)
T ss_dssp             CSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             CCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            7899999999999999999999999999999999999998765443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.9e-36  Score=318.52  Aligned_cols=231  Identities=11%  Similarity=0.041  Sum_probs=164.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhc--CCCceeeccc-------eeccC------------
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKI--NHFNLINLFG-------ACEHD------------  385 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l--~H~niv~l~g-------~~~~~------------  385 (611)
                      |.||+|..  +|+.||||+++.          .+.+|+.+++.+  +||||++++.       ++...            
T Consensus        76 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~  155 (371)
T 3q60_A           76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQ  155 (371)
T ss_dssp             EEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC-
T ss_pred             EEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCc
Confidence            89999997  688999999862          356785555555  6999887553       33221            


Q ss_pred             -----CeEEEEEeecCCCCHHHHhhccCCCCccCHHHH------HHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC
Q 007261          386 -----GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCR------FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK  454 (611)
Q Consensus       386 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~  454 (611)
                           ...+|||||++ |+|.+++....  ..+.+..+      +.++.||+.||+|||   +.+|+||||||+|||++.
T Consensus       156 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~  229 (371)
T 3q60_A          156 DDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMP  229 (371)
T ss_dssp             --CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEECT
T ss_pred             ccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccCcCCHHHEEECC
Confidence                 34899999998 89999998742  12455556      788899999999999   689999999999999999


Q ss_pred             CCcEEEeeecCccccccccCCcccccccccCCCccchhhhcc--CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHH
Q 007261          455 NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY--GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILL  532 (611)
Q Consensus       455 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l  532 (611)
                      ++.+||+|||+++.....      .....+|+.|+|||.+.+  ..++.++||||||++||||++|+.||......... 
T Consensus       230 ~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-  302 (371)
T 3q60_A          230 DGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG-  302 (371)
T ss_dssp             TSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT-
T ss_pred             CCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc-
Confidence            999999999999865321      114556799999999987  67999999999999999999999999765432100 


Q ss_pred             HHHHHHHHhcCCcccccccccCccCC-cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          533 AEAVFSMVEGGNAEAKLSVLVDPNLQ-ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       533 ~~~~~~~~~~~~~~~~l~~~~d~~l~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                                ................ .....++..+.+|+.+||+.||++||++.|++++
T Consensus       303 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          303 ----------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             ----------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             ----------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                      0000000000011111 1122456788999999999999999999999863

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=8.6e-36  Score=314.45  Aligned_cols=237  Identities=22%  Similarity=0.334  Sum_probs=171.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccC------CeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHD------GVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~E~~~~gsL~  401 (611)
                      |.||+|..  +|+.||||++.         +.+.+|+.++++++||||+++++++...      ...++|+||+ +++|.
T Consensus        43 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~  121 (367)
T 2fst_X           43 GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLN  121 (367)
T ss_dssp             CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC
T ss_pred             eEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHH
Confidence            89999987  68999999984         3567899999999999999999998654      5679999999 78999


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +++...    .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....      ...
T Consensus       122 ~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~  188 (367)
T 2fst_X          122 NIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE------MTG  188 (367)
T ss_dssp             -----C----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-------------------
T ss_pred             HHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccccccc------CCC
Confidence            998763    3899999999999999999999   689999999999999999999999999999764321      234


Q ss_pred             cccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccC------
Q 007261          482 AVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVD------  554 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d------  554 (611)
                      ..+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+  ....+........ .+.+..+..      
T Consensus       189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~-~~~~~~~~~~~~~~~  265 (367)
T 2fst_X          189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPG-AELLKKISSESARNY  265 (367)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCC-HHHHTTCCCHHHHHH
T ss_pred             cCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCC-HHHHHHhhhHHHHHH
Confidence            578999999999876 679999999999999999999999997654322  1122222221110 000000000      


Q ss_pred             ----ccCCc-C----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 ----PNLQA-N----KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 ----~~l~~-~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                          +.... .    ....+..+.+|+.+||+.||++|||+.|++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          266 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                00000 0    11235678999999999999999999999975

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.2e-35  Score=307.12  Aligned_cols=260  Identities=19%  Similarity=0.206  Sum_probs=185.0

Q ss_pred             HHHHhhcCCCCCccc----ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCC-----
Q 007261          324 LVVATENFSPKNMID----GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDG-----  386 (611)
Q Consensus       324 l~~at~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----  386 (611)
                      .....++|.....||    |.||+|..  +|..||||++.      ....+|+..+..++||||+++++++...+     
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence            344455666555565    89999998  58899999884      35677888889999999999999985432     


Q ss_pred             --eEEEEEeecCCCCHHHHhhc-cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEee
Q 007261          387 --VFYLVYEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-NLRAKLAN  462 (611)
Q Consensus       387 --~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~D  462 (611)
                        ..++||||+++ +|.+.+.. ......+++..+..++.|++.||.|||.. +.+|+||||||+|||++. ++.+||+|
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~D  175 (360)
T 3e3p_A           98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCD  175 (360)
T ss_dssp             CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred             ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEee
Confidence              37899999986 55554432 22234588999999999999999999932 478999999999999997 89999999


Q ss_pred             ecCccccccccCCcccccccccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHh
Q 007261          463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVE  541 (611)
Q Consensus       463 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  541 (611)
                      ||+++......    ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+. +. .+.....
T Consensus       176 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~-~~~~~~~  249 (360)
T 3e3p_A          176 FGSAKKLSPSE----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-LH-EIVRVLG  249 (360)
T ss_dssp             CTTCBCCCTTS----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH-HHHHHHC
T ss_pred             CCCceecCCCC----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-HH-HHHHHcC
Confidence            99998654322    22345689999999998654 489999999999999999999999976544321 11 1111111


Q ss_pred             cCCcccccc---------cccCcc-------CCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          542 GGNAEAKLS---------VLVDPN-------LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       542 ~~~~~~~l~---------~~~d~~-------l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ... ...+.         ...+..       +.......+..+.+|+.+||+.||.+|||+.|++++
T Consensus       250 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          250 CPS-REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCC-HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCC-HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000 00000         000000       001112246789999999999999999999999975

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.5e-35  Score=303.92  Aligned_cols=243  Identities=24%  Similarity=0.338  Sum_probs=187.5

Q ss_pred             ceEEEEEE---cCcEEEEEEec---------HHHHHHHHHHHhc---CCCceeeccceec-----cCCeEEEEEeecCCC
Q 007261          339 GSVFRGII---NGSTVAIKCMR---------RSISKEVNLLKKI---NHFNLINLFGACE-----HDGVFYLVYEFMENG  398 (611)
Q Consensus       339 g~Vy~g~~---~g~~vavK~~~---------~~~~~E~~~l~~l---~H~niv~l~g~~~-----~~~~~~lV~E~~~~g  398 (611)
                      |.||++..   +|+.||||+++         ..+.+|+.+++.+   +||||+++++++.     .....++||||++ |
T Consensus        25 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~  103 (326)
T 1blx_A           25 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-Q  103 (326)
T ss_dssp             EEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-C
T ss_pred             EEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-C
Confidence            89999987   47899999985         2577898888877   8999999999986     5677899999997 6


Q ss_pred             CHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccc
Q 007261          399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS  478 (611)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  478 (611)
                      +|.+++..... ..+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++.....    ..
T Consensus       104 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~----~~  175 (326)
T 1blx_A          104 DLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ----MA  175 (326)
T ss_dssp             BHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG----GG
T ss_pred             CHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecCcccccccCC----CC
Confidence            99999987542 34899999999999999999999   689999999999999999999999999998765322    12


Q ss_pred             ccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc----------
Q 007261          479 TKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK----------  548 (611)
Q Consensus       479 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~----------  548 (611)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+.  ...+............          
T Consensus       176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~  253 (326)
T 1blx_A          176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPGEEDWPRDVALPRQA  253 (326)
T ss_dssp             GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCGGGSCTTCSSCGGG
T ss_pred             ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCcccCccccccchhh
Confidence            3346789999999999999999999999999999999999999876543321  1222222111110000          


Q ss_pred             cccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       549 l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.......+.......+..+.+|+.+||+.||++||++.|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             SCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00000001111123456778999999999999999999999964

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.5e-35  Score=310.28  Aligned_cols=244  Identities=22%  Similarity=0.324  Sum_probs=183.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccC-----CeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHD-----GVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|..  +|+.||||+++        ..+.+|+.++++++||||+++++++...     ...++||||++ |+|.++
T Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~  103 (353)
T 2b9h_A           25 GVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRV  103 (353)
T ss_dssp             EEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHH
T ss_pred             eEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHH
Confidence            89999998  58999999985        3567899999999999999999987654     67899999997 699999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc-------
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY-------  476 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-------  476 (611)
                      +...    .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.........       
T Consensus       104 ~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  176 (353)
T 2b9h_A          104 ISTQ----MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ  176 (353)
T ss_dssp             HHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-------------
T ss_pred             Hhhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccc
Confidence            9874    3899999999999999999999   5899999999999999999999999999998654321110       


Q ss_pred             ccccccccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccccc--
Q 007261          477 SSTKTAVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV--  553 (611)
Q Consensus       477 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~--  553 (611)
                      .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||......+..  ..+.................  
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  254 (353)
T 2b9h_A          177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL--LLIFGIIGTPHSDNDLRCIESP  254 (353)
T ss_dssp             ---CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCCCSTTTTTTCCCH
T ss_pred             cchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHHHhCCCchhccccccccc
Confidence            11223468999999998754 77899999999999999999999998765433211  11122221111000000000  


Q ss_pred             -------------CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          554 -------------DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       554 -------------d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                                   ...+.......+.++.+|+.+||+.||++|||+.|++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          255 RAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                         000000012345678999999999999999999999974

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.4e-36  Score=321.18  Aligned_cols=240  Identities=24%  Similarity=0.385  Sum_probs=177.3

Q ss_pred             cCCCCCccc----ce-EEEEEEcCcEEEEEEecH----HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCC
Q 007261          330 NFSPKNMID----GS-VFRGIINGSTVAIKCMRR----SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGS  399 (611)
Q Consensus       330 ~f~~~~~ig----g~-Vy~g~~~g~~vavK~~~~----~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gs  399 (611)
                      +|.....||    |. +|++..+|+.||||++..    .+.+|+.+|+++ +||||+++++++.+....|+||||++ |+
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~  103 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT  103 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred             EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence            344444454    66 666777999999999863    467899999999 89999999999999999999999996 69


Q ss_pred             HHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-----CCcEEEeeecCccccccccC
Q 007261          400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-----NLRAKLANFSFVRSAVREES  474 (611)
Q Consensus       400 L~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~Dfgla~~~~~~~~  474 (611)
                      |.+++.....  .+.+...+.++.||+.||+|||   +.+|+||||||+|||++.     ...+||+|||+++.......
T Consensus       104 L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~  178 (432)
T 3p23_A          104 LQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH  178 (432)
T ss_dssp             HHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred             HHHHHHhcCC--CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence            9999987542  2444456789999999999999   589999999999999943     34688999999987654332


Q ss_pred             CcccccccccCCCccchhhhc---cCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccc
Q 007261          475 GYSSTKTAVGTNGYMAPEYME---YGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLS  550 (611)
Q Consensus       475 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~  550 (611)
                      .........||+.|+|||.+.   ...++.++|||||||++|||++ |..||.........      .... ..      
T Consensus       179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~------~~~~-~~------  245 (432)
T 3p23_A          179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN------ILLG-AC------  245 (432)
T ss_dssp             -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH------HHTT-CC------
T ss_pred             ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH------HHhc-cC------
Confidence            223344567999999999997   4667889999999999999999 77777544332211      0111 00      


Q ss_pred             cccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          551 VLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       551 ~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                         ..............+.+|+.+||+.||++|||+.|+++
T Consensus       246 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          246 ---SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             ---CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence               00011112344566889999999999999999999995

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.9e-36  Score=318.85  Aligned_cols=245  Identities=21%  Similarity=0.296  Sum_probs=181.0

Q ss_pred             ceEEEEEE-cCcEEEEEEecH---HHHHHHHHHHhcCCCceeeccceeccC------CeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII-NGSTVAIKCMRR---SISKEVNLLKKINHFNLINLFGACEHD------GVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++.. .+..||+|++.+   ...+|+.+++.++||||+++++++...      ...++||||++++.+........
T Consensus        54 g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~  133 (394)
T 4e7w_A           54 GVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK  133 (394)
T ss_dssp             EEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHH
T ss_pred             eEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHh
Confidence            89999998 566799998852   345799999999999999999998433      34889999998754444443222


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD-KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      ....+++..+..++.||+.||+|||   +.+|+||||||+|||++ .++.+||+|||+++......    ......+|+.
T Consensus       134 ~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~----~~~~~~~t~~  206 (394)
T 4e7w_A          134 LKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE----PNVSYICSRY  206 (394)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC----CCCSSCSCGG
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC----CCcccccCcC
Confidence            3345899999999999999999999   68999999999999999 79999999999998653322    2234578999


Q ss_pred             ccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc------cccccccCccCCcC
Q 007261          488 YMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE------AKLSVLVDPNLQAN  560 (611)
Q Consensus       488 y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~------~~l~~~~d~~l~~~  560 (611)
                      |+|||.+.+. .++.++|||||||++|||++|+.||......+. +.. +.........+      .......-+.....
T Consensus       207 y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~  284 (394)
T 4e7w_A          207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVE-IIKVLGTPSREQIKTMNPNYMEHKFPQIRPH  284 (394)
T ss_dssp             GCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH-HHHHHCCCCHHHHHHHCGGGSSSCCCCCCCC
T ss_pred             ccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHHHhCCCCHHHHHhhChhhhhhccccccCC
Confidence            9999998664 589999999999999999999999976654332 111 11111111000      00000000111111


Q ss_pred             ------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          561 ------KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       561 ------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                            +...+.++.+|+.+||+.||++|||+.|++++
T Consensus       285 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          285 PFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                  12245689999999999999999999999975

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6.1e-35  Score=303.17  Aligned_cols=240  Identities=20%  Similarity=0.319  Sum_probs=187.4

Q ss_pred             ceEEEEEE---cCcEEEEEEec------HHHHHHHHHHHhcCCC------ceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII---NGSTVAIKCMR------RSISKEVNLLKKINHF------NLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~---~g~~vavK~~~------~~~~~E~~~l~~l~H~------niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++..   +|+.||||+++      +.+.+|+.+++.++|+      +++++++++...+..++||||+ +++|.++
T Consensus        28 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~  106 (339)
T 1z57_A           28 GKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDF  106 (339)
T ss_dssp             EEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHH
T ss_pred             eEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHH
Confidence            89999987   57899999986      4578899999998765      4999999999999999999999 8999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-------------------CCcEEEeeec
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-------------------NLRAKLANFS  464 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-------------------~~~~kl~Dfg  464 (611)
                      +..... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.                   ++.+||+|||
T Consensus       107 l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg  182 (339)
T 1z57_A          107 IKENGF-LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG  182 (339)
T ss_dssp             HHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCS
T ss_pred             HHhcCC-CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCc
Confidence            987542 34889999999999999999999   689999999999999987                   6789999999


Q ss_pred             CccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCC
Q 007261          465 FVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN  544 (611)
Q Consensus       465 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  544 (611)
                      +++....      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..  ..+..... ..
T Consensus       183 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~-~~  253 (339)
T 1z57_A          183 SATYDDE------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL--AMMERILG-PL  253 (339)
T ss_dssp             SCEETTS------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH--HHHHHHHC-SC
T ss_pred             ccccCcc------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHhC-CC
Confidence            9875432      123457899999999999999999999999999999999999999765543311  11111111 00


Q ss_pred             ccccccc--------------------------ccCc--cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          545 AEAKLSV--------------------------LVDP--NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       545 ~~~~l~~--------------------------~~d~--~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +......                          ...+  .........+..+.+|+.+||+.||++|||+.|++++
T Consensus       254 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          254 PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             CHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence            0000000                          0000  0011133567789999999999999999999999864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.6e-36  Score=309.99  Aligned_cols=230  Identities=23%  Similarity=0.369  Sum_probs=178.0

Q ss_pred             ceEEEEEE-cCcEEEEEEec---------HHHHHHHHHHHhcC--CCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII-NGSTVAIKCMR---------RSISKEVNLLKKIN--HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~---------~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++.. +|+.||||++.         ..+.+|+.++.+++  |+||+++++++..++..++||| +.+++|.+++..
T Consensus        42 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~  120 (313)
T 3cek_A           42 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK  120 (313)
T ss_dssp             EEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH
T ss_pred             EEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh
Confidence            89999988 68899999984         35788999999996  5999999999999999999999 568899999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..++.++.|++.||.|||   +.+++||||||+|||+++ +.+||+|||+++....... ........|++
T Consensus       121 ~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~-~~~~~~~~gt~  192 (313)
T 3cek_A          121 KK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT-SVVKDSQVGTV  192 (313)
T ss_dssp             CS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---------------CCG
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCccc-cccccCCCCCC
Confidence            53   4899999999999999999999   589999999999999964 8999999999976543221 11223456899


Q ss_pred             Cccchhhhcc-----------CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCc
Q 007261          487 GYMAPEYMEY-----------GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP  555 (611)
Q Consensus       487 ~y~aPE~~~~-----------~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~  555 (611)
                      .|+|||.+.+           ..++.++||||||+++|||++|+.||.........    .........         ..
T Consensus       193 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~---------~~  259 (313)
T 3cek_A          193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK----LHAIIDPNH---------EI  259 (313)
T ss_dssp             GGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----HHHHHCTTS---------CC
T ss_pred             CcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH----HHHHHhccc---------cc
Confidence            9999999875           46888999999999999999999998755432211    111111100         00


Q ss_pred             cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       556 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      ..   +...+..+.+++.+||+.||++||++.|++++-
T Consensus       260 ~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          260 EF---PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             CC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             CC---cccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            01   112245788999999999999999999999753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.3e-35  Score=300.06  Aligned_cols=228  Identities=27%  Similarity=0.415  Sum_probs=184.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.||||+++         ..+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++...
T Consensus        36 g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  115 (287)
T 2wei_A           36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR  115 (287)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH
T ss_pred             EEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc
Confidence            89999998  68899999984         35789999999999999999999999999999999999999999998765


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC---CcEEEeeecCccccccccCCccccccccc
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN---LRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      .   .+++..++.++.|++.||.|||   ..+++||||||+||+++.+   +.+||+|||++.......    ......+
T Consensus       116 ~---~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~  185 (287)
T 2wei_A          116 K---RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIG  185 (287)
T ss_dssp             S---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS----SCSCHHH
T ss_pred             C---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC----ccccccC
Confidence            3   3899999999999999999999   5899999999999999764   479999999987653321    2233457


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      ++.|+|||.+.+ .++.++||||||+++|||++|+.||......+.     ...... +...      .+   .......
T Consensus       186 ~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~-~~~~------~~---~~~~~~~  249 (287)
T 2wei_A          186 TAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-----LKRVET-GKYA------FD---LPQWRTI  249 (287)
T ss_dssp             HHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHH-CCCC------CC---SGGGTTS
T ss_pred             cccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHc-CCCC------CC---chhhhhc
Confidence            889999999875 489999999999999999999999876543221     111111 1100      00   0011234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.++.+++.+||+.||++|||+.|++++
T Consensus       250 ~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          250 SDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            5678999999999999999999999984

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2e-35  Score=301.88  Aligned_cols=232  Identities=22%  Similarity=0.394  Sum_probs=175.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceecc-------------CCeEEEEEeecCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEH-------------DGVFYLVYEFMEN  397 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~-------------~~~~~lV~E~~~~  397 (611)
                      |.||+|..  +|+.||||.++      +.+.+|+.++++++||||+++++++.+             .+..++||||+++
T Consensus        20 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~   99 (303)
T 1zy4_A           20 GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCEN   99 (303)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCS
T ss_pred             EEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCC
Confidence            89999997  78999999985      357889999999999999999998754             4568999999999


Q ss_pred             CCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC---
Q 007261          398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES---  474 (611)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~---  474 (611)
                      |+|.+++....  ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.......   
T Consensus       100 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  174 (303)
T 1zy4_A          100 GTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK  174 (303)
T ss_dssp             CBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC------
T ss_pred             CCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhc
Confidence            99999998643  34788999999999999999999   58999999999999999999999999999876532210   


Q ss_pred             --------CcccccccccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc
Q 007261          475 --------GYSSTKTAVGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA  545 (611)
Q Consensus       475 --------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  545 (611)
                              .........++..|+|||.+.+. .++.++||||||+++|||++   |+..... .   .... ....... 
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-~---~~~~-~~~~~~~-  245 (303)
T 1zy4_A          175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-R---VNIL-KKLRSVS-  245 (303)
T ss_dssp             -------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-H---HHHH-HHHHSTT-
T ss_pred             cccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-H---HHHH-Hhccccc-
Confidence                    01122345689999999999764 78999999999999999998   3322111 1   1111 1111110 


Q ss_pred             ccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          546 EAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       546 ~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                           ....+.   .....+..+.+++.+||+.||++|||+.|++++
T Consensus       246 -----~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          246 -----IEFPPD---FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             -----CCCCTT---CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -----cccCcc---ccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence                 001111   123345668899999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.9e-35  Score=310.94  Aligned_cols=236  Identities=24%  Similarity=0.341  Sum_probs=180.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeE------EEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVF------YLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~------~lV~E~~~~gsL~  401 (611)
                      |.||+|..  +|+.||||+++         +.+.+|+.++++++||||+++++++...+..      ++||||++ ++|.
T Consensus        56 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  134 (371)
T 4exu_A           56 GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQ  134 (371)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHH
T ss_pred             eEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHH
Confidence            89999987  68999999985         3577899999999999999999999876654      99999997 6898


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +++...     +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....      ...
T Consensus       135 ~~~~~~-----~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~------~~~  200 (371)
T 4exu_A          135 KIMGME-----FSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTG  200 (371)
T ss_dssp             HHTTSC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--------------C
T ss_pred             HHhhcC-----CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC------cCC
Confidence            888432     899999999999999999999   589999999999999999999999999998754322      234


Q ss_pred             cccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccc--------
Q 007261          482 AVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVL--------  552 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~--------  552 (611)
                      ..+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.  ...+........ ......+        
T Consensus       201 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~-~~~~~~~~~~~~~~~  277 (371)
T 4exu_A          201 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPG-TEFVQKLNDKAAKSY  277 (371)
T ss_dssp             TTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCC-HHHHTTCSCHHHHHH
T ss_pred             cccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCc-HHHHHHhhhhhhhhh
Confidence            568999999999877 7799999999999999999999999976543321  111111111000 0000000        


Q ss_pred             ---cCccCCcC----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          553 ---VDPNLQAN----KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       553 ---~d~~l~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                         +.......    ....+..+.+|+.+||+.||++|||+.|++++
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          278 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence               00000011    12345779999999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.7e-35  Score=315.19  Aligned_cols=235  Identities=24%  Similarity=0.401  Sum_probs=173.6

Q ss_pred             ceEE-EEEEcCcEEEEEEecH----HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC-
Q 007261          339 GSVF-RGIINGSTVAIKCMRR----SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE-  411 (611)
Q Consensus       339 g~Vy-~g~~~g~~vavK~~~~----~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~-  411 (611)
                      |.|| ++..+|+.||||++..    .+.+|+.+++++ +||||+++++++.+++..++||||++ |+|.+++....... 
T Consensus        29 g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~  107 (434)
T 2rio_A           29 GTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDE  107 (434)
T ss_dssp             TCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC-----
T ss_pred             eEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCch
Confidence            7885 4455899999999863    467899999987 89999999999999999999999995 69999998754211 


Q ss_pred             ---ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-------------CCcEEEeeecCccccccccCC
Q 007261          412 ---FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-------------NLRAKLANFSFVRSAVREESG  475 (611)
Q Consensus       412 ---~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-------------~~~~kl~Dfgla~~~~~~~~~  475 (611)
                         ..++..++.++.||+.||+|||   +.+|+||||||+|||++.             ++.+||+|||+++........
T Consensus       108 ~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~  184 (434)
T 2rio_A          108 NLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS  184 (434)
T ss_dssp             -------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC----
T ss_pred             hhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCcc
Confidence               1133445789999999999999   589999999999999965             458999999999876433221


Q ss_pred             c-ccccccccCCCccchhhhcc-------CCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcc
Q 007261          476 Y-SSTKTAVGTNGYMAPEYMEY-------GLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       476 ~-~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  546 (611)
                      . .......||+.|+|||.+.+       ..++.++|||||||++|||++ |+.||......+.       ........ 
T Consensus       185 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-------~i~~~~~~-  256 (434)
T 2rio_A          185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-------NIIRGIFS-  256 (434)
T ss_dssp             ----------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH-------HHHHTCCC-
T ss_pred             ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH-------HHhcCCCC-
Confidence            1 12234579999999999975       678999999999999999999 8888865433221       11111100 


Q ss_pred             cccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       547 ~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                            .+..........+.++.+|+.+||+.||.+|||+.|+++
T Consensus       257 ------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          257 ------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                  000011124567788999999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.3e-35  Score=303.83  Aligned_cols=232  Identities=22%  Similarity=0.375  Sum_probs=162.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHH-HHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVN-LLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.||||+++        .++..|+. +++.++||||+++++++..++..++||||++ |+|.+++...
T Consensus        36 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~  114 (327)
T 3aln_A           36 GSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYV  114 (327)
T ss_dssp             EEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHHH
T ss_pred             EEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-CChHHHHHHH
Confidence            89999998  58999999985        23445555 6677799999999999999999999999997 5888887641


Q ss_pred             --CCCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          408 --RYPEFVSWNCRFRIALDVAHGLHYLHNCTDP-GYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       408 --~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                        .....+++..+..++.|++.||.|||   .. +++||||||+|||++.++.+||+|||+++......    ......|
T Consensus       115 ~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----~~~~~~g  187 (327)
T 3aln_A          115 YSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI----AKTRDAG  187 (327)
T ss_dssp             HHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----------------
T ss_pred             HhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc----ccccCCC
Confidence              12345899999999999999999999   46 99999999999999999999999999987653321    2223468


Q ss_pred             CCCccchhhh----ccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc-
Q 007261          485 TNGYMAPEYM----EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA-  559 (611)
Q Consensus       485 t~~y~aPE~~----~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~-  559 (611)
                      |..|+|||.+    .+..++.++||||||+++|||++|+.||........        ...      .......+.+.. 
T Consensus       188 t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~------~~~~~~~~~~~~~  253 (327)
T 3aln_A          188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--------QLT------QVVKGDPPQLSNS  253 (327)
T ss_dssp             ------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------C------CCCCSCCCCCCCC
T ss_pred             CccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--------HHH------HHhcCCCCCCCCc
Confidence            9999999998    466789999999999999999999999865432110        000      000000111111 


Q ss_pred             ChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          560 NKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .....+..+.+|+.+||+.||++||++.|++++
T Consensus       254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            122345678999999999999999999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.8e-35  Score=306.84  Aligned_cols=235  Identities=19%  Similarity=0.326  Sum_probs=161.0

Q ss_pred             ceEEEEEE--cCcEEEEEEecH--HHHHHHH-HHHhcCCCceeeccceecc----CCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMRR--SISKEVN-LLKKINHFNLINLFGACEH----DGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~--~~~~E~~-~l~~l~H~niv~l~g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  +|+.||||++..  ...+|+. .++.++||||+++++++..    +...++||||+++|+|.+++.... 
T Consensus        43 g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-  121 (336)
T 3fhr_A           43 GKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERG-  121 (336)
T ss_dssp             EEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC--
T ss_pred             eEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcC-
Confidence            89999998  589999999963  3344444 3556699999999999865    456899999999999999998753 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeecCccccccccCCcccccccccCC
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK---NLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ...+++..++.++.|++.||.|||   ..+|+||||||+|||++.   ++.+||+|||+++.....     ......+|+
T Consensus       122 ~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~t~  193 (336)
T 3fhr_A          122 DQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-----ALQTPCYTP  193 (336)
T ss_dssp             CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc-----ccccCCCCc
Confidence            245899999999999999999999   589999999999999976   456999999998754322     223456899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++||||||+++|||++|+.||..........  .........    . ....    ......++.
T Consensus       194 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~----~-~~~~----~~~~~~~~~  262 (336)
T 3fhr_A          194 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRIRLG----Q-YGFP----NPEWSEVSE  262 (336)
T ss_dssp             ----------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CCC----TTTSTTCCH
T ss_pred             CccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhhhcc----c-cccC----chhhccCCH
Confidence            9999999988889999999999999999999999987554322100  000000000    0 0000    011223566


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVSTL  593 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~L  593 (611)
                      .+.+|+.+||+.||++|||+.|++++-
T Consensus       263 ~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          263 DAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            789999999999999999999999843

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=303.91  Aligned_cols=236  Identities=24%  Similarity=0.331  Sum_probs=180.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCe------EEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGV------FYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~lV~E~~~~gsL~  401 (611)
                      |.||+|..  +|+.||||++.         +.+.+|+.++++++||||+++++++...+.      .++||||++ ++|.
T Consensus        38 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  116 (353)
T 3coi_A           38 GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQ  116 (353)
T ss_dssp             EEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGG
T ss_pred             eEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHH
Confidence            89999988  68999999984         357789999999999999999999977653      599999997 6888


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +++..     .+++..+..++.||+.||+|||   +.+++||||||+|||++.++.+||+|||+++.....      ...
T Consensus       117 ~~~~~-----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~------~~~  182 (353)
T 3coi_A          117 KIMGL-----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTG  182 (353)
T ss_dssp             GTTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------------
T ss_pred             HHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC------ccc
Confidence            87743     2899999999999999999999   589999999999999999999999999998754321      233


Q ss_pred             cccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc------------
Q 007261          482 AVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK------------  548 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~------------  548 (611)
                      ..+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.  ...+........ ...            
T Consensus       183 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~-~~~~~~~~~~~~~~~  259 (353)
T 3coi_A          183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPG-TEFVQKLNDKAAKSY  259 (353)
T ss_dssp             -CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCC-HHHHTTCSCHHHHHH
T ss_pred             cccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCC-HHHHHHHhhHHHHHH
Confidence            568999999999876 6789999999999999999999999976553321  111111111000 000            


Q ss_pred             ---cccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          549 ---LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       549 ---l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                         +.....+.+.......+..+.+|+.+||+.||++|||+.|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          260 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence               00000111111123456789999999999999999999999875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6e-34  Score=302.04  Aligned_cols=189  Identities=23%  Similarity=0.307  Sum_probs=158.5

Q ss_pred             cCCCCCccc----ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcC-CC-----ceeeccceeccCCeEEEE
Q 007261          330 NFSPKNMID----GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKIN-HF-----NLINLFGACEHDGVFYLV  391 (611)
Q Consensus       330 ~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~~~lV  391 (611)
                      +|.....||    |.||+|..  +|+.||||+++      ..+.+|+.+++.++ |+     +|+++++++...+..++|
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv  134 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV  134 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEE
T ss_pred             eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEE
Confidence            344444444    89999988  68899999996      34667899998884 55     499999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC--CCCcEEEeeecCcccc
Q 007261          392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD--KNLRAKLANFSFVRSA  469 (611)
Q Consensus       392 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~Dfgla~~~  469 (611)
                      |||++ |+|.+++..... ..+++..+..++.|++.||.|||+. ..+|+||||||+|||++  .++.+||+|||+++..
T Consensus       135 ~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          135 FEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             EECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence            99996 699999987532 3489999999999999999999942 47899999999999994  5788999999999765


Q ss_pred             ccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCC
Q 007261          470 VREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDG  527 (611)
Q Consensus       470 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~  527 (611)
                      ..      ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus       212 ~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          212 GQ------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             TC------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cc------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            32      12345789999999999999999999999999999999999999976544

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.7e-35  Score=308.17  Aligned_cols=243  Identities=19%  Similarity=0.285  Sum_probs=183.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcC-----------CCceeeccceeccCC----eEEEEEeec
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKIN-----------HFNLINLFGACEHDG----VFYLVYEFM  395 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~-----------H~niv~l~g~~~~~~----~~~lV~E~~  395 (611)
                      |.||++..  +|+.||||+++      ..+.+|+.++++++           |+||+++++++...+    ..++||||+
T Consensus        33 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~  112 (373)
T 1q8y_A           33 STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL  112 (373)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC
T ss_pred             eEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC
Confidence            89999997  78999999986      45778999999886           899999999987644    789999999


Q ss_pred             CCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeeeC------CCCcEEEeeecCccc
Q 007261          396 ENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDP-GYVHKDISSGNILLD------KNLRAKLANFSFVRS  468 (611)
Q Consensus       396 ~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~ivH~Dlk~~NILl~------~~~~~kl~Dfgla~~  468 (611)
                       +++|.+++..... ..+++..++.++.||+.||+|||   +. +|+||||||+|||++      ..+.+||+|||+++.
T Consensus       113 -~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~  187 (373)
T 1q8y_A          113 -GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW  187 (373)
T ss_dssp             -CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEE
T ss_pred             -CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccc
Confidence             8999999987532 34899999999999999999999   56 999999999999994      455899999999876


Q ss_pred             cccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChh----hHHHHHHHHHHhcCC
Q 007261          469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE----ILLAEAVFSMVEGGN  544 (611)
Q Consensus       469 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~----~~l~~~~~~~~~~~~  544 (611)
                      ....      .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||.......    ......+........
T Consensus       188 ~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p  261 (373)
T 1q8y_A          188 YDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP  261 (373)
T ss_dssp             TTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCC
T ss_pred             cCCC------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCC
Confidence            5321      234578999999999999999999999999999999999999997654321    111111111111000


Q ss_pred             c---------------ccccccccCc----------cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          545 A---------------EAKLSVLVDP----------NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       545 ~---------------~~~l~~~~d~----------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .               ...+..+...          .....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          262 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             HHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence            0               0000000000          0011245778899999999999999999999999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.1e-34  Score=296.93  Aligned_cols=230  Identities=20%  Similarity=0.363  Sum_probs=169.4

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||++..  +|+.||||+++.         .+.++..+++.++||||+++++++.+.+..++||||+ ++.+..+....
T Consensus        39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~  117 (318)
T 2dyl_A           39 GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRM  117 (318)
T ss_dssp             -CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHH
T ss_pred             eeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHh
Confidence            89999998  689999999852         2334555677889999999999999999999999999 55666655543


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      .  ..+++..++.++.|++.||.|||+  ..+++||||||+|||++.++.+||+|||++.......    ......+++.
T Consensus       118 ~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~  189 (318)
T 2dyl_A          118 Q--GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK----AKDRSAGCAA  189 (318)
T ss_dssp             T--SCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCTTC------------------CCT
T ss_pred             c--cCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc----cccccCCCcc
Confidence            2  348999999999999999999993  1389999999999999999999999999987553321    2234568999


Q ss_pred             ccchhhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          488 YMAPEYME-----YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       488 y~aPE~~~-----~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      |+|||.+.     ...++.++||||||+++|||++|+.||.........    .........          +.+ ....
T Consensus       190 y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~----------~~~-~~~~  254 (318)
T 2dyl_A          190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV----LTKVLQEEP----------PLL-PGHM  254 (318)
T ss_dssp             TCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----HHHHHHSCC----------CCC-CSSS
T ss_pred             ccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH----HHHHhccCC----------CCC-CccC
Confidence            99999984     567899999999999999999999998764433211    111221110          000 0111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+..+.+++.+||+.||.+||++.|++++
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            244678899999999999999999999874

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.5e-34  Score=298.72  Aligned_cols=240  Identities=21%  Similarity=0.281  Sum_probs=184.2

Q ss_pred             ceEEEEEE--cC-cEEEEEEec------HHHHHHHHHHHhcCCCc------eeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NG-STVAIKCMR------RSISKEVNLLKKINHFN------LINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g-~~vavK~~~------~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++..  ++ ..||||+++      ..+.+|+.++++++|++      ++.+++++...+..++||||+ +++|.++
T Consensus        33 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~  111 (355)
T 2eu9_A           33 GKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEF  111 (355)
T ss_dssp             EEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHH
T ss_pred             eEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHH
Confidence            89999987  34 689999986      35778999999997665      899999999999999999999 6778787


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee-------------------CCCCcEEEeeec
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL-------------------DKNLRAKLANFS  464 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl-------------------~~~~~~kl~Dfg  464 (611)
                      +.... ...+++..++.++.||+.||+|||   +.+|+||||||+|||+                   +.++.+||+|||
T Consensus       112 l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg  187 (355)
T 2eu9_A          112 LKENN-FQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG  187 (355)
T ss_dssp             HHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCT
T ss_pred             HHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecC
Confidence            76643 234899999999999999999999   6899999999999999                   568899999999


Q ss_pred             CccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCC
Q 007261          465 FVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN  544 (611)
Q Consensus       465 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  544 (611)
                      +++....      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..  ..+..... ..
T Consensus       188 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~-~~  258 (355)
T 2eu9_A          188 SATFDHE------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL--VMMEKILG-PI  258 (355)
T ss_dssp             TCEETTS------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHC-CC
T ss_pred             ccccccc------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHcC-CC
Confidence            9875432      223457899999999999999999999999999999999999999765543211  11111111 00


Q ss_pred             cccccc------cccCc----------------------cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          545 AEAKLS------VLVDP----------------------NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       545 ~~~~l~------~~~d~----------------------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +...+.      .....                      .........+..+.+|+.+||+.||++|||+.|++++
T Consensus       259 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          259 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH  334 (355)
T ss_dssp             CHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000000      00000                      0001123446689999999999999999999999864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5e-35  Score=302.69  Aligned_cols=218  Identities=26%  Similarity=0.411  Sum_probs=180.8

Q ss_pred             ceEEEEEE--cCcEEEEEEecH-------------HHHHHHHHHHhcC--CCceeeccceeccCCeEEEEEeecCC-CCH
Q 007261          339 GSVFRGII--NGSTVAIKCMRR-------------SISKEVNLLKKIN--HFNLINLFGACEHDGVFYLVYEFMEN-GSL  400 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~-------------~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~-gsL  400 (611)
                      |.||+|..  +|+.||||+++.             .+.+|+.++++++  |+||+++++++...+..++||||+.+ ++|
T Consensus        57 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L  136 (320)
T 3a99_A           57 GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL  136 (320)
T ss_dssp             CEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEH
T ss_pred             eEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccH
Confidence            89999987  788999999853             3567999999996  59999999999999999999999976 899


Q ss_pred             HHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEeeecCccccccccCCcccc
Q 007261          401 SDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD-KNLRAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      .+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++ +++.+||+|||+++.....     ..
T Consensus       137 ~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-----~~  205 (320)
T 3a99_A          137 FDFITERG---ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY  205 (320)
T ss_dssp             HHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS-----CB
T ss_pred             HHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc-----cc
Confidence            99998753   3899999999999999999999   68999999999999999 7899999999998765322     22


Q ss_pred             cccccCCCccchhhhccCCC-CCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCC
Q 007261          480 KTAVGTNGYMAPEYMEYGLV-TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ  558 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~~~~-s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~  558 (611)
                      ....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....  +         .....       ...     
T Consensus       206 ~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~---------~~~~~-------~~~-----  262 (320)
T 3a99_A          206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E---------IIRGQ-------VFF-----  262 (320)
T ss_dssp             CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H---------HHHCC-------CCC-----
T ss_pred             cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--h---------hhccc-------ccc-----
Confidence            34568999999999987665 688999999999999999999985321  0         01100       001     


Q ss_pred             cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        +...+.++.+|+.+||+.||++||++.|++++
T Consensus       263 --~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          263 --RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             --SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              11234578899999999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.3e-35  Score=299.12  Aligned_cols=218  Identities=28%  Similarity=0.384  Sum_probs=176.3

Q ss_pred             ceEEEEEE--cCcEEEEEEecH-------------HHHHHHHHHHhc----CCCceeeccceeccCCeEEEEEee-cCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMRR-------------SISKEVNLLKKI----NHFNLINLFGACEHDGVFYLVYEF-MENG  398 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~-------------~~~~E~~~l~~l----~H~niv~l~g~~~~~~~~~lV~E~-~~~g  398 (611)
                      |.||+|..  +|+.||||+++.             .+.+|+.++.++    +|+||+++++++...+..++|||| ++++
T Consensus        45 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~  124 (312)
T 2iwi_A           45 GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ  124 (312)
T ss_dssp             EEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEE
T ss_pred             EEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCC
Confidence            89999987  788999999852             245699999999    899999999999999999999999 7899


Q ss_pred             CHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC-CCCcEEEeeecCccccccccCCcc
Q 007261          399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD-KNLRAKLANFSFVRSAVREESGYS  477 (611)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~  477 (611)
                      +|.+++....   .+++..++.++.||+.||+|||   +.+++||||||+|||++ +++.+||+|||+++.....     
T Consensus       125 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~-----  193 (312)
T 2iwi_A          125 DLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-----  193 (312)
T ss_dssp             EHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS-----
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC-----
Confidence            9999998753   3899999999999999999999   58999999999999999 8899999999998765332     


Q ss_pred             cccccccCCCccchhhhccCCCC-CccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCcc
Q 007261          478 STKTAVGTNGYMAPEYMEYGLVT-PEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN  556 (611)
Q Consensus       478 ~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  556 (611)
                      ......++..|+|||.+.+..+. .++||||||+++|||++|+.||....  +         .....     .       
T Consensus       194 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~---------~~~~~-----~-------  250 (312)
T 2iwi_A          194 PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--E---------ILEAE-----L-------  250 (312)
T ss_dssp             CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H---------HHHTC-----C-------
T ss_pred             cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--H---------Hhhhc-----c-------
Confidence            22345689999999999876664 58999999999999999999985321  0         01000     0       


Q ss_pred             CCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       557 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        ..+...+..+.+++.+||+.||++||++.|++++
T Consensus       251 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          251 --HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0112244568899999999999999999999974

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.7e-34  Score=320.30  Aligned_cols=254  Identities=22%  Similarity=0.272  Sum_probs=187.6

Q ss_pred             hcCCCCCccc----ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceecc------CCeE
Q 007261          329 ENFSPKNMID----GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEH------DGVF  388 (611)
Q Consensus       329 ~~f~~~~~ig----g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~  388 (611)
                      ++|.....||    |.||++..  +|+.||||+++        ..+.+|+.++++++||||+++++++..      ++..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            4555566665    89999987  68899999975        357889999999999999999998765      6778


Q ss_pred             EEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCc---EEEeeecC
Q 007261          389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLR---AKLANFSF  465 (611)
Q Consensus       389 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfgl  465 (611)
                      ++||||+++|+|.+++........+++..++.++.|++.||+|||   ..+|+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            999999999999999987655456899999999999999999999   589999999999999987664   99999999


Q ss_pred             ccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHH----HHHHHHHHh
Q 007261          466 VRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILL----AEAVFSMVE  541 (611)
Q Consensus       466 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l----~~~~~~~~~  541 (611)
                      ++......    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........    .........
T Consensus       171 a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          171 AKELDQGE----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCBTTSCC----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             cccccccc----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            98653322    2334678999999999999999999999999999999999999987543211000    000000000


Q ss_pred             cCCcccccccccC-ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 007261          542 GGNAEAKLSVLVD-PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV  589 (611)
Q Consensus       542 ~~~~~~~l~~~~d-~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  589 (611)
                      ............. +.........+..+.+++.+||+.||++|||+.|+
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            0000000000000 01111244577889999999999999999999884

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.5e-33  Score=285.29  Aligned_cols=209  Identities=12%  Similarity=0.090  Sum_probs=167.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|..  +|+.||||+++          +.+.+|+.++.+++||||+++++++.+++..|+||||+++++|.+++..
T Consensus        45 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~  124 (286)
T 3uqc_A           45 LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT  124 (286)
T ss_dssp             CEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT
T ss_pred             eEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc
Confidence            89999998  48999999985          3578899999999999999999999999999999999999999999964


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .     ....+.++|+.|++.||+|||   +.+|+||||||+|||++.++.+||+++|                      
T Consensus       125 ~-----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~----------------------  174 (286)
T 3uqc_A          125 S-----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------  174 (286)
T ss_dssp             C-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC----------------------
T ss_pred             C-----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc----------------------
Confidence            3     345568889999999999999   6899999999999999999999998554                      


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCC---cChHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ---ANKKE  563 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~---~~~~~  563 (611)
                       |++       .++.++||||||+++|||++|+.||......+..              . ...........   .....
T Consensus       175 -~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~--------------~-~~~~~~~~~~~~~~~~~~~  231 (286)
T 3uqc_A          175 -TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL--------------A-PAERDTAGQPIEPADIDRD  231 (286)
T ss_dssp             -CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS--------------E-ECCBCTTSCBCCHHHHCTT
T ss_pred             -ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh--------------H-HHHHHhccCCCChhhcccC
Confidence             222       2688999999999999999999999765432100              0 00000111110   01224


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                      ++.++.+++.+||+.||++| |+.|+++.|.++.....
T Consensus       232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          232 IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            56779999999999999999 99999999999876543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.9e-33  Score=283.65  Aligned_cols=211  Identities=19%  Similarity=0.324  Sum_probs=167.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec--HHHHHHHHHH-HhcCCCceeeccceecc----CCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--RSISKEVNLL-KKINHFNLINLFGACEH----DGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  +|+.||||+++  ..+.+|+.++ +.++||||+++++++..    +...++||||+++|+|.+++.... 
T Consensus        32 g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-  110 (299)
T 3m2w_A           32 GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-  110 (299)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCT-
T ss_pred             eEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhcc-
Confidence            89999988  78899999996  5688899998 44599999999999876    677899999999999999998753 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeecCccccccccCCcccccccccCC
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK---NLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ...+++..++.++.|++.||+|||   +.+++||||||+|||++.   ++.+||+|||+++...                
T Consensus       111 ~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----------------  171 (299)
T 3m2w_A          111 DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----------------  171 (299)
T ss_dssp             TCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----------------
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc----------------
Confidence            245899999999999999999999   689999999999999998   7899999999976431                


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC---hHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN---KKE  563 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~---~~~  563 (611)
                               +..++.++||||||+++|||++|+.||........         .     ...............   ...
T Consensus       172 ---------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---------~-----~~~~~~~~~~~~~~~~~~~~~  228 (299)
T 3m2w_A          172 ---------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---------S-----PGMKTRIRMGQYEFPNPEWSE  228 (299)
T ss_dssp             ---------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------------------CCSCCSSCTTCCSSCHHHHTT
T ss_pred             ---------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh---------h-----HHHHHHHhhccccCCchhccc
Confidence                     13467799999999999999999999865433210         0     000011111111111   123


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+.++.+++.+||+.||++|||+.|++++
T Consensus       229 ~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          229 VSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            56789999999999999999999999985

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.5e-33  Score=317.96  Aligned_cols=217  Identities=23%  Similarity=0.287  Sum_probs=175.3

Q ss_pred             ceEEEEEE---cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCe-----EEEEEeecCCCCHHH
Q 007261          339 GSVFRGII---NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGV-----FYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~---~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~lV~E~~~~gsL~~  402 (611)
                      |.||++.+   +|+.||||++.        ..+.+|+.++++++||||+++++++...+.     .||||||+++++|.+
T Consensus        94 g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~  173 (681)
T 2pzi_A           94 GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR  173 (681)
T ss_dssp             EEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC-
T ss_pred             eEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHH
Confidence            89999997   47899999884        357789999999999999999999976554     799999999999998


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++..     .++|..++.|+.||+.||.|||   +.+|+||||||+|||++.+ .+||+|||+++.....       ...
T Consensus       174 ~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-------~~~  237 (681)
T 2pzi_A          174 SKGQ-----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-------GYL  237 (681)
T ss_dssp             ---C-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-------SCC
T ss_pred             HHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcccC-------Ccc
Confidence            8765     3899999999999999999999   5899999999999999986 8999999998765321       345


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC-h
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN-K  561 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~  561 (611)
                      .||+.|+|||.+.++. +.++||||||++||||++|..|+......                          ...... .
T Consensus       238 ~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------------------------~~~~~~~~  290 (681)
T 2pzi_A          238 YGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD--------------------------GLPEDDPV  290 (681)
T ss_dssp             CCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------------------------SCCTTCHH
T ss_pred             CCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--------------------------cccccccc
Confidence            7999999999987654 89999999999999999998776432110                          000111 2


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhchh
Q 007261          562 KEIAHHLIMLCLACIAREPESRP-SMAEVVSTLMKIQL  598 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~~  598 (611)
                      ...+..+.+++.+||+.||++|| +++++...|..+..
T Consensus       291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence            33456789999999999999999 56667777766543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.98  E-value=3e-33  Score=299.75  Aligned_cols=220  Identities=17%  Similarity=0.181  Sum_probs=167.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCC-Cceeeccce---------------------ecc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINH-FNLINLFGA---------------------CEH  384 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H-~niv~l~g~---------------------~~~  384 (611)
                      |.||+|.+  +|+.||||+++          +.+.+|+.+++.++| +|......+                     +..
T Consensus        92 G~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (413)
T 3dzo_A           92 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD  171 (413)
T ss_dssp             EEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC----------
T ss_pred             EEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCC
Confidence            89999998  59999999986          457899999999977 332211111                     111


Q ss_pred             -----CCeEEEEEeecCCCCHHHHhhcc----CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC
Q 007261          385 -----DGVFYLVYEFMENGSLSDWLHKK----RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN  455 (611)
Q Consensus       385 -----~~~~~lV~E~~~~gsL~~~l~~~----~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~  455 (611)
                           ....+++|+++ +++|.+++...    .....+++..++.++.||+.||+|||   +.+|+||||||+|||++.+
T Consensus       172 ~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDiKp~NILl~~~  247 (413)
T 3dzo_A          172 ERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQR  247 (413)
T ss_dssp             -----CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTT
T ss_pred             CccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcccceEEEecC
Confidence                 12357777766 68999998521    12345889999999999999999999   6899999999999999999


Q ss_pred             CcEEEeeecCccccccccCCcccccccccCCCccchhhh----------ccCCCCCccchHHHHHHHHHHHhCCCCCcCC
Q 007261          456 LRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYM----------EYGLVTPEMDTYAFGVVLLELITGKEAAYKQ  525 (611)
Q Consensus       456 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~  525 (611)
                      +.+||+|||+++.....      .....| +.|+|||.+          ....++.++|||||||++|||++|+.||...
T Consensus       248 ~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~  320 (413)
T 3dzo_A          248 GGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD  320 (413)
T ss_dssp             CCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTT
T ss_pred             CeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            99999999998764322      334566 999999999          5556889999999999999999999998654


Q ss_pred             CChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          526 DGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       526 ~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ...+                  .....+...     ...+..+.+|+.+||+.||++||++.+++++
T Consensus       321 ~~~~------------------~~~~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          321 AALG------------------GSEWIFRSC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             GGGS------------------CSGGGGSSC-----CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             chhh------------------hHHHHHhhc-----ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            3221                  011111110     1234678999999999999999999888764

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=5.8e-33  Score=289.07  Aligned_cols=230  Identities=17%  Similarity=0.173  Sum_probs=172.8

Q ss_pred             cCCCCCccc----ceEEEEEEcCcEEEEEEec---------------HHHHHHHHHHHhcC-------------------
Q 007261          330 NFSPKNMID----GSVFRGIINGSTVAIKCMR---------------RSISKEVNLLKKIN-------------------  371 (611)
Q Consensus       330 ~f~~~~~ig----g~Vy~g~~~g~~vavK~~~---------------~~~~~E~~~l~~l~-------------------  371 (611)
                      +|.....||    |.||+|+.+|+.||||+++               +.+.+|+.++++++                   
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~  100 (336)
T 2vuw_A           21 KLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSV  100 (336)
T ss_dssp             HHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEE
T ss_pred             cchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcce
Confidence            344444554    8999999999999999985               56889999999986                   


Q ss_pred             -------CCceeeccceecc-------------CCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHH
Q 007261          372 -------HFNLINLFGACEH-------------DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHY  431 (611)
Q Consensus       372 -------H~niv~l~g~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~y  431 (611)
                             ||||+++++++.+             .+..+|||||+++|++.+.+.+    ..+++..++.++.||+.||+|
T Consensus       101 ~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A          101 HCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHHHH
T ss_pred             eEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHHHH
Confidence                   5666666666654             7889999999999977666644    238999999999999999999


Q ss_pred             HhcCCCCCeEecCCCCCCeeeCCCC--------------------cEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          432 LHNCTDPGYVHKDISSGNILLDKNL--------------------RAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       432 LH~~~~~~ivH~Dlk~~NILl~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      ||+  +.+|+||||||+|||++.++                    .+||+|||+++....        ....||+.|+||
T Consensus       177 lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y~aP  246 (336)
T 2vuw_A          177 AEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVSMDE  246 (336)
T ss_dssp             HHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCCTTCS
T ss_pred             HHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeecccCh
Confidence            992  37899999999999999887                    999999999986532        134789999999


Q ss_pred             hhhccCCCCCccchHHHHHH-HHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVV-LLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvv-l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      |.+.+.. +.++||||||.+ .+++++|..|+....    ..............       .............+.++.+
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~----~~~~~~~~~~~~~~-------~~~~~~~~~~~~~s~~~~d  314 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL----WLHYLTDKMLKQMT-------FKTKCNTPAMKQIKRKIQE  314 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH----HHHHHHHHHHHTCC-------CSSCCCSHHHHHHHHHHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchh----hhhHHHHhhhhhhc-------cCcccchhhhhhcCHHHHH
Confidence            9998766 889999998777 777888888873210    00111111111000       0011111225578889999


Q ss_pred             HHHHhhccCCCCCCCHHHHH
Q 007261          571 LCLACIAREPESRPSMAEVV  590 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl  590 (611)
                      |+.+||+.|     |+.|++
T Consensus       315 li~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          315 FHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHGGGSS-----SHHHHH
T ss_pred             HHHHHhccC-----CHHHHH
Confidence            999999976     899888

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=6.1e-28  Score=268.01  Aligned_cols=163  Identities=18%  Similarity=0.157  Sum_probs=124.0

Q ss_pred             EcCcEEEEEEec-----------------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          346 INGSTVAIKCMR-----------------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       346 ~~g~~vavK~~~-----------------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      +-|+.+|+|++.                 ++|.+|+++|+++ .|+||+++++++++++..||||||++|++|.++|...
T Consensus       257 ~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~  336 (569)
T 4azs_A          257 FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG  336 (569)
T ss_dssp             EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT
T ss_pred             cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC
Confidence            368889999984                 3588999999999 7999999999999999999999999999999999875


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      +   .++..   +|+.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+......   ......+||+.
T Consensus       337 ~---~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~---~~~~t~vGTp~  404 (569)
T 4azs_A          337 E---EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC---SWPTNLVQSFF  404 (569)
T ss_dssp             C---CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC------CCSHHHHHHHH
T ss_pred             C---CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC---ccccCceechh
Confidence            4   25543   58899999999999   6999999999999999999999999999998654332   23345679999


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhCCCC
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA  521 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p  521 (611)
                      |||||.+.+ .+..++|+||+|++++++.++..+
T Consensus       405 YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          405 VFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHHHHHC------------------CCCCTTHHH
T ss_pred             hccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            999999875 467789999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.89  E-value=2.7e-24  Score=237.36  Aligned_cols=168  Identities=15%  Similarity=0.163  Sum_probs=141.3

Q ss_pred             ceEEEEEEcCcEEEEEEec---------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIINGSTVAIKCMR---------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~---------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||++.+.+..+++|+..               +.+.+|+++|++++||||+++..++...+..+|||||+++++|.++
T Consensus       350 g~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~  429 (540)
T 3en9_A          350 ADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDV  429 (540)
T ss_dssp             EEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHH
T ss_pred             EEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHH
Confidence            9999998899999999852               2378999999999999999777666677777999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc----ccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY----SST  479 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~----~~~  479 (611)
                      +..           ++.++.|++.||+|||   +.+|+||||||+|||+++  .+||+|||+++.........    ...
T Consensus       430 l~~-----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~  493 (540)
T 3en9_A          430 IED-----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFK  493 (540)
T ss_dssp             STT-----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHH
T ss_pred             HHH-----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhh
Confidence            976           3579999999999999   689999999999999999  99999999998764332110    012


Q ss_pred             cccccCCCccchhhhcc--CCCCCccchHHHHHHHHHHHhCCCCC
Q 007261          480 KTAVGTNGYMAPEYMEY--GLVTPEMDTYAFGVVLLELITGKEAA  522 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~--~~~s~ksDV~s~Gvvl~elltG~~p~  522 (611)
                      ....||+.|||||++..  ..|+...|+|+..+-.++-+.++.++
T Consensus       494 ~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          494 KAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             hhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            35679999999999976  56788899999999998888776554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.79  E-value=1.1e-19  Score=184.09  Aligned_cols=124  Identities=16%  Similarity=0.148  Sum_probs=103.2

Q ss_pred             ceEEEEEE-cCcEEEEEEec-------------------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEE
Q 007261          339 GSVFRGII-NGSTVAIKCMR-------------------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVY  392 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~-------------------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  392 (611)
                      |.||+|.. +|+.||||.++                         ..+.+|+.+|++++  | +++.+++.. +..++||
T Consensus       104 g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvm  179 (282)
T 1zar_A          104 SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLM  179 (282)
T ss_dssp             EEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEE
T ss_pred             ceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEE
Confidence            89999999 68899999984                         23678999999999  5 777776644 4569999


Q ss_pred             eecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       393 E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      ||+++|+|.+ +..         .....++.|++.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.    
T Consensus       180 E~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~----  241 (282)
T 1zar_A          180 ELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE----  241 (282)
T ss_dssp             ECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECCCTTCEE----
T ss_pred             EecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE----
Confidence            9999999988 522         123469999999999999   68999999999999999 99999999999763    


Q ss_pred             cCCcccccccccCCCccchhhhcc
Q 007261          473 ESGYSSTKTAVGTNGYMAPEYMEY  496 (611)
Q Consensus       473 ~~~~~~~~~~~gt~~y~aPE~~~~  496 (611)
                                  +..++|||++..
T Consensus       242 ------------~~~~~a~e~l~r  253 (282)
T 1zar_A          242 ------------VGEEGWREILER  253 (282)
T ss_dssp             ------------TTSTTHHHHHHH
T ss_pred             ------------CCCCCHHHHHHH
Confidence                        234789998854

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=99.79  E-value=1.7e-19  Score=172.50  Aligned_cols=109  Identities=19%  Similarity=0.274  Sum_probs=93.4

Q ss_pred             cceeEEEeecCCchhhhhHhhcCCCccH--------HHHHHhc-CCC-CCCCCCCceeeeeccCCCCCCccccCCeeEEE
Q 007261          104 ANTSFIIPTIYHTYFSIANNTYQGLSTC--------NILKHEN-NYS-ETSLDQGLTLRVPLRCACPTSNQIVNGTKFLL  173 (611)
Q Consensus       104 ~~~~y~V~~~gdTl~~IA~~~~~~l~t~--------~~l~~~N-~~~-~~~l~~G~~l~ip~~~~~~~~~~~~~~~~~~~  173 (611)
                      +...|+|++ |||||.||++|.   +++        ++|+++| ++. ++.|.+||.|.||..|.|....    ......
T Consensus         8 a~~~Y~V~~-GDTL~~IA~~~~---vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~----~~~~~~   79 (212)
T 4eby_A            8 ALASYYLEN-GTTLSVINQNLN---SSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGD----FLGHNF   79 (212)
T ss_dssp             EEEEEECCT-TCCHHHHHHHTC---CSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTT----EEEEEE
T ss_pred             ceEEEEeCC-CCCHHHHHHHHC---CCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCc----cccCce
Confidence            456899999 999999997655   666        9999999 775 6789999999999999886421    123457


Q ss_pred             EEEccCCCChhHHH-hHhc--CCHHHHHHhcCCCCCCCCcccceeeeecCCC
Q 007261          174 TYLVSWGDSVPDIS-KRFN--VSIESIVNANGFTEDDPLLFPFTTILIPLTT  222 (611)
Q Consensus       174 ~y~v~~gdtl~~Ia-~~f~--~~~~~l~~~N~~~~~~~~i~~g~~l~ip~~~  222 (611)
                      +|+|++|||||.|| ++|+  +++++|+++|++  .++.|++||.|.||...
T Consensus        80 ~Y~V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~--~~~~l~~Gq~L~IP~~~  129 (212)
T 4eby_A           80 SYSVRQEDTYERVAISNYANLTTMESLQARNPF--PATNIPLSATLNVLVNC  129 (212)
T ss_dssp             EEECCTTCCHHHHHHTTTTTSSCHHHHHHHCCS--CTTCCCTTCEEEEEEEC
T ss_pred             EEEecCCCcHHHHHHHhcCCCCCHHHHHHhcCC--CcccCCCCCEEEEcCCC
Confidence            89999999999999 8999  999999999996  56789999999999765

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.61  E-value=9.8e-16  Score=152.83  Aligned_cols=117  Identities=20%  Similarity=0.181  Sum_probs=92.0

Q ss_pred             ceEEEEEE--cCcE--EEEEEec-------------------------------HHHHHHHHHHHhcCCCce--eeccce
Q 007261          339 GSVFRGII--NGST--VAIKCMR-------------------------------RSISKEVNLLKKINHFNL--INLFGA  381 (611)
Q Consensus       339 g~Vy~g~~--~g~~--vavK~~~-------------------------------~~~~~E~~~l~~l~H~ni--v~l~g~  381 (611)
                      |.||+|..  +|+.  ||||+++                               ..+.+|+.+|.+++|+++  ..++++
T Consensus        61 g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~  140 (258)
T 1zth_A           61 ANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY  140 (258)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE
T ss_pred             EEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc
Confidence            89999998  8989  9999853                               146789999999988764  333322


Q ss_pred             eccCCeEEEEEeecCC-C----CHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC
Q 007261          382 CEHDGVFYLVYEFMEN-G----SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL  456 (611)
Q Consensus       382 ~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~  456 (611)
                          +..+|||||+.+ |    +|.++...      .++.....++.|++.||.|||.  ..+|+||||||.|||+++  
T Consensus       141 ----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp~NILl~~--  206 (258)
T 1zth_A          141 ----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQ--EAELVHADLSEYNIMYID--  206 (258)
T ss_dssp             ----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCSTTSEEESS--
T ss_pred             ----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEEcC--
Confidence                345899999942 4    77776543      2234567899999999999993  378999999999999998  


Q ss_pred             cEEEeeecCcccc
Q 007261          457 RAKLANFSFVRSA  469 (611)
Q Consensus       457 ~~kl~Dfgla~~~  469 (611)
                      .++|+|||++...
T Consensus       207 ~~~liDFG~a~~~  219 (258)
T 1zth_A          207 KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEECCCTTCEET
T ss_pred             cEEEEECcccccC
Confidence            9999999998653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.39  E-value=1.4e-13  Score=143.60  Aligned_cols=119  Identities=14%  Similarity=0.072  Sum_probs=81.8

Q ss_pred             ceEEEEEE-cCcEEEEEEecH---------------------HHHHHHHHHHhcCCCceeeccceeccC------CeEEE
Q 007261          339 GSVFRGII-NGSTVAIKCMRR---------------------SISKEVNLLKKINHFNLINLFGACEHD------GVFYL  390 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~~---------------------~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l  390 (611)
                      |.||+|.. +|+.||||+++.                     ....+..+.....|+|+++++.....-      ...+|
T Consensus       109 a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~~~~~L  188 (397)
T 4gyi_A          109 SDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQSRHTI  188 (397)
T ss_dssp             EEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEEETTEE
T ss_pred             eEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeeccCceE
Confidence            78999987 799999998641                     112222222223344444443322111      11269


Q ss_pred             EEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----------cEEE
Q 007261          391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL----------RAKL  460 (611)
Q Consensus       391 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----------~~kl  460 (611)
                      ||||+++++|..+...         .....++.|++.+|.|||   +.+||||||||.|||+++++          .+.|
T Consensus       189 VME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~i  256 (397)
T 4gyi_A          189 VMSLVDALPMRQVSSV---------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDAEDPSSITLTPII  256 (397)
T ss_dssp             EEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEE
T ss_pred             EEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCcccccccccceEE
Confidence            9999999888654321         123467899999999999   58999999999999998876          3899


Q ss_pred             eeecCcccc
Q 007261          461 ANFSFVRSA  469 (611)
Q Consensus       461 ~Dfgla~~~  469 (611)
                      +||+-+...
T Consensus       257 ID~~Q~V~~  265 (397)
T 4gyi_A          257 IXFPQMVSM  265 (397)
T ss_dssp             CCCTTCEET
T ss_pred             EEeCCcccC
Confidence            999976543

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=99.35  E-value=1.2e-13  Score=126.65  Aligned_cols=95  Identities=14%  Similarity=0.040  Sum_probs=74.8

Q ss_pred             cceeEEEeecCCchhhhhHhhcCCCccHHHHHHhcCCC-CCCCCCCceeeeeccCCCCCCccccCCeeEEEEEEccCCCC
Q 007261          104 ANTSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYS-ETSLDQGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDS  182 (611)
Q Consensus       104 ~~~~y~V~~~gdTl~~IA~~~~~~l~t~~~l~~~N~~~-~~~l~~G~~l~ip~~~~~~~~~~~~~~~~~~~~y~v~~gdt  182 (611)
                      ....|+||+ |||||.||++| .  +++.+|+++|++. ++.|++||+|.||....-+.... .........|+|++|||
T Consensus        61 ~~~~y~V~~-GDTL~~IA~~~-~--~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~~~~~~~~-~~~~~~~~~~~v~~Gdt  135 (167)
T 2l9y_A           61 GTATVTVQQ-GDTLRDIGRRF-D--CDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGAG-NFWDSARDVRLVDGGKV  135 (167)
T ss_dssp             SCEEEEECT-TCCHHHHHHHT-T--CCHHHHHHHHTCCGGGCCCTTEEEEESCCCCCSSSSC-CGGGGEEEEEEETTTTE
T ss_pred             CCceEEECC-CCcHHHHHHHc-C--CCHHHHHHHcCCCCcccccCCCEEEEcCCCCcccccc-ccccccceEEEeCCcCC
Confidence            456899999 99999999765 3  8889999999988 68999999999997643211001 11112346799999999


Q ss_pred             hhHHHhHhcCCHHHHHHhcCC
Q 007261          183 VPDISKRFNVSIESIVNANGF  203 (611)
Q Consensus       183 l~~Ia~~f~~~~~~l~~~N~~  203 (611)
                      |+.||++||.++..++.+|..
T Consensus       136 L~aIA~r~G~~v~s~i~Ln~~  156 (167)
T 2l9y_A          136 LEAELRYSGGWNRSRIYLDEH  156 (167)
T ss_dssp             EEEEEEETTEEEEEEECGGGT
T ss_pred             hHHHHHHcCCceEEEEEcccc
Confidence            999999999999888888864

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=99.33  E-value=1.8e-12  Score=103.48  Aligned_cols=63  Identities=27%  Similarity=0.413  Sum_probs=55.6

Q ss_pred             CCceeeeeccCCCCCCccccCCeeEEEEEEccCCCChhHHHhHhcCCHHHHHHhcCCCCCCCCcccceeeeecCCCC
Q 007261          147 QGLTLRVPLRCACPTSNQIVNGTKFLLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLTTE  223 (611)
Q Consensus       147 ~G~~l~ip~~~~~~~~~~~~~~~~~~~~y~v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~~~~~i~~g~~l~ip~~~~  223 (611)
                      .||+|.||..             ....+|+|++|||||.||++||+++++|+++|++. ....|++||.|.||....
T Consensus         3 ~Gq~l~ip~~-------------~~~~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~l~-~~~~l~~Gq~l~iP~~~~   65 (77)
T 2djp_A            3 SGSSGCSPVR-------------ERRLEHQLEPGDTLAGLALKYGVTMEQIKRANRLY-TNDSIFLKKTLYIPILTE   65 (77)
T ss_dssp             CCCCCCCCCC-------------EEEEEECCCTTCCHHHHHHHHTCCHHHHHHHHTCC-CSSCGGGSSCEEEEEECC
T ss_pred             CCcEeeccCC-------------CCcEEEEECCCCcHHHHHHHHCcCHHHHHHHcCCC-CccccCCCCEEEECCCCC
Confidence            5899999853             24578999999999999999999999999999996 678999999999997653

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=99.19  E-value=4.6e-12  Score=116.17  Aligned_cols=93  Identities=18%  Similarity=0.093  Sum_probs=71.7

Q ss_pred             cceeeeeecCCCCCCHHHHHHhhCCChHhhhhhhCCCCCCCCCCCCCeEEEeeecccC---CCcc-ccceeEEEeecCCc
Q 007261           41 CQGFLIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVSCYCS---GLYY-QANTSFIIPTIYHT  116 (611)
Q Consensus        41 c~~~~~y~~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~vP~~~~c~---~~~~-~~~~~y~V~~~gdT  116 (611)
                      -.+...|++++ ||||+.||++||+++.+|+++|++.+ ++.|.+||.|.||....-.   .... .....|+|++ |||
T Consensus        59 ~~~~~~y~V~~-GDTL~~IA~~~~~~~~~l~~~N~~~~-~~~i~~Gq~L~ip~~~~~~~~~~~~~~~~~~~~~v~~-Gdt  135 (167)
T 2l9y_A           59 GGGTATVTVQQ-GDTLRDIGRRFDCDFHEIARRNNIQN-EDLIYPGQVLQVPTKGGSGGGAGNFWDSARDVRLVDG-GKV  135 (167)
T ss_dssp             CCSCEEEEECT-TCCHHHHHHHTTCCHHHHHHHHTCCG-GGCCCTTEEEEESCCCCCSSSSCCGGGGEEEEEEETT-TTE
T ss_pred             CCCCceEEECC-CCcHHHHHHHcCCCHHHHHHHcCCCC-cccccCCCEEEEcCCCCccccccccccccceEEEeCC-cCC
Confidence            34557899987 99999999999999999999999998 7999999999999764421   1111 1235799999 999


Q ss_pred             hhhhhHhhcCCCccHHHHHHhcC
Q 007261          117 YFSIANNTYQGLSTCNILKHENN  139 (611)
Q Consensus       117 l~~IA~~~~~~l~t~~~l~~~N~  139 (611)
                      |+.||++ +.  .+.++....|.
T Consensus       136 L~aIA~r-~G--~~v~s~i~Ln~  155 (167)
T 2l9y_A          136 LEAELRY-SG--GWNRSRIYLDE  155 (167)
T ss_dssp             EEEEEEE-TT--EEEEEEECGGG
T ss_pred             hHHHHHH-cC--CceEEEEEccc
Confidence            9999987 44  44455544543

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=99.16  E-value=1.4e-11  Score=128.18  Aligned_cols=112  Identities=12%  Similarity=0.054  Sum_probs=85.2

Q ss_pred             ceeEEEeecCCchhhhhHhhcCCCccHHHHHHhcCCC-----CCCCCCCceeeeeccCCCCC--------Cc------cc
Q 007261          105 NTSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYS-----ETSLDQGLTLRVPLRCACPT--------SN------QI  165 (611)
Q Consensus       105 ~~~y~V~~~gdTl~~IA~~~~~~l~t~~~l~~~N~~~-----~~~l~~G~~l~ip~~~~~~~--------~~------~~  165 (611)
                      +..|+|++ ||||+.||+++.   ++.++|.++|+..     .+.|++||+|.||....-.-        ..      ..
T Consensus         7 ~~~~~Vk~-GDTL~~Ia~r~g---vs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~~~l~~l~~~~~~~~~~~~~~~   82 (361)
T 2gu1_A            7 RIHYMVKV-GDTLSGIFAQLG---VPYSILQKILSVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKAIYTRE   82 (361)
T ss_dssp             CEEEECCT-TCCHHHHHHHTT---CCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTTSCEEEEEEEEETTEEEEEEEC
T ss_pred             ceEEEECC-CCcHHHHHHHcC---CCHHHHHHHHhhcccccchhcCCCCCEEEEEECCCCcceEEEEEcCccceEEEEec
Confidence            46899999 999999997665   7889999998765     35799999999997521100        00      00


Q ss_pred             -----------cCCeeEEEEEEccCCCChhHHHhHhcCCHHHHHHhcCCCCCC-----CCcccceeeeecCC
Q 007261          166 -----------VNGTKFLLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDD-----PLLFPFTTILIPLT  221 (611)
Q Consensus       166 -----------~~~~~~~~~y~v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~~~-----~~i~~g~~l~ip~~  221 (611)
                                 ........+|.|+.|||||.||++||+++..|++||++. ..     ..|++|+.+.|+..
T Consensus        83 ~~g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA~~~Gvs~~~i~~ln~i~-~~~idf~~~Lr~GD~l~V~~~  153 (361)
T 2gu1_A           83 NDGSFSYDFQEISGEWREILFSGEINGSFSVSARRVGLTSSQVANITQVM-KDKIDFSRSLRAGDRFDILVK  153 (361)
T ss_dssp             TTSCEEEEEEECCCEEEEEEEEEESSSCHHHHHHHTTCCHHHHHHHHHHH-TTTCCTTTCCCC-CEEEEEEE
T ss_pred             CCCcceeeecccCceEEEEEEEEEECCcHHHHHHHcCCCHHHHHHHHHhh-cccccccccCCCCCEEEEEEE
Confidence                       011123467999999999999999999999999999875 33     46999999999864

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=99.10  E-value=6.4e-11  Score=85.09  Aligned_cols=46  Identities=33%  Similarity=0.465  Sum_probs=41.8

Q ss_pred             EEEEccCCCChhHHHhHhcCCHHHHHHhcCCCCCCCCcccceeeeecCC
Q 007261          173 LTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLT  221 (611)
Q Consensus       173 ~~y~v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~~~~~i~~g~~l~ip~~  221 (611)
                      .+|+|++|||||+||++||+++++|.++|+   ....|+|||.|.||..
T Consensus         3 ~~y~V~~GDtl~~Ia~~~~~~~~~l~~~N~---~~~~l~~G~~l~ip~~   48 (48)
T 1e0g_A            3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNS---DTANLQPGDKLTLFVK   48 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHTCCHHHHHHHCS---CGGGCCTTEEEECCCC
T ss_pred             EEEEEcCCCcHHHHHHHHCcCHHHHHHhCC---CCCcCCcCCEEEEecC
Confidence            369999999999999999999999999998   3467999999999963

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.08  E-value=2.1e-10  Score=113.99  Aligned_cols=121  Identities=12%  Similarity=0.183  Sum_probs=98.4

Q ss_pred             ceEEEEEEcCcEEEEEEecH-------HHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGIINGSTVAIKCMRR-------SISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~~-------~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      +.||+....|..+++|....       ++.+|+.+++.+ .|.++.++++++.+.+..|+||||++|.+|.+.+...   
T Consensus        28 ~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~---  104 (263)
T 3tm0_A           28 AKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE---  104 (263)
T ss_dssp             SEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCTT---
T ss_pred             CeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCCc---
Confidence            56999988889999999863       588999999999 4677888999998888999999999999998764211   


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------------------
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCT------------------------------------------------------  436 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~------------------------------------------------------  436 (611)
                           .....++.+++.+|..||+..                                                      
T Consensus       105 -----~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~  179 (263)
T 3tm0_A          105 -----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP  179 (263)
T ss_dssp             -----TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCC
T ss_pred             -----ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCC
Confidence                 123467889999999999610                                                      


Q ss_pred             --CCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          437 --DPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       437 --~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                        ...++|+|+++.|||++++..+.|+||+.+.
T Consensus       180 ~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          180 EEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence              1458999999999999876667799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.89  E-value=2.8e-09  Score=105.21  Aligned_cols=118  Identities=14%  Similarity=0.132  Sum_probs=90.3

Q ss_pred             ceEEEEEE-cCcEEEEEEec----HHHHHHHHHHHhcCCCc--eeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR----RSISKEVNLLKKINHFN--LINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~----~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      +.||+... +|..+++|...    ..+.+|+.+++.+.+.+  +.+++++...++..++||||++|.+|.  ...     
T Consensus        34 ~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~-----  106 (264)
T 1nd4_A           34 AAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH-----  106 (264)
T ss_dssp             CEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC-----
T ss_pred             ceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc-----
Confidence            67999876 46789999976    35789999999995545  455888888778899999999998884  211     


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------------------
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCT-------------------------------------------------------  436 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~-------------------------------------------------------  436 (611)
                       .+   ...++.+++..|..||+..                                                       
T Consensus       107 -~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  182 (264)
T 1nd4_A          107 -LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE  182 (264)
T ss_dssp             -CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred             -CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCC
Confidence             11   1256778888888888532                                                       


Q ss_pred             CCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          437 DPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       437 ~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      ...++|+|++|.|||++++..+.|+||+.+.
T Consensus       183 ~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          183 DLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence            1229999999999999887667899999864

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=98.89  E-value=1.9e-09  Score=112.03  Aligned_cols=108  Identities=11%  Similarity=0.038  Sum_probs=82.8

Q ss_pred             eeeeecCCCCCCHHHHHHhhCCChHhhhhhhCCCCC---CCCCCCCCeEEEeeecccC--------------------CC
Q 007261           44 FLIFKSQPPYDTVSSISNLTSSDPTELARVNNISNS---AAALPLDKEVIVPVSCYCS--------------------GL  100 (611)
Q Consensus        44 ~~~y~~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~---~~~l~~gq~l~vP~~~~c~--------------------~~  100 (611)
                      ...|++++ ||||++||++||+++++|+++|++...   .+.|.+||.|.||....-.                    .+
T Consensus         7 ~~~~~Vk~-GDTL~~Ia~r~gvs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~~~l~~l~~~~~~~~~~~~~~~~~g   85 (361)
T 2gu1_A            7 RIHYMVKV-GDTLSGIFAQLGVPYSILQKILSVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKAIYTRENDG   85 (361)
T ss_dssp             CEEEECCT-TCCHHHHHHHTTCCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTTSCEEEEEEEEETTEEEEEEECTTS
T ss_pred             ceEEEECC-CCcHHHHHHHcCCCHHHHHHHHhhcccccchhcCCCCCEEEEEECCCCcceEEEEEcCccceEEEEecCCC
Confidence            45688876 999999999999999999999987531   3689999999999753210                    00


Q ss_pred             -cc---------ccceeEEEeecCCchhhhhHhhcCCCccHHHHHHhcCCCC------CCCCCCceeeeecc
Q 007261          101 -YY---------QANTSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSE------TSLDQGLTLRVPLR  156 (611)
Q Consensus       101 -~~---------~~~~~y~V~~~gdTl~~IA~~~~~~l~t~~~l~~~N~~~~------~~l~~G~~l~ip~~  156 (611)
                       +.         .....|+|+. |||||.||+++.   ++.++|+++|++..      ..|++||+|.|+..
T Consensus        86 ~f~~~~~~~~~~~~~~~~~v~i-gdSL~~iA~~~G---vs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~~  153 (361)
T 2gu1_A           86 SFSYDFQEISGEWREILFSGEI-NGSFSVSARRVG---LTSSQVANITQVMKDKIDFSRSLRAGDRFDILVK  153 (361)
T ss_dssp             CEEEEEEECCCEEEEEEEEEES-SSCHHHHHHHTT---CCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEEE
T ss_pred             cceeeecccCceEEEEEEEEEE-CCcHHHHHHHcC---CCHHHHHHHHHhhcccccccccCCCCCEEEEEEE
Confidence             00         0123589999 999999997665   77799999987642      46999999999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.80  E-value=8.1e-09  Score=107.57  Aligned_cols=126  Identities=16%  Similarity=0.272  Sum_probs=99.5

Q ss_pred             ceEEEEEEcCcEEEEEEec----------HHHHHHHHHHHhcC--CCceeeccceeccC---CeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIINGSTVAIKCMR----------RSISKEVNLLKKIN--HFNLINLFGACEHD---GVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~----------~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~E~~~~gsL~~~  403 (611)
                      +.+|+....+..+++|+..          .++.+|+.+++.+.  +..+.++++++.+.   +..++||||++|..+.+.
T Consensus        52 n~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~  131 (359)
T 3dxp_A           52 NPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ  131 (359)
T ss_dssp             SCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT
T ss_pred             ceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC
Confidence            5789988877889999876          25778999999996  45678888888766   458999999998777431


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------------
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCT-----------------------------------------------  436 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----------------------------------------------  436 (611)
                      .     ...++...+..++.++++.|..||...                                               
T Consensus       132 ~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  206 (359)
T 3dxp_A          132 S-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQ  206 (359)
T ss_dssp             T-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGG
T ss_pred             c-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHh
Confidence            1     123677888899999999999999621                                               


Q ss_pred             --------CCCeEecCCCCCCeeeCCCCc--EEEeeecCcccc
Q 007261          437 --------DPGYVHKDISSGNILLDKNLR--AKLANFSFVRSA  469 (611)
Q Consensus       437 --------~~~ivH~Dlk~~NILl~~~~~--~kl~Dfgla~~~  469 (611)
                              ...++|+|+++.|||++.++.  +.|+||+++...
T Consensus       207 ~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          207 HIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             cCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                    257999999999999997753  689999988643

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=98.70  E-value=9.2e-09  Score=73.62  Aligned_cols=45  Identities=16%  Similarity=0.121  Sum_probs=40.3

Q ss_pred             eeEEEeecCCchhhhhHhhcCCCccHHHHHHhcCCCCCCCCCCceeeeec
Q 007261          106 TSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPL  155 (611)
Q Consensus       106 ~~y~V~~~gdTl~~IA~~~~~~l~t~~~l~~~N~~~~~~l~~G~~l~ip~  155 (611)
                      ..|+|++ |||||+||+++.   +++++|+++|+ .++.|.+||+|.||+
T Consensus         3 ~~y~V~~-GDtl~~Ia~~~~---~~~~~l~~~N~-~~~~l~~G~~l~ip~   47 (48)
T 1e0g_A            3 ITYRVRK-GDSLSSIAKRHG---VNIKDVMRWNS-DTANLQPGDKLTLFV   47 (48)
T ss_dssp             CEEEECT-TCCHHHHHHHHT---CCHHHHHHHCS-CGGGCCTTEEEECCC
T ss_pred             EEEEEcC-CCcHHHHHHHHC---cCHHHHHHhCC-CCCcCCcCCEEEEec
Confidence            5799999 999999997765   67899999999 767899999999996

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=98.68  E-value=2.2e-08  Score=79.58  Aligned_cols=52  Identities=17%  Similarity=0.268  Sum_probs=47.3

Q ss_pred             ceeeeeecCCCCCCHHHHHHhhCCChHhhhhhhCCCCCCCCCCCCCeEEEeeec
Q 007261           42 QGFLIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPVSC   95 (611)
Q Consensus        42 ~~~~~y~~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~vP~~~   95 (611)
                      ..+..|++++ ||||+.||++||+++++|+++|++.+ .+.|.+||.|.||..-
T Consensus        13 ~~~~~y~V~~-GDTL~~IA~~~~~~~~~l~~~N~l~~-~~~l~~Gq~l~iP~~~   64 (77)
T 2djp_A           13 ERRLEHQLEP-GDTLAGLALKYGVTMEQIKRANRLYT-NDSIFLKKTLYIPILT   64 (77)
T ss_dssp             EEEEEECCCT-TCCHHHHHHHHTCCHHHHHHHHTCCC-SSCGGGSSCEEEEEEC
T ss_pred             CCcEEEEECC-CCcHHHHHHHHCcCHHHHHHHcCCCC-ccccCCCCEEEECCCC
Confidence            4678899987 99999999999999999999999986 6889999999999854

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.56  E-value=4.3e-08  Score=99.61  Aligned_cols=165  Identities=18%  Similarity=0.176  Sum_probs=104.1

Q ss_pred             cEEEEEEec-----HHHHHHHHHHHhc-CCCc--eeeccceeccCC---eEEEEEeecCCCCHHHHhhccCCCCccCHHH
Q 007261          349 STVAIKCMR-----RSISKEVNLLKKI-NHFN--LINLFGACEHDG---VFYLVYEFMENGSLSDWLHKKRYPEFVSWNC  417 (611)
Q Consensus       349 ~~vavK~~~-----~~~~~E~~~l~~l-~H~n--iv~l~g~~~~~~---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~  417 (611)
                      ..+++|..+     ..+.+|..+|+.+ .+..  +.+++......+   ..|+|||+++|.+|.+....     .++..+
T Consensus        41 ~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~-----~l~~~~  115 (304)
T 3sg8_A           41 RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN-----NLPKQS  115 (304)
T ss_dssp             TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH-----TSCHHH
T ss_pred             CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc-----cCCHHH
Confidence            568888865     3578899999988 3332  334444433332   35899999999888654332     156666


Q ss_pred             HHHHHHHHHHHHHHHhcC-------------------------------------------------------CCCCeEe
Q 007261          418 RFRIALDVAHGLHYLHNC-------------------------------------------------------TDPGYVH  442 (611)
Q Consensus       418 ~~~ia~~ia~gL~yLH~~-------------------------------------------------------~~~~ivH  442 (611)
                      +..++.+++..|..||..                                                       ....++|
T Consensus       116 ~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~H  195 (304)
T 3sg8_A          116 QNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIH  195 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEEC
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEe
Confidence            777788888888888751                                                       1245899


Q ss_pred             cCCCCCCeeeCC--CCcEEEeeecCccccccccCCcccccccccCCCccchhhhcc-----CCC---------CCccchH
Q 007261          443 KDISSGNILLDK--NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY-----GLV---------TPEMDTY  506 (611)
Q Consensus       443 ~Dlk~~NILl~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~---------s~ksDV~  506 (611)
                      +|+++.||++++  +..+.|+||+.+.......   ......... .-..|+....     +..         ....+.|
T Consensus       196 gD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~-~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~  271 (304)
T 3sg8_A          196 NDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFISLMEDD-EEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYW  271 (304)
T ss_dssp             SCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHHTTCCTT-TSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHH
T ss_pred             CCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHHHHHhhc-cccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHH
Confidence            999999999998  5668899999876532211   000000000 0022222110     111         1125899


Q ss_pred             HHHHHHHHHHhCCCCC
Q 007261          507 AFGVVLLELITGKEAA  522 (611)
Q Consensus       507 s~Gvvl~elltG~~p~  522 (611)
                      ++|.++|.+.+|..++
T Consensus       272 ~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          272 SFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHcCCHHH
Confidence            9999999999998664

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.26  E-value=3.6e-06  Score=83.51  Aligned_cols=123  Identities=16%  Similarity=0.136  Sum_probs=89.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec----HHHHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR----RSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      ..||+-..  .+..+.+|+-.    .++.+|...|+.+. +--+.++++++.+.+..++|||++++.++.+......   
T Consensus        39 ~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~---  115 (272)
T 4gkh_A           39 ATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP---  115 (272)
T ss_dssp             CEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG---
T ss_pred             CeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH---
Confidence            46888765  45679999875    46788999999884 3346678888888899999999999988877654321   


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------------------
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCT-------------------------------------------------------  436 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~-------------------------------------------------------  436 (611)
                          .....++.+++..|.-||...                                                       
T Consensus       116 ----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  191 (272)
T 4gkh_A          116 ----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSP  191 (272)
T ss_dssp             ----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCC
T ss_pred             ----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccC
Confidence                122345555666666666311                                                       


Q ss_pred             CCCeEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       437 ~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      ...++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       192 ~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          192 DSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence            12379999999999999887778999997653

>4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A*

Probab=98.08  E-value=2e-06  Score=78.69  Aligned_cols=47  Identities=32%  Similarity=0.441  Sum_probs=41.5

Q ss_pred             EEEEEccCCCChhHHHhHhcCCHHHHHHhcCCCCCCCCcccceeeeecC
Q 007261          172 LLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPL  220 (611)
Q Consensus       172 ~~~y~v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~~~~~i~~g~~l~ip~  220 (611)
                      +++|+||+||||+.||++|+++..+|+++|... + ..+.+|+.+.||.
T Consensus         2 ~~~y~V~~GdtL~~IA~~f~~g~~~l~~aNp~v-d-~~l~~g~~i~ip~   48 (165)
T 4a1k_A            2 MLTYQVKQGDTLNSIAADFRISTAALLQANPSL-Q-AGLTAGQSIVIPG   48 (165)
T ss_dssp             CEEEECCTTCCHHHHHHHTTCCHHHHHHHCGGG-G-GCCCTTCEEEETT
T ss_pred             CEEEEECCCCCHHHHHHHhCCCHHHHHHhCccC-C-CccCCCccccCcc
Confidence            368999999999999999999999999999763 3 4578999999984

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.07  E-value=1.8e-05  Score=80.17  Aligned_cols=121  Identities=17%  Similarity=0.188  Sum_probs=79.3

Q ss_pred             eEEEEEEcCcEEEEEEec-----HHHHHHHHHHHhcCCC---ceeeccceec-cCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          340 SVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHF---NLINLFGACE-HDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       340 ~Vy~g~~~g~~vavK~~~-----~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      .+|+.   |..+++|+.+     ..+.+|..+|+.+.+.   .+.+.+.++. ..+..++||||++|..|.+.....   
T Consensus        34 ~v~~v---g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~~---  107 (306)
T 3tdw_A           34 YAILV---NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMAV---  107 (306)
T ss_dssp             EEEEE---TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHTT---
T ss_pred             eEEEE---CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhhh---
Confidence            46665   6778888865     3578899999999642   2445555553 456678999999998886632111   


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------------------
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNC-------------------------------------------------------  435 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~-------------------------------------------------------  435 (611)
                        ++...+..++.+++..|..||+.                                                       
T Consensus       108 --l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~  185 (306)
T 3tdw_A          108 --LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVY  185 (306)
T ss_dssp             --SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHH
T ss_pred             --CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCccc
Confidence              22333333444444444444421                                                       


Q ss_pred             --CCCCeEecCCCCCCeeeCC---CCc-EEEeeecCccc
Q 007261          436 --TDPGYVHKDISSGNILLDK---NLR-AKLANFSFVRS  468 (611)
Q Consensus       436 --~~~~ivH~Dlk~~NILl~~---~~~-~kl~Dfgla~~  468 (611)
                        ....++|+|+++.|||++.   ++. ..|+||+.+..
T Consensus       186 ~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          186 TRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             ccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence              2346799999999999987   455 58999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.68  E-value=6.5e-05  Score=77.65  Aligned_cols=63  Identities=3%  Similarity=0.079  Sum_probs=45.7

Q ss_pred             ceEEEEEEc--------CcEEEEEEec----------HHHHHHHHHHHhcC-C--CceeeccceeccC---CeEEEEEee
Q 007261          339 GSVFRGIIN--------GSTVAIKCMR----------RSISKEVNLLKKIN-H--FNLINLFGACEHD---GVFYLVYEF  394 (611)
Q Consensus       339 g~Vy~g~~~--------g~~vavK~~~----------~~~~~E~~~l~~l~-H--~niv~l~g~~~~~---~~~~lV~E~  394 (611)
                      ..+|+....        |..+++|...          ..+.+|+.+++.+. +  -.+.++++++.+.   +..++||||
T Consensus        35 n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~  114 (357)
T 3ats_A           35 SETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDY  114 (357)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEEC
T ss_pred             ceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEe
Confidence            467877654        6788999764          24688999999884 3  3566777777654   457899999


Q ss_pred             cCCCCHH
Q 007261          395 MENGSLS  401 (611)
Q Consensus       395 ~~~gsL~  401 (611)
                      ++|..+.
T Consensus       115 l~G~~l~  121 (357)
T 3ats_A          115 VEGVVPP  121 (357)
T ss_dssp             CCCBCCC
T ss_pred             cCCCChh
Confidence            9986653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.58  E-value=0.00044  Score=70.57  Aligned_cols=129  Identities=19%  Similarity=0.345  Sum_probs=79.0

Q ss_pred             ceEEEEEEcCcEEEEEEecH---HHHHHHHHHHhcCC--Cceeeccce------eccCCeEEEEEeecCCCCHH------
Q 007261          339 GSVFRGIINGSTVAIKCMRR---SISKEVNLLKKINH--FNLINLFGA------CEHDGVFYLVYEFMENGSLS------  401 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~~---~~~~E~~~l~~l~H--~niv~l~g~------~~~~~~~~lV~E~~~~gsL~------  401 (611)
                      +.+|+...++..+++|+...   ++..|..+++.|..  -.+.+++..      ....+..+++|||++|..+.      
T Consensus        46 n~~~~v~~~~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~  125 (346)
T 2q83_A           46 ALVWKVHTDSGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEGRPFELTVKQD  125 (346)
T ss_dssp             CEEEEEEETTEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCCBCCCTTSHHH
T ss_pred             CcEEEEEeCCCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecCccCCCCCHHH
Confidence            57898887777799999863   45557777776631  123334431      12456789999999986542      


Q ss_pred             --------HHhhcc--CC--C-------CccCHHHHH-------------------------------HHHHHHHHHHHH
Q 007261          402 --------DWLHKK--RY--P-------EFVSWNCRF-------------------------------RIALDVAHGLHY  431 (611)
Q Consensus       402 --------~~l~~~--~~--~-------~~l~~~~~~-------------------------------~ia~~ia~gL~y  431 (611)
                              ..||..  ..  +       ..-.|....                               .+...+..++++
T Consensus       126 ~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (346)
T 2q83_A          126 LEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGFIEDGLRIKDR  205 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHHHHHHHHHH
Confidence                    112211  00  1       012343211                               011123345666


Q ss_pred             Hhc----------CCCCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          432 LHN----------CTDPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       432 LH~----------~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      |+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       206 l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          206 LLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            652          025789999999999999888899999999764

>4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A*

Probab=97.49  E-value=7.7e-05  Score=68.07  Aligned_cols=47  Identities=21%  Similarity=0.307  Sum_probs=41.4

Q ss_pred             eeeeecCCCCCCHHHHHHhhCCChHhhhhhhCCCCCCCCCCCCCeEEEee
Q 007261           44 FLIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVPV   93 (611)
Q Consensus        44 ~~~y~~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~vP~   93 (611)
                      +++|++++ ||||.+||++|+++..+|+++|+..+  ..+++|+.+.||.
T Consensus         2 ~~~y~V~~-GdtL~~IA~~f~~g~~~l~~aNp~vd--~~l~~g~~i~ip~   48 (165)
T 4a1k_A            2 MLTYQVKQ-GDTLNSIAADFRISTAALLQANPSLQ--AGLTAGQSIVIPG   48 (165)
T ss_dssp             CEEEECCT-TCCHHHHHHHTTCCHHHHHHHCGGGG--GCCCTTCEEEETT
T ss_pred             CEEEEECC-CCCHHHHHHHhCCCHHHHHHhCccCC--CccCCCccccCcc
Confidence            46788876 99999999999999999999998765  4578999999984

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.05  E-value=0.0015  Score=66.06  Aligned_cols=125  Identities=18%  Similarity=0.205  Sum_probs=83.2

Q ss_pred             ceEEEEEEcCcEEEEEEec----HHHHHHHHHHHhcC---CCceeeccceeccCCeEEEEEeecCCCCHH--------H-
Q 007261          339 GSVFRGIINGSTVAIKCMR----RSISKEVNLLKKIN---HFNLINLFGACEHDGVFYLVYEFMENGSLS--------D-  402 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~----~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~gsL~--------~-  402 (611)
                      ..+|+...++..+++|...    ..+..|...|+.|.   ...+.++++++...+..++||||+++..+.        . 
T Consensus        50 n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~~~~~~lG~~  129 (312)
T 3jr1_A           50 NEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQSSFTIFAEK  129 (312)
T ss_dssp             SEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCTTHHHHHHHH
T ss_pred             eeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCchhHHHHHHH
Confidence            4688887778889999875    35788999999883   356778888888788899999999987642        1 


Q ss_pred             --HhhccCC-CC------------------ccCHHHHH---HHH----------------HHHHHHH-HHHh-cCCCCCe
Q 007261          403 --WLHKKRY-PE------------------FVSWNCRF---RIA----------------LDVAHGL-HYLH-NCTDPGY  440 (611)
Q Consensus       403 --~l~~~~~-~~------------------~l~~~~~~---~ia----------------~~ia~gL-~yLH-~~~~~~i  440 (611)
                        .||.... +.                  .-+|....   ++.                ..+...+ ..|. ....+.+
T Consensus       130 LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l  209 (312)
T 3jr1_A          130 IAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTLSKHNPKPSI  209 (312)
T ss_dssp             HHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHHTTCCCCCEE
T ss_pred             HHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHhccCCCCcee
Confidence              2233211 00                  12465322   111                1112122 2342 1235789


Q ss_pred             EecCCCCCCeeeCCCCcEEEeeec
Q 007261          441 VHKDISSGNILLDKNLRAKLANFS  464 (611)
Q Consensus       441 vH~Dlk~~NILl~~~~~~kl~Dfg  464 (611)
                      +|+|+.+.|++++.++ +.|.||.
T Consensus       210 ~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          210 LHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             ECSSCSGGGEEEETTE-EEECSCC
T ss_pred             EeCCCCcCcEeecCCC-eEEEcCc
Confidence            9999999999999887 8899974

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.93  E-value=0.003  Score=64.30  Aligned_cols=127  Identities=13%  Similarity=0.149  Sum_probs=73.9

Q ss_pred             EEEEEEc-CcEEEEEEec----HHHHHHHHHHHhcCC--CceeeccceeccCCeEEEEEeecCCCCHHHHhhcc------
Q 007261          341 VFRGIIN-GSTVAIKCMR----RSISKEVNLLKKINH--FNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK------  407 (611)
Q Consensus       341 Vy~g~~~-g~~vavK~~~----~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~------  407 (611)
                      +|+.... |..+++|...    .++..|+.+++.+..  -.+.+++.+....+  +++||++.+..+.+++...      
T Consensus        35 ~~r~~~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~~~l~~~~~~~~~  112 (333)
T 3csv_A           35 YQRLRSPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFTEVINNDPAQEMP  112 (333)
T ss_dssp             CEEEECTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHHHHHHHCGGGHHH
T ss_pred             EEEEEcCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchHHHhcCCCccHHH
Confidence            5566553 7778887753    456778888888842  23455666554444  6899999877776544321      


Q ss_pred             ---------------CCC--CccCHHHHH-------HH-------------HHHHHHHHHHHh---cCCCCCeEecCCCC
Q 007261          408 ---------------RYP--EFVSWNCRF-------RI-------------ALDVAHGLHYLH---NCTDPGYVHKDISS  447 (611)
Q Consensus       408 ---------------~~~--~~l~~~~~~-------~i-------------a~~ia~gL~yLH---~~~~~~ivH~Dlk~  447 (611)
                                     ...  ..++.....       .+             ...+...++.+.   ......++|+|+.+
T Consensus       113 ~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~~~~lvHgD~~~  192 (333)
T 3csv_A          113 LYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEGDMVFVHRDFHA  192 (333)
T ss_dssp             HHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCSCCEEECSCCSG
T ss_pred             HHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccCCCeeEeCCcCc
Confidence                           000  001111000       00             001111222221   11246799999999


Q ss_pred             CCeeeCCC----CcEEEeeecCcccc
Q 007261          448 GNILLDKN----LRAKLANFSFVRSA  469 (611)
Q Consensus       448 ~NILl~~~----~~~kl~Dfgla~~~  469 (611)
                      .|||++.+    ..+.|+||+.+...
T Consensus       193 ~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          193 QNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             GGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            99999875    68999999987643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=96.82  E-value=0.0026  Score=66.62  Aligned_cols=31  Identities=19%  Similarity=0.387  Sum_probs=26.4

Q ss_pred             CCCeEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       437 ~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      ...++|+|+.+.|||++.+ .++|+||..+..
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            4689999999999999876 489999987654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.72  E-value=0.004  Score=65.71  Aligned_cols=79  Identities=8%  Similarity=-0.002  Sum_probs=48.0

Q ss_pred             CCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc-ccCCCccchhhhccC---CCCCccchHHHHHHH
Q 007261          437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA-VGTNGYMAPEYMEYG---LVTPEMDTYAFGVVL  512 (611)
Q Consensus       437 ~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~s~ksDV~s~Gvvl  512 (611)
                      ...++|+|+++.|||++.++ ++|+||+.+........   ..... .-...|.+|+.....   ......++......+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            57899999999999998876 99999998765432110   00000 011235566544311   111234556778888


Q ss_pred             HHHHhCC
Q 007261          513 LELITGK  519 (611)
Q Consensus       513 ~elltG~  519 (611)
                      |+.+++.
T Consensus       307 ~~~y~~~  313 (420)
T 2pyw_A          307 WNLFNKR  313 (420)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            8877653

>3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis}

Probab=96.69  E-value=0.0032  Score=64.83  Aligned_cols=118  Identities=9%  Similarity=-0.052  Sum_probs=73.9

Q ss_pred             ccceeEEEeecCCchhhhhHhhcCCCccHHHHHHhcCC--CCCCCCCCceeeeeccCCCCC-C---ccccCCeeEE----
Q 007261          103 QANTSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNY--SETSLDQGLTLRVPLRCACPT-S---NQIVNGTKFL----  172 (611)
Q Consensus       103 ~~~~~y~V~~~gdTl~~IA~~~~~~l~t~~~l~~~N~~--~~~~l~~G~~l~ip~~~~~~~-~---~~~~~~~~~~----  172 (611)
                      ..+..|+|++ ||||..|-++....-....++.++...  ....|++||.|.+.+...-.- .   .....+....    
T Consensus        12 ~~W~~~~V~~-GDTL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~~~~l~~l~~~~~~~~~~~~v~i~   90 (371)
T 3slu_A           12 AYWVQEAVQP-GDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVGGDGGAREVQFFTDEDGERNLVALE   90 (371)
T ss_dssp             CEEEEEECCT-TCCHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEECTTSCEEEEEEEECCTTEEEEEEEE
T ss_pred             CceEEEEECC-CCcHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEECCCCCeEEEEEEecCCCceeEEEEE
Confidence            4467899999 999999997776443334444433322  245899999999987521100 0   0000000000    


Q ss_pred             -------------------EEEEccCCCChhHHHhHhcCCHHHHHHhcCCCCCCC----CcccceeeeecCCC
Q 007261          173 -------------------LTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDP----LLFPFTTILIPLTT  222 (611)
Q Consensus       173 -------------------~~y~v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~~~~----~i~~g~~l~ip~~~  222 (611)
                                         ..+.+.-.+||+..|++.|++...+++++.+- ...    .|++|+.+.|....
T Consensus        91 ~~dg~f~~~~~~~~~~~~~~~~~g~I~~Sl~~a~~~agl~~~~~~~l~~i~-~~~idf~~l~~GD~f~v~~~~  162 (371)
T 3slu_A           91 KKGGIWRRSASEADMKVLPTLRSVVVKTSARGSLARAEVPVEIRESLSGIF-AGRFSLDGLKEGDAVRLIYDS  162 (371)
T ss_dssp             EETTEEEECCCGGGEEEEEEEEEEECSSCHHHHHHHTTCCHHHHHHHHHHH-TTTCCTTCCCTTCEEEEEEEE
T ss_pred             ecCCeeEEEeeecccceeeeEEEEEEeccHHHHHHHcCCCHHHHHHHHHHH-ccCcCHHHcCCCCEEEEEEEE
Confidence                               11223347999999999999999888888553 333    48999999887653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.38  E-value=0.0083  Score=60.55  Aligned_cols=129  Identities=15%  Similarity=0.178  Sum_probs=76.7

Q ss_pred             ceEEEEEEcCcEEEEEEecH-----HHHHHHHHHHhcCCCc--eeecccee------ccCCeEEEEEeecCCCCHHH---
Q 007261          339 GSVFRGIINGSTVAIKCMRR-----SISKEVNLLKKINHFN--LINLFGAC------EHDGVFYLVYEFMENGSLSD---  402 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~E~~~~gsL~~---  402 (611)
                      ..+|+...++..+++|....     ++..|+.++..+...+  +.+++...      ...+..++++||++|..+..   
T Consensus        36 n~~~~v~~~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~  115 (322)
T 2ppq_A           36 NSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEA  115 (322)
T ss_dssp             EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCH
T ss_pred             cceEEEEeCCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCH
Confidence            46888877666788998753     5677888888884222  23333221      22456789999999865311   


Q ss_pred             -----------Hhhcc--C--CC-----CccCHHHHHHH------------HHHHHHHHHHHhc----CCCCCeEecCCC
Q 007261          403 -----------WLHKK--R--YP-----EFVSWNCRFRI------------ALDVAHGLHYLHN----CTDPGYVHKDIS  446 (611)
Q Consensus       403 -----------~l~~~--~--~~-----~~l~~~~~~~i------------a~~ia~gL~yLH~----~~~~~ivH~Dlk  446 (611)
                                 .+|..  .  .+     ....|.....-            ...+...+++++.    .....++|+|++
T Consensus       116 ~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~  195 (322)
T 2ppq_A          116 KHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLF  195 (322)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCC
T ss_pred             HHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCC
Confidence                       12221  0  01     01124331110            1123445555542    123579999999


Q ss_pred             CCCeeeCCCCcEEEeeecCcc
Q 007261          447 SGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       447 ~~NILl~~~~~~kl~Dfgla~  467 (611)
                      +.|||++++....|+||+.+.
T Consensus       196 ~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          196 QDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGGEEEETTEEEEECCCTTCE
T ss_pred             ccCEEEeCCceEEEecchhcc
Confidence            999999987666899999764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.94  E-value=0.046  Score=55.12  Aligned_cols=128  Identities=13%  Similarity=0.208  Sum_probs=73.1

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCC--ceeeccce-----eccCCeEEEEEeecCCCCHH---
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHF--NLINLFGA-----CEHDGVFYLVYEFMENGSLS---  401 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~lV~E~~~~gsL~---  401 (611)
                      ..||+... +|+.+++|..+      ..+..|..++..+...  .+.+++..     ...++..+++|||++|..+.   
T Consensus        39 n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~  118 (328)
T 1zyl_A           39 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN  118 (328)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred             cceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCCCCCCC
Confidence            46888766 46689999985      3567789888888422  23444443     12245678999999875431   


Q ss_pred             --H------H---hhcc----CC--CCccCHHHH----------------------HHHHHHHHHHHHHHhc-CCCCCeE
Q 007261          402 --D------W---LHKK----RY--PEFVSWNCR----------------------FRIALDVAHGLHYLHN-CTDPGYV  441 (611)
Q Consensus       402 --~------~---l~~~----~~--~~~l~~~~~----------------------~~ia~~ia~gL~yLH~-~~~~~iv  441 (611)
                        .      .   +|..    ..  ....++...                      ...+..++..+.-+.. .....++
T Consensus       119 ~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~  198 (328)
T 1zyl_A          119 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL  198 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred             HHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeee
Confidence              1      1   1211    00  011222211                      0111112222222211 1246689


Q ss_pred             ecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          442 HKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       442 H~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      |+|+++.|||++ + .+.|+||+.+..
T Consensus       199 HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          199 HGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            999999999999 4 899999987653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.89  E-value=0.037  Score=52.19  Aligned_cols=103  Identities=12%  Similarity=0.032  Sum_probs=67.0

Q ss_pred             CCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcc
Q 007261          398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYS  477 (611)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  477 (611)
                      -||.+.|....  .+++..+++.++.|.+.+|.-+-.. ..+ ..+=+.|..|++..+|.+.+.+ ..+.          
T Consensus        33 vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc----------
Confidence            48999998765  4599999999999999998876210 011 1233456889999999887653 1110          


Q ss_pred             cccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCC
Q 007261          478 STKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEA  521 (611)
Q Consensus       478 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p  521 (611)
                           .....+.+||... ...+.+.=|||+|++||.-+--..+
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                 1122456888763 3456788999999999999875544

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=95.84  E-value=0.016  Score=61.40  Aligned_cols=57  Identities=12%  Similarity=0.200  Sum_probs=39.7

Q ss_pred             ceEEEEEEc---------CcEEEEEEec-----HHHHHHHHHHHhcCCCce-eeccceeccCCeEEEEEeecCCCC
Q 007261          339 GSVFRGIIN---------GSTVAIKCMR-----RSISKEVNLLKKINHFNL-INLFGACEHDGVFYLVYEFMENGS  399 (611)
Q Consensus       339 g~Vy~g~~~---------g~~vavK~~~-----~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gs  399 (611)
                      ..+|+....         +..+.+|+..     ..+.+|..+++.+...++ .++++.+.+    .+|+||++|..
T Consensus        87 N~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~  158 (429)
T 1nw1_A           87 NMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP  158 (429)
T ss_dssp             EEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred             cceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcc
Confidence            468887763         4688999873     456789999998843333 566766643    28999998633

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=95.82  E-value=0.029  Score=55.69  Aligned_cols=58  Identities=14%  Similarity=0.129  Sum_probs=41.3

Q ss_pred             ceEEEEEE-cCcEEEEEEec-------HHHHHHHHHHHhcCCC---ceeeccceeccCCeEEEEEeecCCCCH
Q 007261          339 GSVFRGII-NGSTVAIKCMR-------RSISKEVNLLKKINHF---NLINLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~-------~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      +.||+... +|+.+.+|+..       ..|..|...|+.|...   -+.+++++.    ..++||||++++..
T Consensus        29 ~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           29 WHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERPP   97 (288)
T ss_dssp             EEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCCC
T ss_pred             eEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccCC
Confidence            57999998 78999999864       2478899999988421   233444432    23789999987653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.61  E-value=0.033  Score=55.63  Aligned_cols=31  Identities=19%  Similarity=0.218  Sum_probs=25.7

Q ss_pred             CCCeEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       437 ~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      ...++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            456899999999999 5566789999987754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.60  E-value=0.031  Score=59.56  Aligned_cols=58  Identities=12%  Similarity=0.091  Sum_probs=41.0

Q ss_pred             ceEEEEEEcC--cEEEEEEecH------HHHHHHHHHHhcCCCce-eeccceeccCCeEEEEEeecCCCCH
Q 007261          339 GSVFRGIING--STVAIKCMRR------SISKEVNLLKKINHFNL-INLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~~g--~~vavK~~~~------~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      ..+|+....+  ..+++|+...      +..+|..+++.|...++ .++++.+..    .+||||++|..|
T Consensus       122 N~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l  188 (458)
T 2qg7_A          122 NILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred             eEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence            4688888765  7889998742      23689999999965444 467776632    259999987443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.58  E-value=0.035  Score=57.58  Aligned_cols=126  Identities=17%  Similarity=0.203  Sum_probs=76.5

Q ss_pred             ceEEEEEEc---------CcEEEEEEec------HHHHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGIIN---------GSTVAIKCMR------RSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~~---------g~~vavK~~~------~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      ..+|+....         +..+.+|+..      .++.+|..+++.+. +.-..++++++.+    .+||||++|..|..
T Consensus        64 N~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~  139 (379)
T 3feg_A           64 NLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKT  139 (379)
T ss_dssp             CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCG
T ss_pred             ccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCCh
Confidence            356766652         3678888863      35668999998883 3323566766654    28999999755431


Q ss_pred             --------------H---hhccCC--CCccC--HHHHHHHHHHHHH-------------------HHHHHhc-----CCC
Q 007261          403 --------------W---LHKKRY--PEFVS--WNCRFRIALDVAH-------------------GLHYLHN-----CTD  437 (611)
Q Consensus       403 --------------~---l~~~~~--~~~l~--~~~~~~ia~~ia~-------------------gL~yLH~-----~~~  437 (611)
                                    .   ||....  .+...  |.+..++..++..                   .+..|..     ...
T Consensus       140 ~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~  219 (379)
T 3feg_A          140 QELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSP  219 (379)
T ss_dssp             GGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCC
T ss_pred             hHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCC
Confidence                          1   122111  11122  4444445443321                   2333321     123


Q ss_pred             CCeEecCCCCCCeeeCCC----CcEEEeeecCccc
Q 007261          438 PGYVHKDISSGNILLDKN----LRAKLANFSFVRS  468 (611)
Q Consensus       438 ~~ivH~Dlk~~NILl~~~----~~~kl~Dfgla~~  468 (611)
                      ..++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            568999999999999876    7899999998653

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.46  E-value=0.019  Score=58.69  Aligned_cols=61  Identities=8%  Similarity=0.073  Sum_probs=40.8

Q ss_pred             eEEEEEEcCcEEEEEEecHH-HHHHHHHHHhcCC---Cceeeccce------eccCCeEEEEEeecCCCCH
Q 007261          340 SVFRGIINGSTVAIKCMRRS-ISKEVNLLKKINH---FNLINLFGA------CEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       340 ~Vy~g~~~g~~vavK~~~~~-~~~E~~~l~~l~H---~niv~l~g~------~~~~~~~~lV~E~~~~gsL  400 (611)
                      .||+...++..+++|+.+.. ...|+.++..|..   +++.+.+..      ....+..+++|||++|..+
T Consensus        38 ~vy~v~~~~g~~vLK~~~~~~~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~  108 (339)
T 3i1a_A           38 FAYQADSESKSYFIKLKYGYHDEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG  108 (339)
T ss_dssp             EEEEEECSSCEEEEEEEECSSCCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred             ceEEEEeCCCCEEEEEecCccchHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence            68988775448999987632 3567777777731   224444432      2335778999999998755

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.20  E-value=0.028  Score=58.00  Aligned_cols=31  Identities=19%  Similarity=0.393  Sum_probs=25.3

Q ss_pred             CCCeEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          437 DPGYVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       437 ~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      ...++|+|+++.|||++++. +.|+||..+..
T Consensus       211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             CEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             CeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            35689999999999998655 89999987653

>3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis}

Probab=93.95  E-value=0.069  Score=54.89  Aligned_cols=53  Identities=17%  Similarity=0.139  Sum_probs=43.2

Q ss_pred             eEEEEEEccCCCChhHHHhHhcCCHHHHHHhcCCCC---CCCCcccceeeeecCCC
Q 007261          170 KFLLTYLVSWGDSVPDISKRFNVSIESIVNANGFTE---DDPLLFPFTTILIPLTT  222 (611)
Q Consensus       170 ~~~~~y~v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~---~~~~i~~g~~l~ip~~~  222 (611)
                      .+-.+|+|++||||..|-+++|++..++.+++....   .-..|+|||.+.+.+..
T Consensus        12 ~~W~~~~V~~GDTL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~   67 (371)
T 3slu_A           12 AYWVQEAVQPGDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVGG   67 (371)
T ss_dssp             CEEEEEECCTTCCHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEECT
T ss_pred             CceEEEEECCCCcHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEECC
Confidence            456789999999999999999999999999875421   34689999999987654

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=93.76  E-value=0.023  Score=38.64  Aligned_cols=17  Identities=29%  Similarity=0.307  Sum_probs=7.5

Q ss_pred             eeeeehhHHHHHHHHHH
Q 007261          256 YLWVGIGIGISLLVICF  272 (611)
Q Consensus       256 ~~~i~v~~~~~~~~~~~  272 (611)
                      .|+.++..|++++++++
T Consensus        11 aIA~gVVgGv~~v~ii~   27 (44)
T 2l2t_A           11 LIAAGVIGGLFILVIVG   27 (44)
T ss_dssp             HHHHHHHHHHHHHHHHH
T ss_pred             eEEEeehHHHHHHHHHH
Confidence            34444544444443333

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=93.73  E-value=0.03  Score=38.16  Aligned_cols=16  Identities=19%  Similarity=0.258  Sum_probs=7.4

Q ss_pred             eeeehhHHHHHHHHHH
Q 007261          257 LWVGIGIGISLLVICF  272 (611)
Q Consensus       257 ~~i~v~~~~~~~~~~~  272 (611)
                      |+.+|..|++++++++
T Consensus        13 IA~gVVgGv~~~~ii~   28 (44)
T 2ks1_B           13 IATGMVGALLLLLVVA   28 (44)
T ss_dssp             STHHHHHHHHHHHHHH
T ss_pred             EEeehhHHHHHHHHHH
Confidence            4455554544444333

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=91.42  E-value=0.067  Score=36.27  Aligned_cols=9  Identities=22%  Similarity=0.342  Sum_probs=3.9

Q ss_pred             eeehhHHHH
Q 007261          258 WVGIGIGIS  266 (611)
Q Consensus       258 ~i~v~~~~~  266 (611)
                      +++.++|++
T Consensus        14 Ia~~vVGvl   22 (44)
T 2jwa_A           14 IISAVVGIL   22 (44)
T ss_dssp             HHHHHHHHH
T ss_pred             hHHHHHHHH
Confidence            344444533

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=90.90  E-value=0.7  Score=48.43  Aligned_cols=30  Identities=13%  Similarity=0.417  Sum_probs=26.3

Q ss_pred             CCeEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          438 PGYVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       438 ~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      ..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            46899999999999 7888999999998753

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=88.40  E-value=0.22  Score=32.82  Aligned_cols=24  Identities=17%  Similarity=0.085  Sum_probs=11.1

Q ss_pred             eeeehhHHHHHHHHHHHHHhHhhh
Q 007261          257 LWVGIGIGISLLVICFVLSIVLFH  280 (611)
Q Consensus       257 ~~i~v~~~~~~~~~~~~~~~~~~~  280 (611)
                      .+.|+++|+++.+++++.+++|++
T Consensus        12 aIAGiVvG~v~gv~li~~l~~~~~   35 (38)
T 2k1k_A           12 EIVAVIFGLLLGAALLLGILVFRS   35 (38)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ceeeeehHHHHHHHHHHHHHHHHe
Confidence            345566665544444443333433

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	611
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-55
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-53
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-52
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-52
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-51
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-50
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-49
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-49
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-49
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-49
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-49
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-47
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-47
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-47
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-46
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-46
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-46
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-45
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-45
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-45
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-44
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-44
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-43
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-43
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-42
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-41
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-40
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-40
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-35
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-35
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-35
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-35
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-34
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-33
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-33
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-33
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-31
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-31
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-31
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-31
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-30
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-30
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-28
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-26
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-25
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-24
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-23
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-22
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-19
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-09
d1y7ma2	48	d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-term	2e-05
d1e0ga_	48	d.7.1.1 (A:) Membrane-bound lytic murein transclyc	2e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 3e-58
 Identities = 63/271 (23%), Positives = 114/271 (42%), Gaps = 33/271 (12%)

Query: 339 GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V++G  +G  VA+K +          ++   EV +L+K  H N++   G         
Sbjct: 22  GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 79

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           +V ++ E  SL   LH               IA   A G+ YLH       +H+D+ S N
Sbjct: 80  IVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNN 134

Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEY---MEYGLVTPEMDTY 506
           I L ++L  K+ +F          SG    +   G+  +MAPE     +    + + D Y
Sbjct: 135 IFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193

Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           AFG+VL EL+TG+      +  + ++      MV  G         + P+L   +     
Sbjct: 194 AFGIVLYELMTGQLPYSNINNRDQIIF-----MVGRG--------YLSPDLSKVRSNCPK 240

Query: 567 HLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
            +  L   C+ ++ + RP   ++++++  + 
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 3e-55
 Identities = 61/265 (23%), Positives = 115/265 (43%), Gaps = 33/265 (12%)

Query: 339 GSVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGAC-EHDGVFYLVY 392
           G V  G   G+ VA+KC++     ++   E +++ ++ H NL+ L G   E  G  Y+V 
Sbjct: 21  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80

Query: 393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL 452
           E+M  GSL D+L  +        +C  + +LDV   + YL       +VH+D+++ N+L+
Sbjct: 81  EYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLV 136

Query: 453 DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVL 512
            ++  AK+++F   + A       S+  T      + APE +     + + D ++FG++L
Sbjct: 137 SEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 190

Query: 513 LELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLC 572
            E+ +     Y +        + V   VE G            +         + ++  C
Sbjct: 191 WEIYSFGRVPYPRIPL-----KDVVPRVEKGY---------KMDAPDGCPPAVYEVMKNC 236

Query: 573 LACIAREPESRPSMAEVVSTLMKIQ 597
                 +   RPS  ++   L  I+
Sbjct: 237 W---HLDAAMRPSFLQLREQLEHIK 258

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 1e-53
 Identities = 61/284 (21%), Positives = 103/284 (36%), Gaps = 29/284 (10%)

Query: 339 GSVFRGIINGSTVAIKCMRRSISK------EVNLLKKINHFNLINLFGACEHDG----VF 388
           G V+RG   G  VA+K       +      E+     + H N++    A   D       
Sbjct: 17  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHN-----CTDPGYVHK 443
           +LV ++ E+GSL D+L++      V+     ++AL  A GL +LH         P   H+
Sbjct: 77  WLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132

Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYS-STKTAVGTNGYMAPEYME------Y 496
           D+ S NIL+ KN    +A+                +    VGT  YMAPE ++      +
Sbjct: 133 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 192

Query: 497 GLVTPEMDTYAFGVVLLELITGKE-AAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDP 555
                  D YA G+V  E+          +D +                 +      + P
Sbjct: 193 FESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP 252

Query: 556 NL--QANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
           N+  +    E    +  +   C      +R +   +  TL ++ 
Sbjct: 253 NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 4e-52
 Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 31/266 (11%)

Query: 339 GSVFRGI-INGSTVAIKCMRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V  G  +N   VAIK +R          +E  ++ K++H  L+ L+G C       LV
Sbjct: 19  GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
           +EFME+G LSD+L  +R     +      + LDV  G+ YL    +   +H+D+++ N L
Sbjct: 79  FEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCL 133

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           + +N   K+++F   R     +  Y+S+        + +PE   +   + + D ++FGV+
Sbjct: 134 VGENQVIKVSDFGMTR--FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 191

Query: 512 LLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML 571
           + E+ +  +  Y+           V   +  G        L  P L       + H+  +
Sbjct: 192 MWEVFSEGKIPYENRSN-----SEVVEDISTGF------RLYKPRL------ASTHVYQI 234

Query: 572 CLACIAREPESRPSMAEVVSTLMKIQ 597
              C    PE RP+ + ++  L +I 
Sbjct: 235 MNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 9e-52
 Identities = 68/262 (25%), Positives = 115/262 (43%), Gaps = 31/262 (11%)

Query: 339 GSVFRGIINGST-VAIKCMRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG T VA+K +++          E NL+K++ H  L+ L+     + + Y++
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 85

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E+MENGSL D+L      +  + N    +A  +A G+ ++       Y+H+D+ + NIL
Sbjct: 86  TEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANIL 141

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           +   L  K+A+F   R    E++ Y++ + A     + APE + YG  T + D ++FG++
Sbjct: 142 VSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199

Query: 512 LLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML 571
           L E++T     Y                  G      +  L               L  L
Sbjct: 200 LTEIVTHGRIPY-----------------PGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242

Query: 572 CLACIAREPESRPSMAEVVSTL 593
              C    PE RP+   + S L
Sbjct: 243 MRLCWKERPEDRPTFDYLRSVL 264

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 6e-51
 Identities = 57/303 (18%), Positives = 112/303 (36%), Gaps = 49/303 (16%)

Query: 326 VATENFSPKNMID----GSVFRGI--INGSTVAIKCMRRSISK--------EVNLLKKIN 371
           +  ++F   + +     G VF+     +G  +A K +   I          E+ +L + N
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62

Query: 372 HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHY 431
              ++  +GA   DG   +  E M+ GSL   L K      +      ++++ V  GL Y
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTY 119

Query: 432 LHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP 491
           L        +H+D+   NIL++     KL +F      +      S   + VGT  YM+P
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSP 172

Query: 492 EYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI--------------------- 530
           E ++    + + D ++ G+ L+E+  G+      D +E+                     
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 531 ----LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSM 586
               L +  + S       E    ++ +P  +      +         C+ + P  R  +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292

Query: 587 AEV 589
            ++
Sbjct: 293 KQL 295

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  173 bits (439), Expect = 5e-50
 Identities = 66/306 (21%), Positives = 124/306 (40%), Gaps = 50/306 (16%)

Query: 319 YKYEDLVVATENFSPKNMID-------------GSVFRGII-----NGSTVAIKCMRRSI 360
           + +ED   A   F+ +  I              G V  G +         VAIK ++   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 361 SK--------EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEF 412
           ++        E +++ + +H N+I+L G         ++ EFMENGSL  +L +      
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE 472
            +      +   +A G+ YL +     YVH+D+++ NIL++ NL  K+++F   R    +
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 473 ESGYSSTKTA--VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
            S  + T          + APE ++Y   T   D +++G+V+ E+++  E  Y       
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY------- 234

Query: 531 LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
                          +  ++ +          +    L  L L C  ++   RP   ++V
Sbjct: 235 ----------WDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 591 STLMKI 596
           +TL K+
Sbjct: 285 NTLDKM 290

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 1e-49
 Identities = 53/265 (20%), Positives = 115/265 (43%), Gaps = 31/265 (11%)

Query: 339 GSVFRGII-NGSTVAIKCMRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V  G       VAIK ++          +E  ++  ++H  L+ L+G C      +++
Sbjct: 18  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E+M NG L ++L + R+           +  DV   + YL +     ++H+D+++ N L
Sbjct: 78  TEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCL 132

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           ++     K+++F   R     +  Y+S+  +     +  PE + Y   + + D +AFGV+
Sbjct: 133 VNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 190

Query: 512 LLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML 571
           + E+ +  +  Y++        E    + +G         L  P+L + K      +  +
Sbjct: 191 MWEIYSLGKMPYERFTNS----ETAEHIAQG-------LRLYRPHLASEK------VYTI 233

Query: 572 CLACIAREPESRPSMAEVVSTLMKI 596
             +C   + + RP+   ++S ++ +
Sbjct: 234 MYSCWHEKADERPTFKILLSNILDV 258

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (436), Expect = 1e-49
 Identities = 70/317 (22%), Positives = 118/317 (37%), Gaps = 61/317 (19%)

Query: 320 KYEDLVVATENFSPKNMID----GSVFRGII-------NGSTVAIKCMRRSISK------ 362
           K   L     N      I     G VF+            + VA+K ++   S       
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 363 --EVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY----------- 409
             E  L+ + ++ N++ L G C       L++E+M  G L+++L                
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 410 ----------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAK 459
                     P  +S   +  IA  VA G+ YL       +VH+D+++ N L+ +N+  K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180

Query: 460 LANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGK 519
           +A+F   R+ +     Y +         +M PE + Y   T E D +A+GVVL E+ +  
Sbjct: 181 IADFGLSRN-IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 520 EAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIARE 579
              Y                  G   E  +  + D N+ A  +     L  L   C ++ 
Sbjct: 240 LQPY-----------------YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKL 282

Query: 580 PESRPSMAEVVSTLMKI 596
           P  RPS   +   L ++
Sbjct: 283 PADRPSFCSIHRILQRM 299

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-49
 Identities = 71/262 (27%), Positives = 117/262 (44%), Gaps = 31/262 (11%)

Query: 339 GSVFRGIINGST-VAIKCMRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYLV 391
           G V+ G  NG+T VAIK ++          +E  ++KK+ H  L+ L+     + + Y+V
Sbjct: 31  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 89

Query: 392 YEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNIL 451
            E+M  GSL D+L  +    ++       +A  +A G+ Y+       YVH+D+ + NIL
Sbjct: 90  TEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANIL 145

Query: 452 LDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVV 511
           + +NL  K+A+F   R  + E++ Y++ + A     + APE   YG  T + D ++FG++
Sbjct: 146 VGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 203

Query: 512 LLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML 571
           L EL T     Y                  G      L  +          E    L  L
Sbjct: 204 LTELTTKGRVPY-----------------PGMVNREVLDQVERGYRMPCPPECPESLHDL 246

Query: 572 CLACIAREPESRPSMAEVVSTL 593
              C  +EPE RP+   + + L
Sbjct: 247 MCQCWRKEPEERPTFEYLQAFL 268

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 1e-49
 Identities = 62/275 (22%), Positives = 118/275 (42%), Gaps = 37/275 (13%)

Query: 339 GSVFRGIIN----GSTVAIKCMRRSISK---------EVNLLKKINHFNLINLFGACEHD 385
           G+V +G         TVA+K ++   +          E N+++++++  ++ + G CE +
Sbjct: 21  GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE 80

Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
             + LV E  E G L+ +L + R+   V       +   V+ G+ YL       +VH+D+
Sbjct: 81  S-WMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES---NFVHRDL 133

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+LL     AK+++F   ++   +E+ Y +         + APE + Y   + + D 
Sbjct: 134 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 193

Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           ++FGV++ E  +  +  Y+           V +M+E G               A      
Sbjct: 194 WSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEKGE---------RMGCPAGCPREM 239

Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV 600
           + L+ LC      + E+RP  A V   L     DV
Sbjct: 240 YDLMNLCW---TYDVENRPGFAAVELRLRNYYYDV 271

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 3e-49
 Identities = 55/299 (18%), Positives = 115/299 (38%), Gaps = 40/299 (13%)

Query: 322 EDLVVATENFSPKNMIDGS-----VFRGII----NGSTVAIKCMRRSISK--------EV 364
           + L +  +N    ++  G      V +G+         VAIK +++   K        E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 365 NLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALD 424
            ++ ++++  ++ L G C+ +    LV E    G L  +L  KR    +  +    +   
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQ 117

Query: 425 VAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG 484
           V+ G+ YL       +VH+D+++ N+LL     AK+++F   ++   ++S Y++      
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN 544
              + APE + +   +   D +++GV + E ++  +  YK+          V + +E G 
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIEQGK 229

Query: 545 AEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRS 603
                                + L+  C      + E RP    V   +      +   
Sbjct: 230 ---------RMECPPECPPELYALMSDCW---IYKWEDRPDFLTVEQRMRACYYSLASK 276

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  169 bits (429), Expect = 9e-49
 Identities = 68/289 (23%), Positives = 126/289 (43%), Gaps = 37/289 (12%)

Query: 321 YEDLVVATENFSPKNMID----GSVFRGII--NGSTVAIKCMRRS------ISKEVNLLK 368
           Y+   +   + + K+ +     G V+ G+      TVA+K ++          KE  ++K
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 68

Query: 369 KINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHG 428
           +I H NL+ L G C  +  FY++ EFM  G+L D+L +    E  S      +A  ++  
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSA 127

Query: 429 LHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY 488
           + YL       ++H+D+++ N L+ +N   K+A+F   R  +     Y++   A     +
Sbjct: 128 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTYTAHAGAKFPIKW 182

Query: 489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK 548
            APE + Y   + + D +AFGV+L E+ T   + Y                   G   ++
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------------------PGIDLSQ 224

Query: 549 LSVLVDPNLQANK-KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
           +  L++ + +  + +     +  L  AC    P  RPS AE+      +
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-47
 Identities = 50/268 (18%), Positives = 95/268 (35%), Gaps = 37/268 (13%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGAC--EHD 385
           G   +     +G  +  K +            +  EVNLL+++ H N++  +       +
Sbjct: 18  GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77

Query: 386 GVFYLVYEFMENGSLSDWLHK-KRYPEFVSWNCRFRIALDVAHGLHYLH--NCTDPGYVH 442
              Y+V E+ E G L+  + K  +  +++      R+   +   L   H  +      +H
Sbjct: 78  TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 137

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           +D+   N+ LD     KL +F     A       S  K  VGT  YM+PE M       +
Sbjct: 138 RDLKPANVFLDGKQNVKLGDFGL---ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK 194

Query: 503 MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK 562
            D ++ G +L EL            +E+                     + +   +    
Sbjct: 195 SDIWSLGCLLYELCALMPPFTAFSQKELAGK------------------IREGKFRRIPY 236

Query: 563 EIAHHLIMLCLACIAREPESRPSMAEVV 590
             +  L  +    +  +   RPS+ E++
Sbjct: 237 RYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 4e-47
 Identities = 61/274 (22%), Positives = 113/274 (41%), Gaps = 37/274 (13%)

Query: 339 GSVFRGIINGST-----VAIKCMRRSIS----------KEVNLLKKINHFNLINLFGACE 383
           G V RG  +  +     VA+KC++  +           +EVN +  ++H NLI L+G   
Sbjct: 22  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHK 443
                 +V E    GSL D L K +           R A+ VA G+ YL +     ++H+
Sbjct: 82  -TPPMKMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGYLES---KRFIHR 135

Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           D+++ N+LL      K+ +F  +R+  + +  Y   +       + APE ++    +   
Sbjct: 136 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 195

Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           DT+ FGV L E+ T  +  +       +L +                +  +       ++
Sbjct: 196 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHK----------------IDKEGERLPRPED 239

Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ 597
               +  + + C A +PE RP+   +   L++ Q
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 4e-47
 Identities = 51/264 (19%), Positives = 95/264 (35%), Gaps = 34/264 (12%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS--------ISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G V   +  +    VA+K +           I KE+ + K +NH N++  +G      + 
Sbjct: 19  GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 78

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           YL  E+   G L D +        +      R    +  G+ YLH     G  H+DI   
Sbjct: 79  YLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPE 132

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYG-LVTPEMDTYA 507
           N+LLD+    K+++F       R  +         GT  Y+APE ++        +D ++
Sbjct: 133 NLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 191

Query: 508 FGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
            G+VL  ++ G+    +        ++                           K+I   
Sbjct: 192 CGIVLTAMLAGELPWDQPSDSCQEYSD----------------WKEKKTYLNPWKKIDSA 235

Query: 568 LIMLCLACIAREPESRPSMAEVVS 591
            + L    +   P +R ++ ++  
Sbjct: 236 PLALLHKILVENPSARITIPDIKK 259

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (417), Expect = 1e-46
 Identities = 57/268 (21%), Positives = 98/268 (36%), Gaps = 45/268 (16%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDG 386
           G+V+      N   VAIK M  S          I KEV  L+K+ H N I   G    + 
Sbjct: 29  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88

Query: 387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
             +LV E+    +       K+    +       +      GL YLH       +H+D+ 
Sbjct: 89  TAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLH---SHNMIHRDVK 142

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEY---MEYGLVTPEM 503
           +GNILL +    KL +F             +   + VGT  +MAPE    M+ G    ++
Sbjct: 143 AGNILLSEPGLVKLGDFGSASI-------MAPANSFVGTPYWMAPEVILAMDEGQYDGKV 195

Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++ G+  +EL   K   +  +    L                   +  + +       
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYH-----------------IAQNESPALQSGH 238

Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVS 591
            + +      +C+ + P+ RP+   ++ 
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 1e-46
 Identities = 56/265 (21%), Positives = 97/265 (36%), Gaps = 42/265 (15%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDG 386
           G+V+      +   +A+K + ++          + +EV +   + H N++ L+G      
Sbjct: 20  GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79

Query: 387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
             YL+ E+   G++   L K                 ++A+ L Y H       +H+DI 
Sbjct: 80  RVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH---SKRVIHRDIK 133

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
             N+LL      K+A+F +   A           T  GT  Y+ PE +E  +   ++D +
Sbjct: 134 PENLLLGSAGELKIADFGWSVHAPSSR-----RTTLCGTLDYLPPEMIEGRMHDEKVDLW 188

Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           + GV+  E + GK        +E                  K    V+        E A 
Sbjct: 189 SLGVLCYEFLVGKPPFEANTYQETY----------------KRISRVEFTFPDFVTEGAR 232

Query: 567 HLIMLCLACIAREPESRPSMAEVVS 591
            LI   L      P  RP + EV+ 
Sbjct: 233 DLISRLL---KHNPSQRPMLREVLE 254

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 3e-46
 Identities = 66/289 (22%), Positives = 122/289 (42%), Gaps = 40/289 (13%)

Query: 326 VATENFSPKNMID----GSVFRGIINGST------VAIKCMRRSIS--------KEVNLL 367
           +     + + +I     G V++G++  S+      VAIK ++   +         E  ++
Sbjct: 4   IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63

Query: 368 KKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAH 427
            + +H N+I L G         ++ E+MENG+L  +L +K      S      +   +A 
Sbjct: 64  GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAA 121

Query: 428 GLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG 487
           G+ YL N     YVH+D+++ NIL++ NL  K+++F   R    +     +T        
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA 547
           + APE + Y   T   D ++FG+V+ E++T  E  Y +     ++               
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK-------------- 224

Query: 548 KLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
               + D        +    +  L + C  +E   RP  A++VS L K+
Sbjct: 225 ---AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 3e-46
 Identities = 57/260 (21%), Positives = 107/260 (41%), Gaps = 35/260 (13%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS-------ISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G+V+  +    G  VAI+ M          I  E+ ++++  + N++N   +       +
Sbjct: 34  GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           +V E++  GSL+D + +              +  +    L +LH+      +H+DI S N
Sbjct: 94  VVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDN 146

Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFG 509
           ILL  +   KL +F F      E+   S   T VGT  +MAPE +      P++D ++ G
Sbjct: 147 ILLGMDGSVKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203

Query: 510 VVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI 569
           ++ +E+I G+     ++    L     + +   G  E +    +    +          +
Sbjct: 204 IMAIEMIEGEPPYLNENPLRAL-----YLIATNGTPELQNPEKLSAIFR--------DFL 250

Query: 570 MLCLACIAREPESRPSMAEV 589
             CL     + E R S  E+
Sbjct: 251 NRCL---DMDVEKRGSAKEL 267

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 8e-46
 Identities = 44/265 (16%), Positives = 104/265 (39%), Gaps = 38/265 (14%)

Query: 339 GSVFRGI--INGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G V++          A K +             E+++L   +H N++ L  A  ++   +
Sbjct: 26  GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 85

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           ++ EF   G++   + +   P  ++ +    +       L+YLH+      +H+D+ +GN
Sbjct: 86  ILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGN 140

Query: 450 ILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEY-----GLVTPEMD 504
           IL   +   KLA+F     + +         + +GT  +MAPE +            + D
Sbjct: 141 ILFTLDGDIKLADFGV---SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 197

Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            ++ G+ L+E+   +   ++ +   +LL      + +            +P   A     
Sbjct: 198 VWSLGITLIEMAEIEPPHHELNPMRVLLK-----IAKS-----------EPPTLAQPSRW 241

Query: 565 AHHLIMLCLACIAREPESRPSMAEV 589
           + +       C+ +  ++R + +++
Sbjct: 242 SSNFKDFLKKCLEKNVDARWTTSQL 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 1e-45
 Identities = 75/298 (25%), Positives = 126/298 (42%), Gaps = 54/298 (18%)

Query: 329 ENFSPKNMID----GSVFRGIINGS----TVAIKCMRRSISK--------EVNLLKKI-N 371
            +   +++I     G V +  I         AIK M+   SK        E+ +L K+ +
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 372 HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEF-------------VSWNCR 418
           H N+INL GACEH G  YL  E+  +G+L D+L K R  E              +S    
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 419 FRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS 478
              A DVA G+ YL       ++H+D+++ NIL+ +N  AK+A+F   R     +  Y  
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVK 182

Query: 479 TKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFS 538
                    +MA E + Y + T   D +++GV+L E+++     Y            ++ 
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYE 237

Query: 539 MVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
            +  G                N  +  + L+  C      +P  RPS A+++ +L ++
Sbjct: 238 KLPQG---------YRLEKPLNCDDEVYDLMRQCW---REKPYERPSFAQILVSLNRM 283

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 1e-45
 Identities = 66/303 (21%), Positives = 123/303 (40%), Gaps = 47/303 (15%)

Query: 317 KFYKYEDLVVATENFSPKNMID----GSVFRGII-------NGSTVAIKCMRRSIS---- 361
             Y  ++  VA E  +    +     G V+ G+          + VAIK +  + S    
Sbjct: 8   DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 67

Query: 362 ----KEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEF----- 412
                E +++K+ N  +++ L G         ++ E M  G L  +L   R         
Sbjct: 68  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127

Query: 413 --VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAV 470
              S +   ++A ++A G+ YL+      +VH+D+++ N ++ ++   K+ +F   R  +
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD-I 183

Query: 471 REESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI 530
            E   Y      +    +M+PE ++ G+ T   D ++FGVVL E+ T  E  Y       
Sbjct: 184 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY------- 236

Query: 531 LLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVV 590
                     +G + E  L  +++  L          L  L   C    P+ RPS  E++
Sbjct: 237 ----------QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286

Query: 591 STL 593
           S++
Sbjct: 287 SSI 289

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 3e-45
 Identities = 59/291 (20%), Positives = 113/291 (38%), Gaps = 56/291 (19%)

Query: 339 GSVFRGIINGST-------VAIKCMRRSIS--------KEVNLLKKI-NHFNLINLFGAC 382
           G V      G +       VA+K ++             E+ ++ ++ +H N++NL GAC
Sbjct: 51  GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110

Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKRYP--------------------EFVSWNCRFRIA 422
              G  YL++E+   G L ++L  KR                        +++      A
Sbjct: 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 170

Query: 423 LDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA 482
             VA G+ +L        VH+D+++ N+L+      K+ +F   R  +  +S Y     A
Sbjct: 171 YQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR-DIMSDSNYVVRGNA 226

Query: 483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEG 542
                +MAPE +  G+ T + D +++G++L E+ +     Y     +       + +++ 
Sbjct: 227 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD----ANFYKLIQN 282

Query: 543 GNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTL 593
           G            +      E  + ++  C    A +   RPS   + S L
Sbjct: 283 G---------FKMDQPFYATEEIYIIMQSCW---AFDSRKRPSFPNLTSFL 321

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 8e-45
 Identities = 53/269 (19%), Positives = 102/269 (37%), Gaps = 42/269 (15%)

Query: 339 GSVFRGI--INGSTVAIKCM---------RRSISKEVNLLKKINHFNLINLFGACE---- 383
            +V++G+       VA   +         R+   +E  +LK + H N++  + + E    
Sbjct: 23  KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHK 443
                 LV E M +G+L  +L + +    +           +  GL +LH    P  +H+
Sbjct: 83  GKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTR-TPPIIHR 138

Query: 444 DISSGNILL-DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           D+   NI +       K+ +              S  K  +GT  +MAPE  E       
Sbjct: 139 DLKCDNIFITGPTGSVKIGDLGLAT-----LKRASFAKAVIGTPEFMAPEMYE-EKYDES 192

Query: 503 MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK 562
           +D YAFG+ +LE+ T +    +      +     +  V  G   A    +  P ++    
Sbjct: 193 VDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRVTSGVKPASFDKVAIPEVK---- 243

Query: 563 EIAHHLIMLCLACIAREPESRPSMAEVVS 591
                +I  C+    +  + R S+ ++++
Sbjct: 244 ----EIIEGCI---RQNKDERYSIKDLLN 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 2e-44
 Identities = 61/289 (21%), Positives = 114/289 (39%), Gaps = 51/289 (17%)

Query: 339 GSVFRGII-------NGSTVAIKCMRRS--------ISKEVNLLKKI-NHFNLINLFGAC 382
           G V               TVA+K ++ S        +  E+ +L  + NH N++NL GAC
Sbjct: 37  GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96

Query: 383 EHDGVFYLVYEFMENGSLSDWLHKKRYPEF---------------VSWNCRFRIALDVAH 427
              G   ++ E+   G L ++L +KR                   +        +  VA 
Sbjct: 97  TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156

Query: 428 GLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG 487
           G+ +L +      +H+D+++ NILL      K+ +F   R  ++ +S Y     A     
Sbjct: 157 GMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARD-IKNDSNYVVKGNARLPVK 212

Query: 488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA 547
           +MAPE +   + T E D +++G+ L EL +   + Y     +       + M++ G    
Sbjct: 213 WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----SKFYKMIKEGFR-- 266

Query: 548 KLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
               ++ P      +     +  +   C   +P  RP+  ++V  + K 
Sbjct: 267 ----MLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 3e-44
 Identities = 58/282 (20%), Positives = 115/282 (40%), Gaps = 38/282 (13%)

Query: 339 GSVFRGIINGS------TVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEH 384
           G+V++G+           VAIK +R + S         E  ++  +++ ++  L G C  
Sbjct: 23  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 82

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
             V  L+ + M  G L D++ + +              + +A G++YL +      VH+D
Sbjct: 83  STV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYLEDR---RLVHRD 136

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMD 504
           +++ N+L+      K+ +F   +  +  E      +       +MA E + + + T + D
Sbjct: 137 LAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 195

Query: 505 TYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI 564
            +++GV + EL+T     Y         A  + S++E G        L  P         
Sbjct: 196 VWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEKGE------RLPQP------PIC 238

Query: 565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQTL 606
              + M+ + C   + +SRP   E++    K+  D QR   +
Sbjct: 239 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 280

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 7e-44
 Identities = 63/273 (23%), Positives = 117/273 (42%), Gaps = 37/273 (13%)

Query: 339 GSVFRGIINGST-----VAIKCMRRSIS--------KEVNLLKKINHFNLINLFGAC-EH 384
           G V+ G +  +       A+K + R            E  ++K  +H N+++L G C   
Sbjct: 41  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 100

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
           +G   +V  +M++G L +++  + +    +        L VA G+ +L +     +VH+D
Sbjct: 101 EGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFLAS---KKFVHRD 155

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV-GTNGYMAPEYMEYGLVTPEM 503
           +++ N +LD+    K+A+F   R    +E      KT       +MA E ++    T + 
Sbjct: 156 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 215

Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++FGV+L EL+T     Y          +    +++G         L+ P      + 
Sbjct: 216 DVWSFGVLLWELMTRGAPPYPDVNTF----DITVYLLQGRR-------LLQP------EY 258

Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
               L  + L C   + E RPS +E+VS +  I
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  156 bits (396), Expect = 2e-43
 Identities = 57/262 (21%), Positives = 96/262 (36%), Gaps = 35/262 (13%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS-------ISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G V R      G+  A K +          + KE+  +  + H  L+NL  A E D    
Sbjct: 40  GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           ++YEFM  G L + +  +     +S +        V  GL ++H   +  YVH D+   N
Sbjct: 100 MIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPEN 154

Query: 450 ILL--DKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
           I+    ++   KL +F              S K   GT  + APE  E   V    D ++
Sbjct: 155 IMFTTKRSNELKLIDFGLTAHL----DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 210

Query: 508 FGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
            GV+   L++G      ++ +E L                     +D +  +   E    
Sbjct: 211 VGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAFSGISEDGKD 258

Query: 568 LIMLCLACIAREPESRPSMAEV 589
            I   L     +P +R ++ + 
Sbjct: 259 FIRKLL---LADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  155 bits (393), Expect = 5e-43
 Identities = 53/262 (20%), Positives = 95/262 (36%), Gaps = 35/262 (13%)

Query: 339 GSVFRGI--INGSTVAIKCM-------RRSISKEVNLLKKINHFNLINLFGACEHDGVFY 389
           G V R +    G     K +       + ++  E++++ +++H  LINL  A E      
Sbjct: 43  GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           L+ EF+  G L D +  + Y   +S             GL ++H       VH DI   N
Sbjct: 103 LILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPEN 157

Query: 450 ILLD--KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYA 507
           I+ +  K    K+ +F        +E      K    T  + APE ++   V    D +A
Sbjct: 158 IMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWA 213

Query: 508 FGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH 567
            GV+   L++G      +D  E L              +       + +  A    ++  
Sbjct: 214 IGVLGYVLLSGLSPFAGEDDLETL--------------QNVKRCDWEFDEDAFSS-VSPE 258

Query: 568 LIMLCLACIAREPESRPSMAEV 589
                   + +EP  R ++ + 
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDA 280

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 1e-42
 Identities = 61/279 (21%), Positives = 108/279 (38%), Gaps = 39/279 (13%)

Query: 339 GSVFRGII-----NGSTVAIKCMRRSIS--------KEVNLLKKINHFNLINLFGACEHD 385
           G V +GI          VAIK  +   S        +E   +++ +H +++ L G    +
Sbjct: 21  GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE 79

Query: 386 GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDI 445
              +++ E    G L  +L  ++Y            A  ++  L YL       +VH+DI
Sbjct: 80  NPVWIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAYLE---SKRFVHRDI 134

Query: 446 SSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDT 505
           ++ N+L+  N   KL +F    S   E+S Y           +MAPE + +   T   D 
Sbjct: 135 AARNVLVSSNDCVKLGDFGL--SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 192

Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA 565
           + FGV + E++      ++           V   +E G             +  N     
Sbjct: 193 WMFGVCMWEILMHGVKPFQGVKN-----NDVIGRIENGE---------RLPMPPNCPPTL 238

Query: 566 HHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQRSQ 604
           + L+  C    A +P  RP   E+ + L  I L+ +++Q
Sbjct: 239 YSLMTKCW---AYDPSRRPRFTELKAQLSTI-LEEEKAQ 273

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  151 bits (381), Expect = 4e-42
 Identities = 51/276 (18%), Positives = 108/276 (39%), Gaps = 38/276 (13%)

Query: 339 GSVFRGI--INGSTVAIKCMRRSISK----------EVNLLKKINHFNLINLFGACEHD- 385
             V           VA+K +R  +++          E      +NH  ++ ++   E + 
Sbjct: 21  SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80

Query: 386 ---GVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
               + Y+V E+++  +L D +H +     ++      +  D    L++ H     G +H
Sbjct: 81  PAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH---QNGIIH 134

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           +D+   NI++      K+ +F   R+     +  + T   +GT  Y++PE      V   
Sbjct: 135 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR 194

Query: 503 MDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK 562
            D Y+ G VL E++TG+          +                  +     P    ++ 
Sbjct: 195 SDVYSLGCVLYEVLTGEPPFTGDSPVSVA--------------YQHVREDPIPPSARHEG 240

Query: 563 EIAHHLIMLCLACIAREPESRP-SMAEVVSTLMKIQ 597
            ++  L  + L  +A+ PE+R  + AE+ + L+++ 
Sbjct: 241 -LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 5e-42
 Identities = 68/289 (23%), Positives = 117/289 (40%), Gaps = 52/289 (17%)

Query: 339 GSVFRGI---------INGSTVAIKCMRRSISK--------EVNLLKKI-NHFNLINLFG 380
           G V                + VA+K ++   ++        E+ ++K I  H N+INL G
Sbjct: 27  GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 86

Query: 381 ACEHDGVFYLVYEFMENGSLSDWLHKKRYP-------------EFVSWNCRFRIALDVAH 427
           AC  DG  Y++ E+   G+L ++L  +R P             E +S       A  VA 
Sbjct: 87  ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 146

Query: 428 GLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG 487
           G+ YL        +H+D+++ N+L+ ++   K+A+F   R  +     Y  T        
Sbjct: 147 GMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVK 202

Query: 488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA 547
           +MAPE +   + T + D ++FGV+L E+ T   + Y                  G   E 
Sbjct: 203 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-----------------PGVPVEE 245

Query: 548 KLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
              +L + +         + L M+   C    P  RP+  ++V  L +I
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 6e-41
 Identities = 45/263 (17%), Positives = 97/263 (36%), Gaps = 38/263 (14%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDG 386
            +V            AIK + +           +++E +++ +++H   + L+   + D 
Sbjct: 22  STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 81

Query: 387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
             Y    + +NG L  ++ K          C      ++   L YLH     G +H+D+ 
Sbjct: 82  KLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH---GKGIIHRDLK 135

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
             NILL++++  ++ +F   +  +  ES  +   + VGT  Y++PE +         D +
Sbjct: 136 PENILLNEDMHIQITDFGTAKV-LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW 194

Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           A G ++ +L+ G       +   I        +++            + +        A 
Sbjct: 195 ALGCIIYQLVAGLPPFRAGNEYLIF-----QKIIKL-----------EYDFPEKFFPKAR 238

Query: 567 HLIMLCLACIAREPESRPSMAEV 589
            L+   L     +   R    E+
Sbjct: 239 DLVEKLL---VLDATKRLGCEEM 258

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 3e-40
 Identities = 63/288 (21%), Positives = 112/288 (38%), Gaps = 50/288 (17%)

Query: 339 GSVFRG-------IINGSTVAIKCMRRS---------ISKEVNLLKKINHFNLINLFGAC 382
           G V               TVA+K ++           +S+   L+   +H N++NL GAC
Sbjct: 27  GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86

Query: 383 EHDG-VFYLVYEFMENGSLSDWLHKKR-------------YPEFVSWNCRFRIALDVAHG 428
              G    ++ EF + G+LS +L  KR             Y +F++       +  VA G
Sbjct: 87  TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 146

Query: 429 LHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY 488
           + +L +      +H+D+++ NILL +    K+ +F   R  + ++  Y     A     +
Sbjct: 147 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLPLKW 202

Query: 489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK 548
           MAPE +   + T + D ++FGV+L E+ +   + Y     +                   
Sbjct: 203 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-------------- 248

Query: 549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
              L +             +    L C   EP  RP+ +E+V  L  +
Sbjct: 249 --RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (370), Expect = 4e-40
 Identities = 55/261 (21%), Positives = 98/261 (37%), Gaps = 32/261 (12%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS--------ISKEVNLLKKINHFNLINLFGACEHDGVF 388
             V           VAIKC+ +         +  E+ +L KI H N++ L    E  G  
Sbjct: 23  SEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 82

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
           YL+ + +  G L D + +K    F +     R+   V   + YLH+        K  +  
Sbjct: 83  YLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLL 139

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
              LD++ +  +++F       + E   S   TA GT GY+APE +     +  +D ++ 
Sbjct: 140 YYSLDEDSKIMISDFGL----SKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 195

Query: 509 GVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL 568
           GV+   L+ G    Y ++  ++                 K     D     +  + A   
Sbjct: 196 GVIAYILLCGYPPFYDENDAKLF------------EQILKAEYEFDSPYWDDISDSAKDF 243

Query: 569 IMLCLACIAREPESRPSMAEV 589
           I   +    ++PE R +  + 
Sbjct: 244 IRHLM---EKDPEKRFTCEQA 261

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 7e-40
 Identities = 45/261 (17%), Positives = 102/261 (39%), Gaps = 34/261 (13%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS------ISKEVNLLKKINHFNLINLFGACEHDGVFYL 390
           G V R +   +  T   K ++        + KE+++L    H N+++L  + E      +
Sbjct: 19  GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78

Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           ++EF+    + + ++   +   ++          V   L +LH+       H DI   NI
Sbjct: 79  IFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENI 133

Query: 451 LLD--KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAF 508
           +    ++   K+  F       R+     + +       Y APE  ++ +V+   D ++ 
Sbjct: 134 IYQTRRSSTIKIIEFGQ----ARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189

Query: 509 GVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHL 568
           G ++  L++G      +  ++I+              E  ++     + +A  KEI+   
Sbjct: 190 GTLVYVLLSGINPFLAETNQQII--------------ENIMNAEYTFDEEAF-KEISIEA 234

Query: 569 IMLCLACIAREPESRPSMAEV 589
           +      + +E +SR + +E 
Sbjct: 235 MDFVDRLLVKERKSRMTASEA 255

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  141 bits (356), Expect = 1e-38
 Identities = 68/290 (23%), Positives = 117/290 (40%), Gaps = 54/290 (18%)

Query: 329 ENFSPKNMID----GSVFRGI--INGSTVAIKCM----------------RRSISKEVNL 366
           EN+ PK ++       V R I        A+K +                R +  KEV++
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 367 LKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDV 425
           L+K++ H N+I L    E +  F+LV++ M+ G L D+L +K     +S     +I   +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 119

Query: 426 AHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT 485
              +  LH       VH+D+   NILLD ++  KL +F F       E      +   GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGT 172

Query: 486 NGYMAPEYME------YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSM 539
             Y+APE +E      +     E+D ++ GV++  L+ G    + +    +L       M
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML------RM 226

Query: 540 VEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
           +  GN +             +  +    L+   L     +P+ R +  E 
Sbjct: 227 IMSGNYQ------FGSPEWDDYSDTVKDLVSRFL---VVQPQKRYTAEEA 267

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 3e-37
 Identities = 49/263 (18%), Positives = 91/263 (34%), Gaps = 31/263 (11%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS--ISKEVNLLKKI-NHFNLINLFGACEH----DGVFY 389
           G V +          A+K ++      +EV L  +     +++ +    E+         
Sbjct: 26  GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85

Query: 390 LVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGN 449
           +V E ++ G L   +  +    F +      I   +   + YLH+       H+D+   N
Sbjct: 86  IVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHSI---NIAHRDVKPEN 141

Query: 450 ILLDK---NLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
           +L      N   KL +F F +      S  +   T      Y+APE +         D +
Sbjct: 142 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP----YYVAPEVLGPEKYDKSCDMW 197

Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           + GV++  L+ G    Y   G  I     + + +  G  E                E++ 
Sbjct: 198 SLGVIMYILLCGYPPFYSNHGLAIS--PGMKTRIRMGQYEFP---------NPEWSEVSE 246

Query: 567 HLIMLCLACIAREPESRPSMAEV 589
            + ML    +  EP  R ++ E 
Sbjct: 247 EVKMLIRNLLKTEPTQRMTITEF 269

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 7e-37
 Identities = 56/266 (21%), Positives = 98/266 (36%), Gaps = 36/266 (13%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKINHFNLINLFGACE 383
             V +      G   A K +++              I +EV++LK+I H N+I L    E
Sbjct: 24  AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83

Query: 384 HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHK 443
           +     L+ E +  G L D+L +K                 + +G++YLH        H 
Sbjct: 84  NKTDVILILELVAGGELFDFLAEKESLT---EEEATEFLKQILNGVYYLH---SLQIAHF 137

Query: 444 DISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           D+   NI+L      K            +    +  K   GT  ++APE + Y  +  E 
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 197

Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D ++ GV+   L++G         +E L      + V   N E       +    +N   
Sbjct: 198 DMWSIGVITYILLSGASPFLGDTKQETL------ANVSAVNYE------FEDEYFSNTSA 245

Query: 564 IAHHLIMLCLACIAREPESRPSMAEV 589
           +A   I   L    ++P+ R ++ + 
Sbjct: 246 LAKDFIRRLL---VKDPKKRMTIQDS 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 1e-35
 Identities = 62/277 (22%), Positives = 107/277 (38%), Gaps = 45/277 (16%)

Query: 329 ENFSPKNMID----GSVFRGI--INGSTVAIKCMRRS-----------ISKEVNLLKKIN 371
           E+F    M+     G VF           AIK +++            + ++  L     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 372 HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHY 431
           H  L ++F   +     + V E++  G L   +           +     A ++  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 432 LHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP 491
           LH+    G V++D+   NILLDK+   K+A+F           G + T T  GT  Y+AP
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGM---CKENMLGDAKTNTFCGTPDYIAP 172

Query: 492 EYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV 551
           E +        +D ++FGV+L E++ G+   + QD EE+                     
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF----------------HSIR 216

Query: 552 LVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAE 588
           + +P      ++ A  L++       REPE R  +  
Sbjct: 217 MDNPFYPRWLEKEAKDLLVKLF---VREPEKRLGVRG 250

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  134 bits (337), Expect = 4e-35
 Identities = 47/280 (16%), Positives = 99/280 (35%), Gaps = 47/280 (16%)

Query: 329 ENFSPKNMID----GSVFRGI--INGSTVAIKCMRRSISK-------------EVNLLKK 369
            +FS   +I     G V+       G   A+KC+ +   K              ++L+  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 370 INHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGL 429
            +   ++ +  A         + + M  G L   L +               A ++  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGL 120

Query: 430 HYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM 489
            ++H   +   V++D+   NILLD++   ++++          +        +VGT+GYM
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYM 172

Query: 490 APEYMEYGL-VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK 548
           APE ++ G+      D ++ G +L +L+ G     +   ++                  +
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-------------EIDR 219

Query: 549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAE 588
           +++ +   L  +       L+   L    R+   R     
Sbjct: 220 MTLTMAVELPDSFSPELRSLLEGLL---QRDVNRRLGCLG 256

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 5e-35
 Identities = 58/275 (21%), Positives = 94/275 (34%), Gaps = 33/275 (12%)

Query: 339 GSVFRGI--INGSTVAIKCMR------------RSISKEVNLLKKINHFNLINLFGACEH 384
            +V++         VAIK ++            R+  +E+ LL++++H N+I L  A  H
Sbjct: 12  ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 71

Query: 385 DGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKD 444
                LV++FME                   +      L    GL YLH       +H+D
Sbjct: 72  KSNISLVFDFMETDLEVIIKDNSLVLT---PSHIKAYMLMTLQGLEYLHQHW---ILHRD 125

Query: 445 ISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE-YMEYGLVTPEM 503
           +   N+LLD+N   KLA+F   +S     S   +    V T  Y APE      +    +
Sbjct: 126 LKPNNLLLDENGVLKLADFGLAKSF---GSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182

Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLA---------EAVFSMVEGGNAEAKLSVLVD 554
           D +A G +L EL+            + L           E  +  +              
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242

Query: 555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
             L          L+ L        P +R +  + 
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  131 bits (330), Expect = 9e-35
 Identities = 38/273 (13%), Positives = 74/273 (27%), Gaps = 32/273 (11%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS-----ISKEVNLLKKINHFNLINLFGACEHDG-VFYL 390
           G ++ G     G  VAIK          +  E  + K +     I     C  +G    +
Sbjct: 21  GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80

Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           V E +       +    R     S      +A  +   + Y+H+     ++H+D+   N 
Sbjct: 81  VMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNF 134

Query: 451 LLDKNLRAKLANFS-------FVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEM 503
           L+    +  L           +  +   +   Y   K   GT  Y +         +   
Sbjct: 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD 194

Query: 504 DTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE 563
           D  + G VL+    G                           E      +   ++   K 
Sbjct: 195 DLESLGYVLMYFNLGSLPWQGLKAATKRQ-----------KYERISEKKMSTPIEVLCKG 243

Query: 564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                      C +   + +P  + +      +
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  130 bits (328), Expect = 3e-34
 Identities = 56/262 (21%), Positives = 101/262 (38%), Gaps = 43/262 (16%)

Query: 339 GSVFRGI--INGSTVAIKCMRRSIS----------KEVNLLKKINHFNLINLFGACEHDG 386
           G V       NG   A+K +++ I            E  +L  + H  +I ++G  +   
Sbjct: 18  GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77

Query: 387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
             +++ +++E G L   L K +             A +V   L YLH       +++D+ 
Sbjct: 78  QIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYLH---SKDIIYRDLK 131

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
             NILLDKN   K+ +F F +           T T  GT  Y+APE +        +D +
Sbjct: 132 PENILLDKNGHIKITDFGFAKYV------PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWW 185

Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           +FG+++ E++ G    Y  +  +    E +       NAE +     + +++        
Sbjct: 186 SFGILIYEMLAGYTPFYDSNTMKTY--EKIL------NAELRFPPFFNEDVKD------- 230

Query: 567 HLIMLCLACIAREPESRPSMAE 588
               L    I R+   R    +
Sbjct: 231 ----LLSRLITRDLSQRLGNLQ 248

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 2e-33
 Identities = 59/270 (21%), Positives = 96/270 (35%), Gaps = 54/270 (20%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS-------------ISKEVNLLKKIN--HFNLINLFGA 381
           GSV+ GI   +   VAIK + +              +  EV LLKK++     +I L   
Sbjct: 18  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77

Query: 382 CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYV 441
            E    F L+ E  E          +R    +           V   + + HNC   G +
Sbjct: 78  FERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNC---GVL 132

Query: 442 HKDISSGNILLDKN-LRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYG-LV 499
           H+DI   NIL+D N    KL +F             +      GT  Y  PE++ Y    
Sbjct: 133 HRDIKDENILIDLNRGELKLIDFGSGA-----LLKDTVYTDFDGTRVYSPPEWIRYHRYH 187

Query: 500 TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA 559
                 ++ G++L +++ G      +  EEI+  +  F                      
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIP--FEHDEEIIRGQVFF---------------------- 223

Query: 560 NKKEIAHHLIMLCLACIAREPESRPSMAEV 589
            ++ ++     L   C+A  P  RP+  E+
Sbjct: 224 -RQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 2e-33
 Identities = 46/274 (16%), Positives = 90/274 (32%), Gaps = 26/274 (9%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS--------ISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G V      +N   VAIK +             +E+ +L +  H N+I +        + 
Sbjct: 22  GMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
            +   ++    +   L+K    + +S +        +  GL Y+H+      +H+D+   
Sbjct: 82  QMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPS 138

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLV-TPEMDTYA 507
           N+LL+     K+ +F   R A  +          V T  Y APE M      T  +D ++
Sbjct: 139 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 198

Query: 508 FGVVLLELITGKEAAYKQDGEEILLA------------EAVFSMVEGGNAEAKLSVLVDP 555
            G +L E+++ +     +   + L                    ++  N    L      
Sbjct: 199 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 258

Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
                        + L    +   P  R  + + 
Sbjct: 259 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 4e-33
 Identities = 58/281 (20%), Positives = 99/281 (35%), Gaps = 41/281 (14%)

Query: 339 GSVFRGII---NGSTVAIKCMR---------RSISKEVNLLKKI---NHFNLINLFGAC- 382
           G VF+       G  VA+K +R          S  +EV +L+ +    H N++ LF  C 
Sbjct: 21  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 80

Query: 383 ----EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDP 438
               + +    LV+E ++    +           V       +   +  GL +LH+    
Sbjct: 81  VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLDFLHSH--- 135

Query: 439 GYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL 498
             VH+D+   NIL+  + + KLA+F   R      S   +  + V T  Y APE +    
Sbjct: 136 RVVHRDLKPQNILVTSSGQIKLADFGLARI----YSFQMALTSVVVTLWYRAPEVLLQSS 191

Query: 499 VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ 558
               +D ++ G +  E+   K         + L    +  ++     E     +  P   
Sbjct: 192 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GKILDVIGLPGEEDWPRDVALPRQA 249

Query: 559 ANKK----------EIAHHLIMLCLACIAREPESRPSMAEV 589
            + K          +I      L L C+   P  R S    
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  126 bits (316), Expect = 6e-33
 Identities = 41/275 (14%), Positives = 74/275 (26%), Gaps = 34/275 (12%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS-----ISKEVNLLKKINHFNLIN-LFGACEHDGVFYL 390
           G +F G   +N   VAIK   R      +  E    K +     I  ++   +      L
Sbjct: 19  GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78

Query: 391 VYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNI 450
           V + +            R     S       A  +   +  +H       V++DI   N 
Sbjct: 79  VIDLLGPSLEDLLDLCGRKF---SVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNF 132

Query: 451 LLDKNLR-----AKLANFSFVRSAVREESG----YSSTKTAVGTNGYMAPEYMEYGLVTP 501
           L+ +          + +F  V+      +     Y   K   GT  YM+         + 
Sbjct: 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR 192

Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANK 561
             D  A G V +  + G      Q  +     +    + E   +           L+   
Sbjct: 193 RDDLEALGHVFMYFLRGSL--PWQGLKAATNKQKYERIGEKKQS---------TPLRELC 241

Query: 562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI 596
                              ++ P    +     K+
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 1e-31
 Identities = 57/274 (20%), Positives = 100/274 (36%), Gaps = 30/274 (10%)

Query: 339 GSVFRGI--INGSTVAIKCMR---RSISKEVNLLKKINHFNLINLFGACEHDG------V 387
           G V++     +G  VAIK +    R  ++E+ +++K++H N++ L       G       
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
             LV +++         H  R  + +           +   L Y+H     G  H+DI  
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKP 150

Query: 448 GNILLDKN-LRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP-EYMEYGLVTPEMDT 505
            N+LLD +    KL +F   +  VR E       + + +  Y AP         T  +D 
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNV----SYICSRYYRAPELIFGATDYTSSIDV 206

Query: 506 YAFGVVLLELITGKEAAYKQDGEEILLA----------EAVFSMVEGGNAEAKLSVLVDP 555
           ++ G VL EL+ G+       G + L+           E +  M           +   P
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266

Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
             +  +       I LC   +   P +R +  E 
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  121 bits (305), Expect = 1e-31
 Identities = 46/272 (16%), Positives = 100/272 (36%), Gaps = 30/272 (11%)

Query: 339 GSVFRGI-INGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVF 388
           G V++     G T A+K +R          +  +E+++LK++ H N++ L+         
Sbjct: 16  GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75

Query: 389 YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSG 448
            LV+E ++          +     +         L + +G+ Y H   D   +H+D+   
Sbjct: 76  VLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQ 129

Query: 449 NILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE-YMEYGLVTPEMDTYA 507
           N+L+++    K+A+F     A             + T  Y AP+  M     +  +D ++
Sbjct: 130 NLLINREGELKIADFGL---ARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS 186

Query: 508 FGVVLLELITGKEAAYKQDGEEILLA----------EAVFSMVEGGNAEAKLSVLVDPNL 557
            G +  E++ G          + L+           +   ++ E    +   +V      
Sbjct: 187 VGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW 246

Query: 558 QANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
           ++  K +    I L    +  +P  R +  + 
Sbjct: 247 ESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 2e-31
 Identities = 52/287 (18%), Positives = 97/287 (33%), Gaps = 34/287 (11%)

Query: 329 ENFSPKNMID----GSVFRGI--INGSTVAIKCMRRSIS---------KEVNLLKKINHF 373
           ENF     I     G V++    + G  VA+K +R             +E++LLK++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 374 NLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLH 433
           N++ L      +   YLV+EF+                 +           +  GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 434 NCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE- 492
           +      +H+D+   N+L++     KLA+F   R+       Y+     V T  Y APE 
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWYRAPEI 173

Query: 493 YMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA----------EAVFSMVEG 542
            +     +  +D ++ G +  E++T +         + L                 +   
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233

Query: 543 GNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
            + +         +       +      L    +  +P  R S    
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 2e-31
 Identities = 55/285 (19%), Positives = 109/285 (38%), Gaps = 40/285 (14%)

Query: 339 GSVFRGI--INGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLFGAC----- 382
           G VF+      G  VA+K +     K         E+ +L+ + H N++NL   C     
Sbjct: 24  GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83

Query: 383 ---EHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG 439
                 G  YLV++F E+       +        + +   R+   + +GL+Y+H      
Sbjct: 84  PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF---TLSEIKRVMQMLLNGLYYIHRN---K 137

Query: 440 YVHKDISSGNILLDKNLRAKLANFSFVRS-AVREESGYSSTKTAVGTNGYMAPEYMEYG- 497
            +H+D+ + N+L+ ++   KLA+F   R+ ++ + S  +     V T  Y  PE +    
Sbjct: 138 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER 197

Query: 498 LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEIL---------LAEAVFSMVEGGNAEAK 548
              P +D +  G ++ E+ T          +  L         +   V+  V+      K
Sbjct: 198 DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK 257

Query: 549 LSVLVDPNLQANKKEIAH----HLIMLCLACIAREPESRPSMAEV 589
           L ++     +   +  A+    + + L    +  +P  R    + 
Sbjct: 258 LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 1e-30
 Identities = 56/262 (21%), Positives = 98/262 (37%), Gaps = 40/262 (15%)

Query: 339 GSVFRGI--INGSTVAIKCMRRSIS----------KEVNLLKKINHFNLINLFGACEHDG 386
           G V        G   A+K +R+ +            E  +L+   H  L  L  A +   
Sbjct: 19  GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78

Query: 387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
               V E+   G L   L ++R     +         ++   L YLH       V++DI 
Sbjct: 79  RLCFVMEYANGGELFFHLSRERVF---TEERARFYGAEIVSALEYLH---SRDVVYRDIK 132

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
             N++LDK+   K+ +F   +  + + +   + KT  GT  Y+APE +E       +D +
Sbjct: 133 LENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189

Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
             GVV+ E++ G+   Y QD E +                 +L ++ +          A 
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLF----------------ELILMEEIRFPRTLSPEAK 233

Query: 567 HLIMLCLACIAREPESRPSMAE 588
            L+   L    ++P+ R     
Sbjct: 234 SLLAGLL---KKDPKQRLGGGP 252

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 7e-30
 Identities = 55/274 (20%), Positives = 97/274 (35%), Gaps = 32/274 (11%)

Query: 339 GSVFRGI--INGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGV 387
           G+VF+         VA+K +R          S  +E+ LLK++ H N++ L      D  
Sbjct: 16  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75

Query: 388 FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS 447
             LV+EF +      +       +             +  GL + H+      +H+D+  
Sbjct: 76  LTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCHSR---NVLHRDLKP 129

Query: 448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE-YMEYGLVTPEMDTY 506
            N+L+++N   KLANF   R+       YS+    V T  Y  P+      L +  +D +
Sbjct: 130 QNLLINRNGELKLANFGLARAFGIPVRCYSAE---VVTLWYRPPDVLFGAKLYSTSIDMW 186

Query: 507 AFGVVLLELITGKEAAYKQDGEEILLA-----------EAVFSMVEGGNAEAKLSVLVDP 555
           + G +  EL       +  +  +  L            E   SM +  + +         
Sbjct: 187 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATT 246

Query: 556 NLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
           +L     ++      L    +   P  R S  E 
Sbjct: 247 SLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 8e-28
 Identities = 64/281 (22%), Positives = 103/281 (36%), Gaps = 44/281 (15%)

Query: 339 GSVFRGI--INGSTVAIKCMRRSISK---------EVNLLKKINHFNLINLFGACEHDGV 387
           G+V   +    G+ VAIK + R             E+ LLK + H N+I L      D  
Sbjct: 32  GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91

Query: 388 ------FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYV 441
                 FYLV  FM  G+    L K      +  +    +   +  GL Y+H     G +
Sbjct: 92  LDDFTDFYLVMPFM--GTDLGKLMKHEK---LGEDRIQFLVYQMLKGLRYIHAA---GII 143

Query: 442 HKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE-YMEYGLVT 500
           H+D+  GN+ ++++   K+ +F   R A       S     V T  Y APE  + +   T
Sbjct: 144 HRDLKPGNLAVNEDCELKILDFGLARQA------DSEMTGYVVTRWYRAPEVILNWMRYT 197

Query: 501 PEMDTYAFGVVLLELITGK------------EAAYKQDGEEILLAEAVFSMVEGGNAEAK 548
             +D ++ G ++ E+ITGK            +   K  G             E  N    
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257

Query: 549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
           L  L   +  +     +   + L    +  + E R +  E 
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 3e-26
 Identities = 57/269 (21%), Positives = 102/269 (37%), Gaps = 42/269 (15%)

Query: 339 GSVFRGI-----INGSTVAIKCMRRS-----------ISKEVNLLKKINHF-NLINLFGA 381
           G VF          G   A+K ++++              E  +L+ I     L+ L  A
Sbjct: 38  GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97

Query: 382 CEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYV 441
            + +   +L+ +++  G L   L ++      + +       ++   L +LH     G +
Sbjct: 98  FQTETKLHLILDYINGGELFTHLSQRERF---TEHEVQIYVGEIVLALEHLH---KLGII 151

Query: 442 HKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGL--V 499
           ++DI   NILLD N    L +F    S               GT  YMAP+ +  G    
Sbjct: 152 YRDIKLENILLDSNGHVVLTDFGL--SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 209

Query: 500 TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA 559
              +D ++ GV++ EL+TG  + +  DGE+   AE    +++            +P    
Sbjct: 210 DKAVDWWSLGVLMYELLTGA-SPFTVDGEKNSQAEISRRILKS-----------EPPYPQ 257

Query: 560 NKKEIAHHLIMLCLACIAREPESRPSMAE 588
               +A  LI   L    ++P+ R     
Sbjct: 258 EMSALAKDLIQRLL---MKDPKKRLGCGP 283

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  104 bits (260), Expect = 5e-25
 Identities = 44/265 (16%), Positives = 91/265 (34%), Gaps = 42/265 (15%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS----------ISKEVNLLKKINHFNLINLFGACEHDG 386
           G V       +G+  A+K + +              E  +L+ +N   L+ L  + + + 
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114

Query: 387 VFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDIS 446
             Y+V E++  G +   L +       S       A  +     YLH+      +++D+ 
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLK 168

Query: 447 SGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTY 506
             N+L+D+    ++ +F F +           T T  GT   +APE +        +D +
Sbjct: 169 PENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWW 222

Query: 507 AFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH 566
           A GV++ E+  G    +     +I                 +  V       ++      
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQIY----------------EKIVSGKVRFPSHFSSDLK 266

Query: 567 HLIMLCLAC--IAREPESRPSMAEV 589
            L+   L      R    +  + ++
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDI 291

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  102 bits (256), Expect = 1e-24
 Identities = 51/319 (15%), Positives = 107/319 (33%), Gaps = 56/319 (17%)

Query: 311 NLDRGLKFYKYEDLVVAT---ENFSPKNMID----GSVFRGI--INGSTVAIKCMRRS-- 359
           N  R  +++ YE  VV     +++     +       VF  I   N   V +K ++    
Sbjct: 14  NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK 73

Query: 360 --ISKEVNLLKKIN-HFNLINLFGACEH--DGVFYLVYEFMENGSLSDWLHKKRYPEFVS 414
             I +E+ +L+ +    N+I L    +        LV+E + N               ++
Sbjct: 74  KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LT 127

Query: 415 WNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD-KNLRAKLANFSFVRSAVREE 473
                    ++   L Y H+    G +H+D+   N+++D ++ + +L ++          
Sbjct: 128 DYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL----AEFY 180

Query: 474 SGYSSTKTAVGTNGYMAPEYM-EYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILL 532
                    V +  +  PE + +Y +    +D ++ G +L  +I  KE  +        L
Sbjct: 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 240

Query: 533 AEAV----------------------FSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM 570
                                     F+ + G ++  +    V    Q      A   + 
Sbjct: 241 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD 300

Query: 571 LCLACIAREPESRPSMAEV 589
             L     + +SR +  E 
Sbjct: 301 KLL---RYDHQSRLTAREA 316

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.5 bits (244), Expect = 6e-23
 Identities = 55/291 (18%), Positives = 97/291 (33%), Gaps = 53/291 (18%)

Query: 339 GSVFRGI--INGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACEHDGV 387
           G V      +    VAIK + R            +E+ L+K +NH N+I+L         
Sbjct: 31  GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90

Query: 388 F------YLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYV 441
                  YLV E M+         +              +   +  G+ +LH+      +
Sbjct: 91  LEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGIKHLHSAG---II 141

Query: 442 HKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTP 501
           H+D+   NI++  +   K+ +F   R+A             V T  Y APE +       
Sbjct: 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKE 197

Query: 502 EMDTYAFGVVLLELITGKEAAYKQDGEEIL-----------------LAEAVFSMVEGGN 544
            +D ++ G ++ E++  K     +D  +                   L   V + VE   
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257

Query: 545 AEAKLSV------LVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
             A L+        + P    + K  A     L    +  +P  R S+ + 
Sbjct: 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.5 bits (239), Expect = 2e-22
 Identities = 43/279 (15%), Positives = 92/279 (32%), Gaps = 40/279 (14%)

Query: 339 GSVFRGI--INGSTVAIKCMRRSIS---------KEVNLLKKINHFNLINLFGACE---- 383
           GSV        G  VA+K + R            +E+ LLK + H N+I L         
Sbjct: 32  GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91

Query: 384 -HDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVH 442
             +     +   +    L++ +  ++  +       ++I      GL Y+H+      +H
Sbjct: 92  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR----GLKYIHSA---DIIH 144

Query: 443 KDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPE 502
           +D+   N+ ++++   K+ +F   R      +    T              + +      
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 199

Query: 503 MDTYAFGVVLLELITGK------------EAAYKQDGEEILLAEAVFSMVEGGNAEAKLS 550
           +D ++ G ++ EL+TG+            +   +  G          S     N    L+
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 259

Query: 551 VLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEV 589
            +   N            + L    +  + + R + A+ 
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 88.2 bits (217), Expect = 2e-19
 Identities = 37/202 (18%), Positives = 71/202 (35%), Gaps = 23/202 (11%)

Query: 339 GSVFRGI--INGSTVAIKCMRRS------ISKEVNLLKKINHFNLINLFGACEHDGV--- 387
            +V+     +N + VA+K +R           E+ LL+++N  +         +  +   
Sbjct: 27  STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86

Query: 388 ----------FYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTD 437
                      ++V  F   G     L KK     +      +I+  +  GL Y+H    
Sbjct: 87  DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--R 144

Query: 438 PGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYG 497
            G +H DI   N+L++     +      +               ++ T  Y +PE +   
Sbjct: 145 CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGA 204

Query: 498 LVTPEMDTYAFGVVLLELITGK 519
                 D ++   ++ ELITG 
Sbjct: 205 PWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 54.4 bits (130), Expect = 4e-09
 Identities = 21/154 (13%), Positives = 39/154 (25%), Gaps = 28/154 (18%)

Query: 339 GSVFRGI-INGSTVAIKCMRRSI-----------------SKEVNLLKKINHFNLINLFG 380
            +VF           +K  +                    S       +     L  L G
Sbjct: 14  SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 73

Query: 381 ACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGY 440
                     VY +  N  L + +  K        N    +   +   +   ++      
Sbjct: 74  LAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKFYHRG---I 124

Query: 441 VHKDISSGNILLDKNLRAKLANFSFVRSAVREES 474
           VH D+S  N+L+ +     + +F        E  
Sbjct: 125 VHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGW 157

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} Length = 48

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

 Score = 39.8 bits (93), Expect = 2e-05
 Identities = 15/48 (31%), Positives = 25/48 (52%), Gaps = 2/48 (4%)

Query: 172 LLTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIP 219
           +LTY V  GD++  I+  F +S  +++ AN        L    +I+IP
Sbjct: 1   MLTYQVKQGDTLNSIAADFRISTAALLQANPSL--QAGLTAGQSIVIP 46

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} Length = 48

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

 Score = 37.3 bits (87), Expect = 2e-04
 Identities = 15/48 (31%), Positives = 25/48 (52%), Gaps = 3/48 (6%)

Query: 173 LTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPL 220
           +TY V  GDS+  I+KR  V+I+ ++  N    D   L P   + + +
Sbjct: 3   ITYRVRKGDSLSSIAKRHGVNIKDVMRWNS---DTANLQPGDKLTLFV 47

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	611
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.98
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.77
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	99.43
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	99.42
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	99.04
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	99.02
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.08
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.66
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.39
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.17
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.08
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	93.81
d1ijwc_	47	HIN recombinase (DNA-binding domain) {Synthetic}	82.76

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=397.57  Aligned_cols=250  Identities=25%  Similarity=0.454  Sum_probs=195.8

Q ss_pred             cCCCCCccc----ceEEEEEEcCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecC
Q 007261          330 NFSPKNMID----GSVFRGIINGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFME  396 (611)
Q Consensus       330 ~f~~~~~ig----g~Vy~g~~~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  396 (611)
                      +|.....||    |.||+|++++ .||||+++         +.|.+|+.+|++++|||||+++|++.+ +..+||||||+
T Consensus         9 ~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~   86 (276)
T d1uwha_           9 QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE   86 (276)
T ss_dssp             CCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred             cEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence            344444454    8999998765 59999985         468899999999999999999999865 56799999999


Q ss_pred             CCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc
Q 007261          397 NGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY  476 (611)
Q Consensus       397 ~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  476 (611)
                      +|+|.+++....  ..++|..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus        87 ~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~-~  160 (276)
T d1uwha_          87 GSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-S  160 (276)
T ss_dssp             EEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred             CCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC-c
Confidence            999999997654  34999999999999999999999   58999999999999999999999999999976543322 2


Q ss_pred             ccccccccCCCccchhhhcc---CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccccc
Q 007261          477 SSTKTAVGTNGYMAPEYMEY---GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV  553 (611)
Q Consensus       477 ~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  553 (611)
                      .......||+.|||||.+.+   +.++.++|||||||+||||+||+.||..........     .....+        ..
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~-----~~~~~~--------~~  227 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-----FMVGRG--------YL  227 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH-----HHHHHT--------SC
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH-----HHHhcC--------CC
Confidence            23345679999999999864   458999999999999999999999997655433211     111111        11


Q ss_pred             CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       554 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      .+.+...+..+++++.+|+.+||+.||++||||.||+++|+.+..+.
T Consensus       228 ~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         228 SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            12222223445678999999999999999999999999999987654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.5e-49  Score=398.90  Aligned_cols=258  Identities=27%  Similarity=0.473  Sum_probs=197.1

Q ss_pred             cchhHHHHHhhcCCCC---------Cccc----ceEEEEEE--cCc---EEEEEEec--------HHHHHHHHHHHhcCC
Q 007261          319 YKYEDLVVATENFSPK---------NMID----GSVFRGII--NGS---TVAIKCMR--------RSISKEVNLLKKINH  372 (611)
Q Consensus       319 ~~~~el~~at~~f~~~---------~~ig----g~Vy~g~~--~g~---~vavK~~~--------~~~~~E~~~l~~l~H  372 (611)
                      ++|+|+..++.+|+.+         +.||    |.||+|.+  +|+   .||||.+.        ++|.+|+.+|++++|
T Consensus         7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H   86 (299)
T d1jpaa_           7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH   86 (299)
T ss_dssp             GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence            5677788888777643         2444    89999998  332   69999874        468899999999999


Q ss_pred             CceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeee
Q 007261          373 FNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILL  452 (611)
Q Consensus       373 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl  452 (611)
                      ||||+++|+|.+++..++|||||++|+|.+++....  ..++|.+++.++.||+.||+|||   +.+|+||||||+||||
T Consensus        87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl  161 (299)
T d1jpaa_          87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILV  161 (299)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEE
Confidence            999999999999999999999999999999988653  34999999999999999999999   5899999999999999


Q ss_pred             CCCCcEEEeeecCccccccccCCc--ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChh
Q 007261          453 DKNLRAKLANFSFVRSAVREESGY--SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEE  529 (611)
Q Consensus       453 ~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~  529 (611)
                      +.++.+||+|||+++.........  .......+|+.|+|||.+.++.++.++|||||||+||||+| |+.||......+
T Consensus       162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~  241 (299)
T d1jpaa_         162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD  241 (299)
T ss_dssp             CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999998764432211  12223457899999999999999999999999999999998 788886554332


Q ss_pred             hHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          530 ILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       530 ~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      .      ...+..+.            ....+.+++.++.+|+.+||+.||++||||.||++.|+++..+
T Consensus       242 ~------~~~i~~~~------------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         242 V------INAIEQDY------------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             H------HHHHHTTC------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             H------HHHHHcCC------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            1      11111110            0111334567789999999999999999999999999987654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-49  Score=392.36  Aligned_cols=237  Identities=26%  Similarity=0.502  Sum_probs=187.7

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||+|.+ +++.||||+++      ++|.+|++++++++|||||+++|+|.+++..++||||+++|+|.+++....  .
T Consensus        19 g~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~   96 (263)
T d1sm2a_          19 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--G   96 (263)
T ss_dssp             CCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT--T
T ss_pred             eEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccc--c
Confidence            89999999 67889999985      579999999999999999999999999999999999999999999997653  3


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .++|..++.++.|||.||+|||   +.+|+||||||+|||+++++.+||+|||+++.......  .......||..|+||
T Consensus        97 ~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~gt~~y~aP  171 (263)
T d1sm2a_          97 LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASP  171 (263)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------------CTTSCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc--eeecceecCcccCCh
Confidence            4899999999999999999999   68999999999999999999999999999986543321  223345789999999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML  571 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l  571 (611)
                      |.+.+..++.++|||||||++|||+|++.|++........+ .   .... +.      .      ...+..+++++.+|
T Consensus       172 E~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~-~---~i~~-~~------~------~~~p~~~~~~l~~l  234 (263)
T d1sm2a_         172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-E---DIST-GF------R------LYKPRLASTHVYQI  234 (263)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH-H---HHHH-TC------C------CCCCTTSCHHHHHH
T ss_pred             HHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHH-H---HHHh-cC------C------CCCccccCHHHHHH
Confidence            99999999999999999999999999766665543332111 1   1111 10      0      01123345678999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          572 CLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       572 ~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      +.+||+.||++||||+||+++|++|.++
T Consensus       235 i~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         235 MNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            9999999999999999999999998754

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=393.62  Aligned_cols=239  Identities=24%  Similarity=0.448  Sum_probs=197.2

Q ss_pred             ceEEEEEE----cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII----NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~----~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|.+    ++..||||+++        ++|.+|+++|++++|||||+++|+|.+ +..|||||||++|+|.+++..
T Consensus        23 g~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~  101 (285)
T d1u59a_          23 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG  101 (285)
T ss_dssp             EEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTT
T ss_pred             eEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhc
Confidence            99999987    34579999985        458899999999999999999999975 457999999999999999876


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .+  ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++................||+
T Consensus       102 ~~--~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~  176 (285)
T d1u59a_         102 KR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL  176 (285)
T ss_dssp             CT--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCG
T ss_pred             cc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCc
Confidence            43  34999999999999999999999   58999999999999999999999999999987654433333344567899


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      .|+|||.+.++.++.++|||||||++|||+| |+.||......+.      ...+..+.            ....+..++
T Consensus       177 ~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~------~~~i~~~~------------~~~~p~~~~  238 (285)
T d1u59a_         177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAFIEQGK------------RMECPPECP  238 (285)
T ss_dssp             GGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH------HHHHHTTC------------CCCCCTTCC
T ss_pred             cccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCC------------CCCCCCcCC
Confidence            9999999999999999999999999999998 8888876554332      11121111            111233456


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhhh
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDVQ  601 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~~  601 (611)
                      .++.+|+.+||+.||++||||.+|++.|+.+..+..
T Consensus       239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~  274 (285)
T d1u59a_         239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  274 (285)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence            789999999999999999999999999988765543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-48  Score=395.03  Aligned_cols=238  Identities=28%  Similarity=0.478  Sum_probs=198.7

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      |.||+|.+  +|..||||+++      ++|.+|+.+|++++|||||+++|+|.+++..++||||+++|+|.+++.... .
T Consensus        31 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~-~  109 (287)
T d1opja_          31 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-R  109 (287)
T ss_dssp             SSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSC-T
T ss_pred             eEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhcc-c
Confidence            89999998  58899999985      468999999999999999999999999999999999999999999997653 3


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMA  490 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~a  490 (611)
                      ..++|..++.|+.||+.||+|||   +.+|+||||||+||||++++.+||+|||+++......  ........|++.|+|
T Consensus       110 ~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~~g~~~y~a  184 (287)
T d1opja_         110 QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA  184 (287)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS--SEEETTEEECGGGCC
T ss_pred             cchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCC--ceeeccccccccccC
Confidence            45999999999999999999999   5899999999999999999999999999998654332  123334568899999


Q ss_pred             hhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHH
Q 007261          491 PEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIM  570 (611)
Q Consensus       491 PE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~  570 (611)
                      ||.+.++.++.++|||||||++|||++|+.|++.......     +...+..+.            ....+..+++++.+
T Consensus       185 PE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-----~~~~i~~~~------------~~~~~~~~~~~l~~  247 (287)
T d1opja_         185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKDY------------RMERPEGCPEKVYE  247 (287)
T ss_dssp             HHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHHHHHTTC------------CCCCCTTCCHHHHH
T ss_pred             hHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-----HHHHHhcCC------------CCCCCccchHHHHH
Confidence            9999999999999999999999999998888765544321     112222111            01112345677999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          571 LCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       571 l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      |+.+||+.||++|||+.||++.|+.+..+
T Consensus       248 li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         248 LMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            99999999999999999999999987654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=391.94  Aligned_cols=237  Identities=26%  Similarity=0.470  Sum_probs=193.1

Q ss_pred             ceEEEEEEc----CcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGIIN----GSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~~----g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|.+.    ++.||||+++         ++|.+|+.+|++++|||||+++|+|..+ ..+|||||+++|+|.+++.
T Consensus        21 G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~   99 (277)
T d1xbba_          21 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQ   99 (277)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHH
T ss_pred             eEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHh
Confidence            999999872    3579999985         3588999999999999999999999654 5789999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .++|..++.|+.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++................||
T Consensus       100 ~~~---~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt  173 (277)
T d1xbba_         100 QNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP  173 (277)
T ss_dssp             HCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCC
T ss_pred             hcc---CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCC
Confidence            753   4999999999999999999999   5899999999999999999999999999998765443333344456789


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      +.|+|||.+.+..++.++|||||||++|||+| |+.||......+.      ...+..+.            ....+..+
T Consensus       174 ~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~------~~~i~~~~------------~~~~p~~~  235 (277)
T d1xbba_         174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------TAMLEKGE------------RMGCPAGC  235 (277)
T ss_dssp             GGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHHHHTTC------------CCCCCTTC
T ss_pred             ceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH------HHHHHcCC------------CCCCCccc
Confidence            99999999999999999999999999999998 7888876543221      11222111            11113345


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      +.++.+|+.+||+.||++|||+.+|++.|+..-.+.
T Consensus       236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence            678899999999999999999999999988765443

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-48  Score=389.22  Aligned_cols=237  Identities=28%  Similarity=0.500  Sum_probs=193.5

Q ss_pred             ceEEEEEEc-CcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGIIN-GSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~~-g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||+|.++ +..||||+++      +.|.+|+.+|++++|||||+++|++.+ +..++||||+++|+|.+++.... ..
T Consensus        27 g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~-~~  104 (272)
T d1qpca_          27 GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPS-GI  104 (272)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHH-HH
T ss_pred             cEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcC-CC
Confidence            899999994 5789999986      468999999999999999999998865 45789999999999999886542 13


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .++|..+++|+.||+.||+|||   ..+|+||||||+||||++++.+||+|||+++......  ........||+.|+||
T Consensus       105 ~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~--~~~~~~~~gt~~y~AP  179 (272)
T d1qpca_         105 KLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTAP  179 (272)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC--EECCTTCCCCTTTSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc--cccccccCCcccccCh
Confidence            4899999999999999999999   5899999999999999999999999999998764322  2233456789999999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML  571 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l  571 (611)
                      |.+.++.++.++|||||||+||||+||+.|++........+     ..+..+.            ....+..+++++.+|
T Consensus       180 E~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~-----~~i~~~~------------~~~~p~~~~~~l~~l  242 (272)
T d1qpca_         180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-----QNLERGY------------RMVRPDNCPEELYQL  242 (272)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-----HHHHTTC------------CCCCCTTCCHHHHHH
T ss_pred             HHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH-----HHHHhcC------------CCCCcccChHHHHHH
Confidence            99999999999999999999999999877766544332111     1111110            011123455678999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          572 CLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       572 ~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      +.+||+.||++||||.||++.|+.+-.+
T Consensus       243 i~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         243 MRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            9999999999999999999999987543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=385.70  Aligned_cols=239  Identities=26%  Similarity=0.444  Sum_probs=189.2

Q ss_pred             ceEEEEEEcC------cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGIING------STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~~g------~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.+.+      ..||||+++        .+|.+|+.+|++++|||||+++|+|.+.+..++||||+.+|+|.+++
T Consensus        21 G~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~  100 (283)
T d1mqba_          21 GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL  100 (283)
T ss_dssp             SEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHH
T ss_pred             eEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhh
Confidence            8999999842      369999985        35889999999999999999999999999999999999999999988


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ....  ..++|..++.++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++................|
T Consensus       101 ~~~~--~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~g  175 (283)
T d1mqba_         101 REKD--GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI  175 (283)
T ss_dssp             HHTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CC
T ss_pred             hccc--ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCC
Confidence            7654  34999999999999999999999   689999999999999999999999999999876443322223344568


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      |+.|+|||.+.++.++.++|||||||++|||++|+.|++........     ...+..+            .....+..+
T Consensus       176 t~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~-----~~~i~~~------------~~~~~~~~~  238 (283)
T d1mqba_         176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----MKAINDG------------FRLPTPMDC  238 (283)
T ss_dssp             CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----HHHHHTT------------CCCCCCTTC
T ss_pred             CccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH-----HHHHhcc------------CCCCCchhh
Confidence            99999999999999999999999999999999987777654433211     1111111            111123345


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      +.++.+|+.+||+.||++||||.||++.|+++...
T Consensus       239 ~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            67799999999999999999999999999987654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=375.35  Aligned_cols=242  Identities=21%  Similarity=0.423  Sum_probs=199.1

Q ss_pred             cCCCCCccc----ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCC
Q 007261          330 NFSPKNMID----GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENG  398 (611)
Q Consensus       330 ~f~~~~~ig----g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  398 (611)
                      +|.....||    |.||+|++ ++..||||+++      ++|.+|+.++++++||||++++|+|.+++..++||||+++|
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g   84 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG   84 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred             HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence            344445554    89999999 56689999985      57999999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccc
Q 007261          399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS  478 (611)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  478 (611)
                      +|.+++....  ..+++..+++++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++......  ...
T Consensus        85 ~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~--~~~  157 (258)
T d1k2pa_          85 CLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTS  157 (258)
T ss_dssp             EHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS--CCC
T ss_pred             cHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC--cee
Confidence            9999987653  34889999999999999999999   5899999999999999999999999999998654332  223


Q ss_pred             ccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccC
Q 007261          479 TKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNL  557 (611)
Q Consensus       479 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l  557 (611)
                      .....+|..|+|||.+.+..++.++||||||+++|||+| |+.||......+..     ..... +            ..
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~-----~~i~~-~------------~~  219 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-----EHIAQ-G------------LR  219 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-----HHHHT-T------------CC
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH-----HHHHh-C------------CC
Confidence            334678999999999999999999999999999999998 78887665543221     11111 1            01


Q ss_pred             CcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhc
Q 007261          558 QANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKI  596 (611)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i  596 (611)
                      ...+..+++++.+|+.+||+.||++|||+.|++++|.+|
T Consensus       220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            111234456799999999999999999999999998754

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-46  Score=377.10  Aligned_cols=228  Identities=25%  Similarity=0.441  Sum_probs=192.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|..  +|+.||||+++       +.+.+|+.+|++++|||||++++++.+++..|||||||++|+|.+++.... 
T Consensus        34 g~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~-  112 (293)
T d1yhwa1          34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-  112 (293)
T ss_dssp             CEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC-
T ss_pred             cEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhccC-
Confidence            89999987  69999999985       358899999999999999999999999999999999999999999987653 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                         +++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||+.|+
T Consensus       113 ---l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~Y~  183 (293)
T d1yhwa1         113 ---MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---SKRSTMVGTPYWM  183 (293)
T ss_dssp             ---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---CCBCCCCSCGGGC
T ss_pred             ---CCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc---ccccccccCCCcc
Confidence               899999999999999999999   6899999999999999999999999999998654322   2334567999999


Q ss_pred             chhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHH
Q 007261          490 APEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLI  569 (611)
Q Consensus       490 aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~  569 (611)
                      |||.+.+..++.++|||||||++|||++|+.||......+..     ........          +. ...+..++..+.
T Consensus       184 aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-----~~~~~~~~----------~~-~~~~~~~s~~~~  247 (293)
T d1yhwa1         184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATNGT----------PE-LQNPEKLSAIFR  247 (293)
T ss_dssp             CHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHHCS----------CC-CSSGGGSCHHHH
T ss_pred             ChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH-----HHHHhCCC----------CC-CCCcccCCHHHH
Confidence            999999999999999999999999999999999765433211     11111111          00 112344567789


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 007261          570 MLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       570 ~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +|+.+||+.||++|||+.|++++
T Consensus       248 ~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         248 DFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHccCChhHCcCHHHHhcC
Confidence            99999999999999999999874

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=376.81  Aligned_cols=231  Identities=22%  Similarity=0.333  Sum_probs=189.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|+.  +|+.||||+++        +.+.+|+.+|++++|||||++++++.+++..||||||+++|+|.+++... 
T Consensus        19 g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-   97 (271)
T d1nvra_          19 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-   97 (271)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-
T ss_pred             eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcC-
Confidence            89999998  68999999984        35789999999999999999999999999999999999999999999754 


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                        ..+++..++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+....... ........||+.|
T Consensus        98 --~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~-~~~~~~~~GT~~Y  171 (271)
T d1nvra_          98 --IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPY  171 (271)
T ss_dssp             --TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE-ECCBCCCCSCGGG
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc-cccccceeeCcCc
Confidence              34999999999999999999999   68999999999999999999999999999987643321 1233456899999


Q ss_pred             cchhhhccCCC-CCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHH
Q 007261          489 MAPEYMEYGLV-TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHH  567 (611)
Q Consensus       489 ~aPE~~~~~~~-s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  567 (611)
                      ||||.+.+..+ +.++|||||||+||||++|+.||............    .....            .........+.+
T Consensus       172 ~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~----~~~~~------------~~~~~~~~~s~~  235 (271)
T d1nvra_         172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKK------------TYLNPWKKIDSA  235 (271)
T ss_dssp             SCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH----HHTTC------------TTSTTGGGSCHH
T ss_pred             cCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH----HhcCC------------CCCCccccCCHH
Confidence            99999988776 57899999999999999999999765433222111    11100            001112334567


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.+|+.+||+.||++|||+.|++++
T Consensus       236 ~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         236 PLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcC
Confidence            8899999999999999999999763

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=374.31  Aligned_cols=224  Identities=22%  Similarity=0.334  Sum_probs=189.6

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+++.  +|+.||||++.          ..+.+|+.++++++|||||++++++.+++..|+||||+++|+|.+++..
T Consensus        20 g~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~   99 (263)
T d2j4za1          20 GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK   99 (263)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred             cEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhh
Confidence            89999998  68899999985          2477899999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....     ......||+
T Consensus       100 ~~---~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-----~~~~~~Gt~  168 (263)
T d2j4za1         100 LS---KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTTLCGTL  168 (263)
T ss_dssp             HS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-----CCEETTEEG
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC-----cccccCCCC
Confidence            53   3899999999999999999999   689999999999999999999999999999765322     233467999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++|||||||+||||++|+.||......+.     ...... ..          ..   .+..+++
T Consensus       169 ~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----~~~i~~-~~----------~~---~p~~~s~  229 (263)
T d2j4za1         169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-----YKRISR-VE----------FT---FPDFVTE  229 (263)
T ss_dssp             GGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHT-TC----------CC---CCTTSCH
T ss_pred             cccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-----HHHHHc-CC----------CC---CCccCCH
Confidence            99999999999999999999999999999999999975543221     111111 10          01   1223456


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ++.+|+.+||+.||++|||+.|++++
T Consensus       230 ~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         230 GARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            78999999999999999999999874

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-47  Score=378.32  Aligned_cols=233  Identities=22%  Similarity=0.348  Sum_probs=177.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceecc--CCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEH--DGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|+.  +|+.||||.++         +.+.+|+++|++++|||||++++++.+  ++..|+|||||++|+|.+++.
T Consensus        18 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~   97 (269)
T d2java1          18 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT   97 (269)
T ss_dssp             EEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHH
Confidence            89999998  68999999984         347889999999999999999999864  456899999999999999997


Q ss_pred             ccC-CCCccCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          406 KKR-YPEFVSWNCRFRIALDVAHGLHYLHNCT--DPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       406 ~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ... ....+++..++.++.||+.||+|||+..  ..+|+||||||+|||++.++.+||+|||+++......   ......
T Consensus        98 ~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~---~~~~~~  174 (269)
T d2java1          98 KGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT---SFAKAF  174 (269)
T ss_dssp             HHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------
T ss_pred             hccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC---CccccC
Confidence            532 2345999999999999999999999521  2359999999999999999999999999998764322   233456


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.     ...... +            .....+.
T Consensus       175 ~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-----~~~i~~-~------------~~~~~~~  236 (269)
T d2java1         175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-----AGKIRE-G------------KFRRIPY  236 (269)
T ss_dssp             -CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHH-T------------CCCCCCT
T ss_pred             CCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-----HHHHHc-C------------CCCCCCc
Confidence            899999999999999999999999999999999999999876543221     111111 1            1111123


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      .+++++.+|+.+||+.||++|||+.|++++
T Consensus       237 ~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         237 RYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            345678999999999999999999999863

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-46  Score=380.94  Aligned_cols=249  Identities=27%  Similarity=0.477  Sum_probs=198.0

Q ss_pred             hhcCCCCCccc----ceEEEEEEcC-------cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeE
Q 007261          328 TENFSPKNMID----GSVFRGIING-------STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVF  388 (611)
Q Consensus       328 t~~f~~~~~ig----g~Vy~g~~~g-------~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  388 (611)
                      .++|.....||    |.||+|++.|       +.||||+++        ++|.+|+.+|++++||||++++++|...+..
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            34444444454    9999999743       689999985        4689999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHhhccCC---------------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 007261          389 YLVYEFMENGSLSDWLHKKRY---------------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISS  447 (611)
Q Consensus       389 ~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~  447 (611)
                      ++||||+++|+|.+++.....                     ...++|..++.|+.|++.||+|||   +.+++||||||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp  168 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLAT  168 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcc
Confidence            999999999999999975321                     234899999999999999999999   68999999999


Q ss_pred             CCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCC
Q 007261          448 GNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDG  527 (611)
Q Consensus       448 ~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~  527 (611)
                      +|||+|.++.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++|..|++....
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            999999999999999999986543322 2233456788999999999999999999999999999999999765443333


Q ss_pred             hhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          528 EEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       528 ~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                      ....    ...+.. +            .....+..++.++.+|+.+||+.||++||||.||++.|++|.
T Consensus       248 ~~e~----~~~v~~-~------------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         248 HEEV----IYYVRD-G------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHHH----HHHHHT-T------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHH----HHHHHc-C------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            2211    111111 1            111123345567899999999999999999999999999875

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=373.29  Aligned_cols=230  Identities=19%  Similarity=0.336  Sum_probs=191.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|..  +|..||||+++       +.+.+|+++|++++|||||++++++.+++..+||||||++|+|.+++.+.. 
T Consensus        26 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~-  104 (288)
T d2jfla1          26 GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-  104 (288)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT-
T ss_pred             cEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcC-
Confidence            89999998  68899999985       468899999999999999999999999999999999999999999987643 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCcc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYM  489 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  489 (611)
                       ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||+.|+
T Consensus       105 -~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---~~~~~~~Gt~~y~  177 (288)
T d2jfla1         105 -RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---QRRDSFIGTPYWM  177 (288)
T ss_dssp             -SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH---HHHTCCCSCCTTC
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc---ccccccccccccC
Confidence             34999999999999999999999   6899999999999999999999999999987553321   1234567999999


Q ss_pred             chhhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          490 APEYME-----YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       490 aPE~~~-----~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      |||++.     ...++.++|||||||++|||++|+.||......+..     .......           +.....+...
T Consensus       178 APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~-----~~i~~~~-----------~~~~~~~~~~  241 (288)
T d2jfla1         178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL-----LKIAKSE-----------PPTLAQPSRW  241 (288)
T ss_dssp             CHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-----HHHHHSC-----------CCCCSSGGGS
T ss_pred             CHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH-----HHHHcCC-----------CCCCCccccC
Confidence            999984     456899999999999999999999999766544321     1111111           0111123445


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.++.+|+.+||+.||++|||+.|++++
T Consensus       242 s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         242 SSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            6788999999999999999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-46  Score=383.20  Aligned_cols=235  Identities=24%  Similarity=0.473  Sum_probs=192.0

Q ss_pred             ceEEEEEEcC-------cEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGIING-------STVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~~g-------~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||+|++.+       ..||||.+.        ..+.+|+.+|.++ +|||||+++|+|.+.+..+||||||++|+|.+
T Consensus        51 G~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~  130 (325)
T d1rjba_          51 GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN  130 (325)
T ss_dssp             EEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred             eEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHH
Confidence            8999999732       269999984        3578899999998 89999999999999999999999999999999


Q ss_pred             HhhccCC--------------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 007261          403 WLHKKRY--------------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLAN  462 (611)
Q Consensus       403 ~l~~~~~--------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D  462 (611)
                      +|+..+.                    ...++|..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus       131 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~Nill~~~~~~Kl~D  207 (325)
T d1rjba_         131 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICD  207 (325)
T ss_dssp             HHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEEETTTEEEECC
T ss_pred             HHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchhccccccCCeEEEee
Confidence            9976532                    135899999999999999999999   58999999999999999999999999


Q ss_pred             ecCccccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHh
Q 007261          463 FSFVRSAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVE  541 (611)
Q Consensus       463 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  541 (611)
                      ||+|+....... ........||+.|||||.+.++.++.++|||||||+||||+| |+.||......+..     ...+.
T Consensus       208 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~-----~~~~~  281 (325)
T d1rjba_         208 FGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF-----YKLIQ  281 (325)
T ss_dssp             CGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-----HHHHH
T ss_pred             ccccccccCCCc-eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHH-----HHHHh
Confidence            999986544322 222334568999999999999999999999999999999998 78888765443221     11222


Q ss_pred             cCCcccccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 007261          542 GGNAEAKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLM  594 (611)
Q Consensus       542 ~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  594 (611)
                      .+.            ....+..+++++.+|+.+||+.||++|||++||+++|.
T Consensus       282 ~~~------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         282 NGF------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cCC------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            111            01113345678999999999999999999999999985

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-46  Score=372.49  Aligned_cols=233  Identities=25%  Similarity=0.486  Sum_probs=186.4

Q ss_pred             ceEEEEEEcCcEEEEEEec-----HHHHHHHHHHHhcCCCceeeccceecc-CCeEEEEEeecCCCCHHHHhhccCCCCc
Q 007261          339 GSVFRGIINGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLFGACEH-DGVFYLVYEFMENGSLSDWLHKKRYPEF  412 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~  412 (611)
                      |.||+|.++|+.||||+++     +++.+|++++++++||||++++|+|.+ .+..++||||+++|+|.++|.... ...
T Consensus        21 g~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~   99 (262)
T d1byga_          21 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSV   99 (262)
T ss_dssp             CEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHH-HHH
T ss_pred             eEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcC-CCC
Confidence            8999999999999999996     568999999999999999999999865 466899999999999999997642 234


Q ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccchh
Q 007261          413 VSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAPE  492 (611)
Q Consensus       413 l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE  492 (611)
                      ++|..+++|+.||+.||.|||   +.+++||||||+|||++.++.+||+|||+++....      ......++..|+|||
T Consensus       100 l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~------~~~~~~~~~~y~aPE  170 (262)
T d1byga_         100 LGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS------TQDTGKLPVKWTAPE  170 (262)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------------------CCTTTSCHH
T ss_pred             CCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC------CCccccccccCCChH
Confidence            899999999999999999999   58999999999999999999999999999986432      223346788999999


Q ss_pred             hhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHH
Q 007261          493 YMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML  571 (611)
Q Consensus       493 ~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l  571 (611)
                      ++.++.+++++||||||+++|||+| |+.|+......+.  ...    +..+            .....+..++.++.+|
T Consensus       171 ~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~--~~~----i~~~------------~~~~~~~~~~~~~~~l  232 (262)
T d1byga_         171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPR----VEKG------------YKMDAPDGCPPAVYEV  232 (262)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HHH----HTTT------------CCCCCCTTCCHHHHHH
T ss_pred             HHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH--HHH----HHcC------------CCCCCCccCCHHHHHH
Confidence            9999999999999999999999999 5666554433321  111    1111            1111133445678999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          572 CLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       572 ~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      +.+||+.||++||||.||+++|++++..
T Consensus       233 i~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         233 MKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence            9999999999999999999999998764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=380.41  Aligned_cols=244  Identities=22%  Similarity=0.366  Sum_probs=189.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|..  +|+.||+|+++        ..+.+|+.+|++++|||||+++++|.+++..||||||+++|+|.+++.+..
T Consensus        20 g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~   99 (322)
T d1s9ja_          20 GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG   99 (322)
T ss_dssp             CCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS
T ss_pred             eEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC
Confidence            89999998  68999999985        357899999999999999999999999999999999999999999998753


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                         .+++..+..++.|++.||.|||+  ..+|+||||||+|||+++++.+||+|||+|+.....     .....+||+.|
T Consensus       100 ---~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-----~~~~~~GT~~Y  169 (322)
T d1s9ja_         100 ---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSY  169 (322)
T ss_dssp             ---SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-----TC---CCSSCC
T ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-----ccccccCCccc
Confidence               38999999999999999999994  348999999999999999999999999999865332     22346899999


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHH--HHHhcC------------------Ccc--
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVF--SMVEGG------------------NAE--  546 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~--~~~~~~------------------~~~--  546 (611)
                      +|||++.+..++.++|||||||++|||++|+.||......+........  ......                  ...  
T Consensus       170 ~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (322)
T d1s9ja_         170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMA  249 (322)
T ss_dssp             CCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCC
T ss_pred             cCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchh
Confidence            9999999999999999999999999999999999876544321110000  000000                  000  


Q ss_pred             --cccccccCccCCcC-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          547 --AKLSVLVDPNLQAN-KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       547 --~~l~~~~d~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        ..+........... ....+.++.+|+.+||+.||++|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         250 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             HHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence              00000000000000 11234678899999999999999999999885

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-46  Score=374.14  Aligned_cols=237  Identities=30%  Similarity=0.476  Sum_probs=188.6

Q ss_pred             ceEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCCC
Q 007261          339 GSVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYPE  411 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  411 (611)
                      |.||+|++ ++..||||+++      +.|.+|+.+|++++|||||+++|+|.+ +..++||||+++|+|..++.... ..
T Consensus        31 g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~-~~  108 (285)
T d1fmka3          31 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GK  108 (285)
T ss_dssp             CEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHH-HT
T ss_pred             eEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcc-cc
Confidence            89999999 55689999986      569999999999999999999999965 55789999999999999987642 13


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCccch
Q 007261          412 FVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGYMAP  491 (611)
Q Consensus       412 ~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  491 (611)
                      .++|.+++.++.||+.||+|||   ..+|+||||||+||||++++.+||+|||+++......  ........||+.|+||
T Consensus       109 ~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~--~~~~~~~~gt~~y~aP  183 (285)
T d1fmka3         109 YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAP  183 (285)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------------CCGGGSCH
T ss_pred             cchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC--ceeeccccccccccCh
Confidence            4999999999999999999999   5899999999999999999999999999998654322  2233446789999999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHHHHHHH
Q 007261          492 EYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAHHLIML  571 (611)
Q Consensus       492 E~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~l~~l  571 (611)
                      |++..+.++.++||||||+++|||++|+.|+.........+     ..+..+.            ....+..+++++.++
T Consensus       184 E~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~-----~~i~~~~------------~~~~~~~~~~~l~~l  246 (285)
T d1fmka3         184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-----DQVERGY------------RMPCPPECPESLHDL  246 (285)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-----HHHHTTC------------CCCCCTTSCHHHHHH
T ss_pred             HHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH-----HHHHhcC------------CCCCCcccCHHHHHH
Confidence            99999999999999999999999999887776654432221     1111110            011123456679999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          572 CLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       572 ~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      +.+||+.||++||++++|++.|+....+
T Consensus       247 i~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         247 MCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            9999999999999999999999886544

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-45  Score=364.96  Aligned_cols=226  Identities=22%  Similarity=0.396  Sum_probs=182.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceecc----CCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEH----DGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|..  +|..||+|+++         +.+.+|+++|++++|||||++++++.+    +...|+||||+++|+|.++
T Consensus        23 g~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~  102 (270)
T d1t4ha_          23 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY  102 (270)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHH
T ss_pred             cEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHH
Confidence            99999998  57899999985         357899999999999999999999854    4568999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeeeC-CCCcEEEeeecCccccccccCCccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPG--YVHKDISSGNILLD-KNLRAKLANFSFVRSAVREESGYSSTK  480 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~  480 (611)
                      +....   .+++..++.++.||+.||+|||   +.+  |+||||||+|||++ +++.+||+|||+++.....     ...
T Consensus       103 l~~~~---~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-----~~~  171 (270)
T d1t4ha_         103 LKRFK---VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAK  171 (270)
T ss_dssp             HHHHS---SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-----SBE
T ss_pred             Hhccc---cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-----ccC
Confidence            98753   4899999999999999999999   455  99999999999996 5789999999999754221     234


Q ss_pred             ccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC
Q 007261          481 TAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN  560 (611)
Q Consensus       481 ~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~  560 (611)
                      ...||+.|+|||.+.+ .++.++|||||||++|||++|+.||.........     ...+..+...        +.   .
T Consensus       172 ~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~-----~~~i~~~~~~--------~~---~  234 (270)
T d1t4ha_         172 AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRVTSGVKP--------AS---F  234 (270)
T ss_dssp             ESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----HHHHTTTCCC--------GG---G
T ss_pred             CcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH-----HHHHHcCCCC--------cc---c
Confidence            5689999999999875 5999999999999999999999999755433221     1111111110        00   1


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          561 KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       561 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +...++++.+|+.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            12234568899999999999999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-45  Score=375.30  Aligned_cols=223  Identities=25%  Similarity=0.391  Sum_probs=185.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|+.  +|+.||||+++          +++.+|+.+|++++|||||++++++.+++..|+|||||++|+|..++..
T Consensus        29 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~  108 (309)
T d1u5ra_          29 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH  108 (309)
T ss_dssp             SEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH
T ss_pred             eEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh
Confidence            89999997  68899999984          3578899999999999999999999999999999999999999877765


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....       .....||+
T Consensus       109 ~~---~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-------~~~~~GT~  175 (309)
T d1u5ra_         109 KK---PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANSFVGTP  175 (309)
T ss_dssp             TS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-------BCCCCSCG
T ss_pred             CC---CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC-------CCccccCc
Confidence            43   4899999999999999999999   68999999999999999999999999999975432       23467999


Q ss_pred             Cccchhhhcc---CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          487 GYMAPEYMEY---GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       487 ~y~aPE~~~~---~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      .|||||++.+   +.++.++|||||||++|||++|+.||......+.     +........          +.+  ....
T Consensus       176 ~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-----~~~i~~~~~----------~~~--~~~~  238 (309)
T d1u5ra_         176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNES----------PAL--QSGH  238 (309)
T ss_dssp             GGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCC----------CCC--SCTT
T ss_pred             cccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHhCCC----------CCC--CCCC
Confidence            9999999853   5689999999999999999999999876543221     112222111          111  1123


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVS  591 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~  591 (611)
                      .++.+.+|+.+||+.||++|||+.|+++
T Consensus       239 ~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         239 WSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            4567899999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.3e-45  Score=371.63  Aligned_cols=229  Identities=24%  Similarity=0.415  Sum_probs=177.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||++..  +|+.||||++.        ..+.+|+.+|++++|||||++++++.+++..|||||||++|+|.+++....
T Consensus        23 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~  102 (307)
T d1a06a_          23 SEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG  102 (307)
T ss_dssp             GGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS
T ss_pred             eEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhccc
Confidence            89999998  68899999985        246689999999999999999999999999999999999999999997643


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEeeecCccccccccCCcccccccccC
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD---KNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                         .+++..+..++.||+.||+|||   +.+|+||||||+|||+.   +++.+||+|||+++......    ......||
T Consensus       103 ---~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~----~~~~~~GT  172 (307)
T d1a06a_         103 ---FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS----VLSTACGT  172 (307)
T ss_dssp             ---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC----------------------
T ss_pred             ---CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCCC----eeeeeeeC
Confidence               4999999999999999999999   68999999999999994   57899999999998653322    23446799


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||.+.+..++.++|||||||+||||++|+.||......+.     .........       ..+   .......+
T Consensus       173 ~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-----~~~i~~~~~-------~~~---~~~~~~~s  237 (307)
T d1a06a_         173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-----FEQILKAEY-------EFD---SPYWDDIS  237 (307)
T ss_dssp             CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHTTCC-------CCC---TTTTTTSC
T ss_pred             ccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH-----HHHHhccCC-------CCC---CccccCCC
Confidence            999999999999999999999999999999999999976543321     111111110       000   01123456


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +++.+|+.+||+.||++|||+.|++++
T Consensus       238 ~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         238 DSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            678999999999999999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-45  Score=370.39  Aligned_cols=228  Identities=18%  Similarity=0.342  Sum_probs=187.5

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+|..  +|+.||||++++          .+.+|+++|++++||||+++++++.+++..|+||||+++|+|.+++..
T Consensus        22 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~  101 (288)
T d1uu3a_          22 STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK  101 (288)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc
Confidence            89999998  688999999852          477899999999999999999999999999999999999999999887


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .+   .+++..++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+....... ........||+
T Consensus       102 ~~---~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~~~GT~  174 (288)
T d1uu3a_         102 IG---SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANSFVGTA  174 (288)
T ss_dssp             HS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----------CCCCG
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc-ccccccccCCc
Confidence            54   3899999999999999999999   68999999999999999999999999999987643321 12234467999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||++.+..++.++|||||||+||||++|+.||......+.     ...... ..          ..+   +...++
T Consensus       175 ~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-----~~~i~~-~~----------~~~---p~~~s~  235 (288)
T d1uu3a_         175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIK-LE----------YDF---PEKFFP  235 (288)
T ss_dssp             GGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHT-TC----------CCC---CTTCCH
T ss_pred             cccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-----HHHHHc-CC----------CCC---CccCCH
Confidence            99999999999999999999999999999999999976543221     111111 10          001   123456


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ++.+|+.+||+.||++|||++|++.+
T Consensus       236 ~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         236 KARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             HHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            78999999999999999999997654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-44  Score=369.00  Aligned_cols=239  Identities=25%  Similarity=0.423  Sum_probs=192.4

Q ss_pred             ceEEEEEEc---C--cEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceecc-CCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGIIN---G--STVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEH-DGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~~---g--~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |+||+|.+.   +  ..||||+++        ++|.+|+++|++++||||++++|+|.+ ++..++|||||++|+|.+++
T Consensus        41 g~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~  120 (311)
T d1r0pa_          41 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI  120 (311)
T ss_dssp             EEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHH
T ss_pred             eEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhh
Confidence            899999982   2  269999985        468999999999999999999999864 56899999999999999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCC-cccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESG-YSSTKTAV  483 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~  483 (611)
                      ....  ..+++..+++++.|++.||.|||   ..+|+||||||+|||+++++.+||+|||+++........ ........
T Consensus       121 ~~~~--~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~  195 (311)
T d1r0pa_         121 RNET--HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK  195 (311)
T ss_dssp             HCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSS
T ss_pred             cccc--ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceeccccc
Confidence            8654  34788999999999999999999   689999999999999999999999999999876443221 12233457


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      ||..|+|||.+..+.++.++||||||+++|||+||+.||........    ....... +.            ....+..
T Consensus       196 gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~----~~~~i~~-g~------------~~~~p~~  258 (311)
T d1r0pa_         196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLLQ-GR------------RLLQPEY  258 (311)
T ss_dssp             CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHHT-TC------------CCCCCTT
T ss_pred             ccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH----HHHHHHc-CC------------CCCCccc
Confidence            89999999999999999999999999999999998888765432211    1111111 11            1111234


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                      +++++.+|+.+||+.||++||+|.||+++|+++..+
T Consensus       259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            456789999999999999999999999999998765

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=368.54  Aligned_cols=250  Identities=26%  Similarity=0.377  Sum_probs=190.8

Q ss_pred             ceEEEEEEcCcEEEEEEec----HHHHH--HHHHHHhcCCCceeeccceeccCC----eEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGIINGSTVAIKCMR----RSISK--EVNLLKKINHFNLINLFGACEHDG----VFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~----~~~~~--E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|+++|+.||||+++    +++.+  |+..+.+++|||||+++|+|.+++    ..++|||||++|+|.++|++..
T Consensus        17 g~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~   96 (303)
T d1vjya_          17 GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT   96 (303)
T ss_dssp             SEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC
T ss_pred             eEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCC
Confidence            8999999999999999985    23334  455556789999999999997543    6899999999999999998753


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc-cccccc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNC-----TDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY-SSTKTA  482 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~-----~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~  482 (611)
                          ++|..+++++.|+|.||+|||+.     ..++|+||||||+||||++++.+||+|||+++......... ......
T Consensus        97 ----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~  172 (303)
T d1vjya_          97 ----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR  172 (303)
T ss_dssp             ----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----C
T ss_pred             ----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccce
Confidence                99999999999999999999953     24799999999999999999999999999998765433221 123456


Q ss_pred             ccCCCccchhhhccCC------CCCccchHHHHHHHHHHHhCCCCCcCCCChhh---------HHHHHHHHHHhcCCccc
Q 007261          483 VGTNGYMAPEYMEYGL------VTPEMDTYAFGVVLLELITGKEAAYKQDGEEI---------LLAEAVFSMVEGGNAEA  547 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~------~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~---------~l~~~~~~~~~~~~~~~  547 (611)
                      .||+.|+|||++.+..      ++.++|||||||+||||+||..|+........         ...........      
T Consensus       173 ~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  246 (303)
T d1vjya_         173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC------  246 (303)
T ss_dssp             CSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT------
T ss_pred             ecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHh------
Confidence            7999999999987643      67789999999999999999877643221110         00011111111      


Q ss_pred             ccccccCccCCcC--hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          548 KLSVLVDPNLQAN--KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       548 ~l~~~~d~~l~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                        ....+|.+...  ..+....+.+|+.+||+.||++|||+.||++.|+++..+.
T Consensus       247 --~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         247 --EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             --TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence              11122222222  3456678999999999999999999999999999987653

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-45  Score=366.04  Aligned_cols=236  Identities=23%  Similarity=0.405  Sum_probs=182.6

Q ss_pred             ceEEEEEEc-----CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGIIN-----GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~~-----g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|++.     +..||||.++        +.+.+|+.+|++++|||||+++|++. ++..++||||+++|+|.+++.
T Consensus        21 g~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~   99 (273)
T d1mp8a_          21 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ   99 (273)
T ss_dssp             SEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHH
T ss_pred             cEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhh
Confidence            899999872     3469999985        35889999999999999999999996 467899999999999999887


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...  ..+++..++.++.||+.||+|||   +.+++||||||+|||+++++.+||+|||+++......  ........||
T Consensus       100 ~~~--~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~--~~~~~~~~gt  172 (273)
T d1mp8a_         100 VRK--YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLP  172 (273)
T ss_dssp             HTT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------------------CC
T ss_pred             ccC--CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCc--ceeccceecC
Confidence            654  34899999999999999999999   6899999999999999999999999999998654322  1233456789


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEI  564 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  564 (611)
                      +.|+|||.+.+..++.++|||||||++|||++ |..|+......+..  .   .... +            .....+..+
T Consensus       173 ~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~--~---~i~~-~------------~~~~~~~~~  234 (273)
T d1mp8a_         173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI--G---RIEN-G------------ERLPMPPNC  234 (273)
T ss_dssp             GGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--H---HHHT-T------------CCCCCCTTC
T ss_pred             cccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH--H---HHHc-C------------CCCCCCCCC
Confidence            99999999999999999999999999999998 67777655443321  1   1111 1            111123345


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          565 AHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       565 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      +.++.+|+.+||+.||++|||+.||+++|+++..+.
T Consensus       235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         235 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            678999999999999999999999999999887653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-45  Score=367.94  Aligned_cols=236  Identities=28%  Similarity=0.480  Sum_probs=188.4

Q ss_pred             ceEEEEEEcC-----cEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIING-----STVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~g-----~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|++++     ..||||+++          ++|.+|+.+|++++|||||+++|+|.+ +..++||||+++|+|.++
T Consensus        22 g~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~  100 (273)
T d1u46a_          22 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDR  100 (273)
T ss_dssp             CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHH
T ss_pred             eEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhh
Confidence            8999998732     379999985          358899999999999999999999976 467899999999999998


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      +....  ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++................
T Consensus       101 ~~~~~--~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~  175 (273)
T d1u46a_         101 LRKHQ--GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK  175 (273)
T ss_dssp             HHHHG--GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----
T ss_pred             hhccc--CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccc
Confidence            87653  34999999999999999999999   58999999999999999999999999999987654443333444566


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      ++..|+|||.+.+..++.++||||||+++|||+| |+.||......+.     .......+.            ....+.
T Consensus       176 ~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~-----~~~i~~~~~------------~~~~~~  238 (273)
T d1u46a_         176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LHKIDKEGE------------RLPRPE  238 (273)
T ss_dssp             CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----HHHHHTSCC------------CCCCCT
T ss_pred             cCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH-----HHHHHhCCC------------CCCCcc
Confidence            8889999999999999999999999999999998 7888865543321     122222111            011123


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhch
Q 007261          563 EIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQ  597 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~  597 (611)
                      .++.++.+|+.+||+.||++||||.||++.|.+.+
T Consensus       239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~  273 (273)
T d1u46a_         239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  273 (273)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence            44567899999999999999999999999998753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=370.32  Aligned_cols=238  Identities=30%  Similarity=0.499  Sum_probs=192.2

Q ss_pred             ceEEEEEE--cCc--EEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGS--TVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~--~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|.+  +|.  .||||+++        +++.+|+++|+++ +|||||+++|+|.+++..++||||+++|+|.++|+
T Consensus        24 g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~  103 (309)
T d1fvra_          24 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR  103 (309)
T ss_dssp             CEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH
T ss_pred             cEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHh
Confidence            99999998  343  58888874        3588999999999 79999999999999999999999999999999997


Q ss_pred             ccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          406 KKR-------------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       406 ~~~-------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      ...             ....++|..+++++.||+.||.|||   +.+++||||||+|||++.++.+||+|||+++.....
T Consensus       104 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~  180 (309)
T d1fvra_         104 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY  180 (309)
T ss_dssp             TTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE
T ss_pred             hccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCceEEcccccccccccc
Confidence            541             2356999999999999999999999   689999999999999999999999999999765332


Q ss_pred             cCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccc
Q 007261          473 ESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVL  552 (611)
Q Consensus       473 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~  552 (611)
                      .    ......||..|+|||.+.++.++.++||||||+++|||++|..|++.......     +...+..+         
T Consensus       181 ~----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-----~~~~i~~~---------  242 (309)
T d1fvra_         181 V----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEKLPQG---------  242 (309)
T ss_dssp             C----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHGGGT---------
T ss_pred             c----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHhc---------
Confidence            2    22345689999999999999999999999999999999998765543332211     11111111         


Q ss_pred             cCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          553 VDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       553 ~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                         .....+..+++++.+|+.+||+.||++||||.||+++|+++..+.
T Consensus       243 ---~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         243 ---YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             ---CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ---CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence               011113345678999999999999999999999999999987643

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=371.64  Aligned_cols=237  Identities=24%  Similarity=0.439  Sum_probs=187.7

Q ss_pred             ceEEEEEE--cCc----EEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGS----TVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~----~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|.+  +|+    .||||+++        ++|.+|+.+|++++|||||+++|+|.++ ..++++||+.+|+|.+++
T Consensus        23 G~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~  101 (317)
T d1xkka_          23 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV  101 (317)
T ss_dssp             EEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHH
T ss_pred             eEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccc
Confidence            89999988  443    68999874        4688999999999999999999999865 567889999999999998


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ....  ..+++..+++++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... ........|
T Consensus       102 ~~~~--~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~~g  175 (317)
T d1xkka_         102 REHK--DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-EYHAEGGKV  175 (317)
T ss_dssp             HHTS--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC---------C
T ss_pred             cccc--cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccccc-ccccccccc
Confidence            8754  45999999999999999999999   58999999999999999999999999999987644322 222334568


Q ss_pred             CCCccchhhhccCCCCCccchHHHHHHHHHHHh-CCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHH
Q 007261          485 TNGYMAPEYMEYGLVTPEMDTYAFGVVLLELIT-GKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKE  563 (611)
Q Consensus       485 t~~y~aPE~~~~~~~s~ksDV~s~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  563 (611)
                      |+.|+|||.+.++.++.++|||||||+||||+| |..|+......+.  .    ..+..+.            ....+..
T Consensus       176 t~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~--~----~~i~~~~------------~~~~p~~  237 (317)
T d1xkka_         176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--S----SILEKGE------------RLPQPPI  237 (317)
T ss_dssp             CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH--H----HHHHHTC------------CCCCCTT
T ss_pred             CccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH--H----HHHHcCC------------CCCCCcc
Confidence            999999999999999999999999999999999 5666654443321  1    1111110            0111234


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhhh
Q 007261          564 IAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLDV  600 (611)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~~  600 (611)
                      ++.++.+|+.+||+.||++|||+.||+++|.++..+.
T Consensus       238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~  274 (317)
T d1xkka_         238 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  274 (317)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred             cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence            5667899999999999999999999999999876543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-45  Score=369.74  Aligned_cols=239  Identities=27%  Similarity=0.455  Sum_probs=183.0

Q ss_pred             ceEEEEEEc-------CcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccC-CeEEEEEeecCCCCHH
Q 007261          339 GSVFRGIIN-------GSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHD-GVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~~-------g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~~~lV~E~~~~gsL~  401 (611)
                      |.||+|.+.       ++.||||+++        +.+.+|..++.++ +|+||+.+++++... ...++|||||++|+|.
T Consensus        27 G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~  106 (299)
T d1ywna1          27 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS  106 (299)
T ss_dssp             CEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHH
T ss_pred             eEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHH
Confidence            899999872       3589999986        2467788888887 789999999988654 5689999999999999


Q ss_pred             HHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          402 DWLHKKRY-------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       402 ~~l~~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      ++|+..+.             ...++|..++.++.||+.||+|||   +.+|+||||||+||||++++.+||+|||+|+.
T Consensus       107 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~  183 (299)
T d1ywna1         107 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD  183 (299)
T ss_dssp             HHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECC------
T ss_pred             HHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECCCCcEEEccCcchhh
Confidence            99975421             235899999999999999999999   68999999999999999999999999999986


Q ss_pred             cccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCC-CCcCCCChhhHHHHHHHHHHhcCCccc
Q 007261          469 AVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKE-AAYKQDGEEILLAEAVFSMVEGGNAEA  547 (611)
Q Consensus       469 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~-p~~~~~~~~~~l~~~~~~~~~~~~~~~  547 (611)
                      ...... ........||+.|+|||.+.++.++.++|||||||++|||+||.. ||......+. +.    ..+..+.   
T Consensus       184 ~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-~~----~~~~~~~---  254 (299)
T d1ywna1         184 IYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FC----RRLKEGT---  254 (299)
T ss_dssp             CCSCTT-SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-HH----HHHHHTC---
T ss_pred             cccccc-ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-HH----HHHhcCC---
Confidence            543322 223345679999999999999999999999999999999999865 4544333221 11    1111111   


Q ss_pred             ccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          548 KLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       548 ~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                               ....+..++.++.+++.+||+.||++|||+.||+++|+++..
T Consensus       255 ---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         255 ---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                     011123345678999999999999999999999999998753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-44  Score=364.42  Aligned_cols=228  Identities=22%  Similarity=0.337  Sum_probs=190.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|..  +|+.||||+++             +.+.+|+.+|++++|||||++++++.+++..|||||||++|+|.++
T Consensus        24 g~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~  103 (293)
T d1jksa_          24 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF  103 (293)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccch
Confidence            89999998  68999999974             3588999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC----cEEEeeecCccccccccCCcccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL----RAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      +....   .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++    .+||+|||+++......    ..
T Consensus       104 i~~~~---~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~----~~  173 (293)
T d1jksa_         104 LAEKE---SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EF  173 (293)
T ss_dssp             HHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC----BC
T ss_pred             hcccc---ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhhhcCCCc----cc
Confidence            98753   4999999999999999999999   68999999999999998876    49999999998654322    23


Q ss_pred             cccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc
Q 007261          480 KTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA  559 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~  559 (611)
                      ....+|+.|+|||.+.+..++.++|||||||++|||++|+.||......+.     ...... ..          .....
T Consensus       174 ~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-----~~~i~~-~~----------~~~~~  237 (293)
T d1jksa_         174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----LANVSA-VN----------YEFED  237 (293)
T ss_dssp             SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHT-TC----------CCCCH
T ss_pred             cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-----HHHHHh-cC----------CCCCc
Confidence            456789999999999999999999999999999999999999976543321     111111 10          00111


Q ss_pred             C-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          560 N-KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       560 ~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      . +...+..+.+|+.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1 22345678999999999999999999999874

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.3e-44  Score=371.77  Aligned_cols=229  Identities=24%  Similarity=0.345  Sum_probs=190.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||++..  +|+.||||+++       +.+.+|+.+|++++|||||++++++.+++..|||||||++|+|.+++.... 
T Consensus        40 g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~-  118 (350)
T d1koaa2          40 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-  118 (350)
T ss_dssp             EEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTT-
T ss_pred             eEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhc-
Confidence            89999998  68999999985       357889999999999999999999999999999999999999999996543 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC--CCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD--KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                       ..+++..+..++.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+++.....    .......||+.
T Consensus       119 -~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~----~~~~~~~gT~~  190 (350)
T d1koaa2         119 -NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK----QSVKVTTGTAE  190 (350)
T ss_dssp             -SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT----SCEEEECSCTT
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc----cccceecCccc
Confidence             34999999999999999999999   68999999999999995  4689999999999865432    23345679999


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc-ChHHHHH
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA-NKKEIAH  566 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~-~~~~~~~  566 (611)
                      |||||++.+..++.++|||||||++|||++|+.||......+.     .........           .... ....+++
T Consensus       191 Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----~~~i~~~~~-----------~~~~~~~~~~s~  254 (350)
T d1koaa2         191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-----LRNVKSCDW-----------NMDDSAFSGISE  254 (350)
T ss_dssp             TCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHTCC-----------CSCCGGGGGCCH
T ss_pred             ccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCCC-----------CCCcccccCCCH
Confidence            9999999999999999999999999999999999976543321     111111110           0111 1234556


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ++.+|+.+||+.||++|||+.|++++
T Consensus       255 ~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         255 DGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcC
Confidence            78999999999999999999999885

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.8e-44  Score=369.71  Aligned_cols=229  Identities=22%  Similarity=0.317  Sum_probs=191.1

Q ss_pred             ceEEEEEE--cCcEEEEEEec-------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|..  +|+.||||+++       ..+.+|+.+|++++|||||++++++.+++..|||||||++|+|.+++.... 
T Consensus        43 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~-  121 (352)
T d1koba_          43 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-  121 (352)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT-
T ss_pred             eEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcC-
Confidence            89999997  68999999985       357789999999999999999999999999999999999999999887653 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC--CCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD--KNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                       ..+++..++.|+.||+.||+|||   +.+|+||||||+||||+  .++.+||+|||+|+......    ......||+.
T Consensus       122 -~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~----~~~~~~gt~~  193 (352)
T d1koba_         122 -YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAE  193 (352)
T ss_dssp             -CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS----CEEEECSSGG
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC----ceeeccCccc
Confidence             34999999999999999999999   68999999999999998  67899999999998764322    3345678999


Q ss_pred             ccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc-ChHHHHH
Q 007261          488 YMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA-NKKEIAH  566 (611)
Q Consensus       488 y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~-~~~~~~~  566 (611)
                      |+|||++.+..++.++|||||||+||||++|+.||......+.     ........           ..... .....+.
T Consensus       194 y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~i~~~~-----------~~~~~~~~~~~s~  257 (352)
T d1koba_         194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-----LQNVKRCD-----------WEFDEDAFSSVSP  257 (352)
T ss_dssp             GCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-----HHHHHHCC-----------CCCCSSTTTTSCH
T ss_pred             ccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCC-----------CCCCcccccCCCH
Confidence            9999999999999999999999999999999999976543321     11111110           01111 1234566


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ++.+|+.+||+.||.+|||+.|++++
T Consensus       258 ~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         258 EAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcC
Confidence            78999999999999999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-44  Score=366.49  Aligned_cols=239  Identities=24%  Similarity=0.434  Sum_probs=194.9

Q ss_pred             ceEEEEEEc-------CcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGIIN-------GSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~~-------g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|.+.       ++.||||+++        ..|.+|+.++++++|||||+++|+|..++..++||||+++|+|.++
T Consensus        34 G~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~  113 (308)
T d1p4oa_          34 GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY  113 (308)
T ss_dssp             SEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred             eEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHH
Confidence            899999874       4689999996        2478999999999999999999999999999999999999999999


Q ss_pred             hhccC-------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCc
Q 007261          404 LHKKR-------YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGY  476 (611)
Q Consensus       404 l~~~~-------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  476 (611)
                      +....       ....++|..+++++.|+++||.|||   +.+|+||||||+|||+++++++||+|||+++....... .
T Consensus       114 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~-~  189 (308)
T d1p4oa_         114 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-Y  189 (308)
T ss_dssp             HHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGC-E
T ss_pred             HHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEeecccceeccCCcc-e
Confidence            87531       2234799999999999999999999   58999999999999999999999999999986644332 2


Q ss_pred             ccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCcc
Q 007261          477 SSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPN  556 (611)
Q Consensus       477 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~  556 (611)
                      .......+|+.|+|||.+.++.++.++||||||+++|||+||+.+++........    .....             ++.
T Consensus       190 ~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~----~~~i~-------------~~~  252 (308)
T d1p4oa_         190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----LRFVM-------------EGG  252 (308)
T ss_dssp             EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH----HHHHH-------------TTC
T ss_pred             eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH----HHHHH-------------hCC
Confidence            2334457899999999999999999999999999999999997555443332211    11111             111


Q ss_pred             CCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          557 LQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       557 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      ....+..++..+.+++.+||+.||++||||.||+++|++...
T Consensus       253 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            222233456789999999999999999999999999987644

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-43  Score=357.35  Aligned_cols=238  Identities=22%  Similarity=0.408  Sum_probs=186.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------HHHHHHHHHHHhcCCCceeeccceeccCC----eEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------RSISKEVNLLKKINHFNLINLFGACEHDG----VFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~E~~~~gsL~~  402 (611)
                      |.||+|..  +|+.||||+++          ..+.+|+.+|++++|||||++++++...+    ..||||||+++|+|.+
T Consensus        21 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~  100 (277)
T d1o6ya_          21 SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD  100 (277)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehh
Confidence            89999997  69999999984          24788999999999999999999986543    4899999999999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++...+   .+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++..+|+|||+++...............
T Consensus       101 ~~~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  174 (277)
T d1o6ya_         101 IVHTEG---PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV  174 (277)
T ss_dssp             HHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC------------
T ss_pred             hhcccC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhccccccccccccc
Confidence            997764   3899999999999999999999   6899999999999999999999999999987654443333344556


Q ss_pred             ccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          483 VGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      .||+.|+|||.+.+..+++++|||||||++|||+||+.||......+.     ..........        .+  .....
T Consensus       175 ~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~~~~~~~~--------~~--~~~~~  239 (277)
T d1o6ya_         175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-----AYQHVREDPI--------PP--SARHE  239 (277)
T ss_dssp             ----TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHCCCC--------CG--GGTSS
T ss_pred             cCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-----HHHHHhcCCC--------CC--chhcc
Confidence            899999999999999999999999999999999999999976543322     1122221110        00  00122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhch
Q 007261          563 EIAHHLIMLCLACIAREPESRP-SMAEVVSTLMKIQ  597 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~i~  597 (611)
                      .+++++.+++.+||+.||++|| |++++++.|.+++
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            3456789999999999999999 8999999998875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-43  Score=362.97  Aligned_cols=226  Identities=24%  Similarity=0.362  Sum_probs=190.1

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+++.  +|+.||||++++          .+.+|+.+|++++||||+++++++.+++..|+|||||++|+|.+++..
T Consensus        19 g~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~   98 (337)
T d1o6la_          19 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR   98 (337)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhc
Confidence            89999997  789999999863          367899999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .+   .+++.....++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+......   ......+||+
T Consensus        99 ~~---~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~---~~~~~~~GT~  169 (337)
T d1o6la_          99 ER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTP  169 (337)
T ss_dssp             HS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT---CCBCCCEECG
T ss_pred             cc---CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC---cccccceeCH
Confidence            64   3888899999999999999999   6899999999999999999999999999998654322   2344568999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||++.+..++.++|||||||++|||++|+.||...+..+..     ..... ..          .   ..+...+.
T Consensus       170 ~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-----~~i~~-~~----------~---~~p~~~s~  230 (337)
T d1o6la_         170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-----ELILM-EE----------I---RFPRTLSP  230 (337)
T ss_dssp             GGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHHH-CC----------C---CCCTTSCH
T ss_pred             HHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH-----HHHhc-CC----------C---CCCccCCH
Confidence            999999999999999999999999999999999999876543211     11111 10          0   11223456


Q ss_pred             HHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007261          567 HLIMLCLACIAREPESRPS-----MAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPs-----~~evl~~  592 (611)
                      ++.+|+.+||+.||.+||+     +.|++++
T Consensus       231 ~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            7889999999999999995     7788764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.7e-43  Score=359.16  Aligned_cols=223  Identities=23%  Similarity=0.363  Sum_probs=188.3

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||+++.  +|+.||||++++          .+.+|+.+|++++|||||++++++.+++..|+|||||++|+|..++..
T Consensus        18 g~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~   97 (316)
T d1fota_          18 GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK   97 (316)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH
T ss_pred             cEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccc
Confidence            89999997  689999999863          467899999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ..   .+++.....++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....      ......||+
T Consensus        98 ~~---~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~------~~~~~~Gt~  165 (316)
T d1fota_          98 SQ---RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCGTP  165 (316)
T ss_dssp             TS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS------CBCCCCSCT
T ss_pred             cc---cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc------ccccccCcc
Confidence            64   3788888899999999999999   78999999999999999999999999999986532      233468999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|+|||.+.+..++.++|||||||+||||++|+.||......+.     ........           ..   .+...+.
T Consensus       166 ~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~i~~~~-----------~~---~p~~~s~  226 (316)
T d1fota_         166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNAE-----------LR---FPPFFNE  226 (316)
T ss_dssp             TTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHHCC-----------CC---CCTTSCH
T ss_pred             cccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-----HHHHHcCC-----------CC---CCCCCCH
Confidence            99999999999999999999999999999999999976543321     11111110           00   1123446


Q ss_pred             HHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      ++.+++.+||+.||.+|+     |++|++++
T Consensus       227 ~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         227 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            688999999999999996     89998874

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=362.43  Aligned_cols=241  Identities=24%  Similarity=0.422  Sum_probs=194.9

Q ss_pred             ceEEEEEE-------cCcEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII-------NGSTVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~-------~g~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||+|++       ++..||||+++        ..+.+|+.+++++ +|||||+++|+|.+++..++|||||++|+|.+
T Consensus        37 g~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~  116 (311)
T d1t46a_          37 GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN  116 (311)
T ss_dssp             EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred             eEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHH
Confidence            89999986       23589999985        3578899999999 79999999999999999999999999999999


Q ss_pred             HhhccCC---------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          403 WLHKKRY---------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       403 ~l~~~~~---------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      +++....               ...+++..+++++.||+.||+|||   ..+++||||||+|||++.++.+||+|||+++
T Consensus       117 ~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~  193 (311)
T d1t46a_         117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR  193 (311)
T ss_dssp             HHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETTTEEEECCCGGGS
T ss_pred             HHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccccccCcccccccchhe
Confidence            9986431               235899999999999999999999   6899999999999999999999999999998


Q ss_pred             ccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc
Q 007261          468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA  547 (611)
Q Consensus       468 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  547 (611)
                      ....... ........||+.|+|||.+.++.++.++||||||+++|||+|++.|+.........+..    .+..+.   
T Consensus       194 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~----~i~~~~---  265 (311)
T d1t46a_         194 DIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK----MIKEGF---  265 (311)
T ss_dssp             CTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH----HHHHTC---
T ss_pred             eccCCCc-ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhcCC---
Confidence            7643322 23445568899999999999999999999999999999999966665543322211111    111111   


Q ss_pred             ccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchhh
Q 007261          548 KLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQLD  599 (611)
Q Consensus       548 ~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~~  599 (611)
                        +       ...+...+.++.+|+.+||+.||++||||.||++.|+++..+
T Consensus       266 --~-------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         266 --R-------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             --C-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --C-------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence              0       011223456789999999999999999999999999886554

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-43  Score=357.08  Aligned_cols=238  Identities=29%  Similarity=0.489  Sum_probs=192.9

Q ss_pred             ceEEEEEEcC---------cEEEEEEec--------HHHHHHHHHHHhc-CCCceeeccceeccCCeEEEEEeecCCCCH
Q 007261          339 GSVFRGIING---------STVAIKCMR--------RSISKEVNLLKKI-NHFNLINLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~~g---------~~vavK~~~--------~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      |.||+|+..+         ..||||+++        .++.+|...+.++ +|||||+++++|.+++..++||||+++|+|
T Consensus        27 g~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l  106 (299)
T d1fgka_          27 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  106 (299)
T ss_dssp             -CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred             cEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcH
Confidence            9999998622         379999985        3577899999888 899999999999999999999999999999


Q ss_pred             HHHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          401 SDWLHKKRY-------------PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       401 ~~~l~~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      .+++.....             ...+++..+++++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       107 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~  183 (299)
T d1fgka_         107 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR  183 (299)
T ss_dssp             HHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSTTCCC
T ss_pred             HHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeecCCCCeEeccchhhc
Confidence            999976532             245899999999999999999999   6899999999999999999999999999998


Q ss_pred             ccccccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhC-CCCCcCCCChhhHHHHHHHHHHhcCCcc
Q 007261          468 SAVREESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITG-KEAAYKQDGEEILLAEAVFSMVEGGNAE  546 (611)
Q Consensus       468 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~  546 (611)
                      ....... ........+++.|+|||.+.++.++.++||||||+++|||+++ ..|+......+      +...+..+.  
T Consensus       184 ~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~------~~~~i~~~~--  254 (299)
T d1fgka_         184 DIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGH--  254 (299)
T ss_dssp             CGGGCCT-TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHTTC--
T ss_pred             ccccccc-ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH------HHHHHHcCC--
Confidence            7654332 2234456789999999999999999999999999999999985 55554333221      112222111  


Q ss_pred             cccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       547 ~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                                ....+..++.++.+|+.+||+.||++|||+.||++.|++|.+
T Consensus       255 ----------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         255 ----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             ----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                      011122345678999999999999999999999999998865

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.8e-43  Score=350.77  Aligned_cols=229  Identities=26%  Similarity=0.413  Sum_probs=189.0

Q ss_pred             ceEEEEEE--cCcEEEEEEec----------------HHHHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR----------------RSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGS  399 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----------------~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs  399 (611)
                      |.||+++.  +|+.||||+++                +.+.+|+.+|++++ ||||+++++++.+++..|||||||++|+
T Consensus        17 g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~   96 (277)
T d1phka_          17 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE   96 (277)
T ss_dssp             EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred             eEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCch
Confidence            89999998  78999999974                24778999999996 9999999999999999999999999999


Q ss_pred             HHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccc
Q 007261          400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       400 L~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      |.++|+...   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......    ..
T Consensus        97 L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~----~~  166 (277)
T d1phka_          97 LFDYLTEKV---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KL  166 (277)
T ss_dssp             HHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC----CB
T ss_pred             HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchheeEccCCC----ce
Confidence            999998653   4999999999999999999999   6899999999999999999999999999998664322    23


Q ss_pred             cccccCCCccchhhhcc------CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccccc
Q 007261          480 KTAVGTNGYMAPEYMEY------GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLV  553 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~------~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~  553 (611)
                      ....||..|+|||.+.+      ..++.++||||+||+++||++|+.||......+.     ....... ...     . 
T Consensus       167 ~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-----~~~i~~~-~~~-----~-  234 (277)
T d1phka_         167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-----LRMIMSG-NYQ-----F-  234 (277)
T ss_dssp             CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHT-CCC-----C-
T ss_pred             eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH-----HHHHHhC-CCC-----C-
Confidence            44679999999999853      3478899999999999999999999976543221     1111111 100     0 


Q ss_pred             CccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          554 DPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       554 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                         ........++++.+|+.+||+.||++|||+.|++++
T Consensus       235 ---~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         235 ---GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             ---CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ---CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               011123456789999999999999999999999764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=357.95  Aligned_cols=234  Identities=21%  Similarity=0.337  Sum_probs=188.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec--HHHHHHHHHHHhc-CCCceeeccceecc----CCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR--RSISKEVNLLKKI-NHFNLINLFGACEH----DGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|..  +|+.||||+++  ..+.+|+.++.++ +|||||++++++.+    +...|||||||++|+|.++|.... 
T Consensus        26 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~-  104 (335)
T d2ozaa1          26 GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-  104 (335)
T ss_dssp             CEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCS-
T ss_pred             eEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcC-
Confidence            89999997  68999999996  5688999997766 89999999999864    467899999999999999998643 


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeecCccccccccCCcccccccccCC
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK---NLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      ...+++..+..|+.||+.||+|||   +.+|+||||||+|||+++   ++.+||+|||+++......    ......||+
T Consensus       105 ~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~----~~~~~~gt~  177 (335)
T d2ozaa1         105 DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTP  177 (335)
T ss_dssp             CCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC----CCCCCSCCC
T ss_pred             CCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccCCC----ccccccCCc
Confidence            245999999999999999999999   689999999999999985   5679999999998654332    334567999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC-hHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN-KKEIA  565 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~  565 (611)
                      .|+|||++.+..++.++|||||||+||||+||+.||......+...  .   +..      .+ .......... ...++
T Consensus       178 ~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~--~---~~~------~i-~~~~~~~~~~~~~~~s  245 (335)
T d2ozaa1         178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--G---MKT------RI-RMGQYEFPNPEWSEVS  245 (335)
T ss_dssp             SSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------CC-CSCSSSCCTTHHHHSC
T ss_pred             ccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH--H---HHH------HH-hcCCCCCCCcccccCC
Confidence            9999999999999999999999999999999999997654432110  0   000      00 0001111111 34567


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +++.+|+.+||+.||++|||+.|++++
T Consensus       246 ~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         246 EEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            889999999999999999999999874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.7e-42  Score=361.86  Aligned_cols=227  Identities=20%  Similarity=0.292  Sum_probs=183.7

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHH---HHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKE---VNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDW  403 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E---~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~  403 (611)
                      |.||+|+.  +|+.||||++.+          .+.+|   +.+++.++|||||++++++.+++..|+||||+++|+|.++
T Consensus        18 g~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~   97 (364)
T d1omwa3          18 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH   97 (364)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHH
Confidence            89999998  689999999852          13334   6667777899999999999999999999999999999999


Q ss_pred             hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccc
Q 007261          404 LHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAV  483 (611)
Q Consensus       404 l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  483 (611)
                      |....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....     ......
T Consensus        98 l~~~~---~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-----~~~~~~  166 (364)
T d1omwa3          98 LSQHG---VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASV  166 (364)
T ss_dssp             HHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-----CCCSCC
T ss_pred             HHhcc---cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-----cccccc
Confidence            98753   3788999999999999999999   689999999999999999999999999999865432     234467


Q ss_pred             cCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChH
Q 007261          484 GTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKK  562 (611)
Q Consensus       484 gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  562 (611)
                      ||+.|+|||.+.. ..++.++|||||||+||||++|+.||......+...   +.....             ......+.
T Consensus       167 GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~~~~~~-------------~~~~~~~~  230 (364)
T d1omwa3         167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTL-------------TMAVELPD  230 (364)
T ss_dssp             SCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH---HHHHSS-------------SCCCCCCS
T ss_pred             cccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhcc-------------cCCCCCCC
Confidence            9999999999865 568999999999999999999999997654432210   111100             00011122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007261          563 EIAHHLIMLCLACIAREPESRPS-----MAEVVST  592 (611)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~  592 (611)
                      .++.++.+|+.+||+.||++|||     ++|++++
T Consensus       231 ~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            34567899999999999999999     6788764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-42  Score=358.33  Aligned_cols=223  Identities=20%  Similarity=0.277  Sum_probs=188.2

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHK  406 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  406 (611)
                      |.||++..  +|+.||||++.+          .+.+|+.+|++++|||||++++++.+....++||||+.+|+|.+++..
T Consensus        55 g~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~  134 (350)
T d1rdqe_          55 GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR  134 (350)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred             cEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhh
Confidence            89999998  699999999852          467899999999999999999999999999999999999999999987


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCC
Q 007261          407 KRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       407 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .+   .+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....      ......||+
T Consensus       135 ~~---~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~------~~~~~~Gt~  202 (350)
T d1rdqe_         135 IG---RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTP  202 (350)
T ss_dssp             HC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS------CBCCCEECG
T ss_pred             cC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc------ccccccCcc
Confidence            64   3899999999999999999999   68999999999999999999999999999986532      223467999


Q ss_pred             CccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHHH
Q 007261          487 GYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIAH  566 (611)
Q Consensus       487 ~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  566 (611)
                      .|||||++.+..++.++|||||||+||||++|+.||........     ........           .   ..+..++.
T Consensus       203 ~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~i~~~~-----------~---~~p~~~s~  263 (350)
T d1rdqe_         203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-----YEKIVSGK-----------V---RFPSHFSS  263 (350)
T ss_dssp             GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHCC-----------C---CCCTTCCH
T ss_pred             ccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH-----HHHHhcCC-----------C---CCCccCCH
Confidence            99999999999999999999999999999999999976543221     11111110           0   01223456


Q ss_pred             HHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 007261          567 HLIMLCLACIAREPESRP-----SMAEVVST  592 (611)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RP-----s~~evl~~  592 (611)
                      ++.+|+.+||+.||.+|+     ++.|++++
T Consensus       264 ~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            789999999999999994     88998863

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-42  Score=352.17  Aligned_cols=243  Identities=24%  Similarity=0.294  Sum_probs=186.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGSTVAIKCMR------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|..  +|+.||||+++            +.+.+|+.+|++++|||||++++++.+++..||||||++++++..++
T Consensus        12 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~   91 (299)
T d1ua2a_          12 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK   91 (299)
T ss_dssp             EEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT
T ss_pred             eEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhh
Confidence            89999987  68999999985            24778999999999999999999999999999999999988777666


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ...   ..+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++......   .......|
T Consensus        92 ~~~---~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~---~~~~~~~g  162 (299)
T d1ua2a_          92 DNS---LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN---RAYTHQVV  162 (299)
T ss_dssp             TCC---SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC---CCCCCSCC
T ss_pred             hcc---cCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc---ccccceec
Confidence            543   34888899999999999999999   6899999999999999999999999999997654332   23344679


Q ss_pred             CCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc-----ccccc-CccC
Q 007261          485 TNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK-----LSVLV-DPNL  557 (611)
Q Consensus       485 t~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~-----l~~~~-d~~l  557 (611)
                      |+.|+|||.+... .++.++|||||||++|||++|+.||......+.  ...+............     ..... -...
T Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ua2a_         163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEEQWPDMCSLPDYVTFKSF  240 (299)
T ss_dssp             CCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred             ChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH--HHHHHHhcCCCChhhccchhccchhhhhccC
Confidence            9999999998654 579999999999999999999988876543322  1222222211111000     00000 0000


Q ss_pred             CcC-----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          558 QAN-----KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       558 ~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ...     ....++++.+|+.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            111     11235678999999999999999999999874

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-42  Score=354.27  Aligned_cols=229  Identities=19%  Similarity=0.292  Sum_probs=189.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      |.||+|..  +|+.||||+++      ..+.+|+++|++++|||||++++++.+++..|||||||++|+|.+++....  
T Consensus        19 g~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~--   96 (321)
T d1tkia_          19 GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA--   96 (321)
T ss_dssp             EEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS--
T ss_pred             eEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcC--
Confidence            89999998  68899999996      247799999999999999999999999999999999999999999997653  


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCC--CcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKN--LRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                      ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.+  ..+||+|||+++.....    .......+|+.|
T Consensus        97 ~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~----~~~~~~~~t~~y  169 (321)
T d1tkia_          97 FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG----DNFRLLFTAPEY  169 (321)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT----CEEEEEESCGGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC----Cccccccccccc
Confidence            24899999999999999999999   6899999999999999854  58999999999865332    123445789999


Q ss_pred             cchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcC-hHHHHHH
Q 007261          489 MAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQAN-KKEIAHH  567 (611)
Q Consensus       489 ~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~  567 (611)
                      +|||.+.+..++.++|||||||++|||++|+.||......+.     ........           ...... ...++.+
T Consensus       170 ~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-----~~~i~~~~-----------~~~~~~~~~~~s~~  233 (321)
T d1tkia_         170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-----IENIMNAE-----------YTFDEEAFKEISIE  233 (321)
T ss_dssp             SCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHHTC-----------CCCCHHHHTTSCHH
T ss_pred             ccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCC-----------CCCChhhccCCCHH
Confidence            999999999999999999999999999999999976554321     11111110           000010 1234567


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          568 LIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       568 l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.+|+.+||..||++|||+.|++++
T Consensus       234 ~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         234 AMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcC
Confidence            8999999999999999999999874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-42  Score=354.66  Aligned_cols=225  Identities=26%  Similarity=0.408  Sum_probs=186.2

Q ss_pred             ceEEEEEE--cCcEEEEEEecH----------HHHHHHHHHH-hcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhh
Q 007261          339 GSVFRGII--NGSTVAIKCMRR----------SISKEVNLLK-KINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLH  405 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  405 (611)
                      |.||+|+.  +|+.||||++++          .+..|..++. .++|||||++++++.+++..|||||||++|+|.+++.
T Consensus        16 g~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~   95 (320)
T d1xjda_          16 GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ   95 (320)
T ss_dssp             SEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred             cEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhh
Confidence            89999998  789999999963          3456777665 6799999999999999999999999999999999998


Q ss_pred             ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccC
Q 007261          406 KKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGT  485 (611)
Q Consensus       406 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  485 (611)
                      ...   .+++..++.++.||+.||+|||   +.+++||||||+|||+++++.+||+|||+++......   .......||
T Consensus        96 ~~~---~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~gt  166 (320)
T d1xjda_          96 SCH---KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD---AKTNTFCGT  166 (320)
T ss_dssp             HHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT---CCBCCCCSC
T ss_pred             ccC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc---ccccccCCC
Confidence            754   3888999999999999999999   5899999999999999999999999999998654322   233456799


Q ss_pred             CCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCcChHHHH
Q 007261          486 NGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQANKKEIA  565 (611)
Q Consensus       486 ~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  565 (611)
                      +.|+|||++.+..++.++|||||||++|||++|+.||......+.  ...   ... +          .+..   +..++
T Consensus       167 ~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~~---i~~-~----------~~~~---p~~~s  227 (320)
T d1xjda_         167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FHS---IRM-D----------NPFY---PRWLE  227 (320)
T ss_dssp             GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH---HHH-C----------CCCC---CTTSC
T ss_pred             CCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH--HHH---HHc-C----------CCCC---CccCC
Confidence            999999999999999999999999999999999999976543321  111   111 1          0111   22345


Q ss_pred             HHHHHHHHHhhccCCCCCCCHH-HHHH
Q 007261          566 HHLIMLCLACIAREPESRPSMA-EVVS  591 (611)
Q Consensus       566 ~~l~~l~~~Cl~~dP~~RPs~~-evl~  591 (611)
                      .++.+|+.+||+.||++||++. |+++
T Consensus       228 ~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         228 KEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            6789999999999999999995 6764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-41  Score=344.47  Aligned_cols=244  Identities=21%  Similarity=0.340  Sum_probs=186.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|+.  +|+.||||+++         ..+.+|+++|++++|||||++++++.+++..|+||||+.+ ++.+++...
T Consensus        16 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~   94 (298)
T d1gz8a_          16 GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS   94 (298)
T ss_dssp             SEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHT
T ss_pred             eEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhh
Confidence            89999998  68999999984         4578899999999999999999999999999999999975 455555433


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      . ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......   .......||+.
T Consensus        95 ~-~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~gt~~  167 (298)
T d1gz8a_          95 A-LTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLW  167 (298)
T ss_dssp             T-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS---BCTTCCBCCCT
T ss_pred             c-ccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc---ccceeecccce
Confidence            2 245999999999999999999999   6899999999999999999999999999998654322   23445679999


Q ss_pred             ccchhhhccCC-CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc--ccccccccC-----ccC-C
Q 007261          488 YMAPEYMEYGL-VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA--EAKLSVLVD-----PNL-Q  558 (611)
Q Consensus       488 y~aPE~~~~~~-~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--~~~l~~~~d-----~~l-~  558 (611)
                      |+|||.+.... ++.++|||||||++|||++|+.||...+..+. +... .........  ........+     +.. .
T Consensus       168 y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (298)
T d1gz8a_         168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRI-FRTLGTPDEVVWPGVTSMPDYKPSFPKWAR  245 (298)
T ss_dssp             TCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHH-HHHHCCCCTTTSTTGGGSTTCCTTSCCCCC
T ss_pred             eeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH-HHHH-HHhcCCCchhhccccccccccccccccccc
Confidence            99999876655 58899999999999999999999976543322 1111 111111100  000000000     000 0


Q ss_pred             cC----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 AN----KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 ~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..    ....+.++.+|+.+||+.||++|||+.|++++
T Consensus       246 ~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         246 QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            11    11334678999999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=341.70  Aligned_cols=218  Identities=26%  Similarity=0.407  Sum_probs=180.3

Q ss_pred             ceEEEEEE--cCcEEEEEEecH-------------HHHHHHHHHHhcC--CCceeeccceeccCCeEEEEEeecCC-CCH
Q 007261          339 GSVFRGII--NGSTVAIKCMRR-------------SISKEVNLLKKIN--HFNLINLFGACEHDGVFYLVYEFMEN-GSL  400 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~-------------~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~-gsL  400 (611)
                      |.||+|+.  +|+.||||++++             .+.+|+.+|++++  |||||++++++.+.+..++||||+.+ +++
T Consensus        18 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l   97 (273)
T d1xwsa_          18 GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL   97 (273)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEH
T ss_pred             eEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchH
Confidence            89999998  689999999863             2568999999996  89999999999999999999999976 688


Q ss_pred             HHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-CCcEEEeeecCccccccccCCcccc
Q 007261          401 SDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-NLRAKLANFSFVRSAVREESGYSST  479 (611)
Q Consensus       401 ~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~  479 (611)
                      .+++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++. ++.+||+|||+++.....     ..
T Consensus        98 ~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-----~~  166 (273)
T d1xwsa_          98 FDFITERG---ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY  166 (273)
T ss_dssp             HHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-----CB
T ss_pred             HHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccceecccc-----cc
Confidence            88887653   3899999999999999999999   689999999999999985 479999999999754322     23


Q ss_pred             cccccCCCccchhhhccCCC-CCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCC
Q 007261          480 KTAVGTNGYMAPEYMEYGLV-TPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQ  558 (611)
Q Consensus       480 ~~~~gt~~y~aPE~~~~~~~-s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~  558 (611)
                      ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....  +         .....       ..+     
T Consensus       167 ~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~---------i~~~~-------~~~-----  223 (273)
T d1xwsa_         167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E---------IIRGQ-------VFF-----  223 (273)
T ss_dssp             CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H---------HHHCC-------CCC-----
T ss_pred             cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H---------Hhhcc-------cCC-----
Confidence            45679999999999987765 567899999999999999999985321  1         11100       011     


Q ss_pred             cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          559 ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        +...++++.+|+.+||+.||++|||++|++++
T Consensus       224 --~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         224 --RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             --SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence              11235678999999999999999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-40  Score=337.57  Aligned_cols=243  Identities=23%  Similarity=0.320  Sum_probs=184.7

Q ss_pred             ceEEEEEE---cCcEEEEEEec---------HHHHHHHHHHHhc---CCCceeeccceec-----cCCeEEEEEeecCCC
Q 007261          339 GSVFRGII---NGSTVAIKCMR---------RSISKEVNLLKKI---NHFNLINLFGACE-----HDGVFYLVYEFMENG  398 (611)
Q Consensus       339 g~Vy~g~~---~g~~vavK~~~---------~~~~~E~~~l~~l---~H~niv~l~g~~~-----~~~~~~lV~E~~~~g  398 (611)
                      |.||++..   +++.||||+++         ..+.+|+.+|+.|   +||||++++++|.     .....+++|||++++
T Consensus        21 g~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~  100 (305)
T d1blxa_          21 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD  100 (305)
T ss_dssp             EEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCB
T ss_pred             eEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCC
Confidence            89999987   35679999985         2477898888877   7999999999884     335789999999887


Q ss_pred             CHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccc
Q 007261          399 SLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSS  478 (611)
Q Consensus       399 sL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  478 (611)
                      ++........  ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....    ..
T Consensus       101 ~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~----~~  171 (305)
T d1blxa_         101 LTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ----MA  171 (305)
T ss_dssp             HHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG----GG
T ss_pred             chhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhhhhhhccc----cc
Confidence            7765554432  44899999999999999999999   689999999999999999999999999998765332    23


Q ss_pred             ccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc----------c
Q 007261          479 TKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA----------K  548 (611)
Q Consensus       479 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~----------~  548 (611)
                      .....||+.|+|||.+.+..++.++||||+||++|||++|+.||......+. + ..+...........          .
T Consensus       172 ~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~-~~i~~~~~~~~~~~~~~~~~~~~~~  249 (305)
T d1blxa_         172 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-L-GKILDVIGLPGEEDWPRDVALPRQA  249 (305)
T ss_dssp             GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H-HHHHHHHCCCCGGGSCTTCSSCGGG
T ss_pred             CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH-H-HHHHHhhCCCchhcccccccchhhh
Confidence            4557899999999999999999999999999999999999999976543321 1 11222221111000          0


Q ss_pred             cccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          549 LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       549 l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ................++.+.+|+.+||+.||++|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             SCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00000001111123345678899999999999999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.5e-40  Score=334.72  Aligned_cols=243  Identities=19%  Similarity=0.306  Sum_probs=183.9

Q ss_pred             ceEEEEEE-cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhccC
Q 007261          339 GSVFRGII-NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKR  408 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  408 (611)
                      |.||+|+. +|+.||||+++         +.+.+|+.+|++++|||||++++++.+++..+++|||+.++.+..+.... 
T Consensus        16 g~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~-   94 (286)
T d1ob3a_          16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-   94 (286)
T ss_dssp             EEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTST-
T ss_pred             cEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhc-
Confidence            89999998 68999999984         46889999999999999999999999999999999999877766666544 


Q ss_pred             CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCCc
Q 007261          409 YPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       409 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                        ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++.......   .......+++.|
T Consensus        95 --~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~---~~~~~~~~~~~y  166 (286)
T d1ob3a_          95 --GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEIVTLWY  166 (286)
T ss_dssp             --TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------------CCCTT
T ss_pred             --CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc---cccceecccchh
Confidence              34999999999999999999999   5899999999999999999999999999987654322   223345689999


Q ss_pred             cchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc-----ccccc------cCcc
Q 007261          489 MAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA-----KLSVL------VDPN  556 (611)
Q Consensus       489 ~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~-----~l~~~------~d~~  556 (611)
                      +|||.+.+ ..++.++|||||||++|||++|+.||......+. + ..+...........     .....      ..+.
T Consensus       167 ~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (286)
T d1ob3a_         167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-L-MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL  244 (286)
T ss_dssp             CCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H-HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCC
T ss_pred             hhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-H-HHHHHhhCCCChhhccchhhhhhcccccccccCc
Confidence            99999865 4579999999999999999999999976543322 1 11122211111000     00000      0000


Q ss_pred             C-CcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          557 L-QANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       557 l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      . .......+..+.+|+.+||+.||++|||+.|++++
T Consensus       245 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             chhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0 01122345678999999999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-40  Score=340.81  Aligned_cols=245  Identities=23%  Similarity=0.320  Sum_probs=182.6

Q ss_pred             ceEEEEEE--cCcEEEEEEecH---HHHHHHHHHHhcCCCceeeccceecc------CCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMRR---SISKEVNLLKKINHFNLINLFGACEH------DGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|+.  +|+.||||++++   ...+|+.+|++++||||++++++|..      ....+||||||+++.+..+....
T Consensus        34 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~  113 (350)
T d1q5ka_          34 GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS  113 (350)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhh
Confidence            99999998  689999999963   45689999999999999999999843      33579999999866544444333


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeecCccccccccCCcccccccccCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL-RAKLANFSFVRSAVREESGYSSTKTAVGTN  486 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  486 (611)
                      .....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+++......    ......||.
T Consensus       114 ~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~  186 (350)
T d1q5ka_         114 RAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSR  186 (350)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS----CCCSCCSCT
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccCCc----ccccccccc
Confidence            33346999999999999999999999   68999999999999999775 89999999998654332    233457899


Q ss_pred             Cccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCC-----------cccccccccC
Q 007261          487 GYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGN-----------AEAKLSVLVD  554 (611)
Q Consensus       487 ~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-----------~~~~l~~~~d  554 (611)
                      .|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +.. +........           ....+.....
T Consensus       187 ~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~-i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~  264 (350)
T d1q5ka_         187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVE-IIKVLGTPTREQIREMNPNYTEFKFPQIKA  264 (350)
T ss_dssp             TSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHH-HHHHHCCCCHHHHHHHCC---CCCCCCCCC
T ss_pred             cccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHH-HHHHhCCChHHhhhhhccchhhcccccccc
Confidence            9999998764 5789999999999999999999999876544322 111 111111000           0000100000


Q ss_pred             ccCC-cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 PNLQ-ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 ~~l~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..+. ......+.++.+|+.+||+.||++|||+.|++++
T Consensus       265 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         265 HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000 1122345678999999999999999999999974

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-39  Score=334.12  Aligned_cols=245  Identities=19%  Similarity=0.266  Sum_probs=185.2

Q ss_pred             ceEEEEEE--cCcEEEEEEec--------HHHHHHHHHHHhcCCCceeeccceeccCC----eEEEEEeecCCCCHHHHh
Q 007261          339 GSVFRGII--NGSTVAIKCMR--------RSISKEVNLLKKINHFNLINLFGACEHDG----VFYLVYEFMENGSLSDWL  404 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~E~~~~gsL~~~l  404 (611)
                      |.||+|+.  +|+.||||+++        +.+.+|+.+|++++||||+++++++....    ..++++||+.+|+|.+++
T Consensus        22 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l  101 (345)
T d1pmea_          22 GMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL  101 (345)
T ss_dssp             CCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHH
T ss_pred             eEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhh
Confidence            89999987  69999999985        35778999999999999999999986543    234445667799999999


Q ss_pred             hccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccccc
Q 007261          405 HKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVG  484 (611)
Q Consensus       405 ~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  484 (611)
                      ...+    +++..++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++................|
T Consensus       102 ~~~~----l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~g  174 (345)
T d1pmea_         102 KTQH----LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA  174 (345)
T ss_dssp             HHCC----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCS
T ss_pred             hcCC----CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccc
Confidence            7653    899999999999999999999   689999999999999999999999999999876554433334456779


Q ss_pred             CCCccchhhhc-cCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccc-------cc--cccC
Q 007261          485 TNGYMAPEYME-YGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAK-------LS--VLVD  554 (611)
Q Consensus       485 t~~y~aPE~~~-~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~-------l~--~~~d  554 (611)
                      |+.|+|||.+. ...++.++||||+||+++||++|+.||......+..  ...............       ..  ....
T Consensus       175 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (345)
T d1pmea_         175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL--NHILGILGSPSQEDLNCIINLKARNYLLSL  252 (345)
T ss_dssp             CGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCHHHHHTCCCHHHHHHHHTS
T ss_pred             cceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH--HHHhhhccCCChhhhhhhhhhhhhcccccC
Confidence            99999999984 456789999999999999999999998765433211  111111111100000       00  0000


Q ss_pred             ccCCcC-----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 PNLQAN-----KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 ~~l~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      +.....     ....+.++.+|+.+||+.||++|||+.|++++
T Consensus       253 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         253 PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000000     11234578899999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.7e-39  Score=325.38  Aligned_cols=241  Identities=16%  Similarity=0.166  Sum_probs=184.5

Q ss_pred             ceEEEEEE--cCcEEEEEEec-----HHHHHHHHHHHhcCCCceeecc-ceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-----RSISKEVNLLKKINHFNLINLF-GACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l~H~niv~l~-g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      |.||+|..  +|+.||||+++     .++..|++++++++|+|++..+ ++..+++..++||||+ +++|.+.+....  
T Consensus        21 G~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~--   97 (299)
T d1ckia_          21 GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS--   97 (299)
T ss_dssp             SEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--
T ss_pred             cEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhcc--
Confidence            89999998  58899999875     4688999999999877665555 4556778899999999 567777766543  


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeC---CCCcEEEeeecCccccccccCC----cccccccc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLD---KNLRAKLANFSFVRSAVREESG----YSSTKTAV  483 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgla~~~~~~~~~----~~~~~~~~  483 (611)
                      ..+++..++.++.|++.||+|||   +.+|+||||||+|||++   .+..+||+|||+|+........    ........
T Consensus        98 ~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~  174 (299)
T d1ckia_          98 RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT  174 (299)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCC
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcC
Confidence            34899999999999999999999   68999999999999985   4567999999999876443221    12334567


Q ss_pred             cCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHH--HHHHHHHhcCCcccccccccCccCCcCh
Q 007261          484 GTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLA--EAVFSMVEGGNAEAKLSVLVDPNLQANK  561 (611)
Q Consensus       484 gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~--~~~~~~~~~~~~~~~l~~~~d~~l~~~~  561 (611)
                      ||+.|+|||.+.+..++.++||||||+++|||++|+.||...........  ........             .......
T Consensus       175 gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~  241 (299)
T d1ckia_         175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-------------TPIEVLC  241 (299)
T ss_dssp             CCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-------------SCHHHHT
T ss_pred             CCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-------------CChhHhc
Confidence            99999999999999999999999999999999999999976544321111  11000000             0000001


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          562 KEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      ..++.++.+++.+||+.||++||++.++.+.|+++..
T Consensus       242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            2345678999999999999999999999988887643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-38  Score=326.86  Aligned_cols=245  Identities=19%  Similarity=0.270  Sum_probs=180.9

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceecc--------CCeEEEEEeecCCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEH--------DGVFYLVYEFMENGS  399 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~--------~~~~~lV~E~~~~gs  399 (611)
                      |.||+|+.  +|+.||||+++         .++.+|+.+|++++||||+++++.+..        ++..++||||++++.
T Consensus        24 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~  103 (318)
T d3blha1          24 GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL  103 (318)
T ss_dssp             SEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEH
T ss_pred             eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCc
Confidence            89999998  68999999974         357899999999999999999998854        346899999998776


Q ss_pred             HHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccC-Cccc
Q 007261          400 LSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREES-GYSS  478 (611)
Q Consensus       400 L~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~  478 (611)
                      +..+....   ..++......++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus       104 ~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~  177 (318)
T d3blha1         104 AGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR  177 (318)
T ss_dssp             HHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCC
T ss_pred             cchhhhcc---cccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceeeeccccccccccc
Confidence            66554433   34888889999999999999999   68999999999999999999999999999976543221 1122


Q ss_pred             ccccccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccccccc------
Q 007261          479 TKTAVGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSV------  551 (611)
Q Consensus       479 ~~~~~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~------  551 (611)
                      .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+  ....+......... .....      
T Consensus       178 ~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~-~~~~~~~~~~~  254 (318)
T d3blha1         178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--QLALISQLCGSITP-EVWPNVDNYEL  254 (318)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCT-TTSTTCCCC--
T ss_pred             ccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH--HHHHHHHhcCCCCh-hhccccchhhh
Confidence            3345799999999998765 68999999999999999999999987554322  11222222211110 00000      


Q ss_pred             --ccC-c-cCCcCh-H-----HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          552 --LVD-P-NLQANK-K-----EIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       552 --~~d-~-~l~~~~-~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        ... . ...... .     .....+.+|+.+||+.||++|||++|++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         255 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             -----CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence              000 0 000111 1     123567889999999999999999999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-39  Score=332.57  Aligned_cols=243  Identities=25%  Similarity=0.383  Sum_probs=185.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCC------eEEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDG------VFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV~E~~~~gsL~  401 (611)
                      |.||+|..  +|+.||||+++         +.+.+|+.+|++++|||||+++++|...+      ..|+||||+ +.+|.
T Consensus        32 g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~  110 (346)
T d1cm8a_          32 GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLG  110 (346)
T ss_dssp             -CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHH
T ss_pred             eEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHH
Confidence            99999998  69999999985         25778999999999999999999997654      579999999 67888


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      .+.+..+    +++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||+++....      ....
T Consensus       111 ~~~~~~~----l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~------~~~~  177 (346)
T d1cm8a_         111 KLMKHEK----LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS------EMTG  177 (346)
T ss_dssp             HHHHHCC----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS------SCCS
T ss_pred             HHHHhcc----ccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccCC------cccc
Confidence            8876543    899999999999999999999   68999999999999999999999999999986532      2344


Q ss_pred             cccCCCccchhhhcc-CCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCc--------------c
Q 007261          482 AVGTNGYMAPEYMEY-GLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNA--------------E  546 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~-~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--------------~  546 (611)
                      ..+|+.|+|||.+.+ ..++.++||||+||+++||++|+.||......+. +.. ..........              .
T Consensus       178 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  255 (346)
T d1cm8a_         178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKE-IMKVTGTPPAEFVQRLQSDEAKNYM  255 (346)
T ss_dssp             SCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH-HHHHHCCCCHHHHHTCSCHHHHHHH
T ss_pred             ccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HHH-HHhccCCCcHHHHhhhcchhhhhhh
Confidence            678999999999876 4578999999999999999999999876543321 111 1111100000              0


Q ss_pred             cccccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhch
Q 007261          547 AKLSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST--LMKIQ  597 (611)
Q Consensus       547 ~~l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~i~  597 (611)
                      ..+.......+.......+..+.+|+.+||+.||++|||+.|++++  ++.+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             ccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            0000001111111122345668899999999999999999999986  54443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.8e-38  Score=320.45  Aligned_cols=242  Identities=17%  Similarity=0.139  Sum_probs=192.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec-----HHHHHHHHHHHhcCC-CceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR-----RSISKEVNLLKKINH-FNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      |.||+|+.  +|+.||||++.     ..+.+|++.++.++| +|++.+++++..+...++||||+ +++|.+++....  
T Consensus        19 G~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~--   95 (293)
T d1csna_          19 GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG--   95 (293)
T ss_dssp             CEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--
T ss_pred             eEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhc--
Confidence            89999997  68999999984     357899999999965 89999999999999999999999 689999987654  


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCC-----CCcEEEeeecCccccccccCC----cccccc
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDK-----NLRAKLANFSFVRSAVREESG----YSSTKT  481 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~Dfgla~~~~~~~~~----~~~~~~  481 (611)
                      ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.     ++.+||+|||+++........    ......
T Consensus        96 ~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~  172 (293)
T d1csna_          96 RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN  172 (293)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCC
T ss_pred             cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCc
Confidence            34899999999999999999999   799999999999999974     578999999999875433221    123345


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhh-HHHHHHHHHHhcCCcccccccccCccCCcC
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEI-LLAEAVFSMVEGGNAEAKLSVLVDPNLQAN  560 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~l~~~~d~~l~~~  560 (611)
                      ..||+.|||||.+.+..++.++||||||+++|||++|+.||........ .....+........    ..        ..
T Consensus       173 ~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~----~~--------~l  240 (293)
T d1csna_         173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP----LR--------EL  240 (293)
T ss_dssp             CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC----HH--------HH
T ss_pred             eEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC----hH--------Hh
Confidence            6799999999999999999999999999999999999999976543321 11111111111000    00        00


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhchh
Q 007261          561 KKEIAHHLIMLCLACIAREPESRPSMAEVVSTLMKIQL  598 (611)
Q Consensus       561 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~i~~  598 (611)
                      ...+++++.+++..|+..+|++||+++.+.+.|+++..
T Consensus       241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence            12245678999999999999999999999888887654

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-38  Score=321.14  Aligned_cols=244  Identities=21%  Similarity=0.288  Sum_probs=190.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEEeecCCCCHHHHhhcc
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKK  407 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  407 (611)
                      |.||+|+.  +|+.||||+++         ..+.+|+.+|+.++||||+++++++.+....++|+|++.+++|..++...
T Consensus        16 g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~   95 (292)
T d1unla_          16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN   95 (292)
T ss_dssp             SEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTT
T ss_pred             eEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccc
Confidence            89999998  78899999984         45789999999999999999999999999999999999999998888765


Q ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccccccCCC
Q 007261          408 RYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTAVGTNG  487 (611)
Q Consensus       408 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  487 (611)
                      +   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.++......   .......++..
T Consensus        96 ~---~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~---~~~~~~~~~~~  166 (292)
T d1unla_          96 G---DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSAEVVTLW  166 (292)
T ss_dssp             T---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC---SCCCSCCSCGG
T ss_pred             c---ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCC---ccceeeccccc
Confidence            3   4889999999999999999999   6899999999999999999999999999998664332   23334567888


Q ss_pred             ccchhhhccCC-CCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcc--ccccccc----------C
Q 007261          488 YMAPEYMEYGL-VTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAE--AKLSVLV----------D  554 (611)
Q Consensus       488 y~aPE~~~~~~-~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--~~l~~~~----------d  554 (611)
                      |+|||.+.... ++.++|||||||++|||++|+.||+........+. .+..........  .......          .
T Consensus       167 ~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (292)
T d1unla_         167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT  245 (292)
T ss_dssp             GCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH-HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTT
T ss_pred             hhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHH-HHHhhcCCCChhhhhhhhhccccccccccccc
Confidence            99999987655 68999999999999999999999876554432222 222222111100  0000000          0


Q ss_pred             ccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 PNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ..........+..+.+|+.+||+.||.+|||++|++++
T Consensus       246 ~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         246 TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             chhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            01111133455678899999999999999999999864

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.6e-38  Score=323.62  Aligned_cols=241  Identities=17%  Similarity=0.298  Sum_probs=182.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec----HHHHHHHHHHHhcC-CCceeeccceecc--CCeEEEEEeecCCCCHHHHhhccCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR----RSISKEVNLLKKIN-HFNLINLFGACEH--DGVFYLVYEFMENGSLSDWLHKKRY  409 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~----~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~  409 (611)
                      |.||+|+.  +|+.||||+++    +++.+|+.+|++++ ||||+++++++..  ....++||||+++++|..+.+    
T Consensus        49 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~----  124 (328)
T d3bqca1          49 SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----  124 (328)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTT----
T ss_pred             eEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhc----
Confidence            89999998  68999999986    56889999999995 9999999999864  456899999999999876542    


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeecCccccccccCCcccccccccCCCc
Q 007261          410 PEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL-RAKLANFSFVRSAVREESGYSSTKTAVGTNGY  488 (611)
Q Consensus       410 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  488 (611)
                        .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+++......    ......+|+.|
T Consensus       125 --~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~----~~~~~~~t~~y  195 (328)
T d3bqca1         125 --TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASRYF  195 (328)
T ss_dssp             --SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC----CCCSCCSCGGG
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC----cccccccCccc
Confidence              3889999999999999999999   68999999999999998654 69999999998654332    23446789999


Q ss_pred             cchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHH--------HHHHhcCCc--ccccccccC---
Q 007261          489 MAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAV--------FSMVEGGNA--EAKLSVLVD---  554 (611)
Q Consensus       489 ~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~--------~~~~~~~~~--~~~l~~~~d---  554 (611)
                      +|||.+.+. .++.++||||+|++++||++|+.||..............        .........  .........   
T Consensus       196 ~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (328)
T d3bqca1         196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHS  275 (328)
T ss_dssp             CCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCC
T ss_pred             cCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhccccc
Confidence            999998765 479999999999999999999999976654321111100        001110000  000000000   


Q ss_pred             -----ccCC-cChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 -----PNLQ-ANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 -----~~l~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                           .... ......+.++.+|+.+||+.||++|||++|++++
T Consensus       276 ~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         276 RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 0001 1123456678999999999999999999999863

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-38  Score=324.82  Aligned_cols=231  Identities=23%  Similarity=0.322  Sum_probs=184.5

Q ss_pred             ceEEEEEE-----cCcEEEEEEec-----------HHHHHHHHHHHhcCC-CceeeccceeccCCeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII-----NGSTVAIKCMR-----------RSISKEVNLLKKINH-FNLINLFGACEHDGVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~-----~g~~vavK~~~-----------~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~  401 (611)
                      |.||++..     +|+.||||+++           +.+.+|+++|++++| |||+++++++.+....++||||+.+|+|.
T Consensus        38 g~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~  117 (322)
T d1vzoa_          38 GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF  117 (322)
T ss_dssp             EEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred             eEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHH
Confidence            89999986     47899999874           246789999999966 89999999999999999999999999999


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +++...+.   ++......++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  .....
T Consensus       118 ~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~--~~~~~  189 (322)
T d1vzoa_         118 THLSQRER---FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET--ERAYD  189 (322)
T ss_dssp             HHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG--GGGCG
T ss_pred             HHHHhccc---ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhhccccc--ccccc
Confidence            99987643   677888899999999999999   68999999999999999999999999999976543322  22344


Q ss_pred             cccCCCccchhhhccC--CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCcccccccccCccCCc
Q 007261          482 AVGTNGYMAPEYMEYG--LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEAKLSVLVDPNLQA  559 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~--~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~~~d~~l~~  559 (611)
                      ..|++.|++||.+.+.  .++.++|||||||+||||++|+.||......+... .........           .   ..
T Consensus       190 ~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~-~i~~~~~~~-----------~---~~  254 (322)
T d1vzoa_         190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA-EISRRILKS-----------E---PP  254 (322)
T ss_dssp             GGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH-HHHHHHHHC-----------C---CC
T ss_pred             cccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhcccC-----------C---CC
Confidence            6789999999998754  47889999999999999999999997654433211 111111110           0   01


Q ss_pred             ChHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 007261          560 NKKEIAHHLIMLCLACIAREPESRPS-----MAEVVST  592 (611)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~  592 (611)
                      .+...+.++.+|+.+||+.||++|||     ++|++++
T Consensus       255 ~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            12345678899999999999999995     7888763

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-37  Score=321.89  Aligned_cols=240  Identities=22%  Similarity=0.253  Sum_probs=176.8

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceecc------CCeEEEEEeecCCCCHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEH------DGVFYLVYEFMENGSLS  401 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~~lV~E~~~~gsL~  401 (611)
                      |.||+|..  +|+.||||+++         .++.+|+.+|++++|||||+++++|..      ....|+||||+.++ |.
T Consensus        31 g~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~  109 (355)
T d2b1pa1          31 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LC  109 (355)
T ss_dssp             CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HH
T ss_pred             eEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchH-HH
Confidence            89999998  58999999985         247789999999999999999999853      46899999999755 44


Q ss_pred             HHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCcccccc
Q 007261          402 DWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKT  481 (611)
Q Consensus       402 ~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  481 (611)
                      +.+..     .+++..+..++.||+.||+|||   ..+|+||||||+|||++.++.+|++|||+++.....    .....
T Consensus       110 ~~~~~-----~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~----~~~~~  177 (355)
T d2b1pa1         110 QVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTP  177 (355)
T ss_dssp             HHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----------------
T ss_pred             Hhhhc-----CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhccccc----ccccc
Confidence            55532     2889999999999999999999   689999999999999999999999999998765432    23345


Q ss_pred             cccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHH------------------HHHHhcC
Q 007261          482 AVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAV------------------FSMVEGG  543 (611)
Q Consensus       482 ~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~------------------~~~~~~~  543 (611)
                      ..+|+.|+|||.+.+..+++++||||+||+++||++|+.||...+... ......                  .......
T Consensus       178 ~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (355)
T d2b1pa1         178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKKLQPTVRNYVENR  256 (355)
T ss_dssp             ---CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTS
T ss_pred             ccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhccCCCHHHHHHhhhhHHHHhhcC
Confidence            578999999999999999999999999999999999999987554322 111111                  1111110


Q ss_pred             Ccc--cc----cccccCccCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          544 NAE--AK----LSVLVDPNLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       544 ~~~--~~----l~~~~d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                      ...  ..    ......+.........+..+.+|+.+||+.||++|||++|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000  00    00011111111244567889999999999999999999999975

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-37  Score=317.46  Aligned_cols=239  Identities=19%  Similarity=0.289  Sum_probs=178.4

Q ss_pred             ceEEEEEE--cCcEEEEEEec---------HHHHHHHHHHHhcCCCceeeccceecc-----CCeEEEEEeecCCCCHHH
Q 007261          339 GSVFRGII--NGSTVAIKCMR---------RSISKEVNLLKKINHFNLINLFGACEH-----DGVFYLVYEFMENGSLSD  402 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~lV~E~~~~gsL~~  402 (611)
                      |.||+|..  +|+.||||+++         +.+.+|+.+|++++|||||++++++..     +...++++||+.+|+|.+
T Consensus        32 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~  111 (348)
T d2gfsa1          32 GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN  111 (348)
T ss_dssp             SSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHH
T ss_pred             eEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhh
Confidence            89999987  69999999985         257789999999999999999999853     234466778888999999


Q ss_pred             HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccccCCccccccc
Q 007261          403 WLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVREESGYSSTKTA  482 (611)
Q Consensus       403 ~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  482 (611)
                      ++...+    +++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||++.....      .....
T Consensus       112 ~~~~~~----l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~------~~~~~  178 (348)
T d2gfsa1         112 IVKCQK----LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD------EMTGY  178 (348)
T ss_dssp             HHTTCC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCTG------GGSSS
T ss_pred             hccccc----ccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccCc------ccccc
Confidence            997543    899999999999999999999   68999999999999999999999999999875432      23446


Q ss_pred             ccCCCccchhhhccC-CCCCccchHHHHHHHHHHHhCCCCCcCCCChhhHHHHHHHHHHhcCCccc-------ccccccC
Q 007261          483 VGTNGYMAPEYMEYG-LVTPEMDTYAFGVVLLELITGKEAAYKQDGEEILLAEAVFSMVEGGNAEA-------KLSVLVD  554 (611)
Q Consensus       483 ~gt~~y~aPE~~~~~-~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~-------~l~~~~d  554 (611)
                      .|+..|+|||.+.+. .++.++|||||||++|||++|+.||...+...  ....+.........+.       .......
T Consensus       179 ~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  256 (348)
T d2gfsa1         179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAELLKKISSESARNYIQ  256 (348)
T ss_dssp             CHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCHHHHTTCCCHHHHHHHT
T ss_pred             cccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCChHHhhhccchhhhhhhh
Confidence            789999999987665 46899999999999999999999987654322  1111111111110000       0000000


Q ss_pred             --ccCCcC-----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          555 --PNLQAN-----KKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       555 --~~l~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                        +.....     ....+..+.+|+.+||+.||++|||+.|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             TSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence              000000     11245678899999999999999999999984

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.98  E-value=5e-33  Score=290.17  Aligned_cols=245  Identities=20%  Similarity=0.238  Sum_probs=176.3

Q ss_pred             ceEEEEEE--cCcEEEEEEec------HHHHHHHHHHHhcC-----------CCceeeccceecc--CCeEEEEEeecCC
Q 007261          339 GSVFRGII--NGSTVAIKCMR------RSISKEVNLLKKIN-----------HFNLINLFGACEH--DGVFYLVYEFMEN  397 (611)
Q Consensus       339 g~Vy~g~~--~g~~vavK~~~------~~~~~E~~~l~~l~-----------H~niv~l~g~~~~--~~~~~lV~E~~~~  397 (611)
                      |.||+|+.  +|+.||||+++      +.+.+|+.++++++           |+||+++++++..  ....+++++++..
T Consensus        27 g~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~  106 (362)
T d1q8ya_          27 STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL  106 (362)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC
T ss_pred             eEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccc
Confidence            89999997  79999999986      34678999998885           5789999998854  3566777777766


Q ss_pred             CCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCC------cEEEeeecCcccccc
Q 007261          398 GSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNL------RAKLANFSFVRSAVR  471 (611)
Q Consensus       398 gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~------~~kl~Dfgla~~~~~  471 (611)
                      +..............+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++      .+|++|||.+.....
T Consensus       107 ~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~  184 (362)
T d1q8ya_         107 GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE  184 (362)
T ss_dssp             CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB
T ss_pred             ccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccceeeEeeccccccccc
Confidence            5544444333334558889999999999999999995  47899999999999998665      399999999875432


Q ss_pred             ccCCcccccccccCCCccchhhhccCCCCCccchHHHHHHHHHHHhCCCCCcCCCChh-----hHHHHHHHHHHhcCCc-
Q 007261          472 EESGYSSTKTAVGTNGYMAPEYMEYGLVTPEMDTYAFGVVLLELITGKEAAYKQDGEE-----ILLAEAVFSMVEGGNA-  545 (611)
Q Consensus       472 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~s~Gvvl~elltG~~p~~~~~~~~-----~~l~~~~~~~~~~~~~-  545 (611)
                            ......||+.|+|||.+.+..++.++||||+||+++||++|+.||.......     ..+...+ ..+..... 
T Consensus       185 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~-~~lg~~~~~  257 (362)
T d1q8ya_         185 ------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII-ELLGELPSY  257 (362)
T ss_dssp             ------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH-HHHCSCCHH
T ss_pred             ------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH-HHhCCCCHH
Confidence                  2245679999999999999999999999999999999999999987543321     1111111 11100000 


Q ss_pred             --------c------cccccccCc----------cCCcChHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 007261          546 --------E------AKLSVLVDP----------NLQANKKEIAHHLIMLCLACIAREPESRPSMAEVVST  592 (611)
Q Consensus       546 --------~------~~l~~~~d~----------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  592 (611)
                              .      .........          .........+.++.+|+.+||+.||.+|||++|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         258 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             HHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                    0      000000000          0111245677889999999999999999999999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.77  E-value=7e-20  Score=172.16  Aligned_cols=145  Identities=17%  Similarity=0.156  Sum_probs=106.6

Q ss_pred             ceEEEEEE-cCcEEEEEEec-------------------------HHHHHHHHHHHhcCCCceeeccceeccCCeEEEEE
Q 007261          339 GSVFRGII-NGSTVAIKCMR-------------------------RSISKEVNLLKKINHFNLINLFGACEHDGVFYLVY  392 (611)
Q Consensus       339 g~Vy~g~~-~g~~vavK~~~-------------------------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  392 (611)
                      |.||+|.. +|+.||||+++                         ....+|...+.++.|.+++..+++..    .+++|
T Consensus        14 g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvm   89 (191)
T d1zara2          14 SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG----NAVLM   89 (191)
T ss_dssp             EEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET----TEEEE
T ss_pred             eEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC----CEEEE
Confidence            89999987 78999999864                         12345888999999999988876543    27999


Q ss_pred             eecCCCCHHHHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeeeCCCCcEEEeeecCccccccc
Q 007261          393 EFMENGSLSDWLHKKRYPEFVSWNCRFRIALDVAHGLHYLHNCTDPGYVHKDISSGNILLDKNLRAKLANFSFVRSAVRE  472 (611)
Q Consensus       393 E~~~~gsL~~~l~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~  472 (611)
                      ||+++..+.+          ++......++.|++.+|+|||   ..+|+||||||+|||++++ .++|+|||+|+.....
T Consensus        90 e~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~  155 (191)
T d1zara2          90 ELIDAKELYR----------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEE  155 (191)
T ss_dssp             ECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCCTTCEETTST
T ss_pred             Eeeccccccc----------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEECCCcccCCCC
Confidence            9998765422          333445678999999999999   6899999999999999965 4899999998754322


Q ss_pred             cCCcccccccccCCCccc------hhhhccCCCCCccchHHHHHHHH
Q 007261          473 ESGYSSTKTAVGTNGYMA------PEYMEYGLVTPEMDTYAFGVVLL  513 (611)
Q Consensus       473 ~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~ksDV~s~Gvvl~  513 (611)
                      ...           .|..      .|.+ ...|+.++|+||..--++
T Consensus       156 ~~~-----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         156 GWR-----------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             THH-----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred             CcH-----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence            110           0111      1112 356788999999865443

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=99.43  E-value=3.6e-14  Score=99.04  Aligned_cols=46  Identities=33%  Similarity=0.412  Sum_probs=42.4

Q ss_pred             EEEEccCCCChhHHHhHhcCCHHHHHHhcCCCCCCCCcccceeeeecCC
Q 007261          173 LTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPLT  221 (611)
Q Consensus       173 ~~y~v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~~~~~i~~g~~l~ip~~  221 (611)
                      ++|+|++|||||+||++||+++++|++||++. +  .|+|||.|.||.+
T Consensus         3 v~y~V~~GDTl~~IA~~y~vs~~~i~~~N~l~-~--~l~~Gq~L~i~vk   48 (48)
T d1e0ga_           3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDT-A--NLQPGDKLTLFVK   48 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHTCCHHHHHHHCSCG-G--GCCTTEEEECCCC
T ss_pred             EEEEECCCCCHHHHHHHHCCCHHHHHHHcCCc-c--cCcCCCEEEEEeC
Confidence            57999999999999999999999999999984 2  5999999999964

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=99.42  E-value=2.5e-14  Score=100.39  Aligned_cols=46  Identities=33%  Similarity=0.430  Sum_probs=42.9

Q ss_pred             EEEEccCCCChhHHHhHhcCCHHHHHHhcCCCCCCCCcccceeeeecC
Q 007261          173 LTYLVSWGDSVPDISKRFNVSIESIVNANGFTEDDPLLFPFTTILIPL  220 (611)
Q Consensus       173 ~~y~v~~gdtl~~Ia~~f~~~~~~l~~~N~~~~~~~~i~~g~~l~ip~  220 (611)
                      ++|+|++|||||+||++||+++++|++||++. + +.|++||.|.||.
T Consensus         2 i~y~V~~GDTL~~IA~~y~v~~~~i~~~N~~~-~-~~l~~Gq~L~IPg   47 (48)
T d1y7ma2           2 LTYQVKQGDTLNSIAADFRISTAALLQANPSL-Q-AGLTAGQSIVIPG   47 (48)
T ss_dssp             EEEECCTTCCHHHHHHHTTSCCCCCCCTSCTT-C-SSCCTTCEEEETT
T ss_pred             EEEEECCCCCHHHHHHHhCCCHHHHHHHcCCC-C-CCCCCCCEEEeCC
Confidence            68999999999999999999999999999995 4 5699999999995

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=99.04  E-value=5.1e-11  Score=82.81  Aligned_cols=46  Identities=15%  Similarity=0.126  Sum_probs=40.7

Q ss_pred             eeEEEeecCCchhhhhHhhcCCCccHHHHHHhcCCCCCCCCCCceeeeecc
Q 007261          106 TSFIIPTIYHTYFSIANNTYQGLSTCNILKHENNYSETSLDQGLTLRVPLR  156 (611)
Q Consensus       106 ~~y~V~~~gdTl~~IA~~~~~~l~t~~~l~~~N~~~~~~l~~G~~l~ip~~  156 (611)
                      .+|+|++ |||||.||++|.   +++++|+++|++. +.|++||+|.||++
T Consensus         3 v~y~V~~-GDTl~~IA~~y~---vs~~~i~~~N~l~-~~l~~Gq~L~i~vk   48 (48)
T d1e0ga_           3 ITYRVRK-GDSLSSIAKRHG---VNIKDVMRWNSDT-ANLQPGDKLTLFVK   48 (48)
T ss_dssp             CEEEECT-TCCHHHHHHHHT---CCHHHHHHHCSCG-GGCCTTEEEECCCC
T ss_pred             EEEEECC-CCCHHHHHHHHC---CCHHHHHHHcCCc-ccCcCCCEEEEEeC
Confidence            5799999 999999997665   8889999999986 46999999999973

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=99.02  E-value=7.4e-11  Score=82.33  Aligned_cols=45  Identities=22%  Similarity=0.333  Sum_probs=41.9

Q ss_pred             eeeecCCCCCCHHHHHHhhCCChHhhhhhhCCCCCCCCCCCCCeEEEe
Q 007261           45 LIFKSQPPYDTVSSISNLTSSDPTELARVNNISNSAAALPLDKEVIVP   92 (611)
Q Consensus        45 ~~y~~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~l~~gq~l~vP   92 (611)
                      +.|++++ ||||++||++||+++++|+++|++.+  +.|.+||.|.||
T Consensus         2 i~y~V~~-GDTL~~IA~~y~v~~~~i~~~N~~~~--~~l~~Gq~L~IP   46 (48)
T d1y7ma2           2 LTYQVKQ-GDTLNSIAADFRISTAALLQANPSLQ--AGLTAGQSIVIP   46 (48)
T ss_dssp             EEEECCT-TCCHHHHHHHTTSCCCCCCCTSCTTC--SSCCTTCEEEET
T ss_pred             EEEEECC-CCCHHHHHHHhCCCHHHHHHHcCCCC--CCCCCCCEEEeC
Confidence            5799987 99999999999999999999999977  469999999999

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.08  E-value=5e-06  Score=79.60  Aligned_cols=121  Identities=13%  Similarity=0.184  Sum_probs=86.5

Q ss_pred             ceEEEEEEcCcEEEEEEecH-------HHHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCHHHHhhccCCC
Q 007261          339 GSVFRGIINGSTVAIKCMRR-------SISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSLSDWLHKKRYP  410 (611)
Q Consensus       339 g~Vy~g~~~g~~vavK~~~~-------~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  410 (611)
                      ..||+...++..+.||+...       ++.+|...+..+. +--+.+++.++.+++..++||+++++..+.+.....   
T Consensus        28 ~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~---  104 (263)
T d1j7la_          28 AKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE---  104 (263)
T ss_dssp             SEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC---
T ss_pred             CcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc---
Confidence            47999887888889998753       4778999988873 433566777888888999999999998876554321   


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------------------
Q 007261          411 EFVSWNCRFRIALDVAHGLHYLHNCT------------------------------------------------------  436 (611)
Q Consensus       411 ~~l~~~~~~~ia~~ia~gL~yLH~~~------------------------------------------------------  436 (611)
                        ..   ...++.++++.+..||+..                                                      
T Consensus       105 --~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  179 (263)
T d1j7la_         105 --QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP  179 (263)
T ss_dssp             --SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCC
T ss_pred             --cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCC
Confidence              11   1223445555555555311                                                      


Q ss_pred             --CCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          437 --DPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       437 --~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                        ...++|+|+.+.|||++++...-|+||+.+.
T Consensus       180 ~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         180 EEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence              1237899999999999987777799999765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.66  E-value=2.4e-05  Score=74.21  Aligned_cols=62  Identities=15%  Similarity=0.157  Sum_probs=47.1

Q ss_pred             ceEEEEEEc-CcEEEEEEec----HHHHHHHHHHHhcCC--CceeeccceeccCCeEEEEEeecCCCCH
Q 007261          339 GSVFRGIIN-GSTVAIKCMR----RSISKEVNLLKKINH--FNLINLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       339 g~Vy~g~~~-g~~vavK~~~----~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      ..||+...+ |..+.+|..+    .++..|...++.+..  -.+.++++++.+++..++||||++|.++
T Consensus        25 ~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          25 AAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             CeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            568988874 5568889875    357889999988843  3356677777888889999999987654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.39  E-value=0.0041  Score=62.56  Aligned_cols=31  Identities=19%  Similarity=0.361  Sum_probs=26.2

Q ss_pred             CCeEecCCCCCCeeeCCCCcEEEeeecCcccc
Q 007261          438 PGYVHKDISSGNILLDKNLRAKLANFSFVRSA  469 (611)
Q Consensus       438 ~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~  469 (611)
                      ..++|+|+++.|||++++. ++|+||.++...
T Consensus       223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G  253 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFYG  253 (392)
T ss_dssp             CEEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred             cceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence            4699999999999998765 899999887543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.17  E-value=0.013  Score=56.96  Aligned_cols=127  Identities=14%  Similarity=0.227  Sum_probs=73.1

Q ss_pred             eEEEEEE-cCcEEEEEEec------HHHHHHHHHHHhcCCCce-----eeccc--eeccCCeEEEEEeecCCCCHH----
Q 007261          340 SVFRGII-NGSTVAIKCMR------RSISKEVNLLKKINHFNL-----INLFG--ACEHDGVFYLVYEFMENGSLS----  401 (611)
Q Consensus       340 ~Vy~g~~-~g~~vavK~~~------~~~~~E~~~l~~l~H~ni-----v~l~g--~~~~~~~~~lV~E~~~~gsL~----  401 (611)
                      .||+... +|..+++|+.+      .++..|...+..|...++     +..-|  .+..++..+.++++++|..+.    
T Consensus        37 ~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~  116 (325)
T d1zyla1          37 RVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNI  116 (325)
T ss_dssp             EEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCH
T ss_pred             eeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCH
Confidence            6999987 78889999975      457789999988842222     12211  224456788999999763321    


Q ss_pred             -HH---------hhc----cC--CCCccCHH----------------------HHHHHHHHHHHHHHHH-hcCCCCCeEe
Q 007261          402 -DW---------LHK----KR--YPEFVSWN----------------------CRFRIALDVAHGLHYL-HNCTDPGYVH  442 (611)
Q Consensus       402 -~~---------l~~----~~--~~~~l~~~----------------------~~~~ia~~ia~gL~yL-H~~~~~~ivH  442 (611)
                       .+         ++.    ..  ....+++.                      .....+.++...+.-+ ......+++|
T Consensus       117 ~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liH  196 (325)
T d1zyla1         117 DQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLH  196 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECC
T ss_pred             HHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeec
Confidence             11         111    00  01111211                      1112222333332222 1122457899


Q ss_pred             cCCCCCCeeeCCCCcEEEeeecCccc
Q 007261          443 KDISSGNILLDKNLRAKLANFSFVRS  468 (611)
Q Consensus       443 ~Dlk~~NILl~~~~~~kl~Dfgla~~  468 (611)
                      +|+.+.|||++++  ..++||+.+..
T Consensus       197 gDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         197 GDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             SSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CCCCcccEEEeCC--ceEEechhccc
Confidence            9999999999754  45899997653

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.08  E-value=0.13  Score=49.09  Aligned_cols=31  Identities=23%  Similarity=0.401  Sum_probs=27.7

Q ss_pred             CCCeEecCCCCCCeeeCCCCcEEEeeecCcc
Q 007261          437 DPGYVHKDISSGNILLDKNLRAKLANFSFVR  467 (611)
Q Consensus       437 ~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~  467 (611)
                      ..+++|+|+.+.||+++++...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4679999999999999998878899999864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=93.81  E-value=0.062  Score=53.44  Aligned_cols=57  Identities=12%  Similarity=0.167  Sum_probs=36.9

Q ss_pred             eEEEEEEc---------CcEEEEEEec-----HHHHHHHHHHHhcC-CCceeeccceeccCCeEEEEEeecCCCCH
Q 007261          340 SVFRGIIN---------GSTVAIKCMR-----RSISKEVNLLKKIN-HFNLINLFGACEHDGVFYLVYEFMENGSL  400 (611)
Q Consensus       340 ~Vy~g~~~---------g~~vavK~~~-----~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL  400 (611)
                      .+|+....         ...|.+++.-     -+..+|..+++.+. +.-..++++++.+    .+|+||+++..|
T Consensus        57 ~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          57 MLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             ceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            46766552         2456666642     34668999999884 4333467777754    589999987443

>d1ijwc_ a.4.1.2 (C:) HIN recombinase (DNA-binding domain) {Synthetic}

class: All alpha proteins
fold: DNA/RNA-binding 3-helical bundle
superfamily: Homeodomain-like
family: Recombinase DNA-binding domain
domain: HIN recombinase (DNA-binding domain)
species: Synthetic

Probab=82.76  E-value=0.35  Score=31.86  Aligned_cols=24  Identities=8%  Similarity=0.273  Sum_probs=22.0

Q ss_pred             ccCCCChhHHHhHhcCCHHHHHHh
Q 007261          177 VSWGDSVPDISKRFNVSIESIVNA  200 (611)
Q Consensus       177 v~~gdtl~~Ia~~f~~~~~~l~~~  200 (611)
                      +..|.+..+||+.||||...|.++
T Consensus        18 ~~~G~s~~~iA~~~gVSr~TiYry   41 (47)
T d1ijwc_          18 LEKGHPRQQLAIIFGIGVSTLYRY   41 (47)
T ss_dssp             HHTTCCHHHHHHHHTCCHHHHHHH
T ss_pred             HHCCCCHHHHHHHHCcCHHHHHhh
Confidence            567999999999999999999886